PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mizuhashi, K; Chaya, T; Kanamoto, T; Omori, Y; Furukawa, T				Mizuhashi, Koji; Chaya, Taro; Kanamoto, Takashi; Omori, Yoshihiro; Furukawa, Takahisa			Obif, a Transmembrane Protein, Is Required for Bone Mineralization and Spermatogenesis in Mice	PLOS ONE			English	Article							OSTEOBLAST INDUCTION FACTOR; CELL-INTERACTIONS; MALE-INFERTILITY; DIFFERENTIATION; GLYCOSYLATION; EXPRESSION; TESTIS; GLYCANS; LENGTH; WNT	Background Various kinds of transmembrane and secreted proteins play pivotal roles in development through cell-cell communication. We previously reported that Obif (Osteoblast induction factor, Tmem119), encoding a single transmembrane protein, is expressed in differentiating osteoblasts, and that Obif(-/-) mice exhibit significantly reduced bone volume in the femur. In the current study, we characterized the Obif protein and further investigated the biological phenotypes of a variety of tissues in Obif(-/-) mice. Results First, we found that O-glycosylation of the Obif protein occurs at serine residue 36 in the Obif extracellular domain. Next, we observed that Obif(-/-) mice exhibit bone dysplasia in association with significantly increased osteoid volume per osteoid surface (OV/OS) and osteoid maturation time (Omt), and significantly decreased mineral apposition rate (MAR) and bone formation rate per bone surface (BFR/BS). In addition, we observed that Obif(-/-) mice show a significant decrease in testis weight as well as in sperm number. By histological analysis, we found that Obif is expressed in spermatocytes and spermatids in the developing testis and that spermatogenesis is halted at the round spermatid stage in the Obif(-/-) testis that lacks sperm. However, the number of litters fathered by male mice was slightly reduced in Obif(-/-) mice compared with wild-type mice, although this was not statistically significant. Conclusions Our results, taken together with previous observations, indicate that Obif is a type Ia transmembrane protein whose N-terminal region is O-glycosylated. In addition, we found that Obif is required for normal bone mineralization and late testicular differentiation in vivo. These findings suggest that Obif plays essential roles in the development of multiple tissues.	[Mizuhashi, Koji; Chaya, Taro; Omori, Yoshihiro; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan; [Mizuhashi, Koji; Chaya, Taro; Kanamoto, Takashi; Omori, Yoshihiro; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Suita, Osaka, Japan; [Kanamoto, Takashi] Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Suita, Osaka, Japan; [Chaya, Taro; Omori, Yoshihiro; Furukawa, Takahisa] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Suita, Osaka, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Furukawa, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 565, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp			PRESTO from Japan Science and Technology Agency [4118]; Japan Society for the Promotion of Science [25113519, 23113728, 15H04669, 25293070, 15K18955]; Takeda Science Foundation; Uehara Memorial Foundation; Suzuken Memorial Foundation; Naito Foundation [220]; Hyogo Science and Technology Association; Osaka Community Foundation; Grants-in-Aid for Scientific Research [15K18955] Funding Source: KAKEN	PRESTO from Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Hyogo Science and Technology Association; Osaka Community Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by PRESTO (#4118 for YO) from Japan Science and Technology Agency (http://www.jst.go.jp/), Grants-in-Aid for Scientific Research on Innovative Areas (#25113519, #23113728 for YO), Grant-in-Aid for Scientific Research (B) (#15H04669 for TF, #25293070 for YO), Grant-in-Aid for Young Scientists (B) (#15K18955 for TC) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/), The Takeda Science Foundation (for TF and YO) (http://www.takeda-sci.or.jp/), The Uehara Memorial Foundation (for YO and TC) (http://www.ueharazaidan.or.jp/), Suzuken Memorial Foundation (for YO) (http://www.suzukenzaidan.or.jp/), Naito Foundation (#220 for YO) (https://www.naito-f.or.jp/), Hyogo Science and Technology Association (for TF) (http://www.hyogosta.jp/), The Osaka Community Foundation (for TF) (http://www.osaka-community.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022; Budefeld T, 2009, ANAT HISTOL EMBRYOL, V38, P461, DOI 10.1111/j.1439-0264.2009.00975.x; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ezeh UIO, 2000, HUM REPROD, V15, P2356, DOI 10.1093/humrep/15.11.2356; Fujihara Y, 2012, DEVELOPMENT, V139, P3583, DOI 10.1242/dev.081778; Gabius HJ, 2006, CRIT REV IMMUNOL, V26, P43, DOI 10.1615/CritRevImmunol.v26.i1.30; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hisa I, 2011, J BIOL CHEM, V286, P9787, DOI 10.1074/jbc.M110.179127; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kanamoto T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-70; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Li YM, 2014, CELL REP, V8, P723, DOI 10.1016/j.celrep.2014.06.055; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Mizuhashi K, 2012, DEV GROWTH DIFFER, V54, P474, DOI 10.1111/j.1440-169X.2012.01333.x; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Negishi-Koga Takako, 2012, Bonekey Rep, V1, P183, DOI 10.1038/bonekey.2012.183; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Osato N, 2002, GENOME RES, V12, P1127, DOI 10.1101/gr.75202; Patsos G, 2009, GLYCOBIOLOGY, V19, P382, DOI 10.1093/glycob/cwn149; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Saliba W, 2009, J AM BOARD FAM MED, V22, P574, DOI 10.3122/jabfm.2009.05.090026; Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Ulloa F, 2003, J BIOL CHEM, V278, P12374, DOI 10.1074/jbc.M211909200; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; van der Weyden L, 2006, MOL CELL BIOL, V26, P3595, DOI 10.1128/MCB.26.9.3595-3609.2006; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wong EWP, 2009, INT REV CEL MOL BIO, V278, P309, DOI 10.1016/S1937-6448(09)78007-4; Xiao X, 2013, HUM REPROD UPDATE, V19, P167, DOI 10.1093/humupd/dms049; Zuo C, 2012, OSTEOPOROSIS INT, V23, P1653, DOI 10.1007/s00198-012-1909-x	43	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133704	10.1371/journal.pone.0133704	http://dx.doi.org/10.1371/journal.pone.0133704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207632	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000119
J	Overmars, L; Siezen, RJ; Francke, C				Overmars, Lex; Siezen, Roland J.; Francke, Christof			A Novel Quality Measure and Correction Procedure for the Annotation of Microbial Translation Initiation Sites	PLOS ONE			English	Article							LEADERLESS MESSENGER-RNAS; SEQUENCES; BACTERIAL; GENOMES; GENES; IDENTIFICATION; PREDICTIONS; MECHANISMS; EVOLUTION; FEATURES	The identification of translation initiation sites (TISs) constitutes an important aspect of sequence-based genome analysis. An erroneous TIS annotation can impair the identification of regulatory elements and N-terminal signal peptides, and also may flaw the determination of descent, for any particular gene. We have formulated a reference-free method to score the TIS annotation quality. The method is based on a comparison of the observed and expected distribution of all TISs in a particular genome given prior gene-calling. We have assessed the TIS annotations for all available NCBI RefSeq microbial genomes and found that approximately 87% is of appropriate quality, whereas 13% needs substantial improvement. We have analyzed a number of factors that could affect TIS annotation quality such as GC-content, taxonomy, the fraction of genes with a Shine-Dalgarno sequence and the year of publication. The analysis showed that only the first factor has a clear effect. We have then formulated a straightforward Principle Component Analysis-based TIS identification strategy to self-organize and score potential TISs. The strategy is independent of reference data and a priori calculations. A representative set of 277 genomes was subjected to the analysis and we found a clear increase in TIS annotation quality for the genomes with a low quality score. The PCA-based annotation was also compared with annotation with the current tool of reference, Prodigal. The comparison for the model genome of Escherichia coli K12 showed that both methods supplement each other and that prediction agreement can be used as an indicator of a correct TIS annotation. Importantly, the data suggest that the addition of a PCA-based strategy to a Prodigal prediction can be used to 'flag' TIS annotations for re-evaluation and in addition can be used to evaluate a given annotation in case a Prodigal annotation is lacking.	[Overmars, Lex; Siezen, Roland J.; Francke, Christof] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Overmars, Lex; Siezen, Roland J.; Francke, Christof] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Francke, Christof] Univ Appl Sci Arnhem Nijmegen, HAN BioCtr, Nijmegen, Netherlands	Radboud University Nijmegen	Overmars, L (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Amsterdam, Netherlands.	L.Overmars@gmail.com	Siezen, Roland J/P-5745-2015; Francke, C/AAW-2402-2021		BioRange programme of the Netherlands Bioinformatics Centre (NBIC); Netherlands Genomics Initiative (NGI)	BioRange programme of the Netherlands Bioinformatics Centre (NBIC); Netherlands Genomics Initiative (NGI)	This work was part of the BioRange programme of the Netherlands Bioinformatics Centre (NBIC), which is supported by the Netherlands Genomics Initiative (NGI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dunbar J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-125; Ederveen THA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063523; Hu GQ, 2008, NUCLEIC ACIDS RES, V36, pD114, DOI 10.1093/nar/gkm799; Hu GQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-160; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Klassen JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058387; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Krug K, 2013, MOL CELL PROTEOMICS, V12, P3420, DOI 10.1074/mcp.M113.029165; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Palleja A, 2009, BMC GENOMICS, V10, P1; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; PETTIS GS, 1988, J BIOL CHEM, V263, P18857; Poptsova MS, 2010, MICROBIOL-SGM, V156, P1909, DOI 10.1099/mic.0.033811-0; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; R Core Team, 2018, R LANG ENV STAT COMP; Richardson EJ, 2013, BRIEF BIOINFORM, V14, P1, DOI 10.1093/bib/bbs007; Shah SP, 2003, BIOINFORMATICS, V19, P1296, DOI 10.1093/bioinformatics/btg139; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Skorski P, 2006, J BACTERIOL, V188, P6277, DOI 10.1128/JB.00591-06; Smollett KL, 2009, MICROBIOL-SGM, V155, P186, DOI 10.1099/mic.0.022889-0; Tech M, 2005, BIOINFORMATICS, V21, P3568, DOI 10.1093/bioinformatics/bti563; Udagawa T, 2004, J BIOL CHEM, V279, P8539, DOI 10.1074/jbc.M308784200; Wall ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002284; Wang Chengqi, 2013, Genomics Proteomics & Bioinformatics, V11, P142, DOI 10.1016/j.gpb.2013.04.002; Yada T, 2003, Pac Symp Biocomput, P375; Yok NG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-20; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; Zhu HQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-97; Zur H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003136	42	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133691	10.1371/journal.pone.0133691	http://dx.doi.org/10.1371/journal.pone.0133691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204119	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000037
J	Ragheb, H; Thacker, NA; Guyader, JM; Klein, S; deSouza, NM; Jackson, A				Ragheb, Hossein; Thacker, Neil A.; Guyader, Jean-Marie; Klein, Stefan; deSouza, Nandita M.; Jackson, Alan			The Accuracy of ADC Measurements in Liver Is Improved by a Tailored and Computationally Efficient Local-Rigid Registration Algorithm	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; MUTUAL-INFORMATION; MOTION CORRECTION; BIOMARKER; PERFUSION; BREAST; REPRODUCIBILITY; BREATHHOLD; IMAGES; MAP	This study describes post-processing methodologies to reduce the effects of physiological motion in measurements of apparent diffusion coefficient (ADC) in the liver. The aims of the study are to improve the accuracy of ADC measurements in liver disease to support quantitative clinical characterisation and reduce the number of patients required for sequential studies of disease progression and therapeutic effects. Two motion correction methods are compared, one based on non-rigid registration (NRA) using freely available open source algorithms and the other a local-rigid registration (LRA) specifically designed for use with diffusion weighted magnetic resonance (DW-MR) data. Performance of these methods is evaluated using metrics computed from regional ADC histograms on abdominal image slices from healthy volunteers. While the non-rigid registration method has the advantages of being applicable on the whole volume and in a fully automatic fashion, the local-rigid registration method is faster while maintaining the integrity of the biological structures essential for analysis of tissue heterogeneity. Our findings also indicate that the averaging commonly applied to DW-MR images as part of the acquisition protocol should be avoided if possible.	[Ragheb, Hossein; Thacker, Neil A.] Univ Manchester, Fac Med & Human Sci, Ctr Imaging Sci, Manchester, Lancs, England; [Guyader, Jean-Marie; Klein, Stefan] Univ Med Ctr Rotterdam, Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [Guyader, Jean-Marie; Klein, Stefan] Univ Med Ctr Rotterdam, Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [deSouza, Nandita M.] Inst Canc Res, Canc Res UK Imaging Ctr, Sutton, Surrey, England; [Jackson, Alan] Royal Marsden Hosp, Sutton, Surrey, England; [Jackson, Alan] Univ Manchester, Fac Med & Human Sci, Wolfson Mol Imaging Ctr, Manchester, Lancs, England	University of Manchester; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Manchester	Ragheb, H (corresponding author), Univ Manchester, Fac Med & Human Sci, Ctr Imaging Sci, Manchester, Lancs, England.	hossein.ragheb@manchester.ac.uk		Klein, Stefan/0000-0003-4449-6784; JACKSON, ALAN/0000-0002-1623-0383	Innovative Medicines Initiative [115151]; European Union; EFPIA companies; Cancer Research UK [18097, 16464, 16465] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10162] Funding Source: researchfish	Innovative Medicines Initiative; European Union(European Commission); EFPIA companies; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (www.imi.europa.eu) under grant agreement number 115151, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in-kind contribution. There was, however, no financial or in-kind contribution from EFPIA companies to the research specifically described in this paper. The funders of the research leading to these results had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Arlinghaus LR, 2011, J MAGN RESON IMAGING, V33, P1063, DOI 10.1002/jmri.22562; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Bromiley PA, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0061-1; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Guyader JM, 2015, J MAGN RESON IMAGING, V42, P315, DOI 10.1002/jmri.24792; Guyader JM, 2014, P SPIE, V9034; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Hamstra DA, 2007, J CLIN ONCOL, V25, P4104, DOI 10.1200/JCO.2007.11.9610; IMI QuIC-ConCePT, 2012, TASK 2 3 REPR STUD H; Ivancevic MK, 2009, J MAGN RESON IMAGING, V30, P1027, DOI 10.1002/jmri.21939; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kwee TC, 2008, J MAGN RESON IMAGING, V28, P1141, DOI 10.1002/jmri.21569; Larsen NE, 2013, MAGN RESON MATER PHY, V26, P431, DOI 10.1007/s10334-013-0375-6; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Liau J, 2012, J MAGN RESON IMAGING, V35, P318, DOI 10.1002/jmri.22816; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Mazaheri Y, 2012, ACAD RADIOL, V19, P1573, DOI 10.1016/j.acra.2012.07.005; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Moon WJ, 2012, NEURORADIOLOGY, V54, P555, DOI 10.1007/s00234-011-0947-y; Partridge SC, 2010, MAGN RESON IMAGING, V28, P320, DOI 10.1016/j.mri.2009.10.003; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P339, DOI 10.1002/jmri.22045; Pathak R, 2015, P INT SOC MAGN RES M, P2869; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Pope WB, 2011, AM J NEURORADIOL, V32, P882, DOI 10.3174/ajnr.A2385; Ragheb H, 2014, P INT SOC MAGN RES M, P2650; Ragheb H, 2011, P MED IM UND AN LOND, P221; Ragheb H, 2015, P INT SOC MAGN RES M, P2984; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Seghers D, 2004, LECT NOTES COMPUT SC, V3216, P696; Sinkus R, 2012, EUR J CANCER, V48, P425, DOI 10.1016/j.ejca.2011.11.034; Taouli B, 2010, RADIOLOGY, V254, P47, DOI 10.1148/radiol.09090021; Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876; Thacker N. A., 2008, 5th International Conference on Visual Information Engineering, VIE 2008, P250, DOI 10.1049/cp:20080317; Thacker NA, 2008, 2008010 TIN; Thevenaz P, 2000, IEEE T IMAGE PROCESS, V9, P2083, DOI 10.1109/83.887976; Turkbey B, 2012, DIAGN INTERV RADIOL, V18, P46, DOI 10.4261/1305-3825.DIR.4708-11.2; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Waterton JC, 2012, EUR J CANCER, V48, P409, DOI 10.1016/j.ejca.2011.11.037	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132554	10.1371/journal.pone.0132554	http://dx.doi.org/10.1371/journal.pone.0132554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204105	gold, Green Published, Green Submitted			2022-12-27	WOS:000358621000009
J	Steimer, A; Schindler, K				Steimer, Andreas; Schindler, Kaspar			Random Sampling with Interspike-Intervals of the Exponential Integrate and Fire Neuron: A Computational Interpretation of UP-States	PLOS ONE			English	Article							NEOCORTICAL NEURONS; CORTICAL-NEURONS; IN-VIVO; DYNAMICS; NETWORK; VARIABILITY; MECHANISMS; DISCHARGE; MODELS; INPUT	Oscillations between high and low values of the membrane potential (UP and DOWN states respectively) are an ubiquitous feature of cortical neurons during slow wave sleep and anesthesia. Nevertheless, a surprisingly small number of quantitative studies have been conducted only that deal with this phenomenon's implications for computation. Here we present a novel theory that explains on a detailed mathematical level the computational benefits of UP states. The theory is based on random sampling by means of interspike intervals (ISIs) of the exponential integrate and fire (EIF) model neuron, such that each spike is considered a sample, whose analog value corresponds to the spike's preceding ISI. As we show, the EIF's exponential sodium current, that kicks in when balancing a noisy membrane potential around values close to the firing threshold, leads to a particularly simple, approximative relationship between the neuron's ISI distribution and input current. Approximation quality depends on the frequency spectrum of the current and is improved upon increasing the voltage baseline towards threshold. Thus, the conceptually simpler leaky integrate and fire neuron that is missing such an additional current boost performs consistently worse than the EIF and does not improve when voltage baseline is increased. For the EIF in contrast, the presented mechanism is particularly effective in the high-conductance regime, which is a hallmark feature of UP-states. Our theoretical results are confirmed by accompanying simulations, which were conducted for input currents of varying spectral composition. Moreover, we provide analytical estimations of the range of ISI distributions the EIF neuron can sample from at a given approximation level. Such samples may be considered by any algorithmic procedure that is based on random sampling, such as Markov Chain Monte Carlo or message-passing methods. Finally, we explain how spike-based random sampling relates to existing computational theories about UP states during slow wave sleep and present possible extensions of the model in the context of spike-frequency adaptation.	[Steimer, Andreas; Schindler, Kaspar] Univ Bern, Dept Neurol, Univ Hosp Bern, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern	Steimer, A (corresponding author), Univ Bern, Dept Neurol, Univ Hosp Bern, Inselspital, Bern, Switzerland.	Andreas.Steimer@insel.ch	Schindler, Kaspar/L-7115-2013	Schindler, Kaspar/0000-0002-2387-7767	Swiss National Science Foundation (SNF) [SNF 32003B_155950]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was funded by the Swiss National Science Foundation (SNF) (Project No: SNF 32003B_155950).	Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Badel L, 2006, NEUROCOMPUTING, V69, P1062, DOI 10.1016/j.neucom.2005.12.046; Barranca VJ, 2014, J COMPUT NEUROSCI, V37, P161, DOI 10.1007/s10827-013-0494-0; Bishop C. M, 2006, PATTERN RECOGNITION; Bottou L., 1998, ONLINE LEARNING AND; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cox DR, 1966, THE STATISTICAL ANAL; Dauwels J, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, VOLS 1-6, PROCEEDINGS, P2052, DOI 10.1109/ISIT.2006.261910; Dayan P., 2002, HDB BRAIN THEORY NEU, P522; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; El Boustani S, 2012, J NEUROSCI, V32, P194, DOI 10.1523/JNEUROSCI.2496-11.2012; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fanselow EE, 2010, J NEUROPHYSIOL, V104, P596, DOI 10.1152/jn.00206.2010; Fourcaud-Trocme N, 2005, J COMPUT NEUROSCI, V18, P311, DOI 10.1007/s10827-005-0337-8; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; Gerstner W, 2002, SPIKING NEURON MODEL; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Lundstrom BN, 2006, J NEUROSCI, V26, P9030, DOI 10.1523/JNEUROSCI.0225-06.2006; MacKay D. J. C., 2019, INFORM THEORY INFERE; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Mensi S., 2011, ADV NEURAL INF PROCE, P1377; Milojkovic BA, 2005, J NEUROSCI, V25, P3940, DOI 10.1523/JNEUROSCI.5314-04.2005; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Nawrot MP, 2007, NEUROCOMPUTING, V70, P1717, DOI 10.1016/j.neucom.2006.10.101; Pfister JP, 2010, NAT NEUROSCI, V13, P1271, DOI 10.1038/nn.2640; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Reich DS, 2000, J NEUROSCI, V20, P1964; Rudolph M, 2005, J NEUROPHYSIOL, V94, P2805, DOI 10.1152/jn.01313.2004; Rudolph M, 2003, NEUROSCIENCE, V119, P855, DOI 10.1016/S0306-4522(03)00164-7; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shih JY, 2011, J NEUROPHYSIOL, V105, P1908, DOI 10.1152/jn.01055.2010; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Steimer A., 2012, NEURALLY INSPIRED MO; Steimer A, 2013, NEURAL COMPUT, V25, P2303, DOI 10.1162/NECO_a_00477; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Watson BO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003971; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; Wilson CJ, 1996, J NEUROSCI, V16, P2397	55	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132906	10.1371/journal.pone.0132906	http://dx.doi.org/10.1371/journal.pone.0132906			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203657	Green Published, gold			2022-12-27	WOS:000358621000014
J	Bozorgmehr, K; Razum, O				Bozorgmehr, Kayvan; Razum, Oliver			Effect of Restricting Access to Health Care on Health Expenditures among Asylum-Seekers and Refugees: A Quasi-Experimental Study in Germany, 1994-2013	PLOS ONE			English	Article								Background Access to health care for asylum-seekers and refugees (AS&R) in Germany is initially restricted before regular access is granted, allegedly leading to delayed care and increasing costs of care. We analyse the effects of (a) restricted access; and (b) two major policy reforms (1997, 2007) on incident health expenditures for AS&R in 1994-2013. Methods and Findings We used annual, nation-wide, aggregate data of the German Federal Statistics Office (1994-2013) to compare incident health expenditures among AS&R with restricted access (exposed) to AS&R with regular access (unexposed). We calculated incidence rate differences (Delta IRt) and rate ratios (IRRt), as well as attributable fractions among the exposed (AFe) and the total population (AFp). The effects of between-group differences in need, and of policy reforms, on differences in per capita expenditures were assessed in (segmented) linear regression models. The exposed and unexposed groups comprised 4.16 and 1.53 million person-years. Per capita expenditures (1994-2013) were higher in the group with restricted access in absolute (Delta IRt = 375.80 Euros [375.77; 375.89]) and relative terms (IRR = 1.39). The AFe was 28.07% and the AFp 22.21%. Between-group differences in mean age and in the type of accommodation were the main independent predictors of between-group expenditure differences. Need variables explained 50-75% of the variation in between-group differences over time. The 1997 policy reform significantly increased Delta IRt adjusted for secular trends and between-group differences in age (by 600.0 Euros [212.6; 986.2]) and sex (by 867.0 Euros [390.9; 1342.5]). The 2007 policy reform had no such effect. Conclusion The cost of excluding AS&R from health care appears ultimately higher than granting regular access to care. Excess expenditures attributable to the restriction were substantial and could not be completely explained by differences in need. An evidence-informed discourse on access to health care for AS&R in Germany is needed; it urgently requires high-quality, individual-level data.	[Bozorgmehr, Kayvan] Heidelberg Univ, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Razum, Oliver] Univ Bielefeld, Dept Epidemiol & Int Publ Hlth, Sch Publ Hlth, D-33615 Bielefeld, Germany	Ruprecht Karls University Heidelberg; University of Bielefeld	Bozorgmehr, K (corresponding author), Heidelberg Univ, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	kayvan.bozorgmehr@med.uni-heidelberg.de		Bozorgmehr, Kayvan/0000-0002-1411-1209; Razum, Oliver/0000-0002-1244-7649	Federal State of Baden-Wurttemberg (Germany); German network 'Health Services Research Baden-Wurttemberg' Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg	Federal State of Baden-Wurttemberg (Germany); German network 'Health Services Research Baden-Wurttemberg' Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg	No direct funding was received for this study. KB was funded through a public contract with the Federal State of Baden-Wurttemberg (Germany) whilst conducting this research, and received grants in the scope of the young scientists programme of the German network 'Health Services Research Baden-Wurttemberg' of the 'Ministry of Science, Research and Arts' in collaboration with the 'Ministry of Employment and Social Order, Family, Women and Senior Citizens', Baden-Wurttemberg. The funding sources had no involvement in design, collection, analysis or interpretation of data, in the writing of the article, and in the decision to submit it for publication.	Aday L A, 1974, Health Serv Res, V9, P208; Behrensen B, 2004, WEG NORMALES LEBEN A; Bosswick Wolfgang., 2000, J REFUG STUD, V13, P43, DOI [DOI 10.1093/JRS/13.1.43, 10.1093/jrs/13.1.43]; Burnett A, 2001, BRIT MED J, V322, P544, DOI 10.1136/bmj.322.7285.544; Classen G, 2011, ASYLBEWERBERLEISTUNG; Federal Statistics Office, STAT SOZ AUSG EINN M; Goosen S, 2014, INT J EPIDEMIOL, V43, P94, DOI 10.1093/ije/dyt233; Grove NJ, 2006, SOC SCI MED, V62, P1931, DOI 10.1016/j.socscimed.2005.08.061; Hocking DC, 2015, J NERV MENT DIS, V203, P28, DOI 10.1097/NMD.0000000000000230; Ingleby David, 2012, Psychosocial Intervention, V21, P331, DOI 10.5093/in2012a29; Krieger N, 2004, EPIDEMIOL REV, V26, P92, DOI 10.1093/epirev/mxh009; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Landtag Baden-Wurttemberg, 2014, DRUCKS 15 4595 ANTR; Liedtke M., 2002, CADERNOS SA DE P BLI, V22, P479; Niedermeier A, 2010, EPIDEMIOLOGISCHES B, V48, P479; Norredam Marie, 2006, Eur J Public Health, V16, P286, DOI 10.1093/eurpub/cki191; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Pross, 1998, Health Hum Rights, V3, P40, DOI 10.2307/4065298; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P7; Schneider C, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-139; Schunck R, 2015, ETHNIC HEALTH, V20, P493, DOI 10.1080/13557858.2014.932756; Steel Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001038; Takla A, 2012, EPIDEMIOL INFECT, V140, P1589, DOI 10.1017/S0950268811002597; WHO, 2007, EV BUS STRENGTH HLTH; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034	25	148	148	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131483	10.1371/journal.pone.0131483	http://dx.doi.org/10.1371/journal.pone.0131483			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26201017	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100015
J	Rank, MR; Hirschl, TA				Rank, Mark R.; Hirschl, Thomas A.			The Likelihood of Experiencing Relative Poverty over the Life Course	PLOS ONE			English	Article							MOBILITY	Research on poverty in the United States has largely consisted of examining cross-sectional levels of absolute poverty. In this analysis, we focus on understanding relative poverty within a life course context. Specifically, we analyze the likelihood of individuals falling below the 20th percentile and the 10th percentile of the income distribution between the ages of 25 and 60. A series of life tables are constructed using the nationally representative Panel Study of Income Dynamics data set. This includes panel data from 1968 through 2011. Results indicate that the prevalence of relative poverty is quite high. Consequently, between the ages of 25 to 60, 61.8 percent of the population will experience a year below the 20th percentile, and 42.1 percent will experience a year below the 10th percentile. Characteristics associated with experiencing these levels of poverty include those who are younger, nonwhite, female, not married, with 12 years or less of education, or who have a work disability.	[Rank, Mark R.] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; [Hirschl, Thomas A.] Cornell Univ, Dept Dev Sociol, Ithaca, NY 14850 USA	Washington University (WUSTL); Cornell University	Hirschl, TA (corresponding author), Cornell Univ, Dept Dev Sociol, Ithaca, NY 14850 USA.	tah4@cornell.edu			NICHD NIH HHS [R01 HD069609] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069609] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allison P. D., 1995, SURVIVAL ANAL USING; [Anonymous], 1987, LIFE TABLES THEIR AP; Besharov D. J., 2012, COUNTING POOR NEW TH; Bjorklund A, 1997, AM ECON REV, V87, P1009; Corak M, 2011, INEQUALITY GEN UNPUB; Duncan G.J., 1984, YEARS POVERTY YEARS; Duncan GJ, 2004, TELESCOPE SOC SURVEY, P156; Fitzgerald J, 1998, J HUM RESOUR, V33, P251, DOI 10.2307/146433; Frank R.H., 1995, WINNER TAKE ALL SOC; Gouskova E. S., 2008, PANEL STUDY INCOME D; Hill M.S., 1992, PANEL STUDY INCOME D; Hirschl TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116370; Iceland J, 2005, MEAS-INTERDISCIP RES, V3, P199, DOI 10.1207/s15366359mea0304_1; Iceland John., 2013, POVERTY AM HDB, V3rd; Jantti M., 2006, 1938 I STUD LAB; Kim YS, 2000, PANEL STUDY INCOME D; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Mayer K.U., 1990, EVENT HIST ANAL LIFE, P3; Panel Study of Income Dynamics (PSID), 2014, USER GUID; Piketty T., 2014, CAPITAL 21 CENTURY; Rank M, 2014, CHASING AM DREAM UND; Rank Mark, 2004, ONE NATION UNDERPRIV; Saez Emmanuel, 2013, STRIKING IT RICHER E; Solon G, 2002, J ECON PERSPECT, V16, P59, DOI 10.1257/089533002760278712; Stiglitz G, 2012, PRICE INEQUALITY; U.S. Census Bureau, 2014, CURR POP REP P	26	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133513	10.1371/journal.pone.0133513	http://dx.doi.org/10.1371/journal.pone.0133513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200781	gold, Green Published, Green Submitted			2022-12-27	WOS:000358597100069
J	Agga, GE; Arthur, TM; Durso, LM; Harhay, DM; Schmidt, JW				Agga, Getahun E.; Arthur, Terrance M.; Durso, Lisa M.; Harhay, Dayna M.; Schmidt, John W.			Antimicrobial-Resistant Bacterial Populations and Antimicrobial Resistance Genes Obtained from Environments Impacted by Livestock and Municipal Waste	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; POLYMERASE-CHAIN-REACTION; WATER-TREATMENT PLANTS; ANTIBIOTIC-RESISTANCE; SALMONELLA-ENTERICA; MULTIDRUG-RESISTANT; FEEDLOT CATTLE; FECAL SAMPLES; TYPHIMURIUM; CEFTIOFUR	This study compared the populations of antimicrobial-resistant bacteria and the repertoire of antimicrobial resistance genes in four environments: effluent of three municipal wastewater treatment facilities, three cattle feedlot runoff catchment ponds, three swine waste lagoons, and two "low impact" environments (an urban lake and a relict prairie). Multiple liquid and solid samples were collected from each environment. The prevalences and concentrations of antimicrobial-resistant (AMR) Gram-negative (Escherichia coli and Salmonella enterica) and Gram-positive (enterococci) bacteria were determined from individual samples (n = 174). The prevalences of 84 antimicrobial resistance genes in metagenomic DNA isolated from samples pooled (n = 44) by collection date, location, and sample type were determined. The prevalences and concentrations of AMR E. coli and Salmonella were similar among the livestock and municipal sample sources. The levels of erythromycin-resistant enterococci were significantly higher in liquid samples from cattle catchment ponds and swine waste lagoons than in liquid samples from municipal wastewater treatment facilities, but solid samples from these environments did not differ significantly. Similarly, trimethoprim/sulfamethoxazole-resistant E. coli concentrations were significantly higher in swine liquid than in municipal liquid samples, but there was no difference in solid samples. Multivariate analysis of the distribution of antimicrobial resistance genes using principal coordinate analysis showed distinct clustering of samples with livestock (cattle and swine), low impact environment and municipal samples forming three separate clusters. The numbers of class A beta-lactamase, class C beta-lactamase, and fluoroquinolone resistance genes detected were significantly higher (P < 0.05) in municipal samples than in cattle runoff or swine lagoon samples. In conclusion, we report that AMR is a very widespread phenomenon and that similar prevalences and concentrations of antimicrobial-resistant bacteria and antimicrobial resistance genes exist in cattle, human, and swine waste streams, but a higher diversity of antimicrobial resistance genes are present in treated human waste discharged from municipal wastewater treatment plants than in livestock environments.	[Agga, Getahun E.; Arthur, Terrance M.; Harhay, Dayna M.; Schmidt, John W.] ARS, USDA, Roman L Hruska US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; [Durso, Lisa M.] ARS, USDA, Agroecosyst Management Res Unit, Lincoln, NE USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Schmidt, JW (corresponding author), ARS, USDA, Roman L Hruska US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA.	Terrance.Arthur@ars.usda.gov	Schmidt, John/H-5937-2019	Schmidt, John/0000-0003-0494-2436; Arthur, Terrance/0000-0001-9035-0474; Agga, Getahun/0000-0002-9903-5283	Beef Checkoff [58-5438-3-414]; United States Department of Agriculture-Agricultural Research Service [5438-42000-014-00]	Beef Checkoff; United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was funded in part by the Beef Checkoff (#58-5438-3-414; to TMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remainder of the funding was provided by internal project funding from United States Department of Agriculture-Agricultural Research Service, Project Number 5438-42000-014-00.	Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Aarestrup FM, 2000, APMIS, V108, P5; Agerso Y, 2012, J ANTIMICROB CHEMOTH, V67, P582, DOI 10.1093/jac/dkr507; Agga GE, 2014, PREV VET MED, V114, P231, DOI 10.1016/j.prevetmed.2014.02.010; Alm EW, 2014, J APPL MICROBIOL; Alroy K, 2011, J ZOO WILDLIFE MED, V42, P160, DOI 10.1638/2010-0130.1; Barkocy-Gallagher GA, 2005, J FOOD PROTECT, V68, P2264, DOI 10.4315/0362-028X-68.11.2264; Bartoloni A, 2004, J INFECT DIS, V189, P1291, DOI 10.1086/382191; Bartoloni A, 2009, INT J ANTIMICROB AG, V33, P125, DOI 10.1016/j.ijantimicag.2008.07.029; Berge ACB, 2006, J APPL MICROBIOL, V101, P1309, DOI 10.1111/j.1365-2672.2006.03031.x; Berge AC, 2010, JAVMA-J AM VET MED A, V236, P1338, DOI 10.2460/javma.236.12.1338; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Brichta-Harhay DM, 2007, J APPL MICROBIOL, V103, P1657, DOI 10.1111/j.1365-2672.2007.03405.x; Brooks JP, 2009, J ENVIRON QUAL, V38, P2431, DOI 10.2134/jeq2008.0471; Brooks JP, 2014, WATER RES, V57, P96, DOI 10.1016/j.watres.2014.03.017; Brown KD, 2006, SCI TOTAL ENVIRON, V366, P772, DOI 10.1016/j.scitotenv.2005.10.007; Brown MG, 2009, MICROB ECOL, V57, P484, DOI 10.1007/s00248-008-9431-6; Cox R, 2012, EPIDEMIOL INFECT, V140, P2062, DOI 10.1017/S0950268811002755; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; DAVIS CE, 1970, NEW ENGL J MED, V282, P117, DOI 10.1056/NEJM197001152820302; Deasy BM, 2000, SYST APPL MICROBIOL, V23, P510, DOI 10.1016/S0723-2020(00)80025-9; Durso LM, 2014, CURR OPIN MICROBIOL, V19, P37, DOI 10.1016/j.mib.2014.05.019; Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325; Durso LM, 2011, J MICROBIOL METH, V84, P278, DOI 10.1016/j.mimet.2010.12.008; FDA, 2003, EV SAF ANT NEW AN DR; Frye JG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00135; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris S, 2014, SCI TOTAL ENVIRON, V468, P1078, DOI 10.1016/j.scitotenv.2013.09.017; Horakova K, 2008, J APPL MICROBIOL, V105, P970, DOI 10.1111/j.1365-2672.2008.03838.x; Ibekwe AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020819; Iwane T, 2001, WATER SCI TECHNOL, V43, P91; Kanwar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080575; Kirby WMM, 1944, SCIENCE, V99, P452, DOI 10.1126/science.99.2579.452; Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Kummerer K, 2003, CLIN MICROBIOL INFEC, V9, P1203, DOI 10.1111/j.1469-0691.2003.00739.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWBURY EJL, 1955, BMJ-BRIT MED J, V1, P985, DOI 10.1136/bmj.1.4920.985; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; Luczkiewicz A, 2011, WATER SCI TECHNOL, V64, P2352, DOI 10.2166/wst.2011.769; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Miteva VI, 2004, APPL ENVIRON MICROB, V70, P202, DOI 10.1128/AEM.70.1.202-213.2004; Morley PS, 2011, FOODBORNE PATHOG DIS, V8, P87, DOI 10.1089/fpd.2010.0632; Nagulapally SR, 2009, WATER ENVIRON RES, V81, P82, DOI 10.2175/106143008X304596; Nesme J, 2014, CURR BIOL, V24, P1096, DOI 10.1016/j.cub.2014.03.036; Normand EH, 2000, PREV VET MED, V46, P267, DOI 10.1016/S0167-5877(00)00149-5; Nou XW, 2006, J FOOD PROTECT, V69, P2870, DOI 10.4315/0362-028X-69.12.2870; Novais C, 2005, APPL ENVIRON MICROB, V71, P3364, DOI 10.1128/AEM.71.6.3364-3368.2005; Novo A, 2013, WATER RES, V47, P1875, DOI 10.1016/j.watres.2013.01.010; Nucera DM, 2006, J CLIN MICROBIOL, V44, P3388, DOI 10.1128/JCM.00972-06; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Sayah RS, 2005, APPL ENVIRON MICROB, V71, P1394, DOI 10.1128/AEM.71.3.1394-1404.2005; Schmidt JW, 2013, APPL ENVIRON MICROB, V79, P2273, DOI 10.1128/AEM.03592-12; Schmidt JW, 2014, APPL ENV MICROBIOL; Scott HM, 2005, FOODBORNE PATHOG DIS, V2, P24, DOI 10.1089/fpd.2005.2.24; Singer RS, 2008, APPL ENVIRON MICROB, V74, P6956, DOI 10.1128/AEM.01241-08; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Threlfall EJ, 2006, INT J ANTIMICROB AG, V28, P389, DOI 10.1016/j.ijantimicag.2006.07.009; Udikovic-Kolic N, 2014, P NATL ACAD SCI US; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; USDA-FDA, 2009, SUMM REP ANT SOLD DI; WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR), 2012, CRIT IMP ANT HUM MED; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; Wright GD, 2012, TRENDS MICROBIOL, V20, P157, DOI 10.1016/j.tim.2012.01.002; Zhang YL, 2009, SCI TOTAL ENVIRON, V407, P3702, DOI 10.1016/j.scitotenv.2009.02.013	73	76	78	5	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132586	10.1371/journal.pone.0132586	http://dx.doi.org/10.1371/journal.pone.0132586			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197056	Green Published, gold			2022-12-27	WOS:000358547600041
J	Rahman, K; Ghani, NA; Kamil, AA; Mustafa, A; Chowdhury, MAK				Rahman, Khalidur; Ghani, Noraida Abdul; Kamil, Anton Abdulbasah; Mustafa, Adli; Chowdhury, Md. Ahmed Kabir			An M/M/c/K State-Dependent Model for Pedestrian Flow Control and Design of Facilities	PLOS ONE			English	Article							NETWORKS; SERVICE; LEVEL	Pedestrian overflow causes queuing delay and in turn, is controlled by the capacity of a facility. Flow control or blocking control takes action to avoid queues from building up to extreme values. Thus, in this paper, the problem of pedestrian flow control in open outdoor walking facilities in equilibrium condition is investigated using M/M/c/K queuing models. State dependent service rate based on speed and density relationship is utilized. The effective rate of the Poisson arrival process to the facility is determined so as there is no overflow of pedestrians. In addition, the use of the state dependent queuing models to the design of the facilities and the effect of pedestrian personal capacity on the design and the traffic congestion are discussed. The study does not validate the sustainability of adaptation of Western design codes for the pedestrian facilities in the countries like Bangladesh.	[Rahman, Khalidur; Chowdhury, Md. Ahmed Kabir] Shahjalal Univ Sci & Technol, Sch Phys Sci, Dept Stat, Sylhet 3114, Bangladesh; [Ghani, Noraida Abdul; Kamil, Anton Abdulbasah] Univ Sains Malaysia, Sch Distance Educ, Math Sect, Usm 11800, Penang, Malaysia; [Mustafa, Adli] Univ Sains Malaysia, Sch Math Sci, Usm 11800, Penang, Malaysia	Shahjalal University of Science & Technology (SUST); Universiti Sains Malaysia; Universiti Sains Malaysia	Rahman, K (corresponding author), Shahjalal Univ Sci & Technol, Sch Phys Sci, Dept Stat, Sylhet 3114, Bangladesh.	khalid_sust@yahoo.com	Kamil, Anton Abdulbasah/A-9795-2011	Kamil, Anton Abdulbasah/0000-0001-5410-812X; Mustafa, Adli/0000-0003-0989-674X; Rahman, Khalidur/0000-0002-2899-804X	LRGS Grant Scheme, Ministry of Higher Education, Malaysia [203/PTS/6728002]	LRGS Grant Scheme, Ministry of Higher Education, Malaysia	This study was supported by the LRGS Grant Scheme [203/PTS/6728002], Ministry of Higher Education, Malaysia.	Al-Azzawi M, 2007, J URBAN PLAN DEV, V133, P211, DOI 10.1061/(ASCE)0733-9488(2007)133:3(211); Arita C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051119; Bojkovic Z, 2010, P IEEE, V98, P123, DOI 10.1109/JPROC.2009.2035167; Braess D., 1968, UNTERNEHMENSFORSCHUN, V12, P258, DOI [10.1007/BF01918335, DOI 10.1007/BF01918335]; Chung SP, 1993, IEEE ACM T NETWORK, V1, P105, DOI 10.1109/90.222911; Council N.R., 2000, HIGHWAY CAPACITY MAN; Ding N, 2015, TRAFFIC AND GRANULAR FLOW '13, P145, DOI 10.1007/978-3-319-10629-8_17; Gross D, 2008, FUNDAMENTALS QUEUEIN; HAIGHT FA, 1957, BIOMETRIKA, V44, P360, DOI 10.1093/biomet/44.3-4.360; Hao Q-y, 2011, UNIDIRECTIONAL PEDES, P1054; Hu L, 2015, EUR J OPER RES, V240, P109, DOI 10.1016/j.ejor.2014.06.010; Kumar B. K., 1993, Queueing Systems Theory and Applications, V13, P441, DOI 10.1007/BF01149265; Liu S, 2014, IEEE T INTELLIGENT T, V15; Mitchell DH, 2001, TRANSPORT RES B-METH, V35, P107, DOI 10.1016/S0191-2615(99)00039-9; Navin F, 1969, TRAFFIC ENG, V39, P30; Older S.J., 1968, TRAFFIC ENG CONTROL, V10, P160; POLUS A, 1983, J TRANSP ENG-ASCE, V109, P46, DOI 10.1061/(ASCE)0733-947X(1983)109:1(46); Rahman K., 2012, RES J APPL SCI ENG T, V4, P4299; Rahman K, 2013, MODELLING P IN PRESS; Rahman K, 2013, MODERN APPL SCI, V7, P17, DOI DOI 10.5539/MAS.V7N4P17; SENEVIRATNE PN, 1985, TRANSPORT Q, V39, P109; van Woensel T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102075; Yuhaski S. J.  Jr., 1989, Queueing Systems Theory and Applications, V4, P319, DOI 10.1007/BF01159471	23	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133229	10.1371/journal.pone.0133229	http://dx.doi.org/10.1371/journal.pone.0133229			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196124	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600075
J	Loke, YK; Blanco, P; Thavarajah, M; Wilson, AM				Loke, Yoon Kong; Blanco, Patricia; Thavarajah, Menaka; Wilson, Andrew M.			Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MILD PERSISTENT ASTHMA; BONE-MINERAL DENSITY; LONG-TERM SAFETY; FLUTICASONE PROPIONATE; LINEAR GROWTH; DOUBLE-BLIND; EARLY INTERVENTION; ADULT HEIGHT; BUDESONIDE; BECLOMETHASONE	Background Long-term inhaled corticosteroids (ICS) may reduce growth velocity and final height of children with asthma. We aimed to evaluate the association between ICS use of >12 months and growth. Methods We initially searched MEDLINE and EMBASE in July 2013, followed by a PubMed search updated to December 2014. We selected RCTs and controlled observational studies of ICS use in patients with asthma. We conducted random effects meta-analysis of mean differences in growth velocity (cm/year) or final height (cm) between groups. Heterogeneity was assessed using the I-2 statistic. Results We found 23 relevant studies (twenty RCTs and three observational studies) after screening 1882 hits. Meta-analysis of 16 RCTs showed that ICS use significantly reduced growth velocity at one year follow-up (mean difference -0.48 cm/year (95% CI -0.66 to -0.29)). There was evidence of a dose-response effect in three RCTs. Final adult height showed a mean reduction of -1.20 cm (95% CI -1.90 cm to -0.50 cm) with budesonide versus placebo in a high quality RCT. Meta-analysis of two lower quality observational studies revealed uncertainty in the association between ICS use and final adult height, pooled mean difference -0.85 cm (95% CI -3.35 to 1.65). Conclusion Use of ICS for >12 months in children with asthma has a limited impact on annual growth velocity. In ICS users, there is a slight reduction of about a centimeter in final adult height, which when interpreted in the context of average adult height in England (175 cm for men and 161 cm for women), represents a 0.7% reduction compared to non-ICS users.	[Loke, Yoon Kong; Blanco, Patricia; Thavarajah, Menaka; Wilson, Andrew M.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Loke, YK (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	y.loke@uea.ac.uk			Asthma UK [AUK-PG-2012-181, AUK-AC-2012-01] Funding Source: researchfish	Asthma UK		Acun C, 2005, ALLERGY ASTHMA PROC, V26, P204; Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; Allen DB, 1998, J PEDIATR-US, V132, P472, DOI 10.1016/S0022-3476(98)70023-X; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Becker AB, 2006, ANN ALLERG ASTHMA IM, V96, P800, DOI 10.1016/S1081-1206(10)61342-7; Bensch GW, 2011, ANN ALLERG ASTHMA IM, V107, P323, DOI 10.1016/j.anai.2011.07.017; Bush A, 2014, ARCH DIS CHILD, V99, P191, DOI 10.1136/archdischild-2012-303105; de Benedictis FM, 2001, ARCH PEDIAT ADOL MED, V155, P1248; Ferguson AC, 2007, RESP MED, V101, P118, DOI 10.1016/j.rmed.2006.04.009; Garcia MLG, 2005, PEDIATRICS, V116, P360, DOI 10.1542/peds.2004-1172; Gillman SA, 2002, CLIN PEDIATR, V41, P333, DOI 10.1177/000992280204100506; Gradman J, 2010, PEDIAT ALLERG IMM-UK, V21, pE206, DOI 10.1111/j.1399-3038.2009.00875.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; James-Lind-Alliance, 2010, RES ACT FOLL ASTHM T; Jonasson G, 2000, ALLERGY, V55, P740, DOI 10.1034/j.1398-9995.2000.00661.x; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Loke Y., 2008, COCHRANE HDB SYSTEMA; Loke YK, 2011, THER ADV DRUG SAF, V2, P59, DOI 10.1177/2042098611401129; MERKUS PJFM, 1993, PEDIATRICS, V91, P1121; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Office for National Statistics UK, 2010, AV BRIT HIGHL UN WOR; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pedersen S, 2006, DRUG SAFETY, V29, P599, DOI 10.2165/00002018-200629070-00005; Price JF, 1997, PEDIATR PULM, V24, P178; Pruteanu AI, 2014, COCHRANE DB SYST REV, DOI [10.1002/ebch.1989, 10.1002/14651858.CD009878.pub2]; Rossi GA, 2007, PULM PHARMACOL THER, V20, P23, DOI 10.1016/j.pupt.2005.10.008; Roux C, 2003, PEDIATRICS, V111, pE706, DOI 10.1542/peds.111.6.e706; Silverstein MD, 1997, J ALLERGY CLIN IMMUN, V99, P466, DOI 10.1016/S0091-6749(97)70072-1; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; Skoner DP, 2008, PEDIATRICS, V121, pE1, DOI 10.1542/peds.2006-2206; Skoner DP, 2011, J ASTHMA, V48, P848, DOI 10.3109/02770903.2011.604883; Skoner DP, 2000, J ALLERGY CLIN IMMUN, V105, P259, DOI 10.1016/S0091-6749(00)90074-5; Skoner JD, 2008, ALLERGY ASTHMA PROC, V29, P358, DOI 10.2500/aap.2008.29.3132; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Turpeinen M, 2010, PEDIATR RES, V68, P169, DOI 10.1203/00006450-201011001-00329; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; Wong CA, 2000, LANCET, V355, P1399, DOI 10.1016/S0140-6736(00)02138-3; Zhang LJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009471.pub2	41	53	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133428	10.1371/journal.pone.0133428	http://dx.doi.org/10.1371/journal.pone.0133428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191797	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358546400082
J	Ruben, K; Wurzlbauer, A; Walte, A; Sippl, W; Bracher, F; Becker, W				Rueben, Katharina; Wurzlbauer, Anne; Walte, Agnes; Sippl, Wolfgang; Bracher, Franz; Becker, Walter			Selectivity Profiling and Biological Activity of Novel beta-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors	PLOS ONE			English	Article							DOWN-SYNDROME; PROTEIN-KINASES; ALZHEIMERS-DISEASE; DRUG DISCOVERY; MOUSE MODEL; CYCLIN D1; SPECIFICITY; FAMILY; PHOSPHORYLATION; HASPIN	DYRK1A is a pleiotropic protein kinase with diverse functions in cellular regulation, including cell cycle control, neuronal differentiation, and synaptic transmission. Enhanced activity and overexpression of DYRK1A have been linked to altered brain development and function in Down syndrome and neurodegenerative diseases such as Alzheimer's disease. The beta-carboline alkaloid harmine is a high affinity inhibitor of DYRK1A but suffers from the drawback of inhibiting monoamine oxidase A (MAO-A) with even higher potency. Here we characterized a series of novel harmine analogs with minimal or absent MAO-A inhibitory activity. We identified several inhibitors with submicromolar potencies for DYRK1A and selectivity for DYRK1A and DYRK1B over the related kinases DYRK2 and HIPK2. An optimized inhibitor, AnnH75, inhibited CLK1, CLK4, and haspin/GSG2 as the only off-targets in a panel of 300 protein kinases. In cellular assays, AnnH75 dose-dependently reduced the phosphorylation of three known DYRK1A substrates (SF3B1, SEPT4, and tau) without negative effects on cell viability. AnnH75 inhibited the cotranslational tyrosine autophosphorylation of DYRK1A and threonine phosphorylation of an exogenous substrate protein with similar potency. In conclusion, we have characterized an optimized beta-carboline inhibitor as a highly selective chemical probe that complies with desirable properties of drug-like molecules and is suitable to interrogate the function of DYRK1A in biological studies.	[Rueben, Katharina; Walte, Agnes; Becker, Walter] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Aachen, Germany; [Wurzlbauer, Anne; Bracher, Franz] Univ Munich, Ctr Drug Res, Dept Pharm, Munich, Germany; [Sippl, Wolfgang] Univ Halle Wittenberg, Inst Pharm, D-06108 Halle, Germany	RWTH Aachen University; University of Munich; Martin Luther University Halle Wittenberg	Becker, W (corresponding author), Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Aachen, Germany.	wbecker@ukaachen.de	Sippl, Wolfgang/P-5944-2014; Becker, Walter/B-8889-2008	Sippl, Wolfgang/0000-0002-5985-9261; Becker, Walter/0000-0002-0347-4768	German Research Foundation (DFG) [BE 1967/3-1, BR 1034/6-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG grants BE 1967/3-1 to WB and BR 1034/6-1 to FB; www.dfg.de).	Adayev T, 2011, ARCH BIOCHEM BIOPHYS, V507, P212, DOI 10.1016/j.abb.2010.12.024; Altafaj X, 2013, NEUROBIOL DIS, V52, P117, DOI 10.1016/j.nbd.2012.11.017; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Ashford AL, 2014, BIOCHEM J, V457, P43, DOI 10.1042/BJ20130461; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Becker W, 2014, CNS NEUROL DISORD-DR, V13, P26, DOI 10.2174/18715273113126660186; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Cohen P, 2010, BIOCHEM J, V425, P53, DOI 10.1042/BJ20091428; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; Cozza G, 2013, BBA-PROTEINS PROTEOM, V1834, P1402, DOI 10.1016/j.bbapap.2013.01.018; Cuny GD, 2012, BIOORG MED CHEM LETT, V22, P2015, DOI 10.1016/j.bmcl.2012.01.028; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; De la Torre R, 2014, MOL NUTR FOOD RES, V58, P278, DOI 10.1002/mnfr.201300325; Di Vona C, 2015, MOL CELL, V57, P506, DOI 10.1016/j.molcel.2014.12.026; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Drung B, 2014, BIOORG MED CHEM LETT, V24, P4854, DOI 10.1016/j.bmcl.2014.08.054; Eswaran J, 2010, BBA-PROTEINS PROTEOM, V1804, P429, DOI 10.1016/j.bbapap.2009.10.013; Falke H, 2015, J MED CHEM, V58, P3131, DOI 10.1021/jm501994d; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gao YH, 2013, BIOCHEM J, V451, P313, DOI 10.1042/BJ20121418; Garcia-Cerro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106572; Ginovart N, 2006, J CEREBR BLOOD F MET, V26, P330, DOI 10.1038/sj.jcbfm.9600197; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Hasegawa K, 2012, STEM CELL TRANSL MED, V1, P18, DOI 10.5966/sctm.2011-0033; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Higgins JMG, 2010, CHROMOSOMA, V119, P137, DOI 10.1007/s00412-009-0250-4; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Huertas D, 2012, ONCOGENE, V31, P1408, DOI 10.1038/onc.2011.335; Ionescu A, 2012, MINI-REV MED CHEM, V12, P1315; Keramati AR, 2014, NEW ENGL J MED, V370, P1909, DOI 10.1056/NEJMoa1301824; Knapp S, 2013, NAT CHEM BIOL, V9, P3, DOI 10.1038/nchembio.1113; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Mariano M, 2014, ACS CHEM NEUROSCI, V5, P1198, DOI 10.1021/cn5001815; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Park Joongkyu, 2013, Exp Neurobiol, V22, P244, DOI 10.5607/en.2013.22.4.244; Schmitt C, 2014, ACS MED CHEM LETT, V5, P963, DOI 10.1021/ml500059y; Schmitt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087851; Sitz JH, 2008, NEUROSCIENCE, V157, P596, DOI 10.1016/j.neuroscience.2008.09.034; Smith B, 2012, ACS CHEM NEUROSCI, V3, P857, DOI 10.1021/cn300094k; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104; Stefos GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067470; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Walte A, 2013, FEBS J, V280, P4495, DOI 10.1111/febs.12411; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013	57	46	46	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132453	10.1371/journal.pone.0132453	http://dx.doi.org/10.1371/journal.pone.0132453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192590	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400026
J	Wu, WT; Lin, YJ; Li, CY; Tsai, PJ; Yang, CY; Liou, SH; Wu, TN				Wu, Wei-Te; Lin, Yu-Jen; Li, Chung-Yi; Tsai, Perng-Jy; Yang, Chun-Yuh; Liou, Saou-Hsing; Wu, Trong-Neng			Cancer Attributable to Asbestos Exposure in Shipbreaking Workers: A Matched-Cohort Study	PLOS ONE			English	Article							SHIPYARD WORKERS; MORTALITY; WELDERS	Purpose Long-term follow-up studies of asbestos-related cancer in shipbreaking workers are lacking. This study examines the relationship between cancer incidence and asbestos exposure among former Taiwan shipbreaking workers. Methods A total of 4,427 shipbreaking workers and 22,135 population-based matched controls were successfully followed in this study. The study cohort was linked to the Taiwan Cancer Registry for new cancer cases. The adjusted hazard ratio (aHR) for cancer was calculated for the shipbreaking workers with Total Exposure Potential Scores (TEP) for asbestos. Results Follow-up generated 109,932 person-years, with 940 deaths and 436 cancer cases, among 4,427 shipbreaking workers from 1985 to 2008. The high asbestos exposure group also had a statistically significant increase in the risk of overall cancer (aHR= 1.71; 95% CI: 1.42-2.05), esophagus cancer (aHR= 2.31; 95% CI: 1.00-5.41), liver and intrahepatic bile duct cancer (aHR= 1.60; 95% CI: 1.08-2.36), and trachea, bronchus, and lung cancer (aHR= 3.08; 95% CI: 1.80-5.25). Mesothelioma cases were found in the high asbestos exposure group. Moreover, overall cancer, esophagus cancer, and trachea, bronchus, and lung cancer were seen in a dose-dependent relationship with asbestos exposure. Conclusions This study presented the elevated trend of asbestos exposure with cancer incidence for overall cancer, esophagus cancer, and trachea, bronchus, and lung cancer among shipbreaking workers. Those workers previously exposed to asbestos should receive persistent monitoring in order to early detect adverse health outcomes.	[Wu, Wei-Te; Yang, Chun-Yuh; Liou, Saou-Hsing; Wu, Trong-Neng] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Lin, Yu-Jen] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Tsai, Perng-Jy] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Yang, Chun-Yuh] Kaohsiung Med Univ, Inst Publ Hlth, Kaohsiung, Taiwan; [Wu, Trong-Neng] HungKuang Univ, Dept Nursing, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; Hungkuang University	Wu, TN (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan.	tnwu@hk.edu.tw	LI, CHUNG-YI/ABI-1419-2020; Wu, Wei-Te/S-8189-2019	LI, CHUNG-YI/0000-0002-0321-8908; 	National Health Research Institutes [EO-101-PP-07]; Institute of Occupational Safety and Health (IOSH), Taiwan, ROC [98-M-507]	National Health Research Institutes(National Health Research Institutes, Japan); Institute of Occupational Safety and Health (IOSH), Taiwan, ROC	This study was partly supported by National Health Research Institutes (EO-101-PP-07) and Institute of Occupational Safety and Health (IOSH 98-M-507), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartrip PWJ, 2004, POSTGRAD MED J, V80, P72, DOI 10.1136/pmj.2003.012526; Beckett WS, 2007, OCCUP ENVIRON MED, V64, DOI 10.1136/oem.2006.032284; Berry G, 2000, OCCUP ENVIRON MED, V57, P782, DOI 10.1136/oem.57.11.782; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Bureau of Health Promotion Ministry of Health and Welfare the Executive Yuan Taiwan, CANC REG ANN REP; Coleman M P, 1993, IARC Sci Publ, P1; dos Santos Silva I, 1999, CANC EPIDEMIOLOGY PR; Hein MJ, 2007, OCCUP ENVIRON MED, V64, P616, DOI 10.1136/oem.2006.031005; Kirkeleit J, 2013, AM J EPIDEMIOL; Krstev S, 2007, OCCUP ENVIRON MED, V64, P651, DOI 10.1136/oem.2006.029652; Ladou J, 2010, ENVIRON HEALTH PERSP, V118, P897, DOI 10.1289/ehp.1002285; Liu YK, 2003, J OCCUP HEALTH, V45, P36, DOI 10.1539/joh.45.36; MELKILD A, 1989, SCAND J WORK ENV HEA, V15, P387, DOI 10.5271/sjweh.1834; Musk AW, 2008, OCCUP ENVIRON MED, V65, P541, DOI 10.1136/oem.2007.034280; PETO J, 1985, ANN OCCUP HYG, V29, P305, DOI 10.1093/annhyg/29.3.305; Puntoni R, 2001, AM J IND MED, V40, P363, DOI 10.1002/ajim.1110; Rushworth DH, 2005, NAV ENG J, V117, P35, DOI 10.1111/j.1559-3584.2005.tb00336.x; SANDEN A, 1987, INT ARCH OCC ENV HEA, V59, P455, DOI 10.1007/BF00377839; Sarraf M., 2010, SHIP BREAKING RECYCL; SELIKOFF IJ, 1991, ANN NY ACAD SCI, V643, P1, DOI 10.1111/j.1749-6632.1991.tb24439.x; Shin Hai-Rim, 2008, J Prev Med Public Health, V41, P84; Shipbuilders Association of Japan, 2012, SHIPB STAT; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; TOLA S, 1988, BRIT J IND MED, V45, P209; Tsai SP, 2005, TOB CONTROL, V14, pI33, DOI 10.1136/tc.2003.005561; W.H.O. IARC, 2012, IARC MONOGRAPHS EVAL, P219; WHO (World Health Organization), 2006, ASB HIST; Wu WT, 2014, ENVIRON RES, V132, P370, DOI 10.1016/j.envres.2014.04.026; Wu WT, 2013, AM J IND MED, V56, P701, DOI 10.1002/ajim.22135	29	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133128	10.1371/journal.pone.0133128	http://dx.doi.org/10.1371/journal.pone.0133128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192180	gold, Green Published			2022-12-27	WOS:000358546400059
J	Yu, PT; Wang, YH; Coles, N; Xiong, W; Xu, LH				Yu, Pengtao; Wang, Yanhui; Coles, Neil; Xiong, Wei; Xu, Lihong			Simulation of Runoff Changes Caused by Cropland to Forest Conversion in the Upper Yangtze River Region, SW China	PLOS ONE			English	Article							WATER YIELD; CATCHMENT; EVAPOTRANSPIRATION; REDUCTION	The "Grain for Green Project" is a country-wide ecological program to converse marginal cropland to forest, which has been implemented in China since 2002. To quantify influence of this significant vegetation change, Guanslhe Hydrological (GSH) Model, a validated physically-based distributed hydrological model, was applied to simulate runoff responses to land use change in the Guansihe watershed that is located in the upper reaches of the Yangtze River basin in Southwestern China with an area of only 21.1 km2. Runoff responses to two single rainfall events, 90 mm and 206 mm respectively, were simulated for 16 scenarios of cropland to forest conversion. The model simulations indicated that the total runoff generated after conversion to forest was strongly dependent on whether the land was initially used for dry croplands without standing water in fields or constructed (or walled) paddy fields. The simulated total runoff generated from the two rainfall events displayed limited variation for the conversion of dry croplands to forest, while it strongly decreased after paddy fields were converted to forest. The effect of paddy terraces on runoff generation was dependent on the rainfall characteristics and antecedent moisture (or saturation) conditions in the fields. The reduction in simulated runoff generated from intense rainfall events suggested that afforestation and terracing might be effective in managing runoff and had the potential to mitigate flooding in southwestern China.	[Yu, Pengtao; Wang, Yanhui; Xiong, Wei; Xu, Lihong] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing 100091, Peoples R China; [Coles, Neil] Univ Western Australia, Sch Environm Syst Engn, Ctr Excellence Ecohydrol, Perth, WA 6009, Australia	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; University of Western Australia	Yu, PT (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing 100091, Peoples R China.	yupt@caf.ac.cn	xu, li/GNH-3667-2022; Coles, Neil/ABI-2884-2020; Coles, Neil/C-1669-2018; Coles, Neil/D-4027-2011	Coles, Neil/0000-0003-0289-4098; Coles, Neil/0000-0003-0289-4098; Coles, Neil/0000-0003-0289-4098	National Science Foundation of China (NSFC) [91225302]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The National Science Foundation of China (NSFC #91225302 to P.Y.) granted this work (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beven K, 1985, HYDROLOGICAL FORECAS, P405; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Brooks RH, 1964, HYDROLOGY PAPERS COL, V3, DOI DOI 10.13031/2013.40684; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Calder IR, 2006, WATER INT, V31, P87, DOI 10.1080/02508060608691918; D'Odorico P, 2006, DRYLAND ECOHYDROLOGY, P31, DOI 10.1007/1-4020-4260-4_3; Dye P, 2007, FOREST ECOL MANAG, V251, P121, DOI 10.1016/j.foreco.2007.06.013; FAO, 2000, GLOB FOR RES ASS 200, P140; FAO, 2011, CLIM CHANG WAT FOOD; FAO and CIFOR, 2005, FOR FLOODS DROWN FIC, V2; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; Foresight, 2011, FUT FOOD FARM 2011; Gao JX, 2002, THESIS NW AGR FOREST; Hofer T, 2006, FLOODS BANGLADESH HI, P252; Hoffmann WA, 2000, J CLIMATE, V13, P1593, DOI 10.1175/1520-0442(2000)013<1593:VCFITC>2.0.CO;2; Hu ZY, 2003, J SICHUAN FORESTRY S, V24, P17; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Jiao JuYing, 1999, Transactions of the Chinese Society of Agricultural Engineering, V15, P59; Jiao JY, 1999, TERR DEVEL MANAG, V9, P52; Kang LL, 2005, SCI SOIL WATER CONSE, V3, P51; Laurance WF, 2007, NATURE, V449, P409, DOI 10.1038/449409a; Lei XiaoZhang, 2005, Journal of Beijing Forestry University, V27, P20; Lei XZ, 2008, SCI SOIL WATER CONS, V6, P24; Li CZ, 2001, J SOIL WATER CONSERV, V15, P36; Li FuCheng, 2009, Research of Agricultural Modernization, V30, P727; Li YC, 2009, FORESTRY EC, V9, P4; Luo ZS, 2007, ACTA ECOLOGICA SINIC, V27, P1772; McCuen RH, 2006, J HYDROL ENG, V11, P597, DOI 10.1061/(ASCE)1084-0699(2006)11:6(597); PHILIP J. R., 1957, SOIL SCI, V83, P345, DOI 10.1097/00010694-195705000-00002; Qiu GY, 2011, J HYDROL, V411, P120, DOI 10.1016/j.jhydrol.2011.09.040; Roberts S, 2001, FOREST ECOL MANAG, V143, P153, DOI 10.1016/S0378-1127(00)00514-4; Robinson M, 2003, FOREST ECOL MANAG, V186, P85, DOI 10.1016/S0378-1127(03)00238-X; Sun G, 2005, J HYDROL, V308, P258, DOI 10.1016/j.jhydrol.2004.11.021; Sun G, 2008, J AM WATER RESOUR AS, V44, P1164, DOI 10.1111/j.1752-1688.2008.00241.x; Sun G, 2006, J HYDROL, V328, P548, DOI 10.1016/j.jhydrol.2005.12.013; TRIMBLE SW, 1987, WATER RESOUR RES, V23, P425, DOI 10.1029/WR023i003p00425; Vertessy RA, 2001, FOREST ECOL MANAG, V143, P13, DOI 10.1016/S0378-1127(00)00501-6; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang YH, 2010, EXPLORATION MULTIFUN; Wei XH, 2008, J AM WATER RESOUR AS, V44, P1076, DOI 10.1111/j.1752-1688.2008.00237.x; WHITEHEAD PG, 1993, J HYDROL, V145, P217, DOI 10.1016/0022-1694(93)90055-E; Wilcox BP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041929; Wu XX, 2010, J SICHUAN FORESTRY S, V31, P15; WWF (World Wide Fund for Nature), 2003, REP SUGG CHIN GRAIN; Yang JX, 2008, SCI SOIL WATER CONS, V6, P30; Yu PengTao, 2003, Scientia Silvae Sinicae, V39, P1; Yu PT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036744; Zhao RJ, 1984, HYDROLOGICAL SIMULAT; Zheng SW, 2009, J SICHUAN FORESTRY S, V30, P50; Zheng SW, 2010, J SICHUAN FORESTRY S, V31, P60	50	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132395	10.1371/journal.pone.0132395	http://dx.doi.org/10.1371/journal.pone.0132395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192181	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400023
J	Pellett, S; Tepp, WH; Scherf, JM; Johnson, EA				Pellett, Sabine; Tepp, William H.; Scherf, Jacob M.; Johnson, Eric A.			Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN-I; A NEUROTOXIN; ENDOCYTOSIS; ENTRY; PROTEINS; CELLS; MECHANISMS; SNAP-25; ASSAY	Botulinum neurotoxins (BoNTs) are the causative agent of the severe and long-lasting disease botulism. At least seven different serotypes of BoNTs (denoted A-G) have been described. All BoNTs enter human or animal neuronal cells via receptor mediated endocytosis and cleave cytosolic SNARE proteins, resulting in a block of synaptic vesicle exocytosis, leading to the flaccid paralysis characteristic of botulism. Previous data have indicated that once a neuronal cell has been intoxicated by a BoNT, further entry of the same or other BoNTs is prevented due to disruption of synaptic vesicle recycling. However, it has also been shown that cultured neurons exposed to BoNT/A are still capable of taking up BoNT/E. In this report we show that in general BoNTs can enter cultured human or mouse neuronal cells that have previously been intoxicated with another BoNT serotype. Quantitative analysis of cell entry by assessing SNARE cleavage revealed none or only a minor difference in the efficiency of uptake of BoNTs into previously intoxicated neurons. Examination of the endocytic entry pathway by specific endocytosis inhibitors indicated that BoNTs are taken up by clathrin coated pits in both non pre-exposed and pre-exposed neurons. LDH release assays indicated that hiPSC derived neurons exposed consecutively to two different BoNT serotypes remained viable and healthy except in the case of BoNT/E or combinations of BoNT/E with BoNT/B, /D, or /F. Overall, our data indicate that previous intoxication of neuronal cells with BoNT does not inhibit further uptake of BoNTs.	[Pellett, Sabine; Tepp, William H.; Scherf, Jacob M.; Johnson, Eric A.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pellett, S (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	sludwig@wisc.edu			National Institute of Allergy and Infectious Diseases [R01 AI093504]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093504] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases Award Number R01 AI093504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2001, TOXICON, V39, P233, DOI 10.1016/S0041-0101(00)00120-3; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Band PA, 2010, PROTEIN EXPRES PURIF, V71, P62, DOI 10.1016/j.pep.2009.12.013; Binz T, 2013, CURR TOP MICROBIOL, V364, P139, DOI 10.1007/978-3-642-33570-9_7; Blum FC, 2012, INFECT IMMUN, V80, P1662, DOI 10.1128/IAI.00057-12; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Couesnon A, 2009, CELL MICROBIOL, V11, P289, DOI 10.1111/j.1462-5822.2008.01253.x; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Dover N, 2009, J CLIN MICROBIOL, V47, P2349, DOI 10.1128/JCM.00799-09; Eleopra R, 1998, NEUROSCI LETT, V256, P135, DOI 10.1016/S0304-3940(98)00775-7; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; GIMENEZ DF, 1995, INT J FOOD MICROBIOL, V27, P1, DOI 10.1016/0168-1605(94)00144-U; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Hatheway C.L., 1988, LAB DIAGNOSIS INFECT, P111; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Johnson Eric A, 2008, Handb Clin Neurol, V91, P333, DOI 10.1016/S0072-9752(07)01511-4; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Keller JE, 2006, NEUROSCIENCE, V139, P629, DOI 10.1016/j.neuroscience.2005.12.029; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Keller JE, 2004, BIOCHEMISTRY-US, V43, P526, DOI 10.1021/bi0356698; Koch M, 2012, BBA-MOL CELL BIOL L, V1821, P1114, DOI 10.1016/j.bbalip.2012.02.008; Kroken AR, 2011, J BIOL CHEM, V286, P26828, DOI 10.1074/jbc.M111.254086; Leitz J, 2014, ELIFE, V3, DOI 10.7554/eLife.03658; Malizio CJ, 2000, METH MOL B, V145, P27; Meng JH, 2013, FASEB J, V27, P3167, DOI 10.1096/fj.13-228973; Montaner LJ, 1999, J IMMUNOL, V162, P4606; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Pantano S, 2014, CELL MOL LIFE SCI, V71, P793, DOI 10.1007/s00018-013-1380-7; Pellett S, 2007, FEBS LETT, V581, P4803, DOI 10.1016/j.febslet.2007.08.078; Pellett S, 2010, J PHARMACOL TOX MET, V61, P304, DOI 10.1016/j.vascn.2010.01.003; Peng LS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2462; Peng LS, 2012, J CELL SCI, V125, P3233, DOI 10.1242/jcs.103564; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; Prabakaran S, 2001, TOXICON, V39, P1515, DOI 10.1016/S0041-0101(01)00124-6; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2013, CURR TOP MICROBIOL, V364, P61, DOI 10.1007/978-3-642-33570-9_4; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; SCHANTZ EJ, 1978, J ASSOC OFF ANA CHEM, V61, P96; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Singh BR, 2010, BIOCHIMIE, V92, P1252, DOI 10.1016/j.biochi.2010.03.005; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tabares L, 2007, J NEUROSCI, V27, P5422, DOI 10.1523/JNEUROSCI.0670-07.2007; Vazquez-Cintron EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085517; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Whitemarsh RCM, 2012, TOXICOL SCI, V126, P426, DOI 10.1093/toxsci/kfr354; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739	58	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133737	10.1371/journal.pone.0133737	http://dx.doi.org/10.1371/journal.pone.0133737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207366	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000128
J	Yang, L; Yu, SJ; Hong, Q; Yang, Y; Shao, ZM				Yang, Liu; Yu, San-Jian; Hong, Qi; Yang, Yu; Shao, Zhi-Ming			Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer	PLOS ONE			English	Article							DNA METHYLATION; MAMMALIAN DNA; HUMAN-DISEASE; 5-HYDROXYMETHYLCYTOSINE; MALIGNANCIES; DYNAMICS; MELANOMA; CHINA	Purpose The purpose of this study was to determine the prognostic role of ten eleven translocation (TET) family proteins and DNA glycosylase (TDG) in patients with early breast cancer (EBC). Methods Expression of mRNAs encoding TET1-3 and TDG in 162 breast cancer tissues was quantified using real-time polymerase chain reaction analysis. The general characteristics of patients and clinicopathologic factors were collected. Estimation of patient survival was calculated using the Kaplan-Meier method, and independent prognostic indicators were analyzed using Cox regression analysis. Results The level of TET1 mRNA was significantly related to overall survival (OS) (P = 0.022). Multivariate analysis shows that the TNM stage was an independent predictor of disease-free survival (DFS) (HR = 1.761, 95% CI: 1.124-2.761, P = 0.014) and OS (HR = 2.135, 95% CI: 1.070-4.263, P = 0.032). Further, in patients with EBC who were treated with anthracy-clines, Kaplan-Meier analysis indicates that the levels of TET3 and TDG mRNAs were related to DFS (P = 0.026 and 0.030, respectively), and multivariate analysis reveals that high levels of TET3 (HR = 1.944, 95% CI: 1.029-3.672, P = 0.040) and TDG (HR = 2.178, 95% CI: 1.140-4.163, P = 0.018) mRNAs were independent indicators of favorable DFS. Conclusions Our study indicates that EBC patients with decreased expression of TET1 mRNA had worse OS and that the levels of TET3 and TDG mRNAs were independent prognostic factors for patients who received anthracycline chemotherapy.	[Yang, Liu; Yu, San-Jian; Hong, Qi; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Yang, Liu; Yu, San-Jian; Hong, Qi; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Hong, Qi; Shao, Zhi-Ming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yang, Yu] Chengdu Univ Tradit Chinese Med, Sch Basic Med Sci, Chengdu, Peoples R China	Fudan University; Fudan University; Fudan University; Chengdu University of Traditional Chinese Medicine	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [30971143, 30972936, 81302303]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Key Clinical Program of the Ministry of Health; Shanghai Key laboratory of Breast Cancer [12DZ2260100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai United Developing Technology Project of Municipal Hospitals; Key Clinical Program of the Ministry of Health; Shanghai Key laboratory of Breast Cancer	This research is supported by grants from the National Natural Science Foundation of China (30971143, 30972936, and 81302303), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Key Clinical Program of the Ministry of Health (2010-2012), and the Shanghai Key laboratory of Breast Cancer (12DZ2260100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet A, 2014, J GERONTOL A-BIOL, V69, pS17, DOI 10.1093/gerona/glu042; Chen L, 2012, BREAST CANCER RES TR, V136, P565, DOI 10.1007/s10549-012-2265-4; Chung YR, 2012, INT J HEMATOL, V96, P413, DOI 10.1007/s12185-012-1181-z; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Gambichler T, 2013, MELANOMA RES, V23, P218, DOI 10.1097/CMR.0b013e32835f9bd4; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hassan MSU, 2010, ONCOL REP, V24, P1121, DOI 10.3892/or_00000963; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hong W, 2014, CANCER LETT, V351, P1, DOI 10.1016/j.canlet.2014.04.007; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Justo N, 2013, ONCOLOGIST, V18, P248, DOI 10.1634/theoncologist.2012-0373; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Milstein M, 2007, CANCER RES, V67, P11510, DOI 10.1158/0008-5472.CAN-07-1147; Nickerson ML, 2013, HUM MUTAT, V34, P1231, DOI 10.1002/humu.22346; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi S, 2013, INT J MOL MED, V32, P532, DOI 10.3892/ijmm.2013.1417; Takeshima H, 2015, CARCINOGENESIS, V36, P192, DOI 10.1093/carcin/bgu238; Thiagarajan RD, 2014, EPIGENOMICS-UK, V6, P121, DOI 10.2217/epi.13.80; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu Q, 2014, ONCOTARGET, V5, P11552, DOI 10.18632/oncotarget.2594; Wu YC, 2014, HISTOL HISTOPATHOL, V29, P991, DOI 10.14670/HH-29.991; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	29	47	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133896	10.1371/journal.pone.0133896	http://dx.doi.org/10.1371/journal.pone.0133896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207381	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000168
J	Zhu, ZB; Yuan, DJ; Luo, DH; Lu, XT; Huang, S				Zhu, Zuobin; Yuan, Dejian; Luo, Denghui; Lu, Xitong; Huang, Shi			Enrichment of Minor Alleles of Common SNPs and Improved Risk Prediction for Parkinson's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LRRK2 MUTATION; EFFECT SIZES; GENE; COMPLEX; FREQUENT; ATP13A2; VPS35	Parkinson disease (PD) is the second most common neurodegenerative disorder in the aged population and thought to involve many genetic loci. While a number of individual single nucleotide polymorphisms (SNPs) have been linked with PD, many remain to be found and no known markers or combinations of them have a useful predictive value for sporadic PD cases. The collective effects of genome wide minor alleles of common SNPs, or the minor allele content (MAC) in an individual, have recently been shown to be linked with quantitative variations of numerous complex traits in model organisms with higher MAC more likely linked with lower fitness. Here we found that PD cases had higher MAC than matched controls. A set of 37564 SNPs with MA (MAF < 0.4) more common in cases (P < 0.05) was found to have the best predictive accuracy. A weighted risk score calculated by using this set can predict 2% of PD cases (100% specificity), which is comparable to using familial PD genes to identify familial PD cases. These results suggest a novel genetic component in PD and provide a useful genetic method to identify a small fraction of PD cases.	[Zhu, Zuobin; Yuan, Dejian; Luo, Denghui; Lu, Xitong; Huang, Shi] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China	Central South University	Huang, S (corresponding author), Cent S Univ, State Key Lab Med Genet, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	huangshi@sklmg.edu.cn		zhu, zuobin/0000-0003-1022-5943	National Natural Science Foundation of China grant [81171880]; National Basic Research Program of China grant [2011CB51001]	National Natural Science Foundation of China grant(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China grant(National Basic Research Program of China)	This work was supported by The National Natural Science Foundation of China grant, grant number: 81171880, (URL: http://www.nsfc.gov.cn/) and The National Basic Research Program of China grant, grant number: 2011CB51001 (SH) (URL: http://www.nsfc.gov.cn/).	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chen Bowang, 2009, BMC Res Notes, V2, P214, DOI 10.1186/1756-0500-2-214; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Di Fonzo A, 2005, LANCET, V365, P412; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Fung KL, 2014, CANCER RES, V74, P598, DOI 10.1158/0008-5472.CAN-13-2064; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Hall TO, 2013, GENET MED, V15, P361, DOI 10.1038/gim.2012.109; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hand DJ, 2010, STAT MED, V29, P1502, DOI 10.1002/sim.3859; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Hu TB, 2013, SCI CHINA LIFE SCI, V56, P254, DOI 10.1007/s11427-013-4452-x; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kang J, 2011, HUM MOL GENET, V20, P2435, DOI 10.1093/hmg/ddr116; Kay DM, 2006, MOVEMENT DISORD, V21, P519, DOI 10.1002/mds.20751; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Pepe MS, 2008, JNCI-J NATL CANCER I, V100, P978, DOI 10.1093/jnci/djn215; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yuan D., 2012, ARXIV12092911; Yuan DJ, 2014, SCI CHINA LIFE SCI, V57, P876, DOI 10.1007/s11427-014-4704-4; Zhu Z, 2015, GENOMICS; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	46	15	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133421	10.1371/journal.pone.0133421	http://dx.doi.org/10.1371/journal.pone.0133421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207627	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000089
J	Neufurth, M; Wang, XH; Tolba, E; Dorweiler, B; Schroder, HC; Link, T; Diehl-Seifert, B; Muller, WEG				Neufurth, Meik; Wang, Xiaohong; Tolba, Emad; Dorweiler, Bernhard; Schroeder, Heinz C.; Link, Thorben; Diehl-Seifert, Baerbel; Mueller, Werner E. G.			Modular Small Diameter Vascular Grafts with Bioactive Functionalities	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; CALCIUM POLYPHOSPHATE; ALKALINE-PHOSPHATASE; ENDOTHELIAL-CELLS; VE-CADHERIN; STEM-CELLS; ADHESION; EXPRESSION; BYPASS; PROLIFERATION	We report the fabrication of a novel type of artificial small diameter blood vessels, termed biomimetic tissue-engineered blood vessels (bTEBV), with a modular composition. They are composed of a hydrogel scaffold consisting of two negatively charged natural polymers, alginate and a modified chitosan, N,O-carboxymethyl chitosan (N,O-CMC). Into this biologically inert scaffold two biofunctionally active biopolymers are embedded, inorganic polyphosphate (polyP) and silica, as well as gelatin which exposes the cell recognition signal, Arg-Gly-Asp (RGD). These materials can be hardened by exposure to Ca2+ through formation of Ca2+ bridges between the polyanions, alginate, N, O-CMC, and polyP (alginate-Ca2+-N,O-CMC-polyP). The bTEBV are formed by pressing the hydrogel through an extruder into a hardening solution, containing Ca2+. In this universal scaffold of the bTEBV biomaterial, polycations such as poly(L-Lys), poly(D-Lys) or a His/Gly-tagged RGD peptide (three RGD units) were incorporated, which promote the adhesion of endothelial cells to the vessel surface. The mechanical properties of the biopolymer material (alginate-Ca2+-N,O-CMC-polyP-silica) revealed a hardness (elastic modulus) of 475 kPa even after a short incubation period in CaCl2 solution. The material of the artificial vascular grafts (bTEBVs with an outer size 6 mm and 1.8 mm, and an inner diameter 4 mm and 0.8 mm, respectively) turned out to be durable in 4-week pulsatile flow experiments at an alternating pressure between 25 and 100 mbar (18.7 and 75.0 mm Hg). The burst pressure of the larger (smaller) vessels was 850 mbar (145 mbar). Incorporation of polycationic poly(L-Lys), poly(D-Lys), and especially the His/Gly-tagged RGD peptide, markedly increased the adhesion of human, umbilical vein/vascular endothelial cells, EA.HY926 cells, to the surface of the hydrogel. No significant effect of the polyP samples on the clotting of human plasma is measured. We propose that the metabolically degradable polymeric scaffold bTEBV is a promising biomaterial for future prosthetic vascular grafts.	[Neufurth, Meik; Wang, Xiaohong; Tolba, Emad; Schroeder, Heinz C.; Link, Thorben; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, D-55128 Mainz, Germany; [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Cardiothorac & Vasc Surg, Div Vasc Surg, D-55131 Mainz, Germany; [Diehl-Seifert, Baerbel] NanotecMARIN GmbH, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Muller, WEG (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.	wang013@uni-mainz.de; wmueller@uni-mainz.de	Müller, W. E. G./AAR-8651-2020; wang, jie/GRS-0942-2022; Wang, Xiaohong/AAR-5526-2020; Wang, Zhong Lin/E-2176-2011; Neufurth, Meik/N-4297-2015; Tolba, Emad/E-1049-2016	Müller, W. E. G./0000-0002-8223-3689; Wang, Zhong Lin/0000-0002-5530-0380; Neufurth, Meik/0000-0002-2383-6412; Schroder, Heinz C./0000-0003-0992-6427; Tolba, Emad/0000-0002-3422-2344	NanotecMARIN GmbH; European Research Council (ERC) Advanced Investigator Grant ("BIOSILICA") [268476]; ERC-PoC Grant ("MorphoVES-PoC") [662486]; Deutsche Forschungsgemeinschaft [Schr 277/10-3]; European Commission [604036, 311848]; International Human Frontier Science Program	NanotecMARIN GmbH; European Research Council (ERC) Advanced Investigator Grant ("BIOSILICA")(European Research Council (ERC)); ERC-PoC Grant ("MorphoVES-PoC"); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); International Human Frontier Science Program(Human Frontier Science Program)	NanotecMARIN GmbH provided support in the form of salaries for the author BDS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. WEGM is a holder of a European Research Council (ERC) Advanced Investigator Grant ("BIOSILICA": No. 268476) and the ERC-PoC Grant ("MorphoVES-PoC": No. 662486). This work was supported by grants from the Deutsche Forschungsgemeinschaft (Schr 277/10-3), the European Commission ("Bio-Scaffolds": No. 604036 and "BlueGenics": No. 311848), and the International Human Frontier Science Program.	AHN K, 1995, LIFE SCI, V56, P2331, DOI 10.1016/0024-3205(95)00227-W; ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227; Anitha A, 2012, J BIOMAT SCI-POLYM E, V23, P1381, DOI 10.1163/092050611X581534; Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028; [Anonymous], 2013, REPORT A270; [Anonymous], 2010, HEART DISEASE AND ST; BARSTAD RM, 1995, BLOOD, V86, P212, DOI 10.1182/blood.V86.1.212.bloodjournal861212; Bergmeister H, 2013, EUR SURG, V45, P187, DOI 10.1007/s10353-013-0224-x; Biswas R, 2010, SEMIN DIALYSIS, V23, P105, DOI 10.1111/j.1525-139X.2009.00684.x; Boura C, 2006, BIO-MED MATER ENG, V16, pS115; Boura C, 2006, CELL BIOCHEM BIOPHYS, V44, P223, DOI 10.1385/CBB:44:2:223; Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007; Brewster DC, 2000, VASCULAR SURG, P559; Brini Marisa, 2013, Met Ions Life Sci, V13, P81, DOI 10.1007/978-94-007-7500-8_4; Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Campos DFD, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015003; Catto V, 2014, ISRN VASC MED, V2014, DOI [DOI 10.1155/2014/923030, 10.1155/2014/923030]; Chavan D, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4766959; Chavan D, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3579496; Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002; Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Comeau PA, 2012, J BIOMATER APPL, V27, P267, DOI 10.1177/0885328211401933; Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009; Demirkhanyan L, 2014, BIOPHYS J, V106, p753A, DOI 10.1016/j.bpj.2013.11.4145; Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101; Do KH, 2009, EXP MOL MED, V41, P569, DOI 10.3858/emm.2009.41.8.062; Embi A, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-51; Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005; Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870; Faxalv L, 2013, BLOOD, V122, P3818, DOI 10.1182/blood-2013-05-499384; Felner JM, 1990, CLINICAL METHODS THE, P57; Fischer-Cripps AC, 2011, MECH ENG SER, P21, DOI 10.1007/978-1-4419-9872-9_2; Gorzelanny C, 2010, BIOMATERIALS, V31, P8556, DOI 10.1016/j.biomaterials.2010.07.100; Gu ZP, 2014, RSC ADV, V4, P2783, DOI 10.1039/c3ra44323j; Hanson SR, 2006, ANN NY ACAD SCI, V516, P453; He W, 2013, CELL BIOCHEM BIOPHYS, V66, P855, DOI 10.1007/s12013-013-9528-5; Heng BC, 2011, BIOTECHNOL BIOPROC E, V16, P127, DOI 10.1007/s12257-010-0141-9; Hojo K, 2013, PROTEIN PEPTIDE LETT, V20, P1122; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kader KN, 2000, TISSUE ENG, V6, P241, DOI 10.1089/10763270050044425; Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027; Kulaev IS, 2004, THE BIOCHEMISTRY OF, P1; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; Lee KY, 1997, J APPL POLYM SCI, V63, P425, DOI 10.1002/(SICI)1097-4628(19970124)63:4<425::AID-APP3>3.0.CO;2-T; Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803; Linderman S, 2014, FASEB J, V28; Loh SA, 2013, ANN VASC SURG, V27, P208, DOI 10.1016/j.avsg.2012.04.018; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; MacQuarrie JL, 2011, BLOOD, V117, P4134, DOI 10.1182/blood-2010-07-290551; MASSIA SP, 1992, J BIOL CHEM, V267, P14019; Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823; Mori K, 2007, ONCOL REP, V18, P1365; Moroni F, 2014, AM J STEM CELLS, V3, P1; Muller WEG, 2015, J TISSUE ENG REGEN M, V9, pE39, DOI 10.1002/term.1745; Muller WEG, 2015, J MATER CHEM B, V3, P1722, DOI 10.1039/c4tb01586j; Muller WEG, 2013, BIOMATER SCI-UK, V1, P669, DOI 10.1039/c3bm00001j; Muller WEG, 2011, ACTA BIOMATER, V7, P2661, DOI 10.1016/j.actbio.2011.03.007; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Muller WEG, 2014, Patent application, Patent No. [1413154. 4, 14131544]; Neufurth M, 2014, BIOMATERIALS, V35, P8810, DOI 10.1016/j.biomaterials.2014.07.002; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Nikolova-Krstevski V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-240; Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375; Pradeepa R, 2012, DIABETES TECHNOL THE, V14, pS59, DOI 10.1089/dia.2012.0065; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; SACHS L, 1984, ANGEW STAT, P242; Sakairi N, 1998, CARBOHYD POLYM, V37, P409, DOI 10.1016/S0144-8617(97)00226-9; Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04; Santos MF, 1997, AM J PHYSIOL-GASTR L, V273, pG175, DOI 10.1152/ajpgi.1997.273.1.G175; Sarkar S, 2006, J VASC SURG, V44, P846, DOI 10.1016/j.jvs.2006.07.023; Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5; Schroder HC, 2003, PROG MOLEC, V33, P249; Shantouf R, 2009, CLIN J AM SOC NEPHRO, V4, P1106, DOI 10.2215/CJN.06091108; Smith Paul J, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0725s28; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285; Takei Takayuki, 2006, Biotechnology Journal, V1, P1014, DOI 10.1002/biot.200600055; Tielen P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-159; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van Andel CJ, 2003, ANN THORAC SURG, V76, P58, DOI 10.1016/S0003-4975(03)00263-7; VANDERLUGT A, 1995, EUR J VASC ENDOVASC, V9, P394, DOI 10.1016/S1078-5884(05)80006-1; VANSON JAM, 1990, J THORAC CARDIOV SUR, V99, P703; Varty K, 1996, BRIT J SURG, V83, P1375, DOI 10.1002/bjs.1800831015; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wang XH, 2014, MAR DRUGS, V12, P1131, DOI 10.3390/md12021131; Welschoff J, 2014, FASEB J, V28, P2281, DOI 10.1096/fj.13-246348; Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6; YOSHIKI S, 1970, HISTOCHEMISTRY, V21, P249, DOI 10.1007/BF00304216; Zidi M, 2003, COMPUT BIOL MED, V33, P65, DOI 10.1016/S0010-4825(02)00059-8; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	95	22	22	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133632	10.1371/journal.pone.0133632	http://dx.doi.org/10.1371/journal.pone.0133632			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204529	Green Published, Green Submitted, gold			2022-12-27	WOS:000358621000034
J	Hernandez-Pando, R; Barrios-Payan, J; Mata-Espinosa, D; Marquina-Castillo, B; Hernandez-Ramirez, D; Botasso, OA; Bini, EI				Hernandez-Pando, Rogelio; Barrios-Payan, Jorge; Mata-Espinosa, Dulce; Marquina-Castillo, Brenda; Hernandez-Ramirez, Diego; Adelmo Botasso, Oscar; Isabel Bini, Estela			The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis	PLOS ONE			English	Article							CHROMOSOMAL-PROTEINS; CELL RECRUITMENT; RELEASE; INFLAMMATION; CYTOKINE; LOCALIZATION; ACTIVATION; APOPTOSIS; KINETICS	Background The high mobility group box 1 (HMGB1) is the prototype of alarmin protein released by stressed or dying cells. The redox state of this protein confers different functions in the regulation of inflammation and immune response. Aim Determine the kinetics, cellular sources and function of HMGB1 in experimental tuberculosis. Methods BALB/c mice were infected with Mycobacterium tuberculosis strain H37Rv. At different time points, HMGB1 was quantified in bronchial lavage fluid (BALF) and in lungs was determined its cellular sources by immunohistochemistry. HMGB1 was blocked with specific antibodies or recombinant HMGB1 was administered during early or late infection. Bacilli burdens, inflammation and cytokines expression were determined. Results The maximal concentration of HMGB1 in BALF was at day one of infection. Bronchial epithelium and macrophages were the most important sources. At day 7 to 21 the oxidized HMGB1 was predominant, while during late infection only the reduced form was seen. Blocking HMGB1 during early infection produced significant decrease of bacilli burdens and high production of pro-inflammatory cytokines, while the opposite was seen when HMGB1 was administered. Blocking HMGB1 activity or administrated it in high amounts during late infection worsening the disease. Conclusions HMGB1 is liberated during experimental tuberculosis and promotes or suppress the immune response and inflammation depending on the redox state.	[Hernandez-Pando, Rogelio; Barrios-Payan, Jorge; Mata-Espinosa, Dulce; Marquina-Castillo, Brenda; Isabel Bini, Estela] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City 14000, DF, Mexico; [Hernandez-Ramirez, Diego] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Immunol, Mexico City 14000, DF, Mexico; [Adelmo Botasso, Oscar; Isabel Bini, Estela] Inst Expt & Clin Immunol, Rosario, Santa Fe, Argentina; [Adelmo Botasso, Oscar; Isabel Bini, Estela] Consejo Nacl Invest Cient & Tecn, IDICER, Sch Med Sci, RA-3100 Santa Fe, Argentina; [Adelmo Botasso, Oscar; Isabel Bini, Estela] Consejo Nacl Invest Cient & Tecn, IDICER, Sch Med Sci, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bini, EI (corresponding author), Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City 14000, DF, Mexico.	estelabini@yahoo.com.ar	Bini, Estela/F-8924-2018	Bini, Estela/0000-0001-9256-429X; Hernandez-Ramirez, Diego/0000-0001-7293-2278; Hernandez-Pando, Rogelio/0000-0003-1292-3833	DMM Company of Biologists, England; Bilateral International Project Argentina/Mexico, CONICET/CONACYT [190527]	DMM Company of Biologists, England; Bilateral International Project Argentina/Mexico, CONICET/CONACYT	Estela Isabel Bini was awarded with a travelling fellowship from DMM Company of Biologists, England. This work was supported by the Bilateral International Project Argentina/Mexico, CONICET/CONACYT, number 190527.	Adolfo RBV, 2006, EUR J IMMUNOL, V36, P345, DOI 10.1002/eji.200535202; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Hernandez-Pando R, 2001, EXP TOXICOL PATHOL, V53, P257, DOI 10.1078/0940-2993-00182; HernandezPando R, 1997, IMMUNOLOGY, V90, P607, DOI 10.1046/j.1365-2567.1997.00193.x; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Jiang WW, 2007, J IMMUNOL, V178, P6495, DOI 10.4049/jimmunol.178.10.6495; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Li GQ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00068; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pisetsky DS, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13256; Rook GAW, 1996, ANNU REV MICROBIOL, V50, P259, DOI 10.1146/annurev.micro.50.1.259; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wild CA, 2012, INT IMMUNOL, V24, P485, DOI 10.1093/intimm/dxs051; Wu AH, 2015, EVID BASE COMPL ALTE, V2015, P1; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang LT, 2008, SHOCK, V30, P449, DOI 10.1097/SHK.0b013e3181672495	37	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133200	10.1371/journal.pone.0133200	http://dx.doi.org/10.1371/journal.pone.0133200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201072	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100056
J	Johnston, DW; Frungillo, J; Smith, A; Moore, K; Sharp, B; Schuh, J; Read, AJ				Johnston, David W.; Frungillo, Jaime; Smith, Ainsley; Moore, Katie; Sharp, Brian; Schuh, Janelle; Read, Andrew J.			Trends in Stranding and By-Catch Rates of Gray and Harbor Seals along the Northeastern Coast of the United States: Evidence of Divergence in the Abundance of Two Sympatric Phocid Species?	PLOS ONE			English	Article							HALICHOERUS-GRYPUS; GREY SEALS; POPULATION TRENDS; DISTEMPER VIRUS; SABLE-ISLAND; VITULINA; MORTALITY; MASSACHUSETTS; INFLUENZA	Harbor seals and gray seals are sympatric phocid pinnipeds found in coastal waters of the temperate and sub-Arctic North Atlantic. In the Northwest Atlantic, both species were depleted through a combination of subsistence hunts and government supported bounties, and are now re-occupying substantial portions of their original ranges. While both species appear to have recovered during the past 2 decades, our understanding of their population dynamics in US waters is incomplete. Here we describe trends in stranding and bycatch rates of harbor and gray seals in the North East United States (NEUS) over the past 16 years through an exploratory curve-fitting exercise and structural break-point analysis. Variability in gray seal strandings in Southern New England and bycatch in the Northeast Sink Gillnet Fishery were best described by fitting positive exponential and linear models, and exhibited rates of increase as high as 22%. In contrast, neither linear nor exponential models fit the oscillation of harbor seal strandings and bycatch over the study period. However, a breakpoint Chow test revealed that harbor seal strandings in the Cape Cod, Massachusetts region and harbor seal bycatch in the Northeast Sink Gillnet Fishery increased in the 1990s and then started declining in the early to mid-2000s. Our analysis indicates that ongoing variation in natural and anthropogenic mortality rates of harbor and gray seals in the NEUS is not synchronous, and likely represents diverging trends in abundance of these species as they assume new roles in the marine ecosystems of the region.	[Johnston, David W.; Frungillo, Jaime; Smith, Ainsley; Read, Andrew J.] Duke Univ, Nicholas Sch Environm, Marine Lab, Div Marine Sci & Conservat, Beaufort, NC 28516 USA; [Smith, Ainsley] Integrated Stat, Woods Hole, MA 02543 USA; [Moore, Katie; Sharp, Brian] Int Fund Anim Welf, Marine Mammal Rescue & Res Program, Yarmouth Port, MA 02675 USA; [Schuh, Janelle] Sea Res Fdn, Anim Rescue Program, Mystic, CT 06355 USA	Duke University	Johnston, DW (corresponding author), Duke Univ, Nicholas Sch Environm, Marine Lab, Div Marine Sci & Conservat, 135 Duke Marine Lab Rd, Beaufort, NC 28516 USA.	david.johnston@duke.edu	Read, Andrew/AAE-8386-2019; Johnston, David/AAJ-5013-2020	Frungillo, Jaime/0000-0001-5636-0927; Johnston, David/0000-0003-2424-036X	Duke University Marine Laboratory	Duke University Marine Laboratory	This project would not have been possible without the help of the many volunteers who contributed to stranding response in the NEUS. We would like to thank Jerry Moxley, Susan Heaslip, Kristina Cammen, Ari Friedlaender, Nichola Hill and Wendy Puryear for providing feedback on drafts of this manuscript. This paper constitutes Sea Research Foundation publication #254. This project was supported in part by the Duke University Marine Laboratory.	Baird RW, 2001, CAN FIELD NAT, V115, P663; Barlas ME, 1999, DISTRIBUTION ABUNDAN; Bodewes R, 2015, EMERGING INFECT DIS, V21; Bodewes R, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.2; Boehme L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053000; Bogomolni AL, 2010, DIS AQUAT ORGAN, V88, P143, DOI 10.3354/dao02146; Bowen WD, 2003, ICES J MAR SCI, V60, P1265, DOI 10.1016/S1054-3139(03)00147-4; Bowen WD, 2003, J ZOOL, V261, P155, DOI 10.1017/S0952836903004047; Brasseur SMJM, 2015, MAR MAMMAL SCI, V31, P405, DOI 10.1111/mms.12160; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; CORNWELL HJC, 1992, SCI TOTAL ENVIRON, V115, P99, DOI 10.1016/0048-9697(92)90036-R; Curtis TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099240; DiGiovanni R, 2011, 19 BIENN C BIOL MAR; Geraci JR., 1993, MARINE MAMMALS ASHOR, P371; GILMARTIN WG, 1995, CAN J ZOOL, V73, P1185, DOI 10.1139/z95-141; HANSEN S, 1995, PHYSIOL ZOOL, V68, P290, DOI 10.1086/physzool.68.2.30166505; Hanson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080727; Harris DE, 2003, NORTHEAST NAT, V10, P141, DOI 10.2307/3858283; Hayes S.A., 2012, DRAFT US ATLANTIC GU, P96; Johnston DW, 2012, PLOS ONE, V7; Lelli B, 2009, NORTHEAST NAT, V16, P239, DOI 10.1656/045.016.0206; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; Lonergan M, 2011, ICES J MAR SCI, V68, P2201, DOI 10.1093/icesjms/fsr161; Lucas Z, 2000, J ZOOL, V252, P405, DOI 10.1017/S0952836900000157; McPherson JM, 2009, DIVERS DISTRIB, V15, P880, DOI 10.1111/j.1472-4642.2009.00596.x; Mowat F., 2004, SEA OF SLAUGHTER; Murray MJ, 2008, BEHAV INTERACTIONS H; Osinga N, 2012, J COMP PATHOL, V147, P550, DOI 10.1016/j.jcpa.2012.04.001; Pannozzo L., 2013, DEVIL DEEP BLUE SEA; Peltier H, 2014, ECOL INDIC, V39, P203, DOI 10.1016/j.ecolind.2013.12.019; Pyenson ND, 2011, P ROY SOC B-BIOL SCI, V278, P3608, DOI 10.1098/rspb.2011.0441; R Core Team, 2021, R LANGUAGE ENV STAT; Runstadler J, 2013, INFECT GENET EVOL, V17, P162, DOI 10.1016/j.meegid.2013.02.020; Skomal Gregory B., 2012, P405; Soulen BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068779; Svensson CJ, 2011, AMBIO, V40, P52, DOI 10.1007/s13280-010-0091-7; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thompson Dave, 2010, NAMMCO Scientific Publications, V8, P117; van Neer A, 2014, J SEA RES ELSEVIER B, V97, P1; Waring GT, 2013, US ATLANTIC IN PRESS, P236; WEBSTER RG, 1981, VIROLOGY, V113, P712, DOI 10.1016/0042-6822(81)90200-2; Wood SA, 2011, CAN J ZOOL, V89, P490, DOI 10.1139/Z11-012	43	8	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131660	10.1371/journal.pone.0131660	http://dx.doi.org/10.1371/journal.pone.0131660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200461	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100019
J	Malik, A; Lee, EJ; Jan, AT; Ahmad, S; Cho, KH; Kim, J; Choi, I				Malik, Adeel; Lee, Eun Ju; Jan, Arif Tasleem; Ahmad, Sarafraz; Cho, Kyung-Hyun; Kim, Jihoe; Choi, Inho			Network Analysis for the Identification of Differentially Expressed Hub Genes Using Myogenin Knock-down Muscle Satellite Cells	PLOS ONE			English	Article							COMMUNITY STRUCTURE; CYCLE WITHDRAWAL; SKELETAL; MYOD; MYF-5; ROLES; IG	Muscle, a multinucleate syncytium formed by the fusion of mononuclear myoblasts, arises from quiescent progenitors (satellite cells) via activation of muscle-specific transcription factors (MyoD, Myf5, myogenin: MYOG, and MRF4). Subsequent to a decline in Pax7, induction in the expression of MYOG is a hallmark of myoblasts that have entered the differentiation phase following cell cycle withdrawal. It is evident that MYOG function cannot be compensated by any other myogenic regulatory factors (MRFs). Despite a plethora of information available regarding MYOG, the mechanism by which MYOG regulates muscle cell differentiation has not yet been identified. Using an RNA-Seq approach, analysis of MYOG knock-down muscle satellite cells (MSCs) have shown that genes associated with cell cycle and division, DNA replication, and phosphate metabolism are differentially expressed. By constructing an interaction network of differentially expressed genes (DEGs) using Gene-MANIA, cadherin-associated protein (CTNNA2) was identified as the main hub gene in the network with highest node degree. Four functional clusters (modules or communities) were identified in the network and the functional enrichment analysis revealed that genes included in these clusters significantly contribute to skeletal muscle development. To confirm this finding, in vitro studies revealed increased expression of CTNNA2 in MSCs on day 12 compared to day 10. Expression of CTNNA2 was decreased in MYOG knock-down cells. However, knocking down CTNNA2, which leads to increased expression of extracellular matrix (ECM) genes (type I collagen alpha 1 and type I collagen alpha 2) along with myostatin (MSTN), was not found significantly affecting the expression of MYOG in C2C12 cells. We therefore propose that MYOG exerts its regulatory effects by acting upstream of CTNNA2, which in turn regulates the differentiation of C2C12 cells via interaction with ECM genes. Taken together, these findings highlight a new mechanism by which MYOG interacts with CTNNA2 in order to promote myoblast differentiation.	[Malik, Adeel; Lee, Eun Ju; Jan, Arif Tasleem; Ahmad, Sarafraz; Cho, Kyung-Hyun; Kim, Jihoe; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Malik, Adeel] Perdana Univ, Ctr Bioinformat, Serdang 43400, Selangor, Malaysia; [Lee, Eun Ju; Choi, Inho] Yeungnam Univ, Bovine Genome Resources Bank, Gyongsan, South Korea	Yeungnam University; Perdana University; Yeungnam University	Choi, I (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	inhochoi@ynu.ac.kr	Jan, Arif Tasleem/AAX-6531-2020; Malik, Adeel/ABD-4831-2020	Jan, Arif Tasleem/0000-0002-3607-543X; Malik, Adeel/0000-0002-3453-6001	National Research Foundation of Korea (NRF) - Republic of Korea government (MSIP) [2014R1A2A2A01006324]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2059308]	National Research Foundation of Korea (NRF) - Republic of Korea government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Republic of Korea government (MSIP; no. 2014R1A2A2A01006324) along with the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2059308).	Abe T, 2004, BRAIN RES, V1009, P159, DOI 10.1016/j.brainres.2004.03.003; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; [Anonymous], INT J INFORM TECHNOL; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bischoff R, 1994, MYOLOGY, P97; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; COSSU G, 1987, CURR TOP DEV BIOL, V23, P185; Desaphy JF, 1998, AM J PHYSIOL-CELL PH, V275, pC1465, DOI 10.1152/ajpcell.1998.275.6.C1465; Dinh P, 2007, BREAST, V16, pS10, DOI 10.1016/j.breast.2007.07.032; Firoz A, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/837365; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Janot M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-483; Kablar B, 1998, BIOCHEM CELL BIOL, V76, P1079, DOI 10.1139/bcb-76-6-1079; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079780; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063627; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060372; Lee Seung-Hwan, 2014, J Anim Sci Technol, V56, P2, DOI 10.1186/2055-0391-56-2; Li Y, 2010, INT J BIOL SCI, V6, P350; Liu QC, 2012, J MOL CELL BIOL, V4, P386, DOI 10.1093/jmcb/mjs045; Malik A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095480; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Mohun T, CURR OPIN CELL BIOL, V4, P923; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; OLSON EN, 1991, MOL CELL BIOCHEM, V104, P7; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Rajan S, 2012, PHYSIOL GENOMICS, V44, P183, DOI 10.1152/physiolgenomics.00093.2011; RAWLS A, 1995, DEV BIOL, V172, P37, DOI 10.1006/dbio.1995.0004; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; van Dongen S, MCL ALGORITHM CLUSTE; Van Dongen SM, 2000, THESIS U UTRECHT NET; Wang YK, 1997, DEVELOPMENT, V124, P2507; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wicik Z, 2011, POL J VET SCI, V14, P643, DOI 10.2478/v10181-011-0095-7	52	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133597	10.1371/journal.pone.0133597	http://dx.doi.org/10.1371/journal.pone.0133597			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200109	gold, Green Published, Green Submitted			2022-12-27	WOS:000358597100073
J	Dorantes-Aranda, JJ; Seger, A; Mardones, JI; Nichols, PD; Hallegraeff, GM				Dorantes-Aranda, Juan Jose; Seger, Andreas; Mardones, Jorge I.; Nichols, Peter D.; Hallegraeff, Gustaaf M.			Progress in Understanding Algal Bloom-Mediated Fish Kills: The Role of Superoxide Radicals, Phycotoxins and Fatty Acids	PLOS ONE			English	Article							GYMNODINIOID DINOFLAGELLATES KARENIACEAE; CHATTONELLA-MARINA RAPHIDOPHYCEAE; RAINBOW-TROUT; HETEROSIGMA-AKASHIWO; HYDROGEN-PEROXIDE; CHEMICAL DEFENSE; RED TIDES; ICHTHYOTOXICITY; ASSAY; TOXICITY	Quantification of the role of reactive oxygen species, phycotoxins and fatty acids in fish toxicity by harmful marine microalgae remains inconclusive. An in vitro fish gill (from rainbow trout Oncorhynchus mykiss) assay was used to simultaneously assess the effect in superoxide dismutase, catalase and lactate dehydrogenase enzymatic activities caused by seven species of ichthyotoxic microalgae (Chattonella marina, Fibrocapsa japonica, Heterosigma akashiwo, Karenia mikimotoi, Alexandrium catenella, Karlodinium veneficum, Prymnesium parvum). Quantification of superoxide production by these algae was also performed. The effect of purified phycotoxins and crude extracts was compared, and the effect of fatty acids is discussed. The raphidophyte Chattonella was the most ichthyotoxic (gill cell viability down to 35%) and also the major producer of superoxide radicals (14 pmol cell(-1) hr(-1)) especially after cell lysis. The raphidophyte Heterosigmaand dinoflagellate Alexandrium were the least toxic and had low superoxide production, except when A. catenella was lysed (5.6 pmol cell(-1) hr(-1)). Catalase showed no changes in activity in all the treatments. Superoxide dismutase (SOD) and lactate dehydrogenase exhibited significant activity increases of <= 23% and 51.2% TCC (total cellular content), respectively, after exposure to C. marina, but SOD showed insignificant changes with remaining algal species. A strong relationship between gill cell viability and superoxide production or superoxide dismutase was not observed. Purified brevetoxins PbTx-2 and -3 (from Karenia brevis, LC50 of 22.1 versus 35.2 mu g mL(-1)) and karlotoxin KmTx-2 (from Karlodinium; LC50 = 380 ng mL(-1)) could almost entirely account for the fish killing activity by those two dinoflagellates. However, the paralytic shellfish toxins (PST) GTX1&4, C1&C2, and STX did not account for Alexandriu-michthyotoxicity. Only aqueous extracts of Alexandrium were cytotoxic (<= 65% decrease of viability), whereas crude methanol and acetone extracts of Chattonella, Fibrocapsa, Heterosigma, Karlodinium and Prymnesium decreased cell viability down to 0%. These and our previous findings involving the role of fatty acids confirm that superoxide radicals are only partially involved in ichthyotoxicity and point to a highly variable contribution by other compounds such as lipid peroxidation products (e.g. aldehydes).	[Dorantes-Aranda, Juan Jose; Seger, Andreas; Mardones, Jorge I.; Nichols, Peter D.; Hallegraeff, Gustaaf M.] Univ Tasmania, Inst Marine & Antarct Studies, Hobart, Tas, Australia; [Nichols, Peter D.] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dorantes-Aranda, JJ (corresponding author), Univ Tasmania, Inst Marine & Antarct Studies, Hobart, Tas, Australia.	Juan.DorantesAranda@utas.edu.au	Seger, Andreas/AAH-4093-2019; Nichols, Peter D/C-5128-2011; Hallegraeff, Gustaaf/C-8351-2013	Seger, Andreas/0000-0001-7018-0455; Hallegraeff, Gustaaf/0000-0001-8464-7343; Dorantes-Aranda, Juan Jose/0000-0003-1513-6501	Australian Research Council [DP130102859]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council, Grant DP130102859 to GMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Aguilera-Belmonte A, 2013, HARMFUL ALGAE, V23, P55, DOI 10.1016/j.hal.2012.12.006; Alexander B, 1999, J PHARMACOL TOXICOL, V41, P55, DOI 10.1016/S1056-8719(98)00038-0; Anderson DM, 2000, ESTIMATED ANNUAL ECO; Bachvaroff TR, 2008, HARMFUL ALGAE, V7, P473, DOI 10.1016/j.hal.2007.10.003; BADEN DG, 1989, FASEB J, V3, P1807, DOI 10.1096/fasebj.3.7.2565840; Bertin MJ, 2014, AQUAT TOXICOL, V146, P1, DOI 10.1016/j.aquatox.2013.09.026; BLACKBURN SI, 1989, J PHYCOL, V25, P577, DOI 10.1111/j.1529-8817.1989.tb00264.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns JM, 2012, AQUAT SCI, V74, P683, DOI 10.1007/s00027-012-0251-x; Dayeh VR, 2005, SMALL -SCALE FRESHWATER TOXICITY INVESTIGATIONS, VOL 1 - TOXICITY TEST METHODS, P473, DOI 10.1007/1-4020-3120-3_16; de Boer MK, 2009, HARMFUL ALGAE, V8, P699, DOI 10.1016/j.hal.2009.02.001; Deeds JR, 2006, J AQUAT ANIM HEALTH, V18, P136, DOI 10.1577/H05-027.1; Dorantes-Aranda JJ, 2011, HARMFUL ALGAE, V10, P366, DOI 10.1016/j.hal.2011.01.002; Fossat B, 1999, J APPL TOXICOL, V19, P275, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<275::AID-JAT578>3.0.CO;2-B; Fu M, 2004, TOXICON, V43, P355, DOI 10.1016/j.toxicon.2003.09.012; Godrant A, 2009, LIMNOL OCEANOGR-METH, V7, P682, DOI 10.4319/lom.2009.7.682; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hansen E, 2004, TOXICOLOGY, V199, P207, DOI 10.1016/j.tox.2004.02.026; Henrikson JC, 2010, TOXICON, V55, P1396, DOI 10.1016/j.toxicon.2010.02.017; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hoagland P, 2002, ESTUARIES, V25, P819, DOI 10.1007/BF02804908; Imai Ichiro, 2006, Plankton & Benthos Research, V1, P71; Ishimatsu A, 1996, FISHERIES SCI, V62, P50, DOI 10.2331/fishsci.62.50; Itakura S., 2014, PICES SCI REP, V47, P17; Dorantes-Aranda JJ, 2013, J PHYCOL, V49, P427, DOI 10.1111/jpy.12053; Juttner F, 2005, AQUAT ECOL, V39, P271, DOI 10.1007/s10452-005-3419-9; Kim CS, 1999, J PLANKTON RES, V21, P2105, DOI 10.1093/plankt/21.11.2105; Kim Daekyung, 2010, P245; Kim HakGyoon, 2010, P121; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; LEE TY, 1995, ANAL CHEM, V67, P225, DOI 10.1021/ac00097a034; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; Lush G, 2001, HARMFUL ALGAL BLOOMS, P268; Ma HY, 2009, MAR DRUGS, V7, P497, DOI 10.3390/md7040497; Makri A, 2011, ENG LIFE SCI, V11, P52, DOI 10.1002/elsc.201000086; Marshall JA, 2005, MAR BIOL, V147, P533, DOI 10.1007/s00227-005-1596-7; Marshall JA, 2003, HARMFUL ALGAE, V2, P273, DOI 10.1016/S1568-9883(03)00046-5; Marshall JA, 2002, J APPL PHYCOL, V14, P255, DOI 10.1023/A:1021101203543; Marshall JA, 2002, J PLANKTON RES, V24, P1231, DOI 10.1093/plankt/24.11.1231; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miller CJ, 2011, ANAL CHEM, V83, P261, DOI 10.1021/ac1022748; Mooney BD, 2007, J PHYCOL, V43, P101, DOI 10.1111/j.1529-8817.2006.00312.x; Mooney BD, 2011, MAR ECOL PROG SER, V426, P213, DOI 10.3354/meps09036; Mooney BD, 2010, HARMFUL ALGAE, V9, P557, DOI 10.1016/j.hal.2010.04.005; Mooney BD, 2009, J PHYCOL, V45, P164, DOI 10.1111/j.1529-8817.2008.00630.x; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; Oda T, 1997, BIOSCI BIOTECH BIOCH, V61, P1658, DOI 10.1271/bbb.61.1658; PAGE B, 1993, INT J ONCOL, V3, P473; Park TG, 2013, HARMFUL ALGAE, V30, pS131, DOI 10.1016/j.hal.2013.10.012; Place AR, 2012, HARMFUL ALGAE, V14, P179, DOI 10.1016/j.hal.2011.10.021; Pohnert G, 2002, MAR ECOL PROG SER, V245, P33, DOI 10.3354/meps245033; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Riso RD, 2006, ANAL BIOANAL CHEM, V385, P76, DOI 10.1007/s00216-006-0393-6; Scandalios John G., 2002, Trends in Biochemical Sciences, V27, P483, DOI 10.1016/S0968-0004(02)02170-9; Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7; SHILO M, 1960, ANN NY ACAD SCI, V90, P866, DOI 10.1111/j.1749-6632.1960.tb26429.x; SHILO M, 1953, J GEN MICROBIOL, V8, P333, DOI 10.1099/00221287-8-3-333; Smedes F, 1999, MAR POLLUT BULL, V38, P193, DOI 10.1016/S0025-326X(98)00170-2; Tang JYM, 2005, AQUAT TOXICOL, V72, P351, DOI 10.1016/j.aquatox.2005.01.007; Tang YZ, 2009, HARMFUL ALGAE, V8, P454, DOI 10.1016/j.hal.2008.10.001; Twiner MJ, 2005, HARMFUL ALGAE, V4, P789, DOI 10.1016/j.hal.2004.12.006; Twiner MJ, 2001, LIMNOL OCEANOGR, V46, P1400, DOI 10.4319/lo.2001.46.6.1400; ULITZUF S, 1964, J GEN MICROBIOL, V36, P161, DOI 10.1099/00221287-36-2-161; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; van Deventer M, 2012, BOT MAR, V55, P31, DOI [10.1515/BOT.2011.122, 10.1515/bot.2011.122]; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; Woo SPS, 2006, J EXP MAR BIOL ECOL, V336, P230, DOI 10.1016/j.jembe.2006.05.013; YANG CZ, 1995, DIS AQUAT ORGAN, V23, P101, DOI 10.3354/dao023101; Zou YN, 2013, BIOSCI BIOTECH BIOCH, V77, P345, DOI 10.1271/bbb.120764	73	84	86	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133549	10.1371/journal.pone.0133549	http://dx.doi.org/10.1371/journal.pone.0133549			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197230	gold, Green Published			2022-12-27	WOS:000358547600112
J	Wang, Z; Zhao, F; Gao, Q; Liu, ZL; Zhang, YX; Li, XY; Li, YH; Ma, WL; Deng, T; Zhang, ZZ; Cen, S				Wang, Zhen; Zhao, Fei; Gao, Qian; Liu, Zhenlong; Zhang, Yongxin; Li, Xiaoyu; Li, Yuhuan; Ma, Weilie; Deng, Tao; Zhang, Zhizhen; Cen, Shan			Establishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and Replication	PLOS ONE			English	Article							HOST FACTORS; ANTIVIRAL ACTIVITY; PA SUBUNIT; POLYMERASE; IDENTIFICATION; PROTEIN; GENOME; INTERACTS; NUCLEOPROTEIN; GENERATION	Influenza A virus (IAV) poses significant threats to public health because of the recent emergence of highly pathogenic strains and wide-spread resistance to available anti-influenza drugs. Therefore, new antiviral targets and new drugs to fight influenza virus infections are needed. Although IAV RNA transcription/replication represents a promising target for antiviral drug development, no assay ideal for high-throughput screening (HTS) application is currently available to identify inhibitors targeting these processes. In this work, we developed a novel HTS assay to analyze the transcription and replication of IAV RNA using an A549 cell line stably expressing IAV RNA-dependent RNA polymerase (RdRp) complex, NP and a viral minigenomic RNA. Both secreted Gaussia luciferase (Gluc) and blasticidin resistance gene (Bsd) were encoded in the viral minigenome and expressed under the control of IAV RdRp. Gluc serves as a reporter to monitor the activity of IAV RdRp, and Bsd is used to maintain the expression of all foreign genes. Biochemical studies and the statistical analysis presented herein demonstrate the high specificity, sensitivity and reproducibility of the assay. This work provides an ideal HTS assay for the identification of inhibitors targeting the function of IAV RdRp and a convenient reporting system for mechanism study of IAV RNA transcription / replication.	[Wang, Zhen; Zhao, Fei; Gao, Qian; Liu, Zhenlong; Zhang, Yongxin; Li, Xiaoyu; Li, Yuhuan; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Wang, Zhen; Zhao, Fei; Gao, Qian; Liu, Zhenlong; Zhang, Yongxin; Li, Xiaoyu; Li, Yuhuan; Deng, Tao; Cen, Shan] Pekin Union Med Coll, Beijing, Peoples R China; [Ma, Weilie; Zhang, Zhizhen] Guangdong Med Coll, Dept Biochem, Zhanjiang, Guangdong, Peoples R China; [Deng, Tao] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Guangdong Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Zhang, ZZ (corresponding author), Guangdong Med Coll, Dept Biochem, Zhanjiang, Guangdong, Peoples R China.	zzzhang@gdmc.edu.cn; shancen@imb.pumc.edu.cn	Liu, Zhenlong/AAE-7581-2021; ZHANG, ZHIZHEN/GYA-3230-2022	Liu, Zhenlong/0000-0001-9149-7179	China 973 programs [2012CB911102]; China Mega-Project for Infectious Disease [2013ZX10004601-002]; National S&T Major Special Project on Major New Drug Innovation [2012ZX09301-002-004]	China 973 programs(National Basic Research Program of China); China Mega-Project for Infectious Disease; National S&T Major Special Project on Major New Drug Innovation	This work was supported by China 973 programs 2012CB911102 (SC), China Mega-Project for Infectious Disease 2013ZX10004601-002 (SC), The National S&T Major Special Project on Major New Drug Innovation 2012ZX09301-002-004 (SC), and the Xiehe Scholar (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Chase G, 2011, METHODS, V55, P188, DOI 10.1016/j.ymeth.2011.08.007; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hsu JTA, 2012, ANTIMICROB AGENTS CH, V56, P647, DOI 10.1128/AAC.00125-11; Hsu WB, 2013, J VIROL, V87, P110, DOI 10.1128/JVI.00939-12; HUANG TS, 1990, J VIROL, V64, P5669, DOI 10.1128/JVI.64.11.5669-5673.1990; Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610; Kakugawa S, 2009, J VIROL, V83, P6429, DOI 10.1128/JVI.00293-09; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kawaguchi A, 2011, J VIROL, V85, P6197, DOI 10.1128/JVI.00277-11; Kim CU, 1998, J MED CHEM, V41, P2451, DOI 10.1021/jm980162u; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lackenby A, 2008, EURO SURVEILLANCE B, V13; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035234; LI R, 1989, VIRUS RES, V12, P97, DOI 10.1016/0168-1702(89)90057-9; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mullin AE, 2004, J GEN VIROL, V85, P3689, DOI 10.1099/vir.0.80518-0; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Naito T, 2007, P NATL ACAD SCI USA, V104, P18235, DOI 10.1073/pnas.0705856104; Ortigoza MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002668; Ozawa M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01106; Rodriguez A, 2011, J VIROL, V85, P12062, DOI 10.1128/JVI.00684-11; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107; Tafforeau L, 2011, J VIROL, V85, P13010, DOI 10.1128/JVI.02651-10; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Yamada K, 2012, MICROBES INFECT, V14, P740, DOI 10.1016/j.micinf.2012.02.012; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JJ, 2010, J VIROL, V84, P12619, DOI 10.1128/JVI.01696-10	44	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133558	10.1371/journal.pone.0133558	http://dx.doi.org/10.1371/journal.pone.0133558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196128	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600115
J	Wills, BD; Chong, CD; Wilder, SM; Eubanks, MD; Holway, DA; Suarez, AV				Wills, Bill D.; Chong, Cody D.; Wilder, Shawn M.; Eubanks, Micky D.; Holway, David A.; Suarez, Andrew V.			Effect of Carbohydrate Supplementation on Investment into Offspring Number, Size, and Condition in a Social Insect	PLOS ONE			English	Article							ANT SOLENOPSIS-INVICTA; FIRE ANT; COLONY GROWTH; WORKER CASTE; GRAIN HYPOTHESIS; TROPHIC ECOLOGY; HARVESTER ANT; INVASIVE ANT; BUILDING ANT; RESOURCE USE	Resource availability can determine an organism's investment strategies for growth and reproduction. When nutrients are limited, there are potential tradeoffs between investing into offspring number versus individual offspring size. In social insects, colony investment in offspring size and number may shift in response to colony needs and the availability of food resources. We experimentally manipulated the diet of a polymorphic ant species (Solenopsis invicta) to test how access to the carbohydrate and amino acid components of nectar resources affect colony investment in worker number, body size, size distributions, and individual percent fat mass. We reared field-collected colonies on one of four macronutrient treatment supplements: water, amino acids, carbohydrates, and amino acid and carbohydrates. Having access to carbohydrates nearly doubled colony biomass after 60 days. This increase in biomass resulted from an increase in worker number and mean worker size. Access to carbohydrates also altered worker body size distributions. Finally, we found a negative relationship between worker number and size, suggesting a tradeoff in colony investment strategies. This tradeoff was more pronounced for colonies without access to carbohydrate resources. The monopolization of plant-based resources has been implicated in the ecological success of ants. Our results shed light on a possible mechanism for this success, and also have implications for the success of introduced species. In addition to increases in colony size, our results suggest that having access to plant-based carbohydrates can also result in larger workers that may have better individual fighting ability, and that can withstand greater temperature fluctuations and periods of food deprivation.	[Wills, Bill D.; Suarez, Andrew V.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Chong, Cody D.] Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; [Wilder, Shawn M.; Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Holway, David A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Suarez, Andrew V.] Univ Illinois, Dept Entomol, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign	Wills, BD (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	willsbd@gmail.com		Wilder, Shawn/0000-0003-0359-7220	National Science Foundation, Division of Environmental Biology [0716983, 0717054, 0716966]; University of Illinois, Department of Animal Biology	National Science Foundation, Division of Environmental Biology(National Science Foundation (NSF)); University of Illinois, Department of Animal Biology	National Science Foundation, Division of Environmental Biology (http://www.nsf.gov/dir/index.jsp?org=BIO) 0716983 to MDE, National Science Foundation, Division of Environmental Biology (http://www.nsf.gov/dir/index.jsp?org=BIO) 0717054 to DAH, National Science Foundation, Division of Environmental Biology (http://www.nsf.gov/dir/index.jsp?org=BIO) 0716966 to AVS, and the University of Illinois, Department of Animal Biology to BDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9401; BESHERS SN, 1994, ECOLOGY, V75, P763, DOI 10.2307/1941733; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Bluthgen N, 2004, AUSTRAL ECOL, V29, P418, DOI 10.1111/j.1442-9993.2004.01380.x; Brown WD, 2006, BEHAV ECOL SOCIOBIOL, V60, P612, DOI 10.1007/s00265-006-0204-2; CALABI P, 1989, J INSECT PHYSIOL, V35, P643, DOI 10.1016/0022-1910(89)90127-3; Calder WA., 1984, SIZE FUNCTION LIFE H; Clark RE, 2012, ENVIRON ENTOMOL, V41, P1405, DOI 10.1603/EN12131; DAVIDSON DW, 1978, AM NAT, V112, P523, DOI 10.1086/283294; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Dussutour A, 2012, P ROY SOC B-BIOL SCI, V279, P2402, DOI 10.1098/rspb.2012.0051; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; Evans AR, 2012, P NATL ACAD SCI USA, V109, P4187, DOI 10.1073/pnas.1120774109; Fjerdingstad EJ, 2006, AM NAT, V167, P390, DOI 10.1086/499545; FRANCKE OF, 1985, SOUTHWEST NAT, V30, P59, DOI 10.2307/3670657; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; Hahn DA, 2006, PHYSIOL BIOCHEM ZOOL, V79, P847, DOI 10.1086/505995; Hart LM, 2012, INSECT SOC, V59, P45, DOI 10.1007/s00040-011-0186-6; Helms KR, 2008, ENVIRON ENTOMOL, V37, P487, DOI 10.1603/0046-225X(2008)37[487:PRACGI]2.0.CO;2; Helms KR, 2013, MYRMECOL NEWS, V18, P61; Helms KR, 2011, BIOL INVASIONS, V13, P67, DOI 10.1007/s10530-010-9790-z; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Hou C, 2010, P NATL ACAD SCI USA, V107, P3534; KASPARI M, 1995, AM NAT, V145, P610, DOI 10.1086/285758; Kaspari M, 1999, FUNCT ECOL, V13, P530, DOI 10.1046/j.1365-2435.1999.00343.x; Kaspari M, 2007, ECOL ENTOMOL, V32, P279, DOI 10.1111/j.1365-2311.2007.00870.x; Kay AD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2374; Kay AD, 2010, ECOLOGY, V91, P57, DOI 10.1890/09-0908.1; LANZA J, 1991, ECOL ENTOMOL, V16, P203, DOI 10.1111/j.1365-2311.1991.tb00210.x; McGlynn TP, 2002, INSECT SOC, V49, P8, DOI 10.1007/s00040-002-8270-6; Moczek AP, 1998, BEHAV ECOL, V9, P636, DOI 10.1093/beheco/9.6.636; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; Oster FG, 1978, CASTE ECOLOGY SOCIAL; Passera L, 1996, NATURE, V379, P630, DOI 10.1038/379630a0; PASSERA L, 1974, INSECT SOC, V21, P71, DOI 10.1007/BF02222980; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; PORTER SD, 1985, BEHAV ECOL SOCIOBIOL, V16, P323, DOI 10.1007/BF00295545; PORTER SD, 1989, J KANSAS ENTOMOL SOC, V62, P288; Powell S, 2005, P ROY SOC B-BIOL SCI, V272, P2173, DOI 10.1098/rspb.2005.3196; Powell S, 2009, J EVOLUTION BIOL, V22, P1004, DOI 10.1111/j.1420-9101.2009.01710.x; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; RISSING SW, 1984, BEHAV ECOL SOCIOBIOL, V15, P121, DOI 10.1007/BF00299379; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Shik JZ, 2014, ANIM BEHAV, V95, P33, DOI 10.1016/j.anbehav.2014.06.008; Shik JZ, 2013, BIOL INVASIONS, V15, P829, DOI 10.1007/s10530-012-0330-x; Shik JZ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1981, DOI 10.1007/s00265-010-1009-x; Silva RR, 2010, ECOL MONOGR, V80, P107, DOI 10.1890/08-1298.1; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smith Chris R, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5243; Smith CR, 2010, FUNCT ECOL, V24, P122, DOI 10.1111/j.1365-2435.2009.01604.x; Stearns S.C., 1992, pi; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; TENNANT LE, 1991, J ENTOMOL SCI, V26, P450, DOI 10.18474/0749-8004-26.4.450; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; TSCHINKEL WR, 1988, BEHAV ECOL SOCIOBIOL, V22, P103, DOI 10.1007/BF00303545; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 2006, FIRE ANTS; VINSON SB, 1983, FLA ENTOMOL, V66, P126, DOI 10.2307/3494559; Vogt JT, 2002, ENVIRON ENTOMOL, V31, P47, DOI 10.1603/0046-225X-31.1.47; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; Whitehouse MEA, 1996, ANIM BEHAV, V51, P1207, DOI 10.1006/anbe.1996.0126; Wiescher PT, 2012, OECOLOGIA, V169, P1063, DOI 10.1007/s00442-012-2262-7; Wilder SM, 2013, OECOLOGIA, V172, P197, DOI 10.1007/s00442-012-2477-7; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; Wilder SM, 2011, ECOLOGY, V92, P325, DOI 10.1890/10-0623.1; Wilder SM, 2010, ECOL MODEL, V221, P1505, DOI 10.1016/j.ecolmodel.2010.03.010; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Yang AS, 2004, CURR BIOL, V14, P514, DOI 10.1016/j.cub.2004.03.005	80	24	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132440	10.1371/journal.pone.0132440	http://dx.doi.org/10.1371/journal.pone.0132440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196147	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600035
J	Meijering, RAM; Wiersma, M; van Marion, DMS; Zhang, D; Hoogstra-Berends, F; Dijkhuis, AJ; Schmidt, M; Wieland, T; Kampinga, HH; Henning, RH; Brundel, BJJM				Meijering, Roelien A. M.; Wiersma, Marit; van Marion, Denise M. S.; Zhang, Deli; Hoogstra-Berends, Femke; Dijkhuis, Anne-Jan; Schmidt, Martina; Wieland, Thomas; Kampinga, Harm H.; Henning, Robert H.; Brundel, Bianca J. J. M.			RhoA Activation Sensitizes Cells to Proteotoxic Stimuli by Abrogating the HSF1-Dependent Heat Shock Response	PLOS ONE			English	Article							STRESS; CALPAIN; GTPASES; PHOSPHORYLATION; PROTECTS; COMPLEX; KINASE	Background The heat shock response (HSR) is an ancient and highly conserved program of stress-induced gene expression, aimed at reestablishing protein homeostasis to preserve cellular fitness. Cells that fail to activate or maintain this protective response are hypersensitive to proteotoxic stress. The HSR is mediated by the heat shock transcription factor 1 (HSF1), which binds to conserved heat shock elements (HSE) in the promoter region of heat shock genes, resulting in the expression of heat shock proteins (HSP). Recently, we observed that hyperactivation of RhoA conditions cardiomyocytes for the cardiac arrhythmia atrial fibrillation. Also, the HSR is annihilated in atrial fibrillation, and induction of HSR mitigates sensitization of cells to this disease. Therefore, we hypothesized active RhoA to suppress the HSR resulting in sensitization of cells for proteotoxic stimuli. Methods and Results Stimulation of RhoA activity significantly suppressed the proteotoxic stress-induced HSR in HL-1 atrial cardiomyocytes as determined with a luciferase reporter construct driven by the HSF1 regulated human HSP70 (HSPA1A) promoter and HSP protein expression by Western Blot analysis. Inversely, RhoA inhibition boosted the proteotoxic stress-induced HSR. While active RhoA did not preclude HSF1 nuclear accumulation, phosphorylation, acetylation, or sumoylation, it did impair binding of HSF1 to the hsp genes promoter element HSE. Impaired binding results in suppression of HSP expression and sensitized cells to proteotoxic stress. Conclusion These results reveal that active RhoA negatively regulates the HSR via attenuation of the HSF1-HSE binding and thus may play a role in sensitizing cells to proteotoxic stimuli.	[Meijering, Roelien A. M.; Wiersma, Marit; van Marion, Denise M. S.; Zhang, Deli; Hoogstra-Berends, Femke; Henning, Robert H.; Brundel, Bianca J. J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Dijkhuis, Anne-Jan; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Schmidt, Martina] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Wieland, Thomas] Heidelberg Univ, Mannheim Med Fac, Inst Expt & Clin Pharmacol & Toxicol, Mannheim, Germany; [Brundel, Bianca J. J. M.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Physiol, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam	Brundel, BJJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	B.J.J.M.Brundel@umcg.nl	Wieland, Thomas/G-1772-2012; Wieland, Thomas/Q-1506-2019; Zhang, Deli/ABE-5166-2020; Henning, Robert H/AAY-5222-2020; Schmidt, Martina/C-5339-2018	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Zhang, Deli/0000-0002-8891-9665; Schmidt, Martina/0000-0003-3075-0630; Henning, Robert/0000-0002-5135-4621; Kampinga, Harm/0000-0002-8966-8466	Dutch Heart Foundation [2007B217, 2009B024, 2013T096, 2013T088, 2013T144]; EFRO grant (Operationeel Programma Noord-Nederland (OP-EFRO)); LSH-Impulse grant [40-43100-98-008]	Dutch Heart Foundation(Netherlands Heart Foundation); EFRO grant (Operationeel Programma Noord-Nederland (OP-EFRO)); LSH-Impulse grant	This study was supported by the Dutch Heart Foundation (2007B217, 2009B024, 2013T096, 2013T088 and 2013T144), EFRO grant (Operationeel Programma Noord-Nederland 2007-2013 (OP-EFRO)), Drug delivery and targeting cluster) and LSH-Impulse grant (40-43100-98-008).	Aarti I, 2010, APOPTOSIS, V15, P679, DOI 10.1007/s10495-010-0474-z; Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Brundel BJJM, 2006, J MOL CELL CARDIOL, V41, P555, DOI 10.1016/j.yjmcc.2006.06.068; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V62, P1989; Giguere CJ, 2008, BIOCHEM BIOPH RES CO, V371, P578, DOI 10.1016/j.bbrc.2008.04.133; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Heldens L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023512; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Ke L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020395; Kim DH, 2012, INTEGR BIOL-UK, V4, P1019, DOI 10.1039/c2ib20067h; Li Y, 2009, CARDIOVASC DRUG THER, V23, P361, DOI 10.1007/s10557-009-6199-y; Moepps B, 2008, CELL SIGNAL, V20, P1528, DOI 10.1016/j.cellsig.2008.04.010; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Neef DW, 2014, CELL REP, V9, P955, DOI 10.1016/j.celrep.2014.09.056; PINTER M, 1994, NEUROSCI LETT, V170, P91, DOI 10.1016/0304-3940(94)90246-1; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Schinzel R, 2015, CURR OPIN CELL BIOL, V33, P102, DOI 10.1016/j.ceb.2015.01.006; Schmidt M, 1999, J BIOL CHEM, V274, P14648, DOI 10.1074/jbc.274.21.14648; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Tatum MC, 2015, CURR BIOL, V25, P163, DOI 10.1016/j.cub.2014.11.040; van Oosten-Hawle P, 2014, J EXP BIOL, V217, P129, DOI 10.1242/jeb.091249; Vogt A, 2007, CELL SIGNAL, V19, P1229, DOI 10.1016/j.cellsig.2007.01.003; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Xu GJ, 2013, EXP THER MED, V5, P723, DOI 10.3892/etm.2013.899	37	7	7	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133553	10.1371/journal.pone.0133553	http://dx.doi.org/10.1371/journal.pone.0133553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193369	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400102
J	Hernandez, F; Majoul, E; Montes-Palacios, C; Antignac, M; Cherrier, B; Doursounian, L; Feron, JM; Robert, C; Hejblum, G; Fernandez, C; Hindlet, P				Hernandez, Fabien; Majoul, Elyes; Montes-Palacios, Carlota; Antignac, Marie; Cherrier, Bertrand; Doursounian, Levon; Feron, Jean-Marc; Robert, Cyrille; Hejblum, Gilles; Fernandez, Christine; Hindlet, Patrick			An Observational Study of the Impact of a Computerized Physician Order Entry System on the Rate of Medication Errors in an Orthopaedic Surgery Unit	PLOS ONE			English	Article							DRUG ADMINISTRATION ERRORS; PRESCRIBING ERRORS; EVENTS	Aim To assess the impact of the implementation of a Computerized Physician Order Entry (CPOE) associated with a pharmaceutical checking of medication orders on medication errors in the 3 stages of drug management (i.e. prescription, dispensing and administration) in an orthopaedic surgery unit. Methods A before-after observational study was conducted in the 66-bed orthopaedic surgery unit of a teaching hospital (700 beds) in Paris France. Direct disguised observation was used to detect errors in prescription, dispensing and administration of drugs, before and after the introduction of computerized prescriptions. Compliance between dispensing and administration on the one hand and the medical prescription on the other hand was studied. The frequencies and types of errors in prescribing, dispensing and administration were investigated. Results During the pre and post-CPOE period (two days for each period) 111 and 86 patients were observed, respectively, with corresponding 1,593 and 1,388 prescribed drugs. The use of electronic prescribing led to a significant 92% decrease in prescribing errors (479/1593 prescribed drugs (30.1%) vs 33/1388 (2.4%), p < 0.0001) and to a 17.5% significant decrease in administration errors (209/1222 opportunities (17.1%) vs 200/1413 (14.2%), p < 0.05). No significant difference was found in regards to dispensing errors (430/1219 opportunities (35.3%) vs 449/1407 (31.9%), p = 0.07). Conclusion The use of CPOE and a pharmacist checking medication orders in an orthopaedic surgery unit reduced the incidence of medication errors in the prescribing and administration stages. The study results suggest that CPOE is a convenient system for improving the quality and safety of drug management.	[Hernandez, Fabien; Majoul, Elyes; Montes-Palacios, Carlota; Antignac, Marie; Fernandez, Christine; Hindlet, Patrick] Hop St Antoine, AP HP, Dept Pharm, F-75571 Paris, France; [Cherrier, Bertrand; Doursounian, Levon; Feron, Jean-Marc] Hop St Antoine, AP HP, Dept Orthopaed Surg, F-75571 Paris, France; [Robert, Cyrille] Hop St Antoine, AP HP, Anaesthet & Intens Care Dept, F-75571 Paris, France; [Hejblum, Gilles; Fernandez, Christine; Hindlet, Patrick] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM,UMRS 113, Paris, France; [Fernandez, Christine; Hindlet, Patrick] Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Hindlet, P (corresponding author), Hop St Antoine, AP HP, Dept Pharm, F-75571 Paris, France.	patrick.hindlet@sat.aphp.fr	Hejblum, Gilles/N-6337-2017	Hejblum, Gilles/0000-0003-0127-1964				ALLAN BL, 1987, AM J HOSP PHARM, V44, P1046, DOI 10.1093/ajhp/44.5.1044; ALLAN EL, 1990, AM J HOSP PHARM, V47, P555, DOI 10.1093/ajhp/47.3.555; Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Andersen SE, 2010, BASIC CLIN PHARMACOL, V106, P100, DOI 10.1111/j.1742-7843.2009.00481.x; BARKER K N, 1962, Mod Hosp, V99, P95; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Berdot S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-60; Berdot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068856; Chua SS, 2009, J CLIN PHARM THER, V34, P215, DOI 10.1111/j.1365-2710.2008.00997.x; Colpaert K, 2006, CRIT CARE, V10, DOI 10.1186/cc3983; Dooley MJ, 2012, INTERN MED J, V42, pE19, DOI 10.1111/j.1445-5994.2011.02697.x; Evans, 1998, Crit Care, V2, P73, DOI 10.1186/cc129; Ferner RE, 2009, BRIT J CLIN PHARMACO, V67, P614, DOI 10.1111/j.1365-2125.2009.03417.x; Fijn R, 2002, BRIT J CLIN PHARMACO, V53, P326, DOI 10.1046/j.0306-5251.2001.bjcp1558.doc.x; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Hoffman JM, 2003, DRUG SAFETY, V26, P445, DOI 10.2165/00002018-200326070-00001; Hug BL, 2012, JT COMM J QUAL PATIE, V38, P120, DOI 10.1016/S1553-7250(12)38016-1; Jung M, 2013, METHOD INFORM MED, V52, P99, DOI 10.3414/ME12-02-0007; Kaushal R, 2002, QUAL SAF HEALTH CARE, V11, P261, DOI 10.1136/qhc.11.3.261; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; McDowell SE, 2009, BRIT J CLIN PHARMACO, V67, P605, DOI 10.1111/j.1365-2125.2009.03416.x; Mitchell D., 2004, J INFORM TECH HEALTH, V2, P19; Radley DC, 2013, J AM MED INFORM ASSN, V20, P470, DOI 10.1136/amiajnl-2012-001241; Reckmann MH, 2009, J AM MED INFORM ASSN, V16, P613, DOI 10.1197/jamia.M3050; Shulman R, 2005, CRIT CARE, V9, pR516, DOI 10.1186/cc3793; Smith J., 2004, BUILDING SAFER NATL; Soerensen AL, 2013, RISK MANAG HEALTHC P, V6, P23, DOI 10.2147/RMHP.S47723; Spencer DC, 2005, AM J HEALTH-SYST PH, V62, P416, DOI 10.1093/ajhp/62.4.416; van den Bemt PMLA, 2007, J INTELL DISABIL RES, V51, P528, DOI 10.1111/j.1365-2788.2006.00919.x; van den Bemt PMLA, 2002, CRIT CARE MED, V30, P846, DOI 10.1097/00003246-200204000-00022; van Doormaal JE, 2009, J AM MED INFORM ASSN, V16, P816, DOI 10.1197/jamia.M3099; Westbrook JI, 2013, J AM MED INFORM ASSN, V20, P1150, DOI 10.1136/amiajnl-2012-001414; Westbrook JI, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001164; Westbrook JI, 2010, ARCH INTERN MED, V170, P683, DOI 10.1001/archinternmed.2010.65	39	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134101	10.1371/journal.pone.0134101	http://dx.doi.org/10.1371/journal.pone.0134101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26207363	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000208
J	Rannou, F; Uguen, A; Scotet, V; Le Marechal, C; Rigal, O; Marcorelles, P; Gobin, E; Carre, JL; Zagnoli, F; Giroux-Metges, MA				Rannou, Fabrice; Uguen, Arnaud; Scotet, Virginie; Le Marechal, Cedric; Rigal, Odile; Marcorelles, Pascale; Gobin, Eric; Carre, Jean-Luc; Zagnoli, Fabien; Giroux-Metges, Marie-Agnes			Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study	PLOS ONE			English	Article							METABOLIC MYOPATHIES; SKELETAL-MUSCLE; MITOCHONDRIAL MYOPATHIES; ADENYLATE DEAMINASE; CLINICAL APPROACH; BIOPSY SPECIMENS; CYCLE ERGOMETRY; LACTATE; DISEASE; MECHANISMS	Aim Our aim was to evaluate the accuracy of aerobic exercise testing to diagnose metabolic myopathies. Methods From December 2008 to September 2012, all the consecutive patients that underwent both metabolic exercise testing and a muscle biopsy were prospectively enrolled. Subjects performed an incremental and maximal exercise testing on a cycle ergometer. Lactate, pyruvate, and ammonia concentrations were determined from venous blood samples drawn at rest, during exercise (50% predicted maximal power, peak exercise), and recovery (2, 5, 10, and 15 min). Biopsies from vastus lateralis or deltoid muscles were analysed using standard techniques (reference test). Myoadenylate deaminase (MAD) activity was determined using p-nitro blue tetrazolium staining in muscle cryostat sections. Glycogen storage was assessed using periodic acid-Schiff staining. The diagnostic accuracy of plasma metabolite levels to identify absent and decreased MAD activity was assessed using Receiver Operating Characteristic (ROC) curve analysis. Results The study involved 51 patients. Omitting patients with glycogenoses (n = 3), MAD staining was absent in 5, decreased in 6, and normal in 37 subjects. Lactate/pyruvate at the 10th minute of recovery provided the greatest area under the ROC curves (AUC, 0.893 +/- 0.067) to differentiate Abnormal from Normal MAD activity. The lactate/rest ratio at the 10th minute of recovery from exercise displayed the best AUC (1.0) for discriminating between Decreased and Absent MAD activities. The resulting decision tree achieved a diagnostic accuracy of 86.3%. Conclusion The present algorithm provides a non-invasive test to accurately predict absent and decreased MAD activity, facilitating the selection of patients for muscle biopsy and target appropriate histochemical analysis.	[Rannou, Fabrice; Giroux-Metges, Marie-Agnes] CHRU Cavale Blanche, Physiol Dept EA 1274, Brest, France; [Uguen, Arnaud; Gobin, Eric] CHRU Morvan, Dept Pathol, Brest, France; [Scotet, Virginie; Le Marechal, Cedric] INSERM, UMR 1078, Brest, France; [Rigal, Odile] Robert Debre Hosp, Dept Biochem, AP HP, Paris, France; [Marcorelles, Pascale] CHRU Morvan, Dept Pathol, EA LNB 4685, Brest, France; [Carre, Jean-Luc] CHRU Cavale Blanche, Dept Biochem, Brest, France; [Zagnoli, Fabien] Clermont Tonnerre Armed Forces Hosp, EA LNB 4685, Dept Neurol, Brest, France	CHU Brest; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Brest; CHU Brest	Rannou, F (corresponding author), CHRU Cavale Blanche, Physiol Dept EA 1274, Brest, France.	fabrice.rannou@chu-brest.fr	Rannou, Fabrice/AAI-1924-2021; Uguen, Arnaud/ABF-7583-2020	Scotet, Virginie/0000-0002-5447-4207; Rannou, Fabrice/0000-0002-6643-0527	SFR ScinBioS; French Ministry of Research	SFR ScinBioS; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported in part from external funds awarded by the SFR ScinBioS. The additional part of the funding has come from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader DS, 2000, AM J CARDIOL, V85, P767, DOI 10.1016/S0002-9149(99)00859-0; Burra ML, 2008, CURR OPIN RHEUMATOL, V20, P639, DOI 10.1097/BOR.0b013e328315a05b; Coley W, 2012, ARTHRITIS RHEUM-US, V64, P3750, DOI 10.1002/art.34625; DANDURAND RJ, 1995, CHEST, V108, P182, DOI 10.1378/chest.108.1.182; Darras BT, 2000, PEDIATR NEUROL, V22, P171, DOI 10.1016/S0887-8994(99)00122-8; Darras BT, 2000, PEDIATR NEUROL, V22, P87, DOI 10.1016/S0887-8994(99)00133-2; Drouet A, 2013, REV NEUROL-FRANCE, V169, P613, DOI 10.1016/j.neurol.2013.02.006; Filosto M, 2007, NEUROLOGY, V68, P181, DOI 10.1212/01.wnl.0000252252.29532.cc; Finsterer J, 2004, EUR J NEUROL, V11, P811, DOI 10.1111/j.1468-1331.2004.00859.x; FISHBEIN WN, 1984, ANN NEUROL, V15, P271, DOI 10.1002/ana.410150312; Fishbein WN, 1999, ANN NEUROL, V45, P547, DOI 10.1002/1531-8249(199904)45:4<547::AID-ANA25>3.0.CO;2-L; FISHBEIN WN, 1978, SCIENCE, V200, P545, DOI 10.1126/science.644316; FISHBEIN WN, 1985, BIOCHEM MED METAB B, V33, P158, DOI 10.1016/0006-2944(85)90024-9; FISHBEIN WN, 1980, ARCH PATHOL LAB MED, V104, P462; GOEBEL HH, 1987, KLIN WOCHENSCHR, V65, P1023, DOI 10.1007/BF01726321; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Gross M, 1997, J INHERIT METAB DIS, V20, P186, DOI 10.1023/A:1005352605421; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0; Hanisch F, 2008, J NEUROL, V255, P318, DOI 10.1007/s00415-008-0530-6; HELLER SL, 1987, NEUROLOGY, V37, P1039, DOI 10.1212/WNL.37.6.1039; JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339; Jeppesen TD, 2003, J NEUROL, V250, P293, DOI 10.1007/s00415-003-0993-4; JONES NL, 1989, AM REV RESPIR DIS, V140, P1373, DOI 10.1164/ajrccm/140.5.1373; Khandoker AH, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-3; LIND A, 1991, J HISTOCHEM CYTOCHEM, V39, P589, DOI 10.1177/39.5.1826695; LINDERHOLM H, 1969, ACTA MED SCAND, V185, P153; Lindholm H, 2004, CLIN PHYSIOL FUNCT I, V24, P109, DOI 10.1111/j.1475-097X.2004.00531.x; MERCELIS R, 1987, J NEUROL, V234, P385, DOI 10.1007/BF00314082; Mouadil A, 2012, CLIN PHYSIOL FUNCT I, V32, P274, DOI 10.1111/j.1475-097X.2012.01122.x; Rayavarapu S, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-13; SABINA RL, 1991, ADV EXP MED BIOL, V309, P203; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; SHUMATE JB, 1979, MUSCLE NERVE, V2, P213, DOI 10.1002/mus.880020309; Siciliano G, 1999, NEUROMUSCULAR DISORD, V9, P411, DOI 10.1016/S0960-8966(99)00047-4; SINKELER SP, 1986, MUSCLE NERVE, V9, P731, DOI 10.1002/mus.880090809; SINKELER SPT, 1988, MUSCLE NERVE, V11, P312, DOI 10.1002/mus.880110406; SUGDEN PH, 1975, BIOCHEM J, V150, P113, DOI 10.1042/bj1500113; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028; Tarnopolsky M, 2004, MITOCHONDRION, V4, P529, DOI 10.1016/j.mito.2004.07.011; Tarnopolsky M, 2003, MUSCLE NERVE, V27, P359, DOI 10.1002/mus.10330; Tarnopolsky MA, 2006, APPL PHYSIOL NUTR ME, V31, P21, DOI 10.1139/H05-008; Tarnopolsky MA, 2001, J PHYSIOL-LONDON, V533, P881, DOI 10.1111/j.1469-7793.2001.t01-1-00881.x; Teijeira S, 2009, CLIN NEUROPATHOL, V28, P136; VALEN PA, 1987, ARTHRITIS RHEUM, V30, P661, DOI 10.1002/art.1780300609; van Doormaal JJ, 2012, ALLERGY, V67, P683, DOI 10.1111/j.1398-9995.2012.02809.x; VANANKEN HC, 1974, CLIN CHIM ACTA, V56, P151, DOI 10.1016/0009-8981(74)90223-X; Verzijl HTFM, 1998, ANN NEUROL, V44, P140, DOI 10.1002/ana.410440124; Vladutiu GD, 2002, MUSCLE NERVE, V25, P649, DOI 10.1002/mus.10104; Volpi L, 2011, Musculoskelet Surg, V95, P59, DOI 10.1007/s12306-011-0096-9; WAGNER DR, 1991, ANN NUTR METAB, V35, P297, DOI 10.1159/000177660; WASSERMAN K, 1985, J APPL PHYSIOL, V59, P935, DOI 10.1152/jappl.1985.59.3.935; ZWEIG MH, 1993, CLIN CHEM, V39, P561	54	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132972	10.1371/journal.pone.0132972	http://dx.doi.org/10.1371/journal.pone.0132972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207760	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000050
J	Zhu, JX; Zhan, X; Shi, GG; Yi, KH; Tan, XR				Zhu, Jinxiu; Zhan, Xin; Shi, Ganggang; Yi, Kaihong; Tan, Xuerui			Atrial Fibrillation Is an Independent Risk Factor for Hospital-Acquired Pneumonia	PLOS ONE			English	Article							ACUTE STROKE; HEART; COMPLICATIONS; EPIDEMIOLOGY; ETIOLOGY	Background Patients who were hospitalized for community-based pneumonia frequently had pre-existing atrial fibrillation (AF) and had subsequent cardiovascular complications. Whether patients who had AF would be susceptible to the development of hospital-acquired pneumonia (HAP) is a serious concern but this has not been investigated. In our clinics, we have made empirical observation of such susceptibility. Objectives To investigate the association between newly developed HAP and pre-existing AF, and to identify whether AF is an independent risk factor for HAP. Methods Hospital data from 8657 sequentially admitted inpatients [1059 patients with AF and 7598 without AF (NAF)] were collected from the Department of Cardiology, First Affiliated Hospital of Shantou University Medical College, Shantou, China, from January 1, 2009 to December 31, 2011. Exclusion criteria were: having previous or current pneumonia, pacemakers, sick sinus syndrome and repeated hospitalization. The incidence of HAP (within 48 hours after hospitalization) was identified among all the patients. Results Among the AF patients, 274 had HAP (adjusted rate 25.64%) which was significantly higher than the 276 NAF patients who had HAP (adjusted rate 3.66%; P<0.001). The increased risk was also associated with high blood pressure, heart failure and age, but not with gender, smoking, coronary heart disease, diabetes, congenital heart disease. In addition, our multiple regression analysis indicates that AF is an independent risk factor for HAP. Conclusion We have identified, for the first time, that AF is an important risk factor for HAP. Although additional clinical confirmation is needed, our data provide valuable evidence for use in prevention of HAP which is the most common cause of death from nosocomial infection.	[Zhu, Jinxiu; Yi, Kaihong; Tan, Xuerui] Shantou Univ, Coll Med, Dept Cardiol, Affiliated Hosp 1, Shantou 515041, Guangdong, Peoples R China; [Zhan, Xin] Shantou Univ, Coll Med, Mol Cardiol Lab, Affiliated Hosp 1, Shantou 515041, Guangdong, Peoples R China; [Shi, Ganggang] Shantou Univ, Coll Med, Dept Pharmacol, Shantou 515032, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Tan, XR (corresponding author), Shantou Univ, Coll Med, Dept Cardiol, Affiliated Hosp 1, Shantou 515041, Guangdong, Peoples R China.	tanxuerui@vip.sina.com			Provincial Project of Science and Technology of Guangdong, China [2011b031600011]; National Natural Science Foundation of China [81172776]	Provincial Project of Science and Technology of Guangdong, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Provincial Project of Science and Technology of Guangdong, China (No. 2011b031600011, UCRs:http://www.gdstc.gov.cn/) which was obtained by Dr. Jinxiu Zhu, and partially supported by the National Natural Science Foundation of China (No. 81172776, UCLs:http://www.nsfc.gov.cn/) which was gotten by Dr. Xuerui Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arai Tadashi, 2006, Nihon Rinsho, V64 Suppl 7, P463; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chawla R, 2008, AM J INFECT CONTROL, V36, pS93, DOI 10.1016/j.ajic.2007.05.011; Connelly SM, 2009, AM J INFECT CONTROL, V37, P143, DOI 10.1016/j.ajic.2008.03.011; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Gamst J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006486; Ji RJ, 2013, STROKE, V44, P3436, DOI 10.1161/STROKEAHA.113.001931; Leder SB, 2002, DYSPHAGIA, V17, P214, DOI 10.1007/s00455-002-0054-7; de Oliveira TFL, 2011, REV ASSOC MED BRAS, V57, P630, DOI 10.1590/S0104-42302011000600008; Masrur S, 2013, J STROKE CEREBROVASC, V22, pE301, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.013; McEachern R, 1998, INFECT DIS CLIN N AM, V12, P761, DOI 10.1016/S0891-5520(05)70209-9; Mor A, 2013, EUR J INTERN MED, V24, P349, DOI 10.1016/j.ejim.2013.02.013; Ruff CT, 2014, INT J CARDIOL, V170, P413, DOI 10.1016/j.ijcard.2013.11.030; Soto-Gomez N, 2013, AM J MED, V126, P43, DOI 10.1016/j.amjmed.2012.08.005; Topal AE, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2012-005; Tu HTH, 2011, CEREBROVASC DIS, V32, P454, DOI 10.1159/000332028; Ucgun I, 2013, EUR REV MED PHARMACO, V17, P2; Zhou Zi-qiang, 2004, Zhonghua Nei Ke Za Zhi, V43, P491	21	99	102	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0131782	10.1371/journal.pone.0131782	http://dx.doi.org/10.1371/journal.pone.0131782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204447	Green Submitted, Green Published, gold			2022-12-27	WOS:000358621000004
J	Lupattelli, A; Spigset, O; Torgersen, L; Zerwas, S; Hatle, M; Reichborn-Kjennerud, T; Bulik, CM; Nordeng, H				Lupattelli, Angela; Spigset, Olav; Torgersen, Leila; Zerwas, Stephanie; Hatle, Marianne; Reichborn-Kjennerud, Ted; Bulik, Cynthia M.; Nordeng, Hedvig			Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; LOW-BIRTH-WEIGHT; ANOREXIA-NERVOSA; GENERAL-POPULATION; PERINATAL OUTCOMES; BULIMIA-NERVOSA; DEPRESSION; RISK; MOBA; FERTILITY	Introduction Little is known about medication use among women with eating disorders in relation to pregnancy. Aims To explore patterns of and associations between use of psychotropic, gastrointestinal and analgesic medications and eating disorders in the period before, during and after pregnancy. Method This study is based on the Norwegian Mother and Child Cohort Study (MoBa). A total of 62,019 women, enrolled at approximately 17 weeks' gestation, had valid data from the Norwegian Medical Birth Registry and completed three MoBa questionnaires. The questionnaires provided diagnostic information on broadly defined anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED) and recurrent self-induced purging in the absence of binge eating (EDNOS-P), along with self-reported use of medication six months before, during, and 0-6 months after pregnancy. Results The prevalence of eating disorder subtypes before and/or during pregnancy was: 0.09% AN (n = 54), 0.94% BN (n = 585), 0.10% EDNOS-P (n = 61) and 5.00% BED (n = 3104). The highest over-time prevalence of psychotropic use was within the AN (3.7-22.2%) and EDNOS-P (3.3-9.8%) groups. Compared to controls, BN was directly associated with incident use of psychotropics in pregnancy (adjusted RR: 2.25, 99% CI: 1.17-4.32). Having AN (adjusted RR: 5.11, 99% CI: 1.53-17.01) or EDNOS-P (adjusted RR: 6.77, 99% CI: 1.41-32.53) was directly associated with use of anxiolytics/sedatives postpartum. The estimates of use of analgesics (BED) and laxatives (all eating disorders subtypes) were high at all time periods investigated. Conclusions Use of psychotropic, gastrointestinal, and analgesic medications is extensive among women with eating disorders in the period around pregnancy. Female patients with eating disorders should receive evidence-based counseling about the risk of medication exposure versus the risk of untreated psychiatric illness during pregnancy and postpartum.	[Lupattelli, Angela; Nordeng, Hedvig] Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, PharmaTox Strateg Initiat,Fac Math & Nat Sci, Oslo, Norway; [Spigset, Olav] St Olavs Univ Hosp, Dept Clin Pharmacol, Trondheim, Norway; [Spigset, Olav] Norwegian Univ Sci & Technol, Childrens & Womens Hlth, Dept Lab Med, N-7034 Trondheim, Norway; [Torgersen, Leila; Reichborn-Kjennerud, Ted; Nordeng, Hedvig] Norwegian Inst Publ Hlth, Div Mental Hlth, Oslo, Norway; [Zerwas, Stephanie; Bulik, Cynthia M.] Univ N Carolina, Dept Psychiat, UNC Ctr Excellence Eating Disorders, Chapel Hill, NC USA; [Hatle, Marianne] Clin Eating Disorders, Oslo, Norway; [Reichborn-Kjennerud, Ted] Univ Oslo, Dept Psychiat, Oslo, Norway; [Bulik, Cynthia M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Bulik, Cynthia M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH); University of North Carolina; University of North Carolina Chapel Hill; University of Oslo; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	Lupattelli, A (corresponding author), Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, PharmaTox Strateg Initiat,Fac Math & Nat Sci, Oslo, Norway.	angela.lupattelli@farmasi.uio.no	Zerwas, Stephanie/AAG-1595-2020	Zerwas, Stephanie/0000-0002-8927-3755; Bulik, Cynthia/0000-0001-7772-3264; Lupattelli, Angela/0000-0002-8787-3183	Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; National Institutes of Health [HD047186]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH100435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS (contract no. N01-ES-75558), NIH/NINDS (grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1), and the Norwegian Research Council/FUGE (grant no. 151918/S10). This work is also supported by the grant HD047186 From the National Institutes of Health (PI: CMB).	Aigner M, 2011, WORLD J BIOL PSYCHIA, V12, P400, DOI 10.3109/15622975.2011.602720; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], SUMM PROD CHAR SPC; ATC/DDD Index, 2012, ATC DDD IND 2012; Bacaltchuk J, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003391; Berg CK, 2008, AUST NZ J PSYCHIAT, V42, P396, DOI 10.1080/00048670801961149; Berg CK, 2011, INT J EAT DISORDER, V44, P124, DOI 10.1002/eat.20797; Boyd C, 2005, SCAND J GASTROENTERO, V40, P929, DOI 10.1080/00365520510015836; Briggs GG., 2017, DRUGS PREGNANCY LACT; Bulik CM, 1999, J CLIN PSYCHIAT, V60, P130, DOI 10.4088/JCP.v60n0212; Bulik CM, 2007, PSYCHOL MED, V37, P1109, DOI 10.1017/S0033291707000724; Bulik CM, 2010, OBSTET GYNECOL, V116, P1136, DOI 10.1097/AOG.0b013e3181f7efdc; Bulik CM, 2009, INT J EAT DISORDER, V42, P9, DOI 10.1002/eat.20578; BUSHNELL JA, 1994, PSYCHOL MED, V24, P605, DOI 10.1017/S0033291700027756; Claudino AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004365.pub2; Coughlin JW, 2008, CLIN J PAIN, V24, P406, DOI 10.1097/AJP.0b013e3181633fc5; Coughlin JW, 2010, INT J EAT DISORDER, V43, P737, DOI 10.1002/eat.20766; Dellava JE, 2011, INT J EAT DISORDER, V44, P325, DOI 10.1002/eat.20831; Easter A, 2011, BJOG-INT J OBSTET GY, V118, P1491, DOI 10.1111/j.1471-0528.2011.03077.x; Easter A, 2015, EUR EAT DISORD REV, V23, P19, DOI 10.1002/erv.2328; Easter A, 2013, EUR EAT DISORD REV, V21, P340, DOI 10.1002/erv.2229; Eberhard-Gran M, 2004, J PSYCHOSOM OBST GYN, V25, P15, DOI 10.1080/01674820410001737405; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Fazeli PK, 2012, INT J EAT DISORDER, V45, P970, DOI 10.1002/eat.22037; Fink P, 2004, J PSYCHOSOM RES, V56, P371, DOI 10.1016/S0022-3999(03)00071-0; Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381; Franko DL, 2001, AM J PSYCHIAT, V158, P1461, DOI 10.1176/appi.ajp.158.9.1461; Gable KN, 2005, CURR THER RES CLIN E, V66, P572, DOI 10.1016/j.curtheres.2005.12.011; GOTESTAM KG, 1995, INT J EAT DISORDER, V18, P119, DOI 10.1002/1098-108X(199509)18:2&lt;119::AID-EAT2260180203&gt;3.0.CO;2-U; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Harris JR, 2002, TWIN RES, V5, P415, DOI 10.1375/136905202320906192; Hendrick V., 2006, PSYCHIAT DISORDERS P; Hoffman Elizabeth R, 2011, Expert Rev Obstet Gynecol, V6, P403; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jasper JD, 2001, LANCET, V358, P1237, DOI 10.1016/S0140-6736(01)06353-X; Kaye WH, 2001, BIOL PSYCHIAT, V49, P644, DOI 10.1016/S0006-3223(00)01013-1; Kelly NR, 2013, INT J EAT DISORDER, V46, P127, DOI 10.1002/eat.22096; Knoph C, 2013, INT J EAT DISORDER, V46, P355, DOI 10.1002/eat.22088; Linna MS, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.067; Linna MS, 2013, INT J EAT DISORDER, V46, P826, DOI 10.1002/eat.22179; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Micali N, 2014, BJOG-INT J OBSTET GY, V121, P408, DOI 10.1111/1471-0528.12503; Micali N, 2012, BJOG-INT J OBSTET GY, V119, P1493, DOI 10.1111/j.1471-0528.2012.03467.x; Micali N, 2012, BRIT J NUTR, V108, P2093, DOI 10.1017/S0007114512000256; Micali N, 2011, J AFFECT DISORDERS, V131, P150, DOI 10.1016/j.jad.2010.09.034; Mitchell JE, 2013, INT J EAT DISORDER, V46, P470, DOI 10.1002/eat.22104; Mond JM, 2007, EUR EAT DISORD REV, V15, P403, DOI 10.1002/erv.792; Mulder E, 2012, J OBSTET GYNAECOL CA, V34, P66, DOI 10.1016/S1701-2163(16)35136-2; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Norwegian Institute of Public Health, NOW MOTH CHILD COH S; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Reichborn-Kjennerud T, 2003, ACTA PSYCHIAT SCAND, V108, P196, DOI 10.1034/j.1600-0447.2003.00106.x; Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064; Shakeel N, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-014-0420-0; Skurtveit S, 2013, J CLIN EPIDEMIOL, V66, P964, DOI 10.1016/j.jclinepi.2013.02.011; Solmi F, 2014, EPIDEMIOL REV, V36, P49, DOI 10.1093/epirev/mxt004; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; Swann RA, 2009, INT J EAT DISORDER, V42, P394, DOI 10.1002/eat.20632; TAMBS K, 1993, ACTA PSYCHIAT SCAND, V87, P364, DOI 10.1111/j.1600-0447.1993.tb03388.x; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Torgersen L, 2008, INT J EAT DISORDER, V41, P722, DOI 10.1002/eat.20564; Zerwas SC, 2014, EUR EAT DISORD REV	65	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133045	10.1371/journal.pone.0133045	http://dx.doi.org/10.1371/journal.pone.0133045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200658	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100052
J	Thurner, S; Fuchs, B				Thurner, Stefan; Fuchs, Benedikt			Physical Forces between Humans and How Humans Attract and Repel Each Other Based on Their Social Interactions in an Online World	PLOS ONE			English	Article							NEIGHBORHOOD; ORGANIZATION; EXTREMALITY; NETWORKS; GRAPHS	Physical interactions between particles are the result of the exchange of gauge bosons. Human interactions are mediated by the exchange of messages, goods, money, promises, hostilities, etc. While in the physical world interactions and their associated forces have immediate dynamical consequences (Newton's laws) the situation is not clear for human interactions. Here we quantify the relative acceleration between humans who interact through the exchange of messages, goods and hostilities in a massive multiplayer online game. For this game we have complete information about all interactions (exchange events) between about 430,000 players, and about their trajectories (movements) in the metric space of the game universe at any point in time. We use this information to derive "interaction potentials" for communication, trade and attacks and show that they are harmonic in nature. Individuals who exchange messages and trade goods generally attract each other and start to separate immediately after exchange events end. The form of the interaction potential for attacks mirrors the usual "hit-and-run" tactics of aggressive players. By measuring interaction intensities as a function of distance, velocity and acceleration, we show that "forces" between players are directly related to the number of exchange events. We find an approximate power-law decay of the likelihood for interactions as a function of distance, which is in accordance with previous real world empirical work. We show that the obtained potentials can be understood with a simple model assuming an exchange-driven force in combination with a distance-dependent exchange rate.	[Thurner, Stefan; Fuchs, Benedikt] Med Univ Vienna, Sect Sci Complex Syst, Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Thurner, Stefan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	Medical University of Vienna; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, Vienna, Austria.	stefan.thurner@meduniwien.ac.at			Austrian Science Fund FWF [KPP23378FW]; EU LASAGNE project [318132]; EU MULTIPLEX project [317532]; Austrian Science Fund (FWF) [P 23378] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); EU LASAGNE project; EU MULTIPLEX project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding was provided by the Austrian Science Fund FWF under KPP23378FW (http://www.fwf.ac.at/en/), the EU LASAGNE project, no. 318132 (http://lasagne-project.eu/), and the EU MULTIPLEX project, no. 317532 (http://www.multiplexproject.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L, 2005, SOC NETWORKS, V27, P187, DOI 10.1016/j.socnet.2005.01.007; Backstrom L., 2010, PROCEEDINGS OF THE 1, P61, DOI [10.1145/1772690.1772698, DOI 10.1145/1772690.1772698]; Bayer & Szell OG, 2003, PARD FREE BROWS GAM; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Corominas-Murtra B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112606; Feynman R, 1998, ADV BOOK CLASSICS; Feynman R. P., 1985, QED STRANGE THEORY L; Fuchs B, 2014, SCI REP-UK, V4, DOI 10.1038/srep06526; Fuchs B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103503; Grabowicz PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092196; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Klimek P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063008; Kraus V, 2013, MATCH-COMMUN MATH CO, V70, P885; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Levy M, 2014, PHYSICA A, V393, P418, DOI 10.1016/j.physa.2013.08.067; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Mascolo C., 2011, 5 INT AAAI C WEBL SO, V5, P329; Randic M, 2013, MATCH-COMMUN MATH CO, V70, P221; Sinatra R, 2014, ENTROPY-SWITZ, V16, P543, DOI 10.3390/e16010543; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Thurner S, 2005, EUROPHYS LETT, V72, P197, DOI 10.1209/epl/i2005-10221-1; Thurner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029796; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445; Xu KX, 2014, MATCH-COMMUN MATH CO, V71, P461; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133185	10.1371/journal.pone.0133185	http://dx.doi.org/10.1371/journal.pone.0133185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196505	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000358547600068
J	Chung, SA; Nititham, J; Elboudwarej, E; Quach, HL; Taylor, KE; Barcellos, LF; Criswell, LA				Chung, Sharon A.; Nititham, Joanne; Elboudwarej, Emon; Quach, Hong L.; Taylor, Kimberly E.; Barcellos, Lisa F.; Criswell, Lindsey A.			Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus	PLOS ONE			English	Article							CLINICAL-MANIFESTATIONS; REVISED CRITERIA; HUMAN-DISEASE; I INTERFERON; T-CELLS; RISK; GENE; CLASSIFICATION; PROCAINAMIDE; VARIANTS	Systemic lupus erythematosus (SLE) is characterized by the development of autoantibodies associated with specific clinical manifestations. Previous studies have shown an association between differential DNA methylation and SLE susceptibility, but have not investigated SLE-related autoantibodies. Our goal was to determine whether DNA methylation is associated with production of clinically relevant SLE-related autoantibodies, with an emphasis on the anti-dsDNA autoantibody. In this study, we characterized the methylation status of 467,314 CpG sites in 326 women with SLE. Using a discovery and replication study design, we identified and replicated significant associations between anti-dsDNA autoantibody production and the methylation status of 16 CpG sites (P-discovery<1.07E-07 and P-replication<0.0029) in 11 genes. Associations were further investigated using multivariable regression to adjust for estimated leukocyte cell proportions and population substructure. The adjusted mean DNA methylation difference between anti-dsDNA positive and negative cases ranged from 1.2% to 19%, and the adjusted odds ratio for anti-dsDNA autoantibody production comparing the lowest and highest methylation tertiles ranged from 6.8 to 18.2. Differential methylation for these CpG sites was also associated with anti-SSA, anti-Sm, and anti-RNP autoantibody production. Overall, associated CpG sites were hypomethylated in autoantibody positive compared to autoantibody negative cases. Differential methylation of CpG sites within the major histocompatibility region was not strongly associated with autoantibody production. Genes with differentially methylated CpG sites represent multiple biologic pathways, and have not been associated with autoantibody production in genetic association studies. In conclusion, hypomethylation of CpG sites within genes from different pathways is associated with anti-dsDNA, anti-SSA, anti-Sm, and anti-RNP production in SLE, and these associations are not explained by genetic variation. Thus, studies of epigenetic mechanisms such as DNA methylation represent a complementary method to genetic association studies to identify biologic pathways that may contribute to the clinical heterogeneity of autoimmune diseases.	[Chung, Sharon A.; Nititham, Joanne; Taylor, Kimberly E.; Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Re, San Francisco, CA 94143 USA; [Elboudwarej, Emon; Quach, Hong L.; Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Chung, SA (corresponding author), Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Re, San Francisco, CA 94143 USA.	sharon.chung@ucsf.edu			National Institutes of Health [5R01-AR052300, 5K24-AR02175, 5P60-AR053308, UCSF-CTSI KL2 RR024130, UCSF-CTSI UL1 TR000004]; Alliance for Lupus Research; Mary Kirkland Scholar Award; Russell/Engleman Medical Research Center for Arthritis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052300, K24AR002175, P60AR053308, K23AR063126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Mary Kirkland Scholar Award; Russell/Engleman Medical Research Center for Arthritis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the following: National Institutes of Health (www.nih.gov) grants 5R01-AR052300 (LAC), 5K24-AR02175 (LAC), 5P60-AR053308 (LAC), UCSF-CTSI KL2 RR024130 (SAC), and UCSF-CTSI UL1 TR000004 (SAC); Alliance for Lupus Research (www.lupusresearch.org); Mary Kirkland Scholar Award (http://www.hss.edu/mary-kirkland-scholar-program.asp, LAC); and the Russell/Engleman Medical Research Center for Arthritis (http://www.rosalindrussellcenter.ucsf.edu/, LAC, SAC). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Aguiar RCT, 2000, BLOOD, V96, P4328, DOI 10.1182/blood.V96.13.4328.h8004328_4328_4334; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barbarulo A, 2013, ONCOGENE, V32, P4231, DOI 10.1038/onc.2012.448; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bronson PG, 2012, CURR OPIN IMMUNOL, V24, P530, DOI 10.1016/j.coi.2012.07.008; Buyon J, 2008, PRIMER RHEUMATIC DIS, P303; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Coit P, 2013, J AUTOIMMUN, V43, P78, DOI 10.1016/j.jaut.2013.04.003; CORNACCHIA E, 1988, J IMMUNOL, V140, P2197; Dall'Era MC, 2005, ANN RHEUM DIS, V64, P1692, DOI 10.1136/ard.2004.033753; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Isenberg DA, 2007, RHEUMATOLOGY, V46, P1052, DOI 10.1093/rheumatology/kem112; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kim JH, 2013, ARTHRITIS RHEUM-US, V65, P1055, DOI 10.1002/art.37854; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Morris DL, 2014, GENES IMMUN; NYCE J, 1989, CANCER RES, V49, P5829; Plant D, 2014, NAT REV RHEUMATOL; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Roberti MC, 2009, VIRCHOWS ARCH, V454, P311, DOI 10.1007/s00428-009-0732-z; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thorburn CM, 2007, GENES IMMUN, V8, P279, DOI 10.1038/sj.gene.6364383; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Yan QS, 2009, MOL CELL, V36, P110, DOI 10.1016/j.molcel.2009.08.019; Zhou Y, 2008, AUTOIMMUN REV, V7, P376, DOI 10.1016/j.autrev.2008.03.003	41	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0129813	10.1371/journal.pone.0129813	http://dx.doi.org/10.1371/journal.pone.0129813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192630	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400004
J	Donaldsson, S; Falk, M; Jonsson, B; Drevhammar, T				Donaldsson, Snorri; Falk, Markus; Jonsson, Baldvin; Drevhammar, Thomas			Imposed Work of Breathing for Flow Meters with In-Line versus Flow-Through Technique during Simulated Neonatal Breathing	PLOS ONE			English	Article							PRETERM INFANTS; NEWBORNS; VENTILATION; PRESSURE; BIRTH; CPAP; PARAMETERS; SYSTEMS; TERM	Background The ability to determine airflow during nasal CPAP (NCPAP) treatment without adding dead space or resistance would be useful when investigating the physiologic effects of different NCPAP systems on breathing. The aim of this study was to investigate the effect on pressure stability of different flow measuring devices at the in-line and flow-through position, using simulated neonatal breathing. Methods Six different flow measure devices were evaluated by recording pressure changes and imposed work of breathing for breaths with 16 and 32 ml tidal volumes. The tests were performed initially with the devices in an in line position and with 5 and 10 L/min using flow through technique, without CPAP. The flow meters were then subsequently tested with an Infant Flow CPAP system at 3, 5 and 8 cm H2O pressure using flow through technique. The quality of the recorded signals was compared graphically. Results The resistance of the measuring devices generated pressure swings and imposed work of breathing. With bias flow, the resistance also generated CPAP pressure. Three of the devices had low resistance and generated no changes in pressure stability or CPAP pressure. The two devices intended for neonatal use had the highest measured resistance. Conclusion The importance of pressure stability and increased work of breathing during non-invasive respiratory support are insufficiently studied. Clinical trials using flow-through technique have not focused on pressure stability. Our results indicate that a flow-through technique might be a way forward in obtaining a sufficiently high signal quality without the added effects of rebreathing and increased work of breathing. The results should stimulate further research and the development of equipment for dynamic flow measurements in neonates.	[Donaldsson, Snorri; Jonsson, Baldvin; Drevhammar, Thomas] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Falk, Markus; Drevhammar, Thomas] Ostersund Hosp, Dept Anaesthesiol, Ostersund, Sweden	Karolinska Institutet	Drevhammar, T (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	thomas.drevhammar@regionjh.se	Donaldsson, Snorri/K-6410-2019; Drevhammar, Thomas/ABA-6177-2020	Drevhammar, Thomas/0000-0002-4038-2221; Falk, Markus/0000-0002-4318-5039; Jonsson, Baldvin/0000-0002-9812-732X; Njafloo, Zahra/0000-0003-3151-9625	Research and Development Unit, Jamtland County Council, Sweden [8250]	Research and Development Unit, Jamtland County Council, Sweden	Funding was provided by The Research and Development Unit, Jamtland County Council, Sweden, Grant no 8250 to TD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASSON B, 1988, PEDIATR PULM, V4, P213, DOI 10.1002/ppul.1950040405; Drevhammar T, 2013, PEDIATR CRIT CARE ME, V14, pE196, DOI 10.1097/PCC.0b013e31827212e4; Drevhammar T, 2012, PEDIATR CRIT CARE ME, V13, pE113, DOI 10.1097/PCC.0b013e31822f1b79; Foitzik B, 1998, J APPL PHYSIOL, V85, P1187, DOI 10.1152/jappl.1998.85.3.1187; Foitzik B, 2001, CRIT CARE MED, V29, P413, DOI 10.1097/00003246-200102000-00036; Fouzas S, 2014, J PEDIATR-US, V164, P283, DOI 10.1016/j.jpeds.2013.09.034; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Huckstadt T, 2003, INTENS CARE MED, V29, P1134, DOI 10.1007/s00134-003-1785-0; LAHIRI S, 1978, J APPL PHYSIOL, V44, P673, DOI 10.1152/jappl.1978.44.5.673; RIGATTO H, 1972, J APPL PHYSIOL, V32, P423, DOI 10.1152/jappl.1972.32.3.423; RUTTIMANN UE, 1981, CRIT CARE MED, V9, P801, DOI 10.1097/00003246-198111000-00011; Sandberg KL, 2012, NEONATOLOGY, V102, P282, DOI 10.1159/000341765; Schilleman K, 2013, J PEDIATR-US, V162, P457, DOI 10.1016/j.jpeds.2012.09.036; Schmalisch G, 2001, EUR RESPIR J, V17, P108, DOI 10.1183/09031936.01.17101080; te Pas AB, 2009, PEDIATR RES, V65, P352, DOI 10.1203/PDR.0b013e318193f117; THOMSON A, 1983, ARCH DIS CHILD, V58, P891, DOI 10.1136/adc.58.11.891; Vogt B, 2014, PHYSIOL MEAS, V35, pR59, DOI 10.1088/0967-3334/35/3/R59	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133432	10.1371/journal.pone.0133432	http://dx.doi.org/10.1371/journal.pone.0133432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192188	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400083
J	Kifle, YW; Goeyvaerts, N; Van Kerckhove, K; Willem, L; Faes, C; Leirs, H; Hens, N; Beutels, P				Kifle, Yimer Wasihun; Goeyvaerts, Nele; Van Kerckhove, Kim; Willem, Lander; Faes, Christel; Leirs, Herwig; Hens, Niel; Beutels, Philippe			Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases	PLOS ONE			English	Article							MIXING PATTERNS; PET OWNERSHIP; HOST-RANGE; TRANSMISSION; PARAMETERS; EMERGENCE; HEALTH; RISK; DOGS	Many human infectious diseases originate from animals or are transmitted through animal vectors. We aimed to identify factors that are predictive of ownership and touching of animals, assess whether animal ownership influences social contact behavior, and estimate the probability of a major zoonotic outbreak should a transmissible influenza-like pathogen be present in animals, all in the setting of a densely populated European country. A diary-based social contact survey (n = 1768) was conducted in Flanders, Belgium, from September 2010 until February 2011. Many participants touched pets (46%), poultry (2%) or livestock (2%) on a randomly assigned day, and a large proportion of participants owned such animals (51%, 15% and 5%, respectively). Logistic regression models indicated that larger households are more likely to own an animal and, unsurprisingly, that animal owners are more likely to touch animals. We observed a significant effect of age on animal ownership and touching. The total number of social contacts during a randomly assigned day was modeled using weighted-negative binomial regression. Apart from age, household size and day type (weekend versus weekday and regular versus holiday period), animal ownership was positively associated with the total number of social contacts during the weekend. Assuming that animal ownership and/or touching are at-risk events, we demonstrate a method to estimate the outbreak potential of zoonoses. We show that in Belgium animal-human interactions involving young children (0-9 years) and adults (25-54 years) have the highest potential to cause a major zoonotic outbreak.	[Kifle, Yimer Wasihun; Goeyvaerts, Nele; Willem, Lander; Hens, Niel; Beutels, Philippe] Univ Antwerp, Vaccine & Infect Dis Inst, CHERMID, B-2020 Antwerp, Belgium; [Kifle, Yimer Wasihun; Goeyvaerts, Nele; Van Kerckhove, Kim; Willem, Lander; Faes, Christel; Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Diepenbeek, Belgium; [Willem, Lander] Univ Antwerp, Dept Math & Comp Sci, B-2020 Antwerp, Belgium; [Leirs, Herwig] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Beutels, Philippe] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of Antwerp; Hasselt University; University of Antwerp; University of Antwerp; University of New South Wales Sydney	Beutels, P (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst, CHERMID, B-2020 Antwerp, Belgium.	philippe.beutels@uantwerpen.be	Willem, Lander/AAC-4658-2019; Faes, Christel/E-1384-2017; Hens, Niel/M-4445-2017; Beutels, Philippe/A-1919-2010; Leirs, Herwig/B-8197-2008	Willem, Lander/0000-0002-9210-1196; Faes, Christel/0000-0002-1878-9869; Hens, Niel/0000-0003-1881-0637; Beutels, Philippe/0000-0001-5034-3595; Leirs, Herwig/0000-0002-7612-5024; Goeyvaerts, Nele/0000-0003-0526-5318	Concerted Research Action (Geconcerteerde Onderzoeksacties) (GOA) of the University of Antwerp; IAP Research Network of the Belgian State (Belgian Science Policy) [P7/06]; Special Research Fund (Bijzonder Onderzoeksfonds [BOF]) of the University of Antwerp; AXA Research Fund; University of Antwerp scientific chair in Evidence-Based Vaccinology, by a gift from Pfizer	Concerted Research Action (Geconcerteerde Onderzoeksacties) (GOA) of the University of Antwerp; IAP Research Network of the Belgian State (Belgian Science Policy)(Belgian Federal Science Policy Office); Special Research Fund (Bijzonder Onderzoeksfonds [BOF]) of the University of Antwerp; AXA Research Fund(AXA Research Fund); University of Antwerp scientific chair in Evidence-Based Vaccinology, by a gift from Pfizer	This study was financed as part of a Concerted Research Action (Geconcerteerde Onderzoeksacties) (GOA) of the University of Antwerp. Support from the IAP Research Network P7/06 of the Belgian State (Belgian Science Policy) is gratefully acknowledged. LW is supported by an interdisciplinary PhD grant of the Special Research Fund (Bijzonder Onderzoeksfonds [BOF]) of the University of Antwerp. NG is beneficiary of a postdoctoral grant from the AXA Research Fund. NH gratefully acknowledges support from the University of Antwerp scientific chair in Evidence-Based Vaccinology, financed in 2009-2014 by a gift from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; ALBERT A, 1988, J MARRIAGE FAM, V50, P543, DOI 10.2307/352019; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Friedmann E, 1995, THE WALTHAM BOOK OF, P33; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Greene CE, 2006, INFECT DIS DOG CAT, P1051; Headey B, 2003, MED J AUSTRALIA, V179, P460, DOI 10.5694/j.1326-5377.2003.tb05646.x; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Katcher A. H., 1982, California Veterinarian, V36, P9; Katcher AH, 1981, INTERRELATIONS PEOPL, P41; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; ROBINS DM, 1991, J CONTEMP ETHNOGR, V20, P3, DOI 10.1177/089124191020001001; Sakamoto Y, 1986, AKAIKE INFORMATION C; Singh S, 2013, ARXIV PREPRINT; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Voith VL, 2009, VET CLIN N AM-SMALL, V39, P327, DOI 10.1016/j.cvsm.2008.10.014; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Westgarth Carri, 2007, BMC Vet Res, V3, P5, DOI 10.1186/1746-6148-3-5; Willem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048695; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	29	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133461	10.1371/journal.pone.0133461	http://dx.doi.org/10.1371/journal.pone.0133461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193480	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400091
J	Malaponte, G; Signorelli, SS; Bevelacqua, V; Polesel, J; Taborelli, M; Guarneri, C; Fenga, C; Umezawa, K; Libra, M				Malaponte, Grazia; Signorelli, Salvatore S.; Bevelacqua, Valentina; Polesel, Jerry; Taborelli, Martina; Guarneri, Claudio; Fenga, Concettina; Umezawa, Kazou; Libra, Massimo			Increased Levels of NF-kappa B-Dependent Markers in Cancer-Associated Deep Venous Thrombosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL GROWTH-FACTOR; TISSUE FACTOR EXPRESSION; PROINFLAMMATORY CYTOKINE EXPRESSION; PERIPHERAL ARTERIAL-DISEASE; BLOOD MONONUCLEAR-CELLS; FACTOR-ALPHA; PROCOAGULANT ACTIVITY; INFLAMMATORY STIMULI; PLASMA-LEVELS	Several studies highlight the role of inflammatory markers in thrombosis as well as in cancer. However, their combined role in cancer-associated deep vein thrombosis (DVT) and the molecular mechanisms, involved in its pathophysiology, needs further investigations. In the present study, C-reactive protein, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1 beta), matrix metalloproteases-9 (MMP-9), vascular endothelial growth factor (VEGF), tissue factor (TF), fibrinogen and soluble P-selectin, were analyzed in plasma and in monocyte samples from 385 cancer patients, of whom 64 were concomitantly affected by DVT (+). All these markers were higher in cancer patients DVT+ than in those DVT-. Accordingly, significantly higher NF-kappa B activity was observed in cancer patients DVT + than DVT-. Significant correlation between data obtained in plasma and monocyte samples was observed. NF-kappa B inhibition was associated with decreased levels of all molecules in both cancer DVT+ and DVT-. To further demonstrate the involvement of NF-kappa B activation by the above mentioned molecules, we treated monocyte derived from healthy donors with a pool of sera from cancer patients with and without DVT. These set of experiments further suggest the significant role played by some molecules, regulated by NF-kappa B , and detected in cancer patients with DVT. Our data support the notion that NF-kappa B may be considered as a therapeutic target for cancer patients, especially those complicated by DVT. Treatment with NF-kappa B inhibitors may represent a possible strategy to prevent or reduce the risk of DVT in cancer patients.	[Malaponte, Grazia; Bevelacqua, Valentina; Libra, Massimo] Univ Catania, Dept Biomed & Biotechnol Sci, Sect Gen & Clin Pathol & Oncol, Catania, Italy; [Signorelli, Salvatore S.] Univ Catania, Garibaldi Hosp, Dept Clin & Expt Med, Med Angiol Unit, Catania, Italy; [Polesel, Jerry; Taborelli, Martina] Natl Canc Inst, Ctr Riferimento Oncol, Epidemiol & Biostat Unit, Aviano, Italy; [Guarneri, Claudio] Univ Messina, Dept Clin & Expt Med, Dermatol Sect, Messina, Italy; [Fenga, Concettina] Univ Messina, SASATAS, Dept Environm & Hlth Sci, Messina, Italy; [Umezawa, Kazou] Aichi Med Univ, Dept Mol Target Med Screening, Nagakute, Aichi 48011, Japan	University of Catania; University of Catania; IRCCS Aviano (CRO); University of Messina; University of Messina; Aichi Medical University	Signorelli, SS (corresponding author), Univ Catania, Garibaldi Hosp, Dept Clin & Expt Med, Med Angiol Unit, Catania, Italy.	ssignore@unict.it	Libra, Massimo/L-8241-2018; Taborelli, Martina/J-3595-2018; Libra, Massimo/ABF-6654-2020; Polesel, Jerry/AAA-5750-2019; Fenga, Concettina/AAC-2150-2019	Libra, Massimo/0000-0002-7232-7737; Taborelli, Martina/0000-0002-6731-7569; Libra, Massimo/0000-0002-7232-7737; Polesel, Jerry/0000-0001-9381-1520; Fenga, Concettina/0000-0001-6369-2700; MALAPONTE, Grazia/0000-0001-6595-1198; SIGNORELLI, Salvatore Santo/0000-0001-9264-0061				Adzic M, 2006, REDOX REP, V11, P38, DOI 10.1179/135100006X101002; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Ariga A, 2002, J BIOL CHEM, V277, P24625, DOI 10.1074/jbc.M112063200; Ay C, 2008, BLOOD, V112, P2703, DOI 10.1182/blood-2008-02-142422; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Cardile V, 2010, CELL PHYSIOL BIOCHEM, V25, P543, DOI 10.1159/000303058; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Christiansen SC, 2006, PLOS MED, V3, P1414, DOI 10.1371/journal.pmed.0030334; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; CONKLING PR, 1988, BLOOD, V72, P128; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Culig Z, 2011, BBA-MOL CELL RES, V1813, P308, DOI 10.1016/j.bbamcr.2010.12.010; Dima SO, 2012, PANCREAS, V41, P1001, DOI 10.1097/MPA.0b013e3182546e13; Dong G, 1999, CANCER RES, V59, P3495; Duffey DC, 1999, CANCER RES, V59, P3468; ECONOMOU JS, 1988, INT J CANCER, V42, P712, DOI 10.1002/ijc.2910420514; EDWARDS RL, 1979, BLOOD, V54, P359; Esmon CT, 2000, HAEMOSTASIS, V30, P34; Falanga A, 2001, INT J HEMATOL, V73, P137, DOI 10.1007/BF02981929; Forster Y, 2003, CANCER LETT, V193, P65, DOI 10.1016/S0304-3835(02)00687-0; Goldberg JE, 2010, CURR DRUG TARGETS, V11, P1133; Goldenberg N, 2003, J CLIN ONCOL, V21, P4194, DOI 10.1200/JCO.2003.05.165; Grignani G, 2000, HAEMATOLOGICA, V85, P967; Grignani G, 1998, HAEMATOLOGICA, V83, pS20; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haddad TC, 2006, THROMB RES, V118, P555, DOI 10.1016/j.thromres.2005.10.015; Han X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0054-8; Hopkins MH, 2012, BIOMARK INSIGHTS, V7, P143, DOI 10.4137/BMI.S10092; HU TF, 1994, ONCOL RES, V6, P321; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Khorana AA, 2012, HEMATOL-AM SOC HEMAT, P626, DOI 10.1182/asheducation-2012.1.626; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Kwon KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-203; Lampiasi N, 2009, MOL PHARMACOL, V76, P290, DOI 10.1124/mol.109.055418; Lwaleed BA, 2000, SAUDI MED J, V21, P722; Lwaleed BA, 1999, BRIT J CANCER, V80, P279, DOI 10.1038/sj.bjc.6690352; Macri A, 2006, BIOMARKERS, V11, P184, DOI 10.1080/13547500600565677; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Makin AJ, 2003, CLIN SCI, V104, P397, DOI 10.1042/CS20020182; Malaponte G, 2013, CYTOKINE, V62, P64, DOI 10.1016/j.cyto.2013.02.017; Matsumoto G, 2005, CLIN CANCER RES, V11, P1287; Matsumoto N, 2000, BIOORG MED CHEM LETT, V10, P865, DOI 10.1016/S0960-894X(00)00114-1; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; Merogi AJ, 1997, HUM PATHOL, V28, P321, DOI 10.1016/S0046-8177(97)90131-3; MORGAN D, 1988, HAEMOSTASIS, V18, P55; Moses AGW, 2009, ONCOL REP, V21, P1091, DOI 10.3892/or_00000328; NAKASHIMA J, 1995, CANCER RES, V55, P4881; Nowak M, 2010, SCAND J IMMUNOL, V71, P91, DOI 10.1111/j.1365-3083.2009.02350.x; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Osterud B, 1998, BLOOD COAGUL FIBRIN, V9, pS9; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rak J, 2006, SEMIN THROMB HEMOST, V32, P54, DOI 10.1055/s-2006-933341; RICKLES FR, 1995, THROMB HAEMOSTASIS, V74, P391; RICKLES FR, 1983, BLOOD, V62, P14; Rickles FR, 2001, THROMB RES, V102, pV215, DOI 10.1016/S0049-3848(01)00285-7; Roselli M, 2003, THROMB HAEMOSTASIS, V89, P177; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Sallah S, 2002, THROMB HAEMOSTASIS, V87, P575; Schauer IG, 2013, NEOPLASIA, V15, P409, DOI 10.1593/neo.121228; Setia S, 2014, BIOMED PHARMACOTHER, V68, P119, DOI 10.1016/j.biopha.2013.09.003; Signorelli SS, 2014, INT J MOL MED, V33, P777, DOI 10.3892/ijmm.2014.1657; Signorelli SS, 2003, VASC MED, V8, P15, DOI 10.1191/1358863x03vm466oa; Song CJ, 2006, J THROMB HAEMOST, V4, P98, DOI 10.1111/j.1538-7836.2005.01705.x; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Suzuki E, 2006, BIOMED PHARMACOTHER, V60, P578, DOI 10.1016/j.biopha.2006.07.089; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Szotowski B, 2005, CIRC RES, V96, P1233, DOI 10.1161/01.RES.0000171805.24799.fa; tenCate JW, 1997, THROMB HAEMOSTASIS, V78, P415; Umezawa K, 2002, MOL CELLS, V14, P163; Vieira LM, 2007, THROMB RES, V119, P157, DOI 10.1016/j.thromres.2006.01.005; Wun T, 2009, CANCER INVEST, V27, P63, DOI 10.1080/07357900802656681; Yoshida N, 2002, BRIT J CANCER, V86, P1396, DOI 10.1038/sj.bjc.6600257	78	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132496	10.1371/journal.pone.0132496	http://dx.doi.org/10.1371/journal.pone.0132496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192925	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400028
J	Ramadan, KSE; Evoy, S				Ramadan, Khaled Sayed Elbadawi; Evoy, Stephane			Low Temperature Reactive Sputtering of Thin Aluminum Nitride Films on Metallic Nanocomposites	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; MAGNETIC-FIELD; COLI; BIOSENSORS; PROTEINS; PROBES; PHAGE; ORIENTATION; DEPOSITION; SYSTEM	Piezoelectric aluminum nitride thin films were deposited on aluminum-molybdenum (AlMo) metallic nanocomposites using reactive DC sputtering at room temperature. The effect of sputtering parameters on film properties was assessed. A comparative study between AlN grown on AlMo and pure aluminum showed an equivalent (002) crystallographic texture. The piezoelectric coefficients were measured to be 0.5 +/- 0.1 C m(-2) and 0.9 +/- 0.1 C m(-2), for AlN deposited on Al/0.32Mo and pure Al, respectively. Films grown onto Al/0.32Mo however featured improved surface roughness. Roughness values were measured to be 1.3nm and 5.4 nm for AlN films grown on AlMo and on Al, respectively. In turn, the dielectric constant was measured to be 8.9 +/- 0.7 for AlN deposited on Al/0.32Mo seed layer, and 8.7 +/- 0.7 for AlN deposited on aluminum; thus, equivalent within experimental error. Compatibility of this room temperature process with the lift-off patterning of the deposited AlN is also reported.	[Ramadan, Khaled Sayed Elbadawi; Evoy, Stephane] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB T6G 2V4, Canada	University of Alberta	Evoy, S (corresponding author), Univ Alberta, Dept Elect & Comp Engn, 9211-116th St, Edmonton, AB T6G 2V4, Canada.	sevoy@uaberta.ca			Natural Sciences and Engineering Research Council of Canada, through its Discovery Grant Program	Natural Sciences and Engineering Research Council of Canada, through its Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was funded by the Natural Sciences and Engineering Research Council of Canada, through its Discovery Grant Program. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh A, 2010, MATER SCI ENG B-ADV, V172, P253, DOI 10.1016/j.mseb.2010.05.026; Abdel-Hamid I, 1999, BIOSENS BIOELECTRON, V14, P309, DOI 10.1016/S0956-5663(99)00004-4; Abdel-Hamid I, 1998, SENSOR ACTUAT B-CHEM, V49, P202, DOI 10.1016/S0925-4005(98)00125-7; Amiri-Jami M, 2006, BIOTECHNOL LETT, V28, P1187, DOI 10.1007/s10529-006-9077-8; Arya SK, 2011, ANALYST, V136, P486, DOI 10.1039/c0an00697a; Assouar MB, 2007, J APPL PHYS, V101, DOI 10.1063/1.2739218; Balasubramanian S, 2007, BIOSENS BIOELECTRON, V22, P948, DOI 10.1016/j.bios.2006.04.003; Caliendo C, 2003, THIN SOLID FILMS, V441, P32, DOI 10.1016/S0040-6090(03)00911-8; Campbell GA, 2007, SENSOR ACTUAT B-CHEM, V126, P354, DOI 10.1016/j.snb.2007.03.021; Chibli H, 2014, ANALYST, V139, P179, DOI 10.1039/c3an01608k; Cole M, 2015, SENSOR ACTUAT B-CHEM, V207, P1147, DOI 10.1016/j.snb.2014.09.029; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; Ekinci KL, 2002, APPL PHYS LETT, V81, P2253, DOI 10.1063/1.1507833; Feng XL, 2008, NAT NANOTECHNOL, V3, P342, DOI 10.1038/nnano.2008.125; Fischer LM, 2008, SENSOR ACTUAT B-CHEM, V134, P613, DOI 10.1016/j.snb.2008.06.003; Fung YS, 2001, ANAL CHEM, V73, P5302, DOI 10.1021/ac010655y; Galca AC, 2012, THIN SOLID FILMS, V524, P328, DOI 10.1016/j.tsf.2012.10.015; Gartia MR, 2012, J ENVIRON MONITOR, V14, P3068, DOI 10.1039/c2em30380a; Gau JJ, 2001, BIOSENS BIOELECTRON, V16, P745, DOI 10.1016/S0956-5663(01)00216-0; Gervals L, 2007, SENSOR ACTUAT B-CHEM, V125, P615, DOI 10.1016/j.snb.2007.03.007; Giuliano KA, 1998, TRENDS BIOTECHNOL, V16, P135, DOI 10.1016/S0167-7799(97)01166-9; Guthy C, 2013, SENSOR ACTUAT B-CHEM, V187, P111, DOI 10.1016/j.snb.2012.09.070; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Ilic B, 2004, APPL PHYS LETT, V85, P2604, DOI 10.1063/1.1794378; Ivaldi P, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/8/085023; Jaber B, 1997, SENSOR ACTUAT A-PHYS, V63, P91, DOI 10.1016/S0924-4247(97)01530-6; Jin H, 2012, THIN SOLID FILMS, V520, P4863, DOI 10.1016/j.tsf.2012.03.015; Joung HA, 2008, ANAL CHIM ACTA, V630, P168, DOI 10.1016/j.aca.2008.10.001; Keusgen M, 2002, NATURWISSENSCHAFTEN, V89, P433, DOI 10.1007/s00114-002-0358-3; Khatir NM, 2014, SENSORS-BASEL, V14, P19229, DOI 10.3390/s141019229; Khatir NM, 2012, SENSORS-BASEL, V12, P3578, DOI 10.3390/s120303578; Lee Z, 2006, NANOTECHNOLOGY, V17, P3063, DOI 10.1088/0957-4484/17/12/042; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Liao JC, 2006, J CLIN MICROBIOL, V44, P561, DOI 10.1128/JCM.44.2.561-570.2006; Liao WC, 2009, ANAL CHEM, V81, P2470, DOI 10.1021/ac8020517; Liu HY, 2013, J CRYST GROWTH, V363, P80, DOI 10.1016/j.jcrysgro.2012.10.008; Luber E, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/12/125705; Marauska S, 2012, MICROSYST TECHNOL, V18, P787, DOI 10.1007/s00542-012-1493-1; Martin F, 2004, J VAC SCI TECHNOL A, V22, P361, DOI 10.1116/1.1649343; Medjani F, 2006, THIN SOLID FILMS, V515, P260, DOI 10.1016/j.tsf.2005.12.145; Nelson-Fitzpatrick N, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/11/115022; Oh BK, 2005, BIOSENS BIOELECTRON, V20, P1847, DOI 10.1016/j.bios.2004.05.010; Ophus C, 2009, ACTA MATER, V57, P4296, DOI 10.1016/j.actamat.2009.05.029; Pelegrini MV, 2014, CAN J PHYS, V92, P940, DOI 10.1139/cjp-2013-0556; Poshtiban S, 2013, SENSOR ACTUAT B-CHEM, V181, P410, DOI 10.1016/j.snb.2012.12.082; Singh A, 2012, ANALYST, V137, P3405, DOI 10.1039/c2an35371g; Singh A, 2011, ANALYST, V136, P4780, DOI 10.1039/c1an15547d; Singh A, 2010, BIOSENS BIOELECTRON, V26, P131, DOI 10.1016/j.bios.2010.05.024; Singh AV, 2011, THIN SOLID FILMS, V519, P5846, DOI 10.1016/j.tsf.2011.02.074; Sinha N, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194148; Stoeckel C, 2014, J APPL PHYS, V116, DOI 10.1063/1.4887799; Tadigadapa S, 2009, MEAS SCI TECHNOL, V20; Tawil N, 2012, BIOSENS BIOELECTRON, V37, P24, DOI 10.1016/j.bios.2012.04.048; Taylor AD, 2005, SENSOR ACTUAT B-CHEM, V107, P202, DOI 10.1016/j.snb.2004.11.097; Taylor AD, 2006, BIOSENS BIOELECTRON, V22, P752, DOI 10.1016/j.bios.2006.03.012; Tothill IE, 2009, SEMINARS IN CELL DEV; van den Hurk R, 2013, SENSOR ACTUAT B-CHEM, V176, P960, DOI 10.1016/j.snb.2012.09.023; Villanueva LG, 2011, NANO LETT, V11, P5054, DOI 10.1021/nl2031162; Wan JH, 2007, SENSOR ACTUAT B-CHEM, V127, P559, DOI 10.1016/j.snb.2007.05.017; Xu XH, 2001, THIN SOLID FILMS, V388, P62, DOI 10.1016/S0040-6090(00)01914-3; Zimmermann M, 2008, SENSOR ACTUAT B-CHEM, V131, P254, DOI 10.1016/j.snb.2007.11.016; Zuniga C, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3151919	63	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133479	10.1371/journal.pone.0133479	http://dx.doi.org/10.1371/journal.pone.0133479			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193701	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400093
J	Salaun, M; Peng, J; Hensley, HH; Roder, N; Flieder, DB; Houlle-Crepin, S; Abramovici-Roels, O; Sabourin, JC; Thiberville, L; Clapper, ML				Salauen, Mathieu; Peng, Jing; Hensley, Harvey H.; Roder, Navid; Flieder, Douglas B.; Houlle-Crepin, Solene; Abramovici-Roels, Olivia; Sabourin, Jean-Christophe; Thiberville, Luc; Clapper, Margie L.			MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma	PLOS ONE			English	Article							COLLAGENASE-3 MATRIX METALLOPROTEINASE-13; SQUAMOUS-CELL CARCINOMAS; GENE-EXPRESSION; FLUORESCENT PROTEINS; BREAST CARCINOMAS; MOUSE MODEL; CANCER; TISSUE; CLASSIFICATION; INHIBITORS	Introduction Several matrix metalloproteinases (MMPs) are overexpressed in lung cancer and may serve as potential targets for the development of bioactivable probes for molecular imaging. Objective To characterize and monitor the activity of MMPs during the progression of lung adenocarcinoma. Methods K-ras(LSL-G12D) mice were imaged serially during the development of adenocarcinomas using fluorescence molecular tomography (FMT) and a probe specific for MMP-2, -3, -9 and -13. Lung tumors were identified using FMT and MRI co-registration, and the probe concentration in each tumor was assessed at each time-point. The expression of Mmp2, -3, -9, -13 was quantified by qRT-PCR using RNA isolated from microdissected tumor cells. Immunohistochemical staining of overexpressed MMPs in animals was assessed on human lung tumors. Results In mice, 7 adenomas and 5 adenocarcinomas showed an increase in fluorescent signal on successive FMT scans, starting between weeks 4 and 8. qRT-PCR assays revealed significant overexpression of only Mmp-13 in mice lung tumors. In human tumors, a high MMP-13 immunostaining index was found in tumor cells from invasive lesions (24/27), but in none of the non-invasive (0/4) (p=0.001). Conclusion MMP-13 is detected in early pulmonary invasive adenocarcinomas and may be a potential target for molecular imaging of lung cancer.	[Salauen, Mathieu; Peng, Jing; Roder, Navid; Clapper, Margie L.] Fox Chase Canc Ctr, Prevent & Control Program, Philadelphia, PA 19111 USA; [Salauen, Mathieu; Thiberville, Luc] Univ Rouen, Lab Quant IF LITIS, EA 4108, Rouen, France; [Salauen, Mathieu; Thiberville, Luc] Rouen Univ Hosp, Clin Pneumol, Rouen, France; [Salauen, Mathieu; Thiberville, Luc] Rouen Univ Hosp, CIC INSERM U1404, Rouen, France; [Hensley, Harvey H.] Fox Chase Canc Ctr, Biol Imaging Facil, Philadelphia, PA 19111 USA; [Flieder, Douglas B.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Houlle-Crepin, Solene; Abramovici-Roels, Olivia; Sabourin, Jean-Christophe] Rouen Univ Hosp, Dept Pathol, Rouen, France	Fox Chase Cancer Center; Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Fox Chase Cancer Center; Fox Chase Cancer Center; CHU de Rouen	Salaun, M (corresponding author), Fox Chase Canc Ctr, Prevent & Control Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Mathieu.Salaun@univ-rouen.fr	SALAUN, Mathieu/M-3914-2019	SALAUN, Mathieu/0000-0003-1430-6396	ADIR (Aide a Domicile aux Insuffisants Respiratoires - Association) Association, Bois-Guillaume, France; Fondation ARC pour la Recherche sur le Cancer, Villejuif, France; Keystone Program in Personalized Risk and Prevention, Fox Chase Cancer Center, Philadelphia, PA, USA; National Cancer Institute [CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	ADIR (Aide a Domicile aux Insuffisants Respiratoires - Association) Association, Bois-Guillaume, France; Fondation ARC pour la Recherche sur le Cancer, Villejuif, France; Keystone Program in Personalized Risk and Prevention, Fox Chase Cancer Center, Philadelphia, PA, USA; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MS received grants from ADIR (Aide a Domicile aux Insuffisants Respiratoires - Association) Association, Bois-Guillaume, France (www.adirassistance.com/fr/accueil) and from Fondation ARC pour la Recherche sur le Cancer, Villejuif, France (www.fondation-arc.org), this work (MLC) was supported by the Keystone Program in Personalized Risk and Prevention, Fox Chase Cancer Center, Philadelphia, PA, USA (www.fccc.edu), a Grant CA006927 from the National Cancer Institute (www.cancer.gov/), and by an appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; ASTOUL P, 1994, ANTICANCER RES, V14, P85; Atreya R, 2014, NAT MED, V20, P313, DOI 10.1038/nm.3462; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Bostrom PJ, 2000, INT J CANCER, V88, P417, DOI 10.1002/1097-0215(20001101)88:3<417::AID-IJC14>3.3.CO;2-7; Cazorla M, 1998, J PATHOL, V186, P144, DOI 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#; Clapper ML, 2011, NEOPLASIA, V13, P685, DOI 10.1593/neo.11400; Connolly DC, 2009, CURR PROTOC PHARMACO, V45, p2 1; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Elnemr Ayman, 2003, Gastric Cancer, V6, P30, DOI 10.1007/s101200300004; Etoh T, 2000, GUT, P47; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Galateau-Salle FB, 2000, HUM PATHOL, V31, P296, DOI 10.1016/S0046-8177(00)80242-7; Graves EE, 2004, CURR MOL MED, V4, P419, DOI 10.2174/1566524043360555; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Hensley H, 2007, CANCER BIOL THER, V6, P1717, DOI 10.4161/cbt.6.11.4830; Hensley HH, 2012, NEOPLASIA, V14, P451, DOI 10.1596/neo.12480; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Hoffman RM, 2015, LAB INVEST, V95, P432, DOI 10.1038/labinvest.2014.154; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Hsu CP, 2006, LUNG CANCER, V52, P349, DOI 10.1016/j.lungcan.2006.01.011; Hu ZB, 2005, CLIN CANCER RES, V11, P5433, DOI 10.1158/1078-0432.CCR-05-0311; Johansson N, 1997, AM J PATHOL, V151, P499; Kanomata N, 2005, MODERN PATHOL, V18, P828, DOI 10.1038/modpathol.3800365; Kitamura H, 1999, HUM PATHOL, V30, P331, DOI 10.1016/S0046-8177(99)90013-8; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liu DW, 2005, EUR RESPIR J, V26, P1002, DOI 10.1183/09031936.05.00050205; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Meireles SI, 2010, CANCER PREV RES, V3, P707, DOI 10.1158/1940-6207.CAPR-09-0162; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Morisse H, 2013, MED MYCOL, V51, P352, DOI 10.3109/13693786.2012.729138; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Rath T, 2006, INFLAMM BOWEL DIS, V12, P1025, DOI 10.1097/01.mib.0000234133.97594.04; Salaun M, 2010, EUR RESPIR J, V36, P451, DOI 10.1183/09031936.00194509; Salaun M, 2013, EUR RESPIR J, V42, P1646, DOI 10.1183/09031936.00191911; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; Thomas P, 2000, J PATHOL, V190, P150; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Uria JA, 1997, CANCER RES, V57, P4882; WANG XO, 1992, INT J CANCER, V51, P992; Wernicke D, 1996, J RHEUMATOL, V23, P590; Wistuba II, 2002, ONCOGENE, V21, P7298, DOI 10.1038/sj.onc.1205806; Yamada T, 2010, ANTICANCER RES, V30, P2693; Yang M, 1998, CANCER RES, V58, P4217; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83	53	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132960	10.1371/journal.pone.0132960	http://dx.doi.org/10.1371/journal.pone.0132960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193700	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400045
J	Yu, JM; Ao, YY; Liu, N; Li, LL; Duan, ZJ				Yu, Jie-mei; Ao, Yuan-yun; Liu, Na; Li, Li-li; Duan, Zhao-jun			Salivirus in Children and Its Association with Childhood Acute Gastroenteritis: A Paired Case-Control Study	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; VIRAL GASTROENTERITIS; KLASSEVIRUS INFECTION; GENETIC DIVERSITY; STOOL SPECIMENS; RT-PCR; NOROVIRUS; SAPOVIRUS; DIARRHEA; DISEASE	Salivirus was recently discovered in children with gastroenteritis and in sewage. Though a causative role for salivirus in childhood gastroenteritis was suggested in the previous study, the relationship between salivirus and acute gastroenteritis has not yet been clearly clarified. The sewage strain reported by Ng, although represented by incomplete genome sequencing data, was distinct from previously reported saliviruses, and had not previously been detected in humans. A case-control study examining 461 paired stool samples from children with diarrhea and healthy controls (1:1) was conducted in this study. Also, common diarrheal viruses were detected and complete genome of a salivirus was determined. Results showed that salivirus was detected in 16 (3.5%) and 13 (2.8%) of the case and control samples, respectively; no differences in detection rates (p=0.571) or mean values of viral loads (p=0.400) were observed between the groups. Multivariate Cox regression revealed no association between salivirus and gastroenteritis (p=0.774). The data also demonstrated that salivirus infection did not exacerbate clinical symptoms of gastroenteritis in children. Furthermore, complete genome sequence of a salivirus recovered from the feces of a child with diarrhea (i.e., SaliV-FHB) shared a 99% nucleotide identity with the sewage strain. In conclusion, a paired case-control study did not support a causative role for salivirus strains detected in this study with pediatric gastroenteritis. This study also demonstrated that all known saliviruses can be detected in the feces of children with or without gastroenteritis.	[Yu, Jie-mei; Ao, Yuan-yun; Liu, Na; Li, Li-li; Duan, Zhao-jun] China CDC, Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Duan, ZJ (corresponding author), China CDC, Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	zhaojund@126.com	Ao, yuanyun/ABF-9640-2020		National Natural Science Foundation of China [81290345]; Bill Melinda Gates [OPP1016839]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bill Melinda Gates(Bill & Melinda Gates Foundation)	This work was supported by the National Natural Science Foundation of China (grant no. 81290345), URL: http://www.nsfc.gov.cn/ (JM) and The Bill & Melinda Gates (grant no. OPP1016839), URL: http://www.gatesfoundation.org/ (ZJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambert-Balay K, 2008, J CLIN MICROBIOL, V46, P1252, DOI 10.1128/JCM.02140-07; Baumgarte S, 2008, J CLIN MICROBIOL, V46, P242, DOI 10.1128/JCM.01468-07; Chan MCW, 2006, J VIROL METHODS, V134, P146, DOI 10.1016/j.jviromet.2005.12.013; Chen SY, 2007, J CLIN MICROBIOL, V45, P2054, DOI 10.1128/JCM.01519-06; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Colomba C, 2006, EUR J CLIN MICROBIOL, V25, P570, DOI 10.1007/s10096-006-0188-x; Dennehy PH, 2005, INFECT DIS CLIN N AM, V19, P585, DOI 10.1016/j.idc.2005.05.003; Denno Donna M., 2007, Animal Health Research Reviews, V8, P69, DOI 10.1017/S1466252307001302; EHRNST A, 1993, SCAND J INFECT DIS, V25, P275, DOI 10.3109/00365549309008499; Greninger AL, 2010, CLIN VACCINE IMMUNOL, V17, P1584, DOI 10.1128/CVI.00152-10; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Han TH, 2010, EMERG INFECT DIS, V16, P1623, DOI 10.3201/eid1610.100539; Haramoto E, 2013, APPL ENV MICROBIOL, V79; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Jin Y, 2009, J CLIN VIROL, V44, P238, DOI 10.1016/j.jcv.2008.12.010; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kirkwood CD, 2005, J MED VIROL, V77, P96, DOI 10.1002/jmv.20419; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Logan C, 2007, J VIROL METHODS, V146, P36, DOI 10.1016/j.jviromet.2007.05.031; Pang XLL, 2004, J MED VIROL, V72, P496, DOI 10.1002/jmv.20009; Patil PR, 2014, J MED VIROLOGY; Pham NTK, 2007, J CLIN MICROBIOL, V45, P2287, DOI 10.1128/JCM.00525-07; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Shan TL, 2010, EMERG INFECT DIS, V16, P1303, DOI 10.3201/eid1608.100087; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Wolffs PFG, 2011, J CLIN MICROBIOL, V49, P1926, DOI 10.1128/JCM.01925-10; Wu W, 2014, ARCH VIROL, V159, P1995, DOI 10.1007/s00705-014-1986-6; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6	29	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0130977	10.1371/journal.pone.0130977	http://dx.doi.org/10.1371/journal.pone.0130977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193371	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400008
J	Suominen, T; Piepponen, TP; Kostiainen, R				Suominen, Tina; Piepponen, T. Petteri; Kostiainen, Risto			Permeation of Dopamine Sulfate through the Blood-Brain Barrier	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; IN-VIVO MICRODIALYSIS; RAT-BRAIN; ISOFLURANE ANESTHESIA; MONOAMINE METABOLITES; PREGNENOLONE SULFATE; MOUSE-BRAIN; 5-HYDROXYTRYPTAMINE; SEROTONIN	Dopamine sulfate (DA-3- and DA-4-S) have been determined in the human brain, but it is unclear whether they are locally formed in the central nervous system (CNS), or transported into the CNS from peripheral sources. In the current study, permeation of the blood-brain barrier (BBB) by DA-S was studied by injecting C-13(6)-labelled regioisomers of DA-S ((13)DA-3-S and (13)DA-4-S) and dopamine (DA) subcutaneously (s.c.) in anesthetized rats, then analyzing brain microdialysis and plasma samples by UPLC-MS/MS. The results in the microdialysis samples demonstrated that brain concentrations of (13)DA-S regioisomers clearly increased after the s.c. injections. The concentration of DA did not change, indicating the permeation of DA-S through an intact BBB. The analysis of plasma samples, however, showed that DA-S only permeates the BBB to a small extent, as the concentrations in plasma were substantially higher than in the microdialysis samples. The results also showed that the concentrations of DA-3-S were around three times higher than the concentrations of DA-4-S in rat brain, as well as in the plasma samples after the s.c. injections, indicating that DA-3-S and DA-4-S permeate the BBB with similar efficiency. The fate of (13)DA-S in brain was followed by monitoring C-13(6)-labelled DA-S hydrolysis products, i.e. (13)DA and its common metabolites; however, no C-13(6)-labelled products were detected. This suggests that DA-S either permeates through the BBB back to the peripheral circulation or is dissociated or metabolized by unexpected mechanisms.	[Suominen, Tina; Kostiainen, Risto] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland; [Piepponen, T. Petteri] Univ Helsinki, Fac Pharm, Div Pharmacol & Pharmacotherapy, Helsinki, Finland	University of Helsinki; University of Helsinki	Kostiainen, R (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland.	risto.kostiainen@helsinki.fi	Kostiainen, Risto K/B-5491-2008	Piepponen, Petteri/0000-0002-2318-1612; Kostiainen, Risto/0000-0003-2454-4574	Academy of Finland [251575]	Academy of Finland(Academy of Finland)	Funding was provided to RK: Academy of Finland, project 251575; http://www.aka.fi/en-GB/A/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Adachi Y, 2000, J Anesth, V14, P82, DOI 10.1007/s005400050072; Adachi YU, 2005, BRAIN RES BULL, V67, P176, DOI 10.1016/j.brainresbull.2005.06.020; Adachi YU, 2008, NEUROCHEM INT, V52, P384, DOI 10.1016/j.neuint.2007.07.012; Asaba H, 2000, J NEUROCHEM, V75, P1907, DOI 10.1046/j.1471-4159.2000.0751907.x; BARBEAU A, 1969, Canadian Medical Association Journal, V101, P59; BUU NT, 1981, LIFE SCI, V29, P2311, DOI 10.1016/0024-3205(81)90564-6; BUU NT, 1984, LIFE SCI, V35, P1083, DOI 10.1016/0024-3205(84)90073-0; Davies MI, 2000, ADV DRUG DELIVER REV, V45, P169, DOI 10.1016/S0169-409X(00)00114-9; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Hagenbuch B, 2002, NEWS PHYSIOL SCI, V17, P231, DOI 10.1152/nips.01402.2002; Itaaho K, 2007, BIOCHEM PHARMACOL, V74, P504, DOI 10.1016/j.bcp.2007.05.003; Jantti SE, 2010, ANAL CHEM, V82, P3168, DOI 10.1021/ac902321z; Kauffman FC, 2004, DRUG METAB REV, V36, P823, DOI 10.1081/DMR-200033496; Kimura-Kuroiwa K, 2012, BRAIN RES BULL, V89, P223, DOI 10.1016/j.brainresbull.2012.08.006; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Miyajima M, 2011, DRUG METAB DISPOS, V39, P814, DOI 10.1124/dmd.110.036863; Mukaida K, 2007, ANESTH ANALG, V104, P836, DOI 10.1213/01.ane.0000255200.42574.22; Nowak P, 2007, NEUROTOX RES, V11, P131, DOI 10.1007/BF03033391; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Panin F, 2012, J PHARMACOL TOX MET, V65, P83, DOI 10.1016/j.vascn.2012.01.003; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; RACZ K, 1984, AM J PHYSIOL, V247, pE431, DOI 10.1152/ajpendo.1984.247.4.E431; Gonzalez RR, 2011, J NEUROSCI METH, V198, P187, DOI 10.1016/j.jneumeth.2011.03.023; Ronaldson PT, 2013, PHARMACOL REV, V65, P291, DOI 10.1124/pr.112.005991; Schumacher M, 2008, NEUROCHEM INT, V52, P522, DOI 10.1016/j.neuint.2007.08.022; SHIMOMURA K, 1971, TOHOKU J EXP MED, V105, P45, DOI 10.1620/tjem.105.45; Su FL, 2009, CHROMATOGRAPHIA, V69, P207, DOI 10.1365/s10337-008-0879-9; Suleman FG, 1998, ARCH BIOCHEM BIOPHYS, V358, P63, DOI 10.1006/abbi.1998.0842; Suominen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068007; SWAHN CG, 1976, PSYCHOPHARMACOLOGY, V48, P147, DOI 10.1007/BF00423253; SWAHN CG, 1976, J NEURAL TRANSM, V39, P281, DOI 10.1007/BF01266304; Uutela P, 2009, ANAL CHEM, V81, P8417, DOI 10.1021/ac901320z; Uutela P, 2009, ANAL CHEM, V81, P427, DOI 10.1021/ac801846w; Wang MD, 1997, J STEROID BIOCHEM, V62, P299, DOI 10.1016/S0960-0760(97)00041-1; WARNHOFF M, 1984, J CHROMATOGR, V307, P271, DOI 10.1016/S0378-4347(00)84099-2; Watson C, 2006, RAT BRAIN STEREOTAXI; Webster R. A., 2001, NEUROTRANSMITTERS DR; WERLE E, 1988, N-S ARCH PHARMACOL, V338, P28; Westerink BHC, 2000, J CHROMATOGR B, V747, P21, DOI 10.1016/S0378-4347(00)00338-8; Whittington RA, 2006, ANESTH ANALG, V103, P92, DOI 10.1213/01.ane.0000221488.48352.61; Yoshitake T, 2004, J CHROMATOGR B, V807, P177, DOI 10.1016/j.jchromb.2004.03.069	44	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133904	10.1371/journal.pone.0133904	http://dx.doi.org/10.1371/journal.pone.0133904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207745	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000170
J	de Taffin, M; Carrier, Y; Dubois, L; Bataille, L; Painset, A; Le Gras, S; Jost, B; Crozatier, M; Vincent, A				de Taffin, Mathilde; Carrier, Yannick; Dubois, Laurence; Bataille, Laetitia; Painset, Anais; Le Gras, Stephanie; Jost, Bernard; Crozatier, Michele; Vincent, Alain			Genome-Wide Mapping of Collier In Vivo Binding Sites Highlights Its Hierarchical Position in Different Transcription Regulatory Networks	PLOS ONE			English	Article							B-CELL FACTOR; CHIP-SEQ DATA; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; DROSOPHILA-MELANOGASTER; MUSCLE DEVELOPMENT; ENRICHMENT ANALYSIS; TARGET GENES; DNA; SPECIFICATION	Collier, the single Drosophila COE (Collier/EBF/Olf-1) transcription factor, is required in several developmental processes, including head patterning and specification of muscle and neuron identity during embryogenesis. To identify direct Collier (Col) targets in different cell types, we used ChIP-seq to map Col binding sites throughout the genome, at mid-embryogenesis. In vivo Col binding peaks were associated to 415 potential direct target genes. Gene Ontology analysis revealed a strong enrichment in proteins with DNA binding and/or transcription-regulatory properties. Characterization of a selection of candidates, using transgenic CRM-reporter assays, identified direct Col targets in dorso-lateral somatic muscles and specific neuron types in the central nervous system. These data brought new evidence that Col direct control of the expression of the transcription regulators apterous and eyes-absent (eya) is critical to specifying neuronal identities. They also showed that cross-regulation between coland eya in muscle progenitor cells is required for specification of muscle identity, revealing a new parallel between the myogenic regulatory networks operating in Drosophila and vertebrates. Col regulation of eya, both in specific muscle and neuronal lineages, may illustrate one mechanism behind the evolutionary diversification of Col biological roles.	[de Taffin, Mathilde; Carrier, Yannick; Dubois, Laurence; Bataille, Laetitia; Painset, Anais; Crozatier, Michele; Vincent, Alain] Univ Toulouse 3, Ctr Dev Biol, UMR CNRS 5547, F-31062 Toulouse 09, France; [Painset, Anais] INRA, Plate Forme Bioinformat Genotoul MIA T, F-31326 Castanet Tolosan, France; [Le Gras, Stephanie; Jost, Bernard] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vincent, A (corresponding author), Univ Toulouse 3, Ctr Dev Biol, UMR CNRS 5547, 118 Route Narbonne, F-31062 Toulouse 09, France.	alain.vincent@univ-tlse3.fr	Vincent, Alain/AAE-4712-2019	bataille, laetitia/0000-0002-3897-9520; Le Gras, Stephanie/0000-0001-6293-6507	Fondation de la Recherche Medicale (FRM) [DEQ20090515429]; Agence Nationale de la Recherche [13-BSVE2-0010-0]; Association Francaise contre lesMyopathies	Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre lesMyopathies(Association Francaise contre les Myopathies)	This work was supported by Fondation de la Recherche Medicale (FRM) grant DEQ20090515429, http://www.frm.org/; Agence Nationale de la Recherche grant 13-BSVE2-0010-0, http://www.agence-nationale-recherche.fr/; and Association Francaise contre lesMyopathies, http://www.afm-telethon.fr/association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Blanchette M, 2002, J COMPUT BIOL, V9, P211, DOI 10.1089/10665270252935421; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Boukhatmi H, 2012, DEVELOPMENT, V139, P3572, DOI 10.1242/dev.083410; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Crozatier M, 1999, DEVELOPMENT, V126, P4385; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 1996, CURR BIOL, V6, P707, DOI 10.1016/S0960-9822(09)00452-7; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Crozatier M, 2008, DEV BIOL, V315, P232, DOI 10.1016/j.ydbio.2007.12.030; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; Demilly A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021213; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Dubois L, 2007, DEVELOPMENT, V134, P4347, DOI 10.1242/dev.008409; Eade KT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002501; Enriquez J, 2012, DEV BIOL, V363, P27, DOI 10.1016/j.ydbio.2011.12.018; Enriquez J, 2010, DEVELOPMENT, V137, P457, DOI 10.1242/dev.045286; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Fujioka M, 2002, DEVELOPMENT, V129, P4411; Garel S, 1999, DEVELOPMENT, V126, P5285; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Green YS, 2011, DEV BIOL, V358, P240, DOI 10.1016/j.ydbio.2011.07.034; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x; Hattori Y, 2013, DEV CELL, V27, P530, DOI 10.1016/j.devcel.2013.10.024; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Jackson DJ, 2010, DEV GENES EVOL, V220, P221, DOI 10.1007/s00427-010-0343-3; Jin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4793; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kieslinger M, 2010, CELL STEM CELL, V7, P496, DOI 10.1016/j.stem.2010.07.015; KITAMOTO T, 1992, J NEUROSCI, V12, P1628; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Kuzin A, 2005, DEV BIOL, V277, P347, DOI 10.1016/j.ydbio.2004.09.027; Kuzin II, 2008, J IMMUNOL, V180, P7443, DOI 10.4049/jimmunol.180.11.7443; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Narlikar L, 2012, METHODS MOL BIOL, V802, P305, DOI 10.1007/978-1-61779-400-1_20; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Ntini E, 2011, DEV BIOL, V360, P403, DOI 10.1016/j.ydbio.2011.09.035; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Razy-Krajka F, 2014, DEV CELL, V29, P263, DOI 10.1016/j.devcel.2014.04.001; Relaix F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003425; Richard JP, 2011, DEVELOPMENT, V138, P1483, DOI 10.1242/dev.063115; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Seecoomar M, 2000, MECH DEVELOP, V91, P209, DOI 10.1016/S0925-4773(99)00305-6; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Tsai RYL, 1997, J NEUROSCI, V17, P4159; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 2004, DEVELOPMENT, V131, P1377, DOI 10.1242/dev.01009; Wang SS, 2002, MOL CELL NEUROSCI, V20, P404, DOI 10.1006/mcne.2002.1138; Wilczynski B, 2010, DEV BIOL, V340, P161, DOI 10.1016/j.ydbio.2009.10.032; Zeitlinger J, 2010, DEV BIOL, V339, P230, DOI 10.1016/j.ydbio.2009.12.039	77	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133387	10.1371/journal.pone.0133387	http://dx.doi.org/10.1371/journal.pone.0133387			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204530	Green Published, Green Submitted, gold			2022-12-27	WOS:000358621000027
J	Alvarez-Sandoval, BA; Manzanilla, LR; Gonzalez-Ruiz, M; Malgosa, A; Montiel, R				Alvarez-Sandoval, Brenda A.; Manzanilla, Linda R.; Gonzalez-Ruiz, Mercedes; Malgosa, Assumpcio; Montiel, Rafael			Genetic Evidence Supports the Multiethnic Character of Teopancazco, a Neighborhood Center of Teotihuacan, Mexico (AD 200-600)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MTDNA HAPLOGROUPS; POPULATIONS; ORGANIZATION; AFFINITIES; SEQUENCE	Multiethnicity in Teopancazco, Teotihuacan, is supported by foreign individuals found in the neighborhood center as well as by the diversity observed in funerary rituals at the site. Studies of both stable and strontium isotopes as well as paleodietary analysis, suggest that the population of Teopancazco was composed by three population groups: people from Teotihuacan, people from nearby sites (Tlaxcala-Hidalgo-Puebla), and people from afar, including the coastal plains. In an attempt to understand the genetic dynamics in Teopancazco we conducted an ancient DNA (aDNA) analysis based on mtDNA. Our results show that the level of genetic diversity is consistent with the multiethnicity phenomenon at the neighborhood center. Levels of genetic diversity at different time periods of Teopancazco's history show that multiethnicity was evident since the beginning and lasted until the collapse of the neighborhood center. However, a PCA and a Neighbor-Joining tree suggested the presence of a genetically differentiated group (buried at the Transitional phase) compared to the population from the initial phase (Tlamimilolpa) as well as the population from the final phase (Xolalpan) of the history of Teopancazco. Genetic studies showed no differences in genetic diversity between males and females in the adult population of Teopancazco, this data along with ample archaeological evidence, suggest a neolocal post-marital pattern of residence in Teopancazco. Nevertheless, genetic analyses on the infant population showed that the males are significantly more heterogeneous than the females suggesting a possible differential role in cultural practices by sex in the infant sector. Regarding interpopulation analysis, we found similar indices of genetic diversity between Teopancazco and heterogeneous native groups, which support the multiethnic character of Teopancazco. Finally, our data showed a close genetic relationship between Teopancazco and populations from the "Teotihuacan corridor" and from Oaxaca and the Maya region, in agreement with previous archaeological evidence.	[Alvarez-Sandoval, Brenda A.; Montiel, Rafael] Ctr Invest & Estudios Avanzados, Inst Politecn Nacl, Unidad Genom Avanzada, Lab Nacl Genom Biodivers, Guanajuato, Mexico; [Manzanilla, Linda R.] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Mexico City 04510, DF, Mexico; [Gonzalez-Ruiz, Mercedes; Malgosa, Assumpcio] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol, E-08193 Barcelona, Spain	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Autonomous University of Barcelona	Montiel, R (corresponding author), Ctr Invest & Estudios Avanzados, Inst Politecn Nacl, Unidad Genom Avanzada, Lab Nacl Genom Biodivers, Guanajuato, Mexico.	montiel@langebio.cinvestav.mx	Malgosa, Assumpció/K-2406-2014; Montiel, Rafael/A-6774-2008	Malgosa, Assumpció/0000-0003-1723-3671; Montiel, Rafael/0000-0001-8052-0679	Consejo Nacional de Ciencia y Tecnologia [CB-2008-01-105481]; Consejo Nacional de Ciencia y Tecnologia fellowship [300750]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia fellowship	This work was supported by Consejo Nacional de Ciencia y Tecnologia (www.conacyt.gob.mx) grant No. CB-2008-01-105481 to RM and Consejo Nacional de Ciencia y Tecnologia (www.conacyt.gob.mx) fellowship (Reg. No. 300750) to BAA-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LM, 2007, THESIS NATL AUTONOMO; Alvarado-Vinas LA, 2013, THESIS NATL AUTONOMO; Alvarez-Sandoval BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104629; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Beramendi-Orosco LE, 2012, ESTUDIOS ARQUEOMETRI, P111; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Cowgill GL, 2008, ANTIQUITY, V82, P962, DOI 10.1017/S0003598X00097714; Cowgill George L., 2003, MAYA TEOTIHUACAN REI, P315; Diehl RA., 1989, MESOAMERICA DECLINE, P9; EBIHARA M, 1977, ANN NY ACAD SCI, V293, P51; EMBER M, 1967, T NEW YORK ACAD SCI, V30, P291, DOI 10.1111/j.2164-0947.1967.tb02466.x; Ensor B., 2013, ADV INTERPRETATION C; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 2013, PHYLIP VERSION 3 695; Forster P, 1996, AM J HUM GENET, V59, P935; Gallego JR, 2013, THESIS NATL AUTONOMO; Garcia Cook Angel, 1981, SUPPLEMENT HDB MIDDL, V1, P244; Gonzalez-Jose R, 2007, P ROY SOC B-BIOL SCI, V274, P681, DOI 10.1098/rspb.2006.0151; Gonzalez-Oliver A, 2001, AM J PHYS ANTHROPOL, V116, P230, DOI 10.1002/ajpa.1118; Gonzalez-Ruiz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048904; Gorostiza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044666; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Kemp BM, 2005, BIOMOLECULAR ARCHAEO, P22; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kohl J, 2006, NUCLEIC ACIDS RES, V34, pD700, DOI 10.1093/nar/gkj030; Lailson B., 2009, THESIS NATL AUTONOMO; Lorenz JG, 1996, AM J PHYS ANTHROPOL, V101, P307, DOI 10.1002/(SICI)1096-8644(199611)101:3<307::AID-AJPA1>3.0.CO;2-W; Malgosa A., 2010, NINOS ACTORES SOCIAL, P21; Malhi RS, 2003, AM J PHYS ANTHROPOL, V120, P108, DOI 10.1002/ajpa.10138; Manzanilla L., 2006, CUICUILCO, V13, P13; Manzanilla L.R., 2009, DOMESTIC LIFE PREHIS, V46, P21; Manzanilla Linda, 2006, ARQUEOLOGIA MEXICANA, V80, P28; Manzanilla Linda R., 2011, ANALES ANTROPOLOGIA, V45, P9; Manzanilla LR, 2007, MEMORIA 2007 COLEGIO, P453; Manzanilla LR, 2012, ESTUDIOS ARQUEOMETRI, P17; Manzanilla LR, 2011, PRODUCCION ARTESANAL, P59; Manzanilla LR, 2012, ESTUDIOS ARQUEOMETRI, P449; Mata-Miguez J, 2012, AM J PHYS ANTHROPOL, V149, P504, DOI 10.1002/ajpa.22152; Mejia-Appel GI, 2012, ESTUDIOS ARQUEOMETRI, P347; Mejia-Appel GI, 2011, ESTUDIOS ANTROPOLOGI, V15, P13; MILLON R, 1973, URBANIZATION TEOTI 1, V1; Molero I, 2013, FUTURO PASADO, V4, P87; Montiel R., 2001, THESIS AUTONOMOUS U; Morales-Puente P., 2012, ESTUDIOS ARQUEOM TRI, P347; Murdock GP, 1965, SOCIAL STRUCTURE; Nei M., 1987, MOL EVOLUTIONARY GEN; Ortiz Ceballos P, 1998, RITMOS CAMBIO TEOTIH, P377; Pasternak B., 1976, INTRO KINSHIP SOCIAL; Penaloza-Espinosa RI, 2007, HUM BIOL, V79, P313, DOI 10.1353/hub.2007.0042; Peregrine PN, 2001, AM ANTIQUITY, V66, P36, DOI 10.2307/2694316; PERRY M., 2005, ARCHEOLOGICAL PAPERS, V15, P89, DOI DOI 10.1525/AP3A.2005.15.89; Rattray EC., 1998, RUTAS INTERCAMBIO ME, P77; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; REYNOLDS J, 1983, GENETICS, V105, P767; Rodriguez-Galicia B., 2006, THESIS NATL AUTONOMO; Rodriguez-Galicia B., 2010, THESIS NATL AUTONOMO; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandoval K, 2009, HUM GENET, V126, P521, DOI 10.1007/s00439-009-0693-y; Schroeder S., 2010, OXFORD HIST MEXICO, P45; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Solis-Pichardo G., 2012, ESTUDIOS ARQUEOMETRI, P425; Solorzano-Navarro E., 2006, THESIS AUTONOMOUS U; SPENCE MW, 1974, MAN, V9, P262, DOI 10.2307/2800077; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson J.E. S., 1970, MAYA HIST RELIG; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Valenzuela Juan H., 1945, MUSEO NACL ARQUEOLOG, V5, P83; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Velazquez A, 2012, ESTUDIOS ARQUEOMETRI, P285; Vergara-Perez M., 2006, THESIS AUTONOMOUS U	77	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132371	10.1371/journal.pone.0132371	http://dx.doi.org/10.1371/journal.pone.0132371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200455	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100035
J	Cortes-Vieyra, R; Silva-Garcia, O; Oviedo-Boyso, J; Huante-Mendoza, A; Bravo-Patino, A; Valdez-Alarcon, JJ; Finlay, BB; Baizabal-Aguirre, VM				Cortes-Vieyra, Ricarda; Silva-Garcia, Octavio; Oviedo-Boyso, Javier; Huante-Mendoza, Alejandro; Bravo-Patino, Alejandro; Valdez-Alarcon, Juan J.; Finlay, B. Brett; Baizabal-Aguirre, Vctor M.			The Glycogen Synthase Kinase 3 alpha and beta Isoforms Differentially Regulates Interleukin-12p40 Expression in Endothelial Cells Stimulated with Peptidoglycan from Staphylococcus aureus	PLOS ONE			English	Article							KAPPA-B ACTIVATION; PROINFLAMMATORY CYTOKINE; SIGNALING PATHWAY; INNATE IMMUNITY; TLR2 RECEPTOR; IL-12; PHOSPHORYLATION; PURIFICATION; INFLAMMATION; MACROPHAGES	Glycogen synthase kinase 3 (GSK3) is a constitutively active regulatory enzyme that is important in cancer, diabetes, and cardiovascular, neurodegenerative, and psychiatric diseases. While GSK3 alpha is usually important in neurodegenerative and psychiatric diseases GSK3 beta is fundamental in the inflammatory response caused by bacterial components. Peptidoglycan (PGN), one of the most abundant cell-wall structures of Gram-positive bacteria, is an important inducer of inflammation. To evaluate whether inhibition of GSK3 alpha and GSK3 beta activity in bovine endothelial cells (BEC) regulates the expression of the pro-inflammatory cytokine IL-12p40, we treated BEC with SDS-purified PGN from Staphylococcus aureus. We found that PGN triggered a TLR2/PI3K/Akt-dependent phosphorylation of GSK3 alpha at Ser21, GSK3 beta at Ser9, and NF-kappa B p65 subunit (p65) at Ser536, and the phosphorylation of GSK3 alpha was consistently higher than that of GSK3 beta. The expression of IL-12p40 was inhibited in BEC stimulated with PGN and pre-treated with a specific neutralizing anti-TLR2 antibody that targets the extracellular domain of TLR2 or by the addition of Akt-i IV (an Akt inhibitor). Inhibition of GSK3 alpha and GSK3 beta with LiCl or SB216763 induced an increase in IL-12p40 mRNA and protein. The effect of each isoform on IL-12p40 expression was evaluated by siRNA-gene expression silencing of GSK3 alpha and GSK3 beta. GSK3 alpha gene silencing resulted in a marked increase in IL-12p40 mRNA and protein while GSK3 beta gene silencing had the opposite effect on IL-12p40 expression. These results indicate that the TLR2/PI3K/Akt-dependent inhibition of GSK3 alpha activity also plays an important role in the inflammatory response caused by stimulation of BEC with PGN from S. aureus.	[Cortes-Vieyra, Ricarda; Silva-Garcia, Octavio; Oviedo-Boyso, Javier; Huante-Mendoza, Alejandro; Bravo-Patino, Alejandro; Valdez-Alarcon, Juan J.; Baizabal-Aguirre, Vctor M.] Univ Michoacana, Fac Med Vet & Zootecnia, Ctr Multidisciplinario Estudios Biotecnol, Mol Immunol & Signal Transduct Lab, Morelia, Michoacan, Mexico; [Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	Universidad Michoacana de San Nicolas de Hidalgo; University of British Columbia	Baizabal-Aguirre, VM (corresponding author), Univ Michoacana, Fac Med Vet & Zootecnia, Ctr Multidisciplinario Estudios Biotecnol, Mol Immunol & Signal Transduct Lab, Carretera Morelia Zinapecuaro, Morelia, Michoacan, Mexico.	baizabal@umich.mx	Cortés-Vieyra, Ricarda/L-8405-2019	Cortés-Vieyra, Ricarda/0000-0001-9314-6591	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACyT)-MEXICO [152518]; Coordinacion de Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACyT)-MEXICO(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Coordinacion de Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo	This work was supported by CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACyT)-MEXICO grant number 152518 VMB), Coordinacion de Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo, grant-2014-2015 to VMBA.	Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Barrell WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050422; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cajero-Juarez M, 2002, EUR J CELL BIOL, V81, P1, DOI 10.1078/0171-9335-00213; Chen BC, 2004, J BIOL CHEM, V279, P20889, DOI 10.1074/jbc.M311279200; Chen BC, 2009, MOL IMMUNOL, V46, P1179, DOI 10.1016/j.molimm.2008.11.006; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Dziarski R, 2000, CHEM IMMUNOL, V74, P83; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Fitzner N, 2008, CLIN VACCINE IMMUNOL, V15, P138, DOI 10.1128/CVI.00257-07; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Giambelluca MS, 2014, FASEB J, V28, P3679, DOI 10.1096/fj.14-251900; Gulen MF, 2012, IMMUNITY, V37, P800, DOI 10.1016/j.immuni.2012.08.019; Ha SJ, 1999, J IMMUNOL, V163, P2902; Heidemann J, 2007, AM J PHYSIOL-GASTR L, V293, pG1315, DOI 10.1152/ajpgi.00142.2007; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Konnai S, 2003, VET MICROBIOL, V94, P283, DOI 10.1016/S0378-1135(03)00119-6; Lienenluke B, 2000, EUR J IMMUNOL, V30, P2864, DOI 10.1002/1521-4141(200010)30:10<2864::AID-IMMU2864>3.0.CO;2-W; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mitola S, 2003, J IMMUNOL, V171, P3725, DOI 10.4049/jimmunol.171.7.3725; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Oviedo-Boyso J, 2011, INFECT IMMUN, V79, P4569, DOI 10.1128/IAI.05303-11; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; Strasly M, 2001, J IMMUNOL, V166, P3890, DOI 10.4049/jimmunol.166.6.3890; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Zhang CY, 2012, CELL MOL IMMUNOL, V9, P324, DOI 10.1038/cmi.2012.11	49	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132867	10.1371/journal.pone.0132867	http://dx.doi.org/10.1371/journal.pone.0132867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200352	gold, Green Submitted, Green Published			2022-12-27	WOS:000358597100050
J	Ramiadantsoa, T; Ovaskainen, O; Rybicki, J; Hanski, I				Ramiadantsoa, Tanjona; Ovaskainen, Otso; Rybicki, Joel; Hanski, Ilkka			Large-Scale Habitat Corridors for Biodiversity Conservation: A Forest Corridor in Madagascar	PLOS ONE			English	Article							MOVEMENT CORRIDORS; VARECIA-VARIEGATA; POPULATION; FRAGMENTATION; DEFORESTATION; CONSEQUENCES; EXTINCTION; ABUNDANCE; DYNAMICS; PATTERNS	In biodiversity conservation, habitat corridors are assumed to increase landscape-level connectivity and to enhance the viability of otherwise isolated populations. While the role of corridors is supported by empirical evidence, studies have typically been conducted at small spatial scales. Here, we assess the quality and the functionality of a large 95-km long forest corridor connecting two large national parks (416 and 311 km(2)) in the southeastern escarpment of Madagascar. We analyze the occurrence of 300 species in 5 taxonomic groups in the parks and in the corridor, and combine high-resolution forest cover data with a simulation model to examine various scenarios of corridor destruction. At present, the corridor contains essentially the same communities as the national parks, reflecting its breadth which on average matches that of the parks. In the simulation model, we consider three types of dispersers: passive dispersers, which settle randomly around the source population; active dispersers, which settle only in favorable habitat; and gap-avoiding active dispersers, which avoid dispersing across non-habitat. Our results suggest that long-distance passive dispersers are most sensitive to ongoing degradation of the corridor, because increasing numbers of propagules are lost outside the forest habitat. For a wide range of dispersal parameters, the national parks are large enough to sustain stable populations until the corridor becomes severely broken, which will happen around 2065 if the current rate of forest loss continues. A significant decrease in gene flow along the corridor is expected after 2040, and this will exacerbate the adverse consequences of isolation. Our results demonstrate that simulation studies assessing the role of habitat corridors should pay close attention to the mode of dispersal and the effects of regional stochasticity.	[Ramiadantsoa, Tanjona; Ovaskainen, Otso; Hanski, Ilkka] Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, Helsinki, Finland; [Rybicki, Joel] Aalto Univ, Dept Comp Sci, Espoo, Finland; [Rybicki, Joel] Max Planck Inst Informat, Dept Algorithms & Complex, D-66123 Saarbrucken, Germany	University of Helsinki; Aalto University; Max Planck Society	Ramiadantsoa, T (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tramiada@umn.edu	Ovaskainen, Otso/AGN-4838-2022; Ovaskainen, Otso/D-9119-2012	Ovaskainen, Otso/0000-0001-9750-4421; Ovaskainen, Otso/0000-0001-9750-4421; Rybicki, Joel/0000-0002-6432-6646	Academy of Finland [129636, 256453, 250444]; European Research Council [205905]	Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Academy of Finland (http://www.aka.fi/en-GB/A/) Grants 129636 to OO, 256453 to IH, and 250444 to OO and IH. The work was also supported by the European Research Council (http://erc.europa.eu/) Starting Grant 205905 to OO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; Baden AL, 2014, ECOL EVOL, V4, P2675, DOI 10.1002/ece3.1119; BARANGA J, 1991, NAT CONSERV SER, P371; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Bennett AF, 1999, LINKAGES IN THE LAND; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Butler RA, 2010, EXTENSIVE LOGGING LE; CARROLL C, 2006, CONNECTIVITY CONSERV, P369; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; CBD (Convention on Biological Diversity), 2010, COP 10 DECISION X 2; Conservation International, 2014, CARBON EMISSIONS RED; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Datta A, 2008, BIOL CONSERV, V141, P1429, DOI 10.1016/j.biocon.2008.02.022; Dixon JD, 2006, CONSERV BIOL, V20, P155, DOI 10.1111/j.1523-1739.2005.00292.x; Dunham AE, 2011, GLOBAL CHANGE BIOL, V17, P219, DOI 10.1111/j.1365-2486.2010.02205.x; FORNEY KA, 1989, CONSERV BIOL, V3, P45, DOI 10.1111/j.1523-1739.1989.tb00223.x; Gade DW, 1996, MT RES DEV, V16, P101, DOI 10.2307/3674005; Garcia G, 2003, ORYX, V37, P115, DOI 10.1017/S0030605303000206; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Goodman SM, 2003, THE NATURAL HISTORY; Goodman SM, 2001, INVENTAIRE BIOLOGIQU; Gouvernement Malgache, 2004, J OFF REPUB MADAGASC; Gregory AJ, 2014, CONSERV BIOL, V28, P689, DOI 10.1111/cobi.12252; Gu WD, 2002, LANDSCAPE ECOL, V17, P699, DOI 10.1023/A:1022993317717; Haddad NM, 2014, CONSERV BIOL, V28, P1178, DOI 10.1111/cobi.12323; Haddad NM, 1999, AM NAT, V153, P215, DOI 10.1086/303163; Haddad NM, 2003, ECOLOGY, V84, P609, DOI 10.1890/0012-9658(2003)084[0609:CUBDT]2.0.CO;2; Hanski I, 1999, METAPOPULATION ECOLO; Hanski I., 2004, ECOLOGY GENETICS EVO; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hilty JA, 2006, CORRIDOR ECOLOGY THE; Holmes SM, 2013, CONSERV GENET, V14, P615, DOI 10.1007/s10592-013-0455-1; Hudgens BR, 2003, AM NAT, V161, P808, DOI 10.1086/374343; IUCN, 2014, THE IUCN RED LIST OF; IUCN, 2003, 5TH IUCN WORLD PARKS; J-M Dufils, 2003, THE NATURAL HISTORY, P88; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Johnson S, 2013, LEMURS OF MADAGASCAR, P86; Kappeler P.M., 2003, NATURAL HIST MADAGAS, P1310; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Linden H, 2000, WILDLIFE BIOL, V6, P179, DOI 10.2981/wlb.2000.007; Louis EE, 2005, ANIM CONSERV, V8, P105, DOI 10.1017/S1367943004001891; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Lowry II P. P., 1997, NATURAL CHANGE HUMAN, P93; MAC ARTHUR ROBERT H., 1967; Millennium Ecosystem Assessment, 2005, ECOSYSTEM AND HUMAN; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niemela J, 2001, SCAND J FOREST RES, P70, DOI 10.1080/028275801300090645; Puhakka E., 2012, THESIS; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Service de la Meteorologie, 2000, PERTURBATIONS CYCLON; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; Sinclair I, 2013, BIRDS OF THE INDIAN; SM Goodman, 1996, FLORAL FAUNAL INVENT, V85, P83; Wright Patricia C., 1997, P381; Wright Patricia C., 2008, Primate Conservation, V23, P5, DOI 10.1896/052.023.0102	63	27	27	3	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132126	10.1371/journal.pone.0132126	http://dx.doi.org/10.1371/journal.pone.0132126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200351	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100026
J	Almoguera, B; Li, JK; Jose, PFS; Liu, YC; March, M; Pellegrino, R; Golhar, R; Corton, M; Blanco-Kelly, F; Lopez-Molina, MI; Garcia-Sandoval, B; Guo, YR; Tian, LF; Liu, XZ; Guan, LP; Zhang, JG; Keating, B; Xu, X; Hakonarson, H; Ayuso, C				Almoguera, Berta; Li, Jiankang; Fernandez-San Jose, Patricia; Liu, Yichuan; March, Michael; Pellegrino, Renata; Golhar, Ryan; Corton, Marta; Blanco-Kelly, Fiona; Isabel Lopez-Molina, Maria; Garcia-Sandoval, Blanca; Guo, Yiran; Tian, Lifeng; Liu, Xuanzhu; Guan, Liping; Zhang, Jianguo; Keating, Brendan; Xu, Xun; Hakonarson, Hakon; Ayuso, Carmen			Application of Whole Exome Sequencing in Six Families with an Initial Diagnosis of Autosomal Dominant Retinitis Pigmentosa: Lessons Learned	PLOS ONE			English	Article							ONSET RETINAL DEGENERATION; COPY-NUMBER VARIATION; SPANISH FAMILIES; MUTATION; GENES; RPGR; RP2; PHENOTYPE; IDENTIFICATION; STANDARD	This study aimed to identify the genetics underlying dominant forms of inherited retinal dystrophies using whole exome sequencing (WES) in six families extensively screened for known mutations or genes. Thirty-eight individuals were subjected to WES. Causative variants were searched among single nucleotide variants (SNVs) and insertion/deletion variants (indels) and whenever no potential candidate emerged, copy number variant (CNV) analysis was performed. Variants or regions harboring a candidate variant were prioritized and segregation of the variant with the disease was further assessed using Sanger sequencing in case of SNVs and indels, and quantitative PCR (qPCR) for CNVs. SNV and indel analysis led to the identification of a previously reported mutation in PRPH2. Two additional mutations linked to different forms of retinal dystrophies were identified in two families: a known frameshift deletion in RPGR, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in C1QTNF5 associated with Late-Onset Retinal Degeneration. A novel heterozygous deletion spanning the entire region of PRPF31 was also identified in the affected members of a fourth family, which was confirmed with qPCR. This study allowed the identification of the genetic cause of the retinal dystrophy and the establishment of a correct diagnosis in four families, including a large heterozygous deletion in PRPF31, typically considered one of the pitfalls of this method. Since all findings in this study are restricted to known genes, we propose that targeted sequencing using gene-panel is an optimal first approach for the genetic screening and that once known genetic causes are ruled out, WES might be used to uncover new genes involved in inherited retinal dystrophies.	[Almoguera, Berta; Liu, Yichuan; March, Michael; Pellegrino, Renata; Golhar, Ryan; Guo, Yiran; Tian, Lifeng; Keating, Brendan; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Li, Jiankang; Liu, Xuanzhu; Guan, Liping; Zhang, Jianguo; Xu, Xun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Fernandez-San Jose, Patricia; Corton, Marta; Blanco-Kelly, Fiona; Ayuso, Carmen] IIS Fdn Jimenez Diaz, Dept Genet & Genom, Madrid 28040, Spain; [Fernandez-San Jose, Patricia; Corton, Marta; Blanco-Kelly, Fiona; Isabel Lopez-Molina, Maria; Garcia-Sandoval, Blanca; Ayuso, Carmen] ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain; [Isabel Lopez-Molina, Maria; Garcia-Sandoval, Blanca] Fdn Jimenez Diaz, Dept Ophthalmol, E-28040 Madrid, Spain	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Beijing Genomics Institute (BGI); Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Ayuso, C (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	cayuso@fjd.es	March, Michael/AAB-6502-2019; Liu, Yichuan/AAF-3893-2021; Xu, Xun/AAI-6763-2020; Guo, Yiran/H-4120-2011	March, Michael/0000-0001-9173-6862; Xu, Xun/0000-0002-5338-5173; Corton, Marta/0000-0003-0087-1626; Pellegrino, Renata/0000-0002-2217-7371; LIU, YICHUAN/0000-0003-2023-072X; Ayuso, Carmen/0000-0002-9242-7065; Blanco-Kelly, Fiona/0000-0003-0052-5651	Instituto 429 de Salud Carlos III [CM12/00013, CP/03256]; FJD-Biobank [RD09/0076/00101]; CIBER-ER [06/07/0036]; FIS [PI: 13/00226]; ONCE; Fundaluce [4019-002]; Institution Development Award from The Children's Hospital of Philadelphia [U01-HG006830]; Shenzhen Municipal Government of China [GJHZ20130417140916986]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006830] Funding Source: NIH RePORTER	Instituto 429 de Salud Carlos III; FJD-Biobank; CIBER-ER; FIS(Instituto de Salud Carlos III); ONCE; Fundaluce; Institution Development Award from The Children's Hospital of Philadelphia; Shenzhen Municipal Government of China; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Patricia Fernandez San Jose's work is supported by a Rio Hortega grant (CM12/00013) and Marta Corton by a Miguel Servet grant (CP/03256), both from Instituto 429 de Salud Carlos III. This work was funded in part by FJD-Biobank (RD09/0076/00101), CIBER-ER (06/07/0036), FIS (PI: 13/00226), ONCE 2013 and Fundaluce (4019-002); by an Institution Development Award from The Children's Hospital of Philadelphia, and U01-HG006830 (NHGRI433 sponsored eMERGE Network); and by the Shenzhen Municipal Government of China (No GJHZ20130417140916986).	Almoguera B, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0190-9; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Avila-Fernandez A, 2015, HUM MOL GENET, V24, P4037, DOI 10.1093/hmg/ddv140; AYUSO C, 1995, CLIN GENET, V48, P120; Blanco-Kelly F, 2012, MOL VIS, V18, P1478; Borooah S, 2009, BRIT J OPHTHALMOL, V93, P284, DOI 10.1136/bjo.2008.150151; Borras E, 2013, CLIN GENET, V84, P441, DOI 10.1111/cge.12151; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; Chassine T, 2015, BRIT J OPHTHALMOL, V99, P1360, DOI 10.1136/bjophthalmol-2014-306224; Churchill JD, 2013, INVEST OPHTH VIS SCI, V54, P1411, DOI 10.1167/iovs.12-11541; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Daiger SP, 2008, ADV EXP MED BIOL, V613, P203, DOI 10.1007/978-0-387-74904-4_23; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; FISHMAN GA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1329, DOI 10.1001/archopht.1986.01050210083030; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Garcia-Hoyos M, 2006, INVEST OPHTH VIS SCI, V47, P3777, DOI 10.1167/iovs.06-0323; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Jose PFS, 2015, INVEST OPHTH VIS SCI, V56, P2173, DOI 10.1167/iovs.14-16178; Kitiratschky VBD, 2011, OPHTHALMIC GENET, V32, P151, DOI 10.3109/13816810.2011.559650; Koenekoop RK, 2003, AM J OPHTHALMOL, V136, P678, DOI 10.1016/S0002-9394(03)00331-3; Kohl S, 2012, ADV EXP MED BIOL, V723, P337, DOI 10.1007/978-1-4614-0631-0_44; Kohn L, 2009, EUR J HUM GENET, V17, P651, DOI 10.1038/ejhg.2008.223; Kuntz CA, 1996, INVEST OPHTH VIS SCI, V37, P1772; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ma XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09236; MARMOR MF, 1993, ARCH OPHTHALMOL-CHIC, V111, P601, DOI 10.1001/archopht.1993.01090050035023; Marmor MF, 1999, DOC OPHTHALMOL, V97, P143; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milam AH, 2000, OPHTHALMOLOGY, V107, P2256, DOI 10.1016/S0161-6420(00)00419-X; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nishiguchi KM, 2013, P NATL ACAD SCI USA, V110, P16139, DOI 10.1073/pnas.1308243110; REIG C, 1994, HUM GENET, V94, P283; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Soumplis V, 2013, ACTA OPHTHALMOL, V91, pE191, DOI 10.1111/aos.12010; Trujillo MJ, 1998, MED CLIN-BARCELONA, V110, P501; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Vincent A, 2012, RETINA-J RET VIT DIS, V32, P1643, DOI 10.1097/IAE.0b013e318240a574; Wang F, 2014, INVEST OPHTH VIS SCI, V55, P7159, DOI 10.1167/iovs.14-15520; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu DM, 2010, EYE, V24, P764, DOI 10.1038/eye.2009.270	51	19	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133624	10.1371/journal.pone.0133624	http://dx.doi.org/10.1371/journal.pone.0133624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197217	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600121
J	Huang, JY; Jian, ZH; Nfor, ON; Jhang, KM; Ku, WY; Ko, PC; Jan, SR; Ho, CC; Lung, CC; Pan, HH; Liang, YC; Liaw, YP				Huang, Jing-Yang; Jian, Zhi-Hong; Nfor, Oswald Ndi; Jhang, Kai-Ming; Ku, Wen-Yuan; Ko, Pei-Chieh; Jan, Shiou-Rung; Ho, Chien-Chang; Lung, Chia-Chi; Pan, Hui-Hsien; Liang, Yu-Chiu; Liaw, Yung-Po			The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER-RISK; SURGICAL RESECTION; GENDER-DIFFERENCES; ESTROGEN-RECEPTOR; OVERLAP SYNDROME; COPD-ASTHMA; POPULATION; SMOKING; TAIWAN	Background Pulmonary diseases [asthma, chronic obstructive pulmonary disease (COPD), and tuberculosis (TB)] are associated with lung cancer mortality. However, the relationship between coexisting pulmonary diseases and survival in patients with lung squamous cell carcinoma (SqCC) has not been well defined. Methods Patients newly diagnosed with SqCC between 2003 and 2008 were identified by linking the National Health Insurance Research Database and Taiwan Cancer Registry Database. Cases with SqCC were followed up until death, loss to follow-up, or study end in 2010. Information on health status, date of death and the main causes of death was ascertained from the National Death Registry Database. Cox proportional hazard regression was used to calculate the hazard ratio (HR) of coexisting asthma, COPD and/or TB. Results During the study period, a total of 5406 cases with SqCC were enrolled. For all cause-mortality, HRs were 1.08 [95% confidence interval (CI), 0.99-1.18], 1.04 (95% CI, 0.97-1.12), and 1.14 (95% CI, 1.00-1.31) for individuals with asthma, COPD, and TB, respectively. Specifically, among men with coexisting pulmonary diseases, the HRs were 1.56 (95% CI, 1.23-1.97) and 1.11 (95% CI, 1.00-1.24) for individuals with asthma+COPD+TB and asthma+COPD, respectively. Among male patients with stage III SqCC, HRs were 3.41 (95% CI, 1.27-9.17) and 1.65 (95% CI, 1.10-2.47) for individuals with asthma+TB and asthma+COPD+TB, respectively. Among male patients with stage IV SqCC, HRs were 1.40 (95% CI, 1.00-1.97) and 1.25 (95% CI, 1.03-1.52) for individuals with asthma+ COPD +TB and asthma. Among female patients with stage I and II, HR was 0.19 (95% CI, 005-0.77) for individuals with asthma. Conclusions Coexisting pulmonary diseases increased the risk of mortality from SqCC in male patients. For female patients with early stage SqCC, pre-existing asthma decreased mortality. These patients deserve greater attention while undergoing cancer treatment.	[Huang, Jing-Yang; Jian, Zhi-Hong; Nfor, Oswald Ndi; Jhang, Kai-Ming; Ku, Wen-Yuan; Ko, Pei-Chieh; Jan, Shiou-Rung; Lung, Chia-Chi; Liaw, Yung-Po] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Huang, Jing-Yang; Jian, Zhi-Hong; Nfor, Oswald Ndi; Jhang, Kai-Ming; Ku, Wen-Yuan; Ko, Pei-Chieh; Jan, Shiou-Rung; Lung, Chia-Chi; Liaw, Yung-Po] Chung Shan Med Univ, Inst Publ Hlth, Taichung, Taiwan; [Jhang, Kai-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Ho, Chien-Chang] Fu Jen Catholic Univ, Dept Phys Educ, New Taipei City, Taiwan; [Lung, Chia-Chi; Liaw, Yung-Po] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan; [Pan, Hui-Hsien] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Pan, Hui-Hsien] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Liang, Yu-Chiu] Taipei Med Univ, Coll Humanities & Social Sci, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Fu Jen Catholic University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University	Liaw, YP (corresponding author), Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan.	Liawyp@csmu.edu.tw	Liaw, Yung Po/AAV-6746-2021	Huang, Jing-Yang/0000-0002-0794-9388				Ahmad S, 2011, CLIN DEV IMMUNOL, V2011, DOI [10.1155/2011/814943, DOI 10.1155/2011/814943]; [Anonymous], TAIW TUB CONTR REP 2; Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021; Brown DW, 2005, J ASTHMA, V42, P597, DOI 10.1080/02770900500216234; Caracta CF, 2003, MT SINAI J MED, V70, P215; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Doris K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-118; El-Zein M, 2014, ANN ALLERG ASTHMA IM, V112, P230, DOI 10.1016/j.anai.2013.12.021; El-Zein M, 2010, ANN ALLERG ASTHMA IM, V104, P378, DOI 10.1016/j.anai.2010.03.003; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Fu JJ, 2014, ALLERGY ASTHMA IMMUN, V6, P316, DOI 10.4168/aair.2014.6.4.316; Hardin M, 2014, EUR RESPIR J, V44, P341, DOI 10.1183/09031936.00216013; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Janssen-Heijnen MLG, 2004, THORAX, V59, P602, DOI 10.1136/thx.2003.018044; Jian ZH, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000127; Jonsson F, 2013, BRIT J CANCER, V109, P1921, DOI 10.1038/bjc.2013.411; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Kiri VA, 2009, RESP MED, V103, P85, DOI 10.1016/j.rmed.2008.07.024; Kuo CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033226; Lee CH, 2013, RESP MED, V107, P1222, DOI 10.1016/j.rmed.2012.12.002; Leung CC, 2013, INT J TUBERC LUNG D, V17, P687, DOI 10.5588/ijtld.12.0816; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Pan HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096190; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Rena O, 2013, TUMORI, V99, P661, DOI 10.1700/1390.15453; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Sekine Y, 2007, ANN THORAC SURG, V84, P946, DOI 10.1016/j.athoracsur.2007.04.038; Sekine Y, 2013, THORAC CARDIOV SURG, V61, P124, DOI 10.1055/s-0032-1304543; Singh S, 2013, WORLD J CLIN ONCOL, V4, P43, DOI 10.5306/wjco.v4.i2.43; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Stabile LP, 2005, CANCER RES, V65, P1459, DOI 10.1158/0008-5472.CAN-04-1872; Tammemagi CM, 2003, INT J CANCER, V103, P792, DOI 10.1002/ijc.10882; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Tsai YW, 2008, J WOMENS HEALTH, V17, P971, DOI 10.1089/jwh.2007.0621; Tseng CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109852; VESTERINEN E, 1993, ACTA ONCOL, V32, P517, DOI 10.3109/02841869309096110; Wang YC, 2007, CHEST, V131, P705, DOI 10.1378/chest.06-1829; Wu CT, 2005, J THORAC CARDIOV SUR, V130, P979, DOI 10.1016/j.jtcvs.2005.06.012; Yang TY, 2015, INT J CLIN PRACT, V69, P571, DOI 10.1111/ijcp.12598; Zhai RH, 2014, CHEST, V145, P346, DOI 10.1378/chest.13-1176; Zhou YM, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-123	46	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133367	10.1371/journal.pone.0133367	http://dx.doi.org/10.1371/journal.pone.0133367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196516	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600088
J	Perez, CT; Hill, RH; Grillner, S				Perez, Carolina Thorn; Hill, Russell H.; Grillner, Sten			Substance P Depolarizes Lamprey Spinal Cord Neurons by Inhibiting Background Potassium Channels	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DOMAIN K+ CHANNEL; LOCOMOTOR NETWORK; CALCIUM-CHANNELS; TASK-1; MODULATION; RAT; MOTONEURONS; ANANDAMIDE; RECEPTOR	Substance P is endogenously released in the adult lamprey spinal cord and accelerates the burst frequency of fictive locomotion. This is achieved by multiple effects on interneurons and motoneurons, including an attenuation of calcium currents, potentiation of NMDA currents and reduction of the reciprocal inhibition. While substance P also depolarizes spinal cord neurons, the underlying mechanism has not been resolved. Here we show that effects of substance P on background K+ channels are the main source for this depolarization. Hyperpolarizing steps induced inward currents during whole-cell voltage clamp that were reduced by substance P. These background K+ channels are pH sensitive and are selectively blocked by anandamide and AVE1231. These blockers counteracted the effect of substance P on these channels and the resting membrane potential depolarization in spinal cord neurons. Thus, we have shown now that substance P inhibits background K+ channels that in turn induce depolarization, which is likely to contribute to the frequency increase observed with substance P during fictive locomotion.	[Perez, Carolina Thorn; Hill, Russell H.; Grillner, Sten] Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-10401 Stockholm, Sweden	Karolinska Institutet	Grillner, S (corresponding author), Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, Box 60400, S-10401 Stockholm, Sweden.	sten.grillner@ki.se		Thorn Perez, Carolina/0000-0003-4309-0969; Thorn Perez, Carolina/0000-0002-3480-8599	Swedish Research Council [VRNG 621-2013-4613]; STG; Karolinska Institutet, STG	Swedish Research Council(Swedish Research CouncilEuropean Commission); STG; Karolinska Institutet, STG	This work was supported by the Swedish Research Council VRNG 621-2013-4613, STG, and Karolinska Institutet, STG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthe JY, 1997, EXP BRAIN RES, V115, P485, DOI 10.1007/PL00005718; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Ehrlich JR, 2008, J CARDIOVASC PHARM, V51, P380, DOI 10.1097/FJC.0b013e3181669030; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hille B., 2001, ION CHANNELS EXCITAB, P813; Kettunen P, 2003, J NEUROPHYSIOL, V90, P2341, DOI 10.1152/jn.01132.2002; KOH DS, 1992, J MEMBRANE BIOL, V130, P149; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)90663-5; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; Parker D, 1999, J NEUROSCI, V19, P1647; Parker D, 1998, J NEUROSCI, V18, P8095; Perez CT, 2007, J NEUROPHYSIOL, V97, P3331, DOI 10.1152/jn.01302.2006; Perez CT, 2009, J NEUROPHYSIOL, V102, P1358, DOI 10.1152/jn.00294.2009; Perrier JF, 2013, CURR PHARM DESIGN, V19, P4371, DOI 10.2174/13816128113199990341; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Schiekel J, 2013, CARDIOVASC RES, V97, P97, DOI 10.1093/cvr/cvs285; Schneider ER, 2014, CURR TOP MEMBR, V74, P113, DOI 10.1016/B978-0-12-800181-3.00005-1; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Tegner J, 1997, J NEUROPHYSIOL, V77, P1795, DOI 10.1152/jn.1997.77.4.1795; Thom Perez C, 2012, SUBSTANCE P REDUCES; Wang D, 2013, J PHYSIOL-LONDON, V591, P2509, DOI 10.1113/jphysiol.2012.248526; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133136	10.1371/journal.pone.0133136	http://dx.doi.org/10.1371/journal.pone.0133136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197458	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600064
J	Pham, QD; Wilson, DP; Kerr, CC; Shattock, AJ; Do, HM; Duong, AT; Nguyen, LT; Zhang, L				Quang Duy Pham; Wilson, David P.; Kerr, Cliff C.; Shattock, Andrew J.; Hoa Mai Do; Anh Thuy Duong; Long Thanh Nguyen; Zhang, Lei			Estimating the Cost-Effectiveness of HIV Prevention Programmes in Vietnam, 2006-2010: A Modelling Study	PLOS ONE			English	Article							INJECTING DRUG-USERS; ANTIRETROVIRAL THERAPY; METHADONE-MAINTENANCE; HARM REDUCTION; DISABILITY WEIGHTS; HEALTH; RISK; SEX; INTERVENTIONS; PREVALENCE	Introduction Vietnam has been largely reliant on international support in its HIV response. Over 20062010, a total of US$480 million was invested in its HIV programmes, more than 70% of which came from international sources. This study investigates the potential epidemiological impacts of these programmes and their cost-effectiveness. Methods We conducted a data synthesis of HIV programming, spending, epidemiological, and clinical outcomes. Counterfactual scenarios were defined based on assumed programme coverage and behaviours had the programmes not been implemented. An epidemiological model, calibrated to reflect the actual epidemiological trends, was used to estimate plausible ranges of programme impacts. The model was then used to estimate the costs per averted infection, death, and disability adjusted life-year (DALY). Results Based on observed prevalence reductions amongst most population groups, and plausible counterfactuals, modelling suggested that antiretroviral therapy (ART) and prevention programmes over 2006-2010 have averted an estimated 50,600 [95% uncertainty bound: 36,300-68,900] new infections and 42,600 [36,100-54,100] deaths, resulting in 401,600 [312,200-496,300] fewer DALYs across all population groups. HIV programmes in Vietnam have cost an estimated US$1,972 [1,447-2,747], US$2,344 [1,843-2,765], and US$248 [201-319] for each averted infection, death, and DALY, respectively. Conclusions Our evaluation suggests that HIV programmes in Vietnam have most likely had benefits that are cost-effective. ART and direct HIV prevention were the most cost-effective interventions in reducing HIV disease burden.	[Quang Duy Pham; Wilson, David P.; Kerr, Cliff C.; Shattock, Andrew J.; Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Quang Duy Pham] Inst Pasteur, Dept Dis Control & Prevent, Ho Chi Minh City, Vietnam; [Hoa Mai Do] Hanoi Sch Publ Hlth, Dept Hlth Syst, Hanoi, Vietnam; [Anh Thuy Duong] Vietnam Adm HIV AIDS Control, Dept Planning & Finance, Hanoi, Vietnam; [Long Thanh Nguyen] Minist Heath, Hanoi, Vietnam; [Zhang, Lei] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Zhang, Lei] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Hanoi University of Public Health; Monash University	Zhang, L (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	Lzhang@kirby.unsw.edu.au	Duong, Anh/GPW-9558-2022; Zhang, Lei/D-4039-2011	Zhang, Lei/0000-0003-2343-084X; Shattock, Andrew/0000-0002-2285-8425	World Bank [8004397]; AusAID PhD scholarship; Australian National Health and Medical Research Council; Australian Government, Department of Health and Ageing	World Bank(The World Bank India); AusAID PhD scholarship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government, Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This research was supported by the World Bank under the terms of the contract number: 8004397. QDP is supported by an AusAID PhD scholarship. DPW's work was funded in part by the Australian National Health and Medical Research Council. The Kirby Institute is funded by the Australian Government, Department of Health and Ageing and is affiliated with the UNSW Australia.	Duong AT, 2014, JAIDS-J ACQ IMM DEF, V65, pE1, DOI 10.1097/QAI.0b013e3182a17d15; [Anonymous], 2013, LANCET, DOI DOI 10.1016/S0140-6736(12)61898-4; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; Tran BX, 2012, GLOB PUBLIC HEALTH, V7, P1080, DOI 10.1080/17441692.2012.736259; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Birungi J, 2012, 19 INT AIDS C WASH U; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Craig AP, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18822; Tran DA, 2014, AIDS PATIENT CARE ST, V28, P365, DOI 10.1089/apc.2014.0016; Nguyen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055750; Easterbrook PJ, 2014, AIDS, V28, pS93, DOI 10.1097/QAD.0000000000000253; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Family Health International, 2012, COST AN SEL USAID SU; Family Health International, 2013, IMPR HIV CASC SERV V; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Guinness L, 2010, ADDICTION, V105, P319, DOI 10.1111/j.1360-0443.2009.02755.x; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Iversen J., 2014, AUSTR NEEDLE SYRINGE; Kato M, 2013, JAIDS-J ACQ IMM DEF, V63, pE142, DOI 10.1097/QAI.0b013e31829b535b; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Kumaranayake L, 2004, ADDICTION, V99, P1565, DOI 10.1111/j.1360-0443.2004.00899.x; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; Ministry of Health, 2006, RES HIV STI INT BIOL; Ministry of Health, 2011, RES HIV STI INT BIOL; National AIDS Standing Bureau Family Health International United States Agency for International Development, 2001, HIV AIDS BEH SURV SU; Nguyen TTM, 2012, ADV PREV MED; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Public Health Agency of Canada, 2006, I TRACK ENH SURV RIS; Quan VM, 1998, SUBST USE MISUSE, V33, P1055, DOI 10.3109/10826089809062206; Quan VM, 2000, J ACQ IMMUN DEF SYND, V25, P360, DOI 10.1097/00126334-200012010-00011; Pham QD, 2012, SEX TRANSM DIS, V39, P799, DOI 10.1097/OLQ.0b013e318265b180; Rottingen JA, 2002, SEX TRANSM DIS, V29, P818, DOI 10.1097/00007435-200212000-00014; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; The Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, VIETN NAT AIDS SPEND; The Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, HIV IN ASIA AND THE; Vuong T, 2012, INT J DRUG POLICY, V23, P319, DOI 10.1016/j.drugpo.2011.11.005; Tran BX, 2012, DRUG ALCOHOL DEPEN, V125, P260, DOI 10.1016/j.drugalcdep.2012.02.021; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vassall A, 2014, LANCET GLOB HEALTH, V2, pE531, DOI 10.1016/S2214-109X(14)70277-3; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Wammes JJG, 2012, INT J DRUG POLICY, V23, P358, DOI 10.1016/j.drugpo.2012.06.009; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Zhang L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-250	48	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133171	10.1371/journal.pone.0133171	http://dx.doi.org/10.1371/journal.pone.0133171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196290	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600066
J	Sharp, JA; Hair, PS; Pallera, HK; Kumar, PS; Mauriello, CT; Nyalwidhe, JO; Phelps, CA; Park, D; Thielens, NM; Pascal, SM; Chen, W; Duffy, DM; Lattanzio, FA; Cunnion, KM; Krishna, NK				Sharp, Julia A.; Hair, Pamela S.; Pallera, Haree K.; Kumar, Parvathi S.; Mauriello, Clifford T.; Nyalwidhe, Julius O.; Phelps, Cody A.; Park, Dalnam; Thielens, Nicole M.; Pascal, Stephen M.; Chen, Waldon; Duffy, Diane M.; Lattanzio, Frank A.; Cunnion, Kenji M.; Krishna, Neel K.			Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats	PLOS ONE			English	Article							SERINE PROTEASES; BINDING; IMMUNE; IDENTIFICATION; FICOLINS; PATHWAY	The complement system has been increasingly recognized to play a pivotal role in a variety of inflammatory and autoimmune diseases. Consequently, therapeutic modulators of the classical, lectin and alternative pathways of the complement system are currently in preclinical and clinical development. Our laboratory has identified a peptide that specifically inhibits the classical and lectin pathways of complement and is referred to as Peptide Inhibitor of Complement C1 (PIC1). In this study, we determined that the lead PIC1 variant demonstrates a salt-dependent binding to C1q, the initiator molecule of the classical pathway. Additionally, this peptide bound to the lectin pathway initiator molecule MBL as well as the ficolins H, M and L, suggesting a common mechanism of PIC1 inhibitory activity occurs via binding to the collagen-like tails of these collectin molecules. We further analyzed the effect of arginine and glutamic acid residue substitution on the complement inhibitory activity of our lead derivative in a hemolytic assay and found that the original sequence demonstrated superior inhibitory activity. To improve upon the solubility of the lead derivative, a pegylated, water soluble variant was developed, structurally characterized and demonstrated to inhibit complement activation in mouse plasma, as well as rat, non-human primate and human serum in vitro. After intravenous injection in rats, the pegylated derivative inhibited complement activation in the blood by 90% after 30 seconds, demonstrating extremely rapid function. Additionally, no adverse toxicological effects were observed in limited testing. Together these results show that PIC1 rapidly inhibits classical complement activation in vitro and in vivo and is functional for a variety of animal species, suggesting its utility in animal models of classical complement-mediated diseases.	[Sharp, Julia A.; Pallera, Haree K.; Nyalwidhe, Julius O.; Phelps, Cody A.; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Hair, Pamela S.; Kumar, Parvathi S.; Mauriello, Clifford T.; Park, Dalnam; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Nyalwidhe, Julius O.] Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA USA; [Thielens, Nicole M.] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Thielens, Nicole M.] CNRS, IBS, F-38044 Grenoble, France; [Thielens, Nicole M.] CEA, IBS, F-38044 Grenoble, France; [Pascal, Stephen M.; Chen, Waldon] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA USA; [Duffy, Diane M.; Lattanzio, Frank A.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA; [Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Old Dominion University; Eastern Virginia Medical School	Krishna, NK (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	krishnnk@evms.edu	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302; Krishna, Neel/0000-0002-4615-4035; Pallera, Haree/0000-0002-4576-1626	Virginia Innovation Partnership, a US Department of Commerce i6 Challenge grant [GG11598 142515]; Children's Health Foundation, Children's Hospital of The King's Daughters, Norfolk, Virginia	Virginia Innovation Partnership, a US Department of Commerce i6 Challenge grant; Children's Health Foundation, Children's Hospital of The King's Daughters, Norfolk, Virginia	This study was supported by the grant subaward #GG11598 142515. Virginia Innovation Partnership, a US Department of Commerce i6 Challenge grant; http://www.virginia.edu/vpr/i6/ NKK; Children's Health Foundation, Children's Hospital of The King's Daughters, Norfolk, Virginia; www.chkd.org KMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ACD ACD NMR PROC AC; Bally I, 2013, P NATL ACAD SCI USA, V110, P8650, DOI 10.1073/pnas.1304894110; Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Gronemus JQ, 2010, MOL IMMUNOL, V48, P305, DOI 10.1016/j.molimm.2010.07.012; Hair PS, 2010, MOL IMMUNOL, V47, P792, DOI 10.1016/j.molimm.2009.10.006; JAFFE CJ, 1976, J CLIN INVEST, V58, P942, DOI 10.1172/JCI108547; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Matsushita M, 2013, MOL IMMUNOL, V55, P22, DOI 10.1016/j.molimm.2012.08.017; Mauriello CT, 2013, MOL IMMUNOL, V53, P132, DOI 10.1016/j.molimm.2012.07.012; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Shah TA, 2014, TRANSFUSION, V54, P2892, DOI 10.1111/trf.12695; Sharp JA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00406; Strobel E, 2008, TRANSFUS MED HEMOTH, V35, P346, DOI 10.1159/000154811; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Trau HA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123711; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wasowska BA, 2007, CELL IMMUNOL, V248, P18, DOI 10.1016/j.cellimm.2007.04.009; Zundorf I, 2014, PHARMAZIE, V69, P323, DOI 10.1691/ph.2014.3867	27	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132446	10.1371/journal.pone.0132446	http://dx.doi.org/10.1371/journal.pone.0132446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196285	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600036
J	Thomas, AC; Eijgelaar, WJ; Daemen, MJAP; Newby, AC				Thomas, Anita C.; Eijgelaar, Wouter J.; Daemen, Mat J. A. P.; Newby, Andrew C.			Foam Cell Formation In Vivo Converts Macrophages to a Pro-Fibrotic Phenotype	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; LIPID-METABOLISM; CHOLESTEROL ACCUMULATION; REGULATES EXPRESSION; RECEPTOR; ACTIVATION; DIFFERENTIATION	Formation of foam cell macrophages, which sequester extracellular modified lipids, is a key event in atherosclerosis. How lipid loading affects macrophage phenotype is controversial, with evidence suggesting either pro-or anti-inflammatory consequences. To investigate this further, we compared the transcriptomes of foamy and non-foamy macrophages that accumulate in the subcutaneous granulomas of fed-fat ApoE null mice and normal chow fed wild-type mice in vivo. Consistent with previous studies, LXR/RXR pathway genes were significantly over-represented among the genes up-regulated in foam cell macrophages. Unexpectedly, the hepatic fibrosis pathway, associated with platelet derived growth factor and transforming growth factor-beta action, was also over-represented. Several collagen polypeptides and proteoglycan core proteins as well as connective tissue growth factor and fibrosis-related FOS and JUN transcription factors were up-regulated in foam cell macrophages. Increased expression of several of these genes was confirmed at the protein level in foam cell macrophages from subcutaneous granulomas and in atherosclerotic plaques. Moreover, phosphorylation and nuclear translocation of SMAD2, which is downstream of several transforming growth factor-beta family members, was also detected in foam cell macrophages. We conclude that foam cell formation in vivo leads to a pro-fibrotic macrophage phenotype, which could contribute to plaque stability, especially in early lesions that have few vascular smooth muscle cells.	[Thomas, Anita C.; Newby, Andrew C.] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England; [Eijgelaar, Wouter J.; Daemen, Mat J. A. P.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Daemen, Mat J. A. P.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Bristol; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	Thomas, AC (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol, Avon, England.	a.thomas@bristol.ac.uk	Thomas, Anita C/E-1743-2011	Thomas, Anita C/0000-0002-3792-2653; Daemen, Mat/0000-0003-1076-199X	British Heart Foundation; NIHR Bristol Cardiovascular Biomedical Research Unit; British Heart Foundation [RG/09/006/27918] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); NIHR Bristol Cardiovascular Biomedical Research Unit; British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation and the NIHR Bristol Cardiovascular Biomedical Research Unit (ACT and ACN). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adamson S, 2011, CURR OPIN LIPIDOL, V22, P335, DOI 10.1097/MOL.0b013e32834a97e4; Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Berisha SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065003; Bobik A, 1999, CIRCULATION, V99, P2883, DOI 10.1161/01.CIR.99.22.2883; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Boyle JJ, 2012, CURR OPIN LIPIDOL, V23, P453, DOI 10.1097/MOL.0b013e328356b145; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Chen G, 2013, J CELL SCI, V126, P3697, DOI 10.1242/jcs.126714; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; COOKSON FB, 1971, BRIT J EXP PATHOL, V52, P62; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Draude G, 2000, AM J PHYSIOL-HEART C, V278, pH1042, DOI 10.1152/ajpheart.2000.278.4.H1042; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Grainger DJ, 1996, NAT MED, V2, P381, DOI 10.1038/nm0496-381; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hackshaw A, 2011, J CLIN ONCOL, V29, P1657, DOI 10.1200/JCO.2010.32.2933; Hayes EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00537; Hu YW, 2010, J ATHEROSCLER THROMB, V17, P493, DOI 10.5551/jat.3152; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Johnson JL, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/276457; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P1391, DOI 10.1161/01.ATV.0000133605.89421.79; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li ZY, 2006, J BIOMECH, V39, P2611, DOI 10.1016/j.jbiomech.2005.08.022; Libby P, 2013, J CLIN INVEST, V123, P3201, DOI 10.1172/JCI67526; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Lundberg AM, 2011, CURR OPIN LIPIDOL, V22, P343, DOI 10.1097/MOL.0b013e32834ada80; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2011, EUR J IMMUNOL, V41, P1531, DOI 10.1002/eji.201141670; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Merrilees M, 2000, J VASC RES, V37, P50, DOI 10.1159/000025713; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Moritani NH, 2003, J BONE MINER METAB, V21, P205, DOI 10.1007/s00774-003-0410-1; Newby AC, 2014, CURR OPIN LIPIDOL, V25, P358, DOI 10.1097/MOL.0000000000000111; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; Quillard T, 2014, ARTERIOSCL THROM VAS, V34, P1179, DOI 10.1161/ATVBAHA.114.303326; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ramachandran A, 2011, AM J PATHOL, V179, P2977, DOI 10.1016/j.ajpath.2011.08.034; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rodgers KJ, 2006, ARTERIOSCL THROM VAS, V26, P851, DOI 10.1161/01.ATV.0000203526.75772.4b; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Suwanabol PA, 2011, J SURG RES, V167, P287, DOI 10.1016/j.jss.2010.12.020; Suzuki M, 2012, ARTERIOSCL THROM VAS, V32, P2910, DOI 10.1161/ATVBAHA.112.300383; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thomas AH, 2007, EXP BIOL MED, V232, P406; Thomas AC, 2007, ARTERIOSCL THROM VAS, V27, P571, DOI 10.1161/01.ATV.0000256470.23842.94; Tuomisto TT, 2003, ARTERIOSCL THROM VAS, V23, P2235, DOI 10.1161/01.ATV.0000102551.91154.96; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Weitkamp B, 1999, FASEB J, V13, P1445, DOI 10.1096/fasebj.13.11.1445; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wilson HM, 2005, AM J PATHOL, V167, P27, DOI 10.1016/S0002-9440(10)62950-1; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Xifteri A, 2011, PNEUMON, V24, P149; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200; Yehualaeshet T, 1999, AM J PATHOL, V155, P841, DOI 10.1016/S0002-9440(10)65183-8; Yu Q, 2000, GENE DEV, V14, P163; Zuckerman SH, 2001, ATHEROSCLEROSIS, V155, P79, DOI 10.1016/S0021-9150(00)00540-2	76	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0128163	10.1371/journal.pone.0128163	http://dx.doi.org/10.1371/journal.pone.0128163			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197235	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600002
J	Williams, FM; Kalson, NS; Fabiane, SM; Mann, DA; Deehan, DJ				Williams, Frances M.; Kalson, Nicholas S.; Fabiane, Stella M.; Mann, Derek A.; Deehan, David J.			Joint Stiffness Is Heritable and Associated with Fibrotic Conditions and Joint Replacement	PLOS ONE			English	Article							GENETIC INFLUENCES; FROZEN SHOULDER; TWIN; OSTEOARTHRITIS; DISEASE; KNEE	Objective Joint stiffness is a common, debilitating, age-related symptom, which may be seen after total joint replacement (TJR). Stiffness also occurs in fibrotic conditions such as shoulder capsulitis and Dupuytren's contracture. We speculated that the two traits (TJR and fibrotic disease) are linked pathogenically. Methods Using the Twins UK NIHR BRC BioResource we tested the hypotheses that 1) joint (hip and knee) stiffness, TJR (hip and knee), and fibrotic conditions are associated and 2) genetic factors contribute to them. Results Participating twins (n = 9718) had completed self-reported questionnaires on the traits of interest. All three traits were significantly associated with increasing age and body mass index (BMI), as well as female sex, on univariate analysis. Multivariable logistic regression analyses showed a significant association between TJR and joint stiffness (OR = 3.96, 95% confidence interval, CI 2.77-5.68) and between fibrotic conditions and joint stiffness (OR = 2.39, 1.74-3.29), adjusting for age, sex, BMI and twin relatedness. Monozygotic versus dizygotic intraclass correlations gave heritability estimates for TJR = 46% and joint stiffness = 32%. Conclusion That fibrotic conditions, joint stiffness and TJR are significantly associated suggests a common disease process, possibly fibrosis, which is genetically mediated.	[Williams, Frances M.; Fabiane, Stella M.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Kalson, Nicholas S.; Deehan, David J.] Royal Victoria Infirm, Dept Orthopaed, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Kalson, Nicholas S.; Deehan, David J.] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Kalson, Nicholas S.; Mann, Derek A.; Deehan, David J.] Univ Newcastle, Inst Cellular Med, Fibrosis Res Grp, Newcasltle Upon Tyne, Tyne & Wear, England	University of London; King's College London; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK	Kalson, NS (corresponding author), Royal Victoria Infirm, Dept Orthopaed, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	nickkalson@gmail.com		Williams, Frances/0000-0002-2998-2744; Mann, Derek/0000-0003-0950-243X; Deehan, David/0000-0001-5780-8818	UK MRC Programme Grant [MR/K1001949/1]; Wellcome Trust [WT086755MA]; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR); King's College London; Pain Relief Foundation; Arthritis Research UK; EU FP7 Painomics project; St Thomas' NHS Foundation Trust; Medical Research Council [MR/K001949/1] Funding Source: researchfish; Versus Arthritis [20682] Funding Source: researchfish; MRC [MR/K001949/1] Funding Source: UKRI	UK MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London; Pain Relief Foundation; Arthritis Research UK(Versus Arthritis); EU FP7 Painomics project; St Thomas' NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Fibrosis-related work in DAM lab was funded by a UK MRC Programme Grant (MR/K1001949/1) and by the Wellcome Trust (WT086755MA to D.A.M). TwinsUK. The study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also received support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. SF was funded by the Pain Relief Foundation and FW by Arthritis Research UK and EU FP7 Painomics project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; [Anonymous], 2014, NAT JOINT REG ANN RE; [Anonymous], 2010, MAST CELLS HYPOXIA D; [Anonymous], 2007, FUNCTIONAL PROBLEMS; [Anonymous], 2003, WINNER AGA DONJOY AW; Antony B, 2015, ANN RHEUM DIS, V74, P711, DOI 10.1136/annrheumdis-2013-204161; Becker K, 2015, CLIN GENET, V87, P483, DOI 10.1111/cge.12410; BUNKER TD, 1995, J BONE JOINT SURG BR, V77, P677, DOI 10.1302/0301-620X.77B5.7559688; Chitnavis J, 1997, J BONE JOINT SURG BR, V79B, P660, DOI 10.1302/0301-620X.79B4.7437; Geoghegan JM, 2004, J HAND SURG-BRIT EUR, V29B, P423, DOI 10.1016/j.jhsb.2004.06.006; Hakim AJ, 2003, RHEUMATOLOGY, V42, P739, DOI 10.1093/rheumatology/keg159; Spector TD, 1996, BRIT MED J, V312, P940; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; SPRAGUE NF, 1987, CLIN SPORT MED, V6, P537	15	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133629	10.1371/journal.pone.0133629	http://dx.doi.org/10.1371/journal.pone.0133629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197488	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600124
J	Aadland, E; Ylvisaker, E				Aadland, Eivind; Ylvisaker, Einar			Reliability of Objectively Measured Sedentary Time and Physical Activity in Adults	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; GENERALIZABILITY THEORY; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; LIFE-STYLE; BEHAVIOR; RISK	Background In adults, a minimum of 3-5 days of accelerometer monitoring is usually considered appropriate to obtain reliable estimates of physical activity (PA). However, a longer period of measurement might be needed to obtain reliable estimates of sedentary behavior (SED). The aim of this study was to determine the reliability of objectively assessed SED and PA in adults. Methods Eighty-seven adult subjects (28 men; mean (standard deviation) age 31.3 (12.2) years; body mass index 23.7 (3.1) kg/m(2)) wore the GT3X+ accelerometer for 21 subsequent days, for which the reliability of different wear time criteria (8 to 12 h/day and 3 to 5 d/week) was explored. Variance partitioning along with the Spearman-Brown prophecy formula was used as the basis for determining intraclass-correlation coefficients (ICC) and the number of monitoring days needed (N) to achieve an ICC = 0.80. Week-by-week reliability was reported using ICC, Bland-Altman plots and absolute measures of agreement. Results Seven-10 days of monitoring was needed to reliably assess overall- (axis 1 and vector magnitude (VM) counts per minute (CPM)) and moderate-to-vigorous PA (MVPA), 3-4 days was needed for light PA (LPA), whereas the number of days needed for SED depended on whether adjustments were made for wear time (6-8 days) or not (13-15 days). The week-by-week ICC was >= 0.70 for all variables, with limits of agreement being +/- 267.8 cpm for CPM, +/- 352.3 cpm for VM CPM, +/- 76.8 min/day for SED, +/- 57.8 min/day for LPA and +/- 43.8 min/day for MVPA, equal to 1.0-1.6 standard deviations, when adjustment was made for wear time. Conclusions For most variables, more than one week of measurement was needed to achieve an ICC = 0.80. Correcting for wear time was crucial to reliably determine SED. Considerable week-by-week variability was found for all variables. Researchers need to be aware of substantial intra-individual variability in accelerometer-measurements.	[Aadland, Eivind; Ylvisaker, Einar] Sogn og Fjordane Univ Coll, Fac Teacher Educ & Sport, Sogndal, Norway	Western Norway University of Applied Sciences	Aadland, E (corresponding author), Sogn og Fjordane Univ Coll, Fac Teacher Educ & Sport, Sogndal, Norway.	eivind.aadland@hisf.no						Aadland E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085223; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Baranowski T, 2008, MED SCI SPORT EXER, V40, pS544, DOI 10.1249/MSS.0b013e31817c6651; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Coleman KJ, 1998, RES Q EXERCISE SPORT, V69, P58, DOI 10.1080/02701367.1998.10607667; Colley Rachel, 2010, Health Rep, V21, P63; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2007, DIABETES CARE, V30, P337, DOI 10.2337/dc06-1883; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Green AN, 2014, EUR J APPL PHYSIOL, V114, P907, DOI 10.1007/s00421-014-2822-0; GRETEBECK RJ, 1992, MED SCI SPORT EXER, V24, P1167; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Herrmann SD, 2014, BRIT J SPORT MED, V48, P278, DOI 10.1136/bjsports-2012-091410; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Jerome GJ, 2009, MED SCI SPORT EXER, V41, P110, DOI 10.1249/MSS.0b013e3181846cd8; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Levin S, 1999, ANN EPIDEMIOL, V9, P481, DOI 10.1016/S1047-2797(99)00022-8; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McGuire KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020503; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Sirard JR, 2011, J PHYS ACT HEALTH, V8, P668, DOI 10.1123/jpah.8.5.668; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wickel EE, 2010, MED SCI SPORT EXER, V42, P1528, DOI 10.1249/MSS.0b013e3181d107c4; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	36	60	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133296	10.1371/journal.pone.0133296	http://dx.doi.org/10.1371/journal.pone.0133296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192184	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400071
J	Abysique, A; Tardivel, C; Troadec, JD; Felix, B				Abysique, Anne; Tardivel, Catherine; Troadec, Jean-Denis; Felix, Bernadette			The Food Contaminant Mycotoxin Deoxynivalenol Inhibits the Swallowing Reflex in Anaesthetized Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SUPERIOR LARYNGEAL NERVE; TRICHOTHECENE DEOXYNIVALENOL; TISSUE DISTRIBUTION; ORAL-EXPOSURE; GENE-EXPRESSION; BRAIN-STEM; INDUCTION; VOMITOXIN; ACTIVATION	Deoxynivalenol (DON), one of the most abundant mycotoxins found on cereals, is known to be implicated in acute and chronic illnesses in both humans and animals. Among the symptoms, anorexia, reduction of weight gain and decreased nutrition efficiency were described, but the mechanisms underlying these effects on feeding behavior are not yet totally understood. Swallowing is a major motor component of ingestive behavior which allows the propulsion of the alimentary bolus from the mouth to the esophagus. To better understand DON effects on ingestive behaviour, we have studied its effects on rhythmic swallowing in the rat, after intravenous and central administration. Repetitive electrical stimulation of the superior laryngeal nerve or of the tractus solitarius, induces rhythmic swallowing that can be recorded using electromyographic electrodes inserted in sublingual muscles. Here we provide the first demonstration that, after intravenous and central administration, DON strongly inhibits the swallowing reflex with a short latency and in a dose dependent manner. Moreover, using c-Fos staining, a strong neuronal activation was observed in the solitary tract nucleus which contains the central pattern generator of swallowing and in the area postrema after DON intravenous injection. Our data show that DON modifies swallowing and interferes with central neuronal networks dedicated to food intake regulation.	[Abysique, Anne; Tardivel, Catherine; Troadec, Jean-Denis; Felix, Bernadette] Aix Marseille Univ, Lab Physiol & Physiopathol Syst Nerveux Somato Mo, EA 4674, Marseille, France; [Tardivel, Catherine; Felix, Bernadette] INRA, Dept AlimH, U1189, St Genes Champanelle, France	UDICE-French Research Universities; Aix-Marseille Universite; INRAE	Troadec, JD (corresponding author), Aix Marseille Univ, Lab Physiol & Physiopathol Syst Nerveux Somato Mo, EA 4674, Marseille, France.	j-d.troadec@univ-amu.fr; bernadette.felix@univ-amu.fr	troadec, jean denis/V-1412-2017	Troadec, jean denis/0000-0003-0346-6247	Aix-Marseille University (AMU); Institut National de la Recherche Agronomique (INRA)	Aix-Marseille University (AMU); Institut National de la Recherche Agronomique (INRA)	Funding was received from Aix-Marseille University (AMU) for AA, CT, JDT, BF and Institut National de la Recherche Agronomique (INRA) for CT, BF.	ABBAS HK, 1986, APPL ENVIRON MICROB, V51, P841, DOI 10.1128/AEM.51.4.841-843.1986; Amuzie CJ, 2008, TOXICOLOGY, V248, P39, DOI 10.1016/j.tox.2008.03.005; AZCONAOLIVERA JI, 1995, TOXICOL APPL PHARM, V133, P109, DOI 10.1006/taap.1995.1132; Bae HY, 2010, TOXICOL SCI, V115, P444, DOI 10.1093/toxsci/kfq055; Bao L, 2011, J AOAC INT, V94, P1506, DOI 10.5740/jaoacint.10-477; Bariohay B, 2008, AM J PHYSIOL-REG I, V295, pR1050, DOI 10.1152/ajpregu.90407.2008; Bieger Detlef, 1993, Dysphagia, V8, P308, DOI 10.1007/BF01321768; Binder EM, 2007, ANIM FEED SCI TECH, V133, P149, DOI 10.1016/j.anifeedsci.2006.08.008; Bonnet MS, 2012, TOXINS, V4, P1120, DOI 10.3390/toxins4111120; Bryden WL, 2007, ASIA PAC J CLIN NUTR, V16, P95; BUNNER DL, 1988, TOXICOL APPL PHARM, V92, P113, DOI 10.1016/0041-008X(88)90233-5; Felix B, 2006, AM J PHYSIOL-REG I, V291, pR657, DOI 10.1152/ajpregu.00560.2005; Filtenborg O, 1996, INT J FOOD MICROBIOL, V33, P85, DOI 10.1016/0168-1605(96)01153-1; Flannery BM, 2012, TOXICOL SCI, V130, P289, DOI 10.1093/toxsci/kfs255; Flannery BM, 2011, FOOD CHEM TOXICOL, V49, P1863, DOI 10.1016/j.fct.2011.05.004; Gaige S, 2003, J PHYSIOL-LONDON, V546, P267, DOI 10.1113/jphysiol.2002.029462; Girardet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026134; Harada H, 2005, NEUROSCI RES, V51, P395, DOI 10.1016/j.neures.2004.12.007; He KY, 2012, TOXICOL SCI, V127, P382, DOI 10.1093/toxsci/kfs134; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Jean A, 1994, NUCL SOLITARY TRACT, P361; KESSLER JP, 1985, EXP BRAIN RES, V57, P256; KESSLER JP, 1990, EXP BRAIN RES, V83, P151; KESSLER JP, 1991, EUR J PHARMACOL, V201, P59, DOI 10.1016/0014-2999(91)90323-I; KESSLER JP, 1985, EUR J PHARMACOL, V118, P77, DOI 10.1016/0014-2999(85)90665-X; Kobashi M, 2014, PHYSIOL BEHAV, V130, P6, DOI 10.1016/j.physbeh.2014.03.009; Kobashi M, 2010, REGUL PEPTIDES, V160, P19, DOI 10.1016/j.regpep.2009.12.014; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Mikami O, 2010, J VET SCI, V11, P107, DOI 10.4142/jvs.2010.11.2.107; Moon Y, 2002, TOXICOL SCI, V69, P373, DOI 10.1093/toxsci/69.2.373; Mostafeezur RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050703; Ngampongsa S, 2011, J TOXICOL SCI, V36, P453, DOI 10.2131/jts.36.453; Olsen M, 2001, SAFETY EVALUATION CE, P420; OSSENKOPP KP, 1994, PHARMACOL BIOCHEM BE, V47, P363, DOI 10.1016/0091-3057(94)90024-8; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Paxinos G., 1998, RAT BRAIN STEREOTAXI, Vfourth; Pestka JJ, 2008, FOOD CHEM TOXICOL, V46, P2826, DOI 10.1016/j.fct.2008.05.016; Pestka JJ, 2008, TOXICOL LETT, V178, P83, DOI 10.1016/j.toxlet.2008.02.005; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; PRELUSKY DB, 1988, FUND APPL TOXICOL, V10, P276, DOI 10.1016/0272-0590(88)90312-0; Reinhold Lilli, 2011, Mycotoxin Res, V27, P137, DOI 10.1007/s12550-011-0086-7; Rodrigues I, 2012, TOXINS, V4, P663, DOI 10.3390/toxins4090663; Sirot V, 2013, FOOD CHEM TOXICOL, V52, P1, DOI 10.1016/j.fct.2012.10.036; TRENHOLM HL, 1984, J AM VET MED ASSOC, V185, P527; Turner PC, 2008, ENVIRON HEALTH PERSP, V116, P21, DOI 10.1289/ehp.10663; WANG YT, 1991, AM J PHYSIOL, V261, pR639, DOI 10.1152/ajpregu.1991.261.3.R639; Willis CL, 2007, NEUROSCIENCE, V150, P498, DOI 10.1016/j.neuroscience.2007.09.023; Wolf-Hall CE, 1999, J FOOD PROTECT, V62, P962, DOI 10.4315/0362-028X-62.8.962; Wu WD, 2013, TOXICOL SCI, V133, P186, DOI 10.1093/toxsci/kft033; Yang GH, 2000, TOXICOL APPL PHARM, V164, P149, DOI 10.1006/taap.1999.8888; Yoshino Naoto, 1996, Natural Toxins, V4, P234, DOI 10.1002/(SICI)(1996)4:5<234::AID-NT6>3.0.CO;2-E; Zhou HR, 2003, TOXICOL SCI, V74, P335, DOI 10.1093/toxsci/kfg148; Zhou HR, 2003, TOXICOL SCI, V72, P130, DOI 10.1093/toxsci/kfg006	57	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133355	10.1371/journal.pone.0133355	http://dx.doi.org/10.1371/journal.pone.0133355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192767	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400075
J	Clifton, EH; Jaronski, ST; Hodgson, EW; Gassmann, AJ				Clifton, Eric H.; Jaronski, Stefan T.; Hodgson, Erin W.; Gassmann, Aaron J.			Abundance of Soil-Borne Entomopathogenic Fungi in Organic and Conventional Fields in the Midwestern USA with an Emphasis on the Effect of Herbicides and Fungicides on Fungal Persistence	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; FARMING SYSTEM; MARGINS; INSECT; BIODIVERSITY; AGRICULTURE; ENVIRONMENT; MANAGEMENT; PHYLOGENY	Entomopathogenic fungi (EPF) are widespread in agricultural fields and help suppress crop pests. These natural enemies may be hindered by certain agronomic practices associated with conventional agriculture including the use of pesticides. We tested whether the abundance of EPF differed between organic and conventional fields, and whether specific cropping practices and soil properties were correlated with their abundance. In one year of the survey, soil from organic fields and accompanying margins had significantly more EPF than conventional fields and accompanying margins. Regression analysis revealed that the percentage of silt and the application of organic fertilizer were positively correlated with EPF abundance; but nitrogen concentration, tillage, conventional fields, and margins of conventional fields were negatively correlated with EPF abundance. A greenhouse experiment in which fungicides and herbicides were applied to the soil surface showed no significant effect on EPF. Though organic fields were perceived to be more suitable environments for EPF, abiotic factors and cropping practices such as tillage may have greater impacts on the abundance of EPF. Also, fungicides and herbicides may not be as toxic to soil-borne EPF as originally thought.	[Clifton, Eric H.; Hodgson, Erin W.; Gassmann, Aaron J.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Jaronski, Stefan T.] USDA, Northern Plains Agr Res Lab, Sidney, MT USA	Iowa State University; United States Department of Agriculture (USDA)	Clifton, EH (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	eclifton@iastate.edu	Jaronski, Stefan/AFU-7254-2022; Hodgson, Erin/M-9115-2019	Hodgson, Erin/0000-0003-2492-3558	Leopold Center for Sustainable Agriculture [E2010-18]	Leopold Center for Sustainable Agriculture	This work was supported by Leopold Center for Sustainable Agriculture, Grant: E2010-18 [http://www.leopold.iastate.edu/grants/e2010-18]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kaisi MM, 2013, J SOIL WATER CONSERV, V68, p19A, DOI 10.2489/jswc.68.1.19A; AMS [Agricultural Marketing Service], 2014, NAT ORG PROGR US; [Anonymous], [No title captured]; Bednarek A, 1997, J NEMATOL, V29, P220; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; BING LA, 1993, AGR ECOSYST ENVIRON, V45, P147, DOI 10.1016/0167-8809(93)90065-W; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Bruck DJ, 2009, BIOCONTROL, V54, P597, DOI 10.1007/s10526-009-9213-1; CHASE AR, 1986, FLA ENTOMOL, V69, P285, DOI 10.2307/3494930; Crowder DW, 2012, ECOLOGY, V93, P2001, DOI 10.1890/12-0110.1; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; D'Alessandro CP, 2011, BIOCONTROL SCI TECHN, V21, P189, DOI 10.1080/09583157.2010.536200; de Snoo GR, 1999, LANDSCAPE URBAN PLAN, V46, P151, DOI 10.1016/S0169-2046(99)00039-0; Ekesi S, 2003, J INVERTEBR PATHOL, V83, P157, DOI 10.1016/S0022-2011(03)00069-7; Gardner WH, 1986, AM SOC AGRONOMY MONO, V9; Garratt MPD, 2011, AGR ECOSYST ENVIRON, V141, P261, DOI 10.1016/j.agee.2011.03.014; GEE GW, 1986, AM SOC AGRONOMY MONO, V9; Goettel GM, 1997, MANUAL TECHNIQUES IN; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hummel RL, 2002, ENVIRON ENTOMOL, V31, P84, DOI 10.1603/0046-225X-31.1.84; Imoulan A, 2011, WORLD J MICROB BIOT, V27, P2619, DOI 10.1007/s11274-011-0735-1; Jabbour R, 2009, BIOL CONTROL, V51, P435, DOI 10.1016/j.biocontrol.2009.08.004; Jaronski S. T., 2012, MANUAL TECHNIQUES IN; Jaronski ST, 2010, BIOCONTROL, V55, P159, DOI 10.1007/s10526-009-9248-3; Jaros-Su J, 1999, BIOL CONTROL, V15, P259, DOI 10.1006/bcon.1999.0724; Keyser CA, 2014, J INVERTEBR PATHOL, V120, P67, DOI 10.1016/j.jip.2014.05.008; Klingen I, 2002, AGR ECOSYST ENVIRON, V91, P191, DOI 10.1016/S0167-8809(01)00227-4; LORIA R, 1983, ENVIRON ENTOMOL, V12, P1724, DOI 10.1093/ee/12.6.1724; Marshall EJR, 2002, AGR ECOSYST ENVIRON, V89, P5, DOI 10.1016/S0167-8809(01)00315-2; Meyling NV, 2011, BIOL CONTROL, V59, P180, DOI 10.1016/j.biocontrol.2011.07.017; Meyling NV, 2009, MOL ECOL, V18, P1282, DOI 10.1111/j.1365-294X.2009.04095.x; Mietkiewski RT, 1997, BIOCONTROL SCI TECHN, V7, P565, DOI 10.1080/09583159730622; Mochi DA, 2005, NEOTROP ENTOMOL, V34, P961, DOI 10.1590/S1519-566X2005000600013; National Drought Mitigation Center, 2014, US DROUGHT MON IOW; Quesada-Moraga E, 2007, MYCOL RES, V111, P947, DOI 10.1016/j.mycres.2007.06.006; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rehner SA, 2011, MYCOLOGIA, V103, P1055, DOI 10.3852/10-302; Rudeen ML, 2013, J INVERTEBR PATHOL, V114, P329, DOI 10.1016/j.jip.2013.09.009; Samson PR, 2005, BIOCONTROL, V50, P151, DOI 10.1007/s10526-004-0419-y; SAS Institute Inc., 2012, SAS STAT 9 3 US GUID; Scheepmaker JWA, 2010, BIOCONTROL SCI TECHN, V20, P503, DOI 10.1080/09583150903545035; SOSAGOMEZ DR, 1994, FLA ENTOMOL, V77, P284, DOI 10.2307/3495515; Tarasco E., 2010, IOBC/WPRS Bulletin, V57, P85; Vanninen I, 1996, MYCOL RES, V100, P93, DOI 10.1016/S0953-7562(96)80106-7; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Willer H, 2013, BIOFACH C NUR GERM; Wolfinger, 1996, SAS SYSTEM LINEAR MO; Yaginuma K, 2007, JPN J APPL ENTOMOL Z, V51, P213, DOI 10.1303/jjaez.2007.213; Yanez M, 2010, CHIL J AGR RES, V70, P390, DOI 10.4067/S0718-58392010000300006; Zehnder G, 2007, ANNU REV ENTOMOL, V52, P57, DOI 10.1146/annurev.ento.52.110405.091337; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	53	33	35	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133613	10.1371/journal.pone.0133613	http://dx.doi.org/10.1371/journal.pone.0133613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191815	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400106
J	Johnson, KR; Nicodemus-Johnson, J; Spindler, MJ; Carnegie, GK				Johnson, Keven R.; Nicodemus-Johnson, Jessie; Spindler, Mathew J.; Carnegie, Graeme K.			Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy	PLOS ONE			English	Article							AKAP-LBC; HEART-FAILURE; IN-VIVO; FETAL; REQUIREMENT; METABOLISM; MICROARRAY; PATHWAYS	In the heart, scaffolding proteins such as A-Kinase Anchoring Proteins (AKAPs) play a crucial role in normal cellular function by serving as a signaling hub for multiple protein kinases including protein kinase D1 (PKD1). Under cardiac hypertrophic conditions AKAP13 anchored PKD1 activates the transcription factor MEF2 leading to subsequent fetal gene activation and hypertrophic response. We used an expression microarray to identify the global transcriptional response in the hearts of wild-type mice expressing the native form of AKAP13 compared to a gene-trap mouse model expressing a truncated form of AKAP13 that is unable to bind PKD1 (AKAP13-Delta PKD1). Microarray analysis showed that AKAP13-Delta PKD1 mice broadly failed to exhibit the transcriptional profile normally associated with compensatory cardiac hypertrophy following trans-aortic constriction (TAC). The identified differentially expressed genes in WT and AKAP13-Delta PKD1 hearts are vital for the compensatory hypertrophic response to pressure-overload and include myofilament, apoptotic, and cell growth/differentiation genes in addition to genes not previously identified as affected by AKAP13-anchored PKD1. Our results show that AKAP13-PKD1 signaling is critical for transcriptional regulation of key contractile, cell death, and metabolic pathways during the development of compensatory hypertrophy in vivo.	[Johnson, Keven R.; Carnegie, Graeme K.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Nicodemus-Johnson, Jessie] Univ Chicago, Dept Human Genet, Chicago, IL 60612 USA; [Spindler, Mathew J.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of California System; University of California San Francisco; The J David Gladstone Institutes	Johnson, KR (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA.	kevenj54@gmail.com			American Heart Association SDG [11SDG5230003]; National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences [UL1TR000050]; American Heart Association postdoctoral fellowship [13POST17000023]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER	American Heart Association SDG(American Heart Association); National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences; American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the American Heart Association SDG 11SDG5230003, the National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant UL1TR000050 to GKC, and the American Heart Association postdoctoral fellowship 13POST17000023 to JNJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Darwish H, 2007, ONCOGENE, V26, P4319, DOI 10.1038/sj.onc.1210195; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; el Azzouzi H, 2010, EUR J HEART FAIL, V12, P4, DOI 10.1093/eurjhf/hfp165; EVERETT AW, 1986, J MOL CELL CARDIOL, V18, P607, DOI 10.1016/S0022-2828(86)80968-3; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Iida K, 1999, TOHOKU J EXP MED, V187, P15, DOI 10.1620/tjem.187.15; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marks AR, 2003, CIRCULATION, V107, P1456, DOI 10.1161/01.CIR.0000059745.95643.83; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Picard MH, 2011, J AM SOC ECHOCARDIOG, V24, P1, DOI 10.1016/j.echo.2010.11.006; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SCHWARTZ K, 1992, SYM SOC EXP BIOL, V46, P265; Spindler MJ, PLOS ONE, V8, DOI [10.1371/journal.pone.0062705PONE-D-10-06029, DOI 10.1371/J0URNAL.P0NE.0062705]; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Taglieri DM, 2014, J MOL CELL CARDIOL, V66, P27, DOI 10.1016/j.yjmcc.2013.10.010; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yoav B, 1995, J ROY STAT SOC, V57, P289	33	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132474	10.1371/journal.pone.0132474	http://dx.doi.org/10.1371/journal.pone.0132474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192751	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400027
J	Williams, NE; Thomas, TA; Dunbar, M; Eagle, N; Dobra, A				Williams, Nathalie E.; Thomas, Timothy A.; Dunbar, Matthew; Eagle, Nathan; Dobra, Adrian			Measures of Human Mobility Using Mobile Phone Records Enhanced with GIS Data	PLOS ONE			English	Article							INTERNATIONAL MIGRATION; PATTERNS; UNEMPLOYMENT; POPULATION; OWNERSHIP; MEXICO	In the past decade, large scale mobile phone data have become available for the study of human movement patterns. These data hold an immense promise for understanding human behavior on a vast scale, and with a precision and accuracy never before possible with censuses, surveys or other existing data collection techniques. There is already a significant body of literature that has made key inroads into understanding human mobility using this exciting new data source, and there have been several different measures of mobility used. However, existing mobile phone based mobility measures are inconsistent, inaccurate, and confounded with social characteristics of local context. New measures would best be developed immediately as they will influence future studies of mobility using mobile phone data. In this article, we do exactly this. We discuss problems with existing mobile phone based measures of mobility and describe new methods for measuring mobility that address these concerns. Our measures of mobility, which incorporate both mobile phone records and detailed GIS data, are designed to address the spatial nature of human mobility, to remain independent of social characteristics of context, and to be comparable across geographic regions and time. We also contribute a discussion of the variety of uses for these new measures in developing a better understanding of how human mobility influences micro-level human behaviors and well-being, and macro-level social organization and change.	[Williams, Nathalie E.] Univ Washington, Jackson Sch Int Studies, Seattle, WA 98195 USA; [Williams, Nathalie E.; Thomas, Timothy A.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Dunbar, Matthew] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; [Eagle, Nathan] Harvard Univ, Dept Epidemiol, Boston, MA USA; [Dobra, Adrian] Univ Washington, Dept Stat, Ctr Stat & Social Sci, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA; [Dobra, Adrian] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dobra, A (corresponding author), Univ Washington, Jackson Sch Int Studies, Seattle, WA 98195 USA.	adobra@uw.edu		Thomas, Timothy/0000-0003-1357-6095	National Science Foundation [DMS-1120255]; Eunice Kennedy Shriver National Institute of Child Health & Human Development, Pathways to Independence grant [R00HD067587]; National Institute of Child Health and Human Development research infrastructure grant [R24HD042828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828, R00HD067587, P2CHD042828] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1120255] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Eunice Kennedy Shriver National Institute of Child Health & Human Development, Pathways to Independence grant; National Institute of Child Health and Human Development research infrastructure grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grant DMS-1120255 (http://www.nsf.gov), Eunice Kennedy Shriver National Institute of Child Health & Human Development, Pathways to Independence grant (R00HD067587), and National Institute of Child Health and Human Development research infrastructure grant, R24HD042828.	Alexander L, 2015, TRANSPORT RES C-EMER, V58, P240, DOI 10.1016/j.trc.2015.02.018; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Becker R, 2013, COMMUN ACM, V56, P74, DOI 10.1145/2398356.2398375; Bivand RS, 2013, APPLIED SPATIAL DATA; Blumenstock JE, 2012, INF TECHNOL INT DEV, V8, P1; Blumenstock JE, 2012, INFORM TECHNOL DEV, V18, P107, DOI 10.1080/02681102.2011.643209; Calabrese F, 2013, TRANSPORT RES C-EMER, V26, P301, DOI 10.1016/j.trc.2012.09.009; Chen C, 2014, TRANSPORT RES C-EMER, V46, P326, DOI 10.1016/j.trc.2014.07.001; Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111; Dobra A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120449; DONATO KM, 1993, INT MIGR REV, V27, P748, DOI 10.2307/2546911; Durand J, 1996, DEMOGRAPHY, V33, P249, DOI 10.2307/2061875; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Frizzelle BG, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-24; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Groves R, DESIGNED DATA AND OR; Haining R., 2003, SPATIAL DATA ANALYSI; HARRIS JR, 1970, AM ECON REV, V60, P126; Hawbaker TJ, 2005, LANDSCAPE ECOL, V20, P609, DOI 10.1007/s10980-004-5647-0; Jiang ZQ, 2013, P NATL ACAD SCI USA, V110, P1600, DOI 10.1073/pnas.1220433110; Lars B, 2002, INTERNATIONAL JOURNA, V1; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Massey DS, 2010, INT MIGR, V48, P1, DOI 10.1111/j.1468-2435.2009.00581.x; MASSEY DS, 1993, POPUL DEV REV, V19, P431, DOI 10.2307/2938462; MASSEY DS, 1990, POPUL INDEX, V56, P3, DOI 10.2307/3644186; Massey DS, 1997, AM J SOCIOL, V102, P939, DOI 10.1086/231037; Putnam SH, 1989, ENVIRON PLANN A, V21, P27, DOI [10.1068/a210027, DOI 10.1068/A210027]; STARK O, 1985, AM ECON REV, V75, P173; STARK O, 1991, ECON J, V101, P1163, DOI 10.2307/2234433; Stopher PR, 2007, TRANSPORT RES A-POL, V41, P367, DOI 10.1016/j.tra.2006.09.005; Tatem AJ, 2014, INT HEALTH, V6, P5, DOI 10.1093/inthealth/ihu006; TAYLOR JE, 1987, AM J AGR ECON, V69, P626, DOI 10.2307/1241697; TODARO MP, 1987, POPUL DEV REV, V13, P101, DOI 10.2307/1972122; TODARO MP, 1969, AM ECON REV, V59, P138; Union IT, REPORT; VanWey LK, 2005, INT MIGR REV, V39, P141, DOI 10.1111/j.1747-7379.2005.tb00258.x; Weslowski A, 2013, JOURNAL OF THE ROYAL, V10; Wesolowski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052971; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Williams N, 2009, SOC SCI RES, V38, P883, DOI 10.1016/j.ssresearch.2009.04.005; Wolf J, 2003, TRANSPORT RES REC, P189; Wong DWS, 2004, URBAN GEOGR, V25, P66, DOI 10.2747/0272-3638.25.1.66	45	49	49	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133630	10.1371/journal.pone.0133630	http://dx.doi.org/10.1371/journal.pone.0133630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192322	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400108
J	Wooding, S; Van Leeuwen, TN; Parks, S; Kapur, S; Grant, J				Wooding, Steven; Van Leeuwen, Thed N.; Parks, Sarah; Kapur, Shitij; Grant, Jonathan			Doubles Its "World-Leading" Research in Life Sciences and Medicine in Six Years: Testing the Claim?	PLOS ONE			English	Article							PERFORMANCE	Background The UK, like some other countries, carries out a periodic review of research quality in universities and the most recent Research Excellence Framework (REF) reported a doubling (103% increase) in its "world leading" or so-called "4*" research outputs in the areas of life sciences and medicine between 2008 and 2014. This is a remarkable improvement in six years and if validated internationally could have profound implications for health sciences. Methods We compared the reported changes in 4* quality to bibliometric measures of quality for the 56,639 articles submitted to the RAE 2008 and the 50,044 articles submitted to the REF 2014 to Panel A, which assesses the life sciences, including medicine. Findings UK research submitted to the RAE and REF was of better quality than worldwide research on average. While we found evidence for some increase in the quality of top UK research articles, a 10-25% increase in the top 10% ile papers, depending upon the metrics used, we could not find evidence to support a 103% increase in quality. Instead we found that as compared to the RAE, the REF results implied a lower citation % ile threshold for declaring a 4*. Interpretation There is a wide discrepancy between bibliometric indices and peer-review panel judgements between the RAE 2008 and REF 2014. It is possible that the changes in the funding regime between 2008 and 2014 that significantly increased the financial premium for 4* articles may have influenced research quality evaluation. For the advancement of science and health, evaluation of research quality requires consistency and validity - the discrepancy noted here calls for a closer examination of mass peer- review methods like the REF.	[Wooding, Steven; Parks, Sarah] RAND Europe, Cambridge, England; [Van Leeuwen, Thed N.] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands; [Kapur, Shitij] Kings Coll London, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Grant, Jonathan] Kings Coll London, Policy Inst, London WC2R 2LS, England	RAND Corporation; RAND Europe; Leiden University; Leiden University - Excl LUMC; University of London; King's College London; University of London; King's College London	Grant, J (corresponding author), Kings Coll London, Policy Inst, London WC2R 2LS, England.	jonathan.grant@kcl.ac.uk	Grant, Jonathan C/K-4282-2012	Grant, Jonathan C/0000-0002-1646-3486; van Leeuwen, Thed N/0000-0001-7238-6289; Wooding, Steven/0000-0002-8036-1054				[Anonymous], 2010, 24187 EUR EN EUR COM; [Anonymous], 2008, 012008 RAE; Bornmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014331; De Bellis N., 2009, BIBLIOMETRICS CITATI; den Hertog P, 2014, SCHOLARLY PUBLICATIO; Guthrie S., 2013, MEASURING RES GUIDE; Hicks D, 2012, RES POLICY, V41, P251, DOI 10.1016/j.respol.2011.09.007; MOED HF, 1995, SCIENTOMETRICS, V33, P381, DOI 10.1007/BF02017338; Moed HF., 2005, CITATION ANAL RES EV; Mohammadi D, 2014, LANCET; Research Excellence Framework (REF), 2012, 012012 REF; Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178; van Leeuwen T, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P373; van Leeuwen TN., 2013, BIBLIOMETRIE PRAXIS, V2, P1; van Raan A.F.J., 2007, SCOP STUD US BIBL AN	15	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132990	10.1371/journal.pone.0132990	http://dx.doi.org/10.1371/journal.pone.0132990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204117	Green Published, gold			2022-12-27	WOS:000358621000016
J	Lang, S; Lacombe, JM; Mary-Krause, M; Partisani, M; Bidegain, F; Cotte, L; Aslangul, E; Cheret, A; Boccara, F; Meynard, JL; Pradier, C; Roger, PM; Tattevin, P; Costagliola, D; Molina, JM				Lang, Sylvie; Lacombe, Jean-Marc; Mary-Krause, Murielle; Partisani, Marialuisa; Bidegain, Frederic; Cotte, Laurent; Aslangul, Elisabeth; Cheret, Antoine; Boccara, Franck; Meynard, Jean-Luc; Pradier, Christian; Roger, Pierre-Marie; Tattevin, Pierre; Costagliola, Dominique; Molina, Jean-Michel		French Hosp Database HIV	Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort	PLOS ONE			English	Article							FRENCH-HOSPITAL-DATABASE; RISK; INFLAMMATION; COAGULATION; MARKERS; EVENTS	Background The effect of statins on all-cause mortality in the general population has been estimated as 0.86 (95% CI 0.79-0.94) for primary prevention. Reported values in HIV-infected individuals have been discordant. We assessed the impact of statin-based primary prevention on all-cause mortality among HIV-infected individuals. Methods Patients were selected among controls from a multicentre nested case-control study on the risk of myocardial infarction. Patients with prior cardiovascular or cerebrovascular disorders were not eligible. Potential confounders, including variables that were associated either with statin use and/or death occurrence and statin use were evaluated within the last 3 months prior to inclusion in the case-control study. Using an intention to continue approach, multiple imputation of missing data, Cox's proportional hazard models or propensity based weighting, the impact of statins on the 7-year all-cause mortality was evaluated. Results Among 1,776 HIV-infected individuals, 138 (8%) were statins users. During a median follow-up of 53 months, 76 deaths occurred, including 6 in statin users. Statin users had more cardiovascular risk factors and a lower CD4 T cell nadir than statin non-users. In univariable analysis, the death rate was higher in statins users (11% vs 7%, HR 1.22, 95% CI 0.53-2.82). The confounders accounted for were age, HIV transmission group, current CD4 T cell count, haemoglobin level, body mass index, smoking status, anti-HCV antibodies positivity, HBs antigen positivity, diabetes and hypertension. In the Cox multivariable model the estimated hazard ratio of statin on all-cause mortality was estimated as 0.86 (95% CI 0.34-2.19) and it was 0.83 (95% CI 0.51-1.35) using inverse probability treatment weights. Conclusion The impact of statin for primary prevention appears similar in HIV-infected individuals and in the general population.	[Lang, Sylvie; Lacombe, Jean-Marc; Mary-Krause, Murielle; Costagliola, Dominique] Univ Paris 06, Sorbonne Univ, INSERM, IPLESP UMRS 1136, F-75013 Paris, France; [Mary-Krause, Murielle] Hop Univ Strasbourg, Le Trait Union, Ctr Soins Infect VIH, Strasbourg, France; [Bidegain, Frederic] Hop Avicenne, AP HP, Serv Malad Infect, Bobigny, France; [Cotte, Laurent] Hosp Civils Lyon, Hop Croix Rousse, Serv Malad Infectieuses & Trop, Lyon, France; [Cotte, Laurent] INSERM, U1052, F-69008 Lyon, France; [Aslangul, Elisabeth] AP HP, Hotel Dieu, Med Interna Serv, Paris, France; [Aslangul, Elisabeth] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Cheret, Antoine] AP HP, Hotel Necker, Virol Lab, Paris, France; [Cheret, Antoine] Univ Paris 05, Sorbonne Paris Cite, EA 3620, Paris, France; [Cheret, Antoine] Ctr Hosp Tourcoing, Serv Malad Infect, Tourcoing, France; [Boccara, Franck] Hop St Antoine, AP HP, Serv Cardiol, F-75571 Paris, France; [Boccara, Franck] Univ Paris 06, Sorbonne Univ, INSERM, UMRS 938, F-75012 Paris, France; [Meynard, Jean-Luc] Hop St Antoine, AP HP, Serv Malad Infect & Trop, F-75571 Paris, France; [Pradier, Christian] CHU Nice, Serv Sante Publ, Grp Hosp Archet, F-06202 Nice, France; [Roger, Pierre-Marie] CHU Nice, Serv Infectiol, Grp Hosp Archet, F-06202 Nice, France; [Roger, Pierre-Marie] Univ Nice, Sophia Antipolis, France; [Tattevin, Pierre] Hop Univ Pontchaillou, Serv Malad Infect, Rennes, France; [Tattevin, Pierre] USI, Rennes, France; [Molina, Jean-Michel] Hop St Louis, AP HP, Serv Malad Infect & Trop, Paris, France; [Molina, Jean-Michel] Univ Paris 07, Sorbonne Paris Cite, INSERM, U941, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Nice; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lang, S (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, IPLESP UMRS 1136, F-75013 Paris, France.	slang@ccde.chups.jussieu.fr	Costagliola, Dominique/H-5849-2011; Pradier, Christian/AAE-9669-2022; Pradier, Christian/AFE-8255-2022; Mahamat, Aba/V-7888-2019; Martin-Blondel, Guillaume/K-6762-2014	Costagliola, Dominique/0000-0003-0765-0869; Mahamat, Aba/0000-0001-8755-0424; Martin-Blondel, Guillaume/0000-0002-8363-7028; Lelievre, Jean-Daniel/0000-0002-8182-3628				Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Desai Chintan S, 2014, BMJ, V349, pg3743, DOI 10.1136/bmj.g3743; Drechsler H, 2013, 20 C RETR OPP INF CR; Eapen DJ, 2013, J AM COLL CARDIOL, V62, P329, DOI 10.1016/j.jacc.2013.03.072; Funderburg NT, 2014, CURR OPIN HIV AIDS, V9, P80, DOI 10.1097/COH.0000000000000019; Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Mary-Krause M, 2014, INT J EPIDEMIOL, V43, P1425, DOI 10.1093/ije/dyu002; Moore RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021843; Overton ET, 2013, CLIN INFECT DIS, V56, P1471, DOI 10.1093/cid/cit053; Rasmussen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052828; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rubin DB, 2004, MULTIPLE IMPUTATION; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5	14	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133358	10.1371/journal.pone.0133358	http://dx.doi.org/10.1371/journal.pone.0133358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200661	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100060
J	Bostrom, MM; Irjala, H; Mirtti, T; Taimen, P; Kauko, T; Algars, A; Jalkanen, S; Bostrom, PJ				Bostrom, Minna M.; Irjala, Heikki; Mirtti, Tuomas; Taimen, Pekka; Kauko, Tommi; Algars, Annika; Jalkanen, Sirpa; Bostrom, Peter J.			Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer	PLOS ONE			English	Article							SCAVENGER RECEPTOR; BINDING; MOLECULE; CELLS	Inflammation is an important feature of carcinogenesis. Tumor-associated macrophages (TAMs) can be associated with either poor or improved prognosis, depending on their properties and polarization. Current knowledge of the prognostic significance of TAMs in bladder cancer is limited and was investigated in this study. We analyzed 184 urothelial bladder cancer patients undergoing transurethral resection of a bladder tumor or radical cystectomy. CD68 (pan-macrophage marker), MAC387 (polarized towards type 1 macrophages), and CLEVER-1/Stabilin-1 (type 2 macrophages and lymphatic/blood vessels) were detected immunohistochemically. The median follow-up time was 6.0 years. High macrophage counts associated with a higher pT category and grade. Among patients undergoing transurethral resection, all studied markers apart from CLEVER-1/Stabilin-1 were associated with increased risk of progression and poorer disease-specific and overall survival in univariate analyses. High levels of two macrophage markers (CD68/MAC387(+/+) or CD68/CLEVER-1(+/+) groups) had an independent prognostic role after transurethral resection in multivariate analyses. In the cystectomy cohort, MAC387, alone and in combination with CD68, was associated with poorer survival in univariate analyses, but none of the markers were independent predictors of outcome in multivariate analyses. In conclusion, this study demonstrates that macrophage phenotypes provide significant independent prognostic information, particularly in bladder cancers undergoing transurethral resection.	[Bostrom, Minna M.; Irjala, Heikki; Algars, Annika; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, MediCity Res Lab, Turku, Finland; [Irjala, Heikki] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Mirtti, Tuomas] Helsinki Univ Hosp HUSLAB, Dept Pathol, Helsinki, Finland; [Mirtti, Tuomas] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Taimen, Pekka] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland; [Kauko, Tommi] Univ Turku, Dept Biostat, Turku, Finland; [Algars, Annika] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Bostrom, Peter J.] Turku Univ Hosp, Dept Urol, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Helsinki; University of Turku; University of Turku; University of Turku; University of Turku	Bostrom, MM (corresponding author), Univ Turku, Dept Med Microbiol & Immunol, MediCity Res Lab, Turku, Finland.	mmbost@utu.fi		Kauko, Tommi/0000-0002-7644-3225; Mirtti, Tuomas/0000-0003-0455-9891; Irjala, Heikki/0000-0003-3054-4677; Bostrom, Peter/0000-0003-3647-0015	Juselius Foundation; Cancer Society of Finland; Finnish Medical Foundation; Kirsti and Tor Johanssons Heart and Cancer Foundation; Orion-Farmos; Instrumentariumin tiedesaatio	Juselius Foundation; Cancer Society of Finland; Finnish Medical Foundation; Kirsti and Tor Johanssons Heart and Cancer Foundation; Orion-Farmos; Instrumentariumin tiedesaatio	Peter J. Bostrom received support from the Juselius Foundation (http://www.sigridjuselius.fi/foundation) and Cancer Society of Finland (http://www.cancer.fi/en/). Sirpa Jalkanen received support from the Finnish Medical Foundation (http://www.laaketieteensaatio.fi/fin/in_english/), Kirsti and Tor Johanssons Heart and Cancer Foundation. Minna M. Bostrom received support from the Orion-Farmos (http://www.orion.fi/en/rd/) and Instrumentariumin tiedesaatio (http://www.instrufoundation.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Ayari C, 2009, EUR UROL, V55, P1386, DOI 10.1016/j.eururo.2009.01.040; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; GOEBELER M, 1994, J LEUKOCYTE BIOL, V55, P259, DOI 10.1002/jlb.55.2.259; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Irjala H, 2003, EUR J IMMUNOL, V33, P815, DOI 10.1002/eji.200323859; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kzhyshkowska J, 2010, THESCIENTIFICWORLDJO, V10, P2039, DOI 10.1100/tsw.2010.189; Lima L, 2012, ADV UROL, V2012, DOI 10.1155/2012/232609; Lopez-Beltran A, 2007, J CLIN PATHOL, V60, P332, DOI 10.1136/jcp.2006.038802; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mukhtar RA, 2012, ANN SURG ONCOL, V19, P3979, DOI 10.1245/s10434-012-2415-2; Palani S, 2011, EUR J IMMUNOL, V41, P2052, DOI 10.1002/eji.201041376; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rosevear HM, 2009, CANCER METAST REV, V28, P345, DOI 10.1007/s10555-009-9195-6; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Sauter G, 2004, WHO CLASSIFICATION C, P29; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Sjodahl G, 2014, UROL ONCOL-SEMIN ORI, V32, P791, DOI 10.1016/j.urolonc.2014.02.007; Sobin LH, 2009, TNM CLASSIFICATION M, P262; Soulas C, 2011, AM J PATHOL, V178, P2121, DOI 10.1016/j.ajpath.2011.01.023; Subimerb C, 2010, MOL MED REP, V3, P597, DOI 10.3892/mmr_00000303; Takayama H, 2009, J UROLOGY, V181, P1894, DOI 10.1016/j.juro.2008.11.090; TUNGEKAR MF, 1991, HISTOPATHOLOGY, V19, P245, DOI 10.1111/j.1365-2559.1991.tb00029.x; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	29	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133552	10.1371/journal.pone.0133552	http://dx.doi.org/10.1371/journal.pone.0133552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197470	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600114
J	Jin, H; Tan, ZY; Zhang, XF; Wang, B; Zhao, YY; Liu, P				Jin, Hui; Tan, Zhaoying; Zhang, Xuefeng; Wang, Bei; Zhao, Yueyuan; Liu, Pei			Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; IMMUNE-RESPONSE; DRUG-USERS; IMMUNOGENICITY; IMMUNIZATION; PROPHYLAXIS	Background Selecting the most efficient vaccination schedule is an important issue. Objective To assess the beneficial and harmful effects of accelerated hepatitis B vaccination schedules in high-risk healthy adults. Methods We searched controlled trial registers of The Cochrane Library as well as MEDLINE, EMBASE, VIP Database for Chinese Technical Periodicals, and the Chinese National Knowledge Infrastructure databases for randomized controlled trials published up to December 2013 that compared accelerated hepatitis B vaccine schedules to the standard schedule in adults. The results were presented as relative risk with 95% confidence intervals. Fixed or random effect models were used for analysis. Results We identified 10 randomized trials, all with one or more methodological weaknesses. Compared to the standard schedule, most accelerated schedules resulted in higher proportions of healthy vaccines more rapidly reaching anti-hepatitis B antibody levels >10 IU/L (P<0.05) initially and maintaining similar seroprotection rates after 6 months (P>0.05). Although accelerated schedules produced anti-hepatitis B levels higher than the standard schedule for the first month after the initial vaccine dose, they were significantly lower than the standard schedule after 6 months, except for an accelerated schedule that called for a fourth booster injection 12 months after the initial dose. Subjects administered accelerated vaccine schedules had similar compliance rate as those administered the standard schedule over the first 6 months of vaccination (relative risk = 1.00, 95% confidence interval: 0.84-1.21). Conclusion For rapid seroconversion and almost immediate short-term protection, accelerated vaccination schedules could be useful for at-risk groups. However, additional studies on the longterm protection and effectiveness of the primary doses of accelerated schedules are necessary.	[Jin, Hui; Wang, Bei; Zhao, Yueyuan; Liu, Pei] Southeast Univ, Dept Epidemiol & Hlth Stat, Nanjing, Jiangsu, Peoples R China; [Jin, Hui; Wang, Bei; Zhao, Yueyuan; Liu, Pei] Southeast Univ, Sch Publ Hlth, Key Lab Environm Med Engn, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Tan, Zhaoying; Zhang, Xuefeng] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Jiangsu Provincial Center for Disease Control & Prevention	Liu, P (corresponding author), Southeast Univ, Dept Epidemiol & Hlth Stat, Nanjing, Jiangsu, Peoples R China.	liupeiseu@163.com	JIN, HUI/AAA-8732-2019; Jin, Hui/GXG-2296-2022		National Science and Technology Major Project of China [2009ZX10004-904]; Social development fund of Jiangsu Province [7725000014]; Department of health of Jiangsu Province [Y2012070]	National Science and Technology Major Project of China; Social development fund of Jiangsu Province; Department of health of Jiangsu Province	This work was supported in part by National Science and Technology Major Project of China (2009ZX10004-904), Social development fund of Jiangsu Province (7725000014), and Department of health of Jiangsu Province (Y2012070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asboe D, 1996, GENITOURIN MED, V72, P210; Asli AAZ, 2011, HEALTH POLICY, V100, P297, DOI 10.1016/j.healthpol.2010.12.007; BRUGUERA M, 1990, VACCINE, V8, pS47, DOI 10.1016/0264-410X(90)90218-B; BRUGUERA M, 1987, POSTGRAD MED J, V63, P155; BRYAN JP, 1991, J INFECT DIS, V163, P1384, DOI 10.1093/infdis/163.6.1384; Chen HY, 2006, CHIN HEPATOL, V1, P63; Chen W, 2005, COCHRANE DB SYST REV, V4, pD100; Christensen PB, 2004, VACCINE, V22, P3897, DOI 10.1016/j.vaccine.2004.04.011; ELRESHAID K, 1994, VACCINE, V12, P223, DOI 10.1016/0264-410X(94)90198-8; GIAMMANCO G, 1987, POSTGRAD MED J, V63, P151; GIZARIS V, 1993, VACCINE, V11, P1445, DOI 10.1016/0264-410X(93)90175-W; Goldstein ST, 2002, J INFECT DIS, V185, P713, DOI 10.1086/339192; HESS G, 1992, EUR J CLIN MICROBIOL, V11, P334, DOI 10.1007/BF01962073; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hussain Z, 2005, WORLD J GASTROENTERO, V11, P7165, DOI 10.3748/wjg.v11.i45.7165; Hwang LY, 2010, J INFECT DIS, V202, P1500, DOI 10.1086/656776; IWARSON S, 1989, LANCET, V2, P146; JILG W, 1989, J INFECT DIS, V160, P766, DOI 10.1093/infdis/160.5.766; Marsano LS, 1996, AM J GASTROENTEROL, V91, P111; Nyamathi AM, 2009, J VIRAL HEPATITIS, V16, P666, DOI 10.1111/j.1365-2893.2009.01114.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Ricciardi G, 1990, Boll Ist Sieroter Milan, V69, P385; Rich JD, 2003, AM J MED, V114, P316, DOI 10.1016/S0002-9343(02)01560-7; Rustgi VK, 1995, VACCINE, V13, P1665, DOI 10.1016/0264-410X(95)00118-K; SCHEIERMANN N, 1990, VACCINE, V8, pS44, DOI 10.1016/0264-410X(90)90217-A; Sheffield JS, 2011, OBSTET GYNECOL, V117, P1130, DOI 10.1097/AOG.0b013e3182148efe; Tran TQ, 2012, VACCINE, V30, P342, DOI 10.1016/j.vaccine.2011.10.084; Van Herck K, 2007, SEX TRANSM INFECT, V83, P426, DOI 10.1136/sti.2006.022111; WAHL M, 1988, INFECTION, V16, P229, DOI 10.1007/BF01650758; WINTER AP, 1994, VACCINE, V12, P771, DOI 10.1016/0264-410X(94)90283-6; Wouters K, 2007, VACCINE, V25, P1893, DOI 10.1016/j.vaccine.2006.09.073; Wright N M J, 2002, Commun Dis Public Health, V5, P324; Yuan YB, 2006, CHIN PREV MED, V7, P207; [袁跃彬 Yuan Yuebin], 2004, [第四军医大学学报, Journal of the Fourth Military Medical University], V25, P1042	34	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133464	10.1371/journal.pone.0133464	http://dx.doi.org/10.1371/journal.pone.0133464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196903	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600100
J	Khowaja, K; Salim, SS				Khowaja, Kamran; Salim, Siti Salwah			Heuristics to Evaluate Interactive Systems for Children with Autism Spectrum Disorder (ASD)	PLOS ONE			English	Article							COMPUTER-BASED INTERVENTIONS; AGREEMENT; DESIGN; SKILLS	In this paper, we adapted and expanded a set of guidelines, also known as heuristics, to evaluate the usability of software to now be appropriate for software aimed at children with autism spectrum disorder (ASD). We started from the heuristics developed by Nielsen in 1990 and developed a modified set of 15 heuristics. The first 5 heuristics of this set are the same as those of the original Nielsen set, the next 5 heuristics are improved versions of Nielsen's, whereas the last 5 heuristics are new. We present two evaluation studies of our new heuristics. In the first, two groups compared Nielsen's set with the modified set of heuristics, with each group evaluating two interactive systems. The Nielsen's heuristics were assigned to the control group while the experimental group was given the modified set of heuristics, and a statistical analysis was conducted to determine the effectiveness of the modified set, the contribution of 5 new heuristics and the impact of 5 improved heuristics. The results show that the modified set is significantly more effective than the original, and we found a significant difference between the five improved heuristics and their corresponding heuristics in the original set. The five new heuristics are effective in problem identification using the modified set. The second study was conducted using a system which was developed to ascertain if the modified set was effective at identifying usability problems that could be fixed before the release of software. The post-study analysis revealed that the majority of the usability problems identified by the experts were fixed in the updated version of the system.	[Khowaja, Kamran; Salim, Siti Salwah] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Khowaja, K (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur 50603, Malaysia.	kamran.khowaja@siswa.um.edu.my	Khowaja, Kamran/A-5003-2014; Khowaja, Kamran/AAB-2303-2019; Salim, Siti Salwah/B-7848-2010	Khowaja, Kamran/0000-0002-0624-2428; Khowaja, Kamran/0000-0002-0624-2428; Salim, Siti Salwah/0000-0002-0594-1382	University of Malaya High Impact Research Grant [UM.C/625/1/HIR/MOHE/FCSIT/05]; Ministry of Education Malaysia	University of Malaya High Impact Research Grant; Ministry of Education Malaysia(Ministry of Education, Malaysia)	This research is supported by the University of Malaya High Impact Research Grant UM.C/625/1/HIR/MOHE/FCSIT/05 from the Ministry of Education Malaysia.	ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; B/lte Sven, 2010, WHAT CAN INNOVATIVE; Baker K, 2002, EMPIRICAL DEV HEURIS, P96; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Byrne Barbara M., 2013, STRUCTURAL EQUATION; Carlton S, 1993, OTHER SIDE AUTISM PO; Chua YP, 2014, RES METHODS STAT, V5; Clarkson E, 2007, APPL HEURISTIC EVALU, P44; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DAVIES M, 1982, BIOMETRICS, V38, P1047, DOI 10.2307/2529886; Dykstra DJ, 1993, COMP HEURISTIC EVALU; Fletcher-Watson S, 2014, REV J AUTISM DEV DIS, V1, P87, DOI 10.1007/s40489-013-0003-4; Green S, 1995, SPECIAL NEEDS NEURAL, P740; Gutwin C, 2000, MECH DEV LOW COST US, P98; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Higgins K., 1996, FOCUS AUTISM DEV DIS, V11, P69, DOI [DOI 10.1177/108835769601100202, 10.1177/108835769601100202]; HUCK SW, 1975, PSYCHOL BULL, V82, P511, DOI 10.1037/h0076767; Khowaja K, 2013, RES AUTISM SPECT DIS, V7, P1111, DOI 10.1016/j.rasd.2013.05.009; Kientz JA, 2010, HEURISTIC EVALUATION, P555; KNIGHT GP, 1994, AM J COMMUN PSYCHOL, V22, P767, DOI 10.1007/BF02521558; Koch GG, 1982, ENCY STAT SCI; Konstantinidis Evdokimos I., 2009, P 2 INT C PERVASIVE, DOI [10.1145/1579114.1579172, DOI 10.1145/1579114.1579172]; LIGHT RJ, 1971, PSYCHOL BULL, V76, P365, DOI 10.1037/h0031643; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; MACEINA MJ, 1994, FISHERIES, V19, P14, DOI 10.1577/1548-8446(1994)019<0014:UOASAO>2.0.CO;2; Manka JS, 2003, PROCEEDINGS OF THE TWENTY-NINTH ANNUAL CONFERENCE ON EXPLOSIVES AND BLASTING TECHNIQUE, VOL 1, P169; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; Mobahi H, 2005, CROSSROADS, V12, P3, DOI DOI 10.1145/1144375.1144378; Nielsen J., 1990, P SIGCHI C HUM FACT, P249, DOI [10.1145/97243.97281, DOI 10.1145/97243.97281]; Nielsen J., 1994, CONDUCT HEURISTIC EV; NIELSEN Jakob, 1995, 10 USABILITY HEURIST, P10; Nielsen Jakob, 1994, HEURISTIC EVALUATION; Noor M, 2012, SERIOUS GAME AUTISM, P647; Ould A. Mohamed, 2006, P 8 INT ACM SIGACCES, P133, DOI DOI 10.1145/1168987.1169011; Pinelle D, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1453; Ramdoss S, 2012, DEV NEUROREHABIL, V15, P119, DOI 10.3109/17518423.2011.651655; Ramdoss S, 2011, RES AUTISM SPECT DIS, V5, P1306, DOI 10.1016/j.rasd.2011.03.004; Ramdoss S, 2011, J BEHAV EDUC, V20, P55, DOI 10.1007/s10864-010-9112-7; Rogers Y., 2011, INTERACTION DESIGN H; Sehaba K, 2006, TECHNOLOGY DISABILIT; Trevarthen C., 1996, CHILDREN AUTISM DIAG; Virzi RA, 1993, COMP 3 USABILITY EVA, P309; Whalon KJ, 2011, REM SPEC EDUC, V32, P243, DOI 10.1177/0741932510362174; Wiegers KE, 2002, 7 TRUTHS PEER REV	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132187	10.1371/journal.pone.0132187	http://dx.doi.org/10.1371/journal.pone.0132187			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196385	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600027
J	Lin, N; Jiang, JH; Guo, SC; Xiong, MM				Lin, Nan; Jiang, Junhai; Guo, Shicheng; Xiong, Momiao			Functional Principal Component Analysis and Randomized Sparse Clustering Algorithm for Medical Image Analysis	PLOS ONE			English	Article							FEATURE-SELECTION	Due to the advancement in sensor technology, the growing large medical image data have the ability to visualize the anatomical changes in biological tissues. As a consequence, the medical images have the potential to enhance the diagnosis of disease, the prediction of clinical outcomes and the characterization of disease progression. But in the meantime, the growing data dimensions pose great methodological and computational challenges for the representation and selection of features in image cluster analysis. To address these challenges, we first extend the functional principal component analysis (FPCA) from one dimension to two dimensions to fully capture the space variation of image the signals. The image signals contain a large number of redundant features which provide no additional information for clustering analysis. The widely used methods for removing the irrelevant features are sparse clustering algorithms using a lasso-type penalty to select the features. However, the accuracy of clustering using a lasso-type penalty depends on the selection of the penalty parameters and the threshold value. In practice, they are difficult to determine. Recently, randomized algorithms have received a great deal of attentions in big data analysis. This paper presents a randomized algorithm for accurate feature selection in image clustering analysis. The proposed method is applied to both the liver and kidney cancer histology image data from the TCGA database. The results demonstrate that the randomized feature selection method coupled with functional principal component analysis substantially outperforms the current sparse clustering algorithms in image cluster analysis.	[Lin, Nan; Jiang, Junhai; Guo, Shicheng; Xiong, Momiao] Univ Texas Houston, Ctr Human Genet, Dept Biostat, Sch Publ Hlth,Hlth Sci Ctr, Houston, TX 77030 USA; [Guo, Shicheng] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Guo, Shicheng] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Guo, Shicheng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Fudan University; Fudan University; Fudan University	Xiong, MM (corresponding author), Univ Texas Houston, Ctr Human Genet, Dept Biostat, Sch Publ Hlth,Hlth Sci Ctr, Houston, TX 77030 USA.	Momiao.Xiong@uth.tmc.edu	Guo, Shicheng/A-1204-2016	Guo, Shicheng/0000-0002-7047-9972	National Institutes of Health [1R01AR057120-01]; NHLBI [1R01HL106034-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by grants 1R01AR057120-01 and 1R01HL106034-01 from the National Institutes of Health and NHLBI, respectively.	[Anonymous], ARXIV12016082; Aroquiaraj I. L., 2013, Proceedings of the 2013 International Conference on Pattern Recognition, Informatics and Mobile Engineering (PRIME), P479, DOI 10.1109/ICPRIME.2013.6496718; Bong CW, 2012, IET IMAGE PROCESS, V6, P1, DOI 10.1049/iet-ipr.2010.0122; Boutsidis C., 2011, ARXIV11102897; Boutsidis C, 2014, SIAM J COMPUT, V43, P687, DOI 10.1137/12086755X; Boutsidis C, 2013, IEEE T INFORM THEORY, V59, P6099, DOI 10.1109/TIT.2013.2255021; Erdogan F, 2004, INT J CLIN PRACT, V58, P333, DOI 10.1111/j.1368-5031.2004.00008.x; Frieze DA, 1999, P 10 ANN ACM SIAM S; Gupta MR, 2006, IEEE IMAGE PROC, P1585; Henderson D, 2006, STOCHASTIC DIFFERENTIAL EQUATIONS IN SCIENCE AND ENGINEERING, P1, DOI 10.1142/9789812774798; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; Rudelson M, 2007, J ACM, V54, DOI 10.1145/1255443.1255449; Sagan H., 2012, INTRO CALCULUS VARIA; Samiappan S, 2013, IEEE J-STARS, V6, P792, DOI 10.1109/JSTARS.2013.2237757; Strela V, 1999, IEEE T IMAGE PROCESS, V8, P548, DOI 10.1109/83.753742; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Yang Y, 2010, IEEE T IMAGE PROCESS, V19, P2761, DOI 10.1109/TIP.2010.2049235	19	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132945	10.1371/journal.pone.0132945	http://dx.doi.org/10.1371/journal.pone.0132945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196383	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600057
J	Luo, X; Jellison, KL; Huynh, K; Widmer, G				Luo, Xia; Jellison, Kristen L.; Huynh, Kevin; Widmer, Giovanni			Impact of Bioreactor Environment and Recovery Method on the Profile of Bacterial Populations from Water Distribution Systems	PLOS ONE			English	Article							TAYLOR-COUETTE FLOW; CRYPTOSPORIDIUM-PARVUM; BIOFILM; PATHOGENS; RETENTION; MODEL	Multiple rotating annular reactors were seeded with biofilms flushed from water distribution systems to assess (1) whether biofilms grown in bioreactors are representative of biofilms flushed from the water distribution system in terms of bacterial composition and diversity, and (2) whether the biofilm sampling method affects the population profile of the attached bacterial community. Biofilms were grown in bioreactors until thickness stabilized (9 to 11 weeks) and harvested from reactor coupons by sonication, stomaching, bead-beating, and manual scraping. High-throughput sequencing of 16S rRNA amplicons was used to profile bacterial populations from flushed biofilms seeded into bioreactors as well as biofilms recovered from bioreactor coupons by different methods. beta diversity between flushed and reactor biofilms was compared to beta diversity between (i) biofilms harvested from different reactors and (ii) biofilms harvested by different methods from the same reactor. These analyses showed that average diversity between flushed and bioreactor biofilms was double the diversity between biofilms from different reactors operated in parallel. The diversity between bioreactors was larger than the diversity associated with different biofilm recovery methods. Compared to other experimental variables, the method used to recover biofilms had a negligible impact on the outcome of water biofilm analyses based on 16S amplicon sequencing. Results from this study show that biofilms grown in reactors over 9 to 11 weeks are not representative models of the microbial populations flushed from a distribution system. Furthermore, the bacterial population profile of biofilms grown in replicate reactors from the same flushed water are likely to diverge. However, four common sampling protocols, which differ with respect to disruption of bacterial cells, provide similar information with respect to the 16S rRNA population profile of the biofilm community.	[Luo, Xia; Jellison, Kristen L.] Lehigh Univ, Dept Civil & Environm Engn, Bethlehem, PA 18015 USA; [Huynh, Kevin; Widmer, Giovanni] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA	Lehigh University; Tufts University	Widmer, G (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA.	giovanni.widmer@tufts.edu			Water Research Foundation [4368]	Water Research Foundation	This study was funded by the Water Research Foundation, project 4368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Camper A, 1999, J APPL MICROBIOL, V85, p1S; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DiCesare EAW, 2012, APPL ENVIRON MICROB, V78, P4187, DOI 10.1128/AEM.08026-11; Dou HS, 2008, INT J THERM SCI, V47, P1422, DOI 10.1016/j.ijthermalsci.2007.12.012; Dou HS, 2007, INT J THERM SCI, V46, P262, DOI 10.1016/j.ijthermalsci.2006.05.003; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Helmi K, 2008, APPL ENVIRON MICROB, V74, P2079, DOI 10.1128/AEM.02495-07; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Lawrence JR, 2000, J MICROBIOL METH, V42, P215, DOI 10.1016/S0167-7012(00)00195-0; Liu G, 2014, ENVIRON SCI TECHNOL, V48, P5467, DOI 10.1021/es5009467; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; Searcy KE, 2006, APPL ENVIRON MICROB, V72, P6242, DOI 10.1128/AEM.00344-06; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; September SM, 2007, J WATER HEALTH, V5, P219, DOI [10.2166/wh.2007.004b, 10.2166/wh.2007.004]; Servais P., 1995, Aqua (Oxford), V44, P10; ter Braak CJF, 2002, CANOCO REFERENCE MAN; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867	20	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133427	10.1371/journal.pone.0133427	http://dx.doi.org/10.1371/journal.pone.0133427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196282	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600096
J	Singh, S; Wu, XY; Ljosa, V; Bray, MA; Piccioni, F; Root, DE; Doench, JG; Boehm, JS; Carpenter, AE				Singh, Shantanu; Wu, Xiaoyun; Ljosa, Vebjorn; Bray, Mark-Anthony; Piccioni, Federica; Root, David E.; Doench, John G.; Boehm, Jesse S.; Carpenter, Anne E.			Morphological Profiles of RNAi-Induced Gene Knockdown Are Highly Reproducible but Dominated by Seed Effects	PLOS ONE			English	Article							MULTIPARAMETRIC PROFILES; TARGET IDENTIFICATION; AUTOMATED MICROSCOPY; INTERFERENCE SCREENS; CELLULAR PHENOTYPES; IMAGE-ANALYSIS; LONG DSRNAS; RESPONSES; CELLS; SUPPRESSION	RNA interference and morphological profiling-the measurement of thousands of phenotypes from individual cells by microscopy and image analysis-are a potentially powerful combination. We show that morphological profiles of RNAi-induced knockdown using the Cell Painting assay are in fact highly sensitive and reproducible. However, we find that the magnitude and prevalence of off-target effects via the RNAi seed-based mechanism make morphological profiles of RNAi reagents targeting the same gene look no more similar than reagents targeting different genes. Pairs of RNAi reagents that share the same seed sequence produce image-based profiles that are much more similar to each other than profiles from pairs designed to target the same gene, a phenomenon previously observed in small-scale gene-expression profiling experiments. Various strategies have been used to enrich on-target versus off-target effects in the context of RNAi screening where a narrow set of phenotypes are measured, mostly based on comparing multiple sequences targeting the same gene; however, new approaches will be needed to make RNAi morphological profiling (that is, comparing multi-dimensional phenotypes) viable. We have shared our raw data and computational pipelines to facilitate research.	[Singh, Shantanu; Wu, Xiaoyun; Ljosa, Vebjorn; Bray, Mark-Anthony; Piccioni, Federica; Root, David E.; Doench, John G.; Boehm, Jesse S.; Carpenter, Anne E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Carpenter, AE (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	anne@broadinstitute.org	Bray, Mark/C-5973-2008; Singh, Shantanu/GZB-9333-2022; Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020; Carpenter, Anne/C-4982-2008	Bray, Mark/0000-0002-9748-3592; Singh, Shantanu/0000-0001-5008-8950; Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Carpenter, Anne/0000-0003-1555-8261; Boehm, Jesse/0000-0002-6795-6336	National Science Foundation (NSF CAREER) [DBI 1148823]; National Science Foundation (NSF RIG) [DBI 1119830]; Slim Initiative for Genomic Medicine - Carlos Slim Foundation in Mexico; Direct For Biological Sciences [1148823] Funding Source: National Science Foundation	National Science Foundation (NSF CAREER)(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation (NSF RIG); Slim Initiative for Genomic Medicine - Carlos Slim Foundation in Mexico; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the National Science Foundation (NSF CAREER DBI 1148823, to Anne E. Carpenter; NSF RIG DBI 1119830 to MarkAnthony Bray) and the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Foundation in Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 2006, METHOD ENZYMOL, V414, P440, DOI 10.1016/S0076-6879(06)14024-0; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Bushman FD, 2009, SCIENCE, V5, DOI [10.1371/journal.ppat.1000437, DOI 10.1371/JOURNAL.PPAT.1000437]; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Fischer B, 2015, ELIFE, V4, DOI 10.7554/eLife.05464; Franceschini A, 2014, P NATL ACAD SCI USA, V111, P4548, DOI 10.1073/pnas.1402353111; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Futamura Y, 2012, CHEM BIOL, V19, P1620, DOI 10.1016/j.chembiol.2012.10.014; Gustafsdottir SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080999; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Horvath P, 2011, J BIOMOL SCREEN, V16, P1059, DOI 10.1177/1087057111414878; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Liberali P, 2014, CELL, V157, P1473, DOI 10.1016/j.cell.2014.04.029; Ljosa V, 2013, J BIOMOL SCREEN, V18, P1321, DOI 10.1177/1087057113503553; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Loo LH, 2009, NAT METHODS, V6, P759, DOI [10.1038/NMETH.1375, 10.1038/nmeth.1375]; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30; Moffat J, 2007, TRENDS PHARMACOL SCI, V28, P149, DOI 10.1016/j.tips.2007.02.009; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Panda D, 2012, CURR OPIN VIROL, V2, P784, DOI 10.1016/j.coviro.2012.10.007; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Simeone A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003801; Singh S, 2014, J BIOMOL SCREEN, V19, P640, DOI 10.1177/1087057114528537; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Sundaramurthy V, 2014, NAT PROTOC, V9, P474, DOI 10.1038/nprot.2014.027; Sundaramurthy V, 2013, CELL HOST MICROBE, V13, P129, DOI 10.1016/j.chom.2013.01.008; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI 10.1073/pnas.1410933111; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Zhong R, 2014, NUCLEIC ACIDS RES, V42, P8214, DOI 10.1093/nar/gku306	60	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131370	10.1371/journal.pone.0131370	http://dx.doi.org/10.1371/journal.pone.0131370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197079	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600011
J	Copen, WA; Morais, LT; Wu, O; Schwamm, LH; Schaefer, PW; Gonzalez, RG; Yoo, AJ				Copen, William A.; Morais, Livia T.; Wu, Ona; Schwamm, Lee H.; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Yoo, Albert J.			In Acute Stroke, Can CT Perfusion-Derived Cerebral Blood Volume Maps Substitute for Diffusion-Weighted Imaging in Identifying the Ischemic Core?	PLOS ONE			English	Article							ACUTE HEMISPHERIC STROKE; COMPUTED-TOMOGRAPHY; HYPERACUTE STROKE; INFARCT CORE; MRI; BRAIN; FLOW; REPERFUSION; THRESHOLDS; THROMBOLYSIS	Background and Purpose In the treatment of patients with suspected acute ischemic stroke, increasing evidence suggests the importance of measuring the volume of the irreversibly injured "ischemic core." The gold standard method for doing this in the clinical setting is diffusion-weighted magnetic resonance imaging (DWI), but many authors suggest that maps of regional cerebral blood volume (CBV) derived from computed tomography perfusion imaging (CTP) can substitute for DWI. We sought to determine whether DWI and CTP-derived CBV maps are equivalent in measuring core volume. Methods 58 patients with suspected stroke underwent CTP and DWI within 6 hours of symptom onset. We measured low-CBV lesion volumes using three methods: "objective absolute," i.e. the volume of tissue with CBV below each of six published absolute thresholds (0.9-2.5 mL/100 g), "objective relative," whose six thresholds (51%-60%) were fractions of mean contralateral CBV, and "subjective," in which two radiologists (R1, R2) outlined lesions subjectively. We assessed the sensitivity and specificity of each method, threshold, and radiologist in detecting infarction, and the degree to which each over-or underestimated the DWI core volume. Additionally, in the subset of 32 patients for whom follow-up CT or MRI was available, we measured the proportion of CBV- or DWI-defined core lesions that exceeded the follow-up infarct volume, and the maximum amount by which this occurred. Results DWI was positive in 72% (42/58) of patients. CBV maps' sensitivity/specificity in identifying DWI-positive patients were 100%/0% for both objective methods with all thresholds, 43%/94% for R1, and 83%/44% for R2. Mean core overestimation was 156-699 mL for objective absolute thresholds, and 127-200 mL for objective relative thresholds. For R1 and R2, respectively, mean +/- SD subjective overestimation were -11 +/- 26 mL and -11 +/- 23 mL, but subjective volumes differed from DWI volumes by up to 117 and 124 mL in individual patients. Inter-rater agreement regarding the presence of infarction on CBV maps was poor (kappa = 0.21). Core lesions defined by the six objective absolute CBV thresholds exceeded followup infarct volumes for 81%-100% of patients, by up to 430-1002 mL. Core estimates produced by objective relative thresholds exceeded follow-up volumes in 91% of patients, by up to 210-280 mL. Subjective lesions defined by R1 and R2 exceeded follow-up volumes in 18% and 26% of cases, by up to 71 and 15 mL, respectively. Only 1 of 23 DWI lesions (4%) exceeded final infarct volume, by 3 mL. Conclusion CTP-derived CBV maps cannot reliably substitute for DWI in measuring core volume, or even establish which patients have DWI lesions.	[Copen, William A.; Morais, Livia T.; Wu, Ona; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Yoo, Albert J.] Massachusetts Gen Hosp, Dept Radiol, Div Neuroradiol, Boston, MA 02115 USA; [Schwamm, Lee H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Copen, William A.; Wu, Ona; Schwamm, Lee H.; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Yoo, Albert J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Copen, WA (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Div Neuroradiol, Boston, MA 02115 USA.	wcopen@partners.org	Schaefer, Pamela/AAA-1323-2019	Wu, Ona/0000-0002-5509-9461	National Institutes of Health [R01NS059775]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R01NS059775 to OW and WAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; American Association of Physicists in Medicine, 2012, AD BRAIN PERF CT PRO; American College of Radiology American Society for Neuroradiology Society for Pediatric Radiology, 2012, ACR ASNR SPR PRACTIC; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; Bivard A, 2013, RADIOLOGY, V267, P543, DOI 10.1148/radiol.12120971; Bivard A, 2011, BRAIN, V134, P3408, DOI 10.1093/brain/awr257; Bivard A, 2011, CEREBROVASC DIS, V31, P238, DOI 10.1159/000321897; Boutelier T, 2012, IEEE T MED IMAGING, V31, P1381, DOI 10.1109/TMI.2012.2189890; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Chemmanam T, 2010, NEUROLOGY, V75, P1040, DOI 10.1212/WNL.0b013e3181f39ab6; Copen WA, 2015, AM J NEURORADIOL, V36, P638, DOI 10.3174/ajnr.A4186; Delpolyi AR, 2012, J MAGN RESON IMAGING, V36, P1083, DOI 10.1002/jmri.23740; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Eastwood JD, 2003, AM J NEURORADIOL, V24, P1869; GE Healthcare Publications, 2011, GE HEALTHCARE PUBLIC; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Grandin CB, 2001, STROKE, V32, P1147, DOI 10.1161/01.STR.32.5.1147; Grant PE, 2001, RADIOLOGY, V221, P43, DOI 10.1148/radiol.2211001523; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kamalian S, 2011, STROKE, V42, P1923, DOI 10.1161/STROKEAHA.110.610618; Karonen JO, 2000, RADIOLOGY, V217, P886, DOI 10.1148/radiology.217.3.r00dc02886; Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Nagar VA, 2009, AM J ROENTGENOL, V193, P1629, DOI 10.2214/AJR.09.2664; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sanak D, 2006, NEURORADIOLOGY, V48, P632, DOI 10.1007/s00234-006-0105-0; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Sorensen AG, 1999, RADIOLOGY, V210, P519, DOI 10.1148/radiology.210.2.r99fe06519; Thomalla G, 2010, ANN NEUROL, V68, P435, DOI 10.1002/ana.22125; Ueda T, 1999, J CEREBR BLOOD F MET, V19, P99, DOI 10.1097/00004647-199901000-00011; WESTGARD JO, 1973, CLIN CHEM, V19, P49; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2004, AM J NEURORADIOL, V25, P720; Wintermark M, 2002, STROKE, V33, P2025, DOI 10.1161/01.STR.0000023579.61630.AC; Wintermark M, 2013, J AM COLL RADIOL, V10, P828, DOI [10.1016/j.jacr.2013.06.019, 10.3174/ajnr.A3690]; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656	41	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133566	10.1371/journal.pone.0133566	http://dx.doi.org/10.1371/journal.pone.0133566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193486	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400103
J	Glaser, JI; Zamft, BM; Church, GM; Kording, KP				Glaser, Joshua I.; Zamft, Bradley M.; Church, George M.; Kording, Konrad P.			Puzzle Imaging: Using Large-Scale Dimensionality Reduction Algorithms for Localization	PLOS ONE			English	Article							CONNECTIVITY; OPTIMIZATION	Current high-resolution imaging techniques require an intact sample that preserves spatial relationships. We here present a novel approach, "puzzle imaging," that allows imaging a spatially scrambled sample. This technique takes many spatially disordered samples, and then pieces them back together using local properties embedded within the sample. We show that puzzle imaging can efficiently produce high-resolution images using dimensionality reduction algorithms. We demonstrate the theoretical capabilities of puzzle imaging in three biological scenarios, showing that (1) relatively precise 3-dimensional brain imaging is possible; (2) the physical structure of a neural network can often be recovered based only on the neural connectivity matrix; and (3) a chemical map could be reproduced using bacteria with chemosensitive DNA and conjugative transfer. The ability to reconstruct scrambled images promises to enable imaging based on DNA sequencing of homogenized tissue samples.	[Glaser, Joshua I.; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Glaser, Joshua I.; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Zamft, Bradley M.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kording, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab; Harvard University; Harvard Medical School; Northwestern University; Northwestern University	Glaser, JI (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	j-glaser@u.northwestern.edu	; Kording, Konrad/A-1233-2007	church, george/0000-0001-6232-9969; Kording, Konrad/0000-0001-8408-4499	NIH [5R01MH103910, T32 HD057845, 5R01NS063399, P01NS044393, 1R01NS074044]; Office of Naval Research; NIH Centers of Excellence in Genomic Science; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074044, P01NS044393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NIH Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Joshua Glaser was supported by NIH grant 5R01MH103910 and NIH grant T32 HD057845. Bradley Zamft was supported by NIH grant 5R01MH103910. George Church acknowledges support from the Office of Naval Research and the NIH Centers of Excellence in Genomic Science. Konrad Kording is funded in part by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust, and is also supported by NIH grants 5R01NS063399, P01NS044393, and 1R01NS074044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Church GM, 2003, US Patent, Patent No. 20030228611; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; de Silva V., 2002, ADV NEURAL INFORM PR, V15, P705; De Silva V., 2004, TECHNICAL REPORT; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; FREDMAN ML, 1987, J ACM, V34, P596, DOI 10.1145/28869.28874; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Glaser JI, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003145; Golub G. H., 2012, MATRIX COMPUTATIONS, V3; GROSSMAN N, 1982, J BACTERIOL, V152, P35; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Kaplan H., 2006, Proceedings of the Twenty-Second Annual Symposium on Computational Geometry (SCG'06), P52, DOI 10.1145/1137856.1137866; Kording KP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002291; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Marblestone A.H., 2014, ARXIV14045103; Marblestone AH, 2013, CONNECONOMICS EC LAR; Moser F, 2013, ACS SYNTH BIOL, V2, P614, DOI 10.1021/sb400086p; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; Peikon ID, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku604; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Ponciano JM, 2007, GENETICS, V176, P957, DOI 10.1534/genetics.106.061937; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P66, DOI DOI 10.1080/13506280444000102; WILLETTS N, 1980, ANNU REV GENET, V14, P41, DOI 10.1146/annurev.ge.14.120180.000353; Yuster R, 2005, ACM T ALGORITHMS, V1, P2, DOI 10.1145/1077464.1077465; Zador AM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001411; Zamft BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043876	33	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131593	10.1371/journal.pone.0131593	http://dx.doi.org/10.1371/journal.pone.0131593			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192446	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400013
J	Morais, ICO; Pereira, GJS; Orzaez, M; Jorge, RJB; Bincoletto, C; Toyama, MH; Monteiro, HSA; Smaili, SS; Perez-Paya, E; Martins, AMC				Morais, Isabel C. O.; Pereira, Gustavo J. S.; Orzaez, M.; Jorge, Roberta J. B.; Bincoletto, Claudia; Toyama, Marcos H.; Monteiro, Helena S. A.; Smaili, Soraya S.; Perez-Paya, Enrique; Martins, Alice M. C.			L-Aminoacid Oxidase from Bothrops leucurus Venom Induces Nephrotoxicity via Apoptosis and Necrosis	PLOS ONE			English	Article							SNAKE-VENOM; CYTOTOXICITY; PURIFICATION; MOOJENI; STRESS; CELLS	Acute renal failure is a common complication caused by Bothrops viper envenomation. In this study, the nefrotoxicity of a main component of B. leucurus venom called L-aminoacid oxidase (LAAO-Bl) was evaluated by using tubular epithelial cell lines MDCK and HK-2 and perfused kidney from rats. LAAO-Bl exhibited cytotoxicity, inducing apoptosis and necrosis in MDCK and HK-2 cell lines in a concentration-dependent manner. MDCK apoptosis induction was accompanied by Ca2+ release from the endoplasmic reticulum, reactive oxygen species (ROS) generation and mitochondrial dysfunction with enhanced expression of Bax protein levels. LAAO-Bl induced caspase-3 and caspase-7 activation in both cell lines. LAAO-Bl (10 mu g/mL) exerts significant effects on the isolated kidney perfusion increasing perfusion pressure and urinary flow and decreasing the glomerular filtration rate and sodium, potassium and chloride tubular transport. Taken together our results suggest that LAAO-Bl is responsible for the nephrotoxicity observed in the envenomation by snakebites. Moreover, the cytotoxic of LAAO-Bl to renal epithelial cells might be responsible, at least in part, for the nephrotoxicity observed in isolated kidney.	[Morais, Isabel C. O.; Jorge, Roberta J. B.; Monteiro, Helena S. A.] Univ Fed Ceara, Fac Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Pereira, Gustavo J. S.; Bincoletto, Claudia; Smaili, Soraya S.] Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Orzaez, M.; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Dept Med Chem, Valencia, Spain; [Toyama, Marcos H.] Univ Estadual Paulista, Sao Vicente Unit, Sao Paulo, Brazil; [Martins, Alice M. C.] Univ Fed Ceara, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade Federal de Sao Paulo (UNIFESP); Prince Felipe Research Center; Universidade Estadual Paulista; Universidade Federal do Ceara	Martins, AMC (corresponding author), Univ Fed Ceara, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil.	martinsalice@gmail.com	Toyama, Marcos H/P-4673-2017; JORGE, ROBERTA/AAP-5733-2021; Martins, Alice Maria Costa/AAX-3093-2020; Orzaez, Mar/B-4992-2014; Smaili, Soraya/AAH-2129-2019; Pereira, Gustavo José Silva/ABH-1344-2020; Bincoletto, Claudia/H-4936-2012; Pereira, Gustavo/H-4636-2012	Toyama, Marcos H/0000-0001-6836-3084; Orzaez, Mar/0000-0003-3231-5835; Smaili, Soraya/0000-0001-5844-1368; Pereira, Gustavo José Silva/0000-0002-6765-1276; Bincoletto, Claudia/0000-0001-6666-3673; Pereira, Gustavo/0000-0002-1789-3541; Jorge, Roberta/0000-0002-2703-4302	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior By ICOM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/11515-3, 10/51647-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), AMCM HSAM; Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP), AMCM HSAM; Centro de Investigacion Principe Felipe, Valencia, Spain, MOC EPP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian Ministry of Education)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior By ICOM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), AMCM HSAM(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP), AMCM HSAM; Centro de Investigacion Principe Felipe, Valencia, Spain, MOC EPP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior By ICOM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (08/11515-3 by SSS; 10/51647-6 by CB), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) by AMCM HSAM, Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP) by AMCM HSAM, Centro de Investigacion Principe Felipe, Valencia, Spain by MOC EPP. Isabel C. O. Morais gratefully acknowledges CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian Ministry of Education) for providing a 1-year scholarship to perform this study at Centro de Investigacion Principe Felipe, Valencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Paiva RDA, 2011, BIOCHIMIE, V93, P941, DOI 10.1016/j.biochi.2011.01.009; Alves RM, 2008, COMP BIOCHEM PHYS A, V151, P542, DOI 10.1016/j.cbpa.2008.07.007; Barbosa PSF, 2006, TOXICON, V47, P831, DOI 10.1016/j.toxicon.2006.01.012; Barbosa PS, 2005, TOXICON, V4, P376; BOWMAN RH, 1970, J BIOL CHEM, V245, P1604; Campos LB, 2013, TOXICON, V76, P1, DOI 10.1016/j.toxicon.2013.08.063; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Ciscotto P, 2009, TOXICON, V53, P330, DOI 10.1016/j.toxicon.2008.12.004; Collares-Buzato CB, 2002, TOXICOL APPL PHARM, V181, P124, DOI 10.1006/taap.2002.9404; de Castroa I, 2004, TOXICON, V43, P833, DOI 10.1016/j.toxicon.2004.03.015; de Moura Andrea A, 2014, Biomed Res Int, V2014, P195356, DOI 10.1155/2014/195356; Deolindo P, 2010, TOXICON, V56, P944, DOI 10.1016/j.toxicon.2010.06.019; Guo CM, 2012, TOXICON, V60, P302, DOI 10.1016/j.toxicon.2012.05.001; Havt A, 2005, INT J BIOCHEM CELL B, V37, P130, DOI 10.1016/j.biocel.2004.06.003; Joo HK, 2014, MITOCHONDRION, V17, P42, DOI 10.1016/j.mito.2014.05.006; Lee ML, 2014, INT J MED SCI, V11, P593, DOI 10.7150/ijms.8096; Lin M, 2014, INT J MOL SCI, V15, P12507, DOI 10.3390/ijms150712507; Liu DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068770; Braga MDM, 2008, TOXICON, V51, P199, DOI 10.1016/j.toxicon.2007.09.003; Braga MDM, 2007, TOXICON, V49, P329, DOI 10.1016/j.toxicon.2006.10.005; Braga MDM, 2006, TOXICON, V47, P859, DOI 10.1016/j.toxicon.2006.02.016; Marcussi S, 2013, TOXICON, V65, P9, DOI 10.1016/j.toxicon.2012.12.020; Martines MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086828; Mello CP, 2014, TOXICON, V88, P107, DOI 10.1016/j.toxicon.2014.05.009; Mondragon L, 2008, J MED CHEM, V51, P521, DOI 10.1021/jm701195j; Naumann GB, 2011, BBA-GEN SUBJECTS, V1810, P683, DOI 10.1016/j.bbagen.2011.04.003; de Morais ICO, 2013, TOXICON, V61, P38, DOI 10.1016/j.toxicon.2012.10.005; Samel M, 2006, BBA-PROTEINS PROTEOM, V1764, P707, DOI 10.1016/j.bbapap.2006.01.021; Sitprija V, 2012, TOXICON, V60, P943, DOI 10.1016/j.toxicon.2012.06.012; Smaili SS, 1999, CELL CALCIUM, V26, P121, DOI 10.1054/ceca.1999.0061; Sousa LF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002442; Stabeli RG, 2007, INT J BIOL MACROMOL, V41, P132, DOI 10.1016/j.ijbiomac.2007.01.006; Sun LK, 2003, TOXICOL IN VITRO, V17, P169, DOI 10.1016/S0887-2333(03)00010-9; Sun MZ, 2010, BIOCHIMIE, V92, P343, DOI 10.1016/j.biochi.2010.01.013; Tan N.H., 2009, HDB VENOMS TOXINS RE, P219; Torii S, 2000, BIOCHEMISTRY-US, V39, P3197, DOI 10.1021/bi992416z; Torres AFC, 2010, J VENOM ANIM TOXINS, V16, P614, DOI 10.1590/S1678-91992010000400012; Toyama MH, 2006, TOXICON, V47, P47, DOI 10.1016/j.toxicon.2005.09.008; Zhang L, 2008, NAT PROD RES, V22, P554, DOI 10.1080/14786410701592679; Zhang L, 2007, LIFE SCI, V80, P1189, DOI 10.1016/j.lfs.2006.12.024	40	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132569	10.1371/journal.pone.0132569	http://dx.doi.org/10.1371/journal.pone.0132569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193352	Green Submitted, gold, Green Published			2022-12-27	WOS:000358546400030
J	Shiwaku, Y; Neff, L; Nagano, K; Takeyama, KI; de Bruijn, J; Dard, M; Gori, F; Baron, R				Shiwaku, Yukari; Neff, Lynn; Nagano, Kenichi; Takeyama, Ken-Ichi; de Bruijn, Joost; Dard, Michel; Gori, Francesca; Baron, Roland			The Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the Composition and Structure of Biphasic Calcium Phosphates	PLOS ONE			English	Article							BETA-TRICALCIUM PHOSPHATE; BONE-FORMATION; SPHINGOSINE 1-PHOSPHATE; SEALING ZONE; HYDROXYAPATITE; RESORPTION; ACTIVATION; DIFFERENTIATION; BIOMATERIALS; INHIBITION	Biphasic calcium phosphates (BCPs), consisting of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP), exhibit good biocompatibility and osteoconductivity, maintaining a balance between resorption of the biomaterial and formation of new bone. We tested whether the chemical composition and/or the microstructure of BCPs affect osteoclasts (OCs) differentiation and/or their ability to crosstalk with osteoblasts (OBs). To this aim, OCs were cultured on BCPs with HA content of 5, 20 or 60% and their differentiation and activity were assessed. We found that OC differentiation is partially impaired by increased HA content, but not by the presence of micropores within BCP scaffolds, as indicated by TRAP staining and gene profile expression. We then investigated whether the biomaterial-induced changes in OC differentiation also affect their ability to crosstalk with OBs and regulate OB function. We found that BCPs with low percentage of HA favored the expression of positive coupling factors, including sphingosine-kinase 1 (SPHK1) and collagen triple helix repeat containing 1 (Cthrc1). In turn, the increase of these secreted coupling factors promotes OB differentiation and function. All together our studies suggest that the chemical composition of biomaterials affects not only the differentiation and activity of OCs but also their potential to locally regulate bone formation.	[Shiwaku, Yukari; Neff, Lynn; Nagano, Kenichi; Takeyama, Ken-Ichi; Gori, Francesca; Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Baron, Roland] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Endocrine Unit, Boston, MA USA; [de Bruijn, Joost] Xpand Biotechnol BV, Bilthoven, Netherlands; [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY 10003 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York University	Baron, R (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.	Roland_Baron@hsdm.harvard.edu	Gori, Francesca/S-9422-2019; Nagano, Kenichi/AAH-3246-2019	Nagano, Kenichi/0000-0003-3145-4841	Straumann	Straumann	This work was supported by Straumann in the form of research support for Dr. Baron's laboratory at Harvard.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Benahmed MD, 1996, J HISTOCHEM CYTOCHEM, V44, P1131, DOI 10.1177/44.10.8813078; Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023; Costa-Rodrigues J, 2012, ACTA BIOMATER, V8, P1137, DOI 10.1016/j.actbio.2011.11.032; Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048; Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664; Geblinger D, 2010, J CELL SCI, V123, P1503, DOI 10.1242/jcs.060954; Ghanaati S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015005; GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O; Gonda Y, 2009, BIOMATERIALS, V30, P4390, DOI 10.1016/j.biomaterials.2009.05.002; Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008; Henriksen K, 2014, CALCIFIED TISSUE INT, V94, P88, DOI 10.1007/s00223-013-9741-7; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001; Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187; Matsuzaki E, 2013, BONE, V55, P315, DOI 10.1016/j.bone.2013.04.008; Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0; Nakamura M, 2013, J BIOMED MATER RES A, V101, P3141, DOI 10.1002/jbm.a.34621; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Okuda T, 2007, BIOMATERIALS, V28, P2612, DOI 10.1016/j.biomaterials.2007.01.040; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583; Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6; Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227; Ripamonti U, 2010, BIOMATERIALS, V31, P6400, DOI 10.1016/j.biomaterials.2010.04.037; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130; Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Tanaka T, 2010, J BIOMED MATER RES A, V93A, P469, DOI 10.1002/jbm.a.32560; Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	48	35	37	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132903	10.1371/journal.pone.0132903	http://dx.doi.org/10.1371/journal.pone.0132903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193362	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400042
J	Sun, JJ; Liu, L; Shen, JY; Qi, TK; Wang, ZY; Song, W; Zhang, RF; Lu, HZ				Sun, Jianjun; Liu, Li; Shen, Jiayin; Qi, Tangkai; Wang, Zhenyan; Song, Wei; Zhang, Renfang; Lu, Hongzhou			Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naive Patients with HIV Infection: A Retrospective Cohort Analysis	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INDIVIDUALS; DURABILITY; TENOFOVIR; HAART; DISCONTINUATION; ADOLESCENTS; RESISTANCE; EFFICACY; OUTCOMES	Background To investigate the reasons and risk factors for modification of the first combined antiretroviral therapy (cART) currently used for HIV infected patients who were treatment naive in Shanghai China. Methods Making a retrospective observational research on treatment naive patients with HIV infection who initiated cART during the period of September 1st 2005-December 1st 2013. The demographic and clinical data were collected from the first visit to the time of the first regimen modification or the last visit in December 1st, 2014. The reasons of treatment modification were recorded. Survival analysis of modification was made by Kaplan-Meier curves analysis and log rank test, and a Cox multiple regression model was constructed to identify related factors of modification. Results A total number of the eligible participants were 3372 and 871(25.8%) patients changed their first cART regimen. The median follow up was 22 months [interquartile range (IQR) 14-39]. Among patients who modified the original regimen, drug toxicity occurred in 805(92.4%) participants and 44(5.1%) experienced treatment failure. In multiple regression analysis regimen modification was associated with patients' age more than 40 years old (aHR 1.224, 95%CI 1.051-1.426, P = 0.010), CD4 less than 200(aHR 1.218, 95%CI 1.044-1.421, P = 0.012) and the initial regimen they received. Compared with the regimen of TDF+3TC+EFV, patients with regimen of d4T+3TC+NVP, d4T+3TC+EFV, AZT+3TC+NVP or AZT+3TC+EFV were 10.4, 8.2, 6.4, 2.5 times more likely to modify their initial regimen, respectively. Conclusions The main reason for the regimen switch was drug toxicity and main risk factors for regimen modification were age older than 40 years, CD4 cell counts less than 200 at baseline and regimen they received. Among the 2NRTI plus 1NNRTI regimens, the co-formulation of d4T+3TC+NVP had the highest risk for modification while the regimen of TDF+3TC+EFV was the most tolerable treatment regimen in first years' follow up.	[Sun, Jianjun; Liu, Li; Shen, Jiayin; Qi, Tangkai; Wang, Zhenyan; Song, Wei; Zhang, Renfang; Lu, Hongzhou] Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China; [Lu, Hongzhou] Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai 200433, Peoples R China; [Lu, Hongzhou] Fudan Univ, Shanghai Med Coll, Dept Internal Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Lu, HZ (corresponding author), Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China.	luhongzhou@fudan.edu.cn			grant of the 12th Five year Plan [2012ZX10001003]	grant of the 12th Five year Plan	HZL received the grant of the 12th Five year Plan (grant 2012ZX10001003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Mohand H, 2008, HIV MED, V9, P738, DOI 10.1111/j.1468-1293.2008.00616.x; Anglemyer A, 2014, AIDS, V28, pS105, DOI 10.1097/QAD.0000000000000232; [Anonymous], 2013, LANCET, DOI DOI 10.1016/S0140-6736(12)61898-4; Brennan AT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18794; Cao Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-301; Cicconi P, 2010, HIV MED, V11, P104, DOI 10.1111/j.1468-1293.2009.00750.x; De La Torre-Lima J, 2014, HIV CLIN TRIALS, V15, P27, DOI 10.1310/hct1501-27; Domingos H, 2009, BRAZ J INFECT DIS, V13, P130, DOI 10.1590/S1413-86702009000200012; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Huang HY, 2008, HIV MED, V9, P285, DOI 10.1111/j.1468-1293.2008.00561.x; Kumarasamy N, 2013, CURR OPIN HIV AIDS, V8, P586, DOI 10.1097/COH.0000000000000004; Ma Joseph D, 2010, PLoS Curr, V2, pRRN1203, DOI 10.1371/currents.RRN1203; Mihanovic MP, 2013, MED SCI MONITOR, V19, P483, DOI 10.12659/MSM.889283; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Murphy RA, 2007, J INFECT DIS, V196, pS449, DOI 10.1086/521112; Njuguna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063596; Palladino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096307; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Robison LS, 2008, AIDS RES HUM RETROV, V24, P1347, DOI 10.1089/aid.2008.0083; Sarfo FS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094854; Sharma SK, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-52; Sun J, 2010, INT J STD AIDS, V21, P810, DOI 10.1258/ijsa.2010.010114; Sun Y, 2014, BIOSCI TRENDS, V8, P189, DOI 10.5582/bst.2014.01015; Thida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108615; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; WHO HIV Programme, 2013, CONSOLIDATED GUIDELI; Wu XH, 2015, APPL NURS RES, V28, P169, DOI 10.1016/j.apnr.2014.09.011; Xiao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075915; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zheng H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-831	33	7	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133242	10.1371/journal.pone.0133242	http://dx.doi.org/10.1371/journal.pone.0133242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207639	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000069
J	Al-Marzooq, F; Yusof, MYM; Tay, ST				Al-Marzooq, Farah; Yusof, Mohd Yasim Mohd; Tay, Sun Tee			Molecular Analysis of Antibiotic Resistance Determinants and Plasmids in Malaysian Isolates of Multidrug Resistant Klebsiella pneumoniae	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; INCF PLASMIDS; GENETIC ENVIRONMENTS; DIVERSE CLONES; ENTEROBACTERIACEAE; BLA(CTX-M-15); HYPERPRODUCTION; IDENTIFICATION; DISSEMINATION	Infections caused by multidrug resistant Klebsiella pneumoniae have been increasingly reported in many parts of the world. A total of 93 Malaysian multidrug resistant K. pneumoniae isolated from patients attending to University of Malaya Medical Center, Kuala Lumpur, Malaysia from 2010-2012 were investigated for antibiotic resistance determinants including extended-spectrum beta-lactamases (ESBLs), aminoglycoside and trimethoprim/sulfamethoxazole resistance genes and plasmid replicons. CTX-M-15 (91.3%) was the predominant ESBL gene detected in this study. aacC2 gene (67.7%) was the most common gene detected in aminoglycoside-resistant isolates. Trimethoprim/sulfamethoxazole resistance (90.3%) was attributed to the presence of sul1 (53.8%) and dfrA (59.1%) genes in the isolates. Multiple plasmid replicons (1-4) were detected in 95.7% of the isolates. FIIK was the dominant replicon detected together with 13 other types of plasmid replicons. Conjugative plasmids (1-3 plasmids of similar to 3-100 kb) were obtained from 27 of 43 K. pneumoniae isolates. An ESBL gene (either CTX-M-15, CTX-M-3 or SHV-12) was detected from each transconjugant. Co-detection with at least one of other antibiotic resistance determinants [sul1, dfrA, aacC2, aac(60)-Ib, aac(60)-Ib-cr and qnrB] was noted in most conjugative plasmids. The transconjugants were resistant to multiple antibiotics including beta-lactams, gentamicin and cotrimoxazole, but not ciprofloxacin. This is the first study describing the characterization of plasmids circulating in Malaysian multidrug resistant K. pneumoniae isolates. The results of this study suggest the diffusion of highly diverse plasmids with multiple antibiotic resistance determinants among the Malaysian isolates. Effective infection control measures and antibiotic stewardship programs should be adopted to limit the spread of the multidrug resistant bacteria in healthcare settings.	[Al-Marzooq, Farah; Yusof, Mohd Yasim Mohd; Tay, Sun Tee] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya	Tay, ST (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	tayst@um.edu.my	Ha, Dat Thinh/D-4995-2015; Tay, Sun Tee/N-2295-2019	Ha, Dat Thinh/0000-0003-4260-4876; Tay, Sun Tee/0000-0002-3120-6998; Al-Marzooq, Farah/0000-0001-5711-6264	University of Malaya [PV037-2012A]; HIR-MOHE [E000013-20001]	University of Malaya(Universiti Malaya); HIR-MOHE	This study was supported by University of Malaya postgraduate grant (PV037-2012A) (STT, FA), and HIR-MOHE E000013-20001 (subprogramme 4) grant (STT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzooq F, 2015, INT J ANTIMICROBIAL; Al-Marzooq F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/601630; Al-Marzooq F, 2013, JPN J INFECT DIS, V66, P555, DOI 10.7883/yoken.66.555; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P53, DOI 10.1111/j.1469-0691.2007.01849.x; Canton R, 2003, CURR OPIN INFECT DIS, V16, P315, DOI 10.1097/00001432-200308000-00003; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2006, EMERG INFECT DIS, V12, P1145, DOI 10.3201/eid1207.051555; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Carattoli A, 2010, J ANTIMICROB CHEMOTH, V65, P2070, DOI 10.1093/jac/dkq269; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chen IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065621; Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI S; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; Coelho A, 2009, J ANTIMICROB CHEMOTH, V64, P862, DOI 10.1093/jac/dkp264; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Daxboeck F, 2006, J HOSP INFECT, V62, P214, DOI 10.1016/j.jhin.2005.07.009; Diestra K, 2009, J ANTIMICROB CHEMOTH, V63, P60, DOI 10.1093/jac/dkn453; Dolejska M, 2013, ANTIMICROB AGENTS CH, V57, P1073, DOI 10.1128/AAC.01886-12; Dolejska M, 2012, INT J ANTIMICROB AG, V40, P510, DOI 10.1016/j.ijantimicag.2012.07.016; Du JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095181; Fevre C, 2005, ANTIMICROB AGENTS CH, V49, P5149, DOI 10.1128/AAC.49.12.5149-5152.2005; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Harajly M, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-19; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Heritage J, 1999, J ANTIMICROB CHEMOTH, V44, P309, DOI 10.1093/jac/44.3.309; Ho PL, 2010, J MED MICROBIOL, V59, P702, DOI 10.1099/jmm.0.015032-0; Huang XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040360; Huovinen P, 2001, CLIN INFECT DIS, V32, P1608, DOI 10.1086/320532; Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996; Jones LA, 2005, ANTIMICROB AGENTS CH, V49, P794, DOI 10.1128/AAC.49.2.794-797.2005; Kim YT, 2006, J MICROBIOL BIOTECHN, V16, P889; Kor SB, 2013, J MED MICROBIOL, V62, P412, DOI 10.1099/jmm.0.053645-0; Lai CC, 2014, J GLOB ANTIMICROB RE, V2, P141, DOI 10.1016/j.jgar.2014.02.007; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Li B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042280; Lim KT, 2009, J MED MICROBIOL, V58, P1463, DOI 10.1099/jmm.0.011114-0; Lister PD, 2000, PHARMACOTHERAPY, V20, p213S, DOI 10.1592/phco.20.14.213S.35045; Lu PL, 2012, INT J ANTIMICROB AG, V40, pS37, DOI 10.1016/S0924-8579(12)70008-0; Ma L, 2009, ANTIMICROB AGENTS CH, V53, P104, DOI 10.1128/AAC.00852-08; Markovska R, 2008, MICROB DRUG RESIST, V14, P119, DOI 10.1089/mdr.2008.0814; Mataseje LF, 2011, J ANTIMICROB CHEMOTH, V66, P1273, DOI 10.1093/jac/dkr092; Mendonca N, 2009, INT J ANTIMICROB AG, V34, P29, DOI 10.1016/j.ijantimicag.2008.11.014; Palasubramaniam S, 2005, INT J INFECT DIS, V9, P170, DOI 10.1016/j.ijid.2004.07.005; Palasubramaniam S, 2007, MICROB DRUG RESIST, V13, P186, DOI 10.1089/mdr.2007.726; Palasubramaniam S, 2009, J MICROBIOL IMMUNOL, V42, P129; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6029, DOI 10.1128/AAC.01189-12; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Pornruangwong S, 2011, FOODBORNE PATHOG DIS, V8, P203, DOI 10.1089/fpd.2010.0626; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Roy S, 2013, INDIAN J MED RES, V137, P791; Ruiz E, 2012, J ANTIMICROB CHEMOTH, V67, P886, DOI 10.1093/jac/dkr548; Ryoo NH, 2005, J ANTIMICROB CHEMOTH, V56, P698, DOI 10.1093/jac/dki324; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Shin J, 2012, J ANTIMICROB CHEMOTH, V67, P1853, DOI 10.1093/jac/dks143; Tarnberg M, 2009, MOL CELL PROBE, V23, P195, DOI 10.1016/j.mcp.2009.01.005; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; Villa L, 2009, HIGH THROUGHPUT DNA; Villa L, 2012, J ANTIMICROB CHEMOTH, V67, P1645, DOI 10.1093/jac/dks114; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Voets GM, 2011, INT J ANTIMICROB AG, V37, P356, DOI 10.1016/j.ijantimicag.2011.01.005; Wu PJ, 1995, J ANTIMICROB CHEMOTH, V36, P927, DOI 10.1093/jac/36.6.927; Xiang XQ, 1997, J ANTIMICROB CHEMOTH, V40, P525, DOI 10.1093/jac/40.4.525; Younes A, 2011, J ANTIMICROB CHEMOTH, V66, P313, DOI 10.1093/jac/dkq453; Yu FY, 2009, DIAGN MICR INFEC DIS, V64, P57, DOI 10.1016/j.diagmicrobio.2009.01.020; Zhuo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052222	73	40	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133654	10.1371/journal.pone.0133654	http://dx.doi.org/10.1371/journal.pone.0133654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203651	Green Submitted, gold, Green Published			2022-12-27	WOS:000358621000035
J	Leikfoss, IS; Keshari, PK; Gustavsen, MW; Bjolgerud, A; Brorson, IS; Celius, EG; Spurkland, A; Bos, SD; Harbo, HF; Berge, T				Leikfoss, Ingvild S.; Keshari, Pankaj K.; Gustavsen, Marte W.; Bjolgerud, Anja; Brorson, Ina S.; Celius, Elisabeth G.; Spurkland, Anne; Bos, Steffan D.; Harbo, Hanne F.; Berge, Tone			Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+T Cells	PLOS ONE			English	Article							GENE-EXPRESSION; RHEUMATOID-ARTHRITIS; CIITA; SUSCEPTIBILITY; ASSOCIATION; IDENTIFICATION; POLYMORPHISMS; INFLAMMATION; EPIGENETICS; MECHANISMS	For multiple sclerosis, genome wide association studies and follow up studies have identified susceptibility single nucleotide polymorphisms located in or near CLEC16A at chromosome 16p13.13, encompassing among others CIITA, DEXI and SOCS1 in addition to CLEC16A. These genetic variants are located in intronic or intergenic regions and display strong linkage disequilibrium with each other, complicating the understanding of their functional contribution and the identification of the direct causal variant(s). Previous studies have shown that multiple sclerosis-associated risk variants in CLEC16A act as expression quantitative trait loci for CLEC16A itself in human pancreatic beta-cells, for DEXI and SOCS1 in thymic tissue samples, and for DEXI in monocytes and lymphoblastoid cell lines. Since T cells are major players in multiple sclerosis pathogenesis, we have performed expression analyses of the CIITA-DEXI-CLEC16A-SOCS1 gene cluster in CD4+ and CD8+ T cells isolated from multiple sclerosis patients and healthy controls. We observed a higher expression of SOCS1 and CLEC16A in CD4+ T cells in samples homozygous for the risk allele of CLEC16A rs12927355. Pair-wise linear regression analysis revealed high correlation in gene expression in peripheral T cells of CIITA, DEXI, CLEC16A and SOCS1. Our data imply a possible regulatory role for the multiple sclerosis-associated rs12927355 in CLEC16A.	[Leikfoss, Ingvild S.; Keshari, Pankaj K.; Gustavsen, Marte W.; Bjolgerud, Anja; Brorson, Ina S.; Celius, Elisabeth G.; Bos, Steffan D.; Harbo, Hanne F.; Berge, Tone] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Leikfoss, Ingvild S.; Keshari, Pankaj K.; Gustavsen, Marte W.; Bjolgerud, Anja; Brorson, Ina S.; Celius, Elisabeth G.; Bos, Steffan D.; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Spurkland, Anne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Leikfoss, IS (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	i.s.leikfoss@medisin.uio.no	Spurkland, Anne/L-3369-2019; Celius, Elisabeth Gulowsen/S-1387-2019; Bos, Steffan D/L-7896-2016	Spurkland, Anne/0000-0003-4421-0766; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Bos, Steffan D/0000-0002-2975-7520	South-Eastern Norway Regional Health Authority; Norwegian Research Council; Odd Fellow Society; Novartis; Henrik Homans Minde (UNIFOR)	South-Eastern Norway Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission); Odd Fellow Society; Novartis(Novartis); Henrik Homans Minde (UNIFOR)	This study has been supported by The South-Eastern Norway Regional Health Authority, the Norwegian Research Council, the Odd Fellow Society, Novartis and Henrik Homans Minde (UNIFOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayarsaihan D, 2011, J DENT RES, V90, P9, DOI 10.1177/0022034510378683; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Berge T, 2013, INT J MOL SCI, V14, P4476, DOI 10.3390/ijms14034476; Bos SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117403; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Davison LJ, 2012, HUM MOL GENET, V21, P322, DOI 10.1093/hmg/ddr468; De Santis M, 2012, CLIN REV ALLERG IMMU, V42, P92, DOI 10.1007/s12016-011-8293-8; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Disanto G, 2014, HUM MOL GENET, V23, P942, DOI 10.1093/hmg/ddt489; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Edgar AJ, 2001, AM J RESP CELL MOL, V25, P119, DOI 10.1165/ajrcmb.25.1.4417; Eike MC, 2012, GENES IMMUN, V13, P431, DOI 10.1038/gene.2012.11; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Fowden AL, 2009, EXP PHYSIOL, V94, P607, DOI 10.1113/expphysiol.2008.046359; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Genome UCSC, UCSC GEN BROWS 2002; Gyllenberg A, 2014, GENES IMMUN, V15, P162, DOI 10.1038/gene.2013.71; Gyllenberg A, 2012, GENES IMMUN, V13, P632, DOI 10.1038/gene.2012.44; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Kim S, 2012, P NATL ACAD SCI USA, V109, pE1072, DOI 10.1073/pnas.1120320109; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; KOLMEL HW, 1988, J NEUROIMMUNOL, V20, P229, DOI 10.1016/0165-5728(88)90164-6; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Leikfoss IS, 2013, GENES IMMUN, V14, P62, DOI 10.1038/gene.2012.52; Li J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7804; de Lapuente AL, 2015, MULT SCLER J, V21, P1498, DOI 10.1177/1352458514566418; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mero IL, 2011, GENES IMMUN, V12, P191, DOI 10.1038/gene.2010.59; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; O'Gorman C, 2012, INT J MOL SCI, V13, P11718, DOI 10.3390/ijms130911718; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schuster C, 2015, IMMUNITY, V42, P942, DOI 10.1016/j.immuni.2015.04.011; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tomlinson MJ, 2014, DIABETES, V63, P4360, DOI 10.2337/db13-1785; van Luijn MM, 2015, BRAIN, V138, P1531, DOI 10.1093/brain/awv080; Vandenbroeck K, 2012, GENES IMMUN, V13, P21, DOI 10.1038/gene.2011.44; Zuvich RL, 2011, HUM MOL GENET, V20, P3517, DOI 10.1093/hmg/ddr250	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132957	10.1371/journal.pone.0132957	http://dx.doi.org/10.1371/journal.pone.0132957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203907	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000015
J	Calil, J; Beck, MW; Gleason, M; Merrifield, M; Klausmeyer, K; Newkirk, S				Calil, Juliano; Beck, Michael W.; Gleason, Mary; Merrifield, Matthew; Klausmeyer, Kirk; Newkirk, Sarah			Aligning Natural Resource Conservation and Flood Hazard Mitigation in California	PLOS ONE			English	Article							COASTAL; PROTECTION; SERVICES; WETLANDS; POLICY	Flooding is the most common and damaging of all natural disasters in the United States, and was a factor in almost all declared disasters in U.S. history. Direct flood losses in the U.S. in 2011 totaled $8.41 billion and flood damage has also been on the rise globally over the past century. The National Flood Insurance Program paid out more than $38 billion in claims since its inception in 1968, more than a third of which has gone to the one percent of policies that experienced multiple losses and are classified as "repetitive loss." During the same period, the loss of coastal wetlands and other natural habitat has continued, and funds for conservation and restoration of these habitats are very limited. This study demonstrates that flood losses could be mitigated through action that meets both flood risk reduction and conservation objectives. We found that there are at least 11,243km(2) of land in coastal California, which is both flood-prone and has natural resource conservation value, and where a property/structure buyout and habitat restoration project could meet multiple objectives. For example, our results show that in Sonoma County, the extent of land that meets these criteria is 564km(2). Further, we explore flood mitigation grant programs that can be a significant source of funds to such projects. We demonstrate that government funded buyouts followed by restoration of targeted lands can support social, environmental, and economic objectives: reduction of flood exposure, restoration of natural resources, and efficient use of limited governmental funds.	[Calil, Juliano] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Beck, Michael W.] Nature Conservancy, Global Marine Team, Santa Cruz, CA USA; [Gleason, Mary; Merrifield, Matthew; Klausmeyer, Kirk; Newkirk, Sarah] Nature Conservancy, Calif Chapter, Santa Cruz, CA USA	University of California System; University of California Santa Cruz; Nature Conservancy; Nature Conservancy	Calil, J (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	jcalil@ucsc.edu	Beck, Michael W./AAB-2844-2019	Beck, Michael W./0000-0002-5107-9973				Abell R, 2011, ECOL STUD-ANAL SYNTH, V214, P103, DOI 10.1007/978-3-642-16707-2_7; [Anonymous], 2011, US FLOOD LOSS REPORT; [Anonymous], 2013, HAZARD MITIGATION DI; [Anonymous], 2013, GRANTS NOTICE FY2013; [Anonymous], 2012, NATURAL CATASTROPHES; [Anonymous], 2013, STATE NEW YRK ACTION; [Anonymous], 2013, CALIFORNIA MULTIHAZA; [Anonymous], 2013, GRANS NOTICE FY 2013, P1; [Anonymous], IMP SEA LEV RIS CAL; Barbier EB, 2013, RESOURCES-BASEL, V2, P213, DOI 10.3390/resources2030213; Bartosova A, 2000, USING GIS EVALUATE E, P1; Bernstein GK, 2006, EVALUATION NATL FLOO; Bin O, 2008, J RISK INSUR, V75, P63, DOI 10.1111/j.1539-6975.2007.00248.x; Brander L, 2013, ECOL ENG, V56, P89, DOI 10.1016/j.ecoleng.2012.12.104; Brody SD, 2013, LAND USE POLICY, V32, P89, DOI 10.1016/j.landusepol.2012.10.017; Buchele B, 2006, NAT HAZARD EARTH SYS, V6, P485; Carolan MS, 2007, ENVIRON POLIT, V16, P36, DOI 10.1080/09644010601073507; Cayan D, 2009, SEA LEVEL RISE ESTIM; Conrad D., 1998, HIGHER GROUND REPORT; Conrad DR, 2013, PROPOSAL 2 REFORMING, P8; Costanza R., 1989, ECOL ECON, V1, P17, DOI 10.1016/0921-8009(89)90020-7; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Dahl T. E., 1990, WETLANDS LOSSES US 1, V53, DOI [10.2144/000113917, DOI 10.2144/000113917]; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Field C.B., 2012, MANAGING RISKS EXTRE; Gleason M, 2006, NO CALIFORNIA CURREN; Herrera MHP, 2009, MEAN HIGHER HIGH WAT; Intergovernmental Panel on Climate Change (IPCC), 2000, SUMM POL EM SCEN SPE, P20, DOI 92-9169-113-5; Kick EL, 2011, DISASTERS, V35, P510, DOI 10.1111/j.1467-7717.2011.01226.x; King RO, 2012, NAT6 FLOOD INSURANCE; King RO, 2013, NAT FLOOD INS PROGR; Kousky C, 2014, ECOL ECON, V104, P119, DOI 10.1016/j.ecolecon.2014.05.001; Landry C, 2010, COASTAL COMMUNITY HA, P4; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Mitigation H, 2013, MITIGATION ASSISTANC; Mokany K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089084; Murdock S, 2012, STATEMENT NATURE CON, P7, DOI [10.1007/s11069-011-0046-8.4, DOI 10.1007/S11069-011-0046-8.4]; Richert E, 2011, LANDSCAPE URBAN PLAN, V103, P118, DOI 10.1016/j.landurbplan.2011.07.001; Sarhadi A, 2012, J HYDROL, V458, P68, DOI 10.1016/j.jhydrol.2012.06.039; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Shepard CC, 2012, NAT HAZARDS, V60, P727, DOI 10.1007/s11069-011-0046-8; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; Spalding MD, 2014, OCEAN COAST MANAGE, V90, P50, DOI 10.1016/j.ocecoaman.2013.09.007; State Coastal Zone Boundaries, 2012, DEF STATES COAST ZO, P4; U. S. Fish and Wildlife Service, 2015, ENV COS ONL SYST	46	17	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132651	10.1371/journal.pone.0132651	http://dx.doi.org/10.1371/journal.pone.0132651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200353	Green Published, gold			2022-12-27	WOS:000358597100042
J	Kim, M; Ku, JH; Kwak, C; Kim, HH; Lee, E; Keam, B; Kim, TM; Heo, DS; Lee, SH; Moon, KC				Kim, Miso; Ku, Ja Hyeon; Kwak, Cheol; Kim, Hyeon Hoe; Lee, Eunsik; Keam, Bhumsuk; Kim, Tae Min; Heo, Dae Seog; Lee, Se-Hoon; Moon, Kyung Chul			Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; LONG-TERM-SURVIVAL; PHASE-III TRIAL; BLADDER-CANCER; ERCC1 EXPRESSION; LUNG-CANCER; DNA-REPAIR; CISPLATIN; METHOTREXATE; VINBLASTINE	Preclinical and clinical studies have suggested that expression of ribonucleotide reductase regulatory subunit M1 (RRM1) and excision repair cross-complementation group 1 (ERCC1) is associated with resistance to gemcitabine and cisplatin, respectively. We evaluated the significance of RRM1 and ERCC1 expression to predict tumor response to gemcitabine plus platinum chemotherapy (GP) and survival in advanced UC. We retrospectively collected tumor samples and reviewed clinical data of 53 patients with unresectable or metastatic UC, who were treated with first-line GP. RRM1 and ERCC1 expression were measured by immunohistochemistry. Among 53 patients, 12 (22.6%) and 26 (49.1%) patients had tumors that demonstrated a high expression for RRM1 and ERCC1, respectively. Twenty-nine (70.7%) of 41 patients with low RRM1 expression achieved a clinical response (complete + partial responses), but only 3 (25.0%) of 12 patients with high RRM1 expression achieved a clinical response after GP (P=0.007). Nineteen (70.4%) of 27 patients with low ERCC1 expression achieved a clinical response, while 13 (50.0%) of 26 patients with high ERCC1 expression achieved a clinical response (P=0.130). High RRM1 expression was associated with shorter progression free survival and overall survival (PFS P=0.006, OS P=0.006). Multivariate analysis confirmed that patients with high RRM1 expression had a significantly greater risk of progression and death than those with low RRM1 expression. ERCC1 status was not a significant predictor for PFS and OS. RRM1 expression was predictive and prognostic of clinical outcome in advanced UC treated with gemcitabine plus platinum combination chemotherapy.	[Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Heo, Dae Seog] Seoul Natl Univ Hosp, Dept Internal Med, Div Hematol Oncol, Seoul 110744, South Korea; [Ku, Ja Hyeon; Kwak, Cheol; Kim, Hyeon Hoe; Lee, Eunsik] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Keam, Bhumsuk; Kim, Tae Min; Heo, Dae Seog] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Se-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Moon, Kyung Chul] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital	Moon, KC (corresponding author), Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea.	blue7270@snu.ac.kr	Ku, Ja Hyeon/E-6682-2016		Innovative Research Institute for Cell Therapy, Republic of Korea [A062260]	Innovative Research Institute for Cell Therapy, Republic of Korea	This work was supported by a grant from the Innovative Research Institute for Cell Therapy, Republic of Korea (A062260).	Bajorin DF, 1999, J CLIN ONCOL, V17, P3173, DOI 10.1200/JCO.1999.17.10.3173; Bellmunt J, 2007, ANN ONCOL, V18, P522, DOI 10.1093/annonc/mdl435; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Booton R, 2007, J THORAC ONCOL, V2, P902, DOI 10.1097/JTO.0b013e318155a637; Dreicer R, 2004, CANCER, V100, P1639, DOI 10.1002/cncr.20123; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friboulet L, 2013, NEW ENGL J MED, V368, P1101, DOI 10.1056/NEJMoa1214271; Gong WY, 2012, LUNG CANCER, V75, P374, DOI 10.1016/j.lungcan.2011.08.003; Harshman LC, 2010, BJU INT, V106, P1805, DOI 10.1111/j.1464-410X.2010.09327.x; Hubner RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025164; Jung KW, 2013, CANCER RES TREAT, V45, P1, DOI 10.4143/crt.2013.45.1.1; Kawashima A, 2011, CLIN CANCER RES, V17, P2561, DOI 10.1158/1078-0432.CCR-10-1963; Kim KH, 2010, APMIS, V118, P941, DOI 10.1111/j.1600-0463.2010.02648.x; Lapham RL, 1997, SEMIN SURG ONCOL, V13, P307, DOI 10.1002/(SICI)1098-2388(199709/10)13:5<307::AID-SSU4>3.0.CO;2-H; Lee KH, 2008, LUNG CANCER, V60, P401, DOI 10.1016/j.lungcan.2007.10.014; LOEHRER PJ, 1992, J CLIN ONCOL, V10, P1066, DOI 10.1200/JCO.1992.10.7.1066; MAZEMAN E, 1976, European Urology, V2, P120; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; Shilkrut M, 2014, MOL CLIN ONCOL, V2, P479, DOI 10.3892/mco.2014.264; Sternberg CN, 2001, J CLIN ONCOL, V19, P2638, DOI 10.1200/JCO.2001.19.10.2638; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Yates DR, 2013, WORLD J UROL, V31, P21, DOI 10.1007/s00345-012-0946-6	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133371	10.1371/journal.pone.0133371	http://dx.doi.org/10.1371/journal.pone.0133371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200905	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100062
J	Murphy, S; Barber, JL; Learmonth, JA; Read, FL; Deaville, R; Perkins, MW; Brownlow, A; Davison, N; Penrose, R; Pierce, GJ; Law, RJ; Jepson, PD				Murphy, Sinead; Barber, Jonathan L.; Learmonth, Jennifer A.; Read, Fiona L.; Deaville, Robert; Perkins, Matthew W.; Brownlow, Andrew; Davison, Nick; Penrose, Rod; Pierce, Graham J.; Law, Robin J.; Jepson, Paul D.			Reproductive Failure in UK Harbour Porpoises Phocoena phocoena: Legacy of Pollutant Exposure?	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; CALIFORNIA SEA LIONS; ENDOCRINE-DISRUPTING CHEMICALS; PERSISTENT ORGANIC POLLUTANTS; ST-LAWRENCE ESTUARY; MINK MUSTELA-VISON; POLYCHLORINATED-BIPHENYLS; ZALOPHUS-CALIFORNIANUS; TURSIOPS-TRUNCATUS; DELPHINUS-DELPHIS	Reproductive failure in mammals due to exposure to polychlorinated biphenyls (PCBs) can occur either through endocrine disrupting effects or via immunosuppression and increased disease risk. To investigate further, full necropsies and determination of summed 25 polychlorinated biphenyls congeners (Sigma PCBs lipid weight) in blubber were undertaken on 329 UK-stranded female harbour porpoises (1990-2012). In sexually mature females, 25/127 (19.7%) showed direct evidence of reproductive failure (foetal death, aborting, dystocia or stillbirth). A further 21/127 (16.5%) had infections of the reproductive tract or tumours of reproductive tract tissues that could contribute to reproductive failure. Resting mature females (non-lactating or non-pregnant) had significantly higher mean Sigma PCBs (18.5 mg/kg) than both lactating (7.5 mg/kg) and pregnant females (6 mg/kg), though not significantly different to sexually immature females (14.0 mg/kg). Using multinomial logistic regression models Sigma PCBs was found to be a significant predictor of mature female reproductive status, adjusting for the effects of confounding variables. Resting females were more likely to have a higher PCB burden. Health status (proxied by "trauma" or "infectious disease" causes of death) was also a significant predictor, with lactating females (i.e. who successfully reproduced) more likely to be in good health status compared to other individuals. Based on contaminant profiles (>11 mg/kg lipid), at least 29/60 (48%) of resting females had not off-loaded their pollutant burden via gestation and primarily lactation. Where data were available, these non-offloading females were previously gravid, which suggests foetal or newborn mortality. Furthermore, a lower pregnancy rate of 50% was estimated for "healthy" females that died of traumatic causes of death, compared to other populations. Whether or not PCBs are part of an underlying mechanism, we used individual PCB burdens to show further evidence of reproductive failure in the North-east Atlantic harbour porpoise population, results that should inform conservation management.	[Murphy, Sinead; Deaville, Robert; Perkins, Matthew W.; Law, Robin J.; Jepson, Paul D.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Barber, Jonathan L.; Law, Robin J.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Learmonth, Jennifer A.; Read, Fiona L.; Pierce, Graham J.] Univ Aberdeen, Oceanlab, Newburgh, Aberdeen, Scotland; [Brownlow, Andrew; Davison, Nick] SRUC Vet Serv Drummondhill, Scottish Marine Anim Stranding Scheme, Inverness, Scotland; [Penrose, Rod] Marine Environm Monitoring, Cardigan, Ceredigion, Wales	Zoological Society of London; Centre for Environment Fisheries & Aquaculture Science; University of Aberdeen	Murphy, S (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	sinead.noirin.murphy@gmail.com	Brownlow, Andrew/ABA-4653-2020; Pierce, Graham/A-5404-2018; Brownlow, Andrew C/P-6593-2018	Brownlow, Andrew/0000-0001-9885-7480; Pierce, Graham/0000-0002-4744-4501; Davison, Nicholas/0000-0001-7286-1836; Murphy, Sinead/0000-0002-3810-6439	Marie Curie International Outgoing Fellowship within the Seventh European Community Framework Programme (Project Cetacean-stressors) [PIOF-GA-2010-276145]; Agreement on the Conservation of Small Cetaceans of the Baltic, North East Atlantic, Irish and North Seas (ASCOBANS) [SSFA/2008, SSFA/ASCOBANS/2010/5]; EC [EVK3-2000-00027]; Marine Scotland; Department for Environment, Food and Rural Affairs (Defra); UK Devolved Administration in Scotland; UK Defra; UK Devolved Administration Wales; Centre for Environment, Fisheries and Aquaculture Science	Marie Curie International Outgoing Fellowship within the Seventh European Community Framework Programme (Project Cetacean-stressors); Agreement on the Conservation of Small Cetaceans of the Baltic, North East Atlantic, Irish and North Seas (ASCOBANS); EC(European CommissionEuropean Commission Joint Research Centre); Marine Scotland; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); UK Devolved Administration in Scotland; UK Defra(Department for Environment, Food & Rural Affairs (DEFRA)); UK Devolved Administration Wales; Centre for Environment, Fisheries and Aquaculture Science	This research was supported by a Marie Curie International Outgoing Fellowship within the Seventh European Community Framework Programme (Project Cetacean-stressors, PIOF-GA-2010-276145 to PDJ and SM). Additional funding was provided through the Agreement on the Conservation of Small Cetaceans of the Baltic, North East Atlantic, Irish and North Seas (ASCOBANS) (Grants SSFA/2008 and SSFA/ASCOBANS/2010/5 to SM). Analysis of Scottish reproductive and teeth samples was funded by the EC-funded BIOCET project (BIOaccumulation of persistent organic pollutants in small CETaceans in European waters: transport pathways and impact on reproduction, grant EVK3-2000-00027 to GJP), and Marine Scotland (GJP). Samples examined in this research were collected under the collaborative Cetacean Strandings Investigation Programme (http://ukstrandings.org/), which is funded by the Department for Environment, Food and Rural Affairs (Defra) and the UK's Devolved Administrations in Scotland and Wales (http://sciencesearch.defra.gov.uk/Default.aspx? Menu=Menu&Module=More&Location= None&Completed=0&ProjectID=15331) (grants to PDJ, RD). UK Defra also funded the chemical analysis under a service-level agreement with the Centre for Environment, Fisheries and Aquaculture Science (grants to RJL, JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISON RF, 1989, CAN J FISH AQUAT SCI, V46, P360, DOI 10.1139/f89-047; Aguilar A., 1999, Journal of Cetacean Research and Management Special Issue, V1, P83; AMAP, 2004, AMAP ASS 2002 PERS O; Backlin BM, 1997, J APPL TOXICOL, V17, P297, DOI 10.1002/(SICI)1099-1263(199709)17:5<297::AID-JAT445>3.0.CO;2-N; Backlin BM, 1998, APMIS, V106, P785, DOI 10.1111/j.1699-0463.1998.tb00225.x; BELAND P, 1993, J GREAT LAKES RES, V19, P766, DOI 10.1016/S0380-1330(93)71264-2; Bergman, 2007, THESIS SWEDISH U AGR; Bergman A, 1999, APMIS, V107, P270, DOI 10.1111/j.1699-0463.1999.tb01554.x; Bergman A., 1985, FINNISH GAME RES, V44, P47; Bignert A, 2012, ECOLOGY ANIMAL HLTH, P73; Bjorge A, 1996, SC47SM7 INT WHAL COM; Borrell A, 2005, B ENVIRON CONTAM TOX, V75, P149, DOI 10.1007/s00128-005-0731-y; BORRELL A, 1995, ENVIRON POLLUT, V88, P283, DOI 10.1016/0269-7491(95)93441-2; BOYD IL, 1991, CAN J ZOOL, V69, P1135, DOI 10.1139/z91-162; Bredhult C, 2008, REPROD TOXICOL, V25, P247, DOI 10.1016/j.reprotox.2007.11.008; Brodie EC, 2006, MAR MAMMAL SCI, V22, P700, DOI 10.1111/j.1748-7692.2006.00045.x; Brodie Paul F., 1995, Reports of the International Whaling Commission Special Issue, V16, P181; Caserta D, 2008, HUM REPROD UPDATE, V14, P59, DOI 10.1093/humupd/dmm025; CLEEN, 2005, EUROPCB INV PCB EN 1; COCKCROFT VG, 1989, S AFR J MARINE SCI, V8, P207, DOI 10.2989/02577618909504562; Deaville R, 2011, CSIP FINAL REPORT PE; DEGUISE S, 1994, J WILDLIFE DIS, V30, P287, DOI 10.7589/0090-3558-30.2.287; DELONG RL, 1973, SCIENCE, V181, P1168, DOI 10.1126/science.181.4105.1168; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Duras-Gomercic M, 2010, 24 C EUR CET SOC 22, P269; EEA, 2012, URBAN ADAPTATION CLI; EEA. European Environment Agency, 2013, HAZ SUBST MAR ORG MA; Field A, 2000, INTRO STAT METHODS S; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Frasier TR, 2013, ECOL EVOL, V3, P3483, DOI 10.1002/ece3.738; Fukushima M, 1981, STUDIES LEVELS ORGAN, P97; GASKIN DE, 1984, REP INT WHAL COMMN, V6, P135; Geraci Joseph R., 1999, P367; Geraci JR, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P546; Gibbens J, 2010, J MAMMAL, V91, P510, DOI 10.1644/08-MAMM-A-377.1; Gulland FMD, 1996, J WILDLIFE DIS, V32, P250, DOI 10.7589/0090-3558-32.2.250; Hall, 2011, THESIS U BRIT COLUMB; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P60, DOI 10.1289/ehp.8053; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; HELLE E, 1976, Ambio, V5, P261; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hickie BE, 2013, ENVIRON SCI TECHNOL, V47, P12314, DOI 10.1021/es403166b; Hohn AA, 1989, THESIS U CALIFORNIA; Hohn AA, 2007, REPROD BIOL PHYLOGEN, V7, P371; Houde M, 2005, REV ENVIRON CONTAM T, V184, P1, DOI 10.1007/0-387-27565-7_1; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; Jauniaux TP, 2010, EMERG INFECT DIS, V16, P1966, DOI 10.3201/eid1612.101008; Jepson PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060953; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Jepson PD, TOXIC LEGACY S UNPUB; JEPSON PD, 2003, THESIS U LONDON; Kannan K, 2000, HUM ECOL RISK ASSESS, V6, P181, DOI 10.1080/10807030091124491; KANNAN K, 1993, ARCH ENVIRON CON TOX, V25, P227, DOI 10.1007/BF00212134; King DP, 2002, VET MICROBIOL, V86, P131, DOI 10.1016/S0378-1135(01)00497-7; Kuiken T., 1991, ECS NEWSLETT, V17, P1; LACAVE G, 1991, Aquatic Mammals, V17, P37; Law RJ, 2012, MAR POLLUT BULL, V64, P1485, DOI 10.1016/j.marpolbul.2012.05.024; Le Boeuf Burney J, 2002, BMC Ecol, V2, P11, DOI 10.1186/1472-6785-2-11; Learmonth JA, 2014, MAR MAMMAL SCI, V30, P1427, DOI 10.1111/mms.12130; Letcher RJ, 2010, SCI TOTAL ENVIRON, V408, P2995, DOI 10.1016/j.scitotenv.2009.10.038; Lipscomb TP, 2000, VET PATHOL, V37, P609, DOI 10.1354/vp.37-6-609; Lockyer C., 2003, HARBOUR PORPOISES N, V5, P71; Lockyer CH., 1995, REV FACTORS INVOLVED; Lockyer Christina, 1995, V16, P189; MARTINEAU D, 1987, ARCH ENVIRON CON TOX, V16, P137, DOI 10.1007/BF01055795; MARTINEAU D, 1994, SCI TOTAL ENVIRON, V154, P201, DOI 10.1016/0048-9697(94)90088-4; MARTINEAU D, 2002, ENV HLTH PERSPECT, V110, P1; McKenzie J, 2005, J MAMMAL, V86, P1237, DOI 10.1644/05-MAMM-A-085R.1; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Mendes JJA, 2002, FOOD CHEM TOXICOL, V40, P781, DOI 10.1016/S0278-6915(02)00018-2; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; Munson L, 1998, J WILDLIFE DIS, V34, P656, DOI 10.7589/0090-3558-34.3.656; Murphy S., 2008, MF0736 UK DEP ENV FO; Murphy S., 2010, J NORTHWEST ATL FISH, V42, P153, DOI [10.2960/J.v42.m658, DOI 10.2960/J.V42.M658]; Murphy S, 2012, IWC64SCMRED1 ICES WG; Murphy S, 2013, OCEANOGR MAR BIOL, V51, P193; Murphy S, 2009, MAR ECOL PROG SER, V388, P273, DOI 10.3354/meps08129; Nakamura K, 2008, J ASSIST REPROD GEN, V25, P47, DOI 10.1007/s10815-008-9206-5; Neimanis AS, 2000, J ZOOL, V250, P221, DOI 10.1111/j.1469-7998.2000.tb01072.x; Newman SJ, 2006, VET PATHOL, V43, P865, DOI 10.1354/vp.43-6-865; O'Shea TJ, 1998, MAR POLLUT BULL, V36, P159, DOI 10.1016/S0025-326X(97)00102-1; Olafsdottir D., 2003, NAMMCO Scientific Publications, V5, P195; OLSSON M, 1994, SCI TOTAL ENVIRON, V154, P217, DOI 10.1016/0048-9697(94)90089-2; Padmanabhan V, 2010, INT J ANDROL, V33, P394, DOI 10.1111/j.1365-2605.2009.01024.x; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P1; Pierce GJ, 2008, ENVIRON POLLUT, V153, P401, DOI 10.1016/j.envpol.2007.08.019; Polacheck T, 1995, BIOL PHOCOENIDS, P169; READ AJ, 1995, MAR MAMMAL SCI, V11, P423, DOI 10.1111/j.1748-7692.1995.tb00667.x; READ AJ, 1990, CAN J FISH AQUAT SCI, V47, P561, DOI 10.1139/f90-064; READ AJ, 1990, CAN J FISH AQUAT SCI, V47, P2158, DOI 10.1139/f90-240; Read AJ, 1997, CAN J ZOOL, V75, P122, DOI 10.1139/z97-016; Reijnders PJH, 2003, N P TOX ENV, P55; REIJNDERS PJH, 1986, NATURE, V324, P456, DOI 10.1038/324456a0; Richardson SF, 1992, THESIS MEMORIAL U NE; Rolland, 2001, 0116 NE FISH SCI CTR; Saltzman W, 2010, ENCY APPL ANIMAL BEH, P522; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schwacke LH, 2002, ENVIRON TOXICOL CHEM, V21, P2752, DOI 10.1897/1551-5028(2002)021<2752:PRAORE>2.0.CO;2; Seibel H, 2012, DIS AQUAT ORGAN, V99, P79, DOI 10.3354/dao02449; Sharp SM, 2014, MAR MAMMAL SCI, V30, P864, DOI 10.1111/mms.12093; Siebert U, 2009, J APPL MICROBIOL, V106, P329, DOI 10.1111/j.1365-2672.2008.04006.x; Siebert U, 2006, J COMP PATHOL, V134, P134, DOI 10.1016/j.jcpa.2005.09.002; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; SORENSEN TB, 1994, OPHELIA, V39, P159, DOI 10.1080/00785326.1994.10429541; Steinberg RM, 2008, BIOL REPROD, V78, P1091, DOI 10.1095/biolreprod.107.067249; Stockley P., 2003, P ROYAL SOC LONDON B, V270; Toft G, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-22; Tregenza NJC, 1997, ICES J MAR SCI, V54, P896, DOI 10.1006/jmsc.1996.0212; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Vafeiadi M, 2014, ENVIRON INT, V64, P116, DOI 10.1016/j.envint.2013.12.015; Van Bressem MF, 1999, VET REC, V144, P592, DOI 10.1136/vr.144.21.592; Vinther Morten, 2004, Journal of Cetacean Research and Management, V6, P19; Viquerat S, 2014, MAR BIOL, V161, P745, DOI 10.1007/s00227-013-2374-6; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; Wells RS, 2005, SCI TOTAL ENVIRON, V349, P106, DOI 10.1016/j.scitotenv.2005.01.010; Wells RS, 2014, FLORIDA AQUATIC MAMM, V40, P252, DOI DOI 10.1578/; Williams R, 2013, ICES J MAR SCI, V70, P1273, DOI 10.1093/icesjms/fst059; Ylitalo GM, 2005, MAR POLLUT BULL, V50, P30, DOI 10.1016/j.marpolbul.2004.08.005; Yordy JE, 2010, SCI TOTAL ENVIRON, V408, P2163, DOI 10.1016/j.scitotenv.2010.01.032	121	72	75	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131085	10.1371/journal.pone.0131085	http://dx.doi.org/10.1371/journal.pone.0131085			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200456	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100011
J	Orban, LL; Chartier, S				Orban, Levente L.; Chartier, Sylvain			Unsupervised Neural Network Quantifies the Cost of Visual Information Processing	PLOS ONE			English	Article							1ST FIND FLOWERS; INNATE PREFERENCE; METABOLIC COST; BUMBLEBEES; SYMMETRY; ACUITY; COLOR; SELECTION; VISION; TIME	Untrained, "flower-naive" bumblebees display behavioural preferences when presented with visual properties such as colour, symmetry, spatial frequency and others. Two unsupervised neural networks were implemented to understand the extent to which these models capture elements of bumblebees' unlearned visual preferences towards flower-like visual properties. The computational models, which are variants of Independent Component Analysis and Feature-Extracting Bidirectional Associative Memory, use images of test-patterns that are identical to ones used in behavioural studies. Each model works by decomposing images of floral patterns into meaningful underlying factors. We reconstruct the original floral image using the components and compare the quality of the reconstructed image to the original image. Independent Component Analysis matches behavioural results substantially better across several visual properties. These results are interpreted to support a hypothesis that the temporal and energetic costs of information processing by pollinators served as a selective pressure on floral displays: flowers adapted to pollinators' cognitive constraints.	[Orban, Levente L.; Chartier, Sylvain] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Orban, LL (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	llo@kpu.ca		Chartier, Sylvain/0000-0003-1952-2303	Natural Sciences and Engineering Research Council of the Government of Canada	Natural Sciences and Engineering Research Council of the Government of Canada	A grant from the Natural Sciences and Engineering Research Council of the Government of Canada funded SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2002, PROCEEDINGS OF THE 6TH JOINT CONFERENCE ON INFORMATION SCIENCES, P824; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bingham E, 2000, Int J Neural Syst, V10, P1, DOI 10.1142/S0129065700000028; BRODBECK DR, 1995, J EXP PSYCHOL ANIM B, V21, P64, DOI 10.1037/0097-7403.21.1.64; Buss D.M., 2005, HDB EVOLUTIONARY PSY; Chartier S, 2007, IEEE IJCNN, P1679, DOI 10.1109/IJCNN.2007.4371210; Chartier S, 2009, NEURAL NETWORKS, V22, P568, DOI 10.1016/j.neunet.2009.06.011; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Eldar YC, 2003, IEEE T INFORM THEORY, V49, P1846, DOI 10.1109/TIT.2003.813507; ENQUIST M, 1993, NATURE, V361, P446, DOI 10.1038/361446a0; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; Enquist M, 1997, P ROY SOC B-BIOL SCI, V264, P1345, DOI 10.1098/rspb.1997.0186; Fitzpatrick DC, 2000, J NEUROSCI, V20, P1605; Forrest J, 2009, NATURWISSENSCHAFTEN, V96, P921, DOI 10.1007/s00114-009-0549-2; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; JOHNSTONE RA, 1994, NATURE, V372, P172, DOI 10.1038/372172a0; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; KOSKO B, 1988, IEEE T SYST MAN CYB, V18, P49, DOI 10.1109/21.87054; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Langlois D, 2010, TUTOR QUANT METHODS, V6, P31, DOI 10.20982/tqmp.06.1.p031; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LEHRER M, 1995, PHILOS T R SOC B, V347, P123, DOI DOI 10.1098/rstb.1995.0017; Leonard AS, 2011, FUNCT ECOL, V25, P1293, DOI 10.1111/j.1365-2435.2011.01885.x; Levin R, 2011, WORK MEETS LIFE; Liu XW, 2003, J OPT SOC AM A, V20, P1271, DOI 10.1364/JOSAA.20.001271; Luo JB, 2005, PATTERN RECOGN, V38, P1507, DOI 10.1016/j.patcog.2005.02.015; Macuda T, 2001, J EXP BIOL, V204, P559; MANNING AUBREY, 1956, BEHAVIOUR, V9, P114, DOI 10.1163/156853956X00273; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Orban L.L., 2013, 21 P EUR S NEUR NETW, P149; Orban LL, 2014, JOVE-J VIS EXP, DOI 10.3791/52033; Orban LL, 2013, NATURWISSENSCHAFTEN, V100, P621, DOI 10.1007/s00114-013-1059-9; Orban LL, 2015, J COMP PSY; Orban LL, 2014, BEHAV STUDIES COMPUT; Plowright CMS, 2011, LEARN MOTIV, V42, P76, DOI 10.1016/j.lmot.2010.08.009; Plowright CMS, 2006, LEARN MOTIV, V37, P66, DOI 10.1016/j.lmot.2005.03.002; Rodriguez I, 2004, NATURWISSENSCHAFTEN, V91, P374, DOI 10.1007/s00114-004-0537-5; Simonds V, 2004, ANIM BEHAV, V67, P379, DOI 10.1016/j.anbehav.2003.03.020; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081	46	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132218	10.1371/journal.pone.0132218	http://dx.doi.org/10.1371/journal.pone.0132218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200767	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100029
J	Sorensen, MV; Dal Zotto, M; Rho, HS; Herranz, M; Sanchez, N; Pardos, F; Yamasaki, H				Sorensen, Martin V.; Dal Zotto, Matteo; Rho, Hyun Soo; Herranz, Maria; Sanchez, Nuria; Pardos, Fernando; Yamasaki, Hiroshi			Phylogeny of Kinorhyncha Based on Morphology and Two Molecular Loci	PLOS ONE			English	Article							RIBOSOMAL DNA-SEQUENCES; SP NOV.-A; ECHINODERES KINORHYNCHA; POSTEMBRYONIC DEVELOPMENT; RNA GENE; DEEP-SEA; CYCLORHAGIDA; REDESCRIPTION; ANTYGOMONAS; PHYLUM	The phylogeny of Kinorhyncha was analyzed using morphology and the molecular loci 18S rRNA and 28S rRNA. The different datasets were analyzed separately and in combination, using maximum likelihood and Bayesian Inference. Bayesian inference of molecular sequence data in combination with morphology supported the division of Kinorhyncha into two major clades: Cyclorhagida comb. nov. and Allomalorhagida nom. nov. The latter clade represents a new kinorhynch class, and accommodates Dracoderes, Franciscideres, a yet undescribed genus which is closely related with Franciscideres, and the traditional homalorhagid genera. Homalorhagid monophyly was not supported by any analyses with molecular sequence data included. Analysis of the combined molecular and morphological data furthermore supported a cyclorhagid clade which included all traditional cyclorhagid taxa, except Dracoderes that no longer should be considered a cyclorhagid genus. Accordingly, Cyclorhagida is divided into three main lineages: Echinoderidae, Campyloderidae, and a large clade, 'Kentrorhagata', which except for species of Campyloderes, includes all species with a midterminal spine present in adult individuals. Maximum likelihood analysis of the combined datasets produced a rather unresolved tree that was not regarded in the following discussion. Results of the analyses with only molecular sequence data included were incongruent at different points. However, common for all analyses was the support of several major clades, i.e., Campyloderidae, Kentrorhagata, Echinoderidae, Dracoderidae, Pycnophyidae, and a clade with Paracentrophyes+ New Genus and Franciscideres(in those analyses where the latter was included). All molecular analyses including 18S rRNA sequence data furthermore supported monophyly of Allomalorhagida. Cyclorhagid monophyly was only supported in analyses of combined 18S rRNA and 28S rRNA (both ML and BI), and only in a restricted dataset where taxa with incomplete information from 28S rRNA had been omitted. Analysis of the morphological data produced results that were similar with those from the combined molecular and morphological analysis. E.g., the morphological data also supported exclusion of Dracoderes from Cyclorhagida. The main differences between the morphological analysis and analyses based on the combined datasets include: 1) Homalorhagida appears as monophyletic in the morphological tree only, 2) the morphological analyses position Franciscideres and the new genus within Cyclorhagida near Zelinkaderidae and Cateriidae, whereas analyses including molecular data place the two genera inside Allomalorhagida, and 3) species of Campyloderes appear in a basal trichotomy within Kentrorhagata in the morphological tree, whereas analysis of the combined datasets places species of Campyloderes as a sister clade to Echinoderidae and Kentrorhagata.	[Sorensen, Martin V.] Univ Copenhagen, Nat Hist Museum Denmark, Sect GeoGenet, Copenhagen, Denmark; [Dal Zotto, Matteo] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Rho, Hyun Soo] Korean Inst Ocean Sci & Technol, Dokdo Res Ctr, Uljin, South Korea; [Herranz, Maria; Sanchez, Nuria; Pardos, Fernando] Univ Complutense Madrid, Dept Zool & Anthropol, Madrid, Spain; [Yamasaki, Hiroshi] Univ Ryukyus, Dept Chem Biol & Marine Sci, Okinawa, Japan	University of Copenhagen; Universita di Modena e Reggio Emilia; Complutense University of Madrid; University of the Ryukyus	Sorensen, MV (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Sect GeoGenet, Copenhagen, Denmark.	mvsorensen@snm.ku.dk	Herranz, Maria/J-8042-2014; MARTINEZ, FERNANDO PARDOS/I-5218-2017; Yamasaki, Hiroshi/I-8585-2018; Pardos, Fernando/GNP-2750-2022; Sørensen, Martin V/A-8852-2013; Herranz, Maria/AAT-6007-2020	Herranz, Maria/0000-0002-3020-6072; MARTINEZ, FERNANDO PARDOS/0000-0002-6292-9793; Yamasaki, Hiroshi/0000-0002-0282-982X; Sørensen, Martin V/0000-0002-0377-0276; Herranz, Maria/0000-0002-3020-6072; SANCHEZ, NURIA/0000-0003-4908-8755; Dal Zotto, Matteo/0000-0003-1386-7626	Danish Council for Independent Research \ Natural Sciences [21-04-0331]; Carlsberg Foundation [2011_01_0048, 2013-01-0035]; Korean Institute of Ocean Science and Technology [PE99318, PO01135]; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics from the University of the Ryukyus; grant for cultivation of young scientists from the Research Institute of Marine Invertebrate; Spanish Ministry of Science and Technology [CGL 2009-08928]; Association of European Marine Biological Laboratories	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); Korean Institute of Ocean Science and Technology; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics from the University of the Ryukyus; grant for cultivation of young scientists from the Research Institute of Marine Invertebrate; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Association of European Marine Biological Laboratories(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Danish Council for Independent Research vertical bar Natural Sciences (http://ufm.dk/en Grant no: 21-04-0331 to MVS-collecting and sequencing of specimens), The Carlsberg Foundation (http://www.carlsbergfondet.dk/ Grants no: 2011_01_0048 and 2013-01-0035 to MVS-collecting and sequencing of specimens), Korean Institute of Ocean Science and Technology (http://eng.kiost.ac/kordi_eng/main/ Grant no. PE99318 and PO01135 to HSR-collecting and sequencing of specimens), "International Research Hub Project for Climate Change and Coral Reef/Island Dynamics from the University of the Ryukyus" and "grant for cultivation of young scientists from the Research Institute of Marine Invertebrate" (to HY-collecting and sequencing of specimens), Spanish Ministry of Science and Technology (http://www.csic.es/ Grant no CGL 2009-08928 to FP-collecting of specimens), and Association of European Marine Biological Laboratories (http://www.assemblemarine.org/access-rules/ to FP, MH, and NS-collecting of specimens).	Adrianov AV, 2002, ZOOL SCI, V19, P463, DOI 10.2108/zsj.19.463; Adrianov AV, 2002, P BIOL SOC WASH, V115, P205; Adrianov AV, 1996, ZOOSYST ROSS, V4, P23; Adrianov AV, 1999, CEPHALORHYNCHA WORLD; Altenburger A, 2015, ZOOL STUD IN PRESS; Bauer-Nebelsick Monika, 1995, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V97, P57; Borner J, 2014, MOL PHYLOGENET EVOL, V80, P79, DOI 10.1016/j.ympev.2014.08.001; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Claparede ARE, 1863, KENNTNIS GATTUNG ECH; Dal Zotto M, 2015, MAR BIOL RES, V11, P689, DOI 10.1080/17451000.2015.1007872; Dal Zotto M, 2013, SYST BIODIVERS, V11, P303, DOI 10.1080/14772000.2013.819045; Dujardin F., 1851, ANN SCI NAT ZOOL SE, V3, P158; Gerlach S. A., 1956, Kieler Meeresforschungen, V12, P120; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Goloboff P.A., 2003, TREE ANAL USING NEW; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Herranz M, 2013, ZOOL ANZ, V253, P93, DOI 10.1016/j.jcz.2013.09.005; Herranz M, 2012, ZOOL ANZ, V251, P161, DOI 10.1016/j.jcz.2011.08.004; HIGGINS R P, 1969, Proceedings of the Biological Society of Washington, V82, P113; Higgins R. P., 1969, Smithsonian Contributions to Zoology, VNo. 14, P1; Higgins R.P., 1977, Smithsonian Contributions to Zoology, VNo. 248, P1; Higgins R.P., 1990, SMITHSON CONTR ZOOL, V500, P1, DOI DOI 10.5479/SI.00810282.500; HIGGINS ROBERT P., 1964, BULL MAR SCI GULF CARIBBEAN, V14, P479; HIGGINS RP, 1978, T AM MICROSC SOC, V97, P171, DOI 10.2307/3225589; HIGGINS RP, 1977, T AM MICROSC SOC, V96, P340, DOI 10.2307/3225864; HIGGINS RP, 1968, T AM MICROSC SOC, V87, P21, DOI 10.2307/3224334; HIGGINS RP, 1990, ZOOL SCI, V7, P939; Higgins RP, 1983, SMITHSON CONTRIB MAR, V18, P1, DOI DOI 10.5479/SI.01960768.18.1; Higgins RP, 1988, SMITHSON CONTRIB ZOO, V458, P1, DOI DOI 10.5479/SI.00810282.458; Hyman LH, 1951, INVERTEBRATES ACANTH, V3; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim CG, 2000, MOL BIOL EVOL, V17, P137, DOI 10.1093/oxfordjournals.molbev.a026226; Luan YX, 2005, MOL BIOL EVOL, V22, P1579, DOI 10.1093/molbev/msi148; Maddison W. P, 2014, MESQUITE MODULAR SYS; NEBELSICK M, 1993, ZOOMORPHOLOGY, V113, P211, DOI 10.1007/BF00403313; NEBELSICK M, 1992, ACTA ZOOL-STOCKHOLM, V73, P185, DOI 10.1111/j.1463-6395.1992.tb01186.x; NELLES L, 1984, NUCLEIC ACIDS RES, V12, P8749, DOI 10.1093/nar/12.23.8749; NEUHAUS B, 1995, ZOOL SCR, V24, P179, DOI 10.1111/j.1463-6409.1995.tb00398.x; Neuhaus B, 2002, INTEGR COMP BIOL, V42, P619, DOI 10.1093/icb/42.3.619; Neuhaus B., 2004, MEIOFAUNA MAR, V13, P3; Neuhaus Birger, 1993, Microfauna Marina, V8, P163; Neuhaus B, 2006, ZOOL ANZ, V245, P19, DOI 10.1016/j.jcz.2006.03.003; Neuhaus B, 2014, ZOOTAXA, V3901, P1, DOI 10.11646/zootaxa.3901.1.1; Neuhaus B, 2013, HBK ZOOL, P181; Neuhaus B, 2013, ZOOL ANZ, V252, P48, DOI 10.1016/j.jcz.2012.03.002; Neuhaus B, 2013, CAH BIOL MAR, V54, P109; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Noren M, 2002, ZOOL SCR, V31, P403, DOI 10.1046/j.1463-6409.2002.00082.x; Noren M, 1999, CLADISTICS, V15, P103, DOI 10.1111/j.1096-0031.1999.tb00252.x; Page R.D.M., 2001, NDE NEXUS DATA EDITO; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; Park JK, 2000, MOL PHYLOGENET EVOL, V14, P75, DOI 10.1006/mpev.1999.0691; Park JK, 2006, ZOOL SCI, V23, P943, DOI 10.2108/zsj.23.943; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez N, 2014, HELGOLAND MAR RES, V68, P221, DOI 10.1007/s10152-014-0383-6; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sorensen MV, 2008, J ZOOL SYST EVOL RES, V46, P231, DOI 10.1111/j.1439-0469.2008.00478.x; Sorensen M. V., 2010, OPEN ZOOLOGY J, V3, P42, DOI [DOI 10.2174/187, 10.2174/1874336601003010042, DOI 10.2174/1874336601003010042]; Sorensen MV, 2007, HELGOLAND MAR RES, V61, P247, DOI 10.1007/s10152-007-0073-8; Sorensen Martin V., 2006, Meiofauna Marina, V15, P51; Sorensen MV, 2007, CAH BIOL MAR, V48, P155; Sorensen MV, 2012, ZOOTAXA, P161; Sorensen MV, 2014, MAR BIODIVERS, V44, P251, DOI 10.1007/s12526-013-0181-4; Sorensen MV, 2013, ZOOTAXA, V3703, P63; Sorensen MV, 2013, HELGOLAND MAR RES, V67, P291, DOI 10.1007/s10152-012-0323-2; Sorensen MV, 2012, MAR BIOL RES, V8, P210, DOI 10.1080/17451000.2011.615328; Sorensen Martin V., 2010, Marine Biodiversity, V40, P261, DOI 10.1007/s12526-010-0048-x; Sorensen MV, 2010, MAR BIOL RES, V6, P472, DOI 10.1080/17451000903334702; Sorensen MV, 2010, ZOOL SCI, V27, P234, DOI 10.2108/zsj.27.234; Sorensen MV, 2009, J MAR BIOL ASSOC UK, V89, P1269, DOI 10.1017/S0025315409000526; Sorensen MV, 2009, HELGOLAND MAR RES, V63, P129, DOI 10.1007/s10152-008-0132-9; Sorensen MV, 2008, ORG DIVERS EVOL, V8, P233, DOI 10.1016/j.ode.2007.11.002; Sorensen MV, 2008, ORG DIVERS EVOL, V8, DOI 10.1016/j.ode.2007.11.003; Sorensen MV, 2000, CAH BIOL MAR, V41, P167; Sorensen MV, 2005, P BIOL SOC WASH, V118, P499, DOI 10.2988/0006-324X(2005)118[499:ANSOEF]2.0.CO;2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thomsen VG, 2013, ZOOTAXA, V3682, P133, DOI 10.11646/zootaxa.3682.1.6; Thormar Jonas, 2010, Meiofauna Marina, V18, P67; Todaro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017892; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Yamaguchi S, 2003, MAR BIOL, V143, P23, DOI 10.1007/s00227-003-1062-3; Yamasaki H, 2012, ZOOTAXA, P23; Yamasaki H, 2013, MOL PHYLOGENET EVOL, V67, P303, DOI 10.1016/j.ympev.2013.02.016; Zelinka C., 1907, Zoologischer Anzeiger Leipzig, V32; Zelinka K., 1896, VERH DEUTSCH ZOOL GE, V6, P197	88	63	65	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133440	10.1371/journal.pone.0133440	http://dx.doi.org/10.1371/journal.pone.0133440			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200115	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358597100065
J	Zein, JG; Dweik, RA; Comhair, SA; Bleecker, ER; Moore, WC; Peters, SP; Busse, WW; Jarjour, NN; Calhoun, WJ; Castro, M; Chung, KF; Fitzpatrick, A; Israel, E; Teague, WG; Wenzel, SE; Love, TE; Gaston, BM; Erzurum, SC				Zein, Joe G.; Dweik, Raed A.; Comhair, Suzy A.; Bleecker, Eugene R.; Moore, Wendy C.; Peters, Stephen P.; Busse, William W.; Jarjour, Nizar N.; Calhoun, William J.; Castro, Mario; Chung, K. Fan; Fitzpatrick, Anne; Israel, Elliot; Teague, W. Gerald; Wenzel, Sally E.; Love, Thomas E.; Gaston, Benjamin M.; Erzurum, Serpil C.		Severe Asthma Res Program	Asthma Is More Severe in Older Adults	PLOS ONE			English	Article							LUNG-FUNCTION; RESPIRATORY SYMPTOMS; CLUSTER-ANALYSIS; ONSET ASTHMA; EARLY-LIFE; PREVALENCE; DECLINE; COSTS; RISK; SEX	Background Severe asthma occurs more often in older adult patients. We hypothesized that the greater risk for severe asthma in older individuals is due to aging, and is independent of asthma duration. Methods This is a cross-sectional study of prospectively collected data from adult participants (N=1130; 454 with severe asthma) enrolled from 2002 - 2011 in the Severe Asthma Research Program. Results The association between age and the probability of severe asthma, which was performed by applying a Locally Weighted Scatterplot Smoother, revealed an inflection point at age 45 for risk of severe asthma. The probability of severe asthma increased with each year of life until 45 years and thereafter increased at a much slower rate. Asthma duration also increased the probability of severe asthma but had less effect than aging. After adjustment for most comorbidities of aging and for asthma duration using logistic regression, asthmatics older than 45 maintained the greater probability of severe asthma [OR: 2.73 ( 95 CI: 1.96; 3.81)]. After 45, the age-related risk of severe asthma continued to increase in men, but not in women. Conclusions Overall, the impact of age and asthma duration on risk for asthma severity in men and women is greatest over times of 18-45 years of age; age has a greater effect than asthma duration on risk of severe asthma.	[Zein, Joe G.; Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Bleecker, Eugene R.; Moore, Wendy C.; Peters, Stephen P.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Genom & Personalized Med, Winston Salem, NC USA; [Busse, William W.; Jarjour, Nizar N.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Calhoun, William J.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA; [Castro, Mario] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Chung, K. Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Fitzpatrick, Anne] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Israel, Elliot] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm, Boston, MA 02115 USA; [Teague, W. Gerald] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Wenzel, Sally E.] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA; [Love, Thomas E.] Case Western Reserve Univ, MetroHlth Med Ctr, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Gaston, Benjamin M.] Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Wake Forest University; Wake Forest Baptist Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); Imperial College London; Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Zein, JG (corresponding author), Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA.	zeinj@ccf.org	Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Wenzel, Sally/0000-0002-4242-0164; Calhoun, William/0000-0001-7075-712X; Fitzpatrick, Anne/0000-0002-2933-5926	National Institute of Health-National Heart, Lung, and Blood Institute [HL109250, HL081064, HL69170, HL103453, U10 HL109250, UL1TR000439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL109257, P01HL081064, U10HL109152, U10HL109250, P01HL103453, U10HL109172, R01HL069170] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SCE received funding from the National Institute of Health-National Heart, Lung, and Blood Institute: HL109250, HL081064, HL69170, HL103453, U10 HL109250, UL1TR000439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Akinbami Lara J, 2012, NCHS Data Brief, P1; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; ANGUS GE, 1972, J APPL PHYSIOL, V32, P483, DOI 10.1152/jappl.1972.32.4.483; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; ANTHONISEN NR, 1969, RESP PHYSIOL, V8, P58, DOI 10.1016/0034-5687(69)90044-9; Apostol GG, 2002, AM J RESP CRIT CARE, V166, P166, DOI 10.1164/rccm.2007035; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Ciccone G, 1997, EUR RESPIR J, V10, P1780; Cisternas MG, 2003, J ALLERGY CLIN IMMUN, V111, P1212, DOI 10.1067/mai.2003.1449; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; D'Amato G, 2002, EUR RESPIR J, V20, P763, DOI 10.1183/09031936.02.00401402; Dijkstra A, 2006, THORAX, V61, P105, DOI 10.1136/thx.2004.039271; DODGE RR, 1980, AM REV RESPIR DIS, V122, P567; DUNNILL M. S., 1962, THORAX, V17, P329, DOI 10.1136/thx.17.4.329; Fulop T, 2004, AGING CELL, V3, P217, DOI 10.1111/j.1474-9728.2004.00110.x; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hay WW, 2009, PEDIATR RES, V65, P117, DOI 10.1203/PDR.0b013e31818c7feb; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; Jenkins MA, 2006, CLIN EXP ALLERGY, V36, P609, DOI 10.1111/j.1365-2222.2006.02475.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Kim TB, 2013, EUR RESPIR J, V41, P1308, DOI 10.1183/09031936.00100811; Krumpe P E, 1985, Clin Geriatr Med, V1, P143; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lange P, 2001, THORAX, V56, P613, DOI 10.1136/thorax.56.8.613; LECESSIE S, 1995, BIOMETRICS, V51, P600, DOI 10.2307/2532948; Leynaert B, 2012, THORAX, V67, P625, DOI 10.1136/thoraxjnl-2011-201249; Mandhane PJ, 2005, AM J RESP CRIT CARE, V172, P45, DOI 10.1164/rccm.200412-1738OC; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Meyer KC, 1998, MECH AGEING DEV, V104, P169, DOI 10.1016/S0047-6374(98)00065-7; Milic-Emili J, 2007, EUR J APPL PHYSIOL, V99, P567, DOI 10.1007/s00421-006-0389-0; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; NIEWOEHNER DE, 1974, J APPL PHYSIOL, V36, P412, DOI 10.1152/jappl.1974.36.4.412; PEAT JK, 1987, EUR J RESPIR DIS, V70, P171; Rao CK, 2013, CHEST, V143, P984, DOI 10.1378/chest.12-0973; Real FG, 2006, THORAX, V61, P34, DOI 10.1136/thx.2005.040881; Real FG, 2008, J ALLERGY CLIN IMMUN, V121, P72, DOI 10.1016/j.jaci.2007.08.057; Ronmark E, 2007, RESP MED, V101, P2370, DOI 10.1016/j.rmed.2007.06.011; Schatz M, 2003, ANN ALLERG ASTHMA IM, V91, P553, DOI 10.1016/S1081-1206(10)61533-5; SENNHAUSER FH, 1995, PEDIATR PULM, V19, P161, DOI 10.1002/ppul.1950190304; Serra-Batlles J, 1998, EUR RESPIR J, V12, P1322, DOI 10.1183/09031936.98.12061322; TROISI RJ, 1995, AM J RESP CRIT CARE, V152, P1183, DOI 10.1164/ajrccm.152.4.7551368; ULRIK CS, 1994, AM J RESP CRIT CARE, V150, P629, DOI 10.1164/ajrccm.150.3.8087330; VERBEKEN EK, 1992, CHEST, V101, P793, DOI 10.1378/chest.101.3.793; Zein J, 2014, CHEST, V145, DOI 10.1378/chest.1783148	52	59	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133490	10.1371/journal.pone.0133490	http://dx.doi.org/10.1371/journal.pone.0133490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200463	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358597100067
J	Zengel, S; Bernik, BM; Rutherford, N; Nixon, Z; Michel, J				Zengel, Scott; Bernik, Brittany M.; Rutherford, Nicolle; Nixon, Zachary; Michel, Jacqueline			Heavily Oiled Salt Marsh following the Deepwater Horizon Oil Spill, Ecological Comparisons of Shoreline Cleanup Treatments and Recovery	PLOS ONE			English	Article							FIDDLER-CRABS; LITTORARIA-IRRORATA; JUNCUS-ROEMERIANUS; SOUTH-CAROLINA; COASTAL MARSH; VEGETATION; IMPACTS; GROWTH; PHYTOREMEDIATION; RESTORATION	The Deepwater Horizon oil spill affected hundreds of kilometers of coastal wetland shorelines, including salt marshes with persistent heavy oiling that required intensive shoreline "cleanup" treatment. Oiled marsh treatment involves a delicate balance among: removing oil, speeding the degradation of remaining oil, protecting wildlife, fostering habitat recovery, and not causing further ecological damage with treatment. To examine the effectiveness and ecological effects of treatment during the emergency response, oiling characteristics and ecological parameters were compared over two years among heavily oiled test plots subject to: manual treatment, mechanical treatment, natural recovery (no treatment, oiled control), as well as adjacent reference conditions. An additional experiment compared areas with and without vegetation planting following treatment. Negative effects of persistent heavy oiling on marsh vegetation, intertidal invertebrates, and shoreline erosion were observed. In areas without treatment, oiling conditions and negative effects for most marsh parameters did not considerably improve over two years. Both manual and mechanical treatment were effective at improving oiling conditions and vegetation characteristics, beginning the recovery process, though recovery was not complete by two years. Mechanical treatment had additional negative effects of mixing oil into the marsh soils and further accelerating erosion. Manual treatment appeared to strike the right balance between improving oiling and habitat conditions while not causing additional detrimental effects. However, even with these improvements, marsh periwinkle snails showed minimal signs of recovery through two years, suggesting that some ecosystem components may lag vegetation recovery. Planting following treatment quickened vegetation recovery and reduced shoreline erosion. Faced with comparable marsh oiling in the future, we would recommend manual treatment followed by planting. We caution against the use of intensive treatment methods with lesser marsh oiling. Oiled controls (no treatment "set-asides") are essential for judging marsh treatment effectiveness and ecological effects; we recommend their use when applying intensive treatment methods.	[Zengel, Scott; Rutherford, Nicolle; Nixon, Zachary; Michel, Jacqueline] NOAA, Natl Ocean Serv, Off Response & Restorat, Emergency Response Div, Seattle, WA 98115 USA; [Zengel, Scott] Res Planning Inc, Tallahassee, FL USA; [Bernik, Brittany M.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Nixon, Zachary; Michel, Jacqueline] Res Planning Inc, Columbia, SC USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Tulane University	Zengel, S (corresponding author), NOAA, Natl Ocean Serv, Off Response & Restorat, Emergency Response Div, Seattle, WA 98115 USA.	szengel@researchplanning.com			NOAA Emergency Response Division, Office of Response and Restoration; EPA STAR Fellowship; RPI; BP; NOAA	NOAA Emergency Response Division, Office of Response and Restoration; EPA STAR Fellowship(United States Environmental Protection Agency); RPI; BP; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was conducted in part under The Deepwater Horizon Unified Command (U.S. Coast Guard, State of Louisiana, and BP). Funding was provided by BP in part, as the Responsible Party. However, SZ, NR, ZN and JM were funded through NOAA, serving as members of the NOAA Scientific Support Team to the U.S. Coast Guard. Additional funding was provided by the NOAA Emergency Response Division, Office of Response and Restoration. BMB was supported by an EPA STAR Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BP is a commercial funding source; authors SZ, ZN, and JM are employed by RPI, a commercial company; this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Alexander Steve K., 1987, INT OIL SPILL C P, V1987, P445, DOI [10.7901/2169-3358-1987-1-445., DOI 10.7901/2169-3358-1987-1-445]; Anderson CJ, 2012, MAR POLLUT BULL, V64, P2749, DOI 10.1016/j.marpolbul.2012.09.015; Baca B.J., 1987, P INT OIL SPILL C INT OIL SPILL C P, P459; Baker J.M., 1993, INT OIL SPILL C WASH, P395; Baker JM, 1999, PURE APPL CHEM, V71, P135, DOI 10.1351/pac199971010135; Bergen A., 2000, Wetlands Ecology and Management, V8, P185, DOI 10.1023/A:1008496519697; Bernik B.M., 2015, THESIS TULANE U NEW THESIS TULANE U NEW; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; Bhattacharjee J, 2007, COMMUNITY ECOL, V8, P15, DOI 10.1556/ComEc.8.2007.1.3; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; BURGER J, 1992, ENVIRON MONIT ASSESS, V22, P107, DOI 10.1007/BF00418009; BURGER J, 1991, ARCH ENVIRON CON TOX, V20, P404, DOI 10.1007/BF01064411; Burns CMB, 2014, BIOSCIENCE, V64, P820, DOI 10.1093/biosci/biu124; Chabreck R. H., 1970, THESIS LOUISIANA STA; Coastal Protection and Restoration Authority of Louisiana (CPRA), 2012, LOUIS COMPR MAST PLA; Couvillion BR, 2010, LAND AREA CHANGE COA; CRAIG NJ, 1979, ENVIRON MANAGE, V3, P133, DOI 10.1007/BF01867025; Culbertson JB, 2007, MAR POLLUT BULL, V54, P955, DOI 10.1016/j.marpolbul.2007.02.015; EPA, 2007, 8270D EPA; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Godfrey R.K., 1979, AQUATIC WETLAND PLAN; Gundlach E.R., 2003, P INT OIL SPILL C, V2003, P135, DOI [10.7901/2169-3358-2003-1-135, DOI 10.7901/2169-3358-2003-1-135]; Hale JA, 2011, INT OIL SPILL C P 20, P1; HAMILTON PV, 1978, MAR BIOL, V46, P49, DOI 10.1007/BF00393820; HAMPSON GR, 1978, J FISH RES BOARD CAN, V35, P731, DOI 10.1139/f78-123; HERSHNER C, 1980, MAR BIOL, V56, P163, DOI 10.1007/BF00397133; Hershner C, 1977, P 1977 OIL SPILL C, P529; Khanna S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078989; Kiehn WM, 2009, WETLANDS, V29, P818, DOI 10.1672/08-178.1; Knott DM, 1997, WETLANDS, V17, P65, DOI 10.1007/BF03160719; Kokaly RF, 2013, REMOTE SENS ENVIRON, V129, P210, DOI 10.1016/j.rse.2012.10.028; Krebs C.T., 1981, P INT OIL SPILL C P INT OIL SPILL C, P375; KREBS CT, 1977, SCIENCE, V197, P484, DOI 10.1126/science.197.4302.484; LEE RF, 1981, MAR ENVIRON RES, V5, P125, DOI 10.1016/0141-1136(81)90028-3; Lin Q., 2008, INT OIL SPILL C AM P, P869; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; Lin QX, 2009, ECOL ENG, V35, P85, DOI 10.1016/j.ecoleng.2008.09.010; Lin Qianxin, 2008, Archives of Agronomy and Soil Science, V54, P681, DOI 10.1080/03650340802253937; Lubchenco J, 2012, P NATL ACAD SCI USA, V109, P20212, DOI 10.1073/pnas.1204729109; McCall BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032735; McClenachan G, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044030; Mendelssohn IA, 2012, BIOSCIENCE, V62, P562, DOI 10.1525/bio.2012.62.6.7; Michel J, 2005, INT OIL SPILL C P 20, P957; Michel J, 2014, MAR POLLUT BULL, V82, P19, DOI 10.1016/j.marpolbul.2014.03.030; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Miller DL, 2005, WETLANDS, V25, P648, DOI 10.1672/0277-5212(2005)025[0648:MUCMVP]2.0.CO;2; Minello Thomas J., 2000, Wetlands Ecology and Management, V8, P327, DOI 10.1023/A:1008487303992; Mouton EC, 1996, ESTUARIES, V19, P51, DOI 10.2307/1352651; NOAA, 2012, HOURL GLOB SURF DAT; NOAA, 2012, CLIM SUMM TABL; NOAA, 2013, SHOR ASS MAN, VFourth; ODUM E. P., 1959, PROC NATL ACAD SCI, V45, P617, DOI 10.1073/pnas.45.4.617; Peacock EE, 2007, MAR POLLUT BULL, V54, P214, DOI 10.1016/j.marpolbul.2006.10.007; Penland S., 2000, 00417 USGS; Penland S., 2001, 00418 US GEOL SURV; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Rozas LP, 2014, ESTUAR COAST, V37, P1403, DOI 10.1007/s12237-013-9766-1; SCHINDLER DE, 1994, OECOLOGIA, V97, P49, DOI 10.1007/BF00317908; Sell D., 1995, INT OIL SPILL C, P595; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; SHIFLET THOMAS N., 1963, JOUR RANGE MANAGEMENT, V16, P231, DOI 10.2307/3895331; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Stagg CL, 2012, WETLANDS, V32, P643, DOI 10.1007/s13157-012-0297-5; Staszak LA, 2013, J COASTAL RES, V29, P410, DOI 10.2112/JCOASTRES-D-12-00075.1; Turner RE, 2014, MAR POLLUT BULL, V86, P291, DOI 10.1016/j.marpolbul.2014.07.003; Turner RE, 2014, MAR POLLUT BULL, V87, P57, DOI 10.1016/j.marpolbul.2014.08.011; Vandermeulen JH, 1981, INT OIL SPILL C P 19, P347; Visser JM, 1998, ESTUARIES, V21, P818, DOI 10.2307/1353283; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Wilson CA, 2008, ESTUAR COAST SHELF S, V80, P483, DOI 10.1016/j.ecss.2008.09.004; Zengel S, 2014, INT OIL SPILL C P, P1985, DOI DOI 10.7901/2169-3358-2014.1.1985; Zengel S., 2013, 42 NOAA NOS OR R; Zengel SA, 1996, MAR POLLUT BULL, V32, P876, DOI 10.1016/S0025-326X(96)00049-5	74	75	76	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132324	10.1371/journal.pone.0132324	http://dx.doi.org/10.1371/journal.pone.0132324			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200349	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100034
J	Bourgeois, G; Ney, M; Gaspar, I; Aigueperse, C; Schaefer, M; Kellner, S; Helm, M; Motorin, Y				Bourgeois, Gabrielle; Ney, Michel; Gaspar, Imre; Aigueperse, Christelle; Schaefer, Matthias; Kellner, Stefanie; Helm, Mark; Motorin, Yuri			Eukaryotic rRNA Modification by Yeast 5-Methylcytosine-Methyltransferases and Human Proliferation-Associated Antigen p120	PLOS ONE			English	Article							NUCLEOLAR PROTEIN P120; BOWEN-CONRADI SYNDROME; SACCHAROMYCES-CEREVISIAE; DIMETHYLASE DIM1P; ASSEMBLY FACTOR; NONCODING RNA; MISU NSUN2; NEP1 EMG1; METHYLTRANSFERASE; METHYLATION	Modified nucleotide 5-methylcytosine (m(5)C) is frequently present in various eukaryotic RNAs, including tRNAs, rRNAs and in other non-coding RNAs, as well as in mRNAs. RNA: m(5)C-methyltranferases (MTases) Nop2 from S. cerevisiae and human proliferation-associated nucleolar antigen p120 are both members of a protein family called Nop2/NSUN/NOL1. Protein p120 is well-known as a tumor marker which is over-expressed in various cancer tissues. Using a combination of RNA bisulfite sequencing and HPLC-MS/MS analysis, we demonstrated here that p120 displays an RNA:m(5)C-MTase activity, which restores m(5)C formation at position 2870 in domain V of 25S rRNA in a nop2 Delta yeast strain. We also confirm that yeast proteins Nop2p and Rcm1p catalyze the formation of m(5)C in domains V and IV, respectively. In addition, we do not find any evidence of m(5)C residues in yeast 18S rRNA. We also performed functional complementation of Nop2-deficient yeasts by human p120 and studied the importance of different sequence and structural domains of Nop2 and p120 for yeast growth and m(5)C-MTase activity. Chimeric protein formed by Nop2 and p120 fragments revealed the importance of Nop2 N-terminal domain for correct protein localization and its cellular function. We also validated that the presence of Nop2, rather than the m(5)C modification in rRNA itself, is required for pre-rRNA processing. Our results corroborate that Nop2 belongs to the large family of pre-ribosomal proteins and possesses two related functions in pre-rRNA processing: as an essential factor for cleavages and m(5)C: RNA:modification. These results support the notion of quality control during ribosome synthesis by such modification enzymes.	[Bourgeois, Gabrielle; Ney, Michel; Aigueperse, Christelle; Motorin, Yuri] BioPole UL, CNRS, UMR UL 7365, Lab IMoPA, Vandoeuvre Les Nancy, France; [Gaspar, Imre] EMBL Heidelberg, D-69117 Heidelberg, Germany; [Schaefer, Matthias] German Canc Res Ctr, Div Epigenet, Heidelberg, Germany; [Kellner, Stefanie; Helm, Mark] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz	Motorin, Y (corresponding author), BioPole UL, CNRS, UMR UL 7365, Lab IMoPA, Vandoeuvre Les Nancy, France.	Yuri.Motorin@univ-lorraine.fr	Gaspar, Imre/N-6808-2019; Matthias, Schaefer Ronald/E-9157-2015; MOTORIN, Yuri/AAQ-9527-2020; Helm, Mark/AAD-5433-2022	Matthias, Schaefer Ronald/0000-0003-1952-8115; MOTORIN, Yuri/0000-0002-8018-334X; Gaspar, Imre/0000-0002-6527-637X; /0000-0003-3224-7502; NEY, Michel/0000-0002-7214-7744; Helm, Mark/0000-0002-0154-0928; Motorin, Alexandr/0000-0001-9622-4591	Agence Nationale de la Recherche (ANR FR); Deutsche Forschungsgemeinschaft (DFG DE) [FOR1082]; HTRNAMod [ANR-13-ISV8-0001-01]	Agence Nationale de la Recherche (ANR FR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG DE); HTRNAMod	Funding for this work was supplied by a joint grant from Agence Nationale de la Recherche (ANR FR; www.agence-nationale-recherche.fr/) and Deutsche Forschungsgemeinschaft (DFG DE; www.dfg.de/), HTRNAMod (No ANR-13-ISV8-0001-01) for YM and MH, and by Deutsche Forschungsgemeinschaft (DFG DE; www.dfg.de/) grant FOR1082 for MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auxilien S, 2012, RNA BIOL, V9, P1331, DOI 10.4161/rna.22180; Blagosklonny MV, 1998, BIOCHEM BIOPH RES CO, V244, P368, DOI 10.1006/bbrc.1998.8278; BRAND RC, 1977, EUR J BIOCHEM, V75, P311, DOI 10.1111/j.1432-1033.1977.tb11531.x; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Chi L, 2013, GENE EXPR PATTERNS, V13, P319, DOI 10.1016/j.gep.2013.06.003; DEBEUS E, 1994, J CELL BIOL, V127, P1799, DOI 10.1083/jcb.127.6.1799; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; FONAGY A, 1992, CANCER RES, V52, P5250; FREEMAN JW, 1988, CANCER RES, V48, P5246; FREEMAN JW, 1988, CANCER RES, V48, P1244; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Frye M, 2010, CANCER LETT, V289, P71, DOI 10.1016/j.canlet.2009.08.004; Gigova A, 2014, RNA, V20, P1632, DOI 10.1261/rna.043398.113; GORCZYCA W, 1992, CANCER RES, V52, P3491; Gustafson WC, 1998, BIOCHEM J, V331, P387, DOI 10.1042/bj3310387; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Harris T, 2007, BIOL REPROD, V77, P376, DOI 10.1095/biolreprod.106.058669; Hong B, 2001, NUCLEIC ACIDS RES, V29, P2927, DOI 10.1093/nar/29.14.2927; Hong B, 1997, MOL CELL BIOL, V17, P378, DOI 10.1128/MCB.17.1.378; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JHIANG SM, 1990, CELL GROWTH DIFFER, V1, P319; Kellner S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku733; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; King MY, 2002, BIOCHEMISTRY-US, V41, P11218, DOI 10.1021/bi026055q; KOONIN EV, 1994, NUCLEIC ACIDS RES, V22, P2476, DOI 10.1093/nar/22.13.2476; Kressler D, 1999, NUCLEIC ACIDS RES, V27, P4598, DOI 10.1093/nar/27.23.4598; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; Letoquarta J, 2014, P NATL ACAD SCI USA, V111, pE5518, DOI 10.1073/pnas.1413089111; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Leulliot N, 2008, STRUCTURE, V16, P52, DOI 10.1016/j.str.2007.10.025; MADEN BEH, 1988, J MOL BIOL, V201, P289, DOI 10.1016/0022-2836(88)90139-8; Marchand V, 2011, RNA BIOL, V8, P325, DOI 10.4161/rna.8.2.13984; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Meyer B, 2011, NUCLEIC ACIDS RES, V39, P1526, DOI 10.1093/nar/gkq931; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; PERLAKY L, 1992, CANCER RES, V52, P428; Reid R, 1999, NUCLEIC ACIDS RES, V27, P3138, DOI 10.1093/nar/27.15.3138; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; Salozhin SV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P525, DOI 10.1007/s10541-005-0146-8; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schilling V, 2012, YEAST, V29, P167, DOI 10.1002/yea.2898; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; SMITH JE, 1992, BIOCHEMISTRY-US, V31, P10825, DOI 10.1021/bi00159a025; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Talkish J, 2012, NUCLEIC ACIDS RES, V40, P8646, DOI 10.1093/nar/gks609; Thomas SR, 2011, NUCLEIC ACIDS RES, V39, P2445, DOI 10.1093/nar/gkq1131; Trere D, 2000, J PATHOL, V192, P216, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH695>3.0.CO;2-L; Uchiyama B, 1997, CLIN CANCER RES, V3, P1873; Ueki T, 1997, HUM PATHOL, V28, P74, DOI 10.1016/S0046-8177(97)90282-3; VALDEZ BC, 1992, CANCER RES, V52, P5681; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Wurm JP, 2010, NUCLEIC ACIDS RES, V38, P2387, DOI 10.1093/nar/gkp1189; Yakubovskaya E, 2012, STRUCTURE, V20, P1940, DOI 10.1016/j.str.2012.08.027	64	59	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133321	10.1371/journal.pone.0133321	http://dx.doi.org/10.1371/journal.pone.0133321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196125	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600085
J	Kreit, M; Vertommen, D; Gillet, L; Michiels, T				Kreit, Marguerite; Vertommen, Didier; Gillet, Laurent; Michiels, Thomas			The Interferon-Inducible Mouse Apolipoprotein L9 and Prohibitins Cooperate to Restrict Theiler's Virus Replication	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; ANTIVIRAL RESPONSE; RECEPTOR PROTEIN; EPITHELIAL-CELLS; L FAMILY; IDENTIFICATION; INFECTION; APOPTOSIS; CLONING; SITES	Apolipoprotein L9b (Apol9b) is an interferon-stimulated gene (ISG) that has antiviral activity and is weakly expressed in primary mouse neurons as compared to other cell types. Here, we show that both Apol9 isoforms (Apol9b and Apol9a) inhibit replication of Theiler's murine encephalomyelitis virus (TMEV) but not replication of vesicular stomatitis virus (VSV), Murid herpesvirus-4 (MuHV-4), or infection by a lentiviral vector. Apol9 genes are strongly expressed in mouse liver and, to a lesser extent, in pancreas, adipose tissue and intestine. Their expression is increased by type I interferon and viral infection. In contrast to genuine apolipoproteins that are involved in lipid transport, ApoL9 has an intracytoplasmic localization and does not seem to be secreted. The cytoplasmic localization of ApoL9 is in line with the observation that ApoL9 inhibits the replication step of TMEV infection. In contrast to human ApoL6, ApoL9 did not sensitize cells to apoptosis, in spite of the presence of a conserved putative BH3 domain, required for antiviral activity. ApoL9a and b isoforms interact with cellular prohibitin 1 (Phb1) and prohibitin 2 (Phb2) and this interaction might contribute to ApoL9 antiviral activity. Knocking down Phb2 slightly increased TMEV replication, irrespective of ApoL9 overexpression. The antiviral activity of prohibitins against TMEV contrasts with the pro-viral activity of prohibitins observed for VSV and reported previously for Dengue 2 (DENV-2), Chikungunya (CHIKV) and influenza H5N1 viruses. ApoL9 is thus an example of ISG displaying a narrow antiviral range, which likely acts in complex with prohibitins to restrict TMEV replication.	[Kreit, Marguerite; Vertommen, Didier; Michiels, Thomas] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Gillet, Laurent] Univ Liege, FARAH Res Ctr, Liege, Belgium; [Gillet, Laurent] Fac Med Vet, Liege, Belgium	Universite Catholique Louvain; University of Liege	Michiels, T (corresponding author), Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium.	thomas.michiels@uclouvain.be	Michiels, Thomas/ABE-3203-2021	Michiels, Thomas/0000-0001-9615-8053; Gillet, Laurent/0000-0002-1047-2525; Vertommen, Didier/0000-0001-7648-8282	FRIA fellowship from the belgian Fund for Scientific research; Faculty of Medicine (Univ. of Louvain); DIANE convention of the belgian walloon region; ARC funding of the (Communaute Francaise de Belgique); Interuniversitary Attraction Poles programme [IAP-P7/45 BELVIR]	FRIA fellowship from the belgian Fund for Scientific research(Fonds de la Recherche Scientifique - FNRS); Faculty of Medicine (Univ. of Louvain); DIANE convention of the belgian walloon region; ARC funding of the (Communaute Francaise de Belgique); Interuniversitary Attraction Poles programme	MK was the recipient of a FRIA fellowship from the belgian Fund for Scientific research and was further supported by a fellowship from the Faculty of Medicine (Univ. of Louvain) and by the following programs which also funded research: the DIANE convention of the belgian walloon region, the ARC funding of the (Communaute Francaise de Belgique) and the Interuniversitary Attraction Poles programme initiated by the Belgian Science Policy Office (IAP-P7/45 BELVIR).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Andersson M, 2000, INVEST OPHTH VIS SCI, V41, P2623; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Coronado MJ, 2012, AM J PHYSIOL-HEART C, V302, pH1726, DOI 10.1152/ajpheart.00783.2011; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FIALA M, 1966, J BACTERIOL, V92, P1710, DOI 10.1128/JB.92.6.1710-1715.1966; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Galindo-Moreno J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.237; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Go JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-627; HAMPARIAN VV, 1964, P SOC EXP BIOL MED, V116, P976, DOI 10.3181/00379727-116-29426; Hermant P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071320; Hoffmann M, 2010, J GEN VIROL, V91, P2782, DOI 10.1099/vir.0.023978-0; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hu Y, 2011, J IMMUNOL, V187, P6456, DOI 10.4049/jimmunol.1003691; Jnaoui K, 1998, VIROLOGY, V244, P397, DOI 10.1006/viro.1998.9134; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kreit M, 2014, J VIROL, V88, P3874, DOI 10.1128/JVI.03018-13; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Li J, 2013, MBIO, V4, DOI DOI 10.1128/MBI0.00385-13; Liu C, 2012, J PROTEOME RES, V11, P5396, DOI 10.1021/pr3006342; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Liu ZH, 2005, MOL CANCER RES, V3, P21; Lobert PE, 1999, P NATL ACAD SCI USA, V96, P11560, DOI 10.1073/pnas.96.20.11560; Michiels T, 1997, J VIROL, V71, P9549, DOI 10.1128/JVI.71.12.9549-9556.1997; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Paul S, 2006, J GEN VIROL, V87, P1237, DOI 10.1099/vir.0.81642-0; Rice AD, 2011, J VIROL, V85, P550, DOI 10.1128/JVI.00254-10; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Sorgeloos F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003474; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Sugiura N, 2011, JPN J INFECT DIS, V64, P463; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004; TANGY F, 1989, J VIROL, V63, P1101, DOI 10.1128/JVI.63.3.1101-1106.1989; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vidick S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083842; Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhaorigetu S, 2011, J BIOL CHEM, V286, P27389, DOI 10.1074/jbc.M110.210245	58	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133190	10.1371/journal.pone.0133190	http://dx.doi.org/10.1371/journal.pone.0133190			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196674	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600069
J	O'Hara, NN; Roy, L; O'Hara, LM; Spiegel, JM; Lynd, LD; FitzGerald, JM; Yassi, A; Nophale, LE; Marra, CA				O'Hara, Nathan N.; Roy, Lilla; O'Hara, Lyndsay M.; Spiegel, Jerry M.; Lynd, Larry D.; FitzGerald, J. Mark; Yassi, Annalee; Nophale, Letshego E.; Marra, Carlo A.			Healthcare Worker Preferences for Active Tuberculosis Case Finding Programs in South Africa: A Best-Worst Scaling Choice Experiment	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; INFECTION-CONTROL; SETTINGS	Objective Healthcare workers (HCWs) in South Africa are at a high risk of developing active tuberculosis (TB) due to their occupational exposures. This study aimed to systematically quantify and compare the preferred attributes of an active TB case finding program for HCWs in South Africa. Methods A Best-Worst Scaling choice experiment estimated HCW's preferences using a random-effects conditional logit model. Latent class analysis (LCA) was used to explore heterogeneity in preferences. Results "No cost", "the assurance of confidentiality", "no wait" and testing at the occupational health unit at one's hospital were the most preferred attributes. LCA identified a four class model with consistent differences in preference strength. Sex, occupation, and the time since a previous TB test were statistically significant predictors of class membership. Conclusions The findings support the strengthening of occupational health units in South Africa to offer free and confidential active TB case finding programs for HCWs with minimal wait times. There is considerable variation in active TB case finding preferences amongst HCWs of different gender, occupation, and testing history. Attention to heterogeneity in preferences should optimize screening utilization of target HCW populations.	[O'Hara, Nathan N.; O'Hara, Lyndsay M.; Spiegel, Jerry M.; Yassi, Annalee] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Roy, Lilla; Lynd, Larry D.] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC V5Z 1M9, Canada; [FitzGerald, J. Mark] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Nophale, Letshego E.] Univ Free State, Fac Hlth Sci, Dept Community Hlth, Bloemfontein, South Africa; [Marra, Carlo A.] Mem Univ, Sch Pharm, St John, NF, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of the Free State; Memorial University Newfoundland	Marra, CA (corresponding author), Mem Univ, Sch Pharm, St John, NF, Canada.	cmarra@mun.ca	O'Hara, Nathan/AAD-2819-2019; O'Hara, Nathan/O-7168-2018; Marra, Carlo/AAE-4904-2021	O'Hara, Nathan/0000-0003-0537-3474; O'Hara, Nathan/0000-0003-0537-3474; Marra, Carlo/0000-0002-2625-2121; Roy, Lilla/0000-0003-1725-9732; Lynd, Larry/0000-0002-7622-3919	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was conducted in the context of a collaborative Canadian-South African research program funded by the Canadian Institutes of Health Research [http://www.cihr-irsc.gc.ca/]. The funder had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, PERSAL HLTH HU UNPUB; [Anonymous], 2014, TUB NAT MAN GUID; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Behrman A, 2013, J OCCUP ENVIRON MED, V55, P985, DOI 10.1097/JOM.0b013e3182a0d7cd; Buregyeya E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046069; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; Council SANA, 2012, NAT STRAT PLAN HIV S; Engelbrecht MC, 2015, S AFR J INF IN PRESS; Farley JE, 2012, INT J TUBERC LUNG D, V16, P82, DOI 10.5588/ijtld.10.0791; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Golub JE, 2013, INT J TUBERC LUNG D, V17, P856, DOI 10.5588/ijtld.13.0059; Hol L, 2010, BRIT J CANCER, V102, P972, DOI 10.1038/sj.bjc.6605566; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Khan R, 2015, AIDS CARE, V27, P198, DOI 10.1080/09540121.2014.951308; Kolbe-Alexander T, 2014, J OCCUP ENVIRON MED, V56, P1094, DOI 10.1097/JOM.0000000000000236; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2013, SOC SCI MED, V76, P74, DOI 10.1016/j.socscimed.2012.10.007; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Mabunda G, 2006, J TRANSCULT NURS, V17, P23, DOI 10.1177/1043659605281978; Marley AAJ, 2005, J MATH PSYCHOL, V49, P464, DOI 10.1016/j.jmp.2005.05.003; Matuka O, 2015, J HOSP INFECT, V89, P192, DOI 10.1016/j.jhin.2014.11.013; McCutcheon AL, 1987, LATENT CLASS ANAL; McFadden D., 1974, FRONTIERS ECONOMETRI; McLellan RK, 2009, J OCCUP ENVIRON MED, V51, P797, DOI 10.1097/JOM.0b013e3181a4b9e8; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Naidoo A, 2013, SAMJ S AFR MED J, V103, P176, DOI [10.7196/SAMJ.6266, 10.7196/samj.6266]; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Ryan Mandy, 2003, Appl Health Econ Health Policy, V2, P55; Shisana O, 2004, SAMJ S AFR MED J, V94, P846; The World Bank, 2010, SO AFR HIV AIDS TUB; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, SYST EV REV SUPP DEV; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization International Labour Organization Joint United Nations Programme on HIV/AIDS, 2010, JOINT WHO ILO UNAIDS; Yassi A, 2005, J OCCUP ENVIRON MED, V47, P41, DOI 10.1097/01.jom.0000150207.18085.41; Yassi A, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23594; Yassi A, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S2-S8; Yassi A, 2009, INT J OCCUP ENV HEAL, V15, P360, DOI 10.1179/oeh.2009.15.4.360; Zelnick JR, 2013, J PUBLIC HEALTH POL, V34, P388, DOI 10.1057/jphp.2013.20	44	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133304	10.1371/journal.pone.0133304	http://dx.doi.org/10.1371/journal.pone.0133304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197344	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600082
J	Lin, ZL; Green, RS; Chen, SQ; Wu, H; Liu, TT; Li, JY; Wei, J; Lin, J				Lin, Zhenlang; Green, Robert S.; Chen, Shangqin; Wu, Hui; Liu, Tiantian; Li, Jingyang; Wei, Jia; Lin, Jing			Quantification of EUGR as a Measure of the Quality of Nutritional Care of Premature Infants	PLOS ONE			English	Article							POSTNATAL-GROWTH FAILURE; BIRTH-WEIGHT INFANTS; HEALTH-CARE; RETARDATION; PERFORMANCE; PAY; OUTCOMES; UNIT	Objectives To develop an index of the quality of nutritional care of premature infants based on the change in weight Z score from birth to discharge and to illustrate the use of this index in comparing the performance of different NICUs. Methods Retrospective data analysis was performed to compare the growth of premature infants born in three perinatal centers. Infants with gestational age <= 32 weeks who survived to discharge from 2006 to 2010 were included. Weight Z scores at birth and discharge were calculated by the method of Fenton. Using data from one NICU as the reference, a multivariable linear regression model of change in weight Z score from birth to discharge was developed. Employing this model, a benchmark value of change in weight Z score was calculated for each baby. The difference between this calculated benchmark value and the baby's observed change in weight Z score was defined as the performance gap for that infant. The average value of the performance gaps in a NICU serves as its quality care index. Results 1,714 infants were included for analysis. Change in weight Z score is influenced by birth weight Z score and completed weeks of gestation; thus the model for calculating the benchmark change in weight Z score was adjusted for these two variables. We found statistically significant differences in the average performance gaps for the three units. Conclusions A quality care index was developed based on change in weight Z score from birth to discharge adjusted for two initial risk factors. This objective, easily calculated index may be used as a measurement of the quality of nutritional care to rank the performance of different NICUs.	[Lin, Zhenlang; Chen, Shangqin; Li, Jingyang; Wei, Jia; Lin, Jing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neonatol, Wenzhou 325027, Peoples R China; [Lin, Zhenlang; Chen, Shangqin; Li, Jingyang; Wei, Jia; Lin, Jing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Peoples R China; [Green, Robert S.; Lin, Jing] Icahn Sch Med Mt Sinai, Kravis Childrens Hosp, New York, NY 10029 USA; [Green, Robert S.; Lin, Jing] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Wu, Hui; Liu, Tiantian] Jilin Univ, Hosp 1, Dept Neonatol, Changchun 130021, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Jilin University	Lin, J (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Neonatol, Wenzhou 325027, Peoples R China.	jing.lin@mssm.edu	Lin, Jing/I-5293-2019	Lin, Jing/0000-0002-4405-134X				Bloom BT, 2003, PEDIATRICS, V112, P8, DOI 10.1542/peds.112.1.8; Clark Reese H, 2003, J Perinatol, V23, P337, DOI 10.1038/sj.jp.7210937; Clark RH, 2003, PEDIATRICS, V111, P986, DOI 10.1542/peds.111.5.986; Cooke RJ, 2004, ARCH DIS CHILD-FETAL, V89, pF428, DOI 10.1136/adc.2001.004044; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280; Ehrenkranz RA, 2007, SEMIN PERINATOL, V31, P48, DOI 10.1053/j.semperi.2007.02.001; Eijkenaar F, 2012, MED CARE RES REV, V69, P251, DOI 10.1177/1077558711432891; Embleton NE, 2001, PEDIATRICS, V107, P270, DOI 10.1542/peds.107.2.270; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fenton TR, 2007, EUR J CLIN NUTR, V61, P1380, DOI 10.1038/sj.ejcn.1602667; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Maas C, 2015, ARCH DIS CHILD-FETAL, V100, pF76, DOI 10.1136/archdischild-2014-306195; Marks KA, 2006, ACTA PAEDIATR, V95, P236, DOI 10.1080/08035250500358315; Moltu SJ, 2014, J PEDIATR GASTR NUTR, V58, P344, DOI 10.1097/MPG.0000000000000220; Olsen IE, 2003, J CLIN EPIDEMIOL, V56, P998, DOI 10.1016/S0895-4356(03)00168-9; Olsen IE, 2002, PEDIATRICS, V110, P1125, DOI 10.1542/peds.110.6.1125; Profit J, 2007, PEDIATRICS, V119, P975, DOI 10.1542/peds.2006-1565; Profit J, 2014, PEDIATRICS, V134, P74, DOI 10.1542/peds.2013-3552; Radmacher Paula G, 2003, J Perinatol, V23, P392, DOI 10.1038/sj.jp.7210947; RICHARDSON DK, 1993, PEDIATRICS, V91, P617; Shan HM, 2009, EUR J PEDIATR, V168, P1055, DOI 10.1007/s00431-008-0885-9; Spitzer AR, 2010, CLIN PERINATOL, V37, P167, DOI 10.1016/j.clp.2010.01.010	24	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132584	10.1371/journal.pone.0132584	http://dx.doi.org/10.1371/journal.pone.0132584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193640	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400032
J	Oswald, K; Milucka, J; Brand, A; Littmann, S; Wehrli, B; Kuypers, MMM; Schubert, CJ				Oswald, Kirsten; Milucka, Jana; Brand, Andreas; Littmann, Sten; Wehrli, Bernhard; Kuypers, Marcel M. M.; Schubert, Carsten J.			Light-Dependent Aerobic Methane Oxidation Reduces Methane Emissions from Seasonally Stratified Lakes	PLOS ONE			English	Article							ANAEROBIC OXIDATION; WATER COLUMN; SULFUR CYCLE; IRON; SEDIMENTS; BACTERIA; OXYGEN; METHANOTROPHS; REDUCTION; ABUNDANCE	Lakes are a natural source of methane to the atmosphere and contribute significantly to total emissions compared to the oceans. Controls on methane emissions from lake surfaces, particularly biotic processes within anoxic hypolimnia, are only partially understood. Here we investigated biological methane oxidation in the water column of the seasonally stratified Lake Rotsee. A zone of methane oxidation extending from the oxic/anoxic interface into anoxic waters was identified by chemical profiling of oxygen, methane and delta C-13 of methane. Incubation experiments with C-13-methane yielded highest oxidation rates within the oxycline, and comparable rates were measured in anoxic waters. Despite predominantly anoxic conditions within the zone of methane oxidation, known groups of anaerobic methanotrophic archaea were conspicuously absent. Instead, aerobic gammaproteobacterial methanotrophs were identified as the active methane oxidizers. In addition, continuous oxidation and maximum rates always occurred under light conditions. These findings, along with the detection of chlorophyll a, suggest that aerobic methane oxidation is tightly coupled to light-dependent photosynthetic oxygen production both at the oxycline and in the anoxic bottom layer. It is likely that this interaction between oxygenic phototrophs and aerobic methanotrophs represents a widespread mechanism by which methane is oxidized in lake water, thus diminishing its release into the atmosphere.	[Oswald, Kirsten; Brand, Andreas; Wehrli, Bernhard; Schubert, Carsten J.] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Surface Waters Res & Management, Kastanienbaum, Switzerland; [Oswald, Kirsten; Brand, Andreas; Wehrli, Bernhard] ETH, Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Milucka, Jana; Littmann, Sten; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Oswald, K (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Surface Waters Res & Management, Kastanienbaum, Switzerland.	kirsten.oswald@eawag.ch	Wehrli, Bernhard/A-4406-2013; Wehrli, Bernhard/M-3847-2019; Wehrli, Bernhard/B-4420-2008; Schubert, Carsten/GQQ-1673-2022	Wehrli, Bernhard/0000-0001-7029-1972; Wehrli, Bernhard/0000-0001-7029-1972; Wehrli, Bernhard/0000-0001-7029-1972; Littmann, Sten/0000-0001-8685-5357; Brand, Andreas/0000-0002-3046-037X	Swiss National Science Foundation [135299, 153091, 128707]; Swiss Federal Institute of Aquatic Science and Technology (Eawag); Max-Planck-Gesellschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Institute of Aquatic Science and Technology (Eawag); Max-Planck-Gesellschaft(Max Planck Society)	This study was supported by the Swiss National Science Foundation; grant numbers: 135299, 153091, 128707; http://www.snf.ch/en/Pages/default.aspx; BW CJS; Swiss Federal Institute of Aquatic Science and Technology (Eawag); http://www.eawag.ch; Max-Planck-Gesellschaft; http://www.mpg.de/en.	BARKER JF, 1981, NATURE, V293, P289, DOI 10.1038/293289a0; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Blees J, 2014, LIMNOL OCEANOGR, V59, P311, DOI 10.4319/lo.2014.59.2.0311; Blumenberg M, 2007, ORG GEOCHEM, V38, P84, DOI 10.1016/j.orggeochem.2006.08.011; Boehrer B, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000210; Bogard MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6350; Carini S, 2005, ENVIRON MICROBIOL, V7, P1127, DOI 10.1111/j.1462-2920.2005.00786.x; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Coplen TB, 2002, 014222 US GEOL SURV, P01; Crowe SA, 2011, GEOBIOLOGY, V9, P61, DOI 10.1111/j.1472-4669.2010.00257.x; Crowe SA, 2008, LIMNOL OCEANOGR, V53, P319, DOI 10.4319/lo.2008.53.1.0319; Del Don C, 2001, AQUAT SCI, V63, P70, DOI 10.1007/PL00001345; Deutzmann JS, 2014, P NATL ACAD SCI USA, V111, P18273, DOI 10.1073/pnas.1411617111; Deutzmann JS, 2011, APPL ENVIRON MICROB, V77, P4429, DOI 10.1128/AEM.00340-11; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Dumestre JF, 1999, APPL ENVIRON MICROB, V65, P534; Durisch-Kaiser E, 2005, APPL ENVIRON MICROB, V71, P8099, DOI 10.1128/AEM.71.12.8099-8106.2005; Durisch-Kaiser E, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001323; Ehhalt D., 2001, ATMOSPHERIC CHEM GRE; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Fenchel T., 1979, BACTERIA MINERAL CYC; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI [DOI 10.2147/DDDT.S165440, 10.1002/cber.187901201117., DOI 10.1002/CBER.187901201117]; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; IMBODEN DM, 1985, CHEM PROCESSES LAKES, P1; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; KING GM, 1992, ADV MICROB ECOL, V12, P431; Kirf MK, 2014, AQUAT GEOCHEM, V20, P39, DOI 10.1007/s10498-013-9206-7; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; KOHLER HP, 1984, FEMS MICROBIOL LETT, V21, P279; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lavelli A, 2002, NUMERICAL 3D MODELLI; LEAK DJ, 1986, APPL MICROBIOL BIOT, V23, P470, DOI 10.1007/BF02346062; LEGENDRE L, 1983, LIMNOL OCEANOGR, V28, P996, DOI 10.4319/lo.1983.28.5.0996; Liikanen A, 2002, ARCH HYDROBIOL, V154, P585; MCAULLIF C, 1971, CHEM TECHNOL, P46; Milucka J, 2015, ISME J, V9, P1991, DOI 10.1038/ismej.2015.12; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Murase J, 2005, LIMNOL OCEANOGR, V50, P1339, DOI 10.4319/lo.2005.50.4.1339; Murase J., 2005, FOREST ECOSYSTEMS EN, P143; MURRAY AP, 1986, MAR CHEM, V19, P211, DOI 10.1016/0304-4203(86)90024-1; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Neef L, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003661; Nordi KA, 2013, LIMNOL OCEANOGR, V58, P546, DOI 10.4319/lo.2013.58.2.0546; Nyerges G, 2010, APPL ENVIRON MICROB, V76, P5648, DOI 10.1128/AEM.00747-10; PANGANIBAN AT, 1979, APPL ENVIRON MICROB, V37, P303, DOI 10.1128/AEM.37.2.303-309.1979; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Polerecky L, 2012, ENVIRON MICROBIOL, V14, P1009, DOI 10.1111/j.1462-2920.2011.02681.x; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Riedinger N, 2014, GEOBIOLOGY, V12, P172, DOI 10.1111/gbi.12077; Ross JL, 1997, MICROBIAL ECOL, V34, P97, DOI 10.1007/s002489900039; RUDD JWM, 1975, ARCH HYDROBIOL, V75, P522; RUDD JWM, 1976, LIMNOL OCEANOGR, V21, P357, DOI 10.4319/lo.1976.21.3.0357; Schubert CJ, 2010, AQUAT SCI, V72, P455, DOI 10.1007/s00027-010-0148-5; Schubert CJ, 2006, ENVIRON MICROBIOL, V8, P1844, DOI 10.1111/j.1462-2920.2006.01079.x; Schubert CJ, 2011, FEMS MICROBIOL ECOL, V76, P26, DOI 10.1111/j.1574-6941.2010.01036.x; Sivan O, 2011, LIMNOL OCEANOGR, V56, P1536, DOI 10.4319/lo.2011.56.4.1536; Slomp CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062386; Sundh I, 2005, APPL ENVIRON MICROB, V71, P6746, DOI 10.1128/AEM.71.11.6746-6752.2005; Wankel SD, 2012, ENVIRON MICROBIOL, V14, P2726, DOI 10.1111/j.1462-2920.2012.02825.x; Wetzel R, 2001, LIMNOLOGY 3 E LAKE R; WIESENBURG DA, 1979, J CHEM ENG DATA, V24, P356, DOI 10.1021/je60083a006; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Wise MG, 2001, INT J SYST EVOL MICR, V51, P611, DOI 10.1099/00207713-51-2-611; Wuest A, 2003, ANNU REV FLUID MECH, V35, P373, DOI 10.1146/annurev.fluid.35.101101.161220	70	85	92	5	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132574	10.1371/journal.pone.0132574	http://dx.doi.org/10.1371/journal.pone.0132574			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193458	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400031
J	Qi, P; Chen, M; Zhang, LX; Song, RX; He, ZH; Wang, ZP				Qi, Ping; Chen, Ming; Zhang, Li-xiu; Song, Rui-xia; He, Zhen-hua; Wang, Zhi-ping			A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							ZIBOTENTAN ZD4054; CONTROLLED-TRIAL; PHASE-III; PLACEBO; DOCETAXEL; ATRASENTAN; COMBINATION; EFFICACY; SAFETY; MEN	Background Endothelin A (ET-A) receptor antagonists including zibotentan and atrasentan, have been suggested as a treatment for castration-resistant prostate cancer (CRPC). Our aim was to conduct a meta-analysis and indirect comparison to assess the efficacy and safety of ET-A receptor antagonists for treatment of CRPC. Methods We systematically searched PubMed, EMBASE, the Cochrane Library, and Web of Science from inception to November 2014 to identify randomized controlled trials (RCTs) which assessed ET-A receptor antagonists for treatment of CRPC. Meta-analysis was conducted by STATA version 12.0 software. Results Eight RCTs were identified, involving 6,065 patients. The results of direct comparison showed that compared with placebo, there was no statistically significant difference in the improvement of progression-free survival (PFS), overall survival (OS), time to disease progression (TTP), and total adverse events (AEs) with ET-A receptor antagonist treatment for CRPC. The results of ET-A receptor antagonists plus docetaxel versus docetaxel alone were similar. The indirect comparisons showed that there were no significant differences between zibotentan plus docetaxel versus atrasentan plus docetaxel when compared with docetaxel alone or zibotentan versus atrasenta compared with placebo in the improvement of PFS, OS, TTP, and total adverse events. Conclusions There were no significant benefits for ET-A receptor antagonists with or without docetaxel in the improvement of PFS, OS, TTP, and overall AEs. And there were no significant differences between zibotentan and atrasentan. Single-agent docetaxel should remain as one of the standard treatments.	[Qi, Ping; Zhang, Li-xiu; Song, Rui-xia; He, Zhen-hua; Wang, Zhi-ping] Lanzhou Univ, Hosp 2, Inst Urol, Lanzhou 730030, Peoples R China; [Song, Rui-xia; Wang, Zhi-ping] Key Lab Urol Dis Gansu Prov, Lanzhou 730030, Peoples R China; [Qi, Ping] Lanzhou Univ, Hosp 2, Dept Clin Lab, Lanzhou 730030, Peoples R China; [Chen, Ming] GanSu Prov Hosp Tradit Chinese Med, Dept Urol, Lanzhou 730050, Peoples R China; [He, Zhen-hua] Lanzhou Univ, Hosp 2, Dept Neurosurg, Lanzhou 730030, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Wang, ZP (corresponding author), Lanzhou Univ, Hosp 2, Inst Urol, Lanzhou 730030, Peoples R China.	erywzp@lzu.edu.cn						Carducci MA, 2007, CANCER-AM CANCER SOC, V110, P1959, DOI 10.1002/cncr.22996; Carter NJ, 2014, DRUGS, V74, P699, DOI 10.1007/s40265-014-0211-y; Fizazi KS, 2013, J CLIN ONCOL, V31, P1740, DOI 10.1200/JCO.2012.46.4149; Higgins JPT, 2013, COCHRANCE HDB SYSTEM; Il Kang D, 2013, ASIAN PAC J CANCER P, V14, P6913, DOI 10.7314/APJCP.2013.14.11.6913; James ND, 2010, BJU INT, V106, P966, DOI 10.1111/j.1464-410X.2010.09638.x; James ND, 2009, EUR UROL, V55, P1112, DOI 10.1016/j.eururo.2008.11.002; Kasper S, 2006, UROL CLIN N AM, V33, P201, DOI 10.1016/j.ucl.2005.12.010; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Miller K, 2013, PROSTATE CANCER P D, V16, P187, DOI 10.1038/pcan.2013.2; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P67; Nelson JB, 2008, CANCER-AM CANCER SOC, V113, P2478, DOI 10.1002/cncr.23864; Nelson JB, 2012, CANCER-AM CANCER SOC, V118, P5709, DOI 10.1002/cncr.27674; Quinn DI, 2013, LANCET ONCOL, V14, P893, DOI 10.1016/S1470-2045(13)70294-8; Neto AS, 2011, CLIN GENITOURIN CANC, V9, P115, DOI 10.1016/j.clgc.2011.05.002; Shao N, 2013, INT J CANCER, V133, P1743, DOI 10.1002/ijc.28162; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Trump DL, 2011, PROSTATE, V71, P1264, DOI 10.1002/pros.21342; Zhou ZR, 2014, ASIAN PAC J CANCER P, V15, P1313, DOI 10.7314/APJCP.2014.15.3.1313	19	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133803	10.1371/journal.pone.0133803	http://dx.doi.org/10.1371/journal.pone.0133803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192308	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400120
J	Grieb, M; Burkovski, A; Strang, JE; Kraus, JM; Gross, A; Palm, G; Kuhl, M; Kestler, HA				Grieb, Melanie; Burkovski, Andre; Straeng, J. Eric; Kraus, Johann M.; Gross, Alexander; Palm, Guenther; Kuehl, Michael; Kestler, Hans A.			Predicting Variabilities in Cardiac Gene Expression with a Boolean Network Incorporating Uncertainty	PLOS ONE			English	Article							MODELS	Gene interactions in cells can be represented by gene regulatory networks. A Boolean network models gene interactions according to rules where gene expression is represented by binary values (on / off or {1, 0}). In reality, however, the gene's state can have multiple values due to biological properties. Furthermore, the noisy nature of the experimental design results in uncertainty about a state of the gene. Here we present a new Boolean network paradigm to allow intermediate values on the interval [0, 1]. As in the Boolean network, fixed points or attractors of such a model correspond to biological phenotypes or states. We use our new extension of the Boolean network paradigm to model gene expression in first and second heart field lineages which are cardiac progenitor cell populations involved in early vertebrate heart development. By this we are able to predict additional biological phenotypes that the Boolean model alone is not able to identify without utilizing additional biological knowledge. The additional phenotypes predicted by the model were confirmed by published biological experiments. Furthermore, the new method predicts gene expression propensities for modelled but yet to be analyzed genes.	[Gross, Alexander; Kestler, Hans A.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Grieb, Melanie; Burkovski, Andre; Straeng, J. Eric; Kraus, Johann M.; Kestler, Hans A.] Univ Ulm, Core Unit Med Syst Biol, D-89069 Ulm, Germany; [Burkovski, Andre; Palm, Guenther; Kestler, Hans A.] Univ Ulm, Neural Informat Proc, D-89069 Ulm, Germany; [Kuehl, Michael] Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany; [Grieb, Melanie; Burkovski, Andre] Univ Ulm, Int Grad Sch Mol Med, D-89069 Ulm, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Ulm University; Ulm University; Ulm University; Ulm University	Kuhl, M (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany.	michael.kuehl@uni-ulm.de; hkestler@fli-leibniz.de	Kestler, Hans A./D-5799-2012	Kestler, Hans A./0000-0002-4759-5254; Burkovski, Andreas/0000-0003-1896-4521; Strang, Jan Eric/0000-0001-6681-8735	German federal ministry of education and research (BMBF) within the framework GERONTOSYS II (Forschungskern SyStaR) [0315894A]; European Community [602783]; International Graduate School in Molecular Medicine at Ulm University [GSC270]	German federal ministry of education and research (BMBF) within the framework GERONTOSYS II (Forschungskern SyStaR)(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); International Graduate School in Molecular Medicine at Ulm University	This work was funded in part by the German federal ministry of education and research (BMBF) within the framework GERONTOSYS II (Forschungskern SyStaR, Project ID 0315894A to MK and HAK), European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602783 (to HAK), and the International Graduate School in Molecular Medicine at Ulm University (GSC270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; ALSINA C, 1983, J MATH ANAL APPL, V93, P15, DOI 10.1016/0022-247X(83)90216-0; [Anonymous], 2014, R LANG ENV STAT COMP; Berestovsky N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066031; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; BROYDEN CG, 1965, MATH COMPUT, V19, P557; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; Davidson EH, 2006, REG GEN GEN REG; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dubois D., 1980, FUZZY SETS SYSTEMS T; Dumcke S, 2014, BIOINFORMATICS, V30, P414, DOI 10.1093/bioinformatics/btt696; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Franke R, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-151; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Gessert S, 2009, DEV BIOL, V334, P395, DOI 10.1016/j.ydbio.2009.07.037; Han ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115806; Hasselman B., 2014, NLEQSLV SOLVE SYSTEM; Herrmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046798; Hopfensitz M, 2013, COMPUTATION STAT, V28, P19, DOI 10.1007/s00180-012-0324-2; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kestler HA, 2008, BIOESSAYS, V30, P1110, DOI 10.1002/bies.20834; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; KLEMENT EP, 1982, J MATH ANAL APPL, V85, P543, DOI 10.1016/0022-247X(82)90015-4; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MacNamara A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045003; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Naldi A, 2015, BIOINFORMATICS, V31, P1154, DOI 10.1093/bioinformatics/btv013; Powell M.J.D., 1970, NUMERICAL METHODS NO, P87; Shmulevich I., 2007, GENOMIC SIGNAL PROCE; Sridharan S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S4; Wittmann DM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000569; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Yao JT, 2008, IEEE INT CONF FUZZY, P983, DOI 10.1109/FUZZY.2008.4630489; Zadeh L. A., 1978, Fuzzy Sets and Systems, V1, P3, DOI 10.1016/0165-0114(78)90029-5; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131832	10.1371/journal.pone.0131832	http://dx.doi.org/10.1371/journal.pone.0131832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207376	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000018
J	Karremans, AP; Pupulin, F; Gravendeel, B				Karremans, Adam P.; Pupulin, Franco; Gravendeel, Barbara			Specklinia dunstervillei, a New Species Long Confused with Specklinia endotrachys (Orchidaceae: Pleurothallidinae)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; COSTA-RICA; DNA; NUCLEAR; SEQUENCES; GENUS	Specklinia dunstervillei is described as a new species in recognition of the distinctness of a Venezuelan species related to and confused with Specklinia endotrachys. It was illustrated for the first time by G. C. K. Dunsterville in 1963 from a plant collected in Trujillo on the Cordillera de Merida. The newly named species can be easily recognized by its small habit, short leaves and small reddish-orange flowers, the non-ascending dorsal sepal and the obtuse petals that are shortly apiculate. Specklinia dunstervillei is formally described and illustrated once again and compared morphologically and genetically with its closest relatives.	[Karremans, Adam P.; Pupulin, Franco] Univ Costa Rica, Lankester Bot Garden, Cartago, Costa Rica; [Karremans, Adam P.; Gravendeel, Barbara] Leiden Univ, Naturalis Biodivers Ctr, Leiden, Netherlands; [Pupulin, Franco] Harvard Univ Hebaria, Cambridge, MA 02138 USA; [Pupulin, Franco] Marie Selby Bot Gardens, Sarasota, FL USA	Universidad Costa Rica; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Harvard University	Karremans, AP (corresponding author), Univ Costa Rica, Lankester Bot Garden, POB 302-7050, Cartago, Costa Rica.	adam.karremans@ucr.ac.cr	Karremans, Adam P./H-6996-2019	Karremans, Adam P./0000-0001-5987-7710	University of Costa Rica [814-B1-239, 814-B3-075]	University of Costa Rica	We are very thankful to Gerson Villalobos and Koos Wubben who were happy to allow us access to their cultivated plants used for description and illustrations in this manuscript. Karen Gil was kind enough to share the herbarium and photographical material prepared by Misas Urreta of this species in Colombia. Sylvia Stigari made a beautiful painting of the species and allowed us to reproduce it here. Esmee Winkel prepared an excellent line drawing of the novel taxon for us. Rogier van Vugt photographed the novelty at the Hortus botanicus in Leiden. We are especially thankful to Gustavo Romero, curator of the Orchid Herbarium of Oakes Ames, who kindly provided Dunsterville's material at the Harvard University Herbaria. We are also in debt to the Vice-Presidency of Research of the University of Costa Rica for providing support through the projects "Filogenia molecular de las especies de Orchidaceae endemicas de Costa Rica" (814-B1-239) and "Taxonomia, filogenia molecular, aislamiento reproductivo y diferenciacion de nichos de Specklinia endotrachys" (814-B3-075).	Bogarin D., 2007, LANKESTERIANA, V7, P543; Bogarin D, 2013, PHYTOTAXA, V115, P31, DOI 10.11646/phytotaxa.115.2.1; Chase MW, 2009, ANN BOT-LONDON, V104, P387, DOI 10.1093/aob/mcp067; Chiron GR, 2012, PHYTOTAXA, V46, P34, DOI 10.11646/phytotaxa.46.1.5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunsterville GCK, 1965, VENEZUELAN ORCHIDS I, V3; Karremans A. P., 2013, PLANT SYST EVOL, V29, P69; Karremans AP, 2010, THESIS WAGENINGEN U; KARREMANS AP, 2013, LANKESTERIANA, V13, P132, DOI DOI 10.15517/LANK.V0I0.11556; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Leopardi C, 2012, PHYTOTAXA, V65, P23, DOI 10.11646/phytotaxa.65.1.3; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; MEYER GE, 2012, ORCHIDEENJOURNAL, V19, P107; Ortiz P, 2007, GALERIA ORQUIDEAS CO; Pridgeon A. M., 2005, GENERA ORCHIDACEAR 1, V4, P319; Pridgeon AM, 2001, AM J BOT, V88, P2286, DOI 10.2307/3558390; Pupulin F, 2013, ORCHIDEE HAMBURG 2, V64, P475; Pupulin F, 2013, ORCHIDEE HAMBURG 1, V64, P392; Pupulin F, 2012, PHYTOTAXA, V63, P1; Rambaut A, 2009, FIGTREE V1 3 1; Ramos-Castro SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048822; Staden R, 2003, INTRO BIOINFORMATICS; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978	25	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131971	10.1371/journal.pone.0131971	http://dx.doi.org/10.1371/journal.pone.0131971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207634	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000019
J	Kleint, NI; Wittchen, HU; Lueken, U				Kleint, Nina I.; Wittchen, Hans-Ulrich; Lueken, Ulrike			Probing the Interoceptive Network by Listening to Heartbeats: An fMRI Study	PLOS ONE			English	Article							INFERIOR PARIETAL LOBULE; ANTERIOR INSULA; BRAIN ACTIVATION; CARDIOVASCULAR AROUSAL; CORTEX; ATTENTION; EMOTION	Exposure to cues of homeostatic relevance (i.e. heartbeats) is supposed to increase the allocation of attentional resources towards the cue, due to its importance for self-regulatory, interoceptive processes. This functional magnetic resonance imaging (fMRI) study aimed at determining whether listening to heartbeats is accompanied by activation in brain areas associated with interoception, particularly the insular cortex. Brain activity was measured with fMRI during cue-exposure in 36 subjects while listening to heartbeats vs. sinus tones. Autonomic markers (skin conductance) and subjective measures of state and trait anxiety were assessed. Stimulation with heartbeat sounds triggered activation in brain areas commonly associated with the processing of interoceptive information, including bilateral insular cortices, the inferior frontal operculum, and the middle frontal gyrus. A psychophysiological interaction analysis indicated a functional connectivity between the middle frontal gyrus (seed region) and bilateral insular cortices, the left amygdala and the supplementary motor area. The magnitude of neural activation in the right anterior insular cortex was positively associated with autonomic arousal. The present findings indicate that listening to heartbeats induced activity in areas of the interoception network as well as changes in psychophysiological arousal and subjective emotional experience. As this approach constitutes a promising method for studying interoception in the fMRI environment, a clinical application in anxiety prone populations should be addressed by future studies.	[Kleint, Nina I.; Wittchen, Hans-Ulrich; Lueken, Ulrike] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany; [Kleint, Nina I.; Wittchen, Hans-Ulrich; Lueken, Ulrike] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, D-01062 Dresden, Germany; [Lueken, Ulrike] Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychoatherapy, Wurzburg, Germany	Technische Universitat Dresden; Technische Universitat Dresden; University of Wurzburg	Lueken, U (corresponding author), Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany.	Lueken_U@ukw.de	Lueken, Ulrike/A-8109-2014; Wittchen, Hans-Ulrich/A-8507-2014; Wittchen, Hans-Ulrich/ABA-8901-2020	Lueken, Ulrike/0000-0003-1564-4012; Wittchen, Hans-Ulrich/0000-0002-6311-7711	Open Access Publication Funds of the TU Dresden	Open Access Publication Funds of the TU Dresden	The authors acknowledge support by the Open Access Publication Funds of the TU Dresden.	Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P647, DOI 10.1111/j.1469-8986.2009.00972.x; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Cameron OG, 2000, PSYCHOSOM MED, V62, P549, DOI 10.1097/00006842-200007000-00014; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Cauda F, 2012, NEUROIMAGE, V62, P343, DOI 10.1016/j.neuroimage.2012.04.012; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; Dziobek I, 2011, NEUROIMAGE, V57, P539, DOI 10.1016/j.neuroimage.2011.05.005; EHLERS A, 1993, ADV BEHAV RES THER, V15, P3, DOI 10.1016/0146-6402(93)90001-I; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Holtz K, 2012, NEUROIMAGE, V61, P857, DOI 10.1016/j.neuroimage.2012.03.019; Holzl R, 1996, BIOL PSYCHOL, V42, P199, DOI 10.1016/0301-0511(95)05155-4; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; Lueken U, 2014, SOC COGN AFFECT NEUR, V9, P1668, DOI 10.1093/scan/nst159; LYKKEN DT, 1972, PSYCHOPHYSIOLOGY, V9, P373, DOI 10.1111/j.1469-8986.1972.tb03222.x; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Peterson RA., 1992, ANXIETY SENSITIVITY; Pfleiderer B, 2014, J NEURAL TRANSM, V121, P1417, DOI 10.1007/s00702-014-1248-5; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Sandrini M, 2004, NEUROPSYCHOLOGIA, V42, P1902, DOI 10.1016/j.neuropsychologia.2004.05.005; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Stephani C, 2011, BRAIN STRUCT FUNCT, V216, P137, DOI 10.1007/s00429-010-0296-3; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Terasawa Y, 2013, SOC COGN AFFECT NEUR, V8, P259, DOI 10.1093/scan/nss108; Terasawa Y, 2013, HUM BRAIN MAPP, V34, P598, DOI 10.1002/hbm.21458; Tracy J, 2007, PSYCHOSOM MED, V69, P952, DOI 10.1097/PSY.0b013e31815b60cf; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; Wendt J, 2008, PSYCHOPHYSIOLOGY, V45, P205, DOI 10.1111/j.1469-8986.2007.00620.x; Weston CSE, 2012, NEUROSCI BIOBEHAV R, V36, P90, DOI 10.1016/j.neubiorev.2011.04.014; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	52	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133164	10.1371/journal.pone.0133164	http://dx.doi.org/10.1371/journal.pone.0133164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204524	gold, Green Published, Green Submitted			2022-12-27	WOS:000358621000020
J	Zhou, SM; Chen, LM; Liu, SQ; Wang, XF; Sun, XD				Zhou, Shu-Mei; Chen, Li-Mei; Liu, Shi-Qi; Wang, Xiu-Feng; Sun, Xiu-Dong			De Novo Assembly and Annotation of the Chinese Chive (Allium tuberosum Rottler ex Spr.) Transcriptome Using the Illumina Platform	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; GENERATION; MARKERS; GENOMES; LILIUM; PLANTS; LIFE; TOOL	Chinese chive (A. tuberosum Rottler ex Spr.) is one of the most widely cultivated Allium species in China. However, minimal transcriptomic and genomic data are available to reveal its evolution and genetic diversity. In this study, de novo transcriptome sequencing was performed to produce large transcript sequences using an Illumina HiSeq 2000 instrument. We produced 51,968,882 high-quality clean reads and assembled them into 150,154 contigs. A total of 60,031 unigenes with an average length of 631 bp were identified. Of these, 36,523 unigenes were homologous to existing database sequences, 35,648 unigenes were annotated in the NCBI non-redundant (Nr) sequence database, and 23,509 unigenes were annotated in the Swiss-Prot database. A total of 26,798 unigenes were assigned to 57 Gene Ontology (GO) terms, and 13,378 unigenes were assigned to Cluster of Orthologous Group categories. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database, we mapped 21,361 unigenes onto 128 pathways. Furthermore, 2,125 sequences containing simple sequence repeats (SSRs) were identified. This new dataset provides the most comprehensive resource currently available for gene expression, gene discovery, and future genomic research on Chinese chive. The sequence resources developed in this study can be used to develop molecular markers that will facilitate further genetic research on Chinese chive and related species.	[Zhou, Shu-Mei] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Chen, Li-Mei; Liu, Shi-Qi; Wang, Xiu-Feng; Sun, Xiu-Dong] Shandong Agr Univ, State Key Lab Crop Biol, Key Lab Biol & Genet Improvement Hort Crops Huanh, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Sun, XD (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Key Lab Biol & Genet Improvement Hort Crops Huanh, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China.	xdsun@sdau.edu.cn			National Natural Science Foundation of China [31372084]; Chinese National Department Public Benefit Research Foundation [201303108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Department Public Benefit Research Foundation	This work was supported by the National Natural Science Foundation of China (31372084), ShiqiLiu, (http://www.nsfc.gov.cn/) and the Chinese National Department Public Benefit Research Foundation (201303108); ShiqiLiu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Du F, 2015, PLANT MOL BIOL REP, V33, P281, DOI 10.1007/s11105-014-0746-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths G, 2002, PHYTOTHER RES, V16, P603, DOI 10.1002/ptr.1222; Gross SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-563; Guo H, 2013, FISH SHELLFISH IMMUN, V35, P2008, DOI 10.1016/j.fsi.2013.09.019; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jung WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111982; Kamenetsky R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1212-2; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092087; Kim S, 2014, DNA RES; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106438; Liu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113290; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Peng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090636; Randle W. M., 2002, ALLIUM CROP SCI RECE; Shahin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-640; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Tsukazaki H, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0265-x; Wang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060449; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091740; Zhu LC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/750961	27	25	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133312	10.1371/journal.pone.0133312	http://dx.doi.org/10.1371/journal.pone.0133312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204518	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000026
J	Piacenza, SE; Thurman, LL; Barner, AK; Benkwitt, CE; Boersma, KS; Cerny-Chipman, EB; Ingeman, KE; Kindinger, TL; Lindsley, AJ; Nelson, J; Reimer, JN; Rowe, JC; Shen, CC; Thompson, KA; Heppell, SS				Piacenza, Susan E.; Thurman, Lindsey L.; Barner, Allison K.; Benkwitt, Cassandra E.; Boersma, Kate S.; Cerny-Chipman, Elizabeth B.; Ingeman, Kurt E.; Kindinger, Tye L.; Lindsley, Amy J.; Nelson, Jake; Reimer, Jessica N.; Rowe, Jennifer C.; Shen, Chenchen; Thompson, Kevin A.; Heppell, Selina S.			Evaluating Temporal Consistency in Marine Biodiversity Hotspots	PLOS ONE			English	Article							PROPAGULE DISPERSAL; BIOLOGICAL HOTSPOTS; NORTH PACIFIC; HOT-SPOTS; CONSERVATION; PREDATORS; RECOVERY; RATES	With the ongoing crisis of biodiversity loss and limited resources for conservation, the concept of biodiversity hotspots has been useful in determining conservation priority areas. However, there has been limited research into how temporal variability in biodiversity may influence conservation area prioritization. To address this information gap, we present an approach to evaluate the temporal consistency of biodiversity hotspots in large marine ecosystems. Using a large scale, public monitoring dataset collected over an eight year period off the US Pacific Coast, we developed a methodological approach for avoiding biases associated with hotspot delineation. We aggregated benthic fish species data from research trawls and calculated mean hotspot thresholds for fish species richness and Shannon's diversity indices over the eight year dataset. We used a spatial frequency distribution method to assign hotspot designations to the grid cells annually. We found no areas containing consistently high biodiversity through the entire study period based on the mean thresholds, and no grid cell was designated as a hotspot for greater than 50% of the time-series. To test if our approach was sensitive to sampling effort and the geographic extent of the survey, we followed a similar routine for the northern region of the survey area. Our finding of low consistency in benthic fish biodiversity hotspots over time was upheld, regardless of biodiversity metric used, whether thresholds were calculated per year or across all years, or the spatial extent for which we calculated thresholds and identified hotspots. Our results suggest that static measures of benthic fish biodiversity off the US West Coast are insufficient for identification of hotspots and that long-term data are required to appropriately identify patterns of high temporal variability in biodiversity for these highly mobile taxa. Given that ecological communities are responding to a changing climate and other environmental perturbations, our work highlights the need for scientists and conservation managers to consider both spatial and temporal dynamics when designating biodiversity hotspots.	[Piacenza, Susan E.; Thurman, Lindsey L.; Lindsley, Amy J.; Rowe, Jennifer C.; Thompson, Kevin A.; Heppell, Selina S.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Barner, Allison K.; Benkwitt, Cassandra E.; Boersma, Kate S.; Cerny-Chipman, Elizabeth B.; Ingeman, Kurt E.; Kindinger, Tye L.; Reimer, Jessica N.; Shen, Chenchen] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Nelson, Jake] Oregon State Univ, Dept Geog Environm Sci & Marine Resource Manageme, Corvallis, OR 97331 USA; [Boersma, Kate S.] Univ San Diego, Dept Biol, San Diego, CA 92110 USA; [Nelson, Jake] Drexel Univ, Dept Informat Syst, Philadelphia, PA 19104 USA	Oregon State University; Oregon State University; Oregon State University; University of San Diego; Drexel University	Piacenza, SE (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	susan.hilber@oregonstate.edu	Thurman, Lindsey/AAF-7056-2020; Reimer, Jessica/GQZ-4144-2022	Benkwitt, Cassandra/0000-0001-6756-7958; Nelson, Jake/0000-0001-9300-4892; Thurman, Lindsey/0000-0003-3142-4909; Barner, Allison/0000-0001-9909-5713; Rowe, Jennifer/0000-0002-5253-2223	National Science Foundation Grant [1050680]; University of Washington; Thomas G. Scott Publication Fund	National Science Foundation Grant(National Science Foundation (NSF)); University of Washington(University of Washington); Thomas G. Scott Publication Fund	Funding was provided by a National Science Foundation Grant to Sandy Andelman and Julia Parrish: The Dimensions of Biodiversity Distributed Graduate Seminar (1050680). A sub-grant, via the University of Washington, was provided to Selina Heppell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.nsf.gov/awardsearch/showAward?AWD_ID=1050680&HistoricalAwards=false. Publication of this paper was supported, in part, by the Thomas G. Scott Publication Fund	Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; Aquarone M, 2009, UNEP LARGE MARINE EC, P851; Baird AH, 2002, SCIENCE, V296, P1026, DOI 10.1126/science.296.5570.1026; Bartolino V, 2011, POPUL ECOL, V53, P603, DOI 10.1007/s10144-011-0273-6; Bartolino V, 2011, POPUL ECOL, V53, P351, DOI 10.1007/s10144-010-0229-2; Bonar Scott A., 2011, P11; Bradburn MJ, 2011, 2003 2008 US BOTTOM, P323; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Cayuela L, 2011, POPUL ECOL, V53, P597, DOI 10.1007/s10144-011-0272-7; Davoren G, 2013, MAR BIOL, V160, P3043, DOI 10.1007/s00227-013-2294-5; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Keller AA, 2014, MAR ECOL PROG SER, V501, P169, DOI 10.3354/meps10674; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Lin BB, 2013, ECOL SOC, V18, DOI 10.5751/ES-05128-180128; Link H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074077; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Maurer Brian A., 2011, P55; Maxwell SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3688; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Munasinghe M., 2005, PRIMER CLIMATE CHANG; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; National Oceanic and Atmospheric Administration, 2013, MULTIVARIATE ENSO IN; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Piacenza SE, PLOS ONE IN PRESS; Pico FX, 2003, OIKOS, V103, P69, DOI 10.1034/j.1600-0706.2003.12553.x; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Reese DC, 2006, DEEP-SEA RES PT II, V53, P291, DOI 10.1016/j.dsr2.2006.01.014; Reese DC, 2015, J MARINE SYST, V146, P3, DOI 10.1016/j.jmarsys.2014.10.009; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Sigler MF, 2012, DEEP-SEA RES PT II, V65-70, P292, DOI 10.1016/j.dsr2.2012.02.017; Stefansdottir L, 2010, FISH OCEANOGR, V19, P42, DOI 10.1111/j.1365-2419.2009.00527.x; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Toole CL, 2011, MAR ECOL PROG SER, V428, P201, DOI 10.3354/meps09028; US Department of Commerce NO and AA, 2013, NAT MAR PROT AR CTR; Wallington TJ, 2005, ECOL SOC, V10; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; WILHM JL, 1968, ECOLOGY, V49, P153, DOI 10.2307/1933573; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Willis KJ, 2007, PHILOS T R SOC B, V362, P169, DOI 10.1098/rstb.2006.1976	52	10	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133301	10.1371/journal.pone.0133301	http://dx.doi.org/10.1371/journal.pone.0133301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200354	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100058
J	Bockoven, AA; Wilder, SM; Eubanks, MD				Bockoven, Alison A.; Wilder, Shawn M.; Eubanks, Micky D.			Intraspecific Variation among Social Insect Colonies: Persistent Regional and Colony-Level Differences in Fire Ant Foraging Behavior	PLOS ONE			English	Article							ECOLOGICAL CONSEQUENCES; EVOLUTIONARY ECOLOGY; GENETIC DIVERSITY; HARVESTER ANT; INTERSPECIFIC INTERACTIONS; COLLECTIVE REGULATION; SOLENOPSIS-INVICTA; HYMENOPTERA; SIZE; AGGRESSION	Individuals vary within a species in many ecologically important ways, but the causes and consequences of such variation are often poorly understood. Foraging behavior is among the most profitable and risky activities in which organisms engage and is expected to be under strong selection. Among social insects there is evidence that within-colony variation in traits such as foraging behavior can increase colony fitness, but variation between colonies and the potential consequences of such variation are poorly documented. In this study, we tested natural populations of the red imported fire ant, Solenopsis invicta, for the existence of colony and regional variation in foraging behavior and tested the persistence of this variation over time and across foraging habitats. We also reared single-lineage colonies in standardized environments to explore the contribution of colony lineage. Fire ants from natural populations exhibited significant and persistent colony and regional-level variation in foraging behaviors such as extra-nest activity, exploration, and discovery of and recruitment to resources. Moreover, colony-level variation in extra-nest activity was significantly correlated with colony growth, suggesting that this variation has fitness consequences. Lineage of the colony had a significant effect on extra-nest activity and exploratory activity and explained approximately half of the variation observed in foraging behaviors, suggesting a heritable component to colony-level variation in behavior.	[Bockoven, Alison A.; Wilder, Shawn M.; Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Bockoven, AA (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	abockoven@tamu.edu	Bockoven, Alison/L-9807-2016	Bockoven, Alison/0000-0002-2117-1955; Wilder, Shawn/0000-0003-0359-7220	National Science Foundation [DEB 0716983]; Texas Imported Ant Management & Research Program; Texas A&M University Merit Fellowship; Regents' Graduate Fellowship	National Science Foundation(National Science Foundation (NSF)); Texas Imported Ant Management & Research Program; Texas A&M University Merit Fellowship; Regents' Graduate Fellowship	This work was supported by the National Science Foundation (www.nsf.gov)(DEB 0716983 to ME); the Texas Imported Ant Management & Research Program (ME); and the Texas A&M University Merit Fellowship and Regents' Graduate Fellowship (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ES, 2001, J ANIM ECOL, V70, P355, DOI 10.1046/j.1365-2656.2001.00501.x; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; BALL DE, 1983, ENTOMOL EXP APPL, V33, P195, DOI 10.1111/j.1570-7458.1983.tb03256.x; Banks W.A., 1981, TECHNIQUES COLLECTIN; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Barbosa P., 2005, ECOLOGY PREDATOR PRE; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Bengston SE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0518; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2011, TRENDS ECOLOGY EVOLU; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; CALABI P, 1989, J INSECT PHYSIOL, V35, P643, DOI 10.1016/0022-1910(89)90127-3; Callcott AMA, 1996, FLA ENTOMOL, V79, P240, DOI 10.2307/3495821; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Cole BJ, 2008, ANN ENTOMOL SOC AM, V101, P272, DOI 10.1603/0013-8746(2008)101[272:DFAAFS]2.0.CO;2; Cole BJ, 2010, BEHAV ECOL, V21, P337, DOI 10.1093/beheco/arp193; Cote J, 2011, P ROY SOC B-BIOL SCI, V278, P1670, DOI 10.1098/rspb.2010.1892; CROSLAND MWJ, 1990, J INSECT BEHAV, V3, P359, DOI 10.1007/BF01052114; CUPP EW, 1973, ANN ENTOMOL SOC AM, V66, P743, DOI 10.1093/aesa/66.4.743; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Duffy MA, 2010, FRESHWATER BIOL, V55, P995, DOI 10.1111/j.1365-2427.2009.02336.x; Fjerdingstad EJ, 2005, MOL ECOL, V14, P3123, DOI 10.1111/j.1365-294X.2005.02648.x; Fogarty S, 2011, AM NAT, V177, P273, DOI 10.1086/658174; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Fox JW, 2008, AM NAT, V172, P667, DOI 10.1086/591689; Gordon DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063363; Gordon DM, 2013, NATURE, V498, P91, DOI 10.1038/nature12137; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; HELLMICH RL, 1985, J HERED, V76, P155, DOI 10.1093/oxfordjournals.jhered.a110056; HOLLDOBLER B, 1980, SCIENCE, V210, P732, DOI 10.1126/science.210.4471.732; HOUSTON A, 1988, AM NAT, V131, P107, DOI 10.1086/284776; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes WOH, 2008, J EVOLUTION BIOL, V21, P1090, DOI 10.1111/j.1420-9101.2008.01532.x; Hui A, 2014, ANIM BEHAV, V93, P261, DOI 10.1016/j.anbehav.2014.05.006; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Kaplan I, 2005, ECOLOGY, V86, P1640, DOI 10.1890/04-0016; Knop E, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00154.1; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Laughlin DC, 2012, ECOL LETT, V15, P1291, DOI 10.1111/j.1461-0248.2012.01852.x; Lawson LP, 2012, P ROY SOC B-BIOL SCI, V279, P3217, DOI 10.1098/rspb.2012.0315; LeBoeuf AC, 2014, CURR OPIN INSECT SCI, V5, P16, DOI 10.1016/j.cois.2014.09.010; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Linksvayer TA, 2006, EVOLUTION, V60, P2552, DOI 10.1111/j.0014-3820.2006.tb01889.x; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Modlmeier AP, 2011, BEHAV ECOL, V22, P1026, DOI 10.1093/beheco/arr086; Ness JH, 2004, OECOLOGIA, V138, P448, DOI 10.1007/s00442-003-1440-z; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Pinter-Wollman N, 2012, CURR ZOOL, V58, P580, DOI 10.1093/czoolo/58.4.580; Pintor LM, 2009, ECOLOGY, V90, P581, DOI 10.1890/08-0552.1; Post DM, 2008, ECOLOGY, V89, P2019, DOI 10.1890/07-1216.1; Preisser EL, 2007, ECOLOGY, V88, P2744, DOI 10.1890/07-0260.1; Price P.W., 2011, INSECT ECOLOGY BEHAV; Pruitt JN, 2014, NATURE; Pruitt JN, 2011, ECOLOGY, V92, P1902, DOI 10.1890/11-0701.1; Raine NE, 2006, ENTOMOL GEN, V28, P241; RIECHERT SE, 1991, EVOL ECOL, V5, P327, DOI 10.1007/BF02214236; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Sanders D, 2011, J ANIM ECOL, V80, P569, DOI 10.1111/j.1365-2656.2010.01796.x; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Sih A, 2005, BEHAVIOUR, V142, P1417, DOI 10.1163/156853905774539454; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Stephens D., 2007, FORAGING BEHAV ECOLO; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Styrsky JD, 2010, ECOL ENTOMOL, V35, P190, DOI 10.1111/j.1365-2311.2009.01172.x; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Tschinkel WR, 1998, BIOSCIENCE, V48, P593, DOI 10.2307/1313419; TSCHINKEL WR, 1995, J ANIM ECOL, V64, P473, DOI 10.2307/5650; Tschinkel WR, 2006, FIRE ANTS; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Webster MM, 2009, BEHAV ECOL SOCIOBIOL, V63, P511, DOI 10.1007/s00265-008-0685-2; Wilder SM, 2011, ECOLOGY, V92, P325, DOI 10.1890/10-0623.1; Wilder SM, 2010, BIOL LETTERS, V6, P177, DOI 10.1098/rsbl.2009.0736; Wilder SM, 2011, P NATL ACAD SCI; Wray MK, 2011, BEHAV ECOL SOCIOBIOL, V65, P2061, DOI 10.1007/s00265-011-1215-1	81	19	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133868	10.1371/journal.pone.0133868	http://dx.doi.org/10.1371/journal.pone.0133868			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197456	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600144
J	Coleman, PC; Bale, JS; Hayward, SAL				Coleman, Paul C.; Bale, Jeffrey S.; Hayward, Scott A. L.			Meat Feeding Restricts Rapid Cold Hardening Response and Increases Thermal Activity Thresholds of Adult Blow Flies, Calliphora vicina (Diptera: Calliphoridae)	PLOS ONE			English	Article							BUG NEZARA-VIRIDULA; CHILL COMA RECOVERY; DROSOPHILA-MELANOGASTER; MIGRATORY LOCUST; LOW-TEMPERATURES; ION HOMEOSTASIS; LARVAL DIAPAUSE; CLIMATE-CHANGE; TOLERANCE; MUSCLE	Virtually all temperate insects survive the winter by entering a physiological state of reduced metabolic activity termed diapause. However, there is increasing evidence that climate change is disrupting the diapause response resulting in non-diapause life stages encountering periods of winter cold. This is a significant problem for adult life stages in particular, as they must remain mobile, periodically feed, and potentially initiate reproductive development at a time when resources should be diverted to enhance stress tolerance. Here we present the first evidence of protein/meat feeding restricting rapid cold hardening (RCH) ability and increasing low temperature activity thresholds. No RCH response was noted in adult female blow flies (Calliphora vicina Robineau-Desvoidy) fed a sugar, water and liver (SWL) diet, while a strong RCH response was seen in females fed a diet of sugar and water (SW) only. The RCH response in SW flies was induced at temperatures as high as 10 degrees C, but was strongest following 3h at 0 degrees C. The CTmin (loss of coordinated movement) and chill coma (final appendage twitch) temperature of SWL females (-0.3 +/- 0.5 degrees C and -4.9 +/- 0.5 degrees C, respectively) was significantly higher than for SW females (-3.2 +/- 0.8 degrees C and -8.5 +/- 0.6 degrees C). We confirmed this was not directly the result of altered extracellular K+, as activity thresholds of alanine-fed adults were not significantly different from SW flies. Instead we suggest the loss of cold tolerance is more likely the result of diverting resource allocation to egg development. Between 2009 and 2013 winter air temperatures in Birmingham, UK, fell below the CTmin of SW and SWL flies on 63 and 195 days, respectively, suggesting differential exposure to chill injury depending on whether adults had access to meat or not. We conclude that disruption of diapause could significantly impact on winter survival through loss of synchrony in the timing of active feeding and reproductive development with favourable temperature conditions.	[Coleman, Paul C.; Bale, Jeffrey S.; Hayward, Scott A. L.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Hayward, SAL (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	s.a.hayward@bham.ac.uk		Coleman, Paul/0000-0002-8681-9070; Hayward, Scott/0000-0002-1899-6630	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F016018/1]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F016018/1). The University of Birmingham, United Kingdom, covered the publication costs for this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2012, GLOBAL CHANGE BIOL, V18, P2429, DOI 10.1111/j.1365-2486.2012.02727.x; Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Andersen JL, 2015, FUNCT ECOL, V29, P55, DOI 10.1111/1365-2435.12310; Andersen JL, 2013, J INSECT PHYSIOL, V59, P1041, DOI 10.1016/j.jinsphys.2013.07.008; Andersen LH, 2010, J INSECT PHYSIOL, V56, P336, DOI 10.1016/j.jinsphys.2009.11.006; [Anonymous], 2010, LOW TEMPERATURE BIOL; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; BALE JS, 1984, CRYOBIOLOGY, V21, P340, DOI 10.1016/0011-2240(84)90329-8; COHEN BJ, 1990, AM J PHYSIOL, V258, pC24, DOI 10.1152/ajpcell.1990.258.1.C24; Coleman PC, 2014, J EXP BIOL, V217, P1454, DOI 10.1242/jeb.098053; Coleman PC, 2014, PHYSL ECOLOGY DIAPAU; Colinet H, 2014, COMP BIOCHEM PHYS A, V170, P6, DOI 10.1016/j.cbpa.2014.01.004; Colinet H, 2013, METABOLOMICS, V9, P608, DOI 10.1007/s11306-012-0471-z; Coombs MR, 2013, EXP APPL ACAROL, V59, P435, DOI 10.1007/s10493-012-9619-9; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Faucherre J, 1999, J INSECT BEHAV, V12, P687, DOI 10.1023/A:1020931804597; Findsen A, 2014, J EXP BIOL, V217, P1297, DOI 10.1242/jeb.098442; Findsen A, 2013, J EXP BIOL, V216, P1630, DOI 10.1242/jeb.081141; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hayward SAL, 2007, J EXP BIOL, V210, P836, DOI 10.1242/jeb.02714; Hayward SAL, 2014, J EXP BIOL, V217, P6, DOI 10.1242/jeb.096537; Hazell SP, 2011, J INSECT PHYSIOL, V57, P1085, DOI 10.1016/j.jinsphys.2011.04.004; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; Hercus MJ, 2000, BIOL J LINN SOC, V71, P403, DOI 10.1111/j.1095-8312.2000.tb01266.x; Hoffmann AA, 2001, EVOLUTION, V55, P436, DOI 10.1111/j.0014-3820.2001.tb01305.x; Hosler JS, 2000, J INSECT PHYSIOL, V46, P621, DOI 10.1016/S0022-1910(99)00148-1; HOYLE G, 1954, J EXP BIOL, V31, P260; Hwang C, 2005, MED VET ENTOMOL, V19, P379, DOI 10.1111/j.1365-2915.2005.00583.x; Ju RT, 2011, J INSECT PHYSIOL, V57, P1577, DOI 10.1016/j.jinsphys.2011.08.012; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kostal V, 2006, COMP BIOCHEM PHYS B, V143, P171, DOI 10.1016/j.cbpb.2005.11.005; KRUNIC MD, 1971, CAN J ZOOLOG, V49, P863, DOI 10.1139/z71-129; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Lee RE, 2006, J EXP BIOL, V209, P399, DOI 10.1242/jeb.02001; MacMillan HA, 2012, J EXP BIOL, V215, P1366, DOI 10.1242/jeb.066381; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; MacMillan HA, 2014, J EXP BIOL, V217, P2930, DOI 10.1242/jeb.107516; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; McWatters HG, 1998, PHYSIOL ENTOMOL, V23, P369, DOI 10.1046/j.1365-3032.1998.00101.x; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Musolin DL, 2012, PHYSIOL ENTOMOL, V37, P309, DOI 10.1111/j.1365-3032.2012.00846.x; Musolin DL, 2010, GLOBAL CHANGE BIOL, V16, P73, DOI 10.1111/j.1365-2486.2009.01914.x; NUNAMAKER RA, 1993, J MED ENTOMOL, V30, P913, DOI 10.1093/jmedent/30.5.913; NUNES MV, 1989, PHYSIOL ENTOMOL, V14, P471, DOI 10.1111/j.1365-3032.1989.tb01116.x; Olsen TM, 1997, J COMP PHYSIOL B, V167, P105, DOI 10.1007/s003600050053; Owen EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080061; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Raubenheimer D, 1999, ENTOMOL EXP APPL, V91, P67, DOI 10.1023/A:1003682921131; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Robich RM, 2005, P NATL ACAD SCI USA, V102, P15912, DOI 10.1073/pnas.0507958102; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Saunders DS, 1998, J INSECT PHYSIOL, V44, P541, DOI 10.1016/S0022-1910(98)00049-3; SAUNDERS DS, 1987, PHYSIOL ENTOMOL, V12, P331, DOI 10.1111/j.1365-3032.1987.tb00758.x; Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1; Sisodia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046131; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; STOFFOLANO JG, 1974, CAN J ZOOL, V52, P981, DOI 10.1139/z74-130; STRANGWAYSDIXON J, 1961, J EXP BIOL, V38, P225; Tang QH, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014036; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Teets NM, 2013, PHYSIOL ENTOMOL, V38, P105, DOI 10.1111/phen.12019; Terblanche JS, 2007, J INSECT PHYSIOL, V53, P455, DOI 10.1016/j.jinsphys.2007.01.006; VINOGRADOVA EB, 1972, J INSECT PHYSIOL, V18, P1629, DOI 10.1016/0022-1910(72)90093-5; Vinogradova EB, 2011, ENTOMOL REV, V91, P1; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; WOOD DW, 1963, COMP BIOCHEM PHYSIOL, V9, P151, DOI 10.1016/0010-406X(63)90018-5; Woollings T, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014002	71	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131301	10.1371/journal.pone.0131301	http://dx.doi.org/10.1371/journal.pone.0131301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196923	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358547600010
J	Whiting, CC; Siebert, J; Newman, AM; Du, HW; Alizadeh, AA; Goronzy, J; Weyand, CM; Krishnan, E; Fathman, CG; Maecker, HT				Whiting, Chan C.; Siebert, Janet; Newman, Aaron M.; Du, Hong-wu; Alizadeh, Ash A.; Goronzy, Jorg; Weyand, Cornelia M.; Krishnan, Eswar; Fathman, C. Garrison; Maecker, Holden T.			Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; T-CELLS; GERMINAL-CENTERS; SEX-DIFFERENCES; CYTOMEGALOVIRUS; REPERTOIRE; RESPONSES; HYPERMUTATION; PHENOTYPE; FREQUENCY	While many age-associated immune changes have been reported, a comprehensive set of metrics of immune aging is lacking. Here we report data from 243 healthy adults aged 4097, for whom we measured clinical and functional parameters, serum cytokines, cytokines and gene expression in stimulated and unstimulated PBMC, PBMC phenotypes, and cytokine-stimulated pSTAT signaling in whole blood. Although highly heterogeneous across individuals, many of these assays revealed trends by age, sex, and CMV status, to greater or lesser degrees. Age, then sex and CMV status, showed the greatest impact on the immune system, as measured by the percentage of assay readouts with significant differences. An elastic net regression model could optimally predict age with 14 analytes from different assays. This reinforces the importance of multivariate analysis for defining a healthy immune system. These data provide a reference for others measuring immune parameters in older people.	[Whiting, Chan C.; Du, Hong-wu; Fathman, C. Garrison; Maecker, Holden T.] Stanford Univ, Stanford Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Whiting, Chan C.; Du, Hong-wu; Goronzy, Jorg; Weyand, Cornelia M.; Krishnan, Eswar; Fathman, C. Garrison] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; CytoAnalytics, Denver, CO USA; [Newman, Aaron M.; Alizadeh, Ash A.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Maecker, HT (corresponding author), Stanford Univ, Stanford Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	Maecker@stanford.edu	Newman, Aaron M/ABE-1620-2021; Weyand, Cornelia/AAH-3343-2021; Alizadeh, Ash A/C-5594-2009; krishnan, Eswar/AAY-1269-2020	Newman, Aaron M/0000-0002-1857-8172; Alizadeh, Ash A/0000-0002-5153-5625; Goronzy, Jorg/0000-0001-7670-1856	National Institute on Aging, National Institutes of Health [1RC4AG039014]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108891, U19AI057266, R01AI044142, R01AI108906, R56AI044142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC4AG039014, R01AG045779] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant 1RC4AG039014 from the National Institute on Aging, National Institutes of Health. JS (CytoAnalytics) performed data analysis as work-for-hire, which was paid for from grant funds. JS did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cavanagh MM, 2011, AGING DIS, V2, P398; Couillard C, 1997, DIABETOLOGIA, V40, P1178, DOI 10.1007/s001250050804; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Derhovanessian E, 2009, CURR OPIN IMMUNOL, V21, P440, DOI 10.1016/j.coi.2009.05.012; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Guerrettaz LM, 2008, P NATL ACAD SCI USA, V105, P11898, DOI 10.1073/pnas.0805498105; Jagannathan P, 2009, J VIROL, V83, P2728, DOI 10.1128/JVI.02128-08; Joosse A, 2013, J CLIN ONCOL, V31, P2337, DOI 10.1200/JCO.2012.44.5031; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Lang A, 2011, J IMMUNOL, V187, P3759, DOI 10.4049/jimmunol.1100666; Lee SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089444; Leung J, 2008, GENDER MED, V5, P44, DOI 10.1016/S1550-8579(08)80007-1; Longo DM, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-178; Mervic L, 2011, MELANOMA RES, V21, P244, DOI 10.1097/CMR.0b013e32834577c8; MILLER C, 1995, J IMMUNOL, V155, P3377; Nomura Laurel E, 2006, AIDS Res Ther, V3, P18, DOI 10.1186/1742-6405-3-18; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442; Wang C, 2014, J IMMUNOL; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Yang XH, 1996, J EXP MED, V183, P959, DOI 10.1084/jem.183.3.959; Yang Z, 2010, J CLIN ENDOCR METAB, V95, P3926, DOI 10.1210/jc.2009-2194; Yu MC, 2012, P NATL ACAD SCI USA, V109, pE879, DOI 10.1073/pnas.1109797109; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	32	58	59	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133627	10.1371/journal.pone.0133627	http://dx.doi.org/10.1371/journal.pone.0133627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197454	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600123
J	Xu, MR; Li, Y; Zheng, Z; Dai, ZH; Tao, Y; Deng, XL				Xu, Meirong; Li, Ya; Zheng, Zheng; Dai, Zehan; Tao, Yang; Deng, Xiaoling			Transcriptional Analyses of Mandarins Seriously Infected by 'Candidatus Liberibacter asiaticus'	PLOS ONE			English	Article							ORANGE CITRUS-SINENSIS; SHOCK PROTEINS DNAK; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; O-METHYLTRANSFERASE; RESPONSIVE ELEMENT; FUNCTIONAL-CHARACTERIZATION; DISEASE RESISTANCE; DEFENSE RESPONSE; ABIOTIC STRESSES	A range of leaf symptoms, including blotchy mottle, yellowing, and small, upright leaves with a variety of chlorotic patterns resembling those induced by zinc deficiencies, are associated with huanglongbing (HLB, yellow shoot disease), a worldwide destructive citrus disease. HLB is presumably caused by the phloem-limited fastidious prokaryotic alpha-proteobacterium 'Candidatus Liberibacter spp.' Previous studies focused on the proteome and transcriptome analyses of citrus 5 to 35 weeks after 'Ca. L. spp.' inoculation. In this study, gene expression profiles were analyzed from mandarin Citrus reticulate Blanco cv. jiaogan leaves after a 2 year infection with 'Ca. L. asiaticus'. The Affymetrix microarray analysis explored 2,017 differentially expressed genes. Of the 1,364 genes had known functions, 938 (46.5%) were up-regulated. Genes related to photosynthesis, carbohydrate metabolic, and structure were mostly down-regulated, with rates of 92.7%, 61.0%, and 80.2%, respectively. Genes associated with oxidation-reduction and transport were mostly up-regulated with the rates of 75.0% and 64.6%, respectively. Our data analyses implied that the infection of 'Ca. L. asiaticus' could alter hormone crosstalk, inducing the jasmine acid pathway and depressing the ethylene and salicylic acid pathways in the citrus host. This study provides an enhanced insight into the host response of citrus to 'Ca. L. asiaticus' infection at a two-years infection stage.	[Xu, Meirong; Li, Ya; Zheng, Zheng; Dai, Zehan; Tao, Yang; Deng, Xiaoling] South China Agr Univ, Citrus Huanglongbing Res Lab, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Deng, XL (corresponding author), South China Agr Univ, Citrus Huanglongbing Res Lab, Guangzhou, Guangdong, Peoples R China.	xldeng@scau.edu.cn			National Natural Science Fund from National Natural Science Foundation of China [31201480]; Modern Agricultural Industry Technology System from Chinese Ministry of Agriculture [C09058]	National Natural Science Fund from National Natural Science Foundation of China; Modern Agricultural Industry Technology System from Chinese Ministry of Agriculture	The experiment in this study was funded by National Natural Science Fund (Grant No. 31201480) from National Natural Science Foundation of China and Modern Agricultural Industry Technology System (Grant No. C09058) from Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1995, NATURE, V377, P3; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; Aritua V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073742; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Beck G, 2013, PLANT MOL BIOL, V82, P393, DOI 10.1007/s11103-013-0070-z; Bekh-Ochir D, 2013, PLANTA, V237, P1509, DOI 10.1007/s00425-013-1859-3; Bhadauria V, 2012, PLANT SIGNAL BEHAV, V7, P1206, DOI 10.4161/psb.21368; Carmo-Silva AE, 2013, PLANT PHYSIOL, V161, P1645, DOI 10.1104/pp.112.213348; Chen K, 1998, ACTA PHYTOPHYSIOLOGI, V25, P138; Chen W, 2013, PLANT MOL BIOL, V83, P219, DOI 10.1007/s11103-013-0084-6; Cho YS, 2000, CURR MICROBIOL, V41, P33, DOI 10.1007/s002840010087; Choi DS, 2012, PLANT CELL, V24, P1675, DOI 10.1105/tpc.112.095869; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edstam MM, 2013, PLANT MOL BIOL, V83, P625, DOI 10.1007/s11103-013-0113-5; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Fukayama H, 2012, PLANT CELL PHYSIOL, V53, P976, DOI 10.1093/pcp/pcs042; Gao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015319; Han H, 2010, J PLANT PHYSIOL, V167, P176, DOI 10.1016/j.jplph.2009.08.009; Hong MJ, 2010, GENES GENET SYST, V85, P97, DOI 10.1266/ggs.85.97; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Islam MS, 2009, BMB REP, V42, P611, DOI 10.5483/BMBRep.2009.42.9.611; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Keith LMW, 1999, MOL PLANT MICROBE IN, V12, P563, DOI 10.1094/MPMI.1999.12.7.563; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Lauvergeat V, 2001, PHYTOCHEMISTRY, V57, P1187, DOI 10.1016/S0031-9422(01)00053-X; Liao HL, 2012, J EXP BOT, V63, P3307, DOI 10.1093/jxb/ers070; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado CR, 1996, PLANT MOL BIOL, V31, P585, DOI 10.1007/BF00042231; Mafra V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-247; Mageroy MH, 2012, PLANT J, V69, P1043, DOI 10.1111/j.1365-313X.2011.04854.x; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Martinelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074256; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Mishra P, 2013, BIOMETALS, V26, P97, DOI 10.1007/s10534-012-9597-8; Moriguchi T, 2002, PHYSIOL PLANTARUM, V114, P251, DOI 10.1034/j.1399-3054.2002.1140211.x; Nwugo CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067442; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Park YH, 2012, PLANT CELL REP, V31, P1845, DOI 10.1007/s00299-012-1298-9; Perez-Amador MA, 2000, PLANT PHYSIOL, V122, P169, DOI 10.1104/pp.122.1.169; Pontier D, 2001, PLANT J, V26, P495, DOI 10.1046/j.1365-313x.2001.01049.x; Rejzek M, 2011, MOL BIOSYST, V7, P718, DOI 10.1039/c0mb00204f; Romeis T, 2000, MOL PLANT PATHOL, V1, P3, DOI 10.1046/j.1364-3703.2000.00001.x; Rotblat B, 2002, PLANT J, V32, P1049, DOI 10.1046/j.1365-313X.2002.01490.x; Stracke R, 2009, PLANTA, V229, P427, DOI 10.1007/s00425-008-0841-y; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; Trabucco GM, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-61; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wu AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100498; Wu ZC, 2004, J EXP BOT, V55, P1483, DOI 10.1093/jxb/erh163; Xu MR, 2013, EUR J PLANT PATHOL, V137, P283, DOI 10.1007/s10658-013-0238-z; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Zaare-Nahandi F, 2008, BIOCHEM BIOPH RES CO, V371, P59, DOI 10.1016/j.bbrc.2008.03.157; Zhang Mei, 2009, Yichuan, V31, P236, DOI 10.3724/SP.J.1005.2009.00236; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	63	33	36	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133652	10.1371/journal.pone.0133652	http://dx.doi.org/10.1371/journal.pone.0133652			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196297	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600126
J	Zhang, B; Zheng, JC; Peng, Y; Liu, XX; Hoffmann, AA; Ma, CS				Zhang, Bo; Zheng, Jincheng; Peng, Yu; Liu, Xiaoxia; Hoffmann, Ary A.; Ma, Chun-Sen			Stress Responses of Small Heat Shock Protein Genes in Lepidoptera Point to Limited Conservation of Function across Phylogeny	PLOS ONE			English	Article							TEMPORAL EXPRESSION; COMMON CUTWORM; SMALL HSPS; FLESH FLY; EVOLUTION; DIAPAUSE; SILKWORM; PATTERNS; CLONING; GENOME	The small heat shock protein (sHsp) family is thought to play an important role in protein refolding and signal transduction, and thereby protect organisms from stress. However little is known about sHsp function and conservation across phylogenies. In the current study, we provide a comprehensive assessment of small Hsp genes and their stress responses in the oriental fruit moth (OFM), Grapholita molesta. Fourteen small heat shock proteins of OFM clustered with related Hsps in other Lepidoptera despite a high level of variability among them, and in contrast to the highly conserved Hsp11.1. The only known lepidopteran sHsp ortholog (Hsp21.3) was consistently unaffected under thermal stress in Lepidoptera where it has been characterized. However the phylogenetic position of the sHsps within the Lepidoptera was not associated with conservation of induction patterns under thermal extremes or diapause. These findings suggest that the sHsps have evolved rapidly to develop new functions within the Lepidoptera.	[Zhang, Bo; Zheng, Jincheng; Peng, Yu; Ma, Chun-Sen] Chinese Acad Agr Sci, Inst Plant Protect, Grp Climate Change Biol, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Liu, Xiaoxia] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Hoffmann, Ary A.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; China Agricultural University; University of Melbourne	Ma, CS (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Grp Climate Change Biol, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	machunsen@caas.cn	Hoffmann, Ary/R-2972-2019; Ma, Chun-Sen/K-5414-2019; Hoffmann, Ary/C-2961-2011; peng, yu/GXW-2071-2022	Hoffmann, Ary/0000-0001-9497-7645; Ma, Chun-Sen/0000-0002-3253-6921; 	National Special Fund for Agro-scientific Research in the Public Interest [201103024]; Beijing Natural Science Foundation [5144032]	National Special Fund for Agro-scientific Research in the Public Interest; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research was supported by the National Special Fund for Agro-scientific Research in the Public Interest (No. 201103024) and Beijing Natural Science Foundation (5144032). CSM and BZ are the authors who received the fundings respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bousquet F, 2012, P NATL ACAD SCI USA, V109, P249, DOI 10.1073/pnas.1109166108; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Colinet H, 2012, FUNCT ECOL, V26, P84, DOI 10.1111/j.1365-2435.2011.01898.x; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; DICKSON R. C., 1949, ANN ENT SOC AMERICA, V42, P511; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garczynski SF, 2011, INSECT SCI, V18, P473, DOI 10.1111/j.1744-7917.2010.01401.x; Gkouvitsas T, 2008, J INSECT PHYSIOL, V54, P1503, DOI 10.1016/j.jinsphys.2008.08.009; Gu J, 2012, INSECT MOL BIOL, V21, P535, DOI 10.1111/j.1365-2583.2012.01158.x; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Heckmann LH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-250; Huang LH, 2008, CELL RES, V18, P1074, DOI 10.1038/cr.2008.283; Huang LH, 2007, INSECT MOL BIOL, V16, P491, DOI 10.1111/j.1365-2583.2007.00744.x; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Jones Michael D., 2010, THESIS; Jones MM, 2010, J ECON ENTOMOL, V103, P1815, DOI 10.1603/EC10029; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kirk H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-12; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Levine MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002729; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Lu MX, 2014, CELL STRESS CHAPERON, V19, P91, DOI 10.1007/s12192-013-0437-8; MADDISON WP, 2006, MESQUITE MODULAR SYS; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Michaud Sebastien, 2003, BMC Dev Biol, V3, P9, DOI 10.1186/1471-213X-3-9; Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79; Morrow G, 2012, INT J BIOCHEM CELL B, V44, P1613, DOI 10.1016/j.biocel.2012.03.009; Mukhopadhyay I, 2003, ENVIRON HEALTH PERSP, V111, P1926, DOI 10.1289/ehp.6339; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2000, INSECT MOL BIOL, V9, P641, DOI 10.1046/j.1365-2583.2000.00230.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROTHSCHILD GHL, 1991, TORTRICID PESTS THEI; Russell DA, 1986, THESIS; Sakano D, 2006, BIOSCI BIOTECH BIOCH, V70, P2443, DOI 10.1271/bbb.60176; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shen Y, 2011, J INSECT PHYSIOL, V57, P908, DOI 10.1016/j.jinsphys.2011.03.026; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; [陶卫军 Tao Weijun], 2011, [吉林农业科学, Journal of Jilin Agricultural Sciences], V36, P43; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Tazir Y, 2009, MOL BIOCHEM PARASIT, V168, P149, DOI 10.1016/j.molbiopara.2009.07.007; WHEELER JC, 1995, P NATL ACAD SCI USA, V92, P10408, DOI 10.1073/pnas.92.22.10408; Zhang QR, 2010, J INSECT PHYSIOL, V56, P138, DOI 10.1016/j.jinsphys.2009.09.013; Zhao LM, 2010, J MED ENTOMOL, V47, P367, DOI 10.1603/ME09232; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	53	29	31	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132700	10.1371/journal.pone.0132700	http://dx.doi.org/10.1371/journal.pone.0132700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196395	Green Published, gold			2022-12-27	WOS:000358547600047
J	Li, ZQ; Zhao, YP; Jia, WY; Wang, X; Chen, B; Shahbaz, M; Nie, L; Cheng, L				Li, Ze-qun; Zhao, Yun-peng; Jia, Wen-yu; Wang, Xia; Chen, Bin; Shahbaz, Muhammad; Nie, Lin; Cheng, Lei			Surgical Treatment of Cervical Spondylotic Myelopathy Associated Hypertension-A Retrospective Study of 309 Patients	PLOS ONE			English	Article							JOINT NATIONAL COMMITTEE; BLOOD-PRESSURE; PREOPERATIVE ANXIETY; 7TH REPORT; PATHOGENESIS; PREVENTION; HUMANS	Hypertension is the most prevalent cardiovascular disease, and various risk factors are known to be involved in it. Cervical spondylotic myelopathy (CSM) is the most common non-traumatic cause of myelopathy, which displays neurological symptoms and may induce systemic symptoms. To date, it is still unknown whether CSM is associated with hypertension, and if so, whether the decompression operations can attenuate CSM associated hypertension. Here, a total of 309 patients with CSM who received anterior or posterior decompression surgery were enrolled as subjects. Blood pressure measurements were performed before and within one week after the surgery. Among the 309 subjects, 144 (46.6%) of them exhibited hypertension before surgery, a significantly higher ratio than that of the whole population. One week after surgery, blood pressure of 106 (73.6%) patients turned back to normal. Blood pressure of another 37(25.7%) patients decreased with different degrees, although still higher than normal. Moreover, it appears that both approaches were effective in improving blood pressure, while the posterior approach was more effective in decreasing systolic blood pressure. We speculate this type of hypertension might result from hyperactivity of sympathetic nervous system as the heart rate of these patients decreased after surgery as well. Collectively, compression of spinal cord in CSM patients might be associated with hypertension, and decompression surgery largely attenuated this type of hypertension. These findings prove CSM to be a potential associated factor of high blood pressure and may shed light on therapies of hypertension in clinics.	[Li, Ze-qun; Zhao, Yun-peng; Wang, Xia; Chen, Bin; Nie, Lin; Cheng, Lei] Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan, Shandong, Peoples R China; [Li, Ze-qun; Shahbaz, Muhammad] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan, Shandong, Peoples R China; [Jia, Wen-yu] Shandong Univ, Dept Endocrinol & Metab, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Jia, Wen-yu] Shandong Acad Clin Med, Inst Endocrinol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Nie, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan, Shandong, Peoples R China.	doctor_lizequn@163.com; miraculously2008@163.com			National "973" program of China [2011CB503906]; National Natural Science Foundation of China [81172863, 81128013, 81202069, 81072407]; Natural Science Foundation of Shandong Province [ZR2011CM022]	National "973" program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This research was supported partially by the National "973" program of China (2011CB503906), the National Natural Science Foundation of China (81172863, 81128013, 81202069 and 81072407) and the Natural Science Foundation of Shandong Province (ZR2011CM022).	Baron EM, 2007, NEUROSURGERY, V60, P35, DOI 10.1227/01.NEU.0000215383.64386.82; Belmonte SL, 2011, CIRC RES, V109, P309, DOI 10.1161/CIRCRESAHA.110.231233; BIANCHI G, 1989, AM J HYPERTENS, V2, pS2, DOI 10.1093/ajh/2.2.2S; Ceravolo GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111117; Charkoudian N, 2005, J PHYSIOL-LONDON, V568, P315, DOI 10.1113/jphysiol.2005.090076; Chaturvedi S, 2004, NATL MED J INDIA, V17, P227; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Edwards Charles C 2nd, 2003, Spine J, V3, P68, DOI 10.1016/S1529-9430(02)00566-1; Fehlings MG, 2013, SPINE, V38, P2247, DOI 10.1097/BRS.0000000000000047; GUIDETTI B, 1969, Journal of Neurosurgery, V30, P714, DOI 10.3171/jns.1969.30.6.0714; GUYTON AC, 1989, AM J HYPERTENS, V2, P575, DOI 10.1093/ajh/2.7.575; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; Hsu W, 2009, NEUROSURG QUART, V19, P302, DOI 10.1097/WNQ.0b013e3181bd5f8c; Ishii M, 2000, Nihon Rinsho, V58 Suppl 1, P267; Joyner MJ, 2008, EXP PHYSIOL, V93, P715, DOI 10.1113/expphysiol.2007.039545; Kiray A, 2005, CLIN ANAT, V18, P179, DOI 10.1002/ca.20055; Kohno K, 1997, SURG NEUROL, V48, P237, DOI 10.1016/S0090-3019(97)00166-3; Lebl Darren R, 2011, HSS J, V7, P170, DOI 10.1007/s11420-011-9208-1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LUKE RG, 1993, HYPERTENSION, V21, P380, DOI 10.1161/01.HYP.21.3.380; Mancia G, 1999, HYPERTENSION, V34, P724, DOI 10.1161/01.HYP.34.4.724; Mattei Tobias A, 2011, ISRN Neurol, V2011, P463729, DOI 10.5402/2011/463729; Mccormick WE, 2003, CLEV CLIN J MED, V70, P899, DOI 10.3949/ccjm.70.10.899; Morley AP, 2008, ANAESTHESIA, V63, P467, DOI 10.1111/j.1365-2044.2007.05402.x; Muller DN, 2011, CURR OPIN NEPHROL HY, V20, P113, DOI 10.1097/MNH.0b013e3283436f88; Narkiewicz K, 2005, HYPERTENSION, V45, P522, DOI 10.1161/01.HYP.0000160318.46725.46; Nishihara Masaaki, 2014, Nihon Rinsho, V72, P1374; NURICK S, 1972, BRAIN, V95, P87; Panda N, 1996, ANAESTHESIA, V51, P344, DOI 10.1111/j.1365-2044.1996.tb07745.x; Sacco M, 2013, J CLIN HYPERTENS, V15, P600, DOI 10.1111/jch.12145; Savoia C, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001815; Saylam CY, 2009, CLIN ANAT, V22, P324, DOI 10.1002/ca.20764; Singh M, 2010, CARDIOL CLIN, V28, P545, DOI 10.1016/j.ccl.2010.07.001; Skarphedinsson JO, 1997, J PHYSIOL-LONDON, V501, P671, DOI 10.1111/j.1469-7793.1997.671bm.x; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; Wang XiaoYan, 2014, Journal of Guangxi Normal University - Natural Science Edition, V32, P32; Weyer C, 2000, HYPERTENSION, V36, P531, DOI 10.1161/01.HYP.36.4.531; Witwer BP, 2007, NEUROSURGERY, V60, P130, DOI 10.1227/01.NEU.0000215351.32372.CE; Yamada H, 2001, J COMP NEUROL, V434, P86, DOI 10.1002/cne.1166	39	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133828	10.1371/journal.pone.0133828	http://dx.doi.org/10.1371/journal.pone.0133828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193469	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400127
J	Ma, N; Liu, XW; Yang, YJ; Li, JY; Mohamed, I; Liu, GR; Zhang, JY				Ma, Ning; Liu, Xi-Wang; Yang, Ya-Jun; Li, Jian-Yong; Mohamed, Isam; Liu, Guang-Rong; Zhang, Ji-Yu			Preventive Effect of Aspirin Eugenol Ester on Thrombosis in kappa-Carrageenan-Induced Rat Tail Thrombosis Model	PLOS ONE			English	Article							IN-VIVO; ANTIINFLAMMATORY DRUGS; PLATELET; VITRO; AGGREGATION; BIOSYNTHESIS; INFLAMMATION; MECHANISMS; INHIBITORS	Based on the prodrug principle, aspirin eugenol ester (AEE) was synthesized, which can reduce the side effects of aspirin and eugenol. As a good candidate for new antithrombotic and anti-inflammatory medicine, it is essential to evaluate its preventive effect on thrombosis. Preventive effect of AEE was investigated in kappa-carrageenan-induced rat tail thrombosis model. AEE suspension liquids were prepared in 0.5% sodium carboxymethyl cellulose (CMC-Na). AEE was administrated at the dosage of 18, 36 and 72 mg/kg. Aspirin (20 mg/kg), eugenol (18 mg/kg) and 0.5% CMC-Na (30 mg/kg) were used as control drug. In order to compare the effects between AEE and its precursor, integration of aspirin and eugenol group (molar ratio 1:1) was also designed in the experiment. After drugs were administrated intragastrically for seven days, each rat was injected intraperitoneally with 20 mg/kg BW kappa-carrageen dissolved in physiological saline to induce thrombosis. The length of tail-thrombosis was measured at 24 and 48 hours. The blank group just was given physiological saline for seven days without kappa-carrageenan administrated. The results indicated that AEE significantly not only reduced the average length of thrombus, PT values and FIB concentration, but also reduced the red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT) and platelet (PLT). The effects of AEE on platelet aggregation and anticoagulant in vitro showed that AEE could inhibit adenosine diphosphate (ADP)-induced platelet aggregation as dosedependence but no notable effect on blood clotting. From these results, it was concluded that AEE possessed positive effect on thrombosis prevention in vivo through the reduction of FIB, PLT, inhibition of platelet aggregation and the change of TT and PT values.	[Ma, Ning; Liu, Xi-Wang; Yang, Ya-Jun; Li, Jian-Yong; Mohamed, Isam; Liu, Guang-Rong; Zhang, Ji-Yu] CAAS, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Vet Pharmaceut Dev, Key Lab New Anim Drug Project Gansu Prov,Minist A, Lanzhou 730050, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Li, JY (corresponding author), CAAS, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Vet Pharmaceut Dev, Key Lab New Anim Drug Project Gansu Prov,Minist A, Lanzhou 730050, Peoples R China.	lijy1971@163.com		Ning, Ma/0000-0001-6696-0379	science-technology innovation engineering of CAAS (CAAS-ASTIP-LIHPS); National Natural Science Foundation of China [31402254]	science-technology innovation engineering of CAAS (CAAS-ASTIP-LIHPS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by science-technology innovation engineering of CAAS (CAAS-ASTIP-2014-LIHPS) and the National Natural Science Foundation of China (No. 31402254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anita K, 2014, ORVOSI HETILAP, V155, P851, DOI 10.1556/OH.2014.29899; Arslan R, 2011, THROMB RES, V127, P210, DOI 10.1016/j.thromres.2010.11.028; Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018; Begum R, 2014, PHARM BIOL, P1; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Burdan Franciszek, 2006, Postepy Hig Med Dosw (Online), V60, P129; Chami N, 2005, ORAL MICROBIOL IMMUN, V20, P106, DOI 10.1111/j.1399-302X.2004.00202.x; Chesnutt JKW, 2015, COMPUT BIOL MED, V56, P182, DOI 10.1016/j.compbiomed.2014.11.006; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Ema M, 2008, REPROD TOXICOL, V25, P89, DOI 10.1016/j.reprotox.2007.08.003; FERNANDEZ AG, 1995, NAT MED, V1, P602, DOI 10.1038/nm0795-602a; FLOWER R, 1972, NATURE-NEW BIOL, V238, P104, DOI 10.1038/newbio238104a0; Gambero A, 2007, DIGEST DIS SCI, V52, P425, DOI 10.1007/s10620-006-9487-4; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Gong Y, 2014, BR J PHARM; Hagimori M, 2009, PHARMACOL RES, V60, P320, DOI 10.1016/j.phrs.2009.04.010; Hsiao G, 2002, BRIT J HAEMATOL, V117, P699, DOI 10.1046/j.1365-2141.2002.03492.x; Hussain M, 2012, INT IMMUNOPHARMACOL, V12, P10, DOI 10.1016/j.intimp.2011.11.021; Jin Z, 2013, CHEM ENG J, V221, P331, DOI 10.1016/j.cej.2013.02.011; Jorgensen L, 2006, J THROMB HAEMOST, V4, P1443, DOI 10.1111/j.1538-7836.2006.02006.x; Li J, 2010, ANIM HUSBAND VET MED, V42, P20; Li JY, 2012, MED CHEM RES, V21, P995, DOI 10.1007/s00044-011-9609-1; Li JY, 2013, FOOD CHEM TOXICOL, V62, P805, DOI 10.1016/j.fct.2013.10.010; Li JY, 2012, FOOD CHEM TOXICOL, V50, P1980, DOI 10.1016/j.fct.2012.03.080; Lim K, 2008, CANCER RES, V68, P553, DOI 10.1158/0008-5472.CAN-07-2295; Liu XJ, 2012, BIOORG MED CHEM LETT, V22, P6591, DOI 10.1016/j.bmcl.2012.09.001; Philippou H, 2014, THROMB RES, V133, P1, DOI 10.1016/j.thromres.2013.10.034; Raghavendra RH, 2009, PROSTAG LEUKOTR ESS, V81, P73, DOI 10.1016/j.plefa.2009.04.009; Sadowski M, 2014, ATHEROSCLEROSIS, V237, P555, DOI 10.1016/j.atherosclerosis.2014.10.020; Schaff M, 2013, CIRCULATION, V128, P541, DOI 10.1161/CIRCULATIONAHA.112.000799; Schoemaker RG, 1998, CARDIOVASC RES, V37, P108, DOI 10.1016/S0008-6363(97)00208-3; Schussheim AE, 1997, PROG CARDIOVASC DIS, V40, P205, DOI 10.1016/S0033-0620(97)80035-7; Shen YM, 2015, BIOMED CHROMATOGR, V29, P129, DOI 10.1002/bmc.3249; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Sugiyama K, 2014, J BIOL CHEM, V289, P16303, DOI 10.1074/jbc.M114.564526; Sutcliffe P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081970; Tragoolpua Y, 2007, PHYTOTHER RES, V21, P1153, DOI 10.1002/ptr.2226; VANE J, 1987, FASEB J, V1, P89, DOI 10.1096/fasebj.1.2.3111928; Wan QL, 2013, EXP GERONTOL, V48, P499, DOI 10.1016/j.exger.2013.02.020; Wu Z., 2014, PHILOS T A, V6, P372, DOI [10.1098/rsta.2013.038024982253, DOI 10.1098/RSTA.2013.038024982253]; Yan F, 2009, J THROMB THROMBOLYS, V28, P444, DOI 10.1007/s11239-009-0333-3; Ye De-he, 2011, Zhongguo Yaolixue Yu Dulixue Zazhi, V25, P151, DOI 10.3867/j.issn.1000-3002.2011.02.005; Yuan J, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-36	43	34	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133125	10.1371/journal.pone.0133125	http://dx.doi.org/10.1371/journal.pone.0133125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193677	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400057
J	Beaulieu, JJ; Golden, HE; Knightes, CD; Mayer, PM; Kaushal, SS; Pennino, MJ; Arango, CP; Balz, DA; Elonen, CM; Fritz, KM; Hill, BH				Beaulieu, Jake J.; Golden, Heather E.; Knightes, Christopher D.; Mayer, Paul M.; Kaushal, Sujay S.; Pennino, Michael J.; Arango, Clay P.; Balz, David A.; Elonen, Colleen M.; Fritz, Ken M.; Hill, Brian H.			Urban Stream Burial Increases Watershed-Scale Nitrate Export	PLOS ONE			English	Article							NITROGEN UPTAKE; TRANSFORMATION; SIZE	Nitrogen (N) uptake in streams is an important ecosystem service that reduces nutrient loading to downstream ecosystems. Here we synthesize studies that investigated the effects of urban stream burial on N-uptake in two metropolitan areas and use simulation modeling to scale our measurements to the broader watershed scale. We report that nitrate travels on average 18 times farther downstream in buried than in open streams before being removed from the water column, indicating that burial substantially reduces N uptake in streams. Simulation modeling suggests that as burial expands throughout a river network, N uptake rates increase in the remaining open reaches which somewhat offsets reduced N uptake in buried reaches. This is particularly true at low levels of stream burial. At higher levels of stream burial, however, open reaches become rare and cumulative N uptake across all open reaches in the watershed rapidly declines. As a result, watershed-scale N export increases slowly at low levels of stream burial, after which increases in export become more pronounced. Stream burial in the lower, more urbanized portions of the watershed had a greater effect on N export than an equivalent amount of stream burial in the upper watershed. We suggest that stream daylighting (i.e., uncovering buried streams) can increase watershed-scale N retention.	[Beaulieu, Jake J.] US EPA, Off Res & Dev, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA; [Golden, Heather E.; Fritz, Ken M.] US EPA, Off Res & Dev, Natl Exposure Res Lab, Cincinnati, OH 45268 USA; [Knightes, Christopher D.] US EPA, Off Res & Dev, Natl Exposure Res Lab, Athens, GA USA; [Mayer, Paul M.] US EPA, Off Res & Dev, Natl Risk Management Res Lab, Ada, OK USA; [Kaushal, Sujay S.; Pennino, Michael J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Kaushal, Sujay S.; Pennino, Michael J.] Univ Maryland, Earth Syst Interdisciplinary Ctr, College Pk, MD 20742 USA; [Arango, Clay P.] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA USA; [Balz, David A.] Pegasus Tech Serv, Cincinnati, OH USA; [Elonen, Colleen M.; Hill, Brian H.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Duluth, MN USA	United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Central Washington University; United States Environmental Protection Agency	Beaulieu, JJ (corresponding author), US EPA, Off Res & Dev, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA.	beaulieu.jake@epa.gov		Golden, Heather/0000-0001-5501-9444; Mayer, Paul/0000-0002-8550-1386	Environmental Protection Agency National Network for Environmental Management Studies Award [2010309]; National Science Foundation [DGE-1144243, DBI 0640300, CBET 1058502]; National Aeronautics and Space Administration [NASA NNX11AM28G]; Maryland Sea Grant Awards [SA7528085-U, R/WS-2, NA05OAR4171042]; Baltimore Ecosystem Study LTER project [NSF DEB-0423476]; Pegasus Technical Services; Division Of Environmental Biology [1027188] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1058502] Funding Source: National Science Foundation	Environmental Protection Agency National Network for Environmental Management Studies Award; National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Maryland Sea Grant Awards; Baltimore Ecosystem Study LTER project; Pegasus Technical Services; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by Environmental Protection Agency National Network for Environmental Management Studies Award 2010309, the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1144243, National Science Foundation Awards DBI 0640300 and CBET 1058502, National Aeronautics and Space Administration grant NASA NNX11AM28G, Maryland Sea Grant Awards SA7528085-U, R/WS-2 and NA05OAR4171042, and the Baltimore Ecosystem Study LTER project (NSF DEB-0423476). Pegasus Technical Services provided support in the form of salaries for the author DAB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2000/60/EC Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000, 2000, OFFICIAL J EUROPEA L, VL 327, P1, DOI DOI 10.1039/ap9842100196; Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Alexander RB, 2007, J AM WATER RESOUR AS, V43, P41, DOI 10.1111/j.1752-1688.2007.00005.x; Anderson WP, 2010, J HYDROL, V393, P309, DOI 10.1016/j.jhydrol.2010.08.030; AUMEN NG, 1990, J N AM BENTHOL SOC, V9, P95; Beaulieu JJ, 2014, BIOGEOCHEMISTRY, V121, P107, DOI 10.1007/s10533-014-9971-4; Conradin F, 2005, NATO SCI SERIES, P277; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Elmore AJ, 2008, FRONT ECOL ENVIRON, V6, P308, DOI 10.1890/070101; Grimm NB, 2005, J N AM BENTHOL SOC, V24, P626, DOI 10.1899/04-027.1; Hall RO, 2003, LIMNOL OCEANOGR, V48, P1120, DOI 10.4319/lo.2003.48.3.1120; Hall RO, 2009, LIMNOL OCEANOGR, V54, P653, DOI 10.4319/lo.2009.54.3.0653; Hietala-Koivu R, 2004, AGR ECOSYST ENVIRON, V103, P75, DOI 10.1016/j.agee.2003.10.015; Hopkins J.N.N., 2007, WATERS ROME, V4, P1; Iversen TM, 1997, RIVER RESTORATION 96; Kaushal SS, 2012, URBAN ECOSYST, V15, P409, DOI 10.1007/s11252-012-0226-7; Kim N.C., 2005, LANDSC ECOL ENG, V1, P77, DOI [10.1007/s11355-005-0011-3, DOI 10.1007/S11355-005-0011-3, DOI 10.1007/s11355-005-0011-3]; Klocker CA, 2009, AQUAT SCI, V71, P411, DOI 10.1007/s00027-009-0118-y; Kummert R, 1992, GEWSSER ALS OKOSYSTE; Meyer J.L., 2005, P 2005 GEORG WAT RES; Meyer JL, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P295; Montgomery MR, 2008, SCIENCE, V319, P761, DOI 10.1126/science.1153012; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; O'Driscoll M, 2010, WATER-SUI, V2, P605, DOI 10.3390/w2030605; Pennino MJ, 2014, BIOGEOCHEMISTRY, V121, P247, DOI 10.1007/s10533-014-9958-1; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Royer TV, 2006, ENVIRON SCI TECHNOL, V40, P4126, DOI 10.1021/es052573n; Stammler KL, 2013, LANDSCAPE URBAN PLAN, V114, P37, DOI 10.1016/j.landurbplan.2013.02.008; Steele MK, 2014, ECOSYSTEMS, V17, P685, DOI 10.1007/s10021-014-9751-y; Trice A, 2014, DAYLIGHTING STREAMS; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wild TC, 2011, WATER ENVIRON J, V25, P412, DOI 10.1111/j.1747-6593.2010.00236.x; Wollheim WM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000660; Wollheim WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025845	34	28	28	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132256	10.1371/journal.pone.0132256	http://dx.doi.org/10.1371/journal.pone.0132256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186731	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700032
J	Himes, BE; Koziol-White, C; Johnson, M; Nikolos, C; Jester, W; Klanderman, B; Litonjua, AA; Tantisira, KG; Truskowski, K; MacDonald, K; Panettieri, RA; Weiss, ST				Himes, Blanca E.; Koziol-White, Cynthia; Johnson, Martin; Nikolos, Christina; Jester, William; Klanderman, Barbara; Litonjua, Augusto A.; Tantisira, Kelan G.; Truskowski, Kevin; MacDonald, Kevin; Panettieri, Reynold A., Jr.; Weiss, Scott T.			Vitamin D Modulates Expression of the Airway Smooth Muscle Transcriptome in Fatal Asthma	PLOS ONE			English	Article							RNA-SEQ; DIFFERENTIAL GENE; DRUG-THERAPY; RECEPTOR; CELLS; INFLAMMATION; PROTEIN; MIGRATION; AMERICANS; LUNG	Globally, asthma is a chronic inflammatory respiratory disease affecting over 300 million people. Some asthma patients remain poorly controlled by conventional therapies and experience more life-threatening exacerbations. Vitamin D, as an adjunct therapy, may improve disease control in severe asthma patients since vitamin D enhances glucocorticoid responsiveness and mitigates airway smooth muscle (ASM) hyperplasia. We sought to characterize differences in transcriptome responsiveness to vitamin D between fatal asthma-and non-asthma-derived ASM by using RNA-Seq to measure ASM transcript expression in five donors with fatal asthma and ten non-asthma-derived donors at baseline and with vitamin D treatment. Based on a Benjamini-Hochberg corrected p-value < 0.05, 838 genes were differentially expressed in fatal asthma vs. non-asthma-derived ASM at baseline, and vitamin D treatment compared to baseline conditions induced differential expression of 711 and 867 genes in fatal asthma-and non-asthma-derived ASM, respectively. Functional gene categories that were highly represented in all groups included extracellular matrix, and responses to steroid hormone stimuli and wounding. Genes differentially expressed by vitamin D also included cytokine and chemokine activity categories. Follow-up qPCR and individual analyte ELISA experiments were conducted for four cytokines (i.e. CCL2, CCL13, CXCL12, IL8) to measure TNF alpha-induced changes by asthma status and vitamin D treatment. Vitamin D inhibited TNF alpha-induced IL8 protein secretion levels to a comparable degree in fatal asthma-and non-asthma-derived ASM even though IL8 had significantly higher baseline levels in fatal asthma-derived ASM. Our findings identify vitamin D-specific gene targets and provide transcriptomic data to explore differences in the ASM of fatal asthma-and non-asthma-derived donors.	[Himes, Blanca E.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Koziol-White, Cynthia; Johnson, Martin; Nikolos, Christina; Jester, William; Truskowski, Kevin; MacDonald, Kevin; Panettieri, Reynold A., Jr.] Univ Penn, Airways Biol Initiat, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Klanderman, Barbara; Weiss, Scott T.] Partners Personalized Med, Boston, MA USA; [Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Himes, BE (corresponding author), Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	bhimes@upenn.edu	panettieri, reynold/AAG-9485-2019	Jester Jr., William/0000-0002-2872-6095	National Institutes of Health (NIH) [U01 HL65899]; NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance [R01 HL097796, R01 HL114769, P30 ES013508, P01-HL114471, P30-ES013508]; NIH [R00 HL105663]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL105663, R01HL097796, P01HL114471, R01HL114769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by National Institutes of Health (NIH) U01 HL65899, an NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance, R01 HL097796, R01 HL114769, P30 ES013508, P01-HL114471 and P30-ES013508. BEH was funded by NIH R00 HL105663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2012, J CLIN IMMUNOL, V32, P1093, DOI 10.1007/s10875-012-9696-x; Amrani Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-104; Andrews S, FASTQC QUALITY CONTR; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Banerjee A, 2008, BRIT J PHARMACOL, V155, P84, DOI 10.1038/bjp.2008.232; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bolger AM, 2014, BIOINFORMATICS; Bosse Y, 2007, PHYSIOL GENOMICS, V29, P161, DOI 10.1152/physiolgenomics.00134.2006; Chambers ES, 2011, CURR ALLERGY ASTHM R, V11, P29, DOI 10.1007/s11882-010-0161-8; Chan IHS, 2009, PEDIAT ALLERG IMM-UK, V20, P142, DOI 10.1111/j.1399-3038.2008.00757.x; Collington SJ, 2010, J IMMUNOL, V184, P6114, DOI 10.4049/jimmunol.0904177; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; Daubeuf F, 2013, J BIOL CHEM, V288, P11865, DOI 10.1074/jbc.M112.449348; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; Godot V, 2007, J ALLERGY CLIN IMMUN, V120, P827, DOI 10.1016/j.jaci.2007.05.046; Gupta A, 2012, PAEDIATR RESPIR REV, V13, P236, DOI 10.1016/j.prrv.2011.07.003; Gupta A, 2011, AM J RESP CRIT CARE, V184, P1342, DOI 10.1164/rccm.201107-1239OC; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Hawrylowicz C, 2002, J ALLERGY CLIN IMMUN, V109, P369, DOI 10.1067/mai.2002.121455; Hoshino M, 2003, EUR RESPIR J, V21, P804, DOI 10.1183/09031936.03.00082002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joubert P, 2005, J IMMUNOL, V175, P2702, DOI 10.4049/jimmunol.175.4.2702; Kalayci O, 2004, J ASTHMA, V41, P27, DOI 10.1081/JAS-120024590; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lane SJ, 1998, J CLIN INVEST, V102, P2156, DOI 10.1172/JCI2680; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Moorman JE, 2012, NATL SURVEILLANCE AS, P3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; National Asthma Education Program, 2007, 3 US DEP HLTH HUM SE; NELSON HS, 1995, NEW ENGL J MED, V333, P499, DOI 10.1056/NEJM199508243330807; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Ng K, 2014, AM J CLIN NUTR, V99, P587, DOI 10.3945/ajcn.113.067777; Nocker RET, 1996, INT ARCH ALLERGY IMM, V109, P183, DOI 10.1159/000237218; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri RA, 2008, AM J RESP CRIT CARE, V177, P248, DOI 10.1164/rccm.200708-1217PP; Patel KK, 2010, PEDIATR INFECT DIS J, V29, P1093, DOI 10.1097/INF.0b013e3181eaebdc; Zafra MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091996; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Singh SR, 2014, ALLERGY, V69, P1189, DOI 10.1111/all.12444; Song YF, 2007, RESPIROLOGY, V12, P486, DOI 10.1111/j.1440-1843.2007.01099.x; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang AL, 2015, INT ARCH ALLERGY IMM, V166, P52, DOI 10.1159/000371764; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC	58	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134057	10.1371/journal.pone.0134057	http://dx.doi.org/10.1371/journal.pone.0134057			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207385	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000198
J	Sanchez-Velazquez, EJ; Santillan-Galicia, MT; Novelli, VM; Nunes, MA; Mora-Aguilera, G; Valdez-Carrasco, JM; Otero-Colina, G; Freitas-Astua, J				Sanchez-Velazquez, E. J.; Santillan-Galicia, M. T.; Novelli, V. M.; Nunes, M. A.; Mora-Aguilera, G.; Valdez-Carrasco, J. M.; Otero-Colina, G.; Freitas-Astua, J.			Diversity and Genetic Variation among Brevipalpus Populations from Brazil and Mexico	PLOS ONE			English	Article							CITRI ACARI TETRANYCHIDAE; PHOENICIS ACARI; MITES; LEPROSIS; VECTOR; TENUIPALPIDAE; HISTORY; MARKERS	Brevipalpus phoenicis s.l. is an economically important vector of the Citrus leprosis virus-C (CiLV-C), one of the most severe diseases attacking citrus orchards worldwide. Effective control strategies for this mite should be designed based on basic information including its population structure, and particularly the factors that influence its dynamics. We sampled sweet orange orchards extensively in eight locations in Brazil and 12 in Mexico. Population genetic structure and genetic variation between both countries, among locations and among sampling sites within locations were evaluated by analysing nucleotide sequence data from fragments of the mitochondrial cytochrome oxidase subunit I (COI). In both countries, B. yothersi was the most common species and was found in almost all locations. Individuals from B. papayensis were found in two locations in Brazil. Brevipalpus yothersi populations collected in Brazil were more genetically diverse (14 haplotypes) than Mexican populations (four haplotypes). Although geographical origin had a low but significant effect (ca. 25%) on the population structure, the greatest effect was from the within location comparison (37.02 %). Potential factors driving our results were discussed.	[Sanchez-Velazquez, E. J.; Santillan-Galicia, M. T.; Valdez-Carrasco, J. M.; Otero-Colina, G.] Colegio Postgrad, Postgrado Fitosanidad Entomol & Acarol, Montecillo, Edo De Mexico, Mexico; [Novelli, V. M.; Nunes, M. A.; Freitas-Astua, J.] Ctr APTA Citros Sylvio Moreira IAC, Cordeiropolis, SP, Brazil; [Mora-Aguilera, G.] Colegio Postgrad, Postgrado Fitosanidad Fitopatol, Montecillo, Edo De Mexico, Mexico	Colegio de Postgraduados - Mexico; Instituto Agronomico de Campinas (IAC); Colegio de Postgraduados - Mexico	Santillan-Galicia, MT (corresponding author), Colegio Postgrad, Postgrado Fitosanidad Entomol & Acarol, Montecillo, Edo De Mexico, Mexico.	tgalicia@colpos.mx	Novelli, Valdenice Moreira/C-4341-2012; Freitas-Astua, Juliana/C-5833-2013	Novelli, Valdenice Moreira/0000-0001-7717-4488; Freitas-Astua, Juliana/0000-0002-0506-6880; SANTILLAN-GALICIA, MA TERESA/0000-0002-0408-3638	Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico; Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (SENASICA), Mexico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil	Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (SENASICA), Mexico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	ESV received a scholarship from Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico. This research was done under the project 'Implicaciones epidemiologicas del CTV en el sistema vector - planta: bases epidemiologicas y cuantitativas para la aplicacion de la campana en Mexico' funded by the Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (SENASICA), Mexico and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil.	BAKER E W, 1975, Smithsonian Contributions to Zoology, V194, P1; Baker EW, 1987, USDA ARS TECH B; Bassanezi RB, 2007, PLANT PATHOL, V56, P97, DOI 10.1111/j.1365-3059.2006.01457.x; Bastianel Marinês, 2006, Summa phytopathol., V32, P211, DOI 10.1590/S0100-54052006000300001; Bastianel M, 2010, PLANT DIS, V94, P284, DOI 10.1094/PDIS-94-3-0284; Beard JJ, 2015, ZOOTAXA, V3944, P1, DOI 10.11646/zootaxa.3944.1.1; Beard JJ, 2012, FLAT MITES WORLD 1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brlansky RH, 2006, CITRUS DIS EXOTIC FL; Carbonnelle S, 2007, EXP APPL ACAROL, V41, P225, DOI 10.1007/s10493-007-9068-z; Carew ME, 2004, ENTOMOL EXP APPL, V111, P87, DOI 10.1111/j.0013-8703.2004.00149.x; CHIAVEGATO LG, 1986, PESQUI AGROPECU BRAS, V21, P813; Childers CC, 2003, EXP APPL ACAROL, V30, P1, DOI 10.1023/B:APPA.0000006542.96404.63; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; DE LEON D., 1961, FLORIDA ENT, V44, P41; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Groot TVM, 2006, EXP APPL ACAROL, V39, P257, DOI 10.1007/s10493-006-9019-0; Groot TVM, 2005, EXP APPL ACAROL, V36, P165, DOI 10.1007/s10493-005-3360-6; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HELLE W, 1980, GENETICA, V54, P45, DOI 10.1007/BF00122407; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Krantz G., 2009, MANUAL ACAROLOGY; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x; Mata J, 2010, ANN ENTOMOL SOC AM, V103, P898, DOI 10.1603/AN09099; Mendez Mendez Prisciliano, 2012, Fitosanidad, V16, P73; Mesa NC, 2009, ZOOTAXA, P1; Miller AD, 2013, MOL PHYLOGENET EVOL, V66, P928, DOI 10.1016/j.ympev.2012.11.021; Miranda LC, 2007, NEOTROP ENTOMOL, V36, P587, DOI 10.1590/S1519-566X2007000400018; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; Navajas M, 2000, EXP APPL ACAROL, V24, P751, DOI 10.1023/A:1006497906793; Navia D, 2013, ZOOL SCR, V42, P406, DOI 10.1111/zsc.12013; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Nunes MA, 2012, PLANT DIS, V96, P968, DOI 10.1094/PDIS-06-11-0538; Ochoa R, 2011, 3 SIBAC S BRAS AC CA; PIJNACKER LP, 1980, GENETICA, V51, P211, DOI 10.1007/BF00121613; PIJNACKER LP, 1981, ACAROLOGIA, V22, P157; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Rodrigues JCV, 2004, EXP APPL ACAROL, V34, P275, DOI 10.1007/s10493-004-0571-1; Rodrigues VJC, 2003, EXP APPL ACAROL, V34, P275; Rossi-Zalaf LS, 2006, EXP APPL ACAROL, V40, P37, DOI 10.1007/s10493-006-9024-3; Roy A., 2015, PHYTOPATHOL IN PRESS; Salinas-Vargas D, 2013, NEOTROP ENTOMOL, V42, P419, DOI 10.1007/s13744-013-0140-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weeks AR, 2001, SCIENCE, V292, P2479, DOI 10.1126/science.1060411; Welbourn WC, 2003, EXP APPL ACAROL, V30, P107, DOI 10.1023/B:APPA.0000006545.40017.a0; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; Yuan ML, 2011, ANN ENTOMOL SOC AM, V104, P800, DOI 10.1603/AN10159; Yuan ML, 2010, J ECON ENTOMOL, V103, P2204, DOI 10.1603/EC09392; [No title captured]	55	31	31	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133861	10.1371/journal.pone.0133861	http://dx.doi.org/10.1371/journal.pone.0133861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207373	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000158
J	Barbarossa, MV; Denes, A; Kiss, G; Nakata, Y; Rost, G; Vizi, Z				Barbarossa, Maria Vittoria; Denes, Attila; Kiss, Gabor; Nakata, Yukihiko; Roest, Gergely; Vizi, Zsolt			Transmission Dynamics and Final Epidemic Size of Ebola Virus Disease Outbreaks with Varying Interventions	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; WEST-AFRICA; LIBERIA; MODELS; ZAIRE	The 2014 Ebola Virus Disease (EVD) outbreak in West Africa was the largest and longest ever reported since the first identification of this disease. We propose a compartmental model for EVD dynamics, including virus transmission in the community, at hospitals, and at funerals. Using time-dependent parameters, we incorporate the increasing intensity of intervention efforts. Fitting the system to the early phase of the 2014 West Africa Ebola outbreak, we estimate the basic reproduction number as 1.44. We derive a final size relation which allows us to forecast the total number of cases during the outbreak when effective interventions are in place. Our model predictions show that, as long as cases are reported in any country, intervention strategies cannot be dismissed. Since the main driver in the current slowdown of the epidemic is not the depletion of susceptibles, future waves of infection might be possible, if control measures or population behavior are relaxed.	[Barbarossa, Maria Vittoria; Denes, Attila; Kiss, Gabor; Roest, Gergely; Vizi, Zsolt] Univ Szeged, Bolyai Inst, H-6720 Szeged, Hungary; [Nakata, Yukihiko] Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan	Szeged University; University of Tokyo	Rost, G (corresponding author), Univ Szeged, Bolyai Inst, H-6720 Szeged, Hungary.	rost@math.u-szeged.hu	Barbarossa, Maria Vittoria/AAC-7437-2021; Vizi, Zsolt/ABA-6620-2021; Barbarossa, Maria Vittoria/AAE-8224-2021; Kiss, Gabor/K-4393-2012; Rost, Gergely/L-9376-2016	Vizi, Zsolt/0000-0003-2568-8633; Kiss, Gabor/0000-0002-8255-7843; Rost, Gergely/0000-0001-9476-3284; Barbarossa, Maria Vittoria/0000-0001-8788-1709; Denes, Attila/0000-0003-1827-7932	European Research Council StG [259559]; Hungarian Scientific Research Fund OTKAK [K109782, PD 112463]; Japan Society for the Promotion of Science [268448]; JSPS Bilateral open partnership joint research project; Japan Science and Technology Agency (JST) RISTEX program for Science, Technology and Innovation Policy; Grants-in-Aid for Scientific Research [14J08448] Funding Source: KAKEN	European Research Council StG(European Research Council (ERC)); Hungarian Scientific Research Fund OTKAK; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Bilateral open partnership joint research project; Japan Science and Technology Agency (JST) RISTEX program for Science, Technology and Innovation Policy; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MVB, GK, GR, ZsV were supported by European Research Council StG 259559. GR was supported by Hungarian Scientific Research Fund OTKA K109782. AD was supported by Hungarian Scientific Research Fund OTKA PD 112463. YN was supported by JSPS Fellows, no. 268448 of Japan Society for the Promotion of Science, JSPS Bilateral open partnership joint research project, and Japan Science and Technology Agency (JST) RISTEX program for Science, Technology and Innovation Policy.	Althaus C.L., 2014, PLOS CURR; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; BOWEN ETW, 1977, LANCET, V1, P571; Camacho A, 2014, EPIDEMICS-NETH, V9, P70, DOI 10.1016/j.epidem.2014.09.003; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Chowell G, 2014, PLOS CURR-TREE LIFE, V2014; Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Drake JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002056; Gomes MF, 2014, PLOS CURR; JOHNSON KM, 1977, LANCET, V1, P569; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Ndanguza D, 2013, AFR MAT, V24, P55, DOI 10.1007/s13370-011-0039-5; Nishiura H, 2014, EURO SURVEILL, V19; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Rivers CM, 2014, PLOS CURR; Towers S., 2014, PLOS CURR; WHO, 11 WHO; WHO, EBOL VIR DIS; WHO, ON YEAR EB EP REP; World Health Organization, 28 WHO; World Health Organization, 2014, CAS DEF REC EB MARB; Yamin D, 2015, ANN INTERN MED, V162, P11, DOI 10.7326/M14-2255	28	42	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131398	10.1371/journal.pone.0131398	http://dx.doi.org/10.1371/journal.pone.0131398			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197242	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600012
J	Becking, K; Spijker, AT; Hoencamp, E; Penninx, BWJH; Schoevers, RA; Boschloo, L				Becking, Karlijn; Spijker, Annet T.; Hoencamp, Erik; Penninx, Brenda W. J. H.; Schoevers, Robert A.; Boschloo, Lynn			Disturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive Episodes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SPECTRUM DISORDER; HPA AXIS; GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; CHRONIC STRESS; CORTISOL; INFLAMMATION; CYTOKINES; RELIABILITY	Introduction Differentiating bipolar depression (BD) from unipolar depression (UD) is difficult in clinical practice and, consequently, accurate recognition of BD can take as long as nine years. Research has therefore focused on the discriminatory capacities of biomarkers, such as markers of the hypothalamic-pituitary-adrenal (HPA) axis or immunological activity. However, no previous study included assessments of both systems, which is problematic as they may influence each other. Therefore, this study aimed to explore whether cortisol indicators and inflammatory markers were a) independently associated with and/or b) showed effect modification in relation to a lifetime (hypo) manic episode in a large sample of depressed patients. Methods Data were derived from the Netherlands Study of Depression and Anxiety and comprised 764 patients with a DSM-IV depressive disorder at baseline, of which 124 (16.2%) had a lifetime (hypo) manic episode at the 2-year assessment, or a more recent episode at the 4-year or 6-year assessment. Baseline cortisol awakening response, evening cortisol and diurnal cortisol slope were considered as cortisol indicators, while baseline C-reactive Protein (CRP), Interleukin-6 (IL-6), and Tumor Necrosis Factor Alpha (TNF-alpha) were included as inflammatory markers. Results In depressed men and women, none of the cortisol indicators and inflammatory markers were (independently) associated with a (hypo) manic episode. However, effect modification was found of diurnal cortisol slope and CRP in relation to a (hypo) manic episode. Further analyses showed that depressed men with high levels of diurnal cortisol slope and CRP had an increased odds (OR=10.99, p=.001) of having a (hypo) manic episode. No significant differences were found in women. Conclusion Our findings suggest that the combination of high diurnal cortisol slope and high CRP may differentiate between UD and BD. This stresses the importance of considering HPA-axis and immunological activity simultaneously, but more research is needed to unravel their interrelatedness.	[Becking, Karlijn; Penninx, Brenda W. J. H.; Schoevers, Robert A.; Boschloo, Lynn] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Becking, Karlijn; Penninx, Brenda W. J. H.; Schoevers, Robert A.; Boschloo, Lynn] Univ Groningen, Univ Med Ctr Groningen, UCP, Groningen, Netherlands; [Spijker, Annet T.; Hoencamp, Erik] PsyQ Rijnmond, Dept Mood Disorders, Rotterdam, Netherlands; [Hoencamp, Erik] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] EMGO, Inst Hlth & Care Res, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	University of Groningen; University of Groningen; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Becking, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	k.becking@umcg.nl	Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672; Schoevers, Robert A/0000-0003-0760-9866	Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Health Care (IQ Healthcare); Netherlands Institute for Health Services Research (Nivel); Netherlands Institute of Mental Health and Addiction (TRIMBOS); Neuroscience Campus Amsterdam and VIDI grant; Astra Zeneca Nederland; PsyQ Rijnmond	Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Health Care (IQ Healthcare); Netherlands Institute for Health Services Research (Nivel); Netherlands Institute of Mental Health and Addiction (TRIMBOS); Neuroscience Campus Amsterdam and VIDI grant; Astra Zeneca Nederland; PsyQ Rijnmond	The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Health Care (IQ Healthcare), Netherlands Institute for Health Services Research (Nivel) and the Netherlands Institute of Mental Health and Addiction (TRIMBOS)). Assaying of inflammatory markers was supported by the Neuroscience Campus Amsterdam and VIDI grant (Penninx). Statistical analyses were supported by an unrestricted research grant by Astra Zeneca Nederland (Spijker, Hoencamp, Boschloo). The Netherlands Organization for Health Research and Development had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PsyQ Rijnmond provided support in the form of salaries for authors AS and EH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Astra Zeneca Nederland had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2001, DIAGN STAT MAN MENT; Anisman H, 2003, ANN MED, V35, P2, DOI 10.1080/07853890310004075; Bai Yanbin, 2014, ASME 2014 33 INT C O, DOI [10.1115/OMAE2014-24678, DOI 10.1115/OMAE2014-24678]; Becking K, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.87; Benazzi Franco, 2002, Ann Clin Psychiatry, V14, P97, DOI 10.1023/A:1016854904941; Berk M, 2008, J AFFECT DISORDERS, V110, P126, DOI 10.1016/j.jad.2008.01.018; Berk M, 2007, MED J AUSTRALIA, V187, pS11; Bhagwagar Z, 2005, PSYCHOPHARMACOLOGY, V182, P54, DOI 10.1007/s00213-005-0062-z; Boschloo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106871; Bremmer MA, 2008, J AFFECT DISORDERS, V106, P249, DOI 10.1016/j.jad.2007.07.002; Cervantes P, 2001, J PSYCHIATR NEUROSCI, V26, P411; Cohen LS, 2006, ARCH GEN PSYCHIAT, V63, P385, DOI 10.1001/archpsyc.63.4.385; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; De Fruyt J, 2007, PSYCHOTHER PSYCHOSOM, V76, P77, DOI 10.1159/000097966; Deshauer D, 2003, CAN J PSYCHIAT, V48, P462, DOI 10.1177/070674370304800706; Dickerson F, 2007, PROG NEURO-PSYCHOPH, V31, P952, DOI 10.1016/j.pnpbp.2007.02.018; Dunner DL, 2003, BIPOLAR DISORD, V5, P456, DOI 10.1046/j.1399-5618.2003.00073.x; Edwards S, 2001, LIFE SCI, V68, P2093, DOI 10.1016/S0024-3205(01)00996-1; Ghaemi SN, 1999, J AFFECT DISORDERS, V52, P135, DOI 10.1016/S0165-0327(98)00076-7; Ghaemi SN, 2000, J CLIN PSYCHIAT, V61, P804, DOI 10.4088/JCP.v61n1013; Gobinath A, 2014, FRONT NEUROSCI; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Grande I, 2012, PHYSIOL BEHAV, V106, P46, DOI 10.1016/j.physbeh.2011.10.029; Haefher S, 2008, J PSYCHIATR RES, V42, P163, DOI 10.1016/j.jpsychires.2007.02.002; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Horowitz MA, 2013, MOD TR PHARMACOPSYCH, V28, P127, DOI 10.1159/000343980; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jabben N, 2011, J PSYCHIATR RES, V45, P1208, DOI 10.1016/j.jpsychires.2011.03.010; Kessler RC, 2006, J AFFECT DISORDERS, V96, P259, DOI 10.1016/j.jad.2006.08.018; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kim YK, 2007, J AFFECT DISORDERS, V104, P91, DOI 10.1016/j.jad.2007.02.018; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Kupfer DJ, 2005, JAMA-J AM MED ASSOC, V293, P2528, DOI 10.1001/jama.293.20.2528; Leboyer M, 2012, J AFFECT DISORDERS, V141, P1, DOI 10.1016/j.jad.2011.12.049; Levine DW, 2003, PSYCHOL ASSESSMENT, V15, P137, DOI 10.1037/1040-3590.15.2.137; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Ng F, 2007, J AFFECT DISORDERS, V101, P259, DOI 10.1016/j.jad.2006.11.014; O'Connor MF, 2009, BRAIN BEHAV IMMUN, V23, P887, DOI 10.1016/j.bbi.2009.04.005; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pini S, 2005, EUR NEUROPSYCHOPHARM, V15, P425, DOI 10.1016/j.euroneuro.2005.04.011; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Reed V., 1998, INT J METHODS PSYCHI, V7, P142, DOI [10.1002/mpr.44, DOI 10.1002/MPR.44]; Rybakowski JK, 1999, J PSYCHIAT RES, V33, P363, DOI 10.1016/S0022-3956(99)00014-X; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Sloan DME, 2003, PSYCHIAT CLIN N AM, V26, P581, DOI 10.1016/S0193-953X(03)00044-3; Stalder T, 2009, PSYCHONEUROENDOCRINO, V34, P607, DOI 10.1016/j.psyneuen.2008.10.023; Su SC, 2011, INT J PSYCHIAT MED, V42, P211, DOI 10.2190/PM.42.3.a; Taylor SE, 2006, BIOL PSYCHIAT, V60, P819, DOI 10.1016/j.biopsych.2006.03.016; Tondo L, 2010, ACTA PSYCHIAT SCAND, V121, P446, DOI 10.1111/j.1600-0447.2009.01523.x; Uceyler N, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-245; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112; Vreeburg SA, 2009, PSYCHONEUROENDOCRINO, V34, P1109, DOI 10.1016/j.psyneuen.2009.04.024; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Woo YS, 2015, J AFFECT DISORDERS, V174, P83, DOI 10.1016/j.jad.2014.11.034; Zunszain PA, 2011, PROG NEURO-PSYCHOPH, V35, P722, DOI 10.1016/j.pnpbp.2010.04.011	62	16	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133898	10.1371/journal.pone.0133898	http://dx.doi.org/10.1371/journal.pone.0133898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196286	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600146
J	Heinbockel, L; Marwitz, S; Varela, SB; Ferrer-Espada, R; Reiling, N; Goldmann, T; Gutsmann, T; Mier, W; Schuerholz, T; Droemann, D; Brandenburg, K; de Tejada, GM				Heinbockel, Lena; Marwitz, Sebastian; Barcena Varela, Sergio; Ferrer-Espada, Raquel; Reiling, Norbert; Goldmann, Torsten; Gutsmann, Thomas; Mier, Walter; Schuerholz, Tobias; Droemann, Daniel; Brandenburg, Klaus; Martinez de Tejada, Guillermo			Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; SEPTIC SHOCK; LIPOPOLYSACCHARIDE; INTERLEUKIN-18; MACROPHAGES; STRATEGIES; PHYSIOLOGY; IL-1-BETA; MONOCYTES; BACTERIA	Sepsis is still a major cause of death and many efforts have been made to improve the physical condition of sepsis patients and to reduce the high mortality rate associated with this disease. While achievements were implemented in the intensive care treatment, all attempts within the field of novel therapeutics have failed. As a consequence new medications and improved patient stratification as well as a thoughtful management of the support therapies are urgently needed. In this study, we investigated the simultaneous administration of ibuprofen as a commonly used nonsteroidal anti-inflammatory drug (NSAID) and Pep19-2.5 (Aspidasept), a newly developed antimicrobial peptide. Here, we show a synergistic therapeutic effect of combined Pep19-2.5-ibuprofen treatment in an endotoxemia mouse model of sepsis. In vivo protection correlates with a reduction in plasma levels of both tumor necrosis factor a and prostaglandin E, as a likely consequence of Pep19-2.5 and ibuprofen-dependent blockade of TLR4 and COX pro-inflammatory cascades, respectively. This finding is further characterised and confirmed in a transcriptome analysis of LPS-stimulated human monocytes. The transcriptome analyses showed that Pep19-2.5 and ibuprofen exerted a synergistic global effect both on the number of regulated genes as well as on associated gene ontology and pathway expression. Overall, ibuprofen potentiated the anti-inflammatory activity of Pep19-2.5 both in vivo and in vitro, suggesting that NSAIDs could be useful to supplement future anti-sepsis therapies.	[Heinbockel, Lena; Marwitz, Sebastian] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Clin & Expt Pathol, Borstel, Germany; [Barcena Varela, Sergio; Ferrer-Espada, Raquel; Martinez de Tejada, Guillermo] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Reiling, Norbert; Brandenburg, Klaus] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Microbial Interface Biol, Borstel, Germany; [Gutsmann, Thomas] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Biophys, Borstel, Germany; [Mier, Walter] Univ Heidelberg Hosp, Dept Nucl Med, Heidelberg, Germany; [Schuerholz, Tobias] Univ Hosp Aachen, Dept Intens Care, Aachen, Germany; [Droemann, Daniel] Univ Schleswig Holstein, Med Clin 3, Lubeck, Germany	Forschungszentrum Borstel; University of Navarra; Forschungszentrum Borstel; Forschungszentrum Borstel; Ruprecht Karls University Heidelberg; RWTH Aachen University; RWTH Aachen University Hospital; University of Kiel; Schleswig Holstein University Hospital	Brandenburg, K (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Microbial Interface Biol, Borstel, Germany.	kbrandenburg@fz-borstel.de	Goldmann, Torsten/E-5906-2010; Martinez-de-Tejada, Guillermo/AAT-8535-2020; Schuerholz, Tobias/E-8071-2011; Martinez-de-Tejada, Guillermo/H-3849-2017; Marwitz, Sebastian/P-5316-2016; Marwitz, Sebastian/P-2900-2019; Gutsmann, Thomas/E-6100-2011; Reiling, Norbert/D-6796-2013	Goldmann, Torsten/0000-0002-1621-560X; Martinez-de-Tejada, Guillermo/0000-0003-3755-451X; Martinez-de-Tejada, Guillermo/0000-0003-3755-451X; Marwitz, Sebastian/0000-0003-4920-5552; Marwitz, Sebastian/0000-0003-4920-5552; Ferrer-Espada, Raquel/0000-0002-5711-5349; Schuerholz, Tobias/0000-0003-3830-3499; Reiling, Norbert/0000-0001-6673-4291; Lazaro-Anton, Leticia/0000-0001-7720-5627	Else-Kroner-Fresenius Stiftung [2011_A140]; Deutsche Forschungsgemeinschaft (DFG) [DR797/3-1 611672]; Proyectos de Investigacion Universidad de Navarra, Spain [PIUNA-P2011-17]; Asociacion de Amigos de la Universidad de Navarra; Gobierno Vasco, Spain	Else-Kroner-Fresenius Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Proyectos de Investigacion Universidad de Navarra, Spain; Asociacion de Amigos de la Universidad de Navarra; Gobierno Vasco, Spain(Basque Government)	Research at the laboratories of the authors is supported by the Else-Kroner-Fresenius Stiftung (project 2011_A140), and the Deutsche Forschungsgemeinschaft (DFG, project DR797/3-1 611672). G.M.T. was also funded by a grant from Proyectos de Investigacion Universidad de Navarra (PIUNA-P2011-17), Spain. S.B.V. and R.F.E. were recipients of doctoral fellowships from "Asociacion de Amigos de la Universidad de Navarra" and from Gobierno Vasco, Spain, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Aronoff DM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/696897; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; Celik I, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-26; Cohen J, 2009, CLIN MICROBIOL INFEC, V15, P302, DOI 10.1111/j.1469-0691.2009.02753.x; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Fink MP, 2014, NAT REV DRUG DISCOV, V13, P741, DOI 10.1038/nrd4368; Fink MP, 2001, AM J PHYSIOL-LUNG C, V281, pL534, DOI 10.1152/ajplung.2001.281.3.L534; Garidel P, 2005, BBA-BIOMEMBRANES, V1715, P122, DOI 10.1016/j.bbamem.2005.07.013; GRAGEGRIEBENOW E, 1993, EUR J IMMUNOL, V23, P3126, DOI 10.1002/eji.1830231213; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Heinbockel L, 2013, ANTIMICROB AGENTS CH, V57, P1480, DOI 10.1128/AAC.02066-12; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Kumar A, 2014, VIRULENCE, V5, P80, DOI 10.4161/viru.26913; LEONG D, 1970, Infection and Immunity, V1, P174; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; LUDERITZ O, 1965, J BACTERIOL, V89, P343; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; MansillaRosello A, 1997, J SURG RES, V67, P199, DOI 10.1006/jsre.1996.4982; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Nagai M, 2011, THER APHER DIAL, V15, P342, DOI 10.1111/j.1744-9987.2011.00966.x; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Opal SM, 2014, AM J RESP CRIT CARE, V189, P242, DOI 10.1164/rccm.201312-2292ED; Rubinow KB, 2013, J BIOL CHEM, V288, P9957, DOI 10.1074/jbc.M113.458372; Schuerholz T, 2013, CRIT CARE, V17, DOI 10.1186/cc11920; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Tschoeke SK, 2006, CRIT CARE MED, V34, P1225, DOI 10.1097/01.CCM.0000208356.05575.16; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	36	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133291	10.1371/journal.pone.0133291	http://dx.doi.org/10.1371/journal.pone.0133291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197109	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600081
J	Suwannarong, K; Chapman, RS; Lantican, C; Michaelides, T; Zimicki, S				Suwannarong, Kanokwan; Chapman, Robert S.; Lantican, Cecile; Michaelides, Tula; Zimicki, Susan			Hunting, Food Preparation, and Consumption of Rodents in Lao PDR	PLOS ONE			English	Article							NORTHEASTERN THAILAND; BORNE DISEASES; SCRUB TYPHUS; RISK-FACTORS; LEPTOSPIROSIS; VIRUS; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS; INFECTION	A cross-sectional study was conducted in 29 villages of Khamkeuth District in Bolikhamxay Province in the Lao PDR during March to May 2013. The study aimed to determine the characteristics associated with rodent consumption and related behaviors among different ethnic groups, ages, and genders. Five-hundred-eighty-four (584) males and females from 18-50 years of age participated in this study. Half of them were Hmong (292, 50%) while 152 respondents were Lao-Tai (26%) or other ethnic groups (140, 24%). Most of the respondents (79.5%) had farming as their main occupation. Prevalences of the studied outcomes were high: 39.9 for hunting or capturing rodents in the previous year, 77.7% for preparing rodents as food, and 86.3% for rodent consumption. Multivariable logistic regression analysis showed that likelihood of these types of rodent contact was more consistently associated with behavioral factors (gathering things from the forest and elsewhere, cultivation-related activities, and taking measures to prevent rodent-borne disease) than with socio-demographic, environmental, or cultural factors. The strongest associations were observed for gathering things; these associations were consistently positive and statistically significant. Although this study did not directly assess rodent-borne zoonosis risk, we believe that study findings raise concern that such risk may be substantial in the study area and other similar areas. Further epidemiological studies on the association between rodent-borne disease infection and rodent hunting, preparation for food, and consumption are recommended. Moreover, further studies are needed on the association between these potential exposure factors (i.e., rodent hunting, preparation for food, and consumption) and rodent-borne infections, especially among ethnic groups like the Hmong in Lao PDR and those in neighboring countries with similar socio-demographic, environmental, behavioral and cultural contexts.	[Suwannarong, Kanokwan] APRO, FHI 360, Bangkok, Thailand; [Suwannarong, Kanokwan; Chapman, Robert S.] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand; [Lantican, Cecile] Lao PDR Off, FHI 360, Viangchan, Laos; [Michaelides, Tula; Zimicki, Susan] Washington DC Off, FHI 360, Washington, DC USA	Chulalongkorn University	Suwannarong, K (corresponding author), APRO, FHI 360, Bangkok, Thailand.	kanokwan27@yahoo.com			PREVENT Project [GHN-A-00-09-00002-00]; American people through the United States Agency for International Development (USAID)	PREVENT Project; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The EPT/PREVENT Project allowed authors to access, analyze and publish this data. The PREVENT Project was implemented by FHI 360 under USAID Cooperative Agreement GHN-A-00-09-00002-00; this study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin KP, 2007, RICE LAOS RICE LAOS, P291; Assogbadjo AE, 2005, BELG J ZOOL, V135, P11; Bank W, 2011, LAO PDR EC MONITOR; Bank W, 2010, NATURAL RESOURCE MAN; Blasdell K, 2011, ECOHEALTH, V8, P432, DOI 10.1007/s10393-011-0725-7; Blasdell Kim, 2009, Kasetsart Journal Natural Sciences, V43, P94; Bordes F, 2015, J ANIM ECOL; Bourgeois Luthi N, 2012, DESK REV EXPOSURE HU; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; de Araujo WN, 2013, AM J TROP MED HYG, V88, P359, DOI 10.4269/ajtmh.2012.12-0245; Duckworth J.W., 1999, WILDLIFE LAO PDR 199; ELBEL RE, 1957, AM J TROP MED HYG, V6, P280, DOI 10.4269/ajtmh.1957.6.280; Fiedler LA., 1990, P 14 VERT PEST C 199; Gamage CD, 2011, JPN J INFECT DIS, V64, P72; GRATZ NG, 1973, ISRAEL J MED SCI, V9, P969; Hugot JP, 2001, INFECT GENET EVOL, V1, P13, DOI 10.1016/S1567-1348(01)00003-X; ICEM, 2003, LAO PDR NAT REP PROT; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; KISH L, 1965, AM SOCIOL REV, V30, P564, DOI 10.2307/2091346; Kunarattanapruk K CJ, 1998, FOOD NUTR BULL, V19; Lerdthusnee K, 2003, ANN NY ACAD SCI, V990, P25, DOI 10.1111/j.1749-6632.2003.tb07333.x; Lerdthusnee K, 2008, INTEGR ZOOL, V3, P267, DOI 10.1111/j.1749-4877.2008.00100.x; LIMPAKARNJANARAT K, 1987, Journal of the Medical Association of Thailand, V70, P243; Meerburg BG, 2006, TIJDSCHR DIERGENEESK, V131, P445; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Ministry of Communication T Post and Construction (MoC) and IUCN, 2000, BOL PROV ENV INV, P77; Nitatpattana N, 2002, TROP MED INT HEALTH, V7, P840, DOI 10.1046/j.1365-3156.2002.00830.x; Nitatpattana Narong, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P277; OOSTEROM J, 1991, INT J FOOD MICROBIOL, V12, P41, DOI 10.1016/0168-1605(91)90046-R; Panaphut Thanachai, 2002, International Journal of Infectious Diseases, V6, P52, DOI 10.1016/S1201-9712(02)90137-2; Parola P, 2003, ANN NY ACAD SCI, V990, P173, DOI 10.1111/j.1749-6632.2003.tb07359.x; Sale JB, 1983, IMPORTANCE VALUES WI, P44; Setalaphruk C, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-33; Shih CM, 1997, J CLIN MICROBIOL, V35, P450, DOI 10.1128/JCM.35.2.450-454.1997; Somnasang P RP, 1987, RAPID RURAL APPRAISA, P20; Somnasang Prapimporn, 1998, Food and Nutrition Bulletin, V19, P359; Suwannarong K, 2014, J HEALTH RES, V28, P59; Suwannarong K, 2014, SE ASIAN J TROP MED, V45, P1209; Tangkanakul W., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P281; Tangkanakul W, 2000, AM J TROP MED HYG, V63, P204, DOI 10.4269/ajtmh.2000.63.204; Tangkanakul Waraluk, 2001, Journal of the Medical Association of Thailand, V84, P1674; terMeulen J, 1996, AM J TROP MED HYG, V55, P661; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; Vongkhamheng C, 2002, PARTICIPATORY WILDLI; Walker DH, 1996, JAMA-J AM MED ASSOC, V275, P463, DOI 10.1001/jama.275.6.463; Watson DC, 2014, CRIT REV MICROBIOL, V40, P261, DOI 10.3109/1040841X.2013.783555; Woldehanna S, 2011, PREVENT PILOT UNPUB; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; WWF, 2006, WWF TECHN PAP SER, V8; Yaita K, 2013, INTERNAL MED, V52, P1439, DOI 10.2169/internalmedicine.52.0343	52	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133150	10.1371/journal.pone.0133150	http://dx.doi.org/10.1371/journal.pone.0133150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196134	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600065
J	Via, E; Soriano-Mas, C; Sanchez, I; Forcano, L; Harrison, BJ; Davey, CG; Pujol, J; Martinez-Zalacain, I; Menchon, JM; Fernandez-Aranda, F; Cardoner, N				Via, Esther; Soriano-Mas, Carles; Sanchez, Isabel; Forcano, Laura; Harrison, Ben J.; Davey, Christopher G.; Pujol, Jesus; Martinez-Zalacain, Ignacio; Menchon, Jose M.; Fernandez-Aranda, Fernando; Cardoner, Narcis			Abnormal Social Reward Responses in Anorexia Nervosa: An fMRI Study	PLOS ONE			English	Article							ALTERED INSULA RESPONSE; EATING-DISORDERS; INDIVIDUAL-DIFFERENCES; FRONTAL-CORTEX; BRAIN; SENSITIVITY; PUNISHMENT; SELF; MODELS; QUESTIONNAIRE	Patients with anorexia nervosa (AN) display impaired social interactions, implicated in the development and prognosis of the disorder. Importantly, social behavior is modulated by reward-based processes, and dysfunctional at-brain-level reward responses have been involved in AN neurobiological models. However, no prior evidence exists of whether these neural alterations would be equally present in social contexts. In this study, we conducted a cross-sectional social-judgment functional magnetic resonance imaging (fMRI) study of 20 restrictive-subtype AN patients and 20 matched healthy controls. Brain activity during acceptance and rejection was investigated and correlated with severity measures (Eating Disorder Inventory -EDI-2) and with personality traits of interest known to modulate social behavior (The Sensitivity to Punishment and Sensitivity to Reward Questionnaire). Patients showed hypoactivation of the dorsomedial prefrontal cortex (DMPFC) during social acceptance and hyperactivation of visual areas during social rejection. Ventral striatum activation during rejection was positively correlated in patients with clinical severity scores. During acceptance, activation of the frontal opercula-anterior insula and dorsomedial/dorsolateral prefrontal cortices was differentially associated with reward sensitivity between groups. These results suggest an abnormal motivational drive for social stimuli, and involve overlapping social cognition and reward systems leading to a disruption of adaptive responses in the processing of social reward. The specific association of reward-related regions with clinical and psychometric measures suggests the putative involvement of reward structures in the maintenance of pathological behaviors in AN.	[Via, Esther; Soriano-Mas, Carles; Sanchez, Isabel; Forcano, Laura; Martinez-Zalacain, Ignacio; Menchon, Jose M.; Fernandez-Aranda, Fernando; Cardoner, Narcis] Bellvitge Univ Hosp, IDIBELL, Barcelona, Spain; [Via, Esther; Menchon, Jose M.; Fernandez-Aranda, Fernando; Cardoner, Narcis] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Via, Esther; Harrison, Ben J.; Davey, Christopher G.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic, Australia; [Soriano-Mas, Carles; Menchon, Jose M.; Cardoner, Narcis] Inst Salud Carlos III, CIBER Salud Mental CIBERSAM, Barcelona, Spain; [Soriano-Mas, Carles] Univ Autonoma Barcelona, Dept Psychobiol & Methodol Hlth Sci, E-08193 Barcelona, Spain; [Forcano, Laura] Hosp Mar, IMIM Res Inst, Clin Res Grp Human Pharmacol & Neurosci, Barcelona, Spain; [Forcano, Laura; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Barcelona, Spain; [Davey, Christopher G.] Natl Ctr Excellence Youth Mental Hlth, Orygen, Melbourne, Vic, Australia; [Pujol, Jesus] Hosp Mar, MRI Res Unit, CIBERSAM G21, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Melbourne; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Orygen, The National Centre of Excellence in Youth Mental Health; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Soriano-Mas, C (corresponding author), Bellvitge Univ Hosp, IDIBELL, Barcelona, Spain.	csoriano@idibell.cat; ncadoner@bellvitgehospital.cat	FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Cardoner, Narcis/H-8436-2015; Davey, Christopher G/B-3517-2011; Fernandez-Aranda, Fernando/L-9762-2014; Via, Esther/A-4503-2017; FORCANO, LAURA/AAP-1933-2020; Díaz, Isabel M Sánchez/G-7277-2017; Gamazo, Laura Forcano/B-1154-2017; Cardoner, Narcis/AAD-5449-2022; Soriano-Mas, Carles/E-4028-2019; Menchon, Jose/A-5242-2009	FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Davey, Christopher G/0000-0003-1431-3852; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Via, Esther/0000-0002-2331-3232; FORCANO, LAURA/0000-0002-8478-1451; Díaz, Isabel M Sánchez/0000-0001-5874-8204; Gamazo, Laura Forcano/0000-0002-8478-1451; Cardoner, Narcis/0000-0001-9633-0888; Soriano-Mas, Carles/0000-0003-4574-6597; Martinez-Zalacain, Ignacio/0000-0002-4036-0284; Menchon, Jose/0000-0002-6231-6524	Carlos III Health Institute (ISCIII) [PI08/1549, PI11/210, PI14/290]; Fondos Europeos de Desarrollo Regional (FEDER); Carlos III Health Institute [CP10/00604]; National Health and Medical Research Council of Australia (NHMRC) Clinical Career Development Fellowship [628509]; NHMRC Clinical Career Development Fellowship [1061757]	Carlos III Health Institute (ISCIII)(Instituto de Salud Carlos III); Fondos Europeos de Desarrollo Regional (FEDER)(European Commission); Carlos III Health Institute(Instituto de Salud Carlos III); National Health and Medical Research Council of Australia (NHMRC) Clinical Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Clinical Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported in part by the Carlos III Health Institute (ISCIII, PI08/1549, PI11/210 and PI14/290) and by Fondos Europeos de Desarrollo Regional (FEDER). CIBERobn and CIBERSAM are both initiatives of ISCIII.). Dr. Soriano-Mas is funded by a 'Miguel Servet' contract from the Carlos III Health Institute (I.D. CP10/00604). A/Prof. Harrison is supported by a National Health and Medical Research Council of Australia (NHMRC) Clinical Career Development Fellowship (I.D. 628509). Dr. Davey is supported by a NHMRC Clinical Career Development Fellowship (I.D. 1061757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association Association AP, 2000, DIAGNOSTIC AND STATI; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Avila C, 2008, NEUROTOX RES, V14, P191, DOI 10.1007/BF03033810; Beck I, 2009, PERS INDIV DIFFER, V47, P407, DOI 10.1016/j.paid.2009.04.007; Bergh C, 1996, NAT MED, V2, P21, DOI 10.1038/nm0196-21; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Bruhl AB, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv020; Cardi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113191; Cardi V, 2013, WORLD J BIOL PSYCHIA, V14, P622, DOI 10.3109/15622975.2012.665479; Caria A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00038; Chase HW, 2015, COGN AFFECT BEHAV NE, V15, P435, DOI 10.3758/s13415-015-0338-7; Chavez M, 2007, AM PSYCHOL, V62, P159, DOI 10.1037/0003-066X.62.3.159; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Costumero V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066940; Cowdrey FA, 2011, BIOL PSYCHIAT, V70, P736, DOI 10.1016/j.biopsych.2011.05.028; Daniel R, 2014, NEUROBIOL LEARN MEM, V114, P90, DOI 10.1016/j.nlm.2014.05.002; Davey CG, 2011, BIOL PSYCHIAT, V69, P734, DOI 10.1016/j.biopsych.2010.12.004; Davey CG, 2010, HUM BRAIN MAPP, V31, P660, DOI 10.1002/hbm.20895; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Eisenberger NI, 2012, PSYCHOSOM MED, V74, P126, DOI 10.1097/PSY.0b013e3182464dd1; Fareri DS, 2014, NEUROSCIENTIST, V20, P387, DOI 10.1177/1073858414521869; First MB, 2002, STRUCTURED CLINICAL; First MB, 2007, STRUCTURED CLINICAL; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Frank GKW, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0396-x; Frank GKW, 2012, NEUROPSYCHOPHARMACOL, V37, P2031, DOI 10.1038/npp.2012.51; Garner D.M., 1991, EATING DISORDER INVE; Glashouwer KA, 2014, APPETITE, V75, P97, DOI 10.1016/j.appet.2013.12.019; Gray JA, 1991, NEUROBIOLOGY LEARNIN, P273; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harrison A, 2010, PSYCHOL MED, V40, P1887, DOI 10.1017/S0033291710000036; Harrison A, 2012, BRIT J CLIN PSYCHOL, V51, P261, DOI 10.1111/j.2044-8260.2011.02026.x; Harrison A, 2011, PSYCHIAT RES, V188, P396, DOI 10.1016/j.psychres.2011.04.022; Harrison A, 2010, PSYCHIAT RES, V177, P1, DOI 10.1016/j.psychres.2009.06.010; Hsu DT, 2013, MOL PSYCHIATR, V18, P1211, DOI [10.1038/mp.2013.139, 10.1038/mp.2013.96]; Isoda M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00232; Ivanov I, 2014, EUR NEUROPSYCHOPHARM, V24, P897, DOI 10.1016/j.euroneuro.2014.01.017; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Jiang T, 2010, PSYCHIAT RES, V180, P42, DOI 10.1016/j.psychres.2010.04.041; Karwautz AFK, 2011, MOL PSYCHIATR, V16, P590, DOI 10.1038/mp.2010.125; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Keating C, 2012, NEUROPSYCHOLOGIA, V50, P567, DOI 10.1016/j.neuropsychologia.2012.01.036; Keating C, 2010, NEUROSCI BIOBEHAV R, V34, P73, DOI 10.1016/j.neubiorev.2009.07.004; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kim SF, 2012, NEUROSCIENCE, V211, P2, DOI 10.1016/j.neuroscience.2012.03.024; Kim YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090721; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kontis D, 2012, BEHAV PHARMACOL, V23, P496, DOI 10.1097/FBP.0b013e328357e115; Krach S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00022; Krug I, 2013, EUR EAT DISORD REV, V21, P202, DOI 10.1002/erv.2204; Krug I, 2013, J HEALTH PSYCHOL, V18, P26, DOI 10.1177/1359105311435946; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; LOBO A, 1986, PSYCHOL MED, V16, P135, DOI 10.1017/S0033291700002579; Martinez A., 1998, AR FACE DATABASE; Matton A, 2013, EUR EAT DISORD REV, V21, P184, DOI 10.1002/erv.2226; McAdams CJ, 2014, SOC COGN AFFECT NEUR, V9, P12, DOI 10.1093/scan/nss093; Mitchell JP, 2006, SOC COGN AFFECT NEUR, V1, P49, DOI 10.1093/scan/nsl007; Moor BG, 2010, SOC NEUROSCI-UK, V5, P461, DOI 10.1080/17470910903526155; National Collaborating Centre or Mental Health commissioned by the National Institute for Clinical Excellence, 2004, NATIONAL CLINICAL PR; Oberndorfer TA, 2013, AM J PSYCHIAT, V170, P1143, DOI 10.1176/appi.ajp.2013.11111745; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Park RJ, 2011, INT J COGN THER, V4, P415, DOI 10.1521/ijct.2011.4.4.415; Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0; Renwick B, 2013, EUR EAT DISORD REV, V21, P464, DOI 10.1002/erv.2248; Rieger E, 2010, CLIN PSYCHOL REV, V30, P400, DOI 10.1016/j.cpr.2010.02.001; Rolls ET, 2015, PROG NEUROBIOL, V127, P64, DOI 10.1016/j.pneurobio.2015.03.002; Schienle A, 2010, NEUROSCI LETT, V479, P272, DOI 10.1016/j.neulet.2010.05.078; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schulte-Ruther M, 2012, J AM ACAD CHILD PSY, V51, P832, DOI 10.1016/j.jaac.2012.06.007; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Sodersten P, 2008, FRONT NEUROENDOCRIN, V29, P445, DOI 10.1016/j.yfrne.2008.06.001; Sternheim L, 2011, EUR EAT DISORD REV, V19, P12, DOI 10.1002/erv.1029; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Treasure J, 2012, EUR EAT DISORD REV, V20, P431, DOI 10.1002/erv.2181; Via E, 2014, J PSYCHIATR NEUROSCI, V39, P367, DOI 10.1503/jpn.130135; Vocks S, 2011, J PSYCHIATR RES, V45, P395, DOI 10.1016/j.jpsychires.2010.07.012; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Wagner A, 2008, NEUROPSYCHOPHARMACOL, V33, P513, DOI 10.1038/sj.npp.1301443; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Watson KK, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00036; Zink CF, 2010, NAT MED, V16, P1382, DOI 10.1038/nm1210-1382; Zucker NL, 2007, PSYCHOL BULL, V133, P976, DOI 10.1037/0033-2909.133.6.976	90	40	40	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133539	10.1371/journal.pone.0133539	http://dx.doi.org/10.1371/journal.pone.0133539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197051	Green Published, gold			2022-12-27	WOS:000358547600111
J	Zhang, N; Liang, HY; Farese, RV; Li, J; Musi, N; Hussey, SE				Zhang, Ning; Liang, Hanyu; Farese, Robert V.; Li, Ji; Musi, Nicolas; Hussey, Sophie E.			Pharmacological TLR4 Inhibition Protects against Acute and Chronic Fat-Induced Insulin Resistance in Rats	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; ADIPOSE-TISSUE; ENDOTOXIN ANTAGONIST; SEVERE SEPSIS; TAK-242; OBESITY; ACID; MICE; MUTATION; INFLAMMATION	Aims To evaluate whether pharmacological TLR4 inhibition protects against acute and chronic fat-induced insulin resistance in rats. Materials and Methods For the acute experiment, rats received a TLR4 inhibitor [TAK-242 or E5564 (2x5 mg/kg i.v. bolus)] or vehicle, and an 8-h Intralipid (20%, 8.5 mg/kg/min) or saline infusion, followed by a two-step hyperinsulinemic-euglycemic clamp. For the chronic experiment, rats were subcutaneously implanted with a slow-release pellet of TAK-242 (1.5 mg/d) or placebo. Rats then received a high fat diet (HFD) or a low fat control diet (LFD) for 10 weeks, followed by a two-step insulin clamp. Results Acute experiment; the lipid-induced reduction (18%) in insulin-stimulated glucose disposal (Rd) was attenuated by TAK-242 and E5564 (the effect of E5564 was more robust), suggesting improved peripheral insulin action. Insulin was able to suppress hepatic glucose production (HGP) in saline-but not lipid-treated rats. TAK-242, but not E5564, partially restored this effect, suggesting improved HGP. Chronic experiment; insulin-stimulated Rd was reduced similar to 30% by the HFD, but completely restored by TAK-242. Insulin could not suppress HGP in rats fed a HFD and TAK-242 had no effect on HGP. Conclusions Pharmacological TLR4 inhibition provides partial protection against acute and chronic fat-induced insulin resistance in vivo.	[Zhang, Ning; Liang, Hanyu; Li, Ji; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Liang, Hanyu; Li, Ji; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Liang, Hanyu; Musi, Nicolas] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Farese, Robert V.; Hussey, Sophie E.] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA; [Farese, Robert V.; Hussey, Sophie E.] James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Musi, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.	musi@uthscsa.edu; sophiehussey@icloud.com			NIH [1F32DK095565-01A1, RO1-DK80157, RO1-DK089229]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095565, R01DK080157, R01DK089229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (1F32DK095565-01A1) to S. Hussey, and the NIH (RO1-DK80157 and RO1-DK089229) and American Diabetes Association to N. Musi.	Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hughey CC, 2011, J VISUALIZED EXPT JO; Hussey SE, 2013, DIABETOLOGIA; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Lynn M, 2003, J INFECT DIS, V187, P631, DOI 10.1086/367990; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Phielix E, 2012, DIABETES, V61, P2472, DOI 10.2337/db11-1832; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; REAVEN GM, 1988, AM J MED, V85, P106, DOI 10.1016/0002-9343(88)90402-0; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Reyna SM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/107805; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vella A, 2009, DIABETES, V58, P2168, DOI 10.2337/db09-0318; Vijay-Kumar M, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-2; Wolf R, 1992, RADIOACTIVE STABLE I; Yamada M, 2005, J MED CHEM, V48, P7457, DOI 10.1021/jm050623t	37	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132575	10.1371/journal.pone.0132575	http://dx.doi.org/10.1371/journal.pone.0132575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196892	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600040
J	Fuery, A; Richmond, PC; Currie, AJ				Fuery, Angela; Richmond, Peter C.; Currie, Andrew J.			Human Infant Memory B Cell and CD4+T Cell Responses to HibMenCY-TT Glyco-Conjugate Vaccine	PLOS ONE			English	Article							SEROGROUP-C; IMMUNOLOGICAL MEMORY; CAPSULAR POLYSACCHARIDE; ANTIBODY-RESPONSE; PLASMA; AGE; IMMUNIZATION; IMMUNITY; CARRIER; PERSISTENCE	Carrier-specific T cell and polysaccharide-specific B cell memory responses are not well characterised in infants following glyco-conjugate vaccination. We aimed to determine if the number of Meningococcal (Men) C- and Y- specific memory B cells and; number and quality of Tetanus Toxoid (TT) carrier-specific memory CD4+ T cells are associated with polysaccharide-specific IgG post HibMenCY-TT vaccination. Healthy infants received HibMenCY-TT vaccine at 2, 4 and 6 months with a booster at 12 months. Peripheral blood mononuclear cells were isolated and polysaccharide-specific memory B cells enumerated using ELISpot. TT-specific memory CD4+ T cells were detected and phenotyped based on CD154 expression and intracellular TNF-alpha, IL-2 and IFN-gamma expression following stimulation. Functional polysaccharide-specific IgG titres were measured using the serum bactericidal activity (SBA) assay. Polysaccharide-specific Men C-but not Men Y- specific memory B cell frequencies pre-boost (12 months) were significantly associated with post-boost (13 months) SBA titres. Regression analysis showed no association between memory B cell frequencies post-priming (at 6 or 7 months) and SBA at 12 months or 13 months. TT-specific CD4+ T cells were detected at frequencies between 0.001 and 0.112 as a percentage of CD3+ T cells, but their numbers were not associated with SBA titres. There were significant negative associations between SBA titres at M13 and cytokine expression at M7 and M12. Conclusion: Induction of persistent polysaccharide-specific memory B cells prior to boosting is an important determinant of secondary IgG responses in infants. However, polysaccharide-specific functional IgG responses appear to be independent of the number and quality of circulating carrier-specific CD4+ T cells after priming.	[Fuery, Angela; Richmond, Peter C.; Currie, Andrew J.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Fuery, Angela; Richmond, Peter C.] Univ Western Australia, Wesfarmers Ctr Vaccines & Infect Dis, Telethon Kids Inst, Perth, WA 6008, Australia; [Richmond, Peter C.] Princess Margaret Hosp Children, Perth, WA 6008, Australia; [Currie, Andrew J.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; Wesfarmers Limited; University of Western Australia; Murdoch University	Currie, AJ (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, 35 Stirling Highway, Perth, WA 6009, Australia.	a.currie@murdoch.edu.au	Currie, Andrew/C-2778-2015; Richmond, Peter C/G-3379-2012	Richmond, Peter C/0000-0001-7562-7228; Currie, Andrew/0000-0002-5193-3404	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the National Health and Medical Research Council (AJC and PCR; http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Blanchard-Rohner G, 2013, VACCINE, V31, P2441, DOI 10.1016/j.vaccine.2013.03.036; Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324; Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09; Clarke ET, 2013, J IMMUNOL, V191, P6071, DOI 10.4049/jimmunol.1203254; Clutterbuck EA, 2006, IMMUNOLOGY, V119, P328, DOI 10.1111/j.1365-2567.2006.02436.x; Heath PT, 2002, ARCH DIS CHILD, V86, P396, DOI 10.1136/adc.86.6.396; Henneken M, 2010, VACCINE, V28, P2097, DOI 10.1016/j.vaccine.2009.12.039; Jakobsen H, 2006, EUR J IMMUNOL, V36, P287, DOI 10.1002/eji.200535102; Kamboj KK, 2003, J INFECT DIS, V187, P1629, DOI 10.1086/374785; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Kelly DF, 2009, IMMUNOLOGY, V127, P134, DOI 10.1111/j.1365-2567.2008.02934.x; Khatami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101672; Khatami A, 2012, VACCINE, V30, P2831, DOI 10.1016/j.vaccine.2012.02.046; Lee FEH, 2011, J IMMUNOL, V186, P5514, DOI 10.4049/jimmunol.1002932; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Mawas F, 2000, VACCINE, V19, P1159, DOI 10.1016/S0264-410X(00)00314-5; McCool TL, 1999, INFECT IMMUN, V67, P4862, DOI 10.1128/IAI.67.9.4862-4869.1999; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Nolan T, 2007, VACCINE, V25, P8487, DOI 10.1016/j.vaccine.2007.10.013; Nolan T, 2011, PEDIATR INFECT DIS J, V30, P190, DOI 10.1097/INF.0b013e3181fcb2bf; Perrett KP, 2012, J IMMUNOL, V189, P2673, DOI 10.4049/jimmunol.1200451; Pihlgren M, 2006, J IMMUNOL, V176, P165, DOI 10.4049/jimmunol.176.1.165; Pihlgren M, 2001, EUR J IMMUNOL, V31, P939, DOI 10.1002/1521-4141(200103)31:3<939::AID-IMMU939>3.0.CO;2-I; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Rabian C, 2010, CLIN INFECT DIS, V50, P1174, DOI 10.1086/651418; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; van den Biggelaar AHJ, 2009, VACCINE, V27, P1340, DOI 10.1016/j.vaccine.2008.12.046	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133126	10.1371/journal.pone.0133126	http://dx.doi.org/10.1371/journal.pone.0133126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191794	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400058
J	Korndorfer, M; Egloff, B; Schmukle, SC				Korndoerfer, Martin; Egloff, Boris; Schmukle, Stefan C.			A Large Scale Test of the Effect of Social Class on Prosocial Behavior	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; INDIRECT RECIPROCITY; PUBLICATION BIAS; DATA-COLLECTION; CLASS RANK; REPLICATION; TRUST; COMPASSION; HEALTH; POWER	Does being from a higher social class lead a person to engage in more or less prosocial behavior? Psychological research has recently provided support for a negative effect of social class on prosocial behavior. However, research outside the field of psychology has mainly found evidence for positive or u-shaped relations. In the present research, we therefore thoroughly examined the effect of social class on prosocial behavior. Moreover, we analyzed whether this effect was moderated by the kind of observed prosocial behavior, the observed country, and the measure of social class. Across eight studies with large and representative international samples, we predominantly found positive effects of social class on prosociality: Higher class individuals were more likely to make a charitable donation and contribute a higher percentage of their family income to charity (32,090 >= N >= 3,957; Studies 1-3), were more likely to volunteer (37,136 >= N >= 3,964; Studies 4-6), were more helpful (N = 3,902; Study 7), and were more trusting and trustworthy in an economic game when interacting with a stranger (N = 1,421; Study 8) than lower social class individuals. Although the effects of social class varied somewhat across the kinds of prosocial behavior, countries, and measures of social class, under no condition did we find the negative effect that would have been expected on the basis of previous results reported in the psychological literature. Possible explanations for this divergence and implications are discussed.	[Korndoerfer, Martin; Schmukle, Stefan C.] Univ Leipzig, Dept Psychol, D-04109 Leipzig, Germany; [Egloff, Boris] Johannes Gutenberg Univ Mainz, Dept Psychol, D-55122 Mainz, Germany	Leipzig University; Johannes Gutenberg University of Mainz	Korndorfer, M (corresponding author), Univ Leipzig, Dept Psychol, D-04109 Leipzig, Germany.	martin.korndoerfer@uni-leipzig.de	Egloff, Boris/G-2503-2013; Schmukle, Stefan/P-8986-2014	Egloff, Boris/0000-0002-5736-9912; Schmukle, Stefan/0000-0002-6279-9618	German Research Foundation (DFG); University of Leipzig	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig	The authors acknowledge support from the German Research Foundation (DFG) and the University of Leipzig within the program of Open Access Publishing.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Altmann S, 2008, ECON LETT, V99, P454, DOI 10.1016/j.econlet.2007.09.012; Amanatullah ET, 2008, J PERS SOC PSYCHOL, V95, P723, DOI 10.1037/a0012612; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; [Anonymous], 2010, ECONOMIST; Ariely D, 2013, PERSPECT PSYCHOL SCI, V8, P498, DOI 10.1177/1745691613498907; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Ashraf N, 2006, EXP ECON, V9, P193, DOI 10.1007/s10683-006-9122-4; Auten G.E., 2000, DOES ATLAS SHRUG EC, P392; Auten GE, 2002, AM ECON REV, V92, P371, DOI 10.1257/000282802760015793; Balliet D, 2013, PSYCHOL BULL, V139, P1090, DOI 10.1037/a0030939; Bargh JA, 2012, EMOTION, V12, P154, DOI 10.1037/a0023527; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Bem DJ, 2011, J PERS SOC PSYCHOL, V100, P407, DOI 10.1037/a0021524; Ben-Ner A, 2010, J ECON PSYCHOL, V31, P64, DOI 10.1016/j.joep.2009.10.001; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Berlin DIW, 2010, DOC PGEN PERS REL ST; Beyer H, 2010, KOLNER Z SOZIOL SOZ, V62, P681, DOI 10.1007/s11577-010-0115-0; Blanco C, 2008, AM J PSYCHIAT, V165, P905, DOI 10.1176/appi.ajp.2008.07101660; BLAZETEMPLE D, 1992, BRIT J ADDICT, V87, P215; Bonett DG, 2012, CURR DIR PSYCHOL SCI, V21, P409, DOI 10.1177/0963721412459512; Brandt MJ, 2014, J EXP SOC PSYCHOL, V50, P217, DOI 10.1016/j.jesp.2013.10.005; Brandt MJ, 2013, J PERS SOC PSYCHOL, V104, P765, DOI 10.1037/a0031751; Brooks AC, 2004, ADMIN SOC, V36, P166, DOI 10.1177/0095399704263474; Cai HJ, 2012, EUR J PERSONALITY, V26, P529, DOI 10.1002/per.852; Caprara GV, 2012, J PERS SOC PSYCHOL, V102, P1289, DOI 10.1037/a0025626; Chen Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078254, 10.1371/journal.pone.0080879, 10.1371/journal.pone.0080419]; Cheng JT, 2013, PSYCHOL INQ, V24, P102, DOI 10.1080/1047840X.2013.792576; Cleveland W.S., 1996, P STAT THEORY COMPUT, P10; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cote S, 2013, J PERS SOC PSYCHOL, V104, P490, DOI 10.1037/a0030931; Curhan KB, 2014, SOC PSYCHOL PERS SCI, V5, P855, DOI 10.1177/1948550614538461; Diekmann A, 2004, J CONFLICT RESOLUT, V48, P487, DOI 10.1177/0022002704265948; Diemer MA, 2013, ANAL SOC ISS PUB POL, V13, P77, DOI 10.1111/asap.12001; Diemer MA, 2009, J CAREER ASSESSMENT, V17, P247, DOI 10.1177/1069072708330462; Donnellan MB, 2015, EMOTION, V15, P109, DOI 10.1037/a0036079; Dovidio JF., 2006, SOCIAL PSYCHOL PROSO; Duarte JL, BEHAV BRAIN IN PRESS; Dubois D, 2015, J PERS SOC PSYCHOL, V108, P436, DOI 10.1037/pspi0000008; Egloff B, 2013, P NATL ACAD SCI USA, V110, pE786, DOI 10.1073/pnas.1221451110; Foster JD, 2003, J RES PERS, V37, P469, DOI 10.1016/S0092-6566(03)00026-6; Francis G., 2012, CHECKING COUNTERARGU; Francis G, 2014, PSYCHON B REV, V21, P1180, DOI 10.3758/s13423-014-0601-x; Francis G, 2012, P NATL ACAD SCI USA, V109, pE1587, DOI 10.1073/pnas.1203591109; Francis G, 2012, PSYCHON B REV, V19, P151, DOI 10.3758/s13423-012-0227-9; Frey BS, 2004, AM ECON REV, V94, P1717, DOI 10.1257/0002828043052187; Galak J, 2012, J PERS SOC PSYCHOL, V103, P933, DOI 10.1037/a0029709; Gallo LC, 2005, J PERS SOC PSYCHOL, V88, P386, DOI 10.1037/0022-3514.88.2.386; Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; Gittell R, 2006, NONPROF VOLUNT SEC Q, V35, P721, DOI 10.1177/0899764006289768; Glazer A, 1996, AM ECON REV, V86, P1019; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; GREENWALD AG, 1986, PSYCHOL REV, V93, P216, DOI 10.1037/0033-295X.93.2.216; Greve F., 2009, SEATTLE TIMES; Grossmann I, 2014, WIRES COGN SCI, V5, P1, DOI 10.1002/wcs.1267; Grossmann I, 2013, PSYCHOL INQ, V24, P112, DOI 10.1080/1047840X.2013.792568; Guinote A, 2015, P NATL ACAD SCI USA, V112, P731, DOI 10.1073/pnas.1414550112; Hagenaars AJM, 1996, POVERTY STATISTICS I; Hodgkinson V.A., 1992, GIVING VOLUNTEERING; Hughes P, 2008, NONPROF VOLUNT SEC Q, V37, P264, DOI 10.1177/0899764007310416; Ijzerman H, 2013, EUR J PERSONALITY, V27, P128; Independent Sector, 2002, GIV VOL US; International Labour Organisation, 1990, ISCO88 ILO; James RN, 2007, NONPROF VOLUNT SEC Q, V36, P218, DOI 10.1177/0899764006295993; Johns A, 2010, NATL TAX J, V63, P397, DOI 10.17310/ntj.2010.3.01; Johnson ND, 2011, J ECON PSYCHOL, V32, P865, DOI 10.1016/j.joep.2011.05.007; Kaufmann Franz-Xaver., 2013, VARIATIONS WELFARE S; Keltner D, 2014, ANNU REV PSYCHOL, V65, P425, DOI 10.1146/annurev-psych-010213-115054; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P307; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; KLEIN WM, 1993, PERS SOC PSYCHOL B, V19, P732, DOI 10.1177/0146167293196008; Kraus MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085293; Kraus MW, 2013, J PERS SOC PSYCHOL, V105, P247, DOI 10.1037/a0032895; Kraus MW, 2013, PSYCHOL INQ, V24, P81, DOI 10.1080/1047840X.2013.778803; Kraus MW, 2012, PSYCHOL REV, V119, P546, DOI 10.1037/a0028756; Kraus MW, 2011, CURR DIR PSYCHOL SCI, V20, P246, DOI 10.1177/0963721411414654; Kraus MW, 2011, PERS SOC PSYCHOL B, V37, P1376, DOI 10.1177/0146167211410987; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Kraus MW, 2009, J PERS SOC PSYCHOL, V97, P992, DOI 10.1037/a0016357; Kraus MW, 2009, PSYCHOL SCI, V20, P99, DOI 10.1111/j.1467-9280.2008.02251.x; Kraus MW, 2014, NOTES REPLICATION UN; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037/0022-3514.74.3.763; Lee YK, 2007, SOC BEHAV PERSONAL, V35, P1173, DOI 10.2224/sbp.2007.35.9.1173; Liddell Pearson, 2013, STAT INCOME B    WIN, p[64, 65]; LOADER C, 1997, STAT COMPUT GRAPH NE, V8, P11; Martin R., 2009, J SOCIO-ECON, V38, P722, DOI DOI 10.1016/J.S0CEC.2009.03.010; Martin R, 2008, J ECON BEHAV ORGAN, V67, P228, DOI 10.1016/j.jebo.2007.08.001; Maxwell SE, 2004, PSYCHOL METHODS, V9, P147, DOI 10.1037/1082-989X.9.2.147; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Organization for Economic Cooperation and Development, 1982, THE OECD LIST OF SOC; Organization for Economic Cooperation and Development, 1999, CLASSIFYING EDUCATIO; Oveis C, 2010, J PERS SOC PSYCHOL, V98, P618, DOI 10.1037/a0017628; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Park J, 2013, EMOTION, V13, P1122, DOI 10.1037/a0034273; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Piff PK, 2014, PERS SOC PSYCHOL B, V40, P34, DOI 10.1177/0146167213501699; Piff PK, 2012, P NATL ACAD SCI USA, V109, pE1588, DOI 10.1073/pnas.1205367109; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; Raihani NJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0884; Rajan SS, 2009, NONPROF VOLUNT SEC Q, V38, P413, DOI 10.1177/0899764008316056; Ramirez-Valles J., 2006, INT J VOLUNTEER ADM, V24, P15; Reed PB, 2001, NONPROF VOLUNT SEC Q, V30, P761, DOI 10.1177/0899764001304008; Rotolo T, 2007, SOCIOL QUART, V48, P559, DOI 10.1111/j.1533-8525.2007.00089.x; Rotolo T, 2007, NONPROF VOLUNT SEC Q, V36, P487, DOI 10.1177/0899764006296848; Schervish P.G., 1995, VOLUNTAS, V6, P202; SCHERVISH PG, 1995, NONPROF VOLUNT SEC Q, V24, P79, DOI 10.1177/089976409502400109; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Schlegelmilch B. B., 1989, J MARKETING MANAGEME, V5, P133, DOI DOI 10.1080/0267257X.1989.9964095; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Schwarze J, 1995, SIMULATING GERMAN IN; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simpson B, 2008, SOC PSYCHOL QUART, V71, P37, DOI 10.1177/019027250807100106; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Snibbe AC, 2005, J PERS SOC PSYCHOL, V88, P703, DOI 10.1037/0022-3514.88.4.703; Specht J, 2013, DEV PSYCHOL, V49, P353, DOI 10.1037/a0028243; Stellar JE, 2012, EMOTION, V12, P449, DOI 10.1037/a0026508; Stephens NM, 2012, J PERS SOC PSYCHOL, V102, P1178, DOI 10.1037/a0027143; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Sutter M, 2007, GAME ECON BEHAV, V59, P364, DOI 10.1016/j.geb.2006.07.006; Swann WB, 2010, J PERS SOC PSYCHOL, V99, P824, DOI 10.1037/a0020014; TIBSHIRANI R, 1987, J AM STAT ASSOC, V82, P559, DOI 10.2307/2289465; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Trautmann ST, 2013, PERSPECT PSYCHOL SCI, V8, P487, DOI 10.1177/1745691613491272; Treiman D.J., 1977, OCCUPATIONAL PRESTIG; U.S. Census Bureau for the Bureau of Labor Statistics, 2013, VOL US 2012; UNESCO, 1997, INTERNATIONAL STANDA; van Kleef GA, 2008, PSYCHOL SCI, V19, P1315, DOI 10.1111/j.1467-9280.2008.02241.x; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Wagner G. G., 2007, SCHMOLLERS JB, V127, P139, DOI DOI 10.2139/SSRN.1028709; Wang L, 2014, J BUS ETHICS, V125, P163, DOI 10.1007/s10551-013-1914-9; Warner J., 2010, NEW YORK TIMES MAGAZ; WHELAN CT, 1994, EUR SOCIOL REV, V10, P49, DOI 10.1093/oxfordjournals.esr.a036315	140	112	115	10	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133193	10.1371/journal.pone.0133193	http://dx.doi.org/10.1371/journal.pone.0133193			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26193099	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400065
J	Leal, MF; Astur, DC; Debieux, P; Arliani, GG; Franciozi, CES; Loyola, LC; Andreoli, CV; Smith, MC; Pochini, AD; Ejnisman, B; Cohen, M				Leal, Mariana Ferreira; Astur, Diego Costa; Debieux, Pedro; Arliani, Gustavo Goncalves; Silveira Franciozi, Carlos Eduardo; Loyola, Leonor Casilla; Andreoli, Carlos Vicente; Smith, Marilia Cardoso; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises			Identification of Suitable Reference Genes for Investigating Gene Expression in Anterior Cruciate Ligament Injury by Using Reverse Transcription-Quantitative PCR	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; NORMALIZATION; TISSUES; SELECTION; COLLAGEN	The anterior cruciate ligament (ACL) is one of the most frequently injured structures during high-impact sporting activities. Gene expression analysis may be a useful tool for understanding ACL tears and healing failure. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) has emerged as an effective method for such studies. However, this technique requires the use of suitable reference genes for data normalization. Here, we evaluated the suitability of six reference genes (18S, ACTB, B2M, GAPDH, HPRT1, and TBP) by using ACL samples of 39 individuals with ACL tears (20 with isolated ACL tears and 19 with ACL tear and combined meniscal injury) and of 13 controls. The stability of the candidate reference genes was determined by using the NormFinder, geNorm, BestKeeper DataAssist, and RefFinder software packages and the comparative Delta Ct method. ACTB was the best single reference gene and ACTB+TBP was the best gene pair. The GenEx software showed that the accumulated standard deviation is reduced when a larger number of reference genes is used for gene expression normalization. However, the use of a single reference gene may not be suitable. To identify the optimal combination of reference genes, we evaluated the expression of FN1 and PLOD1. We observed that at least 3 reference genes should be used. ACTB+HPRT1+18S is the best trio for the analyses involving isolated ACL tears and controls. Conversely, ACTB+TBP+18S is the best trio for the analyses involving (1) injured ACL tears and controls, and (2) ACL tears of patients with meniscal tears and controls. Therefore, if the gene expression study aims to compare non-injured ACL, isolated ACL tears and ACL tears from patients with meniscal tear as three independent groups ACTB+TBP+18S+HPRT1 should be used. In conclusion, 3 or more genes should be used as reference genes for analysis of ACL samples of individuals with and without ACL tears.	[Leal, Mariana Ferreira; Astur, Diego Costa; Debieux, Pedro; Arliani, Gustavo Goncalves; Silveira Franciozi, Carlos Eduardo; Loyola, Leonor Casilla; Andreoli, Carlos Vicente; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises] Univ Fed Sao Paulo, Dept Ortoped & Traumatol, BR-04038032 Sao Paulo, SP, Brazil; [Leal, Mariana Ferreira; Loyola, Leonor Casilla; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Genet, BR-04023001 Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Dept Ortoped & Traumatol, BR-04038032 Sao Paulo, SP, Brazil.	mariana.morf@epm.br	Debieux, Pedro/AAN-5092-2020; Leal, Mariana/C-4010-2012; Andreoli, Carlos Vicente/AAW-1228-2021; Arliani, Gustavo/O-2722-2013; de A. C. Smith, Marilia/C-4397-2012; franciozi, carlos/C-1284-2015; Ejnisman, Benno/J-1556-2015	Leal, Mariana/0000-0003-4375-2563; Arliani, Gustavo/0000-0003-4371-5041; de A. C. Smith, Marilia/0000-0002-1441-1033; Debieux, Pedro/0000-0003-0015-1223; franciozi, carlos/0000-0002-0932-6870; Ejnisman, Benno/0000-0002-3301-1457	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants and fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ; MC and MCS) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; MC, MFL and LCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; APLEY AG, 1947, J BONE JOINT SURG, V29, P78; Arliani GG, 2012, REV BRAS ORTOP, V47, P6; Arliani GG, 2012, OPEN ACCESS J SPORTS, V3, P183, DOI 10.2147/OAJSM.S37203; Astur DC, 2012, REV BRAS ORTOP, V47, P5; Astur DC, 2014, BMJ CASE REP, V2014; Astur DC, 2014, KNEE, V21, P911, DOI 10.1016/j.knee.2014.06.003; Astur DC, 2013, ARTHROSCOPY, V29, P913, DOI 10.1016/j.arthro.2013.01.008; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Franciozi CED, 2014, CURR REV MUSCULOSKE, V7, P228, DOI 10.1007/s12178-014-9228-9; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; EYRE DR, 1984, ANAL BIOCHEM, V137, P380, DOI 10.1016/0003-2697(84)90101-5; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Galway R, 1972, J BONE JOINT SURG BR, V54, P2; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Johnson JS, 2015, J BONE JOINT SURG AM, V97A, P71, DOI 10.2106/JBJS.N.00246; Killian ML, 2010, J SURG RES, V164, P234, DOI 10.1016/j.jss.2009.03.006; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Leal MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118821; Leal MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105002; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Llanos A, BMC GENOMICS, V16; Lo IKY, 2003, CLIN ORTHOP RELAT R, P249, DOI 10.1097/01.blo.0000037442.23683.35; Lo IKY, 1998, J ORTHOPAED RES, V16, P421, DOI 10.1002/jor.1100160405; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Marshall J L, 1975, J Sports Med, V3, P152; McMurray T. P, 1949, BRIT J SURG, V29, P1; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Naraoka T, 2012, BONE JOINT RES, V1, P238, DOI 10.1302/2046-3758.110.2000118; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Speziali A, 2015, MUSCULOSKELET SURG; Spindler KP, 1996, J ORTHOP RES, V14, P857, DOI 10.1002/jor.1100140603; Taylor SC, 2014, J MOL MICROB BIOTECH, V24, P46, DOI 10.1159/000356189; Torg J S, 1976, Am J Sports Med, V4, P84, DOI 10.1177/036354657600400206; Tria A.J, 1992, ILLUSTRATED GUIDE KN; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Wisnieski F, 2013, WORLD J GASTROENTERO, V19, P7121, DOI 10.3748/wjg.v19.i41.7121; Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007; Zhou ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088892	45	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133323	10.1371/journal.pone.0133323	http://dx.doi.org/10.1371/journal.pone.0133323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192306	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400072
J	Mashayak, SY; Jochum, MN; Koschke, K; Aluru, NR; Ruhle, V; Junghans, C				Mashayak, S. Y.; Jochum, Mara N.; Koschke, Konstantin; Aluru, N. R.; Ruehle, Victor; Junghans, Christoph			Relative Entropy and Optimization-Driven Coarse-Graining Methods in VOTCA	PLOS ONE			English	Article							MULTISCALE SIMULATION; MOLECULAR-DYNAMICS; BIOMOLECULAR SYSTEMS; SOFT MATTER; WATER; MODELS; POTENTIALS; PACKAGE; ALGORITHMS	We discuss recent advances of the VOTCA package for systematic coarse-graining. Two methods have been implemented, namely the downhill simplex optimization and the relative entropy minimization. We illustrate the new methods by coarse-graining SPC/E bulk water and more complex water-methanol mixture systems. The CG potentials obtained from both methods are then evaluated by comparing the pair distributions from the coarse-grained to the reference atomistic simulations. In addition to the newly implemented methods, we have also added a parallel analysis framework to improve the computational efficiency of the coarse-graining process.	[Mashayak, S. Y.; Aluru, N. R.] Univ Illinois, Dept Mech Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Jochum, Mara N.; Koschke, Konstantin] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Ruehle, Victor] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Junghans, Christoph] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM 87545 USA	University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; University of Cambridge; United States Department of Energy (DOE); Los Alamos National Laboratory	Junghans, C (corresponding author), Los Alamos Natl Lab, Comp Computat & Stat Sci Div, POB 1663, Los Alamos, NM 87545 USA.	junghans@lanl.gov	Junghans, Christoph/G-4238-2010; Mashayak, Sikandar/ABA-4023-2020; Aluru, N/A-4617-2014	Junghans, Christoph/0000-0003-0925-1458; Aluru, N/0000-0002-9622-7837	NSF [480 1264282, 1420882]; AFOSR [11157642]; framework of the multiscale modeling initiative of theMax-Planck Society [SFB 625, M3]; National Science Foundation [NSF PHY11-25915]; LANL; Nestle Research Center; DFG Emmy Noether program [LA-UR-13-26878]; National Nuclear Security Administration of the U.S. DOE [DE-AC52- 06NA25396]	NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); framework of the multiscale modeling initiative of theMax-Planck Society; National Science Foundation(National Science Foundation (NSF)); LANL(United States Department of Energy (DOE)Los Alamos National Laboratory); Nestle Research Center(Nestle SA); DFG Emmy Noether program(German Research Foundation (DFG)); National Nuclear Security Administration of the U.S. DOE(National Nuclear Security Administration)	SYM and NRA acknowledge financial support by the NSF under grant Nos. 480 1264282 and 1420882 and AFOSR under grant No. 11157642. CJ was financially supported by SFB 625 in the framework of the multiscale modeling initiative of the Max-Planck Society (M3). This research was supported in part by the National Science Foundation under grant number NSF PHY11-25915. CJ thanks LANL for a Director's fellowship and the MPG for hospitality in 2013 at MPI-P. K. Koschke acknowledges funding by the Nestle Research Center. MNJ acknowledges DFG Emmy Noether program for financial support. Assigned: LA-UR-13-26878. LANL is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the U.S. DOE under Contract DE-AC52- 06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Apol E, 2014, GROMACS USER MANUAL; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bevc S, 2015, J COMPUT CHEM, V36, P467, DOI 10.1002/jcc.23806; Bezkorovaynaya O, 2012, J COMPUT CHEM, V33, P937, DOI 10.1002/jcc.22915; Chaimovich A, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3557038; Chaimovich A, 2009, PHYS CHEM CHEM PHYS, V11, P1901, DOI 10.1039/b818512c; Cooke IR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011506; Fritsch S, 2012, J CHEM THEORY COMPUT, V8, P398, DOI 10.1021/ct200706f; Fritz D, 2011, PHYS CHEM CHEM PHYS, V13, P10412, DOI 10.1039/c1cp20247b; Ganguly P, 2012, J CHEM THEORY COMPUT, V8, P1802, DOI 10.1021/ct3000958; Hadley KR, 2012, MOL SIMULAT, V38, P671, DOI 10.1080/08927022.2012.671942; Halverson JD, 2012, COMPUTER PHYS COMMUN; Hansen N, 1995, ICGA, P57; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hyeon C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1481; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Johnson ME, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715953; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P463, DOI 10.1098/rspa.1924.0082; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; JORGENSEN WL, 1986, J PHYS CHEM-US, V90, P1276, DOI 10.1021/j100398a015; Karimi-Varzaneh HA, 2011, J COMPUT CHEM, V32, P1475, DOI 10.1002/jcc.21717; Laaksonen A, 1997, J PHYS CHEM A, V101, P5910, DOI 10.1021/jp970673c; Limbach HJ, 2006, COMPUT PHYS COMMUN, V174, P704, DOI 10.1016/j.cpc.2005.10.005; Lu JB, 2014, J CHEM THEORY COMPUT, V10, P4104, DOI 10.1021/ct500487h; Lyubartsev A, 2010, FARADAY DISCUSS, V144, P43, DOI 10.1039/b901511f; LYUBARTSEV AP, 1995, PHYS REV E, V52, P3730, DOI 10.1103/PhysRevE.52.3730; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mashayak SY, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769297; Mirzoev A, 2013, J CHEM THEORY COMPUT, V9, P1512, DOI 10.1021/ct301019v; Molinero V, 2009, J PHYS CHEM B, V113, P4008, DOI 10.1021/jp805227c; Muller-Plathe F, 2002, CHEMPHYSCHEM, V3, P754, DOI 10.1002/1439-7641(20020916)3:9<754::AID-CPHC754>3.0.CO;2-U; Mullinax JW, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3220627; Nagarajan A, 2013, J CHEM THEORY COMPUT, V9, P5168, DOI 10.1021/ct400566j; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nezbeda I, 1997, MOL PHYS, V90, P353, DOI 10.1080/00268979709482616; Noid WG, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818908; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Peter C, 2009, SOFT MATTER, V5, P4357, DOI 10.1039/b912027k; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Poblete S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3357982; Praprotnik M, 2008, ANNU REV PHYS CHEM, V59, P545, DOI 10.1146/annurev.physchem.59.032607.093707; Reith D, 2003, J COMPUT CHEM, V24, P1624, DOI 10.1002/jcc.10307; Rudzinski JF, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3663709; Ruhle V, 2011, MACROMOL THEOR SIMUL, V20, P472, DOI 10.1002/mats.201100011; Ruhle V, 2009, J CHEM THEORY COMPUT, V5, P3211, DOI 10.1021/ct900369w; Shell MS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2992060; Smith W, 2006, MOL SIMULAT, V32, P935, DOI 10.1080/08927020600939830; Voth G. A., 2008, COARSE GRAINING COND; Wallqvist A, 2007, MOL MODELS WATER DER, P183; Wang H, 2009, EUR PHYS J E, V28, P221, DOI 10.1140/epje/i2008-10413-5; Wu D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1992483	52	50	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131754	10.1371/journal.pone.0131754	http://dx.doi.org/10.1371/journal.pone.0131754			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192992	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400016
J	Rose, JJ; Voora, D; Cyr, DD; Lucas, JE; Zaas, AK; Woods, CW; Newby, LK; Kraus, WE; Ginsburg, GS				Rose, Jason J.; Voora, Deepak; Cyr, Derek D.; Lucas, Joseph E.; Zaas, Aimee K.; Woods, Christopher W.; Newby, L. Kristin; Kraus, William E.; Ginsburg, Geoffrey S.			Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction	PLOS ONE			English	Article							INFLUENZA-A VIRUS; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; RISK; VACCINATION; ACTIVATION; ASSOCIATION; MORTALITY; PROTEINS; GAS6	Background Influenza infection is associated with myocardial infarction (MI), suggesting that respiratory viral infection may induce biologic pathways that contribute to MI. We tested the hypotheses that 1) a validated blood gene expression signature of respiratory viral infection (viral GES) was associated with MI and 2) respiratory viral exposure changes levels of a validated platelet gene expression signature (platelet GES) of platelet function in response to aspirin that is associated with MI. Methods A previously defined viral GES was projected into blood RNA data from 594 patients undergoing elective cardiac catheterization and used to classify patients as having evidence of viral infection or not and tested for association with acute MI using logistic regression. A previously defined platelet GES was projected into blood RNA data from 81 healthy subjects before and after exposure to four respiratory viruses: Respiratory Syncytial Virus (RSV) (n= 20), Human Rhinovirus (HRV) (n= 20), Influenza A virus subtype H1N1 (H1N1) (n= 24), Influenza A Virus subtype H3N2 (H3N2) (n= 17). We tested for the change in platelet GES with viral exposure using linear mixed-effects regression and by symptom status. Results In the catheterization cohort, 32 patients had evidence of viral infection based upon the viral GES, of which 25% (8/32) had MI versus 12.2%(69/567) among those without evidence of viral infection (OR 2.3; CI [1.03-5.5], p= 0.04). In the infection cohorts, only H1N1 exposure increased platelet GES over time (time course p-value = 1e-04). Conclusions A viral GES of non-specific, respiratory viral infection was associated with acute MI; 18% of the top 49 genes in the viral GES are involved with hemostasis and/ or platelet aggregation. Separately, H1N1 exposure, but not exposure to other respiratory viruses, increased a platelet GES previously shown to be associated with MI. Together, these results highlight specific genes and pathways that link viral infection, platelet activation, and MI especially in the case of H1N1 influenza infection.	[Rose, Jason J.; Voora, Deepak; Cyr, Derek D.; Lucas, Joseph E.; Zaas, Aimee K.; Woods, Christopher W.; Ginsburg, Geoffrey S.] Duke Univ, Ctr Appl Genom & Precis Med, Med Ctr, Durham, NC 27708 USA; [Rose, Jason J.; Voora, Deepak; Zaas, Aimee K.; Woods, Christopher W.; Newby, L. Kristin; Kraus, William E.; Ginsburg, Geoffrey S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rose, Jason J.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA USA	Duke University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ginsburg, GS (corresponding author), Duke Univ, Ctr Appl Genom & Precis Med, Med Ctr, Durham, NC 27708 USA.	geoffrey.ginsburg@duke.edu	Rose, Jason/AAY-8921-2021		Defense Advanced Research Projects Agency (DARPA) [N66001-09-C-2082]; National Institutes of Health (NIH) [5RC1-GM091083-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091083] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding sources are the following grants: Defense Advanced Research Projects Agency (DARPA)-N66001-09-C-2082 and National Institutes of Health (NIH) 5RC1-GM091083-03.	Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Arbit B, 2011, ACTA CARDIOL, V66, P807, DOI 10.1080/AC.66.6.2136968; Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779; Barrett B, 2006, EUR RESPIR J, V28, P358, DOI 10.1183/09031936.06.00002606; Berri F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003229; Bogomol'tsev B P, 2003, Klin Med (Mosk), V81, P9; Brett SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018120; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Dabek J, 2010, INFLAMMATION, V33, P398, DOI 10.1007/s10753-010-9198-z; Davis MM, 2006, CIRCULATION, V114, P1549, DOI 10.1161/CIRCULATIONAHA.106.178242; Erden I, 2011, CARDIOL J, V18, P552, DOI 10.5603/CJ.2011.0012; Eyers S, 2010, J ROY SOC MED, V103, P403, DOI 10.1258/jrsm.2010.090441; Parguina AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013404; Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Guan XR, 2010, AM J MED SCI, V340, P356, DOI 10.1097/MAJ.0b013e3181eecf29; Guan XR, 2008, INFLAMMATION, V31, P266, DOI 10.1007/s10753-008-9074-2; Guan XR, 2012, INFLAMM RES, V61, P591, DOI 10.1007/s00011-012-0449-3; Han JY, 2009, FASEB J, V23, P4193, DOI 10.1096/fj.09-131862; Hansen GAW, 2009, MOL CELL BIOCHEM, V320, P25, DOI 10.1007/s11010-008-9895-1; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Knapp M, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0294-0; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Lanza GA, 2011, J INTERN MED, V269, P118, DOI 10.1111/j.1365-2796.2010.02285.x; Laurance S, 2012, ADV NUTR, V3, P196, DOI 10.3945/an.111.001826; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lichenstein R, 2012, J INFECT DIS, V206, P821, DOI 10.1093/infdis/jis435; Link A, 2012, DEUT MED WOCHENSCHR, V137, P1853, DOI 10.1055/s-0032-1305311; Loomba RS, 2012, J CARDIOVASC PHARM T, V17, P277, DOI 10.1177/1074248411429965; Lucas JE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000920; Maree AO, 2007, CURR PHARM DESIGN, V13, P2656, DOI 10.2174/138161207781662948; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Moscardo A, 2006, PLATELETS, V17, P405, DOI 10.1080/09537100600757869; Mussa T, 2013, VET IMMUNOL IMMUNOP, V154, P25, DOI 10.1016/j.vetimm.2013.04.004; Naghavi M, 2000, CIRCULATION, V102, P3039; Rondina MT, 2012, CHEST, V141, P1490, DOI 10.1378/chest.11-2860; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schremmer Bruno, 2007, V44, P317; Seki M, 2009, JPN J INFECT DIS, V62, P6; Shah SH, 2010, AM HEART J, V160, P371, DOI 10.1016/j.ahj.2010.06.051; Starko KM, 2009, CLIN INFECT DIS, V49, P1405, DOI 10.1086/606060; Tjwa M, 2008, BLOOD, V111, P4096, DOI 10.1182/blood-2007-05-089565; Turner RB, 2001, CLIN INFECT DIS, V33, P1865, DOI 10.1086/324347; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Vandermeer ML, 2012, J INFECT DIS, V205, P13, DOI 10.1093/infdis/jir695; Voora D, 2013, J AM COLL CARDIOL, V62, P1267, DOI 10.1016/j.jacc.2013.05.073; Wang LY, 2007, AM J HUM GENET, V80, P650, DOI 10.1086/512981; Warren-Gash C, 2012, J INFECT DIS, V206, P1652, DOI 10.1093/infdis/jis597; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Wiwanitkit V, 2013, ANADOLU KARDIYOL DER, V13, P821, DOI 10.5152/akd.2013.4820; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Yamada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031494; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	60	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132259	10.1371/journal.pone.0132259	http://dx.doi.org/10.1371/journal.pone.0132259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193668	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358546400020
J	Tschirren, B				Tschirren, Barbara			Differential Effects of Maternal Yolk Androgens on Male and Female Offspring: A Role for Sex-Specific Selection?	PLOS ONE			English	Article							TESTOSTERONE LEVELS; IMMUNE FUNCTION; GROWTH; ANDROSTENEDIONE; SUSCEPTIBILITY; CONSEQUENCES; ALLOCATION; PHENOTYPE; SURVIVAL; BEHAVIOR	Maternal hormones are important mediators of prenatal maternal effects in animals. Although their effects on offspring phenotype are often sex-specific, the reason why sometimes sons are more sensitive to prenatal hormone exposure and sometimes daughters is not well understood. Here I combine an experimental manipulation of yolk testosterone concentration in the egg and quantification of selection acting on yolk androgen-sensitive traits in a natural population of great tits (Parus major) with a literature review to test the hypothesis that sex-specific selection on traits affected by yolk androgens determines which sex is more sensitive to prenatal hormone exposure. An experimental increase of the testosterone content in the egg boosted the post-hatching growth of male, but not female great tit nestlings. However, I found no evidence that survival selection on body mass or size is acting differently in the two sexes. A literature review revealed that yolk androgen manipulations affect the growth of males and females differently across species. Interestingly, in studies performed in the wild a significant association between the strength and direction of sexual size dimorphism and sex-specific sensitivities to yolk androgens was observed. In studies performed in captivity, no such relationship was found. Thus, across species there is some evidence that sex-specific selection on body size influences how strongly growth trajectories of males and females are affected by maternally-derived yolk androgens.	Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Zurich	Tschirren, B (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	barbara.tschirren@ieu.uzh.ch	Tschirren, Barbara/F-8202-2011	Tschirren, Barbara/0000-0003-4806-4102	Swiss National Science Foundation [PP00P3_128386, PP00P3_157455]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by the Swiss National Science Foundation (http://www.snf.ch) (grant PP00P3_128386 and PP00P3_157455 to BT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CRC HDB AVIAN BODY M, DOI [DOI 10.1201/9781420064452, DOI 10.1080/10888705.2011.527604]; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Balthazart Jacques, 2002, P223; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Benowitz-Fredericks ZM, 2013, GEN COMP ENDOCR, V193, P48, DOI 10.1016/j.ygcen.2013.07.005; Boncoraglio G, 2011, AM NAT, V178, P64, DOI 10.1086/660278; Carere C, 2007, TRENDS ENDOCRIN MET, V18, P73, DOI 10.1016/j.tem.2007.01.003; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hines M, 2011, FRONT NEUROENDOCRIN, V32, P170, DOI 10.1016/j.yfrne.2011.02.006; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Muller W, 2007, BEHAV ECOL, V18, P929, DOI 10.1093/beheco/arm060; Muller W, 2008, HORM BEHAV, V54, P125, DOI 10.1016/j.yhbeh.2008.02.005; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Muller W, 2009, BEHAV ECOL SOCIOBIOL, V63, P809, DOI 10.1007/s00265-009-0714-9; Muriel J, 2013, GEN COMP ENDOCR, V194, P175, DOI 10.1016/j.ygcen.2013.09.013; Pitala N, 2009, J AVIAN BIOL, V40, P225, DOI 10.1111/j.1600-048X.2009.04452.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rice AM, 2013, HORM BEHAV, V63, P813, DOI 10.1016/j.yhbeh.2013.03.019; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Ruuskanen S, 2012, BEHAV ECOL SOCIOBIOL, V66, P1201, DOI 10.1007/s00265-012-1373-9; Ruuskanen S, 2012, FUNCT ECOL, V26, P884, DOI 10.1111/j.1365-2435.2012.01994.x; Ruuskanen S, 2010, HORM BEHAV, V57, P119, DOI 10.1016/j.yhbeh.2009.09.017; Saino N, 2006, BEHAV ECOL, V17, P172, DOI 10.1093/beheco/arj023; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Schwabl H, 2012, AGE, V34, P87, DOI 10.1007/s11357-011-9222-8; Sockman KW, 2008, BEHAV ECOL SOCIOBIOL, V62, P617, DOI 10.1007/s00265-007-0486-z; Stinchcombe JR, 2008, EVOLUTION, V62, P2435, DOI 10.1111/j.1558-5646.2008.00449.x; Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; von Engelhardt N, 2006, P ROY SOC B-BIOL SCI, V273, P65, DOI 10.1098/rspb.2005.3274; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1	38	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133673	10.1371/journal.pone.0133673	http://dx.doi.org/10.1371/journal.pone.0133673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192990	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358546400112
J	Zinicola, M; Higgins, H; Lima, S; Machado, V; Guard, C; Bicalho, R				Zinicola, Martin; Higgins, Hazel; Lima, Svetlana; Machado, Vinicius; Guard, Charles; Bicalho, Rodrigo			Shotgun Metagenomic Sequencing Reveals Functional Genes and Microbiome Associated with Bovine Digital Dermatitis	PLOS ONE			English	Article							ENDOTHELIAL-CELL MONOLAYERS; DAIRY-COWS; BORRELIA-BURGDORFERI; TREPONEMA-DENTICOLA; RHIZOBIUM-LUPINI; IMMUNE-RESPONSE; COPPER-SULFATE; UK CATTLE; LESIONS; PENETRATION	Metagenomic methods amplifying 16S ribosomal RNA genes have been used to describe the microbial diversity of healthy skin and lesion stages of bovine digital dermatitis (DD) and to detect critical pathogens involved with disease pathogenesis. In this study, we characterized the microbiome and for the first time, the composition of functional genes of healthy skin (HS), active (ADD) and inactive (IDD) lesion stages using a whole-genome shotgun approach. Metagenomic sequences were annotated using MG-RAST pipeline. Six phyla were identified as the most abundant. Firmicutes and Actinobacteria were the predominant bacterial phyla in the microbiome of HS, while Spirochetes, Bacteroidetes and Proteobacteria were highly abundant in ADD and IDD. T. denticola-like, T. vincentii-like and T. phagedenis-like constituted the most abundant species in ADD and IDD. Recruitment plots comparing sequences from HS, ADD and IDD samples to the genomes of specific Treponema spp., supported the presence of T. denticola and T. vincentii in ADD and IDD. Comparison of the functional composition of HS to ADD and IDD identified a significant difference in genes associated with motility/chemotaxis and iron acquisition/metabolism. We also provide evidence that the microbiome of ADD and IDD compared to that of HS had significantly higher abundance of genes associated with resistance to copper and zinc, which are commonly used in footbaths to prevent and control DD. In conclusion, the results from this study provide new insights into the HS, ADD and IDD microbiomes, improve our understanding of the disease pathogenesis and generate unprecedented knowledge regarding the functional genetic composition of the digital dermatitis microbiome.	[Zinicola, Martin; Higgins, Hazel; Lima, Svetlana; Machado, Vinicius; Guard, Charles; Bicalho, Rodrigo] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA	Cornell University	Bicalho, R (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA.	rcb28@cornell.edu			USDA/NIFA Federal Formula Funds [NYC-478438]	USDA/NIFA Federal Formula Funds	Funding was provided for research and publication by the USDA/NIFA Federal Formula Funds project NYC-478438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry SL, 2012, VET J, V193, P654, DOI 10.1016/j.tvjl.2012.06.048; BLOWEY RW, 1994, VET REC, V135, P577; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; Bruijnis MRN, 2012, ANIMAL, V6, P962, DOI 10.1017/S1751731111002606; Cha E, 2010, PREV VET MED, V97, P1, DOI 10.1016/j.prevetmed.2010.07.011; COMSTOCK LE, 1989, INFECT IMMUN, V57, P1626, DOI 10.1128/IAI.57.5.1626-1628.1989; DIGUISEPPI J, 1982, J BIOL CHEM, V257, P4046; Dopfer D, 2012, VET J, V193, P685, DOI 10.1016/j.tvjl.2012.06.054; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Ettema J, 2010, PREV VET MED, V95, P64, DOI 10.1016/j.prevetmed.2010.03.001; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Gomez A, 2014, J DAIRY SCI, V97, P4864, DOI 10.3168/jds.2013-7616; Holzhauer M, 2008, VET REC, V162, P41, DOI 10.1136/vr.162.2.41; Holzhauer M, 2006, J DAIRY SCI, V89, P580, DOI 10.3168/jds.S0022-0302(06)72121-X; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kalyuzhnaya MG, 2008, ISME J, V2, P696, DOI 10.1038/ismej.2008.32; Klitgaard K, 2014, APPL ENVIRON MICROB, V80, P4427, DOI 10.1128/AEM.00873-14; Krull AC, 2014, INFECT IMMUN; Laven RA, 2002, VET REC, V151, P144, DOI 10.1136/vr.151.5.144; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08; Losinger WC, 2006, J DAIRY RES, V73, P244, DOI 10.1017/S0022029906001798; Lux R, 2001, INFECT IMMUN, V69, P6276, DOI 10.1128/IAI.69.10.6276-6283.2001; Lux R, 2000, J MOL MICROB BIOTECH, V2, P355; MARUYAMA M, 1978, BIOCHIM BIOPHYS ACTA, V535, P110, DOI 10.1016/0005-2795(78)90038-7; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; NEILANDS JB, 1981, J BIOL CHEM, V256, P3831; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; Peters SR, 1999, ORAL MICROBIOL IMMUN, V14, P379, DOI 10.1034/j.1399-302X.1999.140609.x; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Santos TMA, 2012, FEMS MICROBIOL ECOL, V79, P518, DOI 10.1111/j.1574-6941.2011.01234.x; Schlafer S, 2008, VET MICROBIOL, V128, P118, DOI 10.1016/j.vetmic.2007.09.024; Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08; Schmitz-Esser S, 2010, J BACTERIOL, V192, P1045, DOI 10.1128/JB.01379-09; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Sim JH, 2005, MICROBIOL-SGM, V151, P1801, DOI 10.1099/mic.0.27622-0; Speijers MHM, 2010, J DAIRY SCI, V93, P5782, DOI 10.3168/jds.2010-3468; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Teixeira AGV, 2010, J DAIRY SCI, V93, P3628, DOI 10.3168/jds.2010-3246; THOMAS DD, 1988, P NATL ACAD SCI USA, V85, P3608, DOI 10.1073/pnas.85.10.3608; Thomsen PT, 2015, J DAIRY SCI; TRACHTENBERG S, 1987, J MOL BIOL, V195, P603, DOI 10.1016/0022-2836(87)90185-9; Trott DJ, 2003, J CLIN MICROBIOL, V41, P2522, DOI 10.1128/JCM.41.6.2522-2529.2003; USDA, 2009, DAIR 2007 4; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009; Zinicola M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120504; Zuerner RL, 2007, VET MICROBIOL, V125, P256, DOI 10.1016/j.vetmic.2007.06.001	49	27	27	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133674	10.1371/journal.pone.0133674	http://dx.doi.org/10.1371/journal.pone.0133674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193110	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400113
J	Juarez-Montiel, M; Romero-Maldonado, A; Monreal-Escalante, E; Becerra-Flora, A; Korban, SS; Rosales-Mendoza, S; Jimenez-Bremont, JF				Juarez-Montiel, Margarita; Romero-Maldonado, Andrea; Monreal-Escalante, Elizabeth; Becerra-Flora, Alicia; Korban, Schuyler S.; Rosales-Mendoza, Sergio; Francisco Jimenez-Bremont, Juan			The Corn Smut ('Huitlacoche') as a New Platform for Oral Vaccines	PLOS ONE			English	Article							TOXIN B-SUBUNIT; FUNGUS USTILAGO-MAYDIS; RECOMBINANT PROTEINS; FILAMENTOUS FUNGI; PROTECTS MICE; CHOLERA; ANTIGEN; EXPRESSION; PLANTS; CELLS	The development of new alternative platforms for subunit vaccine production is a priority in the biomedical field. In this study, Ustilago maydis, the causal agent of common corn smut or 'huitlacoche' has been genetically engineered to assess expression and immunogenicity of the B subunit of the cholera toxin (CTB), a relevant immunomodulatory agent in vaccinology. An oligomeric CTB recombinant protein was expressed in corn smut galls at levels of up to 1.3 mg g(-1) dry weight (0.8% of the total soluble protein). Mice orally immunized with 'huitlacoche'-derived CTB showed significant humoral responses that were well-correlated with protection against challenge with the cholera toxin (CT). These findings demonstrate the feasibility of using edible corn smut as a safe, effective, and low-cost platform for production and delivery of a subunit oral vaccine. The implications of this platform in the area of molecular pharming are discussed.	[Juarez-Montiel, Margarita; Becerra-Flora, Alicia; Francisco Jimenez-Bremont, Juan] Inst Potosino Invest Cient & Tecnol AC, Div Biol Mol, Lab Estudios Mol Respuesta Estres Plantas, San Luis Potosi, San Luis Potosi, Mexico; [Romero-Maldonado, Andrea; Monreal-Escalante, Elizabeth; Rosales-Mendoza, Sergio] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Lab Biofarmaceut Recombinantes, San Luis Potosi, San Luis Potosi, Mexico; [Korban, Schuyler S.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Autonoma de San Luis Potosi; University of Massachusetts System; University of Massachusetts Boston	Rosales-Mendoza, S (corresponding author), Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Lab Biofarmaceut Recombinantes, San Luis Potosi, San Luis Potosi, Mexico.	rosales.s@fcq.uaslp.mx; jbremont@ipicyt.edu.mx	Jiménez Bremont, Juan Francisco/CAI-1278-2022; Rosales-Mendoza, Sergio/ABA-2752-2021; Jiménez Bremont, Juan Francisco/C-9256-2011; Monreal-Escalante, Elizabeth/AAY-2441-2020; Jiménez Bremont, Juan Francisco/CAF-4866-2022	Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Monreal-Escalante, Elizabeth/0000-0002-2798-6151	CONACYT Investigacion Ciencia Basica [2008-103106]; UASLP-FAI	CONACYT Investigacion Ciencia Basica; UASLP-FAI	This work was financially supported by CONACYT Investigacion Ciencia Basica 2008-103106 (JFJB) and UASLP-FAI-2014 (SRM) funding.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Banuett F, 1996, DEVELOPMENT, V122, P2965; Banuett F, 1995, ANNU REV GENET, V29, P179, DOI 10.1146/annurev.ge.29.120195.001143; Basset C, 2010, TOXINS, V2, P1774, DOI 10.3390/toxins2071774; Bolker M, 2008, FUNGAL GENET BIOL, V45, pS88, DOI 10.1016/j.fgb.2008.05.007; Bosch D, 2010, EXPERT REV VACCINES, V9, P835, DOI 10.1586/erv.10.83; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Chikwamba R, 2002, TRANSGENIC RES, V11, P479, DOI 10.1023/A:1020393426750; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Feldbrugge M, 2013, APPL MICROBIOL BIOT, V97, P3253, DOI 10.1007/s00253-013-4777-1; Fernandez-Alvarez A, 2010, FUNGAL GENET BIOL, V47, P727, DOI 10.1016/j.fgb.2010.06.004; Franklin S, 2002, PLANT J, V30, P733, DOI 10.1046/j.1365-313X.2002.01319.x; George-Chandy A, 2001, INFECT IMMUN, V69, P5716, DOI 10.1128/IAI.69.9.5716-5725.2001; Giddings G, 2000, NAT BIOTECHNOL, V18, P1151, DOI 10.1038/81132; GILLISSEN B, 1992, CELL, V68, P647, DOI 10.1016/0092-8674(92)90141-X; Hamorsky KT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002046; Harakuni T, 2005, INFECT IMMUN, V73, P5654, DOI 10.1128/IAI.73.9.5654-5665.2005; Hernandez-Rodriguez AA, 2014, PLANT MOL BIOL REP, V32, P1187, DOI [10.1007/s11105-014-0714-4, DOI 10.1007/S11105-014-0714-4]; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Juarez-Montiel M, 2011, REV IBEROAM MICOL, V28, P69, DOI 10.1016/j.riam.2011.01.001; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Karaman S, 2012, PLANT CELL REP, V31, P527, DOI 10.1007/s00299-011-1146-3; Langridge W, 2010, CURR OPIN INVEST DR, V11, P919; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maskery B, 2013, J INFECT DIS, V208, pS15, DOI 10.1093/infdis/jit233; Matsumoto Y, 2009, TRANSGENIC RES, V18, P185, DOI 10.1007/s11248-008-9205-4; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Miyata T, 2012, VACCINE, V30, P948, DOI 10.1016/j.vaccine.2011.11.059; Nevalainen H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00075; Nozoye T, 2009, J VET MED SCI, V71, P995, DOI 10.1292/jvms.71.995; Payero JO, 2006, AGR WATER MANAGE, V84, P101, DOI 10.1016/j.agwat.2006.01.009; RICHARDSON SH, 1984, INFECT IMMUN, V43, P482, DOI 10.1128/IAI.43.2.482-486.1984; Rodriguez-Kessler M, 2012, MICROBIOL RES, V167, P270, DOI 10.1016/j.micres.2011.10.007; Rosales-Mendoza S, 2008, PLANT CELL REP, V27, P79, DOI 10.1007/s00299-007-0439-z; Rosales-Mendoza S, 2014, EXPERT REV VACCINES, V13, P737, DOI 10.1586/14760584.2014.913483; Rosales-Mendoza S, 2012, PLANT CELL REP, V31, P479, DOI 10.1007/s00299-011-1186-8; Ruiz-Herrera J, 1998, Int Microbiol, V1, P149; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shin MK, 2013, VACCINE, V31, P4287, DOI 10.1016/j.vaccine.2013.07.029; Soria-Guerra RE, 2011, PLANT CELL REP, V30, P1367, DOI 10.1007/s00299-011-1065-3; SPELLIG T, 1994, EMBO J, V13, P1620, DOI 10.1002/j.1460-2075.1994.tb06425.x; Spellig T, 1996, MOL GEN GENET, V252, P503, DOI 10.1007/BF02172396; Stock J, 2012, J BIOTECHNOL, V161, P80, DOI 10.1016/j.jbiotec.2012.03.004; Sun JB, 2010, SCAND J IMMUNOL, V71, P1, DOI 10.1111/j.1365-3083.2009.02321.x; Terfruchte M, 2014, FUNGAL GENET BIOL, V62, P1, DOI 10.1016/j.fgb.2013.10.012; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; Valdez-Morales M, 2010, FOOD CHEM, V119, P689, DOI 10.1016/j.foodchem.2009.07.015; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; Wilkhu J, 2011, THER DELIV, V2, P1141, DOI 10.4155/TDE.11.82	50	8	8	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133535	10.1371/journal.pone.0133535	http://dx.doi.org/10.1371/journal.pone.0133535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207365	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000098
J	Si, XY; Li, JJ; Bi, XH; Wu, L; Wu, XY				Si, Xiaoyun; Li, Jingjing; Bi, Xiaohong; Wu, Lan; Wu, Xiaoyan			Clinical Evaluation of High-Volume Hemofiltration with Hemoperfusion Followed by Intermittent Hemodialysis in the Treatment of Acute Wasp Stings Complicated by Multiple Organ Dysfunction Syndrome	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; RENAL REPLACEMENT THERAPY; SEVERE ACUTE-PANCREATITIS; LUNG INJURY; METAANALYSIS; RECOVERY; FAILURE; ALLERGY; SEPSIS; VENOM	Multiple organ dysfunction syndrome (MODS) is a rare complication of wasp stings. Currently, there is no standardized treatment for MODS secondary to multiple wasp stings, although blood purification techniques are often used. This study aimed to analyze our experiences of using intermittent hemodialysis (IHD) with or without high-volume hemofiltration (HVHF) for treating acute wasp stings complicated by MODS. In this retrospective study, 36 patients with wasp stings complicated by MODS received either IHD combined with hemoperfusion, or HVHF (ultrafiltration flow rate, 70 mL/kg/h) combined with hemoperfusion for 5 days followed by IHD. Clinical symptoms, blood biochemical parameters, duration of mechanical ventilation, use of vasoactive agents, duration of hospital stay and survival rate were recorded, and Acute Physiology and Chronic Health Evaluation II (APACHE II) and multiple organ dysfunction (MOD) scores estimated. Patients treated with HVHF followed by IHD appeared to exhibit a faster recovery than those receiving IHD alone, as evidenced by superior improvements in MOD (4.29 +/- 1.08 vs. 2.27 +/- 1.07) and APACHE II (7.09 +/- 2.62 vs. 4.20 +/- 1.69) scores (P < 0.05). Patients treated with HVHF had significantly lower myoglobin, creatine kinase-MB, lactate dehydrogenase, bilirubin and creatinine levels than patients treated with IHD alone. In addition, the durations of hospital stay (13.15 +/- 2.77 vs. 27.92 +/- 3.18 days), vasopressor use (1.76 +/- 0.24 vs. 3.43 +/- 1.01 days), mechanical ventilation (3.02 +/- 1.63 vs. 5.94 +/- 2.11 days) and oliguria (6.57 +/- 2.45 vs. 15.29 +/- 3.51 days) were reduced, and renal function more often recovered (85.1% vs. 53.1%), in the HVHF group compared with the IHD group (P < 0.05). These results raise the possibility that HVHF plus IHD may be superior to IHD alone for the treatment of acute wasp stings complicated by MODS; additional prospective studies are merited to explore this further.	[Si, Xiaoyun; Li, Jingjing; Bi, Xiaohong; Wu, Lan; Wu, Xiaoyan] Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan 430071, Hubei Province, Peoples R China	Wuhan University	Si, XY (corresponding author), Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan 430071, Hubei Province, Peoples R China.	lzgklxm2013@163.com						Bich HNX, 2010, NEPHROL DIAL TRANSPL, V25, P1146, DOI 10.1093/ndt/gfp583; Clark E, 2014, CRIT CARE, V18, DOI 10.1186/cc13184; Du XG, 2011, INT J ARTIF ORGANS, V34, P348, DOI 10.5301/IJAO.2011.7742; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Gong DH, 2010, INT J ARTIF ORGANS, V33, P22; GREENGRAIF Y, 1987, CLIN ALLERGY, V17, P431, DOI 10.1111/j.1365-2222.1987.tb02037.x; Jacka MJ, 2005, CAN J ANAESTH, V52, P327, DOI 10.1007/BF03016071; Lehner GF, 2014, MINERVA ANESTESIOL, V80, P595; Lima Rafael Siqueira Athayde, 2008, Saudi J Kidney Dis Transpl, V19, P721; Lin CJ, 2011, SOUTH MED J, V104, P378, DOI 10.1097/SMJ.0b013e318213ebee; Liu Chang-wen, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P657; Malyszko JS, 2006, J NEPHROL, V19, P150; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Monti G, 2007, CONTRIB NEPHROL, V156, P434; Ozdemir C, 2011, CLIN EXP ALLERGY, V41, P1226, DOI 10.1111/j.1365-2222.2011.03812.x; Paudel B, 2009, Nepal Med Coll J, V11, P52; Rekik Sofiene, 2012, J Emerg Med, V42, pe73, DOI 10.1016/j.jemermed.2009.02.019; Rimmele T, 2012, ANESTHESIOLOGY, V116, P1377, DOI 10.1097/ALN.0b013e318256f0c0; Sharmila RR, 2007, INDIAN J PEDIATR, V74, P1111, DOI 10.1007/s12098-007-0208-6; Yavuz ST, 2013, INT ARCH ALLERGY IMM, V160, P313, DOI 10.1159/000341666; Zhang L, 2009, BLOOD PURIFICAT, V27, P296; Zhang L, 2013, CLIN J AM SOC NEPHRO, V8, P1850, DOI 10.2215/CJN.12081112; Zhang L, 2010, BLOOD PURIFICAT, V30, P106, DOI 10.1159/000319600; Zhang P, 2010, INT J ARTIF ORGANS, V33, P505, DOI 10.1177/039139881003300801; Zhang P, 2012, NEPHROL DIAL TRANSPL, V27, P967, DOI 10.1093/ndt/gfr486; Zhang YuHua, 2009, Zhongguo Shiyong Neike Zazhi / Chinese Journal of Practical Internal Medicine, V29, P1027; Zhu YL, 2011, PANCREAS, V40, P109, DOI 10.1097/MPA.0b013e3181f83019	27	12	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132708	10.1371/journal.pone.0132708	http://dx.doi.org/10.1371/journal.pone.0132708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207371	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000038
J	Walldorf, JA; Cohee, LM; Coalson, JE; Bauleni, A; Nkanaunena, K; Kapito-Tembo, A; Seydel, KB; Ali, D; Mathanga, D; Taylor, TE; Valim, C; Laufer, MK				Walldorf, Jenny A.; Cohee, Lauren M.; Coalson, Jenna E.; Bauleni, Andy; Nkanaunena, Kondwani; Kapito-Tembo, Atupele; Seydel, Karl B.; Ali, Doreen; Mathanga, Don; Taylor, Terrie E.; Valim, Clarissa; Laufer, Miriam K.			School-Age Children Are a Reservoir of Malaria Infection in Malawi	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RISK-FACTORS; PARASITEMIA; AFRICA; FEVER; AREA	Malaria surveillance and interventions in endemic countries often target young children at highest risk of malaria morbidity and mortality. We aimed to determine whether school-age children and adults not captured in surveillance serve as a reservoir for malaria infection and may contribute to malaria transmission. Cross-sectional surveys were conducted in one rainy and one dry season in southern Malawi. Demographic and health information was collected for all household members. Blood samples were obtained for microscopic and PCR identification of Plasmodium falciparum. Among 5796 individuals aged greater than six months, PCR prevalence of malaria infection was 5%, 10%, and 20% in dry, and 9%, 15%, and 32% in rainy seasons in Blantyre, Thyolo, and Chikhwawa, respectively. Over 88% of those infected were asymptomatic. Participants aged 6-15 years were at higher risk of infection (OR=4.8; 95% CI, 4.0-5.8) and asymptomatic infection (OR=4.2; 95% CI, 2.76.6) than younger children in all settings. School-age children used bednets less frequently than other age groups. Compared to young children, school-age children were brought less often for treatment and more often to unreliable treatment sources. Conclusion: School-age children represent an underappreciated reservoir of malaria infection and have less exposure to antimalarial interventions. Malaria control and elimination strategies may need to expand to include this age group.	[Walldorf, Jenny A.; Cohee, Lauren M.; Laufer, Miriam K.] Univ Maryland, Sch Med, Ctr Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA; [Coalson, Jenna E.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bauleni, Andy; Nkanaunena, Kondwani; Kapito-Tembo, Atupele; Mathanga, Don] Univ Malawi, Blantyre Malaria Project, Coll Med, Blantyre, Malawi; [Seydel, Karl B.; Taylor, Terrie E.] Michigan State Univ, E Lansing, MI 48824 USA; [Ali, Doreen] Minist Hlth, Natl Malaria Control Program, Lilongwe, Malawi; [Valim, Clarissa] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan; University of Malawi; Michigan State University; Harvard University; Harvard T.H. Chan School of Public Health	Laufer, MK (corresponding author), Univ Maryland, Sch Med, Ctr Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA.	mlaufer@medicine.umaryland.edu	Coalson, Jenna/AAD-6653-2020	Laufer, Miriam/0000-0001-8300-9593; Kapito-Tembo, Atupele/0000-0001-8619-515X; Coalson, Jenna/0000-0002-8591-5642	U.S. National Institutes of Health, Bethesda, Maryland [U19AI089683]; National Institutes of Health National Research Service Award training grants [T32AI05724]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089683, T32AI007524] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service Award training grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health, Bethesda, Maryland (grant number U19AI089683) for the Malawi International Center for Excellence in Malaria. JAW and LMC were supported by National Institutes of Health National Research Service Award training grants (grant number T32AI05724).	Afrane YA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-405; [Anonymous], 2012, MALAWI MALARIA INDIC; [Anonymous], PLOS ONE; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Gil JP, 2003, MOL CELL PROBE, V17, P85, DOI 10.1016/S0890-8508(03)00006-9; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kachur SP, 2006, TROP MED INT HEALTH, V11, P441, DOI 10.1111/j.1365-3156.2006.01588.x; Kazembe LN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-40; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Mharakurwa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-223; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Molyneux CS, 1999, TROP MED INT HEALTH, V4, P836, DOI 10.1046/j.1365-3156.1999.00489.x; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Pullan RL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-2; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Sumba PO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-245; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Woyessa A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-273	23	118	118	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134061	10.1371/journal.pone.0134061	http://dx.doi.org/10.1371/journal.pone.0134061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207758	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000200
J	Jin, PP; Sun, LL; Ding, BJ; Qin, N; Zhou, B; Xia, F; Li, L; Liu, LJ; Liu, XD; Zhao, G; Wang, W; Deng, YC; Hou, SX				Jin, Peng-Peng; Sun, Li-Li; Ding, Bo-Jun; Qin, Na; Zhou, Bin; Xia, Feng; Li, Li; Liu, Li-Juan; Liu, Xue-Dong; Zhao, Gang; Wang, Wen; Deng, Yan-Chun; Hou, Shuang-Xing			Human Leukocyte Antigen DQB1 (HLA-DQB1) Polymorphisms and the Risk for Guillain-Barre Syndrome: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CLASS-II ALLELES; CAMPYLOBACTER-JEJUNI; HLA-DQ; ASSOCIATION; SUSCEPTIBILITY	Guillain-Barre syndrome (GBS) is an autoimmune disorder of the peripheral nervous system. There is no consensus regarding reported associations between human leukocyte antigen DQB1 (HLA-DQB1) polymorphisms and the risk for developing GBS. Here, we evaluated possible associations between HLA-DQB1 polymorphisms and the risk for GBS using a meta-analysis. We searched PubMed for case-control genetic association studies for HLA-DQB1 polymorphisms (*020x, *030x, *040x, *050x, and *060x) and the risk for GBS. Fixed-effect meta-analytical methods were used for the outcome measure and subgroup analyses. Estimated odds ratios (ORs) and 95% confidence intervals (CIs) were used to investigate the associations between HLA-DQB1 polymorphisms and the risk for GBS. Nine case-control studies involving 780 cases of GBS and 1353 controls were identified in the current study. The meta-analysis demonstrated no significant associations between HLA-DQB1 polymorphisms and the risk for GBS in Asian and Caucasian populations. There were two associations that approached significance: HLA-DQB1*030x in Asian patients (P = 0.07; OR: 0.76, 95% CI: 0.57-1.03) and HLA-DQB1*060x in all patients (P = 0.08; OR: 1.48, 95% CI: 0.96-2.29). Additional studies with larger sample sizes are required to establish a definitive assessment of the contribution of HLA-DQB1 polymorphisms to GBS risk.	[Jin, Peng-Peng] Fudan Univ, Shanghai Pudong Hosp, Ctr Med Res & Innovat, Pudong Med Ctr, Shanghai 201399, Peoples R China; [Sun, Li-Li; Ding, Bo-Jun; Qin, Na; Zhou, Bin; Xia, Feng; Li, Li; Liu, Li-Juan; Liu, Xue-Dong; Zhao, Gang; Deng, Yan-Chun] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China; [Wang, Wen] Fourth Mil Med Univ, Unit Evidence Based Med, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Hou, Shuang-Xing] Fudan Univ, Shanghai Pudong Hosp, Dept Neurol, Pudong Med Ctr, Shanghai 201399, Peoples R China	Fudan University; Air Force Military Medical University; Air Force Military Medical University; Fudan University	Hou, SX (corresponding author), Fudan Univ, Shanghai Pudong Hosp, Dept Neurol, Pudong Med Ctr, 2800 Gongwei Rd, Shanghai 201399, Peoples R China.	housx120@126.com	Sun, lili/GQH-2057-2022		Natural Science Foundation of China [31070976, 81172291, 81030010]; Fourth Military Medical University (China); Key Science and Technology Program of Shaanxi Province, China [2011 SK11-33]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fourth Military Medical University (China); Key Science and Technology Program of Shaanxi Province, China	This study was supported by grants from the Natural Science Foundation of China (No. 31070976, 81172291, and 81030010), intramural funds of the Fourth Military Medical University (China, 2012), and the Key Science and Technology Program of Shaanxi Province, China (2011 SK11-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoni A, 2009, PHOTOCH PHOTOBIO SCI, V8, P1202, DOI 10.1039/b906043j; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ENDERS U, 1993, ANN NEUROL, V34, P136, DOI 10.1002/ana.410340208; Fekih-Mrissa N, 2014, CLIN NEUROL NEUROSUR, V121, P19, DOI 10.1016/j.clineuro.2014.03.014; Geleijns K, 2005, NEUROLOGY, V64, P44, DOI 10.1212/01.WNL.0000148727.02732.01; Geleijns K, 2006, J IMMUNOL, V177, P4211, DOI 10.4049/jimmunol.177.6.4211; GORODEZKY C, 1983, J NEUROIMMUNOL, V4, P1, DOI 10.1016/0165-5728(83)90058-9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILLERT J, 1991, J NEUROIMMUNOL, V31, P67, DOI 10.1016/0165-5728(91)90088-O; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Huang W, 1996, J CLIN ENDOCR METAB, V81, P2559, DOI 10.1210/jc.81.7.2559; Huh K B, 1986, Korean J Intern Med, V1, P243; Kimoto K, 2006, NEUROLOGY, V67, P1837, DOI 10.1212/01.wnl.0000244468.22377.6b; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Koga M, 1998, J NEUROIMMUNOL, V88, P62, DOI 10.1016/S0165-5728(98)00072-1; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li HF, 2000, CHINESE MED J-PEKING, V113, P429; Luppi P, 2001, J AUTOIMMUN, V16, P3, DOI 10.1006/jaut.2000.0462; Ma JJ, 1998, NEUROLOGY, V51, P379, DOI 10.1212/WNL.51.2.379; Magira EE, 2003, J IMMUNOL, V170, P3074, DOI 10.4049/jimmunol.170.6.3074; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCombe PA, 2006, J NEUROIMMUNOL, V180, P172, DOI 10.1016/j.jneuroim.2006.07.017; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nyati KK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852195; Pithadia AB, 2010, PHARMACOL REP, V62, P220, DOI 10.1016/S1734-1140(10)70261-9; REES JH, 1995, J NEUROIMMUNOL, V62, P53, DOI 10.1016/0165-5728(95)00102-8; Repiska V, 2010, INT J GYNECOL OBSTET, V110, P152, DOI 10.1016/j.ijgo.2010.03.019; Schroeder S, 1999, CRIT CARE MED, V27, P1265, DOI 10.1097/00003246-199907000-00006; Sinha S, 2010, ACTA NEUROL SCAND, V122, P21, DOI 10.1111/j.1600-0404.2009.01229.x; Wu LY, 2012, J NEUROIMMUNOL, V243, P18, DOI 10.1016/j.jneuroim.2011.12.003	33	20	20	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0131374	10.1371/journal.pone.0131374	http://dx.doi.org/10.1371/journal.pone.0131374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204120	Green Submitted, gold, Green Published			2022-12-27	WOS:000358621000002
J	Akter, S; Okazaki, H; Kuwahara, K; Miyamoto, T; Murakami, T; Shimizu, C; Shimizu, M; Tomita, K; Nagahama, S; Eguchi, M; Kochi, T; Imai, T; Nishihara, A; Sasaki, N; Nakagawa, T; Yamamoto, S; Honda, T; Uehara, A; Yamamoto, M; Hori, A; Sakamoto, N; Nishiura, C; Totsuzaki, T; Kato, N; Fukasawa, K; Pham, NM; Kurotani, K; Nanri, A; Kabe, I; Mizoue, T; Sone, T; Dohi, S				Akter, Shamima; Okazaki, Hiroko; Kuwahara, Keisuke; Miyamoto, Toshiaki; Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko; Tomita, Kentaro; Nagahama, Satsue; Eguchi, Masafumi; Kochi, Takeshi; Imai, Teppei; Nishihara, Akiko; Sasaki, Naoko; Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru; Uehara, Akihiko; Yamamoto, Makoto; Hori, Ai; Sakamoto, Nobuaki; Nishiura, Chiro; Totsuzaki, Takafumi; Kato, Noritada; Fukasawa, Kenji; Ngoc M. Pham; Kurotani, Kayo; Nanri, Akiko; Kabe, Isamu; Mizoue, Tetsuya; Sone, Tomofumi; Dohi, Seitaro		Japan Epidemiol Collaboration Occu	Smoking, Smoking Cessation, and the Risk of Type 2 Diabetes among Japanese Adults: Japan Epidemiology Collaboration on Occupational Health Study	PLOS ONE			English	Article							CIGARETTE-SMOKING; INSULIN-RESISTANCE; OXIDATIVE STRESS; MELLITUS; INFLAMMATION; OBESITY	Aims To examine the association of smoking status, smoking intensity, and smoking cessation with the risk of type 2 diabetes (T2D) using a large database. Methods The present study included 53,930 Japanese employees, aged 15 to 83 years, who received health check-up and did not have diabetes at baseline. Diabetes was defined as fasting plasma glucose >= 126 mg/dl, random plasma glucose >= 200 mg/dl, HbA1c >= 6.5% (>= 48 mmol/mol), or receiving medication for diabetes. Cox proportional-hazards regression models were used to investigate the association between smoking and the risk of diabetes. Results During 3.9 years of median follow-up, 2,441 (4.5%) individuals developed T2D. The multi-variable-adjusted hazard ratios (95% CI) for diabetes were 1 (reference), 1.16 (1.04 to 1.30) and 1.34 (1.22 to 1.48) for never smokers, former smokers, and current smokers, respectively. Diabetes risk increased with increasing numbers of cigarette consumption among current smokers (P for trend <0.001). Although the relative risk of diabetes was greater among subjects with lower BMIs (<23 kg/m(2)), attributable risk was greater in subjects with higher BMIs (>= 23 kg/m(2)). Compared with individuals who had never smoked, former smokers who quit less than 5 years, 5 to 9 years, and 10 years or more exhibited hazards ratios for diabetes of 1.36 (1.14 to 1.62), 1.23 (1.01 to 1.51), and 1.02 (0.85 to 1.23), respectively. Conclusions Results suggest that cigarette smoking is associated with an increased risk of T2D, which may decrease to the level of a never smoker after 10 years of smoking cessation.	[Akter, Shamima; Kuwahara, Keisuke; Kurotani, Kayo; Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Okazaki, Hiroko; Dohi, Seitaro] Mitsui Chem Inc, Tokyo, Japan; [Kuwahara, Keisuke] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan; [Miyamoto, Toshiaki] Nippon Steel & Sumitomo Met Corp Kimitsu Works, Chiba, Japan; [Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko] JFE Steel Corp, Kanagawa, Japan; [Tomita, Kentaro] Mitsubishi Plast Inc, Tokyo, Japan; [Nagahama, Satsue] All Japan Labour Welf Fdn, Tokyo, Japan; [Eguchi, Masafumi; Kochi, Takeshi; Kabe, Isamu] Furukawa Elect Corp Ltd, Tokyo, Japan; [Imai, Teppei; Nishihara, Akiko] Azbil Corp, Tokyo, Japan; [Sasaki, Naoko] Mitsubishi Fuso Truck & Bus Corp, Kanagawa, Japan; [Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru] Hitachi Ltd, Ibaraki, Japan; [Uehara, Akihiko; Yamamoto, Makoto] YAMAHA Corp, Shizuoka, Japan; [Hori, Ai; Nishiura, Chiro] Tokyo Gas Co Ltd, Dept Safety & Hlth, Tokyo, Japan; [Sakamoto, Nobuaki] Genkiplaza Med Ctr Hlth Care, Tokyo, Japan; [Totsuzaki, Takafumi] Mizuho Bank Ltd, Tokyo, Japan; [Kato, Noritada] Fuji Elect Co Ltd, Kanagawa, Japan; [Fukasawa, Kenji] Ricoh Co Ltd, Kanagawa, Japan; [Ngoc M. Pham] Thai Nguyen Univ Med & Pharm, Fac Publ Hlth, Dept Epidemiol, Thai Nguyen, Thai Nguyen Pro, Vietnam; [Sone, Tomofumi] Natl Inst Publ Hlth, Saitama, Japan	National Center for Global Health & Medicine - Japan; Mitsui Chemicals; Teikyo University; Nippon Steel & Sumitomo Metal Corporation; JFE Holdings, Inc.; JFE Steel; Furukawa Electric; Daimler AG; Hitachi Limited; Yamaha; Fuji Electric Co., LTD.; Ricoh Company, Ltd.; Thai Nguyen University; National Institute of Public Health - Japan	Akter, S (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.	samimarub@yahoo.com	Nishiura, Chihiro/Q-7938-2019; Nishiura, Chihiro/C-4132-2017; Hori, Ai/G-5277-2019	Nishiura, Chihiro/0000-0002-8850-5446; Nishiura, Chihiro/0000-0002-8850-5446; Hori, Ai/0000-0002-0191-5996; Kuwahara, Keisuke/0000-0002-7503-1333; Kochi, Takeshi/0000-0002-3411-1070	Industrial Health Foundation; National Cancer Center Research and Development Fund; Mitsui Chemicals, Inc.; Nippon Steel AMP; Sumitomo Metal Corporation Kimitsu Works; JFE Steel Corporation; Mitsubishi Plastics, Inc.; Furukawa Electric Co., Ltd.; Azbil Corporation; Mitsubishi Fuso Truck and Bus Corporation; Hitachi, Ltd.; YAMAHA CORPORATION; Tokyo Gas Co., Ltd; Mizuho Bank, Ltd; Fuji Electric Co., Ltd; Ricoh Co., Ltd;  [25293146]	Industrial Health Foundation; National Cancer Center Research and Development Fund(National Cancer Center - Japan); Mitsui Chemicals, Inc.; Nippon Steel AMP; Sumitomo Metal Corporation Kimitsu Works; JFE Steel Corporation; Mitsubishi Plastics, Inc.; Furukawa Electric Co., Ltd.; Azbil Corporation; Mitsubishi Fuso Truck and Bus Corporation; Hitachi, Ltd.; YAMAHA CORPORATION; Tokyo Gas Co., Ltd; Mizuho Bank, Ltd(Fukuda Foundation for Medical TechnologyMukai Science and Technology FoundationSENSHIN Medical Research FoundationKayamori FoundationKayamori Foundation of Informational Science AdvancementMizuho Foundation for the Promotion of Sciences); Fuji Electric Co., Ltd; Ricoh Co., Ltd; 	This study was supported by a grant from the Industrial Health Foundation (to Dr Mizoue), the National Cancer Center Research and Development Fund (to Dr Mizoue), and Grant-in-Aid for Scientific Research (B) (25293146) (to Dr Mizoue). "Mitsui Chemicals, Inc.", "Nippon Steel & Sumitomo Metal Corporation Kimitsu Works", "JFE Steel Corporation", "Mitsubishi Plastics, Inc.", "Furukawa Electric Co., Ltd.", "Azbil Corporation", "Mitsubishi Fuso Truck and Bus Corporation", "Hitachi, Ltd.", "YAMAHA CORPORATION", "Tokyo Gas Co., Ltd", "Mizuho Bank, Ltd", "Fuji Electric Co., Ltd" and "Ricoh Co., Ltd" provided support in the form of salaries for authors [H. Okazaki, S. Dohi, T. Miyamoto, T. Murakami, C. Shimizu, M. Shimizu, K. Tomita, M. Eguchi, T. Kochi, I. Kabe, T. Imai, A. Nishihara, N. Sasaki, T. Nakagawa, S. Yamamoto, and T. Honda, A. Uehara, M. Yamamoto, A. Hori, C. Nishiura, T. Totsuzaki, N. Kato, and K. Fukasawa], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Berlin I, 2008, DIABETES METAB, V34, P307, DOI 10.1016/j.diabet.2008.01.008; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Chowdhury P, 2002, EXP BIOL MED, V227, P445, DOI 10.1177/153537020222700708; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Foy CG, 2005, DIABETES CARE, V28, P2501, DOI 10.2337/diacare.28.10.2501; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; IDF, 2019, IDF DIABETES ATLAS; Jee SH, 2010, DIABETES CARE, V33, P2567, DOI 10.2337/dc10-0261; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kuwahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095732; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luo JH, 2013, AM J EPIDEMIOL, V178, P937, DOI 10.1093/aje/kwt071; Ministry of Education Culture Sports Science and Technology. Ministry of Health Labour and Welfare, 2000, ETH GUID EP RES; Morimoto A, 2012, DIABETES RES CLIN PR, V96, P407, DOI 10.1016/j.diabres.2012.03.007; Morimoto A, 2012, PREV MED, V54, P341, DOI 10.1016/j.ypmed.2012.02.016; Nakanishi N, 2000, ANN INTERN MED, V133, P183, DOI 10.7326/0003-4819-133-3-200008010-00009; Oba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0017061; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Teratani T, 2012, DRUG ALCOHOL DEPEN, V125, P276, DOI 10.1016/j.drugalcdep.2012.03.002; TROISI RJ, 1991, AM J CLIN NUTR, V53, P1104, DOI 10.1093/ajcn/53.5.1104; Uehara A, 2014, DIABETES RES CLIN PR, V106, P118, DOI 10.1016/j.diabres.2014.07.013; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Weyer C, 2002, ATHEROSCLEROSIS, V161, P233, DOI 10.1016/S0021-9150(01)00626-8; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087	33	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132166	10.1371/journal.pone.0132166	http://dx.doi.org/10.1371/journal.pone.0132166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200457	gold, Green Published, Green Submitted			2022-12-27	WOS:000358597100027
J	Greenberg, DM; Baron-Cohen, S; Stillwell, DJ; Kosinski, M; Rentfrow, PJ				Greenberg, David M.; Baron-Cohen, Simon; Stillwell, David J.; Kosinski, Michal; Rentfrow, Peter J.			Musical Preferences are Linked to Cognitive Styles	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SPECTRUM QUOTIENT AQ; SYSTEMATIZING QUOTIENT; INDIVIDUAL-DIFFERENCES; ASPERGER-SYNDROME; EMPATHY QUOTIENT; PERSONALITY; EMOTIONS; BRAIN; EXPRESSION	Why do we like the music we do? Research has shown that musical preferences and personality are linked, yet little is known about other influences on preferences such as cognitive styles. To address this gap, we investigated how individual differences in musical preferences are explained by the empathizing-systemizing (E-S) theory. Study 1 examined the links between empathy and musical preferences across four samples. By reporting their preferential reactions to musical stimuli, samples 1 and 2 (Ns = 2,178 and 891) indicated their preferences for music from 26 different genres, and samples 3 and 4 (Ns = 747 and 320) indicated their preferences for music from only a single genre (rock or jazz). Results across samples showed that empathy levels are linked to preferences even within genres and account for significant proportions of variance in preferences over and above personality traits for various music-preference dimensions. Study 2 (N = 353) replicated and extended these findings by investigating how musical preferences are differentiated by E-S cognitive styles (i.e., 'brain types'). Those who are type E (bias towards empathizing) preferred music on the Mellow dimension (R&B/soul, adult contemporary, soft rock genres) compared to type S (bias towards systemizing) who preferred music on the Intense dimension (punk, heavy metal, and hard rock). Analyses of fine-grained psychological and sonic attributes in the music revealed that type E individuals preferred music that featured low arousal (gentle, warm, and sensual attributes), negative valence (depressing and sad), and emotional depth (poetic, relaxing, and thoughtful), while type S preferred music that featured high arousal (strong, tense, and thrilling), and aspects of positive valence (animated) and cerebral depth (complexity). The application of these findings for clinicians, interventions, and those on the autism spectrum (largely type S or extreme type S) are discussed.	[Greenberg, David M.; Rentfrow, Peter J.] Univ Cambridge, Sch Biol Sci, Dept Psychol, Cambridge, England; [Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Stillwell, David J.] Univ Cambridge, Dept Psychol, Psychometr Ctr, Cambridge, England; [Kosinski, Michal] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	University of Cambridge; University of Cambridge; University of Cambridge; Stanford University	Greenberg, DM (corresponding author), Univ Cambridge, Sch Biol Sci, Dept Psychol, Cambridge, England.	dmg39@cam.ac.uk	Kosinski, Michal/AAH-7375-2019; Rentfrow, Peter Jason/ABB-9257-2021	Kosinski, Michal/0000-0003-2936-4775; Rentfrow, Peter Jason/0000-0002-9068-2118; Baron-Cohen, Simon/0000-0001-9217-2544	Cambridge Commonwealth, European and International Trust; UK Medical Research Council; Autism Research Trust; Richard Benjamin Trust; Medical Research Council [G0600977] Funding Source: researchfish; MRC [G0600977] Funding Source: UKRI	Cambridge Commonwealth, European and International Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autism Research Trust; Richard Benjamin Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DMG was supported by the Cambridge Commonwealth, European and International Trust. SBC was funded by the UK Medical Research Council and the Autism Research Trust during the period of this work. DJS was supported by a grant from the Richard Benjamin Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 2005, HDB AUTISM PERVASIVE, P628, DOI [10.1002/9780470939345.ch23, DOI 10.1002/9780470939345.CH23, 10.1002]; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Bauer A.-K. R., 2014, PSYCHOPHYSIOLOGY; Blacking J, 1995, MUSIC CULTURE EXPERI; Boer D, 2011, PERS SOC PSYCHOL B, V37, P1159, DOI 10.1177/0146167211407521; Bonneville-Roussy A, 2013, J PERS SOC PSYCHOL, V105, P703, DOI 10.1037/a0033770; Brown RA, 2012, INT J PSYCHOL, V47, P259, DOI 10.1080/00207594.2011.631544; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa PT, 2007, REVISED NEO PERSONAL; Delsing MJMH, 2008, EUR J PERSONALITY, V22, P109, DOI 10.1002/per.665; DeNora T., 2000, MUSIC EVERYDAY LIFE; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Dunn PG, 2012, PSYCHOL MUSIC, V40, P411, DOI 10.1177/0305735610388897; Egermann H, 2013, MUSIC PERCEPT, V31, P139, DOI 10.1525/MP.2013.31.2.139; Fombonne E, 2005, J APPL RES INTELLECT, V18, P281, DOI 10.1111/j.1468-3148.2005.00266.x; Fonagy P., 2004, MATTER SECURITY APPL, P13; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gabrielsson Alf, 2011, STRONG EXPERIENCES M; George D., 2007, PSYCHOMUSICOLOGY J R, V19, P32, DOI DOI 10.1037/H0094035; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Greenberg D. M., EMPIRICAL M IN PRESS, V10, P79; Greitemeyer T, 2009, J EXP SOC PSYCHOL, V45, P186, DOI 10.1016/j.jesp.2008.08.003; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Harris P.L., 1989, COGNITION EMOTION, V3, P379, DOI DOI 10.1080/02699938908412713; Heaton P, 2005, J AUTISM DEV DISORD, V35, P787, DOI 10.1007/s10803-005-0024-7; Heaton P, 1998, MUSIC PERCEPT, V15, P291; Heaton P, 1999, NEUROCASE, V5, P503, DOI 10.1080/13554799908402745; Huron D.B., 2006, SWEET ANTICIPATION M; Juslin PN, 2010, MUSIC ANAL, V29, P334, DOI 10.1111/j.1468-2249.2011.00323.x; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; Kreutz G, 2008, MUSIC PERCEPT, V26, P57, DOI 10.1525/MP.2008.26.1.57; Lai MC, 2012, NEUROIMAGE, V61, P1347, DOI 10.1016/j.neuroimage.2012.03.018; Langmeyer A, 2012, J INDIVID DIFFER, V33, P119, DOI 10.1027/1614-0001/a000082; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Lundqvist LO, 2009, PSYCHOL MUSIC, V37, P61, DOI 10.1177/0305735607086048; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Miu AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030618; Nettle D, 2008, EUR J PERSONALITY, V22, P323, DOI 10.1002/per.672; Nettle D, 2007, BRIT J PSYCHOL, V98, P237, DOI 10.1348/000712606X117612; North AC, 2010, AM J PSYCHOL, V123, P199, DOI 10.5406/amerjpsyc.123.2.0199; Osuch EA, 2009, NEUROREPORT, V20, P1204, DOI 10.1097/WNR.0b013e32832f4da3; Rabinowitch TC, 2013, PSYCHOL MUSIC, V41, P484, DOI 10.1177/0305735612440609; Rentfrow P. J., 2009, HDB MUSIC EMOTION, P669; Rentfrow PJ, 2012, MUSIC PERCEPT, V30, P161, DOI 10.1525/MP.2012.30.2.161; Rentfrow PJ, 2011, J PERS SOC PSYCHOL, V100, P1139, DOI 10.1037/a0022406; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Rickson DJ, 2003, J MUSIC THER, V40, P283, DOI 10.1093/jmt/40.4.283; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Trainor L. J., 2009, OXFORD HDB MUSIC PSY, P171; Tsay CJ, 2013, P NATL ACAD SCI USA, V110, P14580, DOI 10.1073/pnas.1221454110; Vuoskoski JK, 2012, PSYCHOL AESTHET CREA, V6, P204, DOI 10.1037/a0026937; Vuoskoski JK, 2012, MUSIC PERCEPT, V29, P311, DOI 10.1525/MP.2012.29.3.311; Vuoskoski JK, 2011, CORTEX, V47, P1099, DOI 10.1016/j.cortex.2011.04.011; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494; Zweigenhaft RL, 2008, J INDIVID DIFFER, V29, P45, DOI 10.1027/1614-0001.29.1.45	73	63	64	6	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131151	10.1371/journal.pone.0131151	http://dx.doi.org/10.1371/journal.pone.0131151			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200656	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100012
J	Liu, J; Liu, JX; Gao, YL; Kong, XZ; Wang, XS; Wang, D				Liu, Jian; Liu, Jin-Xing; Gao, Ying-Lian; Kong, Xiang-Zhen; Wang, Xue-Song; Wang, Dong			A P-Norm Robust Feature Extraction Method for Identifying Differentially Expressed Genes	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; PENALIZED MATRIX DECOMPOSITION; CLASSIFICATION; APPROXIMATION; FACTORIZATION; DISCOVERY; ONTOLOGY; CANCER; ARRAYS; RANK	In current molecular biology, it becomes more and more important to identify differentially expressed genes closely correlated with a key biological process from gene expression data. In this paper, based on the Schatten p-norm and L-p-norm, a novel p-norm robust feature extraction method is proposed to identify the differentially expressed genes. In our method, the Schatten p-norm is used as the regularization function to obtain a low-rank matrix and the L-p-norm is taken as the error function to improve the robustness to outliers in the gene expression data. The results on simulation data show that our method can obtain higher identification accuracies than the competitive methods. Numerous experiments on real gene expression data sets demonstrate that our method can identify more differentially expressed genes than the others. Moreover, we confirmed that the identified genes are closely correlated with the corresponding gene expression data.	[Liu, Jian; Liu, Jin-Xing; Kong, Xiang-Zhen; Wang, Dong] Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao 276826, Shandong, Peoples R China; [Gao, Ying-Lian] Qufu Normal Univ, Lib Qufu Normal Univ, Rizhao 276826, Shandong, Peoples R China; [Liu, Jian; Wang, Xue-Song] China Univ Min & Technol, Sch Informat & Elect Engn, Xuzhou 221000, Jiangsu, Peoples R China; [Liu, Jin-Xing] Harbin Inst Technol, Biocomp Res Ctr, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China; [Wang, Xue-Song] Chinese Acad Sci, Inst Automat, Key Lab Complex Syst & Intelligence Sci, Beijing 100000, Peoples R China	Qufu Normal University; Qufu Normal University; China University of Mining & Technology; Harbin Institute of Technology; University Town of Shenzhen; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, JX (corresponding author), Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao 276826, Shandong, Peoples R China.	sdcavell@126.com	Liu, Jin-Xing/AAU-7257-2020	wang, xuesong/0000-0002-5327-1088	NSFC [61373027, 61308116]; China Postdoctoral Science Foundation [2014M560264]; Shandong Provincial Natural Science Foundation [ZR2013FL016, ZR2012FM023]; Shenzhen Municipal Science and Technology Innovation Council [JCYJ20130329151843309, JCYJ20140417172417174]	NSFC(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Shenzhen Municipal Science and Technology Innovation Council	This work was supported in part by the NSFC under grant Nos. 61373027 and 61308116; the China Postdoctoral Science Foundation funded project, No. 2014M560264; the Shandong Provincial Natural Science Foundation, under grant Nos. ZR2013FL016 and ZR2012FM023; Shenzhen Municipal Science and Technology Innovation Council (Nos. JCYJ20130329151843309 and JCYJ20140417172417174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertsekas D. P., 1982, COMPUTER SCI APPL MA, V1982, P1; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Gabay D., 1976, Computers & Mathematics with Applications, V2, P17, DOI 10.1016/0898-1221(76)90003-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hestenes M. R., 1969, Journal of Optimization Theory and Applications, V4, P303, DOI 10.1007/BF00927673; Huang Jin, 2013, P 23 INT JOINT C ART; Journee M, 2010, J MACH LEARN RES, V11, P517; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Liang F, 2007, COMPUT STAT DATA AN, V51, P6355, DOI 10.1016/j.csda.2007.01.022; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106097; Liu JX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S3; Liu JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038873; Liu JX, 2012, COMPUT BIOL MED, V42, P582, DOI 10.1016/j.compbiomed.2012.02.002; Ma S, 2009, BIOINFORMATICS, V25, P882, DOI 10.1093/bioinformatics/btp085; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; Nie F., 2012, P AAAI C ART INT; Nie F., 2013, KNOWL INF SYST, P1; Powell M.J., 1967, METHOD NONLINEAR CON; Sarmah CK, 2011, COMPUT BIOL MED, V41, P980, DOI 10.1016/j.compbiomed.2011.08.007; Toh KC, 2010, PAC J OPTIM, V6, P615; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Wu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066256; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zheng CH, 2011, IEEE T NANOBIOSCI, V10, P86, DOI 10.1109/TNB.2011.2144998	32	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133124	10.1371/journal.pone.0133124	http://dx.doi.org/10.1371/journal.pone.0133124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201006	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100055
J	Moorhead, LL; Holzmeyer, C; Maggio, LA; Steinberg, RM; Willinsky, J				Moorhead, Laura L.; Holzmeyer, Cheryl; Maggio, Lauren A.; Steinberg, Ryan M.; Willinsky, John			In an Age of Open Access to Research Policies: Physician and Public Health NGO Staff Research Use and Policy Awareness	PLOS ONE			English	Article							CARE	Introduction Through funding agency and publisher policies, an increasing proportion of the health sciences literature is being made open access. Such an increase in access raises questions about the awareness and potential utilization of this literature by those working in health fields. Methods A sample of physicians (N=336) and public health non-governmental organization (NGO) staff (N=92) were provided with relatively complete access to the research literature indexed in PubMed, as well as access to the point-of-care service UpToDate, for up to one year, with their usage monitored through the tracking of web-log data. The physicians also participated in a one-month trial of relatively complete or limited access. Results The study found that participants' research interests were not satisfied by article abstracts alone nor, in the case of the physicians, by a clinical summary service such as UpToDate. On average, a third of the physicians viewed research a little more frequently than once a week, while two-thirds of the public health NGO staff viewed more than three articles a week. Those articles were published since the 2008 adoption of the NIH Public Access Policy, as well as prior to 2008 and during the maximum 12-month embargo period. A portion of the articles in each period was already open access, but complete access encouraged a viewing of more research articles. Conclusion Those working in health fields will utilize more research in the course of their work as a result of (a) increasing open access to research, (b) improving awareness of and preparation for this access, and (c) adjusting public and open access policies to maximize the extent of potential access, through reduction in embargo periods and access to pre-policy literature.	[Moorhead, Laura L.; Holzmeyer, Cheryl; Willinsky, John] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA; [Maggio, Lauren A.; Steinberg, Ryan M.] Stanford Univ, Lane Med Lib, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Moorhead, LL (corresponding author), Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA.	lauralm@stanford.edu		Maggio, Lauren/0000-0002-2997-6133; Steinberg, Ryan/0000-0003-0101-4490; Willinsky, John/0000-0001-6192-8687	National Science Foundation's Science of Science & Innovation Policy program [1158673]	National Science Foundation's Science of Science & Innovation Policy program	The National Science Foundation's Science of Science & Innovation Policy program (Grant No. #1158673) granted funding to undertake this study.	Barry H C, 2001, J Am Board Fam Pract, V14, P437; Baxter RJ, 2010, PREV CHRONIC DIS, V7; Bjork BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011273; Carroll-Scott A, 2012, AM J PUBLIC HEALTH, V102, P1384, DOI 10.2105/AJPH.2011.300457; Davis L, 2009, PUBLIC HEALTH REP, V124, P5, DOI 10.1177/00333549091244S102; Davis PM, 2009, STUDIES ACCESS REV; Eldredge JD, 2001, B MED LIBR ASSOC, V89, P71; Gebbie K, 2003, WHO WILL KEEP THE PUBLIC HEALTHY?, P27; Hajek Anna Marie, 2013, Front Health Serv Manage, V29, P45; Hoogendam A, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1012; Increasing Access to the Results of Federally Funded Scientific Research, 2013, COMMUNICATION   0222, P3; Ketchum AM, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1539; Kreindler SA, 2012, MILBANK Q, V90, P347, DOI 10.1111/j.1468-0009.2012.00666.x; Magrabi F, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.974; Marwick Charles, 2005, BMJ, V330, P328, DOI 10.1136/bmj.330.7487.328-b; McManus R., 2013, NIH RECORD, VLXV; Nicholas David, 2011, Information Services & Use, V31, P61, DOI 10.3233/ISU-2011-0623; Nicholas D, 2007, J ACAD LIBR, V33, P446, DOI 10.1016/j.acalib.2007.03.004; Phelps L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-13; Regidor Enrique, 2007, Am J Public Health, V97 Suppl 1, pS93, DOI 10.2105/AJPH.2006.094623; RIN (Research Information Network), 2010, YOU BUILD IT WILL TH; Santosa A, 2014, GLOBAL HEALTH ACTION, V7, P56, DOI 10.3402/gha.v7.23574; Uthman OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078517; Van Noorden R, 2013, NATURE NEWSBLOG 0702; Van Noorden R, 2014, NATURE NEWSBLOG 0409; Younger P, 2010, HEALTH INFO LIBR J, V27, P2, DOI [10.1111/j.1471-1842.2010.00883.x, 10.1111/J.1471-1842.2010.00883.x]	26	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0129708	10.1371/journal.pone.0129708	http://dx.doi.org/10.1371/journal.pone.0129708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200794	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100005
J	Ranasinghe, A; Dasgupta, P; Althoefer, K; Nanayakkara, T				Ranasinghe, Anuradha; Dasgupta, Prokar; Althoefer, Kaspar; Nanayakkara, Thrishantha			Identification of Haptic Based Guiding Using Hard Reins	PLOS ONE			English	Article							MOVEMENTS	This paper presents identifications of human-human interaction in which one person with limited auditory and visual perception of the environment (a follower) is guided by an agent with full perceptual capabilities (a guider) via a hard rein along a given path. We investigate several identifications of the interaction between the guider and the follower such as computational models that map states of the follower to actions of the guider and the computational basis of the guider to modulate the force on the rein in response to the trust level of the follower. Based on experimental identification systems on human demonstrations show that the guider and the follower experience learning for an optimal stable state-dependent novel 3rd and 2nd order auto-regressive predictive and reactive control policies respectively. By modeling the follower's dynamics using a time varying virtual damped inertial system, we found that the coefficient of virtual damping is most appropriate to explain the trust level of the follower at any given time. Moreover, we present the stability of the extracted guiding policy when it was implemented on a planar 1-DoF robotic arm. Our findings provide a theoretical basis to design advanced human-robot interaction algorithms applicable to a variety of situations where a human requires the assistance of a robot to perceive the environment.	[Ranasinghe, Anuradha; Althoefer, Kaspar; Nanayakkara, Thrishantha] Kings Coll London, Ctr Robot Res, Dept Informat, London, England; [Dasgupta, Prokar] Kings Coll London, DTIMB, MRC Ctr Transplantat, London, England; [Dasgupta, Prokar] Kings Coll London, NIHR BRC, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Ranasinghe, A (corresponding author), Kings Coll London, Ctr Robot Res, Dept Informat, London, England.	anuradha.ranasinghe@kcl.ac.uk	Nanayakkara, Thrishantha/AAM-5964-2020; Althoefer, Kaspar/AAA-5984-2022	Nanayakkara, Thrishantha/0000-0002-1882-1232; Dasgupta, Prokar/0000-0001-8690-0445	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/I028765/1]; Guy's and St Thomas' Charity grant on developing clinician-scientific interfaces in robotic assisted surgery: translating technical innovation into improved clinical care [R090705]; Vattikuti foundation; EPSRC [EP/I028765/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I028765/1] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Guy's and St Thomas' Charity grant on developing clinician-scientific interfaces in robotic assisted surgery: translating technical innovation into improved clinical care; Vattikuti foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is supported by the UK Engineering and Physical Sciences Research Council (EPSRC) grant no. EP/I028765/1, the Guy's and St Thomas' Charity grant on developing clinician-scientific interfaces in robotic assisted surgery: translating technical innovation into improved clinical care (grant no. R090705), and Vattikuti foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan MA, 2009, PROC OF THE INTERNAT; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; Casper J, 2003, IEEE T SYST MAN CY B, V33, P367, DOI 10.1109/TSMCB.2003.811794; Duchaine V., 2009, ROBOTICS AUTOMATION, P3383, DOI DOI 10.1109/ROBOT.2009.5152664; Finzi A, 2005, AMERICAN ASSOCIATION; Flanders M, 2002, J NEUROSCI METH, V116, P165, DOI 10.1016/S0165-0270(02)00038-9; Freedy E, 2007, IEEE INTERNATIONAL C; Goodrich Michael A., 2007, Foundations and Trends in Human-Computer Interaction, V1, P203, DOI 10.1561/1100000005; Hancock PA, 2011, HUM FACTORS, V53, P517, DOI 10.1177/0018720811417254; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; JOHANNSEN G, 1979, HUM FACTORS, V21, P733, DOI 10.1177/001872087912210610; Kalia H, 2014, ADV COMPU INTELL ROB, P147, DOI 10.4018/978-1-4666-4936-1.ch007; Loomis JM, 2001, OPTOMETRY VISION SCI, V78, P282, DOI 10.1097/00006324-200105000-00011; Loomis JM, 1998, IEEE T BIOMEDICAL EN, V7, P163; Marston JR, 2007, J VISUAL IMPAIR BLIN, V101, P203, DOI 10.1177/0145482X0710100403; Mitsunaga N., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P218, DOI 10.1109/IROS.2005.1545206; Mortl A, 2012, INT J ROBOT RES, V31, P1656, DOI 10.1177/0278364912455366; Murphy RR, 2004, IEEE T SYST MAN CY C, V34, P138, DOI 10.1109/TSMCC.2004.826267; Park E, 2008, PROCEEDINGS OF THE J, V7; Penders J, 2011, ADV ROBOTICS, V25, P93, DOI 10.1163/016918610X538507; Ranasinghe A, 2013, IEEE SYS MAN CYBERN, P2322, DOI 10.1109/SMC.2013.397; Ranasinghe A, 2013, IEEE INT C INT ROBOT, P116, DOI 10.1109/IROS.2013.6696341; Richardson MJE, 2002, J NEUROSCI, V22, P8201; Saeb S, 2011, PLOS COMPUTATIONAL B, P7; Scheggi S, 2014, IEEE INT CONF ROBOT, P2693, DOI 10.1109/ICRA.2014.6907245; Sterman JD, 1988, SYST DYNAM REV, V4, P148, DOI 10.1002/sdr.4260040109; Stokes IAF, 2001, J BIOMECH, V34, P733, DOI 10.1016/S0021-9290(01)00034-3; Stormont DP, 2008, P HUM IMPL HUM ROB I, P27; TACHI S, 1985, IEEE T BIO-MED ENG, V32, P461, DOI 10.1109/TBME.1985.325561; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Ulrich I, 2001, IEEE T SYST MAN CY A, V31, P131, DOI 10.1109/3468.911370; van Mourik AM, 2006, BIOL CYBERN, V94, P233, DOI 10.1007/s00422-005-0041-9	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132020	10.1371/journal.pone.0132020	http://dx.doi.org/10.1371/journal.pone.0132020			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201076	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100024
J	Anilkumar, NC; Sundaram, MS; Mohan, CD; Rangappa, S; Bulusu, KC; Fuchs, JE; Girish, KS; Bender, A; Basappa; Rangappa, KS				Anilkumar, Nirvanappa C.; Sundaram, Mahalingam S.; Mohan, Chakrabhavi Dhananjaya; Rangappa, Shobith; Bulusu, Krishna C.; Fuchs, Julian E.; Girish, Kesturu S.; Bender, Andreas; Basappa; Rangappa, Kanchugarakoppal S.			A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A(2)	PLOS ONE			English	Article							CARCINOMA IN-VITRO; DESIGN; SUZUKI; 3-COMPONENT; SONOGASHIRA; INHIBITORS; SPACE; ACID; VIVO	Drugs such as necopidem, saripidem, alpidem, zolpidem, and olprinone contain nitrogen-containing bicyclic, condensed-imidazo[1,2-alpha]pyridines as bioactive scaffolds. In this work, we report a high-yield one pot synthesis of 1-(2-methyl-8-aryl-substitued-imidazo[1,2-alpha]pyridin-3-yl)ethan-1-onefor the first-time. Subsequently, we performed in silico mode-of-action analysis and predicted that the synthesized imidazopyridines targets Phospholipase A(2) (PLA(2)). In vitro analysis confirmed the predicted target PLA(2) for the novel imidazopyridine derivative1-(2-Methyl-8-naphthalen-1-yl-imidazo[1,2-alpha]pyridine-3-yl)-ethanone (compound 3f) showing significant inhibitory activity towards snake venom PLA(2) with an IC50 value of 14.3 mu M. Evidently, the molecular docking analysis suggested that imidazopyridine compound was able to bind to the active site of the PLA(2) with strong affinity, whose affinity values are comparable to nimesulide. Furthermore, we estimated the potential for oral bio-availability by Lipinski's Rule of Five. Hence, it is concluded that the compound 3f could be a lead molecule against snake venom PLA(2).	[Anilkumar, Nirvanappa C.; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560001, Karnataka, India; [Sundaram, Mahalingam S.; Girish, Kesturu S.] Univ Mysore, Dept Studies Biochem, Mysore 570006, Karnataka, India; [Mohan, Chakrabhavi Dhananjaya; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Rangappa, Shobith] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0600808, Japan; [Bulusu, Krishna C.; Fuchs, Julian E.; Bender, Andreas] Univ Cambridge, Dept Chem, Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Girish, Kesturu S.] Tumkur Univ, Dept Studies & Res Biochem, Tumkur 572103, Karnataka, India	Bangalore University; University of Mysore; University of Mysore; Hokkaido University; University of Cambridge; Tumkur University	Basappa (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Cent Coll Campus,Palace Rd, Bangalore 560001, Karnataka, India.	salundibasappa@gmail.com; rangappaks@gmail.com	Bender, Andreas/C-6942-2009; Rangappa, Shobith/AAI-2169-2020; Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; KS, Girish/GWZ-7128-2022	Bender, Andreas/0000-0002-6683-7546; Rangappa, Shobith/0000-0002-9800-7192; Mohan, Chakrabhavi Dhananjaya/0000-0002-6810-9219; /0000-0001-6121-0771; KS, Girish/0000-0002-7284-3707; Basappa, Basappa/0000-0002-8844-468X; Bulusu, Krishna/0000-0002-5092-6640	University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology, Department of Science and Technology [SR/FT/LS-142/2012]; DST-JSPS [DST/INT/JAP/P-79/09]; DST Indo-Korea [INT/indo-korea/122/2011-12]; DST-PURSE; European Research Commission (ERC); Unilever; UGC-BSR; Department of Science and Technology	University Grants Commission(University Grants Commission, India); Vision Group Science and Technology, Department of Science and Technology; DST-JSPS; DST Indo-Korea; DST-PURSE; European Research Commission (ERC)(European Research Council (ERC)); Unilever(Unilever); UGC-BSR; Department of Science and Technology(Department of Science & Technology (India))	This research was supported by University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, Department of Science and Technology (NO. SR/FT/LS-142/2012) to Basappa. KSR thanks DST-JSPS (DST/INT/JAP/P-79/09), DST Indo-Korea [INT/indo-korea/122/2011-12] and DST-PURSE for funding. AB thanks Unilever and the European Research Commission (ERC Starting Grant 2013) for funding. MSS thanks UGC-BSR for research fellowship and CDM thanks Department of Science and Technology for INSPIRE fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tel TH, 2011, EUR J MED CHEM, V46, P1874, DOI 10.1016/j.ejmech.2011.02.051; Martinez-Urbina MA, 2010, EUR J MED CHEM, V45, P1211, DOI 10.1016/j.ejmech.2009.11.049; Anusha S, 2014, RSC ADV, V4, P52181, DOI 10.1039/c4ra07839j; Bakherad M, 2008, TETRAHEDRON LETT, V49, P3819, DOI 10.1016/j.tetlet.2008.03.141; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; BOMAN HG, 1957, BIOCHIM BIOPHYS ACTA, V24, P619, DOI 10.1016/0006-3002(57)90256-1; Chernyak N, 2010, ANGEW CHEM INT EDIT, V49, P2743, DOI 10.1002/anie.200907291; Chioua M, 2013, EUR J ORG CHEM, V2013, P35, DOI 10.1002/ejoc.201201258; DeLano W.L., PYMOL MOL GRAPHICS S; DiMauro EF, 2006, J ORG CHEM, V71, P3959, DOI 10.1021/jo060218p; El Kazzouli S, 2011, EUR J MED CHEM, V46, P4252, DOI 10.1016/j.ejmech.2011.06.030; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; JAYANTHI GP, 1989, TOXICON, V27, P875, DOI 10.1016/0041-0101(89)90099-8; Kamal A, 2011, EUR J MED CHEM, V46, P2427, DOI 10.1016/j.ejmech.2011.03.027; Kamal A, 2010, MEDCHEMCOMM, V1, P355, DOI 10.1039/c0md00116c; Keerthy HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107118; Keerthy HK, 2014, J BIOL CHEM, V289, P31879, DOI 10.1074/jbc.M114.593855; Koutsoukas A, 2013, J CHEM INF MODEL, V53, P1957, DOI 10.1021/ci300435j; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Kumar CA, 2007, INVEST NEW DRUG, V25, P343, DOI 10.1007/s10637-006-9033-4; Lamblin M, 2010, ADV SYNTH CATAL, V352, P33, DOI 10.1002/adsc.200900765; Marcussi S, 2007, CURR TOP MED CHEM, V7, P743, DOI 10.2174/156802607780487614; Mohan CD, 2014, J BIOL CHEM, V289, P34296, DOI 10.1074/jbc.M114.601104; Molecular Operating Environment (MOE), 2013, MOL OP ENV MOE CCGI; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Palani T, 2012, EUR J ORG CHEM, V2012, P5038, DOI 10.1002/ejoc.201200679; Penning TD, 2003, BIOORG MED CHEM LETT, V13, P1137, DOI 10.1016/S0960-894X(03)00039-8; Petrovic N, 2001, J LIPID RES, V42, P1706; Rakesh KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107182; Reddy BVS, 2011, TETRAHEDRON LETT, V52, P5789, DOI 10.1016/j.tetlet.2011.08.110; Sekar K, 2003, J MOL BIOL, V333, P367, DOI 10.1016/j.jmb.2003.08.032; Singh N, 2009, J MOL RECOGNIT, V22, P437, DOI 10.1002/jmr.960; Sunitha K, 2011, BASIC CLIN PHARMACOL, V109, P292, DOI 10.1111/j.1742-7843.2011.00725.x; van der Horst E, 2011, CURR TOP MED CHEM, V11, P1964, DOI 10.2174/156802611796391230	36	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131896	10.1371/journal.pone.0131896	http://dx.doi.org/10.1371/journal.pone.0131896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196520	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600018
J	Setamou, M; Bartels, DW				Setamou, Mamoudou; Bartels, David W.			Living on the Edges: Spatial Niche Occupation of Asian Citrus Psyllid, Diaphorina citri Kuwayama (Hemiptera: Liviidae), in Citrus Groves	PLOS ONE			English	Article							VECTOR; TEMPERATURE; RESPONSES; PATTERNS; BIOLOGY; BEETLE	The spatial niche occupation of the Asian citrus psyllid, Diaphorina citri Kuwayama, 1908, was evaluated to determine its field colonization and food resource exploitation strategies in citrus groves. Mature grapefruit and sweet orange groves were surveyed as part of an areawide program in 2009-2010 to determine D. citri population densities and between-tree distribution. In both cultivars, significantly more psyllids were found on perimeter trees throughout the study period suggesting a strong edge effect in D. citri distribution in the groves. D. citri densities and infestation levels gradually declined from the edge to the center of grove. Higher numbers of D. citri were recorded on trees located on the east and south sides of the groves than those on the west and north sides. Citrus groves located at the outer edge of the study with at least one side non-surrounded to other citrus groves harbored significantly more D. citri than groves located within the block cluster and entirely surrounded by other groves. In detailed field studies during 2012, infestation of D. citri started from border trees in the grove where possibly one generation is completed before inner trees become infested. In addition, psyllid densities decreased significantly with increasing distance from the grove edge. Using the selection index, D citri exhibited a strong niche occupation preference for border trees.	[Setamou, Mamoudou] Texas A&M Univ, Dept Agr Agribusiness & Environm Sci, Kingsville Citrus Ctr, Weslaco, TX 78599 USA; [Bartels, David W.] USDA APHIS, Ctr Plant Hlth Sci Technol, Plant Protect Quarantine Miss Lab, Mission, TX USA	Texas A&M University System; Texas A&M University Kingsville; United States Department of Agriculture (USDA)	Setamou, M (corresponding author), Texas A&M Univ, Dept Agr Agribusiness & Environm Sci, Kingsville Citrus Ctr, Weslaco, TX 78599 USA.	mamoudou.setamou@tamuk.edu			United States Department of Agriculture, Animal and Plant Health Inspection Services, Plant Protection and Quarantine [09-8412-1047CA]	United States Department of Agriculture, Animal and Plant Health Inspection Services, Plant Protection and Quarantine	This study was supported by the United States Department of Agriculture, Animal and Plant Health Inspection Services, Plant Protection and Quarantine (09-8412-1047CA).	Alves GR, 2014, J ECON ENTOMOL, V107, P691, DOI 10.1603/EC13339; Arredondo IMJ, 2009, ABUNDANCE POPULATION; Aubert B., 1990, P 4 FAO UNDP INT AS, P133; Boina DR, 2009, ENVIRON ENTOMOL, V38, P1250, DOI 10.1603/022.038.0436; Bove JM, 2006, J PLANT PATHOL, V88, P7; COURTNEY SP, 1982, ECOL ENTOMOL, V7, P131, DOI 10.1111/j.1365-2311.1982.tb00651.x; Drapela T, 2011, EUR J ENTOMOL, V108, P609, DOI 10.14411/eje.2011.079; Flores D, 2009, SOUTHWEST ENTOMOL, V34, P1, DOI 10.3958/059.034.0101; French J. V., 2001, Subtropical Plant Science, V53, P14; Fung Yun-Chung, 2006, Formosan Entomologist, V26, P109; GOTTWALD TR, 2008, INT RES C HUANGL P O, P305; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall D. G., 2011, OUTLOOKS PEST MANAG, V22, P189, DOI DOI 10.1564/22AUG11; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.8301; Haynes KJ, 2006, OIKOS, V113, P43, DOI 10.1111/j.0030-1299.2006.13977.x; KREBS CJ, 1999, ECOLOGICAL METHOLOGY; Manly B. F, 2004, RESOURCE SELECTION A; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nansen C, 2006, ENVIRON ENTOMOL, V35, P516, DOI 10.1603/0046-225X-35.2.516; Olson D, 2008, OECOLOGIA, V155, P549, DOI 10.1007/s00442-007-0933-6; Patti JM, 2010, ENVIRON ENTOMOL, V39, P618, DOI 10.1603/EN09216; Porensky LM, 2013, CONSERV BIOL, V27, P509, DOI 10.1111/cobi.12042; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Sara SA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.3601; SAS, 2008, SAS SAS PROC GUID VE; Savage R. E., 1931, Fisheries Investigations London Ser 2, V12, P1; Setamou M, 2008, J ECON ENTOMOL, V101, P1478, DOI 10.1603/0022-0493(2008)101[1478:DPASPF]2.0.CO;2; Setamou M, 2012, J INSECT BEHAV, V25, P264, DOI 10.1007/s10905-011-9295-3; Thomas CFG, 2001, J APPL ECOL, V38, P100, DOI 10.1046/j.1365-2664.2001.00574.x; Workneh F, 2012, PLANT DIS, V96, P943, DOI 10.1094/PDIS-06-11-0480; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	33	53	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131917	10.1371/journal.pone.0131917	http://dx.doi.org/10.1371/journal.pone.0131917			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193111	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400017
J	Stewart-Malone, A; Misamore, M; Wilmoth, S; Reyes, A; Wong, WH; Gross, J				Stewart-Malone, Alecia; Misamore, Michael; Wilmoth, Siri; Reyes, Alejandro; Wong, Wai Hing; Gross, Jackson			The Effect of UV-C Exposure on Larval Survival of the Dreissenid Quagga Mussel	PLOS ONE			English	Article							WESTERN UNITED-STATES; INDUCED DNA-DAMAGE; ROSTRIFORMIS-BUGENSIS; ULTRAVIOLET-RADIATION; POPULATION-STRUCTURE; GREAT-LAKES; WATER; COLONIZATION; TEMPERATURE; POLYMORPHA	The rapid spread of quagga mussels (Dreissena rostriformis bugensis) has lead to their invasion of Lake Mead, Nevada, the largest reservoir in North America and partially responsible for providing water to millions of people in the southwest. Current strategies for mitigating the growth and spread of quagga mussels primarily include physical and chemical means of removing adults within water treatment, delivery, and hydropower facilities. In the present study, germicidal ultraviolet light (UV-C) was used to target the larval stage of wild-caught quagga mussel. The lethal effect of UV-C was evaluated at four different doses, 0.0, 13.1, 26.2, and 79.6 mJ/cm(2). Tested doses were determined based on results from preliminary trials. The results demonstrate that germicidal UV-C is effective in controlling the free-swimming life history stages of larval quagga mussels.	[Stewart-Malone, Alecia; Reyes, Alejandro; Gross, Jackson] US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT USA; [Misamore, Michael] Texas Christian Univ, Ft Worth, TX 76129 USA; [Wilmoth, Siri] Wilmoth Stat Consulting, Bozeman, MT USA; [Wong, Wai Hing] Univ Nevada, Las Vegas, NV 89154 USA	United States Department of the Interior; United States Geological Survey; Texas Christian University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Stewart-Malone, A (corresponding author), Smith Root Inc, 14014 NE Salmon Creek Ave, Vancouver, WA 98686 USA.	amalone@smith-root.com			US Bureau of Reclamation [R11PG80895]	US Bureau of Reclamation	This work was supported by the US Bureau of Reclamation (http://www.usbr.gov/) under Agreement number R11PG80895. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wilmoth Statistical Consulting provided consultancy support and salary for authors [SW], who had a role in the study design, statistical analysis, and manuscript writing.	ASTM, 2013, E2455062013 ASTM INT, P52, DOI [10.1520/E2455-06R13, DOI 10.1520/E2455-06R13]; Benson A.J., 2013, QUAGGA ZEBRA MUSSELS, P9, DOI DOI 10.1201/B15437-6; Bolton JR, 2005, J ENVIRON ENG SCI, V4, pS27, DOI 10.1139/S04-041; Chalker-Scott L, 1994, P 4 INT ZEBR MUSS C, P162; Choi Wook Jin, 2013, Management of Biological Invasions, V4, P61, DOI 10.3391/mbi.2013.4.1.08; Claudi R, 2007, ASSESSMENT POTENTIAL; Craft CD, 2011, CSU1003 COL DIV WILD, P21; Daniels D, 2007, POWER           0915; Hader DP, 2005, MUTAT RES-FUND MOL M, V571, P221, DOI 10.1016/j.mrfmmm.2004.11.017; Heering W, 2004, IUVA NEWS, V6, P7; LaBounty JF, 2007, LAKELINE, V27, P17; Lewis DP, 1997, METHOD APPARATUS CON; Lupal M, 1993, UV OFFERS RELIABLE D; Matthews J, 2012, REPORTS ENV SCI RADB; Matthews MA, 1999, J MOLLUS STUD, V65, P317, DOI 10.1093/mollus/65.3.317; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; McMahon RF, 2011, AQUAT INVASIONS, V6, P131, DOI 10.3391/ai.2011.6.2.02; Meesters KPH, 2003, WATER RES, V37, P525, DOI 10.1016/S0043-1354(02)00354-8; MILLS EL, 1993, CAN J FISH AQUAT SCI, V50, P2305, DOI 10.1139/f93-255; Mills EL, 1996, AM ZOOL, V36, P271; Peyer SM, 2010, J EXP BIOL, V213, P2602, DOI 10.1242/jeb.042549; Peyer SM, 2009, J EXP BIOL, V212, P2026, DOI 10.1242/jeb.028688; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Prescott TH, 2014, QUAGGA ZEBRA MUSSELS, V2nd, P243; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reef R, 2009, J EXP BIOL, V212, P2760, DOI 10.1242/jeb.031286; Rogers JD, 2010, CIVIL ENG, V80, P52, DOI 10.1061/ciegag.0000325; Rozema J, 2002, J PHOTOCH PHOTOBIO B, V66, P2, DOI 10.1016/S1011-1344(01)00269-X; Schalk S., 2005, TECHNOL APPL SVEN, V8, P32; Seaver RW, 2009, J SHELLFISH RES, V28, P625, DOI 10.2983/035.028.0327; Vanderploeg HA, 2010, J GREAT LAKES RES, V36, P50, DOI 10.1016/j.jglr.2010.04.005; Watters A, 2013, BIOFOULING, V29, P21, DOI 10.1080/08927014.2012.744825; Wong WH, 2011, AQUAT INVASIONS, V6, P125, DOI 10.3391/ai.2011.6.2.01; Wright DA, 1997, ZEBRA MUSSELS AND AQUATIC NUISANCE SPECIES, P467	34	5	5	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133039	10.1371/journal.pone.0133039	http://dx.doi.org/10.1371/journal.pone.0133039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186734	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700088
J	Borges, V; Pinheiro, M; Antelo, M; Sampaio, DA; Vieira, L; Ferreira, R; Nunes, A; Almeida, F; Mota, LJ; Borrego, MJ; Gomes, JP				Borges, Vitor; Pinheiro, Miguel; Antelo, Minia; Sampaio, Daniel A.; Vieira, Luis; Ferreira, Rita; Nunes, Alexandra; Almeida, Filipe; Mota, Luis J.; Borrego, Maria J.; Gomes, Joao P.			Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; GUANYLATE BINDING-PROTEINS; III SECRETION MECHANISM; EARLY-CYCLE DEVELOPMENT; OUTER-MEMBRANE COMPLEX; HISTONE-LIKE PROTEIN; MESSENGER-RNA DECAY; KAPPA-B PATHWAY; LYMPHOGRANULOMA-VENEREUM; ESCHERICHIA-COLI	Research on the obligate intracellular bacterium Chlamydia trachomatis demands culture in cell-lines, but the adaptive process behind the in vivo to in vitro transition is not understood. We assessed the genomic and transcriptomic dynamics underlying C. trachomatis in vitro adaptation of strains representing the three disease groups (ocular, epithelial-genital and lymphogranuloma venereum) propagated in epithelial cells over multiple passages. We found genetic features potentially underlying phase variation mechanisms mediating the regulation of a lipid A biosynthesis enzyme (CT533/LpxC), and the functionality of the cytotoxin (CT166) through an ON/OFF mechanism. We detected inactivating mutations in CT713/porB, a scenario suggesting metabolic adaptation to the available carbon source. CT135 was inactivated in a tropism-specific manner, with CT135-negative clones emerging for all epithelial-genital populations (but not for LGV and ocular populations) and rapidly increasing in frequency (similar to 23% mutants per10 passages). RNA-sequencing analyses revealed that a deletion event involving CT135 impacted the expression of multiple virulence factors, namely effectors known to play a role in the C. trachomatis host-cell invasion or subversion (e.g., CT456/Tarp, CT694, CT875/TepP and CT868/ChlaDub1). This reflects a scenario of attenuation of C. trachomatis virulence in vitro, which may take place independently or in a cumulative fashion with the also observed down-regulation of plasmid-related virulence factors. This issue may be relevant on behalf of the recent advances in Chlamydia mutagenesis and transformation where culture propagation for selecting mutants/transformants is mandatory. Finally, there was an increase in the growth rate for all strains, reflecting gradual fitness enhancement over time. In general, these data shed light on the adaptive process underlying the C. trachomatis in vivo to in vitro transition, and indicates that it would be prudent to restrict culture propagation to minimal passages and check the status of the CT135 genotype in order to avoid the selection of CT135-negative mutants, likely originating less virulent strains.	[Borges, Vitor; Antelo, Minia; Ferreira, Rita; Nunes, Alexandra; Borrego, Maria J.; Gomes, Joao P.] Natl Inst Hlth, Dept Infect Dis, Reference Lab Bacterial Sexually Transmitted Infe, Lisbon, Portugal; [Borges, Vitor; Nunes, Alexandra; Gomes, Joao P.] Natl Inst Hlth, Dept Infect Dis, Bioinformat Unit, Lisbon, Portugal; [Pinheiro, Miguel] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Sampaio, Daniel A.; Vieira, Luis] Natl Inst Hlth, Dept Human Genet, Innovat & Technol Unit, Lisbon, Portugal; [Almeida, Filipe; Mota, Luis J.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, UCIBIO,REQUIMTE, Caparica, Portugal	University of St Andrews; Universidade Nova de Lisboa	Gomes, JP (corresponding author), Natl Inst Hlth, Dept Infect Dis, Reference Lab Bacterial Sexually Transmitted Infe, Lisbon, Portugal.	j.paulo.gomes@insa.min-saude.pt	Vieira, Luis/I-6378-2019; Almeida, Filipe/O-2871-2015; Mota, Luis/B-9497-2008; da Silva Almeida, Filipe Manuel Baeta/AAP-5315-2021; Nunes, Alexandra/ABE-3699-2020; Pinheiro, Miguel/K-6572-2017	Vieira, Luis/0000-0002-7703-1409; Almeida, Filipe/0000-0001-5114-7721; Mota, Luis/0000-0002-5592-8397; da Silva Almeida, Filipe Manuel Baeta/0000-0001-5114-7721; Pinheiro, Miguel/0000-0002-6601-7513; Nunes, Alexandra/0000-0001-6449-8053; Borrego, Maria Jose/0000-0002-8604-8800; Gomes, Joao Paulo/0000-0002-2697-2399; Antelo, Minia/0000-0001-7864-1906; Borges, Vitor/0000-0003-3767-2209; Ferreira, Rita/0000-0002-0016-7543	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/68527/2010]; Wellcome Trust ISSF grant [097831/Z/11/Z]; FCT [SFRH/BD/68532/2010, SFRH/BPD/75295/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust ISSF grant(Wellcome Trust); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	VB was a recipient of Ph.D. fellowship (SFRH/BD/68527/2010) from Fundacao para a Ciencia e a Tecnologia (FCT). MP is funded by a Wellcome Trust ISSF grant (097831/Z/11/Z). RF and AN are recipients of a Ph.D. (SFRH/BD/68532/2010) and post-doctoral fellowships (SFRH/BPD/75295/2010) from FCT, respectively.	Al-Zeer MA, 2013, AUTOPHAGY, V9, P50, DOI 10.4161/auto.22482; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; ALIFANO P, 1994, GENETICA, V94, P157, DOI 10.1007/BF01443430; Almeida F, 2012, J BACTERIOL, V194, P6574, DOI 10.1128/JB.01428-12; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson P, 2013, CLIN MICROBIOL INFEC, V19, pE405, DOI 10.1111/1469-0691.12237; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Bao XF, 2014, J BACTERIOL, V196, P2989, DOI 10.1128/JB.01677-14; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Birkelund S, 2009, FEMS IMMUNOL MED MIC, V55, P187, DOI 10.1111/j.1574-695X.2009.00522.x; Bonner CA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00017; Borges V, 2010, J MICROBIOL METH, V82, P256, DOI 10.1016/j.mimet.2010.06.013; Borges V, 2014, GENOME ANNOUNC, P2; Borges V, 2015, INFECT GENET EVOL, V32, P74, DOI 10.1016/j.meegid.2015.02.026; Borges V, 2013, INFECT GENET EVOL, V17, P23, DOI 10.1016/j.meegid.2013.03.035; Borges V, 2012, J BACTERIOL, V194, P6143, DOI 10.1128/JB.01291-12; Bothe M, 2015, TOXINS, V7, P621, DOI 10.3390/toxins7020621; BRICKMAN TJ, 1993, J BACTERIOL, V175, P4274, DOI 10.1128/JB.175.14.4274-4281.1993; Brinkworth AJ, 2011, MOL MICROBIOL, V82, P131, DOI 10.1111/j.1365-2958.2011.07802.x; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; Carabeo R, 2011, CELL MICROBIOL, V13, P1460, DOI 10.1111/j.1462-5822.2011.01651.x; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Carlson JH, 2004, INFECT IMMUN, V72, P7063, DOI 10.1128/IAI.72.12.7063-7072.2004; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; Carmichael JR, 2013, MICROBES INFECT, V15, P219, DOI 10.1016/j.micinf.2012.12.001; Chellas-Gery B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x; Chen CQ, 2015, INFECT IMMUN, V83, P1881, DOI 10.1128/IAI.03158-14; Chen YS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003954; Christiansen MT, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0591-3; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Cooper KK, 2013, RES MICROBIOL, V164, P6, DOI 10.1016/j.resmic.2012.10.002; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Cowley SC, 1996, MOL MICROBIOL, V20, P867, DOI 10.1111/j.1365-2958.1996.tb02524.x; da Cunha M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-40; Dal Conte I, 2014, PANMINERVA MED, V56, P73; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; Ding HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080534; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Engstrom P, 2015, MBIO, V6, DOI 10.1128/mBio.02304-14; Engstrom P, 2013, J BACTERIOL, V195, P4221, DOI 10.1128/JB.00506-13; Engstrom P, 2010, FEMS IMMUNOL MED MIC, V58, P244, DOI 10.1111/j.1574-695X.2009.00631.x; Fadel S, 2007, J MED MICROBIOL, V56, P15, DOI 10.1099/jmm.0.46801-0; FAHR MJ, 1995, J BACTERIOL, V177, P4252, DOI 10.1128/jb.177.15.4252-4260.1995; Fechtner T, 2013, J BACTERIOL, V195, P5323, DOI 10.1128/JB.00780-13; Ferreira R, 2015, G3-GENES GENOM GENET, V5, P9, DOI 10.1534/g3.114.015354; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Gerard HC, 2013, NANOMED-NANOTECHNOL, V9, P996, DOI 10.1016/j.nano.2013.04.004; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2005, MICROBES INFECT, V7, P410, DOI 10.1016/j.micinf.2004.11.014; Gong SQ, 2011, MICROBIOL-SGM, V157, P1134, DOI 10.1099/mic.0.047746-0; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Griffiths E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-14; Grimwood J, 2001, INFECT IMMUN, V69, P2383, DOI 10.1128/IAI.69.4.2383-2389.2001; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Hobolt-Pedersen AS, 2009, FEMS IMMUNOL MED MIC, V57, P46, DOI 10.1111/j.1574-695X.2009.00581.x; Hong WL, 2013, CELL SIGNAL, V25, P660, DOI 10.1016/j.cellsig.2012.11.019; Hou SP, 2013, J BACTERIOL, V195, P951, DOI 10.1128/JB.02087-12; Hovis KM, 2013, PATHOG DIS, V69, P213, DOI 10.1111/2049-632X.12070; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Iliopoulos I, 2003, BIOINFORMATICS, V19, P717, DOI 10.1093/bioinformatics/btg077; Jansen G, 2013, DRUG RESIST UPDATE, V16, P96, DOI 10.1016/j.drup.2014.02.002; Jasper DK, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv003; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Johnson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083989; Jones HM, 2000, GENE, V258, P173, DOI 10.1016/S0378-1119(00)00367-X; Jorgensen I, 2008, INFECT IMMUN, V76, P3940, DOI 10.1128/IAI.00632-08; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Joubert BC, 2011, J MED MICROBIOL, V60, P1565, DOI 10.1099/jmm.0.032169-0; Kabeya Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-57; Kari L, 2008, J INFECT DIS, V197, P449, DOI 10.1086/525285; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; Kersh GJ, 2011, VECTOR-BORNE ZOONOT, V11, P1433, DOI 10.1089/vbz.2011.0670; Kubo A, 2001, MICROBIOL-SGM, V147, P3135, DOI 10.1099/00221287-147-11-3135; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Labiran C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00068; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Negrate G, 2008, CELL MICROBIOL, V10, P1879, DOI 10.1111/j.1462-5822.2008.01178.x; Lee CJ, 2011, CHEM BIOL, V18, P38, DOI 10.1016/j.chembiol.2010.11.011; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lo CC, 2012, MICROBIOL MOL BIOL R, V76, P405, DOI 10.1128/MMBR.05013-11; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Lu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068764; LUKACOVA M, 1994, INFECT IMMUN, V62, P2270; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Misaghi S, 2006, MOL MICROBIOL, V61, P142, DOI 10.1111/j.1365-2958.2006.05199.x; Mishra MK, 2012, MOL PHARMACEUT, V9, P413, DOI 10.1021/mp200512f; Miyairi I, 2006, J INFECT DIS, V194, P350, DOI 10.1086/505432; Moore ER, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00157; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Muschiol S, 2011, INFECT IMMUN, V79, P571, DOI 10.1128/IAI.00825-10; Nelson DE, 2007, CELL MICROBIOL, V9, P2289, DOI 10.1111/j.1462-5822.2007.00959.x; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Nguyen BD, 2011, P NATL ACAD SCI USA, V108, P10284, DOI 10.1073/pnas.1107478108; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Nunes A, 2013, INFECT GENET EVOL, V16, P392, DOI 10.1016/j.meegid.2013.03.018; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; O'Connell CM, 2011, INFECT IMMUN, V79, P1044, DOI 10.1128/IAI.01118-10; O'Neill CE, 2013, MICROBIOL-SGM, V159, P748, DOI 10.1099/mic.0.065391-0; Orsi RH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-102; Ortega AD, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00162; Pais SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056292; Pedersen AS, 2001, FEMS MICROBIOL LETT, V203, P153, DOI 10.1016/S0378-1097(01)00341-X; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Putman TE, 2013, MICROBIOL-SGM, V159, P2109, DOI 10.1099/mic.0.070029-0; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ramsey KH, 2009, INFECT IMMUN, V77, P3284, DOI 10.1128/IAI.00147-09; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Rosario CJ, 2014, MOL MICROBIOL, V94, P888, DOI 10.1111/mmi.12804; Rosario CJ, 2012, MOL MICROBIOL, V84, P1097, DOI 10.1111/j.1365-2958.2012.08077.x; Russell M, 2011, INFECT IMMUN, V79, P98, DOI 10.1128/IAI.01105-10; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Scidmore MA, 2011, MICROBES INFECT, V13, P527, DOI 10.1016/j.micinf.2011.02.001; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Seth-Smith HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/gr.150037.112; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Skinner MC, 2009, ANTIMICROB AGENTS CH, V53, P1482, DOI 10.1128/AAC.01179-08; Snavely EA, 2014, PATHOG DIS, V71, P336, DOI 10.1111/2049-632X.12179; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Stothard DR, 1998, J CLIN MICROBIOL, V36, P3686, DOI 10.1128/JCM.36.12.3686-3688.1998; Sturdevant GL, 2014, PATHOG DIS, V71, P90, DOI 10.1111/2049-632X.12121; Sturdevant GL, 2010, INFECT IMMUN, V78, P3660, DOI 10.1128/IAI.00386-10; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Subtil A, 2014, TRENDS PLANT SCI, V19, P36, DOI 10.1016/j.tplants.2013.10.005; Suchland RJ, 2008, INFECT IMMUN, V76, P5438, DOI 10.1128/IAI.00984-08; Tattersall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047439; Thalmann J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009887; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vannucci FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046708; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Viratyosin W, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-38; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; WEISBERG RA, 1977, ANNU REV GENET, V11, P451, DOI 10.1146/annurev.ge.11.120177.002315; White JA, 2009, CURR OPIN INFECT DIS, V22, P57, DOI 10.1097/QCO.0b013e328320a8ae; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Yeruva L, 2014, MBIO, V5, DOI 10.1128/mBio.01241-14; Zhong GM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00014; Zinser ER, 2003, GENETICS, V164, P1271	177	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133420	10.1371/journal.pone.0133420	http://dx.doi.org/10.1371/journal.pone.0133420			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207372	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000088
J	Hoffmann, J; Altenbuchner, J				Hoffmann, Jana; Altenbuchner, Josef			Functional Characterization of the Mannitol Promoter of Pseudomonas fluorescens DSM 50106 and Its Application for a Mannitol-Inducible Expression System for Pseudomonas putida KT2440	PLOS ONE			English	Article							BROAD-HOST-RANGE; MELR TRANSCRIPTION ACTIVATOR; META-CLEAVAGE PATHWAY; DNA-BINDING DOMAIN; ESCHERICHIA-COLI; ARAC/XYLS FAMILY; REGULATED EXPRESSION; NUCLEOTIDE-SEQUENCE; PROTEIN EXPRESSION; STRUCTURAL BASIS	A new pBBR1MCS-2-derived vector containing the Pseudomonas fluorescens DSM10506 mannitol promoter P-mtlE and mtlR encoding its AraC/XylS type transcriptional activator was constructed and optimized for low basal expression. Mannitol, arabitol, and glucitol-inducible gene expression was demonstrated with Pseudomonas putida and eGFP as reporter gene. The new vector was applied for functional characterization of P-mtlE. Identification of the DNA binding site of MtlR was achieved by in vivo eGFP measurement with P-mtlE wild type and mutants thereof. Moreover, purified MtlR was applied for detailed in vitro investigations using electrophoretic mobility shift assays and DNaseI footprinting experiments. The obtained data suggest that MtlR binds to P-mtlE as a dimer. The proposed DNA binding site of MtlR is AGTGC-N-5-AGTAT-N-7-AGTGC-N-5-AGGAT. The transcription activation mechanism includes two binding sites with different binding affinities, a strong upstream binding site and a weaker downstream binding site. The presence of the weak downstream binding site was shown to be necessary to sustain mannitol-inducibility of P-mtlE. Two possible functions of mannitol are discussed; the effector might stabilize binding of the second monomer to the downstream half site or promote transcription activation by inducing a conformational change of the regulator that influences the contact to the RNA polymerase.	[Hoffmann, Jana; Altenbuchner, Josef] Univ Stuttgart, Inst Ind Genet, Allmandring 31, D-70569 Stuttgart, Germany	University of Stuttgart	Hoffmann, J (corresponding author), Univ Stuttgart, Inst Ind Genet, Allmandring 31, D-70569 Stuttgart, Germany.	jana.hoffmann@iig.uni-stuttgart.de						AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Bourgerie SJ, 1997, NUCLEIC ACIDS RES, V25, P1685, DOI 10.1093/nar/25.9.1685; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Brenner D.J., 2005, BERGEYS MANUAL SYSTE, V2, P323, DOI DOI 10.1007/0-387-28022-7_9; Brunker P, 1998, GENE, V206, P117, DOI 10.1016/S0378-1119(97)00574-X; Brunker P, 1998, GENE, V215, P19, DOI 10.1016/S0378-1119(98)00274-1; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; CASWELL R, 1992, BIOCHEM J, V287, P501, DOI 10.1042/bj2870501; Chen A, 2014, J IND MICROBIOL BIOT, P1; Dammeyer T, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-49; Dennis J J, 1995, Methods Mol Biol, V47, P125; Dominguez-Cuevas P, 2010, J BACTERIOL, V192, P2682, DOI 10.1128/JB.00165-10; Durante-Rodriguez G, 2014, METHODS MOL BIOL, V1149, P469, DOI 10.1007/978-1-4939-0473-0_36; Duval Valerie, 2013, Int J Biotechnol Wellness Ind, V2, P101; EGAN SM, 1994, J MOL BIOL, V243, P821, DOI 10.1006/jmbi.1994.1684; FANG FC, 1991, J BACTERIOL, V173, P5861, DOI 10.1128/jb.173.18.5861-5868.1991; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Giacalone MJ, 2006, BIOTECHNIQUES, V40, P355, DOI 10.2144/000112112; Gonzalez-Perez MM, 1999, J BIOL CHEM, V274, P2286, DOI 10.1074/jbc.274.4.2286; Graf N, 2013, APPL MICROBIOL BIOT, V97, P8239, DOI 10.1007/s00253-013-5030-7; Graf N, 2011, APPL ENVIRON MICROB, V77, P5549, DOI 10.1128/AEM.05055-11; Griffith KL, 2001, MOL MICROBIOL, V40, P1141, DOI 10.1046/j.1365-2958.2001.02456.x; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; Hoffmann J, 2012, FEBS J, V279, P3911, DOI 10.1111/j.1742-4658.2012.08751.x; Ibarra JA, 2008, GENETICA, V133, P65, DOI 10.1007/s10709-007-9185-y; Itoh N, 2003, APPL MICROBIOL BIOT, V61, P240, DOI 10.1007/s00253-002-1195-1; Jeske M, 2010, APPL MICROBIOL BIOT, V85, P1923, DOI 10.1007/s00253-009-2245-8; Kaldalu N, 1996, MOL MICROBIOL, V20, P569, DOI 10.1046/j.1365-2958.1996.5381060.x; KESSLER B, 1994, MOL GEN GENET, V244, P596, DOI 10.1007/BF00282749; Kolin A, 2008, MOL MICROBIOL, V68, P448, DOI 10.1111/j.1365-2958.2008.06164.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MERMOD N, 1986, J BACTERIOL, V167, P447, DOI 10.1128/jb.167.2.447-454.1986; MICHAN CM, 1995, NUCLEIC ACIDS RES, V23, P1518, DOI 10.1093/nar/23.9.1518; Ni L, 2013, NUCLEIC ACIDS RES, V41, P1998, DOI 10.1093/nar/gks1207; Niland P, 1996, J MOL BIOL, V264, P667, DOI 10.1006/jmbi.1996.0668; Papaneophytou CP, 2014, PROTEIN EXPRES PURIF, V94, P22, DOI 10.1016/j.pep.2013.10.016; Perez-Pantoja D, 2015, ENVIRON MICROBIOL, V17, P64, DOI 10.1111/1462-2920.12443; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Rother D, 1999, MOL GEN GENET, V262, P154, DOI 10.1007/s004380051070; Ruiz R, 2003, J BACTERIOL, V185, P3036, DOI 10.1128/JB.185.10.3036-3041.2003; Samarasinghe S, 2008, NUCLEIC ACIDS RES, V36, P2667, DOI 10.1093/nar/gkn119; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuller A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/103132; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; Sidorova NY, 2010, ELECTROPHORESIS, V31, P648, DOI 10.1002/elps.200900573; Soisson SM, 1997, SCIENCE, V276, P421, DOI 10.1126/science.276.5311.421; Troeschel SC, 2012, J BIOTECHNOL, V161, P71, DOI 10.1016/j.jbiotec.2012.02.020; van den Berg B, 2012, J BIOL CHEM, V287, P41044, DOI 10.1074/jbc.M112.408518; Wang C, 2012, BIOTECHNIQUES, P1; WATERS SH, 1983, NUCLEIC ACIDS RES, V11, P6089, DOI 10.1093/nar/11.17.6089; Wickstrum JR, 2007, J BACTERIOL, V189, P4984, DOI 10.1128/JB.00530-07; WYLIE JL, 1995, J BACTERIOL, V177, P3021, DOI 10.1128/jb.177.11.3021-3026.1995; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	58	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133248	10.1371/journal.pone.0133248	http://dx.doi.org/10.1371/journal.pone.0133248			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207762	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000070
J	Sankavaram, SR; Svensson, MA; Olsson, T; Brundin, L; Johansson, CB				Sankavaram, Sreenivasa R.; Svensson, Mikael A.; Olsson, Tomas; Brundin, Lou; Johansson, Clas B.			Cell Fusion along the Anterior-Posterior Neuroaxis in Mice with Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; MARROW-DERIVED CELLS; BONE-MARROW; PURKINJE NEURONS; HETEROKARYON FORMATION; MUSCLE REGENERATION; SKELETAL-MUSCLE; NEURODEGENERATION; HEPATOCYTES	Background It is well documented that bone marrow-derived cells can fuse with a diverse range of cells, including brain cells, under normal or pathological conditions. Inflammation leads to robust fusion of bone marrow-derived cells with Purkinje cells and the formation of binucleate heterokaryons in the cerebellum. Heterokaryons form through the fusion of two developmentally differential cells and as a result contain two distinct nuclei without subsequent nuclear or chromosome loss. Aim In the brain, fusion of bone marrow-derived cells appears to be restricted to the complex and large Purkinje cells, raising the question whether the size of the recipient cell is important for cell fusion in the central nervous system. Purkinje cells are among the largest neurons in the central nervous system and accordingly can harbor two nuclei. Results Using a well-characterized model for heterokaryon formation in the cerebellum (experimental autoimmune encephalomyelitis - a mouse model of multiple sclerosis), we report for the first time that green fluorescent protein-labeled bone marrow-derived cells can fuse and form heterokaryons with spinal cord motor neurons. These spinal cord heterokaryons are predominantly located in or adjacent to an active or previously active inflammation site, demonstrating that inflammation and infiltration of immune cells are key for cell fusion in the central nervous system. While some motor neurons were found to contain two nuclei, co-expressing green fluorescent protein and the neuronal marker, neuron-specific nuclear protein, a number of small interneurons also co-expressed green fluorescent protein and the neuronal marker, neuron-specific nuclear protein. These small heterokaryons were scattered in the gray matter of the spinal cord. Conclusion This novel finding expands the repertoire of neurons that can form heterokaryons with bone marrow-derived cells in the central nervous system, albeit in low numbers, possibly leading to a novel therapy for spinal cord motor neurons or other neurons that are compromised in the central nervous system.	[Sankavaram, Sreenivasa R.; Olsson, Tomas; Brundin, Lou; Johansson, Clas B.] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Sankavaram, Sreenivasa R.; Svensson, Mikael A.; Olsson, Tomas; Brundin, Lou; Johansson, Clas B.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Johansson, Clas B.] Jamtland Harjedalen Cty Council, Publ Dent Serv Gallo, Gallo, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Johansson, CB (corresponding author), Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden.	clas.johansson@ki.se	Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003; Brundin, Lou/0000-0003-4408-7817; Olsson, Tomas/0000-0002-2938-1877	Alltid Litt Sterkere; Hallsten Research Foundation; Stichting af Jochnick; Magnus Bergvalls Stiftelse; Stroke forbundet; Hjarnfonden; NHR; Tore Nilssons stiftelse; Wenner-Gren Foundations; Stiftelsen Clas Groschinskys Minnesfond; Ake Wibergs Stiftelse; Karolinska Institutes fonder; Familjen Iversens minnesgaveri	Alltid Litt Sterkere; Hallsten Research Foundation; Stichting af Jochnick; Magnus Bergvalls Stiftelse; Stroke forbundet; Hjarnfonden; NHR; Tore Nilssons stiftelse; Wenner-Gren Foundations; Stiftelsen Clas Groschinskys Minnesfond; Ake Wibergs Stiftelse; Karolinska Institutes fonder; Familjen Iversens minnesgaveri	This work was supported by Alltid Litt Sterkere, the Hallsten Research Foundation, Stichting af Jochnick, Magnus Bergvalls Stiftelse, Stroke forbundet, Hjarnfonden, NHR, Tore Nilssons stiftelse, the Wenner-Gren Foundations, Stiftelsen Clas Groschinskys Minnesfond, Ake Wibergs Stiftelse, Karolinska Institutes fonder, and Familjen Iversens minnesgaveri.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Bae JS, 2005, HUM GENE THER, V16, P1006, DOI 10.1089/hum.2005.16.1006; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; GIBSON AJ, 1995, J CELL SCI, V108, P207; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kaji K, 2004, REPRODUCTION, V127, P423, DOI 10.1530/rep.1.00163; Kang H, 2014, CELL REP, V8, P1210, DOI 10.1016/j.celrep.2014.07.032; Kemp K, 2012, BRAIN, V135, P2962, DOI 10.1093/brain/aws226; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Magrassi L, 2007, J NEUROSCI, V27, P9885, DOI 10.1523/JNEUROSCI.2539-07.2007; Nern C, 2009, J NEUROSCI, V29, P3799, DOI 10.1523/JNEUROSCI.5848-08.2009; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Ridder K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001874; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sanges D, 2013, CELL REP, V4, P271, DOI 10.1016/j.celrep.2013.06.015; Sullivan S, 2006, STEM CELL REV, V2, P341, DOI 10.1007/BF02698061; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Willenbring H, 2005, BRIT J SURG, V92, P923, DOI 10.1002/bjs.5110; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	30	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133903	10.1371/journal.pone.0133903	http://dx.doi.org/10.1371/journal.pone.0133903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207625	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000169
J	Chen, Y; Liang, ZY; Fei, EK; Chen, YW; Zhou, XP; Fang, WQ; Fu, WY; Fu, AKY; Ip, NY				Chen, Yu; Liang, Zhuoyi; Fei, Erkang; Chen, Yuewen; Zhou, Xiaopu; Fang, Weiqun; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.			Axin Regulates Dendritic Spine Morphogenesis through Cdc42-Dependent Signaling	PLOS ONE			English	Article							STRUCTURAL PLASTICITY; CEREBRAL-CORTEX; RHO-GTPASES; RECEPTOR; PROTEINS; MECHANISM; INTERACTS; SYNAPSES; SCAFFOLD; ACTIN	During development, scaffold proteins serve as important platforms for orchestrating signaling complexes to transduce extracellular stimuli into intracellular responses that regulate dendritic spine morphology and function. Axin ("axis inhibitor") is a key scaffold protein in canonical Wnt signaling that interacts with specific synaptic proteins. However, the cellular functions of these protein-protein interactions in dendritic spine morphology and synaptic regulation are unclear. Here, we report that Axin protein is enriched in synaptic fractions, colocalizes with the postsynaptic marker PSD-95 in cultured hippocampal neurons, and interacts with a signaling protein Ca2+/calmodulin-dependent protein kinase II (CaMKII) in synaptosomal fractions. Axin depletion by shRNA in cultured neurons or intact hippocampal CA1 regions significantly reduced dendritic spine density. Intriguingly, the defective dendritic spine morphogenesis in Axin-knockdown neurons could be restored by overexpression of the small Rho-GTPase Cdc42, whose activity is regulated by CaMKII. Moreover, pharmacological stabilization of Axin resulted in increased dendritic spine number and spontaneous neurotransmission, while Axin stabilization in hippocampal neurons reduced the elimination of dendritic spines. Taken together, our findings suggest that Axin promotes dendritic spine stabilization through Cdc42-dependent cytoskeletal reorganization.	[Chen, Yu; Liang, Zhuoyi; Fei, Erkang; Chen, Yuewen; Zhou, Xiaopu; Fang, Weiqun; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Chen, Yu; Liang, Zhuoyi; Fei, Erkang; Chen, Yuewen; Zhou, Xiaopu; Fang, Weiqun; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China; [Chen, Yu; Chen, Yuewen; Fu, Amy K. Y.; Ip, Nancy Y.] HKUST Shenzhen Res Inst, Guangdong Key Lab Brain Sci Dis & Drug Dev, Shenzhen, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Chen, Y (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	bcyuchen@ust.hk; boip@ust.hk	Fang, Wei-Qun/AAW-5945-2020; FEI, Erkang/AAI-9825-2021; ZHOU, Xiaopu/ABB-2263-2021	ZHOU, Xiaopu/0000-0001-5307-5805; Fu, Kit Yu/0000-0003-4085-6201; Fang, Weiqun/0000-0002-6741-860X; FEI, Erkang/0000-0002-3581-9521; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Liang, Zhuoyi/0000-0003-1622-524X	Research Grants Council of Hong Kong (HKUST) [660110, 661111, 661013]; National Basic Research Program of China (973 Program) [2013CB530900]; Theme-based Research Scheme of the University Grants Committee [T13607/12-R]; Shenzhen Peacock Plan, funding for establishing the Guangdong Key Laboratory; Asia Fund for Cancer Research [AFCR14SC02]	Research Grants Council of Hong Kong (HKUST)(Hong Kong Research Grants Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Theme-based Research Scheme of the University Grants Committee; Shenzhen Peacock Plan, funding for establishing the Guangdong Key Laboratory; Asia Fund for Cancer Research	This study was supported in part by the Research Grants Council of Hong Kong (HKUST 660110, 661111 and 661013), the National Basic Research Program of China (973 Program; 2013CB530900), the Theme-based Research Scheme of the University Grants Committee (T13607/12-R), the Shenzhen Peacock Plan, funding for establishing the Guangdong Key Laboratory and the Asia Fund for Cancer Research (AFCR14SC02).	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bellot A, 2014, BRAIN RES, V1573, P1, DOI 10.1016/j.brainres.2014.05.024; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chen Y, 2013, IUBMB LIFE, V65, P685, DOI 10.1002/iub.1184; Chen Y, 2012, CELL SIGNAL, V24, P606, DOI 10.1016/j.cellsig.2011.11.016; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Fang WQ, 2014, CELL REP, V9, P1635, DOI 10.1016/j.celrep.2014.11.003; Fang WQ, 2013, NEURON, V79, P665, DOI 10.1016/j.neuron.2013.06.017; Fang WQ, 2011, J NEUROSCI, V31, P13613, DOI 10.1523/JNEUROSCI.3120-11.2011; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hirabayashi S, 2004, J NEUROCHEM, V90, P332, DOI 10.1111/j.1471-4159.2004.02497.x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kim Y, 2013, J BIOL CHEM, V288, P29453, DOI 10.1074/jbc.M113.468801; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Nieland TJF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091744; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Oliva CA, 2013, AGEING RES REV, V12, P786, DOI 10.1016/j.arr.2013.03.006; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shen Y, 2013, J NEUROSCI, V33, P464, DOI 10.1523/JNEUROSCI.3282-12.2013; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931; Yudowski GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053965	34	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133115	10.1371/journal.pone.0133115	http://dx.doi.org/10.1371/journal.pone.0133115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204446	gold, Green Published, Green Submitted			2022-12-27	WOS:000358621000018
J	Foureaux, G; Franca, JR; Nogueira, JC; Fulgencio, GD; Ribeiro, TG; Castilho, RO; Yoshida, MI; Fuscaldi, LL; Fernandes, SOA; Cardoso, VN; Cronemberger, S; Faraco, AAG; Ferreira, AJ				Foureaux, Giselle; Franca, Jucara Ribeiro; Nogueira, Jose Carlos; Fulgencio, Gustavo de Oliveira; Ribeiro, Tatiana Gomes; Castilho, Rachel Oliveira; Yoshida, Maria Irene; Fuscaldi, Leonardo Lima; Antunes Fernandes, Simone Odlia; Cardoso, Valbert Nascimento; Cronemberger, Sebastiao; Faraco, Andre Augusto Gomes; Ferreira, Anderson Jose			Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DRUG-DELIVERY; INTRAOCULAR-PRESSURE; VIVO EVALUATION; NITRIC-OXIDE; HUMAN EYE; IN-VITRO; SYSTEM; RECEPTOR; CHITOSAN	The aim of this study was to develop and evaluate the effects of chitosan inserts for sustained release of the angiotensin-converting enzyme 2 (ACE2) activator, diminazene aceturate (DIZE), in experimental glaucoma. Monolayer DIZE loaded inserts (D+I) were prepared and characterized through swelling, attenuated total reflectance Fourier transformed infrared spectroscopy (ATR-FTIR), differential scanning calorimetry (DSC) and in vitro drug release. Functionally, the effects of D+I were tested in glaucomatous rats. Glaucoma was induced by weekly injections of hyaluronic acid (HA) into the anterior chamber and intraocular pressure (IOP) measurements were performed. Retinal ganglion cells (RGC) and optic nerve head cupping were evaluated in histological sections. Biodistribution of the drug was accessed by scintigraphic images and ex vivo radiation counting. We found that DIZE increased the swelling index of the inserts. Also, it was molecularly dispersed and interspersed in the polymeric matrix as a freebase. DIZE did not lose its chemical integrity and activity when loaded in the inserts. The functional evaluation demonstrated that D+I decreased the IOP and maintained the IOP lowered for up to one month (last week: 11.0 +/- 0.7 mmHg). This effect of D+I prevented the loss of RGC and degeneration of the optic nerve. No toxic effects in the eyes related to application of the inserts were observed. Moreover, biodistribution studies showed that D+I prolonged the retention of DIZE in the corneal site. We concluded that D+I provided sustained DIZE delivery in vivo, thereby evidencing the potential application of polymeric-based DIZE inserts for glaucoma management.	[Foureaux, Giselle; Nogueira, Jose Carlos; Ferreira, Anderson Jose] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil; [Franca, Jucara Ribeiro; Fulgencio, Gustavo de Oliveira; Ribeiro, Tatiana Gomes; Castilho, Rachel Oliveira; Faraco, Andre Augusto Gomes] Univ Fed Minas Gerais, Dept Pharmaceut Prod, Belo Horizonte, MG, Brazil; [Yoshida, Maria Irene] Univ Fed Minas Gerais, Inst Exact Sci, Belo Horizonte, MG, Brazil; [Fuscaldi, Leonardo Lima; Antunes Fernandes, Simone Odlia; Cardoso, Valbert Nascimento] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil; [Cronemberger, Sebastiao] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Ferreira, AJ (corresponding author), Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil.	anderson@icb.ufmg.br	Cronemberger, Sebastião/F-7225-2012; Yoshida, Maria Irene/ABC-8143-2020; Faraco, Andre AG/A-8965-2009; Cardoso, Valbert Nascimento/AAA-7240-2019; Fuscaldi, Leonardo Lima/V-1812-2017; fernandes, simone/AAU-8611-2020	Cronemberger, Sebastião/0000-0003-1466-9963; Yoshida, Maria Irene/0000-0002-6795-9457; Faraco, Andre AG/0000-0002-2344-6158; Fuscaldi, Leonardo Lima/0000-0001-7864-1324; Antunes Fernandes, Simone Odilia/0000-0002-6139-5187	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburahma MH, 2011, AAPS PHARMSCITECH, V12, P1335, DOI 10.1208/s12249-011-9701-3; Aggarwal D, 2005, INT J PHARMACEUT, V290, P155, DOI 10.1016/j.ijpharm.2004.10.026; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Baranowski P, 2014, SCI WORLD J, DOI 10.1155/2014/861904; CHEN RH, 1994, CARBOHYD POLYM, V24, P41, DOI 10.1016/0144-8617(94)90115-5; CONSTAD WH, 1988, AM J OPHTHALMOL, V105, P674, DOI 10.1016/0002-9394(88)90063-3; Costa VP, 2003, PROG RETIN EYE RES, V22, P769, DOI 10.1016/S1350-9462(03)00064-8; Costagliola C, 1995, Eur J Ophthalmol, V5, P19; Costagliola C, 2000, EXP EYE RES, V71, P167, DOI 10.1006/exer.2000.0866; DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008; Dobaria NB, 2009, AAPS PHARMSCITECH, V10, P951, DOI 10.1208/s12249-009-9288-0; Eroglu H, 2007, DRUG DEV IND PHARM, V33, P265, DOI 10.1080/03639040600713134; Ferrario CM, 2006, HYPERTENSION, V47, P515, DOI 10.1161/01.HYP.0000196268.08909.fb; FERRARIO CM, 1990, J CARDIOVASC PHARM, V15, pS1, DOI 10.1097/00005344-199000153-00001; Ferreira AJ, 2012, EXPERT OPIN THER PAT, V22, P567, DOI 10.1517/13543776.2012.682572; Ferreira AJ, 2011, EXP PHYSIOL, V96, P287, DOI 10.1113/expphysiol.2010.055277; Ferreira AJ, 2010, HYPERTENSION, V55, P207, DOI 10.1161/HYPERTENSIONAHA.109.140145; Foureaux G, 2013, INVEST OPHTH VIS SCI, V54, P4296, DOI 10.1167/iovs.12-11427; Ghate D, 2008, J GLAUCOMA, V17, P147, DOI 10.1097/IJG.0b013e31814b990d; Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033; Hashizume K, 2005, INVEST OPHTH VIS SCI, V46, P1993, DOI 10.1167/iovs.04-1100; Inoue T, 2001, CURR EYE RES, V23, P139, DOI 10.1076/ceyr.23.2.139.5470; KAUFMAN PL, 1981, CURR EYE RES, V1, P307, DOI 10.3109/02713688108999452; Kearns VR, 2009, EXPERT REV MED DEVIC, V6, P277, DOI [10.1586/erd.09.4, 10.1586/ERD.09.4]; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Kulemina LV, 2011, J BIOMOL SCREEN, V16, P878, DOI 10.1177/1087057111413919; Kuntner C, 2011, MOL IMAGING BIOL, V13, P222, DOI 10.1007/s11307-010-0352-7; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Lee SS, 2010, PHARM RES-DORDR, V27, P2043, DOI 10.1007/s11095-010-0159-x; Loftsson T, 2010, ACTA OPHTHALMOL, V88, P337, DOI 10.1111/j.1755-3768.2008.01495.x; LOTTI VJ, 1990, J OCUL PHARMACOL, V6, P1, DOI 10.1089/jop.1990.6.1; Ludwig A, 2005, ADV DRUG DELIVER REV, V57, P1595, DOI 10.1016/j.addr.2005.07.005; Luhtala S, 2009, J OCUL PHARMACOL TH, V25, P23, DOI 10.1089/jop.2008.0081; Moradi M, 2012, ANALYST, V137, P3549, DOI 10.1039/c2an35304k; Moreno MC, 2005, EXP EYE RES, V81, P71, DOI 10.1016/j.exer.2005.01.008; Murca TM, 2012, REGUL PEPTIDES, V177, P107, DOI 10.1016/j.regpep.2012.05.093; NATHANSON JA, 1995, INVEST OPHTH VIS SCI, V36, P1765; Natu MV, 2011, INT J PHARMACEUT, V415, P73, DOI 10.1016/j.ijpharm.2011.05.047; Neufeld AH, 1999, SURV OPHTHALMOL, V43, pS129, DOI 10.1016/S0039-6257(99)00010-7; Olbrich C, 2002, J DRUG TARGET, V10, P387, DOI 10.1080/1061186021000001832; Peng CC, 2012, J CONTROL RELEASE, V162, P152, DOI 10.1016/j.jconrel.2012.06.017; Perumal VA, 2008, INT J PHARM, V358, P184, DOI 10.1016/j.ijpharm.2008.03.005; Qiu YG, 2014, INVEST OPHTH VIS SCI, V55, P3809, DOI 10.1167/iovs.14-13883; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramirez M, 1996, J OCUL PHARMACOL TH, V12, P299, DOI 10.1089/jop.1996.12.299; Rodrigues LB, 2009, INT J PHARMACEUT, V368, P1, DOI 10.1016/j.ijpharm.2008.09.047; Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Schindler C, 2007, VASC HEALTH RISK MAN, V3, P125; Senanayake PD, 2007, INVEST OPHTH VIS SCI, V48, P3301, DOI 10.1167/iovs.06-1024; Shah GB, 2000, J CARDIOVASC PHARM, V36, P169, DOI 10.1097/00005344-200008000-00005; Soliman GM, 2008, INT J PHARM, V356, P248, DOI 10.1016/j.ijpharm.2007.12.029; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Tikellis C, 2004, CURR EYE RES, V29, P419, DOI 10.1080/02713680490517944; Vaajanen A, 2011, BASIC CLIN PHARMACOL, V109, P217, DOI 10.1111/j.1742-7843.2011.00729.x; Vaajanen A, 2010, ACTA OPHTHALMOL, V88, P431, DOI 10.1111/j.1755-3768.2009.01563.x; Wagner J, 1996, BRIT J OPHTHALMOL, V80, P159, DOI 10.1136/bjo.80.2.159; Wang RF, 2005, EXP EYE RES, V80, P629, DOI 10.1016/j.exer.2004.11.012; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Zambito Y, 2010, J DRUG DELIV SCI TEC, V20, P45, DOI 10.1016/S1773-2247(10)50005-4	60	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133149	10.1371/journal.pone.0133149	http://dx.doi.org/10.1371/journal.pone.0133149			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204514	Green Submitted, Green Published, gold			2022-12-27	WOS:000358621000019
J	Herrador, Z; Perez-Formigo, J; Sordo, L; Gadisa, E; Moreno, J; Benito, A; Aseffa, A; Custodio, E				Herrador, Zaida; Perez-Formigo, Jesus; Sordo, Luis; Gadisa, Endalamaw; Moreno, Javier; Benito, Agustin; Aseffa, Abraham; Custodio, Estefania			Low Dietary Diversity and Intake of Animal Source Foods among School Aged Children in Libo Kemkem and Fogera Districts, Ethiopia	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SOCIOECONOMIC-STATUS; HOUSEHOLDS; INFECTION; VARIETY; SCORES; WOMEN	Background A low dietary diversity score (DDS) and low consumption of food from animal sources (ASF) are among the factors related to malnutrition in school-aged children living in Libo Kemkem and Fogera (Ethiopia). Objectives This study aimed to identify associated determinants for low dietary diversity and lack of consumption of ASF. Methods In 2009, a cross-sectional survey was carried out in May, at the end of the lean season. Socio-demographic characteristics and diet habits were collected from 886 school-aged children. Additionally, 516 children from rural sites were followed up in the post-harvest season, in December of the same year. Bivariate and multivariable statistical methods were employed to assess low DDS and ASF intake and their association with different factors. Results Up to 80% and 60% of school-aged children living in rural and urban sites, respectively, ate <= 3 food groups the day before the survey. The percentage of children consuming ASF was significantly higher in urban settings (64% vs 18%). In the rural areas, if the head of the household was male (OR: 1.91; 95%CI: 1.00-3.65) and older than 40 years (OR: 1.56; 95%CI: 1.02-2.38) the child had a lower DDS in the lean season, while differences by socioeconomic indexes were observed in the post-harvest season. Males took more ASF than females in rural settings (OR: 1.73; 95%CI: 1.14-2.62) and differences by socioeconomic indexes were observed in both settings in the lean season, though not in post-harvest survey. Conclusions The findings of this study revealed that the diet among school-aged children in Libo Kemkem and Fogera districts lacked diversity, and that the intake of foods from animal sources was low, especially among rural girls. To effectively tackle malnutrition, dietary diversification strategies oriented to the local needs are recommended.	[Herrador, Zaida; Benito, Agustin; Custodio, Estefania] Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Herrador, Zaida; Moreno, Javier; Benito, Agustin; Custodio, Estefania] Trop Dis Res Network RICET Spanish, Madrid, Spain; [Perez-Formigo, Jesus; Sordo, Luis] ISCIII, Natl Ctr Epidemiol, Madrid, Spain; [Perez-Formigo, Jesus] Spanish Field Epidemiol Training Program PEAC, Madrid, Spain; [Sordo, Luis] Univ Complutense, Dept Prevent Med & Publ Hlth, Fac Med, E-28040 Madrid, Spain; [Sordo, Luis] Epidemiol & Publ Hlth CIBERESP, Network Biomed Res Ctr, Madrid, Spain; [Gadisa, Endalamaw; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Moreno, Javier] ISCIII, Natl Ctr Microbiol, Madrid, Spain; [Custodio, Estefania] European Commiss Joint Res Ctr, Monitoring Agr Resources Unit H04, Inst Environm & Sustainabil, Ispra, Italy	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Instituto de Salud Carlos III; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); European Commission Joint Research Centre; EC JRC ISPRA Site	Custodio, E (corresponding author), Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain.	ecustodio2014@gmail.com	Aseffa, Abraham/J-3248-2016; Moreno, Javier/AAB-5386-2021	Aseffa, Abraham/0000-0002-8028-1150; sordo, Luis/0000-0003-1760-9472; Moreno, Javier/0000-0003-0087-4659; Herrador, Zaida/0000-0002-6508-3818; Benito, Agustin/0000-0001-8229-5540	UBS-Optimus Foundation (Switzerland); Instituto de Salud Carlos III [RD06/0021/0009, RD06/0021/0000]	UBS-Optimus Foundation (Switzerland); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was funded by the UBS-Optimus Foundation (Switzerland) through the Visceral Leishmaniasis and Malnutrition in Amhara State, Ethiopia Project. Support was also provided by the Instituto de Salud Carlos III through Tropical Diseases Research Network Grants RICET RD06/0021/0009 and RD06/0021/0000. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; Amare Y., 2000, FOOD SECURITY RESOUR; Andersen O., 2002, FIELD CROPS RES, V11, P347; [Anonymous], 2013, FOOD AGR ETHIOPIA PR; [Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; Arimond M, 2002, PROGR DEV INFANT CHI; Ayele Z, 2003, J NUTR, V133, p3981S, DOI 10.1093/jn/133.11.3981S; Belachew T, 2007, ETHIOP J HLTH SCI, P17; Belew TA, 2008, NUTR COUNTR PROF; Berhane G, 2011, 23 IFPRI EDRI ESSP 2; BOKU-University of Natural Resources and Life Sciences Vienna., 2014, SUST DEV FISH VAL CH; Chaillot C, 2012, ETHIOPIAN ORTHODOX C, P234; Custodio E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001813; de Rezende María José, 2010, Investig. desarro., V18, P218; Degye Goshu, 2013, Journal of Development and Agricultural Economics, V5, P174; Dorosh P, 2010, 13 IFPRI ESSP2; Egata G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-864; FAO [Food and Agriculture Organization of the United Nations] IFAD [International Fund for Agricultural Development] and WFP [World Food Programme], 2013, STAT FOOD INS WORLD; FAO & WFP, 2014, STAT FOOD INS WORLD; Ferro-Luzzi A, 2001, 118 IFPRI; Food and Agriculture Organization of the United Nations, 2009, DECL WORLD SUMM FOOD; Food and Agriculture Organization of the United Nations (FAO), 2010, FAO WFP CROP FOOD SE; Food and Agriculture Organization of the United Nations (FAO), 2001, TARG NUTR IMPR RES A; Fotso JC, 2005, SOC INDIC RES, V72, P189, DOI 10.1007/s11205-004-5579-8; Frehiwot F., 2007, FOOD INSECURITY ITS; Gebre GG, 2012, INTERDISCIP DESCR CO, V10, P159; Gibson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048708; Girma W., 2002, DETERMINANTS NUTR ST; Gordon A., 2007, MARKETING SYSTEMS FI; Headey D D E., 2012, IMPROVING MEASUREMEN; Helen Keller International, 2001, NUTR SURV PROJ B; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112858; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; Keding GB, 2012, FOOD SECUR, V4, P129, DOI 10.1007/s12571-011-0163-y; Kennedy G., 2011, GUID MEAS HOUS IND D; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Paulos Z., 2009, INT FOOD POLICY RES; Popkin BM, 2011, P NUTR SOC, V70, P82, DOI 10.1017/S0029665110003903; Ross J, 1995, DIMENSIONS NEED ATLA; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Sordo L, 2012, AM J TROP MED HYG, V86, P955, DOI 10.4269/ajtmh.2012.11-0436; Steyn NP, 2006, PUBLIC HEALTH NUTR, V9, P644, DOI 10.1079/PHN2005912; Thompson B., 2010, NARROWING NUTR GAP I; Tolossa D, 2002, HOUSEHOLD SEASONAL F; United Nations Children's Fund (UNICEF), 2003, STRAT RED MAT CHILD; United Nations Children's Fund (UNICEF), 2009, SUMM FOOD SEC VULN S; United States Agency for International Development (USAID), 2014, 2014 SCH MILK DAY CA; Viswanath N., 2012, AFR POLICY J, V8, P30; Von Braun J, 2009, FOOD POLICY DEV CTR, V2, P175; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; World Food Program, 2014, TECHN SPEC BARL GRAI; World Health Organization (WHO), 2014, 2012 2013 BIENN REP	54	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133435	10.1371/journal.pone.0133435	http://dx.doi.org/10.1371/journal.pone.0133435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203904	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000029
J	Verma, P; Sengupta, S				Verma, Prateek; Sengupta, Supratim			Bribe and Punishment: An Evolutionary Game-Theoretic Analysis of Bribery	PLOS ONE			English	Article							CORRUPTION; CULTURE	Harassment bribes, paid by citizens to corrupt officers for services the former are legally entitled to, constitute one of the most widespread forms of corruption in many countries. Nation states have adopted different policies to address this form of corruption. While some countries make both the bribe giver and the bribe taker equally liable for the crime, others impose a larger penalty on corrupt officers. We examine the consequences of asymmetric and symmetric penalties by developing deterministic and stochastic evolutionary game-theoretic models of bribery. We find that the asymmetric penalty scheme can lead to a reduction in incidents of bribery. However, the extent of reduction depends on how the players update their strategies over time. If the interacting members change their strategies with a probability proportional to the payoff of the alternative strategy option, the reduction in incidents of bribery is less pronounced. Our results indicate that changing from a symmetric to an asymmetric penalty scheme may not suffice in achieving significant reductions in incidents of harassment bribery.	[Verma, Prateek; Sengupta, Supratim] Indian Inst Sci Educ & Res Kolkata, Dept Phys Sci, Kolkata, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Sengupta, S (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Phys Sci, Kolkata, India.	supratim.sen@iiserkol.ac.in		Verma, Prateek/0000-0003-3431-246X				Abbink K, 2002, J LAW ECON ORGAN, V18, P428, DOI 10.1093/jleo/18.2.428; Abbink K., 2004, EUR J POLIT ECON, V20, P887, DOI [10.1016/j.ejpoleco.2003.10.008, DOI 10.1016/J.EJPOLECO.2003.10.008]; Abbink K, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P418; Abbink K, 2006, EXP ECON, V9, P103, DOI 10.1007/s10683-006-5385-z; Abbink K, 2014, J PUBLIC ECON, V111, P17, DOI 10.1016/j.jpubeco.2013.12.012; Alatas V, 2009, SOUTH ECON J, V75, P663; [Anonymous], 2014, 2014 CORRUPTION PERC; Banuri S, 2010, 0901 CTR BEH EXPT EC; Banuri S, 2012, RES EXP ECON, V15, P51, DOI 10.1108/S0193-2306(2012)0000015005; Barr A, 2009, EXP ECON, V12, P488, DOI 10.1007/s10683-009-9225-9; Cameron L, 2009, J PUBLIC ECON, V93, P843, DOI 10.1016/j.jpubeco.2009.03.004; Dreze J, 2011, INDIAN EXPRESS, P17; Dufwenberg M, 2011, LEGALIZING BRIBES; Dugatkin L. A., 2000, GAME THEORY ANIMAL B; Engel C, 2012, SSRN ELECT J, DOI [10.2139/ssrn.1983969, DOI 10.2139/SSRN.1983969]; European Comission, 2014, EU ANT REP; HELBING D, 1992, PHYSICA A, V181, P29, DOI 10.1016/0378-4371(92)90195-V; Lee JH, 2015, J THEOR BIOL, V367, P1, DOI 10.1016/j.jtbi.2014.10.037; Maynard Smith J., 1982, pi; McBride M, 2012, CRIME PUNISHMENT EVO, P1; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ryvkin D., 2013, DOES COMPETITION PUB; Schickora JT, 2011, BRINGING 4 EYES PRIN; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Serra D., 2012, NEW ADV EXPT RES COR; Serra D, 2012, J LAW ECON ORGAN, V28, P569, DOI 10.1093/jleo/ewr010; Sigmund K, 1998, EVOLUTIONARY GAMES P; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011901	31	16	16	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133441	10.1371/journal.pone.0133441	http://dx.doi.org/10.1371/journal.pone.0133441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NJ	26204110	Green Published, Green Submitted, gold			2022-12-27	WOS:000358621000030
J	Borschitz, T; Schlicht, S; Siegel, E; Hanke, E; von Stebut, E				Borschitz, Thomas; Schlicht, Svenja; Siegel, Ekkehard; Hanke, Eric; von Stebut, Esther			Improvement of a Clinical Score for Necrotizing Fasciitis: 'Pain Out of Proportion' and High CRP Levels Aid the Diagnosis	PLOS ONE			English	Article							LABORATORY RISK INDICATOR; SOFT-TISSUE INFECTIONS; CELL DISTRIBUTION WIDTH; INTENSIVE-CARE; LRINEC SCORE; MANAGEMENT; POPULATION; OUTCOMES; UNIT	Necrotizing fasciitis (NF) is a rare mono-/polymicrobial skin infection that spreads to underlying tissues. NF is quickly progressing and leads to life threatening situations. Immediate surgical debridement together with i.v. antibiotic administration is required to avoid fatal outcome. Early diagnosis is often delayed due to underestimation or confusion with cellulitis. We now compared the initial clinical and laboratory presentation of NF and cellulitis in detail to assess if a typical pattern can be identified that aids timely diagnosis of NF and avoidance of fatal outcome. 138 different clinical and laboratory features of 29 NF patients were compared to those of 59 age-and gender matched patients with severe erysipelas requiring a subsequent hospitalization time of >= 10 days. Differences in clinical presentation were not obvious; however, NF patients suffered significantly more often from strong pain. NF patients exhibited dramatically elevated CRP levels (5-fold, p>0.001). The overall laboratory risk indicator for necrotizing fasciitis (LRINEC) score was significantly higher in NF patients as compared to cellulitis. However, a modification of the score (alteration of laboratory parameters, addition of clinical parameters) led to a clear improvement of the score with a higher positive predictive value without losing specificity. In summary, clinical differentiation of NF from cellulitis appears to be hard. 'Pain out of proportion' may be an early sign for NF. An improvement of the LRINEC score emphasizing only relevant laboratory and clinical findings as suggested may aid the early diagnosis of NF in the future leading to improvement of disease outcome by enabling rapid adequate therapy.	[Borschitz, Thomas] Ctr Coloproctol Surg, Mainz, Germany; [Schlicht, Svenja; von Stebut, Esther] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, D-55122 Mainz, Germany; [Siegel, Ekkehard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol, D-55122 Mainz, Germany; [Hanke, Eric] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Traumatol Orthoped, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	von Stebut, E (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, D-55122 Mainz, Germany.	vonstebu@mail.uni-mainz.de						[Anonymous], 2014, CURR PROB SURG, V51, P344, DOI 10.1067/j.cpsurg.2014.06.001; Bennett M, 2008, ANZ J SURG, V78, P947, DOI 10.1111/j.1445-2197.2008.04710.x; Bozkurt O, 2015, INT UROL NEPHROL, V47, P243, DOI 10.1007/s11255-014-0897-5; Bucca K, 2013, ANZ J SURG, V83, P365, DOI 10.1111/j.1445-2197.2012.06251.x; Corbin V, 2010, ANN DERMATOL VENER, V137, P5, DOI 10.1016/j.annder.2009.12.002; Glass GE, 2015, ANN ROY COLL SURG, V97, P46, DOI 10.1308/003588414X14055925058553; Goh T, 2014, BRIT J SURG, V101, pE119, DOI 10.1002/bjs.9371; Gundeslioglu AO, 2014, ANN PLAS SURG, V73, P202, DOI 10.1097/SAP.0b013e31826cadb7; Hodgins N, 2015, J PLAST RECONSTR AES, V68, P304, DOI 10.1016/j.bjps.2014.11.003; Holland MJ, 2009, ANAESTH INTENS CARE, V37, P588, DOI 10.1177/0310057X0903700416; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Lancerotto L, 2012, J TRAUMA ACUTE CARE, V72, P560, DOI 10.1097/TA.0b013e318232a6b3; Magala John, 2014, BMC Res Notes, V7, P476, DOI 10.1186/1756-0500-7-476; Marks C, 2012, HAUTARZT, V63, P727, DOI 10.1007/s00105-012-2421-0; Murphy G, 2013, J PLAST RECONSTR AES, V66, P1712, DOI [10.1016/j.bjps.2013.07.008, 10.1016/j.bjps.013.07.008]; Pakula AM, 2012, AM SURGEON, V78, P1059; Ryssel H, 2010, ARCH ORTHOP TRAUM SU, V130, P1515, DOI 10.1007/s00402-010-1101-8; Sertoglu E, 2015, AM J EMERG MED, V33, P301, DOI 10.1016/j.ajem.2014.11.021; Shimizu T, 2010, INTERNAL MED, V49, P1051, DOI 10.2169/internalmedicine.49.2964; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Sturgeon JP, 2014, PEDIAT EMERG CARE, DOI 10.1097; Su YC, 2008, ANZ J SURG, V78, P968, DOI 10.1111/j.1445-2197.2008.04713.x; Sugihara T, 2012, BJU INT, V110, pE1096, DOI 10.1111/j.1464-410X.2012.11291.x; Thomas AJ, 2012, LARYNGOSCOPE, V122, P2683, DOI 10.1002/lary.23680; Tsitsilonis S, 2013, LANGENBECK ARCH SURG, V398, P153, DOI 10.1007/s00423-012-0983-z; Waldron C, 2014, SURGEON, DOI 10.1016; Weng CL, 2014, AM J EMERG MED, V32, P1259, DOI 10.1016/j.ajem.2014.08.001; Wong CH, 2004, CRIT CARE MED, V32, P1535, DOI 10.1097/01.CCM.0000129486.35458.7D; Yahav D, 2014, INT J INFECT DIS, V28, P13, DOI 10.1016/j.ijid.2014.05.024	29	49	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132775	10.1371/journal.pone.0132775	http://dx.doi.org/10.1371/journal.pone.0132775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196941	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600050
J	Ryu, S; Han, HM; Song, PI; Armstrong, CA; Park, Y				Ryu, Sunhyo; Han, Hyo Mi; Song, Peter I.; Armstrong, Cheryl A.; Park, Yoonkyung			Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice	PLOS ONE			English	Article							FACTOR-KAPPA-B; IN-VITRO; HUMAN KERATINOCYTES; CYTOKINE PRODUCTION; VULGARIS; SKIN; CELLS; PATHOGENESIS; ACTIVATION; EXPRESSION	The cutaneous inflammation associated with acne vulgaris is caused by the anaerobic bacterium Propionibacterium acnes through activation of the innate immune system in the skin. Current standard treatments for acne have limitations that include adverse effects and poor efficacy in many patients, making development of a more effective therapy highly desirable. In the present study, we demonstrate the protective effects of a novel customized alpha-helical cationic peptide, P5, against P. acnes-induced inflammatory responses in vitro and in vivo. Application of P5 significantly reduced expression of two inflammatory cytokines IL-8 and TNF-alpha in P. acnes-treated primary human keratinocytes, where P5 appeared to act in part by binding to bacterial lipoteichoic acid, thereby suppressing TLR2-to-NF-kappa B signaling. In addition, in a mouse model of acne vulgaris, P5 exerted both anti-inflammatory and antimicrobial effects against P. acnes, but exerted no cytotoxic effects against skin cells. These results demonstrate that P5, and perhaps other cationic antimicrobial peptides, offer the unique ability to reduce numbers P. acnes cells in the skin and to inhibit the inflammation they trigger. This suggests these peptides could potentially be used to effectively treat acne without adversely affecting the skin.	[Ryu, Sunhyo; Han, Hyo Mi; Park, Yoonkyung] Chosun Univ, Dept Biomed Sci, Gwangju, South Korea; [Song, Peter I.; Armstrong, Cheryl A.] Univ Colorado Denver, Dept Dermatol, Aurora, CO 80045 USA; [Park, Yoonkyung] Chosun Univ, Res Ctr Proteineous Mat, Gwangju, South Korea	Chosun University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Chosun University	Armstrong, CA (corresponding author), Univ Colorado Denver, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA.	Cheryl.armstrong@dhha.org; y_k_park@chosun.ac.kr			National Research Foundation of Korea (NRF) grant - Korean Government (MEST) [2011-0017532]; Global Research Laboratory (GRL) Grant [NRF-2014K1A1A2064460]	National Research Foundation of Korea (NRF) grant - Korean Government (MEST); Global Research Laboratory (GRL) Grant	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MEST; No. 2011-0017532) and Global Research Laboratory (GRL) Grant (NRF-2014K1A1A2064460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; An HJ, 2014, INT J MOL MED, V34, P1341, DOI 10.3892/ijmm.2014.1933; Bakry OA, 2014, ANAL QUANT CYTOPATHO, V36, P100; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; Burkhart CG, 1999, POSTGRAD MED J, V75, P328, DOI 10.1136/pgmj.75.884.328; Charakida A, 2004, Expert Opin Drug Saf, V3, P119, DOI 10.1517/14740338.3.2.119; Chun J, 2006, J IMMUNOL, V177, P1330, DOI 10.4049/jimmunol.177.2.1330; Del Rosso JQ, 2008, J DRUGS DERMATOL, V7, pS2; Denda S, 2012, EXP DERMATOL, V21, P535, DOI 10.1111/j.1600-0625.2012.01507.x; Dhawan SS, 2009, CUTIS, V83, P265; Dispenza MC, 2012, J INVEST DERMATOL, V132, P2198, DOI 10.1038/jid.2012.111; Dreno B, 2014, EUR J DERMATOL, V24, P330, DOI 10.1684/ejd.2014.2309; Fejer G, 2013, P NATL ACAD SCI USA, V110, pE2191, DOI 10.1073/pnas.1302877110; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; Guarna MM, 2006, FEMS MICROBIOL LETT, V257, P1, DOI 10.1111/j.1574-6968.2006.00156.x; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Holland DB, 2008, FEMS MICROBIOL LETT, V279, P110, DOI 10.1111/j.1574-6968.2007.01021.x; Itoh T, 2014, ANAEROBE, V27, P56, DOI 10.1016/j.anaerobe.2014.03.006; Jeong MS, 2014, ANN DERMATOL, V26, P296, DOI 10.5021/ad.2014.26.3.296; Jeong N, 2010, BIOCHEM BIOPH RES CO, V399, P581, DOI 10.1016/j.bbrc.2010.07.118; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Koreck A, 2003, DERMATOLOGY, V206, P96, DOI 10.1159/000068476; Koziel J, 2014, J IMMUNOL, V192, P5363, DOI 10.4049/jimmunol.1303062; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Lee DJ, 2003, CURR OPIN PEDIATR, V15, P405, DOI 10.1097/00008480-200308000-00009; Lee WR, 2014, J INVEST DERMATOL, V134, P1922, DOI 10.1038/jid.2014.75; Liu J, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00740-14; Liu X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003480; Masera RG, 1996, REGUL PEPTIDES, V62, P13, DOI 10.1016/0167-0115(95)00150-6; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Murillo N, 2013, FUTURE MICROBIOL, V8, P209, DOI [10.2217/FMB.12.141, 10.2217/fmb.12.141]; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nakase K, 2014, J MED MICROBIOL, V63, P721, DOI 10.1099/jmm.0.067611-0; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Niyonsaba F, 2013, J LEUKOCYTE BIOL, V94, P159, DOI 10.1189/jlb.1012497; Park Y, 2006, BBA-PROTEINS PROTEOM, V1764, P24, DOI 10.1016/j.bbapap.2005.10.019; Park Y, 2003, BBA-PROTEINS PROTEOM, V1645, P172, DOI 10.1016/S1570-9639(02)00541-1; Pickert A, 2009, EXPERT OPIN PHARMACO, V10, P1515, DOI 10.1517/14656560903002097; Pretsch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097929; Ryu S, 2014, BRIT J DERMATOL, V171, P1358, DOI 10.1111/bjd.13480; Ryu S, 2011, J INVEST DERMATOL, V131, P1677, DOI 10.1038/jid.2011.112; Song PI, 2002, J INVEST DERMATOL, V119, P424, DOI 10.1046/j.1523-1747.2002.01847.x; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Stotland M, 2009, AM J CLIN DERMATOL, V10, P221, DOI 10.2165/00128071-200910040-00002; Thiboutot DM, 2014, J INVEST DERMATOL, V134, P595, DOI 10.1038/jid.2013.528; TORCZYNSKI RM, 1985, DNA-J MOLEC CELL BIO, V4, P283, DOI 10.1089/dna.1985.4.283; Toyoda Masahiko, 2001, Medical Electron Microscopy, V34, P29, DOI 10.1007/s007950100002; de Sousa ICVD, 2014, EXPERT OPIN INV DRUG, V23, P1389, DOI 10.1517/13543784.2014.923401; Yang DR, 2009, BIOMATERIALS, V30, P6035, DOI 10.1016/j.biomaterials.2009.07.033; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	52	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132619	10.1371/journal.pone.0132619	http://dx.doi.org/10.1371/journal.pone.0132619			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197393	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600043
J	Vallez, N; Deniz, O; Bueno, G				Vallez, Noelia; Deniz, Oscar; Bueno, Gloria			Sample Selection for Training Cascade Detectors	PLOS ONE			English	Article							DENSITY CLASSIFICATION; PARTIAL AREA; RECOGNITION	Automatic detection systems usually require large and representative training datasets in order to obtain good detection and false positive rates. Training datasets are such that the positive set has few samples and/or the negative set should represent anything except the object of interest. In this respect, the negative set typically contains orders of magnitude more images than the positive set. However, imbalanced training databases lead to biased classifiers. In this paper, we focus our attention on a negative sample selection method to properly balance the training data for cascade detectors. The method is based on the selection of the most informative false positive samples generated in one stage to feed the next stage. The results show that the proposed cascade detector with sample selection obtains on average better partial AUC and smaller standard deviation than the other compared cascade detectors.	[Vallez, Noelia; Deniz, Oscar; Bueno, Gloria] Univ Castilla La Mancha, ETSI Ind, VISILAB Grp, E-13071 Ciudad Real, Spain	Universidad de Castilla-La Mancha	Vallez, N (corresponding author), Univ Castilla La Mancha, ETSI Ind, VISILAB Grp, E-13071 Ciudad Real, Spain.	Noelia.Vallez@uclm.es	Vallez, Noelia/L-3106-2015; Bueno, Gloria/K-6286-2014	Vallez, Noelia/0000-0002-5092-8275; Bueno, Gloria/0000-0002-7345-4869; Deniz, Oscar/0000-0002-0841-4131	Spanish Ministry for Economy and Competitiveness/European Regional Development Fund [TIN2011-24367]; European Union's Horizon Research and Innovation Programme [643924]	Spanish Ministry for Economy and Competitiveness/European Regional Development Fund; European Union's Horizon Research and Innovation Programme	This work was supported by Spanish Ministry for Economy and Competitiveness/European Regional Development Fund through project TIN2011-24367 and European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 643924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourdev L, 2005, PROC CVPR IEEE, P236, DOI 10.1109/cvpr.2005.310; Bueno G, 2011, INT J COMPUT ASS RAD, V6, P309, DOI 10.1007/s11548-010-0510-z; CARPENTER SE, 1991, ANAL CHIM ACTA, V249, P305, DOI 10.1016/S0003-2670(00)83002-0; Chen YT, 2007, LECT NOTES COMPUT SC, V4843, P905; Cheng WC, 2011, IEEE SYS MAN CYBERN, P1430, DOI 10.1109/ICSMC.2011.6083870; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Deng Y, 2006, INT J INFORM TECHNOL, P108; Dodd LE, 2003, BIOMETRICS, V59, P614, DOI 10.1111/1541-0420.00071; Dundar M., 2007, P IEEE C COMP VIS PA, P1; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gan B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/420856; Ganganwar V, 2012, INT J EMERGING TECHN, V2, P2250; Grossmann E, 2004, LECT NOTES COMPUT SC, V3138, P983; HARALICK RM, 1987, IEEE T PATTERN ANAL, V9, P532, DOI 10.1109/TPAMI.1987.4767941; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Ji RR, 2014, IEEE T GEOSCI REMOTE, V52, P1811, DOI 10.1109/TGRS.2013.2255297; Korting TS, 2014, REMOTE SENS-BASEL, V6, P7580, DOI 10.3390/rs6087580; Li SZ, 2015, NEUROCOMPUTING, V151, P565, DOI 10.1016/j.neucom.2014.06.086; Lienhart R, 2002, IEEE IMAGE PROC, P900; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Espinosa-Aranda JL, 2013, LECT NOTES COMPUT SC, V7824, P80, DOI 10.1007/978-3-642-37213-1_9; Ma H, 2013, STAT MED, V32, P3449, DOI 10.1002/sim.5777; Oliveira LS, 2005, INT C DOC AN REC, P570; Papageorgiou CP, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P555, DOI 10.1109/ICCV.1998.710772; Pujara J., 2011, P 8 ANN COLLABORATIO, P55, DOI [10.1145/2030376.2030383, DOI 10.1145/2030376.2030383]; Raykar V. C., 2010, P 16 ACM SIGKDD INT, P853; Saberian M, 2014, J MACH LEARN RES, V15, P2569; Schapire RE, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P1401; Schapire RE, 1998, P 21 ANN INT C RES D, V14, P771; Serrano I, 2015, PLOS ONE, V10; Sochman J, 2004, INT C PATT RECOG, P236, DOI 10.1109/ICPR.2004.1334067; Su SZ, 2015, SIGNAL PROCESS, V112, P43, DOI 10.1016/j.sigpro.2014.11.003; Vallez N, 2014, COMPUT METH PROG BIO, V113, P569, DOI 10.1016/j.cmpb.2013.10.004; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Walter SD, 2005, STAT MED, V24, P2025, DOI 10.1002/sim.2103; Webb G., 2011, ENCY MACHINE LEARNIN, P262, DOI [10.1007/978-0-387-30164-8_202, DOI 10.1007/978-0-387-30164-8_202]; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Zhang C, 2010, BOOSTING BASED FACE; Zhang LM, 2014, IEEE T MULTIMEDIA, V16, P470, DOI 10.1109/TMM.2013.2293424; Zhang Y., 2015, NEURAL PROCESS LETT, P1; Zou Q, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/686090, 10.1155/2013/608430]	42	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133059	10.1371/journal.pone.0133059	http://dx.doi.org/10.1371/journal.pone.0133059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197221	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600062
J	Crisponi, G; Nurchi, VM; Crespo-Alonso, M; Sanna, G; Zoroddu, MA; Alberti, G; Biesuz, R				Crisponi, Guido; Nurchi, Valeria Marina; Crespo-Alonso, Miriam; Sanna, Gavino; Zoroddu, Maria Antonietta; Alberti, Giancarla; Biesuz, Raffaela			A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions	PLOS ONE			English	Article							DESFERRIOXAMINE B; COMPLEX-FORMATION; ZINC; DEFERIPRONE; THALASSEMIA; EQUILIBRIA; COPPER(II); IRON(III); ELEMENTS; THERAPY	A number of reports have appeared in literature calling attention to the depletion of essential metal ions during chelation therapy on beta-thalassaemia patients. We present a speciation study to determine how the iron chelators used in therapy interfere with the homeostatic equilibria of essential metal ions. This work includes a thorough analysis of the pharmacokinetic properties of the chelating agents currently in clinical use, of the amounts of iron, copper and zinc available in plasma for chelation, and of all the implied complex formation constants. The results of the study show that a significant amount of essential metal ions is complexed whenever the chelating agent concentration exceeds the amount necessary to coordinate all disposable iron-a frequently occurring situation during chelation therapy. On the contrary, copper and zinc do not interfere with iron chelation, except for a possible influence of copper on iron speciation during deferiprone treatment.	[Crisponi, Guido; Nurchi, Valeria Marina; Crespo-Alonso, Miriam] Univ Cagliari, Dipartimento Sci Chim & Geol, Cagliari, Italy; [Sanna, Gavino; Zoroddu, Maria Antonietta] Univ Sassari, Dipartimento Chim & Farm, I-07100 Sassari, Italy; [Alberti, Giancarla; Biesuz, Raffaela] Univ Pavia, Dipartmento Chim, I-27100 Pavia, Italy	University of Cagliari; University of Sassari; University of Pavia	Crisponi, G (corresponding author), Univ Cagliari, Dipartimento Sci Chim & Geol, Cagliari, Italy.	crisponi@unica.it	Sanna, Gavino/C-8787-2011; Crisponi, Guido/AAM-5076-2021; Alberti, Giancarla/P-5736-2018; Nurchi, Valeria Marina/E-6216-2013	Sanna, Gavino/0000-0001-9572-4041; Crisponi, Guido/0000-0002-3902-0231; Alberti, Giancarla/0000-0003-4106-2219; Nurchi, Valeria Marina/0000-0002-4004-1988; Biesuz, Raffaela/0000-0002-2192-5032	Regione Sardegna "Integrated approach in the design of metal chelators for human diseases";  [CRP-26712]	Regione Sardegna "Integrated approach in the design of metal chelators for human diseases"; 	This study was supported by the Regione Sardegna "Integrated approach in the design of metal chelators for human diseases" and by VMN and MAZ for the project "CRP-26712".	Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; ALLAIN P, 1991, BRIT J CLIN PHARMACO, V31, P347, DOI 10.1111/j.1365-2125.1991.tb05541.x; ALREFAIE FN, 1994, J CLIN PATHOL, V47, P657, DOI 10.1136/jcp.47.7.657; Alshatwi AA, 2006, PAKISTAN J NUTR, V5, P429; [Anonymous], 1994, ICRP PUBL, V23; Beardmore J, 2009, J INORG BIOCHEM, V103, P205, DOI 10.1016/j.jinorgbio.2008.10.003; Cappellini M.D., 2014, TIF PUBLICATION, V20; CHISOLM JJ, 1985, J PHARMACOL EXP THER, V235, P665; Cooper GJS, 2005, DIABETES, V54, P1468, DOI 10.2337/diabetes.54.5.1468; Crisponi G, 2012, CURR MED CHEM, V19, P2794, DOI 10.2174/092986712800609742; Crisponi G, 2014, THALASS REP, V4, P13, DOI 10.4081/thal.2014.2046; Crisponi G, 2011, MONATSH CHEM, V142, P331, DOI 10.1007/s00706-011-0474-x; Erdogan E, 2013, J TRACE ELEM MED BIO, V27, P109, DOI 10.1016/j.jtemb.2012.10.002; Evans RW, 2012, BBA-GEN SUBJECTS, V1820, P282, DOI 10.1016/j.bbagen.2011.11.007; Farkas E, 1997, J INORG BIOCHEM, V65, P281, DOI 10.1016/S0162-0134(96)00144-4; Farkas E, 1999, POLYHEDRON, V18, P2391, DOI 10.1016/S0277-5387(99)00144-8; Galanello Renzo, 2007, Ther Clin Risk Manag, V3, P795; Galanello Renzo, 2008, Expert Rev Clin Pharmacol, V1, P231, DOI 10.1586/17512433.1.2.231; Gibbs RR, 1986, ORPHAN DIS ORPHAN DR; Heinz U, 1999, ANGEW CHEM INT EDIT, V38, P2568, DOI 10.1002/(SICI)1521-3773(19990903)38:17<2568::AID-ANIE2568>3.0.CO;2-C; Hider RC, 2010, ANN NY ACAD SCI, V1202, P94, DOI 10.1111/j.1749-6632.2010.05573.x; Hider RC, 1983, U.K. Patent, Patent No. [B2118176, 2118176]; Hider RC, 2010, AM J KIDNEY DIS, V55, P614, DOI 10.1053/j.ajkd.2009.10.065; Hyun TH, 2004, AM J CLIN NUTR, V80, P715; Jakusch T, 2006, J INORG BIOCHEM, V100, P1521, DOI 10.1016/j.jinorgbio.2006.05.003; Jamuar SS, 2012, THER ADV HEMATOL, V3, P299, DOI 10.1177/2040620712450252; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Maclean KH, 2001, BLOOD, V98, P3831, DOI 10.1182/blood.V98.13.3831; Nick H, 2003, CURR MED CHEM, V10, P1065, DOI 10.2174/0929867033457610; Nisbet-Brown E, 2003, LANCET, V361, P1597, DOI 10.1016/S0140-6736(03)13309-0; Nurchi VM, 2008, J INORG BIOCHEM, V102, P684, DOI 10.1016/j.jinorgbio.2007.10.012; Nurchi VM, 2014, J INORG BIOCHEM, V141, P132, DOI 10.1016/j.jinorgbio.2014.09.002; Nurchi VM, 2013, DALTON T, V42, P6161, DOI 10.1039/c2dt32252h; Origa R, 2005, HAEMATOLOGICA, V90, P1309; Pashalidis I., 2000, Transfusion Science, V23, P259, DOI 10.1016/S0955-3886(00)00102-8; Pettit LD, 2006, IUPAC STABILITY CONS; Powell JJ, 1999, J INORG BIOCHEM, V75, P159, DOI 10.1016/S0162-0134(99)00054-9; Steinhauser S, 2004, EUR J INORG CHEM, P4177, DOI 10.1002/ejic.200400363; Thuma PE, 1998, AM J TROP MED HYG, V58, P358, DOI 10.4269/ajtmh.1998.58.358	41	32	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133050	10.1371/journal.pone.0133050	http://dx.doi.org/10.1371/journal.pone.0133050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192307	Green Published, gold			2022-12-27	WOS:000358546400048
J	Hartman, W; Helan, M; Smelter, D; Sathish, V; Thompson, M; Pabelick, CM; Johnson, B; Prakash, YS				Hartman, William; Helan, Martin; Smelter, Dan; Sathish, Venkatachalem; Thompson, Michael; Pabelick, Christina M.; Johnson, Bruce; Prakash, Y. S.			Role of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth Muscle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; INDUCED PROLIFERATION; INTRACELLULAR CA2+; PROTEIN EXPRESSION; TRPC EXPRESSION; FACTOR BDNF; HYPERTENSION; RECEPTOR; ACTIVATION	Background Hypoxia effects on pulmonary artery structure and function are key to diseases such as pulmonary hypertension. Recent studies suggest that growth factors called neurotrophins, particularly brain-derived neurotrophic factor (BDNF), can influence lung structure and function, and their role in the pulmonary artery warrants further investigation. In this study, we examined the effect of hypoxia on BDNF in humans, and the influence of hypoxia-enhanced BDNF expression and signaling in human pulmonary artery smooth muscle cells (PASMCs). Methods and Results 48h of 1% hypoxia enhanced BDNF and TrkB expression, as well as release of BDNF. In arteries of patients with pulmonary hypertension, BDNF expression and release was higher at baseline. In isolated PASMCs, hypoxia-induced BDNF increased intracellular Ca2+ responses to serotonin: an effect altered by HIF1 alpha inhibition or by neutralization of extracellular BDNF via chimeric TrkB-Fc. Enhanced BDNF/TrkB signaling increased PASMC survival and proliferation, and decreased apoptosis following hypoxia. Conclusions Enhanced expression and signaling of the BDNF-TrkB system in PASMCs is a potential mechanism by which hypoxia can promote changes in pulmonary artery structure and function. Accordingly, the BDNF-TrkB system could be a key player in the pathogenesis of hypoxia-induced pulmonary vascular diseases, and thus a potential target for therapy.	[Hartman, William; Smelter, Dan; Sathish, Venkatachalem; Thompson, Michael; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Sathish, Venkatachalem; Pabelick, Christina M.; Johnson, Bruce; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Helan, Martin] St Annes Univ Hosp, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Helan, Martin] Masaryk Univ, St Annes Univ Hosp, Dept Anesthesiol & Intens Care, Brno, Czech Republic; [Johnson, Bruce] Mayo Clin, Dept Internal Med, Div Cardiovasc Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Mayo Clinic	Hartman, W (corresponding author), Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA.	hartman.william@mayo.edu	Helan, Martin/A-4159-2018	Helan, Martin/0000-0002-9021-4947; Prakash, Y S/0000-0002-2968-224X; venkatachalem, sathish/0000-0001-9770-8299	Foundation of Anesthesia Education and Research (FAER); American Heart Association; Flight Attendants Medical Research Institute (FAMRI); National Heart Lung and Blood Institute of the National Institutes of Health [R01 HL056470, HL088029]; European Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; ICRC Human Bridge - Support of Study Stays of Czech Researchers Abroad: "Young Talent Incubator" - European Social Fund [CZ.1.07/2.3.00/20.0022]; state budget of the Czech Republic; National Science Foundation [B-179-M]; Mayo Clinic Center for Translational Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088029, R01HL056470] Funding Source: NIH RePORTER	Foundation of Anesthesia Education and Research (FAER); American Heart Association(American Heart Association); Flight Attendants Medical Research Institute (FAMRI); National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Regional Development Fund-Project FNUSA-ICRC; ICRC Human Bridge - Support of Study Stays of Czech Researchers Abroad: "Young Talent Incubator" - European Social Fund; state budget of the Czech Republic; National Science Foundation(National Science Foundation (NSF)); Mayo Clinic Center for Translational Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Foundation of Anesthesia Education and Research (FAER) and an American Heart Association Grant in Aid (Hartman), the Flight Attendants Medical Research Institute (FAMRI; Sathish), the National Heart Lung and Blood Institute of the National Institutes of Health (R01 HL056470 and HL088029, Prakash), and the European Regional Development Fund-Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and ICRC Human Bridge - Support of Study Stays of Czech Researchers Abroad: "Young Talent Incubator" (reg. n. CZ.1.07/2.3.00/20.0022), which is financed by the European Social Fund and the state budget of the Czech Republic through The Education for Competitiveness Operational Program (Helan). Support for the human studies was from the National Science Foundation, B-179-M, as well as funding through the Mayo Clinic Center for Translational Science (Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcejo AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044343; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Araya AV, 2013, EFFECT EXERCISE CIRC; Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Behrens MM, 1999, MICROSC RES TECHNIQ, V45, P276, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<276::AID-JEMT11>3.0.CO;2-4; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Bhang SY, 2012, NEUROSCI LETT, V512, P72, DOI 10.1016/j.neulet.2012.01.012; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Cao XL, 2011, BRAIN RES, V1385, P263, DOI 10.1016/j.brainres.2011.02.016; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Cho HC, 2012, NEUROSCI LETT, V519, P78, DOI 10.1016/j.neulet.2012.05.025; Costello CM, 2008, AM J PHYSIOL-LUNG C, V295, pL272, DOI 10.1152/ajplung.00358.2007; Cotman CW, 2002, EXERC SPORT SCI REV, V30, P75, DOI 10.1097/00003677-200204000-00006; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Frumkin LR, 2012, PHARMACOL REV, V64, P583, DOI 10.1124/pr.111.005587; Fuchs B, 2010, ADV EXP MED BIOL, V661, P187, DOI 10.1007/978-1-60761-500-2_12; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; Helan M, 2014, J MOL CELL CARDIOL, V68, P89, DOI 10.1016/j.yjmcc.2014.01.006; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; IP NY, 1994, ANN NEUROL, V35, pS13, DOI 10.1002/ana.410350706; Karczewska-Kupczewska M, 2012, DIABETES CARE, V35, P358, DOI 10.2337/dc11-1295; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Kwapiszewska G, 2012, AM J PATHOL, V181, P2018, DOI 10.1016/j.ajpath.2012.08.028; Liu ZH, 2007, J HUAZHONG U SCI-MED, V27, P233, DOI 10.1007/s11596-007-0304-x; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lu WJ, 2008, AM J PHYSIOL-LUNG C, V295, pL104, DOI 10.1152/ajplung.00058.2008; Luo CX, 2010, BIOCHEM BIOPH RES CO, V397, P486, DOI 10.1016/j.bbrc.2010.05.140; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; McGlothlin D, 2012, HEART FAIL CLIN, V8, P301, DOI 10.1016/j.hfc.2012.04.013; McGoon MD, 2012, EUR RESPIR REV, V21, P8, DOI 10.1183/09059180.00008211; Meuchel LW, 2011, CARDIOVASC RES, V91, P668, DOI 10.1093/cvr/cvr107; Meuchel LW, 2011, AM J PHYSIOL-LUNG C, V301, pL91, DOI 10.1152/ajplung.00320.2010; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Pak O, 2007, EUR RESPIR J, V30, P364, DOI 10.1183/09031936.00128706; Pardridge William M, 2002, Curr Opin Investig Drugs, V3, P1753; Prakash YS, 2006, AM J PHYSIOL-LUNG C, V291, pL447, DOI 10.1152/ajplung.00501.2005; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Ricci A, 2004, AM J RESP CELL MOL, V30, P12, DOI 10.1165/rcmb.2002-0110OC; Ricci A, 2000, J VASC RES, V37, P355, DOI 10.1159/000025751; Sakao S, 2010, AM J RESP CELL MOL, V43, P629, DOI 10.1165/rcmb.2009-0389TR; Sciesielski LK, 2009, ACTA PHYSIOL, V197, P253, DOI 10.1111/j.1748-1716.2009.02016.x; Shimoda LA, 2006, AM J PHYSIOL-LUNG C, V291, pL941, DOI 10.1152/ajplung.00528.2005; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Slack SE, 2005, J COMP NEUROL, V489, P59, DOI 10.1002/cne.20606; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stenmark KR, 2010, PEDIATR CRIT CARE ME, V11, pS85, DOI 10.1097/PCC.0b013e3181c76db3; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Wang H, 2006, J NEUROCHEM, V96, P694, DOI 10.1111/j.1471-4159.2005.03572.x; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Whitman EM, 2008, AM J PHYSIOL-LUNG C, V294, pL309, DOI 10.1152/ajplung.00091.2007; Xu M, 2008, AM J PHYSIOL-HEART C, V295, pH1529, DOI 10.1152/ajpheart.00115.2008; Yi B, 2012, GENE, V492, P354, DOI 10.1016/j.gene.2011.11.010; Zhang JM, 2003, EXP NEUROL, V183, P469, DOI 10.1016/S0014-4886(03)00222-X; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003	61	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0129489	10.1371/journal.pone.0129489	http://dx.doi.org/10.1371/journal.pone.0129489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192455	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400003
J	Kalvelage, T; Lavik, G; Jensen, MM; Revsbech, NP; Loscher, C; Schunck, H; Desai, DK; Hauss, H; Kiko, R; Holtappels, M; LaRoche, J; Schmitz, RA; Graco, MI; Kuypers, MMM				Kalvelage, Tim; Lavik, Gaute; Jensen, Marlene M.; Revsbech, Niels Peter; Loescher, Carolin; Schunck, Harald; Desai, Dhwani K.; Hauss, Helena; Kiko, Rainer; Holtappels, Moritz; LaRoche, Julie; Schmitz, Ruth A.; Graco, Michelle I.; Kuypers, Marcel M. M.			Aerobic Microbial Respiration In Oceanic Oxygen Minimum Zones	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; NITROGEN LOSS; DEFICIENT CONDITIONS; NITRITE OXIDATION; ORGANIC-CARBON; WATER COLUMN; TIME-SERIES; IN-VIVO; MARINE; ANAMMOX	Oxygen minimum zones are major sites of fixed nitrogen loss in the ocean. Recent studies have highlighted the importance of anaerobic ammonium oxidation, anammox, in pelagic nitrogen removal. Sources of ammonium for the anammox reaction, however, remain controversial, as heterotrophic denitrification and alternative anaerobic pathways of organic matter remineralization cannot account for the ammonium requirements of reported anammox rates. Here, we explore the significance of microaerobic respiration as a source of ammonium during organic matter degradation in the oxygen-deficient waters off Namibia and Peru. Experiments with additions of double-labelled oxygen revealed high aerobic activity in the upper OMZs, likely controlled by surface organic matter export. Consistently observed oxygen consumption in samples retrieved throughout the lower OMZs hints at efficient exploitation of vertically and laterally advected, oxygenated waters in this zone by aerobic microorganisms. In accordance, metagenomic and metatranscriptomic analyses identified genes encoding for aerobic terminal oxidases and demonstrated their expression by diverse microbial communities, even in virtually anoxic waters. Our results suggest that microaerobic respiration is a major mode of organic matter remineralization and source of ammonium (similar to 45-100%) in the upper oxygen minimum zones, and reconcile hitherto observed mismatches between ammonium producing and consuming processes therein.	[Kalvelage, Tim; Lavik, Gaute; Jensen, Marlene M.; Holtappels, Moritz; Kuypers, Marcel M. M.] Max Planck Inst Marine Mikrobiol, Biogeochem Dept, D-28359 Bremen, Germany; [Revsbech, Niels Peter] Univ Aarhus, Dept Biol Sci, Aarhus, Denmark; [Loescher, Carolin; Schunck, Harald] Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Schunck, Harald; Desai, Dhwani K.; Hauss, Helena; Kiko, Rainer; LaRoche, Julie] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Graco, Michelle I.] Inst Mar Peru, Direcc Invest Oceanog, Lima, Peru	Max Planck Society; Aarhus University; University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Instituto del Mar del Peru	Kalvelage, T (corresponding author), Max Planck Inst Marine Mikrobiol, Biogeochem Dept, D-28359 Bremen, Germany.	tim.kalvelage@usys.ethz.ch	Löscher, Carolin/AAB-3701-2019; Hauss, Helena M/S-1718-2018; Desai, Dhwani/AAA-4237-2020; Holtappels, Moritz/ABC-7901-2020; Revsbech, Niels P/I-8040-2013	Hauss, Helena M/0000-0002-0754-3388; Desai, Dhwani/0000-0002-1447-5360; Kiko, Rainer/0000-0002-7851-9107; Jensen, Marlene Mark/0000-0002-9711-763X; Holtappels, Moritz/0000-0003-3682-1903; Loscher, Carolin/0000-0002-2044-6849; Revsbech, Niels Peter/0000-0002-2193-262X; Graco, Michelle Ivette/0000-0002-6193-3256; LaRoche, Julie/0000-0003-4809-6411; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	DFG [Sonderforschungsbereich 754]; Climate-Biogeochemistry Interactions in the Tropical Ocean; Max Planck Society; Canada Excellence Research Chair in Ocean Science and Technology; European Research Council [267233]; Danish Council for Independent Research: Natural Sciences [10-083140, 272-07-0057]	DFG(German Research Foundation (DFG)); Climate-Biogeochemistry Interactions in the Tropical Ocean; Max Planck Society(Max Planck SocietyFoundation CELLEX); Canada Excellence Research Chair in Ocean Science and Technology; European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research: Natural Sciences(Det Frie Forskningsrad (DFF))	The authors were supported by the following funders: TK, GL, CL, HS, DKD, HH, RK, JLR, RS, MIG, MMK: DFG-funded Sonderforschungsbereich 754 "Climate-Biogeochemistry Interactions in the Tropical Ocean" (www.sfb754.de); TK, GL, MMJ, MH, MMMK: Max Planck Society (www.mpg.de); TK: Canada Excellence Research Chair in Ocean Science and Technology (http://www.cerc.gc.ca/chairholders-titulaires/wallace-eng.aspx); NPR: European Research Council (http://erc.europa.eu), grant 267233, and Danish Council for Independent Research: Natural Sciences (http://ufm.dk/en/research-and-innovation/councils-and-commissions/ the-danish-council-for-independent-research/thecouncil-1/the-danish-council-for-independentresearch- natural-sciences), grants 10-083140 and 272-07-0057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; Babbin AR, 2014, SCIENCE, V344, P406, DOI 10.1126/science.1248364; Belmar L, 2011, FEMS MICROBIOL ECOL, V78, P314, DOI 10.1111/j.1574-6941.2011.01159.x; Beman JM, 2013, ISME J, V7, P2192, DOI 10.1038/ismej.2013.96; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Canfield DE, 2013, ENVIRON MICROBIOL, P1462; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; CODISPOTI LA, 1980, J MAR RES, V38, P453; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Dalsgaard T, 2014, MBIO, V5, DOI 10.1128/mBio.01966-14; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Das A, 2005, J BACTERIOL, V187, P2020, DOI 10.1128/JB.187.6.2020-2029.2005; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; Franz J, 2012, DEEP-SEA RES PT I, V62, P20, DOI 10.1016/j.dsr.2011.12.004; Fussel J, 2012, ISME J, V6, P1200, DOI 10.1038/ismej.2011.178; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Goericke R, 2000, DEEP-SEA RES PT I, V47, P1183, DOI 10.1016/S0967-0637(99)00108-9; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Gundersen K, 2002, LIMNOL OCEANOGR, V47, P1525, DOI 10.4319/lo.2002.47.5.1525; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Holtappels M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089369; Holtappels M, 2011, LIMNOL OCEANOGR-METH, V9, P1, DOI 10.4319/lom.2011.9.1; Jensen MM, 2011, ISME J, V5, P1660, DOI 10.1038/ismej.2011.44; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Klawonn I, 2015, ISME J, V9, P1456, DOI 10.1038/ismej.2014.232; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2011, BIOGEOSCIENCES, V8, P1565, DOI 10.5194/bg-8-1565-2011; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Landolfi A, 2013, BIOGEOSCIENCES, V10, P1351, DOI 10.5194/bg-10-1351-2013; Lavin P, 2010, ENV MICROBIOL REP, V2, P728, DOI 10.1111/j.1758-2229.2010.00167.x; Levipan HA, 2007, PROG OCEANOGR, V75, P531, DOI 10.1016/j.pocean.2007.08.029; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; Loscher CR, 2012, BIOGEOSCIENCES, V9, P2419, DOI 10.5194/bg-9-2419-2012; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Morris RL, 2013, NAT REV MICROBIOL, V11, P205, DOI 10.1038/nrmicro2970; NAQVI SWA, 1987, J MAR RES, V45, P1049, DOI 10.1357/002224087788327118; Paulmier A, 2009, BIOGEOSCIENCES, V6, P923, DOI 10.5194/bg-6-923-2009; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; Ploug H, 1997, AQUAT MICROB ECOL, V13, P285, DOI 10.3354/ame013285; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Schunck H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068661; SHANKS AL, 1993, MAR ECOL PROG SER, V96, P43, DOI 10.3354/meps096043; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; Strous M, 1997, APPL ENVIRON MICROB, V63, P2446, DOI 10.1128/AEM.63.6.2446-2448.1997; Su B, 2015, BIOGEOSCIENCES, V12, P1113, DOI 10.5194/bg-12-1113-2015; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Thamdrup B, 2012, DEEP RES 1, P65; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Tiano L, 2014, DEEP-SEA RES PT I, V94, P173, DOI 10.1016/j.dsr.2014.10.001; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; WARD BB, 1989, DEEP-SEA RES, V36, P1031, DOI 10.1016/0198-0149(89)90076-9; Ward BB, 2013, SCIENCE, V341, P352, DOI 10.1126/science.1240314; Ward BB, 2008, DEEP-SEA RES PT I, V55, P1672, DOI 10.1016/j.dsr.2008.07.005; Weiland N, 2010, METHODS MOL BIOL, V668, P51, DOI 10.1007/978-1-60761-823-2_3; Whitmire AL, 2009, OPT EXPRESS, V17, P21992, DOI 10.1364/OE.17.021992; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	69	78	79	5	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133526	10.1371/journal.pone.0133526	http://dx.doi.org/10.1371/journal.pone.0133526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192623	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358546400098
J	Lei, WJ; Long, YJ; Li, S; Liu, Z; Zhu, FX; Hou, FF; Nie, J				Lei, Wenjing; Long, Yanjun; Li, Shuang; Liu, Ze; Zhu, Fengxin; Hou, Fan Fan; Nie, Jing			Homocysteine Induces Collagen I Expression by Downregulating Histone Methyltransferase G9a	PLOS ONE			English	Article							ENDOTHELIAL-CELL GROWTH; DNA METHYLATION; PLASMA HOMOCYSTEINE; HEMATOPOIETIC STEM; OXIDATIVE STRESS; LIVER; BETA; TRANSCRIPTION; STEATOSIS; REPRESSOR	Hyperhomocysteinemia (HHcy) leads to several clinical manifestations including hepatic fibrosis. Excess deposition of extracellular matrix (ECM) components including collagen is the eponymous lesion of liver fibrosis. In this study, we demonstrated that elevated concentration of Hcy induced the expression of collagen type I in cultured human liver cells as well as in liver tissue of HHcy mice. Meanwhile, Hcy inhibited the expression of histone methyltransferase G9a. Mechanistically, silencing endogenous G9a by siRNA enhanced the promoter activity of COL1A1 in LO2 cells. Conversely, overexpressing G9a inhibited the promoter activity of COL1A1. CHIP assay demonstrated that G9a binds to the neuron-restrictive silencer element (NRSE) on the promoter of COL1A1. Hcy treatment decreased the binding of G9a on NRSE, which in turn decreased the level of H3K9me2 on the promoter of COL1A1, led to upregulation of COL1A1. Taken together, these results provide a novel mechanism on explaining how HHcy promotes ECM production.	[Lei, Wenjing; Long, Yanjun; Li, Shuang; Liu, Ze; Zhu, Fengxin; Hou, Fan Fan; Nie, Jing] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol,State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Nie, J (corresponding author), Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol,State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	niejing@smu.edu.cn			National 973 Program [2012CB517700]; Nature and Science Foundation of China [81288001]; Natural Science Foundation of Guangdong province [S2013020012748]	National 973 Program(National Basic Research Program of China); Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	National 973 Program (2012CB517700) JN. Nature and Science Foundation of China (81288001) JN. Natural Science Foundation of Guangdong province (S2013020012748) JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosy-Westphal A, 2001, HEPATOL RES, V20, P28, DOI 10.1016/S1386-6346(00)00119-4; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chen XJ, 2012, GENE DEV, V26, P2499, DOI 10.1101/gad.200329.112; Cho MK, 2004, BIOCHEM PHARMACOL, V67, P2239, DOI 10.1016/j.bcp.2004.02.024; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Diao JS, 2011, ARCH DERMATOL RES, V303, P573, DOI 10.1007/s00403-011-1140-1; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fahrner JA, 2003, GENE DEV, V17, P1805, DOI 10.1101/gad.1123303; Faraci FM, 2003, ARTERIOSCL THROM VAS, V23, P371, DOI 10.1161/01.ATV.0000063607.56590.7F; Finkelstein JD, 2000, SEMIN THROMB HEMOST, V26, P219, DOI 10.1055/s-2000-8466; Garcia-Tevijano ER, 2001, HYPERTENSION, V38, P1217, DOI 10.1161/hy1101.099499; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016; Heil SG, 2007, MOL GENET METAB, V91, P55, DOI 10.1016/j.ymgme.2007.01.008; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jamaluddin MS, 2007, BLOOD, V110, P3648, DOI 10.1182/blood-2007-06-096701; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Keum YS, 2013, ONCOGENE, V32, P444, DOI 10.1038/onc.2012.71; Li SF, 2013, AM J PHYSIOL-ENDOC M, V304, pE990, DOI 10.1152/ajpendo.00608.2012; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Liu S, 2013, BIOL REV, V88, P40, DOI 10.1111/j.1469-185X.2012.00237.x; Liu XH, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0115-7; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Michalopolous G, 2015, HEPATOLOGY, V61, P32, DOI 10.1002/hep.27329; Qu Y, 2015, INT J CLIN EXP PATHO, V8, P1292; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Roblin X, 2007, GASTROEN CLIN BIOL, V31, P415, DOI 10.1016/S0399-8320(07)89402-4; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sibani S, 2002, CARCINOGENESIS, V23, P61, DOI 10.1093/carcin/23.1.61; St-Germain ME, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-7; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tyagi N, 2009, ANTIOXID REDOX SIGN, V11, P25, DOI 10.1089/ars.2008.2073; Wang H, 2002, BLOOD, V99, P939; Waterland RA, 2006, J NUTR, V136, p1706S, DOI 10.1093/jn/136.6.1706S; Yoshida K, 2014, INT J ONCOL, V45, P1363, DOI 10.3892/ijo.2014.2552; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	46	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0130421	10.1371/journal.pone.0130421	http://dx.doi.org/10.1371/journal.pone.0130421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192994	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400006
J	Lopez, A; Sanderman, R; Smink, A; Zhang, Y; van Sonderen, E; Ranchor, A; Schroevers, MJ				Lopez, Angelica; Sanderman, Robbert; Smink, Ans; Zhang, Ying; van Sonderen, Eric; Ranchor, Adelita; Schroevers, Maya J.			A Reconsideration of the Self-Compassion Scale's Total Score: Self-Compassion versus Self-Criticism	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; NEGATIVE AFFECT; 5-FACTOR MODEL; NUMBER; MINDFULNESS; PERSONALITY; COMPONENTS; RUMINATION; RULES; NEUROTICISM	The Self-Compassion Scale (SCS) is currently the only self-report instrument to measure self-compassion. The SCS is widely used despite the limited evidence for the scale's psychometric properties, with validation studies commonly performed in college students. The current study examined the factor structure, reliability, and construct validity of the SCS in a large representative sample from the community. The study was conducted in 1,736 persons, of whom 1,643 were included in the analyses. Besides the SCS, data was collected on positive and negative indicators of psychological functioning, as well as on rumination and neuroticism. Analyses included confirmatory factor analyses (CFA), exploratory factor analyses (EFA), and correlations. CFA showed that the SCS's proposed six-factor structure could not be replicated. EFA suggested a two-factor solution, formed by the positively and negatively formulated items respectively. Internal consistency was good for the two identified factors. The negative factor (i.e., sum score of the negatively formulated items) correlated moderately to strongly to negative affect, depressive symptoms, perceived stress, as well as to rumination and neuroticism. Compared to this negative factor, the positive factor (i.e., sum score of the positively formulated items) correlated weaker to these indicators, and relatively more strongly to positive affect. Results from this study do not justify the common use of the SCS total score as an overall indicator of self-compassion, and provide support for the idea, as also assumed by others, that it is important to make a distinction between self-compassion and self-criticism.	[Lopez, Angelica; Sanderman, Robbert; Smink, Ans; van Sonderen, Eric; Ranchor, Adelita; Schroevers, Maya J.] Univ Groningen, Univ Med Ctr Groningen, Hlth Psychol Sect, Dept Hlth Sci, Groningen, Netherlands; [Sanderman, Robbert] Univ Twente, Dept Psychol Hlth & Technol, NL-7500 AE Enschede, Netherlands; [Zhang, Ying] Lingnan Univ, Dept Appl Psychol, Hong Kong, Hong Kong, Peoples R China	University of Groningen; University of Twente; Lingnan University	Schroevers, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Hlth Psychol Sect, Dept Hlth Sci, Groningen, Netherlands.	m.j.schroevers@umcg.nl	Ranchor, Adelita/X-5725-2019	Ranchor, Adelita/0000-0001-7048-3771				Bagby RM, 1998, PERS INDIV DIFFER, V24, P895, DOI 10.1016/S0191-8869(97)00238-9; Birnie K, 2010, STRESS HEALTH, V26, P359, DOI 10.1002/smi.1305; Bouma J, 1995, METEN DEPRESSIE MET; Clara IP, 2003, PERS INDIV DIFFER, V35, P91, DOI 10.1016/S0191-8869(02)00143-5; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Costa PT, 2007, REVISED NEO PERSONAL; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; De Vries J, 1998, PERCEIVED STRESS SCA; Dunkley DM, 2009, COMPR PSYCHIAT, V50, P335, DOI 10.1016/j.comppsych.2008.09.004; Dunkley DM, 2006, COMPR PSYCHIAT, V47, P106, DOI 10.1016/j.comppsych.2005.06.003; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Garcia-Campayo J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-4; Gilbert P, 2011, PSYCHOL PSYCHOTHER-T, V84, P239, DOI [10.1348/147608310X526511, 10.1111/j.2044-8341.2011.02046.x]; Gilbert P, 2010, INT J COGN THER, V3, P97, DOI 10.1521/ijct.2010.3.2.97; HAKSTIAN AR, 1982, MULTIVAR BEHAV RES, V17, P193, DOI 10.1207/s15327906mbr1702_3; Hoekstra HA, 2003, BIG 5 PERSOONLIJKHEI; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hupfeld J, 2011, Z KL PSYCH PSYCHOTH, V40, P115, DOI 10.1026/1616-3443/a000088; Jazaieri H, 2013, J HAPPINESS STUD, V14, P1113, DOI 10.1007/s10902-012-9373-z; KAISER HF, 1961, BRIT J STATIST PSYCH, V14, P1, DOI 10.1111/j.2044-8317.1961.tb00061.x; Keng SL, 2012, J COGN PSYCHOTHER, V26, P270, DOI 10.1891/0889-8391.26.3.270; Krieger T, 2013, BEHAV THER, V44, P501, DOI 10.1016/j.beth.2013.04.004; Kuyken W, 2010, BEHAV RES THER, V48, P1105, DOI 10.1016/j.brat.2010.08.003; Longe O, 2010, NEUROIMAGE, V49, P1849, DOI 10.1016/j.neuroimage.2009.09.019; Luyckx K, 2008, J RES PERS, V42, P58, DOI 10.1016/j.jrp.2007.04.004; MacBeth A, 2012, CLIN PSYCHOL REV, V32, P545, DOI 10.1016/j.cpr.2012.06.003; Mills A, 2007, CLIN PSYCHOL PSYCHOT, V14, P358, DOI 10.1002/cpp.537; MONGRAIN M, 1993, PERS INDIV DIFFER, V15, P455, DOI 10.1016/0191-8869(93)90073-C; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Neff K, 2003, SELF IDENTITY, V2, P85, DOI 10.1080/15298860390129863; Neff KD, 2008, J CROSS CULT PSYCHOL, V39, P267, DOI 10.1177/0022022108314544; Neff KD, 2007, J RES PERS, V41, P908, DOI 10.1016/j.jrp.2006.08.002; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Neff KD, 2009, J PERS, V77, P23, DOI 10.1111/j.1467-6494.2008.00537.x; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Nye CD, 2011, ORGAN RES METHODS, V14, P548, DOI 10.1177/1094428110368562; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Peeters F., 1999, HANDLEIDING BIJ NEDE; Petrocchi N, 2014, J MENT HEALTH, V23, P72, DOI 10.3109/09638237.2013.841869; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schroevers MJ, 2000, QUAL LIFE RES, V9, P1015, DOI 10.1023/A:1016673003237; Smith BW, 2008, J CONSULT CLIN PSYCH, V76, P799, DOI 10.1037/0022-006X.76.5.799; Spasojevic J, 2001, EMOTION, V1, P25, DOI 10.1037/1528-3542.1.1.25; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Van Dam NT, 2012, ASSESSMENT, V19, P198, DOI 10.1177/1073191112438743; Van Dam NT, 2011, J ANXIETY DISORD, V25, P123, DOI 10.1016/j.janxdis.2010.08.011; Van Horn PS, 2009, EDUC PSYCHOL MEAS, V69, P389, DOI 10.1177/0013164408324462; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; WATKINS D, 1989, INT J PSYCHOL, V24, P685; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Williams MJ, 2014, PSYCHOL ASSESSMENT, V26, P407, DOI 10.1037/a0035566; Wood AM, 2010, PSYCHIAT RES, V177, P120, DOI 10.1016/j.psychres.2010.02.003; Yu CY, 2012, THESIS U CALIFORNIA; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	57	194	194	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132940	10.1371/journal.pone.0132940	http://dx.doi.org/10.1371/journal.pone.0132940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26193654	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400044
J	Niegowska, M; Paccagnini, D; Burrai, C; Palermo, M; Sechi, LA				Niegowska, Magdalena; Paccagnini, Daniela; Burrai, Carlo; Palermo, Mario; Sechi, Leonardo A.			Antibodies against Proinsulin and Homologous MAP Epitopes Are Detectable in Hashimoto's Thyroiditis Sardinian Patients, an Additional Link of Association	PLOS ONE			English	Article							COMPETITIVE INSULIN AUTOANTIBODIES; GLUTAMIC-ACID DECARBOXYLASE; AUTOIMMUNE-DISEASES; TRANSPORTER ZNT8; CHILDREN; EPIDEMIOLOGY; PREVALENCE; SENSITIVITY; ADOLESCENTS; DISORDERS	Hashimoto's thyroiditis (HT) is the prevailing organ-specific autoimmune disease in Sardinia, often complicated with other autoimmune disorders, most commonly type 1 diabetes (T1D). While numerous studies describe levels of anty-thyroid antibodies (Abs) in T1D patients, few papers evaluate the status of anti-islet autoimmunity in subjects affected by HT. Previously, we portrayed Mycobacteriumavium subspecies paratuberculosis (MAP) as an environmental factor strongly associated with both diseases. In this study, we analyzed plasma of Sardinian HT patients (n=177) and healthy controls (HCs; n=175) for the presence of Abs against proinsulin and MAP-derived homologous epitopes: MAP1,4 alpha gbp(157-173)/PI64-80 were recognized by 5,08% and 18,64% of HT vs 0,57% and 7,43% of HCs (AUC=0,6 for both; p<0,0003 and 0,002, respectively), whereas the prevalence of Abs against MAP2404c(70-85)/PI46-61 peptides was higher but not significant in patients when compared to HCs. In women (n=152), Abs against MAP1,4 alpha gbp(157-173) were detected in 12,50% of HT vs 2,75% of HCs (AUC=0,63; p<0,0002), while positivity to its human homolog PI64-80 was observed in 16,42% of HT vs 6,42% of HCs (AUC=0,61; p<0,001). In men (n=25), a significant anti-PI46-61 Abs levels were detected in 4% of HT vs none of the HCs (AUC=0,7; p<0,003). Age-related analyses revealed the highest prevalence between 31-40 years old (45,83%) in the total study population and among males (33,33%); in contrast, women had a higher seroreactivity between 51-60 years (42,11%). A further follow-up and determination of anti-islet Abs levels is needed to evaluate the association of immune responses directed against the MAP/PI homologous peptides with progression to overt diabetes in HT subjects.	[Niegowska, Magdalena; Paccagnini, Daniela; Sechi, Leonardo A.] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy; [Burrai, Carlo; Palermo, Mario] ASL 1, Dept Endocrinol, Sassari, Italy	University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy.	sechila@uniss.it	Sechi, Leonardo Antonio/Y-3109-2018	sechi, leonardo antonio/0000-0003-0566-2049	Sardinian Region [L.R.7 2010]; Fondazione Banco di Sardegna	Sardinian Region(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This research was supported by the Sardinian Region L.R.7 2010 and Fondazione Banco di Sardegna 2014 both to LAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy DY, 2006, EXP CLIN ENDOCR DIAB, V114, P412, DOI 10.1055/s-2006-924153; BRIGHT GM, 1982, J PEDIATR-US, V100, P8, DOI 10.1016/S0022-3476(82)80227-8; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Culina S, 2013, EUR J ENDOCRINOL, V168, pR19, DOI 10.1530/EJE-12-0693; DIMARIO U, 1990, ACTA ENDOCRINOL-COP, V122, P303, DOI 10.1530/acta.0.1220303; Eaton WW, 2007, J AUTOIMMUN, V29, P1, DOI 10.1016/j.jaut.2007.05.002; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Good M, 2009, IRISH VET J, V62, P597, DOI 10.1186/2046-0481-62-9-597; HEGEWALD MJ, 1992, J IMMUNOL METHODS, V154, P61, DOI 10.1016/0022-1759(92)90213-D; HENKIN RI, 1976, MED CLIN N AM, V60, P779, DOI 10.1016/S0025-7125(16)31861-2; KAWASAKI E, 1995, J AUTOIMMUN, V8, P633, DOI 10.1006/jaut.1995.0047; Kawasaki Eiji, 2014, Clin Pediatr Endocrinol, V23, P99, DOI 10.1297/cpe.23.99; Kordonouri O, 2005, ARCH DIS CHILD, V90, P411, DOI 10.1136/adc.2004.056424; Kordonouri O, 2002, DIABETES CARE, V25, P1346, DOI 10.2337/diacare.25.8.1346; Mantovani RM, 2007, J PEDIATR ENDOCR MET, V20, P669; Masala S, 2015, PEDIATR DIABETES, V16, P189, DOI 10.1111/pedi.12269; Masala S, 2014, ACTA DIABETOL, V51, P577, DOI 10.1007/s00592-014-0558-2; Masala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097621; Masala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063371; Masala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026931; Moriguchi M, 2011, METABOLISM, V60, P761, DOI 10.1016/j.metabol.2010.07.025; NUOVO JA, 1988, DIABETES, V37, P317, DOI 10.2337/diabetes.37.3.317; Rogowicz-Frontczak A, 2014, EUR J ENDOCRINOL, V170, P651, DOI 10.1530/EJE-13-0901; Rosu Valentina, 2008, Ann Clin Microbiol Antimicrob, V7, P9, DOI 10.1186/1476-0711-7-9; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Severinski S, 2009, COLLEGIUM ANTROPOL, V33, P273; Somers EC, 2006, EPIDEMIOLOGY, V17, P202, DOI 10.1097/01.ede.0000193605.93416.df; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; VARDI P, 1993, DIABETES RES CLIN PR, V21, P161, DOI 10.1016/0168-8227(93)90064-C; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wndell PE, 2013, CURR DIABETES REV, V9, P342, DOI 10.2174/15733998113099990064; Ziegler AG, 2012, DIABETOLOGIA, V55, P1937, DOI 10.1007/s00125-012-2472-x	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133497	10.1371/journal.pone.0133497	http://dx.doi.org/10.1371/journal.pone.0133497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192189	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400095
J	Zhang, GD; Wang, MQ; Duan, F; Yuan, K; Li, K; Yan, JY; Chang, ZF; Wang, Y				Zhang, Guodong; Wang, Maoqiang; Duan, Feng; Yuan, Kai; Li, Kai; Yan, Jieyu; Chang, Zhongfei; Wang, Yan			Radiological Findings of Prostatic Arterial Anatomy for Prostatic Arterial Embolization: Preliminary Study in 55 Chinese Patients with Benign Prostatic Hyperplasia	PLOS ONE			English	Article							CONE-BEAM CT	Objective To describe the prostatic arterial supply using Cone-beam computed tomography (CT) and digital subtraction angiography (DSA) before prostatic arterial embolization (PAE) for benign prostatic hyperplasia (BPH). Methods In a retrospective study from January 2012 to January 2014, 55 male patients (110 hemipelves) with BPH who underwent PAE were evaluated by Cone-beam CT in addition to pelvic DSA during embolization planning. Each hemipelvis was evaluated regarding the number of prostatic arteries (PA) and their origins, diameters, territorial perfusion, and anastomoses with adjacent arteries. Results A total of 114 PAs were identified in 110 hemipelves. There was one PA in 96.4% of the hemipelves (n=106), and two independent PAs in the other 3.6% (n=4). The PA was found to originate from the anterior trunk of the internal iliac artery in 39.5% of cases (n=45), from the superior vesical artery in 32.6%(n=37), and from the internal pudendal artery in 27.9% of cases (n=32). Extra-prostatic anastomoses between PA and adjacent arteries were found in 39.1% of hemipelves (n=43). Intra-prostatic anastomoses between PAs and contra- lateral prostatic branches were found in 61.8% of hemipelves (n=68). In 67.3% of our study population (n=37), the prostate was dominantly supplied via a unilateral PA. Conclusion The prostatic vascularization is complex with frequent anatomic variations. Knowledge of the vascular anatomy of the prostate may provide indications for planning PAE and avoiding nontarget embolization.	[Zhang, Guodong; Wang, Maoqiang; Duan, Feng; Yuan, Kai; Li, Kai; Yan, Jieyu; Chang, Zhongfei; Wang, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Radiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Wang, MQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Radiol, Beijing, Peoples R China.	wangmq@vip.sina.com			fifth central health research projects in China	fifth central health research projects in China	This work was supported by the fifth central health research projects in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes AA, 2013, CARDIOVASC INTER RAD, V36, P978, DOI 10.1007/s00270-013-0611-5; Bagla S, 2013, J VASC INTERV RADIOL, V24, P1603, DOI 10.1016/j.jvir.2013.06.024; Bilhim T, 2012, TECH VASC INTERV RAD, V15, P276, DOI 10.1053/j.tvir.2012.09.006; Bilhim T, 2012, J VASC INTERV RADIOL, V23, P1403, DOI 10.1016/j.jvir.2012.07.028; Bilhim T, 2011, EUR RADIOL, V21, P1119, DOI 10.1007/s00330-010-2015-0; BOUISSOU H, 1959, Ann Anat Pathol (Paris), V4, P63; CLEGG EJ, 1955, J ANAT, V89, P209; Ding HM, 2008, SURG RADIOL ANAT, V30, P437, DOI 10.1007/s00276-008-0348-z; Garcia-Monaco R, 2014, J VASC INTERV RADIOL, V25, P315, DOI 10.1016/j.jvir.2013.10.026; Kakeda S, 2007, J VASC INTERV RADIOL, V18, P1508, DOI 10.1016/j.jvir.2007.08.003; Louie JD, 2009, J VASC INTERV RADIOL, V20, P606, DOI 10.1016/j.jvir.2009.01.021; Moreira AM, 2013, CARDIOVASC INTER RAD, V36, P1690, DOI 10.1007/s00270-013-0739-3; Pisco J, 2013, RADIOLOGY, V266, P668, DOI 10.1148/radiol.12111601; Pisco JM, 2011, J VASC INTERV RADIOL, V22, P11, DOI 10.1016/j.jvir.2010.09.030; Venuti JM, 2004, CLIN ANAT, V17, P261, DOI 10.1002/ca.10233; Wallace MJ, 2007, J VASC INTERV RADIOL, V18, P1500, DOI 10.1016/j.jvir.2007.07.021; Wallace MJ, 2009, J VASC INTERV RADIOL, V20, pS523, DOI 10.1016/j.jvir.2009.04.059	17	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132678	10.1371/journal.pone.0132678	http://dx.doi.org/10.1371/journal.pone.0132678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191796	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400034
J	Jiang, T; Liu, GX; Wang, L; Liu, HC				Jiang, Tao; Liu, Guoxia; Wang, Lin; Liu, Hongchen			Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ARREST-SPECIFIC GENE-6; NF-KAPPA-B; GROWTH-ARREST; AXL; CANCER; ACTIVATION; EXPRESSION; INVASION; DIAGNOSIS	Objective This study explored the level and clinical significance of serum Gas6 in patients with oral squamous cell carcinoma (OSCC). Methods A total of 128 OSCC patients and 145 normal controls were selected. Enzyme-linked immunosorbent assay was used to detect Gas6 concentration in sera from the OSCC patients and controls. The correlations of serum Gas6 concentration and clinicopathological characteristics of OSCC patients were assessed, and the prognostic significance of serum Gas6 was evaluated with a Kaplan-Meier curve and log-rank test. Results The results showed that serum Gas6 concentration was significantly higher in OSCC patients than in controls (P < 0.05). OSCC patients with late TNM stage (III, IV) had a relatively high serum Gas6 concentration compared with those with early stage (I, II) (P < 0.01) and patients with poorly differentiated tumors had a higher level of serum Gas6 than those with well-differentiated tumors (P < 0.01). Multivariate logistic regression analysis demonstrated that high serum Gas6 was an independent risk factor for lymph nodal metastases in OSCC patients (OR = 2.79, 95% CI: 1.72-4.48). For predicting OSCC development, ROC curve analysis showed a sensitivity of 0.63 with a specificity of 0.92 (AUC = 0.79, 95% CI: 0.74-0.85). Cox analysis revealed that high serum Gas6 was an independent biomarker for predicting poor overall survival in OSCC patients (HR = 2.07, 95% CI: 1.79-3.62). In addition, we found that Gas6 expression was increased in OSCC tissues and it may significantly decrease E-cadherin expression, and increase P-cadherin and N-cadherin expression, in OSCC cells. Further, Gas6 could promote the migratory and invasive ability of OSCC cells in vitro. Conclusion Taken together, these results suggest that Gas6 increases the metastatic capacity of OSCC cells and serum Gas6 could be a candidate biomarker for diagnostic and prognostic use in OSCC patients.	[Jiang, Tao; Wang, Lin; Liu, Hongchen] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing, Peoples R China; [Jiang, Tao] Jinan Stomatol Hosp, Dept Gen Dent, Jinan, Shandong, Peoples R China; [Liu, Guoxia] Jinan Stomatol Hosp, Dept Clin Lab, Jinan, Shandong, Peoples R China	Chinese People's Liberation Army General Hospital	Liu, HC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing, Peoples R China.	liuhcoral@163.com						Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Angelillo-Scherrer A, 2008, J CLIN INVEST, V118, P583, DOI 10.1172/JCI30375; Buehler M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/238284; Chippagiri P, 2014, J CLIN DIAGN RES, V8, pZC1, DOI 10.7860/JCDR/2014/7534.4211; Cummings CT, 2013, CLIN CANCER RES, V19, P5275, DOI 10.1158/1078-0432.CCR-12-1451; Ding L, 2014, TUMOR BIOL, V35, P10539, DOI 10.1007/s13277-014-2306-1; Ekyalongo RC, 2014, ANTICANCER RES, V34, P3337; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lee CH, 2014, ANN SURG ONCOL, V21, P1031, DOI 10.1245/s10434-013-3400-0; Lee CH, 2012, ANN SURG ONCOL, V19, pS500, DOI 10.1245/s10434-011-1985-8; Lee HJ, 2014, CARCINOGENESIS, V35, P769, DOI 10.1093/carcin/bgt372; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lin CW, 2014, INT J ONCOL, V45, P710, DOI 10.3892/ijo.2014.2427; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Mirjalili N, 2014, ORAL ONCOL, V50, pE52, DOI 10.1016/j.oraloncology.2014.07.005; Paccez JD, 2015, MOL BIOL CELL, V26, P821, DOI 10.1091/mbc.E14-04-0868; Petrick JL, 2014, BRIT J CANCER, V110, P2369, DOI 10.1038/bjc.2014.96; Prabhu A, 2013, ALIMENT PHARM THER, V38, P1145, DOI 10.1111/apt.12514; RESCIGNO J, 1991, ONCOGENE, V6, P1909; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Sawabu T, 2007, MOL CARCINOGEN, V46, P155, DOI 10.1002/mc.20211; Schmidt T, 2012, CELL MOL LIFE SCI, V69, P1391, DOI 10.1007/s00018-011-0863-7; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Sun WS, 2003, ANN ONCOL, V14, P898, DOI 10.1093/annonc/mdg257; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Tsantoulis PK, 2007, ORAL ONCOL, V43, P523, DOI 10.1016/j.oraloncology.2006.11.010; van Ginkel PR, 2004, CANCER RES, V64, P128, DOI 10.1158/0008-5472.CAN-03-0245; Whitman SP, 2014, LEUKEMIA, V28, P1252, DOI 10.1038/leu.2013.371; Yang CZ, 2014, J ORAL PATHOL MED, V43, P28, DOI 10.1111/jop.12091; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	35	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133940	10.1371/journal.pone.0133940	http://dx.doi.org/10.1371/journal.pone.0133940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207647	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000179
J	Rejc, E; Angeli, C; Harkema, S				Rejc, Enrico; Angeli, Claudia; Harkema, Susan			Effects of Lumbosacral Spinal Cord Epidural Stimulation for Standing after Chronic Complete Paralysis in Humans	PLOS ONE			English	Article							LUMBAR CORD; NEUROPHYSIOLOGICAL ASSESSMENT; INTRASPINAL MICROSTIMULATION; SENSORIMOTOR INTERACTIONS; ELECTRICAL-STIMULATION; POSTERIOR STRUCTURES; EVOKED-POTENTIALS; INJURY; LOCOMOTION; REFLEXES	Sensory and motor complete spinal cord injury (SCI) has been considered functionally complete resulting in permanent paralysis with no recovery of voluntary movement, standing or walking. Previous findings demonstrated that lumbosacral spinal cord epidural stimulation can activate the spinal neural networks in one individual with motor complete, but sensory incomplete SCI, who achieved full body weight-bearing standing with independent knee extension, minimal self-assistance for balance and minimal external assistance for facilitating hip extension. In this study, we showed that two clinically sensory and motor complete participants were able to stand over-ground bearing full body-weight without any external assistance, using their hands to assist balance. The two clinically motor complete, but sensory incomplete participants also used minimal external assistance for hip extension. Standing with the least amount of assistance was achieved with individual-specific stimulation parameters, which promoted overall continuous EMG patterns in the lower limbs' muscles. Stimulation parameters optimized for one individual resulted in poor standing and additional need of external assistance for hip and knee extension in the other participants. During sitting, little or negligible EMG activity of lower limb muscles was induced by epidural stimulation, showing that the weight-bearing related sensory information was needed to generate sufficient EMG patterns to effectively support full weight-bearing standing. In general, electrode configurations with cathodes selected in the caudal region of the array at relatively higher frequencies (25-60 Hz) resulted in the more effective EMG patterns for standing. These results show that human spinal circuitry can generate motor patterns effective for standing in the absence of functional supraspinal connections; however the appropriate selection of stimulation parameters is critical.	[Rejc, Enrico; Angeli, Claudia; Harkema, Susan] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Angeli, Claudia; Harkema, Susan] Kentucky One Hlth, Frazier Rehab Inst, Louisville, KY USA	University of Louisville	Harkema, S (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.	SusanHarkema@KentuckyOneHealth.org		Angeli, Claudia/0000-0003-4127-7121	US National Institutes of Health, NIBIB [R01EB007615]; NIGMS [P30 GM103507]; Christopher and Dana Reeve Foundation; Kessler Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Kentucky Spinal Cord Injury Research Center; Jewish Hospital; St. Mary's Foundation; University of Louisville Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER	US National Institutes of Health, NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Christopher and Dana Reeve Foundation; Kessler Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Kentucky Spinal Cord Injury Research Center; Jewish Hospital; St. Mary's Foundation; University of Louisville Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: US National Institutes of Health, NIBIB, under the award number R01EB007615 and NIGMS P30 GM103507, Christopher and Dana Reeve Foundation, Kessler Foundation, the Leona M. and Harry B. Helmsley Charitable Trust, Kentucky Spinal Cord Injury Research Center, University of Louisville Foundation, Jewish Hospital and St. Mary's Foundation.	Angeli CA, 2014, BRAIN; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Barthelemy D, 2007, J NEUROPHYSIOL, V97, P1986, DOI 10.1152/jn.00818.2006; Beauparlant J, 2013, BRAIN, V136, P3347, DOI 10.1093/brain/awt204; Budh CN, 2007, CLIN REHABIL, V21, P89, DOI 10.1177/0269215506070313; BURNS S, 2012, TOP SPINAL CORD INJ, V18, P85, DOI DOI 10.1310/SCI1801-85; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; de Leon RD, 1999, J NEUROPHYSIOL, V81, P85, DOI 10.1152/jn.1999.81.1.85; Dimitrijevic M R, 1988, Adv Neurol, V47, P138; DIMITRIJEVIC MR, 1992, ELECTROEN CLIN NEURO, V85, P365, DOI 10.1016/0168-5597(92)90049-H; DIMITRIJEVIC MR, 1983, J NEUROL SCI, V60, P253, DOI 10.1016/0022-510X(83)90067-9; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; DIMITRIJEVIC MR, 1992, J NEUROTRAUM, V9, pS293; Etlin A, 2010, J NEUROSCI, V30, P10324, DOI 10.1523/JNEUROSCI.1208-10.2010; Gad P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-2; Gaunt RA, 2006, J NEUROPHYSIOL, V96, P2995, DOI 10.1152/jn.00061.2006; Gerasimenko Yu P, 2002, Neurosci Behav Physiol, V32, P417, DOI 10.1023/A:1015836428932; Gerasimenko Y, 2008, EXP NEUROL, V209, P417, DOI 10.1016/j.expneurol.2007.07.015; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1588, DOI 10.1016/j.apmr.2012.04.032; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; Ivanenko YP, 2006, J NEUROPHYSIOL, V95, P602, DOI 10.1152/jn.00767.2005; IWAHARA T, 1992, BRAIN RES BULL, V28, P99, DOI 10.1016/0361-9230(92)90235-P; Jilge B, 2004, BIOL CYBERN, V91, P359, DOI 10.1007/s00422-004-0511-5; Jilge B, 2004, EXP BRAIN RES, V154, P308, DOI 10.1007/s00221-003-1666-3; Lavrov I, 2006, J NEUROPHYSIOL, V96, P1699, DOI 10.1152/jn.00325.2006; Li K, 2012, J NEUROSURG-SPINE, V17, P77, DOI 10.3171/2012.6.AOSPINE12117; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Mckay WB, 2011, SPINAL CORD, V49, P421, DOI 10.1038/sc.2010.145; McKay WB, 1997, J NEUROTRAUM, V14, P539, DOI 10.1089/neu.1997.14.539; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Minassian K, 2007, HUM MOVEMENT SCI, V26, P275, DOI 10.1016/j.humov.2007.01.005; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Murg M, 2000, SPINAL CORD, V38, P394, DOI 10.1038/sj.sc.3101038; Musienko P E, 2013, Ross Fiziol Zh Im I M Sechenova, V99, P392; Musienko PE, 2010, J NEUROPHYSIOL, V103, P1080, DOI 10.1152/jn.00575.2009; Musienko P, 2012, EXP NEUROL, V235, P100, DOI 10.1016/j.expneurol.2011.08.025; Musienko P, 2012, J NEUROPHYSIOL, V107, P2072, DOI 10.1152/jn.00730.2011; NELSON SG, 1978, J NEUROPHYSIOL, V41, P778, DOI 10.1152/jn.1978.41.3.778; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rossignol S, 2008, BRAIN RES REV, V57, P228, DOI 10.1016/j.brainresrev.2007.06.019; Sayenko DG, 2014, J NEUROPHYSIOL, V111, P1088, DOI 10.1152/jn.00489.2013; Schindler-Ivens S, 2000, EXP BRAIN RES, V133, P233, DOI 10.1007/s002210000377; Tseng SC, 2013, CLIN NEUROPHYSIOL, V124, P982, DOI 10.1016/j.clinph.2012.10.020; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784	54	92	97	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133998	10.1371/journal.pone.0133998	http://dx.doi.org/10.1371/journal.pone.0133998			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207623	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000189
J	Sudhoff, H; Klenke, C; Greiner, JFW; Muller, J; Brotzmann, V; Ebmeyer, J; Kaltschmidt, B; Kaltschmidt, C				Sudhoff, Holger; Klenke, Christin; Greiner, Johannes F. W.; Mueller, Janine; Brotzmann, Viktoria; Ebmeyer, Joerg; Kaltschmidt, Barbara; Kaltschmidt, Christian			1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis	PLOS ONE			English	Article							NF-KAPPA-B; PLACEBO-CONTROLLED TRIAL; EPITHELIAL-CELLS; DOUBLE-BLIND; RESPIRATORY-TRACT; GENE-EXPRESSION; ESSENTIAL OILS; UP-REGULATION; MUCIN GENES; AIRWAYS	Inflammatory diseases of the respiratory system such as rhinosinusitis, chronic obstructive pulmonary disease, or bronchial asthma are strongly associated with overproduction and hypersecretion of mucus lining the epithelial airway surface. 1,8-cineol, the active ingredient of the pharmaceutical drug Soledum, is commonly applied for treating such inflammatory airway diseases. However, its potential effects on mucus overproduction still remain unclear. In the present study, we successfully established ex vivo cultures of human nasal turbinate slices to investigate the effects of 1,8-cineol on mucus hypersecretion in experimentally induced rhinosinusitis. The presence of acetyl-alpha-tubulin-positive cilia confirmed the integrity of the ex vivo cultured epithelium. Mucin-filled goblet cells were also detectable in nasal slice cultures, as revealed by Alcian Blue and Periodic acid-Schiff stainings. Treatment of nasal slice cultures with lipopolysaccharides mimicking bacterial infection as observed during late rhinosinusitis led to a significantly increased number of mucin-filled goblet cells. Notably, the number of mucin-filled goblet cells was found to be significantly decreased after co-treatment with 1,8-cineol. On a molecular level, real time PCR-analysis further showed 1,8-cineol to significantly reduce the expression levels of the mucin genes MUC2 and MUC19 in close association with significantly attenuated NF-kappa B-activity. In conclusion, we demonstrate for the first time a 1,8-cineol-dependent reduction of mucin-filled goblet cells and MUC2-gene expression associated with an attenuated NF-kappa B-activity in human nasal slice cultures. Our findings suggest that these effects partially account for the clinical benefits of 1,8-cineol-based therapy during rhinosinusitis. Therefore, topical application of 1,8-cineol may offer a novel therapeutic approach to reduce bacteria-induced mucus hypersecretion.	[Sudhoff, Holger; Klenke, Christin; Greiner, Johannes F. W.; Mueller, Janine; Brotzmann, Viktoria; Ebmeyer, Joerg] Klinikum Bielefeld, Dept Otolaryngol Head & Neck Surg, D-33604 Bielefeld, Germany; [Greiner, Johannes F. W.; Brotzmann, Viktoria; Kaltschmidt, Barbara; Kaltschmidt, Christian] Univ Bielefeld, Dept Cell Biol, D-33501 Bielefeld, Germany; [Mueller, Janine; Kaltschmidt, Barbara] Univ Bielefeld, AG Mol Neurobiol, D-33501 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Kaltschmidt, C (corresponding author), Univ Bielefeld, Dept Cell Biol, D-33501 Bielefeld, Germany.	c.kaltschmidt@uni-bielefeld.de	Sudhoff, Holger/AAV-9741-2020; Greiner, Johannes/Y-6372-2019	Sudhoff, Holger/0000-0002-9274-5645; Greiner, Johannes/0000-0002-0524-662X	Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany	Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany	This study was sponsored by Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos VPD, 2011, BASIC CLIN PHARMACOL, V108, P34, DOI 10.1111/j.1742-7843.2010.00622.x; Bomer K, 1998, ARCH OTOLARYNGOL, V124, P1227, DOI 10.1001/archotol.124.11.1227; Caramori G, 2004, HISTOPATHOLOGY, V45, P477, DOI 10.1111/j.1365-2559.2004.01952.x; Cloez M.S., 1870, COMPTES RENDUS, V70, P687; Davies JR, 1996, BIOCHEM J, V313, P431, DOI 10.1042/bj3130431; Djenane D, 2011, FOOD SCI TECHNOL INT, V17, P505, DOI 10.1177/1082013211398803; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; Greiner JFW, 2013, BBA-MOL CELL RES, V1833, P2866, DOI 10.1016/j.bbamcr.2013.07.001; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Inoue KI, 2005, INT J MOL MED, V16, P315; Jono H, 2002, J BIOL CHEM, V277, P45547, DOI 10.1074/jbc.M206883200; Juergens U R, 2014, Drug Res (Stuttg), V64, P638, DOI 10.1055/s-0034-1372609; Juergens U R, 1998, Eur J Med Res, V3, P508; Juergens UR, 2003, RESP MED, V97, P250, DOI 10.1053/rmed.2003.1432; Kehrl W, 2004, LARYNGOSCOPE, V114, P738, DOI 10.1097/00005537-200404000-00027; Kerschner JE, 2009, GLYCOCONJUGATE J, V26, P1275, DOI 10.1007/s10719-009-9245-x; Kim DH, 2004, ARCH OTOLARYNGOL, V130, P747, DOI 10.1001/archotol.130.6.747; Kim DH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/360457; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lane AP, 2010, J NEUROSCI, V30, P2324, DOI 10.1523/JNEUROSCI.4507-09.2010; LEVINE SJ, 1995, AM J RESP CELL MOL, V12, P196, DOI 10.1165/ajrcmb.12.2.7865217; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Morcillo EJ, 2006, CURR OPIN PULM MED, V12, P1, DOI 10.1097/01.mcp.0000198064.27586.37; Mygind N, 1998, ADV DRUG DELIVER REV, V29, P3, DOI 10.1016/S0169-409X(97)00058-6; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Santos FA, 2000, PHYTOTHER RES, V14, P240, DOI 10.1002/1099-1573(200006)14:4&lt;240::AID-PTR573&gt;3.0.CO;2-X; STEEDMAN HF, 1950, Q J MICROSC SCI, V91, P477; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; THORNTON DJ, 1991, BIOCHEM J, V276, P667, DOI 10.1042/bj2760667; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Worth H, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-69; Zhao CZ, 2014, INFLAMMATION, V37, P566, DOI 10.1007/s10753-013-9770-4	36	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133040	10.1371/journal.pone.0133040	http://dx.doi.org/10.1371/journal.pone.0133040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207629	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000059
J	Carro, A; Toral, R; Miguel, MS				Carro, Adrian; Toral, Raul; San Miguel, Maxi			Markets, Herding and Response to External Information	PLOS ONE			English	Article							STOCK-MARKET; STOCHASTIC RESONANCE; CAPITAL-MARKETS; MODEL; BEHAVIOR; DEPENDENCE; RETURNS; PRICES; AGENTS; MEDIA	We focus on the influence of external sources of information upon financial markets. In particular, we develop a stochastic agent-based market model characterized by a certain herding behavior as well as allowing traders to be influenced by an external dynamic signal of information. This signal can be interpreted as a time-varying advertising, public perception or rumor, in favor or against one of two possible trading behaviors, thus breaking the symmetry of the system and acting as a continuously varying exogenous shock. As an illustration, we use a well-known German Indicator of Economic Sentiment as information input and compare our results with Germany's leading stock market index, the DAX, in order to calibrate some of the model parameters. We study the conditions for the ensemble of agents to more accurately follow the information input signal. The response of the system to the external information is maximal for an intermediate range of values of a market parameter, suggesting the existence of three different market regimes: amplification, precise assimilation and undervaluation of incoming information.	[Carro, Adrian; Toral, Raul; San Miguel, Maxi] CSIC UIB, Inst Fis Interdisciplinar & Sistemas Complejos, Palma De Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona	Carro, A (corresponding author), CSIC UIB, Inst Fis Interdisciplinar & Sistemas Complejos, Palma De Mallorca, Spain.	adrian.carro@ifisc.uib-csic.es	Carro, Adrián/F-7290-2016; Toral, Raul/K-4653-2012; San Miguel, Maxi/G-3224-2015	Carro, Adrián/0000-0001-9838-3027; Toral, Raul/0000-0003-2046-7620; San Miguel, Maxi/0000-0001-6237-425X	FEDER (EU); MINECO (Spain) [FIS2012-30634]; FPU program of MECD	FEDER (EU)(European Commission); MINECO (Spain); FPU program of MECD(German Research Foundation (DFG))	This work was supported by FEDER (EU) and MINECO (Spain) under Grant INTENSE@COSYP (FIS2012-30634). AC acknowledges support by the FPU program of MECD.	Alanyali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03578; Alfarano S., 2005, Computational Economics, V26, P19, DOI 10.1007/s10614-005-6415-1; Alfarano S, 2013, EUR J FINANC, V19, P449, DOI 10.1080/1351847X.2011.601871; Alfarano S, 2008, J ECON DYN CONTROL, V32, P101, DOI 10.1016/j.jedc.2006.12.014; Alfarano S, 2009, J ECON DYN CONTROL, V33, P78, DOI 10.1016/j.jedc.2008.05.003; Arin KP, 2008, ECON LETT, V101, P164, DOI 10.1016/j.econlet.2008.07.007; BENZI R, 1982, TELLUS, V34, P10, DOI 10.1111/j.2153-3490.1982.tb01787.x; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Bornholdt S, 2001, INT J MOD PHYS C, V12, P667, DOI 10.1142/S0129183101001845; Bouchaud JP, 2010, ARXIV PREPRINT ARXIV; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Chang SK, 2007, J ECON DYN CONTROL, V31, P1300, DOI 10.1016/j.jedc.2006.04.008; Collins JJ, 1996, PHYS REV E, V54, P5575, DOI 10.1103/PhysRevE.54.5575; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Cont R, 2000, MACROECON DYN, V4, P170; Cont R., 2005, FRACTALS ENG; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; Davis A, 2006, MEDIA CULT SOC, V28, P603, DOI 10.1177/0163443706065035; De Vries CG, 1994, HDB INT MACROECONOMI, P348; Ding Z, 1993, J EMPIR FINANC, V1, P83, DOI [10.1016/0927-5398(93)90006-D, DOI 10.1016/0927-5398(93)90006-D]; Drakos K, 2010, REV FINANC ECON, V19, P128, DOI 10.1016/j.rfe.2010.01.001; Eguiluz VM, 2000, PHYS REV LETT, V85, P5659, DOI 10.1103/PhysRevLett.85.5659; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gillespie DT, 1992, MARKOV PROCESSES AN; Golub A, 2015, ENTROPY-SWITZ, V17, P2606, DOI 10.3390/e17052606; Rangel JG, 2011, J BANK FINANC, V35, P1263, DOI 10.1016/j.jbankfin.2010.10.009; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Hanousek J, 2009, J FINANC STABIL, V5, P199, DOI 10.1016/j.jfs.2008.01.003; Harras G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011150; Harras G, 2011, J ECON BEHAV ORGAN, V80, P137, DOI 10.1016/j.jebo.2011.03.003; Healy PM, 2001, J ACCOUNT ECON, V31, P405, DOI 10.1016/S0165-4101(01)00018-0; Heneghan C, 1996, PHYS REV E, V54, pR2228, DOI 10.1103/PhysRevE.54.R2228; Hommes CH, 2006, HANDB ECON, V13, P1109; Iori G, 2002, J ECON BEHAV ORGAN, V49, P269, DOI 10.1016/S0167-2681(01)00164-0; Ito K., 1951, MEM AM MATH SOC, V4, P1, DOI DOI 10.1090/MEMO/0004; Jegadeesh N, 2006, J FINANC MARK, V9, P274, DOI 10.1016/j.finmar.2006.05.001; Johansen A., 2002, ENDOGENOUS VERSUS EX; Joulin A., 2008, STOCK PRICE JUMPS NE; KIRMAN A, 1993, Q J ECON, V108, P137, DOI 10.2307/2118498; Kirman A., 1991, MONEY FINANCIAL MARK, P354; Kirman A, 2002, STUDIES NONLINEAR DY, V5, P1; KIRMAN AP, 1992, J ECON PERSPECT, V6, P117, DOI 10.1257/jep.6.2.117; Kiymaz H., 2001, J MULTINATL FINANC M, V11, P105, DOI [DOI 10.1016/S1042-444X(00), DOI 10.1016/S1042-444X(00)00045-1]; Kononovicius A, 2012, PHYSICA A, V391, P1309, DOI 10.1016/j.physa.2011.08.061; Lillo F, 2015, QUANT FINANC, V15, P213, DOI 10.1080/14697688.2014.931593; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Lux T, 2006, TECHNICAL REPORT; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mandelbrot Benoit, 1997, FRACTALS SCALING FIN; Miguel M. S., 2000, INSTABILITIES NONEQU, P35, DOI DOI 10.1007/978-94-011-4247-2_; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; NICOLIS C, 1981, TELLUS, V33, P225, DOI 10.1111/j.2153-3490.1981.tb01746.x; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Rambaldi M, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012819; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; Shapira Y, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/053040; Stauffer D, 1999, PHYSICA A, V271, P496, DOI 10.1016/S0378-4371(99)00290-3; Tetlock PC, 2007, J FINANC, V62, P1139, DOI 10.1111/j.1540-6261.2007.01232.x; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Walras L., 1954, ELEMENTS PURE EC THE	64	27	28	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133287	10.1371/journal.pone.0133287	http://dx.doi.org/10.1371/journal.pone.0133287			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NJ	26204451	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000025
J	Song, YN; Hakoda, Y; Sanefuji, W; Cheng, C				Song, Yongning; Hakoda, Yuji; Sanefuji, Wakako; Cheng, Chen			Can They See It? The Functional Field of View Is Narrower in Individuals with Autism Spectrum Disorder	PLOS ONE			English	Article							SUPERIOR VISUAL-SEARCH; ASPERGER-SYNDROME; LOCAL PRECEDENCE; CHILDREN; PERCEPTION; AGE; ADOLESCENTS; PERFORMANCE; ATTENTION; DETAIL	Although social cognitive deficits have long been thought to underlie the characteristic and pervasive difficulties with social interaction observed in individuals with autism spectrum disorder (ASD), several recent behavioral and neuroimaging studies have indicated that visual perceptual impairments might also play a role. People with ASD show a robust bias towards detailed information at the expense of global information, although the mechanisms that underlie this phenomenon remain elusive. To address this issue, we investigated the functional field of view in a group of high-functioning children with autism (n = 13) and a paired non-ASD group (n = 13). Our results indicate that the ability to correctly detect and identify stimuli sharply decreases with greater eccentricity from the fovea in people with ASD. Accordingly, a probe analysis revealed that the functional field of view in the ASD group was only about 6.62 degrees of retinal eccentricity, compared with 8.57 degrees in typically developing children. Thus, children with ASD appear to have a narrower functional field of view. These results challenge the conventional hypothesis that the deficit in global processing in individuals with ASD is solely due to weak central coherence. Alternatively, our data suggest that a narrower functional field of view may also contribute to this bias.	[Song, Yongning] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Shanghai Key Lab Brain Funct Genom,Sch Psychol &, Shanghai 200062, Peoples R China; [Hakoda, Yuji] Kyoto Womens Univ, Fac Human Dev & Educ, Kyoto, Japan; [Sanefuji, Wakako] Kyushu Univ, Fac Human Environm Studies, Fukuoka 812, Japan; [Cheng, Chen] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA	East China Normal University; Kyoto Womens University; Kyushu University; University of Massachusetts System; University of Massachusetts Boston	Song, YN (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Shanghai Key Lab Brain Funct Genom,Sch Psychol &, Shanghai 200062, Peoples R China.	Ynsong@psy.ecnu.edu.cn			National Natural Foundation of China [31300839]; JSPS Postdoctoral Fellowship for Foreign Researchers [P13311]; Shanghai Pujiang Program [12PJC034]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [13YJC190020]; SRF for ROCS, SEM	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); JSPS Postdoctoral Fellowship for Foreign Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Shanghai Pujiang Program(Shanghai Pujiang Program); MOE (Ministry of Education in China) Project of Humanities and Social Sciences; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Foundation of China (31300839), Grant-in-Aid for JSPS Postdoctoral Fellowship for Foreign Researchers (P13311), Shanghai Pujiang Program (12PJC034), MOE (Ministry of Education in China) Project of Humanities and Social Sciences (13YJC190020) and SRF for ROCS, SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2007, AUTISM, V11, P173, DOI 10.1177/1362361307075710; ANGOLD A, 1995, PSYCHOL MED, V25, P739, DOI 10.1017/S003329170003498X; APA, 2000, DIAGN STAT MAN MENT; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Ball KK, 2002, GERONTECHNOLOGY, V1, P251, DOI DOI 10.4017/GT.2002.01.04.004.00; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brian JA, 1996, J CHILD PSYCHOL PSYC, V37, P865, DOI 10.1111/j.1469-7610.1996.tb01482.x; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Deruelle C, 2004, J AUTISM DEV DISORD, V34, P199, DOI 10.1023/B:JADD.0000022610.09668.4c; Ehlers S, 1999, J AUTISM DEV DISORD, V29, P129, DOI 10.1023/A:1023040610384; Finney DJ, 1947, PROBIT ANAL STAT TRE; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gagnon L, 2004, J AUTISM DEV DISORD, V34, P679, DOI 10.1007/s10803-004-5288-9; Gernsbacher MA, 2008, CHILD DEV PERSPECT, V2, P38, DOI 10.1111/j.1750-8606.2008.00039.x; Gillberg C, 2001, AUTISM, V5, P57, DOI 10.1177/1362361301005001006; Greenaway R, 2013, NEUROPSYCHOLOGIA, V51, P592, DOI 10.1016/j.neuropsychologia.2013.01.005; Gross TF, 2005, J AUTISM DEV DISORD, V35, P773, DOI 10.1007/s10803-005-0023-8; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Happe F., 1994, AUTISM INTRO PSYCHOL; Happe FGE., 1991, THESIS U LONDON; Jarrold C, 1997, J AUTISM DEV DISORD, V27, P25, DOI 10.1023/A:1025817121137; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kemner C, 2008, J AUTISM DEV DISORD, V38, P553, DOI 10.1007/s10803-007-0406-0; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Lahaie A, 2006, NEUROPSYCHOLOGY, V20, P30, DOI 10.1037/0894-4105.20.1.30; LAMB MR, 1988, PERCEPT PSYCHOPHYS, V44, P172, DOI 10.3758/BF03208710; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Loukusa S, 2007, J AUTISM DEV DISORD, V37, P1049, DOI 10.1007/s10803-006-0247-2; Mackworth N. H., 1965, PSYCHON SCI, V3, P67, DOI DOI 10.3758/BF03343023; Mann TA, 2003, J CHILD PSYCHOL PSYC, V44, P274, DOI 10.1111/1469-7610.00120; McCleery JP, 2007, BIOL PSYCHIAT, V62, P1007, DOI 10.1016/j.biopsych.2007.02.009; Mitsudo H, 2007, PERCEPTION, V36, P125, DOI 10.1068/p5562; Mottron L, 2003, J CHILD PSYCHOL PSYC, V44, P904, DOI 10.1111/1469-7610.00174; MOTTRON L, 1993, BRAIN COGNITION, V23, P279, DOI 10.1006/brcg.1993.1060; O'Riordan M, 2001, Q J EXP PSYCHOL-A, V54, P961, DOI 10.1080/02724980042000543; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; O'Riordan MA, 2004, AUTISM, V8, P229, DOI 10.1177/1362361304045219; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Plaisted K, 2003, PHILOS T ROY SOC B, V358, P375, DOI 10.1098/rstb.2002.1211; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Raven J, 2003, STANDARD PROGR MATRI; Rinehart NJ, 2000, J CHILD PSYCHOL PSYC, V41, P769, DOI 10.1017/S002196309900596X; Ropar D, 2001, J CHILD PSYCHOL PSYC, V42, P539, DOI 10.1017/S002196300100717X; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Teunisse JP, 2003, BRAIN COGNITION, V52, P285, DOI 10.1016/S0278-2626(03)00042-3; TOWNSEND J, 1994, J COGNITIVE NEUROSCI, V6, P220, DOI 10.1162/jocn.1994.6.3.220; van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055; VANESSEN DC, 1983, TRENDS NEUROSCI, V6, P370, DOI 10.1016/0166-2236(83)90167-4; Witkin HA, MANUAL EMBEDDED FIGU	54	13	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133237	10.1371/journal.pone.0133237	http://dx.doi.org/10.1371/journal.pone.0133237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204121	gold, Green Published, Green Submitted			2022-12-27	WOS:000358621000023
J	Davy, CM; Kidd, AG; Wilson, CC				Davy, Christina M.; Kidd, Anne G.; Wilson, Chris C.			Development and Validation of Environmental DNA (eDNA) Markers for Detection of Freshwater Turtles	PLOS ONE			English	Article							CONSERVATION; GENETICS; SAMPLES; PCR	Environmental DNA (eDNA) is a potentially powerful tool for detection and monitoring of rare species, including threatened native species and recently arrived invasive species. Here, we develop DNA primers for a suite of nine sympatric freshwater turtles, and use it to test whether turtle eDNA can be successfully detected in samples from aquaria and an outdoor pond. We also conduct a cost comparison between eDNA detection and detection through traditional survey methods, using data from field surveys at two sites in our target area. We find that eDNA from turtles can be detected using both conventional polymerase chain reaction (PCR) and quantitative PCR (qPCR), and that the cost of detection through traditional survey methods is 2-10X higher than eDNA detection for the species in our study range. We summarize necessary future steps for application of eDNA surveys to turtle monitoring and conservation and propose specific cases in which the application of eDNA could further the conservation of threatened turtle species.	[Davy, Christina M.] Wildlife Preservat Canada, Guelph, ON, Canada; [Davy, Christina M.] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Kidd, Anne G.; Wilson, Chris C.] Ontario Minist Nat Resources & Forestry, Peterborough, ON, Canada	Trent University; Ministry of Natural Resources & Forestry	Davy, CM (corresponding author), Wildlife Preservat Canada, Guelph, ON, Canada.	christinadavy@trentu.ca	Wilson, Chris C/J-4851-2012	Wilson, Chris C/0000-0002-9528-0652	Government of Ontario [31-14]; Wildlife Preservation Canada; Rogers Foundation; Liber Ero Fellowship	Government of Ontario; Wildlife Preservation Canada; Rogers Foundation; Liber Ero Fellowship	This study was funded by the Government of Ontario (Species at Risk Research Fund for Ontario grant #31-14 to CMD) and by Wildlife Preservation Canada and the Rogers Foundation (www.wildlifepreservation.ca; Canada Collections grant to CMD). CMD is supported by a Liber Ero Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Amato ML, 2008, MOL ECOL, V17, P570, DOI 10.1111/j.1365-294X.2007.03580.x; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bronnenhuber JE, 2013, CONSERV GENET RESOUR, V5, P971, DOI 10.1007/s12686-013-9946-0; Browne CL, 2007, BIOL CONSERV, V138, P421, DOI 10.1016/j.biocon.2007.05.008; Chambers EA, 2014, THESIS U GUELPH; COSEWIC, 2007, COSEWIC ASS UPD STAT; COSEWIC, 2006, COSEWIC ASS STAT REP; COSEWIC, 2005, COSEWIC ASS UPD STAT; COSEWIC, 2008, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2002, COSEWIC ASS STAT REP; Davy CM, 2014, ANIM BEHAV, V93, P15, DOI 10.1016/j.anbehav.2014.04.013; Davy CM, 2014, CONSERV GENET, V15, P319, DOI 10.1007/s10592-013-0540-5; Davy CM, 2014, CAN J ZOOL, V92, P149, DOI 10.1139/cjz-2013-0188; Davy CM, 2013, EUR J WILDLIFE RES, V59, P123, DOI 10.1007/s10344-012-0680-9; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Ficetola G F, 2015, MOL ECOL RES, V15, P1755; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Innis MA, 1990, PCR PROTOCOLS GUIDE; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lepitzki D.A.W., 2008, COSEWIC ASSESSMENT U; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Polo-Cavia N, 2008, ETHOLOGY, V114, P115, DOI 10.1111/j.1439-0310.2007.01441.x; Polo-Cavia N, 2010, ANIM BEHAV, V80, P461, DOI 10.1016/j.anbehav.2010.06.004; Rainwater TR, 2012, CHELONIAN CONSERV BI, V11, P97, DOI 10.2744/CCB-0932.1; Rhodin A. G. J, 2011, IUCN SSC TORTOISE FR; Rozen S, 2000, Methods Mol Biol, V132, P365; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Sterrett SC, 2010, HERPETOL CONSERV BIO, V5, P490; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; United Stated Fish and Wildlife Service, 2013, QUAL ASS PROJ PLAN E; van Dijk P. P., 2012, CHELYDRA SERPENTINA; van Dijk PP, 2013, CLEMMYS GUTTATA IUCN; van Dijk PP, 2013, APALONE SPINIFERA IU; van Dijk PP, 2013, EMYDOIDEA BLANDINGII; van Dijk PP, 2013, TRACHEMYS SCRIPTA IU; van Dijk PP, 2013, GLYPTEMYS INSCULPTA; van Dijk PP, 2013, CHRYSEMYS PICTA IUCN; van Dijk PP, 2013, GRAPTEMYS GEOGRAPHIC; van Dijk PP, 2013, STERNOTHERUS ODORATU; Walker D, 1998, ANIM CONSERV, V1, P55, DOI 10.1111/j.1469-1795.1998.tb00226.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wilson C, 2014, MANAGE BIOL IN PRESS, V5	55	76	81	8	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0130965	10.1371/journal.pone.0130965	http://dx.doi.org/10.1371/journal.pone.0130965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200348	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100010
J	Deol, P; Evans, JR; Dhahbi, J; Chellappa, K; Han, DS; Spindler, S; Sladek, FM				Deol, Poonamjot; Evans, Jane R.; Dhahbi, Joseph; Chellappa, Karthikeyani; Han, Diana S.; Spindler, Stephen; Sladek, Frances M.			Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver	PLOS ONE			English	Article							DIETARY LINOLEIC-ACID; WESTERN-TYPE DIETS; HIGH-FAT DIETS; SWEETENED BEVERAGES; INSULIN-RESISTANCE; GAMMA-TOCOPHEROL; GENE-EXPRESSION; LIPID DROPLETS; BODY-WEIGHT; EPOXYEICOSATRIENOIC ACIDS	The obesity epidemic in the U.S. has led to extensive research into potential contributing dietary factors, especially fat and fructose. Recently, increased consumption of soybean oil, which is rich in polyunsaturated fatty acids (PUFAs), has been proposed to play a causal role in the epidemic. Here, we designed a series of four isocaloric diets (HFD, SO-HFD, F-HFD, F-SO-HFD) to investigate the effects of saturated versus unsaturated fat, as well as fructose, on obesity and diabetes. C57/BL6 male mice fed a diet moderately high in fat from coconut oil and soybean oil (SO-HFD, 40% kcal total fat) showed statistically significant increases in weight gain, adiposity, diabetes, glucose intolerance and insulin resistance compared to mice on a diet consisting primarily of coconut oil (HFD). They also had fatty livers with hepatocyte ballooning and very large lipid droplets as well as shorter colonic crypt length. While the high fructose diet (F-HFD) did not cause as much obesity or diabetes as SO-HFD, it did cause rectal prolapse and a very fatty liver, but no balloon injury. The coconut oil diet (with or without fructose) increased spleen weight while fructose in the presence of soybean oil increased kidney weight. Metabolomics analysis of the liver showed an increased accumulation of PUFAs and their metabolites as well as.-tocopherol, but a decrease in cholesterol in SO-HFD. Liver transcriptomics analysis revealed a global dysregulation of cytochrome P450 (Cyp) genes in SO-HFD versus HFD livers, most notably in the Cyp3a and Cyp2c families. Other genes involved in obesity (e.g., Cidec, Cd36), diabetes (Igfbp1), inflammation (Cd63), mitochondrial function (Pdk4) and cancer (H19) were also upregulated by the soybean oil diet. Taken together, our results indicate that in mice a diet high in soybean oil is more detrimental to metabolic health than a diet high in fructose or coconut oil.	[Deol, Poonamjot; Evans, Jane R.; Chellappa, Karthikeyani; Han, Diana S.; Sladek, Frances M.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Dhahbi, Joseph; Spindler, Stephen] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Sladek, FM (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	frances.sladek@ucr.edu		Deol, Sonia/0000-0002-7109-0619	National Institute of Environmental Health Sciences [T32 5T32-ES018827]; National Institutes of Health [R01DK053892]; University of California Riverside Collaborative Seed grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES018827] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1429826] Funding Source: National Science Foundation	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Riverside Collaborative Seed grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Institute of Environmental Health Sciences T32 5T32-ES018827 to PD (http://www.niehs.nih.gov/), the National Institutes of Health R01DK053892 to FMS (http://nih.gov/), and University of California Riverside Collaborative Seed grant to FMS (http://www.research.ucr.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abel S, 2009, PROSTAG LEUKOTR ESS, V81, P391, DOI 10.1016/j.plefa.2009.08.003; Ackerman Z, 2005, HYPERTENSION, V45, P1012, DOI 10.1161/01.HYP.0000164570.20420.67; Alvheim AR, 2013, BRIT J NUTR, V109, P1508, DOI 10.1017/S0007114512003364; Alvheim AR, 2012, OBESITY, V20, P1984, DOI 10.1038/oby.2012.38; ANDERSSON DEH, 1978, ACTA MED SCAND, V203, P87; ARAVANIS C, 1970, Circulation Research Supplement, V41, P88; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831; Bantle JP, 2009, J NUTR, V139, pS1263, DOI 10.3945/jn.108.098020; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; BIERI JG, 1974, AM J CLIN NUTR, V27, P980, DOI 10.1093/ajcn/27.8.980; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bocarsly ME, 2010, PHARMACOL BIOCHEM BE, V97, P101, DOI 10.1016/j.pbb.2010.02.012; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bray GA, 2007, AM J CLIN NUTR, V86, P895, DOI 10.1093/ajcn/86.4.895; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Burr GOB, 1929, J BIOL CHEM, VLXXXII; Burr GOB, 1930, J BIOL CHEM, VLXXXVI; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; CERECEDO LR, 1952, J NUTR, V48, P41, DOI 10.1093/jn/48.1.41; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Cohen E, 2015, NUTRITION, V31, P727, DOI 10.1016/j.nut.2015.02.007; da Costa CAS, 2013, HORM METAB RES, V45, P652, DOI 10.1055/s-0033-1345150; DAYTON S, 1966, J LIPID RES, V7, P103; de Roos NM, 2001, J NUTR, V131, P242, DOI 10.1093/jn/131.2.242; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190; Fang X, 1999, J LIPID RES, V40, P699; Farah V, 2006, AUTON NEUROSCI-BASIC, V130, P41, DOI 10.1016/j.autneu.2006.05.006; GARFINKEL M, 1992, J SURG RES, V52, P328, DOI 10.1016/0022-4804(92)90111-C; Ghosh S, 2013, BRIT J NUTR, V110, P515, DOI 10.1017/S0007114512005326; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Haguenauer A, 2005, J BIOL CHEM, V280, P22036, DOI 10.1074/jbc.M412136200; Hashimoto Y, 2013, LIPIDS, V48, P803, DOI 10.1007/s11745-013-3805-3; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hoekstra M, 2006, J LIPID RES, V47, P2198, DOI 10.1194/jlr.M600095-JLR200; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Howlader N, 2014, SEER CANC STAT REV 1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010; Ichi I, 2014, BBA-MOL CELL BIOL L, V1841, P204, DOI 10.1016/j.bbalip.2013.10.013; Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Queipo-Ortuno MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048605; Jeoung Nam Ho, 2010, Korean Diabetes J, V34, P274, DOI 10.4093/kdj.2010.34.5.274; Jiang Q, 2004, P NATL ACAD SCI USA, V101, P17825, DOI 10.1073/pnas.0408340102; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; Jiang Q, 2003, FASEB J, V17, P816, DOI 10.1096/fj.02-0877com; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Jurgonski A, 2014, NUTRIENTS, V6, P616, DOI 10.3390/nu6020616; Kahn R, 2014, DIABETES CARE, V37, P957, DOI 10.2337/dc13-2506; KEYS A, 1957, JAMA-J AM MED ASSOC, V164, P1912, DOI 10.1001/jama.1957.62980170024007e; Kimura N, 1970, CIRCULATION, V41, pI101; Klurfeld DM, 2012, INT J OBES LOND; Konig R, 2008, CHEM RES TOXICOL, V21, P572, DOI 10.1021/tx7002728; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Kritchevsky D, 1998, J NUTR, V128, p449S, DOI 10.1093/jn/128.2.449S; Lamarche B, 2014, APPL PHYSIOL NUTR ME, P1, DOI [10.1139/apnm-2013-0026, DOI 10.1139/APNM-2013-0026]; LANDS WEM, 1990, LIPIDS, V25, P505, DOI 10.1007/BF02537156; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Lazic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107658; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lee KT, 2000, J AGR FOOD CHEM, V48, P5696, DOI 10.1021/jf000072+; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; LOCKERETZ W, 1988, FOOD POLICY, V13, P154, DOI 10.1016/0306-9192(88)90028-0; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Marriott BP, 2010, CRIT REV FOOD SCI, V50, P228, DOI 10.1080/10408391003626223; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Massiera F, 2010, J LIPID RES, V51, P2352, DOI 10.1194/jlr.M006866; McCullough JS, 1998, GUT, V42, P799, DOI 10.1136/gut.42.6.799; MCGARRITY TJ, 1988, GASTROENTEROLOGY, V95, P343, DOI 10.1016/0016-5085(88)90489-1; Merat S, 1999, ARTERIOSCL THROM VAS, V19, P1223, DOI 10.1161/01.ATV.19.5.1223; MESJJ J, 2015, NANOTECHONOLOGY FUNC; Midtbo LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053094; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Mumme K, 2015, J ACAD NUTR DIET, V115, P249, DOI 10.1016/j.jand.2014.10.022; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nieto G., 2012, MODIFICATION FATTY A; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ogbolu DO, 2007, J MED FOOD, V10, P384, DOI 10.1089/jmf.2006.1209; Oliveros J.C., 2007, VENNY INTERACTIVE TO; OOI GT, 1992, MOL ENDOCRINOL, V6, P2219, DOI 10.1210/me.6.12.2219; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; PAGE IH, 1961, CIRCULATION, V23, P133, DOI 10.1161/01.CIR.23.1.133; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PARK YMK, 1993, AM J CLIN NUTR, V58, P737; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Reebye V, 2014, HEPATOLOGY, V59, P216, DOI 10.1002/hep.26669; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rett BS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-36; Roat R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086815; Roccisano D, 2011, AM J PHYS ANTHROPOL, V144, P255; Rogue A, 2010, PPAR RES, V2010, DOI 10.1155/2010/325183; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosillo-Calle F., 2009, GLOBAL OVERVIEW VEGE, V40; Sanders TAB, 2014, P NUTR SOC, V73, P73, DOI 10.1017/S0029665113003789; Schaefer EJ, 2009, J NUTR, V139, pS1257, DOI 10.3945/jn.108.098186; Sena CM, 2008, MED CHEM, V4, P293, DOI 10.2174/157340608784325115; Shimonishi T, 2001, HUM PATHOL, V32, P302, DOI 10.1053/hupa.2001.22767; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; da Costa CAS, 2011, CLINICS, V66, P1811, DOI 10.1590/S1807-59322011001000022; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Spector AA, 2014, BIOCH BIOPHYS ACTA; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stanhope KL, 2013, CURR OPIN LIPIDOL, V24, P198, DOI 10.1097/MOL.0b013e3283613bca; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; SUNTER JP, 1979, VIRCHOWS ARCH B, V32, P75; Swarbrick MM, 2008, BRIT J NUTR, V100, P947, DOI 10.1017/S0007114508968252; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; TAYLOR H L, 1970, Circulation Research Supplement, V41, P20; Thompson F., 2014, OVERCOMING OBESITY I; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; Tsuchiya H, 2013, METABOLISM, V62, P62, DOI 10.1016/j.metabol.2012.06.008; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; van Buul VJ, 2014, NUTR RES REV, V27, P119, DOI 10.1017/S0954422414000067; van Waterschoot RAB, 2008, MOL PHARMACOL, V73, P1029, DOI 10.1124/mol.107.043869; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Wu H, 2012, J GASTROEN HEPATOL, V27, P1312, DOI 10.1111/j.1440-1746.2012.07130.x; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xue C, 2009, EUR J CLIN NUTR, V63, P879, DOI 10.1038/ejcn.2008.76; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Yarmishyn AA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00145; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zha WB, 2014, J LIPID RES, V55, P2124, DOI 10.1194/jlr.M053199; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhang XH, 2007, ASIA PAC J CLIN NUTR, V16, P368; Zhang ZF, 2015, J ADOLESCENT HEALTH, V56, P352, DOI 10.1016/j.jadohealth.2014.12.001; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	167	62	64	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132672	10.1371/journal.pone.0132672	http://dx.doi.org/10.1371/journal.pone.0132672			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200659	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100044
J	Fedrizzi, N; Stiassny, MLJ; Boehm, JT; Dougherty, ER; Amato, G; Mendez, M				Fedrizzi, Nathan; Stiassny, Melanie L. J.; Boehm, J. T.; Dougherty, Eric R.; Amato, George; Mendez, Martin			Population Genetic Structure of the Dwarf Seahorse (Hippocampus zosterae) in Florida	PLOS ONE			English	Article							DNA POLYMORPHISM; LOOP CURRENT; TAMPA BAY; CONSERVATION; MANAGEMENT; CONNECTIVITY; SYNGNATHIDAE; PHYLOGEOGRAPHY; SOFTWARE; DISTANCE	The dwarf seahorse (Hippocampus zosterae) is widely distributed throughout near-shore habitats of the Gulf of Mexico and is of commercial significance in Florida, where it is harvested for the aquarium and curio trades. Despite its regional importance, the genetic structure of dwarf seahorse populations remains largely unknown. As an aid to ongoing conservation efforts, we employed three commonly applied mtDNA markers (ND4, DLoop and CO1) to investigate the genetic structuring of H. zosterae in Florida using samples collected throughout its range in the state. A total of 1450 bp provided sufficient resolution to delineate four populations of dwarf seahorses, as indicated by significant fixation indices. Despite an overall significant population structure, we observed evidence of interbreeding between individuals from geographically distant sites, supporting the hypothesis that rafting serves to maintain a degree of population connectivity. All individuals collected from Pensacola belong to a single distinct subpopulation, which is highly differentiated from the rest of Floridian dwarf seahorses sampled. Our findings highlight the utility of mtDNA markers in evaluating barriers to gene flow and identifying genetically distinct populations, which are vital to the development of comprehensive conservation strategies for exploited taxa.	[Fedrizzi, Nathan] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Fedrizzi, Nathan; Stiassny, Melanie L. J.; Boehm, J. T.; Dougherty, Eric R.; Amato, George; Mendez, Martin] Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA; [Stiassny, Melanie L. J.] Amer Museum Nat Hist, Div Vertebrate Zool, Dept Ichthyol, New York, NY 10024 USA; [Boehm, J. T.] CUNY, Grad Ctr, Dept Ecol Evolut & Behav, New York, NY 10021 USA; [Dougherty, Eric R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Mendez, Martin] Wildlife Conservat Soc, Latin Amer & Caribbean Program, Bronx, NY USA	Columbia University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); City University of New York (CUNY) System; University of California System; University of California Berkeley; Wildlife Conservation Society	Fedrizzi, N (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	nathanfedrizzi@gmail.com			Columbia University Earth Institute Travel Grant; Lerner Gray Memorial Fund of the American Museum of Natural History	Columbia University Earth Institute Travel Grant; Lerner Gray Memorial Fund of the American Museum of Natural History	This work was supported by The Columbia University Earth Institute Travel Grant for field work, and The Lerner Gray Memorial Fund of the American Museum of Natural History funded laboratory work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 2001, AQUARIUM SCI CONSERV, V3, P25, DOI DOI 10.1023/A:1011389603693; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boehm JT, 2013, J BIOGEOGR, V40, P1839, DOI 10.1111/jbi.12127; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Carney RS, 2012, GULF MEXICO LOOP CUR; Chang CH, 2013, MITOCHONDR DNA, V24, P199, DOI 10.3109/19401736.2012.744983; Choo CK, 2006, J FISH BIOL, V69, P426, DOI 10.1111/j.1095-8649.2006.01105.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dias TL, 2002, ENVIRON BIOL FISH, V65, P326, DOI 10.1023/A:1020539222587; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Fu YX, 1997, GENETICS, V147, P915; Goswami M, 2009, HYDROBIOLOGIA, V621, P213, DOI 10.1007/s10750-008-9642-3; Hartl :D. L, 2000, PRIMER POPULATION GE; HUH OK, 1981, J GEOPHYS RES-OCEANS, V86, P4186, DOI 10.1029/JC086iC05p04186; IVERSON RL, 1986, ESTUAR COAST SHELF S, V22, P577, DOI 10.1016/0272-7714(86)90015-6; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; KIMURA M, 1964, GENETICS, V49, P561; LEE TN, 1992, CONT SHELF RES, V12, P971, DOI 10.1016/0278-4343(92)90055-O; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOURIE S, 2003, PROJECT SEAHORSE TEC, V3, P1; Lourie S.A., 2004, GUIDE IDENTIFICATION; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Masonjones HD, 2000, ANIM BEHAV, V59, P11, DOI 10.1006/anbe.1999.1269; Masonjones HD, 2010, CURR ZOOL, V56, P118, DOI 10.1093/czoolo/56.1.118; Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7; Meyer DL, 1999, FISH B-NOAA, V97, P193; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Murugan A, 2009, AQUACULTURE, V290, P87, DOI 10.1016/j.aquaculture.2009.01.033; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi SR, 2003, ECOL APPL, V13, pS146; Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499; Powell AB, 2002, NMFSSEFSC488 NOAA; Project Seahorse, 2003, HIPP ZOST IUCN RED L; Rose E, 2014, J HERED, V105, P828, DOI 10.1093/jhered/esu050; Sefc KM, 2007, EVOL ECOL RES, V9, P21; STRAWN K, 1954, COPEIA, P195; STRAWN KIRK, 1958, COPEIA, V1958, P16, DOI 10.2307/1439534; STURGES W, 1983, J MAR RES, V41, P639, DOI 10.1357/002224083788520487; TAJIMA F, 1989, GENETICS, V123, P585; Teske PR, 2005, MAR ECOL PROG SER, V286, P249, DOI 10.3354/meps286249; Tollis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038474; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woodall L., 2009, THESIS U LONDON; Woodall LC, 2011, J FISH BIOL, V78, P1738, DOI 10.1111/j.1095-8649.2011.02974.x; Woodall LC, 2009, J FISH BIOL, V75, P1505, DOI 10.1111/j.1095-8649.2009.02371.x	51	14	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132308	10.1371/journal.pone.0132308	http://dx.doi.org/10.1371/journal.pone.0132308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200110	Green Published, gold			2022-12-27	WOS:000358597100033
J	Hopcraft, JGC; Bigurube, G; Lembeli, JD; Borner, M				Hopcraft, J. Grant C.; Bigurube, Gerald; Lembeli, James Daudi; Borner, Markus			Balancing Conservation with National Development: A Socio-Economic Case Study of the Alternatives to the Serengeti Road	PLOS ONE			English	Article							RURAL AFRICA; TANZANIA; WILDLIFE; HIGHWAY; WILL; PARK	Developing countries often have rich natural resources but poor infrastructure to capitalize on them, which leads to significant challenges in terms of balancing poverty alleviation with conservation. The underlying premise in development strategies is to increase the socioeconomic welfare of the people while simultaneously ensuring environmental sustainability, however these objectives are often in direct conflict. National progress is dependent on developing infrastructure such as effective transportation networks, however roads can be ecologically catastrophic in terms of disrupting habitat connectivity and facilitating illegal activity. How can national development and conservation be balanced? The proposed Serengeti road epitomizes the conflict between poverty alleviation on one hand, and the conservation of a critical ecosystem on the other. We use the Serengeti as an exemplar case-study in which the relative economic and social benefits of a road can be assessed against the ecological impacts. Specifically, we compare three possible transportation routes and ask which route maximizes the socio-economic returns for the people while minimizing the ecological costs. The findings suggest that one route in particular that circumnavigates the Serengeti links the greatest number of small and medium sized entrepreneurial businesses to the largest labour force in the region. Furthermore, this route connects the most children to schools, provisions the greatest access to hospitals, and opens the most fertile crop and livestock production areas, and does not compromise the ecology and tourism revenue of the Serengeti. This route would improve Tanzania's food security and self-reliance and would facilitate future infrastructure development which would not be possible if the road were to pass through the Serengeti. This case study provides a compelling example of how a detailed spatial analysis can balance the national objectives of poverty alleviation while maintaining ecological integrity.	[Hopcraft, J. Grant C.; Borner, Markus] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Bigurube, Gerald; Borner, Markus] Frankfurt Zool Soc, Arusha, Tanzania; [Lembeli, James Daudi] Parliamentary Comm Land Nat Resources & Environm, Kahama, Tanzania	University of Glasgow	Hopcraft, JGC (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland.	Grant.Hopcraft@glasgow.ac.uk			Lord Kelvin Adam Smith Fellowship; European Union Horizon grant [641918]	Lord Kelvin Adam Smith Fellowship; European Union Horizon grant	JGCH is supported by a Lord Kelvin Adam Smith Fellowship and through European Union Horizon 2020 grant number 641918 AfricanBioServices. The Frankfurt Zoological Society provided logistical and field support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa Infrastructure Country Diagnostic, 2010, AFR INFR COUNTR DIAG; Alexander SM, 2000, TRANSPORT RES C-EMER, V8, P307, DOI 10.1016/S0968-090X(00)00014-0; Anderson TM, 2007, J BIOGEOGR, V34, P313, DOI 10.1111/j.1365-2699.2006.01598.x; [Anonymous], 2011, GLOB LIV DENS; [Anonymous], 1995, ON LIN LANDC MAPP SA; Arvis J. F., 2010, CONNECTING COMPETE 2; Barrett CB, 2001, FOOD POLICY, V26, P315, DOI 10.1016/S0306-9192(01)00014-8; Borner L, 2013, IMPACT TOURISM SEREN; Caro T, 2014, CURR BIOL, V24, pR722, DOI 10.1016/j.cub.2014.07.007; Christ N, 2011, WORLD DEV, V39, P1749, DOI 10.1016/j.worlddev.2011.04.028; Conservation Development Company Ltd, 1998, LOL WILDL MAN PROJ; Damania R, 2014, ECOSYSTEMS BURDEN BO; Dobson A, 2010, NATURE, V467, P272, DOI 10.1038/467272a; Fratkin E, 2003, HUM ORGAN, V62, P112, DOI 10.17730/humo.62.2.am1qpp36eqgxh3h1; Fryxell J. M., 2008, SERENGETI; Gereta E, 2004, IMPORTANCE WATER QUA; Government of Alberta, 2010, APPL PROC PLAC UND O; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; Holdo RM, 2009, ECOL APPL, V19, P95, DOI 10.1890/07-1954.1; Hoogeveen J, 2009, POVERTY REDUCTION TA; Hopcraft JGC, SERENGETI IN PRESS, P125; Hopcraft JGC, 2011, CONNECTING NO TANZAN; International Soil Reference and Information Centre, 2003, CART SOIL TERR DAT S; Ismail FA, 2010, CONSULTANCY SERVICE; Jin SQ, 2009, J AFR ECON, V18, P319, DOI 10.1093/jae/ejn016; Lanjouw JO, 2001, AGR ECON-BLACKWELL, V26, P1, DOI 10.1111/j.1574-0862.2001.tb00051.x; LIEDHOLM C, 1994, AM J AGR ECON, V76, P1177, DOI 10.2307/1243413; Mold A, 2012, J INT DEV, V24, P237, DOI 10.1002/jid.2818; Newmark WD, 1996, AFR J ECOL, V34, P15, DOI 10.1111/j.1365-2028.1996.tb00590.x; NORTONGRIFFITHS M, 1995, SERENGETI, V2, P588; O'Flaherty C.A., 2002, HIGHWAYS LOCATION DE; Olff H., 2008, SERENGETI, P95; Pena J., 2010, ASSESSING IMPACT INF; Perkin S, 1995, SERENGETI, P571; Robbins G, 2012, J INT DEV, V24, P220, DOI 10.1002/jid.2817; Roughton International Dataconsult Ltd, 2001, FEAS ENV STUD MAK LA; Sinclair ARE, 2002, P ROY SOC B-BIOL SCI, V269, P2401, DOI 10.1098/rspb.2002.2116; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; SWECO International AB and the Nordic Consult Group AB, 2003, REV IMPL STAT T AFR, V2; SWECO International AB and the Nordic Consult Group AB, 2003, REV IMPL STAT T AFR, V1; Tanzania National Resource Forum, 2011, SER HIGHW CONTR LAYM, P14; Thompson M, 2002, HUM ECOL, V30, P107, DOI 10.1023/A:1014519113923; Ulubasoglu MA, 2007, EUR ECON REV, V51, P1828, DOI 10.1016/j.euroecorev.2006.11.003; United Republic of Tanzania, 2009, MILL DEV GOALS REP M; United Republic of Tanzania, 2009, GUID PREP MED TERM P; United Republic of Tanzania, 2003, NAT HLTH POL; United Republic of Tanzania, 2010, MKUKUTA; United Republic of Tanzania, 2009, KIL KWANZ RES 10 PIL; World Bank, 2022, WORLD DEV IND; World Bank, 2011, TANZ COUNTR ASS STRA	50	9	9	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0130577	10.1371/journal.pone.0130577	http://dx.doi.org/10.1371/journal.pone.0130577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200107	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000358597100009
J	Legendre, F; Nel, A; Svenson, GJ; Robillard, T; Pellens, R; Grandcolas, P				Legendre, Frederic; Nel, Andre; Svenson, Gavin J.; Robillard, Tony; Pellens, Roseli; Grandcolas, Philippe			Phylogeny of Dictyoptera: Dating the Origin of Cockroaches, Praying Mantises and Termites with Molecular Data and Controlled Fossil Evidence	PLOS ONE			English	Article							ORTHOPTEROID INSECTS POLYNEOPTERA; DIVERGENCE TIMES; CLARENS FORMATION; ABSOLUTE RATES; ISOPTERA NESTS; TULI BASIN; CLADE AGES; EVOLUTION; MITOCHONDRIAL; MANTODEA	Understanding the origin and diversification of organisms requires a good phylogenetic estimate of their age and diversification rates. This estimate can be difficult to obtain when samples are limited and fossil records are disputed, as in Dictyoptera. To choose among competing hypotheses of origin for dictyopteran suborders, we root a phylogenetic analysis (similar to 800 taxa, 10 kbp) within a large selection of outgroups and calibrate datings with fossils attributed to lineages with clear synapomorphies. We find the following topology: (mantises, (other cockroaches, (Cryptocercidae, termites)). Our datings suggest that crown-Dictyoptera-and stem-mantises-would date back to the Late Carboniferous (similar to 300 Mya), a result compatible with the oldest putative fossil of stem-dictyoptera. Crown-mantises, however, would be much more recent (similar to 200 Mya; Triassic/Jurassic boundary). This pattern (i.e., old origin and more recent diversification) suggests a scenario of replacement in carnivory among polyneopterous insects. The most recent common ancestor of (cockroaches + termites) would date back to the Permian (similar to 275 Mya), which contradicts the hypothesis of a Devonian origin of cockroaches. Stem-termites would date back to the Triassic/Jurassic boundary, which refutes a Triassic origin. We suggest directions in extant and extinct species sampling to sharpen this chronological framework and dictyopteran evolutionary studies.	[Legendre, Frederic; Nel, Andre; Robillard, Tony; Pellens, Roseli; Grandcolas, Philippe] Univ Paris 06, Sorbonne Univ, ISYEB UMR MNHN 7205,CNRS, Dept Systemat & Evolut,Inst Systemat,Evolut,Biodi, Paris, France; [Svenson, Gavin J.] Cleveland Museum Nat Hist, Dept Invertebrate Zool, Cleveland, OH USA	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Cleveland Museum of Natural History	Legendre, F (corresponding author), Univ Paris 06, Sorbonne Univ, ISYEB UMR MNHN 7205,CNRS, Dept Systemat & Evolut,Inst Systemat,Evolut,Biodi, Paris, France.	legendre@mnhn.fr	Legendre, Frederic/B-5101-2013; Robillard, Tony/H-3523-2011	Legendre, Frederic/0000-0001-5900-8048; Robillard, Tony/0000-0002-2177-9549; Grandcolas, Philippe/0000-0003-1374-1222	Agence Nationale de la Recherche; US National Science Foundation [DEB-1216309]; Museum national d'Histoire naturelle; Direct For Biological Sciences [1216309] Funding Source: National Science Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); US National Science Foundation(National Science Foundation (NSF)); Museum national d'Histoire naturelle; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by Agence Nationale de la Recherche under the grant BIONEOCAL to PG (www.agence-nationale-recherche.fr) and by the US National Science Foundation under the grant DEB-1216309 to GJS (www.nsf.gov/funding). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Molecular analyses were partially funded by Museum national d'Histoire naturelle (www.mnhn.fr) under the grant "ATM - Taxonomie moleculaire: DNA barcode et gestion durable des collections" to FL. Some specimens were collected through fieldworks supported by Museum national d'Histoire naturelle under the grant "ATM - Biodiversite actuelle et fossile. Crises, stress, restaurations et panchronisme: le message systematique" to FL.	Agudelo AA, 2014, ZOOTAXA, V3797, P194, DOI 10.11646/zootaxa.3797.1.14; Akaike H, 1973, 2 INT S INF THEOR, P276; Aristov DS, 2013, PALEONTOL J+, V47, P641, DOI 10.1134/S0031030113070010; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bethoux O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-248; Bethoux O, 2010, J PALEONTOL, V84, P746, DOI 10.1666/09-121.1; Bethoux O, 2009, ZOOL J LINN SOC-LOND, V156, P79, DOI 10.1111/j.1096-3642.2008.00485.x; Bordy EM, 2009, S AFR J SCI, V105, P356; Bordy EM, 2004, PALAIOS, V19, P68, DOI 10.1669/0883-1351(2004)019<0068:AEJTII>2.0.CO;2; Bourguignon T, 2015, MOL BIOL EVOL, V32, P406, DOI 10.1093/molbev/msu308; Bumby A.J., 2006, P5; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Cornwell PB, 1968, THE COCKROACH, V1; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Davis RB, 2009, J EVOLUTION BIOL, V22, P1750, DOI 10.1111/j.1420-9101.2009.01789.x; De Man E, 2010, EPISODES, V33, P3; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Djernaes M, 2015, MOL PHYLOGENET EVOL; Djernaes M, 2012, SYST ENTOMOL, V37, P65, DOI 10.1111/j.1365-3113.2011.00598.x; Donoghue MJ, 2003, INTEGR COMP BIOL, V43, P261, DOI 10.1093/icb/43.2.261; Dornburg A, 2011, SYST BIOL, V60, P519, DOI 10.1093/sysbio/syr019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel MS, 2008, J KANSAS ENTOMOL SOC, V81, P194, DOI 10.2317/JKES-0802.01.1; Engel MS, 2011, ZOOKEYS, P105, DOI 10.3897/zookeys.148.1797; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3592[1:NDFEAI]2.0.CO;2; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; Escudero M, 2013, AM J BOT, V100, P2403, DOI 10.3732/ajb.1300162; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gade G, 1997, P ROY SOC B-BIOL SCI, V264, P763, DOI 10.1098/rspb.1997.0108; Garwood R, 2010, BIOL LETTERS, V6, P699, DOI 10.1098/rsbl.2010.0199; Genise JF, 2005, PALAIOS, V20, P303, DOI 10.2110/palo.2004.p05-C01; Gorochov AV, 2006, PALEONTOL J+, V40, P646, DOI 10.1134/S0031030106060074; Gorochov A. V., 2012, ZOOSYSTEMATICA ROSSICA, V22, P6; Gorokhov AV, 2007, PALEONTOL J+, V41, P156, DOI 10.1134/S0031030107020062; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; Grandcolas P, 1996, CAN J ZOOL, V74, P508, DOI 10.1139/z96-059; GRANDCOLAS P, 1994, SYST ENTOMOL, V19, P145; Grandcolas P, 2004, CLADISTICS, V20, P579, DOI 10.1111/j.1096-0031.2004.00037.x; Grandcolas P, 1996, CLADISTICS, V12, P93, DOI 10.1111/j.1096-0031.1996.tb00195.x; Grandcolas Philippe, 1997, Memoires du Museum National d'Histoire Naturelle, V171, P91; Grimaldi D, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)412<0001:AROCMA>2.0.CO;2; Grimaldi David, 2005, pi; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/616.1; Guan Z, 2015, ACTA PALAEONTOL POL; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasiotis Stephen T., 1995, Ichnos, V4, P119; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Hedman MM, 2010, PALEOBIOLOGY, V36, P16, DOI 10.1666/0094-8373-36.1.16; Hennig W., 1981, INSECT PHYLOGENY; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Howard KJ, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P97, DOI 10.1007/978-90-481-3977-4_5; Huang CJ, 2010, GEOLOGY, V38, P899, DOI 10.1130/G31177.1; Huang DY, 2008, NATURWISSENSCHAFTEN, V95, P947, DOI 10.1007/s00114-008-0412-x; Imms AD, 1937, RECENT ADVANCES IN E; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; IturraldeVinent MA, 1996, SCIENCE, V273, P1850, DOI 10.1126/science.273.5283.1850; Jovane L, 2010, EARTH PLANET SC LETT, V298, P77, DOI 10.1016/j.epsl.2010.07.027; Kambhampati S, 1996, SYST ENTOMOL, V21, P89; KAMBHAMPATI S, 1995, P NATL ACAD SCI USA, V92, P2017, DOI 10.1073/pnas.92.6.2017; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Klass K-D, 1995, THESIS; Klass Klaus-Dieter, 1997, Bonner Zoologische Monographien, V42, P1; Klass Klaus-Dieter, 2006, Entomologische Abhandlungen (Dresden), V63, P3; Knittel U, 2013, NEUES JAHRB GEOL P-A, V270, P1, DOI 10.1127/0077-7749/2013/0353; Krishna Kumar, 2013, Bulletin of the American Museum of Natural History, V377, P1; Krishna Kumar, 1996, American Museum Novitates, V3176, P1; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; Kukalova-Peck J, 2012, EUR J ENTOMOL, V109, P633, DOI 10.14411/eje.2012.075; Kupczok A, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-37; LAURENTIAUX D, 1960, CR HEBD ACAD SCI, V250, P1700; Laurentiaux D, 1951, ANN PALEONTOL, V37, P186; Laurentiaux D, 1966, ANN SOC GEOL NORD, V86, P231; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Legendre F, 2014, BIOL J LINN SOC, V111, P58, DOI 10.1111/bij.12199; Legendre F, 2013, EVOL DEV, V15, P146, DOI 10.1111/ede.12023; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; LEWIS SE, 1973, ANN ENTOMOL SOC AM, V66, P1359, DOI 10.1093/aesa/66.6.1359; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032152; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Liu YX, 2006, ACTA GEOL SIN-ENGL, V80, P733; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Lo N, 2007, BIOL LETTERS, V3, P327, DOI 10.1098/rsbl.2006.0614; Loader C., 1999, LOCAL REGRESSION LIK; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; [卢立伍 Lu Liwu], 2002, [地球学报, Acta Geoscientia Sinica], V23, P165; Maekawa K, 2000, SYST ENTOMOL, V25, P511, DOI 10.1046/j.1365-3113.2000.00128.x; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; Martinez-Delclos X., 1993, Boletin Geologico y Minero (Madrid), V104, P516; MARTINEZDELCLOS X, 1995, J PALEONTOL, V69, P594, DOI 10.1017/S0022336000034983; McKittrick F. A., 1964, Memoirs Cornell Agric Expt Sta Ithaca, Vno. 389, P1; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Murienne J, 2009, ORG DIVERS EVOL, V9, P44, DOI 10.1016/j.ode.2008.10.005; Nel A, 1996, EUR J ENTOMOL, V93, P223; Nel A., 1993, CAHIERS PALEONTOLOGI, P102; Nylander JAA, 2004, PROGRAM DISTRIBUTED; Palfy J, 2000, CAN J EARTH SCI, V37, P923, DOI 10.1139/cjes-37-6-923; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pellens R, 2007, MOL PHYLOGENET EVOL, V43, P616, DOI 10.1016/j.ympev.2006.12.017; Pointon MA, 2012, J GEOL SOC LONDON, V169, P713, DOI 10.1144/jgs2011-092; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prokop J, 2014, J SYST PALAEONTOL, V12, P601, DOI 10.1080/14772019.2013.823468; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Pyron RA, 2014, ECOL LETT, V17, P13, DOI 10.1111/ele.12168; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; RAU PHIL, 1941, ENT NEWS, V52, P256; Raymond A, 2001, EVOLUTIONARY PALEOECOLOGY, P235; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; ROTH LM, 1970, ANNU REV ENTOMOL, V15, P75, DOI 10.1146/annurev.en.15.010170.000451; ROTH LM, 1989, P ENTOMOL SOC WASH, V91, P441; Roth LM, 2003, ORIENT INSECTS, V37, P1, DOI 10.1080/00305316.2003.10417344; Roth S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-50; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sanderson MJ, 2002, R8S VERSION 1 50 USE; Sharaf E, 2005, STRATIGRAPHY, V2, P239; Siddall ME, 1999, CLADISTICS, V15, P9, DOI 10.1111/j.1096-0031.1999.tb00391.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan J, 1999, MOL BIOL EVOL, V16, P1347, DOI 10.1093/oxfordjournals.molbev.a026045; Svenson GJ, 2009, CLADISTICS, V25, P468, DOI 10.1111/j.1096-0031.2009.00263.x; Svenson GJ, 2004, SYST ENTOMOL, V29, P359, DOI 10.1111/j.0307-6970.2004.00240.x; Symmank L, 2011, J BIOGEOGR, V38, P2337, DOI 10.1111/j.1365-2699.2011.02586.x; Tanner Lawrence H., 2006, Ichnos, V13, P21, DOI 10.1080/10420940500511520; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Tillyard R. J., 1936, Nature London, V137, P655, DOI 10.1038/137655a0; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; von Haeseler A, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-13; Von Rosen K, 1913, T 2 INT C ENTOMOLOGY, V2, P318; Vrsansky P, 2002, HIST INSECTS, P263; Vrsansky Peter, 2002, AMBA Projekty, V6, P1; Vrsansky P, 2014, EUR J ENTOMOL, V111, P137, DOI 10.14411/eje.2014.014; Vrsansky P, 2013, ZOOTAXA, V3635, P117, DOI 10.11646/zootaxa.3635.2.2; Vrsansky Peter, 1997, Entomological Problems, V28, P67; Vrsansky P, 2010, ACTA GEOL SIN-ENGL, V84, P793, DOI 10.1111/j.1755-6724.2010.00261.x; WANG Y, 2013, PLOS ONE, V2013; Wappler T, 2009, P ROY SOC B-BIOL SCI, V276, P4271, DOI 10.1098/rspb.2009.1255; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; Ware JL, 2010, ARTHROPOD STRUCT DEV, V39, P204, DOI 10.1016/j.asd.2009.11.003; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Wieland F., 2013, SPECIES PHYLOGENY EV, V3, P3, DOI [10.17875/gup2013-711, DOI 10.17875/GUP2013-711]; Yager DD, 2008, BIOL J LINN SOC, V94, P541, DOI 10.1111/j.1095-8312.2008.00996.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhang ZJ, 2013, J SYST PALAEONTOL, V11, P27, DOI 10.1080/14772019.2011.634443	156	133	136	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0130127	10.1371/journal.pone.0130127	http://dx.doi.org/10.1371/journal.pone.0130127			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200914	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100006
J	Zech, J; Godfrey, EL; Masai, H; Hartsuiker, E; Dalgaard, JZ				Zech, Juergen; Godfrey, Emma Louise; Masai, Hisao; Hartsuiker, Edgar; Dalgaard, Jacob Zeuthen			The DNA-Binding Domain of S-pombe Mrc1 (Claspin) Acts to Enhance Stalling at Replication Barriers	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; FISSION YEAST HOMOLOGS; CHECKPOINT KINASE CDS1; RIBOSOMAL-RNA GENES; SCHIZOSACCHAROMYCES-POMBE; FORK ARREST; SACCHAROMYCES-CEREVISIAE; IN-VIVO; EUKARYOTIC DNA; CGG REPEATS	During S-phase replication forks can stall at specific genetic loci. At some loci, the stalling events depend on the replisome components Schizosaccharomyces pombe Swi1 (Saccharomyces cerevisiae Tof1) and Swi3 (S. cerevisiae Csm3) as well as factors that bind DNA in a site-specific manner. Using a new genetic screen we identified Mrc1 (S. cerevisiae Mrc1/metazoan Claspin) as a replisome component involved in replication stalling. Mrc1 is known to form a sub-complex with Swi1 and Swi3 within the replisome and is required for the intra-S phase checkpoint activation. This discovery is surprising as several studies show that S. cerevisiae Mrc1 is not required for replication barrier activity. In contrast, we show that deletion of S. pombe mrc1 leads to an approximately three-fold reduction in barrier activity at several barriers and that Mrc1's role in replication fork stalling is independent of its role in checkpoint activation. Instead, S. pombe Mrc1 mediated fork stalling requires the presence of a functional copy of its phylogenetically conserved DNA binding domain. Interestingly, this domain is on the sequence level absent from S. cerevisiae Mrc1. Our study indicates that direct interactions between the eukaryotic replisome and the DNA are important for site-specific replication stalling.	[Zech, Juergen; Godfrey, Emma Louise; Dalgaard, Jacob Zeuthen] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo 1568613, Japan; [Hartsuiker, Edgar] Bangor Univ, Sch Biol Sci, Bangor LI57 2UW, Gwynedd, Wales	University of Warwick; Tokyo Metropolitan Institute of Medical Science; Bangor University	Zech, J (corresponding author), Univ St Andrews, Sch Biol, St Andrews KY16 9TF, Fife, Scotland.	jz42@st-andrews.ac.uk; j.z.dalgaard@warwick.ac.uk		Dalgaard, Jacob/0000-0001-9545-7254; Hartsuiker, Edgar/0000-0002-7257-6389	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council; Cancer Research UK; Cancer Research UK [11809] Funding Source: researchfish	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	Marie Curie Cancer Care (J.Z. and J.Z.D.), Biotechnology and Biological Sciences Research Council (J.Z.D.) and Cancer Research UK (E.H.) supported this work.	Ahn JS, 2005, EMBO J, V24, P2011, DOI 10.1038/sj.emboj.7600670; Akamatsu Y, 2015, MOL CELL BIOL; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Codlin S, 2003, EMBO J, V22, P3431, DOI 10.1093/emboj/cdg330; Dalgaard JZ, 2011, DNA REPLICATION - CURRENT ADVANCES, P269; Dalgaard JZ, 2012, TRENDS GENET, V28, P592, DOI 10.1016/j.tig.2012.07.008; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dalgaard JZ, 2001, GENE DEV, V15, P2060, DOI 10.1101/gad.200801; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; EGEL R, 1984, P NATL ACAD SCI-BIOL, V81, P3481, DOI 10.1073/pnas.81.11.3481; Eydmann T, 2008, GENETICS, V180, P27, DOI 10.1534/genetics.108.089243; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Gordon M, 2007, MOL CELL BIOL, V27, P4058, DOI 10.1128/MCB.02044-06; Gruber M, 2000, MOL CELL BIOL, V20, P5777, DOI 10.1128/MCB.20.15.5777-5787.2000; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Holmes A, 2012, CELL REP, V2, P1513, DOI 10.1016/j.celrep.2012.10.011; Inagawa T, 2009, P NATL ACAD SCI USA, V106, P7927, DOI 10.1073/pnas.0812323106; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KIGER JA, 1969, J MOL BIOL, V40, P467, DOI 10.1016/0022-2836(69)90166-1; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; Krasilnikova Maria M., 2004, V277, P19; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Krings G, 2005, J BIOL CHEM, V280, P39135, DOI 10.1074/jbc.M508996200; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Kumar S, 2004, J BIOL CHEM, V279, P43574, DOI 10.1074/jbc.M407819200; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Liu GQ, 2012, J BIOL CHEM, V287, P33412, DOI 10.1074/jbc.M112.402503; MacLeod RAF, 2000, LEUKEMIA, V14, P1803, DOI 10.1038/sj.leu.2401894; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Matsumoto S, 2010, CELL CYCLE, V9, P4627, DOI 10.4161/cc.9.23.13937; Mejia-Ramirez E, 2005, MOL CELL BIOL, V25, P8755, DOI 10.1128/MCB.25.19.8755-8761.2005; Mohanty BK, 2009, EUKARYOT CELL, V8, P487, DOI 10.1128/EC.00382-08; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Naylor ML, 2009, P NATL ACAD SCI USA, V106, P12765, DOI 10.1073/pnas.0904623106; Nicolas E, 2006, J BIOL CHEM, V281, P35983, DOI 10.1074/jbc.M606349200; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Opel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000386; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pryce DW, 2009, P NATL ACAD SCI USA, V106, P4770, DOI 10.1073/pnas.0807739106; Rao BS, 1996, MOL CELL BIOCHEM, V156, P163; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Sanchez JA, 1998, EXP CELL RES, V238, P220, DOI 10.1006/excr.1997.3835; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Sayrac S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001328; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2010, BIOSCI BIOTECH BIOCH, V74, P2367, DOI 10.1271/bbb.100583; Tanaka T, 2010, J BIOL CHEM, V285, P39609, DOI 10.1074/jbc.M110.173344; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Vengrova S, 2004, GENE DEV, V18, P794, DOI 10.1101/gad.289404; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; WEAVER DT, 1984, J MOL BIOL, V180, P961, DOI 10.1016/0022-2836(84)90266-3; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876; Yasuhira S, 2009, MOL GENET GENOMICS, V281, P497, DOI 10.1007/s00438-009-0426-x; Yue M, 2011, J BIOL CHEM, V286, P22864, DOI 10.1074/jbc.M111.236687; Zaratiegui M, 2011, NATURE, V469, P112, DOI 10.1038/nature09608; Zhao H, 2004, J BIOL CHEM, V279, P53023, DOI 10.1074/jbc.M410449200; Zhu M, 2014, NUCLEIC ACIDS RES, V42, P13074, DOI 10.1093/nar/gku978	85	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132595	10.1371/journal.pone.0132595	http://dx.doi.org/10.1371/journal.pone.0132595			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201080	Green Published, gold			2022-12-27	WOS:000358597100040
J	Andreotti, G; Hoppin, JA; Hou, LF; Koutros, S; Gadalla, SM; Savage, SA; Lubin, J; Blair, A; Hoxha, M; Baccarelli, A; Sandler, D; Alavanja, M; Freeman, LEB				Andreotti, Gabriella; Hoppin, Jane A.; Hou, Lifang; Koutros, Stella; Gadalla, Shahinaz M.; Savage, Sharon A.; Lubin, Jay; Blair, Aaron; Hoxha, Mirjam; Baccarelli, Andrea; Sandler, Dale; Alavanja, Michael; Freeman, Laura E. Beane			Pesticide Use and Relative Leukocyte Telomere Length in the Agricultural Health Study	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; OXIDATIVE STRESS; INSECTICIDE USE; APPLICATORS; LYMPHOCYTES; WORKERS; CANCER	Some studies suggest that telomere length (TL) may be influenced by environmental exposures, including pesticides. We examined associations between occupational pesticide use reported at three time points and relative telomere length (RTL) in the Agricultural Health Study (AHS), a prospective cohort study of pesticide applicators in Iowa and North Carolina. RTL was measured by qPCR using leukocyte DNA from 568 cancer-free male AHS participants aged 31-94 years with blood samples collected between 2006 and 2008. Self-reported information, including pesticide use, was collected at three time points: enrollment (1993-1997) and two follow-up questionnaires (1998-2003, 2005-2008). For each pesticide, we evaluated cumulative use (using data from all three questionnaires), and more recent use (using data from the last follow-up questionnaire). Multivariable linear regression was used to examine the associations between pesticide use (ever, lifetime days, intensity-weighted lifetime days (lifetime days*intensity score)) and RTL, adjusting for age at blood draw and use of other pesticides. Of the 57 pesticides evaluated with cumulative use, increasing lifetime days of 2,4-D (p-trend=0.001), diazinon (p-trend=0.002), and butylate (p-trend=0.01) were significantly associated with shorter RTL, while increasing lifetime days of alachlor was significantly associated with longer RTL (p-trend=0.03). Only the association with 2,4-D was significant after adjustment for multiple comparisons. Of the 40 pesticides evaluated for recent use, malathion was associated with shorter RTL (p=0.03), and alachlor with longer RTL (p=0.03). Our findings suggest that leukocyte TL may be impacted by cumulative use and recent use of certain pesticides.	[Andreotti, Gabriella; Koutros, Stella; Gadalla, Shahinaz M.; Savage, Sharon A.; Lubin, Jay; Blair, Aaron; Alavanja, Michael; Freeman, Laura E. Beane] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hoppin, Jane A.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Hoxha, Mirjam] Univ Milan, Dept Clin Sci & Community Hlth, Ctr Mol & Genet Epidemiol, Milan, Italy; [Baccarelli, Andrea] Harvard Univ, Sch Publ Hlth, Exposure Epidemiol & Risk Program, Lab Environm Epigenet,Dept Environm Hlth, Boston, MA 02115 USA; [Sandler, Dale] NIEHS, Epidemiol Branch, NIH DHHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; North Carolina State University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Milan; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Andreotti, G (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	andreotg@mail.nih.gov	Savage, Sharon A/B-9747-2015; Savage, Sharon/AAB-5160-2019; Koutros, Stella/W-5788-2019; Gadalla, Shahinaz/U-2848-2019; Gadalla, Shahinaz M/C-4005-2015; Freeman, Laura E. Beane/C-4468-2015	Savage, Sharon A/0000-0001-6006-0740; Savage, Sharon/0000-0001-6006-0740; Koutros, Stella/0000-0001-5294-5485; Gadalla, Shahinaz M/0000-0002-3255-8143; Freeman, Laura E. Beane/0000-0003-1294-4124; Baccarelli, Andrea/0000-0002-3436-0640	Intramural Department of National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030, ZIAES049028] Funding Source: NIH RePORTER	Intramural Department of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Intramural Department of the National Institutes of Health.	Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Appendix B, 2004, INT HUMAN DOSING STU; Banerjee B D, 2001, Rev Environ Health, V16, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair A, 2002, EPIDEMIOLOGY, V13, P94, DOI 10.1097/00001648-200201000-00015; Boulay JL, 1999, BIOTECHNIQUES, V27, P228, DOI 10.2144/99272bm03; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Coble J, 2011, INT J ENV RES PUB HE, V8, P4608, DOI 10.3390/ijerph8124608; Coluzzi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110963; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Dioni L, 2011, ENVIRON HEALTH PERSP, V119, P622, DOI 10.1289/ehp.1002486; Figgs LW, 2000, CANCER CAUSE CONTROL, V11, P373, DOI 10.1023/A:1008925824242; Gadalla SM, 2010, AGING-US, V2, P867, DOI 10.18632/aging.100235; Holland NT, 2002, MUTAT RES-GEN TOX EN, V521, P165, DOI 10.1016/S1383-5718(02)00237-1; Hoppin JA, 2002, J EXPO ANAL ENV EPID, V12, P313, DOI 10.1038/sj.jea.7500232; Hoppin JA, 2012, J EXPO SCI ENV EPID, V22, P584, DOI 10.1038/jes.2012.79; Hou LF, 2013, ENVIRON HEALTH PERSP, V121, P919, DOI 10.1289/ehp.1206432; Hou LF, 2012, CANCER LETT, V319, P130, DOI 10.1016/j.canlet.2012.01.028; Lin JG, 2014, DNA REPAIR, V20, P142, DOI 10.1016/j.dnarep.2014.01.012; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Muniz JF, 2008, TOXICOL APPL PHARM, V227, P97, DOI 10.1016/j.taap.2007.10.027; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Rigolin GM, 2004, EUR J HAEMATOL, V73, P351, DOI 10.1111/j.1600-0609.2004.00305.x; Rollison DE, 2011, LEUKEMIA LYMPHOMA, V52, P1528, DOI 10.3109/10428194.2011.568648; Schinasi L, 2014, INT J ENV RES PUB HE, V11, P4449, DOI 10.3390/ijerph110404449; Schreinemachers DM, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-11; Shin JY, 2010, MUTAGENESIS, V25, P511, DOI 10.1093/mutage/geq035; Starks SE, 2012, NEUROTOXICOL TERATOL, V34, P168, DOI 10.1016/j.ntt.2011.08.014; US EPA, 2005, 738R05002 USEPA; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wong JYY, 2014, J TOXICOL ENV HEAL A, V77, P441, DOI 10.1080/15287394.2013.875497; Zhang X, 2013, OCCUP ENVIRON MED, V70, P743, DOI 10.1136/oemed-2012-101350	34	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133382	10.1371/journal.pone.0133382	http://dx.doi.org/10.1371/journal.pone.0133382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196902	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600090
J	Depraetere, O; Deschoenmaeker, F; Badri, H; Monsieurs, P; Foubert, I; Leys, N; Wattiez, R; Muylaert, K				Depraetere, Orily; Deschoenmaeker, Frederic; Badri, Hanene; Monsieurs, Pieter; Foubert, Imogen; Leys, Natalie; Wattiez, Ruddy; Muylaert, Koenraad			Trade-Off between Growth and Carbohydrate Accumulation in Nutrient-Limited Arthrospira sp PCC 8005 Studied by Integrating Transcriptomic and Proteomic Approaches	PLOS ONE			English	Article							POLY-BETA-HYDROXYBUTYRATE; NITROGEN STARVATION; GENE-EXPRESSION; GENOME SEQUENCE; LIGHT-INTENSITY; CYANOBACTERIUM; MICROALGAE; PLATENSIS; GLYCOGEN; POLYHYDROXYBUTYRATE	Cyanobacteria have a strong potential for biofuel production due to their ability to accumulate large amounts of carbohydrates. Nitrogen (N) stress can be used to increase the content of carbohydrates in the biomass, but it is expected to reduce biomass productivity. To study this trade-off between carbohydrate accumulation and biomass productivity, we characterized the biomass productivity, biomass composition as well as the transcriptome and proteome of the cyanobacterium Arthrospira sp. PCC 8005 cultured under N-limiting and N-replete conditions. N limitation resulted in a large increase in the carbohydrate content of the biomass (from 14 to 74%) and a decrease in the protein content (from 37 to 10%). Analyses of fatty acids indicated that no lipids were accumulated under N-limited conditions. Nevertheless, it did not affect the biomass productivity of the culture up to five days after N was depleted from the culture medium. Transcriptomic and proteomic analysis indicated that de novo protein synthesis was down-regulated in the N-limited culture. Proteins were degraded and partly converted into carbohydrates through gluconeogenesis. Cellular N derived from protein degradation was recycled through the TCA and GS-GOGAT cycles. In addition, photosynthetic energy production and carbon fixation were both down-regulated, while glycogen synthesis was up-regulated. Our results suggested that N limitation resulted in a redirection of photosynthetic energy from protein synthesis to glycogen synthesis. The fact that glycogen synthesis has a lower energy demand than protein synthesis might explain why Arthrospira is able to achieve a similar biomass productivity under N-limited as under N-replete conditions despite the fact that photosynthetic energy production was impaired by N limitation.	[Depraetere, Orily; Muylaert, Koenraad] KU Leuven Campus Kortrijk, Lab Aquat Biol, B-8500 Kortrijk, Belgium; [Deschoenmaeker, Frederic; Wattiez, Ruddy] Univ Mons, Res Inst Biosci, Dept Prote & Microbiol, B-7000 Mons, Belgium; [Badri, Hanene; Monsieurs, Pieter; Leys, Natalie] Belgian Nucl Res Ctr SCK CEN, Expert Grp Mol & Cellular Biol MCB, B-2400 Mol, Belgium; [Foubert, Imogen] KU Leuven Campus Kortrijk, Dept Mol & Microbial Syst Kulak, Res Unit Food & Lipids, B-8500 Kortrijk, Belgium	KU Leuven; University of Mons; Belgian Nuclear Research Centre (SCK-CEN); KU Leuven	Depraetere, O (corresponding author), KU Leuven Campus Kortrijk, Lab Aquat Biol, E Sabbelaan 53, B-8500 Kortrijk, Belgium.	Orily.Depraetere@kuleuven-kortrijk.be	Leys, Natalie M.E.J./P-2761-2017; Monsieurs, Pieter/A-2917-2009; Monsieurs, Pieter/W-3916-2019	Monsieurs, Pieter/0000-0003-2214-6652; Foubert, Imogen/0000-0001-8735-8926; wattiez, ruddy/0000-0003-2071-4310; Muylaert, Koenraad/0000-0001-9645-4063	innovation by science and technology (IWT) grant [111275]; fund for research training in industry and agriculture (FRIA) [2877824]; FWO project [1509513N]; KU Leuven OT project [14/065]	innovation by science and technology (IWT) grant(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); fund for research training in industry and agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); FWO project(FWO); KU Leuven OT project	The innovation by science and technology (IWT) grant 111275 was awarded to Depraetere O. and the fund for research training in industry and agriculture (FRIA) 2877824 was awarded to Deschoenmaeker F. Depraetere O. is an IWT PhD student and Deschoenmaeker is an FRIA PhD student. Additionally, financial support was provided by FWO project 1509513N and KU Leuven OT project 14/065. Deschoenmaeker F., Wattiez R., Monsieurs P., Badri H. and Leys N. are partners of MELiSSA project from European Space Agency. Thanks to the IRBB team (Institute for Research of Biomedicines in Barcelona) for the cDNA library preparation and amplification.	Aguirre von Wobeser E, 2011, PLANT PHYSIOL, V155, P1445, DOI 10.1104/pp.110.165837; Aikawa S, 2012, BIORESOURCE TECHNOL, V108, P211, DOI 10.1016/j.biortech.2012.01.004; Badri H, 2015, MICROBIOLOGYOPEN, V4, P187, DOI 10.1002/mbo3.229; BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Benemann J, 2013, ENERGIES, V6, P5869, DOI 10.3390/en6115869; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borowitzka MA, 2013, MITIG ADAPT STRAT GL, V18, P13, DOI 10.1007/s11027-010-9271-9; Branyikova I, 2011, BIOTECHNOL BIOENG, V108, P766, DOI 10.1002/bit.23016; Bryant DA, 2006, THE MOLECULAR BIOLOG; CAMPBELL J, 1982, J BACTERIOL, V149, P361, DOI 10.1128/JB.149.1.361-363.1982; Cheevadhanarak S, 2012, STAND GENOMIC SCI, V6, P43, DOI 10.4056/sigs.2525955; Cho S, 2013, BIORESOURCE TECHNOL, V131, P515, DOI 10.1016/j.biortech.2012.12.176; Cogne G, 2003, BIOTECHNOL BIOENG, V81, P588, DOI 10.1002/bit.10504; DEPHILIPPIS R, 1992, J GEN MICROBIOL, V138, P1623, DOI 10.1099/00221287-138-8-1623; Depraetere O, 2015, BIORESOURCE TECHNOL, V180, P16, DOI 10.1016/j.biortech.2014.12.084; Deschoenmaeker F, 2014, MICROBIOL-SGM, V160, P1224, DOI 10.1099/mic.0.074641-0; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eaton A.D., 2005, STANDARD METHODS FOR; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Fujisawa T, 2010, DNA RES, V17, P85, DOI 10.1093/dnares/dsq004; Gonzalez-Fernandez C, 2012, BIOTECHNOL ADV, V30, P1655, DOI 10.1016/j.biotechadv.2012.07.003; Gordillo FJL, 1998, J APPL PHYCOL, V10, P461, DOI 10.1023/A:1008090402847; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Hasunuma T, 2013, J EXP BOT, V64, P2943, DOI 10.1093/jxb/ert134; Huang SQ, 2013, MOL BIOSYST, V9, P2565, DOI 10.1039/c3mb70188c; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janssen PJ, 2010, J BACTERIOL, V192, P2465, DOI 10.1128/JB.00116-10; Kolodny NH, 2006, J BACTERIOL, V188, P934, DOI 10.1128/JB.188.3.934-940.2006; Krasikov V, 2012, PHYSIOL PLANTARUM, V145, P426, DOI 10.1111/j.1399-3054.2012.01585.x; Lam MK, 2012, BIOTECHNOL ADV, V30, P673, DOI 10.1016/j.biotechadv.2011.11.008; Lefort F, 2014, GENOME ANNOUNC, V2, P4, DOI [10.1128/genomeA.00751-14, DOI 10.1128/GENOMEA.00751-14.COPYRIGHT]; LEPAGE G, 1984, J LIPID RES, V25, P1391; Li X, 2010, BIORESOURCE TECHNOL, V101, P5494, DOI 10.1016/j.biortech.2010.02.016; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Luddecke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083181; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Markou G, 2012, WORLD J MICROB BIOT, V28, P2661, DOI 10.1007/s11274-012-1076-4; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matallana-Surget S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099076; Monshupanee T, 2014, J APPL MICROBIOL, V116, P830, DOI 10.1111/jam.12409; Nagase H, 2001, BIOCHEM ENG J, V7, P241, DOI 10.1016/S1369-703X(00)00122-4; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; PENNINGDEVRIES FW, 1974, J THEOR BIOL, V45, P339; Pienkos PT, 2009, BIOFUEL BIOPROD BIOR, V3, P431, DOI 10.1002/bbb.159; Poorter Hendrik, 1994, P111; Qualls RG, 1989, DETERMINATION OF TOT; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Reijnders MJMF, 2014, TRENDS BIOTECHNOL, V32, P617, DOI 10.1016/j.tibtech.2014.10.003; Sassano CEN, 2010, BIOMASS BIOENERG, V34, P1732, DOI 10.1016/j.biombioe.2010.07.002; Sauer J, 2001, PLANT PHYSIOL, V126, P233, DOI 10.1104/pp.126.1.233; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schlebusch M, 2010, APPL ENVIRON MICROB, V76, P6101, DOI 10.1128/AEM.00484-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian S, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-150; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083485; Wang HL, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-6; Wegener KM, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.000109; Yoshikawa N, 2008, J AOAC INT, V91, P524	65	35	36	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132461	10.1371/journal.pone.0132461	http://dx.doi.org/10.1371/journal.pone.0132461			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196510	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600038
J	Ferreira, RJ; Firmino, PRA; Cristino, CT				Ferreira, Ricardo Jose; Alves Firmino, Paulo Renato; Cristino, Claudio Tadeu			A Mixed Kijima Model Using the Weibull-Based Generalized Renewal Processes	PLOS ONE			English	Article							RELIABILITY; REPAIR; POLICY	Generalized Renewal Processes are useful for approaching the rejuvenation of dynamical systems resulting from planned or unplanned interventions. We present new perspectives for the Generalized Renewal Processes in general and for the Weibull-based Generalized Renewal Processes in particular. Disregarding from literature, we present a mixed Generalized Renewal Processes approach involving Kijima Type I and II models, allowing one to infer the impact of distinct interventions on the performance of the system under study. The first and second theoretical moments of this model are introduced as well as its maximum likelihood estimation and random sampling approaches. In order to illustrate the usefulness of the proposed Weibull-based Generalized Renewal Processes model, some real data sets involving improving, stable, and deteriorating systems are used.	[Ferreira, Ricardo Jose; Cristino, Claudio Tadeu] Univ Fed Rural Pernambuco, Dept Stat & Informat, Postgrad Program Biometry & Appl Stat, Recife, PE, Brazil; [Alves Firmino, Paulo Renato] Fed Univ Cariri, Juazeiro Do Norte, Ceara, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal do Cariri	Ferreira, RJ (corresponding author), Univ Fed Rural Pernambuco, Dept Stat & Informat, Postgrad Program Biometry & Appl Stat, Recife, PE, Brazil.	ricardo.jferreir@gmail.com	FIRMINO, PAULO RENATO ALVES/AAW-8904-2020; Cristino, Claudio Tadeu/AAP-3564-2020	FIRMINO, PAULO RENATO ALVES/0000-0002-3308-2650; 	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by CNPq with the following URL: www.cnpq.br. This foundation supported the Ph.D student Ricardo Jose Ferreira with a Ph.D scholarship during two years.	[Anonymous], 2000, MONTE CARLO APPROACH; Cristino CT, 2008, RISCO CONFIABILIDADE; Fragola JR, 1996, RELIAB ENG SYST SAFE, V51, P125, DOI 10.1016/0951-8320(95)00110-7; Guo HRR, 2007, IEEE T RELIAB, V56, P40, DOI 10.1109/TR.2006.890895; Jain M, 2006, ASIA PAC J OPER RES, V23, P215, DOI 10.1142/S0217595906000917; Jiang R, 2004, WEIBULL MODELS, V505; Jimenez P, 2006, TRANSM DISTR C EXP L, P1, DOI DOI 10.1109/TDCLA.2006.311621; KIJIMA M, 1986, J APPL PROBAB, V23, P71, DOI 10.2307/3214117; Langseth H, 2006, J STAT PLAN INFER, V136, P1687, DOI 10.1016/j.jspi.2004.10.032; Love CE, 2000, EUR J OPER RES, V125, P398, DOI 10.1016/S0377-2217(99)00009-0; MAKIS V, 1993, EUR J OPER RES, V69, P75, DOI 10.1016/0377-2217(93)90092-2; Modarres M., 1999, RELIABILITY ENG RISK; Moura MD, 2014, P I MECH ENG O-J RIS, V228, P590, DOI 10.1177/1748006X14540878; R Development Core Team, 2009, R LANG ENV STAT COMP; Ross Sheldon M., 2014, INTRO PROBABILITY MO; ROSS SM, 1997, SIMULATION STAT MODE; Scarsini M, 2000, EUR J OPER RES, V122, P625, DOI 10.1016/S0377-2217(99)00078-8; Tanwar M, 2014, RELIAB ENG SYST SAFE, V124, P24, DOI 10.1016/j.ress.2013.10.007; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Yanez M, 2002, RELIAB ENG SYST SAFE, V77, P167, DOI 10.1016/S0951-8320(02)00044-3; Yuan FQ, 2012, IEEE T RELIAB, V61, P95, DOI 10.1109/TR.2011.2182222	21	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133772	10.1371/journal.pone.0133772	http://dx.doi.org/10.1371/journal.pone.0133772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197222	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600142
J	Lemarie, F; Beauchamp, E; Dayot, S; Duby, C; Legrand, P; Rioux, V				Lemarie, Fanny; Beauchamp, Erwan; Dayot, Stephanie; Duby, Cecile; Legrand, Philippe; Rioux, Vincent			Dietary Caprylic Acid (C8:0) Does Not Increase Plasma Acylated Ghrelin but Decreases Plasma Unacylated Ghrelin in the Rat	PLOS ONE			English	Article							MEDIUM-CHAIN TRIGLYCERIDES; O-ACYLTRANSFERASE GOAT; FATTY-ACIDS; GASTRIC ABSORPTION; ADIPOSE-TISSUE; WEIGHT CONTROL; MYRISTIC ACID; BODY-WEIGHT; FOOD-INTAKE; IN-VIVO	Focusing on the caprylic acid (C8:0), this study aimed at investigating the discrepancy between the formerly described beneficial effects of dietary medium chain fatty acids on body weight loss and the C8:0 newly reported effect on food intake via ghrelin octanoylation. During 6 weeks, Sprague-Dawley male rats were fed with three dietary C8:0 levels (0, 8 and 21% of fatty acids) in three experimental conditions (moderate fat, caloric restriction and high fat). A specific dose-response enrichment of the stomach tissue C8:0 was observed as a function of dietary C8:0, supporting the hypothesis of an early preduodenal hydrolysis of medium chain triglycerides and a direct absorption at the gastric level. However, the octanoylated ghrelin concentration in the plasma was unchanged in spite of the increased C8:0 availability. A reproducible decrease in the plasma concentration of unacylated ghrelin was observed, which was consistent with a decrease in the stomach preproghrelin mRNA and stomach ghrelin expression. The concomitant decrease of the plasma unacylated ghrelin and the stability of its acylated form resulted in a significant increase in the acylated/total ghrelin ratio which had no effect on body weight gain or total dietary consumption. This enhanced ratio measured in rats consuming C8:0 was however suspected to increase (i) growth hormone (GH) secretion as an increase in the GH-dependent mRNA expression of the insulin like growth Factor 1 (IGF-1) was measured (ii) adipocyte diameters in subcutaneous adipose tissue without an increase in the fat pad mass. Altogether, these results show that daily feeding with diets containing C8:0 increased the C8:0 level in the stomach more than all the other tissues, affecting the acylated/total ghrelin plasma ratio by decreasing the concentration of circulating unacylated ghrelin. However, these modifications were not associated with increased body weight or food consumption.	[Lemarie, Fanny; Beauchamp, Erwan; Dayot, Stephanie; Duby, Cecile; Legrand, Philippe; Rioux, Vincent] INRA, Agrocampus Ouest, Lab Biochem & Human Nutr, USC 1378, Rennes, France	INRAE; Institut Agro; Agrocampus Ouest	Rioux, V (corresponding author), INRA, Agrocampus Ouest, Lab Biochem & Human Nutr, USC 1378, Rennes, France.	Vincent.Rioux@agrocampus-ouest.fr	Legrand, Philippe/AAM-6060-2020; Rioux, Vincent/Y-8845-2019; Rioux, Vincent/AAY-4077-2020	Rioux, Vincent/0000-0001-9837-1675; Rioux, Vincent/0000-0001-9837-1675; Legrand, Philippe/0000-0001-5763-4854	CNIEL (Comite National Interprofessionnel de l'Economie Laitiere)	CNIEL (Comite National Interprofessionnel de l'Economie Laitiere)	This work was supported by grants from the CNIEL (Comite National Interprofessionnel de l'Economie Laitiere). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Albarran-Zeckler RG, 2011, PEPTIDES, V32, P2229, DOI 10.1016/j.peptides.2011.07.003; Astrup A, 2011, AM J CLIN NUTR, V93, P684, DOI 10.3945/ajcn.110.004622; BABA N, 1987, LIPIDS, V22, P442, DOI 10.1007/BF02537276; Bach AC, 1996, J LIPID RES, V37, P708; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Briggs DI, 2011, CURR DIABETES REV, V7, P201, DOI 10.2174/157339911795843140; CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Chen CY, 2012, MOL MED REP, V6, P191, DOI 10.3892/mmr.2012.901; Chen W, 2014, TRANSL GASTROINTEST, V4, P14; Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099; CLARK SB, 1969, GASTROENTEROLOGY, V56, P214; CROZIER G, 1987, METABOLISM, V36, P807, DOI 10.1016/0026-0495(87)90122-3; Cummings DE, 2005, CURR DRUG TARGETS, V6, P153, DOI 10.2174/1389450053174569; Delhanty PJD, 2015, CLIN ENDOCRINOL, V82, P142, DOI 10.1111/cen.12489; Delporte C., 2013, SCIENTIFICA, V2013, DOI DOI 10.1155/2013/518909; EGELRUD T, 1971, SCAND J GASTROENTERO, V6, P329, DOI 10.3109/00365527109181129; Ezanno H, 2015, EUR J LIPID SCI TECH, V117, P281, DOI 10.1002/ejlt.201400304; Ferreira L, 2014, J ANIM PHYSIOL AN N, V98, P1, DOI 10.1111/jpn.12030; Fukumori R, 2013, DOMEST ANIM ENDOCRIN, V45, P216, DOI 10.1016/j.domaniend.2013.09.005; GARGOURI Y, 1986, BIOCHIM BIOPHYS ACTA, V879, P419, DOI 10.1016/0005-2760(86)90234-1; GELIEBTER A, 1983, AM J CLIN NUTR, V37, P1; Goebel-Stengel M, 2013, PEPTIDES, V43, P13, DOI 10.1016/j.peptides.2013.02.011; Gong Z, 2014, AM J PHYSIOL-ENDOC M, V306, pE28, DOI 10.1152/ajpendo.00306.2013; Guillou H, 2002, LIPIDS, V37, P981, DOI 10.1007/s11745-006-0990-3; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103; Han JR, 2002, J NUTR, V132, P904, DOI 10.1093/jn/132.5.904; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Hosoda H, 2012, METHOD ENZYMOL, V514, P113, DOI 10.1016/B978-0-12-381272-8.00008-8; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Inhoff T, 2008, PEPTIDES, V29, P2159, DOI 10.1016/j.peptides.2008.09.014; Janssen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040168; JENSEN RG, 1990, J DAIRY SCI, V73, P223, DOI 10.3168/jds.S0022-0302(90)78666-3; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Knockaert L, 2012, LAB INVEST, V92, P396, DOI 10.1038/labinvest.2011.193; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kumar R, 2010, REGUL PEPTIDES, V164, P65, DOI 10.1016/j.regpep.2010.06.005; Lai HC, 1998, J NUTR, V128, P2403, DOI 10.1093/jn/128.12.2403; Lee HM, 2002, ENDOCRINOLOGY, V143, P185, DOI 10.1210/en.143.1.185; Legrand P, 2011, WORLD REV NUTR DIET, V102, P137, DOI 10.1159/000327800; Legrand P, 2010, LIPIDS, V45, P975, DOI 10.1007/s11745-010-3481-5; Leidy HJ, 2007, OBESITY, V15, P446, DOI 10.1038/oby.2007.542; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2709, DOI 10.1210/en.2004-0645; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Nishi Yoshihiro, 2013, Front Endocrinol (Lausanne), V4, P84, DOI 10.3389/fendo.2013.00084; Nishi Y, 2012, METHOD ENZYMOL, V514, P303, DOI 10.1016/B978-0-12-381272-8.00019-2; Ooyama K, 2009, J NUTR SCI VITAMINOL, V55, P423, DOI 10.3177/jnsv.55.423; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Patterson M, 2005, J CLIN ENDOCR METAB, V90, P2205, DOI 10.1210/jc.2004-1641; PERRET JP, 1980, J PHYSIOL-PARIS, V76, P159; Rioux V, 2007, ANIMAL, V1, P820, DOI 10.1017/S1751731107000122; Rioux V, 2005, REPROD NUTR DEV, V45, P599, DOI 10.1051/rnd:2005048; Rioux V, 2013, J LIPID RES, V54, P3438, DOI 10.1194/jlr.M042572; SARDA P, 1987, AM J CLIN NUTR, V45, P399, DOI 10.1093/ajcn/45.2.399; St-Onge MP, 2008, J AM COLL NUTR, V27, P547, DOI 10.1080/07315724.2008.10719737; St-Onge MP, 2002, J NUTR, V132, P329; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Takagi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3685; Takeuchi H, 2008, ASIA PAC J CLIN NUTR, V17, P320; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsuji H, 2001, J NUTR, V131, P2853, DOI 10.1093/jn/131.11.2853; Wang Q, 2014, MOL METAB, V3, P64, DOI 10.1016/j.molmet.2013.10.001; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yi CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032100; You YQN, 2008, JPEN-PARENTER ENTER, V32, P169, DOI 10.1177/0148607108314758; ZAMMIT VA, 1984, PROG LIPID RES, V23, P39, DOI 10.1016/0163-7827(84)90005-5; Zhang YY, 2015, P NATL ACAD SCI USA, V112, P1226, DOI 10.1073/pnas.1423643112; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	78	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133600	10.1371/journal.pone.0133600	http://dx.doi.org/10.1371/journal.pone.0133600			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196391	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600117
J	Luo, M; Zhou, XH; Ji, HH; Ma, WJ; Liu, GL; Dai, DJ; Li, JY; Chang, L; Xu, L; Jiang, LT; Duan, SW; Wang, QW				Luo, Mei; Zhou, Xiaohui; Ji, Huihui; Ma, Wenjuan; Liu, Guili; Dai, Dongjun; Li, Jingyun; Chang, Lan; Xu, Lei; Jiang, Liting; Duan, Shiwei; Wang, Qinwen			Population Difference in the Associations of KLOTH Promoter Methylation with Mild Cognitive Impairment in Xinjiang Uygur and Han Populations	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; WORKING-MEMORY; DNA-REPAIR; ALPHA; CHOLESTEROL; AMERICANS; PROTEIN	Background Mild cognitive impairment (MCI) is the intermediate stage of the cognitive changes between normal aging and dementia. KLOTH is an age-related gene that may contribute to the risk of MCI. The aim of our study was to explore the association between KLOTHO promoter methylation and MCI in Xinjiang Uygur and Han populations. Methods DNA methylation assay was performed using the bisulphite pyrosequencing technology among 96 Uygur (48 MCI and 48 controls) and 96 Han (48 MCI and 48 controls) Chinese individuals from Xinjiang province of China. Results We found significant association between KLOTHO promoter methylation and MCI in the Han Chinese (CpG1: p = 3.77E-06; CpG2: p = 1.91E-07; CpG3: p = 5.83E-07; CpG4: p = 2.23E-05; CpG5: p = 3.03E-06) but not in the Uygur Chinese. Higher KLOTHO promoter methylation levels were found in Han MCI patients than Uygur MCI patients for all the five CpGs (adjusted p values by age < 0.02). Conclusion Our results showed that KLOTHO promoter hypermethylation contributed to the MCI risk in Xinjiang Han Chinese but not in Xinjiang Uygur Chinese. The population difference of KLOTHO methylation in the risk of MCI required further investigation in the future.	[Luo, Mei; Zhou, Xiaohui; Ma, Wenjuan] Xinjiang Med Univ, Affiliated Hosp 1, Dept Internal Med Cadres, Urumqi 830000, Peoples R China; [Ji, Huihui; Liu, Guili; Dai, Dongjun; Li, Jingyun; Chang, Lan; Xu, Lei; Jiang, Liting; Duan, Shiwei; Wang, Qinwen] Ningbo Univ, Sch Med, Ningbo Key Lab Behav Neurosci, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China	Xinjiang Medical University; Ningbo University	Zhou, XH (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Internal Med Cadres, Urumqi 830000, Peoples R China.	zhouxiaohui858@sina.com; duanshiwei@nbu.edu.cn; wangqinwen@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022	Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [81471398, 81070873, 31100919, 81371469]; Ministry of Science and Technology of China [2013CB835100]; Natural Science Foundation of Zhejiang Province [LR13H020003]; Disciplinary Project of Ningbo University [B01350104900]; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Disciplinary Project of Ningbo University; K. C. Wong Magna Fund in Ningbo University	The research was supported by the grants from the National Natural Science Foundation of China (81471398, 81070873, 31100919 and 81371469), the 973 Program from the Ministry of Science and Technology of China (2013CB835100), the Natural Science Foundation of Zhejiang Province (LR13H020003), the Disciplinary Project of Ningbo University (B01350104900), and the3 K. C. Wong Magna Fund in Ningbo University.	Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Blasko I, 2011, J NEURAL TRANSM, V118, P663, DOI 10.1007/s00702-011-0599-4; Brobey R. GD, KLOTHO ACTIVATION NE; Caselli RJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt123; Chang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110773; Chang XY, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/761938; Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n; Cheng Yan, 2014, Shanghai Arch Psychiatry, V26, P4, DOI 10.3969/j.issn.1002-0829.2014.01.002; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Christa Maree Stephan B, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2012-001909, DOI 10.1136/BMJ0PEN-2012-001909]; Coppede F, 2010, J ALZHEIMERS DIS, V20, P953, DOI 10.3233/JAD-2010-1415; Dai DJ, 2014, PSYCHIAT RES, V220, P772, DOI 10.1016/j.psychres.2014.08.032; Dohnel K, 2008, NEUROPSYCHOLOGIA, V46, P37, DOI 10.1016/j.neuropsychologia.2007.08.012; Gupta R, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-28; Hahn D, 1997, EUR J BIOCHEM, V247, P933, DOI 10.1111/j.1432-1033.1997.00933.x; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Johnson LA, 2014, AGE AGEING, V43, P364, DOI 10.1093/ageing/aft189; Kalkonde YV, 2009, DEMENT GERIATR COGN, V28, P145, DOI 10.1159/000235577; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Lee HB, 2012, AGING MENT HEALTH, V16, P372, DOI 10.1080/13607863.2011.609533; Lin HC, 2009, NEUROTOXICOLOGY, V30, P622, DOI 10.1016/j.neuro.2009.03.011; Lou Zhongzhang, 2012, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V26, P795; Low LF, 2012, AM J GERIAT PSYCHIAT, V20, P866, DOI 10.1097/JGP.0b013e31823e31e2; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570; Manly J., 2004, CRIT PERSPECT; McDougall GJ, 2007, ETHNIC DIS, V17, P381; Merkin SS, 2009, INT J PUBLIC HEALTH, V54, P166, DOI 10.1007/s00038-008-7030-4; Nagai Taku, 2003, FASEB Journal, V17, P50; Niu MJ, 2013, J DIABETES COMPLICAT, V27, P443, DOI 10.1016/j.jdiacomp.2013.06.001; O'Bryant SE, 2013, J ALZHEIMERS DIS, V33, P373, DOI 10.3233/JAD-2012-121420; Parnowski T, 2013, PSYCHIATR POL, V47, P1087; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Semba RD, 2014, NEUROSCI LETT, V558, P37, DOI 10.1016/j.neulet.2013.10.058; Shan MH, 2014, INT J CLIN EXP MED, V7, P3482; Takahashi G, 2004, ANN THORAC SURG, V78, P602, DOI 10.1016/j.athoracsur.2004.02.133; Toro P, 2014, EUR ARCH PSY CLIN N, V264, P485, DOI 10.1007/s00406-013-0468-2; Triebel KL, 2010, ALZ DIS ASSOC DIS, V24, P365, DOI 10.1097/WAD.0b013e3181e7cb05; Wang ZhiZhong, 2014, Int J Alzheimers Dis, V2014, P150628, DOI 10.1155/2014/150628; Xiaohui Zhou ZY, 2014, CHIN J PSYCHIAT, V47, P4; Xie BA, 2013, HUM PATHOL, V44, P795, DOI 10.1016/j.humpath.2012.07.023; Xu LM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/151723; Young JW, 2009, NEUROBIOL AGING, V30, P1430, DOI 10.1016/j.neurobiolaging.2007.11.018; Yu ZY, 2013, AM J PHYSIOL-RENAL, V305, pF1006, DOI 10.1152/ajprenal.00407.2013; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhang JP, 2006, CLIN CHIM ACTA, V365, P337, DOI 10.1016/j.cca.2005.09.005; Zhang LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063455; Zou Y, 2014, AM J ALZHEIMERS DIS, V29, P242, DOI 10.1177/1533317513517042	53	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132156	10.1371/journal.pone.0132156	http://dx.doi.org/10.1371/journal.pone.0132156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197428	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600023
J	Revah, O; Libman, L; Fleidervish, IA; Gutnick, MJ				Revah, Omer; Libman, Lior; Fleidervish, Ilya A.; Gutnick, Michael J.			The Outwardly Rectifying Current of Layer 5 Neocortical Neurons that was Originally Identified as "Non-Specific Cationic" Is Essentially a Potassium Current	PLOS ONE			English	Article							DELAYED RECTIFIER CURRENT; TRPM7 CHANNELS; MOUSE; PROTEIN; SLICES; TRPC1; ADAPTATION; EXPRESSION; PERSISTENT; RECEPTORS	In whole-cell patch clamp recordings from layer 5 neocortical neurons, blockade of voltage gated sodium and calcium channels leaves a cesium current that is outward rectifying. This current was originally identified as a "non-specific cationic current", and subsequently it was hypothesized that it is mediated by TRP channels. In order to test this hypothesis, we used fluorescence imaging of intracellular sodium and calcium indicators, and found no evidence to suggest that it is associated with influx of either of these ions to the cell body or dendrites. Moreover, the current is still prominent in neurons from TRPC1(-/-) and TRPC5(-/-) mice. The effects on the current of various blocking agents, and especially its sensitivity to intracellular tetraethylammonium, suggest that it is not a non-specific cationic current, but rather that it is generated by cesium-permeable delayed rectifier potassium channels.	[Revah, Omer; Libman, Lior; Gutnick, Michael J.] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Fleidervish, Ilya A.] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Fleidervish, Ilya A.] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel	Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University	Gutnick, MJ (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	michael.gutnick@mail.huji.ac.il	Gutnick, Michael/P-7910-2019; Revah, Omer/AAW-4048-2021	Revah, Omer/0000-0002-4002-5689; Fleidervish, Ilya/0000-0002-5501-726X; Gutnick, Michael/0000-0003-2564-5094	Israel Science Foundation [1593/10]	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation (grant No. 1593/10)	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; ALZHEIMER C, 1994, J PHYSIOL-LONDON, V479, P199, DOI 10.1113/jphysiol.1994.sp020288; Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Block BM, 1997, J PHYSIOL-LONDON, V499, P403, DOI 10.1113/jphysiol.1997.sp021937; Boisseau S, 2009, HISTOCHEM CELL BIOL, V131, P355, DOI 10.1007/s00418-008-0532-6; Briand LA, 2014, NEUROPSYCHOPHARMACOL, V39, P759, DOI 10.1038/npp.2013.265; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; HAAS HL, 1979, J NEUROSCI METH, V1, P323, DOI 10.1016/0165-0270(79)90021-9; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Klemic KG, 1998, J NEUROPHYSIOL, V79, P2345, DOI 10.1152/jn.1998.79.5.2345; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Liapi A, 2005, EUR J NEUROSCI, V22, P825, DOI 10.1111/j.1460-9568.2005.04270.x; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Parnas M, 2011, COMPREHENSIVE BIOPHYSICS, VOL 6: CHANNELS, P68, DOI 10.1016/B978-0-12-374920-8.00617-2; Peters M, 2012, J NEUROTRAUM, V29, P2831, DOI 10.1089/neu.2012.2575; Phelan KD, 2013, MOL PHARMACOL, V83, P429, DOI 10.1124/mol.112.082271; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; RENNIE KJ, 1994, J NEUROPHYSIOL, V71, P317, DOI 10.1152/jn.1994.71.1.317; Rennie KJ, 2000, J MEMBRANE BIOL, V173, P139, DOI 10.1007/s002320001015; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Rusch A, 1996, J NEUROPHYSIOL, V76, P995, DOI 10.1152/jn.1996.76.2.995; Rychkov G., 2007, V179, P23; SANGUINETTI MC, 1990, AM J PHYSIOL, V259, pH1881, DOI 10.1152/ajpheart.1990.259.6.H1881; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Trequattrini C, 1996, J MEMBRANE BIOL, V154, P143, DOI 10.1007/s002329900139; Tytgat J, 1997, BRAIN RES, V749, P232, DOI 10.1016/S0006-8993(96)01171-7; Voronova IP, 2013, J THERM BIOL, V38, P300, DOI 10.1016/j.jtherbio.2013.03.009; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Wigmore MA, 2000, J PHYSIOL-LONDON, V527, P493, DOI 10.1111/j.1469-7793.2000.t01-1-00493.x; Zechel S, 2007, CELL TISSUE RES, V328, P651, DOI 10.1007/s00441-007-0388-4	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132108	10.1371/journal.pone.0132108	http://dx.doi.org/10.1371/journal.pone.0132108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197082	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600021
J	Guo, JY; Li, W; Liu, X; Kong, QL; Zhao, CM; Guo, B				Guo, Jinyun; Li, Wang; Liu, Xin; Kong, Qiaoli; Zhao, Chunmei; Guo, Bin			Temporal-Spatial Variation of Global GPS-Derived Total Electron Content, 1999-2013	PLOS ONE			English	Article							POSITIONING SYSTEM; TEC; IONOSPHERE; DENSITY; THERMOSPHERE; PREDICTION	To investigate the temporal-spatial distribution and evolutions of global Total Electron Content (TEC), we estimate the global TEC data from 1999 to 2013 by processing the GPS data collected by the International Global Navigation Satellite System (GNSS) Service (IGS) stations, and robustly constructed the TEC time series at each of the global 5 degrees x2.5 degrees grids. We found that the spatial distribution of the global TEC has a pattern where the number of TECs diminishes gradually from a low-latitude region to high-latitude region, and anomalies appear in the equatorial crest and Greenland. Temporal variations show that the peak TEC appears in equinoctial months, and this corresponds to the semiannual variation of TEC. Furthermore, the winter anomaly is also observed in the equatorial area of the northern hemisphere and high latitudes of the southern hemisphere. Morlet wavelet analysis is used to determine periods of TEC variations and results indicate that the 1-day, 26.5-day, semiannual and annual cycles are the major significant periods. The fitting results of a quadratic polynomial show that the effect of solar activity on TEC is stronger in low latitudes than in mid-high latitudes, and stronger in the southern hemisphere than in the northern hemisphere. But the effect in low latitudes in the northern hemisphere is stronger than that in low latitudes in the southern hemisphere. The effect of solar activity on TECs was analyzed with the cross wavelet analysis and the wavelet coherence transformation, and we found that there appears to be a strong coherence in the period of about 27 days. So the sunspot as one index of solar activity seriously affects the TEC variations with the sun's rotation. We fit the TEC data with the least squares spectral analysis to study the periodic variations of TEC. The changing trend of TEC is generally -0.08 TECu per year from 1999 to 2013. So TECs decrease over most areas year by year, but TECs over the Arctic around Greenland maintained a rising trend during these 15 years.	[Guo, Jinyun; Li, Wang; Liu, Xin; Kong, Qiaoli; Guo, Bin] Shandong Univ Sci & Technol, Coll Geodesy & Geomat, Qingdao 266590, Peoples R China; [Guo, Jinyun; Kong, Qiaoli; Guo, Bin] Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Cofo, Qingdao 266590, Peoples R China; [Guo, Jinyun; Kong, Qiaoli; Guo, Bin] Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China; [Zhao, Chunmei] Chinese Acad Surveying & Mapping, Beijing 100830, Peoples R China	Shandong University of Science & Technology; Shandong University of Science & Technology; Shandong University of Science & Technology; Chinese Academy of Surveying & Mapping	Guo, JY (corresponding author), Shandong Univ Sci & Technol, Coll Geodesy & Geomat, Qingdao 266590, Peoples R China.	jinyunguo1@126.com		guo, jinyun/0000-0003-1817-1505; Guo, Bin/0000-0001-7886-0172	National Natural Science Foundation of China [41374009]; National Basic Research Program of China [2013CB7333 02]; Public Benefit Scientific Research Project of China [201412001]; Shandong Natural Science Foundation of China [ZR2013DM009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Public Benefit Scientific Research Project of China; Shandong Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	The National Natural Science Foundation of China (41374009) and the National Basic Research Program of China (2013CB7333 02) fund to estimate TEC data, the Public Benefit Scientific Research Project of China (201412001) and the Shandong Natural Science Foundation of China (ZR2013DM009) fund to buy software to analyze data.	An Yu-zhu, 2012, Journal of PLA University of Science and Technology (Natural Science Edition), V13, P571; Anderson D, 1999, SPACE ENV TOPICS; ANDERSON DN, 1973, PLANET SPACE SCI, V21, P409, DOI 10.1016/0032-0633(73)90040-8; Bernhardt PA, 1998, PHYS PLASMAS, V5, P2010, DOI 10.1063/1.872872; Dach R, 2009, J GEODESY, V83, P353, DOI 10.1007/s00190-008-0281-2; Fuller-Rowell TJ, 1998, J GEOPHYS RES-SPACE, V103, P3951, DOI 10.1029/97JA03335; FULLERROWELL TJ, 1988, PURE APPL GEOPHYS, V127, P189, DOI 10.1007/BF00879811; FULLERROWELL TJ, 1994, J GEOPHYS RES-SPACE, V99, P3893, DOI 10.1029/93JA02015; Galav P, 2010, J ATMOS SOL-TERR PHY, V72, P1309, DOI 10.1016/j.jastp.2010.09.017; Guo JY, 2015, GEOSCI J, V19, P721, DOI 10.1007/s12303-015-0005-6; Guo JY, 2012, SCI CHINA EARTH SCI, V55, P2068, DOI 10.1007/s11430-012-4524-y; Hajj GA, 1998, RADIO SCI, V33, P175, DOI 10.1029/97RS03183; HANSON WB, 1966, J GEOPHYS RES, V71, P5559, DOI 10.1029/JZ071i023p05559; Kenpankho P, 2011, EARTH PLANETS SPACE, V63, P365, DOI 10.5047/eps.2011.01.010; Kiang CH, 1996, PHYS REV LETT, V76, P2515, DOI 10.1103/PhysRevLett.76.2515; LANYI GE, 1988, RADIO SCI, V23, P483, DOI 10.1029/RS023i004p00483; Li ZG, 2007, CHINESE J GEOPHYS-CH, V50, P327; Liu L, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012283; Liu Libo, 2012, [空间科学学报, Chinese Journal of Space Science], V32, P665; Liu LB, 2011, CHINESE SCI BULL, V56, P1202, DOI 10.1007/s11434-010-4226-9; Liu LB, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014533; Liu LB, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014244; MALLIS M, 1993, J ATMOS TERR PHYS, V55, P1021, DOI 10.1016/0021-9169(93)90095-G; Mannucci AJ, 1998, RADIO SCI, V33, P565, DOI 10.1029/97RS02707; [孟泱 Meng Yang], 2011, [测绘学报, Acta Geodetica et Cartographica Sinica], V40, P37; Mikhailov A.V., 2004, INT J GEOMAGN AERON, V5, pGI1006, DOI [10.1029/2003GI000058, DOI 10.1029/2003GI000058]; Millward GH, 1996, J GEOPHYS RES-SPACE, V101, P5149, DOI 10.1029/95JA03343; Moussas X, 2005, ADV SPACE RES-SERIES, V35, P725, DOI 10.1016/j.asr.2005.03.148; Prasad R, 2001, ACTA ASTRONAUT, V48, P579; Prikryl P, 2010, ANN GEOPHYS-GERMANY, V28, P1307, DOI 10.5194/angeo-28-1307-2010; Richard B.L., 2000, GPS WORLD, V11, P44; Rishbeth H, 1998, J ATMOS SOL-TERR PHY, V60, P1385, DOI 10.1016/S1364-6826(98)00062-5; Saito A, 1998, GEOPHYS RES LETT, V25, P3079, DOI 10.1029/98GL52361; SCHUNK RW, 1975, J GEOPHYS RES-SPACE, V80, P3121, DOI 10.1029/JA080i022p03121; STENING RJ, 1992, J ATMOS TERR PHYS, V54, P1387, DOI 10.1016/0021-9169(92)90147-D; [万卫星 WAN Weixing], 2007, [地球物理学进展, Progress in Geophysiscs], V22, P1040; Wang L, 2014, GEOD GEODYN, V5, P54, DOI 10.3724/SP.J.1246.2014.02054; Wang Weimin, 2012, Chinese Journal of Space Science, V32, P40; Wei Na, 2009, Geomatics and Information Science of Wuhan University, V34, P1363; Wielgosz P, 2004, ANN GEOPHYS-GERMANY, V22, P405, DOI 10.5194/angeo-22-405-2004; Xu JS, 2013, CHINESE J GEOPHYS-CH, V56, P1425, DOI 10.6038/cjg20130501; Yu T, 2006, CHINESE J GEOPHYS-CH, V49, P943; [余涛 YU Tao], 2008, [科技导报, Science & Technology Review], V26, P25; Zhao BQ, 2006, THESIS CHINESE ACAD; Zhu AQ, 2008, THESIS XI DIAN U	45	37	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133378	10.1371/journal.pone.0133378	http://dx.doi.org/10.1371/journal.pone.0133378			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193101	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400077
J	Han, B; Chen, L; Wang, J; Wu, ZL; Yan, LF; Hou, SW				Han, Bing; Chen, Liang; Wang, Jing; Wu, Zhongliang; Yan, Longfeng; Hou, Suiwen			Constitutive Expresser of Pathogenesis Related Genes 1 Is Required for Pavement Cell Morphogenesis in Arabidopsis	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; PROTEIN-DEGRADATION; EPIDERMAL-CELLS; E3 LIGASE; GROWTH; SHAPE; CYTOSKELETON; ACTIN; UBIQUITINATION; PATHWAYS	For over 50 years, researchers have focused on the mechanisms underlying the important roles of the cytoskeleton in controlling the cell growth direction and cell expansion. In our study, we performed ethyl methane sulfonate mutagenesis on Col-0 background and identified two new CONSTITUTIVE EXPRESSER OF PATHOGENESIS RELATED GENES 1 (CPR1) alleles with pavement cell (PC) morphogenetic defects. Morphological characterizations showed that polar growth initiation and expansion of PCs are seriously suppressed in cpr1. Closer cytoskeleton investigation showed that the directional arrangement of microtubules (MTs) during PC development is defective and the cortical fine actin filaments cannot be aggregated effectively to form actin cable networks in cpr1 mutants. These results suggest that the abnormal PC morphogenesis in cpr1 is accompanying with the aberrant arrangement of cytoskeleton. Site-directed mutagenesis and knockout within the F-box-associated (FBA) domain, which is reported to be a motif for recognizing particular substrates of CPR1, proved that the FBA domain is indispensable for normal CPR1 regulation of the PC morphogenesis. Further genetic analysis indicated that the defects on PC morphogenesis of cpr1 depend on two lipase-like proteins, ENHANCED DISEASE SUSCEPTIBILITY 1 and PHYTOALEXIN DEFICIENT 4. Our results provide further insights into the relationship between the cytoskeleton and PC morphogenesis, and suggest that the cytoskeleton-mediated PC morphogenesis control might be tightly linked to plant defense responses.	[Han, Bing; Chen, Liang; Wang, Jing; Wu, Zhongliang; Yan, Longfeng; Hou, Suiwen] Lanzhou Univ, Minist Educ, Key Lab Cell Act & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Peoples R China	Lanzhou University	Hou, SW (corresponding author), Lanzhou Univ, Minist Educ, Key Lab Cell Act & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Peoples R China.	housw@lzu.edu.cn		Wang, Jing/0000-0001-6381-1239	Ministry of Agriculture of the People's Republic of China [2014ZX08009-003-002]; National Basic Research Program of China [2011CB915401]; Natural Science Foundation of China (NSFC) [31470372, 31271460]; foundation of Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations [lzujbky-2014-bt05]	Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); foundation of Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations	This work was supported by the Ministry of Agriculture of the People's Republic of China (Grant NO. 2014ZX08009-003-002) the National Basic Research Program of China (Grant NO. 2011CB915401), the Natural Science Foundation of China (NSFC) (Grant NO. 31470372, 31271460) and the foundation of the Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations (lzujbky-2014-bt05).	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Cadart C, 2014, DEV CELL, V29, P159, DOI 10.1016/j.devcel.2014.04.009; Cheng YT, 2011, P NATL ACAD SCI USA, V108, P14694, DOI 10.1073/pnas.1105685108; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deeks MJ, 2003, CURR OPIN PLANT BIOL, V6, P561, DOI 10.1016/j.pbi.2003.09.013; del Pozo JC, 2000, PLANT MOL BIOL, V44, P123, DOI 10.1023/A:1006413007456; Dong S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-76; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank MJ, 2002, CURR BIOL, V12, P849, DOI 10.1016/S0960-9822(02)00819-9; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Fu Y, 2009, CURR BIOL, V19, P1827, DOI 10.1016/j.cub.2009.08.052; Glazebrook J, 1996, GENETICS, V143, P973; Gou MY, 2012, PLANT J, V69, P411, DOI 10.1111/j.1365-313X.2011.04799.x; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Guimil S, 2007, J EXP BOT, V58, P3829, DOI 10.1093/jxb/erm253; Hou XH, 2010, PLANT J, V63, P880, DOI 10.1111/j.1365-313X.2010.04277.x; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Kobayashi I, 2003, PLANTA, V217, P340, DOI 10.1007/s00425-003-1042-3; Le J, 2006, CURR BIOL, V16, P895, DOI 10.1016/j.cub.2006.03.061; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Mathur J, 2006, CURR OPIN CELL BIOL, V18, P40, DOI 10.1016/j.ceb.2005.12.002; Mathur J, 2004, TRENDS PLANT SCI, V9, P583, DOI 10.1016/j.tplants.2004.10.006; Mathur J, 2002, CURR BIOL, V12, pR669, DOI 10.1016/S0960-9822(02)01164-8; Poraty-Gavra L, 2013, PLANT PHYSIOL, V161, P1172, DOI 10.1104/pp.112.213165; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Sampathkumar A, 2011, PLANT CELL, V23, P2302, DOI 10.1105/tpc.111.087940; Schmidt SM, 2007, PHYSIOL MOL PLANT P, V71, P135, DOI 10.1016/j.pmpp.2008.01.001; Smith LG, 2003, CURR OPIN PLANT BIOL, V6, P63, DOI 10.1016/S1369-5266(02)00012-2; Sorek N, 2011, PLANT PHYSIOL, V155, P706, DOI 10.1104/pp.110.166850; Wang L, 2004, PLANT MOL BIOL, V56, P929, DOI 10.1007/s11103-004-6236-y; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Zhang CH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-27; Zhao J, 2013, FASEB J, V27, P2611, DOI 10.1096/fj.12-223099; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	41	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133249	10.1371/journal.pone.0133249	http://dx.doi.org/10.1371/journal.pone.0133249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193674	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400069
J	Hu, GQ; Liu, X; He, HB; Zhang, W; Xie, HT; Wu, YY; Cui, JH; Sun, C; Zhang, XD				Hu, Guoqing; Liu, Xiao; He, Hongbo; Zhang, Wei; Xie, Hongtu; Wu, Yeye; Cui, Jiehua; Sun, Ci; Zhang, Xudong			Multi-Seasonal Nitrogen Recoveries from Crop Residue in Soil and Crop in a Temperate Agro-Ecosystem	PLOS ONE			English	Article							MANAGEMENT-PRACTICES; FERTILIZER; TILLAGE; DECOMPOSITION; QUALITY; STRAW; CORN; DYNAMICS; CARBON; INPUTS	In conservation tillage systems, at least 30% of the soil surface was covered by crop residues which generally contain significant amounts of nitrogen (N). However, little is known about the multi-seasonal recoveries of the N derived from these crop residues in soil-crop systems, notably in northeastern China. In a temperate agro-ecosystem, N-15-labeled maize residue was applied to field surfaces in the 1st year (2009). From the 2nd to 4th year (2010-2012), one treatment halted the application of maize residue, whereas the soil in the second treatment was re-applied with unlabeled maize residue. Crop and soil samples were collected after each harvest, and their N-15 enrichments were determined on an isotope ratio mass spectrometer to trace the allocation of N derived from the initially applied maize residue in the soil-crop systems. On average, 8.4% of the maize residue N was recovered in the soil-crop in the 1st year, and the vastmajority (61.9%-91.9%) was recovered during subsequent years. Throughout the experiment, the cumulative recovery of the residue N in the crop increased gradually (18.2%-20.9%), but most of the residue N was retained in the soil, notably in the 0-10 cm soil layer. Compared to the single application, the sequential residue application significantly increased the recovery of the residue N in the soil profile (73.8% vs. 40.9%) and remarkably decreased the total and the initially applied residue derived mineral N along the soil profile. Our results suggested that the residue N was actively involved in N cycling, and its release and recovery in crop and soil profile were controlled by the decomposition process. Sequential residue application significantly enhanced the retention and stabilization of the initially applied residue N in the soil and retarded its translocation along the soil profile.	[Hu, Guoqing; Liu, Xiao; He, Hongbo; Zhang, Wei; Xie, Hongtu; Wu, Yeye; Cui, Jiehua; Sun, Ci; Zhang, Xudong] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110164, Peoples R China; [Hu, Guoqing; Liu, Xiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wu, Yeye; Zhang, Xudong] Natl Field Observat & Res Stn Shenyang Agroecosys, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, HB (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110164, Peoples R China.	hehongbo@iae.ac.cn; xdzhang@iae.ac.cn		Xie, Hongtu/0000-0002-8640-828X	Natural Science Foundation of China [41135024, 41271251]; "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences [XDA05050501]; State Key Laboratory of Forest and Soil Ecology [LFSE2013-14]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Forest and Soil Ecology	This work was financially supported by the Natural Science Foundation of China (Nos. 41135024 and 41271251), "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (No. XDA05050501), and State Key Laboratory of Forest and Soil Ecology (No. LFSE2013-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal-Corfini N, 2010, PLANT SOIL, V328, P17, DOI 10.1007/s11104-009-0104-0; Alijani K, 2012, SOIL TILL RES, V124, P78, DOI 10.1016/j.still.2012.05.005; Alvarez CR, 2008, COMMUN SOIL SCI PLAN, V39, P574, DOI 10.1080/00103620701826886; Bending GD, 1998, SOIL BIOL BIOCHEM, V30, P2055, DOI 10.1016/S0038-0717(98)00081-9; Burgess MS, 2002, SOIL SCI SOC AM J, V66, P1350, DOI 10.2136/sssaj2002.1350; Burgess MS, 2002, CAN J SOIL SCI, V82, P127, DOI 10.4141/S01-013; Chen Y, 2010, PEDOSPHERE, V20, P198, DOI 10.1016/S1002-0160(10)60007-0; Coppens F, 2006, EUR J SOIL SCI, V57, P570, DOI 10.1111/j.1365-2389.2006.00825.x; Coppens F, 2007, SOIL BIOL BIOCHEM, V39, P2339, DOI 10.1016/j.soilbio.2007.04.005; Damon PM, 2014, SOIL BIOL BIOCHEM, V74, P127, DOI 10.1016/j.soilbio.2014.03.003; Dourado Neto D, 2010, SOIL SCI SOC AM J, V74, P139, DOI 10.2136/sssaj2009.0192; Douxchamps S, 2011, PLANT SOIL, V341, P179, DOI 10.1007/s11104-010-0633-6; Fosu M, 2003, BIOL FERT SOILS, V39, P117, DOI 10.1007/s00374-003-0677-3; Fowler R, 2001, SOIL TILL RES, V61, P93, DOI 10.1016/S0167-1987(01)00181-7; Geisseler D, 2012, EUR J SOIL BIOL, V53, P107, DOI 10.1016/j.ejsobi.2012.09.006; Gentile R, 2008, SOIL BIOL BIOCHEM, V40, P2375, DOI 10.1016/j.soilbio.2008.05.018; Halpern MT, 2010, SOIL SCI SOC AM J, V74, P1211, DOI 10.2136/sssaj2009.0406; HAUCK RD, 1976, ADV AGRON, V28, P219, DOI 10.1016/S0065-2113(08)60556-8; Huang Y, 2006, CHINESE SCI BULL, V51, P1785, DOI 10.1007/s11434-006-2056-6; Hubbard VC, 1996, SOIL SCI SOC AM J, V60, P1405, DOI 10.2136/sssaj1996.03615995006000050016x; Ibewiro B, 2000, BIOL FERT SOILS, V31, P261, DOI 10.1007/s003740050655; Kumar K, 2000, ADV AGRON, V68, P197; Kumar K, 2001, J AGR SCI-CAMBRIDGE, V136, P35, DOI 10.1017/S0021859600008522; Lu HJ, 2013, PLANT SOIL, V373, P595, DOI 10.1007/s11104-013-1824-8; Lupwayi NZ, 2006, CAN J SOIL SCI, V86, P11, DOI 10.4141/S05-015; Luxhoi J, 2007, SOIL USE MANAGE, V23, P368, DOI 10.1111/j.1475-2743.2007.00126.x; Malhi SS, 2007, SOIL TILL RES, V96, P269, DOI 10.1016/j.still.2007.06.011; Malhi SS, 2011, FIELD CROP RES, V124, P378, DOI 10.1016/j.fcr.2011.07.009; Mubarak AR, 2003, COMMUN SOIL SCI PLAN, V34, P2375, DOI 10.1081/CSS-120024774; Palm CA, 2001, AGR ECOSYST ENVIRON, V83, P27, DOI 10.1016/S0167-8809(00)00267-X; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; Powlson DS, 2011, AGRON J, V103, P279, DOI 10.2134/agronj2010.0146s; POWLSON DS, 1985, J SCI FOOD AGR, V36, P26, DOI 10.1002/jsfa.2740360105; Redin M, 2014, SOIL BIOL BIOCHEM, V78, P65, DOI 10.1016/j.soilbio.2014.07.014; Scopel E, 2013, AGRON SUSTAIN DEV, V33, P113, DOI 10.1007/s13593-012-0106-9; Soil Survey Staff, 2003, KEYS TO SOIL TAXONOM; Zhang JB, 2012, EUR J SOIL SCI, V63, P75, DOI 10.1111/j.1365-2389.2011.01410.x	37	12	12	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133437	10.1371/journal.pone.0133437	http://dx.doi.org/10.1371/journal.pone.0133437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192436	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400085
J	Jansen, SW; Roelfsema, F; Akintola, AA; Oei, NY; Cobbaert, CM; Ballieux, BE; van der Grond, J; Westendorp, RG; Pijl, H; van Heemst, D				Jansen, Steffy W.; Roelfsema, Ferdinand; Akintola, Abimbola A.; Oei, Nicole Y.; Cobbaert, Christa M.; Ballieux, Bart E.; van der Grond, Jeroen; Westendorp, Rudi G.; Pijl, Hanno; van Heemst, Diana			Characterization of the Hypothalamic-Pituitary-Adrenal-Axis in Familial Longevity under Resting Conditions	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR GENE; CORTISOL DOSE RESPONSIVENESS; CARDIOVASCULAR RISK-FACTORS; OBESE PREMENOPAUSAL WOMEN; BROWN-NORWAY RAT; BODY-MASS INDEX; LEIDEN LONGEVITY; PLASMA-CORTISOL; ADRENOCORTICOTROPIC HORMONE; NONAGENARIAN SIBLINGS	Objective The hypothalamic-pituitary-adrenal (HPA)-axis is the most important neuro-endocrine stress response system of our body which is of critical importance for survival. Disturbances in HPA-axis activity have been associated with adverse metabolic and cognitive changes. Humans enriched for longevity have less metabolic and cognitive disturbances and therefore diminished activity of the HPA axis may be a potential candidate mechanism underlying healthy familial longevity. Here, we compared 24-h plasma ACTH and serum cortisol concentration profiles and different aspects of the regulation of the HPA-axis in offspring from long-lived siblings, who are enriched for familial longevity and age-matched controls. Design Case-control study within the Leiden Longevity study cohort consisting of 20 middle-aged offspring of nonagenarian siblings (offspring) together with 18 partners (controls). Methods During 24 h, venous blood was sampled every 10 minutes for determination of circulatory ACTH and cortisol concentrations. Deconvolution analysis, cross approximate entropy analysis and ACTH-cortisol-dose response modeling were used to assess, respectively, ACTH and cortisol secretion parameters, feedforward and feedback synchrony and adrenal gland ACTH responsivity. Results Mean (95% Confidence Interval) basal ACTH secretion was higher in male offspring compared to male controls (645 (324-1286) ngl/L/24 h versus 240 (120-477) ng/L/24 h, P = 0.05). Other ACTH and cortisol secretion parameters did not differ between offspring and controls. In addition, no significant differences in feedforward and feedback synchrony and adrenal gland ACTH responsivity were observed between groups. Conclusions These results suggest that familial longevity is not associated with major differences in HPA-axis activity under resting conditions, although modest, sex-specific differences may exist between groups that might be clinically relevant.	[Jansen, Steffy W.; Akintola, Abimbola A.; Westendorp, Rudi G.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Roelfsema, Ferdinand; Pijl, Hanno] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, Leiden, Netherlands; [Oei, Nicole Y.] Univ Amsterdam, Dev Psychol ADAPT Lab, Amsterdam, Netherlands; [Oei, Nicole Y.] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Oei, Nicole Y.; van der Grond, Jeroen] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Cobbaert, Christa M.; Ballieux, Bart E.] Leiden Univ, Med Ctr, Dept Clin Chem & Lab Med, Leiden, Netherlands; [van der Grond, Jeroen] Leiden Univ, LIBC, Leiden, Netherlands; [Westendorp, Rudi G.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Copenhagen	van Heemst, D (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	D.van_Heemst@lumc.nl	Oei, Nicole/T-1219-2019; Akintola, Abi/T-5361-2019; Pijl, Hanno/W-8719-2018	Cobbaert, Christa/0000-0003-3565-1404; Pijl, Hanno/0000-0002-3076-1551	European Commission Project Switchbox (FP7) [Health-F2-2010-2597772]	European Commission Project Switchbox (FP7)	This work was supported by the European Commission Project Switchbox (FP7, Health-F2-2010-2597772).	Bowers J, 2013, ENDOCR REV, V34, P556, DOI 10.1210/er.2012-1056; Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010; Deuschle M, 1997, LIFE SCI, V61, P2239, DOI 10.1016/S0024-3205(97)00926-0; FERRARI E, 1995, NEUROENDOCRINOLOGY, V61, P464, DOI 10.1159/000126869; Fraser CG, 2001, BIOL VARIATION PRINC; HALBREICH U, 1984, PSYCHIAT RES, V13, P221, DOI 10.1016/0165-1781(84)90037-4; Jansen SW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11525; Keenan DM, 2010, AM J PHYSIOL-REG I, V299, pR11, DOI 10.1152/ajpregu.00201.2010; Keenan DM, 2009, AM J PHYSIOL-REG I, V297, pR515, DOI 10.1152/ajpregu.00200.2009; Keenan DM, 2005, J THEOR BIOL, V236, P242, DOI 10.1016/j.jtbi.2005.03.008; Keenan DM, 2001, P NATL ACAD SCI USA, V98, P4028, DOI 10.1073/pnas.051624198; Keenan DM, 2003, AM J PHYSIOL-REG I, V285, pR664, DOI 10.1152/ajpregu.00195.2003; Kok P, 2009, J CLIN ENDOCR METAB, V94, P1176, DOI 10.1210/jc.2008-2303; Kuningas M, 2006, BIOGERONTOLOGY, V7, P231, DOI 10.1007/s10522-006-9021-2; Liu PY, 2009, AM J PHYSIOL-ENDOC M, V297, pE538, DOI 10.1152/ajpendo.00071.2009; Marissal-Arvy N, 2004, J BIOL CHEM, V279, P39232, DOI 10.1074/jbc.M407436200; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MOS J, 1987, MECH AGEING DEV, V38, P89, DOI 10.1016/0047-6374(87)90113-8; Noordam R, 2012, PSYCHONEUROENDOCRINO, V37, P1669, DOI 10.1016/j.psyneuen.2012.02.013; Noordam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031166; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; Pincus SM, 2000, METHOD ENZYMOL, V321, P149; Purnell JQ, 2004, J CLIN ENDOCR METAB, V89, P281, DOI 10.1210/jc.2003-030440; Roelfsema F, 2012, EUR J ENDOCRINOL, V167, P633, DOI 10.1530/EJE-12-0592; Roelfsema F, 2009, J CLIN ENDOCR METAB, V94, P2991, DOI 10.1210/jc.2009-0350; Rozing MP, 2010, J AM GERIATR SOC, V58, P564, DOI 10.1111/j.1532-5415.2010.02725.x; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; SHARMA M, 1989, BIOL PSYCHIAT, V25, P305, DOI 10.1016/0006-3223(89)90178-9; SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439; Stijntjes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057962; TIZABI Y, 1992, NEUROBIOL AGING, V13, P227, DOI 10.1016/0197-4580(92)90034-U; TOUITOU Y, 1983, J ENDOCRINOL, V96, P53, DOI 10.1677/joe.0.0960053; van den Beukel JC, 2014, FASEB J, V28, P4857, DOI 10.1096/fj.14-254839; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; van Rossum EFC, 2004, AM J MED, V117, P158, DOI 10.1016/j.amjmed.2004.01.027; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; VANEEKELEN JAM, 1992, NEUROBIOL AGING, V13, P159, DOI 10.1016/0197-4580(92)90024-R; Veldhuis JD, 2001, AM J PHYSIOL-REG I, V280, pR721; Veldhuis JD, 2013, ENDOCRIN METAB CLIN, V42, P201, DOI 10.1016/j.ecl.2013.02.002; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P2874, DOI 10.1210/jc.2011-0084; Veldhuis JD, 2009, J CLIN ENDOCR METAB, V94, P4045, DOI 10.1210/jc.2009-1143; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Vierhapper H, 2004, METABOLISM, V53, P1174, DOI 10.1016/j.metabol.2004.02.021; Walker BR, 2000, J INTERN MED, V247, P198, DOI 10.1046/j.1365-2796.2000.00609.x; Walker BR, 1998, HYPERTENSION, V31, P891, DOI 10.1161/01.HYP.31.4.891; WALTMAN C, 1991, J CLIN ENDOCR METAB, V73, P495, DOI 10.1210/jcem-73-3-495; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x; Wirtz PH, 2007, PSYCHONEUROENDOCRINO, V32, P430, DOI 10.1016/j.psyneuen.2007.02.006	52	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133119	10.1371/journal.pone.0133119	http://dx.doi.org/10.1371/journal.pone.0133119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193655	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400056
J	Lamoury, FMJ; Jacka, B; Bartlett, S; Bull, RA; Wong, A; Amin, J; Schinkel, J; Poon, AF; Matthews, GV; Grebely, J; Dore, GJ; Applegate, TL				Lamoury, Francois M. J.; Jacka, Brendan; Bartlett, Sofia; Bull, Rowena A.; Wong, Arthur; Amin, Janaki; Schinkel, Janke; Poon, Art F.; Matthews, Gail V.; Grebely, Jason; Dore, Gregory J.; Applegate, Tanya L.			The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; MOLECULAR EVOLUTION; TRANSMISSION; GENOTYPES; HCV; CLASSIFICATION; DIVERGENCE; DIVERSITY; ACCURATE; SUBTYPES	Sequencing is important for understanding the molecular epidemiology and viral evolution of hepatitis C virus (HCV) infection. To date, there is little standardisation among sequencing protocols, in-part due to the high genetic diversity that is observed within HCV. This study aimed to develop a novel, practical sequencing protocol that covered both conserved and variable regions of the viral genome and assess the influence of each subregion, sequence concatenation and unrelated reference sequences on phylogenetic clustering analysis. The Core to the hypervariable region 1 (HVR1) of envelope-2 (E2) and non-structural-5B (NS5B) regions of the HCV genome were amplified and sequenced from participants from the Australian Trial in Acute Hepatitis C (ATAHC), a prospective study of the natural history and treatment of recent HCV infection. Phylogenetic trees were constructed using a general time-reversible substitution model and sensitivity analyses were completed for every subregion. Pairwise distance, genetic distance and bootstrap support were computed to assess the impact of HCV region on clustering results as measured by the identification and percentage of participants falling within all clusters, cluster size, average patristic distance, and bootstrap value. The Robinson-Foulds metrics was also used to compare phylogenetic trees among the different HCV regions. Our results demonstrated that the genomic region of HCV analysed influenced phylogenetic tree topology and clustering results. The HCV Core region alone was not suitable for clustering analysis; NS5B concatenation, the inclusion of reference sequences and removal of HVR1 all influenced clustering outcome. The Core-E2 region, which represented the highest genetic diversity and longest sequence length in this study, provides an ideal method for clustering analysis to address a range of molecular epidemiological questions.	[Lamoury, Francois M. J.; Jacka, Brendan; Bartlett, Sofia; Wong, Arthur; Amin, Janaki; Matthews, Gail V.; Grebely, Jason; Dore, Gregory J.; Applegate, Tanya L.] Univ New South Wales Australia, Kirby Inst, Sydney, NSW, Australia; [Bull, Rowena A.] Univ New South Wales Australia, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia; [Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Sect Clin Virol, NL-1105 AZ Amsterdam, Netherlands; [Poon, Art F.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Poon, Art F.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Dore, Gregory J.] St Vincents Hosp, HIV Immunol Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Amsterdam; Academic Medical Center Amsterdam; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; St Vincents Hospital Sydney	Lamoury, FMJ (corresponding author), Univ New South Wales Australia, Kirby Inst, Sydney, NSW, Australia.	flamoury@kirby.unsw.edu.au	Dore, Gregory John/ABD-5665-2021; matthews, gail/AFL-8501-2022; Bartlett, Sofia/U-3708-2018; Jacka, Brendan/T-3553-2018; Schinkel, Janke/I-3099-2012; Poon, Art/W-9811-2019; matthews, gail/AAG-8626-2022	Dore, Gregory John/0000-0002-4741-2622; Bartlett, Sofia/0000-0003-0699-2250; Jacka, Brendan/0000-0002-5910-853X; Schinkel, Janke/0000-0002-1112-0644; Poon, Art/0000-0003-3779-154X; Amin, Janaki/0000-0003-2161-9366; Bull, Rowena/0000-0002-9844-3744; Matthews, Gail/0000-0002-1048-6396; Applegate, Tanya/0000-0002-8657-4261	National Health and Medical Research Council (NHMRC) grant HIV and HCV vaccines and immunopathogenesis [510448]; NHMRC grant Hepatitis C infection: epidemiology, pathogenesis, and treatment, Australia [1053206]; National Institutes of Health [R01 DA 15999-01]	National Health and Medical Research Council (NHMRC) grant HIV and HCV vaccines and immunopathogenesis(National Health and Medical Research Council (NHMRC) of Australia); NHMRC grant Hepatitis C infection: epidemiology, pathogenesis, and treatment, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Health and Medical Research Council (NHMRC) grant HIV and HCV vaccines and immunopathogenesis (#510448) and NHMRC grant Hepatitis C infection: epidemiology, pathogenesis, and treatment (#1053206), Australia. http://www.nhmrc.gov.au/. The ATAHC study was funded by the National Institutes of Health grant R01 DA 15999-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avo AP, 2013, J MED VIROL, V85, P815, DOI 10.1002/jmv.23545; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Brocchieri L, 2001, THEOR POPUL BIOL, V59, P27, DOI 10.1006/tpbi.2000.1485; BUKH J, 1993, P NATL ACAD SCI USA, V90, P8234, DOI 10.1073/pnas.90.17.8234; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cai QX, 2013, INT J MOL MED, V31, P347, DOI 10.3892/ijmm.2012.1209; Cantarel BL, 2006, MOL BIOL EVOL, V23, P2090, DOI 10.1093/molbev/msl080; Ciccozzi M, 2011, J MED VIROL, V83, P1565, DOI 10.1002/jmv.22154; Cruz-Rivera M, 2013, J CLIN MICROBIOL, V51, P629, DOI 10.1128/JCM.03042-12; Danielsson Axel, 2014, Infection Ecology & Epidemiology, V4, P22251, DOI 10.3402/iee.v4.22251; DAY WHE, 1985, J CLASSIF, V2, P7, DOI 10.1007/BF01908061; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Escobar-Gutierrez A, 2012, J CLIN MICROBIOL, V50, P1461, DOI 10.1128/JCM.00005-12; Feray C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086098; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Galli A, 2014, TRENDS MICROBIOL, V22, P354, DOI 10.1016/j.tim.2014.02.005; Gonzalez-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; Jacka B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067073; Jackowiak P, 2014, INFECT GENET EVOL, V21, P67, DOI 10.1016/j.meegid.2013.10.021; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Lampe E, 2013, ANTIVIR THER, V18, P435, DOI 10.3851/IMP2606; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Matthews GV, 2009, CLIN INFECT DIS, V48, P650, DOI 10.1086/596770; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nei M., MOL EVOLUTION PHYLOG; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Saludes V, 2013, J CLIN VIROL, V57, P263, DOI 10.1016/j.jcv.2013.03.007; Samimi-Rad K, 2013, HEPAT MON, V13, DOI [10.5812/hepatmon.7699, 10.5812/hepatmon.76]; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sulbaran MZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014315; Sultana C, 2011, J GASTROINTEST LIVER, V20, P261; Sunbul M, 2013, INTERVIROLOGY, V56, P201, DOI 10.1159/000346775; Svennblad B, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1313; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; Vanhommerig JW, 2014, CLIN INFECT DIS, V59, P1678, DOI 10.1093/cid/ciu695; Zhang EZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-53	50	42	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131437	10.1371/journal.pone.0131437	http://dx.doi.org/10.1371/journal.pone.0131437			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192190	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400011
J	Lin, CH; Chou, LW; Luo, HJ; Tsai, PY; Lieu, FK; Chiang, SL; Chiang, L; Sung, WH				Lin, Chueh-Ho; Chou, Li-Wei; Luo, Hong-Ji; Tsai, Po-Yi; Lieu, Fu-Kong; Chiang, Shang-Lin; Chiang, Lin; Sung, Wen-Hsu			Effects of Computer-Aided Interlimb Force Coupling Training on Paretic Hand and Arm Motor Control following Chronic Stroke: A Randomized Controlled Trial	PLOS ONE			English	Article							STATIC BIMANUAL MANIPULATION; UPPER-EXTREMITY FUNCTION; ADULT SQUIRREL-MONKEYS; UPPER-LIMB; HEMIPARETIC STROKE; ASSESSMENT SCALE; POST-STROKE; CORTEX; COORDINATION; GRIP	Objective We investigated the training effects of interlimb force coupling training on paretic upper extremity outcomes in patients with chronic stroke and analyzed the relationship between motor recovery of the paretic hand, arm and functional performances on paretic upper limb. Design A randomized controlled trial with outcome assessment at baseline and after 4 weeks of intervention. Setting Taipei Veterans General Hospital, National Yang-Ming University. Participants Thirty-three subjects with chronic stroke were recruited and randomly assigned to training (n = 16) and control groups (n = 17). Interventions The computer-aided interlimb force coupling training task with visual feedback included different grip force generation methods on both hands. Main Outcome Measures The Barthel Index (BI), the upper extremity motor control Fugl-Meyer Assessment (FMA-UE), the Motor Assessment Score (MAS), and the Wolf Motor Function Test (WMFT). All assessments were executed by a blinded evaluator, and data management and statistical analysis were also conducted by a blinded researcher. Results The training group demonstrated greater improvement on the FMA-UE (p<.001), WMFT (p<.001), MAS (p = .004) and BI (p = .037) than the control group after 4 weeks of intervention. In addition, a moderate correlation was found between the improvement of scores for hand scales of the FMA and other portions of the FMA UE (r = .528, p = .018) or MAS (r = .596, p = .015) in the training group. Conclusion Computer-aided interlimb force coupling training improves the motor recovery of a paretic hand, and facilitates motor control and enhances functional performance in the paretic upper extremity of people with chronic stroke.	[Lin, Chueh-Ho] Taipei Med Univ, Sch Gerontol Hlth Management, Taipei, Taiwan; [Lin, Chueh-Ho] Taipei Med Univ, Master Program Long Term Care, Taipei, Taiwan; [Chou, Li-Wei; Luo, Hong-Ji; Chiang, Shang-Lin; Chiang, Lin; Sung, Wen-Hsu] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Tsai, Po-Yi] Taipei Vet Gen Hosp, Phys Med & Rehabil Dept, Taipei, Taiwan; [Lieu, Fu-Kong] Cheng Hsin Hosp, Taipei, Taiwan; [Chiang, Lin] Tri Serv Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chiang, Lin] Natl Def Med Ctr, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Cheng Hsin General Hospital; Tri-Service General Hospital; National Defense Medical Center	Sung, WH (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, 155 Sec 2,Linong St, Taipei 112, Taiwan.	whsung@ym.edu.tw			Ministry of Science and Technology of Taiwan [MOST 103-2221-E-010-008-MY2]; Taipei Medical University [TMU103-AE1-B24]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University	This study was supported by the Ministry of Science and Technology of Taiwan (MOST 103-2221-E-010-008-MY2) and Taipei Medical University (TMU103-AE1-B24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blennerhassett JM, 2008, J HAND THER, V21, P245, DOI 10.1197/j.jht.2007.10.021; Bohannon R. W., 1987, PHYS THER, V67, P206; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Cauraugh JH, 2010, HUM MOVEMENT SCI, V29, P853, DOI 10.1016/j.humov.2009.09.004; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Colle F., 2006, Annales de Readaptation et de Medecine Physique, V49, P361, DOI 10.1016/j.annrmp.2006.04.010; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; DUNCAN PW, 1994, PHYS THER, V74, P399, DOI 10.1093/ptj/74.5.399; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1980, SCAND J REHABIL MED, P85; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GOWLAND C, 1992, PHYS THER, V72, P624, DOI 10.1093/ptj/72.9.624; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Hu XG, 2011, EXP BRAIN RES, V208, P533, DOI 10.1007/s00221-010-2502-1; Jaric S, 2006, EXP BRAIN RES, V168, P88, DOI 10.1007/s00221-005-0070-6; Jaric S, 2005, J ELECTROMYOGR KINES, V15, P556, DOI 10.1016/j.jelekin.2005.03.003; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kang N, 2015, NEUROSCI RES, V94, P79, DOI 10.1016/j.neures.2014.12.005; Kang N, 2015, NEUROSCI LETT, V587, P41, DOI 10.1016/j.neulet.2014.12.028; Kazennikov O, 1999, NEUROSCIENCE, V89, P661, DOI 10.1016/S0306-4522(98)00348-0; Kilbreath SL, 2005, AUST J PHYSIOTHER, V51, P119, DOI 10.1016/S0004-9514(05)70040-4; Krishnan V, 2010, MOTOR CONTROL, V14, P528, DOI 10.1123/mcj.14.4.528; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; Lin JH, 2009, PHYS THER, V89, P840, DOI 10.2522/ptj.20080285; Lodha N, 2012, CLIN NEUROPHYSIOL, V123, P787, DOI 10.1016/j.clinph.2011.08.014; Mayo NE, 1999, DISABIL REHABIL, V21, P258; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Naik SK, 2011, EXP BRAIN RES, V211, P1, DOI 10.1007/s00221-011-2637-8; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Reistetter T, 2009, OCCUP THER INT, V16, P218, DOI 10.1002/oti.278; Rose Dorian K, 2004, Top Stroke Rehabil, V11, P20, DOI 10.1310/XAUM-LPBM-0RXD-RLDK; Rosenstein L, 2008, AM J OCCUP THER, V62, P28, DOI 10.5014/ajot.62.1.28; Rouiller EM, 1998, EUR J NEUROSCI, V10, P729, DOI 10.1046/j.1460-9568.1998.00075.x; Sabari JS, 2005, ARCH PHYS MED REHAB, V86, P1609, DOI 10.1016/j.apmr.2004.12.028; Stinear JW, 2002, J PHYSIOL-LONDON, V543, P307, DOI 10.1113/jphysiol.2002.023986; Sveen U, 1999, DISABIL REHABIL, V21, P372, DOI 10.1080/096382899297477; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; van Delden AEQ, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/972069; van Delden AEQ, 2013, STROKE, V44, P2613, DOI 10.1161/STROKEAHA.113.001969; van Delden AEQ, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-57; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wu CY, 2011, NEUROREHAB NEURAL RE, V25, P130, DOI 10.1177/1545968310380686	51	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131048	10.1371/journal.pone.0131048	http://dx.doi.org/10.1371/journal.pone.0131048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193492	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400009
J	Liu, B; Chen, S; Guan, YJ; Chen, LM				Liu, Bing; Chen, Shan; Guan, Yujuan; Chen, Limin			Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SUSTAINED VIROLOGICAL RESPONSE; PEGINTERFERON LAMBDA-1A; VIRUS-INFECTION; THERAPY; ALPHA; LIVER; SUPPRESSOR; RESISTANCE; DERIVATION	Suppressor of cytokine signaling 1 (SOCS1) has long been thought to block type I interferon signaling. However, IFN-lambda, a type III IFN with limited receptor expression in hepatic cells, efficiently inhibits HCV (Hepatitis C virus) replication in vivo with potentially less side effects than IFN-alpha. Previous studies demonstrated that type I and type III activated Janus kinase/signal transducer and activator of transcription (Jak/STAT) signaling pathway differently, with delayed but prolonged activation by IFN-lambda stimulation compared to IFN alpha/beta. However, the molecular mechanisms underlying this observation is not well understood. Here, we found that there are distinct differences in SOCS1 expression patterns in Huh-7.5.1 cells following stimulation with IFN-alpha and IFN-lambda. IFN-lambda induced a faster but shorter expression of SOCS1. Furthermore, we confirmed that SOCS1 over-expression abrogates anti-HCV effect of both IFN-alpha and IFN-lambda, leading to increased HCV RNA replication in both HCV replicon cells and JFH1 HCV culture system. In line with this, SOCS1 over-expression inhibited STAT1 phosphorylation, attenuated IFN-stimulated response elements (ISRE) reporter activity, and blocked IFN-stimulated genes (ISGs) expression. Finally, we measured SOCS1 mRNA expression levels in peripheral blood mononuclear cells (PBMCs) with or without IFN-alpha treatment from 48 chronic hepatitis C patients and we found the baseline SOCS1 expression levels are higher in treatment non-responders than in responders before IFN-alpha treatment. Taken together, SOCS1 acts as a suppressor for both type I and type III IFNs and is negatively associated with sustained virological response (SVR) to IFN-based therapy in patients with HCV. More importantly, faster but shorter induction of SOCS1 by IFN-lambda may contribute to delayed but prolonged activation of IFN signaling and ISG expression kinetics by type III IFN.	[Liu, Bing; Chen, Shan; Chen, Limin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China; [Liu, Bing; Chen, Shan; Chen, Limin] Peking Union Med Coll, Chengdu, Sichuan, Peoples R China; [Guan, Yujuan] Guangzhou 8 Peoples Hosp, Guangzhou, Guangdong, Peoples R China; [Chen, Limin] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Chen, LM (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China.	limin_chen_99@yahoo.com	Chen, Limin/A-8813-2012		Natural Science Foundation of China (NSFC) [81471956, 91442128]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Natural Science Foundation of China (NSFC, 81471956, 91442128), (http://www.amazon.com/gp/product/B00C4OE79K?tag = topone03-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Chen LM, 2011, INT J BIOCHEM CELL B, V43, P1427, DOI 10.1016/j.biocel.2011.06.006; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Feld JJ, 2014, ANTIVIR RES, V105, P32, DOI 10.1016/j.antiviral.2014.02.005; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Friborg J, 2013, ANTIMICROB AGENTS CH, V57, P1312, DOI 10.1128/AAC.02239-12; Fujimoto M, 2010, THERMODYNAMICS OF CRYSTALLINE STATES, P1, DOI 10.1007/978-1-4419-6688-9_1; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Hruska M, 2015, J CLIN PHARMACOL, V55, P73, DOI 10.1002/jcph.361; Iijima S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118000; Imanaka K, 2005, J VIRAL HEPATITIS, V12, P130, DOI 10.1111/j.1365-2893.2005.00576.x; Jaroszewicz J, 2014, LIVER INT, V34, P6, DOI 10.1111/liv.12294; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Koh C, 2014, ANTIVIR RES, V104, P34, DOI 10.1016/j.antiviral.2014.01.005; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Li S, 2014, J VIRAL HEPATITIS, V21, P121, DOI 10.1111/jvh.12131; Li YJ, 2014, REV MED VIROL, V24, P332, DOI 10.1002/rmv.1795; Lin WY, 2005, GASTROENTEROLOGY, V128, P1034, DOI 10.1053/j.gastro.2005.02.006; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Olagnier D, 2014, HEPATOLOGY, V59, P1225, DOI 10.1002/hep.26959; Pascarella S, 2013, LIVER INT, V33, P94, DOI 10.1111/liv.12031; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Pfeffer LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104202; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Shao RX, 2013, ANTIVIR RES, V97, P101, DOI 10.1016/j.antiviral.2012.12.001; Shao RX, 2010, J VIROL, V84, P6060, DOI 10.1128/JVI.02484-09; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Sorrell MF, 2009, HEPATOLOGY, V49, pS4, DOI 10.1002/hep.22946; Wang XD, 2015, J CLIN PHARMACOL, V55, P63, DOI 10.1002/jcph.363; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao C, 2013, TRENDS MICROBIOL, V21, P181, DOI 10.1016/j.tim.2013.01.005; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	40	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133800	10.1371/journal.pone.0133800	http://dx.doi.org/10.1371/journal.pone.0133800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193702	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400117
J	Park, Y; Shin, JA; Yang, SW; Yim, HW; Kim, HS; Park, YH				Park, Yuli; Shin, Jeong Ah; Yang, Suk Woo; Yim, Hyeon Woo; Kim, Hyun Seung; Park, Young-Hoon		Korean Ophthalmologic Soc	The Relationship between Visual Impairment and Health-Related Quality of Life in Korean Adults: The Korea National Health and Nutrition Examination Survey (2008-2012)	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; COST-EFFECTIVENESS; INSTRUMENT; ORDER; EUROQOL; INDEX; EQ-5D	Introduction To evaluate health-related quality of life (HRQoL) in Korean adults with visual impairment (VI) using various measures based on a nationally distributed sample. Methods Using the Korea National Health and Nutrition Examination Survey (KNHANES, 20082012) data, we compared EuroQol five-dimensional questionnaire (EQ-5D) and EQ-visual analogue scale (VAS) scores after adjusting for socio-demographic and psychosocial factors as well as for comorbidities with VI. Logistic regressions were used to elucidate determinants for the lowest quintile HRQoL scales according to VI severity. Uncorrected visual acuity (VA) which implies vision of ordinary life was measured using an international standard vision chart based on Snellen scale. Results 28,825 participants (sum of weights; 37,562,376) were included in the analysis. The mean EQ-5D and EQ-VAS scores were significantly lower in the VI groups than in the normal vision (defined as VA 20/20-20/25) group based on the better or worse seeing eye (P<.0001 and P<.0001, respectively). Participants with moderate (VA 20/80-20/160) and severe VI (VA <= 20/200) had higher scores of multivariate-adjusted odd ratios (aORs) for the lowest quintile than did the normal vision group which was particularly evident in the results from EQ-5D, whereas the results of the mild VI (VA 20/32-20/63) group did not identify significant differences from the normal vision group independent of classification according to the better or the worse seeing eye. Conversely, EQ-VAS revealed significantly higher score of multivariate-aORs for the lowest quintile in participants with mild VI either for the better or worse seeing eye. Conclusions The severity of VI was definitely associated with impaired HRQoL compared with the normal vision population. The analyses presented here elicited even mild VI could potentially deteriorate the health-related quality of life (or subjective perception of health quality) and therefore, therapeutic approaches should also focus on the subjective perception and better management of health condition.	[Park, Yuli; Kim, Hyun Seung] Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Shin, Jeong Ah; Yang, Suk Woo; Park, Young-Hoon] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Yim, Hyeon Woo] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Park, YH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	parkyh@catholic.ac.kr		Kim, Hyun Seung/0000-0001-6825-8612	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	The authors acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2012.	Aoki N, 2004, DIABETES CARE, V27, P1095, DOI 10.2337/diacare.27.5.1095; Brandle M, 2004, CURR MED RES OPIN, V20, pS1, DOI 10.1185/030079904X1962; Brazier J, 2007, MEASURING VALUING HL; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Childs A, 2005, QUAL LIFE RES, V14, P493, DOI 10.1007/s11136-004-0727-9; *CONST WHO, 1952, HDB BAS DOC, P3; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; Glasziou P, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-21; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Kontodimopoulos N, 2009, QUAL LIFE RES, V18, P87, DOI 10.1007/s11136-008-9420-8; Kopec JA, 2003, J CLIN EPIDEMIOL, V56, P317, DOI 10.1016/S0895-4356(02)00609-1; Longworth L, 2003, HEALTH ECON, V12, P1061, DOI 10.1002/hec.787; McColl E, 2003, MED CARE, V41, P777, DOI 10.1097/00005650-200307000-00002; McPhail S, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-48; Nam HS., 2007, EQ 5D KOREAN VALUATI; Patrick D L, 1973, Health Serv Res, V8, P228; Rat AC, 2008, OSTEOARTHR CARTILAGE, V16, P429, DOI 10.1016/j.joca.2007.07.011; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Saito I, 2006, DIABETES RES CLIN PR, V73, P51, DOI 10.1016/j.diabres.2005.11.015; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Smith DW, 2004, QUAL LIFE RES, V13, P1391, DOI 10.1023/B:QURE.0000040785.59444.7c; Squirrell DM, 2003, J ROY SOC MED, V96, P273, DOI 10.1258/jrsm.96.6.273; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Torrance G W, 1972, Health Serv Res, V7, P118; Van Wijck EEE, 1998, MED DECIS MAKING, V18, P400, DOI 10.1177/0272989X9801800407; VICKREY BG, 1994, EPILEPSIA, V35, P597, DOI 10.1111/j.1528-1157.1994.tb02480.x; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wu AW, 1997, QUAL LIFE RES, V6, P3, DOI 10.1023/A:1026471020698; Zhou H, 2005, DIABETES CARE, V28, P2856, DOI 10.2337/diacare.28.12.2856	31	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132779	10.1371/journal.pone.0132779	http://dx.doi.org/10.1371/journal.pone.0132779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192763	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400039
J	Saint-Mont, U				Saint-Mont, Uwe			Randomization Does Not Help Much, Comparability Does	PLOS ONE			English	Article							STATISTICS; TRIALS	According to R.A. Fisher, randomization "relieves the experimenter from the anxiety of considering innumerable causes by which the data may be disturbed." Since, in particular, it is said to control for known and unknown nuisance factors that may considerably challenge the validity of a result, it has become very popular. This contribution challenges the received view. First, looking for quantitative support, we study a number of straightforward, mathematically simple models. They all demonstrate that the optimism surrounding randomization is questionable: In small to medium-sized samples, random allocation of units to treatments typically yields a considerable imbalance between the groups, i.e., confounding due to randomization is the rule rather than the exception. In the second part of this contribution, the reasoning is extended to a number of traditional arguments in favour of randomization. This discussion is rather non-technical, and sometimes touches on the rather fundamental Frequentist/ Bayesian debate. However, the result of this analysis turns out to be quite similar: While the contribution of randomization remains doubtful, comparability contributes much to a compelling conclusion. Summing up, classical experimentation based on sound background theory and the systematic construction of exchangeable groups seems to be advisable.	Nordhausen Univ Appl Sci, Nordhausen, Germany		Saint-Mont, U (corresponding author), Nordhausen Univ Appl Sci, Nordhausen, Germany.	saint-mont@fh-nordhausen.de						Abel U, 1999, J CLIN EPIDEMIOL, V52, P487; ALTMAN DG, 1985, J ROY STAT SOC D-STA, V34, P125; [Anonymous], 1908, BIOMETRIKA, V6, P1; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; BASU D, 1980, J AM STAT ASSOC, V75, P575, DOI 10.2307/2287648; Basu D., 1988, STAT INFORM LIKELIHO; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Berger VW, 2004, CONTROL CLIN TRIALS, V25, P515, DOI 10.1016/j.cct.2004.04.001; Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641; Berk R.A., 2005, J EXP CRIMINOL, V1, P417, DOI [DOI 10.1007/S11292-005-3538-2, 10.1007/s11292-005-3538-2]; Bookstein FL, 2014, MEASURING AND REASONING: NUMERICAL INFERENCE IN THE SCIENCES, P1, DOI 10.1017/CBO9781139161923; Brillinger D.R., 1978, ROLE STAT WEATHER RE; Carpenter S, 2012, SCIENCE, V335, P1558, DOI 10.1126/science.335.6076.1558; Chu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036677; Cohen J., 1988, STAT POWER ANAL SOCI, V2; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Cornfield J, AM J EPIDEM, V104, P408; DEFINETTI B, 1974, THEORY PROBABILITY; DRAPER D, 1993, J ROY STAT SOC A STA, V156, P9, DOI 10.2307/2982858; Efron B, 1998, STAT SCI, V13, P95; Efron B, 2001, COMMUNICATION; Elston DA, 1990, J ROYAL STAT SOC A, V153, P340; Fisher RA, 1936, J R ANTHROPOL INST G, V66, P57, DOI 10.2307/2844116; Fisher RA, 1935, DESIGN EXPT; Fisher RA, 1959, SMOKING CANC CONTROV; Freedman DA, 2008, STAT SCI, V23, P237, DOI 10.1214/08-STS262; Freedman DA, 2008, ADV APPL MATH, V40, P180, DOI 10.1016/j.aam.2006.12.003; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Greenland S, 1999, STAT SCI, V14, P29; Greenland S., 2000, EPIDEMIOLOGY, V1, P421; HACKING I, 1988, ISIS, V79, P427, DOI 10.1086/354775; Heckman JJ, 2005, SOCIOL METHODOL, V35, P1, DOI 10.1111/j.0081-1750.2006.00164.x; HINKLEY DV, 1980, J AM STAT ASSOC, V75, P582, DOI 10.2307/2287649; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; Howson C., 2006, SCI REASONING; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Jaynes E.T., 2003, PROBABILITY THEORY L; Johnson NL, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471715816; JOHNSTONE DJ, 1988, BRIT J PHILOS SCI, V39, P353, DOI 10.1093/bjps/39.3.353; KADANE JB, 1990, J STAT PLAN INFER, V25, P329, DOI 10.1016/0378-3758(90)90080-E; LEE KL, 1980, CIRCULATION, V61, P508, DOI 10.1161/01.CIR.61.3.508; Li M., 2008, INTRO KOLMOGOROV COM; Lindley, 1982, S INVITED PAPERS, V2, P431; Mill J., 1843, SYSTEM LOGIC RATIOCI; National Institute of Health, 2013, REPL KEY CLIN TRIALS; Nelder JA, 1999, STATISTICIAN, V48, P257, DOI DOI 10.1111/1467-9884.00187; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Penston J., 2003, FICTION FANTASY MED; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rissanen J., 2007, INFORM COMPLEXITY ST; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Rosenberger WF, 2002, RANDOMIZATION CLIN T; RUBIN DB, 1978, ANN STAT, V6, P34, DOI 10.1214/aos/1176344064; Saint-Mont U, 2014, RANDOMIZATION DOES N; Savage L., 1962, FDN STAT INFERENCE D; SAVAGE LJ, 1976, ANN STAT, V4, P441, DOI 10.1214/aos/1176343456; Seidenfeld T., 1979, PHILOS PROBLEMS STAT; SENN S, 1994, STAT MED, V13, P217, DOI 10.1002/sim.4780130305; Senn S, 2000, J ROY STAT SOC D-STA, V49, P135, DOI 10.1111/1467-9884.00227; Sornette D, 2006, CRITICAL PHENOMENA N; Treasure T, 1998, BRIT MED J, V317, P362; Tu DS, 2000, DRUG INF J, V34, P511, DOI 10.1177/009286150003400220; URBACH P, 1985, PHILOS SCI, V52, P256, DOI 10.1086/289243; *US DEP HLTH ED WE, 1964, PHS PUBL, V1103; WANG C, 1993, SENSE NONSENSE STAT; Worrall J, 2007, BRIT J PHILOS SCI, V58, P451, DOI 10.1093/bjps/axm024	68	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132102	10.1371/journal.pone.0132102	http://dx.doi.org/10.1371/journal.pone.0132102			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193621	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400019
J	Vrancken, ACT; Madej, W; Hannink, G; Verdonschot, N; van Tienen, TG; Buma, P				Vrancken, A. C. T.; Madej, W.; Hannink, G.; Verdonschot, N.; van Tienen, T. G.; Buma, P.			Short Term Evaluation of an Anatomically Shaped Polycarbonate Urethane Total Meniscus Replacement in a Goat Model	PLOS ONE			English	Article							HUMAN CADAVERIC KNEE; ALLOGRAFT TRANSPLANTATION; CONTACT MECHANICS; MEDIAL MENISCUS; IN-VIVO; MENISCECTOMY; CARTILAGE; SHEEP; OSTEOARTHRITIS; SUBSTITUTION	Purpose Since the treatment options for symptomatic total meniscectomy patients are still limited, an anatomically shaped, polycarbonate urethane (PCU), total meniscus replacement was developed. This study evaluates the in vivo performance of the implant in a goat model, with a specific focus on the implant location in the joint, geometrical integrity of the implant and the effect of the implant on synovial membrane and articular cartilage histopathological condition. Methods The right medial meniscus of seven Saanen goats was replaced by the implant. Sham surgery (transection of the MCL, arthrotomy and MCL suturing) was performed in six animals. The contralateral knee joints of both groups served as control groups. After three months follow-up the following aspects of implant performance were evaluated: implant position, implant deformation and the histopathological condition of the synovium and cartilage. Results Implant geometry was well maintained during the three month implantation period. No signs of PCU wear were found and the implant did not induce an inflammatory response in the knee joint. In all animals, implant fixation was compromised due to suture breakage, wear or elongation, likely causing the increase in extrusion observed in the implant group. Both the femoral cartilage and tibial cartilage in direct contact with the implant showed increased damage compared to the sham and sham-control groups. Conclusion This study demonstrates that the novel, anatomically shaped PCU total meniscal replacement is biocompatible and resistant to three months of physiological loading. Failure of the fixation sutures may have increased implant mobility, which probably induced implant extrusion and potentially stimulated cartilage degeneration. Evidently, redesigning the fixation method is necessary. Future animal studies should evaluate the improved fixation method and compare implant performance to current treatment standards, such as allografts.	[Vrancken, A. C. T.; Hannink, G.; Verdonschot, N.; van Tienen, T. G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Orthopaed Res Lab, NL-6525 ED Nijmegen, Netherlands; [Madej, W.; Buma, P.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Orthopaed Res Lab, NL-6525 ED Nijmegen, Netherlands; [Verdonschot, N.] Univ Twente, Lab Biomech Engn, NL-7500 AE Enschede, Netherlands; [van Tienen, T. G.] Dept Orthopaed Surg, Mill, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Twente	Vrancken, ACT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Orthopaed Res Lab, NL-6525 ED Nijmegen, Netherlands.	Anne.Vrancken@radboudumc.nl	Hannink, Gerjon/A-2597-2015; Buma, P./H-8019-2014; Verdonschot, N.J.J./H-8104-2014	Verdonschot, N.J.J./0000-0002-7531-6523; Hannink, Gerjon/0000-0001-9526-3775	TRAMMPOLIN of research program of BioMedical Materials institute [P2.03]; Dutch Ministry of Economic Affairs	TRAMMPOLIN of research program of BioMedical Materials institute; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research forms part of the Project P2.03 TRAMMPOLIN of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs (www.bmm-program.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abat F, 2013, KNEE SURG SPORT TR A, V21, P1516, DOI 10.1007/s00167-012-2032-4; Abrams GD, 2013, AM J SPORT MED, V41, P2333, DOI 10.1177/0363546513495641; Alhalki MM, 1999, AM J SPORT MED, V27, P320, DOI 10.1177/03635465990270030901; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; BARATZ ME, 1986, AM J SPORT MED, V14, P270, DOI 10.1177/036354658601400405; Bellemans J, 2010, MENISCAL RECONSTRUCT, P303; Bradley MP, 2007, ORTHOPEDICS, V30, P650, DOI 10.3928/01477447-20070801-15; Brophy RH, 2010, J BIOMED MATER RES A, V92A, P1154, DOI 10.1002/jbm.a.32384; Carbone A, 2006, J ARTHROPLASTY, V21, P899, DOI 10.1016/j.arth.2005.07.023; Chen MI, 1996, ARTHROSCOPY, V12, P174, DOI 10.1016/S0749-8063(96)90007-9; De Coninck T, 2014, CLIN BIOMECH, V29, P898, DOI 10.1016/j.clinbiomech.2014.07.001; Dienst M, 2007, AM J SPORT MED, V35, P34, DOI 10.1177/0363546506291404; ElAttar M, 2011, KNEE SURG SPORT TR A, V19, P147, DOI 10.1007/s00167-010-1351-6; Elsner JJ, 2010, J BIOMECH ENG, V132; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; Fabbriciani C, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P124; Flanagan S., 2010, FRICTION LUBRICATION; Gruchenberg K, 2015, KNEE SURG SPORT TR A, V23, P2218, DOI 10.1007/s00167-014-3009-2; Hommen JP, 2007, ARTHROSCOPY, V23, P388, DOI 10.1016/j.arthro.2006.11.032; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Jang SH, 2011, ARTHROSCOPY, V27, DOI 10.1016/j.arthro.2011.02.017; Kelly BT, 2007, AM J SPORT MED, V35, P43, DOI 10.1177/0363546506292848; Khan M, 2005, BIOMATERIALS, V26, P633, DOI 10.1016/j.biomaterials.2004.02.064; Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028; Kon E, 2012, TISSUE ENG A; Kon E, 2012, TISSUE ENG PT A, V18, P1573, DOI [10.1089/ten.TEA.2011.0572, 10.1089/ten.tea.2011.0572]; Lee BS, 2012, AM J SPORT MED, V40, P1384, DOI 10.1177/0363546512442341; Lee DH, 2010, AM J SPORT MED, V38, P247, DOI 10.1177/0363546509346399; Lee SJ, 2006, AM J SPORT MED, V34, P1334, DOI 10.1177/0363546506286786; Little CB, 2010, OSTEOARTHR CARTILAGE, V18, pS80, DOI 10.1016/j.joca.2010.04.016; Liu WH, 2003, J ORTHOP RES, V21, P730, DOI 10.1016/S0736-0266(03)00002-0; MESSNER K, 1993, BIOMATERIALS, V14, P163, DOI 10.1016/0142-9612(93)90018-W; MESSNER K, 1994, BIOMATERIALS, V15, P223, DOI 10.1016/0142-9612(94)90071-X; Paletta GA, 1997, AM J SPORT MED, V25, P692, DOI 10.1177/036354659702500519; Proffen BL, 2012, KNEE, V19, P493, DOI 10.1016/j.knee.2011.07.005; Rath E, 2001, AM J SPORT MED, V29, P410, DOI 10.1177/03635465010290040401; Rosso F, 2015, AM J SPORT MED, V43, P998, DOI 10.1177/0363546514536021; Szomor ZL, 2000, J BONE JOINT SURG AM, V82A, P80, DOI 10.2106/00004623-200001000-00010; TIRGARI M, 1975, VET REC, V96, P394, DOI 10.1136/vr.96.18.394; Vandeweerd JM, 2013, OSTEOARTHR CARTILAGE, V21, P1125, DOI 10.1016/j.joca.2013.05.006; Verdonk P, 2004, KNEE SURG SPORT TR A, V12, P411, DOI 10.1007/s00167-004-0500-1; Vrancken ACT, 2014, KNEE, V21, P1033, DOI 10.1016/j.knee.2014.08.006; Welsing RTC, 2008, AM J SPORT MED, V36, P1978, DOI 10.1177/0363546508319900; Zur G, 2011, KNEE SURG SPORT TR A, V19, P255, DOI 10.1007/s00167-010-1210-5	44	23	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133138	10.1371/journal.pone.0133138	http://dx.doi.org/10.1371/journal.pone.0133138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192414	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400061
J	Wu, JY; Hu, LR; Zhang, GH; Wu, FP; He, TP				Wu, Jiayuan; Hu, Liren; Zhang, Gaohua; Wu, Fenping; He, Taiping			Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PREDICTING BACTEREMIA; SUBTYPE PRESEPSIN; PROGNOSTIC VALUE; SEPTIC SHOCK; SCD14-ST; PROCALCITONIN; MANAGEMENT; INFECTION; UTILITY	Objective It's difficult to differentiate sepsis from non-sepsis, especially non-infectious SIRS, because no good standard exists for proof of infection. Soluble CD14 subtype (sCD14-ST), recently re-named presepsin, was identified as a new marker for the diagnosis of sepsis in several reports. However, the findings were based on the results of individual clinical trials, rather than a comprehensive and overall estimation. Thus, we conducted this systematic review and meta-analysis to estimate the pooled accuracy of presepsin in patients with sepsis suspect. Methods A comprehensive electronic search was performed via internet retrieval system up to 15 December 2014. Methodological quality assessment was applied by using the QUADAS2 tool. The diagnostic value of presepsin in sepsis was evaluated by using the pooled estimate of sensitivity, specificity, likelihood ratio, and diagnostic odds ratio, as well as summary receiver operating characteristics curve. Results Nine studies with 10 trials and 2159 cases were included in the study. Only two trials had low concerns regarding applicability, whereas all trials were deemed to be at high risk of bias. Heterogeneity existed in the non-threshold effect, but not in the threshold effect. The pooled sensitivity of presepsin for sepsis was 0.78 (0.76-0.80), pooled specificity was 0.83 (0.80-0.85), pooled positive likelihood ratio was 4.63 (3.27-6.55), pooled negative likelihood ratio was 0.22 (0.16-0.30), and pooled diagnostic odds ratio was 21.73 (12.81-36.86). The area under curve of summary receiver operating characteristics curve was 0.89 (95% CI: 0.84 to 0.94) and Q* index was 0.82 (95% CI: 0.77 to 0.87). Conclusion This meta-analysis demonstrates that presepsin had some superiority in the management of patients, and may be a helpful and valuable biomarker in early diagnosis of sepsis. However, presepsin showed a moderate diagnostic accuracy in differentiating sepsis from nonsepsis which prevented it from being recommended as a definitive test for diagnosing sepsis in isolation, but the results should be interpreted cautiously.	[Wu, Jiayuan] Guangdong Med Coll, Affiliated Hosp, Dept Nutr, Zhanjiang, Guangdong, Peoples R China; [Hu, Liren; Zhang, Gaohua] Guangdong Med Coll, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Zhanjiang, Guangdong, Peoples R China; [Wu, Fenping] Oncol Hosp Chengdu, Peoples Hosp Chengdu 7, Dept Radiotherapy, Chengdu, Sichuan, Peoples R China; [He, Taiping] Guangdong Med Coll, Sch Publ Hlth, Zhanjiang, Guangdong, Peoples R China	Guangdong Medical University; Guangdong Medical University; Guangdong Medical University	Wu, JY (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Nutr, Zhanjiang, Guangdong, Peoples R China.	87537665@qq.com; taipinghe@163.com	Wu, Jiayuan/GZA-7649-2022; Wu, Jiayuan/AAM-9603-2020	Wu, Jiayuan/0000-0002-4626-2773; Wu, Jiayuan/0000-0002-4626-2773; taiping, He/0000-0001-6213-0837	Scientific and Technological Innovation Project of Educational Commission of Guangdong Province [2013KJCX0092]	Scientific and Technological Innovation Project of Educational Commission of Guangdong Province	This study (TH) was funded by the Scientific and Technological Innovation Project of Educational Commission of Guangdong Province (Grant No. 2013KJCX0092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACCP/SCCM Consensus Conference Committee, 1992, CRIT CARE MED, V20, P867; Balci C, 2003, CRIT CARE, V7, P85, DOI 10.1186/cc1843; BATES DW, 1990, ANN INTERN MED, V113, P495, DOI 10.7326/0003-4819-113-7-495; Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behnes M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0507-z; Cargnin S, 2014, PHARMACOGENOMICS, V15, P963, DOI 10.2217/pgs.14.52; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Dwamena B., 2007, MIDAS STATA MODULE M; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Endo S, 2012, J INFECT CHEMOTHER, V18, P891, DOI 10.1007/s10156-012-0435-2; Gatsonis C, 2006, AM J ROENTGENOL, V187, P271, DOI 10.2214/AJR.06.0226; Kweon OJ, 2014, J CRIT CARE, V29, P965, DOI 10.1016/j.jcrc.2014.06.014; Lamy PJ, 2000, LUNG CANCER, V29, P197, DOI 10.1016/S0169-5002(00)00113-6; Lee SH, 2013, INT J CLIN PRACT, V67, P1350, DOI 10.1111/ijcp.12278; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Liu B, 2013, CRIT CARE, V17, DOI 10.1186/cc13070; Liu T, 2014, INT J LAB MED, V35, P2794; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mussap M, 2011, J MATERN-FETAL NEO M, V24, P13, DOI 10.3109/14767058.2011.601923; Nisman B, 2009, ANTICANCER RES, V29, P4827; Okamura Y, 2011, CLIN CHIM ACTA, V412, P2157, DOI 10.1016/j.cca.2011.07.024; Palmiere C, 2013, INT J LEGAL MED, V127, P799, DOI 10.1007/s00414-012-0804-5; Sandquist M, 2014, EXPERT REV CLIN IMMU, V10, P1349, DOI 10.1586/1744666X.2014.949675; Sargentini V, 2015, CLIN CHEM LAB MED, V53, P567, DOI 10.1515/cclm-2014-0119; Shirakawa K, 2011, CLIN CHEM LAB MED, V49, P937, DOI 10.1515/CCLM.2011.145; Shozushima T, 2011, J INFECT CHEMOTHER, V17, P764, DOI 10.1007/s10156-011-0254-x; [苏明环 Su Minghuan], 2014, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V32, P106; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vodnik T, 2013, CLIN CHEM LAB MED, V51, P2053, DOI 10.1515/cclm-2013-0061; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Walker SD, 2002, STAT MED, V15, P1237; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yaegashi Yasunori, 2005, Journal of Infection and Chemotherapy, V11, P234, DOI 10.1007/s10156-005-0400-4; [余建 Yu Jian], 2014, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V32, P200; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zou Q, 2014, WORLD J EMERG MED, V5, P16, DOI [10.5847/wjem.j.1920-8642.2014.01.002, 10.5847/wjem.j.issn.1920-8642.2014.01.002]	43	81	87	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133057	10.1371/journal.pone.0133057	http://dx.doi.org/10.1371/journal.pone.0133057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192602	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400050
J	Feng, J; Mertz, B				Feng, Jun; Mertz, Blake			Novel Phosphotidylinositol 4,5-Bisphosphate Binding Sites on Focal Adhesion Kinase	PLOS ONE			English	Article							DOMAIN; PIP2; FAK	Focal adhesion kinase (FAK) is a protein tyrosine kinase that is ubiquitously expressed, recruited to focal adhesions, and engages in a variety of cellular signaling pathways. Diverse cellular responses, such as cell migration, proliferation, and survival, are regulated by FAK. Prior to activation, FAK adopts an autoinhibited conformation in which the FERM domain binds the kinase domain, blocking access to the activation loop and substrate binding site. Activation of FAK occurs through conformational change, and acidic phospholipids such as phosphatidylinositol 4,5-bisphosphate (PIP2) are known to facilitate this process. PIP2 binding alters the autoinhibited conformation of the FERM and kinase domains and subsequently exposes the activation loop to phosphorylation. However, the detailed molecular mechanism of PIP2 binding and its role in FAK activation remain unclear. In this study, we conducted coarse-grained molecular dynamics simulations to investigate the binding of FAK to PIP2. Our simulations identified novel areas of basic residues in the kinase domain of FAK that potentially undergo transient binding to PIP2 through electrostatic attractions. Our investigation provides a molecular picture of PIP2-initiated FAK activation and introduces promising new pathways for future studies of FAK regulation.	[Feng, Jun; Mertz, Blake] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA	West Virginia University	Mertz, B (corresponding author), W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.	blake.mertz@mail.wvu.edu			West Virginia University	West Virginia University	West Virginia University provided startup funds to conduct this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron R, 2007, CHEMPHYSCHEM, V8, P452, DOI 10.1002/cphc.200600658; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Ellenbroek WG, 2011, BIOPHYS J, V101, P2178, DOI 10.1016/j.bpj.2011.09.039; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irino Y, 2012, J LIPID RES, V53, P810, DOI 10.1194/jlr.D019547; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Periole Xavier, 2013, Methods Mol Biol, V924, P533, DOI 10.1007/978-1-62703-017-5_20; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Zhou J, 2015, BIOPHYS J, V108, P698, DOI 10.1016/j.bpj.2014.11.3454	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132833	10.1371/journal.pone.0132833	http://dx.doi.org/10.1371/journal.pone.0132833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186725	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700064
J	Cabanel, M; Brand, C; Oliveira-Nunes, MC; Cabral-Piccin, MP; Lopes, MF; Brito, JM; de Oliveira, FL; El-Cheikh, MC; Carneiro, K				Cabanel, Mariana; Brand, Camila; Oliveira-Nunes, Maria Cecilia; Cabral-Piccin, Mariela Pires; Lopes, Marcela Freitas; Brito, Jose Marques; de Oliveira, Felipe Leite; El-Cheikh, Marcia Cury; Carneiro, Katia			Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity	PLOS ONE			English	Article							TRICHOSTATIN-A; ACTIVATION; PU.1; CELL; DIFFERENTIATION; PROLIFERATION; PROGENITORS; INHIBITION	Inflammatory chronic pathologies are complex processes characterized by an imbalance between the resolution of the inflammatory phase and the establishment of tissue repair. The main players in these inflammatory pathologies are bone marrow derived monocytes (BMDMs). However, how monocyte differentiation is modulated to give rise to specific macrophage subpopulations (M1 or M2) that may either maintain the chronic inflammatory process or lead to wound healing is still unclear. Considering that inhibitors of Histone Deacetylase (HDAC) have an anti-inflammatory activity, we asked whether this enzyme would play a role on monocyte differentiation into M1 or M2 phenotype and in the cell shape transition that follows. We then induced murine bone marrow progenitors into monocyte/macrophage differentiation pathway using media containing GM-CSF and the HDAC blocker, Trichostatin A (TSA). We found that the pharmacological inhibition of HDAC activity led to a shape transition from the typical macrophage pancake-like shape into an elongated morphology, which was correlated to a mixed M1/M2 profile of cytokine and chemokine secretion. Our results present, for the first time, that HDAC activity acts as a regulator of macrophage differentiation in the absence of lymphocyte stimuli. We propose that HDAC activity down regulates macrophage plasticity favoring the pro-inflammatory phenotype.	[Cabanel, Mariana; Brand, Camila; Oliveira-Nunes, Maria Cecilia; Brito, Jose Marques; de Oliveira, Felipe Leite; El-Cheikh, Marcia Cury; Carneiro, Katia] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Cabral-Piccin, Mariela Pires; Lopes, Marcela Freitas] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Carneiro, K (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.	kcarneiro@histo.ufrj.br	Carneiro, Katia/I-6014-2015; Oliveira, Felipe L/H-9902-2012; Lopes, Marcela Freitas/E-2201-2012; Carneiro, Katia/AAQ-3415-2020; Brand, Camila/D-8873-2014	Lopes, Marcela Freitas/0000-0002-4508-0505; Carneiro, Katia/0000-0001-5915-5486; Leite de Oliveira, Felipe/0000-0001-6193-1616	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES) from the Ministry of Education for Fellowship; National Council for Technological and Scientific Development (CNPq) [474076/2013-0]; Rio de Janeiro State Research Foundation (FAPERJ) [E-26-110.812-2013]; PEW Foundation [2008-000746-012]	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES) from the Ministry of Education for Fellowship; National Council for Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PEW Foundation	This work was supported by Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES) from the Ministry of Education for Fellowship to MC; National Council for Technological and Scientific Development (CNPq 474076/2013-0; www.cnpq.br) to KC; Rio de Janeiro State Research Foundation (FAPERJ E-26-110.812-2013, www.faperj.br) to KC; and PEW Foundation (2008-000746-012; www.pewtrusts.org) to KC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-29; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; ELCHEIKH MC, 1990, INFECT IMMUN, V58, P816, DOI 10.1128/IAI.58.3.816-821.1990; Green L.C., 1982, BIOCHEMISTRY-US, V126, P131, DOI DOI 10.1016/0003-2697(82)90118-X; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han SB, 2009, ARCH PHARM RES, V32, P613, DOI 10.1007/s12272-009-1418-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kittan NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078045; KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x; Laribee RN, 2001, J IMMUNOL, V167, P5160, DOI 10.4049/jimmunol.167.9.5160; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Shivdasani RA, 1997, BLOOD, V90, P1821, DOI 10.1182/blood.V90.5.1821; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Shivdasani RA, 1997, HEMATOL ONCOL CLIN N, V11, P1199, DOI 10.1016/S0889-8588(05)70489-5; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tseng AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026382; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	26	31	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132984	10.1371/journal.pone.0132984	http://dx.doi.org/10.1371/journal.pone.0132984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196676	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600059
J	Jin, ZN; Wang, WQ; Jiang, N; Zhang, L; Li, YM; Xu, XY; Cai, SL; Wei, L; Liu, XH; Chen, GL; Zhou, YZ; Liu, C; Li, Z; Jin, F; Chen, B				Jin, Zining; Wang, Wenqian; Jiang, Nan; Zhang, Lei; Li, Yiming; Xu, Xiaoyin; Cai, Shouliang; Wei, Liang; Liu, Xuhong; Chen, Guanglei; Zhou, Yizhen; Liu, Cheng; Li, Zhan; Jin, Feng; Chen, Bo			Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy	PLOS ONE			English	Article							NITRIC-OXIDE; THERAPEUTIC OPPORTUNITIES; PREDICTS POOR; CISPLATIN; SURVIVAL; ANGIOGENESIS; EXPRESSION; RESISTANCE; APOPTOSIS; ANALOGS	Triple-negative breast cancer is a high-risk breast cancer with poor survival rate. To date, there is a lack of targeted therapy for this type of cancer. One unique phenomenon is that inflammatory breast cancer is frequently triple negative. However, it is still ambiguous how inflammation influences triple-negative breast cancer growth and responding to chemotherapy. Herein, we investigated the levels of inflammation-associated enzyme, iNOS, in 20 triple-negative breast cancer patients' tumors, and examined its correlation with patients' responses to platinum-based neoadjuvant chemotherapy. Our studies showed that triple-negative breast cancer patients with attenuated iNOS levels in tumor cells after treatment showed better responses to platinum-based neoadjuvant chemotherapy than other triple-negative breast cancer patients. Our further in vitro studies confirmed that induction of proper levels of NO increased the resistance to cisplatin in triple-negative MDA-MB-231 cells. Our data suggest that aberrant high level of iNOS/NO are associated with less effectiveness of platinum-based neoadjuvant chemotherapy in triple-negative breast cancer. Therefore, we propose to monitor iNOS levels as a new predictor for triple-negative breast cancer patient's response to platinum-based neoadjuvant chemotherapy. Moreover, iNOS/NO is considered as a potential target for combination therapy with platinum drugs for triple-negative breast cancer.	[Jin, Zining; Wang, Wenqian; Jiang, Nan; Zhang, Lei; Li, Yiming; Xu, Xiaoyin; Cai, Shouliang; Wei, Liang; Liu, Xuhong; Chen, Guanglei; Zhou, Yizhen; Liu, Cheng; Li, Zhan; Jin, Feng; Chen, Bo] China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning, Peoples R China	China Medical University	Chen, B (corresponding author), China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning, Peoples R China.	chbyxl@163.com	JIANG, NAN/AHB-1945-2022	Wang, Wenqian/0000-0003-2925-4306	National Natural Science Foundation of China [81372811]; Science and Technology Agency of Liaoning Province [2013225049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Agency of Liaoning Province	Dr. Chen Bo received funding from the National Natural Science Foundation of China (No. 81372811, http://www.nsfc.gov.cn/publish/portal1/) and the Science and Technology Agency of Liaoning Province (No. 2013225049, http://www.lninfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 1998, CANCER RES, V58, P334; Belotte J, 2014, REPROD SCI, V21, P503, DOI 10.1177/1933719113503403; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Chaher N, 2012, BREAST CANCER RES TR, V131, P437, DOI 10.1007/s10549-011-1422-5; DAWOOD S, 2010, CANCER, V117, P1819, DOI DOI 10.1002/CNCR.25682; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Godoy LC, 2012, P NATL ACAD SCI USA, V109, P20373, DOI 10.1073/pnas.1218938109; Kilburn LS, 2008, CLIN ONCOL-UK, V20, P35, DOI 10.1016/j.clon.2007.09.010; KOLARIC K, 1983, CANCER CHEMOTH PHARM, V11, P108, DOI 10.1007/BF00254257; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Li J, 2011, ONCOLOGIST, V16, P1675, DOI 10.1634/theoncologist.2011-0196; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; Moynahan ME, 2001, CANCER RES, V61, P4842; Pance Alena, 2006, Future Oncol, V2, P275, DOI 10.2217/14796694.2.2.275; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Ray GN, 2001, BRIT J BIOMED SCI, V58, P169; Seitz S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-847; SLEDGE GW, 1988, J CLIN ONCOL, V6, P1811, DOI 10.1200/JCO.1988.6.12.1811; SMITH IE, 1992, BRIT J CANCER, V65, P787, DOI 10.1038/bjc.1992.169; Switzer CH, 2011, TRENDS PHARMACOL SCI, V32, P644, DOI 10.1016/j.tips.2011.07.001; Tang CH, 2004, J BIOL CHEM, V279, P288, DOI 10.1074/jbc.M310821200; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Vakkala M, 2000, CLIN CANCER RES, V6, P2408; Yadav BS, 2014, WORLD J CLIN ONCOL, V5, P125, DOI 10.5306/wjco.v5.i2.125	25	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0130286	10.1371/journal.pone.0130286	http://dx.doi.org/10.1371/journal.pone.0130286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196284	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600006
J	Yu, GQ; Fadrosh, D; Goedert, JJ; Ravel, J; Goldstein, AM				Yu, Guoqin; Fadrosh, Doug; Goedert, James J.; Ravel, Jacques; Goldstein, Alisa M.			Nested PCR Biases in Interpreting Microbial Community Structure in 16S rRNA Gene Sequence Datasets	PLOS ONE			English	Article								Background Sequencing of the PCR-amplified 16S rRNA gene has become a common approach to microbial community investigations in the fields of human health and environmental sciences. This approach, however, is difficult when the amount of DNA is too low to be amplified by standard PCR. Nested PCR can be employed as it can amplify samples with DNA concentration several-fold lower than standard PCR. However, potential biases with nested PCRs that could affect measurement of community structure have received little attention. Results In this study, we used 17 DNAs extracted from vaginal swabs and 12 DNAs extracted from stool samples to study the influence of nested PCR amplification of the 16S rRNA gene on the estimation of microbial community structure using Illumina MiSeq sequencing. Nested and standard PCR methods were compared on alpha-and beta-diversity metrics and relative abundances of bacterial genera. The effects of number of cycles in the first round of PCR (10 vs. 20) and microbial diversity (relatively low in vagina vs. high in stool) were also investigated. Vaginal swab samples showed no significant difference in alpha diversity or community structure between nested PCR and standard PCR (one round of 40 cycles). Stool samples showed significant differences in alpha diversity (except Shannon's index) and relative abundance of 13 genera between nested PCR with 20 cycles in the first round and standard PCR (P<0.01), but not between nested PCR with 10 cycles in the first round and standard PCR. Operational taxonomic units (OTUs) that had low relative abundance (sum of relative abundance <0.167) accounted for most of the distortion (>27% of total OTUs in stool). Conclusions Nested PCR introduced bias in estimated diversity and community structure. The bias was more significant for communities with relatively higher diversity and when more cycles were applied in the first round of PCR. We conclude that nested PCR could be used when standard PCR does not work. However, rare taxa detected by nested PCR should be validated by other technologies.	[Yu, Guoqin; Goedert, James J.; Goldstein, Alisa M.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Fadrosh, Doug; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genom Sci, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Yu, GQ (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	yug3@mail.nih.gov	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233	Intramural Research Program of the NIH, National Cancer Institute	Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the NIH, National Cancer Institute.	Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Coldham T, 2013, VET MICROBIOL, V166, P429, DOI 10.1016/j.vetmic.2013.06.026; Delgado S, 2013, MICROB ECOL, V65, P763, DOI 10.1007/s00248-013-0192-5; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fan ZY, 2009, WORLD J MICROB BIOT, V25, P1447, DOI 10.1007/s11274-009-0033-3; Flores R, 2012, EUR J CLIN INVEST, V42, P855, DOI 10.1111/j.1365-2362.2012.02659.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koido S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086702; Li W, 2014, MICROB ECOL, V67, P679, DOI 10.1007/s00248-013-0345-6; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon CE, 1997, M D COMPUT, V14, P306; SIEGEL S., 1956, NONPARAMETRIC STAT B; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x	20	45	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132253	10.1371/journal.pone.0132253	http://dx.doi.org/10.1371/journal.pone.0132253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196512	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600028
J	Zhou, C; Zhang, L; Wang, H; Ma, XX; Shi, BH; Chen, WK; He, JJ; Wang, K; Liu, PJ; Ren, Y				Zhou, Can; Zhang, Li; Wang, Hua; Ma, Xiaoxia; Shi, Bohui; Chen, Wuke; He, Jianjun; Wang, Ke; Liu, Peijun; Ren, Yu			Superiority of Minimally Invasive Oesophagectomy in Reducing In-Hospital Mortality of Patients with Resectable Oesophageal Cancer: A Meta-Analysis	PLOS ONE			English	Article							LAPAROSCOPIC GASTRIC MOBILIZATION; OPEN TRANSHIATAL ESOPHAGECTOMY; IVOR-LEWIS ESOPHAGECTOMY; OUTCOMES FOLLOWING OPEN; QUALITY-OF-LIFE; THORACOSCOPIC ESOPHAGECTOMY; PERIOPERATIVE OUTCOMES; ASSISTED ESOPHAGECTOMY; TRANSTHORACIC ESOPHAGECTOMY; PULMONARY COMPLICATIONS	Background Compared with open oesophagectomy (OE), minimally invasive oesophagectomy (MIO) proves to have benefits in reducing the risk of pulmonary complications for patients with resectable oesophageal cancer. However, it is unknown whether MIO has superiority in reducing the occurrence of in-hospital mortality (IHM). Objective The objective of this meta-analysis was to explore the effect of MIO vs. OE on the occurrence of in-hospital mortality (IHM). Data Sources Sources such as Medline (through December 31, 2014), Embase (through December 31, 2014), Wiley Online Library (through December 31, 2014), and the Cochrane Library (through December 31, 2014) were searched. Study Selection Data of randomized and non-randomized clinical trials related to MIO versus OE were included. Interventions Eligible studies were those that reported patients who underwent MIO procedure. The control group included patients undergoing conventional OE. Study Appraisal and Synthesis Methods Fixed or random-effects models were used to calculate summary odds ratios (ORs) or relative risks (RRs) for quantification of associations. Heterogeneity among studies was evaluated by using Cochran's Q and I-2 statistics. Results A total of 48 studies involving 14,311 cases of resectable oesophageal cancer were included in the meta-analysis. Compared to patients undergoing OE, patients undergoing MIO had statistically reduced occurrence of IHM (OR=0.69, 95%CI = 0.55-0.86). Patients undergoing MIO also had significantly reduced incidence of pulmonary complications (PCs) (RR=0.73, 95%CI = 0.63-0.86), pulmonary embolism (PE) (OR=0.71, 95%CI = 0.51-0.99) and arrhythmia (OR=0.79, 95%CI = 0.68-0.92). Non-significant reductions were observed among the included studies in the occurrence of anastomotic leak (AL) (OR=0.93, 95%CI = 0.78-1.11), or Gastric Tip Necrosis (GTN) (OR=0.89, 95%CI = 0.54-1.49). Limitation Most of the included studies were non-randomized case-control studies, with a diversity of study designs, demographics of participants and surgical intervention. Conclusions Minimally invasive oesophagectomy (MIO) has superiority over open oesophagectomy (OE) in terms of the occurrence of in-hospital mortality (IHM) and should be the first-choice surgical procedure in esophageal surgery.	[Zhou, Can; Zhang, Li; Wang, Hua; Ma, Xiaoxia; Shi, Bohui; Chen, Wuke; He, Jianjun; Wang, Ke; Ren, Yu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Breast Surg, Xian 710049, Shaanxi, Peoples R China; [Liu, Peijun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Ctr, Dept Translat, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Liu, PJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Ctr, Dept Translat, Xian 710049, Shaanxi, Peoples R China.	peijun1020@163.com; renyyyyy@126.com			Department of Breast Surgery, First Affiliated Hospital of Xi'an Jiaotong University	Department of Breast Surgery, First Affiliated Hospital of Xi'an Jiaotong University	This study has funding support (i.e. a total of 1,350 dollars) for initiation and management from Professor Yu Ren, Department of Breast Surgery, the First Affiliated Hospital of Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg MCJ, 2014, BEST PRACT RES CL GA, V28, P41, DOI 10.1016/j.bpg.2013.11.002; Avery KNL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-200; Bailey L, 2013, EUR J CARDIO-THORAC, V43, P268, DOI 10.1093/ejcts/ezs314; Bare Marisa, 2009, BMC Public Health, V9, P312, DOI 10.1186/1471-2458-9-312; Benzoni E, 2007, J GASTROINTEST LIVER, V16, P395; Berger AC, 2011, J AM COLL SURGEONS, V212, P560, DOI 10.1016/j.jamcollsurg.2010.12.042; Bernabe KQ, 2005, SURG ENDOSC, V19, P334, DOI 10.1007/s00464-004-8807-z; Biere SSAY, 2009, MINERVA CHIR, V64, P121; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Braghetto I, 2006, SURG ENDOSC, V20, P1681, DOI 10.1007/s00464-006-0009-4; Bresadola V, 2006, SURG LAPARO ENDO PER, V16, P63, DOI 10.1097/00129689-200604000-00001; Briez N, 2012, BRIT J SURG, V99, P1547, DOI 10.1002/bjs.8931; Briez N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-310; Burdall OC, 2015, SURG ENDOSC, V29, P431, DOI 10.1007/s00464-014-3694-4; Butler N, 2011, SURG ENDOSC, V25, P2071, DOI 10.1007/s00464-010-1511-2; Chen BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082428; Cuesta MA, 2012, J THORAC DIS, V4, P462, DOI 10.3978/j.issn.2072-1439.2012.08.12; Cuschieri A, 1992, J R Coll Surg Edinb, V37, P7; Dantoc M, 2012, ARCH SURG-CHICAGO, V147, P768, DOI 10.1001/archsurg.2012.1326; Dantoc MM, 2012, J GASTROINTEST SURG, V16, P486, DOI 10.1007/s11605-011-1792-3; DEPAULA AL, 1995, SURG LAPAROSC ENDOSC, V5, P1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimick JB, 2006, MED CARE, V44, P774, DOI 10.1097/01.mlr.0000215898.33228.c7; EARLAM R, 1980, BRIT J SURG, V67, P381, DOI 10.1002/bjs.1800670602; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fabian T, 2008, DIS ESOPHAGUS, V21, P220, DOI 10.1111/j.1442-2050.2007.00783.x; Ferguson MK, 2011, ANN THORAC SURG, V91, P1494, DOI 10.1016/j.athoracsur.2010.12.036; Gao YS, 2011, INTERACT CARDIOV TH, V12, P366, DOI 10.1510/icvts.2010.258632; Gemmill EH, 2007, BRIT J SURG, V94, P1461, DOI 10.1002/bjs.6015; Gex G, 2012, J THROMB HAEMOST, V10, P347, DOI 10.1111/j.1538-7836.2011.04608.x; Hamouda AH, 2010, SURG ENDOSC, V24, P865, DOI 10.1007/s00464-009-0679-9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Ichikawa H, 2013, ANN SURG, V257, P873, DOI 10.1097/SLA.0b013e31826c87cd; Jacobs M, 2014, QUAL LIFE RES, V23, P1155, DOI 10.1007/s11136-013-0576-5; Jamieson GG, 2004, BRIT J SURG, V91, P943, DOI 10.1002/bjs.4596; Javidfar J, 2012, J THORAC CARDIOV SUR, V143, P1125, DOI 10.1016/j.jtcvs.2012.01.071; Kauppi J, 2014, SURG ENDOSC; Khan O, 2012, J THORAC DIS, V4, P465, DOI 10.3978/j.issn.2072-1439.2012.08.16; Kinjo Y, 2012, SURG ENDOSC, V26, P381, DOI 10.1007/s00464-011-1883-y; KIPFMUELLER K, 1989, Surgical Endoscopy, V3, P63, DOI 10.1007/BF00590902; Kitagawa H, 2013, J LAPAROENDOSC ADV S, V23, P452, DOI 10.1089/lap.2012.0377; Kitagawa H, 2009, LANGENBECK ARCH SURG, V394, P617, DOI 10.1007/s00423-008-0354-y; Korst RJ, 2005, ANN THORAC SURG, V80, P1185, DOI 10.1016/j.athoracsur.2005.04.020; Kubo N, 2014, ANTICANCER RES, V34, P2399; Kunisaki C, 2009, LANGENBECK ARCH SURG, V394, P617; Law S, 1997, SURGERY, V122, P8, DOI 10.1016/S0039-6060(97)90257-9; Law S, 2006, BEST PRACT RES CL GA, V20, P925, DOI 10.1016/j.bpg.2006.03.011; Lee JM, 2011, WORLD J SURG, V35, P790, DOI 10.1007/s00268-011-0955-4; Lee L, 2013, ANN SURG ONCOL, V20, P3732, DOI 10.1245/s10434-013-3103-6; Li JP, 2015, SURG ENDOSC, V29, P925, DOI 10.1007/s00464-014-3753-x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Luketich JD, 2003, ANN SURG, V238, P486, DOI 10.1097/01.sla.0000089858.40725.68; Maas KW, 2012, REV ESP ENFERM DIG, V104, P197, DOI 10.4321/s1130-01082012000400005; Mamidanna R, 2012, ANN SURG, V255, P197, DOI 10.1097/SLA.0b013e31823e39fa; Markar SR, 2013, ANN SURG ONCOL, V20, P4274, DOI 10.1245/s10434-013-3189-x; Meng FY, 2014, J THORAC DIS, V6, P1218, DOI 10.3978/j.issn.2072-1439.2014.07.20; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morita M, 2011, ANN SURG ONCOL, V18, P1757, DOI 10.1245/s10434-010-1502-5; Mu JW, 2014, CHINESE MED J-PEKING, V127, P747, DOI 10.3760/cma.j.issn.0366-6999.20132224; Nafteux P, 2011, EUR J CARDIO-THORAC, V40, P1455, DOI 10.1016/j.ejcts.2011.01.086; Nagpal K, 2010, SURG ENDOSC, V24, P1621, DOI 10.1007/s00464-009-0822-7; Nguyen NT, 2000, ARCH SURG-CHICAGO, V135, P920, DOI 10.1001/archsurg.135.8.920; Noble F, 2013, DIS ESOPHAGUS, V26, P263, DOI 10.1111/j.1442-2050.2012.01356.x; ORRINGER MB, 1984, ANN SURG, V200, P282, DOI 10.1097/00000658-198409000-00005; Osugi H, 2003, BRIT J SURG, V90, P108, DOI 10.1002/bjs.4022; Parameswaran R, 2013, ANN SURG ONCOL, V20, P1970, DOI 10.1245/s10434-012-2848-7; Parameswaran R, 2009, WORLD J SURG, V33, P1868, DOI 10.1007/s00268-009-0116-1; Perry KA, 2009, ARCH SURG-CHICAGO, V144, P679, DOI 10.1001/archsurg.2009.113; Pham TH, 2010, AM J SURG, V199, P594, DOI 10.1016/j.amjsurg.2010.01.005; Safranek PM, 2010, BRIT J SURG, V97, P1845, DOI 10.1002/bjs.7231; Saha AK, 2009, SURG ENDOSC, V23, P119, DOI 10.1007/s00464-008-0065-z; Saito T, 1990, Nihon Kyobu Geka Gakkai Zasshi, V38, P1402; Scheepers JJG, 2009, DIS ESOPHAGUS, V22, P42, DOI 10.1111/j.1442-2050.2008.00898.x; Schneider C, 2014, INT J SURG, V12, P1342, DOI 10.1016/j.ijsu.2014.10.016; Schoppmann SF, 2010, SURG ENDOSC, V24, P3044, DOI 10.1007/s00464-010-1083-1; Schroder W, 2010, WORLD J SURG, V34, P738, DOI 10.1007/s00268-010-0403-x; Schumer E, 2012, SURG LAPARO ENDO PER, V22, P383, DOI 10.1097/SLE.0b013e31826295a4; Seng CS, 2013, SPINE, V38, P2049, DOI 10.1097/BRS.0b013e3182a8212d; Sgourakis G, 2010, DIGEST DIS SCI, V55, P3031, DOI 10.1007/s10620-010-1153-1; Shiraishi T, 2006, ANN THORAC SURG, V81, P1083, DOI 10.1016/j.athoracsur.2005.08.057; Sihag S, 2012, EUR J CARDIO-THORAC, V42, P430, DOI 10.1093/ejcts/ezs031; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Smithers BM, 2007, ANN SURG, V245, P232, DOI 10.1097/01.sla.0000225093.58071.c6; Sundaram A, 2012, SURG ENDOSC, V26, P168, DOI 10.1007/s00464-011-1850-7; Taguchi S, 2003, SURG ENDOSC, V17, P1445, DOI 10.1007/s00464-002-9232-9; Takeno S, 2013, WORLD J SURG, V37, P1673, DOI 10.1007/s00268-013-2008-7; Thomson IG, 2010, ANN SURG, V252, P281, DOI 10.1097/SLA.0b013e3181e909a2; Trujillo-Santos J, 2005, CHEST, V127, P1631, DOI 10.1378/chest.127.5.1631; Tsujimoto H, 2012, SURGERY, V151, P667, DOI 10.1016/j.surg.2011.12.006; Tsujimoto H, 2010, WORLD J SURG, V34, P2830, DOI 10.1007/s00268-010-0757-0; Uttley L, 2013, SURG ENDOSC, V27, P724, DOI 10.1007/s00464-012-2546-3; Van den Broek WT, 2004, SURG ENDOSC, V18, P812, DOI 10.1007/s00464-003-9173-y; Veeramootoo D, 2012, SURG ENDOSC, V26, P1822, DOI 10.1007/s00464-011-2123-1; Wang H, 2010, DIS ESOPHAGUS, V23, P408, DOI 10.1111/j.1442-2050.2009.01025.x; Weidenhagen R, 2010, ANN THORAC SURG, V90, P1674, DOI 10.1016/j.athoracsur.2010.07.007; Willer BL, 2012, HERNIA, V16, P185, DOI 10.1007/s10029-011-0884-z; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Xue L, 2009, WORLD J SURG, V33, P2615, DOI 10.1007/s00268-009-0222-0; Yamamoto M, 2013, CANCER CONTROL, V20, P130, DOI 10.1177/107327481302000206; Yamasaki M, 2011, J SURG ONCOL, V104, P623, DOI 10.1002/jso.21991; Zhang Junfeng, 2014, Zhonghua Wei Chang Wai Ke Za Zhi, V17, P915; Zingg U, 2009, ANN THORAC SURG, V87, P911, DOI 10.1016/j.athoracsur.2008.11.060	106	55	59	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132889	10.1371/journal.pone.0132889	http://dx.doi.org/10.1371/journal.pone.0132889			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196135	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600055
J	Luo, H; Huang, B; Yuan, D; Yang, Y; Xiong, F; Zeng, GJ; Wu, ZP; Chen, XY; Du, XJ; Wen, XR; Liu, CC; Yang, HL; Zhao, JC				Luo, Han; Huang, Bin; Yuan, Ding; Yang, Yi; Xiong, Fei; Zeng, Guojun; Wu, Zhoupeng; Chen, Xiyang; Du, Xiaojiong; Wen, Xiaorong; Liu, Chuncheng; Yang, Hongliu; Zhao, Jichun			8-Year Long-Term Outcome Comparison: Two Ways to Exclude the Internal Iliac Artery during Endovascular Aorta Repair (EVAR) Surgery	PLOS ONE			English	Article							AORTOILIAC ANEURYSM REPAIR; COIL EMBOLIZATION; OCCLUSION; SAFE	Purpose To evaluate the 8-year long-term outcome after internal iliac artery (IIA) coverage with or without embolization in EVAR. Patients and Methods From January 2006 to December 2013, abdominal aortic aneurysm (AAA) subjects that underwent EVAR and IIA exclusion were recruited and analyzed retrospectively. All the subjects were divided into group A or B based on the presence or absence of intraoperative IIA embolization before coverage (group A: without embolization; group B: with embolization). The 30-day mortality, stent patency, and the incidences of endoleaks and ischemia of the buttocks and lower limbs were compared. The follow-up period was 96 months. Result There were 137 subjects (A: 74 vs. B: 63), 124 male (91.1%) and 13 female (9.5%), with a mean age of 71.6 years. There were no significant differences in the early outcomes of intraoperative blood loss (87.23 +/- 14.07 ml; A: 86.53 +/- 9.57 ml vs. B: 88.06 +/- 18.04 ml, p = .545) and surgery time (87.13 +/- 9.25 min; A: 85.99 +/- 7.07 min vs. B: 88.48 +/- 11.19 min, p = .130). However, there were significant differences in contrast consumption (65.18 +/- 9.85 ml; A: 61.89 +/- 7.95 ml vs. B: 69.05 +/- 10.50 ml, p<.001) and intraoperative X-ray time (5.9 +/- 0.86 min; A: 5.63 +/- 0.49 min vs. B: 6.22 +/- 1.07 min, P<.001). The 30-day mortality was approximately 0.73%. In the follow-up analysis, no significant differences were identified in the incidence of endoleak (22 subjects; type I: A: 2 vs. B: 2, p = 1.000; type II: A: 8 vs. B: 4, p = .666; type III: A: 4 vs. B: 3, p = 1.000), occlusion (5 subjects; 4.35%; A: 1 vs. B: 4, p = .180), or ischemia (9 subjects; 7.83%; A: 3 vs. B: 6, p = .301). In the analysis of group B, although there were no significant differences between subjects with unilateral and bilateral IIA embolization, but longer hospital stays were required (P<.001), and a more severe complication (skin and gluteus necrosis) occurred in 1 subject with bilateral IIA embolization. Conclusion IIA could be excluded during EVAR. IIA coverage without embolization had a good surgical and prognostic outcome, and this procedure was not different significantly from coverage with embolization in terms of endoleaks, patency and ischemia.	[Luo, Han; Yang, Hongliu] Sichuan Univ, West China Med Sch, Chengdu 610041, Sichuan, Peoples R China; [Huang, Bin; Yuan, Ding; Yang, Yi; Xiong, Fei; Zeng, Guojun; Wu, Zhoupeng; Chen, Xiyang; Du, Xiaojiong; Zhao, Jichun] West China Hosp, Dept Vasc Surg, Chengdu 610041, Sichuan, Peoples R China; [Wen, Xiaorong; Liu, Chuncheng] West China Hosp, Dept Ultrasound, Chengdu 610041, Sichuan, Peoples R China	Sichuan University	Zhao, JC (corresponding author), West China Hosp, Dept Vasc Surg, 37 Guo Xue Alley, Chengdu 610041, Sichuan, Peoples R China.	hxzhao9@163.com	luo, han/AAS-3459-2021	luo, han/0000-0002-9674-0139	Planned Science and Technology Project of Sichuan Province, China [2012SZ0023]	Planned Science and Technology Project of Sichuan Province, China	This study was funded by the Planned Science and Technology Project of Sichuan Province, China (2012SZ0023).	Bratby MJ, 2008, CARDIOVASC INTER RAD, V31, P246, DOI 10.1007/s00270-007-9203-6; Chun JY, 2014, CARDIOVASC INTER RAD, V37, P329, DOI 10.1007/s00270-013-0659-2; Cochennec F, 2010, J VASC SURG, V51, P1360, DOI 10.1016/j.jvs.2010.01.032; Criado FJ, 2000, J VASC SURG, V32, P684, DOI 10.1067/mva.2000.110052; Engelke C, 2002, J VASC INTERV RADIOL, V13, P667, DOI 10.1016/S1051-0443(07)61842-9; Heye S, 2005, J VASC INTERV RADIOL, V16, P235, DOI 10.1097/01.RVI.0000143842.36512.DF; Hinchliffe RJ, 2002, J ENDOVASC THER, V9, P488, DOI 10.1583/1545-1550(2002)009<0488:AHEPTP>2.0.CO;2; Hoshina Katsuyuki, 2014, Ann Vasc Dis, V7, P34, DOI 10.3400/avd.oa.13-00073; JOHNSTON KW, 1989, J VASC SURG, V9, P437, DOI 10.1067/mva.1989.vs0090437; Kritpracha B, 2003, J VASC SURG, V37, P943, DOI 10.1067/mva.2003.251; Lin PH, 2002, J VASC SURG, V36, P500, DOI 10.1067/mva.2002.127350; Mehta M, 2006, J VASC SURG, V44, P1, DOI 10.1016/j.jvs.2006.02.057; Nakai M, 2013, JPN J RADIOL, V31, P585, DOI 10.1007/s11604-013-0223-7; Papazoglou KO, 2012, J VASC SURG, V56, P298, DOI 10.1016/j.jvs.2011.08.063; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Rana MA, 2014, J VASC SURG, V59, P634, DOI 10.1016/j.jvs.2013.09.060; Schoder M, 2001, AM J ROENTGENOL, V177, P599, DOI 10.2214/ajr.177.3.1770599; Verzini F, 2009, J VASC SURG, V49, P1154, DOI 10.1016/j.jvs.2008.11.100; Wolpert LM, 2001, J VASC SURG, V33, P1193, DOI 10.1067/mva.2001.115608; Wyers MC, 2002, J VASC SURG, V36, P1138, DOI 10.1067/mva.2002.129639; Yao JST, 2012, ANN VASC SURG, V26, P895, DOI 10.1016/j.avsg.2012.06.001	21	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0130586	10.1371/journal.pone.0130586	http://dx.doi.org/10.1371/journal.pone.0130586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193113	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400007
J	Metz, S; Ganter, C; Lorenzen, S; van Marwick, S; Holzapfel, K; Herrmann, K; Rummeny, EJ; Wester, HJ; Schwaiger, M; Nekolla, SG; Beer, AJ				Metz, Stephan; Ganter, Carl; Lorenzen, Sylvie; van Marwick, Sandra; Holzapfel, Konstantin; Herrmann, Ken; Rummeny, Ernst J.; Wester, Hans-Juergen; Schwaiger, Markus; Nekolla, Stephan G.; Beer, Ambros J.			Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; POSITRON-EMISSION-TOMOGRAPHY; ALPHA(V)BETA(3) EXPRESSION; GLUCOSE-METABOLISM; COEFFICIENT ADC; BODY; LESIONS; F-18-FDG; HYPOXIA; PET/MRI	Objectives Diffusion-weighted magnetic resonance imaging (DW-MRI) and imaging of glucose metabolism by positron emission tomography (FDG-PET) provide quantitative information on tissue characteristics. Combining the two methods might provide novel insights into tumor heterogeneity and biology. Here, we present a solution to analyze and visualize the relationship between the apparent diffusion coefficient (ADC) and glucose metabolism on a spatially resolved voxel-by-voxel basis using dedicated quantitative software. Materials and Methods In 12 patients with non small cell lung cancer (NSCLC), the primary tumor or metastases were examined with DW-MRI and PET using F-18-fluorodeoxyglucose (FDG). The ADC's from DW-MRI were correlated with standardized-uptake-values on a voxel-by-voxel basis using custom made software (Anima (MP)-P-3). For cluster analysis, we used prospectively defined thresholds for F-18-FDG and ADC to define tumor areas of different biological activity. Results Combined analysis and visualization of ADC maps and PET data was feasible in all patients. Spatial analysis showed relatively homogeneous ADC values over the entire tumor area, whereas FDG showed a decreasing uptake towards the tumor center. As expected, restricted water diffusivity was notable in areas with high glucose metabolism but was also found in areas with lower glucose metabolism. In detail, 72% of all voxels showed low ADC values (<1.5x10(-3) mm(2)/s) and high tracer uptake of F-18-FDG (SUV>3.6). However, 83% of the voxels with low FDG uptake also showed low ADC values, increasingly towards the tumor center. Conclusions Multiparametric analysis and visualization of DW-MRI and FDG-PET is feasible on a spatially resolved voxel-by-voxel respectively cluster basis using dedicated imaging software. Our preliminary data suggest that water diffusivity and glucose metabolism in metastatic NSCLC are not necessarily correlated in all tumor areas.	[Metz, Stephan; Ganter, Carl; Holzapfel, Konstantin; Rummeny, Ernst J.] Tech Univ Munich, Dept Radiol, D-80290 Munich, Germany; [Lorenzen, Sylvie] Tech Univ Munich, Dept Hematooncol, D-80290 Munich, Germany; [van Marwick, Sandra; Herrmann, Ken; Wester, Hans-Juergen; Schwaiger, Markus; Nekolla, Stephan G.; Beer, Ambros J.] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany; [Wester, Hans-Juergen] Tech Univ Munich, Inst Radiopharmaceut Chem, Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Metz, S (corresponding author), Tech Univ Munich, Dept Radiol, D-80290 Munich, Germany.	stephan.metz@tum.de	Nekolla, Stephan G/L-1857-2013; Herrmann, Ken/GOH-1465-2022; Ganter, Carl/U-6895-2017; Beer, Ambros J./AAA-5539-2022	Nekolla, Stephan G/0000-0002-8817-1482; Ganter, Carl/0000-0002-6735-7448; Beer, Ambros J./0000-0001-9042-7806; schwaiger, markus/0000-0002-2305-7144	German Research Foundation (DFG) within the SFB Initiative 824 (collaborative research center 824) "Imaging for Selection, Monitoring and Individualization of Cancer Therapies" [SFB 824]; German Research Foundation (DFG); Technische Universitat Munchen	German Research Foundation (DFG) within the SFB Initiative 824 (collaborative research center 824) "Imaging for Selection, Monitoring and Individualization of Cancer Therapies"; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by the German Research Foundation (DFG) within the SFB Initiative 824 (collaborative research center 824) "Imaging for Selection, Monitoring and Individualization of Cancer Therapies" (SFB 824, project C5), and by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program Open Access Publishing. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer AJ, 2008, J NUCL MED, V49, P22, DOI 10.2967/jnumed.107.045864; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; HAMACHER K, 1986, J NUCL MED, V27, P235; Haubner R, 2004, BIOCONJUGATE CHEM, V15, P61, DOI 10.1021/bc034170n; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kwee TC, 2010, J NUCL MED, V51, P1549, DOI 10.2967/jnumed.109.073908; Metz S, 2010, J NUCL MED, V51, P1691, DOI 10.2967/jnumed.110.077719; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Pichler BJ, 2010, J NUCL MED, V51, P333, DOI 10.2967/jnumed.109.061853; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Ratib O, 2011, EUR J NUCL MED MOL I, V38, P992, DOI 10.1007/s00259-011-1790-4; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Sotak CH, 2004, NEUROCHEM INT, V45, P569, DOI 10.1016/j.neuint.2003.11.010; van Marwick S, 2011, RADIOLOGY S; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Weber WA, 1999, J NUCL MED, V40, P1771; Weber WA, 2006, J CLIN ONCOL, V24, P3282, DOI 10.1200/JCO.2006.06.6068; Yu JX, 2014, ADV COND MATTER PHYS, V2014, DOI 10.1155/2014/364627	23	23	24	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132386	10.1371/journal.pone.0132386	http://dx.doi.org/10.1371/journal.pone.0132386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186719	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700040
J	Anetsberger, A; Blobner, M; Krautheim, V; Umgelter, K; Schmid, S; Jungwirth, B				Anetsberger, Aida; Blobner, Manfred; Krautheim, Veronika; Umgelter, Katrin; Schmid, Sebastian; Jungwirth, Bettina			Self-Reported, Structured Measures of Recovery to Detect Postoperative Morbidity	PLOS ONE			English	Article							PATIENT-SATISFACTION; ANESTHESIA; SURGERY; MORTALITY; QUALITY; SCORE	Previous studies have focused on postoperative anaesthetic visit as a tool for measuring postoperative recovery or patient's satisfaction. Whether it could also improve timely recognition of complications has not been studied yet. Aim of our study was to assess pathological findings in physical examination requiring further intervention during postoperative visit and to explore whether a self-administered version of the Quality of Recovery (QoR)-9 score, compared to a detailed medical history, can act as a screening tool for identification of patients who show a low risk to develop postoperative complications. This observational study included 918 patients recovering from various types of non-cardiac surgery and anaesthesia. The postoperative visit implied three steps: measuring the QoR-9 score, a structured medical history and a physical examination. QoR-9-score showed a comparable negative predictive value (0.93 vs. 0.92) and a higher sensitivity of finding at least one pathological examination than a detailed medical history (0.92 vs. 0.81 respectively). At least one postoperative pathological examination finding was observed in 23.7% of the patients. Our approach presents a strategy on screening postoperative patients in order to identify patients whose examination and consequent treatment should be intensified. In further studies the question could be addressed whether the postoperative visit may help to reduce complications and mortality after surgery.	[Anetsberger, Aida; Blobner, Manfred; Krautheim, Veronika; Umgelter, Katrin; Schmid, Sebastian; Jungwirth, Bettina] Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80290 Munich, Bavaria, Germany	Technical University of Munich	Jungwirth, B (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80290 Munich, Bavaria, Germany.	b.jungwirth@lrz.tum.de	Blobner, Manfred/R-4411-2017; Schmid, Sebastian/AAW-3026-2021	Blobner, Manfred/0000-0002-0370-5247; Schmid, Sebastian/0000-0002-1232-5350; Jungwirth, Bettina/0000-0001-9749-7460				Arnberger M, 2009, EUR J ANAESTH, V26, P559, DOI 10.1097/EJA.0b013e328328f552; Barnett SF, 2013, ANESTHESIOLOGY, V119, P452, DOI 10.1097/ALN.0b013e3182976014; Bennett-Guerrero E, 1999, ANESTH ANALG, V89, P514, DOI 10.1097/00000539-199908000-00050; Dexter F, 1997, ANESTHESIOLOGY, V87, P865, DOI 10.1097/00000542-199710000-00021; Eberhart LHJ, 2002, ANAESTHESIST, V52, P463; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Gornall BF, 2013, BRIT J ANAESTH, V111, P161, DOI 10.1093/bja/aet014; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Herrera FJ, 2007, ANESTH ANALG, V105, P63, DOI 10.1213/01.ane.0000265534.73169.95; Myles PS, 1999, ANESTH ANALG, V88, P83, DOI 10.1097/00000539-199901000-00016; Myles PS, 2000, BRIT J ANAESTH, V84, P11, DOI 10.1093/oxfordjournals.bja.a013366; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Saal D, 2011, BRIT J ANAESTH, V107, P703, DOI 10.1093/bja/aer261; SILBER JH, 1992, MED CARE, V30, P615, DOI 10.1097/00005650-199207000-00004; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	15	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133871	10.1371/journal.pone.0133871	http://dx.doi.org/10.1371/journal.pone.0133871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207620	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000159
J	Osthoff, M; Dean, MM; Baird, PN; Richardson, AJ; Daniell, M; Guymer, RH; Eisen, DP				Osthoff, Michael; Dean, Melinda M.; Baird, Paul N.; Richardson, Andrea J.; Daniell, Mark; Guymer, Robyn H.; Eisen, Damon P.			Association Study of Mannose-Binding Lectin Levels and Genetic Variants in Lectin Pathway Proteins with Susceptibility to Age-Related Macular Degeneration: A Case-Control Study	PLOS ONE			English	Article							ENVIRONMENT INTERACTION; H-FICOLIN; COMPLEMENT; RISK; INFECTION; CELLS; AMD; HAPLOTYPE; GENOTYPES; CANCER	Background In age-related macular degeneration (AMD) the complement system is thought to be activated by chronic oxidative damage with genetic variants identified in the alternative pathway as susceptibility factors. However, the involvement of the lectin pathway of complement, a key mediator of oxidative damage, is controversial. This study investigated whether mannose-binding lectin (MBL) levels and genetic variants in lectin pathway proteins, are associated with the predisposition to and severity of AMD. Methods MBL levels and single nucleotide polymorphisms (SNPs) in the MBL2 and the ficolin-2 (FCN2) gene were determined in 109 patients with AMD and 109 age-and sex-matched controls. Results MBL expression levels were equally distributed in both cases (early and late AMD) and controls (p>0.05). However, there was a trend towards higher median MBL levels in cases with late AMD compared to cases with early AMD (1.0 vs. 0.4 mu g/ml, p = 0.09) and MBL deficiency (<0.5 mu g/ml) was encountered less frequently in the late AMD group (35% vs 56%, p = 0.03). FCN2 and MBL2 allele frequencies were similarly distributed in early and late AMD cases compared with controls (p>0.05 for all analyses) as were MBL2 genotypes. Similarly, there was no significant difference in allele frequencies in any SNPs in either the MBL2 or FCN2 gene in cases with early vs. late AMD. Conclusions SNPs of lectin pathway proteins investigated in this study were not associated with AMD or AMD severity. However, MBL levels deserve further study in a larger cohort of early vs. late AMD patients to elucidate any real effect on AMD severity.	[Osthoff, Michael; Eisen, Damon P.] Melbourne Hlth, Victorian Infect Dis Serv, Doherty Inst, Melbourne, Vic, Australia; [Osthoff, Michael; Eisen, Damon P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Osthoff, Michael] Univ Basel Hosp, Dept Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Dean, Melinda M.] Australian Red Cross Blood Serv, Res & Dev, Kelvin Grove, Qld, Australia; [Baird, Paul N.; Richardson, Andrea J.; Daniell, Mark; Guymer, Robyn H.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; University of Basel; Australian Red Cross Blood Service; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Osthoff, M (corresponding author), Melbourne Hlth, Victorian Infect Dis Serv, Doherty Inst, Melbourne, Vic, Australia.	michael.osthoff@usb.ch	eisen, damon/AAC-7433-2019; Daniell, Mark/AAS-1363-2020	Daniell, Mark/0000-0001-9528-7005; Osthoff, Michael/0000-0001-5439-957X; Guymer, Robyn/0000-0002-9441-4356; Baird, Paul/0000-0002-1305-3502				Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Adams MKM, 2011, AM J EPIDEMIOL, V173, P1246, DOI 10.1093/aje/kwr005; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Baird PN, 2008, HUM MOL GENET, V17, P1299, DOI 10.1093/hmg/ddn018; Bernig T, 2007, CARCINOGENESIS, V28, P828, DOI 10.1093/carcin/bgl198; Cipriani V, 2012, HUM MOL GENET, V21, P4138, DOI 10.1093/hmg/dds225; Dinu V, 2007, GENET EPIDEMIOL, V31, P224, DOI 10.1002/gepi.20204; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu BJ, 2013, FASEB J, V27, P1479, DOI 10.1096/fj.12-215368; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; Kilpatrick DC, 2013, HUM IMMUNOL, V74, P867, DOI 10.1016/j.humimm.2013.04.011; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/138797; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Miller DM, 2004, AM J OPHTHALMOL, V138, P323, DOI 10.1016/j.ajo.2004.03.018; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Naj AC, 2013, ANN HUM GENET, V77, P215, DOI 10.1111/ahg.12011; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Rohrer Barbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Shen D, 2009, BRIT J OPHTHALMOL, V93, P405, DOI 10.1136/bjo.2008.145383; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zanetti KA, 2012, CANCER RES, V72, P1467, DOI 10.1158/0008-5472.CAN-11-3073; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134107	10.1371/journal.pone.0134107	http://dx.doi.org/10.1371/journal.pone.0134107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207622	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000358622000209
J	Sun, JM; Tang, YM; Ling, F; Chang, Y; Ye, XH; Shi, W; Zhang, L; Chen, ZP; Lin, HJ; Qiu, ZP; Zhang, YJ; Zhang, R; Mao, HY; Chen, EF; Lin, JF; Jiang, JM; Xia, SC; Gong, ZY				Sun, Jimin; Tang, Yuming; Ling, Feng; Chang, Yue; Ye, Xiaohong; Shi, Wen; Zhang, Lei; Chen, Zhiping; Lin, Haijiang; Qiu, Zaiping; Zhang, Yanjun; Zhang, Rong; Mao, Haiyan; Chen, Enfu; Lin, Junfen; Jiang, Jianmin; Xia, Shichang; Gong, Zhenyu			Genetic Susceptibility Is One of the Determinants for Severe Fever with Thrombocytopenia Syndrome Virus Infection and Fatal Outcome: An Epidemiological Investigation	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; SYNDROME BUNYAVIRUS; HEMORRHAGIC-FEVER; CHINA; VARIANTS; CLUSTER	Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease in China and case-fatality rate of SFTS is very high (approximately 10%). However, genetic susceptibility for SFTS virus (SFTSV) infection and fatal outcome of SFTSV infection in humans are unclear. In this study, we investigated the clinical, laboratory and epidemiological features of SFTS in a cluster of three sisters who died of SFTSV infection between late April and mid-May 2014. Before disease onset, two of the sisters (Case A and case B) had common exposure history for ticks by working together in a field to pick tea leaves from April 8 to April 12. The third sister (Case C) did not live or work together with case A and B, but had ticks in her living environment. SFTSV RNA sequences were amplified from three cases were not identical, suggesting that the three sisters were most likely infected with SFTSV through tick bite rather than through person-to-person transmission of SFTSV. The sequence of SFTSV from case C was identical to SFTSV sequences from 3 groups of ticks collected around the residential area of case C. Seroprevalence of SFTSV IgG antibody among healthy population in the area where the patients resided was 4.05% (3/74). The majority of SFTSV infections were mild cases and all three sisters died of SFTSV infection suggested that they were highly susceptible to SFTSV. Our findings indicated that genetic susceptibility was a risk factor for SFTSV infection and fatal outcome.	[Sun, Jimin; Ling, Feng; Shi, Wen; Zhang, Lei; Chen, Zhiping; Zhang, Yanjun; Zhang, Rong; Mao, Haiyan; Chen, Enfu; Lin, Junfen; Jiang, Jianmin; Xia, Shichang; Gong, Zhenyu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Tang, Yuming; Ye, Xiaohong; Qiu, Zaiping] Linhai Ctr Dis Control & Prevent, Linhai, Peoples R China; [Chang, Yue; Lin, Haijiang] Taizhou Municipal Ctr Dis Control & Prevent, Taizhou, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Xia, SC (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	zjcdcxsc@126.com; zjcdcgzy@126.com			Zhejiang Province major science and technology program [2012C13016-2]; Project of the State Scientific & Technological Development of the 12th Five Year Plan grant [2012ZX10004219]; medical research program of Zhejiang province [2014RCA002, 2014ZDA003]; National Natural Science Foundation of China (NSFC) grant [81171609]	Zhejiang Province major science and technology program; Project of the State Scientific & Technological Development of the 12th Five Year Plan grant; medical research program of Zhejiang province; National Natural Science Foundation of China (NSFC) grant(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from Zhejiang Province major science and technology program (2012C13016-2), the Project of the State Scientific & Technological Development of the 12th Five Year Plan grant (2012ZX10004219), the medical research program of Zhejiang province (2014RCA002, 2014ZDA003) and National Natural Science Foundation of China (NSFC) grant 81171609.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Bao CJ, 2011, NEW ENGL J MED, V365, P862, DOI 10.1056/NEJMc1106000; Chen HB, 2013, INT J INFECT DIS, V17, pE206, DOI 10.1016/j.ijid.2012.11.006; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Kang Kai, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P106; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Liu YX, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-37; Loeb M, 2011, J INFECT DIS, V204, P1031, DOI 10.1093/infdis/jir493; Sun JM, 2015, EPIDEMIOL INFECT, V143, P851, DOI 10.1017/S0950268814001319; Sun JM, 2014, INT J INFECT DIS, V25, P180, DOI 10.1016/j.ijid.2014.02.022; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Wang ML, 2009, INT J IMMUNOGENET, V36, P227, DOI 10.1111/j.1744-313X.2009.00848.x; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang L, 2013, INT J INFECT DIS, V17, pE137, DOI 10.1016/j.ijid.2012.07.007; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804	22	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132968	10.1371/journal.pone.0132968	http://dx.doi.org/10.1371/journal.pone.0132968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207638	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000049
J	Wei, W; Yu, Y; Chen, LD				Wei, Wei; Yu, Yun; Chen, Liding			Response of Surface Soil Hydrology to the Micro-Pattern of Bio-Crust in a Dry-Land Loess Environment, China	PLOS ONE			English	Article							BIOLOGICAL CRUSTS; EROSION PROCESSES; TENGGER DESERT; RUNOFF; RAINFALL; DYNAMICS; INFILTRATION; ECOSYSTEMS; IMPACT; COVER	The specific bio-species and their spatial patterns play crucial roles in regulating eco-hydrologic process, which is significant for large-scale habitat promotion and vegetation restoration in many dry-land ecosystems. Such effects, however, are not yet fully studied. In this study, 12 micro-plots, each with size of 0.5 m in depth and 1 m in length, were constructed on a gentle grassy hill-slope with a mean gradient of 8 degrees in a semiarid loess hilly area of China. Two major bio-crusts, including mosses and lichens, had been cultivated for two years prior to the field simulation experiments, while physical crusts and non-crusted bare soils were used for comparison. By using rainfall simulation method, four designed micropatterns (i.e., upper bio-crust and lower bare soil, scattered bio-crust, upper bare soil and lower bio-crust, fully-covered bio-crust) to the soil hydrological response were analyzed. We found that soil surface bio-crusts were more efficient in improving soil structure, water holding capacity and runoff retention particularly at surface 10 cm layers, compared with physical soil crusts and non-crusted bare soils. We re-confirmed that mosses functioned better than lichens, partly due to their higher successional stage and deeper biomass accumulation. Physical crusts were least efficient in water conservation and erosion control, followed by non-crusted bare soils. More importantly, there were marked differences in the efficiency of the different spatial arrangements of bio-crusts in controlling runoff and sediment generation. Fully-covered bio-crust pattern provides the best option for soil loss reduction and runoff retention, while a combination of upper bio-crust and lower bare soil pattern is the least one. These findings are suggested to be significant for surface-cover protection, rainwater infiltration, runoff retention, and erosion control in water-restricted and degraded natural slopes.	[Wei, Wei; Yu, Yun; Chen, Liding] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Chen, LD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	liding@rcees.ac.cn			National Natural Science Foundation of China [41390462, 41371123]; Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China [SKLURE2013-1-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China	This research was supported by the National Natural Science Foundation of China (No. 41390462; No. 41371123) and the Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China (SKLURE2013-1-02).	Arnau-Rosalen E, 2008, GEOMORPHOLOGY, V101, P595, DOI 10.1016/j.geomorph.2008.03.001; Badorreck A, 2013, SOIL TILL RES, V129, P1, DOI 10.1016/j.still.2013.01.001; Belnap J, 2006, APPL SOIL ECOL, V32, P63, DOI 10.1016/j.apsoil.2004.12.010; Belnap J, 2005, ECOLOGY, V86, P298, DOI 10.1890/03-0567; Belnap J, 1998, J ARID ENVIRON, V39, P133, DOI 10.1006/jare.1998.0388; Bowker MA, 2008, SOIL BIOL BIOCHEM, V40, P2309, DOI 10.1016/j.soilbio.2008.05.008; Chamizo S, 2013, J HYDROL, V489, P74, DOI 10.1016/j.jhydrol.2013.02.051; Chamizo S, 2012, SOIL BIOL BIOCHEM, V49, P96, DOI 10.1016/j.soilbio.2012.02.017; Chen L, 2006, J ARID ENVIRON, V67, P521, DOI 10.1016/j.jaridenv.2006.02.018; Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290; Concostrina-Zubiri L, 2013, SOIL BIOL BIOCHEM, V64, P28, DOI 10.1016/j.soilbio.2013.03.029; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P389, DOI 10.1071/SR9940389; Eldridge DJ, 2003, J ARID ENVIRON, V53, P457, DOI 10.1006/jare.2002.1068; Eldridge DJ, 2002, LANDSCAPE ECOL, V17, P587, DOI 10.1023/A:1021575503284; Eldridge DJ, 2000, CATENA, V40, P323, DOI 10.1016/S0341-8162(00)00082-5; Fiener P, 2011, EARTH-SCI REV, V106, P92, DOI 10.1016/j.earscirev.2011.01.004; Fox DM, 2004, GEODERMA, V120, P109, DOI 10.1016/j.geoderma.2003.08.010; Greene RSB, 2004, EARTH SURF PROC LAND, V29, P1077, DOI 10.1002/esp.1103; HOOGMOED WB, 1984, SOIL TILL RES, V4, P5, DOI 10.1016/0167-1987(84)90013-8; Jiang DS, 1997, CONTROLLING PATTERNS, P446; Aguilar AJ, 2009, J ARID ENVIRON, V73, P1158, DOI 10.1016/j.jaridenv.2009.05.009; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kidron GJ, 2014, J HYDROL, V509, P398, DOI 10.1016/j.jhydrol.2013.11.041; Kidron GJ, 2012, GEOMORPHOLOGY, V139, P484, DOI 10.1016/j.geomorph.2011.11.013; Kirkby M, 2002, CATENA, V46, P89, DOI 10.1016/S0341-8162(01)00160-6; Li XR, 2007, GEOMORPHOLOGY, V88, P254, DOI 10.1016/j.geomorph.2006.11.009; Li XR, 2011, APPL SOIL ECOL, V47, P59, DOI 10.1016/j.apsoil.2010.10.010; Li X. R., 2012, ECOHYDROLOGY BIOL SO; MALAMISSA O, 2011, GEODERMA, V167, P22; MORIN J, 1981, J HYDROL, V52, P321, DOI 10.1016/0022-1694(81)90178-5; Neave M, 2007, GEOMORPHOLOGY, V87, P378, DOI 10.1016/j.geomorph.2006.10.007; POESEN J, 1992, CATENA, V19, P451, DOI 10.1016/0341-8162(92)90044-C; Powell JT, 2015, J ARID ENVIRON, V112, P127, DOI 10.1016/j.jaridenv.2013.11.004; Ram A, 2007, CATENA, V70, P437, DOI 10.1016/j.catena.2006.11.012; Rodriguez-Caballero E, 2012, GEOMORPHOLOGY, V145, P81, DOI 10.1016/j.geomorph.2011.12.042; Sinoga JDR, 2009, GEOMORPHOLOGY, V108, P234, DOI 10.1016/j.geomorph.2009.01.012; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Shi ZH, 2010, CATENA, V81, P240, DOI 10.1016/j.catena.2010.04.007; Sole-Benet A, 1997, CATENA, V31, P23, DOI 10.1016/S0341-8162(97)00032-5; Summer ME, 1992, ADV SOIL SCI; Svircev Z, 2013, QUATERN INT, V296, P206, DOI 10.1016/j.quaint.2012.10.048; Viles HA, 2008, GEOGR COMPASS, V2, P899, DOI 10.1111/j.1749-8198.2008.00099.x; Wei W, 2014, J HYDROL, V513, P115, DOI 10.1016/j.jhydrol.2014.03.022; Wei W, 2010, CATENA, V81, P24, DOI 10.1016/j.catena.2010.01.002; Wei W, 2009, PROG PHYS GEOG, V33, P307, DOI 10.1177/0309133309341426; Whisenant SG, 1999, REPAIRING DAMAGED WI, P1; Williams JD, 1999, ARID SOIL RES REHAB, V13, P145, DOI 10.1080/089030699263384; Wuest SB, 2006, J SOIL WATER CONSERV, V61, P218; Xiao Bo, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P35; Xiao B, 2011, APPL SOIL ECOL, V48, P11, DOI 10.1016/j.apsoil.2011.02.006; Xu XL, 2008, FOREST ECOL MANAG, V256, P656, DOI 10.1016/j.foreco.2008.05.015; YANG XH, 2001, ACTA ECOLOGICA SINIC, V21, P474; Zaady E, 2007, J ARID ENVIRON, V70, P463, DOI 10.1016/j.jaridenv.2007.01.004; [赵允格 ZHAO Yunge], 2006, [自然资源学报, Journal of Natural Resources], V21, P441	54	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133565	10.1371/journal.pone.0133565	http://dx.doi.org/10.1371/journal.pone.0133565			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207757	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000100
J	Karch, S; Keeser, D; Hummer, S; Paolini, M; Kirsch, V; Karali, T; Kupka, M; Rauchmann, BS; Chrobok, A; Blautzik, J; Koller, G; Ertl-Wagner, B; Pogarell, O				Karch, Susanne; Keeser, Daniel; Huemmer, Sebastian; Paolini, Marco; Kirsch, Valerie; Karali, Temmuz; Kupka, Michael; Rauchmann, Boris-Stephan; Chrobok, Agnieszka; Blautzik, Janusch; Koller, Gabi; Ertl-Wagner, Birgit; Pogarell, Oliver			Modulation of Craving Related Brain Responses Using Real-Time fMRI in Patients with Alcohol Use Disorder	PLOS ONE			English	Article							CINGULATE CORTEX ACTIVITY; SLOW CORTICAL POTENTIALS; COMPUTER COMMUNICATION; PREFRONTAL CORTEX; SELF-REGULATION; ACTIVATION; NEUROFEEDBACK; REDUCTION; FEASIBILITY; ADDICTION	Literature One prominent symptom in addiction disorders is the strong desire to consume a particular substance or to display a certain behaviour (craving). Especially the strong association between craving and the probability of relapse emphasises the importance of craving in the therapeutic process. Neuroimaging studies have shown that craving is associated with increased responses, predominantly in fronto-striatal areas. Aim and Methods The aim of the present study is the modification of craving-related neuronal responses in patients with alcohol addiction using fMRI real-time neurofeedback. For that purpose, patients with alcohol use disorder and healthy controls participated once in neurofeedback training; during the sessions neuronal activity within an individualized cortical region of interest (ROI) (anterior cingulate cortex, insula, dorsolateral prefrontal cortex) was evaluated. In addition, variations regarding the connectivity between brain regions were assessed in the resting state. Results and Discussion The results showed a significant reduction of neuronal activity in patients at the end of the training compared to the beginning, especially in the anterior cingulate cortex, the insula, the inferior temporal gyrus and the medial frontal gyrus. Furthermore, the results show that patients were able to regulate their neuronal activities in the ROI, whereas healthy subjects achieved no significant reduction. However, there was a wide variability regarding the effects of the training within the group of patients. After the neurofeedback-sessions, individual craving was slightly reduced compared to baseline. The results demonstrate that it seems feasible for patients with alcohol dependency to reduce their neuronal activity using rtfMRI neurofeedback. In addition, there is some evidence that craving can be influenced with the help of this technique. Future Prospects In future, real-time fMRI might be a complementary neurophysiological-based strategy for the psychotherapy of patients with psychiatric or psychosomatic diseases. For that purpose, the stability of this effect and the generalizability needs to be assessed.	[Karch, Susanne; Keeser, Daniel; Huemmer, Sebastian; Chrobok, Agnieszka; Koller, Gabi; Pogarell, Oliver] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Keeser, Daniel; Paolini, Marco; Karali, Temmuz; Kupka, Michael; Rauchmann, Boris-Stephan; Blautzik, Janusch; Ertl-Wagner, Birgit] Univ Munich, Inst Clin Radiol, Munich, Germany; [Kirsch, Valerie] Univ Munich, Dept Neurol, D-80539 Munich, Germany	University of Munich; University of Munich; University of Munich	Karch, S (corresponding author), Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany.	Susanne.Karch@med.uni-muenchen.de	Rauchmann, Boris-Stephan/GLQ-9798-2022; Ertl-Wagner, Birgit/AAD-5708-2020; Keeser, Daniel/C-8888-2016	Rauchmann, Boris-Stephan/0000-0003-4547-6240; Keeser, Daniel/0000-0002-0244-1024; Kirsch, Valerie/0000-0002-9397-436X; Ertl-Wagner, Birgit/0000-0002-7896-7049				Arnold LE, 2012, J ATTEN DISORD; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Canterberry M, 2013, NICOTINE TOB RES, V15, P2120, DOI 10.1093/ntr/ntt122; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Caria A, 2012, NEUROSCIENTIST, V18, P487, DOI 10.1177/1073858411407205; Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020; Chapin H, 2012, NEUROSCI LETT, V520, P174, DOI 10.1016/j.neulet.2012.02.076; de Ruiter MA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-581; Decharms RC, 2007, TRENDS COGN SCI, V11, P473, DOI 10.1016/j.tics.2007.08.014; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Dyck M, 2011, NEUROIMAGE, V54, P2503, DOI 10.1016/j.neuroimage.2010.10.013; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fagerstrom K, 2008, ADDICTION, V103, P841, DOI 10.1111/j.1360-0443.2008.02190.x; George MS, 2001, ARCH GEN PSYCHIAT, V58, P345, DOI 10.1001/archpsyc.58.4.345; Gevensleben H, 2012, EXPERT REV NEUROTHER, V12, P447, DOI [10.1586/ERN.12.22, 10.1586/ern.12.22]; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Hanlon CA, 2013, PSYCHIAT RES-NEUROIM, V213, P79, DOI 10.1016/j.pscychresns.2013.03.003; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Heinz A, 2009, ADDICT BIOL, V14, P108, DOI 10.1111/j.1369-1600.2008.00136.x; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Johnston S, 2011, COGN AFFECT BEHAV NE, V11, P44, DOI 10.3758/s13415-010-0010-1; Kaiser J, 2001, CLIN NEUROPHYSIOL, V112, P551, DOI 10.1016/S1388-2457(01)00470-9; Kotchoubey B, 2001, EPILEPSIA, V42, P406, DOI 10.1046/j.1528-1157.2001.22200.x; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Lee S, 2011, NEUROREHAB NEURAL RE, V25, P259, DOI 10.1177/1545968310385128; Li XB, 2013, ADDICT BIOL, V18, P739, DOI 10.1111/j.1369-1600.2012.00449.x; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; Myrick H, 2004, J CLIN PSYCHOPHARM, V30, P365; Nazari MA, 2012, CLIN EEG NEUROSCI, V43, P315, DOI 10.1177/1550059412451880; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Posse S, 2001, HUM BRAIN MAPP, V12, P25, DOI 10.1002/1097-0193(200101)12:1<25::AID-HBM30>3.0.CO;2-H; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Schmidt T, 2012, BIOMED TECH BERL; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007; WHO, 2010, INT STAT CLASS DIS R; Wrase J, 2002, EUR PSYCHIAT, V17, P287, DOI 10.1016/S0924-9338(02)00676-4; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Yoo SS, 2002, NEUROREPORT, V13, P1377, DOI 10.1097/00001756-200208070-00005; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	50	56	56	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133034	10.1371/journal.pone.0133034	http://dx.doi.org/10.1371/journal.pone.0133034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204262	Green Published, gold			2022-12-27	WOS:000358621000017
J	Niven, J; Hoare, J; McGowan, D; Devarajan, G; Itohara, S; Gannage, M; Teismann, P; Crane, I				Niven, Jennifer; Hoare, Joseph; McGowan, Debbie; Devarajan, Gayathri; Itohara, Shigeyoshi; Gannage, Monique; Teismann, Peter; Crane, Isabel			S100B Up-Regulates Macrophage Production of IL1 beta and CCL22 and Influences Severity of Retinal Inflammation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; GLYCATION END-PRODUCTS; GUANYLATE-CYCLASE; CA2+ SENSOR; ACTIVATION; EXPRESSION; RECEPTOR; RAGE; PROTEIN; ENCEPHALOMYELITIS	S100B is a Ca2+ binding protein and is typically associated with brain and CNS disorders. However, the role of S100B in an inflammatory situation is not clear. The aim of the study was to determine whether S100B is likely to influence inflammation through its effect on macrophages. A murine macrophage cell line (RAW 264.7) and primary bone marrow derived macrophages were used for in vitro studies and a model of retinal inflammatory disease in which pathogenesis is highly dependent on macrophage infiltration, Experimental Autoimmune Uveoretinitis, for in vitro study. Experimental Autoimmune Uveoretinitis is a model for the human disease posterior endogenous uveoretinitis, a potentially blinding condition, with an autoimmune aetiology, that mainly affects the working age group. To date the involvement of S100B in autoimmune uveoretinitis has not been investigated. Real-time PCR array analysis on RAW 246.7 cells indicated up-regulation of gene expression for various cytokines/chemokines in response to S100B, IL-1 beta and CCL22 in particular and this was confirmed by real-time PCR. In addition flow cytometry and ELISA confirmed up-regulation of protein production in response to S100B for pro-IL-1 beta and CCL22 respectively. This was the case for both RAW 264.7 cells and bone marrow derived macrophages. Induction of EAU with retinal antigen in mice in which S100B had been deleted resulted in a significantly reduced level of disease compared to wild-type mice, as determined by topical endoscopic fundus imaging and histology grading. Macrophage infiltration was also significantly reduced in S100B deleted mice. Real-time PCR analysis indicated that this was associated with reduction in CCL22 and IL-1 beta in retinas from S100B knock-out mice. In conclusion S100B augments the inflammatory response in uveoretinitis and this is likely to be, at least in part, via a direct effect on macrophages.	[Niven, Jennifer; Hoare, Joseph; McGowan, Debbie; Devarajan, Gayathri; Teismann, Peter; Crane, Isabel] Univ Aberdeen, Inst Med Sci, Div Appl Med, Aberdeen, Scotland; [Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Niven, Jennifer; Gannage, Monique] Univ Geneva, Sch Med, Div Rheumatol, CH-1211 Geneva, Switzerland; [Niven, Jennifer; Gannage, Monique] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland	University of Aberdeen; RIKEN; University of Geneva; University of Geneva	Crane, I (corresponding author), Univ Aberdeen, Inst Med Sci, Div Appl Med, Foresterhill, Aberdeen, Scotland.	i.j.crane@abdn.ac.uk	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989; Gannage, Monique/0000-0003-3533-1937	National Eye Research Centre, Bristol, UK [SCIAD 058]; NHS Grampian Endowment Trust [10/16]	National Eye Research Centre, Bristol, UK; NHS Grampian Endowment Trust	This work was supported by funding awards to Dr Isabel Crane from the National Eye Research Centre, Bristol, UK (Grant ref. SCIAD 058); and NHS Grampian Endowment Trust (Grant ref. 10/16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJB, 2009, CLIN OPHTHALMOL, V3, P235; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Bryan NB, 2014, J INFLAMM, V7, P23; Chen MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109214; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; Dagkalis A, 2009, INVEST OPHTH VIS SCI, V50, P4288, DOI 10.1167/iovs.09-3434; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dogan RNE, 2011, J LEUKOCYTE BIOL, V89, P93, DOI 10.1189/jlb.0810442; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Duda T, 1996, BIOCHEMISTRY-US, V35, P6263, DOI 10.1021/bi960007m; Duda T, 2002, EMBO J, V21, P2547, DOI 10.1093/emboj/21.11.2547; Esposito G, 2006, LIFE SCI, V78, P2707, DOI 10.1016/j.lfs.2005.10.023; Forde EA, 2011, J NEUROIMMUNOL, V236, P17, DOI 10.1016/j.jneuroim.2011.04.008; Forrester JV, 1998, CURR EYE RES, V17, P426, DOI 10.1080/02713689808951224; Foxman EF, 2002, J IMMUNOL, V168, P2483, DOI 10.4049/jimmunol.168.5.2483; Fujiya A, 2014, OBESITY, V22, P371, DOI 10.1002/oby.20532; Fukami N, 2009, J IMMUNOL, V182, P309, DOI 10.4049/jimmunol.182.1.309; Gasparotto J, 2013, SCI TOTAL ENVIRON, V463, P743, DOI 10.1016/j.scitotenv.2013.06.086; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hu JR, 1999, BRAIN RES, V842, P46, DOI 10.1016/S0006-8993(99)01804-1; Huang SM, 2006, MOL NUTR FOOD RES, V50, P1129, DOI 10.1002/mnfr.200600075; Kerr EC, 2008, PROG RETIN EYE RES, V27, P527, DOI 10.1016/j.preteyeres.2008.07.001; Kim SH, 2004, NEUROBIOL AGING, V25, P431, DOI 10.1016/S0197-4580(03)00126-X; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Mrak RE, 2011, NEUROBIOL AGING, V22, P915; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Poppensieker K, 2012, P NATL ACAD SCI USA, V109, P3897, DOI 10.1073/pnas.1114153109; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sathe K, 2012, BRAIN, V135, P3336, DOI 10.1093/brain/aws250; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Steiner J, 2011, BRAIN BEHAV IMMUN, V25, P1233, DOI 10.1016/j.bbi.2011.03.015; Trujillo G, 2008, AM J PATHOL, V172, P1209, DOI 10.2353/ajpath.2008.070832; Tsuchiya K, 2014, CRIT REV IMMUNOL, V34, P41, DOI 10.1615/CritRevImmunol.2013008686; Watanabe T, 2009, INVEST OPHTH VIS SCI, V50, P2283, DOI 10.1167/iovs.08-2709; Wen XH, 2012, CELL PHYSIOL BIOCHEM, V29, P417, DOI 10.1159/000338496; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	49	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132688	10.1371/journal.pone.0132688	http://dx.doi.org/10.1371/journal.pone.0132688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204512	gold, Green Published, Green Submitted			2022-12-27	WOS:000358621000012
J	Aguilar-Raab, C; Grevenstein, D; Schweitzer, J				Aguilar-Raab, Corina; Grevenstein, Dennis; Schweitzer, Jochen			Measuring Social Relationships in Different Social Systems: The Construction and Validation of the Evaluation of Social Systems (EVOS) Scale	PLOS ONE			English	Article							GOODNESS-OF-FIT; COVARIANCE STRUCTURE-ANALYSIS; MEASUREMENT INVARIANCE; CIRCUMPLEX MODEL; FAMILY-THERAPY; INDEXES; COUPLE; PERCEPTIONS; PSYCHOLOGY; INVENTORY	Social interactions have gained increasing importance, both as an outcome and as a possible mediator in psychotherapy research. Still, there is a lack of adequate measures capturing relational aspects in multi-person settings. We present a new measure to assess relevant dimensions of quality of relationships and collective efficacy regarding interpersonal interactions in diverse personal and professional social systems including couple partnerships, families, and working teams: the EVOS. Theoretical dimensions were derived from theories of systemic family therapy and organizational psychology. The study was divided in three parts: In Study 1 (N = 537), a short 9-item scale with two interrelated factors was constructed on the basis of exploratory factor analysis. Quality of relationship and collective efficacy emerged as the most relevant dimensions for the quality of social systems. Study 2 (N = 558) confirmed the measurement model using confirmatory factor analysis and established validity with measures of family functioning, life satisfaction, and working team efficacy. Measurement invariance was assessed to ensure that EVOS captures the same latent construct in all social contexts. In Study 3 (N = 317), an English language adaptation was developed, which again confirmed the original measurement model. The EVOS is a theory-based, economic, reliable, and valid measure that covers important aspects of social relationships, applicable for different social systems. It is the first instrument of its kind and an important addition to existing measures of social relationships and related outcome measures in therapeutic and other counseling settings involving multiple persons.	[Aguilar-Raab, Corina; Schweitzer, Jochen] Univ Heidelberg Hosp, Ctr Psychosocial Med, Inst Med Psychol, Heidelberg, Germany; [Grevenstein, Dennis] Heidelberg Univ, Inst Psychol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Aguilar-Raab, C (corresponding author), Univ Heidelberg Hosp, Ctr Psychosocial Med, Inst Med Psychol, Heidelberg, Germany.	Corina.Aguilar-Raab@med.uni-heidelberg.de		Grevenstein, Dennis/0000-0002-1422-0309	Heidehof Foundation; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Heidehof Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Funding was provided by the Heidehof Foundation (http://www.heidehof-stiftung.de/) to CAR and JS. We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRELL A, 1994, J OCCUP ORGAN PSYCH, V67, P143, DOI 10.1111/j.2044-8325.1994.tb00557.x; Anderson H., 1992, THERAPY SOCIAL CONST, P25; Anderson NR, 1996, EUR J WORK ORGAN PSY, V5, P53, DOI [10.1080/13594329608414840, DOI 10.1080/13594329608414840]; [Anonymous], 2003, UNDERSTANDING UNDERS; [Anonymous], 1967, PRAGMATICS HUMAN COM; BACON DR, 1995, EDUC PSYCHOL MEAS, V55, P394, DOI 10.1177/0013164495055003003; Bandura A, 2000, CURR DIR PSYCHOL SCI, V9, P75, DOI 10.1111/1467-8721.00064; Bandura A, 2011, APPL PSYCHOL-INT REV, V60, P421, DOI 10.1111/j.1464-0597.2010.00442.x; Bateson G., 1979, MIND NATURE; Bateson G., 1972, STEPS ECOLOGY MIND C; BEAVERS WR, 1981, J MARITAL FAM THER, V7, P299, DOI 10.1111/j.1752-0606.1981.tb01382.x; Beckhard R, 1972, J CONTEMP BUS, V1, P22; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Browne MW, 1993, TESTING STRUCTURAL E; Cecchin G, 1994, J SYST THER, V13, P13; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cierpka MF, 1994, FAMILIENBOGEN FB INV; Cohen GL, 2014, ANNU REV PSYCHOL, V65, P333, DOI 10.1146/annurev-psych-010213-115137; De Mol J, 2010, J FAM THER, V32, P259, DOI 10.1111/j.1467-6427.2010.00504.x; Epstein N.B., 1993, NORMAL FAMILY PROCES; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EPSTEIN NB, 1978, J MARRIAGE FAM COUNS, V4, P19, DOI 10.1111/j.1752-0606.1978.tb00537.x; Escudero V, 2008, J FAM THER, V30, P194, DOI 10.1111/j.1467-6427.2008.00425.x; Fahrenberg J., 2000, FRAGEBOGEN LEBENSZUF; Faulstich P, 1998, STRATEGIEN BETRIEBLI; FISHER L, 1985, FAM PROCESS, V24, P213, DOI 10.1111/j.1545-5300.1985.00213.x; Flemons DG, 1989, Z SYSTEMISCHE THERAP, V7, P159; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Goncalo JA, 2010, ORGAN BEHAV HUM DEC, V113, P13, DOI 10.1016/j.obhdp.2010.05.001; GOOLISHIAN HA, 1992, J MARITAL FAM THER, V18, P5, DOI 10.1111/j.1752-0606.1992.tb01732.x; Gorsuch R., 1983, FACTOR ANAL; HAKEN H, 2004, SYNERGETICS INTRO AD; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunger C, EXPERIENCE PER UNPUB; IBM, 2012, IBM SPSS STAT WIND V; Kauffeld S., 2001, TEAMDIAGNOSE; Kauffeld S., 2004, FAT FRAGEBOGEN ARBEI; Keiley M. K., 2005, RES METHODS FAMILY T, P405; Kenny DA, 2001, J PERS SOC PSYCHOL, V80, P439, DOI 10.1037//0022-3514.80.3.439; Kreppner K., 1999, WAS WIRD KINDERN CHA, P91; MARCUS DK, 1994, J CONSULT CLIN PSYCH, V62, P776, DOI 10.1037/0022-006X.62.4.776; Maturana Humberto R., 1992, TREE KNOWLEDGE BIOL; McGrath JE, 2000, PERS SOC PSYCHOL REV, V4, P95, DOI 10.1207/S15327957PSPR0401_8; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Muthen B., 2010, MPLUS USERS GUIDE; OLSON DH, 1979, FAM PROCESS, V18, P3, DOI 10.1111/j.1545-5300.1979.00003.x; OLSON DH, 1986, FAM PROCESS, V25, P337, DOI 10.1111/j.1545-5300.1986.00337.x; Olson DH., 1985, FACES 3 FAMILY ADAPT; Pinsof WM, 2009, PSYCHOTHER RES, V19, P143, DOI 10.1080/10503300802669973; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Sanderson J, 2009, AM J FAM THER, V37, P239, DOI 10.1080/01926180802405935; Santtila P, 2008, J SEX MARITAL THER, V34, P29, DOI 10.1080/00926230701620548; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schweitzer J, 2012, LEHRBUCH SYSTEMISCHE, VI; Shulman S, 2000, J RES ADOLESCENCE, V10, P99, DOI 10.1207/SJRA1001_5; Simon FB, 2013, ZIRKULARES FRAGEN SY; Sprenkle D. H., 2005, FAMILY ASSESSMENT IN, P211; STEINHAUER PD, 1984, CAN J PSYCHIAT, V29, P77, DOI 10.1177/070674378402900202; Stratton P, 2010, J FAM THER, V32, P232, DOI 10.1111/j.1467-6427.2010.00507.x; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tschacher W., 1992, SELF ORG CLIN PSYCHO, DOI DOI 10.1007/978-3-642-77534-5; Tschacher W, 2009, PSYCHOTHER RES, V19, P469, DOI 10.1080/10503300802654496; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; WATZLAWICK P, 1967, AM BEHAV SCI, V10, P4, DOI 10.1177/0002764201000802; Watzlawick P, 1984, INVENTED REALITY DO; West M., 1996, HDB WORK GROUP PSYCH; West M. A, 1994, EFFECTIVE TEAMWORK; Willke H, 1993, SYSTEMTHEORIE; Yuan KH, 1998, BRIT J MATH STAT PSY, V51, P289, DOI 10.1111/j.2044-8317.1998.tb00682.x; Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078	74	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133442	10.1371/journal.pone.0133442	http://dx.doi.org/10.1371/journal.pone.0133442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200357	Green Submitted, gold, Green Published			2022-12-27	WOS:000358597100066
J	Islam, FMA; Chakrabarti, R; Islam, SZ; Finger, RP; Critchley, C				Islam, Fakir M. Amirul; Chakrabarti, Rahul; Islam, Silvia Z.; Finger, Robert P.; Critchley, Christine			Factors Associated with Awareness, Attitudes and Practices Regarding Common Eye Diseases in the General Population in a Rural District in Bangladesh: The Bangladesh Population-based Diabetes and Eye Study (BPDES)	PLOS ONE			English	Article							LOW-VISION SURVEY; NATIONAL BLINDNESS; RISK-FACTORS; KNOWLEDGE; RETINOPATHY; PREVALENCE; ADULTS; HEALTH; INDIA; COMMUNITY	Background To assess the awareness, attitudes, and practices associated with common eye diseases and eye care utilization in a rural district of Bangladesh. Methods Data were collected using a multilevel cluster random sampling technique from 3104 adults aged >= 30 years from the Banshgram union with a questionnaire assessing the awareness, attitudes and practice about diabetes and common eye diseases, educational attainment, socio-economic status, and medical history. Results Participants were aged between 30 and 89 years with a mean (SD) age of 51 (12) years and 65% were female. The majority of participants had heard of cataracts (90%), trachoma (86%) and Pterygium (84%), yet only 4% had heard of diabetic retinopathy (DR), 7% of glaucoma and 8% of Age-related macular degeneration (AMD). However, 58% of participants did not know vision loss could be prevented. Factors associated with lower awareness regarding common eye diseases were increasing age, lack of formal schooling, and lower socio-economic status. A lower proportion (57%) of people with no schooling compared to those who had attained at least secondary school certificate education (72%) reported that they knew that vision loss could be prevented (p<0.001). Overall 51% of people had heard of at least six (67%) out of nine items relating to awareness of common eye diseases. This included 41% of participants aged 65 years or older compared to 61% of those aged 30-35 years (p<0.001). Only 4% had an eye check at least once a year and higher education and better SES were associated with higher frequency of eye checks. Conclusions In rural Bangladesh awareness of cataract, trachoma and pterygium was good but limited in relation to the potentially blinding conditions of glaucoma, DR, and AMD. The results show a large gap between public awareness and treatment practices about common eye diseases. Public health promotion should be designed to address these knowledge gaps.	[Islam, Fakir M. Amirul; Critchley, Christine] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Hawthorn, Vic 3122, Australia; [Islam, Fakir M. Amirul; Chakrabarti, Rahul; Islam, Silvia Z.] Org Rural Community Dev, Dariapur, Narail, Bangladesh; [Chakrabarti, Rahul; Finger, Robert P.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Islam, Silvia Z.] RMIT Univ Technol, Sch Econ Finance & Mkt, Melbourne, Vic, Australia	Swinburne University of Technology; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Islam, FMA (corresponding author), Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Hawthorn, Vic 3122, Australia.	fislam@swin.edu.au	Islam, Fakir M Amirul/P-6665-2015	Islam, Fakir M Amirul/0000-0003-3897-3302; Finger, Robert P/0000-0003-4253-7597				Aitaoto Nia, 2012, Prev Chronic Dis, V9, pE82; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; Alam DS, 2013, B WORLD HEALTH ORGAN, V91, P757, DOI 10.2471/BLT.13.120196; Attebo K, 1997, AUST NZ J OPHTHALMOL, V25, P283, DOI 10.1111/j.1442-9071.1997.tb01516.x; Bangladesh Bureau of Statistics, 2010, POP HOUS CENS; Basgram Union Parisad Office, 2011, EL LIST; Bhowmik B, 2013, DIABETES METAB J, V37, P46, DOI 10.4093/dmj.2013.37.1.46; Bourne RRA, 2004, OPHTHALMOLOGY, V111, P1150, DOI 10.1016/j.ophtha.2003.09.046; Bylsma GW, 2004, CLIN EXP OPHTHALMOL, V32, P573, DOI 10.1111/j.1442-9071.2004.00905.x; Chakrabarti R, 2015, BANGLADESH J MED SCI, V14; Cheng YH, 2002, SOC SCI MED, V55, P1415, DOI 10.1016/S0277-9536(01)00271-4; Dandona R, 2001, B WORLD HEALTH ORGAN, V79, P96; Demaio AR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-236; Dineen BP, 2003, BRIT J OPHTHALMOL, V87, P820, DOI 10.1136/bjo.87.7.820; Huang OS, 2013, OPHTHAL EPIDEMIOL, V20, P52, DOI 10.3109/09286586.2012.751429; Huang OS, 2009, ANN ACAD MED SINGAP, V38, P1048; Islam FMA, 2016, J DIABETES, V8, P260, DOI 10.1111/1753-0407.12294; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Muhit M A, 2011, Mymensingh Med J, V20, P671; Muller A, 2006, CLIN EXP OPHTHALMOL, V34, P445, DOI 10.1111/j.1442-9071.2006.01234.x; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Ormsby GM, 2012, ASIA-PAC J OPHTHALMO, V1, P331, DOI 10.1097/APO.0b013e31826d9e06; Rani PK, 2008, RURAL REMOTE HEALTH, V8; Shrestha MK, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-2; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI DOI 10.1016/J.0PHTHA.2013.05.025; Varma R, 2011, AM J OPHTHALMOL, V152, P515, DOI 10.1016/j.ajo.2011.06.004; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Zafar S, 2012, JCR-J CLIN RHEUMATOL, V18, P279, DOI 10.1097/RHU.0b013e3182676975; Zaman MJ, 2012, INT J EPIDEMIOL, V41, P1302, DOI 10.1093/ije/dyr226	31	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133043	10.1371/journal.pone.0133043	http://dx.doi.org/10.1371/journal.pone.0133043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200458	Green Published, gold			2022-12-27	WOS:000358597100051
J	Lopez, G; Bill, KLJ; Bid, HK; Braggio, D; Constantino, D; Prudner, B; Zewdu, A; Batte, K; Lev, D; Pollock, RE				Lopez, Gonzalo; Bill, Kate Lynn J.; Bid, Hemant Kumar; Braggio, Danielle; Constantino, Dylan; Prudner, Bethany; Zewdu, Abeba; Batte, Kara; Lev, Dina; Pollock, Raphael E.			HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)	PLOS ONE			English	Article							HISTONE DEACETYLASE; PROTEIN; ACETYLATION; INHIBITOR; COHESIN	Introduction HDAC isoform-specific inhibitors may improve the therapeutic window while limiting toxicities. Developing inhibitors against class I isoforms poses difficulties as they share high homology among their catalytic sites; however, HDAC8 is structurally unique compared to other class I isoforms. HDAC8 inhibitors are novel compounds and have affinity for class I HDAC isoforms demonstrating anti-cancer effects; little is known about their activity in malignant peripheral nerve sheath tumors (MPNST). Recently, we demonstrated anti-MPNST efficacy of HDAC8i in human and murine-derived MPNST pre-clinical models; we now seek to consider the potential therapeutic inhibition of HDAC8 in MPNST. Methods Four Human MPNST cell lines, a murine-derived MPNST cell line, and two HDAC8 inhibitors (PCI-34051, PCI-48012; Pharmacyclics, Inc. Sunnyvale, CA) were studied. Proliferation was determined using MTS and clonogenic assays. Effects on cell cycle were determined via PI FACS analysis; effects on apoptosis were determined using Annexin VPI FACS analysis and cleaved caspase 3 expression. In vivo growth effects of HDAC8i were evaluated using MPNST xenograft models. 2D gel electrophoresis and mass spectrometry were used to identify potential HDAC8 deacetylation substrates. Results HDAC8i induced cell growth inhibition and marked S-phase cell cycle arrest in human and murine-derived MPNST cells. Relative to control, HDAC8i induced apoptosis in both human and murine-derived MPNST cells. HDAC8i exhibited significant effects on MPNST xenograft growth (p=0.001) and tumor weight (p=0.02). Four potential HDAC8 substrate targets were identified using a proteomic approach: PARK7, HMGB1, PGAM1, PRDX6. Conclusions MPNST is an aggressive sarcoma that is notoriously therapy-resistant, hence the urgent need for improved anti-MPNST therapies. HDAC8 inhibition may be useful for MPNST by improving efficacy while limiting toxicities as compared to pan-HDACis.	[Lopez, Gonzalo; Bill, Kate Lynn J.; Bid, Hemant Kumar; Braggio, Danielle; Constantino, Dylan; Prudner, Bethany; Zewdu, Abeba; Batte, Kara] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lev, Dina] Sheba Med Ctr, Surg B, Tel Aviv, Israel; [Pollock, Raphael E.] Ohio State Univ, Surg Oncol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Chaim Sheba Medical Center; University System of Ohio; Ohio State University	Pollock, RE (corresponding author), Ohio State Univ, Surg Oncol, Columbus, OH 43210 USA.	raphael.pollock@osumc.edu		Pollock, Raphael/0000-0002-0443-1583	National Cancer Institute of the National Institutes of Health [U54CA168512]; NATIONAL CANCER INSTITUTE [P30CA016058, U54CA168512] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health: U54CA168512 (RP) (https://urldefense.proofpoint.com/v2/url?u=http-3A_gsspubssl.nci.nih.gov_nciportfolio_search_details-3Bjsessionid-3DE09B3BF14FB00F6638F7736412CC4FB8-3Faction-3Dabstract-26grantNum- 3D5U54CA1 68512- 2D02- 26grantID- 3D8551649- 26grtSCDC3DFY-25202013-26absID-3D8551649-26absSCDC3DPUB2013&d=BQIGaQ&c=k9MF1d71ITtkuJxPdWme51dKbmfPEvxwt8SFEkBfs4&r=WlCJiS 1JcGqgTnM0Ltj2R6XxIkYTI7SdcJwmuK5r PJw&m=4-wHTbdb1Z326N6PEYFZuqHX_WU1 zqO7GvpeQng0UbE&s=QWOz6wxh3BZDapHEcz WiWKWvGqZrukK5GITFr-T-keg&e=). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; DAHLBERG WK, 1993, INT J RADIAT BIOL, V63, P191, DOI 10.1080/09553009314550251; de Leval L, 2006, AM J SURG PATHOL, V30, P319; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; FLETCHER JA, 1991, NEW ENGL J MED, V324, P436, DOI 10.1056/NEJM199102143240702; Frahm S, 2004, NEUROBIOL DIS, V16, P85, DOI 10.1016/j.nbd.2004.01.006; Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Jeong J, 2012, PROTEOMICS, V12, P1452, DOI 10.1002/pmic.201100558; Jo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091508; Karolczak-Bayatti M, 2011, J BIOL CHEM, V286, P34346, DOI 10.1074/jbc.M111.278549; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kramer OH, 2014, TRENDS PHARMACOL SCI, V35, P501, DOI 10.1016/j.tips.2014.08.001; KrennHrubec K, 2007, BIOORG MED CHEM LETT, V17, P2874, DOI 10.1016/j.bmcl.2007.02.064; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Lopez G, 2011, CANCER RES, V71, P185, DOI 10.1158/0008-5472.CAN-10-2799; Lopez G, 2009, CLIN CANCER RES, V15, P3472, DOI 10.1158/1078-0432.CCR-08-2714; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Oehme I, 2009, EXPERT OPIN INV DRUG, V18, P1605, DOI 10.1517/14728220903241658; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ross PJ, 1997, ANN ONCOL, V8, P111, DOI 10.1023/A:1008274522483; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; van Pelt K, 2005, EXP HEMATOL, V33, P226, DOI 10.1016/j.exphem.2004.10.013; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zou CYY, 2009, MOL CANCER THER, V8, P1157, DOI 10.1158/1535-7163.MCT-08-1008	41	30	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133302	10.1371/journal.pone.0133302	http://dx.doi.org/10.1371/journal.pone.0133302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200462	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100059
J	Puerta, P; Hunsicker, ME; Quetglas, A; Alvarez-Berastegui, D; Esteban, A; Gonzalez, M; Hidalgo, M				Puerta, Patricia; Hunsicker, Mary E.; Quetglas, Antoni; Alvarez-Berastegui, Diego; Esteban, Antonio; Gonzalez, Mara; Hidalgo, Manuel			Spatially Explicit Modeling Reveals Cephalopod Distributions Match Contrasting Trophic Pathways in the Western Mediterranean Sea	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; SOUTH CATALAN SEA; ENVIRONMENTAL-CONDITIONS; POPULATION-DYNAMICS; FISH LARVAE; ECOLOGY; SQUID; VARIABILITY; CLIMATE; TEMPERATURE	Populations of the same species can experience different responses to the environment throughout their distributional range as a result of spatial and temporal heterogeneity in habitat conditions. This highlights the importance of understanding the processes governing species distribution at local scales. However, research on species distribution often averages environmental covariates across large geographic areas, missing variability in population-environment interactions within geographically distinct regions. We used spatially explicit models to identify interactions between species and environmental, including chlorophyll a (Chla) and sea surface temperature (SST), and trophic (prey density) conditions, along with processes governing the distribution of two cephalopods with contrasting life-histories (octopus and squid) across the western Mediterranean Sea. This approach is relevant for cephalopods, since their population dynamics are especially sensitive to variations in habitat conditions and rarely stable in abundance and location. The regional distributions of the two cephalopod species matched two different trophic pathways present in the western Mediterranean Sea, associated with the Gulf of Lion upwelling and the Ebro river discharges respectively. The effects of the studied environmental and trophic conditions were spatially variant in both species, with usually stronger effects along their distributional boundaries. We identify areas where prey availability limited the abundance of cephalopod populations as well as contrasting effects of temperature in the warmest regions. Despite distributional patterns matching productive areas, a general negative effect of Chla on cephalopod densities suggests that competition pressure is common in the study area. Additionally, results highlight the importance of trophic interactions, beyond other common environmental factors, in shaping the distribution of cephalopod populations. Our study presents a valuable approach for understanding the spatially variant ecology of cephalopod populations, which is important for fisheries and ecosystem management.	[Puerta, Patricia; Quetglas, Antoni; Hidalgo, Manuel] Inst Espanol Oceanog, Ctr Oceanog Baleares, Palma De Mallorca, Islas Baleares, Spain; [Hunsicker, Mary E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Alvarez-Berastegui, Diego] Balear Isl Coastal Observing & Forecasting Syst, Palma De Mallorca, Islas Baleares, Spain; [Esteban, Antonio] Inst Espanol Oceanog, Ctr Oceanog Murcia, Murcia, Spain; [Gonzalez, Mara] Inst Espanol Oceanog, Ctr Oceanog Malaga, Malaga, Spain	Spanish Institute of Oceanography; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Spanish Institute of Oceanography; Spanish Institute of Oceanography	Puerta, P (corresponding author), Inst Espanol Oceanog, Ctr Oceanog Baleares, Palma De Mallorca, Islas Baleares, Spain.	patrix.puerta@gmail.com	Quetglas, Antoni/K-9089-2014; Puerta, Patricia/GPG-3786-2022; Hidalgo, Manuel/B-8023-2015	Quetglas, Antoni/0000-0002-1303-8003; Puerta, Patricia/0000-0003-4413-4601; Alvarez-Berastegui, Diego/0000-0003-1304-7185; Hidalgo, Manuel/0000-0002-3494-9658	project "ECLIPSAME" (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean) - Spanish Ministry of Economy and Competitiveness [CTM2012-37701]; European Commission; Directorate-General for Maritime Affairs and Fisheries (DG-MARE) of the European Commission; Spanish Institute of Oceanography; FPI grant from the Spanish Ministry of Economy and Competitiveness [BES-2010-030315]; Gordon and Betty Moore Foundation [2897.01]; European Community [289257]; Direccion General d'Educacio, Personal Docent, Universitats i Recerca - European Social Fund	project "ECLIPSAME" (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean) - Spanish Ministry of Economy and Competitiveness; European Commission(European CommissionEuropean Commission Joint Research Centre); Directorate-General for Maritime Affairs and Fisheries (DG-MARE) of the European Commission; Spanish Institute of Oceanography; FPI grant from the Spanish Ministry of Economy and Competitiveness(Spanish Government); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); European Community(European Commission); Direccion General d'Educacio, Personal Docent, Universitats i Recerca - European Social Fund	This research is supported by the project "ECLIPSAME" (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean, CTM2012-37701) co-financed by the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/) and the European Commission. Surveys were co-funded by the Directorate-General for Maritime Affairs and Fisheries (DG-MARE) of the European Commission (http://ec.europa.eu/dgs/maritimeaffairs_fisheries/index_en.htm) and the Spanish Institute of Oceanography (www.ieo.es). PP is supported by the funding of FPI grant BES-2010-030315 from the Spanish Ministry of Economy and Competitiveness. MEH's funding is provided by the Gordon and Betty Moore Foundation, grant number 2897.01, (www.moore.org) through the "Ocean Tipping Points" project (www.oceantippingpoints.org). MH is supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement MYFISH no 289257 (www.myfishproject.eu/) and a postdoctoral contract of the Direccion General d'Educacio, Personal Docent, Universitats i Recerca (http://dguni.caib.es/) funded by the European Social Fund 2014-2020 (http://ec.europa.eu/esf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy C, 2014, GLOBAL CHANGE BIOL, V20, P730, DOI 10.1111/gcb.12467; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Andre J, 2008, J EXP MAR BIOL ECOL, V354, P81, DOI 10.1016/j.jembe.2007.10.008; Andrews JM, 2006, CAN J FISH AQUAT SCI, V63, P1027, DOI 10.1139/F06-006; [Anonymous], 2014, R LANG ENV STAT COMP; Antoine D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004472; Bacheler NM, 2012, DEEP-SEA RES PT II, V65-70, P208, DOI 10.1016/j.dsr2.2012.02.001; Bacheler NM, 2009, MAR ECOL PROG SER, V391, P1, DOI 10.3354/meps08259; Balbin R, 2014, J MARINE SYST, V138, P70, DOI 10.1016/j.jmarsys.2013.07.004; Balbin R, 2012, CONT SHELF RES, V47, P28, DOI 10.1016/j.csr.2012.06.008; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Bartolino V, 2011, ECOLOGY, V92, P189, DOI 10.1890/09-1129.1; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; Brown OB, 1999, UNDER CONTRACT NUMBE; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Ciannelli L, 2004, ECOLOGY, V85, P3418, DOI 10.1890/03-0755; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Coll M, 2006, J MARINE SYST, V59, P63, DOI 10.1016/j.jmarsys.2005.09.001; Coll M, 2008, ECOL MODEL, V217, P95, DOI 10.1016/j.ecolmodel.2008.06.013; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Dahlhoff EP, 2002, INTEGR COMP BIOL, V42, P862, DOI 10.1093/icb/42.4.862; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Fanelli E, 2012, MAR FRESHWATER RES, V63, P264, DOI 10.1071/MF11157; Fauchald P, 2002, MAR ECOL PROG SER, V231, P279, DOI 10.3354/meps231279; Fernandez de Puelles ML, 2008, HYDROBIOLOGIA, V617, P3; Field JC, 2007, CAL COOP OCEAN FISH, V48, P131; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Friedland KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028945; Gruss A, 2014, FISH RES, V159, P11, DOI 10.1016/j.fishres.2014.05.005; Guijarro B, 2008, J MARINE SYST, V71, P385, DOI 10.1016/j.jmarsys.2007.04.003; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hidalgo M, 2009, ESTUAR COAST SHELF S, V83, P227, DOI 10.1016/j.ecss.2009.03.037; Hidalgo M, 2008, J MARINE SYST, V71, P367, DOI 10.1016/j.jmarsys.2007.03.005; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Koubbi P, 2006, SCI MAR, V70, P147, DOI 10.3989/scimar.2006.70s2147; Llope M, 2009, LIMNOL OCEANOGR, V54, P512, DOI 10.4319/lo.2009.54.2.0512; Llope M, 2012, GLOBAL CHANGE BIOL, V18, P106, DOI 10.1111/j.1365-2486.2011.02492.x; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; Lloret J, 2001, FISH OCEANOGR, V10, P33, DOI 10.1046/j.1365-2419.2001.00151.x; de Puelles MLF, 2007, PROG OCEANOGR, V74, P329, DOI 10.1016/j.pocean.2007.04.009; McCain C., 2006, EOS T AM GEOPHYSUNIO, V87, P337, DOI DOI 10.1029/2006EO340002; Millot C, 2005, SCI MAR, V69, P5, DOI 10.3989/scimar.2005.69s15; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Moreno A, 2002, B MAR SCI, V71, P515; Oguz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111482; OReilly J.E., 2000, SEAWIFS POSTLAUNCH C, P9; Otero J, 2009, MAR ECOL PROG SER, V386, P123, DOI 10.3354/meps08041; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pertierra Juan Pablo, 2005, Phuket Marine Biological Center Research Bulletin, V66, P283; Phillips AJ, 2014, ICES J MAR SCI, V71, P1717, DOI 10.1093/icesjms/fst238; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Puerta P., 2014, 2014P02 ICES CM; Puerta P, 2014, MAR ECOL PROG SER, V514, P105, DOI 10.3354/meps10972; Quetglas A, 2011, ACTA OECOL, V37, P476, DOI 10.1016/j.actao.2011.06.002; Rodhouse PGK, 2014, ADV MAR BIOL, V67, P99, DOI 10.1016/B978-0-12-800287-2.00002-0; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Salat J, 1996, SCI MAR, V60, P21; Sanchez P, 2004, FISH RES, V68, P319, DOI 10.1016/j.fishres.2003.11.008; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Smith JM, 2013, DEEP-SEA RES PT II, V95, P145, DOI 10.1016/j.dsr2.2013.03.039; Sveegaard S, 2012, MAR ECOL PROG SER, V468, P245, DOI 10.3354/meps09959; Torres AP, 2011, J PLANKTON RES, V33, P1793, DOI 10.1093/plankt/fbr078; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Valls M, 2011, SCI MAR, V75, P633, DOI 10.3989/scimar.2011.75n4633; Vargas-Yanez M, 2009, FISH RES, V99, P159, DOI 10.1016/j.fishres.2009.05.013; Villanueva R, 2011, J EXP MAR BIOL ECOL, V407, P54, DOI 10.1016/j.jembe.2011.07.012; Walton CC, 1998, J GEOPHYS RES-OCEANS, V103, P27999, DOI 10.1029/98JC02370; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	75	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133439	10.1371/journal.pone.0133439	http://dx.doi.org/10.1371/journal.pone.0133439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201075	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100064
J	Kegler, K; Spitzbarth, I; Imbschweiler, I; Wewetzer, K; Baumgartner, W; Seehusen, F				Kegler, Kristel; Spitzbarth, Ingo; Imbschweiler, Ilka; Wewetzer, Konstantin; Baumgaertner, Wolfgang; Seehusen, Frauke			Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIN RECEPTOR EXPRESSION; OLFACTORY ENSHEATHING CELLS; SPINAL-CORD; MULTIPLE-SCLEROSIS; NEURAL CREST; DISTEMPER VIRUS; GROWTH-FACTOR; GRANULOMATOUS MENINGOENCEPHALOMYELITIS; MONOCLONAL-ANTIBODIES	Gliogenesis under pathophysiological conditions is of particular clinical relevance since it may provide evidence for regeneration promoting cells recruitable for therapeutic purposes. There is evidence that neurotrophin receptor p75 (p75NTR)-expressing cells emerge in the lesioned CNS. However, the phenotype and identity of these cells, and signals triggering their in situ generation under normal conditions and certain pathological situations has remained enigmatic. In the present study, we used a spontaneous, idiopathic and inflammatory CNS condition in dogs with prominent lympho-histiocytic infiltration as a model to study the phenotype of Schwann cells and their relation to Schwann cell remyelination within the CNS. Furthermore, the phenotype of p75NTR-expressing cells within the injured CNS was compared to their counter-part in control sciatic nerve and after peripheral nerve injury. In addition, organotypic slice cultures were used to further elucidate the origin of p75NTR-positive cells. In cerebral and cerebellar white and grey matter lesions as well as in the brain stem, p75NTR-positive cells co-expressed the transcription factor Sox2, but not GAP-43, GFAP, Egr2/Krox20, periaxin and PDGFR-a. Interestingly, and contrary to the findings in control sciatic nerves, p75NTR-expressing cells only co-localized with Sox2 in degenerative neuropathy, thus suggesting that such cells might represent dedifferentiated Schwann cells both in the injured CNS and PNS. Moreover, effective Schwann cell remyelination represented by periaxin-and P0-positive mature myelinating Schwann cells, was strikingly associated with the presence of p75NTR/Sox2-expressing Schwann cells. Intriguingly, the emergence of dedifferentiated Schwann cells was not affected by astrocytes, and a macrophage-dominated inflammatory response provided an adequate environment for Schwann cells plasticity within the injured CNS. Furthermore, axonal damage was reduced in brain stem areas with p75(NTR)/Sox2-positive cells. This study provides novel insights into the involvement of Schwann cells in CNS remyelination under natural occurring CNS inflammation. Targeting p75(NTR)/Sox2-expressing Schwann cells to enhance their differentiation into competent remyelinating cells appears to be a promising therapeutic approach for inflammatory/demyelinating CNS diseases.	[Kegler, Kristel; Spitzbarth, Ingo; Imbschweiler, Ilka; Baumgaertner, Wolfgang; Seehusen, Frauke] Univ Vet Med, Dept Pathol, Hannover, Germany; [Kegler, Kristel; Spitzbarth, Ingo; Wewetzer, Konstantin; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany; [Wewetzer, Konstantin] Hannover Med Sch, Ctr Anat, Dept Funct & Appl Anat, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Hannover Medical School	Baumgartner, W (corresponding author), Univ Vet Med, Dept Pathol, Hannover, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Seehusen, Frauke/Q-8192-2018	Seehusen, Frauke/0000-0001-6701-7868	Deutscher Akademischer Austauschdienst (DAAD, Germany); German Research Foundation [FOR1103, BA815/10-2, BA815/9-1, WE1617/6-1, UL 421/12]	Deutscher Akademischer Austauschdienst (DAAD, Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG))	KK received financial support from Deutscher Akademischer Austauschdienst (DAAD, Germany). This study was in part supported by the German Research Foundation (FOR1103: grant BA815/10-2, BA815/9-1, WE1617/6-1 and UL 421/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; ARCHELOS JJ, 1993, J NEUROSCI RES, V35, P46, DOI 10.1002/jnr.490350107; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barber RM, 2012, J VET INTERN MED, V26, P962, DOI 10.1111/j.1939-1676.2012.00954.x; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; BLAKEMORE WF, 1975, J NEUROCYTOL, V4, P745, DOI 10.1007/BF01181634; Blakemore WF, 2005, NEUROPATH APPL NEURO, V31, P1, DOI 10.1111/j.1365-2990.2005.00637.x; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Cotman CW, 2008, J ALZHEIMERS DIS, V15, P685; Crawford AH, 2013, J COMP PATHOL, V149, P242, DOI 10.1016/j.jcpa.2013.05.004; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; Czasch S, 2006, NEUROBIOL AGING, V27, P293, DOI 10.1016/j.neurobiolaging.2005.02.017; Dowling P, 1999, NEUROLOGY, V53, P1676, DOI 10.1212/WNL.53.8.1676; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; DUSART I, 1992, NEUROSCIENCE, V51, P137, DOI 10.1016/0306-4522(92)90478-K; Franklin R.J.M., 2013, MYELIN REPAIR NEUROP, P71, DOI 10.1007/978-1-4614-2218-1_4; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2014, GLIA, V62, P1905, DOI 10.1002/glia.22622; Geuna Stefano, 2010, Italian Journal of Anatomy and Embryology, V115, P91; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gilmore S. A., 1995, P829; Gudino-Cabrera G, 1999, J NEUROBIOL, V40, P458, DOI 10.1002/(SICI)1097-4695(19990915)40:4<458::AID-NEU4>3.0.CO;2-9; Gudino-Cabrera G, 2000, GLIA, V30, P49, DOI 10.1002/(SICI)1098-1136(200003)30:1<49::AID-GLIA6>3.0.CO;2-M; HARRISON BM, 1987, BRAIN RES, V409, P163, DOI 10.1016/0006-8993(87)90754-2; HARRISON BM, 1980, J NEUROL SCI, V46, P63, DOI 10.1016/0022-510X(80)90044-1; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; HEIMRICH B, 1993, HIPPOCAMPUS, V3, P11; Imbschweiler I, 2012, GLIA, V60, P358, DOI 10.1002/glia.22270; ITOYAMA Y, 1985, ACTA NEUROPATHOL, V65, P217, DOI 10.1007/BF00687001; ITOYAMA Y, 1983, ANN NEUROL, V14, P339, DOI 10.1002/ana.410140313; Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440; Iwashita Y, 2000, GLIA, V31, P232, DOI 10.1002/1098-1136(200009)31:3<232::AID-GLIA40>3.0.CO;2-8; Jeffery ND, 2005, J NEUROTRAUM, V22, P1282, DOI 10.1089/neu.2005.22.1282; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kegler K, 2014, J NEURAL TRANSM, V121, P569, DOI 10.1007/s00702-014-1163-9; Kioke T, 2014, HISTOCHEM CELL BIOL, V141, P301, DOI 10.1007/s00418-013-1158-x; Kipar A, 1998, VET PATHOL, V35, P43, DOI 10.1177/030098589803500104; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; Lavdas AA, 2008, CURR MED CHEM, V15, P151; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee HJ, 2013, J NEUROSCI RES, V91, P196, DOI 10.1002/jnr.23151; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nagoshi N, 2011, GLIA, V59, P771, DOI 10.1002/glia.21150; Omar M, 2011, CELL TISSUE RES, V344, P391, DOI 10.1007/s00441-011-1168-8; Orlando EA, 2008, NEUROPATH APPL NEURO, V34, P621, DOI 10.1111/j.1365-2990.2008.00958.x; Park ES, 2013, VET PATHOL, V50, P1127, DOI 10.1177/0300985813488957; Park ES, 2012, VET PATHOL, V49, P682, DOI 10.1177/0300985811429311; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; PERRY VH, 1995, EUR J NEUROSCI, V7, P271, DOI 10.1111/j.1460-9568.1995.tb01063.x; Petratos S, 2004, GLIA, V48, P64, DOI 10.1002/glia.20056; Poduslo JF, 1993, PERIPHERAL NEUROPATH, P282; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Richner M, 2014, MOL NEUROBIOL, V50, P945, DOI 10.1007/s12035-014-8706-9; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Schwab S, 2007, J COMP PATHOL, V136, P96, DOI 10.1016/j.jcpa.2006.11.006; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Sim FJ, 2002, MOL CELL NEUROSCI, V20, P669, DOI 10.1006/mcne.2002.1145; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Smith PM, 2002, EXP NEUROL, V176, P402, DOI 10.1006/exnr.2002.7936; SNYDER DH, 1975, J NEUROPATH EXP NEUR, V34, P209, DOI 10.1097/00005072-197505000-00001; Spitzbarth I, 2015, BRAIN RES, V1595, P29, DOI 10.1016/j.brainres.2014.11.027; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; STEMPLE DL, 1991, NEUROSCI LETT, V124, P57, DOI 10.1016/0304-3940(91)90821-A; Talarico LR, 2010, J SMALL ANIM PRACT, V51, P138, DOI 10.1111/j.1748-5827.2009.00823.x; Techangamsuwan S, 2008, BRAIN RES, V1240, P31, DOI 10.1016/j.brainres.2008.08.092; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Ulrich R, 2014, GLIA, V62, P1559, DOI 10.1002/glia.22700; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z; Wewetzer K, 1997, GLIA, V19, P213, DOI 10.1002/(SICI)1098-1136(199703)19:3<213::AID-GLIA4>3.0.CO;2-#; Wewetzer K, 2011, EXP NEUROL, V229, P80, DOI 10.1016/j.expneurol.2010.08.029; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zujovic V, 2013, MYELIN REPAIR AND NE, P129; Zujovic V, 2007, NEUROSCIENTIST, V13, P383, DOI 10.1177/10738584070130041001	88	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133916	10.1371/journal.pone.0133916	http://dx.doi.org/10.1371/journal.pone.0133916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196511	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600148
J	Krayter, L; Schnur, LF; Schonian, G				Krayter, Lena; Schnur, Lionel F.; Schoenian, Gabriele			The Genetic Relationship between Leishmania aethiopica and Leishmania tropica Revealed by Comparing Microsatellite Profiles	PLOS ONE			English	Article							WORLD CUTANEOUS LEISHMANIASIS; OLD-WORLD; SPECIES DISCRIMINATION; IDENTIFICATION; EVOLUTION; DONOVANI; MARKERS; EPIDEMIOLOGY; DIAGNOSIS; TAXONOMY	Background Leishmania (Leishmania) aethiopica and L. (L.) tropica cause cutaneous leishmaniases and appear to be related. L. aethiopica is geographically restricted to Ethiopia and Kenya; L. tropica is widely dispersed from the Eastern Mediterranean, through the Middle East into eastern India and in north, east and south Africa. Their phylogenetic inter-relationship is only partially revealed. Some studies indicate a close relationship. Here, eight strains of L. aethiopica were characterized genetically and compared with 156 strains of L. tropica from most of the latter species' geographical range to discern the closeness. Methodology/Principal Findings Twelve unlinked microsatellite markers previously used to genotype strains of L. tropica were successfully applied to the eight strains of L. aethiopica and their microsatellite profiles were compared to those of 156 strains of L. tropica from various geographical locations that were isolated from human cases of cutaneous and visceral leishmaniasis, hyraxes and sand fly vectors. All the microsatellite profiles were subjected to various analytical algorithms: Bayesian statistics, distance-based and factorial correspondence analysis, revealing: (i) the species L. aethiopica, though geographically restricted, is genetically very heterogeneous; (ii) the strains of L. aethiopica formed a distinct genetic cluster; and (iii) strains of L. aethiopica are closely related to strains of L. tropica and more so to the African ones, although, by factorial correspondence analysis, clearly separate from them. Conclusions/Significance The successful application of the 12 microsatellite markers, originally considered species-specific for the species L. tropica, to strains of L. aethiopica confirmed the close relationship between these two species. The Bayesian and distance-based methods clustered the strains of L. aethiopica among African strains of L. tropica, while the factorial correspondence analysis indicated a clear separation between the two species. There was no correlation between microsatellite profiles of the eight strains of L. aethiopica and the type of leishmaniasis, localized (LCL) versus diffuse cutaneous leishmaniasis (DCL), displayed by the human cases.	[Krayter, Lena; Schoenian, Gabriele] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Schnur, Lionel F.] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Parasitol, IL-91010 Jerusalem, Israel	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hebrew University of Jerusalem	Krayter, L (corresponding author), Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany.	lena.krayter@charite.de		Schoenian, Gabriele/0000-0002-1565-4942	Deutsche Forschungsgemeinschaft (DFG) [SCHO 448/8-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	GS, LK and LFS received funding from the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de) (SCHO 448/8-2). The funder had no role in the design of the study, data collection, analysis, decision to publish, and preparation of the manuscript.	AKUFFO HO, 1988, J IMMUNOL, V141, P2461; Al-Jawabreh A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-183; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ASHFORD RW, 1973, T ROY SOC TROP MED H, V67, P568, DOI 10.1016/0035-9203(73)90088-6; Belkhir K., 2004, GENETIX 4 05 LOGICIE; BRAY RS, 1973, T ROY SOC TROP MED H, V67, P345, DOI 10.1016/0035-9203(73)90111-9; CHANCE ML, 1978, ANN TROP MED PARASIT, V72, P533, DOI 10.1080/00034983.1978.11719357; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Downing T, 2012, INFECT GENET EVOL, V12, P149, DOI 10.1016/j.meegid.2011.11.005; El Baidouri F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002255; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fraga J, 2013, INFECT GENET EVOL, V18, P229, DOI 10.1016/j.meegid.2013.05.020; Gebre-Michael T, 2004, T ROY SOC TROP MED H, V98, P64, DOI 10.1016/S0035-9203(03)00008-7; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; GROVE SS, 1989, S AFR MED J, V75, P290; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jamjoom MB, 2002, MOL ECOL NOTES, V2, P104, DOI 10.1046/j.1471-8286.2002.00161.x; Jamjoom MB, 2002, ANN TROP MED PARASIT, V96, P265, DOI 10.1179/000349802125000790; Kebede N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-160; Krayter L, 2014, INFECT GENET EVOL, V28, P233, DOI 10.1016/j.meegid.2014.09.037; Krayter L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-123; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Kuru T, 2011, EXP PARASITOL, V128, P391, DOI 10.1016/j.exppara.2011.05.006; LEBLANCQ SM, 1986, T ROY SOC TROP MED H, V80, P517, DOI 10.1016/0035-9203(86)90128-8; LEBLANCQ SM, 1986, T ROY SOC TROP MED H, V80, P360, DOI 10.1016/0035-9203(86)90318-4; Lewis PO, 2001, GENETIC DATA ANAL GD; Montalvo AM, 2010, PARASITOLOGY, V137, P1159, DOI 10.1017/S0031182010000089; Nasereddin A, 2008, J CLIN MICROBIOL, V46, P2848, DOI 10.1128/JCM.00951-08; Oddone R, 2009, J CLIN MICROBIOL, V47, P2818, DOI 10.1128/JCM.00645-09; Pratlong F, 1999, LES LEISHMANIOSES, P22; Pratlong F, 2009, TROP MED INT HEALTH, V14, P1071, DOI 10.1111/j.1365-3156.2009.02336.x; Pritchard JK, 2000, GENETICS, V155, P945; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; SCHNUR LF, 1977, ANN TROP MED PARASIT, V71, P273, DOI 10.1080/00034983.1977.11687191; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Schonian G, 2000, MOL BIOCHEM PARASIT, V106, P239, DOI 10.1016/S0166-6851(99)00216-9; Schwenkenbecher JM, 2004, INFECT GENET EVOL, V4, P99, DOI 10.1016/j.meegid.2004.01.005; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; Svobodova M, 2006, EMERG INFECT DIS, V12, P1860; Talmi-Frank D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000581; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TURK J L, 1974, P101	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131227	10.1371/journal.pone.0131227	http://dx.doi.org/10.1371/journal.pone.0131227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196393	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600007
J	Tanaka, K; Ogata, K; Mukai, H; Yamawo, A; Tokuda, M				Tanaka, Koki; Ogata, Kanako; Mukai, Hiromi; Yamawo, Akira; Tokuda, Makoto			Adaptive Advantage of Myrmecochory in the Ant-Dispersed Herb Lamium amplexicaule (Lamiaceae): Predation Avoidance through the Deterrence of Post-Dispersal Seed Predators	PLOS ONE			English	Article							DIRECTED-DISPERSAL; DECIDUOUS FOREST; MATERNAL-CARE; BURROWER BUG; CONSEQUENCES; PLANT; MUTUALISM; FATE; RECRUITMENT; REDISPERSAL	Seed dispersal by ants (myrmecochory) is found worldwide, but the benefits that plants obtain from this mutualism remain uncertain. In the present study, we conducted laboratory experiments to demonstrate seed predator avoidance as a benefit of myrmecochory using the annual ant-dispersed herb Lamium amplexicaule, the disperser ant Tetramorium tsushimae, and the seed predatory burrower bug Adomerus rotundus. We compared the predation intensity of Lamium amplexicaule seeds by Adomerus rotundus under the presence or absence of Tetramorium tsushimae. Both the number of seeds sucked by Adomerus rotundus adults and the feeding duration of sucked seeds by nymphs were significantly reduced in the presence of ants. This effect was most likely due to the behavioral alteration of Adomerus rotundus in response to the ant presence, because ants seldom predated Adomerus rotundus during the experiment. Our results demonstrated that the presence of ants decreases post-dispersal seed predation, even when the ants do not bury the seeds. The present study thus suggests that the non-consumptive effects of ants on seed predators benefit myrmecochorous plants.	[Tanaka, Koki; Ogata, Kanako; Tokuda, Makoto] Saga Univ, Fac Agr, Saga 840, Japan; [Tanaka, Koki] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Mukai, Hiromi] Forestry & Forest Prod Res Inst, Ibaraki, Japan; [Yamawo, Akira] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan	Saga University; Kagoshima University; Forestry & Forest Products Research Institute - Japan; Hirosaki University	Tanaka, K (corresponding author), Saga Univ, Fac Agr, Saga 840, Japan.	koukin817@gmail.com		Tokuda, Makoto/0000-0001-7162-0715	Sasakawa Scientific Research Grant; Grants-in-Aid for Scientific Research [15K18611] Funding Source: KAKEN	Sasakawa Scientific Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Sasakawa Scientific Research Grant (http://www.jss.or.jp/ikusel/sasakawa/, KT, in data collection).	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; Canner JE, 2012, ACTA OECOL, V40, P31, DOI 10.1016/j.actao.2012.02.004; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; Clinchy M, 2013, FUNCT ECOL, V27, P56, DOI 10.1111/1365-2435.12007; CULVER DC, 1980, AM J BOT, V67, P710, DOI 10.2307/2442664; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; Depieri RA, 2011, NEOTROP ENTOMOL, V40, P197, DOI 10.1590/S1519-566X2011000200007; Do Bae S, 2014, J ASIA-PAC ENTOMOL, V17, P477, DOI 10.1016/j.aspen.2014.04.006; Fischer RC, 2008, OECOLOGIA, V155, P539, DOI 10.1007/s00442-007-0931-8; Freitas AVL, 1996, J ANIM ECOL, V65, P205, DOI 10.2307/5723; Gammans N, 2006, J CHEM ECOL, V32, P1935, DOI 10.1007/s10886-006-9119-7; GIBSON W, 1993, OIKOS, V67, P334, DOI 10.2307/3545480; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gorb, 2003, SEED DISPERSAL ANTS; Gorb SN, 2000, ACTA OECOL, V21, P293, DOI 10.1016/S1146-609X(00)01081-X; Halpern SL, 2005, AM J BOT, V92, P205, DOI 10.3732/ajb.92.2.205; HANDEL SN, 1978, EVOLUTION, V32, P151, DOI 10.1111/j.1558-5646.1978.tb01105.x; HANDEL SN, 1990, SCI AM, V263, P76, DOI 10.1038/scientificamerican0890-76; HANZAWA FM, 1988, AM NAT, V131, P1, DOI 10.1086/284769; HEITHAUS ER, 1981, ECOLOGY, V62, P136, DOI 10.2307/1936677; HUGHES L, 1992, ECOLOGY, V73, P1285, DOI 10.2307/1940676; Inadomi K, 2014, CAN ENTOMOL, V146, P211, DOI 10.4039/tce.2013.69; Ishikawa T, 2012, FIELD GUIDE JAPANESE, P445; Japanese Ant Database Group, 2008, JAP ANT IM DAT; KJELLSSON G, 1991, OECOLOGIA, V88, P435, DOI 10.1007/BF00317590; Leal IR, 2015, BIOTROPICA, V47, P281, DOI 10.1111/btp.12213; Lengyel S, 2010, PERSPECT PLANT ECOL, V12, P43, DOI 10.1016/j.ppees.2009.08.001; Lobo D, 2011, NEOTROP ENTOMOL, V40, P440, DOI 10.1590/S1519-566X2011000400005; Lonnberg K, 2013, PLANT BIOLOGY, V15, P601, DOI 10.1111/j.1438-8677.2012.00676.x; Manzaneda AJ, 2005, ECOGRAPHY, V28, P583, DOI 10.1111/j.2005.0906-7590.04309.x; Manzaneda AJ, 2012, ECOGRAPHY, V35, P322, DOI 10.1111/j.1600-0587.2011.06923.x; Mukai H, 2012, ANIM BEHAV, V84, P1443, DOI 10.1016/j.anbehav.2012.09.012; Nakahira T, 2008, J INSECT BEHAV, V21, P306, DOI 10.1007/s10905-008-9129-0; Nakamura H., 2006, Journal of the Japanese Forest Society, V88, P141, DOI 10.4005/jjfs.88.141; Offenberg J, 2004, P ROY SOC B-BIOL SCI, V271, pS433, DOI 10.1098/rsbl.2004.0210; Ohnishi YK, 2013, PLANT ECOL, V214, P907, DOI 10.1007/s11258-013-0217-7; Ohnishi YK, 2011, POPUL ECOL, V53, P441, DOI 10.1007/s10144-010-0247-0; R Core Team, 2021, R LANGUAGE ENV STAT; Rudgers JA, 2003, OECOLOGIA, V135, P51, DOI 10.1007/s00442-002-1168-1; Ruhren S, 1996, AM J BOT, V83, P633, DOI 10.2307/2445923; Saska P, 2008, B ENTOMOL RES, V98, P169, DOI 10.1017/S0007485307005512; Satake Y, 1985, WILD FLOWERS JAPAN; Sernander R., 1906, KGL SVENSK VETENSK, V41, P1; Spiegel O, 2010, ECOLOGY, V91, P1538, DOI 10.1890/09-1166.1; TURNBULL CL, 1983, OECOLOGIA, V59, P360, DOI 10.1007/BF00378862; Van Mele P, 2009, PHYSIOL ENTOMOL, V34, P256, DOI 10.1111/j.1365-3032.2009.00685.x; Vaughton G, 1998, J ECOL, V86, P563, DOI 10.1046/j.1365-2745.1998.00279.x; Youngsteadt E, 2008, P NATL ACAD SCI USA, V105, P4571, DOI 10.1073/pnas.0708643105; Zuur Alain F., 2009, P1	49	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133677	10.1371/journal.pone.0133677	http://dx.doi.org/10.1371/journal.pone.0133677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197397	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600133
J	Yuan, YH; Wen, Y; You, YG; Xing, Y; Li, HY; Weng, XM; Wu, N; Liu, S; Zhang, SS; Zhang, WH; Zhang, Y				Yuan, Youhua; Wen, Yan; You, Yuangang; Xing, Yan; Li, Huanying; Weng, Xiaoman; Wu, Nan; Liu, Shuang; Zhang, Shanshan; Zhang, Wenhong; Zhang, Ying			Characterization of Mycobacterium leprae Genotypes in China-Identification of a New Polymorphism C251T in the 16S rRNA Gene	PLOS ONE			English	Article							LEPROSY PATIENTS; LEPROMATOSIS; TRANSMISSION; EPIDEMIOLOGY; COUNTRIES; REVEALS; REGIONS; MEXICO	Leprosy continues to be prevalent in some mountainous regions of China, and genotypes of leprosy strains endemic to the country are not known. Mycobacterium lepromatosis is a new species that was discovered in Mexico in 2008, and it remains unclear whether this species exists in China. Here, we conducted PCR-restriction fragment length polymorphism (RFLP) analysis to classify genotypes of 85 DNA samples collected from patients from 18 different provinces. All 171 DNA samples from skin biopsies of leprosy patients were tested for the presence of Mycobacterium leprae and Mycobacterium lepromatosis by amplifying the 16S rRNA gene using nested PCR, followed by DNA sequencing. The new species M. lepromatosis was not found among the 171 specimens from leprosy patients in 22 provinces in China. However, we found three SNP genotypes among 85 leprosy patients. A mutation at C251T in the 16S rRNA gene was found in 76% of the strains. We also found that the strains that showed the 16S rRNA C251T mutation belonged to SNP type 3, whereas strains without the point mutation belonged to SNP type 1. The SNP type 3 leprosy strains were observed in patients from both the inner and coastal regions of China, but the SNP type 1 strains were focused only in the coastal region. This indicated that the SNP type 3 leprosy strains were more prevalent than the SNP type 1 strains in China. In addition, the 16S rRNA gene sequence mutation at C251T also indicated a difference in the geographical distribution of the strains. To our knowledge, this is the first report of a new polymorphism in 16S rRNA gene in M. leprae in China. Our findings shed light on the prevalent genotypes and provide insight about leprosy transmission that are important for leprosy control in China.	[Yuan, Youhua; Wu, Nan; Liu, Shuang; Zhang, Shanshan; Zhang, Wenhong; Zhang, Ying] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Infect Dis,Key Lab Med Virol, Shanghai 200433, Peoples R China; [Wen, Yan; You, Yuangang; Xing, Yan; Li, Huanying; Weng, Xiaoman] Capital Med Univ, Beijing Friendship Hosp, Beijing Trop Med Res Inst, Beijing, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Fudan University; Capital Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wen, Y (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Beijing Trop Med Res Inst, Beijing, Peoples R China.	weny8@163.com; yzhang@jhsph.edu			Key Technologies Research and Development Program of China [2011ZX09102-008, 2013ZX10003008-003]; Shanghai Science and Technology Development Funds [13XD1401200]	Key Technologies Research and Development Program of China(National Key Technology R&D Program); Shanghai Science and Technology Development Funds	This work was supported by Key Technologies Research and Development Program of China (2011ZX09102-008, 2013ZX10003008-003) and Shanghai Science and Technology Development Funds (13XD1401200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Fontes ANB, 2012, MEM I OSWALDO CRUZ, V107, P143, DOI 10.1590/S0074-02762012000900021; Fontes ANB, 2009, LEPROSY REV, V80, P302; Chae GT, 2002, LEPROSY REV, V73, P41; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Han XY, 2008, AM J CLIN PATHOL, V130, P856, DOI 10.1309/AJCPP72FJZZRRVMM; Han XY, 2014, AM J CLIN PATHOL, V142, P524, DOI 10.1309/AJCP1GLCBE5CDZRM; Han XY, 2012, INT J DERMATOL, V51, P952, DOI 10.1111/j.1365-4632.2011.05414.x; Han XY, 2009, J BACTERIOL, V191, P6067, DOI 10.1128/JB.00762-09; Han XY, 2012, J DRUGS DERMATOL, V11, P168; Jessamine PG, 2012, J DRUGS DERMATOL, V11, P229; Lavania M, 2013, CLIN MICROBIOL INFEC, V19, P1058, DOI 10.1111/1469-0691.12125; Li Ming, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P424; Matsuoka M, 2006, FEMS MICROBIOL LETT, V261, P150, DOI 10.1111/j.1574-6968.2006.00346.x; Matsuoka M, 2009, LEPROSY REV, V80, P322; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Phetsuksiri B, 2012, JPN J INFECT DIS, V65, P52; Sakamuri RM, 2009, J CLIN MICROBIOL, V47, P2844, DOI 10.1128/JCM.02021-08; Weng XM, 2007, J CLIN MICROBIOL, V45, P1728, DOI 10.1128/JCM.00018-07; Weng XM, 2013, INFECT GENET EVOL, V14, P361, DOI 10.1016/j.meegid.2012.12.009; Weng XM, 2011, INFECT GENET EVOL, V11, P363, DOI 10.1016/j.meegid.2010.11.014; Yu M., 2010, ZHONGHUA LIU XING BI, V31, P1155; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	24	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133268	10.1371/journal.pone.0133268	http://dx.doi.org/10.1371/journal.pone.0133268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196543	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600078
J	Zhao, WJ; Song, Q; Zhang, ZJ; Mao, L; Zheng, WJ; Hu, X; Lian, HZ				Zhao, Wen-jie; Song, Qun; Zhang, Zi-jin; Mao, Li; Zheng, Wei-juan; Hu, Xin; Lian, Hong-zhen			The Kinetic Response of the Proteome in A549 Cells Exposed to ZnSO4 Stress	PLOS ONE			English	Article							EXOGENOUS ZINC; HEAVY-METALS; TRANSPORTERS; PROTEINS; METALLOTHIONEIN; HOMEOSTASIS; METABOLISM; TOXICITY; REVEALS; CYCLE	Zinc, an essential trace element, is involved in many important physiological processes. Cell responses to zinc stress show time-dependent effects besides concentration-dependence and tissue-specificity. Herein, we investigated the time-dependent differential expression of the proteome in A549 cells after administered with ZnSO4 for both 9 and 24 h using 2DE. 123 differentially expressed protein spots were detected, most of which were up-regulated by Zn2+ treatment. Interestingly, 49 proteins exhibited significant differential expression repeatedly during these two treatment periods, and moreover showed a conserved change with different ratios and four time-dependent expression patterns. Pattern 1 (up-regulated with rapid initial induction and subsequent repression) and pattern 4 (downregulated with steady repression) were the predominant expression patterns. The abundances of the proteins in patterns 1 and 4 after 24 h of zinc treatment are always lower than that after 9 h, indicating that exogenous zinc reduced the expression of proteins in cells after 24 h or longer. Importantly, these findings could also reflect the central challenge in detecting zinc homeostasis proteins by 2DE or other high throughput analytical methods resulting from slight variation in protein expression after certain durations of exogenous zinc treatment and/or low inherent protein content in cells. These time-dependent proteome expression patterns were further validated by measuring dynamic changes in protein content in cells and in expression of two proteins using the Bradford method and western blotting, respectively. The time-dependent changes in total zinc and free Zn2+ ion contents in cells were measured using ICP-MS and confocal microscopy, respectively. The kinetic process of zinc homeostasis regulated by muffling was further revealed. In addition, we identified 50 differentially expressed proteins which are predominantly involved in metabolic process, cellular process or developmental process, and function as binding, catalytic activity or structural molecule activity. This study further elucidates our understanding of dynamic nature of the cellular response to zinc stress and the mechanism of zinc homeostasis.	[Zhao, Wen-jie; Song, Qun; Zhang, Zi-jin; Hu, Xin; Lian, Hong-zhen] Nanjing Univ, Collaborat Innovat Ctr Chem Life Sci, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Wen-jie; Song, Qun; Zhang, Zi-jin; Hu, Xin; Lian, Hong-zhen] Nanjing Univ, Ctr Mat Anal, Nanjing 210008, Jiangsu, Peoples R China; [Mao, Li] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Zheng, Wei-juan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University; Nanjing University	Lian, HZ (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Chem Life Sci, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China.	hzlian@nju.edu.cn	Hu, Xin/B-1792-2009	Hu, Xin/0000-0003-3400-554X	National Natural Science Foundation of China [21275069, 90913012]; National Basic Research Program of China (973 program) [2011CB911003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (21275069, 90913012), the National Basic Research Program of China (973 program, 2011CB911003). (http://www.nsfc.gov.cn/publish/portal0/default. htmhttp://www.973.gov.cn/AreaAppl. aspx).	Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Barkla BJ, 2014, J PROTEOMICS, V111, P128, DOI 10.1016/j.jprot.2014.03.006; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Costello LC, 2011, J BIOL INORG CHEM, V16, P3, DOI 10.1007/s00775-010-0736-9; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; Dalton T, 1996, J NUTR, V126, P825, DOI 10.1093/jn/126.4.825; Dean KM, 2012, BBA-MOL CELL RES, V1823, P1406, DOI 10.1016/j.bbamcr.2012.04.001; Devergnas S, 2004, BIOCHEM PHARMACOL, V68, P699, DOI 10.1016/j.bcp.2004.05.024; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Gauci Victoria J, 2011, J Chem Biol, V4, P3, DOI 10.1007/s12154-010-0043-5; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Haase H, 2007, BIOMETALS, V20, P579, DOI 10.1007/s10534-006-9029-8; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Kalin M, 2011, EUR UROL, V60, P1235, DOI 10.1016/j.eururo.2011.06.038; Kaler P, 2007, AM J PHYSIOL-RENAL, V292, pF217, DOI 10.1152/ajprenal.00014.2006; KIPRIJANOVSKA S, 2014, INT J PROTEOM, V2014, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu YF, 2012, MED ONCOL, V29, P174, DOI 10.1007/s12032-010-9761-3; Luisi S, 2014, FASEB J, V28; Luque-Garcia JL, 2011, TRAC-TREND ANAL CHEM, V30, P703, DOI 10.1016/j.trac.2011.01.014; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; Maret W, 2013, METAL IONS LIFE SCI, V12, P479, DOI 10.1007/978-94-007-5561-1_14; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; Miao X, 2013, FRONT MED-PRC, V7, P31, DOI 10.1007/s11684-013-0251-9; Mocchegiani Eugenio, 2006, Immun Ageing, V3, P6, DOI 10.1186/1742-4933-3-6; Mohammad MK, 2012, NUTR CLIN PRACT, V27, P305, DOI 10.1177/0884533612441470; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Padmini E, 2011, CELL STRESS CHAPERON, V16, P411, DOI 10.1007/s12192-011-0255-9; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Qian F, 2009, J AM CHEM SOC, V131, P1460, DOI 10.1021/ja806489y; Requejo R, 2005, PHYTOCHEMISTRY, V66, P1519, DOI 10.1016/j.phytochem.2005.05.003; Rink L., 2011, ZINC HUMAN HLTH; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; THOMAS RC, 1991, NATURE, V350, P564, DOI 10.1038/350564b0; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Ugarte M, 2014, METALLOMICS, V6, P189, DOI 10.1039/c3mt00291h; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang YH, 2013, BIOL TRACE ELEM RES, V154, P418, DOI 10.1007/s12011-013-9737-1; Wu HF, 2011, MAR DRUGS, V9, P1566, DOI 10.3390/md9091566; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005; Yildirim V, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-12; Yuan N, 2012, BIOSCI BIOTECH BIOCH, V76, P2014, DOI 10.1271/bbb.120216; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003; Zhao WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105797; Zheng JL, 2014, FISH PHYSIOL BIOCHEM, V40, P1349, DOI 10.1007/s10695-014-9929-4	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133451	10.1371/journal.pone.0133451	http://dx.doi.org/10.1371/journal.pone.0133451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196515	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600098
J	Bloch, N; Weiss, G; Szekely, S; Harel, D				Bloch, Naamah; Weiss, Guy; Szekely, Smadar; Harel, David			An Interactive Tool for Animating Biology, and Its Use in Spatial and Temporal Modeling of a Cancerous Tumor and Its Microenvironment	PLOS ONE			English	Article							REACTIVE ANIMATION; GROWTH; ANGIOGENESIS; SIMULATION; INVASION; HISTORY	The ability to visualize the ongoing events of a computational model of biology is critical, both in order to see the dynamics of the biological system in action and to enable interaction with the model from which one can observe the resulting behavior. To this end, we have built a new interactive animation tool, SimuLife, for visualizing reactive models of cellular biology. SimuLife is web- based, and is freely accessible at http://simulife.weizmann.ac.il/. We have used SimuLife to animate a model that describes the development of a cancerous tumor, based on the individual components of the system and its environment. This has helped in understanding the dynamics of the tumor and its surrounding blood vessels, and in verifying the behavior, fine-tuning the model accordingly, and learning in which way different factors affect the tumor.	[Bloch, Naamah; Weiss, Guy; Szekely, Smadar; Harel, David] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bloch, N (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	naamah.bloch@weizmann.ac.il			European Research Council (ERC) under the European Community's FP7 Programme [710932]; I- CORE program of the Israel Planning & Budgeting Committee; Israel Science Foundation	European Research Council (ERC) under the European Community's FP7 Programme; I- CORE program of the Israel Planning & Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	The research was supported by an Advanced Research Grant from the European Research Council (ERC) under the European Community's FP7 Programme, number 710932. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Part of this research was supported by the I- CORE program of the Israel Planning & Budgeting Committee and the Israel Science Foundation.	Aebersold R, 2009, MOL ONCOL, V3, P9, DOI 10.1016/j.molonc.2008.11.003; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2009, J MATH BIOL, V58, P579, DOI 10.1007/s00285-008-0210-2; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Avni R, 2011, NMR BIOMED, V24, P569, DOI 10.1002/nbm.1632; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Cobb K, 2007, MODELING CANC BIOL B; Efroni S, 2005, COMPUTER, V38, P38, DOI 10.1109/MC.2005.31; Efroni S, 2003, GENOME RES, V13, P2485, DOI 10.1101/gr.1215303; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Fisher J, 2011, COMMUN ACM, V54, P72, DOI 10.1145/2001269.2001289; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman U, 2003, HOLLAND FREI CANC ME; Fukumura D, 2008, APMIS, V116, P695, DOI 10.1111/j.1600-0463.2008.01148.x; Gevertz JL, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Harel D, 2003, LECT NOTES COMPUT SC, V2852, P136; Harel D, 1997, EXECUTABLE OBJECT MO, V30; Harel D, 2003, EUROPEAN ASS THEORET, V81, P226; Harel D, 2008, LECT N BIOINFORMAT, V5054, P1, DOI 10.1007/978-3-540-68413-8_1; Hinow P, 2009, MATH BIOSCI ENG, V6, P521, DOI 10.3934/mbe.2009.6.521; Hoehme S, 2010, BIOINFORMATICS, V26, P2641, DOI 10.1093/bioinformatics/btq437; Iwasa JH, 2010, TRENDS CELL BIOL, V20, P699, DOI 10.1016/j.tcb.2010.08.005; Kam N, 2001, IEEE SYMPOSIA ON HUMAN-CENTRIC COMPUTING LANGUAGES AND ENVIRONMENTS, PROCEEDINGS, P15, DOI 10.1109/HCC.2001.995228; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Mahoney AW, 2010, IEEE ACM T COMPUT BI; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; MUTHUKKARUPPAN VR, 1982, J NATL CANCER I, V69, P699; Narang V., 2011, DEF SCI RES C EXP DS, P1; Quaranta V, 2005, CLIN CHIM ACTA, V357, P173, DOI 10.1016/j.cccn.2005.03.023; Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13; Ribatti D, 2007, LEUKEMIA, V21, P44, DOI 10.1038/sj.leu.2404402; Setty Y, 2008, P NATL ACAD SCI USA, V105, P20374, DOI 10.1073/pnas.0808725105; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Swerdlin N, 2008, P IEEE, V96, P1421, DOI 10.1109/JPROC.2008.925435	42	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133484	10.1371/journal.pone.0133484	http://dx.doi.org/10.1371/journal.pone.0133484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191814	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400094
J	Chen, KC; Hsieh, YS; Tseng, YF; Shieh, MJ; Chen, JS; Lai, HS; Lee, JM				Chen, Ke-Cheng; Hsieh, Yi-Shan; Tseng, Ying-Fan; Shieh, Ming-Jium; Chen, Jin-Shing; Lai, Hong-Shiee; Lee, Jang-Ming			Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread	PLOS ONE			English	Article							FORTHCOMING 7TH EDITION; TNM CLASSIFICATION; INVASIVE THYMOMA; STAGING PROJECT; REVISION; PROPOSALS; EFFUSION; DISSEMINATION; CHEMOTHERAPY; DESCRIPTORS	Pleural spread is difficult to treat in malignancies, especially in lung cancer and thymoma. Monotherapy with surgery fails to have a better survival benefit than palliative chemotherapy, the currently accepted treatment. Photodynamic therapy utilizes a photosensitizer to target the tumor site, and the tumor is exposed to light after performing a pleurectomy and tumor resection. However, the benefits of this procedure to lung cancer or thymoma patients are unknown. We retrospectively reviewed the clinical characteristics and treatment outcomes of patients with lung cancer or thymoma with pleural seeding who underwent pleural photodynamic therapy and surgery between 2005 and 2013. Eighteen patients enrolled in this study. The mean patient age was 52.9 +/- 12.2 years. Lung cancer was the inciting cancer of pleural dissemination in 10 patients (55.6%), and thymoma in 8 (44.4%). There was no procedure-related mortality. Using Kaplan-Meier survival analysis, the 3-year survival rate and the 5-year survival rate were 68.9% and 57.4%, respectively. We compared the PDT lung cancer patients with those receiving chemotherapy or target therapy (n = 51) and found that the PDT group had better survival than non-PDT patients (mean survival time: 39.0 versus 17.6 months; P = .047). With proper patient selection, radical surgical resection combined with intrapleural photodynamic therapy for pleural spread in patients with non-small cell lung cancer or thymoma is feasible and may provide a survival benefit.	[Chen, Ke-Cheng; Shieh, Ming-Jium] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan; [Chen, Ke-Cheng; Shieh, Ming-Jium] Natl Taiwan Univ, Coll Engn, Taipei, Taiwan; [Chen, Ke-Cheng; Tseng, Ying-Fan; Chen, Jin-Shing; Lai, Hong-Shiee; Lee, Jang-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hsieh, Yi-Shan] Tao Yuan Gen Hosp, Minist Hlth & Welf, Dept Surg, Taoyuan, Taiwan; [Shieh, Ming-Jium] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, JM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	jangminglee@gmail.com		Lai, Hong-Shiee/0000-0002-7958-2183; LEE, JANG-MING/0000-0001-9727-227X; CHEN, JIN-SHING/0000-0001-5077-4483	National Science Council (NSC) [101-2314-B002-020-MY3]; National Health Research Institute [NHRI-EX102-10032BI]; Ministry of Health and Welfare [DOH101-TD-I-111-NSC003]; Excellent Translational Medicine Research Projects of National Taiwan University [102C101-51]; National Taiwan University Hospital of Republic of China [NTUH.102-S2140, NTUH 102-N2253, NTUH 104-M2914]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Excellent Translational Medicine Research Projects of National Taiwan University; National Taiwan University Hospital of Republic of China(National Taiwan University)	This study was supported by the National Science Council (NSC 101-2314-B002-020-MY3), National Health Research Institute (NHRI-EX102-10032BI), Ministry of Health and Welfare (DOH101-TD-I-111-NSC003), Excellent Translational Medicine Research Projects of National Taiwan University (102C101-51), and National Taiwan University Hospital (NTUH.102-S2140, NTUH 102-N2253, NTUH 104-M2914) of the Republic of China.	Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Friedberg JS, 2012, ANN THORAC SURG, V93, P1658, DOI 10.1016/j.athoracsur.2012.02.009; Friedberg JS, 2004, J CLIN ONCOL, V22, P2192, DOI 10.1200/JCO.2004.07.097; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; GOMER CJ, 1979, CANCER RES, V39, P146; Hahn SM, 1999, REV CONTEMP PHARMACO, V10, P69; ICHINOSE Y, 1993, J SURG ONCOL, V54, P180, DOI 10.1002/jso.2930540311; Ishikawa Y, 2009, ANN THORAC SURG, V88, P952, DOI 10.1016/j.athoracsur.2009.05.019; Liu TJ, 2014, ANN SURG ONCOL, V21, P322, DOI 10.1245/s10434-013-3228-7; Lucchi M, 2009, J THORAC CARDIOV SUR, V137, P1185, DOI 10.1016/j.jtcvs.2008.09.033; MARTINI N, 1975, CANCER, V35, P734, DOI 10.1002/1097-0142(197503)35:3<734::AID-CNCR2820350328>3.0.CO;2-N; Mordant P, 2011, EUR J CARDIO-THORAC, V40, P1444, DOI 10.1016/j.ejcts.2011.02.076; Mott FE, 2001, CHEST, V119, P317, DOI 10.1378/chest.119.1.317; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Murakawa T, 2015, EUR J CARDIO-THORAC, V47, P567, DOI 10.1093/ejcts/ezu210; Postmus PE, 2007, J THORAC ONCOL, V2, P686, DOI 10.1097/JTO.0b013e31811f4703; Rami-Porta R, 2007, J THORAC ONCOL, V2, P593, DOI 10.1097/JTO.0b013e31807a2f81; REYES L, 1991, J THORAC CARDIOV SUR, V101, P946; Wang BY, 2011, J SURG RES, V169, pE1, DOI 10.1016/j.jss.2011.02.028; Werner-Wasik M, 2000, INT J RADIAT ONCOL, V48, P1475, DOI 10.1016/S0360-3016(00)00801-4; Yu L, 2013, ONCOTARGETS THER, V6, P517, DOI 10.2147/OTT.S41347	21	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133230	10.1371/journal.pone.0133230	http://dx.doi.org/10.1371/journal.pone.0133230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193470	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400067
J	de Visser, KL; Landman, GWD; Meyboom-de Jong, B; de Visser, W; te Meerman, GJ; Bilo, HJG				de Visser, Kees L.; Landman, Gijs W. D.; Meyboom-de Jong, Betty; de Visser, Wim; te Meerman, Gerard J.; Bilo, Henk J. G.			Familial Aggregation between the 14th and 21st Century and Type 2 Diabetes Risk in an Isolated Dutch Population	PLOS ONE			English	Article							MELLITUS; TWINS; CONCORDANCE; OBESITY	Introduction The development of type 2 diabetes results from an interaction of hereditary factors and environmental factors. This study aimed to investigate the contribution of interrelatedness to the risk of developing type 2 diabetes in an isolated Dutch population. Materials and Methods A genealogical database from inhabitants living on the former island Urk between the 14th and 21st century was constructed. In a case-control study, effects of interrelatedness and the risk of type 2 diabetes were estimated with Kinship Coefficients (KCs). Relative risks in first, second, and third degree relatives and spouses of inhabitants with type 2 diabetes were compared to matched controls. Results Patients with type 2 diabetes were more interrelated, expressed by a higher KC compared to controls (7.2 vs. 5.2, p=0.001). First, second and third degree relatives had an increased risk of developing type 2 diabetes. Second degree relatives had a similar risk, 1.7 (1.5-2.0) as third degree relatives, 1.8 (1.5-2.2). Spouses of patients with diabetes had a 3.4 (2.7-4.4) higher risk of developing type 2 diabetes. Conclusions Interrelatedness was higher among inhabitants with type 2 diabetes compared to controls. This differences extended beyond the nuclear family, thereby supporting the hypothesis that interrelatedness contributed to the development of type 2 diabetes on Urk. However, the size of this effect was small and the patterns of risk in first, second and third degree relatives suggested that factors other than interrelatedness were the main contributors to the development of type 2 diabetes on Urk.	[de Visser, Kees L.; Landman, Gijs W. D.; Meyboom-de Jong, Betty; Bilo, Henk J. G.] Isala, Ctr Diabet, NL-8025 BT Zwolle, Netherlands; [de Visser, Kees L.; Meyboom-de Jong, Betty] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9700 RB Groningen, Netherlands; [Landman, Gijs W. D.] Gelre Hosp, Dept Internal Med, NL-7334 DZ Apeldoorn, Netherlands; [Landman, Gijs W. D.] Langerhans Med Res Inst, Zwolle, Netherlands; [Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [te Meerman, Gerard J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands	University of Groningen; Gelre Hospitals; Langerhans Medical Research Group; University of Groningen; University of Groningen	Landman, GWD (corresponding author), Isala, Ctr Diabet, NL-8025 BT Zwolle, Netherlands.	g.w.d.landman@isala.nl	Landman, Gijs/AAJ-5540-2021	Landman, Gijs/0000-0002-6852-6450; Kleefstra, Nanne/0000-0003-1473-8519				Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; [Anonymous], 2002, THESIS U GRONINGEN G; [Anonymous], 1997, MATH STAT METHODS GE, P70; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Di Castelnuovo A, 2009, AM J EPIDEMIOL, V169, P1, DOI 10.1093/aje/kwn234; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; Grant SFA, 2001, ARTHRITIS RHEUM-US, V44, P2247, DOI 10.1002/1529-0131(200110)44:10<2247::AID-ART387>3.0.CO;2-Y; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HAMMAN RF, 1992, DIABETES METAB REV, V8, P287, DOI 10.1002/dmr.5610080402; Hermanides J, 2008, Ned Tijdschr Geneeskd, V152, P2415; Hopper JL, 1999, DIABETOLOGIA, V42, P125, DOI 10.1007/s001250051129; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Masel J, 2011, CURR BIOL, V21, pR837, DOI 10.1016/j.cub.2011.08.007; Medici F, 1999, DIABETOLOGIA, V42, P146, DOI 10.1007/s001250051132; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Rathmann W, 2011, DIABETOLOGIA, V54, P2217, DOI 10.1007/s00125-011-2222-5; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Statistiek. CBvd, 1988, STAT BEST NED GEM 19; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Vaag AA, 2012, DIABETOLOGIA, V55, P2085, DOI 10.1007/s00125-012-2589-y; Vaag A, 2007, CURR OPIN CLIN NUTR, V10, P591, DOI 10.1097/MCO.0b013e3282ab9ea6; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	26	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132549	10.1371/journal.pone.0132549	http://dx.doi.org/10.1371/journal.pone.0132549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193086	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400029
J	Fernandes, CAH; Cardoso, FF; Cavalcante, WGL; Soares, AM; Dal-Pai, M; Gallacci, M; Fontes, MRM				Fernandes, Carlos A. H.; Cardoso, Fabio Florena; Cavalcante, Walter G. L.; Soares, Andreimar M.; Dal-Pai, Maeli; Gallacci, Marcia; Fontes, Marcos R. M.			Structural Basis for the Inhibition of a Phospholipase A(2)-Like Toxin by Caffeic and Aristolochic Acids	PLOS ONE			English	Article							SNAKE-VENOM; BIOLOGICAL-ACTIVITIES; MYOTOXIC MECHANISM; A(2); LYS49; FLACOURTIACEAE; NEUTRALIZATION; IDENTIFICATION; PEPTIDES; SYSTEM	One of the main challenges in toxicology today is to develop therapeutic alternatives for the treatment of snake venom injuries that are not efficiently neutralized by conventional serum therapy. Venom phospholipases A(2) (PLA(2)s) and PLA(2)-like proteins play a fundamental role in skeletal muscle necrosis, which can result in permanent sequelae and disability. This leads to economic and social problems, especially in developing countries. In this work, we performed structural and functional studies with Piratoxin-I, a Lys49-PLA(2) from Bothropspirajai venom, complexed with two compounds present in several plants used in folk medicine against snakebites. These ligands partially neutralized the myotoxic activity of PrTX-I towards binding on the two independent sites of interaction between Lys49-PLA(2) and muscle membrane. Our results corroborate the previously proposed mechanism of action of PLA(2)s-like and provide insights for the design of structure-based inhibitors that could prevent the permanent injuries caused by these proteins in snakebite victims.	[Fernandes, Carlos A. H.; Cardoso, Fabio Florena; Cavalcante, Walter G. L.; Fontes, Marcos R. M.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil; [Fernandes, Carlos A. H.; Cardoso, Fabio Florena; Cavalcante, Walter G. L.; Fontes, Marcos R. M.] CNPq, Inst Nacl Ciencia Tecnol Toxinas, Sao Paulo, SP, Brazil; [Cardoso, Fabio Florena; Cavalcante, Walter G. L.; Gallacci, Marcia; Fontes, Marcos R. M.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Farmacol, Botucatu, SP, Brazil; [Soares, Andreimar M.] Fundacao Oswaldo Cruz FIOCRUZ, Porto Velho, Rondonia, Brazil; [Soares, Andreimar M.] Univ Fed Rondonia, Ctr Estudos Biomol Aplicadas, Porto Velho, Rondonia, Brazil; [Dal-Pai, Maeli] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Morfol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Federal de Rondonia; Universidade Estadual Paulista	Fontes, MRM (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil.	fontes@ibb.unesp.br	Soares, Andreimar M/K-5556-2014; Soares, Andrei/ABG-3545-2020; Cavalcante, Walter L G/B-1212-2013; Gallacci, Márcia/C-8479-2013; Soares, Andreimar/AAE-4657-2021; Fernandes, Carlos/AAY-6730-2020; Fontes, Marcos Roberto/B-1941-2009; Dal-Pai-Silva, Maeli/GLR-1413-2022; Cardoso, Fábio/G-2265-2016	Cavalcante, Walter L G/0000-0002-2354-636X; Gallacci, Márcia/0000-0001-6149-4030; Fernandes, Carlos/0000-0001-6515-6872; Fontes, Marcos Roberto/0000-0002-4634-6221; Cardoso, Fábio/0000-0003-2779-9564; Dal Pai, Maeli/0000-0001-7269-9197; Soares, Andreimar/0000-0003-1032-2188	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to CAHF, FFC, WGLC, MDP, MRMF; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to MDP, AMS, MRMF and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to MRMF.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGORO JW, 1978, Patent No. 4124724; Araujo F.A.A., 2003, ANIMAIS PECONHENTOS, P6; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bahnson BJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P96, DOI 10.1016/j.abb.2004.08.013; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bancroft JD, 1990, THEORY PRACTICE HIST; Bowman WC, 1980, TXB PHARM, P1711; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavalcante WLG, 2007, J ETHNOPHARMACOL, V112, P490, DOI 10.1016/j.jep.2007.04.002; Chandra V, 2002, BIOCHEMISTRY-US, V41, P10914, DOI 10.1021/bi0258593; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chioato L, 2007, BBA-BIOMEMBRANES, V1768, P1247, DOI 10.1016/j.bbamem.2007.01.023; Cintra-Francischinelli M, 2008, PHYTOTHER RES, V22, P784, DOI 10.1002/ptr.2365; Correia-de-Sa P, 2013, TOXICON, V61, P16, DOI 10.1016/j.toxicon.2012.10.014; dos Santos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028521; dos Santos JI, 2009, J STRUCT BIOL, V167, P106, DOI 10.1016/j.jsb.2009.04.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes CAH, 2014, BBA-PROTEINS PROTEOM, V1844, P2265, DOI 10.1016/j.bbapap.2014.09.015; Fernandes CAH, 2013, BBA-PROTEINS PROTEOM, V1834, P2772, DOI 10.1016/j.bbapap.2013.10.009; Fernandes CAH, 2010, J STRUCT BIOL, V171, P31, DOI 10.1016/j.jsb.2010.03.019; Gallacci M, 2010, TOXICON, V55, P1, DOI 10.1016/j.toxicon.2009.10.025; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; HUANG MT, 1988, CANCER RES, V48, P5941; JOHNSON EK, 1994, COMP BIOCHEM PHYS C, V107, P359, DOI 10.1016/1367-8280(94)90062-0; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LOMONTE B, 1994, J BIOL CHEM, V269, P29867; Magro AJ, 2009, PROTEIN PEPTIDE LETT, V16, P852, DOI 10.2174/092986609788923301; MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B; Marchi-Salvador DP, 2009, BBA-PROTEINS PROTEOM, V1794, P1583, DOI 10.1016/j.bbapap.2009.07.005; McPherson A., 2003, INTRO MACROMOLECULAR; Mebs D, 2006, TOXICON, V47, P797, DOI 10.1016/j.toxicon.2006.01.031; Ministerio da Saude (Brasil), 2001, FUNDACAO NACL SAUDE, V2nd; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Mors WB, 2000, PHYTOCHEMISTRY, V55, P627, DOI 10.1016/S0031-9422(00)00229-6; Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RODRIGUESSIMIONI L, 1983, NEUROSCIENCE, V10, P475, DOI 10.1016/0306-4522(83)90147-1; Salvador GHM, 2013, TOXICON, V72, P52, DOI 10.1016/j.toxicon.2013.06.013; Salvador GHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060610; Samy RP, 2008, J ETHNOPHARMACOL, V115, P302, DOI 10.1016/j.jep.2007.10.006; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Shimabuku PS, 2011, ACTA CRYSTALLOGR F, V67, P249, DOI 10.1107/S1744309110051407; Soares AM, 2005, CURR MED CHEM, V12, P2625, DOI 10.2174/092986705774370655; Sousa LF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002442; Ticli FK, 2005, TOXICON, V46, P318, DOI 10.1016/j.toxicon.2005.04.023; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VISHWANATH BS, 1987, TOXICON, V25, P501; VISHWANATH BS, 1987, TOXICON, V25, P929, DOI 10.1016/0041-0101(87)90155-3; VISHWANATH BS, 1987, TOXICON, V25, P939, DOI 10.1016/0041-0101(87)90156-5; Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Xie YC, 2013, BIOORG MED CHEM LETT, V23, P3556, DOI 10.1016/j.bmcl.2013.04.033; Zhou X, 2008, BIOPHYS J, V95, P3366, DOI 10.1529/biophysj.107.117747	60	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133370	10.1371/journal.pone.0133370	http://dx.doi.org/10.1371/journal.pone.0133370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192963	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400076
J	Lovy, M; Skliba, J; Hrouzkova, E; Dvorakova, V; Nevo, E; Sumbera, R				Loevy, Matej; Skliba, Jan; Hrouzkova, Ema; Dvorakova, Veronika; Nevo, Eviatar; Sumbera, Radim			Habitat and Burrow System Characteristics of the Blind Mole Rat Spalax galili in an Area of Supposed Sympatric Speciation	PLOS ONE			English	Article							CRYPTOMYS-HOTTENTOTUS-HOTTENTOTUS; SUBTERRANEAN RODENT; REPRODUCTIVE-BEHAVIOR; SOIL TYPES; EHRENBERGI; ISRAEL; PATTERNS; BATHYERGIDAE; ARCHITECTURE; POPULATIONS	A costly search for food in subterranean rodents resulted in various adaptations improving their foraging success under given ecological conditions. In Spalax ehrenbergi superspecies, adaptations to local ecological conditions can promote speciation, which was recently supposed to occur even in sympatry at sites where two soil types of contrasting characteristics abut each other. Quantitative description of ecological conditions in such a site has been, nevertheless, missing. We measured characteristics of food supply and soil within 16 home ranges of blind mole rats Spalax galili in an area subdivided into two parts formed by basaltic soil and pale rendzina. We also mapped nine complete mole rat burrow systems to compare burrowing patterns between the soil types. Basaltic soil had a higher food supply and was harder than rendzina even under higher moisture content and lower bulk density. Population density of mole rats was five-times lower in rendzina, possibly due to the lower food supply and higher cover of Sarcopoterium shrubs which seem to be avoided by mole rats. A combination of food supply and soil parameters probably influences burrowing patterns resulting in shorter and more complex burrow systems in basaltic soil.	[Loevy, Matej; Skliba, Jan; Hrouzkova, Ema; Dvorakova, Veronika; Sumbera, Radim] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel	University of South Bohemia Ceske Budejovice; University of Haifa	Lovy, M (corresponding author), Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	mates.lovy@gmail.com	Šumbera, Radim/D-9072-2016; Lövy, Matěj/AGN-3116-2022	Šumbera, Radim/0000-0001-8658-9378; Lövy, Matěj/0000-0002-6451-2393; Hrouzkova, Ema/0000-0002-6289-7613; Skliba, Jan/0000-0002-0567-9302	Czech Science Foundation (GACR) [P506/11/1512, 14-31670P]; Ancell-Teicher Research Foundation of Genetics and Molecular Evolution	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Ancell-Teicher Research Foundation of Genetics and Molecular Evolution	This study was supported by the Czech Science Foundation (GACR), projects P506/11/1512 (to RS) and 14-31670P (to ML) and by the Ancell-Teicher Research Foundation of Genetics and Molecular Evolution (to EN).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Atlas of Israel, 1985, CART PHYS HUMAN GEOG; Auguie B, 2017, GRIDEXTRA MISCELLANE; Begall S., 2007, SUBTERRANEAN RODENTS; BLOCK A, 1990, PHYS REV A, V42, P1869, DOI 10.1103/PhysRevA.42.1869; Busch C, 2000, LIFE UNDERGROUND, P183; CAMERON GN, 1988, J MAMMAL, V69, P667, DOI 10.2307/1381621; DAFNI A, 1981, ANN MO BOT GARD, V68, P652, DOI 10.2307/2398893; Danin A, 2015, VEGETATION ISRAEL NE; Ebdon D., 1985, A PRACTICAL APPROACH, V2nd; Gazit I, 2000, CAN J ZOOL, V78, P570, DOI 10.1139/cjz-78-4-570; GRADSTEIN FM, 1994, J GEOPHYS RES-SOL EA, V99, P24051, DOI 10.1029/94JB01889; Grishkan I, 2008, EUR J SOIL BIOL, V44, P180, DOI 10.1016/j.ejsobi.2008.01.001; Hadid Y, 2013, P NATL ACAD SCI USA, V110, P2587, DOI 10.1073/pnas.1222588110; Henkin Z, 2007, RANGELAND ECOL MANAG, V60, P453, DOI 10.2111/1551-5028(2007)60[453:STAMOA]2.0.CO;2; HETH G, 1989, OECOLOGIA, V79, P496, DOI 10.1007/BF00378667; HETH G, 1989, J ZOOL, V217, P39, DOI 10.1111/j.1469-7998.1989.tb02473.x; Hillel D., 1998, ENV SOIL PHYS; Jarvis JUM, 1998, OECOLOGIA, V113, P290, DOI 10.1007/s004420050380; JARVIS JUM, 1973, J ZOOL, V171, P1; Karpien A, 1999, FRACLAC FOR IMAGEJ; Le Comber SC, 2002, CAN J ZOOL, V80, P436, DOI 10.1139/Z02-026; Levitte D, 2001, JERUSALEM; Lovy M, 2012, J ZOOL, V286, P145, DOI 10.1111/j.1469-7998.2011.00860.x; Luna F, 2006, CAN J ZOOL, V84, P661, DOI 10.1139/Z06-040; Mohammad AG, 2013, CATENA, V100, P10, DOI 10.1016/j.catena.2012.07.013; Nevo, 1999, MOSAIC EVOLUTION SUB; Nevo E., 1961, Mammalia Paris, V25, P127, DOI 10.1515/mamm.1961.25.2.127; NEVO E, 1982, EVOLUTION, V36, P1283, DOI 10.1111/j.1558-5646.1982.tb05497.x; NEVO E, 1994, P NATL ACAD SCI USA, V91, P8160, DOI 10.1073/pnas.91.17.8160; NEVO E, 1986, J GENET, V65, P65, DOI 10.1007/BF02923537; NEVO E., 2001, ADAPTIVE RAD BLIND S; PEARSON O. P., 1968, INV ZOOL CHILENAS, V13, P47; Polyakov A, 2004, P ROY SOC B-BIOL SCI, V271, pS156, DOI 10.1098/rsbl.2003.0112; RADO R, 1991, ANIM BEHAV, V42, P15, DOI 10.1016/S0003-3472(05)80601-3; REICHMAN OJ, 1982, ECOLOGY, V63, P687, DOI 10.2307/1936789; Romanach SS, 2005, J MAMMAL, V86, P750, DOI 10.1644/1545-1542(2005)086[0750:EOSSAA]2.0.CO;2; SAVIC IR, 1990, PROG CLIN BIOL RES, V335, P129; Shams I, 2005, COMP BIOCHEM PHYS A, V142, P376, DOI 10.1016/j.cbpa.2005.09.003; SHANAS U, 1995, J ZOOL, V237, P195, DOI 10.1111/j.1469-7998.1995.tb02758.x; Skliba J, 2011, ECOL RES, V26, P1081, DOI 10.1007/s11284-011-0860-1; Skliba J, 2010, ACTA THERIOL, V55, P271, DOI 10.4098/j.at.0001-7051.099.2009; SMITH CW, 1985, GEODERMA, V35, P47, DOI 10.1016/0016-7061(85)90055-2; SMITHGILL SJ, 1975, J MORPHOL, V146, P35, DOI 10.1002/jmor.1051460103; Spinks AC, 1999, J ZOOL, V249, P143; Spinks AC, 2000, OECOLOGIA, V125, P341, DOI 10.1007/s004420000460; Sumbera R, 2003, NATURWISSENSCHAFTEN, V90, P370, DOI 10.1007/s00114-003-0439-y; Sumbera R, 2008, J ZOOL, V274, P77, DOI 10.1111/j.1469-7998.2007.00359.x; Sumbera R, 2012, ACTA THERIOL, V57, P121, DOI 10.1007/s13364-011-0059-4; Ter Braak JFC, 2002, CANOCO REFERENCE MAN; Topachevskii VA, 1976, FAUNA USSR MAMMALS M; Verheye W., 2005, ENCY LIFE SUPPORT SY; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; VLECK D, 1979, PHYSIOL ZOOL, V52, P122, DOI 10.1086/physzool.52.2.30152558; Weinstein Y, 2006, J PETROL, V47, P1017, DOI 10.1093/petrology/egl003; Zelova J, 2010, PHYSIOL BEHAV, V99, P54, DOI 10.1016/j.physbeh.2009.10.007; Zuri I, 1996, J ZOOL, V240, P123, DOI 10.1111/j.1469-7998.1996.tb05490.x; [No title captured]	58	33	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133157	10.1371/journal.pone.0133157	http://dx.doi.org/10.1371/journal.pone.0133157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192762	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400063
J	Osei-Owusu, P; Owens, EA; Jie, L; Reis, JS; Forrester, SJ; Kawai, T; Eguchi, S; Singh, H; Blumer, KJ				Osei-Owusu, Patrick; Owens, Elizabeth A.; Jie, Li; Reis, Janaina S.; Forrester, Steven J.; Kawai, Tatsuo; Eguchi, Satoru; Singh, Harpreet; Blumer, Kendall J.			Regulation of Renal Hemodynamics and Function by RGS2	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; GLOMERULAR-FILTRATION-RATE; PRESSURE-NATRIURESIS; BLOOD-FLOW; ANGIOTENSIN-II; EXPRESSION; NA+; MECHANISMS; KIDNEYS; MICE	Regulator of G protein signaling 2 (RGS2) controls G protein coupled receptor (GPCR) signaling by acting as a GTPase-activating protein for heterotrimeric G proteins. Certain Rgs2 gene mutations have been linked to human hypertension. Renal RGS2 deficiency is sufficient to cause hypertension in mice; however, the pathological mechanisms are unknown. Here we determined how the loss of RGS2 affects renal function. We examined renal hemodynamics and tubular function by monitoring renal blood flow (RBF), glomerular filtration rate (GFR), epithelial sodium channel (ENaC) expression and localization, and pressure natriuresis in wild type (WT) and RGS2 null (RGS2-/-) mice. Pressure natriuresis was determined by stepwise increases in renal perfusion pressure (RPP) and blood flow, or by systemic blockade of nitric oxide synthase with L-NG-Nitroarginine methyl ester (L-NAME). Baseline GFR was markedly decreased in RGS2-/-mice compared to WT controls (5.0 +/- 0.8 vs. 2.5 +/- 0.1 mu l/min/g body weight, p<0.01). RBF was reduced (35.4 +/- 3.6 vs. 29.1 +/- 2.1 mu l/min/g body weight, p=0.08) while renal vascular resistance (RVR; 2.1 +/- 0.2 vs. 3.0 +/- 0.2 mmHg/mu l/min/g body weight, p<0.01) was elevated in RGS2-/-compared to WT mice. RGS2 deficiency caused decreased sensitivity and magnitude of changes in RVR and RBF after a step increase in RPP. The acute pressure-natriuresis curve was shifted rightward in RGS2-/-relative to WT mice. Sodium excretion rate following increased RPP by L-NAME was markedly decreased in RGS2-/-mice and accompanied by increased translocation of ENaC to the luminal wall. We conclude that RGS2 deficiency impairs renal function and autoregulation by increasing renal vascular resistance and reducing renal blood flow. These changes impair renal sodium handling by favoring sodium retention. The findings provide a new line of evidence for renal dysfunction as a primary cause of hypertension.	[Osei-Owusu, Patrick; Owens, Elizabeth A.; Jie, Li; Reis, Janaina S.; Singh, Harpreet] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Forrester, Steven J.; Kawai, Tatsuo; Eguchi, Satoru] Temple Univ, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Forrester, Steven J.; Kawai, Tatsuo; Eguchi, Satoru] Temple Univ, Dept Physiol, Philadelphia, PA 19140 USA; [Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Washington University (WUSTL)	Osei-Owusu, P (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA.	patrick.osei-owusu@drexelmed.edu	Singh, Harpreet/M-9822-2019; Osei-Owusu, Patrick/AAH-9063-2019; Osei-Owusu, Patrick/L-9104-2018	Singh, Harpreet/0000-0002-6135-1897; 	NIH [HL075632, GM44592]; Washington University O'Brien Kidney Center; American Heart Association [13GRNT17060036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University O'Brien Kidney Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by institutional support from the Drexel University College of Medicine to Patrick Osei-Owusu, grants to Kendall Blumer from the NIH (HL075632 and GM44592) and the Washington University O'Brien Kidney Center, and an American Heart Association grant (13GRNT17060036) to Satoru Eguchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MS, 2011, CAN J PHYSIOL PHARM, V89, P159, DOI 10.1139/Y11-005; Anantharam A, 2007, J GEN PHYSIOL, V130, P55, DOI 10.1085/jgp.200609716; Arendshorst WJ, 1999, J AM SOC NEPHROL, V10, pS149; Asico LD, 1998, J CLIN INVEST, V102, P493, DOI 10.1172/JCI3685; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BONVALET JP, 1977, J PHYSIOL-LONDON, V269, P627, DOI 10.1113/jphysiol.1977.sp011919; Brinks HL, 2010, BBA-MOL BASIS DIS, V1802, P1268, DOI 10.1016/j.bbadis.2010.01.005; CASELLAS D, 1993, AM J PHYSIOL, V264, pF315, DOI 10.1152/ajprenal.1993.264.2.F315; Chaston DJ, 2013, ARTERIOSCL THROM VAS, V33, P962, DOI 10.1161/ATVBAHA.112.300957; Cheng C, 1998, J BIOL CHEM, V273, P22693, DOI 10.1074/jbc.273.35.22693; Choi JY, 2007, EUR J PHARMACOL, V567, P19, DOI 10.1016/j.ejphar.2007.04.026; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Cupples WA, 2007, AM J PHYSIOL-RENAL, V292, pF1105, DOI 10.1152/ajprenal.00194.2006; EHMKE H, 1990, AM J PHYSIOL, V259, pF466, DOI 10.1152/ajprenal.1990.259.3.F466; Evans RG, 2004, J HYPERTENS, V22, P1439, DOI 10.1097/01.hjh.0000133744.85490.9d; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; FLORIJN KW, 1994, KIDNEY INT, V46, P252, DOI 10.1038/ki.1994.267; Frindt G, 2007, AM J PHYSIOL-RENAL, V292, pF1190, DOI 10.1152/ajprenal.00399.2006; Grifoni SC, 2010, AM J PHYSIOL-RENAL, V298, pF285, DOI 10.1152/ajprenal.00496.2009; Gross V, 1997, HYPERTENSION, V29, P1252, DOI 10.1161/01.HYP.29.6.1252; Gurley SB, 2010, J AM SOC NEPHROL, V21, P1847, DOI 10.1681/ASN.2009121306; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; GUYTON AC, 1989, AM J HYPERTENS, V2, P575, DOI 10.1093/ajh/2.7.575; Hahntow IN, 2009, AM J HYPERTENS, V22, P80, DOI 10.1038/ajh.2008.310; Hercule HC, 2007, EXP PHYSIOL, V92, P1014, DOI 10.1113/expphysiol.2007.038240; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Husted RF, 1996, AM J PHYSIOL-RENAL, V271, pF1029, DOI 10.1152/ajprenal.1996.271.5.F1029; Jang HS, 2014, BBA-MOL BASIS DIS, V1842, P1733, DOI 10.1016/j.bbadis.2014.06.022; Just A, 2003, AM J PHYSIOL-REG I, V285, pR619, DOI 10.1152/ajpregu.00766.2002; Kemp BA, 2014, CIRC RES, V115, P388, DOI 10.1161/CIRCRESAHA.115.304110; Kim SW, 2006, KIDNEY INT, V69, P89, DOI 10.1038/sj.ki.5000018; Kimura G, 1997, J HYPERTENS, V15, P1055, DOI 10.1097/00004872-199715100-00002; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Mattson DL, 2005, AM J PHYSIOL-REG I, V289, pR991, DOI 10.1152/ajpregu.00207.2005; MIZELLE HL, 1989, AM J PHYSIOL, V257, pR1169, DOI 10.1152/ajpregu.1989.257.5.R1169; MORAN K, 1992, J UROLOGY, V148, P463, DOI 10.1016/S0022-5347(17)36629-6; Noonan WT, 2005, AM J PHYSIOL-REG I, V288, pR685, DOI 10.1152/ajpregu.00209.2004; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Ren YL, 2001, KIDNEY INT, V59, P222, DOI 10.1046/j.1523-1755.2001.00482.x; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; ROMAN RJ, 1985, AM J PHYSIOL, V248, pF190, DOI 10.1152/ajprenal.1985.248.2.F190; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Singh H, 2012, MITOCHONDRION, V12, P230, DOI 10.1016/j.mito.2011.09.004; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Sturgeon C, 1998, J APPL PHYSIOL, V84, P2154, DOI 10.1152/jappl.1998.84.6.2154; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zhong JY, 2012, PEDIATR RES, V72, P241, DOI 10.1038/pr.2012.81; Zuber AM, 2007, J AM SOC NEPHROL, V18, P1672, DOI 10.1681/ASN.2007010032	61	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132594	10.1371/journal.pone.0132594	http://dx.doi.org/10.1371/journal.pone.0132594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193676	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400033
J	Mou, LS; Xie, N; Yang, LH; Liu, YC; Diao, RY; Cai, ZM; Li, HG; Gui, YT				Mou, Lisha; Xie, Nie; Yang, Lihua; Liu, Yuchen; Diao, Ruiying; Cai, Zhiming; Li, Honggang; Gui, Yaoting			A Novel Mutation of DAX-1 Associated with Secretory Azoospermia	PLOS ONE			English	Article							ADRENAL HYPOPLASIA CONGENITA; ANDROGEN RECEPTOR; HYPOGONADOTROPIC HYPOGONADISM; SEX DETERMINATION; INFERTILITY; EXPRESSION; MALES	Secretory azoospermia is a severe form of male infertility caused by unknown factors. DAX-1 is predominantly expressed in mammalian reproductive tissues and plays an important role in spermatogenesis because Dax-1 knockout male mice show spermatogenesis defects. To examine whether DAX-1 is involved in the pathogenesis of secretory azoospermia in humans, we sequenced all of the exons of DAX-1 in 776 patients diagnosed with secretory azoospermia and 709 proven fertile men. A number of coding mutations unique to the patient group, including two synonymous mutations and six missense mutations, were identified. Of the missense mutations, our functional assay demonstrated that the V385L mutation caused the reduced functioning of DAX-1. This novel mutation (p. V385L) of DAX-1 is the first to be identified in association with secretory azoospermia, thereby highlighting the important role of DAX-1 in spermatogenesis.	[Mou, Lisha; Xie, Nie; Liu, Yuchen; Diao, Ruiying; Cai, Zhiming] Shenzhen Univ, Shenzhen Domesticated Organ Med Engn Res & Dev Ct, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Genitourinary Tumor,Affiliated H, Shenzhen 518035, Peoples R China; [Mou, Lisha; Xie, Nie; Yang, Lihua; Gui, Yaoting] Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen PKU HKUST Med Ctr, Biomed Res Inst,Shenzhen Hosp,Inst Urol, Shenzhen, Peoples R China; [Li, Honggang] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Wuhan 430030, Peoples R China	Shenzhen University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Huazhong University of Science & Technology	Li, HG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Wuhan 430030, Peoples R China.	lhgyx@hotmail.com; guiyaoting2007@aliyun.com	liu, yuchen/GYQ-6286-2022; Mou, Lisha/I-4739-2012; gui, yaoting/GLT-3684-2022	Mou, Lisha/0000-0001-6232-8341; 	National Natural Science Foundation of China [31271244, 81200465]; Shenzhen Foundation of Science and Technology [GJHZ20140414170821192, JCYJ20140414170821337, GJHZ20130412153906740]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Foundation of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (grant number 31271244 to YG, 81200465 to LM) and the Shenzhen Foundation of Science and Technology (grant number GJHZ20140414170821192 to NX, JCYJ20140414170821337 to NX, GJHZ20130412153906740 to NX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agoulnik IU, 2003, J BIOL CHEM, V278, P31136, DOI 10.1074/jbc.M305153200; Bae DS, 1996, ENDOCRINOLOGY, V137, P3921, DOI 10.1210/en.137.9.3921; Hirsh A, 2003, BMJ-BRIT MED J, V327, P669, DOI 10.1136/bmj.327.7416.669; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Jadhav U, 2011, MOL CELL ENDOCRINOL, V346, P65, DOI 10.1016/j.mce.2011.04.017; Jarvi K, 2010, CUAJ-CAN UROL ASSOC, V4, P163, DOI 10.5489/cuaj.10050; Jouravel N, 2007, ACTA CRYSTALLOGR D, V63, P1198, DOI 10.1107/S0907444907045702; Li J, 2008, ANAL BIOCHEM, V373, P389, DOI 10.1016/j.ab.2007.10.034; Li ZS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08785; Mantovani G, 2005, FERTIL STERIL, V84, P1542, DOI 10.1016/j.fertnstert.2005.05.037; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P44, DOI 10.1210/jc.87.1.44; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Meeks JJ, 2003, NAT GENET, V34, P32, DOI 10.1038/ng1141; Mou LS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.103648; MULLERTZ A, 1990, LIPIDS, V25, P415, DOI 10.1007/BF02537987; Ozisik G, 2003, J CLIN ENDOCR METAB, V88, P417, DOI 10.1210/jc.2002-021034; Ponikwicka-Tyszko D, 2012, J ASSIST REPROD GEN, V29, P811, DOI 10.1007/s10815-012-9778-y; Raffin-Sanson ML, 2013, EUR J ENDOCRINOL, V168, pK45, DOI 10.1530/EJE-12-1055; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seminara SB, 1999, J CLIN ENDOCR METAB, V84, P4501, DOI 10.1210/jc.84.12.4501; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tabarin A, 2000, J CLIN INVEST, V105, P321, DOI 10.1172/JCI7212; Wu CM, 2011, J ENDOCRINOL INVEST, V34, pE235, DOI 10.3275/7484; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zuccarello D, 2008, CLIN ENDOCRINOL, V68, P580, DOI 10.1111/j.1365-2265.2007.03069.x	29	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133997	10.1371/journal.pone.0133997	http://dx.doi.org/10.1371/journal.pone.0133997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207377	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000188
J	Pan, N; Liu, ZZ; He, JJ; Li, S; Lv, XW; Wang, LM; Liu, QL				Pan, Ning; Liu, Zhenzhen; He, Jinjing; Li, Song; Lv, Xiangwei; Wang, Liming; Liu, Qinlong			Comparison of Methods for the Reconstruction of the Hepatic Artery in Mouse Orthotopic Liver Transplantation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MODEL; MICE	Background The mouse model of arterialized orthotopic liver transplantation (AOLT) has played an important role in biomedical research. The available methods of sutured anastomosis for reconstruction of the hepatic artery are complicated, resulting in a high incidence of complications and failure. Therefore, we developed and evaluated a new model of AOLT in mice. Materials and methods Male inbred C57BL/6 mice were used in this study. A continuous suture approach was applied to connect the suprahepatic inferior vena cava (SHVC). The portal vein and infrahepatic inferior vena cava (IHVC) were connected according to the "two-cuff" method. The common bile duct was connected by a biliary stent. We used the stent (G3 group) or aortic trunk (G2 group) to reconstruct the hepatic artery. The patency of the hepatic artery was verified by transecting the artery near the graft after one week. The survival rate of the recipients and serum alanine aminotransferase (ALT) levels, hepatic pathologic alterations, apoptosis and necrosis were observed at one week postoperatively. Results The patency of the hepatic artery was verified in eight of ten mice in G3 and in six of ten mice in G2. The 7-day survival rate, extents of necrosis and apoptosis, and TGF-beta levels were not significantly different among the three groups (P>0.05). However, the serum ALT levels and operation time were markedly lower in G3 compared with G2 or G1 (both P<0.05). Conclusions Reconstruction of the hepatic artery using a stent can be performed quickly with a high rate of patency. This model simplifies hepatic artery anastomosis and should be promoted in the field of biomedical research.	[Pan, Ning] Dalian Med Univ, Dept Anesthesiol, Affiliated Hosp 2, Dalian, Liaoning Provin, Peoples R China; [Liu, Zhenzhen; He, Jinjing; Li, Song; Lv, Xiangwei; Wang, Liming; Liu, Qinlong] Dalian Med Univ, Dept Gen Surg, Affiliated Hosp 2, Dalian, Liaoning Provin, Peoples R China; [Liu, Zhenzhen; He, Jinjing; Li, Song; Lv, Xiangwei] Dalian Med Univ, Dalian, Liaoning Provin, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University	Liu, QL (corresponding author), Dalian Med Univ, Dept Gen Surg, Affiliated Hosp 2, Dalian, Liaoning Provin, Peoples R China.	qinlongliu@163.com			National Natural Science Foundation of China [81470878, 81272368, 81471755]; Industry and Technology Bureau of Dalian [2013J21DW022]; Supporting Plan for Talents in Colleges and Universities of Liaoning Province, Department of Education of Liaoning Province [LJQ2013099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Industry and Technology Bureau of Dalian; Supporting Plan for Talents in Colleges and Universities of Liaoning Province, Department of Education of Liaoning Province	This study was supported by: National Natural Science Foundation of China (81470878) http://npd.nsfc.gov.cn/fundingProjectSearchAction.action; The Industry and Technology Bureau of Dalian (Number 2013J21DW022) http://kjjh.dlinfo.gov.cn/index.shtml; Supporting Plan for Talents in Colleges and Universities of Liaoning Province, Department of Education of Liaoning Province Number: LJQ2013099 http://www.lnein.gov.cn/kj/web/index.asp; National Natural Science Foundation of China (81272368) http://npd.nsfc.gov.cn/fundingProjectSearchAction.action; and National Natural Science Foundation of China (81471755) http://npd.nsfc.gov.cn/fundingProjectSearchAction.action. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birsner JH, J SURG RES, V120, P97; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Huang DR, 2010, HEPATOB PANCREAT DIS, V9, P264; Humar B, 2013, J SURG RES, V184, pE1, DOI 10.1016/j.jss.2013.03.022; LEE S, 1973, TRANSPLANTATION, V16, P664, DOI 10.1097/00007890-197312000-00019; Ma Y, 2007, CHINESE MED J-PEKING, V120, P1914, DOI 10.1097/00029330-200711010-00013; QIAN SG, 1991, TRANSPLANTATION, V52, P562; Qian SG, 1997, J IMMUNOL, V158, P4654; Que XY, 2004, J SURG RES, V116, P262, DOI 10.1016/j.jss.2003.07.005; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Rehman H, 2011, TRANSPLANTATION, V91, P406, DOI 10.1097/TP.0b013e318204bdb2; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steger U, 2003, TRANSPLANTATION, V76, P327, DOI 10.1097/01.TP.0000071521.36828.F7; Tian YH, 2002, TRANSPLANTATION, V74, P1242, DOI 10.1097/00007890-200211150-00008; TYGSTRUP N, 1962, J CLIN INVEST, V41, P447, DOI 10.1172/JCI104497; Ueki S, 2010, HEPATOLOGY, V51, P1692, DOI 10.1002/hep.23501; Yan S, 2009, HEPATOB PANCREAT DIS, V8, P575; Zhong Z, 2008, AM J PHYSIOL-GASTR L, V295, pG823, DOI 10.1152/ajpgi.90287.2008; Zhou ST, 2014, J SURG RES, V187, P297, DOI 10.1016/j.jss.2013.10.024	21	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133030	10.1371/journal.pone.0133030	http://dx.doi.org/10.1371/journal.pone.0133030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207367	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000058
J	Lionetti, V; Raiola, A; Mattei, B; Bellincampi, D				Lionetti, Vincenzo; Raiola, Alessandro; Mattei, Benedetta; Bellincampi, Daniela			The Grapevine VvPMEI1 Gene Encodes a Novel Functional Pectin Methylesterase Inhibitor Associated to Grape Berry Development	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; CELL-WALL; METHYL-ESTERIFICATION; KIWI FRUIT; GLYCOPROTEIN INHIBITOR; DISEASE RESISTANCE; MODIFYING ENZYMES; EXPRESSION; POLYGALACTURONASE; HOMOGALACTURONAN	Pectin is secreted in a highly methylesterified form and partially de-methylesterified in the cell wall by pectin methylesterases (PMEs). PME activity is expressed during plant growth, development and stress responses. PME activity is controlled at the post-transcriptional level by proteins named PME inhibitors (PMEIs). We have identified, expressed and characterized VvPMEI1, a functional PME inhibitor of Vitis vinifera. VvPMEI1 typically affects the activity of plant PMEs and is inactive against microbial PMEs. The kinetics of PMEI-PME interaction, studied by surface plasmon resonance, indicates that the inhibitor strongly interacts with PME at apoplastic pH while the stability of the complex is reduced by increasing the pH. The analysis of VvPMEI1 expression in different grapevine tissues and during grape fruit development suggests that this inhibitor controls PME activity mainly during the earlier phase of berry development. A proteomic analysis performed at this stage indicates a PME isoform as possible target of VvPMEI1.	[Lionetti, Vincenzo; Mattei, Benedetta; Bellincampi, Daniela] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Raiola, Alessandro] Univ Padua, Dipartimento Terr & Sistemi Agroforestali, Legnaro, PD, Italy	Sapienza University Rome; University of Padua	Bellincampi, D (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	daniela.bellincampi@uniroma1.it	Mattei, Benedetta/C-3013-2019; Lionetti, Vincenzo/J-6145-2014; raiola, alessandro/K-8262-2015; Mattei, Benedetta/F-1504-2015; Raiola, Alessandro/AAV-7186-2020	Mattei, Benedetta/0000-0003-2927-6329; Lionetti, Vincenzo/0000-0002-2262-1479; raiola, alessandro/0000-0002-3635-9117; Mattei, Benedetta/0000-0003-2927-6329; Raiola, Alessandro/0000-0002-3635-9117	Ministero dell'Istruzione, dell'Universita e della Ricerca; PRIN [2010T7247Z]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca; PRIN Grant n. 2010T7247Z, http://www.istruzione.it/, to DB.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; Atkinson RG, 1998, PLANT MOL BIOL, V38, P449, DOI 10.1023/A:1006065926397; BALESTRIERI C, 1990, EUR J BIOCHEM, V193, P183, DOI 10.1111/j.1432-1033.1990.tb19321.x; Barnavon L, 2001, PHYTOCHEMISTRY, V58, P693, DOI 10.1016/S0031-9422(01)00274-6; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Bellincampi D, 2004, BBA-PROTEINS PROTEOM, V1696, P265, DOI 10.1016/j.bbapap.2003.10.011; Bellincampi D, 2004, Patent Application, Patent No. [PCT/IT2004/000390, 2004000390]; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Camardella L, 2000, EUR J BIOCHEM, V267, P4561, DOI 10.1046/j.1432-1327.2000.01510.x; CASTALDO D, 1991, J FOOD SCI, V56, P1632, DOI 10.1111/j.1365-2621.1991.tb08658.x; Ciardiello MA, 2008, PROTEINS, V71, P195, DOI 10.1002/prot.21681; da Silva FG, 2005, PLANT PHYSIOL, V139, P574, DOI 10.1104/pp.105.065748; Derbyshire P, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-31; Deytieux-Belleau C, 2008, PLANT PHYSIOL BIOCH, V46, P638, DOI 10.1016/j.plaphy.2008.04.008; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Dietrich DE, 2014, PEPTIDES, V53, P265, DOI 10.1016/j.peptides.2014.01.017; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; Ezaki N, 2005, PLANT CELL PHYSIOL, V46, P1831, DOI 10.1093/pcp/pci199; Fusada N, 2005, PLANT MOL BIOL, V59, P631, DOI 10.1007/s11103-005-0579-x; Geroyiannaki M, 2007, FOOD CONTROL, V18, P988, DOI 10.1016/j.foodcont.2006.06.005; GIOVANE A, 1995, EUR J BIOCHEM, V233, P926, DOI 10.1111/j.1432-1033.1995.926_3.x; Giovane A, 2004, BBA-PROTEINS PROTEOM, V1696, P245, DOI 10.1016/j.bbapap.2003.08.011; Hong MJ, 2010, GENES GENET SYST, V85, P97, DOI 10.1266/ggs.85.97; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Jolie RP, 2010, FOOD CHEM, V121, P207, DOI 10.1016/j.foodchem.2009.11.073; Kanellis AK, 1993, BIOCH FRUIT RIPENING, P189, DOI DOI 10.1007/978-94-011-1584-1_6; KLAVONS JA, 1986, J AGR FOOD CHEM, V34, P597, DOI 10.1021/jf00070a004; Lante A, PCTEP2008052347; LECAM B, 1994, PHYSIOL MOL PLANT P, V44, P187, DOI 10.1016/S0885-5765(05)80003-7; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Lionetti V, 2015, PHYTOCHEMISTRY, V112, P188, DOI 10.1016/j.phytochem.2014.07.025; Lionetti V, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0369-1; Lionetti V, 2014, MOL PLANT PATHOL, V15, P265, DOI 10.1111/mpp.12090; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; Luo H, 2005, PLANT BIOLOGY, V7, P459, DOI 10.1055/s-2005-865851; Mattei B, 2002, ROY SOC CH, P160, DOI 10.1039/9781847550323-00160; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Muller K, 2013, PLANT PHYSIOL, V161, P305, DOI 10.1104/pp.112.205724; Nunan KJ, 2001, PLANTA, V214, P257, DOI 10.1007/s004250100609; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raiola A, 2004, FEBS LETT, V557, P199, DOI 10.1016/S0014-5793(03)01491-1; Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157; Rausch T, 2004, BBA-PROTEINS PROTEOM, V1696, P253, DOI 10.1016/j.bbapap.2003.09.017; Reca IB, 2012, PLANT MOL BIOL, V79, P429, DOI 10.1007/s11103-012-9921-2; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Rocchi V, 2012, PLANT BIOLOGY, V14, P365, DOI 10.1111/j.1438-8677.2011.00508.x; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Saez-Aguayo S, 2013, PLANT CELL, V25, P308, DOI 10.1105/tpc.112.106575; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sorensen JF, 2004, BBA-PROTEINS PROTEOM, V1696, P275, DOI 10.1016/j.bbapap.2003.09.016; Srivastava Sudhakar, 2012, Physiology and Molecular Biology of Plants, V18, P191, DOI 10.1007/s12298-012-0102-1; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Volpi C, 2011, MOL PLANT MICROBE IN, V24, P1012, DOI 10.1094/MPMI-01-11-0021; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Wolf S, 2003, FEBS LETT, V555, P551, DOI 10.1016/S0014-5793(03)01344-9; Wolf S, 2012, CURR BIOL, V22, P1732, DOI 10.1016/j.cub.2012.07.036; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Xu NF, 1997, PLANT SCI, V126, P193, DOI 10.1016/S0168-9452(97)00110-6; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Zhang GY, 2010, PLANTA, V231, P1323, DOI 10.1007/s00425-010-1136-7; Zocca F, 2008, J I BREWING, V114, P262, DOI 10.1002/j.2050-0416.2008.tb00337.x; Zocca F, 2007, FOOD CHEM, V102, P59, DOI 10.1016/j.foodchem.2006.01.061	73	25	27	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133810	10.1371/journal.pone.0133810	http://dx.doi.org/10.1371/journal.pone.0133810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204516	Green Submitted, gold, Green Published			2022-12-27	WOS:000358621000040
J	Valdez-Tah, A; Huicochea-Gomez, L; Ortega-Canto, J; Nazar-Beutelspacher, A; Ramsey, JM				Valdez-Tah, Alba; Huicochea-Gomez, Laura; Ortega-Canto, Judith; Nazar-Beutelspacher, Austreberta; Ramsey, Janine M.			Social Representations and Practices Towards Triatomines and Chagas Disease in Calakmul, Mexico	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; RISK-FACTORS; AMERICAN TRYPANOSOMIASIS; YUCATAN PENINSULA; HOUSE INFESTATION; LATIN-AMERICA; VECTOR; INFECTION; TRANSMISSION; PALLIDIPENNIS	Vector-borne transmission of Trypanosoma cruzi (VBTTc) is dependent on the concomitant interaction between biological and environmental hazard over the entire landscape, and human vulnerability. Representations and practices of health-disease-care-seeking and territorial appropriation and use were analyzed for VBTTc in a qualitative ethnographic study in the Zoh-Laguna landscape, Campeche, Mexico. In-depth interviews and participatory observation explored representations and practices regarding ethno-ecological knowledge related to vector- transmission, health-disease-care-seeking, and land use processes. The population has a broad knowledge of biting insects, which they believe are all most abundant in the rainy season; the community ' s proximity to natural areas is perceived as a barrier to control their abundance. Triatomines are mostly recognized by men, who have detailed knowledge regarding their occurrence and association with mammals in non-domestic fragments, where they report being bitten. Women emphasize the dermal consequences of triatomine bites, but have little knowledge about the disease. Triatomine bites and the chinchoma are "normalized" events which are treated using home remedies, if at all. The neglected condition of Chagas disease in Mexican public health policies, livelihoods which are dependent on primary production, and gender-related knowledge (or lack thereof) are structural circumstances which influence the environment and inhabitants ' living conditions; in turn, these trigger triatomine-human contact. The most important landscape practices producing vulnerability are the activities and mobility within and between landscape fragments causing greater exposure of inhabitants primarily in the dry season. A landscape approach to understanding vulnerability components of VBTTc from health-disease-care-seeking perspectives and based on territorial appropriation and use, is essential where there is continuousmovement of vectors between and within all habitats. An understanding of the structural factors whichmotivate the population's perceptions, beliefs, and practices and which create and maintain vulnerability is essential to develop culturally relevant and sustainable community-based VBTTc prevention and control.	[Valdez-Tah, Alba; Huicochea-Gomez, Laura] El Colegio Frontera Sur, Dept Sociedad & Cultura, Campeche, Campeche, Mexico; [Valdez-Tah, Alba; Ramsey, Janine M.] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Ortega-Canto, Judith] Univ Autonoma Yucatan, Ctr Reg Invest Biomed Dr Hideyo Noguchi, Merida, Yucatan, Mexico; [Nazar-Beutelspacher, Austreberta] El Colegio Frontera, Dept Salud, San Cristobal Las Casas, Chiapas, Mexico	El Colegio de la Frontera Sur (ECOSUR); Instituto Nacional de Salud Publica; Universidad Autonoma de Yucatan	Ramsey, JM (corresponding author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.	jramsey@insp.mx	Ramsey, Janine M./AAS-2220-2021	Ramsey, Janine M./0000-0002-5950-0830	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [69997, 161405, 151816]; CONACYT [203790]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	JMR received financial support for this investigation from Consejo Nacional de Ciencia y Tecnologia (CONACYT) #69997, #161405 and #151816. AVT received a PhD scholarship from CONACYT #203790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2009, ACTA TROP, V110, P159, DOI 10.1016/j.actatropica.2008.06.005; Lopez-Cancino SA, 2015, ACTA TROP, V151, P58, DOI 10.1016/j.actatropica.2015.07.021; AZOGUE E, 1993, SOC SCI MED, V37, P503, DOI 10.1016/0277-9536(93)90285-C; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Briceno-Leon R, 2007, MEM I OSWALDO CRUZ, V102, P109, DOI 10.1590/S0074-02762007005000095; Caballero Zamora A, 1999, ENFERMEDAD CHAGAS BO; Carabarin-Lima A, 2013, ACTA TROP, V127, P126, DOI 10.1016/j.actatropica.2013.04.007; Cardona OD, NECESIDAD PENSAR MAN; Cecere MC, 1998, B WORLD HEALTH ORGAN, V76, P373; Ciannameo A., 1998, ARCHIVOS, V17, P39; Civetta A, 2003, PREC ARG ASS SPEC LA; Costa-Neto EM, 2002, HUM ECOL, V30, P245, DOI 10.1023/A:1015696830997; Coura JR, 1999, MEM I OSWALDO CRUZ, V94, P379, DOI 10.1590/S0074-02761999000700074; De Rego PI, 2006, PARASITE, V13, P237, DOI 10.1051/parasite/2006133237; DEANDRADE ALSS, 1995, AM J TROP MED HYG, V53, P443, DOI 10.4269/ajtmh.1995.53.443; Dell'Arciprete A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-6; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Dumonteil E, 2007, AM J TROP MED HYG, V76, P930, DOI 10.4269/ajtmh.2007.76.930; Emperaire L, 2006, PARASITE, V13, P171, DOI 10.1051/parasite/2006132171; Enger KS, 2004, J MED ENTOMOL, V41, P760, DOI 10.1603/0022-2585-41.4.760; Farfán-García Ana E, 2011, Rev. salud pública, V13, P163, DOI 10.1590/S0124-00642011000100014; Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052; Gomes TF, 2003, WORLD HLTH POPUL, V14, P14; Gottdenker NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001884; Grijalva MJ, 2010, MEM I OSWALDO CRUZ, V105, P677, DOI 10.1590/S0074-02762010000500013; Gurtler RE, 1998, AM J TROP MED HYG, V58, P748, DOI 10.4269/ajtmh.1998.58.748; Hammersley M., 2010, ETHNOGRAPHY PRINCIPL; Hashimoto K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-45; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Inhorn C, 1997, INT HLTH PERSPECTIVE; Instituto Nacional de Estadstica e Informatica, 2011, SIST EST NAC ANC COM; Jodelet D., 1986, PSICOLOGIA SOCIAL, P469; Kroeger A, 1999, TROP MED INT HEALTH, V4, P194, DOI 10.1046/j.1365-3156.1999.43370.x; Leon Canelon M, 2002, REV INTERAMERICANA P, V36, P21; Magnani C, 2009, CAD SAUDE PUBLICA, V25, P1624; Bustamante DM, 2009, CAD SAUDE PUBLICA, V25, pS83, DOI 10.1590/S0102-311X2009001300008; Mastrangelo A, 2009, RELACIONES SOCIALES; Mota J, 2007, VECTOR-BORNE ZOONOT, V7, P617, DOI 10.1089/vbz.2007.0106; Ramsey JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046013; Ramsey JM, 2005, MED VET ENTOMOL, V19, P219, DOI 10.1111/j.0269-283X.2005.00563.x; Ramsey JM, 2003, SALUD PUBLICA MEXICO, V45, P123, DOI 10.1590/S0036-36342003000200010; Ramsey JM, 2003, INICIATIVA VIGILANCI, P85; Reidpath DD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-1; Rodriguez M, 2002, MEMORIAS ECLAT AMCHA; Rodriguez-Cerda O, 2003, RELACIONES INVIERNO, V93, P81; Rosecrans K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002763; Buitrago NLR, 2013, INFECT GENET EVOL, V19, P141, DOI 10.1016/j.meegid.2013.07.002; Roux E, 2011, GEOSPATIAL HEALTH, V6, P41, DOI 10.4081/gh.2011.156; SALAZARSCHETTINO PM, 1983, AM J TROP MED HYG, V32, P1179, DOI 10.4269/ajtmh.1983.32.1179; Sanmartino M, 2009, REV SALUD PUBLICA, VXIII, P74, DOI [DOI 10.31052/1853.1180.V13.N1.7112, 10.31052/1853.1180.v13.n1.7112]; Sanmartino M, 2009, REV BIOMED, V20, P216; Sanmartino M, 2005, HACER FRENTE CHAGAS; Silveira AC, 1999, MEM I OSWALDO CRUZ, V94, P405, DOI 10.1590/S0074-02761999000700080; Sosa-Estani S, 2006, CURR OPIN INFECT DIS, V19, P583, DOI 10.1097/01.qco.0000247592.21295.a5; Strauss A., 1990, BASICS QUALITATIVE R; Suárez Roberto, 2006, Antipod. Rev. Antropol. Arqueol., P123; Taylor StevenJ., 1994, INTRO METODOS CUALIT; Telleria J, 2010, ELSEV INSIGHT, P1, DOI 10.1016/B978-0-12-384876-5.00021-6; Valdez-Tah A, 2015, SALUD COLEC IN PRESS; Vazquez-Prokopec GM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001788; Velasco-Castrejon O, 1992, Salud Publica Mex, V34, P186; Ventura-Garcia L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002410; Vinas Albajar Pedro, 2003, Rev Soc Bras Med Trop, V36, P401; Waleckx E, 2015, MEM I OSWALDO CRUZ, V110, P324, DOI 10.1590/0074-02760140409; Walter Annie, 2005, Cad. Saúde Pública, V21, P974, DOI 10.1590/S0102-311X2005000300034; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; Xavier SCC, 2007, PARASITOL INT, V56, P119, DOI 10.1016/j.parint.2007.01.003	67	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132830	10.1371/journal.pone.0132830	http://dx.doi.org/10.1371/journal.pone.0132830			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NJ	26204555	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000013
J	Sanchez, MB; Decorosi, F; Viti, C; Oggioni, MR; Martinez, JL; Hernandez, A				Blanca Sanchez, Maria; Decorosi, Francesca; Viti, Carlo; Oggioni, Marco Rinaldo; Luis Martinez, Jose; Hernandez, Alvaro			Predictive Studies Suggest that the Risk for the Selection of Antibiotic Resistance by Biocides Is Likely Low in Stenotrophomonas maltophilia	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIONS; MUTATION FREQUENCIES; FUNCTIONAL-ANALYSIS; OXIDASE LEADS; TRICLOSAN; SMEDEF; OVEREXPRESSION; MECHANISMS	Biocides are used without restriction for several purposes. As a consequence, large amounts of biocides are released without any control in the environment, a situation that can challenge the microbial population dynamics, including selection of antibiotic resistant bacteria. Previous work has shown that triclosan selects Stenotrophomonas maltophilia antibiotic resistant mutants overexpressing the efflux pump SmeDEF and induces expression of this pump triggering transient low-level resistance. In the present work we analyze if two other common biocides, benzalkonium chloride and hexachlorophene, trigger antibiotic resistance in S. maltophilia. Bioinformatic and biochemical methods showed that benzalkonium chloride and hexachlorophene bind the repressor of smeDEF, SmeT. Only benzalkonium chloride triggers expression of smeD and its effect in transient antibiotic resistance is minor. None of the hexachlorophene-selected mutants was antibiotic resistant. Two benzalkonium chloride resistant mutants presented reduced susceptibility to antibiotics and were impaired in growth. Metabolic profiling showed they were more proficient than their parental strain in the use of some dipeptides. We can then conclude that although bio-informatic predictions and biochemical studies suggest that both hexachlorophene and benzalkonium chloride should induce smeDEF expression leading to transient S. maltophilia resistance to antibiotics, phenotypic assays showed this not to be true. The facts that hexachlorophene resistant mutants are not antibiotic resistant and that the benzalkonium chloride resistant mutants presenting altered susceptibility to antibiotics were impaired in growth suggests that the risk for the selection (and fixation) of S. maltophilia antibiotic resistant mutants by these biocides is likely low, at least in the absence of constant selection pressure.	[Blanca Sanchez, Maria; Luis Martinez, Jose; Hernandez, Alvaro] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain; [Decorosi, Francesca; Viti, Carlo] Univ Florence, Dipartimento Sci Prod Agroalimentari & Ambiente, Florence, Italy; [Oggioni, Marco Rinaldo] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Florence; University of Leicester	Martinez, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Darwin 3, Madrid 28049, Spain.	jlmtnez@cnb.csic.es; ahernandez@cicbiomagune.es	Sanchez, Maria Blanca/AAD-8294-2020; Ríos-Muñoz, Cesar A./J-9384-2012; Oggioni, Marco Rinaldo/K-3839-2016; Martinez, Jose L/A-4725-2013	Sanchez, Maria Blanca/0000-0002-5209-4518; Ríos-Muñoz, Cesar A./0000-0002-3423-8936; Oggioni, Marco Rinaldo/0000-0003-4117-793X; Martinez, Jose L/0000-0001-8813-7607; VITI, CARLO/0000-0001-7188-549X	Spanish Ministry of Economy and Competitivity; Madrid Autonomous Community [BIO2011-25255, S2010/BMD2414 (PROMPT)]; Instituto de Salud Carlos III (Spanish Network for Research on Infectious Diseases) [REIPI RD12/0015]; European Union [HEALTH-F3-2011-282004 (EVOTAR)]	Spanish Ministry of Economy and Competitivity(Spanish Government); Madrid Autonomous Community; Instituto de Salud Carlos III (Spanish Network for Research on Infectious Diseases)(Instituto de Salud Carlos III); European Union(European Commission)	This study was supported by grants from the Spanish Ministry of Economy and Competitivity; (BIO2011-25255) from Madrid Autonomous Community (S2010/BMD2414 (PROMPT)); from the Instituto de Salud Carlos III (Spanish Network for Research on Infectious Diseases (REIPI RD12/0015)); and from the European Union (HEALTH-F3-2011-282004 (EVOTAR)) to JLM.	Aiello AE, 2003, LANCET INFECT DIS, V3, P501, DOI 10.1016/S1473-3099(03)00723-0; Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P3079, DOI 10.1128/AAC.44.11.3079-3086.2000; Alonso A, 2004, J ANTIMICROB CHEMOTH, V53, P432, DOI 10.1093/jac/dkh074; Alonso A, 1997, ANTIMICROB AGENTS CH, V41, P1140, DOI 10.1128/AAC.41.5.1140; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; Ceragioli M, 2010, APPL ENVIRON MICROB, V76, P3352, DOI 10.1128/AEM.03003-09; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; CORNER TR, 1971, J BACTERIOL, V108, P501, DOI 10.1128/JB.108.1.501-507.1971; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; De Muynck W, 2010, J APPL MICROBIOL, V108, P62, DOI 10.1111/j.1365-2672.2009.04395.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; FREDERICK JJ, 1974, ANTIMICROB AGENTS CH, V6, P712, DOI 10.1128/AAC.6.6.712; Garcia-Leon G, 2014, APPL ENVIRON MICROB, V80, P4559, DOI 10.1128/AEM.01058-14; Garcia-Leon G, 2014, ENVIRON MICROBIOL, V16, P1282, DOI 10.1111/1462-2920.12408; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Hernandez A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002103; Hernandez A, 2009, J BIOL CHEM, V284, P14428, DOI 10.1074/jbc.M809221200; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Karatzas KAG, 2007, J ANTIMICROB CHEMOTH, V60, P947, DOI 10.1093/jac/dkm314; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Lin YT, 2015, ANTIMICROB AGENTS CH; Lira F, 2012, J BACTERIOL, V194, P3563, DOI 10.1128/JB.00602-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez JL, 2011, CURR OPIN PHARMACOL, V11, P439, DOI 10.1016/j.coph.2011.07.005; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; McMurry LM, 1999, ANTIMICROB AGENTS CH, V43, P711, DOI 10.1128/AAC.43.3.711; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Morales G, 2006, ENVIRON MICROBIOL, V8, P1764, DOI 10.1111/j.1462-2920.2006.01061.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Russell AD, 2002, J ANTIMICROB CHEMOTH, V49, P597, DOI 10.1093/jac/49.4.597; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Sanchez MB, 2009, FUTURE MICROBIOL, V4, P655, DOI 10.2217/FMB.09.45; Sanchez P, 2002, ANTIMICROB AGENTS CH, V46, P3386, DOI 10.1128/AAC.46.11.3386-3393.2002; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; Sanchez P, 2004, ANTIMICROB AGENTS CH, V48, P2274, DOI 10.1128/AAC.48.6.2274-2276.2004; Tavankar GR, 2003, J BIOL CHEM, V278, P4524, DOI 10.1074/jbc.M210355200; Walsh SE, 2003, J HOSP INFECT, V55, P98, DOI 10.1016/S0195-6701(03)00240-8; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Whitehead RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022833; Zinchenko AA, 2004, CHEMBIOCHEM, V5, P360, DOI 10.1002/cbic.200300797	58	28	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132816	10.1371/journal.pone.0132816	http://dx.doi.org/10.1371/journal.pone.0132816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201074	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100048
J	Carson, DS; Garner, JP; Hyde, SA; Libove, RA; Berquist, SW; Hornbeak, KB; Jackson, LP; Sumiyoshi, RD; Howerton, CL; Hannah, SL; Partap, S; Phillips, JM; Hardan, AY; Parker, KJ				Carson, Dean S.; Garner, Joseph P.; Hyde, Shellie A.; Libove, Robin A.; Berquist, Sean W.; Hornbeak, Kirsten B.; Jackson, Lisa P.; Sumiyoshi, Raena D.; Howerton, Christopher L.; Hannah, Sadie L.; Partap, Sonia; Phillips, Jennifer M.; Hardan, Antonio Y.; Parker, Karen J.			Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism	PLOS ONE			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; INTRANASAL OXYTOCIN; SPECTRUM; INTERVIEW; BRAIN; INDIVIDUALS; ACTIVATION; PHENOTYPE; MULTIPLE; SIBLINGS	Brain arginine vasopressin (AVP) critically regulates normative social behavior in mammals, and experimental disruption of the AVP signaling pathway produces social impairments in rodent models. We therefore hypothesized that AVP signaling deficits may contribute to social impairments in children with autism spectrum disorder (ASD). Since blood measures (which are far easier to obtain than brain measures) of AVP are most meaningful if they are related to brain AVP activity, Study 1 tested the relationship between AVP concentrations in concomitantly collected blood and CSF samples from children and adults (N = 28) undergoing clinical procedures. Study 2 tested whether blood AVP concentrations: 1) differed between children with ASD (N = 57), their ASD discordant siblings (N = 47), and neurotypical controls (N = 55); and 2) predicted social functioning (using the NEPSY-II Theory of Mind and Affect Recognition tasks and the Social Responsiveness Scale) in this large, well-characterized child cohort. Blood AVP concentrations significantly and positively predicted CSF AVP concentrations (F-1,F-26 = 7.17, r = 0.46, p = 0.0127) in Study 1. In Study 2, blood AVP concentrations did not differ between groups or by sex, but significantly and positively predicted Theory of Mind performance, specifically in children with ASD, but not in non-ASD children (F-1,F-144 = 5.83, p = 0.017). Blood AVP concentrations can be used: 1) as a surrogate for brain AVP activity in humans; and 2) as a robust biomarker of theory of mind ability in children with ASD. These findings also suggest that AVP biology may be a promising therapeutic target by which to improve social cognition in individuals with ASD.	[Carson, Dean S.; Garner, Joseph P.; Hyde, Shellie A.; Libove, Robin A.; Berquist, Sean W.; Hornbeak, Kirsten B.; Jackson, Lisa P.; Sumiyoshi, Raena D.; Phillips, Jennifer M.; Hardan, Antonio Y.; Parker, Karen J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Garner, Joseph P.; Howerton, Christopher L.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Hannah, Sadie L.] Stanford Univ, Sch Med, Div Pediat Hematol Oncol SCT & Canc Biol, Dept Pediat, Stanford, CA 94305 USA; [Partap, Sonia] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Parker, KJ (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	kjparker@stanford.edu	Parker, Karen/G-1347-2012; Garner, Joseph P/C-8422-2009	Parker, Karen/0000-0002-6836-6338; Phillips, Jennifer/0000-0002-6360-2346; Partap, Sonia/0000-0001-5615-7689; Hornbeak, Kirsten/0000-0001-9859-2259	Simons Foundation Autism Research Initiative Pilot Award [93231]; National Institutes of Health [R21MH100387, UL1 RR025774, RR000167]; Katherine D. McCormick Fund; Mosbacher Family Fund for Autism Research; Stanford's Bio-X NeuroVentures Program; Weston Havens Foundation; Autism Speaks Meixner Fellowship in Translational Research [7895]; Stanford University School of Medicine; Stanford University Child Health Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, UL1RR025774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH100387] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative Pilot Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katherine D. McCormick Fund; Mosbacher Family Fund for Autism Research; Stanford's Bio-X NeuroVentures Program; Weston Havens Foundation; Autism Speaks Meixner Fellowship in Translational Research; Stanford University School of Medicine; Stanford University Child Health Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a Simons Foundation Autism Research Initiative Pilot Award (#93231), the National Institutes of Health (R21MH100387; UL1 RR025774; RR000167), the Katherine D. McCormick Fund, the Mosbacher Family Fund for Autism Research, Stanford's Bio-X NeuroVentures Program, the Weston Havens Foundation, the Stanford University Child Health Research Institute, an Autism Speaks Meixner Fellowship in Translational Research (#7895), and a Stanford University School of Medicine Dean's Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P47; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Auyeung B, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.146; Bishop DVM, 2006, AM J MED GENET B, V141B, P117, DOI 10.1002/ajmg.b.30267; Boso M, 2007, ARCH MED RES, V38, P70, DOI 10.1016/j.arcmed.2006.08.003; Bott NT, UNPUB; Carson DS, 2014, PEPTIDES, V61, P12, DOI 10.1016/j.peptides.2014.08.003; Carson DS, MOL PSYCHIA IN PRESS; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Dadds MR, 2014, J AUTISM DEV DISORD, V44, P521, DOI 10.1007/s10803-013-1899-3; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Donaldson ZR, 2010, BEHAV NEUROSCI, V124, P159, DOI 10.1037/a0018094; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Francis SM, 2014, BRAIN RES, V1580, P199, DOI 10.1016/j.brainres.2014.01.021; Freeman SM, 2014, PSYCHONEUROENDOCRINO, V45, P128, DOI 10.1016/j.psyneuen.2014.03.023; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Guastella AJ, 2011, PSYCHONEUROENDOCRINO, V36, P294, DOI 10.1016/j.psyneuen.2010.07.023; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P1220, DOI 10.1016/j.biopsych.2010.03.014; Guastella AJ, J CHILD PSY IN PRESS; Hall SS, 2012, PSYCHONEUROENDOCRINO, V37, P509, DOI 10.1016/j.psyneuen.2011.07.020; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kemp, 2007, NEPSY 2 CLIN INTERPR; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 1999, AUTISM DIAGNOSTIC OB; Miller M, 2013, AUTISM RES, V6, P91, DOI 10.1002/aur.1270; Nephew BC, 2008, PHYSIOL BEHAV, V95, P182, DOI 10.1016/j.physbeh.2008.05.016; Parker KJ, 2014, P NATL ACAD SCI USA, V111, P12258, DOI 10.1073/pnas.1402236111; Piven J, 1997, AM J PSYCHIAT, V154, P185; Rilling JK, 2012, PSYCHONEUROENDOCRINO, V37, P447, DOI 10.1016/j.psyneuen.2011.07.013; Roid G., 2003, TECHNICAL MANUAL; Webb S, 2010, NAT BIOTECHNOL, V28, P772, DOI 10.1038/nbt0810-772; Wingate M, 2014, MMWR SURVEILL SUMM, V63	40	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132224	10.1371/journal.pone.0132224	http://dx.doi.org/10.1371/journal.pone.0132224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200852	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100030
J	Gentili, C; Castor, D; Kaden, S; Lauterbach, D; Gysi, M; Steigemann, P; Gerlich, DW; Jiricny, J; Ferrari, S				Gentili, Christian; Castor, Dennis; Kaden, Svenja; Lauterbach, David; Gysi, Mario; Steigemann, Patrick; Gerlich, Daniel W.; Jiricny, Josef; Ferrari, Stefano			Chromosome Missegregation Associated with RUVBL1 Deficiency	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; MISMATCH REPAIR; ATPASE ACTIVITY; DNA HELICASE; ANAPHASE BRIDGES; COMPLEX; PONTIN; PROTEIN; MITOSIS; REPTIN	RUVBL1 (RuvB-like1) and RUVBL2 (RuvB-like 2) are integral components of multisubunit protein complexes involved in processes ranging from cellular metabolism, transcription and chromatin remodeling to DNA repair. Here, we show that although RUVBL1 and RUVBL2 are known to form heterodimeric complexes in which they stabilize each other, the subunits separate during cytokinesis. In anaphase-to-telophase transition, RUVBL1 localizes to structures of the mitotic spindle apparatus, where it partially co-localizes with polo-like kinase 1 (PLK1). The ability of PLK1 to phosphorylate RUVBL1-but not RUVBL2-in vitro and their physical association in vivo suggest that this kinase differentially regulates the function of the RuvB-like proteins during mitosis. We further show that siRNA-mediated knock-down of RuvB-like proteins causes severe defects in chromosome alignment and segregation. In addition, we show that the ATPase activity of RUVBL1 is indispensable for cell proliferation. Our data thus demonstrate that RUVBL1 is essential for efficient mitosis and proliferation.	[Gentili, Christian; Castor, Dennis; Kaden, Svenja; Lauterbach, David; Gysi, Mario; Jiricny, Josef; Ferrari, Stefano] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Gentili, Christian; Castor, Dennis; Kaden, Svenja; Lauterbach, David; Gysi, Mario; Jiricny, Josef; Ferrari, Stefano] ETH, CH-8057 Zurich, Switzerland; [Steigemann, Patrick; Gerlich, Daniel W.] Swiss Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch; sferrari@imcr.uzh.ch	Ferrari, Stefano/I-7357-2016; Gerlich, Daniel Wolfram W/A-6991-2016	Ferrari, Stefano/0000-0002-6607-215X; Gerlich, Daniel Wolfram W/0000-0003-1637-3365	Swiss National Science Foundation [3100/3A-144009/1, 3100A0-114120, 3100/068182.02/1]; European Community [241548, 258068]; Promedica Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); Promedica Foundation	The financial support of the Swiss National Science Foundation (SF, grant no. 3100/3A-144009/1; DG, grant no. 3100A0-114120; JJ, grant no. 3100/068182.02/1) is gratefully acknowledged. Research in the Gerlich laboratory has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreements no 241548 (MitoSys) and no 258068 (Systems Microscopy). CG was supported by a project grant from the Promedica Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bereshchenko O, 2012, HAEMATOL-HEMATOL J, V97, P1291, DOI 10.3324/haematol.2011.060251; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Broderick R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7572; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Ducat D, 2008, MOL BIOL CELL, V19, P3097, DOI 10.1091/mbc.E07-11-1202; Dufner P, 2000, J BIOL CHEM, V275, P36550, DOI 10.1074/jbc.M005987200; Elkaim J, 2012, BIOCHEM J, V443, P549, DOI 10.1042/BJ20111779; Ferrari S, 2006, CELL MOL LIFE SCI, V63, P781, DOI 10.1007/s00018-005-5515-3; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Gartner W, 2003, CELL MOTIL CYTOSKEL, V56, P79, DOI 10.1002/cm.10136; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Grigoletto A, 2013, MOL CANCER RES, V11, P133, DOI 10.1158/1541-7786.MCR-12-0455; Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lakomek K, 2015, STRUCTURE, V23, P483, DOI 10.1016/j.str.2014.12.015; Lauscher JC, 2007, HUM PATHOL, V38, P978, DOI 10.1016/j.humpath.2007.01.005; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Magalska A, 2014, DEV CELL, V31, P305, DOI 10.1016/j.devcel.2014.09.001; Makino Y, 1999, J BIOL CHEM, V274, P15329, DOI 10.1074/jbc.274.22.15329; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Menard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Rajendra E, 2014, NUCLEIC ACIDS RES, V42, P13736, DOI 10.1093/nar/gku1230; Rieder CL, 2011, CHROMOSOME RES, V19, P291, DOI 10.1007/s10577-010-9178-z; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sigala B, 2005, EXP CELL RES, V310, P357, DOI 10.1016/j.yexcr.2005.07.030; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; von Morgen P, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00069; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X	57	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133576	10.1371/journal.pone.0133576	http://dx.doi.org/10.1371/journal.pone.0133576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201077	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100072
J	Javanbakht, M; Mashayekhi, A; Baradaran, HR; Haghdoost, A; Afshin, A				Javanbakht, Mehdi; Mashayekhi, Atefeh; Baradaran, Hamid R.; Haghdoost, AliAkbar; Afshin, Ashkan			Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; QUALITY-OF-LIFE; RISK-FACTORS; NONCOMMUNICABLE DISEASES; ADULT-POPULATION; NATIONAL-SURVEY; MORTALITY; PREVALENCE; OBESITY; COSTS	Background The aim of this study was to estimate the economic burden of diabetes mellitus (DM) in Iran from 2009 to 2030. Methods A Markov micro-simulation (MM) model was developed to predict the DM population size and associated economic burden. Age-and sex-specific prevalence and incidence of diagnosed and undiagnosed DM were derived from national health surveys. A systematic review was performed to identify the cost of diabetes in Iran and the mean annual direct and indirect costs of patients with DM were estimated using a random-effect Bayesian meta-analysis. Face, internal, cross and predictive validity of the MM model were assessed by consulting an expert group, performing sensitivity analysis (SA) and comparing model results with published literature and national survey reports. Sensitivity analysis was also performed to explore the effect of uncertainty in the model. Results We estimated 3.78 million cases of DM (2.74 million diagnosed and 1.04 million undiagnosed) in Iran in 2009. This number is expected to rise to 9.24 million cases (6.73 million diagnosed and 2.50 million undiagnosed) by 2030. The mean annual direct and indirect costs of patients with DM in 2009 were US$ 556 (posterior standard deviation, 221) and US$ 689 (619), respectively. Total estimated annual cost of DM was $3.64 (2009 US$) billion (including US$1.71 billion direct and US$1.93 billion indirect costs) in 2009 and is predicted to increase to $9.0 (in 2009 US$) billion (including US$4.2 billion direct and US$4.8 billion indirect costs) by 2030. Conclusions The economic burden of DM in Iran is predicted to increase markedly in the coming decades. Identification and implementation of effective strategies to prevent and manage DM should be considered as a public health priority.	[Javanbakht, Mehdi] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen, Scotland; [Mashayekhi, Atefeh; Baradaran, Hamid R.] Iran Univ Med Sci, Endocrine Res Ctr, Inst Endocrinol & Metab, Tehran, Iran; [Haghdoost, AliAkbar] Kerman Univ Med Sci, Kerman, Iran; [Afshin, Ashkan] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	University of Aberdeen; Iran University of Medical Sciences; Kerman University of Medical Sciences; Tufts University	Javanbakht, M (corresponding author), Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen, Scotland.	m.javanbakht@abdn.ac.uk	Haghdoost, Ali Akbar/C-2823-2009; Baradaran, Hamid Reza/C-1556-2017; Baradaran, Hamid R/N-2577-2019	Haghdoost, Ali Akbar/0000-0003-4628-4849; Baradaran, Hamid Reza/0000-0002-5070-5864; Baradaran, Hamid R/0000-0002-5070-5864; Javanbakht, Mehdi/0000-0002-8661-8439	Iran University of Medical sciences [891113]; Chief Scientist Office [HERU1] Funding Source: researchfish	Iran University of Medical sciences; Chief Scientist Office	This project was part of MJ Ph.D program thesis and was funded by Iran University of Medical sciences, Grant number: 891113. URL:http://en.iums.ac.ir/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amini M, 2002, IRAN J ENDOCRINOL ME, V4, P97; [Anonymous], 2009, STEPWISE APPROACH CH; [Anonymous], TREEAGE PRO 2014 R1; [Anonymous], 2009, FACT SHEET IR STEPS; Azizi F, 2003, East Mediterr Health J, V9, P1114; Azizi F., 2000, IRAN J ENDOCRINOL ME, V2, P77; Bagust A, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.19.s4.2.x; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Briggs A, 2006, DECISION MODELLING H; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563; Esteghamati A, 2009, DIABETOLOGIA, V52, P1520, DOI 10.1007/s00125-009-1398-4; Esteghamati A, 2008, DIABETES CARE, V31, P96, DOI 10.2337/dc07-0959; Esteghamati A, 2014, DIABETES RES CLIN PR, V103, P319, DOI 10.1016/j.diabres.2013.12.034; Esteghamati A, 2010, METAB SYNDR RELAT D, V8, P209, DOI 10.1089/met.2009.0064; Esteghamati A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-167; Farshchi A, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-42; Farzadfar F, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-55; Flores-Le Roux JA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-39; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Ghaffari S, 2012, J CLIN RES GOVERNANC, V1, P16; group WB, 2013, URB POP; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Harati H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-186; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Honeycutt Amanda A, 2003, Health Care Manag Sci, V6, P155, DOI 10.1023/A:1024467522972; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Javanbakht M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044526; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Jones AP, 2006, AM J PUBLIC HEALTH, V96, P488, DOI 10.2105/AJPH.2005.063529; Lee WJ, 2012, J KOREAN MED SCI, V27, P255, DOI 10.3346/jkms.2012.27.3.255; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Ng CS, 2014, DIABETES RES CLIN PR, V105, P151, DOI 10.1016/j.diabres.2014.03.020; O'Reilly DJ, 2011, QUAL LIFE RES, V20, P939, DOI 10.1007/s11136-010-9828-9; Ohinmaa A, 2004, CANADIAN J DIABETES, P28; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Pishdad GR, 2005, DIABETES CARE, V28, P927, DOI 10.2337/diacare.28.4.927; Ranjbar Ezzatabadi M, 2013, IRAN J DIABETES OBES, V5, P60; Roberts M, 2012, MED DECIS MAKING, V32, P678, DOI [10.1177/0272989X12454941, 10.1016/j.jval.2012.06.016]; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Soltesz G, 2009, DIABETES YOUNG GLOBA; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; UN, 2009, INT MIGR 2009 WALLCH; UNPOP, 2012, LIF EXP BIRTH; Valdes S, 2009, REV ESP CARDIOL, V62, P528, DOI 10.1016/S0300-8932(09)71033-4; Waldeyer R, 2013, DIABETIC MED, V30, P999, DOI 10.1111/dme.12177; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Wilborn C, 2005, J INT SOC SPORT NUTR, V2, DOI 10.1186/1550-2783-2-2-4; Wild SH, 2005, DIABETIC MED, V22, P490, DOI 10.1111/j.1464-5491.2004.01433.x; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zhang YD, 2009, POPUL HEALTH MANAG, V12, P95, DOI 10.1089/pop.2009.12202; Zhou H, 2005, DIABETES CARE, V28, P2856, DOI 10.2337/diacare.28.12.2856	57	58	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132505	10.1371/journal.pone.0132505	http://dx.doi.org/10.1371/journal.pone.0132505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200913	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100038
J	Oniki, K; Saruwatari, J; Izuka, T; Kajiwara, A; Morita, K; Sakata, M; Otake, K; Ogata, Y; Nakagawa, K				Oniki, Kentaro; Saruwatari, Junji; Izuka, Tomoko; Kajiwara, Ayami; Morita, Kazunori; Sakata, Misaki; Otake, Koji; Ogata, Yasuhiro; Nakagawa, Kazuko			Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PRACTICE GUIDELINE; DIABETES-MELLITUS; GENE POLYMORPHISM; I148M VARIANT; PROGRESSION; METAANALYSIS; ASSOCIATION; PREVALENCE; MANAGEMENT	In normal weight subjects (body mass index < 25 kg/m(2)), non-alcoholic fatty liver disease (NAFLD) is likely to coexist with metabolic diseases. The patatin-like phospholipase 3 (PNPLA3) polymorphism rs738409 (c.444C>G) is associated with the risk of NAFLD and/or renal dysfunction; however, the influence of the weight status on the associations remains unknown. We aimed to clarify the associations of the PNPLA3 polymorphism with the risk of NAFLD and/or renal dysfunction, while also paying careful attention to the weight status of the subjects. Cross-sectional and retrospective longitudinal studies with 5.5 +/- 1.1 years of followup were conducted in 740 and 393 Japanese participants (61.2 +/- 10.5 and 67.5 +/- 6.0 years), respectively, during a health screening program. Among 591 subjects who did not have a habitual alcohol intake and/or hepatitis B or C virus infections, the PNPLA3 G/G genotype was associated with the risk for NAFLD in normal weight subjects [odds ratio (95% CI): 3.06 (1.11-8.43), P < 0.05]. Among all subjects, carriers of the PNPLA3 G/G genotype with a normal weight had a lower eGFR than those of the C/C genotype [partial regression coefficient (SE): -3.26 (1.48), P < 0.05]. These associations were replicated in the longitudinal analyses. Among the overweight subjects, none of the genotypes were significantly associated in the cross-sectional and longitudinal analyses; however, the power of the analyses was small, especially in the analyses among overweight subjects. The findings of this study suggest that carriers of the PNPLA3 G/G genotype with a normal weight status should nevertheless be carefully monitored for the presence of NAFLD and/or renal dysfunction.	[Oniki, Kentaro; Saruwatari, Junji; Izuka, Tomoko; Kajiwara, Ayami; Morita, Kazunori; Sakata, Misaki; Nakagawa, Kazuko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan; [Otake, Koji; Ogata, Yasuhiro] Japanese Red Cross Kumamoto Hlth Care Ctr, Kumamoto, Japan; [Nakagawa, Kazuko] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto, Japan	Kumamoto University; Kumamoto University	Saruwatari, J (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan.	junsaru@gpo.kumamoto-u.ac.jp	Saruwatari, Junji/Q-7748-2019	Saruwatari, Junji/0000-0001-6266-1347	Ministry of Education, Culture, Sports, Science and Technology, Japan; Smoking Research Foundation [25860117, 26360049, 15K18925]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	The work was supported in full by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan; http://www.jsps.go.jp/english/index.html; (Grant Numbers: 25860117, 26360049 and 15K18925), and in part by a grant from Smoking Research Foundation.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Dongiovanni P, 2013, WORLD J GASTROENTERO, V19, P6969, DOI 10.3748/wjg.v19.i41.6969; Feng RN, 2014, WORLD J GASTROENTERO, V20, P17932, DOI 10.3748/wjg.v20.i47.17932; Fung J, 2015, LIVER INT, V35, P542, DOI 10.1111/liv.12619; Garland JS, 2014, DIABET METAB SYND OB, V7, P347, DOI 10.2147/DMSO.S46674; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Hyysalo J, 2014, DIABETES, V63, P312, DOI 10.2337/db13-0774; Inker LA, 2014, AM J KIDNEY DIS, V64, P74, DOI 10.1053/j.ajkd.2014.02.020; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kim NH, 2014, LIVER INT, V34, P604, DOI 10.1111/liv.12454; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; Machado MV, 2012, LIVER INT, V32, P241, DOI 10.1111/j.1478-3231.2011.02623.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Musso G, 2015, HEPATOLOGY, V62, P658, DOI 10.1002/hep.27643; Musso G, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001680; Petta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074089; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Romeo S, 2015, HEPATOLOGY, V62, P660, DOI 10.1002/hep.27642; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Shen J, 2014, ALIMENT PHARM THER, V39, P532, DOI 10.1111/apt.12609; Shen JH, 2015, J LIPID RES, V56, P167, DOI 10.1194/jlr.M048777; Shen JY, 2015, J GASTROEN HEPATOL, V30, P139, DOI 10.1111/jgh.12656; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Zhang L, 2015, J GASTROEN HEPATOL, V30, P821, DOI 10.1111/jgh.12889; Zhang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108381	37	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132640	10.1371/journal.pone.0132640	http://dx.doi.org/10.1371/journal.pone.0132640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200108	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100041
J	Sindhu, S; Thomas, R; Shihab, P; Sriraman, D; Behbehani, K; Ahmad, R				Sindhu, Sardar; Thomas, Reeby; Shihab, Puthiyaveetil; Sriraman, Devarajan; Behbehani, Kazem; Ahmad, Rasheed			Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MACROPHAGE DIFFERENTIATION ANTIGEN; MUSCLE-DERIVED INTERLEUKIN-6; LOW-GRADE INFLAMMATION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; FACTOR-ALPHA; TNF-ALPHA; IN-VIVO; RECEPTOR	The role of IL-6R/IL-6 axis in metabolic inflammation remains controversial. We determined the changes in adipose tissue expression of IL-6R and IL-6 in obese, overweight, and lean non-diabetic individuals. Subcutaneous adipose tissue biopsies were collected from 33 obese, 22 overweight, and 10 lean individuals and the expression of IL-6R, IL-6, TNF-alpha, MCP-1, IP-10, CD11b, CD163, and CD68 was detected by immunohistochemistry; results were also confirmed by real-time RT-PCR and confocal microscopy. The data were compared using unpaired t-test and the dependence between two variables was assessed by Pearson's correlation test. Obese individuals showed higher IL-6R expression (103.8 +/- 4.807) in the adipose tissue as compared with lean/overweight (68.06 +/- 4.179) subjects (P<0.0001). The elevated IL-6R expression correlated positively with body mass index (BMI) (r=0.80 P< 0.0001) and percent body fat (r=0.69 P=0.003). The increased IL-6R expression in obesity was also confirmed by RT-PCR (Obese: 3.921 +/- 0.712 fold; Lean/ Overweight: 2.191 +/- 0.445 fold; P=0.0453) and confocal microscopy. IL-6 expression was also enhanced in obese adipose tissue (127.0 +/- 15.91) as compared with lean/overweight (86.69 +/- 5.25) individuals (P=0.03) which correlated positively with BMI (r=0.58 P=0.008). IL-6 mRNA expression was concordantly higher in obese (16.60 +/- 2.214 fold) versus lean/overweight (9.376 +/- 1.656 fold) individuals (P=0.0108). These changes in the IL-6R/IL-6 expression correlated positively with the adipose tissue expression of CD11b (IL-6R r=0.44 P=0.063; IL-6 r=0.77 P< 0.0001), CD163 (IL-6R r=0.45 P=0.045; IL-6 r=0.55 P=0.013), TNF-alpha (IL-6R r=0.73 P=0.0003; IL-6 r=0.60 P=0.008), MCP-1 (IL-6R r=0.61 P=0.005; IL-6 r=0.63 P=0.004) and IP-10 (IL-6R r=0.41 P=0.08; IL-6 r=0.50 P=0.026). It was, therefore, concluded that obesity was a positive modulator of IL-6R and IL-6 expression in the adipose tissue which might be a contributory mechanism to induce metabolic inflammation.	[Sindhu, Sardar; Thomas, Reeby; Shihab, Puthiyaveetil; Behbehani, Kazem; Ahmad, Rasheed] DDI, Immunol & Innovat Cell Therapy Unit, Dasman, Kuwait; [Sriraman, Devarajan; Behbehani, Kazem] DDI, Tissue Bank Core Facil, Dasman, Kuwait		Ahmad, R (corresponding author), DDI, Immunol & Innovat Cell Therapy Unit, POB 1180, Dasman, Kuwait.	rasheed.ahmad@dasmaninstitute.org	sindhu, sardar/ABE-3565-2021	THOMAS, REEBY/0000-0001-9933-0285	Kuwait Foundation for Advancement of sciences (KFAS) [RA2010-003]	Kuwait Foundation for Advancement of sciences (KFAS)	Kuwait Foundation for Advancement of sciences (KFAS) (Grant#: RA2010-003) Recipient Name: Dr Rasheed Ahmad	Alvarez B, 2002, BBA-MOL CELL RES, V1542, P66, DOI 10.1016/S0167-4889(01)00167-7; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; BACKE E, 1991, J CLIN PATHOL, V44, P936, DOI 10.1136/jcp.44.11.936; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Corica F, 1999, INT J OBESITY, V23, P355, DOI 10.1038/sj.ijo.0800826; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herder C, 2007, INT J OBESITY, V31, P403, DOI 10.1038/sj.ijo.0803432; Hoene M, 2008, OBES REV, V9, P20, DOI 10.1111/j.1467-789X.2007.00410.x; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Jansson JO, 2007, J APPL PHYSIOL, V102, P821, DOI 10.1152/japplphysiol.01353.2006; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; LUST JA, 1992, CYTOKINE, V4, P96, DOI 10.1016/1043-4666(92)90043-Q; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Michaud A, 2013, OBESITY, V21, P2342, DOI 10.1002/oby.20341; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2001, J PHYSIOL-LONDON, V536, P329, DOI 10.1111/j.1469-7793.2001.0329c.xd; PULFORD KAF, 1990, INT IMMUNOL, V2, P973, DOI 10.1093/intimm/2.10.973; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; SAITO N, 1991, AM J PATHOL, V139, P1053; Schultz O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014328; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sundararaj KP, 2009, J BIOL CHEM, V284, P13714, DOI 10.1074/jbc.M806573200; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514	43	128	134	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133494	10.1371/journal.pone.0133494	http://dx.doi.org/10.1371/journal.pone.0133494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200663	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100068
J	Becker, AM; Callahan, DJ; Richner, JM; Choi, J; DiPersio, JF; Diamond, MS; Bhattacharya, D				Becker, Amy M.; Callahan, Derrick J.; Richner, Justin M.; Choi, Jaebok; DiPersio, John F.; Diamond, Michael S.; Bhattacharya, Deepta			GPR18 Controls Reconstitution of Mouse Small Intestine Intraepithelial Lymphocytes following Bone Marrow Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; T-CELL-RECEPTOR; HEMATOPOIETIC STEM-CELLS; RECENT THYMIC EMIGRANTS; B-CELL; LINEAGE SPECIFICATION; PROGENITORS; IDENTIFICATION; EXPRESSION; INTEGRINS	Specific G protein coupled receptors (GPRs) regulate the proper positioning, function, and development of immune lineage subsets. Here, we demonstrate that GPR18 regulates the reconstitution of intraepithelial lymphocytes (IELs) of the small intestine following bone marrow transplantation. Through analysis of transcriptional microarray data, we find that GPR18 is highly expressed in IELs, lymphoid progenitors, and mature follicular B cells. To establish the physiological role of this largely uncharacterized GPR, we generated Gpr18(-/-) mice. Despite high levels of GPR18 expression in specific hematopoietic progenitors, Gpr18(-/-) mice have no defects in lymphopoiesis or myelopoiesis. Moreover, antibody responses following immunization with hapten-protein conjugates or infection with West Nile virus are normal in Gpr18(-/-) mice. Steady-state numbers of IELs are also normal in Gpr18(-/-) mice. However, competitive bone marrow reconstitution experiments demonstrate that GPR18 is cell-intrinsically required for the optimal restoration of small intestine TCR gamma delta(+) and TCR alpha beta(+) CD8 alpha(+) IELs. In contrast, GPR18 is dispensable for the reconstitution of large intestine IELs. Moreover, Gpr18(-/-) bone marrow reconstitutes small intestine IELs similarly to controls in athymic recipients. Gpr18(-/-) chimeras show no changes in susceptibility to intestinal insults such as Citrobacter rodentium infections or graft versus host disease. These data reveal highly specific requirements for GPR18 in the development and reconstitution of thymus-derived intestinal IEL subsets in the steady-state and after bone marrow transplantation.	[Becker, Amy M.; Callahan, Derrick J.; Diamond, Michael S.; Bhattacharya, Deepta] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Richner, Justin M.; Choi, Jaebok; DiPersio, John F.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Richner, Justin M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Choi, Jaebok; DiPersio, John F.] Washington Univ, Sch Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bhattacharya, D (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	deeptab@wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Richner, Justin/0000-0002-5344-118X; Choi, Jaebok/0000-0002-5590-087X	National Institutes of Health [P30AR48335, K01DK078318, T32CA009547, K01DK099395]; New York Stem Cell Foundation; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078318, K01DK099395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Transgenic, Microinjection, and Knockout core facility was supported in part by National Institutes of Health grant P30AR48335. D.B. is a New York Stem Cell Foundation-Robertson Investigator. This research was supported by The New York Stem Cell Foundation, National Institutes of Health grants K01DK078318 (D.B.), T32CA009547 (A.M.B.), and K01DK099395 (A.M.B.). The funders had no role in study design, data collection and	Andrew DP, 1996, EUR J IMMUNOL, V26, P897, DOI 10.1002/eji.1830260427; Bagriacik EU, 2000, IMMUNOL LETT, V75, P77, DOI 10.1016/S0165-2478(00)00275-3; BANDEIRA A, 1991, P NATL ACAD SCI USA, V88, P43, DOI 10.1073/pnas.88.1.43; BARTHOLD SW, 1976, LAB ANIM SCI, V26, P889; Becker AM, 2015, EXP HEMATOL, V43, P44, DOI 10.1016/j.exphem.2014.10.001; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Burstein SH, 2011, J CELL BIOCHEM, V112, P3227, DOI 10.1002/jcb.23245; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Console-Bram L, 2014, BRIT J PHARMACOL, V171, P3908, DOI 10.1111/bph.12746; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; FINDLY RC, 1993, EUR J IMMUNOL, V23, P2557, DOI 10.1002/eji.1830231027; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Gantz I, 1997, GENOMICS, V42, P462, DOI 10.1006/geno.1997.4752; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; GUYGRAND D, 1974, EUR J IMMUNOL, V4, P435, DOI 10.1002/eji.1830040610; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; Huleatt JW, 1996, IMMUNITY, V5, P263, DOI 10.1016/S1074-7613(00)80321-0; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; JONES JM, 1971, RADIAT RES, V45, P577, DOI 10.2307/3573066; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Lai AY, 2009, BLOOD, V113, P5757, DOI 10.1182/blood-2009-01-201939; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Lepage AC, 1998, J IMMUNOL, V161, P4902; Lin TS, 1998, J CLIN INVEST, V101, P570, DOI 10.1172/JCI896; Lu VB, 2013, MOL PHARMACOL, V83, P267, DOI 10.1124/mol.112.081182; Luangsay S, 2003, GASTROENTEROLOGY, V125, P491, DOI 10.1016/S0016-5085(03)00903-X; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; McHugh D, 2012, BRIT J PHARMACOL, V165, P2414, DOI 10.1111/j.1476-5381.2011.01497.x; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rettig MP, 2004, J IMMUNOL, V173, P3620, DOI 10.4049/jimmunol.173.6.3620; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Sakai T, 1997, GASTROENTEROLOGY, V113, P168, DOI 10.1016/S0016-5085(97)70092-1; SAKAI T, 1995, EUR J IMMUNOL, V25, P87, DOI 10.1002/eji.1830250117; Samuelson LC, 1996, MAMM GENOME, V7, P920, DOI 10.1007/s003359900272; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Staton TL, 2004, J IMMUNOL, V172, P7282, DOI 10.4049/jimmunol.172.12.7282; Staton TL, 2006, NAT IMMUNOL, V7, P482, DOI 10.1038/ni1319; Stenstad H, 2007, P NATL ACAD SCI USA, V104, P10122, DOI 10.1073/pnas.0700269104; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takenouchi R, 2012, BIOCHEM BIOPH RES CO, V418, P366, DOI 10.1016/j.bbrc.2012.01.027; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; TSUZUKI T, 1994, EUR J IMMUNOL, V24, P709, DOI 10.1002/eji.1830240333; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wang XM, 2014, J EXP MED, V211, P2351, DOI 10.1084/jem.20140646; Wang YN, 2014, J EXP MED, V211, P841, DOI 10.1084/jem.20131821; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zhou S, 2008, INT IMMUNOL, V20, P385, DOI 10.1093/intimm/dxm153	83	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133854	10.1371/journal.pone.0133854	http://dx.doi.org/10.1371/journal.pone.0133854			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197390	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600143
J	Kern, A; Schnell, G; Bernard, Q; Boeuf, A; Jaulhac, B; Collin, E; Barthel, C; Ehret-Sabatier, L; Boulanger, N				Kern, Aurelie; Schnell, Gilles; Bernard, Quentin; Boeuf, Amandine; Jaulhac, Benoit; Collin, Elody; Barthel, Cathy; Ehret-Sabatier, Laurence; Boulanger, Nathalie			Heterogeneity of Borrelia burgdorferi Sensu Stricto Population and Its Involvement in Borrelia Pathogenicity: Study on Murine Model with Specific Emphasis on the Skin Interface	PLOS ONE			English	Article							EARLY LYME-DISEASE; PROTEOME ANALYSIS; HEMATOGENOUS DISSEMINATION; BACTERIAL-INFECTION; GENE-EXPRESSION; DEFENSE SYSTEM; IN-VITRO; HOST; MOUSE; PROTEINS	Lyme disease is a multisystemic disorder caused by B. burgdorferi sl. The molecular basis for specific organ involvement is poorly understood. The skin plays a central role in the development of Lyme disease as the entry site of B. burgdorferi in which specific clones are selected before dissemination. We compared the skin inflammatory response (antimicrobial peptides, cytokines and chemokines) elicited by spirochete populations recovered from patients presenting different clinical manifestations. Remarkably, these spirochete populations induced different inflammatory profiles in the skin of C3H/HeN mice. As spirochete population transmitted into the host skin is heterogeneous, we isolated one bacterial clone from a population recovered from a patient with neuroborreliosis and compared its virulence to the parental population. This clone elicited a strong cutaneous inflammatory response characterized by MCP-1, IL-6 and antimicrobial peptides induction. Mass spectrometry of this clone revealed 110 overexpressed proteins when compared with the parental population. We further focused on the expression of nine bacterial surface proteins. bb0347 coding for a protein that interacts with host fibronectin, allowing bacterial adhesion to vascular endothelium and extracellular matrix, was found to be induced in host skin with another gene bb0213 coding for a hypothetical protein. These findings demonstrate the heterogeneity of the B. burgdorferi ss population and the complexity of the interaction involved early in the skin.	[Kern, Aurelie; Bernard, Quentin; Jaulhac, Benoit; Collin, Elody; Barthel, Cathy; Boulanger, Nathalie] Univ Strasbourg, Fac Med & Pharmacie, EA7290 Virulence Bacterienne Precoce Grp Borrelio, Strasbourg, France; [Schnell, Gilles; Boeuf, Amandine; Ehret-Sabatier, Laurence] Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien, Lab Spectrometrie Masse BioOrgan,UMR7178, Strasbourg, France; [Kern, Aurelie] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tufts Medical Center	Boulanger, N (corresponding author), Univ Strasbourg, Fac Med & Pharmacie, EA7290 Virulence Bacterienne Precoce Grp Borrelio, Strasbourg, France.	nboulanger@unistra.fr	Boulanger, Nathalie/ABF-1353-2020		Conseil Regional d'Alsace [2009.60.053, 2012.60.0033]; Direction Generale de l'Armement; Fulbright grant; Monahan grant	Conseil Regional d'Alsace(Region Grand-Est); Direction Generale de l'Armement; Fulbright grant; Monahan grant	Aurelie Kern was supported by a grant #2009.60.053 from the Conseil Regional d'Alsace and Direction Generale de l'Armement. Quentin Bernard is supported by a grant 2012.60.0033 from the Conseil Regional d'Alsace and Direction Generale de l'Armement. Nathalie Boulanger was supported by a Fulbright grant and a Monahan grant for her sabbatical.	Angel TE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013800; Antonara S, 2010, INFECT IMMUN, V78, P4723, DOI 10.1128/IAI.00464-10; Baranton Guy, 2009, V37, P1, DOI 10.1159/000213066; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; Bernardi Q, 2014, J INVEST DERMATOL, V134, P1211, DOI 10.1038/jid.2014.36; Brisson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022926; De Martino SJ, 2006, RES MICROBIOL, V157, P726, DOI 10.1016/j.resmic.2006.05.002; Ellis TC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003567; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gaultney RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075643; Gesslbauer B, 2012, PROTEOMICS, V12, P845, DOI 10.1002/pmic.201100211; Hodzic E, 2003, INFECT IMMUN, V71, P5042, DOI 10.1128/IAI.71.9.5042-5055.2003; Hodzic E, 2002, INFECT IMMUN, V70, P3382, DOI 10.1128/IAI.70.7.3382-3388.2002; Imai DM, 2011, VET PATHOL, V48, P1151, DOI 10.1177/0300985811398246; Jacobs JM, 2005, PROTEOMICS, V5, P1446, DOI 10.1002/pmic.200401052; Jones KL, 2006, J CLIN MICROBIOL, V44, P4407, DOI 10.1128/JCM.01077-06; Jungblut PR, 1999, ELECTROPHORESIS, V20, P3611, DOI 10.1002/(SICI)1522-2683(19991201)20:18&lt;3611::AID-ELPS3611&gt;3.0.CO;2-4; Kern A, 2011, VECTOR-BORNE ZOONOT, V11, P1343, DOI 10.1089/vbz.2010.0197; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Liveris D, 1996, J CLIN MICROBIOL, V34, P1306, DOI 10.1128/JCM.34.5.1306-1309.1996; Marchal C, 2011, INFECT IMMUN, V79, P774, DOI 10.1128/IAI.00482-10; Marchal CMP, 2009, J INVEST DERMATOL, V129, P2515, DOI 10.1038/jid.2009.73; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Nowalk AJ, 2006, INFECT IMMUN, V74, P3864, DOI 10.1128/IAI.00189-06; Pal U, 2003, MICROBES INFECT, V5, P659, DOI 10.1016/S1286-4579(03)00097-2; Rego ROM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101009, DOI 10.1371/journal.pone.0101009]; Rohrl J, 2012, J IMMUNOL, V188, P4931, DOI 10.4049/jimmunol.1102442; Russell TM, 2013, MOL MICROBIOL, V90, P241, DOI 10.1111/mmi.12377; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schnell G, 2015, PROTEOMICS, V15, P1280, DOI 10.1002/pmic.201400177; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Woods A, 2008, INFECT IMMUN, V76, P1657, DOI 10.1128/IAI.00951-07; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922	40	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133195	10.1371/journal.pone.0133195	http://dx.doi.org/10.1371/journal.pone.0133195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197047	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600071
J	Liu, ZY; Liu, XY; Yu, HY; Pei, JH; Zhang, YH; Gong, J; Pu, JL				Liu, Zhouying; Liu, Xiaoyan; Yu, Haiyun; Pei, Juanhui; Zhang, Yinhui; Gong, Jing; Pu, Jielin			Common Variants in TRDN and CALM1 Are Associated with Risk of Sudden Cardiac Death in Chronic Heart Failure Patients in Chinese Han Population	PLOS ONE			English	Article							VENTRICULAR-ARRHYTHMIAS; NOS1AP; MECHANISMS; TRIADIN; PROTEIN	Background Recent studies suggest that variants in two calcium handling genes (RyR2 and CASQ2) associated with sudden cardiac death (SCD) and non-sudden cardiac death (NSCD) in subjects with heart failure and coronary artery disease, respectively. The purpose of this study was to identify other calcium handling genes associated with SCD in the long-term of chronic heart failure (CHF) in Chinese Han population. Methods and Results We investigated 20 SNPs representing 10 genes that regulated calcium handling in 1429 patients with CHF, and the genetic association with SCD and all-cause death was analysed. During a median follow-up period of 63 months, 538 patients (37.65%) died from CHF, of whom 185 (34.38%) had SCD and the others were NSCD. SNPs that pass a P value cut-off of 0.0025 were considered as significant. We found that patients carrying the CC genotype of rs3814843 on CALM1 gene had greater risks of SCD (HR 5.542, 95% CI 2.054-14.948, P = .001) and all cause death (HR 3.484, 95% CI 1.651-7.350, P = .001). After adjusting for other risk factors, significant associations remained. Moreover, patients carrying G allele of rs361508 on TRDN gene also had increased risk of SCD. Conclusions Common variants in TRDN and CALM1 are associated with increased risk of SCD in patients with CHF. These findings provide further evidence for association of variants in calcium handling regulating proteins and SCD in chronic heart failure.	[Liu, Zhouying; Liu, Xiaoyan; Yu, Haiyun; Pei, Juanhui; Zhang, Yinhui; Gong, Jing; Pu, Jielin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Physiol & Pathophysiol Lab,State Key Lab Cardiova, 167 Bei Li Shi Rd, Beijing 100037, Peoples R China; [Liu, Zhouying; Liu, Xiaoyan; Yu, Haiyun; Pei, Juanhui; Zhang, Yinhui; Gong, Jing; Pu, Jielin] Peking Union Med Coll, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Pu, JL (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Physiol & Pathophysiol Lab,State Key Lab Cardiova, 167 Bei Li Shi Rd, Beijing 100037, Peoples R China.; Pu, JL (corresponding author), Peking Union Med Coll, Beijing 100037, Peoples R China.	jielinpu@yahoo.com			National Basic Research Program of China (973 program) [2013CB531105]	National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was funded by National Basic Research Program of China (973 program projects, program number: 2013CB531105 to J. Pu).	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Darbar D, 2010, HEART FAIL REV, V15, P229, DOI 10.1007/s10741-008-9095-9; Fatkin Diane, 2007, Heart Lung Circ, V16, P19, DOI 10.1016/j.hlc.2006.10.018; Francia P, 2013, J INTERV CARD ELECTR, V38, P169, DOI 10.1007/s10840-013-9827-1; Jiang H, 2009, HEART, V95, P1727, DOI 10.1136/hrt.2008.150177; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Liu XY, 2014, J CARD FAIL, V20, P244, DOI 10.1016/j.cardfail.2014.01.006; Marks AR, 2001, J MOL CELL CARDIOL, V33, P615, DOI 10.1006/jmcc.2000.1343; Mohler PJ, 2007, PHYSIOLOGY, V22, P342, DOI 10.1152/physiol.00018.2007; Narang R, 1996, EUR HEART J, V17, P1390; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Ran YQ, 2010, CLIN SCI, V119, P215, DOI 10.1042/CS20090656; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Westaway SK, 2011, CIRC-CARDIOVASC GENE, V4, P397, DOI 10.1161/CIRCGENETICS.111.959916; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	18	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132459	10.1371/journal.pone.0132459	http://dx.doi.org/10.1371/journal.pone.0132459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196381	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600037
J	Palmer, M; Groce, N; Mont, D; Nguyen, OH; Mitra, S				Palmer, Michael; Groce, Nora; Mont, Daniel; Oanh Hong Nguyen; Mitra, Sophie			The Economic Lives of People with Disabilities in Vietnam	PLOS ONE			English	Article							POVERTY; COST; WELFARE	Through a series of focus group discussions conducted in northern and central Vietnam, this study gives voice to the lived economic experience of families with disabilities and how they manage the economic challenges associated with disability. The dynamic of low and unstable income combined with on-going health care and other disability-related costs gives rise to a range of coping mechanisms (borrowing, reducing and foregoing expenditures, drawing upon savings and substituting labour) that helps to maintain living standards in the short-run yet threatens the longer-term welfare of both the individual with disability and their household. Current social protection programs were reported as not accessible to all and while addressing some immediate economic costs of disability, do not successfully meet current needs nor accommodate wider barriers to availing benefits.	[Palmer, Michael] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Groce, Nora; Mont, Daniel] UCL, Div Epidemiol & Publ Hlth, London, England; [Oanh Hong Nguyen] Inclus Dev Act IDEA, Hanoi, Vietnam; [Mitra, Sophie] Fordham Univ, Dept Econ, New York, NY 10023 USA	University of Melbourne; University of London; University College London; Fordham University	Groce, N (corresponding author), UCL, Div Epidemiol & Publ Hlth, London, England.	nora.groce@ucl.ac.uk		Groce, Nora/0000-0002-7885-7042; Palmer, Michael/0000-0003-0033-5073; Mitra, Sophie/0000-0001-7283-6630	Economic and Social Research Council; Department for International Development (UK) [ES/J018864/1]; Economic and Social Research Council [ES/J018864/1] Funding Source: researchfish; ESRC [ES/J018864/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department for International Development (UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by the Economic and Social Research Council and the Department for International Development (UK) (Grant code: ES/J018864/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CONV RIGHTS PERS DIS; Bales S, 182013 HEFPA; Buckup S, 2009, IDEAS WORKING PAPER; Cullinan J, 2011, HEALTH ECON, V20, P582, DOI 10.1002/hec.1619; Cullinan J, 2013, EUR J HEALTH ECON, V14, P171, DOI 10.1007/s10198-011-0357-4; Down E, 2014, NEEDS AVAILABILITY A; Erb S., 2002, OUTCAST SOCIAL WELFA; Groce N, 2011, THIRD WORLD Q, V32, P1493, DOI 10.1080/01436597.2011.604520; Haveman R, 2000, HDB HLTH EC B, V1B; Minh HV, 2015, GLOB PUBLIC HEALTH, V10, pS70, DOI 10.1080/17441692.2014.971332; Hoogeveen JG, 2005, J AFR ECON, V14, P603, DOI 10.1093/jae/eji020; Islam A, 2012, J DEV ECON, V97, P232, DOI 10.1016/j.jdeveco.2011.05.003; Loyalka P, 2014, DEMOGRAPHY, V51, P97, DOI 10.1007/s13524-013-0272-7; Mersland R., 2009, DISABILITY STUDIES Q, V29; Mitra S, 2016, HEALTH ECON, V25, P888, DOI 10.1002/hec.3196; Mitra S, 2013, WORLD DEV, V41, P1, DOI 10.1016/j.worlddev.2012.05.024; MOLISA, 2012, LABOUR; Mont D, 2013, 20 U COLL LOND L CHE; Mont D, 2013, WORLD DEV, V48, P88, DOI 10.1016/j.worlddev.2013.04.001; Mont D, 2011, WORLD BANK ECON REV, V25, P323, DOI 10.1093/wber/lhr019; Morciano M, 2014, REV INCOME WEALTH, DOI [10.1111/roiw.12108, DOI 10.1111/R0IW.12108]; Ngo AD, 2013, DISABIL SOC, V28, P955, DOI 10.1080/09687599.2012.741516; Palmer M, 2015, SOC SCI MED, V145, P217, DOI 10.1016/j.socscimed.2014.08.012; Palmer MG, 2014, WORLD DEV, V64, P384, DOI 10.1016/j.worlddev.2014.06.008; Palmer MG, 2012, J ASIAN ECON, V23, P600, DOI 10.1016/j.asieco.2012.06.003; Patrinos H. A., 2010, INT ENCY ED, DOI [10.1016/B978-0-08-044894-7.01216-1, DOI 10.1016/B978-0-08-044894-7.01216-1]; Saunders P, 2007, AUSTR J SOCIAL ISSUE, V42; Sen A, 2004, DIS INCL DEV C WASH; Shore S, 2012, MED SCI MONITOR, V18, pCR533, DOI 10.12659/MSM.883348; Sparrow R, 2014, HEALTH ECON, V23, P719, DOI 10.1002/hec.2945; Trani JF, 2012, J INT DEV, V24, pS19, DOI 10.1002/jid.1709; UNESCAP, 2012, STRATEGY; UNFPA, 2011, PEOPL DIS VIETN KEY; Ha VS, 2014, SOC SCI MED, V120, P278, DOI 10.1016/j.socscimed.2014.09.038; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Zaidi A, 2005, REV INCOME WEALTH, V51	36	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133623	10.1371/journal.pone.0133623	http://dx.doi.org/10.1371/journal.pone.0133623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197034	Green Published, gold			2022-12-27	WOS:000358547600120
J	Spaans, VM; Trietsch, MD; Peters, AAW; Osse, M; ter Haar, N; Fleuren, GJ; Jordanova, ES				Spaans, Vivian M.; Trietsch, Marjolijn D.; Peters, Alexander A. W.; Osse, Michelle; ter Haar, Natalja; Fleuren, Gert J.; Jordanova, Ekaterina S.			Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; WNT/BETA-CATENIN; GENE-MUTATIONS; BETA-CATENIN; LUNG-CANCER; ADENOCARCINOMA; PATHWAY; INHIBITORS; BREAST; PI3K	Introduction Squamous cell carcinoma (SCC), adenocarcinoma (AC), and adenosquamous carcinoma (ASC) are the most common histological subtypes of cervical cancer. Differences in the somatic mutation profiles of these subtypes have been suggested. We investigated the prevalence of somatic hot-spot mutations in three well-defined cohorts of SCC, AC, and ASC and determined the additional value of mutation profiling in predicting disease outcome relative to well-established prognostic parameters. Materials and Methods Clinicopathological data were collected for 301 cervical tumors classified as SCC (n=166), AC (n=55), or ASC (n=80). Mass spectrometry was used to analyze 171 somatic hot-spot mutations in 13 relevant genes. Results In 103 (34%) tumors, 123 mutations were detected (36% in SCC, 38% in AC, and 28% in ASC), mostly in PIK3CA (20%) and KRAS (7%). PIK3CA mutations occurred more frequently in SCC than AC (25% vs. 11%, P=0.025), whereas KRAS mutations occurred more frequently in AC than SCC (24% vs. 3%, P<0.001) and ASC (24% vs. 3%, P<0.001). A positive mutation status correlated with worse disease-free survival (HR 1.57, P=0.043). In multivariate analysis, tumor diameter, parametrial infiltration, and lymph node metastasis, but not the presence of a somatic mutation, were independent predictors of survival. Conclusion Potentially targetable somatic mutations occurred in 34% of cervical tumors with different distributions among histological subtypes. Precise classification of cervical carcinomas in combination with mutation profiling is valuable for predicting disease outcome and may guide the development and selection of tumor-specific treatment approaches.	[Spaans, Vivian M.; Peters, Alexander A. W.] Leiden Univ, Med Ctr, Dept Gynecol & Obstet, Leiden, Netherlands; [Spaans, Vivian M.; Trietsch, Marjolijn D.; Osse, Michelle; ter Haar, Natalja; Fleuren, Gert J.; Jordanova, Ekaterina S.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Jordanova, Ekaterina S.] Ctr Gynecol Oncol, Dept Gynecol & Obstet, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jordanova, ES (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands.	E.S.Jordanova@lumc.nl		Jordanova, Ekaterina S./0000-0002-8121-1322				Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Bulk S, 2005, INT J CANCER, V113, P1005, DOI 10.1002/ijc.20678; Chen YW, 2012, J CELL PHYSIOL, V227, P2818, DOI 10.1002/jcp.23038; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cui B, 2009, INT J ONCOL, V34, P409, DOI 10.3892/ijo_00000164; de Jong AE, 2004, CLIN CANCER RES, V10, P972, DOI 10.1158/1078-0432.CCR-0956-3; de la Rochefordiere A, 2015, CLIN CANCER RES, V21, P2530, DOI 10.1158/1078-0432.CCR-14-2368; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Dutton-Regester K, 2012, MOL CANCER THER, V11, P888, DOI 10.1158/1535-7163.MCT-11-0676; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Galic V, 2012, GYNECOL ONCOL, V125, P287, DOI 10.1016/j.ygyno.2012.01.012; Gien LT, 2010, GYNECOL ONCOL, V116, P140, DOI 10.1016/j.ygyno.2009.09.040; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Kloth JN, 2005, CARCINOGENESIS, V26, P1493, DOI 10.1093/carcin/bgi110; Konopka B, 2011, HUM PATHOL, V42, P1710, DOI 10.1016/j.humpath.2010.01.030; Kurman RJ, 2014, WHO CLASSIFICATION T, P169; Lee JY, 2014, INT J GYNECOL CANCER, V24, P289, DOI 10.1097/IGC.0000000000000063; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Miyake T, 2008, CANCER LETT, V261, P120, DOI 10.1016/j.canlet.2007.11.004; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Nout RA, 2012, GYNECOL ONCOL, V126, P466, DOI 10.1016/j.ygyno.2012.05.012; Ogita S, 2011, TARGET ONCOL, V6, P103, DOI 10.1007/s11523-011-0176-7; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Oosterhuis JW, 2003, NAT REV CANCER, V3, P73, DOI 10.1038/nrc973; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Rose PG, 2012, GYNECOL ONCOL, V125, P285, DOI 10.1016/j.ygyno.2012.03.010; Santarpia L, 2012, BREAST CANCER RES TR, V134, P333, DOI 10.1007/s10549-012-2035-3; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; Shinohara A, 2001, GYNECOL ONCOL, V82, P450, DOI 10.1006/gyno.2001.6298; Spaans VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093451; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tornesello ML, 2013, GYNECOL ONCOL, V128, P442, DOI 10.1016/j.ygyno.2012.11.017; Trietsch MD, 2014, GYNECOL ONCOL, V135, P149, DOI 10.1016/j.ygyno.2014.07.094; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; van Eijk R, 2013, EXP MOL PATHOL, V94, P121, DOI 10.1016/j.yexmp.2012.06.004; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634, DOI 10.2174/138161213804581837; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226; Wright AA, 2013, CANCER-AM CANCER SOC, V119, P3776, DOI 10.1002/cncr.28288; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	55	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133670	10.1371/journal.pone.0133670	http://dx.doi.org/10.1371/journal.pone.0133670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197069	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600131
J	Tan, XH; Gao, Y; Nan, YL; Zhang, JX; Di, CH; Wang, XB; Lian, FZ; Cao, YF; Hu, Y; Xu, LW; Ma, HY; Hong, Y; Liu, TJ; Wu, YY; Xu, XR; Yan, YT; Yang, L				Tan, Xiaohua; Gao, Yuan; Nan, Yulong; Zhang, Jinxia; Di, Chunhong; Wang, Xiaobo; Lian, Fuzhi; Cao, Yifei; Hu, Yu; Xu, Liangwen; Ma, Haiyan; Hong, Yu; Liu, Tingjie; Wu, Yinyin; Xu, Xianrong; Yan, Yutao; Yang, Lei			Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSI-SARCOMA; TUMOR-SUPPRESSOR; EXPRESSION; REACTIVATION; INFECTION; ESTABLISHMENT; INTERFERON; MODULATION; PREDICTION	Background Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is the etiologic agent of KS, the most common AIDS-related malignancy. The majority of KS tumor cells harbor latent KSHV virus but only a small percentage undergoes spontaneous lytic replication. Viral reactivation from latency is crucial for the pathogenesis and development of KS, but the cellular mechanisms underlying the switch between viral latency and replication are not well understood. Methods The level of let-7 miRNAs and MAP4K4 in KSHV infected 293T cells were quantified by real-time PCRs. Let-7 expression was silenced by the miRNA sponge technique. In let-7a transfected 293T cells, the expression of MAP4K4 was measured by real-time PCR and western blot. Luciferease expression was employed to examine the effect of let-7a on the 3'-untranslated region (UTR) of the MAP4K4 gene in 293T cells. Real-time PCR was used to quantify the KSHV copy numbers in BC-3 cells in which the expression of let-7a and/or MAP4K4 were altered. Finally, ERK, JNK and p38 protein production and their phosphorylation status were detected by western blots in let-7a or MAP4K4 transfected BCBL-1 cells. Results The expression of microRNA let-7 was dramatically decreased in KSHV infected 293T cells, but that of MAP4K4 was increased significantly. Let-7a is physically associated with and targets the MAP4K4 3'UTR, and inhibits MAP4K4 expression at both mRNA and protein levels. MAP4K4 stimulates KSHV reactivation from latency, whereas let-7a inhibits the function of MAP4K4 by reversing the function of MAP4K4 on JNK, phospho-JNK and phospho-ERK1/2 levels. Conclusion Our results establish that let-7a specifically suppresses MAP4K4 expression, and further inhibits KSHV reactivation by interfering with the function of MAP4K4 on the MAPK pathway, highlighting let-7a as a potential treatment for KS.	[Tan, Xiaohua; Gao, Yuan; Nan, Yulong; Zhang, Jinxia; Di, Chunhong; Wang, Xiaobo; Lian, Fuzhi; Cao, Yifei; Hu, Yu; Xu, Liangwen; Ma, Haiyan; Hong, Yu; Liu, Tingjie; Wu, Yinyin; Xu, Xianrong; Yan, Yutao; Yang, Lei] Hangzhou Normal Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Yang, L (corresponding author), Hangzhou Normal Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China.	yanglei62@hznu.edu.cn	ma, haiyan/GWQ-7425-2022; Lian, Fuzhi/F-9083-2015	Lian, Fuzhi/0000-0002-0733-579X	Natural Science Foundation of China [81071636, 81161120420]; International Cooperation Project of Zhe-Jiang Province [2009C14014]; Natural Science Foundation of Zhejiang Province [LY12H16028]; Program for Zhejiang Leading Team of Science and Technology Innovation [2011R50021]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Zhe-Jiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Program for Zhejiang Leading Team of Science and Technology Innovation	This work was supported by grants from the Natural Science Foundation of China (81071636, 81161120420), the International Cooperation Project of Zhe-Jiang Province (2009C14014), the Natural Science Foundation of Zhejiang Province (LY12H16028), and the Program for Zhejiang Leading Team of Science and Technology Innovation (2011R50021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bajaj BG, 2006, VIROLOGY, V351, P18, DOI 10.1016/j.virol.2006.03.037; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Catrina AM, 2014, PATHOL ONCOL RES, V20, P153, DOI 10.1007/s12253-013-9678-1; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cheng F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000324; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Chugh PE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003484; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Dillon PJ, 2013, CELL HOST MICROBE, V13, P204, DOI 10.1016/j.chom.2012.12.005; DiMaio TA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002424; Dittmer DP, 2003, CANCER RES, V63, P2010; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; Fu M, 2014, GENE, V536, P272, DOI 10.1016/j.gene.2013.12.012; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Haas DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003737; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang DG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00271; Lu CC, 2010, EMBO REP, V11, P784, DOI 10.1038/embor.2010.132; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Pozharskaya VP, 2004, J GEN VIROL, V85, P2779, DOI 10.1099/vir.0.80214-0; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Slack F, 2009, CELL CYCLE, V8, P1823, DOI 10.4161/cc.8.12.8639; Tan XH, 2014, J CUTAN PATHOL, V41, P630, DOI 10.1111/cup.12332; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wang JZ, 2005, J VIROL, V79, P2420, DOI 10.1128/JVI.79.4.2420-2431.2005; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Xie JP, 2005, J VIROL, V79, P15027, DOI 10.1128/JVI.79.24.15027-15037.2005; Yan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055832; Ye FC, 2007, J VIROL, V81, P3980, DOI 10.1128/JVI.02089-06; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044; Zhao G, 2013, MOL CANCER THER, V12, P83, DOI 10.1158/1535-7163.MCT-12-0534-T	42	15	16	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132148	10.1371/journal.pone.0132148	http://dx.doi.org/10.1371/journal.pone.0132148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197270	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600022
J	Bai, YT; Xu, ZG; Lu, B; Sun, QH; Tang, WG; Liu, XB; Yang, WZ; Xu, XY; Liu, QY				Bai, Yuntao; Xu, Zhiguang; Lu, Bo; Sun, Qinghua; Tang, Wenge; Liu, Xiaobo; Yang, Weizhong; Xu, Xinyi; Liu, Qiyong			Effects of Climate and Rodent Factors on Hemorrhagic Fever with Renal Syndrome in Chongqing, China, 1997-2008	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; HANTAVIRUS INFECTION; SYNDROME EPIDEMIC; TRANSMISSION; RESERVOIR; EUROPE; CITY; SURVEILLANCE; VARIABILITY; VARIABLES	China has the highest global incidence of hemorrhagic fever with renal syndrome (HFRS), constituting 90% of the cases in the world. Chongqing, located in the Three Gorges Reservoir Region, has been experiencing differences in the occurrence of HFRS from 1997 to 2008. The current study was designed to explore the effects of climate and rodent factors on the transmission of HFRS in Chongqing. Data on monthly HFRS cases, rodent strains, and climatic factors were collected from 1997 to 2008. Spatio-temporal analysis indicated that most HFRS cases were clustered in central Chongqing and that the incidence of HFRS decreased from 1997 to 2008. Poisson regression models showed that temperature (with lagged months of 0 and 5) and rainfall (with 2 lagged months) were key climatic factors contributing to the transmission of HFRS. A zero-inflated negative binomial model revealed that rodent density was also significantly associated with the occurrence of HFRS in the Changshou district. The monthly trend in HFRS incidence was positively associated with rodent density and rainfall and negatively associated with temperature. Possible mechanisms are proposed through which construction of the dam influenced the incidence of HFRS in Chongqing. The findings of this study may contribute to the development of early warning systems for the control and prevention of HFRS in the Three Gorges Reservoir Region.	[Bai, Yuntao; Sun, Qinghua] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Xu, Zhiguang; Xu, Xinyi] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Lu, Bo] Ohio State Univ, Div Biostat, Coll Publ Hlth, Columbus, OH 43210 USA; [Tang, Wenge] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Liu, Xiaobo; Yang, Weizhong; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Liu, Xiaobo; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yangwz@chinacdc.cn; xinyi@stat.osu.edu; liuqiyong@icdc.cn	Bai, Yuntao/S-8408-2016; Yang, Wei/HIA-0360-2022		National Basic Research Program of China (973 Program) [2012CB955504]; Special Research Program for Health [200802019]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID106]; Ohio State University Office of International Affairs Gateway Research Seed Grant; National Science Foundation [DMS-1209194]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Research Program for Health; State Key Laboratory for Infectious Disease Prevention and Control; Ohio State University Office of International Affairs Gateway Research Seed Grant; National Science Foundation(National Science Foundation (NSF))	This study was supported in part by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955504), the Special Research Program for Health (Grant No. 200802019), and the State Key Laboratory for Infectious Disease Prevention and Control (Grant No. 2014SKLID106) to Qiyong Liu; in part by the Ohio State University Office of International Affairs Gateway Research Seed Grant (2011) to Qinghua Sun; and in part by the National Science Foundation under award number DMS-1209194 to Xinyi Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084326; Bi P, 2003, JAMA-J AM MED ASSOC, V289, P176, DOI 10.1001/jama.289.2.176-d; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3; CHEN HX, 1994, CHINESE MED J-PEKING, V107, P107; CHEN HX, 1993, CHINESE MED J-PEKING, V106, P857; CLEMENT J, 1994, LANCET, V343, P114, DOI 10.1016/S0140-6736(94)90841-9; Cui F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067490; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; Haredasht SA, 2013, INT J ENV RES PUB HE, V10, P499, DOI 10.3390/ijerph10020499; LEE HW, 1989, PROG MED VIROL, V36, P62; Lin H, 2013, INT J BIOMETEOROL; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Michalski A, 2014, VECTOR-BORNE ZOONOT, V14, P514, DOI 10.1089/vbz.2013.1468; Papa A, 2006, EMERG INFECT DIS, V12, P1015, DOI 10.3201/eid1206.051564; Sleigh AC, 2001, LANCET, V357, P570, DOI 10.1016/S0140-6736(00)04072-1; Tersago K, 2009, EPIDEMIOL INFECT, V137, P250, DOI 10.1017/S0950268808000940; Tersago K, 2011, VECTOR-BORNE ZOONOT, V11, P715, DOI 10.1089/vbz.2010.0007; VERHAGEN R, 1986, ARCH VIROL, V91, P193, DOI 10.1007/BF01314280; Xiao H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002615; Xiao H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-305; Xiao H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002260; Xu XB, 2011, SCI TOTAL ENVIRON, V409, P4656, DOI 10.1016/j.scitotenv.2011.08.004; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Zalesny G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0457-y; Zhang Sheng, 2008, Huanjing Kexue, V29, P7; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang WY, 2009, AM J TROP MED HYG, V80, P678, DOI 10.4269/ajtmh.2009.80.678; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470	31	9	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133218	10.1371/journal.pone.0133218	http://dx.doi.org/10.1371/journal.pone.0133218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193359	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400066
J	Frigerio, A; Wright, K; Wooderchak-Donahue, W; Tan, OT; Margraf, R; Stevenson, DA; Grimmer, JF; Bayrak-Toydemir, P				Frigerio, Alice; Wright, Karol; Wooderchak-Donahue, Whitney; Tan, Oon T.; Margraf, Rebecca; Stevenson, David A.; Grimmer, J. Fredrik; Bayrak-Toydemir, Pinar			Genetic Variants Associated with Port-Wine Stains	PLOS ONE			English	Article							MALFORMATION-ARTERIOVENOUS MALFORMATION; STURGE-WEBER SYNDROME; RASA1 MUTATIONS; BLOOD-VESSELS; CAPILLARY; GNAQ	Background Port-wine stains (PWS) are capillary malformations, typically located in the dermis of the head and neck, affecting 0.3% of the population. Current theories suggest that port-wine stains are caused by somatic mutations that disrupt vascular development. Objectives Understanding PWS genetic determinants could provide insight into new treatments. Methods Our study used a custom next generation sequencing (NGS) panel and digital polymerase chain reaction to investigate genetic variants in 12 individuals with isolated port-wine stains. Importantly, affected and healthy skin tissue from the same individual were compared. A subtractive correction method was developed to eliminate background noise from NGS data. This allowed the detection of a very low level of mosaicism. Results A novel somatic variant GNAQ, c.547C>G, p.Arg183Gly was found in one case with 4% allele frequency. The previously reported GNAQ c.548G>A, p.Arg183Gln was confirmed in 9 of 12 cases with an allele frequency ranging from 1.73 to 7.42%. Digital polymerase chain reaction confirmed novel variants detected by next generation sequencing. Two novel somatic variants were also found in RASA1, although neither was predicted to be deleterious. Conclusions This is the second largest study on isolated, non-syndromic PWS. Our data suggest that GNAQ is the main genetic determinant in this condition. Moreover, isolated port-wine stains are distinct from capillary malformations seen in RASA1 disorders, which will be helpful in clinical evaluation.	[Frigerio, Alice; Tan, Oon T.] Harvard Univ, Carolyn & Peter Lynch Ctr Laser & Reconstruct Sur, Div Facial Plast & Reconstruct Surg,Sch Med, Dept Otol & Laryngol,Massachusetts Eye & Ear Infi, Boston, MA 02115 USA; [Wright, Karol; Wooderchak-Donahue, Whitney; Margraf, Rebecca; Bayrak-Toydemir, Pinar] ARUP, Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Wooderchak-Donahue, Whitney; Bayrak-Toydemir, Pinar] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Stevenson, David A.] Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; [Grimmer, J. Fredrik] Univ Utah, Dept Surg, Div Otolaryngol, Salt Lake City, UT USA	Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Stanford University; Utah System of Higher Education; University of Utah	Frigerio, A (corresponding author), Harvard Univ, Carolyn & Peter Lynch Ctr Laser & Reconstruct Sur, Div Facial Plast & Reconstruct Surg,Sch Med, Dept Otol & Laryngol,Massachusetts Eye & Ear Infi, Boston, MA 02115 USA.	alice_frigerio@meei.harvard.edu			Lynch Foundation, Boston, MA	Lynch Foundation, Boston, MA	This work was supported by a grant awarded by the Lynch Foundation, Boston, MA, to Dr. Oon T. Tan.	Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Frigerio A, 2014, LASER SURG MED, V46, P180, DOI 10.1002/lsm.22193; Frigerio A, 2012, CURR OPIN OTOLARYNGO, V20, P527, DOI 10.1097/MOO.0b013e3283587415; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; JACOBS AH, 1976, PEDIATRICS, V58, P218; Lian CG, 2014, JAMA DERMATOL, V150, P1336, DOI 10.1001/jamadermatol.2014.1244; Margraf Rebecca L, 2011, J Biomol Tech, V22, P74; Margraf Rebecca L, 2010, J Biomol Tech, V21, P126; Nakashima M, 2014, J HUM GENET, V59, P691, DOI 10.1038/jhg.2014.95; Revencu N, 2013, HUM MUTAT, V34, P1632, DOI 10.1002/humu.22431; Sanchez-Carpintero I, 2004, J AM ACAD DERMATOL, V50, P608, DOI 10.1016/j.jaad.2003.04.002; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; SMOLLER BR, 1986, ARCH DERMATOL, V122, P177, DOI 10.1001/archderm.122.2.177; Tan WB, 2014, J AM ACAD DERMATOL, V71, P964, DOI 10.1016/j.jaad.2014.07.025; Troilius Rubin A, 2015, J COSMET LASERTHER, V20, P1; Waelchli R, 2014, BRIT J DERMATOL, V171, P861, DOI 10.1111/bjd.13203; Wooderchak-Donahue WL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-50	20	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133158	10.1371/journal.pone.0133158	http://dx.doi.org/10.1371/journal.pone.0133158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192947	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400064
J	Renaud, S; Dufour, AB; Hardouin, EA; Ledevin, R; Auffray, JC				Renaud, Sabrina; Dufour, Anne-Beatrice; Hardouin, Emilie A.; Ledevin, Ronan; Auffray, Jean-Christophe			Once upon Multivariate Analyses: When They Tell Several Stories about Biological Evolution	PLOS ONE			English	Article							MOLAR SHAPE-ANALYSIS; HOUSE MOUSE; GEOMETRIC MORPHOMETRICS; LEAST RESISTANCE; MICE; DIVERGENCE; LINES; PATTERNS; RODENT; DIFFERENTIATION	Geometric morphometrics aims to characterize of the geometry of complex traits. It is therefore by essence multivariate. The most popular methods to investigate patterns of differentiation in this context are (1) the Principal Component Analysis (PCA), which is an eigenvalue decomposition of the total variance-covariance matrix among all specimens; (2) the Canonical Variate Analysis (CVA, a.k.a. linear discriminant analysis (LDA) for more than two groups), which aims at separating the groups by maximizing the between-group to withingroup variance ratio; (3) the between-group PCA (bgPCA) which investigates patterns of between-group variation, without standardizing by the within-group variance. Standardizing within-group variance, as performed in the CVA, distorts the relationships among groups, an effect that is particularly strong if the variance is similarly oriented in a comparable way in all groups. Such shared direction of main morphological variance may occur and have a biological meaning, for instance corresponding to the most frequent standing genetic variation in a population. Here we undertake a case study of the evolution of house mouse molar shape across various islands, based on the real dataset and simulations. We investigated how patterns of main variance influence the depiction of among-group differentiation according to the interpretation of the PCA, bgPCA and CVA. Without arguing about a method performing ` better' than another, it rather emerges that working on the total or between-group variance (PCA and bgPCA) will tend to put the focus on the role of direction of main variance as line of least resistance to evolution. Standardizing by the within-group variance (CVA), by dampening the expression of this line of least resistance, has the potential to reveal other relevant patterns of differentiation that may otherwise be blurred.	[Renaud, Sabrina; Dufour, Anne-Beatrice; Ledevin, Ronan] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Hardouin, Emilie A.] Max Planck Inst Evolut Biol, D-24306 Plon, Germany; [Hardouin, Emilie A.] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England; [Auffray, Jean-Christophe] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Max Planck Society; Bournemouth University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Renaud, S (corresponding author), Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	Sabrina.Renaud@univ-lyon1.fr	Dufour, Anne-Béatrice/I-9475-2016; Renaud, Sabrina/AAV-3141-2020; Auffray, Jean-Christophe/AAW-1052-2020; Auffray, jean-christophe/HCI-4881-2022; Auffray, Jean-Christophe/AAH-6131-2019; Renaud, Sabrina/D-4247-2009	Dufour, Anne-Béatrice/0000-0002-9339-4293; Renaud, Sabrina/0000-0002-8730-3113; Auffray, Jean-Christophe/0000-0002-5184-0507; Renaud, Sabrina/0000-0002-8730-3113	BIGTOOTH [ANR-11-BSV7-008]; Agence Nationale de la Recherche ECODEV [ANR-13-BSV7-005]; Agence Nationale de la Recherche	BIGTOOTH; Agence Nationale de la Recherche ECODEV(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR))	BIGTOOTH, grant ANR-11-BSV7-008 to SR, JCA and RL from the Agence Nationale de la Recherche ECODEV, grant ANR-13-BSV7-005 to SR, ABD and RL from the Agence Nationale de la Recherche.	Ackermann RR, 2004, P NATL ACAD SCI USA, V101, P17946, DOI 10.1073/pnas.0405919102; ADLER GH, 1994, Q REV BIOL, V69, P473, DOI 10.1086/418744; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; Begin M, 2003, EVOLUTION, V57, P1107; Berry RJ, 1996, PHILOS T R SOC B, V351, P753, DOI 10.1098/rstb.1996.0070; Boell L, 2013, EVOL DEV, V15, P197, DOI 10.1111/ede.12033; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.1111/j.1558-5646.1988.tb02514.x; Claude J, 2004, SYST BIOL, V53, P933, DOI 10.1080/10635150490889498; Cucchi T, 2008, J ARCHAEOL SCI, V35, P2953, DOI 10.1016/j.jas.2008.06.016; Cucchi T, 2006, HUMAN EVOLUTION, V21, P95, DOI DOI 10.1007/S11598-006-9011-Z; Cucchi T, 2014, EVOLUTION, V68, P2804, DOI 10.1111/evo.12476; Cucchi T, 2013, BIOL J LINN SOC, V108, P917, DOI 10.1111/bij.12004; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAVIS SJM, 1983, J ZOOL, V199, P521; Drake AG, 2010, AM NAT, V175, P289, DOI 10.1086/650372; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fadda C, 2001, J ZOOL SYST EVOL RES, V39, P235, DOI 10.1046/j.1439-0469.2001.00169.x; Firmat C, 2012, BIOL J LINN SOC, V105, P369, DOI 10.1111/j.1095-8312.2011.01802.x; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Gardner S, 2006, COMPUT STAT DATA AN, V50, P107, DOI 10.1016/j.csda.2004.07.020; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hallgrimsson B, 2006, EVOL DEV, V8, P61, DOI 10.1111/j.1525-142X.2006.05075.x; Hardouin EA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-325; Helvaci Z, 2012, BIOL J LINN SOC, V107, P611, DOI 10.1111/j.1095-8312.2012.01952.x; Hunt G, 2007, EVOLUTION, V61, P1560, DOI 10.1111/j.1558-5646.2007.00129.x; Ihle S, 2006, MOL BIOL EVOL, V23, P790, DOI 10.1093/molbev/msj096; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Jones EP, 2011, J ZOOL, V283, P257, DOI 10.1111/j.1469-7998.2010.00767.x; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Linnenbrink M, 2013, MOL ECOL, V22, P1904, DOI 10.1111/mec.12206; Marroig G, 2005, EVOLUTION, V59, P1128; Martinez-Abadias N, 2012, EVOLUTION, V66, P1010, DOI 10.1111/j.1558-5646.2011.01496.x; McGuigan K, 2005, AM NAT, V165, P32, DOI 10.1086/426600; Michaux J, 2007, J BIOGEOGR, V34, P1412, DOI 10.1111/j.1365-2699.2007.01701.x; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; NACHMAN MW, 1994, GENETICS, V136, P1105; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paradis MR, 2013, EVOL DEV, V15, P268, DOI 10.1111/ede.12026; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091944; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; PRAGER EM, 1993, BIOL J LINN SOC, V50, P85; R Core Team, 2021, R LANGUAGE ENV STAT; Rajabi-Maham H, 2008, MOL ECOL, V17, P627, DOI 10.1111/j.1365-294X.2007.03601.x; Rambaut A, 2009, FIGTREE VER 1 3 1; Renaud S, 2005, MAMM BIOL, V70, P157, DOI 10.1016/j.mambio.2004.10.004; Renaud S, 2013, J EVOLUTION IN PRESS; Renaud S, CAMBRIDGE S IN PRESS; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Renaud S, 2006, EVOLUTION, V60, P1701; Renaud S, 2013, HYSTRIX, V24, P85, DOI 10.4404/hystrix-24.1-6296; Renaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018951; Rodrigues HG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3504; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P201, DOI 10.1098/rspb.2008.0958; Siahsarvie R, 2012, BIOL J LINN SOC, V105, P635, DOI 10.1111/j.1095-8312.2011.01821.x; Staubach F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002891; Suzuki H, 2013, HEREDITY, V111, P375, DOI 10.1038/hdy.2013.60; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valenzuela-Lamas S, 2011, BIOL J LINN SOC, V102, P483, DOI 10.1111/j.1095-8312.2010.01603.x; Willmore KE, 2006, EVOL DEV, V8, P550, DOI 10.1111/j.1525-142X.2006.00127.x; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x	70	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132801	10.1371/journal.pone.0132801	http://dx.doi.org/10.1371/journal.pone.0132801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192946	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400040
J	Jathanna, D; Karanth, KU; Kumar, NS; Karanth, KK; Goswami, VR				Jathanna, Devcharan; Karanth, K. Ullas; Kumar, N. Samba; Karanth, Krithi K.; Goswami, Varun R.			Patterns and Determinants of Habitat Occupancy by the Asian Elephant in the Western Ghats of Karnataka, India	PLOS ONE			English	Article							RUHUNA-NATIONAL-PARK; LOXODONTA-AFRICANA; LANDSCAPE HETEROGENEITY; ESTIMATING ABUNDANCE; SPATIAL-DISTRIBUTION; RELATIVE ABUNDANCE; SPECIES OCCURRENCE; POPULATION-SIZE; SOUTHERN AFRICA; LARGE MAMMALS	Understanding species distribution patterns has direct ramifications for the conservation of endangered species, such as the Asian elephant Elephas maximus. However, reliable assessment of elephant distribution is handicapped by factors such as the large spatial scales of field studies, survey expertise required, the paucity of analytical approaches that explicitly account for confounding observation processes such as imperfect and variable detectability, unequal sampling probability and spatial dependence among animal detections. We addressed these problems by carrying out 'detection-non-detection' surveys of elephant signs across a c. 38,000-km(2) landscape in the Western Ghats of Karnataka, India. We analyzed the resulting sign encounter data using a recently developed modeling approach that explicitly addresses variable detectability across space and spatially dependent non-closure of occupancy, across sampling replicates. We estimated overall occupancy, a parameter useful to monitoring elephant populations, and examined key ecological and anthropogenic drivers of elephant presence. Our results showed elephants occupied 13,483 km(2) (SE = 847 km(2)) corresponding to 64% of the available 21,167 km(2) of elephant habitat in the study landscape, a useful baseline to monitor future changes. Replicate-level detection probability ranged between 0.56 and 0.88, and ignoring it would have underestimated elephant distribution by 2116 km(2) or 16%. We found that anthropogenic factors predominated over natural habitat attributes in determining elephant occupancy, underscoring the conservation need to regulate them. Human disturbances affected elephant habitat occupancy as well as site-level detectability. Rainfall is not an important limiting factor in this relatively humid bioclimate. Finally, we discuss cost-effective monitoring of Asian elephant populations and the specific spatial scales at which different population parameters can be estimated. We emphasize the need to model the observation and sampling processes that often obscure the ecological process of interest, in this case relationship between elephants to their habitat.	[Jathanna, Devcharan; Karanth, K. Ullas; Kumar, N. Samba; Karanth, Krithi K.; Goswami, Varun R.] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Karanth, K. Ullas; Kumar, N. Samba; Goswami, Varun R.] Wildlife Conservat Soc, India Program, Bangalore, Karnataka, India; [Karanth, K. Ullas; Karanth, Krithi K.] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA; [Karanth, Krithi K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Wildlife Conservation Society; Duke University	Goswami, VR (corresponding author), Ctr Wildlife Studies, Bangalore, Karnataka, India.	varunr.goswami@gmail.com	Kumar, Samba/ADR-7829-2022; Goswami, Varun R/AAE-8780-2019; Jathanna, Devcharan/AAL-9107-2020	Kumar, Samba/0000-0002-1226-8552; Goswami, Varun R/0000-0003-2575-7301; Jathanna, Devcharan/0000-0002-7962-4582	Vision Group on Science and Technology, Government of Karnataka [Vi Ya Ei 170 Vi Tra Ma 2010]; Department of Biotechnology, Government of India [BT/PR13854/BCE/08/809/2010]	Vision Group on Science and Technology, Government of Karnataka; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by a grant to the Centre for Wildlife Studies, Bangalore from Vision Group on Science and Technology, Government of Karnataka vide G.O. No. Vi Ya Ei 170 Vi Tra Ma 2010 dated 19-4-2011, and from Department of Biotechnology, Government of India vide No. BT/PR13854/BCE/08/809/2010 dated 10-1-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfred R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031400; Amstrup SC, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; BARNES RFW, 1982, J APPL ECOL, V19, P411, DOI 10.2307/2403476; Barnes RFW, 2002, AFR J ECOL, V40, P159, DOI 10.1046/j.1365-2028.2002.00362.x; Barnes RFW, 1997, AFR J ECOL, V35, P39, DOI 10.1111/j.1365-2028.1997.061-89061.x; Baskaran N., 2010, Gajah, V32, P6; Baskaran N., 1993, WEEK ELEPHANTS, P298; Biru Y, 2009, THESIS ADIS ABABA U; Bist S., 2003, GAJAH, V22, P67; Bist S S, 2006, GAJAH, V25, P27; Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Blake S., 2003, THESIS U EDINBURGH; Borowik T, 2013, EUR J WILDLIFE RES, V59, P675, DOI 10.1007/s10344-013-0720-0; Brandt PT, 2007, MSBVAR BAYESIAN VECT; Buckland S.T., 2001, pi; Buij R, 2007, BIOL CONSERV, V135, P189, DOI 10.1016/j.biocon.2006.10.028; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Daniels R. J. R., 2001, NATL BIODIVERS UNPUB; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; de Beer Y, 2008, J ARID ENVIRON, V72, P2017, DOI 10.1016/j.jaridenv.2008.07.002; de Silva S, 2011, BIOL CONSERV, V144, P1742, DOI 10.1016/j.biocon.2011.03.011; Diemer N., 2003, THESIS INT I GEOINFO; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Efron B., 1982, JACKNIFE BOOTSTRAP O; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Gaucherel C, 2010, J ZOOL, V280, P185, DOI 10.1111/j.1469-7998.2009.00652.x; Goswami VR, 2007, ANIM CONSERV, V10, P391, DOI 10.1111/j.1469-1795.2007.00124.x; Goswami VR, 2014, BIOL CONSERV, V177, P74, DOI 10.1016/j.biocon.2014.06.013; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Harris GM, 2008, ORYX, V42, P66, DOI 10.1017/S0030605308000483; Hedges S., 2012, MONITORING ELEPHANT, P61; Hedges S., 2012, MONITORING ELEPHANT; Hedges S, 2013, BIOL CONSERV, V159, P101, DOI 10.1016/j.biocon.2012.12.010; Hema EM, 2011, AFR J ECOL, V49, P141, DOI 10.1111/j.1365-2028.2010.01239.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines JE., 2006, PRESENCESOFTWARE EST; Hoare RE, 1999, CONSERV BIOL, V13, P633, DOI 10.1046/j.1523-1739.1999.98035.x; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jathanna D, 2015, BIOL CONSERV, V187, P212, DOI 10.1016/j.biocon.2015.04.030; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; KARANTH KU, 1992, J TROP ECOL, V8, P21, DOI 10.1017/S0266467400006040; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Krishnaswamy J, 2004, INT J REMOTE SENS, V25, P1185, DOI 10.1080/0143116031000149989; Krishnaswamy J, 2003, ECOCLIMATIC VEGETATI; Kumar MA, 2010, TROP CONSERV SCI, V3, P143, DOI 10.1177/194008291000300203; Kumar NS, 2011, THESIS MANIPAL U; Lakshminarayanan N, 2014, THESIS NATL CTR BIOL, P37; Leimgruber P, 2003, ANIM CONSERV, V6, P347, DOI 10.1017/S1367943003003421; Leuthold W., 1973, E AFR WILDL J, V11, P369; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Madhusudan MD, 2015, BIOL CONSERV, V187, P34, DOI 10.1016/j.biocon.2015.04.003; Martin J, 2010, ECOL APPL, V20, P1173, DOI 10.1890/09-0276.1; Menon V., 1997, GOD DISTRESS THREATS; Morley RC, 2007, J ZOOL, V271, P418, DOI 10.1111/j.1469-7998.2006.00225.x; MUELLERDOMBOIS D, 1972, ECOLOGY, V53, P208, DOI 10.2307/1934074; Mukeka JM, 2010, ANAL DISTRIBUTION AF; Murwira A, 2005, LANDSCAPE ECOL, V20, P217, DOI 10.1007/s10980-004-3159-6; Ntumi CP, 2005, S AFR J WILDL RES, V35, P139; OTTICHILO WK, 1986, AFR J ECOL, V24, P53, DOI 10.1111/j.1365-2028.1986.tb00342.x; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; R Development Core Team, 2012, R LANG ENV STAT COMP; Rangarajan M., 2010, GAJAH SECURING FUTUR; Redfern JV, 2002, THESIS U CALIFORNIA; Rood E, 2010, DIVERS DISTRIB, V16, P975, DOI 10.1111/j.1472-4642.2010.00704.x; Rota CT, 2011, ECOGRAPHY, V34, P659, DOI 10.1111/j.1600-0587.2010.06433.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; SANTIAPILLAI C, 1984, BIOL CONSERV, V29, P47, DOI 10.1016/0006-3207(84)90013-2; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098803; Sukumar R., 2012, REPORT KARNATAKA ELE; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Thomas B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003902; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; van Aarde RJ, 2007, BIOL CONSERV, V134, P289, DOI 10.1016/j.biocon.2006.08.027; Varma S, 2008, CURR SCI INDIA, V94, P501; VARMAN KS, 1995, J BIOSCIENCE, V20, P273, DOI 10.1007/BF02703274; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Young KD, 2009, AUSTRAL ECOL, V34, P329, DOI 10.1111/j.1442-9993.2009.01934.x	97	21	24	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133233	10.1371/journal.pone.0133233	http://dx.doi.org/10.1371/journal.pone.0133233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207378	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000068
J	Kim, IY; Kim, BR; Kim, YW				Kim, Ik Yong; Kim, Bo Ra; Kim, Young Wan			Impact of Prior Abdominal Surgery on Rates of Conversion to Open Surgery and Short-Term Outcomes after Laparoscopic Surgery for Colorectal Cancer	PLOS ONE			English	Article							MRC CLASICC TRIAL; RECTAL-CANCER; RESECTION; MULTICENTER; OPERATIONS; COLECTOMY	Purpose To evaluate the impact of prior abdominal surgery (PAS) on rates of conversion to open surgery and short-term outcomes after laparoscopic surgery for colon and rectal cancers. Methods We compared three groups as follows: colon cancer patients with no PAS (n = 272), major PAS (n = 24), and minor PAS (n = 33), and rectal cancer patients with no PAS (n = 282), major PAS (n = 16), and minor PAS (n = 26). Results In patients with colon and rectal cancers, the rate of conversion to open surgery was significantly higher in the major PAS group (25% and 25%) compared with the no PAS group (8.1% and 8.9%), while the conversion rate was similar between the no PAS and minor PAS groups (15.2% and 15.4%). The 30-day complication rate did not differ among the three groups (28.7% and 29.1% in the no PAS group, 29.2% and 25% in the major PAS group, and 27.3% and 26.9% in the minor PAS group). The mean operative time did not differ among the three groups (188 min and 227 min in the no PAS group, 191 min and 210 min in the major PAS group, and 192 min and 248 min in the minor PAS group). The rate of conversion to open surgery was significantly higher in patients with prior gastrectomy or colectomy compared with the no PAS group, while the conversion rate was similar between the no PAS group and patients with prior radical hysterectomy in patients with colon and rectal cancers. Conclusions Our results suggest that colorectal cancer patients with minor PAS or patients with prior radical hysterectomy can be effectively managed with a laparoscopic approach. In addition, laparoscopy can be selected as the primary surgical approach even in patients with major PAS (prior gastrectomy or colectomy) given the assumption of a higher conversion rate.	[Kim, Ik Yong; Kim, Young Wan] Yonsei Univ, Wonju Coll Med, Dept Surg, Div Gastrointestinal Surg, Wonju, South Korea; [Kim, Bo Ra] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Gastroenterol, Wonju, South Korea	Yonsei University; Yonsei University	Kim, YW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Surg, Div Gastrointestinal Surg, Wonju, South Korea.	youngwkim@yonsei.ac.kr						Allaix ME, 2013, SURG ENDOSC, V27, P4596, DOI 10.1007/s00464-013-3072-7; Aytac E, 2015, SURG ENDOSC, V29, P537, DOI 10.1007/s00464-014-3719-z; Barleben A, 2009, AM SURGEON, V75, P1015; Beck DE, 2000, DIS COLON RECTUM, V43, P1749, DOI 10.1007/BF02236862; Belizon A, 2006, SURG ENDOSC, V20, P947, DOI 10.1007/s00464-005-0553-3; Braga M, 2007, DIS COLON RECTUM, V50, P464, DOI 10.1007/s10350-006-0798-5; Chan ACY, 2008, SURG ENDOSC, V22, P2625, DOI 10.1007/s00464-008-9813-3; Coleman MG, 2000, DIS COLON RECTUM, V43, P1297, DOI 10.1007/BF02237441; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Franko Jan, 2006, JSLS, V10, P169; Gervaz P, 2001, SURG ENDOSC, V15, P827, DOI 10.1007/s004640080062; Gonzalez IA, 2006, SURG LAPARO ENDO PER, V16, P8, DOI 10.1097/01.sle.0000202188.57537.07; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Hamel CT, 2000, SURG ENDOSC-ULTRAS, V14, P853, DOI 10.1007/s004640000218; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Kim YW, 2010, SURG LAPARO ENDO PER, V20, P36, DOI 10.1097/SLE.0b013e3181cdb762; Kumar AS, 2013, SURG CLIN N AM, V93, P217, DOI 10.1016/j.suc.2012.09.006; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Law WL, 2005, SURG ENDOSC, V19, P326, DOI 10.1007/s00464-004-8114-8; Marks JH, 2008, SURG ENDOSC, V22, P1899, DOI 10.1007/s00464-008-9828-9; Miskovic D, 2012, DIS COLON RECTUM, V55, P1300, DOI 10.1097/DCR.0b013e31826ab4dd; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Offodile AC, 2008, DIS COLON RECTUM, V51, P1669, DOI 10.1007/s10350-008-9278-4; Swank DJ, 2003, SURG LAPARO ENDO PER, V13, P88, DOI 10.1097/00129689-200304000-00006; van der Voort M, 2004, BRIT J SURG, V91, P1253, DOI 10.1002/bjs.4716; Vignali A, 2007, Tech Coloproctol, V11, P241, DOI 10.1007/s10151-007-0358-6; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yamamoto M, 2013, DIS COLON RECTUM, V56, P336, DOI 10.1097/DCR.0b013e31827ba103	30	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134058	10.1371/journal.pone.0134058	http://dx.doi.org/10.1371/journal.pone.0134058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207637	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000199
J	Parke, HL; Epiphaniou, E; Pearce, G; Taylor, SJC; Sheikh, A; Griffiths, CJ; Greenhalgh, T; Pinnock, H				Parke, Hannah L.; Epiphaniou, Eleni; Pearce, Gemma; Taylor, Stephanie J. C.; Sheikh, Aziz; Griffiths, Chris J.; Greenhalgh, Trish; Pinnock, Hilary			Self-Management Support Interventions for Stroke Survivors: A Systematic Meta-Review	PLOS ONE			English	Review							CHRONIC DISEASE; OCCUPATIONAL-THERAPY; CASE-FATALITY; CARE; POPULATION; EFFICACY	Background There is considerable policy interest in promoting self-management in patients with long-term conditions, but it remains uncertain whether these interventions are effective in stroke patients. Design Systematic meta-review of the evidence for self-management support interventions with stroke survivors to inform provision of healthcare services. Methods We searched MEDLINE, EMBASE, CINAHL, PsychINFO, AMED, BNI, Database of Abstracts of Reviews for Effectiveness, and Cochrane Database of Systematic Reviews for systematic reviews of self-management support interventions for stroke survivors. Quality was assessed using the R-AMSTAR tool, and data extracted using a customised data extraction form. We undertook a narrative synthesis of the reviews' findings. Results From 12,400 titles we selected 13 systematic reviews (published 2003-2012) representing 101 individual trials. Although the term 'self-management' was rarely used, key elements of self-management support such as goal setting, action planning, and problem solving were core components of therapy rehabilitation interventions. We found high quality evidence that supported self-management in the context of therapy rehabilitation delivered soon after the stroke event resulted in short-term (<1 year) improvements in basic and extended activities of daily living, and a reduction in poor outcomes (dependence/death). There is some evidence that rehabilitation and problem solving interventions facilitated reintegration into the community. Conclusions Self-management terminology is rarely used in the context of stroke. However, therapy rehabilitation currently successfully delivers elements of self-management support to stroke survivors and their caregivers with improved outcomes. Future research should focus on managing the emotional, medical and social tasks of long-term survivorship.	[Parke, Hannah L.; Epiphaniou, Eleni; Taylor, Stephanie J. C.; Griffiths, Chris J.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Primary Care & Publ Hlth, mEsh, London, England; [Pearce, Gemma] Coventry Univ, CTEHR, Coventry, W Midlands, England; [Sheikh, Aziz; Pinnock, Hilary] Univ Edinburgh, Usher Inst Med Informat & Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Greenhalgh, Trish] Univ Oxford, Div Med Sci, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of London; Queen Mary University London; Coventry University; University of Edinburgh; University of Oxford	Pinnock, H (corresponding author), Univ Edinburgh, Usher Inst Med Informat & Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk	Greenhalgh, Trisha/B-1825-2015; TAYLOR, STEPHANIE/GYV-4768-2022	Greenhalgh, Trisha/0000-0003-2369-8088; Pearce, Gemma/0000-0002-2928-0048; Sheikh, Aziz/0000-0001-7022-3056; Taylor, Stephanie/0000-0001-7454-6354	National Institute for Health Research Health Services and Delivery Research Programme [11/1014/04]; Chief Scientist's Office of the Scottish Government; National Institute for Health Research [11/1014/04, NF-SI-0512-10031] Funding Source: researchfish	National Institute for Health Research Health Services and Delivery Research Programme; Chief Scientist's Office of the Scottish Government; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research Health Services and Delivery Research Programme (project number 11/1014/04. http://www.nets.nihr.ac.uk/projects/hsdr/11101404). The funders wrote the brief, called for applications, arranged peer review, and approved the study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. HP was supported at the time of the study by a Primary Care Research Career Award from the Chief Scientist's Office of the Scottish Government.	Adams K., 2004, I MED US COMMITTEE C; [Anonymous], 2010, MULT CHRON COND STRA; Aziz NA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005952.pub2; Bandura A., 1978, ADV BEHAV RES THER, V1, P139, DOI [10.1016/0146-6402(78)90002-4, DOI 10.1016/0146-6402(78)90002-4]; Beaglehole R., 2003, WORLD HLTH REPORT 20; Becker L. A., 2011, COCHRANE HDB SYSTEMA; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Corbin J. M., 1988, UNENDING WORK CARE M; Ellis G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005066.pub2; Expert Patients Programme, CONTR YOUR COND DONT; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Greveson G, 1991, Health Trends, V23, P161; Hoffmann T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006430.pub2; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Jones F, 2006, DISABIL REHABIL, V28, P841, DOI 10.1080/09638280500534952; Kennedy A, 2007, BMJ-BRIT MED J, V335, P968, DOI 10.1136/bmj.39372.540903.94; Ko H, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.037531; Korpershoek C, 2011, J ADV NURS, V67, P1876, DOI 10.1111/j.1365-2648.2011.05659.x; Kung Jason, 2010, Open Dent J, V4, P84, DOI 10.2174/1874210601004020084; Latham CAT., 2014, OCCUPATIONAL THERAPY; Lawrence Maggie, 2011, JBI Libr Syst Rev, V9, P1782; Legg LA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003585.pub2; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lui MHL, 2005, STROKE, V36, P2514, DOI 10.1161/01.STR.0000185743.41231.85; National Health Service, YOUR HLTH YOUR WAY Y; National Institute for Health and Clinical Excellence, 2008, MAN TYP 2 DIAB NICE; Outpatient Service Trialists, 2003, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002925; Poulin V, 2012, TOP STROKE REHABIL, V19, P158, DOI 10.1310/tsr1902-158; Rae-Grant AD, 2011, J REHABIL RES DEV, V48, P1087, DOI 10.1682/JRRD.2010.08.0159; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Royal College of Physicians Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Scottish Intercollegiate Guideline Network British Thoracic Society, 2008, THORAX S4, V63, pS1; Secretary of State for Health, 2006, OUR HLTH OUR CAR OUR; Smith J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub2; Steultjens EMJ, 2003, STROKE, V34, P676, DOI 10.1161/01.STR.0000057576.77308.30; Taylor SJC, 2014, HLTH SERV DELIV RES, V2, P54, DOI DOI 10.3310/HSDR02530; Walker MF, 2004, STROKE, V35, P2226, DOI 10.1161/01.STR.0000137766.17092.fb; WHO, 2002, INNOVATIVE CARE CHRO	38	73	74	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0131448	10.1371/journal.pone.0131448	http://dx.doi.org/10.1371/journal.pone.0131448			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NJ	26204266	Green Published, gold			2022-12-27	WOS:000358621000003
J	Yan, JY; Zhang, L; Sultana, N; Park, DS; Shekhar, A; Bu, L; Hu, J; Razzaque, S; Cai, CL				Yan, Jianyun; Zhang, Lu; Sultana, Nishat; Park, David S.; Shekhar, Akshay; Bu, Lei; Hu, Jun; Razzaque, Shegufta; Cai, Chen-Leng			A Murine Myh6(MerCreMer) Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; MYOSIN HEAVY-CHAIN; CRE-RECOMBINASE; TRANSGENIC MICE; SMOOTH-MUSCLE; EXPRESSION; MOUSE; CARDIOMYOPATHY; FAILURE; CELLS	A mouse model that mediates temporal, specific, and efficient myocardial deletion with Cre-LoxP technology will be a valuable tool to determine the function of genes during heart formation. Mhy6 encodes a cardiac muscle specific protein: alpha-myosin heavy chain. Here, we generated a new Myh6-MerCreMer (Myh6(MerCreMer/+)) inducible Cre knock-in mouse by inserting a MerCreMer cassette into the Myh6 start codon. By crossing knock-in mice with Rosa26 reporter lines, we found the Myh6(MerCreMer/+) mice mediate complete Cre-LoxP recombination in cardiomyocytes after tamoxifen induction. X-gal staining and immunohistochemistry analysis revealed that Myh6-driven Cre recombinase was specifically activated in cardiomyocytes at embryonic and adult stages. Furthermore, echocardiography showed that Myh6(MerCreMer/+) mice maintained normal cardiac structure and function before and after tamoxifen administration. These results suggest that the new Myh6(MerCreMer/+) mouse can serve as a robust tool to dissect the roles of genes in heart development and function. Additionally, myocardial progeny during heart development and after cardiac injury can be traced using this mouse line.	[Yan, Jianyun; Zhang, Lu; Sultana, Nishat; Hu, Jun; Razzaque, Shegufta; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Yan, Jianyun; Zhang, Lu; Sultana, Nishat; Hu, Jun; Razzaque, Shegufta; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Park, David S.; Shekhar, Akshay; Bu, Lei] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University	Cai, CL (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	chenleng.cai@mssm.edu	Yan, Jianyun/AAX-4510-2020	Yan, Jianyun/0000-0002-6962-1169; Razzaque, Shegufta/0000-0003-1220-5364; Shekhar, Akshay/0000-0002-9168-9987; BU, LEI/0000-0003-4476-2157	NHLBI [1R01HL095810, 1K02HL094688]; NYSTEM [C026426]; American Heart Association [15GRNT25710153]; March of Dimes Foundation [5-FY07-642]; NIH [T32 GM066704]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL094688, R01HL095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066704] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NYSTEM; American Heart Association(American Heart Association); March of Dimes Foundation(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants to C.L.C. from the NHLBI (1R01HL095810 and 1K02HL094688), NYSTEM (C026426), the American Heart Association (15GRNT25710153) and the March of Dimes Foundation (5-FY07-642), and to A.S. from NIH T32 GM066704 (Bach). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SR, 2014, P NATL ACAD SCI USA, V111, P8850, DOI 10.1073/pnas.1408233111; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; Bruneau BG, 2014, CIRC RES, V114, P598, DOI 10.1161/CIRCRESAHA.113.303060; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Cai XQ, 2013, DEVELOPMENT, V140, P3176, DOI 10.1242/dev.092502; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gelb BD, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013953; Hall ME, 2011, AM J PHYSIOL-HEART C, V301, pH253, DOI 10.1152/ajpheart.00786.2010; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hougen K, 2010, AM J PHYSIOL-HEART C, V299, pH1671, DOI 10.1152/ajpheart.01155.2009; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Jaisser F, 2000, J AM SOC NEPHROL, V11, pS95; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Koyanagi M, 2007, CIRC RES, V101, P1139, DOI 10.1161/CIRCRESAHA.107.151381; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Mack CP, 1999, CIRC RES, V84, P852; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Molkentin JD, 2009, J MOL CELL CARDIOL, V46, P130, DOI 10.1016/j.yjmcc.2008.09.002; Nemir M, 2014, EUR HEART J, V35, P2174, DOI 10.1093/eurheartj/ehs269; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; Park EJ, 2008, DEV DYNAM, V237, P447, DOI 10.1002/dvdy.21415; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pinkert CA., 2002, TRANSGENIC ANIMAL TE; Posch MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028872; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Robbins J, 2004, J MOL CELL CARDIOL, V36, P643, DOI 10.1016/j.yjmcc.2004.02.012; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Tsuchihashi T, 2011, DEV BIOL, V351, P62, DOI 10.1016/j.ydbio.2010.12.023; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wolf M, 2010, CURR OPIN CARDIOL, V25, P192, DOI 10.1097/HCO.0b013e328337b4ce; Wu BR, 2010, GENESIS, V48, P63, DOI 10.1002/dvg.20573; Xie LL, 2012, DEV CELL, V23, P280, DOI 10.1016/j.devcel.2012.06.006; Yan JY, 2015, GENESIS, V53, P377, DOI 10.1002/dvg.22861; Yan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104503; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133472	10.1371/journal.pone.0133472	http://dx.doi.org/10.1371/journal.pone.0133472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204265	Green Submitted, Green Published, gold			2022-12-27	WOS:000358621000031
J	Bellinger, MR; Banks, MA; Bates, SJ; Crandall, ED; Garza, JC; Sylvia, G; Lawson, PW				Bellinger, M. Renee; Banks, Michael A.; Bates, Sarah J.; Crandall, Eric D.; Garza, John Carlos; Sylvia, Gil; Lawson, Peter W.			Geo-Referenced, Abundance Calibrated Ocean Distribution of Chinook Salmon (Oncorhynchus tshawytscha) Stocks across the West Coast of North America	PLOS ONE			English	Article							PACIFIC SALMON; COHO SALMON; TEMPORAL PATTERNS; BRITISH-COLUMBIA; GENETIC DATA; IDENTIFICATION; CALIFORNIA; MANAGEMENT; FISHERIES; DNA	Understanding seasonal migration and localized persistence of populations is critical for effective species harvest and conservation management. Pacific salmon (genus Oncorhynchus) forecasting models predict stock composition, abundance, and distribution during annual assessments of proposed fisheries impacts. Most models, however, fail to account for the influence of biophysical factors on year-to-year fluctuations in migratory distributions and stock-specific survival. In this study, the ocean distribution and relative abundance of Chinook salmon (O. tshawytscha) stocks encountered in the California Current large marine ecosystem, U.S. A were inferred using catch-per-unit effort (CPUE) fisheries and genetic stock identification data. In contrast to stock distributions estimated through coded-wire-tag recoveries (typically limited to hatchery salmon), stock-specific CPUE provides information for both wild and hatchery fish. Furthermore, in contrast to stock composition results, the stock-specific CPUE metric is independent of other stocks and is easily interpreted over multiple temporal or spatial scales. Tests for correlations between stock-specific CPUE and stock composition estimates revealed these measures diverged once proportional contributions of locally rare stocks were excluded from data sets. A novel aspect of this study was collection of data both in areas closed to commercial fisheries and during normal, open commercial fisheries. Because fishing fleet efficiency influences catch rates, we tested whether CPUE differed between closed area (non-retention) and open area (retention) data sets. A weak effect was indicated for some, but not all, analyzed cases. Novel visualizations produced from stock-specific CPUE-based ocean abundance facilitates consideration of how highly refined, spatial and genetic information could be incorporated in ocean fisheries management systems and for investigations of biogeographic factors that influence migratory distributions of fish.	[Bellinger, M. Renee; Banks, Michael A.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA; [Bates, Sarah J.] Calif Salmon Council, Oakland, CA USA; [Crandall, Eric D.; Garza, John Carlos] Natl Marine Fisheries Serv, Natl Oceanog & Atmospher Adm, Southwest Fisheries Sci Ctr, Santa Cruz, CA USA; [Garza, John Carlos] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Sylvia, Gil] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Appl Econ, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA; [Lawson, Peter W.] Natl Marine Fisheries Serv, Natl Oceanog & Atmospher Adm, Northwest Fisheries Sci Ctr, Newport, OR USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Bellinger, MR (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA.	reneebellinger@gmail.com	CRANDALL, EDWARD/AAD-8382-2020	Crandall, Eric/0000-0001-8580-3651	National Oceanic and Atmospheric Administration (NOAA); NOAA [NA07NMF4540337]; California Salmon Council;  [NA07NMF4540337 NA08NMF4720662 NA09NMF4720381];  [NA08NMF4270421]	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); California Salmon Council; ; 	This study was designed and conducted as an industry-science collaboration between industry partners California Salmon Council and OregonSalmon Commission and scientific investigators affiliated with academic and federal institutions. Major funding originated from the National Oceanic and Atmospheric Administration (NOAA). Funds were awarded to Nancy Fitzpatrick, Oregon Salmon Commission and David Goldenberg, California Salmon Council NA07NMF4540337 NA08NMF4720662 NA09NMF4720381, Saltonstall Kennedy Grant Program NA08NMF4270421. NOAA scientists and university scientists were co-Principal Investigators on all major grants except the Saltonstall-Kennedy Grant (University only). Pacific States Marine Fisheries Commission acted via contract with NOAA to help distribute Klamath Disaster funds (NA07NMF4540337) to the states. The California Salmon Council and Oregon Salmon Commission helped to facilitate the industry partnership and distributed funds to industry for their participation in at-sea sampling and data collection. The California Salmon Council provided support in the form of salary for author SJB, who was hired to manage California at-sea sample collections and contribute to manuscript preparation. The specific role of this author is articulated in the 'author contributions' section.	Allison P.D., 2008, P SAS GLOBAL FORUM, V360, P1; Anderson EC, 2008, CAN J FISH AQUAT SCI, V65, P1475, DOI 10.1139/F08-049; Beacham TD, 2004, CONSERV GENET, V5, P411, DOI 10.1023/B:COGE.0000031140.41379.73; BEACHAM TD, 2012, DYNAMICS MANAGE ECOS, P1, DOI DOI 10.1080/19425120.2011.649391; Beacham TD, 2008, N AM J FISH MANAGE, V28, P849, DOI 10.1577/M06-167.1; Beacham TD, 2006, T AM FISH SOC, V135, P861, DOI 10.1577/T05-241.1; Clemento AJ, 2011, MOL ECOL RESOUR, V11, P50, DOI 10.1111/j.1755-0998.2010.02972.x; Clemento AJ, 2014, FISH B-NOAA, V112, P112, DOI 10.7755/FB.112.2-3.2; Dann TH, 2013, CAN J FISH AQUAT SCI, V70, P785, DOI 10.1139/cjfas-2012-0449; Drenner SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031311; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Garza JC, CALIFORNIA GENETIC S; GRANT WS, 1980, CAN J FISH AQUAT SCI, V37, P1236, DOI 10.1139/f80-159; Heard William R., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P77; Hedgecock D., 2001, APPLICATIONS OF POPU, V179, P45; Hess JE, 2011, MOL ECOL RESOUR, V11, P137, DOI 10.1111/j.1755-0998.2010.02958.x; Hinke JT, 2005, MAR ECOL PROG SER, V285, P181, DOI 10.3354/meps285181; Hobday AJ, 2001, CAN J FISH AQUAT SCI, V58, P2021, DOI 10.1139/cjfas-58-10-2021; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JEFFERTS KB, 1963, NATURE, V198, P460, DOI 10.1038/198460a0; Johnson KJ, 2004, REGIONAL OVERVIEW OF; Kalinowsi ST, 2007, ONCOR A COMPUTER PRO; Kallio-Nyberg I, 1999, CAN J FISH AQUAT SCI, V56, P853, DOI 10.1139/cjfas-56-5-853; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; MCDONALD J, 1981, CAN J FISH AQUAT SCI, V38, P1657, DOI 10.1139/f81-214; MILNER GB, 1985, MAR FISH REV, V47, P1; Moran P, 2013, CAN J FISH AQUAT SCI, V70, P415, DOI 10.1139/cjfas-2012-0135; Natural Resources Consultants Inc. Northwest Emergency Assistance Plan at-sea Research Programs, 1998, FINAL REPORT; O'Malley KG, 2013, EVOL APPL, V6, P1184, DOI 10.1111/eva.12095; Pacific Fishery Management Council, 2010, PRESEASON REPORT III; Pacific Fishery Management Council A, 2007, FISHERIES REGULATION; Park SDE, 2001, THESIS; Pearcy WG, 1992, OCEAN ECOLOGY OF NOR; Peyronnet A, 2008, J FISH BIOL, V73, P945, DOI 10.1111/j.1095-8649.2008.01984.x; Satterthwaite WH, 2013, CAN J FISH AQUAT SCI, V70, P574, DOI 10.1139/cjfas-2012-0395; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; Shaklee JB, 1999, FISH RES, V43, P45, DOI 10.1016/S0165-7836(99)00066-1; Shaul Leon, 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P93; Steele CA, 2013, CAN J FISH AQUAT SCI, V70, P1046, DOI 10.1139/cjfas-2012-0451; Theriault V, 2011, MOL ECOL, V20, P1860, DOI 10.1111/j.1365-294X.2011.05058.x; Tufte ER, 1986, THE VISUAL DISPLAY O; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 2008, EVOL APPL, V1, P189, DOI 10.1111/j.1752-4571.2008.00023.x; Waples RS, 2001, J FISH BIOL, V59, P1, DOI 10.1006/jfbi.2001.1764; Weitkamp LA, 2010, T AM FISH SOC, V139, P147, DOI 10.1577/T08-225.1; Wells BK, 2008, FISH OCEANOGR, V17, P101, DOI 10.1111/j.1365-2419.2008.00467.x; Wessa P., 2012, FREE STATISTICS SOFT; Winans Gary A., 2001, Reviews in Fisheries Science, V9, P213, DOI 10.1080/20016491101753	50	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131276	10.1371/journal.pone.0131276	http://dx.doi.org/10.1371/journal.pone.0131276			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200779	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100013
J	Krypotos, AM; Arnaudova, I; Effting, M; Kindt, M; Beckers, T				Krypotos, Angelos-Miltiadis; Arnaudova, Inna; Effting, Marieke; Kindt, Merel; Beckers, Tom			Effects of Approach-Avoidance Training on the Extinction and Return of Fear Responses	PLOS ONE			English	Article							AUTOMATIC ACTION-TENDENCIES; HUMANS; REINSTATEMENT; ALCOHOL	Background and Objectives Exposure therapy for anxiety involves confronting a patient with fear-evoking stimuli, a procedure based partially on Pavlovian extinction. Exposure and other extinction-based therapies usually lead to (partial) reduction of fear symptoms, but a substantial number of patients experience a return of fear after treatment. Here we tested whether the combination of fear extinction with modification of approach-avoidance tendencies using an Approach-Avoidance Task (AAT) would result in the further reduction of conditioned fear and/or help prevent return of fear after extinction. Methods Two groups of participants underwent a fear acquisition procedure during which pictures of one neutral object were sometimes paired with shock (CS+), whereas pictures of another neutral object were not (CS-). The next day, in a fear extinction procedure, both objects were presented without shock. During the subsequent joystick AAT, one group primarily pulled CS+ pictures towards themselves and pushed CS- pictures away from themselves; reversed contingencies applied for the other group. Results Approach training was effective in modifying conditioned action tendencies, with some evidence for transfer to a different approach/avoidance task. No group differences in subjective fear or physiological arousal were found during subsequent post-training and return-of-fear testing. Limitations No reliable return-of-fear was observed in either group for either subjective or physiological fear measures. Conclusions Our results suggest that approach training may be of limited value for enhancing the short- and long-term effects of extinction-based interventions.	[Krypotos, Angelos-Miltiadis; Arnaudova, Inna; Effting, Marieke; Kindt, Merel; Beckers, Tom] Univ Amsterdam, Dept Clin Psychol, NL-1018 XA Amsterdam, Netherlands; [Krypotos, Angelos-Miltiadis; Arnaudova, Inna; Effting, Marieke; Kindt, Merel; Beckers, Tom] Amsterdam Brain & Cognit Ctr, Amsterdam, Netherlands; [Beckers, Tom] Katholieke Univ Leuven, Dept Psychol, Leuven, Belgium	University of Amsterdam; KU Leuven	Beckers, T (corresponding author), Univ Amsterdam, Dept Clin Psychol, Weesperplein 4, NL-1018 XA Amsterdam, Netherlands.	tom.beckers@uva.nl	Beckers, Tom/C-6164-2008; Krypotos, Angelos-Miltiadis/ABD-1739-2020	Beckers, Tom/0000-0002-9581-1505; Krypotos, Angelos-Miltiadis/0000-0001-9704-6520; Arnaudova, Inna/0000-0002-4837-9780	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek; NWO) [452-09-001]	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek; NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by Innovation Scheme (Vidi) Grant 452-09-001 of the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek; NWO) awarded to TB. During the first stages of the study, AMK was a scholar of the Alexander S. Onassis Public Benefit Foundation (FZE 039/2011-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2013, EMOTION, V13, P478, DOI 10.1037/a0030443; Barlow D. H., 2002, ANXIETY AND ITS DISO; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Craske MG., 1999, ANXIETY DISORDERS PS; Craske MG, 2008, BEHAV RES THER, V46, P5, DOI 10.1016/j.brat.2007.10.003; Dirikx T, 2004, LEARN MEMORY, V11, P549, DOI 10.1101/lm.78004; Frijda NH, 2010, BIOL PSYCHOL, V84, P570, DOI 10.1016/j.biopsycho.2010.01.005; Haaker J, 2014, LEARN MEMORY, V21, P424, DOI 10.1101/lm.036053.114; Hofmann W, 2010, PSYCHOL BULL, V136, P390, DOI 10.1037/a0018916; Huijding J, 2009, BEHAV RES THER, V47, P471, DOI 10.1016/j.brat.2009.02.011; Krieglmeyer R, 2010, COGNITION EMOTION, V24, P810, DOI 10.1080/02699930903047298; Krypotos AM, 2014, CLIN PSYCHOL SCI, V2, P336, DOI 10.1177/2167702613503139; Lang P. J., 1985, ANXIETY ANXIETY DISO, P131; Milad MR, 2006, BEHAV NEUROSCI, V120, P1196, DOI 10.1037/0735-7044.120.5.1196; Neumann R, 2003, PSYCHOLOGY OF EVALUATION, P371; Peterson RA., 1992, ANXIETY SENSITIVITY; Sevenster D, 2012, PSYCHOPHYSIOLOGY, V49, P1426, DOI 10.1111/j.1469-8986.2012.01450.x; Spielberger C. D., 1970, STAI MANUAL FOR THE; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Taylor CT, 2012, BEHAV RES THER, V50, P529, DOI 10.1016/j.brat.2012.05.004; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; Woud ML, 2013, J COGN PSYCHOL, V25, P738, DOI 10.1080/20445911.2013.817413	25	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131581	10.1371/journal.pone.0131581	http://dx.doi.org/10.1371/journal.pone.0131581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200111	Green Submitted, gold, Green Published			2022-12-27	WOS:000358597100017
J	Allareddy, V; Rampa, S; Nalliah, RP; Martinez-Schlurmann, NI; Lidsky, KB; Allareddy, V; Rotta, AT				Allareddy, Veerajalandhar; Rampa, Sankeerth; Nalliah, Romesh P.; Martinez-Schlurmann, Natalia I.; Lidsky, Karen B.; Allareddy, Veerasathpurush; Rotta, Alexandre T.			Prevalence and Predictors of Gastrostomy Tube and Tracheostomy Placement in Anoxic/Hypoxic Ischemic Encephalopathic Survivors of In-Hospital Cardiopulmonary Resuscitation in the United States	PLOS ONE			English	Article							CARDIAC-ARREST; INSURANCE STATUS; MECHANICAL VENTILATION; COMATOSE SURVIVORS; CARE; OUTCOMES; MORTALITY; ILLNESS; END; EPIDEMIOLOGY	Introduction Current prevalence estimates of gastrostomy tube (GT)/tracheostomy placement in hospitalized patients with anoxic/hypoxic ischemic encephalopathic injury (AHIE) post cardiopulmonary resuscitation (CPR) are unknown. We sought, to estimate the prevalence of AHIE in hospitalized patients who had CPR and to identify patient/hospital level factors that predict the performance of GT/tracheostomy in those with AHIE. Methods We performed a retrospective analysis of the Nationwide Inpatient Sample (years 20042010). All patients who developed AHIE following CPR were included. In this cohort the odds of having GT and tracheostomy was computed by multivariable logistic regression analysis. Patient and hospital level factors were the independent variables. Results During the study period, a total of 686,578 CPR events occurred in hospitalized patients. Of these, 94,336 (13.7%) patients developed AHIE. In this AHIE cohort, 6.8% received GT and 8.3% tracheostomy. When compared to the 40-49 yrs age group, those aged >70 yrs were associated with lower odds for GT (OR = 0.65, 95% CI:0.53-0.80, p<0.0001). Those aged <18 years & those >60 years were associated with lower odds for having tracheostomy when compared to the 40-49 years group (p<0.0001). Each one unit increase in co-morbid burden was associated with higher odds for having GT (OR = 1.23, p<0.0001) or tracheostomy (OR = 1.17, p<0.0001). Blacks, Hispanics, Asians/Pacific Islanders, and other races were associated with higher odds for having GT or tracheostomy when compared to whites (p<0.05). Hospitals located in northeastern regions were associated with higher odds for performing GT (OR = 1.48, p<0.0001) or tracheostomy (OR = 1.63, p<0.0001) when compared to those in Western regions. Teaching hospitals (TH) were associated with higher odds for performing tracheostomy when compared to non-TH (OR = 1.36, 1.20-1.54, p<0.0001). Conclusions AHIE injury occurs in a significant number of in-hospital arrests requiring CPR. Certain predictors of GT/Tracheostomy placement are identified. Patients in teaching hospitals were more likely to receive tracheostomy than their counterparts.	[Allareddy, Veerajalandhar; Martinez-Schlurmann, Natalia I.; Lidsky, Karen B.; Rotta, Alexandre T.] Case Western Reserve Univ, UH Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Rampa, Sankeerth] Univ Nebraska, Hlth Serv & Res Dept, Omaha, NE 68182 USA; [Nalliah, Romesh P.] Univ Michigan, Coll Dent, Ann Arbor, MI 48109 USA; [Allareddy, Veerasathpurush] Univ Iowa, Sch Dent, Coll Dent & Dent Clin, Iowa City, IA USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Nebraska System; University of Michigan System; University of Michigan; University of Iowa	Allareddy, V (corresponding author), Case Western Reserve Univ, UH Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA.	Veerajalandhar.Allareddy@UHhospitals.org	Nalliah, Romesh/AAV-2016-2020	Nalliah, Romesh/0000-0002-6287-0656; Rotta, Alexandre/0000-0002-4406-2276				Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; Alosh H, 2009, SPINE, V34, P1956, DOI 10.1097/BRS.0b013e3181ab930e; Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Edelson DP, 2008, ARCH INTERN MED, V168, P1063, DOI 10.1001/archinte.168.10.1063; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Fowler RA, 2010, AM J RESP CRIT CARE, V181, P1003, DOI 10.1164/rccm.200902-0281ST; GARRETT JM, 1993, J GEN INTERN MED, V8, P361, DOI 10.1007/BF02600073; Girotra S, 2013, CIRC-CARDIOVASC QUAL, V6, P42, DOI 10.1161/CIRCOUTCOMES.112.967968; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Goldberger ZD, 2012, LANCET, V380, P1473, DOI 10.1016/S0140-6736(12)60862-9; Healthcare Cost and Utilization Project (HCUP), 2004, HCUP NAT INP SAMPL N; Hunt EA, 2008, PEDIATRICS, V121, pE34, DOI 10.1542/peds.2007-0029; International Classification of Diseases, 9 REV CLIN MOD ICD 9; JENNETT B, 1975, LANCET, V1, P480; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kazaure HS, 2013, RESUSCITATION, V84, P1255, DOI 10.1016/j.resuscitation.2013.02.021; Khuri SF, 2001, ANN SURG, V234, P370, DOI 10.1097/00000658-200109000-00011; Kokoska ER, 2007, J SURG RES, V137, P83, DOI 10.1016/j.jss.2006.06.020; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lyon SM, 2011, AM J RESP CRIT CARE, V184, P809, DOI 10.1164/rccm.201101-0089OC; Matos RI, 2013, CIRCULATION, V127, P442, DOI 10.1161/CIRCULATIONAHA.112.125625; Mebane EW, 1999, J AM GERIATR SOC, V47, P579, DOI 10.1111/j.1532-5415.1999.tb02573.x; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Muni S, 2011, CHEST, V139, P1025, DOI 10.1378/chest.10-3011; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nelson JE, 2006, ARCH INTERN MED, V166, P1993, DOI 10.1001/archinte.166.18.1993; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Patil SP, 2003, ARCH INTERN MED, V163, P1180, DOI 10.1001/archinte.163.10.1180; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Periyakoil VS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122321; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; Sandroni C, 2007, INTENS CARE MED, V33, P237, DOI 10.1007/s00134-006-0326-z; Scheinhorn DJ, 2007, CHEST, V131, P76, DOI 10.1378/chest.06-1079; Skinner J, 2003, NEW ENGL J MED, V349, P1350, DOI 10.1056/NEJMsa021569; Slonim AD, 1997, CRIT CARE MED, V25, P1951, DOI 10.1097/00003246-199712000-00008; Suominen P, 2000, RESUSCITATION, V45, P17, DOI 10.1016/S0300-9572(00)00167-2; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zilberberg MD, 2008, CRIT CARE MED, V36, P724, DOI 10.1097/CCM.0B013E31816536F7	44	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132612	10.1371/journal.pone.0132612	http://dx.doi.org/10.1371/journal.pone.0132612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197229	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600042
J	Fellows, IE; Morris, M; Birnbaum, JK; Dombrowski, JC; Buskin, S; Bennett, A; Golden, MR				Fellows, Ian E.; Morris, Martina; Birnbaum, Jeanette K.; Dombrowski, Julia C.; Buskin, Susan; Bennett, Amy; Golden, Matthew R.			A New Method for Estimating the Number of Undiagnosed HIV Infected Based on HIV Testing History, with an Application to Men Who Have Sex with Men in Seattle/King County, WA	PLOS ONE			English	Article								We develop a new approach for estimating the undiagnosed fraction of HIV cases, the first step in the HIV Care Cascade. The goal is to address a critical blindspot in HIV prevention and treatment planning, with an approach that simplifies data requirements and can be implemented with open-source software. The primary data required is HIV testing history information on newly diagnosed cases. Two methods are presented and compared. The first is a general methodology based on simplified back-calculation that can be used to assess changes in the undiagnosed fraction over time. The second makes an assumption of constant incidence, allowing the estimate to be expressed as a simple closed formula calculation. We demonstrate the methods with an application to HIV diagnoses among men who have sex with men (MSM) from Seattle/King County. The estimates suggest that 6% of HIV-infected MSM in King County are undiagnosed, about one-third of the comparable national estimate. A sensitivity analysis on the key distributional assumption gives an upper bound of 11%. The undiagnosed fraction varies by race/ethnicity, with estimates of 4.9% among white, 8.6% of African American, and 9.3% of Hispanic HIV-infected MSM being undiagnosed.	[Fellows, Ian E.] Fellows Stat, San Diego, CA USA; [Morris, Martina] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Birnbaum, Jeanette K.] Univ Washington, Ctr AIDS Res, Seattle, WA 98195 USA; [Dombrowski, Julia C.; Golden, Matthew R.] Univ Washington, Sch Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Buskin, Susan; Bennett, Amy] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Buskin, Susan; Golden, Matthew R.] Publ Hlth Seattle King Cty, HIV AIDS Program, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Morris, M (corresponding author), Univ Washington, Dept Sociol, Seattle, WA 98195 USA.	morrism@uw.edu	Golden, Matthew/AAE-4314-2020		NIH [P30 AI027757]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH P30 AI027757.	[Anonymous], 2010, NAT HIV AIDS STRAT U; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Chen Mi, 2012, MMWR Suppl, V61, P57; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; [HIV/AIDS Epidemiology Unit PHSKC and the Infectious Disease and Reproductive Health Assessment Unit WSDoH Health PH-SKCaWSDo], 2013, HIV AIDS EP REP 2 HA; Lodwick R, 2011, AIDS, V25, P1017, DOI 10.1097/QAD.0b013e3283467087; LUI KJ, 1986, P NATL ACAD SCI USA, V83, P3051, DOI 10.1073/pnas.83.10.3051; Marzinke MA, 2013, CLIN INFECT DIS; Mugavero MJ, 2013, CLIN INFECT DIS; R Studio, 2014, SHIN WEB APPL FRAM; Sanchez TH, 2012, LACK AWARENESS HIV I, V2012; Skar H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060906; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201	14	8	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0129551	10.1371/journal.pone.0129551	http://dx.doi.org/10.1371/journal.pone.0129551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196132	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600005
J	Getty, CM; Dilger, RN				Getty, Caitlyn M.; Dilger, Ryan N.			Moderate Perinatal Choline Deficiency Elicits Altered Physiology and Metabolomic Profiles in the Piglet	PLOS ONE			English	Article							COGNITIVE FUNCTION; DIETARY CHOLINE; BRAIN GROWTH; PHOSPHATIDYLCHOLINE; SUPPLEMENTATION; PREGNANCY; CARNITINE; DEPLETION; SOWS; AGE	Few studies have evaluated the impact of dietary choline on the health and well-being of swine, and those pivotal papers were aimed at determining dietary requirements for sows and growing pigs. This is of importance as the piglet is becoming a widely accepted model for human infant nutrition, but little is known about the impacts of perinatal choline status on overall health and metabolism of the growing piglet. In the present study, sows were provided either a choline deficient (CD, 625 mg choline/kg dry matter) or choline sufficient (CS, 1306 mg choline/kg dry matter) diet for the last 65 d of gestation (prenatal intervention). Piglets were weaned from the sow 48 h after farrowing and provided either a CD (477 mg choline/kg dry matter) or CS (1528 mg choline/kg dry matter) milk replacer (postnatal intervention) for 29 +/- 2 d, resulting in a factorial arrangement of 4 treatment (prenatal/postnatal) groups: CS/CS, CS/CD, CD/CS, and CD/CD. Piglet growth was normal for artificially-reared piglets, and was not impacted by perinatal choline status. Piglets receiving the postnatal CD treatment had lower (P < 0.01) plasma choline and choline-containing phospholipid concentrations and higher (P < 0.05) liver enzyme (alkaline phosphatase and gamma-glutamyl transferase) values compared with piglets receiving the postnatal CS treatment. Hepatic lipid content of piglets receiving the postnatal CD treatment was higher (P < 0.01) compared with piglets receiving the postnatal CS treatment. Additionally, postnatally CD piglets had lower (P = 0.01) plasma cholesterol than postnatally CS piglets. Brain development was also impacted by perinatal choline status, with brains of piglets exposed to prenatal CD being smaller (P = 0.01) than those of prenatally CS piglets. These findings support the hypothesis that the piglet is a sensitive model for choline deficiency during the perinatal period. In the present study, piglets exhibited similarities in health markers and metabolomic profiles to rodents and humans when exposed to moderate choline deficiency.	[Getty, Caitlyn M.; Dilger, Ryan N.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Getty, Caitlyn M.; Dilger, Ryan N.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Getty, Caitlyn M.] Univ Illinois, Coll Vet Med, Urbana, IL 61801 USA; [Dilger, Ryan N.] Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Dilger, RN (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	rdilger2@illinois.edu		Dilger, Ryan/0000-0003-2538-2845	United States Department of Agriculture National Institute of Food and Agriculture, Hatch project [0224124]	United States Department of Agriculture National Institute of Food and Agriculture, Hatch project	This work was supported by the United States Department of Agriculture National Institute of Food and Agriculture, Hatch project 0224124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; CARTER AL, 1978, J NUTR, V108, P1748, DOI 10.1093/jn/108.11.1748; Cheatham CL, 2012, AM J CLIN NUTR, V96, P1465, DOI 10.3945/ajcn.112.037184; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Conrad MS, 2012, PEDIATR RES, V71, P179, DOI 10.1038/pr.2011.21; CORREDOR C, 1967, BIOCHIM BIOPHYS ACTA, V144, P366, DOI 10.1016/0005-2760(67)90165-8; da Costa KA, 2011, AM J CLIN NUTR, V93, P968, DOI 10.3945/ajcn.110.011064; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Donovan SM, 1997, J NUTR BIOCHEM, V8, P603, DOI 10.1016/S0955-2863(97)00115-0; Elmore MR, 2012, ANIM COGN; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Institute of Medicine aNAoSU, 1998, DIET REF INT FOL THI; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Jakob S, 1998, Z ERNAHRUNGSWISS, V37, P353, DOI 10.1007/s003940050036; Jensen LJ, 2007, FASEB J, V21, pA519; KORNEGAY ET, 1973, J ANIM SCI, V37, P506, DOI 10.2527/jas1973.372506x; Matrenza C, 2004, J PSYCHOPHARMACOL, V18, P21, DOI 10.1177/0269881104040215; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Michel V, 2011, FOOD FUNCT, V2, P53, DOI 10.1039/c0fo00069h; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Moughan P J, 1992, World Rev Nutr Diet, V67, P40; NRC, 2012, 2012 NUTR REQ SWIN; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Pacelli C, 2010, J NUTR, V140, P1072, DOI 10.3945/jn.109.116673; [Pond WGaXGL Southern LaLL], 2001, OF PIGS AND PEOPL; Pyapali GK, 1998, J NEUROPHYSIOL, V79, P1790, DOI 10.1152/jn.1998.79.4.1790; Rytych JL, 2012, J NUTR, V142, P2050, DOI 10.3945/jn.112.165522; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; STOCKLAND WL, 1974, J ANIM SCI, V39, P1113, DOI 10.2527/jas1974.3961113x; Wu GC, 2012, J APPL MATH, DOI 10.1155/2012/102850; Yan J, 2013, AM J CLIN NUTR, V98, P1459, DOI 10.3945/ajcn.113.066092; Yan J, 2012, AM J CLIN NUTR, V95, P1060, DOI 10.3945/ajcn.111.022772; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061	36	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133500	10.1371/journal.pone.0133500	http://dx.doi.org/10.1371/journal.pone.0133500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196148	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600105
J	Liang, MM; Adisetiyo, H; Liu, XQ; Liu, R; Gill, P; Roy-Burman, P; Jones, JO; Mulholland, DJ				Liang, Mengmeng; Adisetiyo, Helty; Liu, Xiuqing; Liu, Ren; Gill, Parkash; Roy-Burman, Pradip; Jones, Jeremy O.; Mulholland, David J.			Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model	PLOS ONE			English	Article							TARGET GENES; CELL-LINES; RESISTANCE; GROWTH; ENZALUTAMIDE; PROGRESSION; THERAPY; AR-V7	Androgen receptor (AR) variants are associated with resistance to anti androgen therapy both in human prostate cancer cell lines and clinical samples. These observations support the hypothesis that AR isoform accumulation is a consequence of selective therapeutic pressure on the full length AR. The Pten deficient prostate cancer model proceeds with well-defined kinetics including progression to castration resistant prostate cancer (CRPC). While surgical castration and enzalutamide treatments yield an initial therapeutic response, Pten(-/-)epithelia continue to proliferate yielding locally invasive primary tumor pathology. That most epithelium remains AR positive, but ligand independent, suggests the presence of oncogenic AR variants. To address this hypothesis, we have used a panel of recently described Pten(-/-)tumor cell lines derived from both from hormone intact (E4, E8) and castrated Pten mutants (cE1, cE2) followed by RACE PCR to identify and characterize three novel truncated, amino terminus containing AR variants (mAR-Va, b, c). Variants appear not only conserved throughout progression but are correlated with nearly complete loss of full length AR (AR-FL) at castrate androgen levels. The overexpression of variants leads to enhanced transcriptional activity of AR while knock down studies show reduced transcriptional output. Collectively, the identification of truncated AR variants in the conditional PTEN deletion model supports a role for maintaining the CRPC phenotype and provides further therapeutic applications of this preclinical model.	[Liang, Mengmeng; Mulholland, David J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Adisetiyo, Helty] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Liu, Xiuqing] St Lukes Hosp, Internal Med Resident, Chesterfield, MO USA; [Liu, Ren; Gill, Parkash] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Roy-Burman, Pradip] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Jones, Jeremy O.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	Icahn School of Medicine at Mount Sinai; Children's Hospital Los Angeles; Saint Luke's Hospital - Missouri; University of Southern California; University of Southern California; City of Hope; Beckman Research Institute of City of Hope	Jones, JO (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA.	jjones@coh.org; david.mulholland@mssm.edu			NIH grant [RO1CA059705]; PCF Young Investigator Award; Icahn School of Medicine Cancer Research Funds; NATIONAL CANCER INSTITUTE [R01CA059705, R01CA197910] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCF Young Investigator Award; Icahn School of Medicine Cancer Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant RO1CA059705 to PR, the PCF Young Investigator Award and Icahn School of Medicine Cancer Research Funds awarded to DJM.	Agoulnik IU, 2006, J CELL BIOCHEM, V99, P362, DOI 10.1002/jcb.20811; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haile S, 2011, CELL MOL LIFE SCI, V68, P3971, DOI 10.1007/s00018-011-0766-7; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jia SD, 2013, CANCER DISCOV, V3, P44, DOI 10.1158/2159-8290.CD-12-0262; Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202; Knudsen KE, 2011, EXPERT REV ENDOCRINO, V6, P483, DOI 10.1586/EEM.11.33; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Liao CP, 2010, CANCER RES, V70, P7294, DOI 10.1158/0008-5472.CAN-09-3982; Liao Chun-Peng, 2010, Hormones & Cancer, V1, P44, DOI 10.1007/s12672-009-0005-y; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Pham LK, 2013, ENDOCR-RELAT CANCER, V20, P861, DOI 10.1530/ERC-13-0100; Qu YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07654; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Yang X, 2011, J BIOL CHEM, V286, P36152, DOI 10.1074/jbc.M111.265124	36	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131232	10.1371/journal.pone.0131232	http://dx.doi.org/10.1371/journal.pone.0131232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196517	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600008
J	Molinaro, R; Pecli, C; Guilherme, RF; Alves-Filho, JC; Cunha, FQ; Canetti, C; Kunkel, SL; Bozza, MT; Benjamim, CF				Molinaro, Raphael; Pecli, Cyntia; Guilherme, Rafael F.; Alves-Filho, Jose Carlos; Cunha, Fernando Q.; Canetti, Claudio; Kunkel, Steven L.; Bozza, Marcelo T.; Benjamim, Claudia F.			CCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis	PLOS ONE			English	Article							MURINE POLYMICROBIAL SEPSIS; CHEMOKINE RECEPTOR 4; NITRIC-OXIDE; NEUTROPHIL MIGRATION; SEPTIC SHOCK; PULMONARY-FIBROSIS; IMMUNE DYSFUNCTION; TUMOR-GROWTH; FAILURE; EXPRESSION	Sepsis is a deadly disease characterized by an overwhelming release of inflammatory mediators and the activation of different types of cells. This altered state of cell activation, termed leukocyte reprogramming, contributes to patient outcome. However, the understanding of the process underlying sepsis and the role of regulatory T cells (Tregs) in sepsis remains to be elucidated. In this study, we investigated the role of CCR4, the CCL17/CCL22 chemokine receptor, in the innate and acquired immune responses during severe sepsis and the role of Tregs in effecting the outcome. In contrast with wild-type (WT) mice subjected to cecal ligation and puncture (CLP) sepsis, CCR4-deficient (CCR4(-/-)) septic mice presented an increased survival rate, significant neutrophil migration toward the infection site, a low bacterial count in the peritoneum, and reduced lung inflammation and serum cytokine levels. Thus, a better early host response may favor an adequate long-term response. Consequently, the CCR4(-/-) septic mice were not susceptible to secondary fungal infection, in contrast with the WT septic mice. Furthermore, Tregs cells from the CCR4(-/-) septic mice showed reduced suppressive effects on neutrophil migration (both in vivo and in vitro), lymphocyte proliferation and ROS production from activated neutrophils, in contrast with what was observed for Tregs from the WT septic mice. These data show that CCR4 is involved in immunosuppression after severe sepsis and suggest that CCR4(+) Tregs negatively modulate the short and long-term immune responses.	[Molinaro, Raphael; Pecli, Cyntia; Guilherme, Rafael F.; Benjamim, Claudia F.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, RJ, Brazil; [Alves-Filho, Jose Carlos; Cunha, Fernando Q.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, Ribeirao Preto, SP, Brazil; [Canetti, Claudio] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil; [Kunkel, Steven L.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Imunol, BR-21941 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; University of Michigan System; University of Michigan; Universidade Federal do Rio de Janeiro	Benjamim, CF (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, RJ, Brazil.	cbenjamim@icb.ufrj.br	Alves-Filho, Jose Carlos/B-5814-2008; Cunha, Fernando Q/M-3090-2014; Claudio, Canetti A/C-2774-2009; Benjamim, Claudia/T-5090-2019	Alves-Filho, Jose Carlos/0000-0002-9918-8714; Benjamim, Claudia/0000-0001-6247-9596; Pecli, Cyntia/0000-0003-0129-3514; Cunha, Fernando Queiroz/0000-0003-4755-1670; Bozza, Marcelo/0000-0003-3683-7550	Universal- CNPq; APQ1- FAPERJ; CAPES	Universal- CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); APQ1- FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding provided by Universal- CNPq, APQ1- FAPERJ and Fellowship - CAPES.	Alves-Filho J. C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P151; Annane D, 2009, CRIT CARE MED, V37, pS117, DOI 10.1097/CCM.0b013e318192078b; Baatar D, 2007, J IMMUNOL, V178, P4891, DOI 10.4049/jimmunol.178.8.4891; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Benjamim CF, 2002, INFECT IMMUN, V70, P3602, DOI 10.1128/IAI.70.7.3602-3610.2002; Benjamim CF, 2000, J INFECT DIS, V182, P214, DOI 10.1086/315682; Benjamim CF, 2005, BLOOD, V105, P3588, DOI 10.1182/blood-2004-08-3251; BONE RC, 1992, CHEST, V101, P320, DOI 10.1378/chest.101.2.320; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Cavaillon JM, 2005, J ENDOTOXIN RES, V11, P311, DOI 10.1179/096805105X58733; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Cuenca AG, 2010, BLOOD, V115, P4324, DOI 10.1182/blood-2010-03-271379; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Doerschug KC, 2004, CRIT CARE MED, V32, P489, DOI 10.1097/01.CCM.0000109450.66450.23; Guilherme RF, 2013, AM J RESP CELL MOL, V49, P1029, DOI 10.1165/rcmb.2012-0462OC; HOYT DB, 1988, J SURG RES, V45, P342, DOI 10.1016/0022-4804(88)90129-1; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Inoue T, 2004, EUR RESPIR J, V24, P49, DOI 10.1183/09031936.04.00110203; Ishii M, 2008, EUR J IMMUNOL, V38, P2290, DOI 10.1002/eji.200838360; Jakubzick C, 2004, AM J PATHOL, V165, P1211, DOI 10.1016/S0002-9440(10)63381-0; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Katoh S, 2003, ALLERGY, V58, P518, DOI 10.1034/j.1398-9995.2003.00149.x; Kim SH, 2002, J CLIN INVEST, V110, P1675, DOI 10.1172/JCI200215547; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kox WJ, 2000, INTENS CARE MED, V26, pS124, DOI 10.1007/s001340051129; Landelle C, 2008, INFECT CONT HOSP EP, V29, P1054, DOI 10.1086/591859; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lewkowicz P, 2006, J IMMUNOL, V177, P7155, DOI 10.4049/jimmunol.177.10.7155; LIN RY, 1993, CHEST, V104, P847, DOI 10.1378/chest.104.3.847; Margry B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088869; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Nascimento DC, 2010, CRIT CARE MED, V38, P1718, DOI 10.1097/CCM.0b013e3181e78ad0; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Ness TL, 2006, J IMMUNOL, V177, P7531, DOI 10.4049/jimmunol.177.11.7531; NISHIJIMA MK, 1986, CRIT CARE MED, V14, P87, DOI 10.1097/00003246-198602000-00002; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Paula-Neto HA, 2011, SHOCK, V35, P17, DOI 10.1097/SHK.0b013e3181e37ea8; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Rios-Santos F, 2007, AM J RESP CRIT CARE, V175, P490, DOI 10.1164/rccm.200601-103OC; Rudensky AY, 2006, J EXP MED, V203, P489, DOI 10.1084/jem.20060214; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Scumpia PO, 2007, BLOOD, V110, P3673, DOI 10.1182/blood-2007-04-087171; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017; Torres-Duenas D, 2006, SHOCK, V25, P267, DOI 10.1097/01.shk.0000208804.34292.38; Traeger T, 2008, INFECT IMMUN, V76, P5285, DOI 10.1128/IAI.00310-08; Valenca SS, 2004, TOXICOL PATHOL, V32, P351, DOI 10.1080/01926230490431466; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Weighardt H, 2000, SURGERY, V127, P309, DOI 10.1067/msy.2000.104118; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Wysocka M, 2001, J IMMUNOL, V166, P7504, DOI 10.4049/jimmunol.166.12.7504; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; ZHANG XK, 1993, J LEUKOCYTE BIOL, V54, P444, DOI 10.1002/jlb.54.5.444	61	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133227	10.1371/journal.pone.0133227	http://dx.doi.org/10.1371/journal.pone.0133227			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197455	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600074
J	Powell, JSV; Babbitt, KJ				Powell, Jessica S. Veysey; Babbitt, Kimberly J.			An Experimental Test of Buffer Utility as a Technique for Managing Pool-Breeding Amphibians	PLOS ONE			English	Article							SALAMANDERS AMBYSTOMA-MACULATUM; TERRESTRIAL HABITAT USE; FROG RANA-SYLVATICA; SPOTTED SALAMANDERS; WOOD FROG; POSTBREEDING EMIGRATION; FOREST MANAGEMENT; RETURN RATES; POND; CONSERVATION	Vegetated buffers are used extensively to manage wetland-dependent wildlife. Despite widespread application, buffer utility has not been experimentally validated for most species. To address this gap, we conducted a six-year, landscape-scale experiment, testing how buffers of different widths affect the demographic structure of two amphibian species at 11 ephemeral pools in a working forest of the northeastern U.S. We randomly assigned each pool to one of three treatments (i.e., reference, 100m buffer, 30m buffer) and clearcut to create buffers. We captured all spotted salamanders and wood frogs breeding in each pool and examined the impacts of treatment and hydroperiod on breeding-population abundance, sex ratio, and recapture rate. The negative effects of clearcutting tended to increase as forest-buffer width decreased and be strongest for salamanders and when other stressors were present (e.g., at short-hydroperiod pools). Recapture rates were reduced in the 30m, but not 100m, treatment. Throughout the experiment for frogs, and during the first year post-cut for salamanders, the predicted mean proportion of recaptured adults in the 30m treatment was only 62% and 40%, respectively, of that in the reference treatment. Frog sex ratio and abundance did not differ across treatments, but salamander sex ratios were increasingly male-biased in both cut treatments. By the final year, there were on average, only about 40% and 65% as many females predicted in the 100m and 30m treatments, respectively, compared to the first year. Breeding salamanders at short-hydroperiod pools were about 10% as abundant in the 100m versus reference treatment. Our study demonstrates that buffers partially mitigate the impacts of habitat disturbance on wetland-dependent amphibians, but buffer width and hydroperiod critically mediate that process. We provide the first experimental evidence showing that 30-m-wide buffers may be insufficient for maintaining resilient breeding populations of pool-dependent amphibians, at least during the first six years post-disturbance.	[Powell, Jessica S. Veysey; Babbitt, Kimberly J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Powell, JSV (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	jss4@unh.edu		Veysey Powell, Jessica/0000-0002-6706-9075	National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service [2003-35101-12922, 2007-35101-18281]; Northeastern States Research Cooperative; Robert and Patricia Switzer Foundation; University of New Hampshire Graduate School; University of New Hampshire Cooperative Extension; New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture McIntire-Stennis Project [0226124]	National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Northeastern States Research Cooperative; Robert and Patricia Switzer Foundation; University of New Hampshire Graduate School; University of New Hampshire Cooperative Extension; New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture McIntire-Stennis Project	This work was supported by grants to KJB from the National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service (http://www.csrees.usda.gov/funding/rfas/nri_rfa.html) grant numbers: 2003-35101-12922 and 2007-35101-18281; and the Northeastern States Research Cooperative (http://nsrcforest.org/). The project was also supported by fellowships to JSVP from the Robert and Patricia Switzer Foundation (http://www.switzernetwork.org/) the University of New Hampshire Graduate School (http://www.gradschool.unh.edu/), and the University of New Hampshire Cooperative Extension (http://extension.unh.edu/). Partial funding was provided by a grant to KJB from the New Hampshire Agricultural Experiment Station (http://www.colsa.unh.edu/aes). This is Scientific Contribution number: 2593. This work was also supported by the USDA National Institute of Food and Agriculture McIntire-Stennis Project, accession number: 0226124. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JH, 2007, VERMONT J ENV LAW, V56; [Anonymous], 2015, US DROUGHT MON; ARNOLD SJ, 1976, Z TIERPSYCHOL, V42, P247; Babbitt KJ, 2003, CAN J ZOOL, V81, P1539, DOI 10.1139/Z03-131; Bailey LL, 2004, ECOLOGY, V85, P2456, DOI 10.1890/03-0539; Baldwin RF, 2006, CAN J ZOOL, V84, P1604, DOI 10.1139/Z06-146; Baldwin RF, 2006, J HERPETOL, V40, P442, DOI 10.1670/0022-1511(2006)40[442:CPFASW]2.0.CO;2; Barber KN, 1997, GLCX1 NAT RES CAN CA; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bauer DM, 2010, ECOL APPL, V20, P798, DOI 10.1890/08-2209.1; BERVEN KA, 1981, EVOLUTION, V35, P707, DOI 10.1111/j.1558-5646.1981.tb04931.x; BERVEN KA, 1988, COPEIA, P605, DOI 10.2307/1445378; BERVEN KA, 1995, AUST J ECOL, V20, P385, DOI 10.1111/j.1442-9993.1995.tb00554.x; BERVEN KA, 1982, EVOLUTION, V36, P962, DOI 10.1111/j.1558-5646.1982.tb05466.x; BERVEN KA, 1990, EVOLUTION, V44, P2047, DOI 10.1111/j.1558-5646.1990.tb04310.x; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Berven KA, 2009, COPEIA, P328, DOI 10.1643/CH-08-052; BLANCHARD FRANK N., 1933, COPEIA, V1933, P216, DOI 10.2307/1435562; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Broadmeadow S, 2004, HYDROL EARTH SYST SC, V8, P286, DOI 10.5194/hess-8-286-2004; Brodman R, 1996, COPEIA, P372, DOI 10.2307/1446853; BULL JJ, 1979, AM NAT, V114, P296, DOI 10.1086/283476; Calhoun A.J.K., 2002, FORESTRY HABITAT MAN; Caruso G, 2007, REG SCI URBAN ECON, V37, P542, DOI 10.1016/j.regsciurbeco.2007.01.005; CASTELLE AJ, 1994, J ENVIRON QUAL, V23, P878, DOI 10.2134/jeq1994.00472425002300050004x; Chase VP, 1997, BUFFERS WETLANDS SUR; Church DR, 2007, ECOLOGY, V88, P891, DOI 10.1890/06-0896; Cline BB, 2014, J APPL ECOL, V51, P319, DOI 10.1111/1365-2664.12197; Coster SS, 2013, THESIS U NEW HAMPSHI; Coster SS, HERPETOLOGI IN PRESS; Coster SS, 2015, MOL ECOL, V24, P742, DOI 10.1111/mec.13062; Cotton S, 2009, CONSERV BIOL, V23, P196, DOI 10.1111/j.1523-1739.2008.01053.x; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Dodd Jr C. K., 1994, MEASURING MONITORING, P125; Egan RS, 2004, WETLANDS, V24, P1, DOI 10.1672/0277-5212(2004)024[0001:WPAOBW]2.0.CO;2; ENGE KM, 1986, FOREST ECOL MANAG, V14, P177, DOI 10.1016/0378-1127(86)90116-7; Faccio SD, 2003, J HERPETOL, V37, P479, DOI 10.1670/155-02A; Ferner John W., 2010, P123; Finkler MS, 2013, COPEIA, P338, DOI 10.1643/CP-11-076; Finkler MS, 2003, COPEIA, P887, DOI 10.1643/h203-110.1; FLAGEOLE S, 1992, CAN J ZOOL, V70, P740, DOI 10.1139/z92-108; Freeman RC, 2012, WETLANDS, V32, P509, DOI 10.1007/s13157-012-0284-x; Freidenfelds NA, 2011, FOREST ECOL MANAG, V261, P2115, DOI 10.1016/j.foreco.2011.03.005; Gabrielsen CG, 2013, CONSERV GENET, V14, P1083, DOI 10.1007/s10592-013-0497-4; Gamble LR, 2006, WETLANDS, V26, P298, DOI 10.1672/0277-5212(2006)26[298:LORBZF]2.0.CO;2; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; Goates MC, 2007, BIOL CONSERV, V138, P474, DOI 10.1016/j.biocon.2007.05.016; Graeter GJ, 2008, J WILDLIFE MANAGE, V72, P473, DOI 10.2193/2006-330; Grayson KL, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-24; Harper EB, 2008, CONSERV BIOL, V22, P1205, DOI 10.1111/j.1523-1739.2008.01015.x; Harper EB, 2007, OECOLOGIA, V153, P879, DOI 10.1007/s00442-007-0796-x; Harris RN, 2004, ECOLOGY, V85, P1585, DOI 10.1890/03-0492; Hector KL, 2012, J ANIM ECOL, V81, P583, DOI 10.1111/j.1365-2656.2011.01942.x; Heinen J. T., 2000, Journal of Environment & Development, V9, P45; Homan RN, 2007, J HERPETOL, V41, P401, DOI 10.1670/0022-1511(2007)41[401:CLHOTS]2.0.CO;2; Homan RN, 2003, J HERPETOL, V37, P617; HOWARD RD, 1985, EVOLUTION, V39, P260, DOI 10.1111/j.1558-5646.1985.tb05665.x; Husting E. L., 1965, Copeia, V1965, P352, DOI 10.2307/1440800; Johnston B, 2002, CAN J ZOOL, V80, P2170, DOI 10.1139/Z02-213; Kinkead KE, 2007, HERPETOLOGICA, V63, P151, DOI 10.1655/0018-0831(2007)63[151:ESSAAP]2.0.CO;2; Knapp SM, 2003, CONSERV BIOL, V17, P752, DOI 10.1046/j.1523-1739.2003.02061.x; Lee P, 2004, J ENVIRON MANAGE, V70, P165, DOI 10.1016/j.jenvman.2003.11.009; Lovell ST, 2006, AGR ECOSYST ENVIRON, V112, P249, DOI 10.1016/j.agee.2005.08.002; Madison DM, 1997, J HERPETOL, V31, P542, DOI 10.2307/1565607; Mangel M, 2005, AM NAT, V166, pE155, DOI 10.1086/444439; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; Mayer PM, 2007, J ENVIRON QUAL, V36, P1172, DOI 10.2134/jeq2006.0462; McCarthy MA, 2004, J APPL ECOL, V41, P780, DOI 10.1111/j.0021-8901.2004.00919.x; McCarthy MA, 2009, J HERPETOL, V43, P394, DOI 10.1670/08-096R2.1; Miller A, 2001, THESIS N DAKOTA STAT; Montieth KE, 2006, J HERPETOL, V40, P195, DOI 10.1670/130-04A.1; Morey S, 2001, ECOLOGY, V82, P510, DOI 10.2307/2679876; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Parris KM, 2001, AMPHIBIA-REPTILIA, V22, P275, DOI 10.1163/156853801317050070; Parris MJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P526; Patrick DA, 2008, ECOLOGY, V89, P2563, DOI 10.1890/07-0906.1; Patrick DA, 2008, BIOL CONSERV, V141, P807, DOI 10.1016/j.biocon.2007.12.026; Pechmann J.H.K., 1989, Wetlands Ecology and Management, V1, P3; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Penman T. D., 2008, Endangered Species Research, V5, P45, DOI 10.3354/esr00111; Peterson CE, 2009, FOREST ECOL MANAG, V258, P409, DOI 10.1016/j.foreco.2008.12.029; Petranka JW, 2004, ECOL APPL, V14, P1065, DOI 10.1890/02-5394; Pinheiro J, 2001, MIXED EFFECTS MODELS; Popescu VD, 2012, FOREST ECOL MANAG, V270, P163, DOI 10.1016/j.foreco.2012.01.027; Popescu VD, 2011, ECOL APPL, V21, P1283, DOI 10.1890/10-0658.1; R Core Team, 2011, R LANG ENV STAT COMP; Regosin JV, 2005, J WILDLIFE MANAGE, V69, P1481, DOI 10.2193/0022-541X(2005)69[1481:VITHUB]2.0.CO;2; Regosin JV, 2004, COPEIA, P152, DOI 10.1643/CE-02-119R2; Regosin JV, 2003, CAN J ZOOL, V81, P596, DOI 10.1139/Z03-046; Regosin JV, 2003, J HERPETOL, V37, P390, DOI 10.1670/0022-1511(2003)037[0390:THUAWD]2.0.CO;2; Renken RB, 2004, CONSERV BIOL, V18, P174, DOI 10.1111/j.1523-1739.2004.00312.x; RIDEM Rhode Island Department of Environmental Management, 2010, RUL REG GOV ADM ENF; Riffell S, 2011, FOREST ECOL MANAG, V261, P878, DOI 10.1016/j.foreco.2010.12.021; Rittenhouse TAG, 2007, J HERPETOL, V41, P645, DOI 10.1670/07-015.1; Rittenhouse TAG, 2007, WETLANDS, V27, P153, DOI 10.1672/0277-5212(2007)27[153:DOAITH]2.0.CO;2; Rothermel BB, 2002, CONSERV BIOL, V16, P1324, DOI 10.1046/j.1523-1739.2002.01085.x; Rothermel BB, 2005, J HERPETOL, V39, P619, DOI 10.1670/251-04A.1; Savage WK, 2005, AMPHIBIAN DECLINES C, P621; Schulte LA, 2006, FOREST ECOL MANAG, V232, P1, DOI 10.1016/j.foreco.2006.05.009; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; SEMLITSCH RD, 1987, ECOLOGY, V68, P994, DOI 10.2307/1938370; SEMLITSCH RD, 1987, COPEIA, P61, DOI 10.2307/1446038; Semlitsch RD, 2000, J WILDLIFE MANAGE, V64, P615, DOI 10.2307/3802732; Semlitsch RD, 1998, CONSERV BIOL, V12, P1113, DOI 10.1046/j.1523-1739.1998.97274.x; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; SEXTON OJ, 1990, COPEIA, P781, DOI 10.2307/1446443; Seymour RS, 2002, FOREST ECOL MANAG, V155, P357, DOI 10.1016/S0378-1127(01)00572-2; SHOOP CR, 1974, ECOLOGY, V55, P440, DOI 10.2307/1935233; Smith R., 2014, AMPHIBIAN CONSERVATI; SMITHGILL SJ, 1980, COPEIA, P723, DOI 10.2307/1444450; Stoffyn-Egli P, 2011, ENVIRON REV, V19, P479, DOI [10.1139/A11-019, 10.1139/a11-019]; Sztatecsny M, 2006, J ZOOL, V270, P517, DOI 10.1111/j.1469-7998.2006.00120.x; Tennessen JA, 2003, MOL ECOL, V12, P1567, DOI 10.1046/j.1365-294X.2003.01830.x; Thomas R., 2008, STATE WETLAND PROTEC; Tilghman JM, 2012, BIOL CONSERV, V152, P1, DOI 10.1016/j.biocon.2012.03.030; Todd BD, 2008, BIOL INVASIONS, V10, P539, DOI 10.1007/s10530-007-9150-9; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; Verrell PA, 1998, BEHAVIOUR, V135, P121, DOI 10.1163/156853998793066357; Veysey JS, 2011, LANDSCAPE ECOL, V26, P661, DOI 10.1007/s10980-011-9590-6; Veysey JS, 2009, BIOL CONSERV, V142, P2227, DOI 10.1016/j.biocon.2009.04.024; Veysey Powell JS, 2014, THESIS U NEW HAMPSHI; WILBUR HM, 1977, AM NAT, V111, P43, DOI 10.1086/283137; Willett TR, 2001, RESTOR ECOL, V9, P410, DOI 10.1046/j.1526-100X.2001.94010.x; Willson John D., 2010, P229; Windmiller Bryan, 2008, P41; WOODWARD BD, 1982, COPEIA, P157, DOI 10.2307/1444279	129	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133642	10.1371/journal.pone.0133642	http://dx.doi.org/10.1371/journal.pone.0133642			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196129	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600125
J	Craddock, TJA; Del Rosario, RR; Rice, M; Zysman, JP; Fletcher, MA; Klimas, NG; Broderick, G				Craddock, Travis J. A.; Del Rosario, Ryan R.; Rice, Mark; Zysman, Joel P.; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon			Achieving Remission in Gulf War Illness: A Simulation-Based Approach to Treatment Design	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; GLUCOCORTICOID-RECEPTOR ANTAGONISTS; POSTTRAUMATIC-STRESS-DISORDER; IFN-GAMMA; MULTIPLE-SCLEROSIS; MUSCULOSKELETAL MANIFESTATIONS; ENDOCRINE DISORDERS; REGULATORY NETWORKS; ALZHEIMERS-DISEASE; ANTIBODIES	Gulf War Illness (GWI) is a chronic multi-symptom disorder affecting up to one-third of the 700,000 returning veterans of the 1991 Persian Gulf War and for which there is no known cure. GWI symptoms span several of the body's principal regulatory systems and include debilitating fatigue, severe musculoskeletal pain, cognitive and neurological problems. Using computational models, our group reported previously that GWI might be perpetuated at least in part by natural homeostatic regulation of the neuroendocrine-immune network. In this work, we attempt to harness these regulatory dynamics to identify treatment courses that might produce lasting remission. Towards this we apply a combinatorial optimization scheme to the Monte Carlo simulation of a discrete ternary logic model that represents combined hypothalamic-pituitary-adrenal (HPA), gonadal (HPG), and immune system regulation in males. In this work we found that no single intervention target allowed a robust return to normal homeostatic control. All combined interventions leading to a predicted remission involved an initial inhibition of Th1 inflammatory cytokines (Th1Cyt) followed by a subsequent inhibition of glucocorticoid receptor function (GR). These first two intervention events alone ended in stable and lasting return to the normal regulatory control in 40% of the simulated cases. Applying a second cycle of this combined treatment improved this predicted remission rate to 2 out of 3 simulated subjects (63%). These results suggest that in a complex illness such as GWI, a multi-tiered intervention strategy that formally accounts for regulatory dynamics may be required to reset neuroendocrine-immune homeostasis and support extended remission.	[Craddock, Travis J. A.; Del Rosario, Ryan R.; Rice, Mark; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon] Nova SE Univ, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.; Broderick, Gordon] Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.] Nova SE Univ, Grad Sch Comp & Informat Sci, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon] Nova SE Univ, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Zysman, Joel P.] Univ Miami, Ctr Computat Sci, Miami, FL USA; [Klimas, Nancy G.] Vet Affairs Med Ctr, Miami, FL 33125 USA; [Broderick, Gordon] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA	Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Nova Southeastern University	Craddock, TJA (corresponding author), Nova SE Univ, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA.	tcraddock@nova.edu		Craddock, Travis/0000-0001-7244-6317	U.S. Department of Defense [W81XWH-10-1-0774, W81XWH-09-2-0071]; U.S. Department of Veterans Affairs	U.S. Department of Defense(United States Department of Defense); U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was funded under U.S. Department of Defense (CDMRP program cdmrp.army.mil) grant W81XWH-10-1-0774 (G. Broderick, PI) and grant W81XWH-09-2-0071 (N. Klimas, PI). Additional funding was received from the U.S. Department of Veterans Affairs (va.gov) (Merit Award, N. Klimas, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2006, CLIN INFECT DIS, V43, P1, DOI 10.1086/504806; Amourette C, 2009, BEHAV BRAIN RES, V203, P207, DOI 10.1016/j.bbr.2009.05.002; Barbier L, 2009, BEHAV BRAIN RES, V197, P292, DOI 10.1016/j.bbr.2008.08.032; Ben-Zvi A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000273; Bielekova B, 2010, NEUROLOGY, V74, pS31, DOI 10.1212/WNL.0b013e3181c97ed3; Boswell SB, 2014, CLIN IMAG, V38, P384, DOI 10.1016/j.clinimag.2014.02.014; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Broderick G, 2011, BRAIN BEHAV IMMUN, V25, P302, DOI 10.1016/j.bbi.2010.10.011; Clark RD, 2008, CURR TOP MED CHEM, V8, P813, DOI 10.2174/156802608784535011; Craddock TJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084839; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Dunn James P, 2004, Curr Opin Ophthalmol, V15, P293, DOI 10.1097/00055735-200408000-00003; Fritsch P, 2014, SYSTEMS BIOMED, V1, P0; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Golier J, 2008, CONTROLLED TRIAL MIF; Golier J. A., 2012, DEPRESS RES TREAT, V2012, DOI DOI 10.1155/2012/393251; Golier JA, 2007, BIOL PSYCHIAT, V62, P1175, DOI 10.1016/j.biopsych.2007.04.027; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Healy DL, 2009, AUST PRESCR, V32, P152; Jacobs-Kosmin D, 2005, CURR OPIN RHEUMATOL, V17, P64, DOI 10.1097/01.bor.0000150950.43282.df; Kim SE, 2009, PHARMACOTHERAPY, V29, P227, DOI 10.1592/phco.29.2.227; Lamproglou I, 2009, BEHAV BRAIN RES, V197, P301, DOI 10.1016/j.bbr.2008.08.031; Lees JR, 2007, J CLIN INVEST, V117, P297, DOI 10.1172/JCI31254; Liscinsky M, 2012, FDA APPROVES KORLYM; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Mikics E, 2004, PSYCHONEUROENDOCRINO, V29, P618, DOI 10.1016/S0306-4530(03)00090-8; Nicolson GL, 2000, CLIN PRACT ALTERN ME, V1, P92; Peeters BWMM, 2004, STRESS, V7, P233, DOI 10.1080/10253890400019672; Rankin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030978; Rasmuson S, 2011, INT PSYCHOGERIATR, V23, P1386, DOI 10.1017/S1041610211000810; Research Advisory Committee on Gulf War Veterans' Illness (RAC-GWVI), 2008, GULF WAR ILLN HLTH G; Sigidin YA, 2001, SCAND J RHEUMATOL, V30, P203; Skowera A, 2004, J CLIN IMMUNOL, V24, P66, DOI 10.1023/B:JOCI.0000018065.64685.82; Skurkovich B, 2006, E SCHERING RES FDN W, V56, P1; Skurkovich S, 2001, MULT SCLER, V7, P277, DOI 10.1177/135245850100700502; Strittmatter M, 2005, SCHMERZ, V19, P109, DOI 10.1007/s00482-004-0330-6; Swanwick GRJ, 1998, AM J PSYCHIAT, V155, P286; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Tennant F, 2013, PAIN THER, V2, P75, DOI 10.1007/s40122-013-0015-x; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Vinther F, 2011, J MATH BIOL, V63, P663, DOI 10.1007/s00285-010-0384-2; Walker JJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001341; Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148; Weiner MW, 2011, MIL MED, V176, P896, DOI 10.7205/MILMED-D-10-00332; Whitley D, 2003, LECT NOTES COMPUT SC, V2724, P1469; Wilson CGM, 2011, CURR TOP MICROBIOL, V348, P25, DOI 10.1007/82_2010_93; Yeh S, 2008, J AUTOIMMUN, V31, P91, DOI 10.1016/j.jaut.2008.05.001; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999	51	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132774	10.1371/journal.pone.0132774	http://dx.doi.org/10.1371/journal.pone.0132774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192591	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400038
J	Li, QW; Li, W; Wang, L; Wang, WD; Niu, SQ; Bi, XW; Wang, HY; Zhang, YJ				Li, Qiwen; Li, Wei; Wang, Liang; Wang, Weida; Niu, Shaoqing; Bi, Xiwen; Wang, Hanyu; Zhang, Yujing			Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; LOCALIZED AGGRESSIVE LYMPHOMA; INVOLVED-FIELD RADIOTHERAPY; CHOP PLUS RADIOTHERAPY; CLINICAL-FEATURES; ONCOLOGY-GROUP; CHEMOTHERAPY; SURGERY; TRIAL; EXPERIENCE	Background To investigate the effects of consolidation radiation in patients with stage IE-IIE, non-bulky primary gastric diffuse large B-cell lymphoma (DLBCL). Methods A cohort consisted of 71 consecutive patients with stage IE-IIE, non-bulky primary gastric DLBCL was retrospectively analyzed. All of them had been in complete remission after receiving at least four cycles of chemotherapy, containing rituximab or not. Consolidation radiation was delivered thereafter in 28 patients while other 43 received clinical observation only. Locoregional relapse-free survival (LRFS), disease-free survival (DFS), overall survival (OS) and distant metastasis-free survival (DMFS) were compared between patients with or without radiotherapy. Results The 10-year LRFS, DFS, OS and DMFS were 100% and 81.4%(p = 0.028), 91.7% and 77.1% (p = 0.14), 91.7% and 77.8% (p = 0.67), 91.7% and 78.0%(p = 0.42) for patients with or without radiotherapy. Conclusions Radiotherapy is associated with improved locoregional control of patients with early stage primary gastric DLBCL, who have achieved complete remission following at least four cycles of chemotherapy.	[Li, Qiwen; Wang, Hanyu; Zhang, Yujing] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Wei] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Liang; Wang, Weida] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Niu, Shaoqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Xiwen] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Zhang, YJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	zhangyj@sysucc.org.cn	Wang, Weida/HGV-1933-2022					AMER MH, 1994, GASTROENTEROLOGY, V106, P846, DOI 10.1016/0016-5085(94)90742-0; Aviles A, 2004, ANN SURG, V240, P44, DOI 10.1097/01.sla.0000129354.31318.f1; Bonnet C, 2007, J CLIN ONCOL, V25, P787, DOI 10.1200/JCO.2006.07.0722; BROOKS JJ, 1983, CANCER, V51, P701, DOI 10.1002/1097-0142(19830215)51:4<701::AID-CNCR2820510425>3.0.CO;2-D; DAMORE F, 1994, J CLIN ONCOL, V12, P1673, DOI 10.1200/JCO.1994.12.8.1673; Ferreri AJM, 1999, LEUKEMIA LYMPHOMA, V33, P531, DOI 10.3109/10428199909058457; Fischbach W, 2011, Z GASTROENTEROL, V49, P430, DOI 10.1055/s-0029-1246012; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; HERRMANN R, 1980, CANCER, V46, P215, DOI 10.1002/1097-0142(19800701)46:1<215::AID-CNCR2820460136>3.0.CO;2-6; Horning SJ, 2004, J CLIN ONCOL, V22, P3032, DOI 10.1200/JCO.2004.06.088; Koch P, 2001, J CLIN ONCOL, V19, P3861, DOI 10.1200/JCO.2001.19.18.3861; Liu HT, 2000, AM J HEMATOL, V64, P175, DOI 10.1002/1096-8652(200007)64:3<175::AID-AJH6>3.3.CO;2-Z; Liu Hui, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P36; Mafune K I, 2001, Gastric Cancer, V4, P137, DOI 10.1007/PL00011736; Martinelli G, 2009, LEUKEMIA LYMPHOMA, V50, P925, DOI 10.1080/10428190902912478; Mihaljevic B, 2006, MED ONCOL, V23, P225, DOI 10.1385/MO:23:2:225; Miller TP, 1998, NEW ENGL J MED, V339, P21, DOI 10.1056/NEJM199807023390104; Narita M, 1996, PATHOL INT, V46, P623, DOI 10.1111/j.1440-1827.1996.tb03664.x; Persky DO, 2008, J CLIN ONCOL, V26, P2258, DOI 10.1200/JCO.2007.13.6929; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Phan Jack, 2010, J Clin Oncol, V28, P4170, DOI 10.1200/JCO.2009.27.3441; Reyes F, 2005, NEW ENGL J MED, V352, P1197, DOI 10.1056/NEJMoa042040; Sbitti Y, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-23; Shenkier TN, 2002, J CLIN ONCOL, V20, P197, DOI 10.1200/JCO.20.1.197	24	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133469	10.1371/journal.pone.0133469	http://dx.doi.org/10.1371/journal.pone.0133469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193661	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400092
J	Renault, KM; Carlsen, EM; Norgaard, K; Nilas, L; Pryds, O; Secher, NJ; Olsen, SF; Halldorsson, TI				Renault, Kristina M.; Carlsen, Emma M.; Norgaard, Kirsten; Nilas, Lisbeth; Pryds, Ole; Secher, Niels J.; Olsen, Sjurdur F.; Halldorsson, Thorhallur I.			Intake of Sweets, Snacks and Soft Drinks Predicts Weight Gain in Obese Pregnant Women: Detailed Analysis of the Results of a Randomised Controlled Trial	PLOS ONE			English	Article							NATIONAL-BIRTH-COHORT; GLYCEMIC-INDEX DIET; OBSTETRIC OUTCOMES; PHYSICAL-ACTIVITY; MATERNAL WEIGHT; LIFE-STYLE; INTERVENTION; SUGAR; LOAD; MEN	Background Lifestyle interventions targeting obese pregnant women often result in modest reduction in gestational weight gain, pregnancy complications and related risk factors. Examining adherence to the intervention can, however, provide valuable information on the importance of the different factors targeted. Objective To evaluate improvements and relevance of different dietary factors targeted with respect to gestational weight gain in a 3-arm Randomised Controlled Trial (n=342) among obese pregnant women with BMI >= 30 kg/m(2). Methods Randomisation 1:1:1 to either hypocaloric Mediterranean type of diet and physical activity intervention (D+PA); physical activity intervention alone (PA); or control (C). Diet was assessed at baseline (weeks 11-14) and endpoint (weeks 36-37) using a validated food frequency questionnaire. Results During the intervention women in the D+PA group significantly lowered their intakes of added sugars and saturated fat and increased their protein intake by similar to 1% of total energy compared to controls. Of these dietary variables only intakes of added sugar appeared to be related to GWG, while no association was observed for saturated fat or protein. Further analyses revealed that foods that contributed to intake of added sugars, including sweets, snacks, cakes, and soft drinks were strongly associated with weight gain, with women consuming sweets >= 2/day having 5.4 kg (95% CI 2.1-8.7) greater weight gain than those with a low (<1wk) intake. The results for soft drinks were more conflicting, as women with high weight gain tended to favour artificially sweetened soft drinks. Conclusion In our sample of obese pregnant women, craving for sweets, snacks, and soft drinks strongly predicts GWG. Emphasis on reducing intakes of these foods may be more relevant for limiting gestational weight gain than encouraging strict compliance to more specific diets.	[Renault, Kristina M.; Nilas, Lisbeth] Univ Copenhagen, Hvidovre Hosp, Dept Obstet & Gynaecol, Copenhagen, Denmark; [Renault, Kristina M.] Univ Southern Denmark, Odense Univ Hosp, Dept Obstet & Gynaecol, Odense, Denmark; [Carlsen, Emma M.; Pryds, Ole] Univ Copenhagen, Hvidovre Hosp, Dept Paediat, Copenhagen, Denmark; [Norgaard, Kirsten] Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, Copenhagen, Denmark; [Secher, Niels J.] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Res Unit Womens & Childrens Hlth, DK-2100 Copenhagen, Denmark; [Olsen, Sjurdur F.; Halldorsson, Thorhallur I.] Statens Serum Inst, Ctr Foetal Programming, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Olsen, Sjurdur F.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Halldorsson, Thorhallur I.] Univ Iceland, Fac Food Sci & Nutr, Reykjavik, Iceland	University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland	Renault, KM (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Obstet & Gynaecol, Copenhagen, Denmark.	krta@dadlnet.dk	Halldorsson, Tohrhallur/M-1823-2015; Nørgaard, Kirsten/AAC-9803-2020; Renault, Kristina Martha/H-7265-2019	Halldorsson, Tohrhallur/0000-0001-5115-0162; Nørgaard, Kirsten/0000-0003-1620-8271; Carlsen, Emma Malchau/0000-0002-5563-1964; Olsen, Sjurdur/0000-0003-3017-7096; Halldorsson, Thorhallur/0000-0002-3488-0777; Renault, Kristina Martha/0000-0002-6387-9652	Danish Council for Strategic Research (Centre for Fetal Programming) [09067124]	Danish Council for Strategic Research (Centre for Fetal Programming)	"Sygekassernes Helsefond" and "Brodrene Hartmann Fonden" were not involved in data collection, management or analysis of the data, nor the decision to submit the manuscript for publication. The Danish Council for Strategic Research (09067124, Centre for Fetal Programming): to finance processing and development of questionnaire data regarding dietary intake and physical activity in pregnancy.	Clapp JF, 2002, P NUTR SOC, V61, P45, DOI 10.1079/PNS2001129; de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922; Deierlein AL, 2008, AM J CLIN NUTR, V88, P693, DOI 10.1093/ajcn/88.3.693; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; HEITMANN BL, 1995, BRIT MED J, V311, P986; Hinkle SN, 2010, AM J CLIN NUTR, V92, P644, DOI 10.3945/ajcn.2010.29726; Jensen DM, 2005, DIABETES CARE, V28, P2118, DOI 10.2337/diacare.28.9.2118; Kahn R, 2014, DIABETES CARE, V37, P957, DOI 10.2337/dc13-2506; Khoury J, 2005, AM J OBSTET GYNECOL, V193, P1292, DOI 10.1016/j.ajog.2005.05.016; Knudsen VK, 2013, BRIT J NUTR, V109, P1471, DOI 10.1017/S0007114512003443; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Mikkelsen TB, 2006, PUBLIC HEALTH NUTR, V9, P771, DOI 10.1079/PHN2005883; Moses RG, 2006, AM J CLIN NUTR, V84, P807, DOI 10.1093/ajcn/84.4.807; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Olsen S, 2005, REPORT NO 38, P1; Olsen SF, 2007, PAEDIATR PERINAT EP, V21, P76, DOI 10.1111/j.1365-3016.2007.00777.x; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Pedersen AN, 2010, DIETARY HABITS IN DE; Poston L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-148; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Renault K, 2010, ACTA OBSTET GYN SCAN, V89, P956, DOI 10.3109/00016341003792459; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Walsh JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5605; Willett WC, 2013, NUTRITIONAL EPIDEMIO; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007	29	36	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133041	10.1371/journal.pone.0133041	http://dx.doi.org/10.1371/journal.pone.0133041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192183	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400047
J	Cohen, EN; Gao, H; Anfossi, S; Mego, M; Reddy, NG; Debeb, B; Giordano, A; Tin, SD; Wu, Q; Garza, RJ; Cristofanilli, M; Mani, SA; Croix, DA; Ueno, NT; Woodward, WA; Luthra, R; Krishnamurthy, S; Reuben, JM				Cohen, Evan N.; Gao, Hui; Anfossi, Simone; Mego, Michal; Reddy, Neelima G.; Debeb, Bisrat; Giordano, Antonio; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Cristofanilli, Massimo; Mani, Sendurai A.; Croix, Denise A.; Ueno, Naoto T.; Woodward, Wendy A.; Luthra, Raja; Krishnamurthy, Savitri; Reuben, James M.			Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells	PLOS ONE			English	Article							E-CADHERIN; CYTOKINE SYNTHESIS; EXPRESSION; INVADOPODIA; VIRUS; PLAYS; ALPHA; LINES	Inflammatory breast cancer (IBC) is the most insidious form of locally advanced breast cancer; about a third of patients have distant metastasis at initial staging. Emerging evidence suggests that host factors in the tumor microenvironment may interact with underlying IBC cells to make them aggressive. It is unknown whether immune cells associated to the IBC microenvironment play a role in this scenario to transiently promote epithelial to mesenchymal transition (EMT) in these cells. We hypothesized that soluble factors secreted by activated immune cells can induce an EMT in IBC and thus promote metastasis. In a pilot study of 16 breast cancer patients, TNF-alpha production by peripheral blood T cells was correlated with the detection of circulating tumor cells expressing EMT markers. In a variety of IBC model cell lines, soluble factors from activated T cells induced expression of EMT-related genes, including FN1, VIM, TGM2, ZEB1. Interestingly, although IBC cells exhibited increased invasion and migration following exposure to immune factors, the expression of E-cadherin (CDH1), a cell adhesion molecule, increased uniquely in IBC cell lines but not in non-IBC cell lines. A combination of TNF-alpha, IL-6, and TGF-beta was able to recapitulate EMT induction in IBC, and conditioned media preloaded with neutralizing antibodies against these factors exhibited decreased EMT. These data suggest that release of cytokines by activated immune cells may contribute to the aggressiveness of IBC and highlight these factors as potential target mediators of immune-IBC interaction.	[Cohen, Evan N.; Gao, Hui; Anfossi, Simone; Reddy, Neelima G.; Giordano, Antonio; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Luthra, Raja; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Mani, Sendurai A.; Krishnamurthy, Savitri] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Debeb, Bisrat; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Cohen, Evan N.; Gao, Hui; Anfossi, Simone; Debeb, Bisrat; Giordano, Antonio; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Ueno, Naoto T.; Woodward, Wendy A.; Krishnamurthy, Savitri; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Cohen, Evan N.; Anfossi, Simone; Tin, Sanda; Mani, Sendurai A.; Ueno, Naoto T.; Woodward, Wendy A.; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Mego, Michal] Natl Canc Inst, Bratislava, Slovakia; [Cristofanilli, Massimo] Thomas Jefferson Univ, Med Oncol, Philadelphia, PA 19107 USA; [Croix, Denise A.] Roche Diagnost, Indianapolis, IN USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institute of Oncology (NOU); Jefferson University; Roche Holding	Reuben, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	jreuben@mdanderson.org	Cohen, Evan N/AFP-3323-2022; Giordano, Antonio/AAU-1201-2020; Woodward, Wendy/AAX-6593-2020; Mani, Sendurai A./A-7244-2009	Cohen, Evan N/0000-0003-4192-9644; Giordano, Antonio/0000-0002-5959-016X; Mani, Sendurai A./0000-0002-5918-4276; Woodward, Wendy/0000-0002-7935-739X; Anfossi, Simone/0000-0001-5745-7587	Human Breast Cancer Stem Cell Surrogates, National Institutes of Health/National Cancer Institute [CA138239-02]; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, US Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP) [W81XWH-09-1-0031 01]; NIH/NCI [P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA138239, P30CA016672] Funding Source: NIH RePORTER	Human Breast Cancer Stem Cell Surrogates, National Institutes of Health/National Cancer Institute; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, US Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by: Human Breast Cancer Stem Cell Surrogates, CA138239-02, National Institutes of Health/National Cancer Institute (MC, WAW, JMR); State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic (NTU, MC); Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, W81XWH-09-1-0031 01, US Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP) (ENC). FACS analysis was performed in MD Anderson's Flow Cytometry and Cellular Imaging core facility supported by the NIH/NCI under award number P30CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalay I, 2013, CANCER RES, V73, P2418, DOI 10.1158/0008-5472.CAN-12-2432; Alpaugh ML, 1999, CANCER RES, V59, P5079; Anfossi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083113; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bertucci F, 2014, ANN ONCOL, V25, P358, DOI 10.1093/annonc/mdt496; BONNIER P, 1995, INT J CANCER, V62, P382, DOI 10.1002/ijc.2910620404; Brewer TM, 2013, BRIT J CANCER, V109, P318, DOI 10.1038/bjc.2013.342; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Eckert MA, 2011, ONCOTARGET, V2, P562; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gao H, 2005, LEUKEMIA, V19, P1905, DOI 10.1038/sj.leu.2403933; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Hajra KM, 2002, CANCER RES, V62, P1613; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Jung U, 2003, BLOOD, V102, P3439, DOI 10.1182/blood-2002-12-3936; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Lacerda L, 2014, STEM CELL TRANSL MED, V3, P849, DOI 10.5966/sctm.2013-0204; Lefer DJ, 2002, CIRCULATION, V106, P2041, DOI 10.1161/01.CIR.0000033635.42612.88; Levine PH, 2014, WORLD J CLIN ONCOL, V5, P539, DOI 10.5306/wjco.v5.i3.539; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Medler TR, 2014, J INVEST DERMATOL, V134, pE23, DOI 10.1038/skinbio.2014.5; Mego M, 2012, INT J CANCER, V130, P808, DOI 10.1002/ijc.26037; Mohamed MM, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-3; Mohamed MM, 2008, BIOL CHEM, V389, P1117, DOI 10.1515/BC.2008.117; MOURALI N, 1978, INT J CANCER, V22, P1, DOI 10.1002/ijc.2910220102; Pogo BGT, 2010, CANCER-AM CANCER SOC, V116, P2741, DOI 10.1002/cncr.25179; Reuben JM, 2006, CANCER, V106, P2437, DOI 10.1002/cncr.21854; Reuben JM, 2002, J ALLERGY CLIN IMMUN, V110, P255, DOI 10.1067/mai.2002.125979; Reuben JM, 2000, CLIN CANCER RES, V6, P1671; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Singh R, 2014, CELL SIGNAL, V26, P1604, DOI 10.1016/j.cellsig.2014.03.028; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Starsichova A, 2009, BIOL PROCED ONLINE, V11, P316, DOI 10.1007/s12575-009-9017-9; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Takkouche B, 2008, JNCI-J NATL CANCER I, V100, P1439, DOI 10.1093/jnci/djn324; Tomlinson JS, 2001, CANCER RES, V61, P5231; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; van Golen Kenneth L, 2013, Breast Cancer Res, V15, P318, DOI 10.1186/bcr3571; Yamauchi H, 2012, ONCOLOGIST, V17, P891, DOI 10.1634/theoncologist.2012-0039; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	56	71	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132710	10.1371/journal.pone.0132710	http://dx.doi.org/10.1371/journal.pone.0132710			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207636	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000039
J	Sanchez-Montes, S; Espinosa-Martinez, DV; Rios-Munoz, CA; Berzunza-Cruz, M; Becker, I				Sanchez-Montes, Sokani; Espinosa-Martinez, Deborah V.; Rios-Munoz, Cesar A.; Berzunza-Cruz, Miriam; Becker, Ingeborg			Leptospirosis in Mexico: Epidemiology and Potential Distribution of Human Cases	PLOS ONE			English	Article							UNITED-STATES; NICHE; VECTORS; DISEASE; HAWAII; MODELS; FEVER; HOSTS; SETS	Background Leptospirosis is widespread in Mexico, yet the potential distribution and risk of the disease remain unknown. Methodology/Principal Findings We analysed morbidity and mortality according to age and gender based on three sources of data reported by the Ministry of Health and the National Institute of Geography and Statics of Mexico, for the decade 2000-2010. A total of 1,547 cases were reported in 27 states, the majority of which were registered during the rainy season, and the most affected age group was 25-44 years old. Although leptospirosis has been reported as an occupational disease of males, analysis of morbidity in Mexico showed no male preference. A total number of 198 deaths were registered in 21 states, mainly in urban settings. Mortality was higher in males (61.1%) as compared to females (38.9%), and the case fatality ratio was also increased in males. The overall case fatality ratio in Mexico was elevated (12.8%), as compared to other countries. We additionally determined the potential disease distribution by examining the spatial epidemiology combined with spatial modeling using ecological niche modeling techniques. We identified regions where leptospirosis could be present and created a potential distribution map using bioclimatic variables derived from temperature and precipitation. Our data show that the distribution of the cases was more related to temperature (75%) than to precipitation variables. Ecological niche modeling showed predictive areas that were widely distributed in central and southern Mexico, excluding areas characterized by extreme climates. Conclusions/Significance In conclusion, an epidemiological surveillance of leptospirosis is recommended in Mexico, since 55.7% of the country has environmental conditions fulfilling the criteria that favor the presence of the disease.	[Sanchez-Montes, Sokani; Rios-Munoz, Cesar A.; Berzunza-Cruz, Miriam; Becker, Ingeborg] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Mexico City 04510, DF, Mexico; [Sanchez-Montes, Sokani; Rios-Munoz, Cesar A.; Berzunza-Cruz, Miriam; Becker, Ingeborg] Univ Nacl Autonoma Mexico, Fac Med, Ctr Med Trop, Mexico City 04510, DF, Mexico; [Espinosa-Martinez, Deborah V.; Rios-Munoz, Cesar A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool Alfonso L Herrera, Dept Biol Evolut, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Becker, I (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Mexico City 04510, DF, Mexico.	becker@unam.mx	Sanchez, Maria Blanca/AAD-8294-2020; Ríos-Muñoz, Cesar A./J-9384-2012; Oggioni, Marco Rinaldo/K-3839-2016; Martinez, Jose L/A-4725-2013	Sanchez, Maria Blanca/0000-0002-5209-4518; Ríos-Muñoz, Cesar A./0000-0002-3423-8936; Oggioni, Marco Rinaldo/0000-0003-4117-793X; Martinez, Jose L/0000-0001-8813-7607; VITI, CARLO/0000-0001-7188-549X	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN217515]; Consejo Nacional de Ciencia y Tecnologia CONACyT [221405]; CONACyT	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Consejo Nacional de Ciencia y Tecnologia CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funded by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT No IN217515) and Consejo Nacional de Ciencia y Tecnologia CONACyT 221405 to IB. Daniel Sokani Sanchez Montes was supported by a PhD fellowship from CONACyT and is a doctoral student of (Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico UNAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 2003, ZOONOSES COMMUNICABL, V1, P157; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Centro Nacional de Vigilancia Epidemiologica y Control de Enfermedades (CENAVECE), 2013, AN MORB 1984 2011; Ciceroni L, 1995, EUR J EPIDEMIOL, V11, P707, DOI 10.1007/BF01720308; Ciceroni L, 2000, EUR J EPIDEMIOL, V16, P79, DOI 10.1023/A:1007658607963; Costa J, 2012, ADV EXP MED BIOL, V710, P59, DOI 10.1007/978-1-4419-5638-5_7; Cuervo-Robayo AP, 2014, INT J CLIMATOL, V34, P2427, DOI 10.1002/joc.3848; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Espinosa-Martinez DV, 2015, REV INST MED TROP SP, V57, P181, DOI 10.1590/S0036-46652015000200015; EVERARD COR, 1995, EUR J EPIDEMIOL, V11, P311, DOI 10.1007/BF01719436; GADM database Global Administrative Areas (GADM), 2014, ADM AR WORLD VER 2 0; GALTON MM, 1959, PUBLIC HEALTH REP, V74, P141, DOI 10.2307/4590398; Gavaldon D, 1988, GAC MED MEX, V131, P289; GEISTFELD JG, 1975, J INFECT DIS, V131, P743, DOI 10.1093/infdis/131.6.743; Giles J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000925; Hartskeerl R A, 2006, Indian J Med Microbiol, V24, P309; HEATH CW, 1965, NEW ENGL J MED, V273, P915, DOI 10.1056/NEJM196510212731706; Hervada Vidal Xurxo, 2004, Rev. Esp. Salud Publica, V78, P277, DOI 10.1590/s1135-57272004000200013; Holveck JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-6; IBM Corp, 2011, IBM SPSS STAT WIND V; INEGI (Instituto Nacional de Geografia y Estadistica), 2013, CAT UN CLAV AR GEOES; Instituto de Diagnostico y Referencia Epidemiologicos [InDRE], 2014, LIN DIAGN LEPT MED A; Instituto Nacional de Estadistica y Geografia (INEGI), 2013, MEX CIFR INF NAC POR; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Jansen A, 2005, EMERG INFECT DIS, V11, P1048, DOI 10.3201/eid1107.041172; Jimenez-Sastre A, 2010, REV CHIL INFECTOL, V29, P32; Katz AR, 2011, EMERG INFECT DIS, V17, P221, DOI 10.3201/eid1702.101109; Katz AR, 2002, AM J TROP MED HYG, V66, P61, DOI 10.4269/ajtmh.2002.66.61; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011; Maher SP, 2010, AM J TROP MED HYG, V83, P736, DOI 10.4269/ajtmh.2010.10-0042; Mak S, 2010, ENVIRON HEALTH PERSP, V118, P653, DOI 10.1289/ehp.0901448; Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220; Mohammed H., 2011, Asian Journal of Epidemiology, V4, P17, DOI 10.3923/aje.2011.17.22; Mohan ARM, 2009, ACTA TROP, V112, P260, DOI 10.1016/j.actatropica.2009.08.007; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; Noguchi H, 1920, J EXP MED, V32, P627, DOI 10.1084/jem.32.5.627; Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; R Core Team, 2012, R LANG ENV STAT COMP; Rios-Munoz CA, 2009, ORNITOL NEOTROP, V20, P491; Sánchez-Cordero Víctor, 2005, Acta Zool. Mex, V21, P79; SAS Institute Inc, 2010, JMP 9 MOD MULT METH; Scachetti-Pereira R, 2001, DESKTOP GARP 1 1 3; Servicio Meteorologico Nacional de Mexico. Comision Nacional Del Agua [SMNCONAGUA], 2011, AN TEMP CICL TROP 20; SHENBERG E, 1982, AM J EPIDEMIOL, V115, P352, DOI 10.1093/oxfordjournals.aje.a113312; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; VARELA G, 1958, Rev Inst Salubr Enferm Trop, V18, P31; VARELA G., 1961, REV INST SALUBRIDAD Y ENFERMEDADES TROP, V21, P49; VARELA GERARDO, 1965, SALUD PUBLICA MEX, V7, P189; Vieira ML, 2006, INT J INFECT DIS, V10, P378, DOI 10.1016/j.ijid.2005.07.006; World Health Organization, 2008, ICD 10 INT STAT CLAS; Zavala J, 1967, SALUD PUBLICA MEXICO, V18, P989; Zavala Velazquez J, 1984, Salud Publica Mex, V26, P254; ZAVALAVELAZQUEZ J, 1985, REV INVEST CLIN, V37, P353; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1; Zuniga-Carrasco IR, 2013, ENF INF MICROBIOL, V33, P71	68	28	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133720	10.1371/journal.pone.0133720	http://dx.doi.org/10.1371/journal.pone.0133720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26201074	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000121
J	Tocchetti, A; Bordoni, R; Gallo, G; Petiti, L; Corti, G; Alt, S; Cruz, JCS; Salzano, AM; Scaloni, A; Puglia, AM; De Bellis, G; Peano, C; Donadio, S; Sosio, M				Tocchetti, Arianna; Bordoni, Roberta; Gallo, Giuseppe; Petiti, Luca; Corti, Giorgio; Alt, Silke; Cruz, Joao C. S.; Salzano, Anna Maria; Scaloni, Andrea; Puglia, Anna Maria; De Bellis, Gianluca; Peano, Clelia; Donadio, Stefano; Sosio, Margherita			A Genomic, Transcriptomic and Proteomic Look at the GE2270 Producer Planobispora rosea, an Uncommon Actinomycete	PLOS ONE			English	Article							SP NOV.; PATHWAYS; INHIBITOR; SEQUENCE	We report the genome sequence of Planobispora rosea ATCC 53733, a mycelium-forming soil-dweller belonging to one of the lesser studied genera of Actinobacteria and producing the thiopeptide GE2270. The P. rosea genome presents considerable convergence in gene organization and function with other members in the family Streptosporangiaceae, with a significant number (44%) of shared orthologs. Patterns of gene expression in P. rosea cultures during exponential and stationary phase have been analyzed using whole transcriptome shotgun sequencing and by proteome analysis. Among the differentially abundant proteins, those involved in protein metabolism are particularly represented, including the GE2270-insensitive EF-Tu. Two proteins from the pbt cluster, directing GE2270 biosynthesis, slightly increase their abundance values over time. While GE2270 production starts during the exponential phase, most pbt genes, as analyzed by qRT-PCR, are down-regulated. The exception is represented by pbtA, encoding the precursor peptide of the ribosomally synthesized GE2270, whose expression reached the highest level at the entry into stationary phase.	[Tocchetti, Arianna; Alt, Silke; Donadio, Stefano; Sosio, Margherita] NAICONS Srl, Milan, Italy; [Tocchetti, Arianna; Cruz, Joao C. S.; Donadio, Stefano; Sosio, Margherita] KtedoGen Srl, Milan, Italy; [Bordoni, Roberta; Petiti, Luca; Corti, Giorgio; De Bellis, Gianluca; Peano, Clelia] CNR, Inst Biomed Technol, Segrate, Italy; [Gallo, Giuseppe; Puglia, Anna Maria] Univ Palermo, Dept STEBICEF, Palermo, Italy; [Salzano, Anna Maria] CNR, ISPAAM, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Peano, C (corresponding author), CNR, Inst Biomed Technol, Segrate, Italy.	clelia.peano@itb.cnr.it; msosio@naicons.com	Peano, Clelia/C-4015-2018; Gallo, Giuseppe/O-4920-2015; Salzano, Anna Maria/C-7139-2012; De Bellis, Gianluca/H-9725-2013	Peano, Clelia/0000-0001-7055-3629; Gallo, Giuseppe/0000-0003-4727-5653; Salzano, Anna Maria/0000-0001-7192-8760; Sosio, Margherita/0000-0003-4297-6936; De Bellis, Gianluca/0000-0002-1622-4477; Scaloni, Andrea/0000-0001-9362-8515; Tocchetti, Arianna/0000-0001-7004-7582; Corti, Giorgio/0000-0001-6379-4117	Regione Lombardia [13810096]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); European Union [289285]	Regione Lombardia(Regione Lombardia); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was supported by Regione Lombardia (ID project 13810096) and by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (project). J.C. was supported by funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No 289285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [AT, JC, SD and MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aigle B, 2014, J IND MICROBIOL BIOT, V41, P251, DOI 10.1007/s10295-013-1379-y; Alduina R, 2003, FEMS MICROBIOL LETT, V218, P181, DOI 10.1111/j.1574-6968.2003.tb11516.x; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Corre C, 2009, NAT PROD REP, V26, P977, DOI 10.1039/b713024b; Donadio S, 2010, APPL MICROBIOL BIOT, V88, P1261, DOI 10.1007/s00253-010-2877-8; Fischer S., 2011, CURRENT PROTOCOLS BI; Flinspach K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090499; Gallo G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-152; Gallo G, 2012, APPL MICROBIOL BIOT, V94, P1289, DOI 10.1007/s00253-012-4046-8; GOODFELLOW M, 1990, J GEN MICROBIOL, V136, P19, DOI 10.1099/00221287-136-1-19; Hiller K, 2003, NUCLEIC ACIDS RES, V31, P3862, DOI 10.1093/nar/gkg536; Jabes D, 2011, ANTIMICROB AGENTS CH, V55, P1671, DOI 10.1128/AAC.01288-10; LaMarche MJ, 2011, J MED CHEM, V54, P2517, DOI 10.1021/jm101602q; Ludwig WEJ, 2012, BERGEYS MANUAL SYS A; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Ngaemthao W, 2014, INT J SYST EVOL MICR, V64, P1180, DOI 10.1099/ijs.0.057968-0; Ngaemthao W, 2013, INT J SYST EVOL MICR, V63, P2649, DOI 10.1099/ijs.0.046946-0; Nolan M, 2010, STAND GENOMIC SCI, V2, P29, DOI 10.4056/sigs.631049; Peano C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093009; Peano Clelia, 2013, Microb Inform Exp, V3, P1, DOI 10.1186/2042-5783-3-1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SELVA E, 1991, J ANTIBIOT, V44, P693, DOI 10.7164/antibiotics.44.693; Sosio E, 2000, MOL GEN GENET, V264, P213; Sosio M, 1996, MOL MICROBIOL, V22, P43, DOI 10.1111/j.1365-2958.1996.tb02654.x; Sosio M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01198-13; Sosio M, 2006, J IND MICROBIOL BIOT, V33, P569, DOI 10.1007/s10295-006-0124-1; Talamo F, 2003, PROTEOMICS, V3, P440, DOI 10.1002/pmic.200390059; THIEMAN J. E., 1970, The Actinomycetales". Jena International Symposium on Taxonomy, 1968., P245; THIEMANN JE, 1968, ARCH MIKROBIOL, V62, P157, DOI 10.1007/BF00410402; Tocchetti A, 2013, CHEM BIOL, V20, P1067, DOI 10.1016/j.chembiol.2013.07.005; Vobis G, 2012, BERGEYS MANUAL SYSTE, V5, P1861; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444	35	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133705	10.1371/journal.pone.0133705	http://dx.doi.org/10.1371/journal.pone.0133705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207753	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000120
J	Ahmad, A; Cai, YF; Chen, XQ; Shuai, JW; Han, AD				Ahmad, Ashfaq; Cai, Yongfei; Chen, Xingqiang; Shuai, Jianwei; Han, Aidong			Conformational Dynamics of Response Regulator RegX3 from Mycobacterium tuberculosis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; RECEIVER DOMAIN; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; 2-COMPONENT SYSTEM; ESCHERICHIA-COLI; STRUCTURAL BASIS; PROTEIN; DIMERIZATION; TRANSITION	Two-component signal transduction systems (TCS) are vital for adaptive responses to various environmental stresses in bacteria, fungi and even plants. A TCS typically comprises of a sensor histidine kinase (SK) with its cognate response regulator (RR), which often has two domains-N terminal receiver domain (RD) and C terminal effector domain (ED). The histidine kinase phosphorylates the RD to activate the ED by promoting dimerization. However, despite significant progress on structural studies, how RR transmits activation signal from RD to ED remains elusive. Here we analyzed active to inactive transition process of OmpR/PhoB family using an active conformation of RegX3 from Mycobacterium tuberculosis as a model system by computational approaches. An inactive state of RegX3 generated from 150 ns molecular dynamic simulation has rotameric conformations of Thr(79) and Tyr(98) that are generally conserved in inactive RRs. Arg(81) in loop beta 4 alpha 4 acts synergistically with loop beta 1 alpha 1 to change its interaction partners during active to inactive transition, potentially leading to the N-terminal movement of RegX3 helix alpha 1. Global conformational dynamics of RegX3 is mainly dependent on alpha 4 beta 5 region, in particular seven 'hot-spot' residues (Tyr(98) to Ser(104)), adjacent to which several coevolved residues at dimeric interface, including Ile(76)-Asp(96), Asp(97)-Arg(111) and Glu(24)-Arg(113) pairs, are critical for signal transduction. Taken together, our computational analyses suggest a molecular linkage between Asp phosphorylation, proximal loops and alpha 4 beta 5 alpha 5 dimeric interface during RR active to inactive state transition, which is not often evidently defined from static crystal structures.	[Ahmad, Ashfaq; Cai, Yongfei; Han, Aidong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Chen, Xingqiang; Shuai, Jianwei] Xiamen Univ, Dept Phys, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University	Han, AD (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.	ahan@xmu.edu.cn	Cai, Yongfei/ABI-7748-2020; Cai, Yongfei/J-1167-2019; AHMED, Ashfaq/AAP-4828-2020	Cai, Yongfei/0000-0002-3628-3802; Cai, Yongfei/0000-0002-3628-3802; AHMED, Ashfaq/0000-0003-4949-0808	National Science Foundation of China [31070647, 31370723, 31370830, 11125419]; National Key Basic Research Program [2013CB910603]; Project 985 [2011121028]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Project 985	This work was supported by National Science Foundation of China (31070647 and 31370723 to AH; 31370830 and 11125419 to JS), National Key Basic Research Program (2013CB910603 to AH.), Project 985 (2011121028 to AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Banerjee R, 2014, J PHYS CHEM B, V118, P4727, DOI 10.1021/jp4122968; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Best RB, 2005, STRUCTURE, V13, P1755, DOI 10.1016/j.str.2005.08.009; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Bobay Benjamin G, 2012, Biomol Concepts, V3, P175; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Cerutti DS, 2008, BIOCHEMISTRY-US, V47, P12065, DOI 10.1021/bi800894u; Choudhury HG, 2013, PROTEIN SCI, V22, P1287, DOI 10.1002/pro.2311; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2008, MOL MICROBIOL, V69, P1358, DOI 10.1111/j.1365-2958.2008.06355.x; Gao R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003927; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gardino AK, 2003, J MOL BIOL, V331, P245, DOI 10.1016/S0022-2836(03)00733-2; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hickey JM, 2011, J BIOL CHEM, V286, P32606, DOI 10.1074/jbc.M111.220574; Jeong KW, 2013, MOL CELLS, V35, P158, DOI 10.1007/s10059-013-2303-z; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; King-Scott J, 2007, J BIOL CHEM, V282, P37717, DOI 10.1074/jbc.M705081200; Knaggs MH, 2007, BIOPHYS J, V92, P2062, DOI 10.1529/biophysj.106.081950; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; McDonald LR, 2013, J MOL BIOL, V425, P2372, DOI 10.1016/j.jmb.2013.04.029; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; NEEDHAM JV, 1993, BIOCHEMISTRY-US, V32, P3363, DOI 10.1021/bi00064a020; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Park S, 2002, FASEB J, V16, P1964, DOI 10.1096/fj.02-0395fje; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pioszak AA, 2004, J BACTERIOL, V186, P5730, DOI 10.1128/JB.186.17.5730-5740.2004; Porter SL, 2006, J BIOL CHEM, V281, P32694, DOI 10.1074/jbc.M606016200; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Roberts G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021090; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Smith JG, 2004, MOL MICROBIOL, V51, P887, DOI 10.1046/j.1365-2958.2003.03882.x; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; Stephenson SJ, 2002, MOL MICROBIOL, V44, P1455, DOI 10.1046/j.1365-2958.2002.02974.x; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zheng WJ, 2007, PROTEINS, V69, P43, DOI 10.1002/prot.21465; Zheng WJ, 2005, STRUCTURE, V13, P565, DOI 10.1016/j.str.2005.01.017; Zheng WJ, 2005, J MOL BIOL, V346, P745, DOI 10.1016/j.jmb.2004.12.020	59	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133389	10.1371/journal.pone.0133389	http://dx.doi.org/10.1371/journal.pone.0133389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201027	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100063
J	Carroll, P; Parish, T				Carroll, Paul; Parish, Tanya			Deletion of cyp125 Confers Increased Sensitivity to Azoles in Mycobacterium tuberculosis	PLOS ONE			English	Article							CYTOCHROME-P450; GENOME; MACROPHAGES; ANTIFUNGALS; SURVIVAL; REQUIREMENTS; ADAPTATION; RESISTANCE; VIRULENCE; GROWTH	Mycobacterium tuberculosis is able to utilize cholesterol as a carbon source, and this ability is linked to its virulence in macrophages and in the mouse model of infection. The M. tuberculosis cytochrome P450 Cyp125 plays a key role in cholesterol metabolism being involved in the first steps of its degradation. Cyp125 is a cholesterol hydroxylase which is essential for cholesterol catabolism in M. bovis BCG and some strains of M. tuberculosis. We generated an unmarked, in-frame deletion of Cyp125 in M. tuberculosis H37Rv. The deletion strain was able to grow as well as wild-type in medium containing glucose as the carbon source. The Cyp125 deletion strain was more sensitive to growth inhibition by clotrimazole consistent with the ability of Cyp125 to bind azoles with high affinity. The deletion strain showed no difference in sensitivity to nitric oxide or hydrogen peroxide and was not attenuated for growth inside THP-1 human macrophage-like cells. These data suggest that the attenuation of virulence seen in operon deletion strains is not linked to the lack of Cyp125 alone.	[Carroll, Paul; Parish, Tanya] Queen Mary Univ London, Ctr Infect Dis, Barts & London Sch Med & Dent, London, England; [Parish, Tanya] Infect Dis Res Inst, TB Discovery Res, Seattle, WA USA	University of London; Queen Mary University London	Parish, T (corresponding author), Queen Mary Univ London, Ctr Infect Dis, Barts & London Sch Med & Dent, London, England.	tanya.parish@idri.org			European Union Project [LSHP-CT-2005-018923]	European Union Project(European Commission)	This work was funded by the European Union Project LSHP-CT-2005-018923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, FEMS MICROBIOL LETT, V258, P200, DOI 10.1111/j.1574-6968.2006.00224.x; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Driscoll MD, 2011, BBA-PROTEINS PROTEOM, V1814, P76, DOI 10.1016/j.bbapap.2010.05.015; Giavini E, 2010, TOXICOL LETT, V198, P106, DOI 10.1016/j.toxlet.2010.07.005; Gomez-Valero L, 2007, GENOME RES, V17, P1178, DOI 10.1101/gr.6360207; Guardiola-Diaz HM, 2001, BIOCHEM PHARMACOL, V61, P1463, DOI 10.1016/S0006-2952(01)00571-8; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; KELLY SL, 2004, CYTOCHROME P450 STRU, P585; Lukey P T, 2001, Methods Mol Med, V54, P271, DOI 10.1385/1-59259-147-7:271; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; McLean KJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P228, DOI 10.1016/j.abb.2007.03.026; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vanden Bossche H, 1985, Curr Top Med Mycol, V1, P313; WHO, 2014, GLOB TUB REP 2014; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	35	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133129	10.1371/journal.pone.0133129	http://dx.doi.org/10.1371/journal.pone.0133129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197389	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600063
J	Cho, EJ; Kim, MY; Lee, JH; Lee, IY; Lim, YL; Choi, DH; Kim, YJ; Yoon, JH; Baik, SK				Cho, Eun Ju; Kim, Moon Young; Lee, Jeong-Hoon; Lee, Il Young; Lim, Yoo Li; Choi, Dae Hee; Kim, Yoon Jun; Yoon, Jung-Hwan; Baik, Soon Koo			Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis	PLOS ONE			English	Article							LIVER STIFFNESS MEASUREMENT; CHRONIC HEPATITIS-C; ESOPHAGEAL-VARICES; COMPENSATED CIRRHOSIS; SIGNIFICANT FIBROSIS; DISEASE; INDEX; DECOMPENSATION; MODEL; ELASTOGRAPHY	Portal hypertension is a direct consequence of hepatic fibrosis, and several hepatic fibrosis markers have been evaluated as a noninvasive alternative to the detection of portal hypertension and esophageal varices. In the present study, we compared the diagnostic and prognostic values of the noninvasive fibrosis markers in patients with alcoholic cirrhosis. A total of 219 consecutive alcoholic cirrhosis patients were included. Biochemical scores and liver stiffness (LS) were compared with hepatic venous pressure gradient (HVPG). For the detection of clinically significant portal hypertension (CSPH; HVPG >= 10 mmHg) in compensated patients, LS and LS-spleen diameter to platelet ratio score (LSPS) showed significantly better performance with area under the curves (AUCs) of 0.85 and 0.82, respectively, than aspartate aminotransferase-to-platelet ratio index, FIB-4, Forns' index, Lok index, (platelet count)(2)/[monocyte fraction (%) x segmented neutrophil fraction (%)], and platelet count-to-spleen diameter ratio (all P<0.001). However, for the detection of high-risk varices, none of the non-invasive tests showed reliable performance (AUCs of all investigated tests < 0.70). During a median follow-up period of 42.6 months, 46 patients with decompensated cirrhosis died. Lok index (hazard ratio [HR], 1.13; 95% confidence interval [CI], 1.05-1.22; P = 0.001) and FIB-4 (HR, 1.06; 95% CI, 1.01-1.10; P = 0.009) were independently associated with all-cause death in decompensated patients. Among the tested noninvasive markers, only Lok index significantly improved discrimination function of MELD score in predicting overall survival. In conclusion, LS and LSPS most accurately predict CSPH in patients with compensated alcoholic cirrhosis. In the prediction of overall survival in decompensated patients, however, Lok index is an independent prognostic factor and improves the predictive performance of MELD score.	[Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Moon Young; Lee, Il Young; Lim, Yoo Li; Baik, Soon Koo] Yonsei Univ, Coll Med, Dept Internal Med, Wonju, South Korea; [Choi, Dae Hee] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Kangwon National University; Kangwon National University Hospital	Yoon, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	yoonjh@snu.ac.kr; baiksk@yonsei.ac.kr	Lee, Jeong-Hoon/Q-1055-2018	Lee, Jeong-Hoon/0000-0002-0315-2080; Kim, Yoon Jun/0000-0001-9141-7773; Yoon, Jung-Hwan/0000-0002-9128-3610; Cho, Eun Ju/0000-0002-2677-3189	National Research Foundation of Korea - Ministry of Education, Science and Technology [2010-000-7381]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-000-7381) (http://www.nrf.re.kr/nrf_eng_cms). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Gelsi E, 2011, ALCOHOL CLIN EXP RES, V35, P566, DOI 10.1111/j.1530-0277.2010.01374.x; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; Girard D E, 1987, Hematol Oncol Clin North Am, V1, P321; Kim BK, 2010, LIVER INT, V30, P1073, DOI 10.1111/j.1478-3231.2010.02269.x; Kim BK, 2010, AM J GASTROENTEROL, V105, P1382, DOI 10.1038/ajg.2009.750; Kim MY, 2012, HEPATOLOGY, V56, P1053, DOI 10.1002/hep.25752; Lee JH, 2009, J VIRAL HEPATITIS, V16, P444, DOI 10.1111/j.1365-2893.2009.01091.x; Lemoine M, 2008, ALIMENT PHARM THER, V28, P1102, DOI 10.1111/j.1365-2036.2008.03825.x; Lisotti A, 2014, HEPATOLOGY, V59, P643, DOI 10.1002/hep.26700; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Robic MA, 2011, J HEPATOL, V55, P1017, DOI 10.1016/j.jhep.2011.01.051; Saha P, 2010, BIOMETRICS, V66, P999, DOI 10.1111/j.1541-0420.2009.01375.x; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sebastiani G, 2010, J HEPATOL, V53, P630, DOI 10.1016/j.jhep.2010.04.019; Shah V, 1998, HEPATOLOGY, V27, P279, DOI 10.1002/hep.510270141; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Thabut D, 2007, ALIMENT PHARM THER, V26, P359, DOI 10.1111/j.1365-2036.2007.03378.x; Thabut D, 2011, HEPATOLOGY, V53, P683, DOI 10.1002/hep.24129; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	32	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133935	10.1371/journal.pone.0133935	http://dx.doi.org/10.1371/journal.pone.0133935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196942	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600150
J	Chowdhary, N; Selvaraj, A; KrishnaKumaar, L; Kumar, GR				Chowdhary, Nupoor; Selvaraj, Ashok; KrishnaKumaar, Lakshmi; Kumar, Gopal Ramesh			Genome Wide Re-Annotation of Caldicellulosiruptor saccharolyticus with New Insights into Genes Involved in Biomass Degradation and Hydrogen Production	PLOS ONE			English	Article							PROTEIN-FUNCTION; HYPOTHETICAL PROTEINS; ESCHERICHIA-COLI; PREDICTION; BACTERIUM; SEQUENCE; CLONING; PURIFICATION; DATABASE; WASTE	Caldicellulosiruptor saccharolyticus has proven itself to be an excellent candidate for biological hydrogen (H-2) production, but still it has major drawbacks like sensitivity to high osmotic pressure and low volumetric H-2 productivity, which should be considered before it can be used industrially. A whole genome re-annotation work has been carried out as an attempt to update the incomplete genome information that causes gap in the knowledge especially in the area of metabolic engineering, to improve the H-2 producing capabilities of C. saccharolyticus. Whole genome re-annotation was performed through manual means for 2,682 Coding Sequences (CDSs). Bioinformatics tools based on sequence similarity, motif search, phylogenetic analysis and fold recognition were employed for re-annotation. Our methodology could successfully add functions for 409 hypothetical proteins (HPs), 46 proteins previously annotated as putative and assigned more accurate functions for the known protein sequences. Homology based gene annotation has been used as a standard method for assigning function to novel proteins, but over the past few years many non-homology based methods such as genomic context approaches for protein function prediction have been developed. Using non-homology based functional prediction methods, we were able to assign cellular processes or physical complexes for 249 hypothetical sequences. Our re-annotation pipeline highlights the addition of 231 new CDSs generated from MicroScope Platform, to the original genome with functional prediction for 49 of them. The re-annotation of HPs and new CDSs is stored in the relational database that is available on the MicroScope web-based platform. In parallel, a comparative genome analyses were performed among the members of genus Caldicellulosiruptor to understand the function and evolutionary processes. Further, with results from integrated re-annotation studies (homology and genomic context approach), we strongly suggest that Csac_0437 and Csac_0424 encode for glycoside hydrolases (GH) and are proposed to be involved in the decomposition of recalcitrant plant polysaccharides. Similarly, HPs: Csac_0732, Csac_1862, Csac_1294 and Csac_0668 are suggested to play a significant role in biohydrogen production. Function prediction of these HPs by using our integrated approach will considerably enhance the interpretation of large-scale experiments targeting this industrially important organism.	[Chowdhary, Nupoor; Selvaraj, Ashok; KrishnaKumaar, Lakshmi; Kumar, Gopal Ramesh] Anna Univ, AU KBC Res Ctr, Chennai 600044, Tamil Nadu, India	Anna University; Anna University Chennai	Kumar, GR (corresponding author), Anna Univ, AU KBC Res Ctr, MIT Campus, Chennai 600044, Tamil Nadu, India.	grameshpub@au-kbc.org			Department of Science and Technology under "Women Scientists Scheme (WOS)-A" [SR/WOS-A/LS-362/2013]	Department of Science and Technology under "Women Scientists Scheme (WOS)-A"(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	Nupoor Chowdhary sincerely thanks Department of Science and Technology for financial assistance under "Women Scientists Scheme (WOS)-A" (File No.-SR/WOS-A/LS-362/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson GD, 1997, BBA-GENE STRUCT EXPR, V1354, P35, DOI 10.1016/S0167-4781(97)00123-1; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benemann JR, 1997, INT J HYDROGEN ENERG, V22, P979, DOI 10.1016/S0360-3199(96)00189-9; Bielen Abraham A. M., 2013, Life-Basel, V3, P52, DOI 10.3390/life3010052; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Cheng F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00198; D'Afonseca V, 2012, OPEN ACCESS BIOINFOR, V4, P1, DOI DOI 10.2147/OAB.S25500; Das D, 2001, INT J HYDROGEN ENERG, V26, P13, DOI 10.1016/S0360-3199(00)00058-6; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Vrije T, 2007, APPL MICROBIOL BIOT, V74, P1358, DOI 10.1007/s00253-006-0783-x; de Vrije T, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-12; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doerks T, 2004, NUCLEIC ACIDS RES, V32, P6321, DOI 10.1093/nar/gkh973; Doerks T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034302; Eng J, 2015, ROC ANAL WEB BASED C; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Godzik A, 2005, STRUCTURAL BIOINFORM, V44, P525; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallenbeck PC, 2009, TRENDS BIOTECHNOL, V27, P287, DOI 10.1016/j.tibtech.2009.02.004; HUDSON RC, 1991, BIOCHEM J, V273, P645, DOI 10.1042/bj2730645; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kalia VC, 2003, TRENDS BIOTECHNOL, V21, P152, DOI 10.1016/S0167-7799(03)00028-3; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAMED R, 1988, ADV APPL MICROBIOL, V33, P1, DOI 10.1016/S0065-2164(08)70203-X; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee R. A., 2013, Animal Frontiers, V3, P6, DOI 10.2527/af.2013-0010; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; LOVE DR, 1987, BIO-TECHNOL, V5, P384, DOI 10.1038/nbt0487-384; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; LUTHI E, 1991, APPL ENVIRON MICROB, V57, P694; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nandi R, 1998, CRIT REV MICROBIOL, V24, P61, DOI 10.1080/10408419891294181; Ofran Y, 2005, DRUG DISCOV TODAY, V10, P1475, DOI 10.1016/S1359-6446(05)03621-4; Ooi HS, 2009, NUCLEIC ACIDS RES, V37, pW435, DOI 10.1093/nar/gkp254; RAINEY FA, 1994, FEMS MICROBIOL LETT, V120, P263, DOI 10.1016/0378-1097(94)90481-2; Rajadurai CP, 2013, INDIAN J BIOTECHNOL, V12, P356; Rajadurai CP, 2011, CURR BIOINFORM, V6, P450; SCHMITZ O, 1995, EUR J BIOCHEM, V233, P266, DOI 10.1111/j.1432-1033.1995.266_1.x; SCHOFIELD LR, 1993, INT J BIOCHEM, V25, P609, DOI 10.1016/0020-711X(93)90670-A; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; SMITH ET, 1992, BIOCHEM J, V285, P181, DOI 10.1042/bj2850181; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Ueno Y, 1996, J FERMENT BIOENG, V82, P194, DOI 10.1016/0922-338X(96)85050-1; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; VanFossen AL, 2008, ANN NY ACAD SCI, V1125, P322, DOI 10.1196/annals.1419.017; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Willquist K, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-89; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhou Y, 2007, NUCLEIC ACIDS RES, V35, pW678, DOI 10.1093/nar/gkm278	63	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133183	10.1371/journal.pone.0133183	http://dx.doi.org/10.1371/journal.pone.0133183			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196387	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600067
J	Rowe, W; Baker, KS; Verner-Jeffreys, D; Baker-Austin, C; Ryan, JJ; Maskell, D; Pearce, G				Rowe, Will; Baker, Kate S.; Verner-Jeffreys, David; Baker-Austin, Craig; Ryan, Jim J.; Maskell, Duncan; Pearce, Gareth			Search Engine for Antimicrobial Resistance: A Cloud Compatible Pipeline and Web Interface for Rapidly Detecting Antimicrobial Resistance Genes Directly from Sequence Data	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; IDENTIFICATION; METAGENOME; ALIGNMENT	Background Antimicrobial resistance remains a growing and significant concern in human and veterinary medicine. Current laboratory methods for the detection and surveillance of antimicrobial resistant bacteria are limited in their effectiveness and scope. With the rapidly developing field of whole genome sequencing beginning to be utilised in clinical practice, the ability to interrogate sequencing data quickly and easily for the presence of antimicrobial resistance genes will become increasingly important and useful for informing clinical decisions. Additionally, use of such tools will provide insight into the dynamics of antimicrobial resistance genes in metagenomic samples such as those used in environmental monitoring. Results Here we present the Search Engine for Antimicrobial Resistance (SEAR), a pipeline and web interface for detection of horizontally acquired antimicrobial resistance genes in raw sequencing data. The pipeline provides gene information, abundance estimation and the reconstructed sequence of antimicrobial resistance genes; it also provides web links to additional information on each gene. The pipeline utilises clustering and read mapping to annotate full-length genes relative to a user-defined database. It also uses local alignment of annotated genes to a range of online databases to provide additional information. We demonstrate SEAR's application in the detection and abundance estimation of antimicrobial resistance genes in two novel environmental metagenomes, 32 human faecal microbiome datasets and 126 clinical isolates of Shigella sonnei. Conclusions We have developed a pipeline that contributes to the improved capacity for antimicrobial resistance detection afforded by next generation sequencing technologies, allowing for rapid detection of antimicrobial resistance genes directly from sequencing data. SEAR uses raw sequencing data via an intuitive interface so can be run rapidly without requiring advanced bioinformatic skills or resources. Finally, we show that SEAR is effective in detecting antimicrobial resistance genes in metagenomic and isolate sequencing data from both environmental metagenomes and sequencing data from clinical isolates.	[Rowe, Will; Maskell, Duncan; Pearce, Gareth] Univ Cambridge, Dept Vet Med, Cambridge, England; [Baker, Kate S.] Wellcome Trust Sanger Inst, Cambridge, England; [Verner-Jeffreys, David; Baker-Austin, Craig] Ctr Environm Fisheries & Aquaculture Sci, Weymouth, MA USA; [Ryan, Jim J.] GlaxoSmithKline, Environm Hlth & Safety, Ware, Herts, England	University of Cambridge; Wellcome Trust Sanger Institute; GlaxoSmithKline	Rowe, W (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	wpmr2@cam.ac.uk	Pearce, Gareth P/D-1044-2013; Baker, Kate/P-2087-2016	Baker, Kate/0000-0001-5850-1949; Rowe, Will/0000-0003-0384-4463; Pearce, Gareth/0000-0002-0656-6553	GlaxoSmithKline; Centre for Environment, Fisheries and Aquaculture Science; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [1075426] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Centre for Environment, Fisheries and Aquaculture Science; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by GlaxoSmithKline, the Centre for Environment, Fisheries and Aquaculture Science and the Biotechnology and Biological Sciences Research Council under an industrial CASE studentship. The funder Centre for Environment, Fisheries and Aquaculture Science provided support in the form of salaries, research materials and facilities for authors DVJ and CBA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder GlaxoSmithKline provided support in the form of salaries for author JR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; CDC CfDCaP, 2013, ANT RES THREATS US; Diekema DJ, 2013, CLIN INFECT DIS, V56, P1614, DOI 10.1093/cid/cit038; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Heiman KE, 2014, MMWR-MORBID MORTAL W, V63, P132; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Illumina, 2013, ILL MYSEQ BENCHT SEQ; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Kidenya BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057527; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lewin A, 2014, ENVIRON MICROBIOL, V16, P545, DOI 10.1111/1462-2920.12181; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Miller RR, 2013, GENOME MED, V5, DOI 10.1186/gm485; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Oh S, 2013, ENVIRON MICROBIOL, V15, P2850, DOI 10.1111/1462-2920.12154; Port JA, 2014, ENVIRON HEALTH PERSP, V122, P222, DOI 10.1289/ehp.1307009; Rozen S, 1988, PRIMER3; Sack D.A., 2001, ANTIMICROBIAL RESIST; Tsafnat G, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar054; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	33	36	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133492	10.1371/journal.pone.0133492	http://dx.doi.org/10.1371/journal.pone.0133492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197475	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600104
J	Subbaraman, R; Nolan, L; Sawant, K; Shitole, S; Shitole, T; Nanarkar, M; Patil-Deshmukh, A; Bloom, DE				Subbaraman, Ramnath; Nolan, Laura; Sawant, Kiran; Shitole, Shrutika; Shitole, Tejal; Nanarkar, Mahesh; Patil-Deshmukh, Anita; Bloom, David E.			Multidimensional Measurement of Household Water Poverty in a Mumbai Slum: Looking Beyond Water Quality	PLOS ONE			English	Article							FECAL CONTAMINATION; DRINKING-WATER; HEALTH; INDIA; ACCESS; SANITATION; QUANTITY; DELIVERY; MAPUTO; POWER	Objective A focus on bacterial contamination has limited many studies of water service delivery in slums, with diarrheal illness being the presumed outcome of interest. We conducted a mixed methods study in a slum of 12,000 people in Mumbai, India to measure deficiencies in a broader array of water service delivery indicators and their adverse life impacts on the slum's residents. Methods Six focus group discussions and 40 individual qualitative interviews were conducted using purposeful sampling. Quantitative data on water indicators-quantity, access, price, reliability, and equity-were collected via a structured survey of 521 households selected using population-based random sampling. Results In addition to negatively affecting health, the qualitative findings reveal that water service delivery failures have a constellation of other adverse life impacts-on household economy, employment, education, quality of life, social cohesion, and people's sense of political inclusion. In a multivariate logistic regression analysis, price of water is the factor most strongly associated with use of inadequate water quantity (<= 20 liters per capita per day). Water service delivery failures and their adverse impacts vary based on whether households fetch water or have informal water vendors deliver it to their homes. Conclusions Deficiencies in water service delivery are associated with many non-health-related adverse impacts on slum households. Failure to evaluate non-health outcomes may underestimate the deprivation resulting from inadequate water service delivery. Based on these findings, we outline a multidimensional definition of household "water poverty" that encourages policymakers and researchers to look beyond evaluation of water quality and health. Use of multidimensional water metrics by governments, slum communities, and researchers may help to ensure that water supplies are designed to advance a broad array of health, economic, and social outcomes for the urban poor.	[Subbaraman, Ramnath; Sawant, Kiran; Shitole, Shrutika; Shitole, Tejal; Nanarkar, Mahesh; Patil-Deshmukh, Anita] PUKAR, Bombay, Maharashtra, India; [Subbaraman, Ramnath] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Subbaraman, Ramnath] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nolan, Laura] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Off Populat Res, Princeton, NJ 08544 USA; [Bloom, David E.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Princeton University; Harvard University; Harvard T.H. Chan School of Public Health	Subbaraman, R (corresponding author), PUKAR, Bombay, Maharashtra, India.	ramnath.sub@gmail.com	Kuang, Jinyi/L-8488-2017	Kuang, Jinyi/0000-0003-4173-3246; Subbaraman, Ramnath/0000-0002-2063-943X	Fogarty International Clinical Research Fellows Program at Vanderbilt University [R24 TW007988]; Harvard T32 post-doctoral research fellowship (NIAID) [AI007433]; National Institutes of Health [5T32HD007163]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R24HD047879]; Weatherhead Center for International Affairs at Harvard University; Rockefeller Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879, T32HD007163] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER	Fogarty International Clinical Research Fellows Program at Vanderbilt University; Harvard T32 post-doctoral research fellowship (NIAID); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Weatherhead Center for International Affairs at Harvard University; Rockefeller Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RS was funded by the Fogarty International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988) and a Harvard T32 post-doctoral research fellowship (NIAID AI007433). LN was supported by the National Institutes of Health (5T32HD007163) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (5R24HD047879). The Weatherhead Center for International Affairs at Harvard University and the Rockefeller Foundation provided additional funding. No funding bodies had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiga H, 1999, Environ Health Prev Med, V4, P111, DOI 10.1007/BF02932265; Aiga H, 2002, SOC SCI MED, V55, P627, DOI 10.1016/S0277-9536(01)00192-7; Alam MJ, 2007, BRAC U J, V4, P103; [Anonymous], 1999, DEV FREEDOM; Appadurai A, 2006, GLOB SOC EDUC, V4, P167, DOI 10.1080/14767720600750696; Bakker K, 2008, WORLD DEV, V36, P1891, DOI 10.1016/j.worlddev.2007.09.015; Bhatt J, 2014, WATER POLICY, V16, P102, DOI 10.2166/wp.2013.083; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Carolini GY, 2012, AM J PUBLIC HEALTH, V102, P256, DOI 10.2105/AJPH.2011.300399; Clasen TF, 2012, TROP MED INT HEALTH, V17, P1178, DOI 10.1111/j.1365-3156.2012.03052.x; Copeland CC, 2009, J WATER HEALTH, V7, P324, DOI 10.2166/wh.2009.081; Creswell J. W., 2012, BEST PRACTICES MIXED; Cumming O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114699; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Dreze J., 2002, ECON POLIT WEEKLY, P817; Galiani S, 2009, ECONOMICA, V76, P607, DOI 10.1111/j.1468-0335.2008.00719.x; Howard G., 2003, DOMESTIC WATER QUANT; Jain B, 2013, TIMES OF INDIA  0418; Kayser GL, 2013, INT J ENV RES PUB HE, V10, P4812, DOI 10.3390/ijerph10104812; Kimani-Murage EW, 2007, J URBAN HEALTH, V84, P829, DOI 10.1007/s11524-007-9199-x; Lawrence P.R., 2002, WATER POVERTY INDEX; Murthy SL, 2012, HEALTH HUM RIGHTS, V14, P61; Nolan LB, 2015, POPUL DEV REV, V41, P59, DOI 10.1111/j.1728-4457.2015.00026.x; Obeng-Odoom F, 2012, DEV PRACT, V22, P1135, DOI 10.1080/09614524.2012.714744; Oswald WE, 2007, AM J TROP MED HYG, V77, P699, DOI 10.4269/ajtmh.2007.77.699; Palit A, 2012, WATER SCI TECHNOL, V66, P299, DOI 10.2166/wst.2012.177; Pandey P, 2007, JAMA-J AM MED ASSOC, V298, P1867, DOI 10.1001/jama.298.16.1867; Patel S, 2002, ENVIRON URBAN, V14, P159, DOI 10.1177/095624780201400113; Patel S, 2012, ENVIRON URBAN, V24, P13, DOI 10.1177/0956247812438366; Peloso M, 2014, WATER ALTERN, V7, P121; Shaheed A, 2014, B WORLD HEALTH ORGAN, V92, P283, DOI 10.2471/BLT.13.119594; Stelmach RD, 2015, INT J ENV RES PUB HE, V12, P5954, DOI 10.3390/ijerph120605954; Subbaraman R, 2014, SOC SCI MED, V119, P155, DOI 10.1016/j.socscimed.2014.08.021; Subbaraman R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-173; Subbaraman R, 2012, ENVIRON URBAN, V24, P643, DOI 10.1177/0956247812456356; Sullivan CA, 2003, NAT RESOUR FORUM, V27, P189, DOI 10.1111/1477-8947.00054; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UN-HABITAT, 2002, DEF SLUMS OP DEF MEA; UN-Habitat, 2013, STAT WORLDS CIT 2012; United Nations, 2014, OPEN WORKING GROUP G, V24, P1; VANDERSLICE J, 1993, WATER RESOUR RES, V29, P1983, DOI 10.1029/92WR02994; Wheeldon J., 2009, INT J QUAL METH, V8, P68, DOI [DOI 10.1177/160940690900800307, https://doi.org/10.1177/160940690900800307]; Wutich A, 2008, SOC SCI MED, V67, P2116, DOI 10.1016/j.socscimed.2008.09.042	43	31	31	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133241	10.1371/journal.pone.0133241	http://dx.doi.org/10.1371/journal.pone.0133241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196295	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600076
J	Moreira-Souza, ACA; Marinho, Y; Correa, G; Santoro, GF; Coutinho, CMLM; Vommaro, RC; Coutinho-Silva, R				Abreu Moreira-Souza, Aline Cristina; Marinho, Ygor; Correa, Gladys; Santoro, Giani Franca; Lara Melo Coutinho, Claudia Mara; Vommaro, Rossiane Claudia; Coutinho-Silva, Robson			Pyrimidinergic Receptor Activation Controls Toxoplasma gondii Infection in Macrophages	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; SIGNALING CASCADES; IMMUNE-RESPONSE; HOST-CELLS; UTP; APOPTOSIS; INVASION; TRIGGERS; EGRESS; STORES	Infection by the protozoan parasite Toxoplasma gondii is highly prevalent worldwide and may have serious clinical manifestations in immunocompromised patients. T. gondii is an obligate intracellular parasite that infects almost any cell type in mammalian hosts, including immune cells. The immune cells express purinergic P2 receptors in their membrane subdivided into P2Y and P2X subfamilies - whose activation is important for infection control. Here, we examined the effect of treatment with UTP and UDP in mouse peritoneal macrophages infected with T. gondii tachyzoites. Treatment with these nucleotides reduced parasitic load by 90%, but did not increase the levels of the inflammatory mediators NO and ROS, nor did it modulate host cell death by apoptosis or necrosis. On the other hand, UTP and UDP treatments induced early egress of tachyzoites from infected macrophages, in a Ca2+-dependent manner, as shown by scanning electron microscopy analysis, and video-microscopy. In subsequent infections, prematurely egressed parasites had reduced infectivity, and could neither replicate nor inhibit the fusion of lysosomes to the parasitophorous vacuole. The use of selective agonists and antagonists of the receptor subtypes P2Y(2) and P2Y(4) and P2Y(6) showed that premature parasite egress may be mediated by the activation of these receptor subtypes. Our results suggest that the activity of P2Y host cell receptors controls T. gondii infection in macrophages, highlighting the importance of pyrimidinergic signaling for innate immune system response against infection. Finally the P2Y receptors should be considered as new target for the development of drugs against T. gondii infection.	[Abreu Moreira-Souza, Aline Cristina; Marinho, Ygor; Correa, Gladys; Santoro, Giani Franca; Coutinho-Silva, Robson] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Imunofisiol, BR-21941902 Rio De Janeiro, RJ, Brazil; [Santoro, Giani Franca; Lara Melo Coutinho, Claudia Mara] Fiocruz MS, Inst Oswaldo Cruz, LITEB, BR-21040900 Rio De Janeiro, RJ, Brazil; [Lara Melo Coutinho, Claudia Mara] Univ Fed Fluminense, Inst Biol, BR-24020140 Niteroi, RJ, Brazil; [Abreu Moreira-Souza, Aline Cristina; Correa, Gladys; Vommaro, Rossiane Claudia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941902 Rio De Janeiro, RJ, Brazil; [Abreu Moreira-Souza, Aline Cristina; Marinho, Ygor; Correa, Gladys; Santoro, Giani Franca; Coutinho-Silva, Robson] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Pesquisa Translac Saud, BR-21941902 Rio de Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Coutinho-Silva, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Imunofisiol, BR-21941902 Rio De Janeiro, RJ, Brazil.	rcsilva@biof.ufrj.br	vommaro, Rossiane/AAD-7193-2021; Coutinho-Silva, Robson/M-4690-2013	Coutinho-Silva, Robson/0000-0002-7318-0204; Moreira-Souza, Aline Cristina Abreu/0000-0002-9814-340X; Vommaro, Rossiane/0000-0003-4768-1555; Correa, Gladys/0000-0002-9707-7615	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa de Nucleos de Excelencia (PRONEX); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica INPeTAm/UFRJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica INPeTAm/UFRJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Programa de Nucleos de Excelencia (PRONEX), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica INPeTAm/UFRJ.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; Aliberti J, 2002, MOL IMMUNOL, V38, P891, DOI 10.1016/S0161-5890(02)00015-9; Bertaux L, 2008, PARASITE IMMUNOL, V30, P620, DOI 10.1111/j.1365-3024.2008.01064.x; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Caldas LA, 2007, VET PARASITOL, V147, P210, DOI 10.1016/j.vetpar.2007.05.012; Caldas LA, 2010, VET PARASITOL, V167, P8, DOI 10.1016/j.vetpar.2009.09.051; Correa G, 2010, MICROBES INFECT, V12, P497, DOI 10.1016/j.micinf.2010.03.004; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Coutinho-Silva R, 2007, PURINERG SIGNAL, V3, P83, DOI 10.1007/s11302-006-9039-6; Coutinho-Silva R, 2009, PURINERG SIGNAL, V5, P197, DOI 10.1007/s11302-009-9130-x; D'Angelillo A, 2011, APOPTOSIS, V16, P551, DOI 10.1007/s10495-011-0586-0; Denkers EY, 2003, FEMS IMMUNOL MED MIC, V39, P193, DOI 10.1016/S0928-8244(03)00279-7; Denkers EY, 2003, CELL MICROBIOL, V5, P75, DOI 10.1046/j.1462-5822.2003.00258.x; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Ko HJ, 2008, BIOORGAN MED CHEM, V16, P6319, DOI 10.1016/j.bmc.2008.05.013; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Lavine MD, 2008, EUKARYOT CELL, V7, P131, DOI 10.1128/EC.00301-07; Lazarowski ER, 2001, NEWS PHYSIOL SCI, V16, P1; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Magno RC, 2005, MICROSC RES TECHNIQ, V67, P45, DOI 10.1002/jemt.20182; Marques-da-Silva C, 2011, CELL MICROBIOL, V13, P1410, DOI 10.1111/j.1462-5822.2011.01630.x; Morandini Ana Carolina, 2014, Biomed J, V37, P169, DOI 10.4103/2319-4170.127803; Mordue DG, 1997, J IMMUNOL, V159, P4452; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rossi L, 2007, BLOOD, V109, P533, DOI 10.1182/blood-2006-01-035634; Shainberg A, 2009, CAN J PHYSIOL PHARM, V87, P287, DOI 10.1139/Y09-010; Sibley LD, 2003, TRAFFIC, V4, P581, DOI 10.1034/j.1600-0854.2003.00117.x; Yamamoto JH, 2000, J INFECT DIS, V181, P2018, DOI 10.1086/315494; Zhang Z, 2011, J IMMUNOL, V186, P5376, DOI 10.4049/jimmunol.1002946	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133502	10.1371/journal.pone.0133502	http://dx.doi.org/10.1371/journal.pone.0133502			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192447	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400097
J	Gardin, C; Ricci, S; Ferroni, L; Guazzo, R; Sbricoli, L; De Benedictis, G; Finotti, L; Isola, M; Bressan, E; Zavan, B				Gardin, Chiara; Ricci, Sara; Ferroni, Letizia; Guazzo, Riccardo; Sbricoli, Luca; De Benedictis, Giulia; Finotti, Luca; Isola, Maurizio; Bressan, Eriberto; Zavan, Barbara			Decellularization and Delipidation Protocols of Bovine Bone and Pericardium for Bone Grafting and Guided Bone Regeneration Procedures	PLOS ONE			English	Article							IN-VITRO; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; TISSUE REGENERATION; SINUS AUGMENTATION; BARRIER MEMBRANES; FUTURE-DIRECTIONS; CRITICAL-SIZE; DEFECTS; COLLAGEN	The combination of bone grafting materials with guided bone regeneration (GBR) membranes seems to provide promising results to restore bone defects in dental clinical practice. In the first part of this work, a novel protocol for decellularization and delipidation of bovine bone, based on multiple steps of thermal shock, washes with detergent and dehydration with alcohol, is described. This protocol is more effective in removal of cellular materials, and shows superior biocompatibility compared to other three methods tested in this study. Furthermore, histological and morphological analyses confirm the maintenance of an intact bone extracellular matrix (ECM). In vitro and in vivo experiments evidence osteoinductive and osteoconductive properties of the produced scaffold, respectively. In the second part of this study, two methods of bovine pericardium decellularization are compared. The osmotic shock-based protocol gives better results in terms of removal of cell components, biocompatibility, maintenance of native ECM structure, and host tissue reaction, in respect to the freeze/thaw method. Overall, the results of this study demonstrate the characterization of a novel protocol for the decellularization of bovine bone to be used as bone graft, and the acquisition of a method to produce a pericardium membrane suitable for GBR applications.	[Gardin, Chiara; Ferroni, Letizia; Zavan, Barbara] Univ Padua, Dept Biomed Sci, Padua, Italy; [Ricci, Sara; Guazzo, Riccardo; Sbricoli, Luca; Bressan, Eriberto] Univ Padua, Dept Neurosci, Padua, Italy; [De Benedictis, Giulia; Finotti, Luca; Isola, Maurizio] Univ Padua, Dept Anim Med Prod & Hlth, Padua, Italy	University of Padua; University of Padua; University of Padua	Ferroni, L (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	letizia.ferroni@unipd.it; barbara.zavan@unipd.it	De Benedictis, Giulia Maria/ABH-1546-2020; Sbricoli, Luca/AAX-2640-2020	De Benedictis, Giulia Maria/0000-0002-8422-6829; Sbricoli, Luca/0000-0003-2222-5764; Gardin, Chiara/0000-0003-3817-0032; Ferroni, Letizia/0000-0002-5457-0338	University of Padova (progetto di Ateneo) grant	University of Padova (progetto di Ateneo) grant	This research was supported by a University of Padova (progetto di Ateneo) grant to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Aral A, 2008, CLIN ORAL IMPLAN RES, V19, P612, DOI 10.1111/j.1600-0501.2007.01518.x; ASHLEY F L, 1959, Plast Reconstr Surg Transplant Bull, V23, P526, DOI 10.1097/00006534-195905000-00006; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bai M, 2014, J PERIODONTAL RES, V49, P499, DOI 10.1111/jre.12129; Becker W, 1996, J PERIODONTOL, V67, P641, DOI 10.1902/jop.1996.67.7.641; Berardinelli P, 2013, CLIN ORAL INVEST, V17, P1661, DOI 10.1007/s00784-012-0857-3; Bressan E, 2011, POLYMERS-BASEL, V3, P509, DOI 10.3390/polym3010509; CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Cucchi A, 2014, OPEN DENT J, V8, P194, DOI 10.2174/1874210601408010194; Cruz Gabriela Alessandra da, 2007, Braz. Dent. J., V18, P129, DOI 10.1590/S0103-64402007000200008; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dong JM, 2013, J SURG RES, V183, P56, DOI 10.1016/j.jss.2012.11.047; Donos N, 2004, CLIN ORAL IMPLAN RES, V15, P101, DOI 10.1111/j.1600-0501.2004.00986.x; Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P203, DOI 10.1034/j.1600-0501.2002.130211.x; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI 10.1055/s-0029-1215875; Ereno C, 2010, J BIOMED MATER RES A, V95A, P932, DOI 10.1002/jbm.a.32919; Estaca E, 2008, CLIN ORAL IMPLAN RES, V19, P1044, DOI 10.1111/j.1600-0501.2008.01557.x; FAGES J, 1994, BIOMATERIALS, V15, P650, DOI 10.1016/0142-9612(94)90162-7; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gardin C, 2012, STEM CELLS DEV, V21, P767, DOI 10.1089/scd.2011.0147; Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Guo TW, 2015, PHARMACOGN MAG, V11, P219, DOI 10.4103/0973-1296.149741; Hammerle CHF, 2003, PERIODONTOL 2000, V33, P36, DOI 10.1046/j.0906-6713.2003.03304.x; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Heinze J, 2004, ANN C INT ASS DENT R; Hirata HH, 2015, INJURY, V46, P1215, DOI 10.1016/j.injury.2015.03.039; Hsiong SX, 2006, PERIODONTOL 2000, V41, P109, DOI 10.1111/j.1600-0757.2006.00158.x; Jimbo R, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/279167; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Katz J, 2009, J BIOMATER APPL, V24, P159, DOI 10.1177/0885328208095174; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Keskin D, 2007, MED PRIN PRACT, V16, P299, DOI 10.1159/000102153; Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010; Kim JY, 2014, J ADV PROSTHODONT, V6, P539, DOI 10.4047/jap.2014.6.6.539; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai PH, 2006, TISSUE ENG, V12, P2499, DOI 10.1089/ten.2006.12.2499; Liu Jie, 2014, Open Dent J, V8, P56, DOI 10.2174/1874210601408010056; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mirsadraee S, 2007, J SURG RES, V143, P407, DOI 10.1016/j.jss.2007.01.026; Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Peng F, 2011, ACTA BIOMATER, V7, P2585, DOI 10.1016/j.actbio.2011.02.021; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips JE, 2006, J CELL SCI, V119, P581, DOI 10.1242/jcs.02758; Rakhmatia YD, 2013, J PROSTHODONT RES, V57, P3, DOI 10.1016/j.jpor.2012.12.001; Salata LA, 2001, CLIN ORAL IMPLAN RES, V12, P62, DOI 10.1034/j.1600-0501.2001.012001062.x; Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2; SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129; Seibel MJ, 2000, OSTEOPOROSIS INT, V11, P18; SHAPOFF CA, 1980, J PERIODONTOL, V51, P625, DOI 10.1902/jop.1980.51.11.625; Silva-Correia J, 2013, ADV HEALTHC MATER, V2, P568, DOI 10.1002/adhm.201200256; Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233; Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thomaidis V, 2008, MED SCI MONITOR, V14, pBR67; Wang YB, 2013, MAT SCI ENG C-MATER, V33, P3489, DOI 10.1016/j.msec.2013.04.038; Zhang NL, 2014, CELL TISSUE BANK, V15, P357, DOI 10.1007/s10561-013-9391-z	65	62	62	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132344	10.1371/journal.pone.0132344	http://dx.doi.org/10.1371/journal.pone.0132344			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191793	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400022
J	Hancock, LG; Walker, SE; Perez-Huerta, A; Bowser, SS				Hancock, Leanne G.; Walker, Sally E.; Perez-Huerta, Alberto; Bowser, Samuel S.			Population Dynamics and Parasite Load of a Foraminifer on Its Antarctic Scallop Host with Their Carbonate Biomass Contributions	PLOS ONE			English	Article							GLOBAL OCEAN CARBONATE; MCMURDO SOUND; ADAMUSSIUM-COLBECKI; EXPLORERS COVE; SEA-ICE; BENTHIC FORAMINIFERA; ORGANIC-CARBON; FOOD WEBS; ROSS SEA; DIVERSITY	We studied the population dynamics and parasite load of the foraminifer Cibicides antarcticus on its host the Antarctic scallop Adamussium colbecki from three localities differing by sea ice cover within western McMurdo Sound, Ross Sea, Antarctica: Explorers Cove, Bay of Sails and Herbertson Glacier. We also estimated CaCO3 biomass and annual production for both species. Cibicides populations varied by locality, valve type, and depth. Explorers Cove with multiannual sea ice had larger populations than the two annual sea ice localities, likely related to differences in nutrients. Populations were higher on Adamussium top valves, a surface that is elevated above the sediment. Depth did not affect Cibicides distributions except at Bay of Sails. Cibicides parasite load (the number of complete boreholes in Adamussium valves) varied by locality between 2% and 50%. For most localities the parasite load was < 20%, contrary to a previous report that similar to 50% of Cibicides were parasitic. The highest and lowest parasite load occurred at annual sea ice localities, suggesting that sea ice condition is not important. Rather, the number of adults that are parasitic could account for these differences. Cibicides bioerosion traces were categorized into four ontogenetic stages, ranging from newly attached recruits to parasitic adults. These traces provide an excellent proxy for population structure, revealing that Explorers Cove had a younger population than Bay of Sails. Both species are important producers of CaCO3. Cibicides CaCO3 biomass averaged 47-73 kg ha(-1) and Adamussium averaged 4987-6806 kg ha(-1) by locality. Annual production rates were much higher. Moreover, Cibicides represents 1.0-2.3% of the total host-parasite CaCO3 biomass. Despite living in the coldest waters on Earth, these species can contribute a substantial amount of CaCO3 to the Ross Sea and need to be incorporated into food webs, ecosystem models, and carbonate budgets for Antarctica.	[Hancock, Leanne G.; Walker, Sally E.] Univ Georgia, Dept Geol, Athens, GA 30602 USA; [Perez-Huerta, Alberto] Univ Alabama, Dept Geol Sci, Tuscaloosa, AL USA; [Bowser, Samuel S.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA	University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Tuscaloosa; State University of New York (SUNY) System; Wadsworth Center	Walker, SE (corresponding author), Univ Georgia, Dept Geol, Athens, GA 30602 USA.	swalker@gly.uga.edu			NSF from Polar Programs Earth Sciences [ANT 0739512, ANT 0739583]; NSF from Office of Polar Programs (Biology) [PLR 0944646, PLR 0433575]; Directorate For Geosciences [0944646] Funding Source: National Science Foundation	NSF from Polar Programs Earth Sciences; NSF from Office of Polar Programs (Biology); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	NSF grants from Polar Programs Earth Sciences: ANT 0739512 and ANT 0739583. NSF grants from Office of Polar Programs (Biology): PLR 0944646 and PLR 0433575.	ALEXANDER SP, 1987, BIOL BULL, V173, P136, DOI 10.2307/1541868; ANDERSON JB, 1975, MAR GEOL, V19, P315, DOI 10.1016/0025-3227(75)90083-3; [Anonymous], 1995, OCEANOGR; Arrigo KR, 2014, ANNU REV MAR SCI, V6, P439, DOI 10.1146/annurev-marine-010213-135103; BARRY JP, 1988, POLAR BIOL, V8, P367, DOI 10.1007/BF00442028; Berkman P.A., 1990, P281; BERNHARD JM, 1987, J FORAMIN RES, V17, P286, DOI 10.2113/gsjfr.17.4.286; BERNHARD JM, 1989, LIMNOL OCEANOGR, V34, P1131, DOI 10.4319/lo.1989.34.6.1131; Beuck L, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P329, DOI 10.1007/978-3-540-77598-0_17; BOWSER SS, 1993, J EUKARYOT MICROBIOL, V40, P121, DOI 10.1111/j.1550-7408.1993.tb04891.x; Cerrano C, 2006, CHEM ECOL, V22, pS235; Chiantore M., 2000, P563; Chiantore MC, 2003, POLAR BIOL, V26, P416, DOI 10.1007/s00300-003-0491-2; Crawley M.J., 2005, STAT INTRO USING R, P1; CRENSHAW MA, 1972, BIOL BULL, V143, P506, DOI 10.2307/1540180; Culver SJ, 2003, T GEOBIOL, V20, P7; Dayton P.K., 1990, P631; Dayton PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056939; DAYTON PK, 1986, POLAR BIOL, V6, P207, DOI 10.1007/BF00443397; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; DELACA TE, 1981, NATURE, V289, P287, DOI 10.1038/289287a0; DeLaca TE., 1985, ANTARCT J US, V20, P147; DUNBAR RB, 1989, MAR GEOL, V85, P155, DOI 10.1016/0025-3227(89)90152-7; Ebert D, 2001, ECOLOGY, V82, P3417; Fountain AG, 2006, J GLACIOL, V52, P451, DOI 10.3189/172756506781828511; Freiwald A, 1996, MAR MICROPALEONTOL, V28, P199, DOI 10.1016/0377-8398(96)00002-3; Gazdzicki Andrzej, 1996, Palaeontologia Polonica, V55, P147; GOODAY AJ, 1992, NATO ADV SCI I C-MAT, V360, P63; Gooday AJ, 1996, PROG OCEANOGR, V37, P117, DOI 10.1016/S0079-6611(96)00007-9; Hatcher MJ, 2012, FRONT ECOL ENVIRON, V10, P186, DOI 10.1890/110016; Hauck J, 2012, J MARINE SYST, V90, P77, DOI 10.1016/j.jmarsys.2011.09.005; Heilmayer O, 2003, J EXP MAR BIOL ECOL, V288, P239, DOI 10.1016/S0022-0981(03)00020-0; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; Huntley JW, 2007, J SHELLFISH RES, V26, P253, DOI 10.2983/0730-8000(2007)26[253:TEAMBF]2.0.CO;2; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Langer MR, 1997, J FORAMIN RES, V27, P271, DOI 10.2113/gsjfr.27.4.271; Lartaud F, 2010, J EXP MAR BIOL ECOL, V393, P158, DOI 10.1016/j.jembe.2010.07.016; LEVENTER A, 1987, MAR MICROPALEONTOL, V12, P49, DOI 10.1016/0377-8398(87)90013-2; Lipps J.H., 1983, Topics in Geobiology, V3, P331; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Mager SM, 2013, PROG PHYS GEOG, V37, P468, DOI 10.1177/0309133313479815; McClintock JB, 2010, ANTARCT SCI, V22, P173, DOI 10.1017/S0954102009990757; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Mojtahid M, 2011, J EXP MAR BIOL ECOL, V399, P25, DOI 10.1016/j.jembe.2011.01.011; MULLINEAUX LS, 1984, POLAR BIOL, V3, P185, DOI 10.1007/BF00292622; Murray J, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; Pawlowski J, 2002, POLAR BIOL, V25, P96, DOI 10.1007/s003000100317; Poulin R., 2007, EVOLUTIONARY ECOLOGY, P1; Pullan RL, 2012, PARASITOLOGY, V139, P1870, DOI 10.1017/S0031182012000698; Quaglio F, 2010, POL POLAR RES, V31, P291, DOI 10.2478/v10183.010.0006.0; R Core Team, 2012, R LANG ENV STAT COMP; Radford D, 2014, J FORAMIN RES, V44, P255, DOI 10.2113/gsjfr.44.3.255; Richardson-White S, 2011, PALAEOGEOGR PALAEOCL, V312, P305, DOI 10.1016/j.palaeo.2011.02.021; Schiaparelli S, 2006, DEEP-SEA RES PT II, V53, P912, DOI 10.1016/j.dsr2.2006.02.004; Schonfeld J, 2002, DEEP-SEA RES PT I, V49, P1853, DOI 10.1016/S0967-0637(02)00088-2; Schweizer M, 2012, J FORAMIN RES, V42, P340, DOI 10.2113/gsjfr.42.4.340; Schweizer M, 2009, J FORAMIN RES, V39, P300, DOI 10.2113/gsjfr.39.4.300; Sen Gupta BK, 2009, MODERN FORAMINIFERA, P3; Smith WO, 2007, PHILOS T R SOC B, V362, P95, DOI 10.1098/rstb.2006.1956; STOCKTON WL, 1984, MAR BIOL, V78, P171, DOI 10.1007/BF00394697; Suhr SB, 2008, MAR ECOL PROG SER, V371, P155, DOI 10.3354/meps07693; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Walker SE, 2011, PALAEOGEOGR PALAEOCL, V312, P325, DOI 10.1016/j.palaeo.2011.04.028; Wisshak M, 2006, FACIES, V52, P1, DOI 10.1007/s10347-005-0033-1; Wolinska J, 2011, J PLANKTON RES, V33, P1284, DOI 10.1093/plankt/fbr016; ZUMWALT GS, 1980, J PALEONTOL, V54, P477	73	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132534	10.1371/journal.pone.0132534	http://dx.doi.org/10.1371/journal.pone.0132534			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186724	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700048
J	DeLuca, S; Khar, K; Meiler, J				DeLuca, Samuel; Khar, Karen; Meiler, Jens			Fully Flexible Docking of Medium Sized Ligand Libraries with RosettaLigand	PLOS ONE			English	Article							MOLECULAR DOCKING; PROTEIN; PREDICTION; DESIGN	RosettaLigand has been successfully used to predict binding poses in protein-small molecule complexes. However, the RosettaLigand docking protocol is comparatively slow in identifying an initial starting pose for the small molecule (ligand) making it unfeasible for use in virtual High Throughput Screening (vHTS). To overcome this limitation, we developed a new sampling approach for placing the ligand in the protein binding site during the initial 'low-resolution' docking step. It combines the translational and rotational adjustments to the ligand pose in a single transformation step. The new algorithm is both more accurate and more time-efficient. The docking success rate is improved by 10-15% in a benchmark set of 43 protein/ligand complexes, reducing the number of models that typically need to be generated from 1000 to 150. The average time to generate a model is reduced from 50 seconds to 10 seconds. As a result we observe an effective 30-fold speed increase, making RosettaLigand appropriate for docking medium sized ligand libraries. We demonstrate that this improved initial placement of the ligand is critical for successful prediction of an accurate binding position in the 'high-resolution' full atom refinement step.	[DeLuca, Samuel; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37240 USA; [Khar, Karen] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA	Vanderbilt University; University of Kansas	Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37240 USA.	jens@meilerlab.org		Meiler, Jens/0000-0001-8945-193X	PhRMA foundation; NIH [R01 GM080403, R01 GM099842, R01 DK097376]; NSF [CHE 1305874]; Direct For Mathematical & Physical Scien [1305874] Funding Source: National Science Foundation	PhRMA foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was funded by a Predoctoral fellowship from the PhRMA foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Work in the Meiler laboratory is supported through NIH (R01 GM080403, R01 GM099842, R01 DK097376) and NSF (CHE 1305874).	Bauer MR, 2013, J CHEM INF MODEL, V53, P1447, DOI [10.1021/ci400115b, 10.1021/ci400115bl]; BYSTROFF C, 1991, BIOCHEMISTRY-US, V30, P2227, DOI 10.1021/bi00222a028; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Davis IW, 2009, PROTEIN SCI, V18, P1998, DOI 10.1002/pro.192; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Hindle SA, 2002, J COMPUT AID MOL DES, V16, P129, DOI 10.1023/A:1016399411208; Kaufmann KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050769; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Lemmon G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067536; Lemmon G, 2012, CHEM BIOL DRUG DES, V79, P888, DOI 10.1111/j.1747-0285.2012.01356.x; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Reymond JL, 2012, WIRES COMPUT MOL SCI, V2, P717, DOI 10.1002/wcms.1104; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Turlington M, 2013, J MED CHEM, V56, P7976, DOI 10.1021/jm401028t; Zhang XH, 2013, J COMPUT CHEM, V34, P915, DOI 10.1002/jcc.23214	27	59	59	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132508	10.1371/journal.pone.0132508	http://dx.doi.org/10.1371/journal.pone.0132508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207742	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000030
J	Maama-Maime, LB; Mareka, M; Ershova, JV; Tlali, TE; Kao, K; Phalatse, M; Polansky, L; Beres, LK; Letsie, M; Holtz, TH				Maama-Maime, Llang B.; Mareka, Mathabo; Ershova, Julia V.; Tlali, Thabong E.; Kao, Kekeletso; Phalatse, Mamakhetha; Polansky, Lauren; Beres, Laura K.; Letsie, Moselinyane; Holtz, Timothy H.			Antituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons Learned	PLOS ONE			English	Article							TUBERCULOSIS	Setting Drug resistance is an increasing threat to tuberculosis (TB) control worldwide. The World Health Organization advises monitoring for drug resistance, with either ongoing surveillance or periodic surveys. Methods The antituberculosis drug resistance survey was conducted in Lesotho in 2008-2009. Basic demographic and TB history information was collected from individuals with positive sputum smear results at 17 diagnostic facilities. Additional sputum sample was sent to the national TB reference laboratory for culture and drug susceptibility testing. Results Among 3441 eligible smear-positive persons, 1121 (32.6%) were not requested to submit sputum for culture. Among 2320 persons submitted sputum, 1164 (50.2%) were not asked for clinical information or did not have valid sputum samples for testing. In addition, 445/ 2320 (19.2%) were excluded from analysis because of other laboratory or data management reasons. Among 984/3441 (28.6%) persons who had data available for analysis, MDR-TB was present in 24/773 (3.1%) of new and 25/195 (12.8%) of retreatment TB cases. Logistical, operational and data management challenges affected survey results. Conclusion MDR-TB is prevalent in Lesotho, but limitations reduced the reliability of our findings. Multiple lessons learned during this survey can be applied to improve the next drug resistance survey in Lesotho and other resource constrained countries may learn how to avoid these bottlenecks.	[Maama-Maime, Llang B.] Minist Hlth, Natl TB Programme, Maseru, Lesotho; [Mareka, Mathabo; Tlali, Thabong E.; Kao, Kekeletso; Phalatse, Mamakhetha] Minist Hlth, Lab Serv, Maseru, Lesotho; [Ershova, Julia V.; Polansky, Lauren; Holtz, Timothy H.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Beres, Laura K.] Emory Univ, Atlanta, GA 30322 USA; [Letsie, Moselinyane] Minist Hlth, Dis Control, Maseru, Lesotho	Centers for Disease Control & Prevention - USA; Emory University	Ershova, JV (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	jhe3@cdc.gov		Beres, Laura/0000-0002-4731-7828				[Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2007, KINGD LES ANN REP 20; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Kingdom of Lesotho, 2014, MILL DEV GOASL STAT; Moodley P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017513; ODonnell MR, 2013, EMERGING INFECT DIS, V19; Satti H, 2008, EMERG INFECT DIS, V14, P992, DOI 10.3201/eid1406.071654; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 4 WHO; World Health Organization, WHOHTMTB2009422	13	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133808	10.1371/journal.pone.0133808	http://dx.doi.org/10.1371/journal.pone.0133808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207630	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000149
J	Read, KB; Sheehan, JR; Huerta, MF; Knecht, LS; Mork, JG; Humphreys, BL				Read, Kevin B.; Sheehan, Jerry R.; Huerta, Michael F.; Knecht, Lou S.; Mork, James G.; Humphreys, Betsy L.		NIH Big Data Annotator Grp	Sizing the Problem of Improving Discovery and Access to NIH-Funded Data: A Preliminary Study	PLOS ONE			English	Article							PUBLICATION	Objective This study informs efforts to improve the discoverability of and access to biomedical datasets by providing a preliminary estimate of the number and type of datasets generated annually by research funded by the U.S. National Institutes of Health (NIH). It focuses on those datasets that are "invisible" or not deposited in a known repository. Methods We analyzed NIH-funded journal articles that were published in 2011, cited in PubMed and deposited in PubMed Central (PMC) to identify those that indicate data were submitted to a known repository. After excluding those articles, we analyzed a random sample of the remaining articles to estimate how many and what types of invisible datasets were used in each article. Results About 12% of the articles explicitly mention deposition of datasets in recognized repositories, leaving 88% that are invisible datasets. Among articles with invisible datasets, we found an average of 2.9 to 3.4 datasets, suggesting there were approximately 200,000 to 235,000 invisible datasets generated from NIH-funded research published in 2011. Approximately 87% of the invisible datasets consist of data newly collected for the research reported; 13% reflect reuse of existing data. More than 50% of the datasets were derived from live human or non-human animal subjects. Conclusion In addition to providing a rough estimate of the total number of datasets produced per year by NIH-funded researchers, this study identifies additional issues that must be addressed to improve the discoverability of and access to biomedical research data: the definition of a "dataset," determination of which (if any) data are valuable for archiving and preservation, and better methods for estimating the number of datasets of interest. Lack of consensus amongst annotators about the number of datasets in a given article reinforces the need for a principled way of thinking about how to identify and characterize biomedical datasets.	[Read, Kevin B.] NYU, Langone Med Ctr, Med Lib, New York, NY 11201 USA; [Sheehan, Jerry R.; Huerta, Michael F.; Knecht, Lou S.; Mork, James G.; Humphreys, Betsy L.] NIH, Natl Lib Med, Bethesda, MD 20892 USA; [NIH Big Data Annotator Grp] NIH, Bethesda, MD 20892 USA	New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA	Read, KB (corresponding author), NYU, Langone Med Ctr, Med Lib, New York, NY 11201 USA.	kevin.read@nyumc.org		Kochar, Preeti G./0000-0003-2109-1100; Read, Kevin/0000-0002-7511-9036	U.S. National Institutes of Health, National Library of Medicine; National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the Intramural Research Program of the U.S. National Institutes of Health, National Library of Medicine (NLM) and in part by an appointment to the NLM Associate Fellowship Program sponsored by the National Library of Medicine and administered by the Oak Ridge Institute for Science and Education.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 2005, SEC SOURC ID; [Anonymous], 2015, NAT I HLTH PLAN INCR; [Anonymous], 2000, PMC OP ACC SUBS; [Anonymous], 1993, MEDLINE PUBMED XML E; [Anonymous], 2005, ACKN ACK; [Anonymous], DAT MET SCHEM REP; [Anonymous], 2008, MET PROF DRYAD MET A; Arino AH, 2010, BIODIVERS INFORM, V7, P81, DOI [10.17161/bi.v7i2.3991, DOI 10.17161/BI.V7I2.3991]; Belter CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092590; Callaghan S., 2014, LEARN PUBL, V27, P15, DOI [10.1087/20140504, DOI 10.1087/20140504]; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chavan V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-S2; Costello MJ, 2013, TRENDS ECOL EVOL, V28, P454, DOI 10.1016/j.tree.2013.05.002; European Commission, 2013, ACCESS MEMORIAL SITE; European Research Council Scientific Council, 2014, OP ACC GUID RES RES; Government of Canada, 2015, TRIAG OP ACC POL PUB; Hinchliff CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098986; Holdren JP, 2013, COMMUNICATIONS  0222; Lindberg DAB, 2005, METHOD INFORM MED, V44, P483; LYNCH C, 2007, CTWATCH Q, V3, P5; Margolis R, 2014, J AM MED INFORM ASSN, V21, P957, DOI 10.1136/amiajnl-2014-002974; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; Mooney H, 2012, J LIBRARIANSHIP SCHO, V1, DOI [10.7710/2162-3309.1035, DOI 10.7710/2162-3309.1035]; National Institutes of Health Trans-NIH BioMedical Informatics Coordinating Committee, 2021, BIOMEDICAL INFORMATI; National Institutes of Health (US), NIH BUDG; Neveol A, 2011, BIOINFORMATICS, V27, P3306, DOI 10.1093/bioinformatics/btr573; Parsons MA., 2010, EOS T AM GEOPHYS UN, V91, P297, DOI [10.1029/2010EO340001, DOI 10.1029/2010E0340001, DOI 10.1029/2010EO340001]; Piwowar HA, 2011, P AM SOC INFORM SCI, V48, P1, DOI DOI 10.1002/MEET.2011.14504801337; Robinson-Garcia N, 2016, J ASSOC INF SCI TECH, V67, P2964, DOI 10.1002/asi.23529; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Rousidis Dimitris, 2014, Information Services & Use, V34, P279, DOI 10.3233/ISU-140746; Thoma GR, 2010, J WEB SEMANT, V8, P145, DOI 10.1016/j.websem.2010.04.001; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; W3C, 2014, DAT CAT VOC DCAT	35	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132735	10.1371/journal.pone.0132735	http://dx.doi.org/10.1371/journal.pone.0132735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207759	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000040
J	Bianucci, R; Habicht, ME; Buckley, S; Fletcher, J; Seiler, R; Ohrstrom, LM; Vassilika, E; Boni, T; Ruhli, FJ				Bianucci, Raffaella; Habicht, Michael E.; Buckley, Stephen; Fletcher, Joann; Seiler, Roger; Oehrstroem, Lena M.; Vassilika, Eleni; Boeni, Thomas; Ruehli, Frank J.			Shedding New Light on the 18th Dynasty Mummies of the Royal Architect Kha and His Spouse Merit	PLOS ONE			English	Article							EGYPTIAN MUMMY; ARCHAEOLOGIES	The mummies of Kha and his wife Merit were found intact in an undisturbed tomb in western Thebes near the ancient workers' village of Deir el-Medina. Previous MDCT (this abbreviation needs spelling out) investigations showed that the bodies of Kha and Merit did not undergo classical royal 18th Dynasty artificial mummification, which included removal of the internal organs. It was, therefore, concluded that the retention of the viscera in the body, combined with an absence of canopic jars in the burial chamber, meant the couple underwent a short and shoddy funerary procedure, despite their relative wealth at death. Nevertheless, all internal organs - brain, ocular bulbs/ocular nerves, thoracic and abdominal organs - showed a very good state of preservation, which contradicts the previous interpretation above. In order to better understand the type of mummification used to embalm these bodies, both wrapped mummies were reinvestigated using new generation X-ray imaging and chemical microanalyses Here we provide evidence that both individuals underwent a relatively high quality of mummification, fundamentally contradicting previous understanding. Elucidated "recipes", whose components had anti-bacterial and anti-insecticidal properties, were used to treat their bodies. The time and effort undoubtedly employed to embalm both Kha and Merit and the use of imported costly resins, notably Pistacia, do not support the previously held view that the two individuals were poorly mummified. Despite a lack of evisceration, the approach clearly allowed their in situ preservation as well as affording a fairly successful mummification.	[Bianucci, Raffaella] Univ Turin, Legal Med Sect, Lab Phys Anthropol, Dept Publ Hlth & Paediat Sci, Turin, Italy; [Bianucci, Raffaella] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Bianucci, Raffaella] Fac Med Marseille, Lab Anthropol Bioculturelle Droit Etique & Sante, F-13385 Marseille, France; [Habicht, Michael E.; Seiler, Roger; Boeni, Thomas; Ruehli, Frank J.] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland; [Buckley, Stephen; Fletcher, Joann] Univ York, BioArCh, York YO10 5DD, N Yorkshire, England; [Oehrstroem, Lena M.] Univ Zurich Hosp, Dept Radiol, CH-8091 Zurich, Switzerland; [Vassilika, Eleni] Fdn Museo Antichita Egizie Torino, Turin, Italy	University of Turin; University of Oslo; UDICE-French Research Universities; Aix-Marseille Universite; University of Zurich; University of York - UK; University of Zurich; University Zurich Hospital	Ruhli, FJ (corresponding author), Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland.	frank.ruehli@iem.uzh.ch	Habicht, Michael/AAF-4033-2020; Bianucci, Raffaella/AAW-1433-2020	Habicht, Michael/0000-0002-0193-9672	Pharos Research; Maxi Foundation	Pharos Research; Maxi Foundation	Funding for the chemical research was provided by Pharos Research. The activities of the IEM members are funded by the Maxi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred C, 1971, JEWELS PHARAOS EGYPT; Andrews C., 1990, ANCIENT EGYPTIAN JEW; Aufderheide A.C., 2003, SCI STUDY MUMMIES; Binder S., 2008, ACE STUDIES, V8, P161; Buckley SA, 1999, ANALYST, V124, P443, DOI 10.1039/a809022j; Buckley SA, 2004, NATURE, V431, P294, DOI 10.1038/nature02849; Buckley SA, 2001, NATURE, V413, P837, DOI 10.1038/35101588; Cesarani F, 2009, RADIOGRAPHICS, V29, P1191, DOI 10.1148/rg.294085246; Cockburn A, 1998, DIS ANCIENT CULTURES; Colombini MP, 2000, STUD CONSERV, V45, P19, DOI 10.2307/1506680; Curto S., 1968, J EGYPT ARCHAEOL, V54, P77; Curto S, 1980, ORIENS ANTIQ, V19, P147; Davies N de G., 1903, ROCK TOMBS EL AMAMA; Davis TM, 1907, TOMB IOIVA TOUIVOU; Delorenzi E, 1989, MUMMIE MUSEO EGIZIO; Derry DE, 1942, ASAE, V41, P240; Desroches-Noblecourt C, 1986, GRABKAMMER BURGERMEI; Edwards IES, 1978, TUTANCHAMUN GRAB SEI; FDI, 1971, INT DENT J, V21, P104; Fletcher J., 2004, SEARCH NEFERTITI; Fletcher J., 2014, AGYPTEN LEBEN STERBE; Gabolde M., 2013, ENIM, V6, P177; Habicht ME, 2011, NOFRETETE ECHNATON G; Habicht ME, 2014, GRABER PHARAONEN KON, P1; Habicht ME, 2015, AM J PHYS ANTHROPOL, V157, P519, DOI 10.1002/ajpa.22728; Harrell JA, 2002, ARCHAEOMETRY, V44, P285, DOI 10.1111/1475-4754.t01-1-00060; HERODOTUS, 1954, HISTORIES; Hornung E., 2006, ANCIENT EGYPTIAN CHR; Ikram S, 1998, MUMMY ANCIENT EGYPT; James TGH, 2000, TUTANCHAMUN; Jones J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103608; Koller J, 2003, NATURE, V425, P784, DOI 10.1038/425784a; Koller J, 1998, NATURE, V391, P343, DOI 10.1038/34809; Lilyquist C, 2004, TOMB TUTHMOSIS 3S FO; Lucas A., 1989, ANCIENT EGYPTIAN MAT, V4th; Martin G., 1991, HIDDEN TOMBS MEMPHIS; Martina MC, 2005, J BIOL RES, VLXXX, P42; Melcher AH, 1997, AM J PHYS ANTHROPOL, V103, P329, DOI 10.1002/(SICI)1096-8644(199707)103:3<329::AID-AJPA3>3.0.CO;2-L; Meskell L, 1999, AM J ARCHAEOL, V103, P181, DOI 10.2307/506744; Meskell L, 1998, WORLD ARCHAEOL, V29, P363, DOI 10.1080/00438243.1998.9980385; Millet NB, 1998, DIS ANCIENT CULTURES, P91; Moiso B., 2008, ERNESTO SCHIAPARELLI; Muller HW, 1998, SCHATZE PHARAONEN; Ohrstrom LM, 2015, ANAT REC; Pearson K, 1899, PHIL T R SOC LOND A, V192, P169, DOI [DOI 10.1098/RSTA.1899.0004, 10.1098/rsta.1899.0004]; Peck W.H., 1998, MUMMIES DIS ANCIENT, P15, DOI [DOI 10.1017/CBO9781139878340, 10.1017/CBO9781139878340, 10. 1017/CBO9781139878340]; Pliny, 1968, NATURAL HIST; Reeves NC, 1992, COMPLETE TUTANKHAMUN; Ruhli FJ, 2015, ANAT REC; Rutica D, 2015, KLEIDUNG ALTEN UNPUB; Saleem SN, 2015, J COMPUT ASSIST TOMO, V39, P301, DOI 10.1097/RCT.0000000000000205; Saleem SN, 2013, AM J ROENTGENOL, V200, pW336, DOI 10.2214/AJR.12.9405; Saleh A, 2010, THE ROYAL MUMMIES; Saleh M, 1986, HAUPTWERKE AGYPTISCH; Schiaparelli E., 1927, TOMBA INTATTA ARCHIT; Schiaparelli Ernesto, 1927, TOMBA INTATTA ARCHIT; Schlogl HA, 2012, NOFRETETE WAHRHEIT S; Siculus Diodorus, 1935, LIB HIST; Smith G. E., 1923, TUTANKHAMEN DISCOVER; Smith GE., 1924, EGYPTIAN MUMMIES; Stierlin H, 1987, TANIS VERGESSENE SCH; Strabo, 1932, THE GEOGRAPHY; Sydler C, 2015, ANAT REC; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407; Vassilika E, 2010, THE TOMB OF KHA; Vernier E, 1911, BIFAO, V8, P15; Vogelsang-Eastwood GM, 1993, PHARAONIC EGYPTIAN C; Wade AD, 2013, HOMO, V64, P1, DOI 10.1016/j.jchb.2012.11.005; Watson PJ, 1987, COSTUME ANCIENT EGYP; Winlock H. E., 1948, TREASURE 3 EGYPTIAN; Yoyotte J, 1987, TANIS PHARAONS	71	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131916	10.1371/journal.pone.0131916	http://dx.doi.org/10.1371/journal.pone.0131916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN7EO	26200778	Green Published, gold, Green Accepted			2022-12-27	WOS:000358597100021
J	Reuter, M; Wiedl, T; Piller, WE				Reuter, Markus; Wiedl, Thomas; Piller, Werner E.			Parascolymia (Scleractinia: Lobophylliidae) in the Central Paratethys Sea (Vienna Basin, Austria) and its possible biogeographic implications	PLOS ONE			English	Article							CARBONATE PLATFORM; LEITHA LIMESTONE; MIOCENE REEFS; OLIGOCENE; CORALS; PACIFIC; EVOLUTION; ATLANTIC; FACIES; TRENDS	Palaeobiogeographical and palaeodiversity patterns of scleractinian reef corals are generally biased due to uncertain taxonomy and a loss of taxonomic characters through dissolution and recrystallization of the skeletal aragonite in shallow marine limestones. Herein, we describe a fossil lobophylliid coral in mouldic preservation from the early middle Miocene Leitha Limestone of the Central Paratethys Sea (Vienna Basin, Austria). By using grey-scale image inversion and silicone rubber casts for the visualization of the original skeletal anatomy and the detection of distinct micromorphological characters (i.e. shape of septal teeth, granulation of septocostae) Parascolymia bracherti has been identified as a new species in spite of the dissolved skeleton. In the recent era, Parascolymia like all Lobophylliidae is restricted to the Indo-Pacific region, where it is represented by a single species. The new species proves the genus also in the Miocene Mediterranean reef coral province. A review of the spatio-temporal relationships of fossil corals related to Parascolymia indicates that the genus was probably rooted in the Eastern Atlantic-Western Tethys region during the Paleocene to Eocene and reached the Indo-Pacific region not before the Oligocene. The revealed palaeobiogeographical pattern shows an obvious congruence with that of Acropora and tridacnine bivalves reflecting a gradual equatorwards retreat of the marine biodiversity center parallel to the Cenozoic climate deterioration.	[Reuter, Markus; Wiedl, Thomas; Piller, Werner E.] Graz Univ, Inst Earth Sci, Graz, Austria	University of Graz	Reuter, M (corresponding author), Graz Univ, Inst Earth Sci, Graz, Austria.	markus.reuter@uni-graz.at			Austrian Science Fund [P 23492-B17]; NAWI Graz Advanced School of Science; Austrian Science Fund (FWF) [P 23492] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); NAWI Graz Advanced School of Science; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work received funding from the Austrian Science Fund (https://www.fwf.ac.at) by grant P 23492-B17 to WEP and the NAWI Graz Advanced School of Science (http://www.nawigraz.at).	Alvarez G., 1994, Courier Forschungsinstitut Senckenberg, V172, P249; BARTA-CALMUS S, 1969, Bulletin du Museum National d'Histoire Naturelle, V41, P817; Barta-Calmus S, 1973, THESIS U PARIS 6; Bellwood D. R., 2012, BIOTIC EVOLUTION ENV, P216, DOI [10.1017/CBO9780511735882.011, DOI 10.1017/CBO9780511735882.011]; Beydoun ZR, 1970, Q J GEOL SOC LOND, V125, P413, DOI DOI 10.1144/GSJGS.125.1.0413; Bosellini FR, 2008, PALAEOGEOGR PALAEOCL, V258, P71, DOI 10.1016/j.palaeo.2007.10.028; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Budd AF, 2009, ACTA ZOOL-STOCKHOLM, V90, P142, DOI 10.1111/j.1463-6395.2008.00345.x; Cahuzac Bruno, 1996, Concepts in Sedimentology and Paleontology, V5, P105; Chaix Christian, 2001, Annales de Paleontologie, V87, P3, DOI 10.1016/S0753-3969(01)88001-0; CHEVALIER JEAN- PIERRE, 1961, MEM SOC GEOL FRANCE, V93, P1; Dai C, 2009, SCLERACTINIA FAUNA T; Dullo W., 1983, FACIES, V8, P1, DOI DOI 10.1007/BF02536740; Duncan PM., 1884, J LINNEAN SOC LONDON, V18, P1, DOI [10.1111/j.1096-3642.1884.tb02013.x, DOI 10.1111/J.1096-3642.1884.TB02013.X]; Esteban Mateu, 1996, Concepts in Sedimentology and Paleontology, V5, P3; Filliozat M., 1915, Bulletin de la Societe des Sciences Naturelles Nantes, V4; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Gerth H., 1933, Wetenschappelijke Mededeelingen, V25, P1; Gerth H, 1923, SAMMLUNGEN GEOLOGISC, V10, P37; Gerth H., 1921, FOSSILIEN JAVA GRUND, P387; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Gregory J.W., 1916, GEOLOGICAL MAGAZINE, V3, P481, DOI 10.1017/s0016756800208297; Hall R., 2012, BIOTIC EVOLUTION ENV, P32, DOI DOI 10.1017/CBO9780511735882.005; Hardenbol J., 1998, MESOZOIC CENOZOIC SE, V60, P3; Harzhauser M, 2008, PALAEONTOLOGY, V51, P199, DOI 10.1111/j.1475-4983.2007.00742.x; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; Harzhauser M, 2007, PALAEONTOGR ABT A, V280, P75, DOI 10.1127/pala/280/2007/75; Harzhauser M, 2014, PALAEONTOGR ABT A, V302, P73; Harzhauser M, 2013, RIV ITAL PALEONTOL S, V119, P351, DOI 10.13130/2039-4942/6044; Harzhauser M, 2009, PALAEONTOGR ABT A, V289, P123; Harzhauser M, 2009, PALAEONTOL Z, V83, P333, DOI 10.1007/s12542-009-0025-5; Helm Carsten, 2003, Palaeontologische Zeitschrift, V77, P77; Hoeksema B, 2014, SCOLYMIA VITIENSIS B; Hoeksema B, 2014, LITHOPHYLLIA M EDWAR; Hoeksema B.W., 2014, WORLD REGISTER MARIN; Hoeksma B, 2014, ACANTHOPHYLLIA WELLS; Kolosvary, 1967, GEOLOGIJA, V10, P205; KOLOSVARY GABOR. A., 1956, FOLDTANI KOZLONY, V86, P67; Kroh A, 2011, ACTA GEOL POL, V61, P419; Kuhn O., 1933, Palaeontographica Stuttgart, V79, P143; KUHN OTHMAR, 1926, JAHRB GEOL BUNDESANST, V76, P65; LATHAM MH, 1929, T ROY SOC EDINBURGH, V56, P273; Maddaleni P., 1997, Gortania Atti del Museo Friulano di Storia Naturale, V19, P61; McCall Joe, 1994, Facies, V31, P141, DOI 10.1007/BF02536938; Milne Edwards H., 1850, MONOGRAPH BRIT FOSSI; Milne-Edwards H., 1848, MONOGRAPHIE ASTEREID, V3, P209; Oosberger R, 1954, N JB GEOL PALAONT AB, V100, P119; Oosterbaan A.F.F., 1990, Contributions to Tertiary and Quaternary Geology, V27, P3; Perrin C, 2012, EARTH-SCI REV, V111, P1, DOI 10.1016/j.earscirev.2011.12.007; PILLAI C S G, 1976, Zoologica (Stuttgart), V43, P1; Piller WE, 2007, STRATIGRAPHY, V4, P151; R/gl F., 1998, ANN NATURHIST MUS A, V99A, P279, DOI DOI 10.2307/41702129; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Reuss von A.E.R., 1871, DENKSCHR K AKAD W MN, V2, P1; Reuter M, 2013, CLIM PAST, V9, P2101, DOI 10.5194/cp-9-2101-2013; Reuter M, 2011, CORAL REEFS, V30, P889, DOI 10.1007/s00338-011-0798-3; Reuter M, 2009, INT J EARTH SCI, V98, P627, DOI 10.1007/s00531-007-0269-9; Reuter M, 2012, PALAEOGEOGR PALAEOCL, V350, P198, DOI 10.1016/j.palaeo.2012.06.032; Reuter M, 2012, PERSPECT PLANT ECOL, V14, P303, DOI 10.1016/j.ppees.2012.03.003; Reuter M, 2008, SEDIMENT GEOL, V212, P12, DOI 10.1016/j.sedgeo.2008.09.001; Riegl B, 2000, PALAIOS, V15, P399, DOI 10.2307/3515512; RIEGL B. M., 2002, P 9 INT COR REEF S B, V1, P211; Rus Monica, 2008, Acta Palaeontologica Romaniae, V6, P325; Schouppe A., 1949, Mitteilungen der Naturwissenschaftlichen Vereins fuer Steiermark, V1949, P142; Schuster F, 1999, INT J EARTH SCI, V88, P571, DOI 10.1007/s005310050285; Stolarski J, 2001, J PALEONTOL, V75, P1090, DOI 10.1666/0022-3360(2001)075<1090:TANSOE>2.0.CO;2; Tomascik T, 1997, ECOLOGY INDONESIAN S; UMBGROVE J. H. F., 1926, WETENSCHAPPELIJKE MEDEDEEL, VNo. 4, P25; Umbgrove JHF, 1945, P R SOC AMSTERDAM, V48, P244; Veron J.E.N., 1988, Memoir of the Association of Australasian Palaeontologists, V6, P1; VERON JEN, 1995, CORALS SPACE TIME BI; Veron JEN, 2000, CORALS WORLD, V3; Veron J, 2013, ZOOL J LINN SOC-LOND, V169, P485, DOI 10.1111/zoj.12076; Wallace CC, 2008, J PALEONTOL, V82, P313, DOI 10.1666/06-091.1; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; Wells J. W., 1964, Zoologische Mededeelingen Leiden, V39, P375; Wells J. W., 1956, pf328; White C.H., 2008, P 11 INT COR REEF S, P7; Wiedl T, 2013, PALAEOGEOGR PALAEOCL, V370, P232, DOI 10.1016/j.palaeo.2012.12.015; Wiedl T, 2012, FACIES, V58, P523, DOI 10.1007/s10347-011-0290-0; Wilson Moyra E. J., 1998, P165; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	85	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132243	10.1371/journal.pone.0132243	http://dx.doi.org/10.1371/journal.pone.0132243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201071	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100032
J	Blanchet, MA; Lydersen, C; Ims, RA; Kovacs, KM				Blanchet, Marie-Anne; Lydersen, Christian; Ims, Rolf A.; Kovacs, Kit M.			Seasonal, Oceanographic and Atmospheric Drivers of Diving Behaviour in a Temperate Seal Species Living in the High Arctic	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; PRINCE-WILLIAM-SOUND; ADULT HARBOR SEALS; PHOCA-VITULINA; FORAGING BEHAVIOR; ATLANTIC WATER; POLAR COD; BOREOGADUS-SAIDA; KARLS FORLAND; BARENTS SEA	The harbour seal (Phoca vitulina) population in Svalbard marks the northernmost limit of the species' range. This small population experiences environmental extremes in sea and air temperatures, sea ice cover and also in light regime for this normally temperate species. This study deployed Conductivity Temperature Depth Satellite Relay Data Loggers (CTD-SRDLs) on 30 adult and juvenile harbour seals in 2009 and 2010 to study their foraging behaviour across multiple seasons. A total of 189,104 dives and 16,640 CTD casts (mean depth 72 m +/- 59) were recorded. Individuals dove to a mean depth of 41 m +/- 24 with a maximum dive depth range of 24 - 403 m. Dives lasted on average 204 sec +/- 120 with maximum durations ranging between 240 - 2,220 sec. Average daily depth and duration of dives, number of dives, time spent diving and dive time/surface time were influenced by date, while sex, age, sea-ice concentration and their interactions were not particularly influential. Dives were deeper (similar to 150 m), longer (similar to 480 sec), less numerous (similar to 250 dives/day) and more pelagic during the winter/early spring compared to the fall and animals spent proportionally less time at the bottom of their dives during the winter. Influxes of warm saline water, corresponding to Atlantic Water characteristics, were observed intermittently at depths similar to 100 m during both winters in this study. The seasonal changes in diving behaviour were linked to average weekly wind stresses from the north or north-east, which induced upwelling events onto the shelf through offshore Ekman transport. During these events the shelf became flooded with AW from the West Spitsbergen Current, which presumably brought Atlantic fish species close to shore and within the seals' foraging depth-range. Predicted increased in the influx of AW in this region are likely going to favour the growth and geographic expansion of this harbour seal population in the future.	[Blanchet, Marie-Anne; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Blanchet, Marie-Anne; Ims, Rolf A.] Arct Univ Norway, UiT, Dept Arct & Marine Biol, N-9037 Tromso, Norway	Norwegian Polar Institute; UiT The Arctic University of Tromso	Blanchet, MA (corresponding author), Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway.	blanchet@npolar.no			Norwegian Research Council [184644/S40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Norwegian Research Council Grant no 184644/S40.	Alexeev V. A., 2013, CRYOSPHERE DISCUSS, V7, P245, DOI [DOI 10.5194/TCD-7-245-2013, 10.5194/tcd-7-245-2013]; Andersen SM, 2004, CAN J ZOOL, V82, P1230, DOI 10.1139/Z04-093; Arthun MT, 2012, J PHYS OCEANOGR, V25, P359; Baechler J, 2002, CAN J ZOOL, V80, P1569, DOI 10.1139/Z02-150; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bennett KA, 2001, J EXP BIOL, V204, P649; Benoit D, 2010, POLAR BIOL, V33, P1505, DOI 10.1007/s00300-010-0840-x; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Bigg MA, 1969, FISHERIES RES BOARD, V172; Biuw M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013816; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Bjorge A, 1995, DEV MAR BIO, V4, P211; Bjorge Arne, 2007, Aquatic Mammals, V33, P269, DOI 10.1578/AM.33.3.2007.269; Blanchet MA, 2014, AQUAT BIOL, V21, P167, DOI 10.3354/ab00580; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bowen WD, 1996, CAN J ZOOL, V74, P125, DOI 10.1139/z96-017; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Charrassin JB, 2002, ECOL LETT, V5, P317, DOI 10.1046/j.1461-0248.2002.00341.x; Chen J., 2000, PARAMETRIC STAT CHAN, DOI 10.1007/978-1-4757-3131-6; Colominas R, 2012, THESIS U BERGEN NORW; Cotte C, 2011, LIMNOL OCEANOGR, V56, P219, DOI 10.4319/lo.2011.56.1.0219; Cottier FR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029948; de Bruyn PJN, 2009, MAR ECOL PROG SER, V394, P263, DOI 10.3354/meps08292; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; Falk-Petersen S, 2015, POLAR BIOL, V38, P5, DOI 10.1007/s00300-014-1482-1; FALKPETERSEN IB, 1986, SARSIA, V71, P235, DOI 10.1080/00364827.1986.10419693; Floor J, 2006, THESIS U UTRECHT UTR; Freitas C, 2014, ARGOSFILTER R PACKAG; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; Frost KJ, 2001, MAR MAMMAL SCI, V17, P813, DOI 10.1111/j.1748-7692.2001.tb01300.x; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Gjertz I, 2001, POLAR BIOL, V24, P209, DOI 10.1007/s003000000197; Hamilton CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086055; HARKONEN T, 1991, OPHELIA, V34, P191; Hastings KK, 2004, CAN J ZOOL, V82, P1755, DOI 10.1139/Z04-145; Hauksson Erlingur, 2010, NAMMCO Scientific Publications, V8, P227; Hijmans R, 2014, RASTER R PACKAGE VER; Hop H, 2013, MAR BIOL RES, V9, P878, DOI 10.1080/17451000.2013.775458; Jakobsson M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052219; Jessopp M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063720; Johnson D, 2013, CRAWL FIT CONTINUOUS; Jorgensen C, 2001, J EXP BIOL, V204, P3993; Kelley D., 2014, OCE ANAL OCEANOGRAPH; King JE., 1983, SEALS WORLD BRIT MUS; Koc N, 2002, POLAR RES, V21, P307, DOI 10.1111/j.1751-8369.2002.tb00085.x; Krafft BA, 2002, POLAR BIOL, V25, P230, DOI 10.1007/s00300-001-0330-2; Kuhn CE, 2011, MAR BIOL, V158, P649, DOI 10.1007/s00227-010-1589-z; Lance MM, 2012, MAR ECOL PROG SER, V464, P257, DOI 10.3354/meps09880; Lea MA, 2003, ICES J MAR SCI, V60, P990, DOI 10.1016/S1054-3139(03)00101-2; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Lind S, 2012, DEEP-SEA RES PT I, V62, P70, DOI 10.1016/j.dsr.2011.12.007; Lowther AD, 2014, ANTARCTIC SCI, V26, P1; Lowther AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074348; Lydersen C, 2005, POLAR BIOL, V28, P156, DOI 10.1007/s00300-004-0656-7; Lydersen C, 2004, J MARINE SYST, V46, P99, DOI 10.1016/j.jmarsys.2003.11.019; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; McDougall T, 2010, IOCCP REPORT; McIntyre T, 2013, POLAR BIOL, V36, P1693, DOI 10.1007/s00300-013-1384-7; Middlemas SJ, 2006, P ROY SOC B-BIOL SCI, V273, P193, DOI 10.1098/rspb.2005.3215; Mishin VL, 2001, MAMMALIA, V65, P295, DOI 10.1515/mamm.2001.65.3.295; Nilsen F, 2008, CONT SHELF RES, V28, P1838, DOI 10.1016/j.csr.2008.04.015; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Nilssen Kjell Tormod, 2010, NAMMCO Scientific Publications, V8, P61; Nordli O, 2014, POLAR RES, V33, DOI 10.3402/polar.v33.21349; Nordstrom CA, 2013, DEEP-SEA RES PT II, V88-89, P78, DOI 10.1016/j.dsr2.2012.07.010; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Owrid G, 2000, POLAR RES, V19, P155, DOI 10.1111/j.1751-8369.2000.tb00340.x; Pavlov AK, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.11206; Peterson SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039046; Photopoulou T, 2015, METHODS ECOL EVOL, V6, P278, DOI 10.1111/2041-210X.12328; Pierce G.J., 1990, P222; PIERCE GJ, 1990, J MAR BIOL ASSOC UK, V70, P829, DOI 10.1017/S0025315400059099; R Development Core Team, 2012, R LANG ENV STAT COMP; Renaud PE, 2012, POLAR BIOL, V35, P401, DOI 10.1007/s00300-011-1085-z; Ribic CA, 2008, DEEP-SEA RES PT II, V55, P485, DOI 10.1016/j.dsr2.2007.11.006; Roquet F, 2011, J ATMOS OCEAN TECH, V28, P787, DOI 10.1175/2010JTECHO801.1; Rosing-Asvid Aqqalu, 2010, NAMMCO Scientific Publications, V8, P161; Schlitzer R, 2002, COMPUT GEOSCI-UK, V28, P1211, DOI 10.1016/S0098-3004(02)00040-7; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Stensholt BK, 2001, ICES J MAR SCI, V58, P770, DOI 10.1006/jmsc.2001.1067; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; THOMPSON PM, 1990, J APPL ECOL, V27, P492, DOI 10.2307/2404296; THOMPSON PM, 1989, J ZOOL, V217, P281, DOI 10.1111/j.1469-7998.1989.tb02488.x; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; Tollit DJ, 1997, BEHAV ECOLOGY COMMON, P1; Troupin C, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005512; Tverberg V, 2014, J GEOPHYS RES-OCEANS, V119, P5945, DOI 10.1002/2014JC010013; Wienerroither Rupert, 2011, IMR-PINRO Joint Report Series, V1, P1; Willis KJ, 2008, POLAR BIOL, V31, P475, DOI 10.1007/s00300-007-0373-0; Wilson K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092838; Zyryanov Sergey V., 2010, NAMMCO Scientific Publications, V8, P37	95	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132686	10.1371/journal.pone.0132686	http://dx.doi.org/10.1371/journal.pone.0132686			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196289	Green Published, gold			2022-12-27	WOS:000358547600046
J	Cho, YH; Woo, HD; Jang, Y; Porter, V; Christensen, S; Hamilton, RF; Chung, HW				Cho, Yoon Hee; Woo, Hae Dong; Jang, Yoonhee; Porter, Virginia; Christensen, Sonja; Hamilton, Raymond F., Jr.; Chung, Hai Won			The Association of LINE-1 Hypomethylation with Age and Centromere Positive Micronuclei in Human Lymphocytes	PLOS ONE			English	Article							GENOMIC DNA METHYLATION; EPIGENETIC CHANGES; HEALTHY-SUBJECTS; BLADDER-CANCER; BLOOD; LEVEL; PREDICTORS; LEUKOCYTES; BIOMARKER; HISTORY	Global hypomethylation in white blood cell (WBC) DNA has recently been proposed as a potential biomarker for determining cancer risk through genomic instability. However, the amplitude of the changes associated with age and the impacts of environmental factors on DNA methylation are unclear. In this study, we investigated the association of genomic hypomethylation with age, cigarette use, drinking status and the presence of centromere positive micronuclei (MNC+)-a biomarker for age-dependent genomic instability. Genomic hypomethylation of the repetitive element LINE-1 was measured in WBC DNA from 32 healthy male volunteers using the pyrosequencing assay. We also measured MNC+ with the micronucleus-centromere assay using a pan-centromeric probe. Possibly due to the small sample size and resulting low statistical power, smoking and drinking status had no significant effect on LINE-1 hypomethylation or the occurrence of MNC+. Consequently, we did not include them in further analyses. In contrast, LINE-1 hypomethylation and age significantly predicted MNC+; therefore, we examined whether LINE-1 hypomethylation plays a role in MNC+ formation by age, since genomic hypomethylation is associated with genomic instability. However, LINE-1 hypomethylation did not significantly mediate the effect of age on MNC+. Our data indicate that the repetitive element LINE-1 is demethylated with age and increasing MNC+ frequency, but additional studies are needed to fully understand the relation between genomic DNA hypomethylation, age and genomic instability.	[Cho, Yoon Hee; Porter, Virginia; Christensen, Sonja; Hamilton, Raymond F., Jr.] Univ Montana, Ctr Environm Hlth Sci, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Woo, Hae Dong] Natl Canc Ctr, Res Inst, Div Canc Epidemiol & Prevent, Mol Epidemiol Branch, Goyang Si, Gyeonggi Do, South Korea; [Jang, Yoonhee] Univ Montana, Dept Psychol, Missoula, MT 59812 USA; [Chung, Hai Won] Seoul Natl Univ, Sch Publ Hlth, Dept Mol Epidemiol, Seoul 151, South Korea	University of Montana System; University of Montana; National Cancer Center - Korea (NCC); University of Montana System; University of Montana; Seoul National University (SNU)	Cho, YH (corresponding author), Univ Montana, Ctr Environm Hlth Sci, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	yoonhee.cho@umontana.edu		Cho, Yoon Hee/0000-0002-4290-7140	National Institute of General Medical Sciences [P30GM103338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103338] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (P30GM103338).	Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Bonassi S, 2001, ENVIRON MOL MUTAGEN, V37, P31; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Cho YH, 2009, MUTAT RES-GEN TOX EN, V680, P17, DOI 10.1016/j.mrgentox.2009.08.007; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Cook T.C., 1979, QUASIEXPERIMENTATION; Dunn BK, 2003, ANN NY ACAD SCI, V983, P28, DOI 10.1111/j.1749-6632.2003.tb05960.x; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fenech M, 1997, ENVIRON MOL MUTAGEN, V30, P112, DOI 10.1002/(SICI)1098-2280(1997)30:2<112::AID-EM3>3.0.CO;2-P; Fenech M, 1999, MUTAT RES-FUND MOL M, V428, P271, DOI 10.1016/S1383-5742(99)00053-8; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Guz J, 2008, MUTAT RES-FUND MOL M, V640, P170, DOI 10.1016/j.mrfmmm.2007.12.013; Hamid A, 2009, FEBS J, V276, P2175, DOI 10.1111/j.1742-4658.2009.06959.x; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HOALVANHELDEN EG, 1989, MUTAT RES, V219, P263, DOI 10.1016/0921-8734(89)90027-1; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Issa JP, 2003, CLIN IMMUNOL, V109, P103, DOI 10.1016/S1521-6616(03)00203-1; JAMES LR, 1984, J APPL PSYCHOL, V69, P307, DOI 10.1037/0021-9010.69.2.307; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jose P. E., 2013, DOING STAT MEDIATION; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Pavanello S, 2009, INT J CANCER, V125, P1692, DOI 10.1002/ijc.24492; Pisner R, 2009, EPIDEMIOLOGY, V20, pS84; Piyathilake C, 2011, CANCER EPIDEM BIOMAR, V20, P719, DOI 10.1158/1055-9965.EPI-11-0094; Ricceri F, 2014, SEASONALITY MODIFIES; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Thierens H, 1999, MUTAT RES-GEN TOX EN, V445, P105, DOI 10.1016/S1383-5718(99)00134-5; Thierens H, 2000, MUTAGENESIS, V15, P245, DOI 10.1093/mutage/15.3.245; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; VIG BK, 1986, MUTAGENESIS, V1, P461, DOI 10.1093/mutage/1.6.461; Vral A, 1997, INT J RADIAT BIOL, V71, P61, DOI 10.1080/095530097144427; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wu HC, 2012, CARCINOGENESIS, V33, P1946, DOI 10.1093/carcin/bgs201; Wu HC, 2011, EPIGENETICS-US, V6, P29, DOI 10.4161/epi.6.1.13393; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	55	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133909	10.1371/journal.pone.0133909	http://dx.doi.org/10.1371/journal.pone.0133909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196382	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600147
J	Hudson, RR				Hudson, Richard R.			A New Proof of the Expected Frequency Spectrum under the Standard Neutral Model	PLOS ONE			English	Article								The sample frequency spectrum is an informative and frequently employed approach for summarizing DNA variation data. Under the standard neutral model the expectation of the sample frequency spectrum has been derived by at least two distinct approaches. One relies on using results from diffusion approximations to the Wright-Fisher Model. The other is based on Polya urn models that correspond to the standard coalescent model. A new proof of the expected frequency spectrum is presented here. It is a proof by induction and does not require diffusion results and does not require the somewhat complex sums and combinatorics of the derivations based on urn models.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Hudson, RR (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	rr-hudson@uchicago.edu						Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Ewens W. J., 1979, MATH POPULATION GENE; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; FU YX, 1993, GENETICS, V133, P693; Griffiths R., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; TAJIMA F, 1989, GENETICS, V123, P585; Wakeley J., 2009, COALESCENT THEORY	7	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0118087	10.1371/journal.pone.0118087	http://dx.doi.org/10.1371/journal.pone.0118087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197064	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600001
J	Rossouw, TM; Feucht, UD; Melikian, G; van Dyk, G; Thomas, W; du Plessis, NM; Avenant, T				Rossouw, Theresa M.; Feucht, Ute D.; Melikian, George; van Dyk, Gisela; Thomas, Winifred; du Plessis, Nicolette M.; Avenant, Theunis			Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; THAN 2 YEARS; VIROLOGICAL RESPONSE; VIRAL LOAD; POPULATION PHARMACOKINETICS; ANTITUBERCULAR TREATMENT; DISEASE PROGRESSION; TREATMENT FAILURE; COMBINATION; RIFAMPICIN	Objective Limited data are available from the developing world on antiretroviral drug resistance in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy, especially in the context of a high tuberculosis burden. We describe the proportion of children with drug resistance mutations after failed protease inhibitor-based antiretroviral therapy as well as associated factors. Methods Data from children initiated on protease inhibitor-based antiretroviral therapy with subsequent virological failure referred for genotypic drug resistance testing between 2008 and 2012 were retrospectively analysed. Frequencies of drug resistance mutations were determined and associations with these mutations identified through logistic regression analysis. Results The study included 65 young children (median age 16.8 months [IQR 7.8; 23.3]) with mostly advanced clinical disease (88.5% WHO stage 3 or 4 disease), severe malnutrition (median weight-for-age Z-score -2.4 [IQR -3.7;-1.5]; median height-for-age Z-score -3.1 [IQR -4.3;2.4]), high baseline HIV viral load (median 6.04 log(10), IQR 5.34; 6.47) and frequent tuberculosis co-infection (66%) at antiretroviral therapy initiation. Major protease inhibitor mutations were found in 49% of children and associated with low weight-for-age and height-for-age (p = 0.039; p = 0.05); longer duration of protease inhibitor regimens and virological failure (p = 0.001; p = 0.005); unsuppressed HIV viral load at 12 months of antiretroviral therapy (p = 0.001); tuberculosis treatment at antiretroviral therapy initiation (p = 0.048) and use of ritonavir as single protease inhibitor (p = 0.038). On multivariate analysis, cumulative months on protease inhibitor regimens and use of ritonavir as single protease inhibitor remained significant (p = 0.008; p = 0.033). Conclusion Major protease inhibitor resistance mutations were common in this study of HIV-1-infected children, with the timing of tuberculosis treatment and subsequent protease inhibitor dosing strategy proving to be important associated factors. There is an urgent need for safe, effective, and practicable HIV/tuberculosis co-treatment in young children and the optimal timing of treatment, optimal dosing of antiretroviral therapy, and alternative tuberculosis treatment strategies should be urgently addressed.	[Rossouw, Theresa M.; van Dyk, Gisela] Univ Pretoria, Fac Hlth Sci, Inst Cellular & Mol Med, Dept Immunol, ZA-0002 Pretoria, South Africa; [Feucht, Ute D.; Thomas, Winifred; du Plessis, Nicolette M.; Avenant, Theunis] Univ Pretoria, Kalafong Prov Tertiary Hosp, Dept Paediat, ZA-0002 Pretoria, South Africa; [Melikian, George] AIDS Healthcare Fdn, Los Angeles, CA USA	University of Pretoria; University of Pretoria	Rossouw, TM (corresponding author), Univ Pretoria, Fac Hlth Sci, Inst Cellular & Mol Med, Dept Immunol, ZA-0002 Pretoria, South Africa.	theresa.rossouw@up.ac.za	Feucht, Ute/AGE-5579-2022; Feucht, Ute/GQH-8596-2022	Feucht, Ute/0000-0002-6339-1040; Avenant, Theunis/0000-0003-2367-6479; Rossouw, Theresa/0000-0003-4066-922X	Delegation of the European Union [Sante 2007/147-790]; National Research Council of South Africa, Unlocking the Future [61509]	Delegation of the European Union; National Research Council of South Africa, Unlocking the Future	This research and selected researchers (TR and GVD) were partially funded by a grant from the Delegation of the European Union to South Africa: "Drug Resistance Surveillance and Treatment Monitoring Network for the Public Sector HIV Antiretroviral Treatment Programme in the Free State" - Sante 2007/147-790 - and National Research Council of South Africa, Unlocking the Future 61509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EJ, 1998, J INFECT DIS, V178, P101, DOI 10.1086/515596; Agwu A, 2008, AIDS PATIENT CARE ST, V22, P545, DOI 10.1089/apc.2007.0200; Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; [Anonymous], 2010, GUID MAN HIV CHILDR; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Baciewicz AM, 2008, AM J MED SCI, V335, P126, DOI 10.1097/MAJ.0b013e31814a586a; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V41, P323; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P185; Chadwick EG, 2005, PEDIATR INFECT DIS J, V24, P793, DOI [10.1097/01.inf.0000111281.93658.df, 10.1097/01.inf.0000177281.93658.df]; Donegan KL, 2012, ANTIVIR THER, V17, P599, DOI 10.3851/IMP2015; Ebonyi Augustine O, 2015, Niger Med J, V56, P43, DOI 10.4103/0300-1652.149170; Elsherbiny D, 2010, EUR J CLIN PHARMACOL, V66, P1017, DOI 10.1007/s00228-010-0847-9; Feucht UD, 2014, PEDIATR INFECT DIS J, V33, pE53, DOI 10.1097/INF.0b013e31829f2694; Frohoff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017273; Grabar S, 2000, AIDS, V14, P141, DOI 10.1097/00002030-200001280-00009; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Heidari S, 2012, JAIDS-J ACQ IMM DEF, V59, P161, DOI 10.1097/QAI.0b013e3182427029; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Jimenez JL, 2005, J ANTIMICROB CHEMOTH, V56, P1081, DOI 10.1093/jac/dki356; Kariminia A, 2014, JAIDS-J ACQ IMM DEF, V67, P71, DOI 10.1097/QAI.0000000000000227; Kerac M, 2007, MALAWI MED J, V19, P96; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Lathouwers E, 2011, ANTIVIR THER, V16, P99, DOI 10.3851/IMP1719; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Lepri AC, 2001, AIDS, V15, P47, DOI 10.1097/00002030-200101050-00008; Maartens G, 2009, ANTIVIR THER, V14, P1039, DOI 10.3851/IMP1455; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Maiga AI, 2012, J ANTIMICROB CHEMOTH, V67, P2943, DOI [10.1093/jac/dks310, 10.1093]; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; McIlleron H, 2011, ANTIVIR THER, V16, P417, DOI 10.3851/IMP1757; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Moorthy A, 2011, CLIN INFECT DIS, V52, P514, DOI 10.1093/cid/ciq161; Moultrie H, 2015, J ANTIMICROB CHEMOTH, V70, P543, DOI 10.1093/jac/dku382; Musoke PM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-56; Naidoo R, 2010, PEDIATR INFECT DIS J, V29, P511, DOI 10.1097/INF.0b013e3181d1e989; Niemi M, 2003, CLIN PHARMACOKINET, V42, P819, DOI 10.2165/00003088-200342090-00003; Orrell C, 2012, J INT AIDS SOC S4, V15, P18086; Oshikoya KA, 2010, EUR J CLIN PHARMACOL, V66, P1025, DOI 10.1007/s00228-010-0851-0; Palumbo P, 2009, 5 INT AIDS SOC C HIV; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Peacock-Villada E, 2011, PEDIATRICS, V127, pE423, DOI 10.1542/peds.2009-2701; Pillay S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-3; Prendergast A, 2011, AIDS, V25, P951, DOI 10.1097/QAD.0b013e328345e56b; Prendergast AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001273; Regazzi M, 2014, CLIN PHARMACOKINET, V53, P489, DOI 10.1007/s40262-014-0144-3; Reitz C, 2010, J INFECT DIS, V201, P1121, DOI 10.1086/651454; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Riddick A, 2009, P 5 IAS C HIV PATH T; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Saez-Llorens X, 2003, PEDIATR INFECT DIS J, V22, P216, DOI 10.1097/00006454-200303000-00003; Scherpbier HJ, 2006, PEDIATRICS, V117, pE528, DOI 10.1542/peds.2005-1272; Schlaudecker EP, 2011, CURR OPIN INFECT DIS, V24, P496, DOI 10.1097/QCO.0b013e328349287d; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Soeters HM, 2014, JAIDS-J ACQ IMM DEF, V67, P136, DOI 10.1097/QAI.0000000000000284; Sohn AH, 2010, CURR OPIN HIV AIDS, V5, P54, DOI 10.1097/COH.0b013e3283339bd8; Taylor BS, 2011, AIDS RES HUM RETROV, V27, P945, DOI 10.1089/aid.2010.0205; Trehan I, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/790786; van Zyl GU, 2009, PEDIATR INFECT DIS J, V28, P1125, DOI 10.1097/INF.0b013e3181af829d; Vaz P, 2012, CLIN INFECT DIS, V54, pS369, DOI 10.1093/cid/cis006; Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5; Violari A, 2012, J INT AIDS SOC S4, V15, P18085; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Wallis CL, 2009, PEDIATR INFECT DIS J, V28, P1123, DOI 10.1097/INF.0b013e3181af5a00; Weigel R, 2014, 20TH INTERNATIONAL A; WHO, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2006, WHO MULT GROWTH REF; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Zanoni BC, 2011, AIDS, V25, P49, DOI 10.1097/QAD.0b013e32833f9e04; Zhang C, 2012, ANTIVIR THER, V17, P25, DOI 10.3851/IMP1915	73	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133452	10.1371/journal.pone.0133452	http://dx.doi.org/10.1371/journal.pone.0133452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196688	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600099
J	Torres, OY; Areste, ME; Mora, JRM; Soler-Gonzalez, J				Yuguero Torres, Oriol; Esquerda Areste, Montserrat; Marsal Mora, Josep Ramon; Soler-Gonzalez, Jorge			Association between Sick Leave Prescribing Practices and Physician Burnout and Empathy	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; PATIENT SATISFACTION; JEFFERSON SCALE; COMMUNICATION; SPECIALTY; ADHERENCE; PERSONALITY; BEHAVIOR; OUTCOMES; DISEASE	Objectives To investigate the association between sick leave prescription and physician burnout and empathy in a primary care health district in Lleida, Spain. Methods This descriptive study included 108 primary care doctors from 22 primary care centers in Lleida in 2014 (183,600 patients). Burnout was measured with the Maslach Burnout Inventory and empathy with the Jefferson Scale of Physician Empathy. The reliability of the instruments was measured by calculating Cronbach's alpha and normal distribution was analyzed using the Kolmogorov-Smirnov-Lilliefors and chi(2) tests. Burnout and empathy scores were analyzed by age, sex, and place of work (urban vs rural). Sick leave data were obtained from the Catalan Health Institute. Results High empathy was significantly associated with low burnout. Neither empathy nor burnout were significantly associated with sick leave prescription. Conclusion Sick leave prescription by physicians is not associated with physicians' empathy or burnout and may mostly depend on prescribing guidelines.	[Yuguero Torres, Oriol; Soler-Gonzalez, Jorge] Hosp Arnau Vilanova, Lleida Hlth Reg, Primary Care Serv, Lleida, Spain; [Esquerda Areste, Montserrat] Borja Bioeth Inst, Barcelona, Spain; [Esquerda Areste, Montserrat; Soler-Gonzalez, Jorge] Univ Lleida, Sch Med, Lleida, Spain; [Marsal Mora, Josep Ramon] IDIAP Jordi Gol, Jordi Gol Inst Res Primary Care, Lleida, Spain	University Hospital Arnau de Vilanova; Universitat de Lleida	Torres, OY (corresponding author), Hosp Arnau Vilanova, Lleida Hlth Reg, Primary Care Serv, Lleida, Spain.	oriol.yuguero@gmail.com	Esquerda, Montse/A-8757-2012; soler-gonzalez, jorge/D-1686-2011; Yuguero, Oriol/AAV-3749-2021; MARSAL MORA, JOSEP RAMON/A-9355-2013	Esquerda, Montse/0000-0002-5781-8298; soler-gonzalez, jorge/0000-0001-8359-3355; MARSAL MORA, JOSEP RAMON/0000-0003-0675-6119	Bioethics Victor Grifols Foundation; Spanish Society of Family Medicine (SEMFYC)	Bioethics Victor Grifols Foundation; Spanish Society of Family Medicine (SEMFYC)	The authors have received funds from Bioethics Victor Grifols Foundation (www.fundaciogrifols.org) whom apported 3500 [SIC] and Spanish Society of Family Medicine (SEMFYC) (www.semfyc.es) whom apported 2500[SIC].	Alcorta-Garza A, 2005, SALUD MENT, V28, P57; Brazeau CMLR, 2010, ACAD MED, V85, pS33, DOI 10.1097/ACM.0b013e3181ed4c47; Burnout Maslach C., 1982, BURNOUT COST CARING; BURNS DD, 1992, J CONSULT CLIN PSYCH, V60, P441, DOI 10.1037/0022-006X.60.3.441; Carmel S, 1996, SOC SCI MED, V43, P1253, DOI 10.1016/0277-9536(95)00445-9; Colliver JA, 1998, TEACH LEARN MED, V10, P8, DOI 10.1207/S15328015TLM1001_2; De las Cuevas C., 1997, DESGASTE PROFESIONAL; Del Canale S, 2012, ACAD MED, V87, P1243, DOI 10.1097/ACM.0b013e3182628fbf; Dewa CS, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-325; Diaz Gonzalez RJ, 1994, REV CLIN ESP, V194, P670; DIMATTEO MR, 1986, HEALTH PSYCHOL, V5, P581, DOI 10.1037/0278-6133.5.6.581; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; DUBNICKI C, 1977, J CONSULT CLIN PSYCH, V45, P958, DOI 10.1037/0022-006X.45.5.958; DUXBURY ML, 1984, NURS RES, V33, P97; FALVO D, 1988, J FAM PRACTICE, V26, P643; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061526; Greenberg LS, 2001, PSYCHOTHERAPY, V38, P380, DOI 10.1037/0033-3204.38.4.380; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; Hojat M, 2002, ACAD MED, V77, pS58, DOI 10.1097/00001888-200210001-00019; Hojat M, ACAD MED IN PRESS; Hojat M, 2007, EMPATHY PATIENT CARE; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; Kankaanpaa AT, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-168; Kankaanpaa AT, 2012, EUR J PUBLIC HEALTH, V22, P92, DOI 10.1093/eurpub/ckr031; Kim SS, 2004, EVAL HEALTH PROF, V27, P237, DOI 10.1177/0163278704267037; Lara JRL, 2009, ATEN PRIM, V41, P646, DOI 10.1016/j.aprim.2009.01.005; Maslach C, 2016, MASLACH BURNOUT INVE; Moreno-Jimenez B., 2001, FACTORIALIZACION MBI, V7, P69; Muldary T., 1983, BURNOUT HLTH PROFESS; Pohl CA, 2011, ACAD MED, V86, P747, DOI 10.1097/ACM.0b013e318217e464; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Salyers MP, 2015, PSYCHIAT SERV, V66, P204, DOI 10.1176/appi.ps.201400138; Soler-Gonzalez J, 2008, SCAND J WORK ENV HEA, V34, P438, DOI 10.5271/sjweh.1288; SQUIER RW, 1990, SOC SCI MED, V30, P325, DOI 10.1016/0277-9536(90)90188-X; STAUDENMAYER H, 1981, SOC SCI MED-MED PSYC, V15, P77, DOI 10.1016/S0277-9536(81)80010-X; Stephenson A, 2001, LANCET, V357, P867, DOI 10.1016/S0140-6736(00)04201-X; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Swartling MS, 2008, SCAND J PUBLIC HEALT, V36, P408, DOI 10.1177/1403494808090903; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Zachariae R, 2003, BRIT J CANCER, V88, P658, DOI 10.1038/sj.bjc.6600798	43	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133379	10.1371/journal.pone.0133379	http://dx.doi.org/10.1371/journal.pone.0133379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196687	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600089
J	Milara, J; Morcillo, E; Monleon, D; Tenor, H; Cortijo, J				Milara, Javier; Morcillo, Esteban; Monleon, Daniel; Tenor, Herman; Cortijo, Julio			Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; INDUCED LUNG INJURY; PHOSPHODIESTERASE-4 INHIBITOR; N-OXIDE; PDE4 INHIBITORS; CIGARETTE-SMOKE; TETRAHYDROBIOPTERIN; DIFFERENTIATION; PENTOXIFYLLINE; EXPRESSION	Fibrotic remodeling is a process common to chronic lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, acute respiratory distress syndrome and asthma. Based on preclinical studies phosphodiesterase 4 (PDE4) inhibitors may exhibit beneficial anti-inflammatory and anti-remodeling properties for the treatment of these respiratory disorders. Effects of PDE4 inhibitors on changes in the lung metabolome in models of pulmonary fibrotic remodeling have not yet been explored. This work studies the effects of the PDE4 inhibitor roflumilast on changes in the lung metabolome in the common murine model of bleomycin-induced lung fibrosis by nuclear magnetic resonance (NMR) metabolic profiling of intact lung tissue. Metabolic profiling reveals strong differences between fibrotic and non-fibrotic tissue. These differences include increases in proline, glycine, lactate, taurine, phosphocholine and total glutathione and decreases in global fatty acids. In parallel, there was a loss in plasma BH4. This profile suggests that bleomycin produces alterations in the oxidative equilibrium, a strong inflammatory response and activation of the collagen synthesis among others. Roflumilast prevented most of these metabolic effects associated to pulmonary fibrosis suggesting a favorable anti-fibrotic profile.	[Milara, Javier; Cortijo, Julio] Univ Gen Hosp Consortium, Clin Res Unit, Valencia, Spain; [Milara, Javier; Morcillo, Esteban; Cortijo, Julio] Hlth Inst Carlos III, CIBERES, Valencia, Spain; [Milara, Javier; Cortijo, Julio] Res Fdn Gen Hosp Valencia, E-46104 Valencia, Spain; [Morcillo, Esteban; Tenor, Herman; Cortijo, Julio] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain; [Monleon, Daniel] Fdn Invest Hosp Clin Univ, INCLIVA, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Valencia	Milara, J (corresponding author), Univ Gen Hosp Consortium, Clin Res Unit, Valencia, Spain.	xmilara@hotmail.com	Monleon, Daniel/A-5078-2010; Morcillo, Esteban/I-1552-2015; Monleon, Daniel/GNP-4083-2022	Monleon, Daniel/0000-0002-4803-1573; Morcillo, Esteban/0000-0003-4373-9457; Monleon, Daniel/0000-0002-4803-1573; MILARA, JAVIER/0000-0001-6033-4211	Spanish government grants [SAF2011-26443, SAF2012-31042, FIS CP11/00293, FIS PI14/01733]; centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES) [CB06/06/0027]; fondos de la Generalitat Valenciana Prometeo [II/2013/014]	Spanish government grants; centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES); fondos de la Generalitat Valenciana Prometeo	The study was supported by the Spanish government grants SAF2011-26443 (JC; http://www.idi.mineco.gob.es/stfls/MICINN/Ayudas/PN_2008_2011/LIA_Proyectos_I+D+I/FICHERO/Proyect_Invest_Fund_No_Orientada_2011/Anexo_40.1_P.R.Prov_Biomedicina_Presel.pdf), SAF2012-31042 (EM; https://sede.micinn.gob.es/stfls/eSede/Ficheros/2012/Anexo177saf_preselecc.pdf), FIS CP11/00293, FIS PI14/01733 (JM; http://gesdoc.isciii.es/?action=download&id=08/10/2014-fe2a818ac5) and centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES; CB06/06/0027; http://www.ciberes.org/) as well as by fondos de la Generalitat Valenciana Prometeo II/2013/014 ( EM, JC, JM; http://www.cece.gva.es/poci/docs/2013/NUEVAS/RESOLUCIONES/PROMETEOII13_Resolucion_Concesion_c.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almudever P, 2013, THORAX, V68, P938, DOI 10.1136/thoraxjnl-2013-203408; Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Benahmed MA, 2012, MAGN RESON MED, V68, P1026, DOI 10.1002/mrm.24110; Boorsma CE, 2014, PULM PHARMACOL THER, V29, P166, DOI 10.1016/j.pupt.2014.08.009; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Cortijo J, 2009, BRIT J PHARMACOL, V156, P534, DOI 10.1111/j.1476-5381.2008.00041.x; Cortijo J, 2001, EUR RESPIR J, V17, P1228, DOI 10.1183/09031936.01.00049701; Dastidar SG, 2007, CURR OPIN INVEST DR, V8, P364; FDA, 2018, BIOANALYTICAL METHOD; Fiege B, 2004, MOL GENET METAB, V81, P45, DOI 10.1016/j.ymgme.2003.09.014; Foster MW, 2015, J PROTEOME RES, V14, P1238, DOI 10.1021/pr501149m; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; HORIUCHI H, 1995, EUR J PHARMACOL, V287, P27, DOI 10.1016/0014-2999(95)00468-7; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; Lauterbach R, 1999, EUR J PEDIATR, V158, P607, DOI 10.1007/s004310051158; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Liu RM, 2012, FREE RADICAL BIO MED, V53, P554, DOI 10.1016/j.freeradbiomed.2012.05.016; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Marcinkiewicz J, 2000, IMMUNOPHARMACOLOGY, V49, P335, DOI 10.1016/S0162-3109(00)00249-6; Martinez-Granados B, 2011, INT J MOL MED, V27, P111, DOI 10.3892/ijmm.2010.563; Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x; Milara J, 2015, COPD, V12, P320, DOI 10.3109/15412555.2014.948995; Milara J, 2014, PULM PHARMACOL THER, V28, P138, DOI 10.1016/j.pupt.2014.02.001; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nobakht BF, 2015, BIOMARKERS, V20, P5, DOI 10.3109/1354750X.2014.983167; Page CP, 2012, CURR OPIN PHARMACOL, V12, P275, DOI 10.1016/j.coph.2012.02.016; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Piotto M, 2005, J MAGN RESON, V173, P84, DOI 10.1016/j.jmr.2004.11.022; Sabatini F, 2010, PULM PHARMACOL THER, V23, P283, DOI 10.1016/j.pupt.2010.02.004; Sanz MJ, 2005, PHARMACOL THERAPEUT, V106, P269, DOI 10.1016/j.pharmthera.2004.12.001; Selige J, 2011, J CELL PHYSIOL, V226, P1970, DOI 10.1002/jcp.22529; Serrano-Mollar A, 2002, THORAX, V57, P629, DOI 10.1136/thorax.57.7.629; Vecchio D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/745984; Wheelock CE, 2013, EUR RESPIR J, V42, P802, DOI 10.1183/09031936.00078812; Wuyts WA, 2013, EUR RESPIR J, V41, P1207, DOI 10.1183/09031936.00073012	41	11	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133453	10.1371/journal.pone.0133453	http://dx.doi.org/10.1371/journal.pone.0133453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192616	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400086
J	Silva, O; Crocetti, J; Humphries, LA; Burkhardt, JK; Miceli, MC				Silva, Oscar; Crocetti, Jillian; Humphries, Lisa A.; Burkhardt, Janis K.; Miceli, M. Carrie			Discs Large Homolog 1 Splice Variants Regulate p38-Dependent and -Independent Effector Functions in CD8+T Cells	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; NF-KAPPA-B; LARGE TUMOR-SUPPRESSOR; T-CELLS; IMMUNOLOGICAL SYNAPSE; P38 ACTIVATION; ACTIN POLYMERIZATION; GENE-TRANSCRIPTION; RECEPTOR; DLGH1	Functionally diverse CD8+ T cells develop in response to antigenic stimulation with differing capacities to couple TCR engagement to downstream signals and functions. However, mechanisms of diversifying TCR signaling are largely uncharacterized. Here we identified two alternative splice variants of scaffold protein Dlg1, Dlg1AB and Dlg1B, that diversify signaling to regulate p38 -dependent and -independent effector functions in CD8+ T cells. Dlg1AB, but not Dlg1B associated with Lck, coupling TCR stimulation to p38 activation and proinflammatory cytokine production. Conversely, both Dlg1AB and Dlg1B mediated p38-independent degranulation. Degranulation depended on a Dlg1 fragment containing an intact Dlg1SH3-domain and required the SH3-ligand WASp. Further, Dlg1 controlled WASp activation by promoting TCR-triggered conformational opening of WASp. Collectively, our data support a model where Dlg1 regulates p38-dependent proinflammatory cytokine production and p38-independent cytotoxic granule release through the utilization of alternative splice variants, providing a mechanism whereby TCR engagement couples downstream signals to unique effector functions in CD8+ T cells.	[Silva, Oscar; Humphries, Lisa A.; Miceli, M. Carrie] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Crocetti, Jillian] Univ Calif Los Angeles, Mol Biol Interdept Program, Los Angeles, CA USA; [Burkhardt, Janis K.] Childrens Hosp Philadelphia, Dept Lab Med, Philadelphia, PA 19104 USA; [Burkhardt, Janis K.] Univ Penn, Philadelphia, PA 19104 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Miceli, MC (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	cmiceli@ucla.edu		Burkhardt, Janis/0000-0002-8176-1375	National Institutes of Health [R01-AI067253]; University of California, Los Angeles Microbial Pathogenesis Training Grant [T32-AI07323]; Arthritis Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323, R01AI067253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Los Angeles Microbial Pathogenesis Training Grant; Arthritis Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work by M.C.M. was supported by National Institutes of Health grant R01-AI067253 and by a University of California, Los Angeles Microbial Pathogenesis Training Grant T32-AI07323 to O.S. and J.C., and an Arthritis Foundation Postdoctoral Fellowship to L.A.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; Calvez R, 2011, HAEMATOL-HEMATOL J, V96, P1415, DOI 10.3324/haematol.2011.040204; Cavatorta AL, 2011, FEBS J, V278, P2596, DOI 10.1111/j.1742-4658.2011.08188.x; Crocetti J, 1950, J IMMUNOL, V193, P2651, DOI [10.4049/jimmunol.1401196, DOI 10.4049/JIMMUN0L.1401196]; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Meester J, 2010, J LEUKOCYTE BIOL, V88, P1031, DOI 10.1189/jlb.0410197; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Gmyrek GB, 2013, EUR J IMMUNOL, V43, P1185, DOI 10.1002/eji.201142362; Godreau D, 2003, J BIOL CHEM, V278, P47046, DOI 10.1074/jbc.M308463200; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang CJ, 2006, J IMMUNOL, V176, P4173, DOI 10.4049/jimmunol.176.7.4173; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Humphries LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045276; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Jirmanova L, 2009, BLOOD, V113, P2229, DOI 10.1182/blood-2008-04-153304; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lopez-Santalla M, 2011, ARTHRITIS RHEUM-US, V63, P1833, DOI 10.1002/art.30375; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Morales-Tirado V, 2004, J IMMUNOL, V173, P726, DOI 10.4049/jimmunol.173.2.726; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Rebeaud F, 2007, TRENDS IMMUNOL, V28, P196, DOI 10.1016/j.it.2007.03.004; Roberts S, 2007, EXP CELL RES, V313, P2521, DOI 10.1016/j.yexcr.2007.05.017; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stephenson LM, 2007, MOL CELL BIOL, V27, P7574, DOI 10.1128/MCB.00439-07; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zanin-Zhorov A, 2012, P NATL ACAD SCI USA, V109, P1625, DOI 10.1073/pnas.1110120109	52	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133353	10.1371/journal.pone.0133353	http://dx.doi.org/10.1371/journal.pone.0133353			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186728	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700128
J	Kreizinger, Z; Sulyok, KM; Pasztor, A; Erdelyi, K; Felde, O; Povazsan, J; Korosi, L; Gyuranecz, M				Kreizinger, Zsuzsa; Sulyok, Kinga Maria; Pasztor, Alexandra; Erdelyi, Karoly; Felde, Orsolya; Povazsan, Janos; Korosi, Laszlo; Gyuranecz, Miklos			Rapid, Simple and Cost-Effective Molecular Method to Differentiate the Temperature Sensitive (ts(+)) MS-H Vaccine Strain and Wild-Type Mycoplasma synoviae Isolates	PLOS ONE			English	Article							FIELD; ABNORMALITIES; POLYMORPHISM	Mycoplasma synoviae infection in chickens and turkeys can cause respiratory disease, infectious synovitis and eggshell apex abnormality; thus it is an economically important pathogen. Control of M. synoviae infection comprises eradication, medication or vaccination. The differentiation of the temperature sensitive (ts(+)) MS-H vaccine strain from field isolates is crucial during vaccination programs. Melt-curve and agarose gel based mismatch amplification mutation assays (MAMA) are provided in the present study to distinguish between the ts(+) MS-H vaccine strain, its non-temperature sensitive re-isolates and wildtype M. synoviae isolates based on the single nucleotide polymorphisms at nt367 and nt629 of the obg gene. The two melt-MAMAs and the two agarose-MAMAs clearly distinguish the ts(+) MS-H vaccine strain genotype from its non-temperature sensitive re-isolate genotype and wild-type M. synoviae isolate genotype, and no cross-reactions with other Mycoplasma species infecting birds occur. The sensitivity of the melt-MAMAs and agarose-MAMAs was 103 and 104 copy numbers, respectively. The assays can be performed directly on clinical samples and they can be run simultaneously at the same annealing temperature. The assays can be performed in laboratories with limited facilities, using basic real-time PCR machine or conventional thermocycler coupled with agarose gel electrophoresis. The advantages of the described assays compared with previously used methods are simplicity, sufficient sensitivity, time and cost effectiveness and specificity.	[Kreizinger, Zsuzsa; Sulyok, Kinga Maria; Pasztor, Alexandra; Felde, Orsolya; Gyuranecz, Miklos] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, H-1581 Budapest, Pest, Hungary; [Erdelyi, Karoly] Natl Food Chain Safety Off, Vet Diagnost Directorate, Budapest, Hungary; [Povazsan, Janos; Korosi, Laszlo] Rhone Vet Kft, Herceghalom, Pest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Gyuranecz, M (corresponding author), Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, H-1581 Budapest, Pest, Hungary.	m.gyuranecz@gmail.com	Erdélyi, Károly/A-9600-2016; Erdélyi, Károly/AAB-6540-2022	Gyuranecz, Miklos/0000-0002-5698-5713	Lendulet program of the Hungarian Academy of Sciences [LP2012-22]	Lendulet program of the Hungarian Academy of Sciences	This work was supported by the Lendulet (Momentum; http://mta.hu/articles/momentum-program- of-the-hungarian-academy-of-sciences-130009) program (LP2012-22) of the Hungarian Academy of Sciences dedicated to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayatzadeh MA, 2014, BRIT POULTRY SCI, V55, P148, DOI 10.1080/00071668.2013.878781; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Catania S, 2010, AVIAN DIS, V54, P961, DOI 10.1637/9121-110309-Case.1; Dijkman R, 2014, AVIAN PATHOL, V43, P465, DOI 10.1080/03079457.2014.958980; Feberwee A, 2009, AVIAN PATHOL, V38, P77, DOI 10.1080/03079450802662772; Harada K, 2009, AVIAN DIS, V53, P538, DOI 10.1637/8934-052309-Reg.1; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Kleven S., 2008, DIS POULTRY, P845; Kleven SH, 2008, AVIAN DIS, V52, P367, DOI 10.1637/8323-041808-Review.1; Marois C, 2000, VET MICROBIOL, V73, P311, DOI 10.1016/S0378-1135(00)00178-4; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; Ogino S, 2011, AVIAN DIS, V55, P187, DOI 10.1637/9461-071310-Reg.1; Shahid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092215; Shahid MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073954; Shahid MA, 2013, AVIAN PATHOL, V42, P185, DOI 10.1080/03079457.2013.779363	15	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133554	10.1371/journal.pone.0133554	http://dx.doi.org/10.1371/journal.pone.0133554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207635	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000358622000099
J	Formoso, AE; Martin, GM; Teta, P; Carbajo, AE; Sauthier, DEU; Pardinas, UFJ				Formoso, Anahi E.; Martin, Gabriel M.; Teta, Pablo; Carbajo, Anbal E.; Sauthier, Daniel E. Udrizar; Pardinas, Ulyses F. J.			Regional Extinctions and Quaternary Shifts in the Geographic Range of Lestodelphys halli, the Southernmost Living Marsupial: Clues for Its Conservation	PLOS ONE			English	Article							BUENOS-AIRES PROVINCE; SMALL MAMMALS DIDELPHIMORPHIA; LATE-HOLOCENE; SIGMODONTINE RODENTS; LATE PLEISTOCENE; MONTE DESERT; ARGENTINA; PATAGONIA; CLIMATE; MICROMAMMALS	The Patagonian opossum (Lestodelphys halli), the southernmost living marsupial, inhabits dry and open environments, mainly in the Patagonian steppe (between similar to 32 degrees S and similar to 49 degrees S). Its rich fossil record shows its occurrence further north in Central Argentina during the Quaternary. The paleoenvironmental meaning of the past distribution of L. halli has been mostly addressed in a subjective framework without an explicit connection with the climatic "space" currently occupied by this animal. Here, we assessed the potential distribution of this species and the changes occurred in its geographic range during late Pleistocene-Holocene times and linked the results obtained with conservation issues. To this end, we generated three potential distribution models with fossil records and three with current ones, using MaxEnt software. These models showed a decrease in the suitable habitat conditions for the species, highlighting a range shift from Central-Eastern to South-Western Argentina. Our results support that the presence of L. halli in the Pampean region during the Pleistocene-Holocene can be related to precipitation and temperature variables and that its current presence in Patagonia is more related to temperature and dominant soils. The models obtained suggest that the species has been experiencing a reduction in its geographic range since the middle Holocene, a process that is in accordance with a general increase in moisture and temperature in Central Argentina. Considering the findings of our work and the future scenario of global warming projected for Patagonia, we might expect a harsh impact on the distribution range of this opossum in the near future.	[Formoso, Anahi E.; Pardinas, Ulyses F. J.] Consejo Nacl Invest Cient & Tecn, Inst Diversidad & Evoluc Austral, Puerto Madryn, Chubut, Argentina; [Martin, Gabriel M.] Univ Nacl Patagonia San Juan Bosco, Fac Ciencias Nat, Lab Invest Evoluc & Biodiversidad, Sede Esquel, Esquel, Chubut, Argentina; [Teta, Pablo] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Mastozool, Buenos Aires, DF, Argentina; [Carbajo, Anbal E.] Univ Nacl San Martin, Inst Invest & Ingn Ambiental, Ecol Enfermedades Transmitidas Vectores, Buenos Aires, DF, Argentina; [Sauthier, Daniel E. Udrizar] Univ Nacl Patagonia San Juan Bosco, Inst Patagon Estudio Ecosistemas Continentales IP, Puerto Madryn, Chubut, Argentina; [Sauthier, Daniel E. Udrizar] Univ Nacl Patagonia San Juan Bosco, Fac Ciencias Nat, Puerto Madryn, Chubut, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidad Nacional de la Patagonia San Juan Bosco; Universidad Nacional de la Patagonia San Juan Bosco	Formoso, AE (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Diversidad & Evoluc Austral, Puerto Madryn, Chubut, Argentina.	formoso@cenpat-conicet.gob.ar	Carbajo, Anibal Eduardo/AAF-3405-2020		Consejo Nacional de Investigaciones Cientificas y Tecnicas; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2008-547]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This research was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2008-547 to UFJP).	Ameghino F., 1889, ACTAS ACAD NACL CIEN, V6; ANDRADE A, 2003, ATEKNA, V1, P274; Andrade A, 2002, HIST NAT SEGUNDA SER, V1, P9, DOI [10.35537/10915/59171, DOI 10.35537/10915/59171]; [Anonymous], 1979, RELACIONES SOC ARGEN, VXIII, P229; [Anonymous], P 21 INT C MACH LEAR; BIRNEY EC, 1996, CONTRIBUTIONS MAMMAL, P149; BIRNEY EC, 1996, MASTOZOOL NEOTROP, V3, P171; Cabrera A. L., 1971, SOC ARGENTINA BOT, V14, P1; Cabrera A.L., 1973, BIOGEOGRAFIA AM; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; CRESPO J A, 1974, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" e Instituto Nacional de Investigacion de las Ciencias Naturales Zoologia, V11, P1; De Santis LJM, 1995, NEOTROPICA, V41, P85; Deschamps Cecilia M., 1992, Ameghiniana, V29, P201; Deschamps CM, 2005, AMEGHINIANA, V42, P733; Dijkshoorn J.A., 2005, 200501 ISRIC WORLD S; Formoso A.E., 2013, THESIS U NACL LA PLA; Formoso AE, 2011, MAMMALIA, V75, P371, DOI 10.1515/MAMM.2011.043; Gasco A, 2006, ANALES ARQUEOLOGIA E, V61, P135; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Giarla TC, 2014, J BIOGEOGR, V41, P1547, DOI 10.1111/jbi.12320; Goin F.J., 1995, EVOLUCION BIOL CLIMA, P165; Goin FJ, 1991, THESIS U NACL LA PLA; Goin FJ, 2001, PUBLICACION ESPECIAL, V1, P75; Gomez DA, 1999, ECOREGIONES ARGENTIN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horovitz I., 2003, ARQUEOLOGIA Y PALEOA, P87; IRIONDO MH, 1993, PALAEOGEOGR PALAEOCL, V101, P209, DOI 10.1016/0031-0182(93)90013-9; Labraga JC, 2009, J ARID ENVIRON, V73, P154, DOI 10.1016/j.jaridenv.2008.03.016; Leon Rolando J. C., 1998, Ecologia Austral, V8, P125; Magrin G, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P581; MARSHALL L G, 1977, Mammalian Species, V81, P1; Martin Gabriel, 2003, Mastozoologia Neotropical, V10, P148; Martin GM, 2008, MAMMALIA, V72, P131, DOI 10.1515/MAMM.2008.017; Martin GM, 2005, J MAMMAL, V86, P793, DOI 10.1644/1545-1542(2005)086[0793:IVILHM]2.0.CO;2; Martin GM, 2008, THESIS U NACL LA PLA; Martinelli Agustín G., 2013, Pap. Avulsos Zool. (São Paulo), V53, P151, DOI 10.1590/S0031-10492013001200001; Massoia E., 1982, REV INVESTIG AGROPEC, V17, P39; Massoia E, 1997, B CIENT ASOC PROTEC, V33, P18; Massoia E., 1988, B CIENTIFICO APRONA, V4, P14; Massoia E, 1988, B CIENTIFICO ASOCIAC, V3, P23; MCNAB BK, 1971, ECOLOGY, V52, P845, DOI 10.2307/1936032; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nabte MJ, 2006, ORNITOL NEOTROP, V17, P27; Neme G, 2002, REV CHIL HIST NAT, V75, P409; Odreman R, 1969, ACT 4 JORN GEOL ARG, V1, p[269, 291]; OLIVA F., 1991, SHINCAL, V3, P135; Pardi?as UFJ., 1999, THESIS U NACL LA PLA; Pardinas UFJ, 2012, J ARID ENVIRON, V85, P71, DOI 10.1016/j.jaridenv.2012.05.009; Pardinas U. F. J., 1996, Estudios Geologicos (Madrid), V52, P367; Pardinas U.F.J., 1989, B CIENTIFICO ASOCIAC, V13, P9; Pardinas UFJ, 2004, AMEGHINIANA, V41, P437; Pardinas UFJ, 2001, AMEGHINIANA, V38, P227; PARDINAS UFJ, 2000, REV CHIL HIST NAT, V72, P541; Pardinas Ulyses F., 2008, Check List, V4, P218; Pardinas Ulyses F. J., 1998, Neotropica (La Plata), V44, P123; Pardinas Ulyses F. J., 2003, Mastozoologia Neotropical, V10, P69; Pardinas UFJ, 2013, QUATERN INT, V305, P127, DOI 10.1016/j.quaint.2012.08.001; Parry M. L., 2007, CLIMATE CHANGE 2007; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; Pearson AK, 1993, PRAEHISTORIA, V1, P73; PEARSON OP, 1987, J MAMMAL, V68, P469, DOI 10.2307/1381583; Perrota EJB, 1987, COMUNICACIONES PRIME, P249; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pradol JL, 1985, QUATERNARY S AM ANTA, P93; Prevosti Francisco J., 2001, Mastozoologia Neotropical, V8, P21; Rabassa J, 2011, BIOL J LINN SOC, V103, P316, DOI 10.1111/j.1095-8312.2011.01681.x; Reig O. A., 1959, Neotropica, V5, P57; Reig O.A., 1987, P1; Rodríguez Valeria A., 2007, Mastozool. neotrop., V14, P97; Scheifler N, 2012, QUATERN INT, V278, P32, DOI 10.1016/j.quaint.2012.02.001; Schiaffini MI, 2013, J MAMMAL, V94, P339, DOI 10.1644/12-MAMM-A-155.1; Schiaffini Mauro I., 2011, Check List, V7, P704; SIMPSON GG, 1972, REV MUSEO MUNICIPAL, V2, P1; Teta P, 2005, ARCHAEOFAUNA, V14, P183; TETA P, 2002, NEOTROPICA, V48, P88; Teta Pablo, 2014, Therya, V5, P7; Teta Pablo, 2013, Mastozoologia Neotropical, V20, P171; Teta Pablo, 2009, Mastozool. neotrop., V16, P183; Thomas O., 1921, Annals & Magazine of Natural History Series 9, V8, P136; THOMAS OLDFIELD, 1929, ANN AND MAG NAT HIST SER, V10-4, P35; Tonni E.P., 1982, Ameghiniana, V19, P79; Tonni EP, 1999, PALAEOGEOGR PALAEOCL, V147, P257, DOI 10.1016/S0031-0182(98)00140-0; Udrizar Sauthier D, 2007, CHECK LIST, V3, P137; Udrizar Sauthier D, 2009, THESIS U NACL LA PLA; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; VIGLIZZO EF, 1995, AGR ECOSYST ENVIRON, V55, P7, DOI 10.1016/0167-8809(95)00608-U; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112; Zapata SC, 2013, GAYANA, V77, P64, DOI 10.4067/S0717-65382013000100009; ZUBIMENDI MIGUEL A, 2006, Magallania, V34, P107, DOI 10.4067/S0718-22442006000200010	89	14	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132130	10.1371/journal.pone.0132130	http://dx.doi.org/10.1371/journal.pone.0132130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203650	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000007
J	Bauer, R; Garnica, S; Oberwinkler, F; Riess, K; Weiss, M; Begerow, D				Bauer, Robert; Garnica, Sigisfredo; Oberwinkler, Franz; Riess, Kai; Weiss, Michael; Begerow, Dominik			Entorrhizomycota: A New Fungal Phylum Reveals New Perspectives on the Evolution of Fungi	PLOS ONE			English	Article							SMUT FUNGI; PHYLOGENETIC INFERENCE; SEQUENCE ALIGNMENT; CASPARYANA; POSITION; MEIOSIS; LINEAGE; LIGHT; DNA	Entorrhiza is a small fungal genus comprising 14 species that all cause galls on roots of Cyperaceae and Juncaceae. Although this genus was established 130 years ago, crucial questions on the phylogenetic relationships and biology of this enigmatic taxon are still unanswered. In order to infer a robust hypothesis about the phylogenetic position of Entorrhiza and to evaluate evolutionary trends, multiple gene sequences and morphological characteristics of Entorrhiza were analyzed and compared with respective findings in Fungi. In our comprehensive five-gene analyses Entorrhiza appeared as a highly supported monophyletic lineage representing the sister group to the rest of the Dikarya, a phylogenetic placement that received but moderate maximum likelihood and maximum parsimony boot-strap support. An alternative maximum likelihood tree with the constraint that Entorrhiza forms a monophyletic group with Basidiomycota could not be rejected. According to the first phylogenetic hypothesis, the teliospore tetrads of Entorrhiza represent the prototype of the dikaryan meiosporangium. The alternative hypothesis is supported by similarities in septal pore structure, cell wall and spindle pole bodies. Based on the isolated phylogenetic position of Entorrhiza and its peculiar combination of features related to ultrastructure and reproduction mode, we propose a new phylum Entorrhizomycota, for the genus Entorrhiza, which represents an apparently widespread group of inconspicuous fungi.	[Bauer, Robert; Garnica, Sigisfredo; Oberwinkler, Franz; Riess, Kai] Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, D-72076 Tubingen, Germany; [Weiss, Michael] Univ Tubingen, Dept Biol, D-72076 Tubingen, Germany; [Weiss, Michael] Inst Organismal Mycol & Microbiol, D-72076 Tubingen, Germany; [Begerow, Dominik] Univ Bochum, AG Geobot, D-44780 Bochum, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ruhr University Bochum	Riess, K (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, Morgenstelle 1, D-72076 Tubingen, Germany.	kai.riess@uni-tuebingen.de; dominik.begerow@rub.de	Weiß, Michael/F-6206-2012; Sigisfredo, Garnica/P-6506-2014; Riess, Kai/B-5491-2015	Weiß, Michael/0000-0002-4869-9186; Riess, Kai/0000-0002-8804-0175; Begerow, Dominik/0000-0002-8286-1597	German Research Foundation, DFG [BA 75/3-1]; Open Access Publishing Fund of Tuebingen University	German Research Foundation, DFG(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This research was funded by the German Research Foundation, DFG (BA 75/3-1) and the Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDONI RJ, 1984, T MYCOL SOC JPN, V25, P489; BAUER R, 1991, CAN J BOT, V69, P245, DOI 10.1139/b91-035; BAUER R, 1988, BOT ACTA, V101, P272, DOI 10.1111/j.1438-8677.1988.tb00044.x; BAUER R, 1986, Zeitschrift fuer Mykologie, V52, P259; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; BAUER R, 1994, CAN J BOT, V72, P1229, DOI 10.1139/b94-151; Bauer R, 2001, MYCOTA, V7, P57; Begerow D, 2004, MYCOL RES, V108, P1257, DOI 10.1017/S0953756204001066; Begerow D, 1997, CAN J BOT, V75, P2045, DOI 10.1139/b97-916; Begerow D, 2006, MYCOLOGIA, V98, P906, DOI 10.3852/mycologia.98.6.906; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; DEML G, 1981, MYCOLOGIA, V73, P392, DOI 10.2307/3759592; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FINERAN JM, 1982, CAN J BOT, V60, P2903, DOI 10.1139/b82-351; FINERAN JM, 1980, NOVA HEDWIGIA, V32, P265; FINERAN JM, 1978, NOVA HEDWIGIA, V30, P1; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; GERSTERBERGER P, 1979, BER DEUT BOT GES, V91, P381; HEATH IB, 1981, INT REV CYTOL, V69, P191; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Humber RA, 2012, MYCOTAXON, V120, P477, DOI 10.5248/120.477; INGOLD CT, 1979, AM J BOT, V66, P218, DOI 10.2307/2442527; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KREGERVA.NJ, 1971, J GEN MICROBIOL, V68, P87, DOI 10.1099/00221287-68-1-87; Le SQ, 2012, MOL BIOL EVOL, V29, P2921, DOI 10.1093/molbev/mss112; Liu YJJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-74; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Matheny PB, 2006, CAN J BOT, V84, P1794, DOI 10.1139/B06-128; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; NAGLER A, 1989, MYCOLOGIA, V81, P884, DOI 10.2307/3760107; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Oberwinkler, 2012, ANDRIAS, V19, P23; OBERWINKLER F, 1981, CAN J BOT, V59, P1034, DOI 10.1139/b81-141; Oberwinkler F., 2012, STAPFIA, V96, P45; Piepenbring M, 1998, PROTOPLASMA, V204, P155, DOI 10.1007/BF01280322; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salichos L, 2014, MOL BIOL EVOL, V31, P1261, DOI 10.1093/molbev/msu061; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vanky K, 2012, SMUT FUNGI OF THE WO; Weber C, 1884, BOT ZTG BERLIN, V42, P369; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	50	31	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0128183	10.1371/journal.pone.0128183	http://dx.doi.org/10.1371/journal.pone.0128183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200112	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100001
J	Carey, M; Xiao, JJ; Farias, JG; Meharg, AA				Carey, Manus; Xiao Jiujin; Farias, Julia Gomes; Meharg, Andrew A.			Rethinking Rice Preparation for Highly Efficient Removal of Inorganic Arsenic Using Percolating Cooking Water	PLOS ONE			English	Article							COOKED RICE; WHITE	A novel way of cooking rice to maximize the removal of the carcinogen inorganic arsenic (As-i) is presented here. In conventional rice cooking water and grain are in continuous contact, and it is known that the larger the water: rice cooking ratio, the more As-i removed by cooking, suggesting that the As-i in the grain is mobile in water. Experiments were designed where rice is cooked in a continual stream of percolating near boiling water, either low in As-i, or As-i free. This has the advantage of not only exposing grain to large volumes of cooking water, but also physically removes any As-i leached from the grain into the water receiving vessel. The relationship between cooking water volume and As-i removal in conventional rice cooking was demonstrated for the rice types under study. At a water-to-rice cooking ratio of 12:1, 57 +/- 5% of As-i could be removed, average of 6 wholegrain and 6 polished rice samples. Two types of percolating technology were tested, one where the cooking water was recycled through condensing boiling water steam and passing the freshly distilled hot water through the grain in a laboratory setting, and one where tap water was used to cook the rice held in an off-the-shelf coffee percolator in a domestic setting. Both approaches proved highly effective in removing As-i from the cooking rice, with up to 85% of As-i removed from individual rice types. For the recycled water experiment 59 +/- 8% and 69 +/- 10% of As-i was removed, on average, compared to uncooked rice for polished (n=27) and wholegrain (n=13) rice, respectively. For coffee percolation there was no difference between wholegrain and polished rice, and the effectiveness of As-i removal was 49 +/- 7% across 6 wholegrain and 6 polished rice samples. The manuscript explores the potential applications and further optimization of this percolating cooking water, high As-i removal, discovery.	[Carey, Manus; Xiao Jiujin; Farias, Julia Gomes; Meharg, Andrew A.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Xiao Jiujin] Sichuan Agr Univ, Chengdu, Sichuan, Peoples R China; [Farias, Julia Gomes] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Biol, BR-97119900 Santa Maria, RS, Brazil	Queens University Belfast; Sichuan Agricultural University; Universidade Federal de Santa Maria (UFSM)	Meharg, AA (corresponding author), Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland.	aa.meharg@qub.ac.uk	Meharg, Andrew Alexander/F-8182-2014; Carey, Manus/K-8180-2015	Meharg, Andrew Alexander/0000-0003-2019-0449; Carey, Manus/0000-0002-1065-4943; Farias, Julia/0000-0002-2268-5501				[Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Bae M, 2002, LANCET, V360, P1839, DOI 10.1016/S0140-6736(02)11738-7; Juhasz AL, 2006, ENVIRON HEALTH PERSP, V114, P1826, DOI 10.1289/ehp.9322; Meharg A.A., 2012, ARSENIC RICE; Meharg AA, 2008, ENVIRON POLLUT, V152, P746, DOI 10.1016/j.envpol.2008.01.043; Meharg AA, 2008, J ENVIRON MONITOR, V10, P428, DOI 10.1039/b800981c; Meharg AA, 2008, ENVIRON SCI TECHNOL, V42, P1051, DOI 10.1021/es702212p; Raab A, 2009, J ENVIRON MONITOR, V11, P41, DOI 10.1039/b816906c; Sengupta MK, 2006, FOOD CHEM TOXICOL, V44, P1823, DOI 10.1016/j.fct.2006.06.003; Sharma S, 2013, NUTR J, V12, P65; Signes-Pastor AJ, 2015, FOOD CHEM IN PRESS; Sun GX, 2008, ENVIRON SCI TECHNOL, V42, P7542, DOI 10.1021/es801238p; Watanabe T, 1999, J JPN SOC FOOD SCI, V46, P731	14	35	35	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131608	10.1371/journal.pone.0131608	http://dx.doi.org/10.1371/journal.pone.0131608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200355	gold, Green Published, Green Submitted			2022-12-27	WOS:000358597100018
J	Svaldi, J; Naumann, E; Biehl, S; Schmitz, F				Svaldi, Jennifer; Naumann, Eva; Biehl, Stefanie; Schmitz, Florian			Impaired Early-Response Inhibition in Overweight Females with and without Binge Eating Disorder	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT-LOSS; PSYCHOMETRIC PROPERTIES; CARDIOVASCULAR-DISEASE; COGNITIVE FUNCTION; ATTENTIONAL BIAS; FOOD STIMULI; OBESE WOMEN; SELF-REPORT; ACTIVATION	Objective Several studies report increased reward sensitivity towards food in overweight individuals. By contrast, data is inconclusive with respect to response inhibition in overweight individuals without binge eating disorder (BED). Hence, the latter was addressed in the present study in a group of overweight/obese females with and without BED and a normal-weight control group without eating disorders. Method A group of women with BED (n = 29), a group of overweight women without BED (n = 33) and normal-weight females (n = 30) participated in a pictorial priming paradigm, with food items (relevant primes) and office utensils (neutral primes) and color blobs (neutral primes) as stimuli. Increased response priming effects (i.e. priming with switches between stimulus categories) were taken as indicators of deficient behavioral inhibition. Results Priming effects for neutral primes were moderate and comparable across all groups. However, primes associated with the food task set lead to increased priming effects in both overweight groups. But, effects were comparable for overweight/obese participants with and without BED. Discussion Results suggest that early response inhibition in the context of food is impaired in overweight individuals compared to normal-weight individuals.	[Svaldi, Jennifer; Biehl, Stefanie] Univ Tubingen, Dept Clin Psychol & Psychotherapy, Tubingen, Germany; [Naumann, Eva] Univ Freiburg, Dept Clin Psychol & Psychotherapy, D-79106 Freiburg, Germany; [Schmitz, Florian] Univ Ulm, Inst Psychol & Pedag, D-89069 Ulm, Germany	Eberhard Karls University of Tubingen; University of Freiburg; Ulm University	Svaldi, J (corresponding author), Univ Tubingen, Dept Clin Psychol & Psychotherapy, Tubingen, Germany.	jennifer.svaldi@uni-tuebingen.de	Schmitz, Florian/G-8014-2018; Biehl, Stefanie/L-2771-2019; Naumann, Eva/ABE-1671-2021	Schmitz, Florian/0000-0001-6368-628X; 	Ministry of Science and Art of Baden Wurttemberg; Research Innovation Fund of the Albert-Ludwigs-University of Freiburg	Ministry of Science and Art of Baden Wurttemberg; Research Innovation Fund of the Albert-Ludwigs-University of Freiburg	This research was supported by the Ministry of Science and Art of Baden Wurttemberg (http://mwk.baden-wuerttemberg.de/de/startseite/) and the Research Innovation Fund of the Albert-Ludwigs-University of Freiburg (http://www.frs.unifreiburg.de/abteilungen/ssc/forschungsfoerderung/innovationsfonds-en?set_language=en) accorded	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Berridge K. C., 2007, APPETITE BODY WEIGHT, P191, DOI 10.1016/B978-012370633-1/50008-6; Bischoff SC, 2012, INT J OBESITY, V36, P614, DOI 10.1038/ijo.2011.107; Carpiniello B, 2009, EPIDEMIOL PSICHIAT S, V18, P119, DOI 10.1017/S1121189X00001007; CHALMERS DK, 1990, INT J ADDICT, V25, P803, DOI 10.3109/10826089009056219; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Corr PJ, 2008, THE REINFORCEMENT SE; Cortese S, 2008, CRIT REV FOOD SCI, V48, P524, DOI 10.1080/10408390701540124; Cyders MA, 2012, J RES PERS, V46, P121, DOI 10.1016/j.jrp.2011.11.005; Davids S, 2010, INT J OBESITY, V34, P94, DOI 10.1038/ijo.2009.193; Davis C, 2004, OBES RES, V12, P929, DOI 10.1038/oby.2004.113; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; DeYoung C. G, 2011, HDB SELF REGULATION, P485; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn Christopher G., 1993, P317; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Friedman KE, 2005, OBES RES, V13, P907, DOI 10.1038/oby.2005.105; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Galioto R, 2012, COMPR PSYCHIAT, V53, P490, DOI 10.1016/j.comppsych.2011.09.002; Garcia-Garcia I, 2013, EUR EAT DISORD REV, V21, P89, DOI 10.1002/erv.2216; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Geliebter A, 2006, APPETITE, V46, P31, DOI 10.1016/j.appet.2005.09.002; Giel KE, 2013, EUR EAT DISORD REV, V21, P488, DOI 10.1002/erv.2245; Gladwin TE, 2011, DEV COGN NEUROS-NETH, V1, P364, DOI 10.1016/j.dcn.2011.06.008; Gray JA, 2000, THE NEUROPSYCHOLOGY; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742; Hautzinger M., 2006, DAS BECK DEPRESSIONS; Hilbert A, 2004, DIAGNOSTICA, V50, P98, DOI 10.1026/0012-1924.50.2.98; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Hommel B, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P247; Houben K, 2014, OBESITY, V22, pE6, DOI 10.1002/oby.20670; Johansson K, 2014, AM J CLIN NUTR, V99, P14, DOI 10.3945/ajcn.113.070052; Klauer KC, 2005, PSYCHON B REV, V12, P897, DOI 10.3758/BF03196783; Koch I, 2006, MEM COGNITION, V34, P433, DOI 10.3758/BF03193420; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Lake A, 2006, J R SOC PROMO HEALTH, V126, P262, DOI 10.1177/1466424006070487; Lehnert T, 2013, BEST PRACT RES CL EN, V27, P105, DOI 10.1016/j.beem.2013.01.002; Loeber S, 2012, INT J OBESITY, V36, P1334, DOI 10.1038/ijo.2011.184; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan GD, 1994, ON THE ABILITY TO IN; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Mobbs O, 2011, APPETITE, V57, P263, DOI 10.1016/j.appet.2011.04.023; Ng J, 2011, APPETITE, V57, P65, DOI 10.1016/j.appet.2011.03.017; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; R Core Team, 2014, R A LANGUAGE AND ENV; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rissanen AM, 1996, CIBA F SYMP, V201, P194; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Rothermund K, 2004, J EXP PSYCHOL GEN, V133, P139, DOI 10.1037/0096-3445.133.2.139; Schag K, 2013, OBES REV, V14, P477, DOI 10.1111/obr.12017; Schag K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076542; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; Schmidt F, 2012, EUR EAT DISORD REV, V20, pe144, DOI 10.1002/erv.2162; Schmitz F, 2014, APPETITE, V80, P70, DOI 10.1016/j.appet.2014.04.023; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Sebastian A, 2013, NEUROIMAGE, V64, P601, DOI 10.1016/j.neuroimage.2012.09.020; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Shaw K, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003818.pub2; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stahl C, 2014, J EXP PSYCHOL GEN, V143, P850, DOI 10.1037/a0033981; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Stoeckel LE, 2009, BRAIN RES BULL, V79, P388, DOI 10.1016/j.brainresbull.2009.05.016; Svaldi J, 2014, INT J EAT DISORDER, V47, P534, DOI 10.1002/eat.22260; Svaldi J, 2010, APPETITE, V55, P685, DOI 10.1016/j.appet.2010.10.002; Tammela LI, 2010, CLIN PHYSIOL FUNCT I, V30, P135, DOI 10.1111/j.1475-097X.2009.00916.x; Tukey JW, 1977, EXPLORATORY DATA ANA; Villarejo C, 2014, EUR EAT DISORD REV, V22, P25, DOI 10.1002/erv.2267; Wadden TA, 2014, OBESITY, V22, P5, DOI 10.1002/oby.20662; Waszak F, 2007, MEM COGNITION, V35, P1175, DOI 10.3758/BF03193487; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Werrij MQ, 2009, J BEHAV THER EXP PSY, V40, P136, DOI 10.1016/j.jbtep.2008.07.003; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WILLIAMSON DA, 1985, J CONSULT CLIN PSYCH, V53, P161, DOI 10.1037/0022-006X.53.2.161; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Wittchen HU, 1997, SKID; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Wu M, 2013, THE INTERNATIONAL JO	90	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133534	10.1371/journal.pone.0133534	http://dx.doi.org/10.1371/journal.pone.0133534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26201025	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100071
J	Bowers, JR; Kitchel, B; Driebe, EM; MacCannell, DR; Roe, C; Lemmer, D; de Man, T; Rasheed, JK; Engelthaler, DM; Keim, P; Limbago, BM				Bowers, Jolene R.; Kitchel, Brandon; Driebe, Elizabeth M.; MacCannell, Duncan R.; Roe, Chandler; Lemmer, Darrin; de Man, Tom; Rasheed, J. Kamile; Engelthaler, David M.; Keim, Paul; Limbago, Brandi M.			Genomic Analysis of the Emergence and Rapid Global Dissemination of the Clonal Group 258 Klebsiella pneumoniae Pandemic	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; STRAIN CAUSING OUTBREAKS; BETA-LACTAMASE; CARBAPENEM RESISTANCE; MULTIDRUG-RESISTANCE; EFFLUX PUMP; MARR FAMILY; 1ST REPORT; EPIDEMIOLOGY; PORIN	Multidrug-resistant Klebsiella pneumoniae producing the KPC carbapenemase have rapidly spread throughout the world, causing severe healthcare-associated infections with limited antimicrobial treatment options. Dissemination of KPC-producing K. pneumoniae is largely attributed to expansion of a single dominant strain, ST258. In this study, we explore phylogenetic relationships and evolution within ST258 and its clonal group, CG258, using whole genome sequence analysis of 167 isolates from 20 countries collected over 17 years. Our results show a common ST258 ancestor emerged from its diverse parental clonal group around 1995 and likely acquired bla(KPC) prior to dissemination. Over the past two decades, ST258 has remained highly clonal despite diversity in accessory elements and divergence in the capsule polysaccharide synthesis locus. Apart from the large recombination event that gave rise to ST258, few mutations set it apart from its clonal group. However, one mutation occurs in a global transcription regulator. Characterization of outer membrane protein sequences revealed a profile in ST258 that includes a truncated OmpK35 and modified OmpK37. Our work illuminates potential genomic contributors to the pathogenic success of ST258, helps us better understand the global dissemination of this strain, and identifies genetic markers unique to ST258.	[Bowers, Jolene R.; Driebe, Elizabeth M.; Roe, Chandler; Lemmer, Darrin; Engelthaler, David M.; Keim, Paul] Translat Genom Res Inst, Flagstaff, AZ 86001 USA; [Kitchel, Brandon; MacCannell, Duncan R.; de Man, Tom; Rasheed, J. Kamile; Limbago, Brandi M.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA	Translational Genomics Research Institute; Centers for Disease Control & Prevention - USA	Bowers, JR (corresponding author), Translat Genom Res Inst, Flagstaff, AZ 86001 USA.	jbowers@tgen.org	de Man, Tom/M-5453-2019	de Man, Tom/0000-0003-0511-5053; Lemmer, Darrin/0000-0003-2785-6928	National Institutes of Health [R01AI090782]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by award number R01AI090782 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2014, DIAGN MICR INFEC DIS, V78, P12, DOI 10.1016/j.diagmicrobio.2013.10.003; Adler A, 2012, J CLIN MICROBIOL, V50, P3180, DOI 10.1128/JCM.00987-12; America TSfHEo, 2011, LARG VET HLTH ADM ST; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bialek-Davenet S, 2015, J ANTIMICROB CHEMOTH, V70, P81, DOI 10.1093/jac/dku340; Bialek-Davenet S, 2014, EMERG INFECT DIS, V20, P1812, DOI 10.3201/eid2011.140206; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brink AJ, 2012, J CLIN MICROBIOL, V50, P525, DOI 10.1128/JCM.05956-11; Brisse S, 2013, J CLIN MICROBIOL, V51, P4073, DOI 10.1128/JCM.01924-13; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Chen Liang, 2014, Antimicrob Agents Chemother, V58, P2871, DOI 10.1128/AAC.00120-14; Chen L, 2014, MBIO, V5, DOI 10.1128/mBio.01355-14; Chen Luke F, 2012, Infect Drug Resist, V5, P133, DOI 10.2147/IDR.S26613; Chmelnitsky I, 2013, J ANTIMICROB CHEMOTH, V68, P74, DOI 10.1093/jac/dks370; Croucher NJ, 2014, MBIO, V5, DOI 10.1128/mBio.01550-14; Croucher NJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0202; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P5370, DOI 10.1128/AAC.05202-11; De Majumdar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004627; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Domenech-Sanchez A, 2003, ANTIMICROB AGENTS CH, V47, P3332, DOI 10.1128/AAC.47.10.3332-3335.2003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V63, P427, DOI 10.1093/jac/dkn547; Frank CG, 2013, CELL MICROBIOL, V15, P1212, DOI 10.1111/cmi.12110; Frasson I, 2012, J CLIN MICROBIOL, V50, P3768, DOI 10.1128/JCM.01892-12; Gaiarsa S, 2015, ANTIMICROB AGENTS CH, V59, P389, DOI 10.1128/AAC.04224-14; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Garcia-Sureda L, 2011, ANTIMICROB AGENTS CH, V55, P4742, DOI 10.1128/AAC.00309-11; Giani T, 2009, J CLIN MICROBIOL, V47, P3793, DOI 10.1128/JCM.01773-09; Gomez SA, 2011, CLIN MICROBIOL INFEC, V17, P1520, DOI 10.1111/j.1469-0691.2011.03600.x; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grundmann H, 2010, EUROSURVEILLANCE, V15, P22; Hammerum AM, 2010, INT J ANTIMICROB AG, V35, P610, DOI 10.1016/j.ijantimicag.2010.01.024; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; Hao ZY, 2014, NAT CHEM BIOL, V10, P21, DOI [10.1038/NCHEMBIO.1380, 10.1038/nchembio.1380]; Holt K, 2013, SRST2 SHORT READ SEQ; Huntington P, 2011, AUSTR SOC MICR 2011; Jacob JT, 2013, MMWR-MORBID MORTAL W, P62; Jiang Y, 2010, ANTIMICROB AGENTS CH, V54, P3967, DOI 10.1128/AAC.00137-10; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Kitchel B, 2010, ANTIMICROB AGENTS CH, V54, P4201, DOI 10.1128/AAC.00008-10; Lascols C, 2013, ANTIMICROB AGENTS CH, V57, P130, DOI 10.1128/AAC.01686-12; Leavitt A, 2010, ANTIMICROB AGENTS CH, V54, P4493, DOI 10.1128/AAC.00175-10; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; March C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056847; Mataseje LF, 2011, J ANTIMICROB CHEMOTH, V66, P1273, DOI 10.1093/jac/dkr092; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Naas T, 2012, ANTIMICROB AGENTS CH, V56, P4753, DOI 10.1128/AAC.00334-12; Navon-Venezia S, 2009, ANTIMICROB AGENTS CH, V53, P818, DOI 10.1128/AAC.00987-08; Osterblad M, 2009, EURO SURVEILLANCE B, V14; Pan YJ, 2015, ANTIMICROB AGENTS CH, V59, P1038, DOI 10.1128/AAC.03560-14; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pena I, 2014, INT J ANTIMICROB AG, V43, P460, DOI 10.1016/j.ijantimicag.2014.01.021; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Perez F, 2013, ANTIMICROB AGENTS CH, V57, P4602, DOI 10.1128/AAC.00725-13; Segura M, 2012, CAN J MICROBIOL, V58, P249, DOI [10.1139/w2012-003, 10.1139/W2012-003]; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Almeida ACS, 2012, INT J ANTIMICROB AG, V40, P374, DOI 10.1016/j.ijantimicag.2012.05.022; Souli M, 2010, CLIN INFECT DIS, V50, P364, DOI 10.1086/649865; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4450, DOI 10.1128/AAC.00456-12; Voulgari E, 2014, J ANTIMICROB CHEMOTH, V69, P2091, DOI 10.1093/jac/dku105; Wang XJ, 2015, INT J ANTIMICROB AG, V45, P635, DOI 10.1016/j.ijantimicag.2014.12.022; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Wyres KL, 2015, GENOME BIOL EVOL, V7, P1267, DOI 10.1093/gbe/evv062; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhong X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115185	77	123	131	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133727	10.1371/journal.pone.0133727	http://dx.doi.org/10.1371/journal.pone.0133727			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196384	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600137
J	Dale, TP; de Castro, A; Kuiper, NJ; Parkinson, EK; Forsyth, NR				Dale, Tina P.; de Castro, Alice; Kuiper, Nicola J.; Parkinson, E. Kenneth; Forsyth, Nicholas R.			Immortalisation with hTERT Impacts on Sulphated Glycosaminoglycan Secretion and Immunophenotype in a Variable and Cell Specific Manner	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; MARROW STROMAL CELLS; DNA-DAMAGE-RESPONSE; TELOMERASE REVERSE-TRANSCRIPTASE; LIFE-SPAN; IN-VITRO; BETA-GALACTOSIDASE; GROWTH-FACTOR; OSTEOARTHRITIC CHONDROCYTES	Background Limited options for the treatment of cartilage damage have driven the development of tissue engineered or cell therapy alternatives reliant on ex vivo cell expansion. The study of chondrogenesis in primary cells is difficult due to progressive cellular aging and senescence. Immortalisation via the reintroduction of the catalytic component of telomerase, hTERT, could allow repeated, longitudinal studies to be performed while bypassing senescent phenotypes. Methods Three human cell types: bone marrow-derived stromal cells (BMA13), embryonic stem cell-derived (1C6) and chondrocytes (OK3) were transduced with hTERT (BMA13H, 1C6H and OK3H) and proliferation, surface marker expression and tri-lineage differentiation capacity determined. The sulphated glycosaminoglycan (sGAG) content of the monolayer and spent media was quantified in maintenance media (MM) and pro-chondrogenic media (PChM) and normalised to DNA. Results hTERT expression was confirmed in transduced cells with proliferation enhancement in 1C6H and OK3H cells but not BMA13H. All cells were negative for leukocyte markers (CD19, CD34, CD45) and CD73 positive. CD14 was expressed at low levels on OK3 and OK3H and HLA-DR on BMA13 (84.8%). CD90 was high for BMA13 (84.9%) and OK3 (97.3%) and moderate for 1C6 (56.7%), expression was reduced in BMA13H (33.7%) and 1C6H (1.6%). CD105 levels varied (BMA13 87.7%, 1C6 8.2%, OK3 43.3%) and underwent reduction in OK3H (25.1%). 1C6 and BMA13 demonstrated osteogenic and adipogenic differentiation but mineralised matrix and lipid accumulation appeared reduced post hTERT transduction. Chondrogenic differentiation resulted in increased monolayer-associated sGAG in all primary cells and 1C6H (p<0.001), and BMA13H (p<0.05). In contrast OK3H demonstrated reduced monolayer-associated sGAG in PChM (p<0.001). Media-associated sGAG accounted for >= 55% (PChM-1C6) and >= 74% (MM-1C6H). Conclusion In conclusion, hTERT transduction could, but did not always, prevent senescence and cell phenotype, including differentiation potential, was affected in a variable manner. As such, these cells are not a direct substitute for primary cells in cartilage regeneration research.	[Dale, Tina P.; Kuiper, Nicola J.; Forsyth, Nicholas R.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [de Castro, Alice; Parkinson, E. Kenneth] Queen Mary Univ London, Barts & London Sch Med & Dent, Res Ctr Clin & Diagnost Oral Sci, London, England	Keele University; University of London; Queen Mary University London	Forsyth, NR (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	n.r.forsyth@keele.ac.uk	Dale, Tina/AAA-3560-2022; Dale, Tina Patricia/ABA-7020-2021	Dale, Tina/0000-0001-9461-8220; 	UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (Keele University) [EP/F500491/1]; UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (Loughborough University) [EP/F500491/1]; UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (University of Nottingham) [EP/F500491/1]; EPSRC [EP/H028277/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1119373, EP/H028277/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (Keele University); UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (Loughborough University); UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (University of Nottingham); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was received from the UK Engineering and Physical Sciences Research Council as part of the Regenerative Medicine Doctoral Training Centre (Keele University, Loughborough University, The University of Nottingham (EP/F500491/1), http://www.dtcregenmed.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2012, J ORTHOP RES, V30, P482, DOI 10.1002/jor.21534; Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Benz K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-27; Bernstein P, 2010, OSTEOARTHR CARTILAGE, V18, P1596, DOI 10.1016/j.joca.2010.09.007; Bocelli-Tyndall C, 2010, ARTHRITIS RHEUM-US, V62, P3815, DOI 10.1002/art.27736; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; DESSAU W, 1981, J CELL BIOL, V90, P78, DOI 10.1083/jcb.90.1.78; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Forsyth NR, 2008, REJUV RES, V11, P5, DOI 10.1089/rej.2007.0567; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; Goldring MB, 2004, METH MOLEC MED, V100, P23; Goldring MB, 2004, METH MOLEC MED, V100, P37; Graakjaer J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-49; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171; Kay A., 2010, THESIS; Kay Alasdair, 2011, Front Biosci (Elite Ed), V3, P1365; Kokenyesi R, 2000, ARCH BIOCHEM BIOPHYS, V383, P79, DOI 10.1006/abbi.2000.2044; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Kuh SU, 2009, JOINT BONE SPINE, V76, P70, DOI 10.1016/j.jbspin.2008.02.021; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO;2-U; Maroudas A, 1998, ARCH BIOCHEM BIOPHYS, V350, P61, DOI 10.1006/abbi.1997.0492; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Martin JA, 2004, J GERONTOL A-BIOL, V59, P324; Martin JA, 2002, J GERONTOL A-BIOL, V57, pB48, DOI 10.1093/gerona/57.2.B48; Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172; Mastrogiacomo M, 2001, OSTEOARTHR CARTILAGE, V9, pS36, DOI 10.1053/joca.2001.0442; Mihara K, 2003, BRIT J HAEMATOL, V120, P846, DOI 10.1046/j.1365-2141.2003.04217.x; Musina RA, 2007, B EXP BIOL MED+, V143, P127, DOI 10.1007/s10517-007-0032-z; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Parsch D, 2004, J MOL MED-JMM, V82, P49, DOI 10.1007/s00109-003-0506-z; Parsch D, 2002, ARTHRITIS RHEUM, V46, P2911, DOI 10.1002/art.10626; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915; Piera-Velazquez S, 2002, ARTHRITIS RHEUM, V46, P683, DOI 10.1002/art.10116; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Serakinci N, 2008, BIOCHIMIE, V90, P33, DOI 10.1016/j.biochi.2007.09.005; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119; Shay JW, 2005, ANN NY ACAD SCI, V1057, P479, DOI 10.1196/annals.1356.037; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Stewart MC, 2011, VET CLIN N AM-EQUINE, V27, P243, DOI 10.1016/j.cveq.2011.06.004; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132; Tang H, 2013, BIOCHEM BIOPH RES CO, V440, P502, DOI 10.1016/j.bbrc.2013.09.053; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Teng Y, 2014, BRAZ ARCH BIOL TECHN, V57, P37, DOI 10.1590/S1516-89132014000100006; Tew SR, 2008, METHODS, V45, P2, DOI 10.1016/j.ymeth.2008.01.006; Tew SR, 2005, OSTEOARTHR CARTILAGE, V13, P80, DOI 10.1016/j.joca.2004.10.011; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Untergasser G, 2003, EXP GERONTOL, V38, P1179, DOI 10.1016/j.exger.2003.08.008; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wieland HA, 2005, NAT REV DRUG DISCOV, V4, P331, DOI 10.1038/nrd1693; Wimpenny I, 2010, TISSUE ENG PART C-ME, V16, P503, DOI [10.1089/ten.tec.2009.0128, 10.1089/ten.TEC.2009.0128]; Wolbank S, 2009, TISSUE ENG PT A, V15, P1843, DOI 10.1089/ten.tea.2008.0205; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	80	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133745	10.1371/journal.pone.0133745	http://dx.doi.org/10.1371/journal.pone.0133745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196672	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000358547600139
J	Khan, SN; Shaeib, F; Najafi, T; Kavdia, M; Gonik, B; Saed, GM; Goud, PT; Abu-Soud, HM				Khan, Sana N.; Shaeib, Faten; Najafi, Tohid; Kavdia, Mahendra; Gonik, Bernard; Saed, Ghassan M.; Goud, Pravin T.; Abu-Soud, Husam M.			Diffused Intra-Oocyte Hydrogen Peroxide Activates Myeloperoxidase and Deteriorates Oocyte Quality	PLOS ONE			English	Article							FREE IRON RELEASE; II MOUSE OOCYTES; HYPOCHLOROUS ACID; OXIDATIVE STRESS; IN-VITRO; MAMMALIAN PEROXIDASES; SPINDLE STRUCTURE; FOLLICULAR-FLUID; HEME DESTRUCTION; PLASMA-MEMBRANE	Hydrogen peroxide (H2O2) is a relatively long-lived signaling molecule that plays an essential role in oocyte maturation, implantation, as well as early embryonic development. Exposure to relatively high levels of H2O2 functions efficiently to accelerate oocyte aging and deteriorate oocyte quality. However, little precise information exists regarding intra-oocyte H2O2 concentrations, and its diffusion to the oocyte milieu. In this work, we utilized an L-shaped amperometric integrated H2O2-selective probe to directly and quantitatively measure the real-time intra-oocyte H2O2 concentration. This investigation provides an exact measurement of H2O2 in situ by reducing the possible loss of H2O2 caused by diffusion or reactivity with other biological systems. This experiment suggests that the intra-oocyte H2O2 levels of oocytes obtained from young animals are reasonably high and remained constant during the procedure measurements. However, the intra-oocyte H2O2 concentration dropped significantly (40-50% reduction) in response to catalase pre-incubation, suggesting that the measurements are truly H2O2 based. To further confirm the extracellular diffusion of H2O2, oocytes were incubated with myeloperoxidase (MPO), and the diffused H2O2 triggered MPO chlorinating activity. Our results show that the generated hypochlorous acid (HOCl) facilitated the deterioration in oocyte quality, a process that could be prevented by pre-incubating the oocytes with melatonin, which was experimentally proven to be oxidized utilizing HPLC methods. This study is the first to demonstrate direct quantitative measurement of intracellular H2O2, and its extracellular diffusion and activation of MPO as well as its impact on oocyte quality. These results may help in designing more accurate treatment plans in assisted reproduction under inflammatory conditions.	[Khan, Sana N.; Shaeib, Faten; Najafi, Tohid; Gonik, Bernard; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Najafi, Tohid; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Kavdia, Mahendra] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA; [Goud, Pravin T.] Univ Calif Davis, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Sacramento, CA 95817 USA; [Goud, Pravin T.] Calif IVF Fertil Ctr, Davis, CA USA; [Goud, Pravin T.] Calif IVF Fertil Ctr, Sacramento, CA USA	Wayne State University; Wayne State University; Wayne State University; University of California System; University of California Davis	Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	habusoud@med.wayne.edu			National Institute of Health [RO1 HL066367]; Children's Hospital of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066367] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health RO1 HL066367, a grant from Children's Hospital of Michigan (H.M.A-S).	Abu-Soud HM, 2014, J INORG BIOCHEM, V140, P245, DOI 10.1016/j.jinorgbio.2014.06.018; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Antunes F, 1996, FREE RADICAL BIO MED, V21, P917, DOI 10.1016/S0891-5849(96)00185-2; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Banerjee J, 2013, FERTIL STERIL, V100, P578, DOI 10.1016/j.fertnstert.2013.04.030; Banerjee J, 2012, J PINEAL RES, V53, P122, DOI 10.1111/j.1600-079X.2012.00977.x; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Binder V, 2013, ARTERIOSCL THROM VAS, V33, P1020, DOI 10.1161/ATVBAHA.113.301235; Blair SA, 2013, J REPROD MED, V58, P107; Boveris A, 2002, METHOD ENZYMOL, V349, P280, DOI 10.1016/S0076-6879(02)49342-1; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Cheng WM, 2009, REPRODUCTION, V137, P633, DOI 10.1530/REP-08-0143; Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; Conde A, 2010, INT J BIOCHEM CELL B, V42, P857, DOI 10.1016/j.biocel.2009.12.012; da Silva CM, 2014, BIOMEDICINE PHARMACO; Dalla Sega FV, 2014, BBA-MOL CELL RES, V1843, P806, DOI 10.1016/j.bbamcr.2014.01.011; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; de Matos DG, 2002, THERIOGENOLOGY, V57, P1443, DOI 10.1016/S0093-691X(02)00643-X; Fletcher NM, 2011, CANCER BIOMARK, V10, P267, DOI 10.3233/CBM-2012-0255; Galijasevic S, 2008, BIOCHEMISTRY-US, V47, P2668, DOI 10.1021/bi702016q; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Goud AP, 2005, REPROD BIOMED ONLINE, V11, P43, DOI 10.1016/S1472-6483(10)61297-7; Goud P, 1997, FERTIL STERIL, V67, P979, DOI 10.1016/S0015-0282(97)90147-3; Goud PT, 2008, FREE RADICAL BIO MED, V45, P453, DOI 10.1016/j.freeradbiomed.2008.04.035; Goud PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098720; GUTTERIDGE JMC, 1992, FREE RADICAL BIO MED, V12, P93, DOI 10.1016/0891-5849(92)90062-L; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hennet ML, 2013, J ASSIST REPROD GEN, V30, P333, DOI 10.1007/s10815-012-9925-5; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Jimenez-Jimenez F J, 1998, Rev Neurol, V26 Suppl 1, pS112; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kulagina NV, 2003, ANAL CHEM, V75, P4875, DOI 10.1021/ac034573g; Li LY, 2014, TRENDS BIOCHEM SCI, V39, P130, DOI 10.1016/j.tibs.2014.01.002; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Maitra D, 2012, J PINEAL RES, V53, P198, DOI 10.1111/j.1600-079X.2012.00988.x; Maitra D, 2011, FREE RADICAL BIO MED, V51, P374, DOI 10.1016/j.freeradbiomed.2011.04.011; Makino N, 2004, BBA-GEN SUBJECTS, V1673, P149, DOI 10.1016/j.bbagen.2004.04.011; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; MILLS JL, 1988, NEW ENGL J MED, V318, P671, DOI 10.1056/NEJM198803173181104; Mueller S, 2000, FREE RADICAL BIO MED, V29, P410, DOI 10.1016/S0891-5849(00)00261-6; Navarro-Alarcon M, 2014, FOOD FUNCT, V5, P2806, DOI [10.1039/C4FO00317A, 10.1039/c4fo00317a]; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; OSHINO N, 1973, ARCH BIOCHEM BIOPHYS, V154, P117, DOI 10.1016/0003-9861(73)90040-4; PICK E, 1981, CELL IMMUNOL, V59, P301, DOI 10.1016/0008-8749(81)90411-1; Pogorelov AG, 2008, J MICROSC-OXFORD, V232, P36, DOI 10.1111/j.1365-2818.2008.02077.x; Presnell CE, 2013, CURR NEUROVASC RES, V10, P185; Proteasa G, 2007, BIOCHEMISTRY-US, V46, P398, DOI 10.1021/bi0609725; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; Rambow J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00199; Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014; Riley CF, 2007, ACTA OBSTET GYN SCAN, V86, P877, DOI 10.1080/00016340701417398; Saito H, 2002, GYNECOL OBSTET INVES, V53, P46, DOI 10.1159/000049424; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Shaeib F, 2013, FREE RADICAL BIO MED, V58, P154, DOI 10.1016/j.freeradbiomed.2012.12.007; Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005; Sliskovic I, 2009, FREE RADICAL BIO MED, V47, P1005, DOI 10.1016/j.freeradbiomed.2009.07.007; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Tripathi A, 2009, FREE RADICAL RES, V43, P287, DOI 10.1080/10715760802695985; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200	65	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132388	10.1371/journal.pone.0132388	http://dx.doi.org/10.1371/journal.pone.0132388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197395	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600033
J	Mouratis, MA; Magkrioti, C; Oikonomou, N; Katsifa, A; Prestwich, GD; Kaffe, E; Aidinis, V				Mouratis, Marios-Angelos; Magkrioti, Christiana; Oikonomou, Nikos; Katsifa, Aggeliki; Prestwich, Glenn D.; Kaffe, Eleanna; Aidinis, Vassilis			Autotaxin and Endotoxin-Induced Acute Lung Injury	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; RESPIRATORY-DISTRESS-SYNDROME; LYSOPHOSPHOLIPASE-D ACTIVITY; PULMONARY-FIBROSIS; SURFACTANT DYSFUNCTION; LPA AXIS; EXPRESSION; INFLAMMATION; MICE; PATHOGENESIS	Acute Lung Injury (ALI) is a life-threatening, diffuse heterogeneous lung injury characterized by acute onset, pulmonary edema and respiratory failure. Lipopolysaccharide (LPS) is a common cause of both direct and indirect lung injury and when administered to a mouse induces a lung phenotype exhibiting some of the clinical characteristics of human ALI. Here, we report that LPS inhalation in mice results in increased bronchoalveolar lavage fluid (BALF) levels of Autotaxin (ATX, Enpp2), a lysophospholipase D largely responsible for the conversion of lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA) in biological fluids and chronically inflamed sites. In agreement, gradual increases were also detected in BALF LPA levels, following inflammation and pulmonary edema. However, genetic or pharmacologic targeting of ATX had minor effects in ALI severity, suggesting no major involvement of the ATX/LPA axis in acute inflammation. Moreover, systemic, chronic exposure to increased ATX/LPA levels was shown to predispose to and/or to promote acute inflammation and ALI unlike chronic inflammatory pathophysiological situations, further suggesting a differential involvement of the ATX/LPA axis in acute versus chronic pulmonary inflammation.	[Mouratis, Marios-Angelos; Magkrioti, Christiana; Oikonomou, Nikos; Katsifa, Aggeliki; Kaffe, Eleanna; Aidinis, Vassilis] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Athens, Greece; [Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Alexander Fleming Biomedical Sciences Research Center; Utah System of Higher Education; University of Utah	Aidinis, V (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Athens, Greece.	v.aidinis@fleming.gr	Aidinis, Vassilis/AAF-5380-2021	Aidinis, Vassilis/0000-0001-9531-7729	Hellenic Ministry for education and religion/General Secretariat of research and technology Aristia II of the National Strategic Reference Framework (NSRF) [INFLALIPID-3311, ATX-09SYN-11-679]; European Commission	Hellenic Ministry for education and religion/General Secretariat of research and technology Aristia II of the National Strategic Reference Framework (NSRF); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Hellenic Ministry for education and religion/General Secretariat of research and technology Aristia II (INFLALIPID-3311) and Synergasia 2009 (ATX-09SYN-11-679) grants, through the Operational Programs "Education and Lifelong Learning" and "Competitiveness and Entrepreneurship" (respectively) of the National Strategic Reference Framework (NSRF), co-funded by the European Commission (European Social Fund and European Regional Development Fund respectively) and National resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Barbayianni E, 2015, PROG LIPID RES, V58, P76, DOI 10.1016/j.plipres.2015.02.001; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Emo J, 2012, J IMMUNOL, V188, P3784, DOI 10.4049/jimmunol.1102956; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Ganguly K, 2007, PHYSIOL GENOMICS, V31, P410, DOI 10.1152/physiolgenomics.00260.2006; Huang LS, 2013, AM J RESP CELL MOL, V49, P912, DOI 10.1165/rcmb.2013-0070OC; Ingenito EP, 2001, AM J RESP CELL MOL, V25, P35, DOI 10.1165/ajrcmb.25.1.4021; Jiang GW, 2011, BIOORG MED CHEM LETT, V21, P5098, DOI 10.1016/j.bmcl.2011.03.068; Kennedy M, 1997, EXP LUNG RES, V23, P171, DOI 10.3109/01902149709087366; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Kotanidou A, 2006, VASC PHARMACOL, V45, P134, DOI 10.1016/j.vph.2006.06.016; Luquain C, 2003, TRENDS BIOCHEM SCI, V28, P377, DOI 10.1016/S0968-0004(03)00139-7; Magkrioti C., 2013, WORLD J RESPIROL, V3, P77, DOI [DOI 10.5320/WJR.V3.I3.77, 10.5320/wjr.v3.i3.77]; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nikitopoulou I, 2013, PLOS ONE IN PRESS; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Oikonomou N, 2010, AM THOR SOC INT C; Oikonomou N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000108; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Park GY, 2013, AM J RESP CRIT CARE, DOI [10.1164/rccm.201306-1014OC, DOI 10.1164/RCCM.201306-10140C]; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ren YL, 2013, MICROVASC RES, V85, P59, DOI 10.1016/j.mvr.2012.10.004; Shea Barry S, 2012, Proc Am Thorac Soc, V9, P102, DOI 10.1513/pats.201201-005AW; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tager AM, 2012, AM J RESP CELL MOL, V47, P563, DOI 10.1165/rcmb.2012-0235ED; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhao J, 2011, AM J PHYSIOL-LUNG C, V301, pL547, DOI 10.1152/ajplung.00058.2011; Zhao J, 2011, BIOCHEM J, V439, P45, DOI 10.1042/BJ20110274; Zhao YT, 2013, BBA-MOL CELL BIOL L, V1831, P86, DOI 10.1016/j.bbalip.2012.06.014	44	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133619	10.1371/journal.pone.0133619	http://dx.doi.org/10.1371/journal.pone.0133619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196781	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600119
J	Peplonska, B; Bukowska, A; Sobala, W				Peplonska, Beata; Bukowska, Agnieszka; Sobala, Wojciech			Association of Rotating Night Shift Work with BMI and Abdominal Obesity among Nurses and Midwives	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; WEIGHT-GAIN; CHRONIC DISEASE; RISK-FACTORS; HEALTH; OVERWEIGHT; SLEEP; PREVALENCE	Background Mounting epidemiological evidence suggests that night shift work may contribute to the etiology of increased body weight. The present study aimed to examine association between rotating night shift work and body mass index (BMI), and abdominal adiposity respectively among nurses and midwives. Methods A cross-sectional study was conducted among 724 female nurses and midwives, aged 40-60 years (354 rotating night shift and 370 daytime workers) in Lod, Poland, between 2008 and 2011. Information about occupational history and potential confounders was collected during personal interviews. Anthropometric measurements of body weight, height, waist (WC) and hip (HC) circumference were made, and body mass index (BMI), waist to hip ratio (WHR) and waist to height ratio (WHtR) were calculated. GLM regression models and multinomial logit regression models were fitted to explore the association between night shift work and anthropometric parameters, with adjustment for age, body silhouette at age 20, current smoking status, packyears, marital status, and menopausal hormone therapy use. Results Cumulative night shift work showed significant associations with BMI, WC, HC and WHtR, with BMI increasing by 0.477 kg/m(2) per 1000 night duties and by 0.432 kg/m(2) per 10000 night shift hours, WC increasing respectively by 1.089 cm and 0.99 cm, and HC by 0.72 cm and WHtR by 0.007 cm for both metrics. Both current and cumulative night work was associated with obesity (BMI >= 30kg/m(2)), with OR=3.9 (95% CI: 1.5-9.9), in women reporting eight or more night shifts per month. Conclusion The results of the study support the previously reported relations between night shift work and development of obesity.	[Peplonska, Beata; Bukowska, Agnieszka; Sobala, Wojciech] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland	Nofer Institute of Occupational Medicine	Peplonska, B (corresponding author), Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland.	beatap@imp.lodz.pl	Peplonska, Beata/AAO-1265-2020	Peplonska, Beata/0000-0003-3915-2872; Bukowska-Damska, Agnieszka/0000-0002-3223-6750	Norway Grants under the Polish-Norwegian Research Programme [PNRF - 243 - AI - 1/07, EOG 89/2013-clockshift]	Norway Grants under the Polish-Norwegian Research Programme	This project was supported by the Norway Grants, under the Polish-Norwegian Research Programme (Grant no. PNRF - 243 - AI - 1/07 and EOG 89/2013-clockshift) to BP.	Allen TD, 2006, AM BEHAV SCI, V49, P1204, DOI 10.1177/0002764206286386; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Barbadoro P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063289; Barton J, 1995, WORK STRESS, V9, P109, DOI 10.1080/02678379508256545; Biggi N, 2008, CHRONOBIOL INT, V25, P443, DOI 10.1080/07420520802114193; Bolt HM, 2003, INT ARCH OCC ENV HEA, V76, P174, DOI 10.1017/s00420-002-0407-4; Borruel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114112; Bushnell PT, 2010, IND HEALTH, V48, P395, DOI 10.2486/indhealth.MSSW-03; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Elgar FJ, 2008, CAN J PUBLIC HEALTH, V99, P423, DOI 10.1007/BF03405254; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Geliebter A, 2000, NUTRITION, V16, P27, DOI 10.1016/S0899-9007(99)00228-2; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kim MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1204; Kubo T, 2011, OCCUP ENVIRON MED, V68, P327, DOI 10.1136/oem.2009.054445; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Macagnan J, 2012, CHRONOBIOL INT, V29, P336, DOI 10.3109/07420528.2011.653851; Manenschijn L, 2011, J CLIN ENDOCR METAB, V96, pE1862, DOI 10.1210/jc.2011-1551; Marqueze EC, 2012, WORK, V41, P2043, DOI 10.3233/WOR-2012-0429-2043; McElhone S, 1999, PUBLIC HEALTH NUTR, V2, P143, DOI 10.1017/S1368980099000191; Morikawa Y, 2008, J OCCUP HEALTH, V50, P270, DOI 10.1539/joh.L7116; Mudge Stephen M., 2008, P1; Nakamura K, 1997, OCCUP MED-OXFORD, V47, P142, DOI 10.1093/occmed/47.3.142; Niedhammer I, 1996, INT J OBESITY, V20, P625; Peplonska B, 2014, CHRONOBIOL INT, V31, P1152, DOI 10.3109/07420528.2014.957296; Peplonska B, 2014, INT J OCCUP MED ENV, V27, P693, DOI 10.2478/s13382-014-0298-0; Peplonska B, 2012, OCCUP ENVIRON MED, V69, P339, DOI 10.1136/oemed-2011-100273; Phipps AM, 2012, HANDBOOK OF ANTHROPO, P1703; Poulsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103425; Ramin C, 2015, OCCUP ENVIRON MED, V72, P100, DOI 10.1136/oemed-2014-102292; Roos E, 2013, ARCH ENVIRON OCCUP H, V68, P166, DOI 10.1080/19338244.2012.686931; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Smith P, 2013, APPL NURS RES, V26, P24, DOI 10.1016/j.apnr.2012.10.001; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Stunkard AJ, 1983, GENETICS NEUROLOGICA, P115; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; van Amelsvoort LGMP, 1999, INT J OBESITY, V23, P973, DOI 10.1038/sj.ijo.0801028; van Amelsvoort LGPM, 2004, J OCCUP ENVIRON MED, V46, P699, DOI 10.1097/01.jom.0000131794.83723.45; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Watari M, 2006, PREV MED, V43, P107, DOI 10.1016/j.ypmed.2006.04.012; Wehrens SMT, 2010, J ENDOCRINOL, V206, P205, DOI 10.1677/JOE-10-0077; Zhao I, 2011, J OCCUP ENVIRON MED, V53, P153, DOI 10.1097/JOM.0b013e318205e1e8	51	94	98	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133761	10.1371/journal.pone.0133761	http://dx.doi.org/10.1371/journal.pone.0133761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196859	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600140
J	Shorr, AF; Puzniak, LA; Biswas, P; Niederman, MS				Shorr, Andrew F.; Puzniak, Laura A.; Biswas, Pinaki; Niederman, Michael S.			Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP)	PLOS ONE			English	Article							VANCOMYCIN	Methicillin-resistant Staphylococcus aureus (MRSA) remains an important pathogen in nosocomial pneumonia and is associated with significant morbidity and mortality. Clinical outcomes for nosocomial pneumonia are dependent on patient age, co-morbidities, severity of illness and appropriate antibiotic therapy. The objective of this secondary analysis was to identify baseline clinical variables that are associated with clinical success at the end of the study observation period. Data from a randomized blinded trial (NCT00084266) comparing linezolid (600-mg twice daily) to vancomycin (15-mg/kg twice daily, dose-adjusted) for the treatment of culture-proven MRSA pneumonia were analyzed to evaluate baseline clinical and demographic factors that may predict clinical success at end of study (EOS) (7-30 days after end of treatment). A multivariate logistic regression was conducted to identify baseline factors that are associated with clinical success. Patients treated with linezolid (OR 1.55 95% CI: 1.013, 2.355), no vasopressor receipt (OR 2.30, 95% CI: 1.303, 4.069), unilateral involvement (OR 1.70, 95% CI: 1.078, 2.681) and normal renal function (eGFR 30-80 vs >80 OR 0.48, 95% CI: 0.303, 0.750) were more likely to have clinical success. From a clinical standpoint, identifying reliable predictors of outcome and who might benefit more from one therapy versus another can help inform treatment decisions.	[Shorr, Andrew F.] Washington Hosp Ctr, Pulm Crit Care, Washington, DC 20010 USA; [Puzniak, Laura A.] Pfizer Inc, Infect Dis & Vaccines, Collegeville, PA USA; [Biswas, Pinaki] Pfizer Inc, Biostat, Collegeville, PA USA; [Niederman, Michael S.] Weill Cornell Med Coll, Pulm & Crit Care Med, New York, NY USA	MedStar Washington Hospital Center; Pfizer; Pfizer; Cornell University	Shorr, AF (corresponding author), Washington Hosp Ctr, Pulm Crit Care, Washington, DC 20010 USA.	andrew.shorr@gmail.com; laurapuzniak@yahoo.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	This study was sponsored by Pfizer Inc. Pfizer Inc. provided support in the form of salaries for authors LAP and PB and played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Austin PC, 2008, STAT MED, V27, P3286, DOI 10.1002/sim.3104; Haque NZ, 2012, J CLIN MICROBIOL, V50, P1640, DOI 10.1128/JCM.06701-11; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kollef MH, 2004, INTENS CARE MED, V30, P388, DOI 10.1007/s00134-003-2088-1; Lahey T, 2012, CLIN INFECT DIS, V55, P159, DOI 10.1093/cid/cis329; Masuta K, 2012, CLIN INFECT DIS, V55, P161, DOI 10.1093/cid/cis331; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; Wunderink RG, 2011, AM J RESP CRIT CARE, V183; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895	9	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131932	10.1371/journal.pone.0131932	http://dx.doi.org/10.1371/journal.pone.0131932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196695	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600019
J	Morgado, FN; Nascimento, MTC; Saraiva, EM; de Oliveira-Ribeiro, C; Madeira, MD; da Costa-Santos, M; Vasconcellos, ECF; Pimentel, MIF; Lyra, MR; Schubach, AD; Conceicao-Silva, F				Morgado, Fernanda Nazare; Nascimento, Michelle T. C.; Saraiva, Elvira M.; de Oliveira-Ribeiro, Carla; Madeira, Maria de Fatima; da Costa-Santos, Marcela; Vasconcellos, Erica C. F.; Pimentel, Maria Ines F.; Lyra, Marcelo Rosandiski; Schubach, Armando de Oliveira; Conceicao-Silva, Fatima			Are Neutrophil Extracellular Traps Playing a Role in the Parasite Control in Active American Tegumentary Leishmaniasis Lesions?	PLOS ONE			English	Article							SITU INFLAMMATORY REACTION; CUTANEOUS LEISHMANIASIS; ANTIMICROBIAL ACTIVITY; HUMAN MACROPHAGES; IMMUNE-RESPONSE; MAJOR INFECTION; HOST-CELLS; MAST-CELLS; IN-VIVO; AMAZONENSIS	Neutrophil extracellular traps (NETs) have been described as a network of extracellular fibers composed by DNA, histones and various proteins/enzymes. Studies have demonstrated that NETs could be responsible for the trapping and elimination of a variety of infectious agents. In order to verify the presence of NETs in American tegumentary leishmaniasis (ATL) and their relationship with the presence of amastigotes we evaluated active cutaneous lesions of 35 patients before treatment by the detection of parasites, neutrophils (neutrophil elastase) and histones through immunohistochemistry and confocal immunofluorescence. Intact neutrophils could be detected in all ATL lesions. NETs were present in 27 patients (median 1.1; range from 0.1 to 23.5/mm(2)) with lesion duration ranging from one to seven months. NETs were in close proximity with neutrophils (r = 0.586; p = 0.0001) and amastigotes (r = 0.710; p = 0.0001). Two patterns of NET formation were detected: small homogeneously distributed networks observed in all lesions; and large structures that could be visualized at a lower magnification in lesions presenting at least 20% of neutrophils. Lesions presenting the larger NET formation showed high parasite detection. A correlation between NET size and the number of intact amastigotes was observed (p=0.02). As we detected an association between NET and amastigotes, our results suggest that neutrophil migration and NET formation could be stimulated and maintained by stimuli derived from the parasite burden/parasite antigen in the extracellular environment. The observation of areas containing only antigens not intermingled with NETs (elastase and histone) suggests that the involvement of these structures in the control of parasite burden is a dynamic process in which the formation of NETs is exhausted with the destruction of the parasites. Since NETs were also associated with granulomas, this trapping would favor the activity of macrophages in order to control the parasite burden.	[Morgado, Fernanda Nazare; de Oliveira-Ribeiro, Carla; da Costa-Santos, Marcela; Conceicao-Silva, Fatima] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunoparasitol, BR-21045900 Rio De Janeiro, Brazil; [Nascimento, Michelle T. C.; Saraiva, Elvira M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Imunol, Rio De Janeiro, Brazil; [de Oliveira-Ribeiro, Carla; Madeira, Maria de Fatima; Vasconcellos, Erica C. F.; Pimentel, Maria Ines F.; Lyra, Marcelo Rosandiski; Schubach, Armando de Oliveira] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, Lab Vigilancia Leishmanioses VigiLeish, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Conceicao-Silva, F (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Imunoparasitol, BR-21045900 Rio De Janeiro, Brazil.	fconcei@ioc.fiocruz.br	Saraiva, Elvira M/L-2864-2017; nascimento, Michelle Tanny Cunha/O-7844-2018; Morgado, Fernanda N/K-2527-2013; Morgado, Fernanda/AAV-4435-2021; Morgado, Fernanda/O-3577-2017	Saraiva, Elvira M/0000-0002-6388-5286; Morgado, Fernanda N/0000-0002-7188-251X; Morgado, Fernanda/0000-0002-7188-251X; Morgado, Fernanda/0000-0002-7188-251X	Instituto Oswaldo Cruz-IOC (POM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [470886/2003-0, 471744/2012-3, 308236/2013-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq-Proep [402557/2011-5]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E26.111.717/2012, E-26/102.456/2012, E26/102.988/2012, E26/111.230/2014, E26/203638/2014, E-26/111.101/2014]; Coordenacao de Aperfeicomento de Pessoal de Nivel Superior-CAPES, Brazil [23038.005291/2011-61]; CNPq, Brazil; FAPERJ, Brazil; Instituto Nacional de Infectologia-INI (PA)-Fundacao Oswaldo Cruz-FIOCRUZ; Fundacao Nacional de Saude/Ministerio da Saude-FUNASA/MS	Instituto Oswaldo Cruz-IOC (POM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq-Proep(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicomento de Pessoal de Nivel Superior-CAPES, Brazil; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Infectologia-INI (PA)-Fundacao Oswaldo Cruz-FIOCRUZ; Fundacao Nacional de Saude/Ministerio da Saude-FUNASA/MS	This work was funded by Instituto Oswaldo Cruz-IOC (POM 2010-2011) and Instituto Nacional de Infectologia-INI (PA2010)- Fundacao Oswaldo Cruz-FIOCRUZ, Fundacao Nacional de Saude/Ministerio da Saude-FUNASA/MS, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (470886/2003-0; 471744/2012-3; 308236/2013-0); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq-Proep (402557/2011-5); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (E26.111.717/2012; E-26/102.456/2012, E26/102.988/2012, E26/111.230/2014, E26/203638/2014 and E-26/111.101/2014), and Coordenacao de Aperfeicomento de Pessoal de Nivel Superior-CAPES (23038.005291/2011-61), Brazil. AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. The funders had no role in study design data collection and analysis, decision to publish, or preparing the manuscript.	Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Abi Abdallah Delbert S, 2012, Front Immunol, V3, P382, DOI 10.3389/fimmu.2012.00382; Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Bartneck M, 2010, NANO LETT, V10, P59, DOI 10.1021/nl902830x; Behrendt JH, 2010, VET IMMUNOL IMMUNOP, V133, P1, DOI 10.1016/j.vetimm.2009.06.012; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Gabriel C, 2010, J IMMUNOL, V185, P4319, DOI 10.4049/jimmunol.1000893; Guimaraes-Costa Anderson B, 2012, J Parasitol Res, V2012, P929743, DOI 10.1155/2012/929743; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hespanhol RC, 2005, J HISTOCHEM CYTOCHEM, V53, P35, DOI 10.1369/jhc.4A6384.2005; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Laskay T, 2008, IMMUNOBIOLOGY, V213, P183, DOI 10.1016/j.imbio.2007.11.010; Lima GMAC, 1998, IMMUNOL LETT, V64, P145, DOI 10.1016/S0165-2478(98)00099-6; Lugo-Yarbuh Ana, 2003, Invest. clín, V44, P61; Madeira MF, 2006, T ROY SOC TROP MED H, V100, P442, DOI 10.1016/j.trstmh.2005.07.011; Marzochi M C, 1994, Cad Saude Publica, V10 Suppl 2, P359, DOI 10.1590/S0102-311X1994000800014; Menezes MJ, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-12; Morgado FN, 2008, BRIT J DERMATOL, V158, P50, DOI 10.1111/j.1365-2133.2007.08255.x; Morgado FN, 2010, PARASITE IMMUNOL, V32, P285, DOI 10.1111/j.1365-3024.2009.01188.x; Morgado FN, 2011, MED MYCOL, V49, P612, DOI 10.3109/13693786.2011.552532; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; POMPEU ML, 1991, ACTA TROP, V48, P185, DOI 10.1016/0001-706X(91)90046-M; Quintella LP, 2009, REV I MED TROP, V51, P83, DOI 10.1590/S0036-46652009000200005; Ramos-Kichik V, 2009, TUBERCULOSIS, V89, P29, DOI 10.1016/j.tube.2008.09.009; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Ribeiro-Gomes FL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00059; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Tacchini-Cottier F, 2000, J IMMUNOL, V165, P2628, DOI 10.4049/jimmunol.165.5.2628; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2002, INFECT IMMUN, V70, P4177, DOI 10.1128/IAI.70.8.4177-4184.2002; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Von Stebut E, 2007, EUR J DERMATOL, V17, P115, DOI 10.1684/ejd.2007.0122; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	47	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133063	10.1371/journal.pone.0133063	http://dx.doi.org/10.1371/journal.pone.0133063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192752	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400051
J	Oguchi, M; Okajima, M; Tanaka, S; Koizumi, M; Kikusui, T; Ichihara, N; Kato, S; Kobayashi, K; Sakagami, M				Oguchi, Mineki; Okajima, Miku; Tanaka, Shingo; Koizumi, Masashi; Kikusui, Takefumi; Ichihara, Nobutsune; Kato, Shigeki; Kobayashi, Kazuto; Sakagami, Masamichi			Double Virus Vector Infection to the Prefrontal Network of the Macaque Brain	PLOS ONE			English	Article							RETROGRADE GENE-TRANSFER; TRANSDUCTION EFFICIENCY; CORTICAL CONNECTIONS; SUBSTANTIA-NIGRA; PATHWAY; CIRCUIT; DREADDS; CORTEX; KEY	To precisely understand how higher cognitive functions are implemented in the prefrontal network of the brain, optogenetic and pharmacogenetic methods to manipulate the signal transmission of a specific neural pathway are required. The application of these methods, however, has been mostly restricted to animals other than the primate, which is the best animal model to investigate higher cognitive functions. In this study, we used a double viral vector infection method in the prefrontal network of the macaque brain. This enabled us to express specific constructs into specific neurons that constitute a target pathway without use of germline genetic manipulation. The double-infection technique utilizes two different virus vectors in two monosynaptically connected areas. One is a vector which can locally infect cell bodies of projection neurons (local vector) and the other can retrogradely infect from axon terminals of the same projection neurons (retrograde vector). The retrograde vector incorporates the sequence which encodes Cre recombinase and the local vector incorporates the "Cre-On" FLEX double-floxed sequence in which a reporter protein (mCherry) was encoded. mCherry thus came to be expressed only in doubly infected projection neurons with these vectors. We applied this method to two macaque monkeys and targeted two different pathways in the prefrontal network: The pathway from the lateral prefrontal cortex to the caudate nucleus and the pathway from the lateral prefrontal cortex to the frontal eye field. As a result, mCherry-positive cells were observed in the lateral prefrontal cortex in all of the four injected hemispheres, indicating that the double virus vector transfection is workable in the prefrontal network of the macaque brain.	[Oguchi, Mineki; Tanaka, Shingo; Koizumi, Masashi; Sakagami, Masamichi] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Okajima, Miku] Univ Tokyo, Grad Sch Arts & Sci, Meguro, Tokyo, Japan; [Kikusui, Takefumi; Ichihara, Nobutsune] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan; [Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ, Inst Biomed Sci, Dept Mol Genet, Fukushima, Fukushima, Japan	University of Tokyo; Azabu University; Fukushima Medical University	Sakagami, M (corresponding author), Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan.	sakagami@lab.tamagawa.ac.jp	Kato, Shigeki/S-8016-2018	Kato, Shigeki/0000-0002-8792-7591	MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan [4303]; AMED (Japan Agency for Medical Research and Development); JSPS KAKENHI from MEXT of Japan [23243071]; Grants-in-Aid for Scientific Research [23243071] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED (Japan Agency for Medical Research and Development)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI from MEXT of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (4303) from MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan (http://decisions.naist.jp/index.html). This work was partially supported by a Grant-in-Aid for "Development of BMI Technologies for Clinical Application" carried out under the Strategic Research Program for Brain Sciences from AMED (Japan Agency for Medical Research and Development) and JSPS KAKENHI Grant Number 23243071 from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Becnel J, 2013, CELL REP, V4, P1049, DOI 10.1016/j.celrep.2013.08.003; Boender AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095392; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Castle MJ, 2014, MOL THER, V22, P554, DOI 10.1038/mt.2013.237; Condy C, 2007, CEREB CORTEX, V17, P221, DOI 10.1093/cercor/bhj140; ElMallah MK, 2012, HUM GENE THER METHOD, V23, P148, DOI 10.1089/hgtb.2012.009; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Ferguson SM, 2013, J NEUROSCI, V33, P11668, DOI 10.1523/JNEUROSCI.4783-12.2013; Gerbella M, 2010, CEREB CORTEX, V20, P141, DOI 10.1093/cercor/bhp087; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Hirano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075896; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Kato S, 2014, J NEUROSCI METH, V227, P151, DOI 10.1016/j.jneumeth.2014.02.015; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Kobayashi S, 2007, EXP BRAIN RES, V176, P341, DOI 10.1007/s00221-006-0622-4; Mahler SV, 2014, NAT NEUROSCI, V17, P577, DOI 10.1038/nn.3664; Markakis EA, 2010, MOL THER, V18, P588, DOI 10.1038/mt.2009.286; Masamizu Y, 2011, NEUROSCIENCE, V193, P249, DOI 10.1016/j.neuroscience.2011.06.080; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohayon S, 2013, J NEUROSCI, V33, P16684, DOI 10.1523/JNEUROSCI.2675-13.2013; Padmanabhan A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00814; Pan XC, 2008, NAT NEUROSCI, V11, P703, DOI 10.1038/nn.2128; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; San Sebastian W, 2013, GENE THER, V20, P1178, DOI 10.1038/gt.2013.48; SELEMON LD, 1985, J NEUROSCI, V5, P776; Sooksawate T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00162; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Stuber GD, 2013, PHARMACOL REV, V65, P156, DOI 10.1124/pr.111.005611; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Williams DP, 1997, J PHARMACOL EXP THER, V283, P1375; YETERIAN EH, 1991, J COMP NEUROL, V312, P43, DOI 10.1002/cne.903120105; Yoon JH, 2013, BIOL PSYCHIAT, V74, P122, DOI 10.1016/j.biopsych.2012.11.018	40	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132825	10.1371/journal.pone.0132825	http://dx.doi.org/10.1371/journal.pone.0132825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193102	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400041
J	Sims, J; Scarborough, P; Foster, C				Sims, Jamie; Scarborough, Peter; Foster, Charlie			The Effectiveness of Interventions on Sustained Childhood Physical Activity: A Systematic Review and Meta-Analysis of Controlled Studies	PLOS ONE			English	Article							SEDENTARY TIME; RISK-FACTORS; CHILDREN; HEALTH; ADOLESCENTS; PREVENTION; BEHAVIORS; CALCIUM; GIRLS; OVERWEIGHT	Background Increased physical activity (PA) has been associated with a reduction in non-communicable disease risk factors and outcomes. However, interventions to increase childhood PA typically produce small to negligible effects. Recent reviews are limited due to lack of post-intervention follow-up measurement. This review aimed to examine measured effects at least six months post-intervention. Methods and Findings We searched PubMed, MEDLINE, EMBASE, PsychINFO, ScienceDirect, SportDiscus and Google Scholar between 1st January 1991 and 1st November 2014 for controlled studies reporting six-month post-intervention measurement for children aged 5 to 18 years. 14 studies met inclusion criteria; 12 reported moderate-to-vigorous PA (MVPA) (n = 5790) and 10 reported total PA (TPA) (n = 4855). We calculated overall effect estimates and 95% CI's using random effects modelling with inverse variance weighting. Mean difference was calculated for MVPA, with standardised mean difference calculated to TPA due to measurement variation. Meta-regression assessed heterogeneity by continuous level variables. Negligible mean difference in MVPA existed in favour of the intervention group, amounting to 1.47 (95% CI -1.88, 4.82) mins/day compared to controls, while no difference was recorded on TPA. Sub-group analyses revealed males (2.65 mins/day: 95% CI 2.03, 3.27) reported higher levels of MVPA than females (-0.42 mins/day: 95% CI -7.77, 6.94), community settings (2.67 mins/day: 95% CI 2.05, 3.28) were more effective than school settings (1.70 mins/day: 95% CI -4.84, 8.25), and that treatment (4.47 mins/day: 95% CI -0.81, 9.76) demonstrated greater effects than population approaches (1.03 mins/day: 95% CI -2.54, 4.60). Meta-regression revealed no significant differences by factor on pooled effects. Significant heterogeneity existed between studies and potential for small study effects was present. Conclusions Improved PA levels subsequent to intervention were not maintained six month post-intervention. A potentially useful avenue of future research is to specifically explore community treatment of high risk individuals.	[Sims, Jamie; Scarborough, Peter; Foster, Charlie] Univ Oxford, British Heart Fdn Ctr Populat Approaches Non Comm, Nuffield Dept Populat Hlth, Oxford, England; [Sims, Jamie] Univ Chichester, Dept Sport Dev & Management, Chichester, England	University of Oxford; University of Chichester	Sims, J (corresponding author), Univ Oxford, British Heart Fdn Ctr Populat Approaches Non Comm, Nuffield Dept Populat Hlth, Oxford, England.	jamie.sims@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944				Araujo-Soares V, 2009, PSYCHOL HEALTH, V24, P805, DOI 10.1080/08870440802040707; Bailey DA, 2000, J BONE MINER RES, V15, P2245, DOI 10.1359/jbmr.2000.15.11.2245; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Biddle SJH, 2004, J SPORT SCI, V22, P679, DOI 10.1080/02640410410001712412; Black MM, 2010, PEDIATRICS, V126, P280, DOI 10.1542/peds.2009-1832; Boreham C, 2001, J SPORT SCI, V19, P915, DOI 10.1080/026404101317108426; Borenstein M., 2009, INTRO METAANALYSIS; Bugge A, 2012, MED SCI SPORT EXER, V44, P1310, DOI 10.1249/MSS.0b013e31824bd579; Chaput JP, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.14; Chen JL, 2010, J PUBLIC HEALTH-UK, V32, P219, DOI 10.1093/pubmed/fdp105; Chief Medical Officer C, 2004, LEAST 5 WEEK EV IMP; Corder K, 2013, BRIT J SPORTS MED, V2013; Cui ZH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000721; Dewar DL, 2014, J SCI MED SPORT, V17, P39, DOI 10.1016/j.jsams.2013.02.003; Dewar DL, 2013, AM J PREV MED, V45, P313, DOI 10.1016/j.amepre.2013.04.014; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Duncan MJ, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-11; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Foster C., 2005, COCHRANE DB SYST REV, V1, P1, DOI 10.1002/14651858.cd003180.pub2; French SA, 2000, PREV MED, V31, P722, DOI 10.1006/pmed.2000.0758; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hovell MF, 2009, AM J HEALTH PROMOT, V24, P118, DOI 10.4278/ajhp.08021111; Jago R, 2006, PREV MED, V42, P181, DOI 10.1016/j.ypmed.2005.12.010; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Lai SK, 2014, SPORTS MED, V44, P67, DOI 10.1007/s40279-013-0099-9; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Liu Ai-Ling, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P901; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; Marshall SJ, 2001, ANN BEHAV MED, V23, P229, DOI 10.1207/S15324796ABM2304_2; McManus AM, 2008, PREV MED, V47, P402, DOI 10.1016/j.ypmed.2008.06.001; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Microsoft Corporation, 2013, MICR EXC; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Monzavi R, 2006, PEDIATRICS, V117, pE1111, DOI 10.1542/peds.2005-1532; Nader PR, 1999, ARCH PEDIAT ADOL MED, V153, P695, DOI 10.1001/archpedi.153.7.695; Nemet D, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-2172; NICE, 2012, PROC METH GUID APP C; NICE, 2010, PROM PHYS ACT ACT PL; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, V3, P1, DOI DOI 10.1002/14651858.CD001872.PUB2; Ridgers ND, 2014, MED SCI SPORT EXER, V46, P1564, DOI 10.1249/MSS.0000000000000275; Roemmich JN, 2012, PEDIATR EXERC SCI, V24, P384, DOI 10.1123/pes.24.3.384; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Shah S, 2011, AUST FAM PHYSICIAN, V40, P1011; StataCorp, 2013, PANCREATOLOGY; Steinbeck K S, 2001, Obes Rev, V2, P117, DOI 10.1046/j.1467-789x.2001.00033.x; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; van Sluijs EMF, 2008, BRIT J SPORT MED, V42, P653, DOI 10.1136/bmj.39320.843947.BE; Wake M, 2009, PEDIATRICS, V339; Westerterp KR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00090; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 2021, CONSOLIDATED GUIDELI; Wright K, 2013, INT J NURS STUD, V50, P727, DOI 10.1016/j.ijnurstu.2012.09.004	63	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132935	10.1371/journal.pone.0132935	http://dx.doi.org/10.1371/journal.pone.0132935			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26193472	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400043
J	Hafiane, A; Bielicki, JK; Johansson, JO; Genest, J				Hafiane, Anouar; Bielicki, John K.; Johansson, Jan O.; Genest, Jacques			Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of pre beta-1 HDL In Vitro	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEINS; MIMETIC PEPTIDE; CELLULAR CHOLESTEROL; LIPID EFFLUX; BIDIRECTIONAL FLUX; METABOLISM; ATHEROSCLEROSIS; ACYLTRANSFERASE; MECHANISMS	Apolipoprotein (apo) mimetic peptides replicate some aspects of HDL function. We have previously reported the effects of compound ATI-5261 on its ability to replicate many functions of native apo A-I in the process of HDL biogenesis. ATI-5261 induced muscle toxicity in wild type C57Bl/6 mice, increased CPK, ALT and AST and increase in triglyceride (Tg) levels. Aromatic phenylalanine residues on the non-polar face of ATI-5261, together with positively charged arginine residues at the lipid-water interface were responsible for these effects. This information was used to create a novel analog (CS-6253) that was non-toxic. We evaluated this peptide designed from the carboxyl terminus of apo E, in its ability to mimic apo A-I functionality. Our data shows that the lipidated particles generated by incubating cells overexpressing ABCA1 with lipid free CS-6253 enhances the rate of ABCA1 lipid efflux with high affinity interactions with native ABCA1 oligomeric forms and plasma membrane micro-domains. Interaction between ABCA1 and lipid free CS-6253 resulted in formation of nascent HDL-CS-6253 particles that are actively remodeled in plasma. Mature HDL-CS-6253 particles deliver cholesterol to liver cells via SR-BI in-vitro. CS-6253 significantly increases cholesterol efflux in murine macrophages and in human THP-1 macrophage-derived foam cells expressing ABCA1. Addition of CS-6253 to plasma dose-dependently displaced apo A-I from alpha-HDL particles and led to de novo formation of pre beta-1 HDL that stimulates ABCA1 dependent cholesterol efflux efficiently. When incubated with human plasma CS-6253 was also found to bind with HDL and LDL and promoted the transfer of cholesterol from HDL to LDL predominantly. Our data shows that CS-6253 mimics apo A-I in its ability to promote ABCA1-mediated formation of nascent HDL particles, and enhances formation of pre beta-1 HDL with increase in the cycling of apo A-I between the pre beta and alpha-HDL particles in-vitro. These mechanisms are potentially anti-atherogenic.	[Hafiane, Anouar; Genest, Jacques] McGill Univ, Cardiovasc Res Labs Lab, Res Inst, Ctr Hlth, Montreal, PQ H4A 3J1, Canada; [Bielicki, John K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Donner Lab, Berkeley, CA 94720 USA; [Johansson, Jan O.] Artery Therapeut, San Ramon, CA USA	McGill University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Genest, J (corresponding author), McGill Univ, Cardiovasc Res Labs Lab, Res Inst, Ctr Hlth, Montreal, PQ H4A 3J1, Canada.	Jacques.genest@mcgill.ca	Hafiane, Anouar/AAE-3481-2020	Hafiane, Anouar/0000-0001-7494-722X; Johansson, Jan/0000-0002-3576-2748	Canadian Institutes of Health Research (CIHR) fund [MOP 15042]; Artery Therapeutics; NATIONAL CANCER INSTITUTE [R33CA094304] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR) fund; Artery Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is funded by the Canadian Institutes of Health Research (CIHR) fund MOP 15042 (JG). Artery Therapeutics provided support in the form of salaries for authors JJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Alexander ET, 2011, ARTERIOSCL THROM VAS, V31, P320, DOI 10.1161/ATVBAHA.110.216226; Amar MJA, 2010, J PHARMACOL EXP THER, V334, P634, DOI 10.1124/jpet.110.167890; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Bailey D, 2010, J LIPID RES, V51, P785, DOI 10.1194/jlr.M001875; Bielicki JK, 2010, J LIPID RES, V51, P1496, DOI 10.1194/jlr.M003665; Bolin DJ, 1996, J BIOL CHEM, V271, P19152, DOI 10.1074/jbc.271.32.19152; Calabresi L, 2010, TRENDS CARDIOVAS MED, V20, P50, DOI 10.1016/j.tcm.2010.03.007; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chen X, 2009, INT J BIOL SCI, V5, P489; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; de Souza JA, 2008, ATHEROSCLEROSIS, V197, P84, DOI 10.1016/j.atherosclerosis.2007.08.009; Denis M, 2004, J BIOL CHEM, V279, P41529, DOI 10.1074/jbc.M406881200; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Dergunov AD, 2013, MOL CELL BIOCHEM, V378, P283, DOI 10.1007/s11010-013-1619-5; Diditchenko S, 2013, ARTERIOSCL THROM VAS, V33, P2202, DOI 10.1161/ATVBAHA.113.301981; Doonan RJ, 2014, ARTERIOSCL THROM VAS, V34, P921, DOI 10.1161/ATVBAHA.113.302590; Favari E, 2009, BIOCHEMISTRY-US, V48, P11067, DOI 10.1021/bi901564g; GARBER DW, 1992, ARTERIOSCLER THROMB, V12, P886, DOI 10.1161/01.ATV.12.8.886; Getz GS, 2014, CURR OPIN ENDOCRINOL, V21, P129, DOI 10.1097/MED.0000000000000045; Getz GS, 2010, CURR ATHEROSCLER REP, V12, P96, DOI 10.1007/s11883-010-0097-4; Getz GS, 2009, CURR OPIN LIPIDOL, V20, P171, DOI 10.1097/MOL.0b013e32832ac051; Hafiane A, 2014, BIOCH BIOPHYS ACTA; Hafiane A, 2014, BBA-MOL CELL BIOL L, V1841, P1498, DOI 10.1016/j.bbalip.2014.07.018; Hafiane A, 2014, CURR OPIN ENDOCRINOL, V21, P134, DOI 10.1097/MED.0000000000000049; Hafiane A, 2014, AM J CARDIOL, V113, P249, DOI 10.1016/j.amjcard.2013.09.006; Hafiane A, 2013, CHOLESTEROL, DOI 10.1155/2013/891403; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; Hassan HH, 2006, CAN J CARDIOL, V22, p35B, DOI 10.1016/S0828-282X(06)70985-0; Hatch F T, 1968, Adv Lipid Res, V6, P1; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; KAWANO M, 1993, BIOCHEMISTRY-US, V32, P5025, DOI 10.1021/bi00070a008; Kee P, 2002, ARTERIOSCL THROM VAS, V22, P1912, DOI 10.1161/01.ATV.0000038485.94020.7F; Krimbou L, 1997, J LIPID RES, V38, P35; Krimbou L, 2005, J LIPID RES, V46, P1668, DOI 10.1194/jlr.M500038-JLR200; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; LAW SW, 1983, BIOCHEM BIOPH RES CO, V112, P257, DOI 10.1016/0006-291X(83)91824-7; Leman LJ, 2014, J MED CHEM, V57, P2169, DOI 10.1021/jm4005847; Liu RJ, 2007, ARTERIOSCL THROM VAS, V27, P190, DOI 10.1161/01.ATV.0000249721.96666.e5; Liu XH, 2010, J CARDIOVASC PHARM, V56, P309, DOI 10.1097/FJC.0b013e3181edaf69; Liu YH, 2012, BBA-MOL CELL BIOL L, V1821, P522, DOI 10.1016/j.bbalip.2011.08.015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lund-Katz S, 2013, J BIOL CHEM, V288, P23150, DOI 10.1074/jbc.M113.495523; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mazzone T, 1996, CURR OPIN LIPIDOL, V7, P303, DOI 10.1097/00041433-199610000-00008; Miyazaki O, 2014, J LIPID RES, V55, P214, DOI 10.1194/jlr.M041038; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Nordskog BK, 1999, J LIPID RES, V40, P1806; Oram JF, 1996, J LIPID RES, V37, P2473; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Remaley Alan T, 2008, Expert Rev Cardiovasc Ther, V6, P1203, DOI 10.1586/14779072.6.9.1203; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200; Smith JD, 2010, CURR OPIN INVEST DR, V11, P989; Smythies LE, 2010, AM J PHYSIOL-CELL PH, V298, pC1538, DOI 10.1152/ajpcell.00467.2009; Song XL, 2009, INT J BIOL SCI, V5, P637; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Sviridov DO, 2013, J PHARMACOL EXP THER, V344, P50, DOI 10.1124/jpet.112.198143; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Tang CK, 2004, ACTA BIOCH BIOPH SIN, V36, P218, DOI 10.1093/abbs/36.3.218; Tardy C, 2014, ATHEROSCLEROSIS, V232, P110, DOI 10.1016/j.atherosclerosis.2013.10.018; Tavori H, 2015, J LIPID RES; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Troutt JS, 2008, J LIPID RES, V49, P581, DOI 10.1194/jlr.M700385-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Waksman R, 2010, J AM COLL CARDIOL, V55, P2727, DOI 10.1016/j.jacc.2009.12.067; White CR, 2012, ARTERIOSCL THROM VAS, V32, P2631, DOI 10.1161/ATVBAHA.112.300167; Wool GD, 2008, J LIPID RES, V49, P1268, DOI 10.1194/jlr.M700552-JLR200; Wroblewska M, 2011, ACTA BIOCHIM POL, V58, P275; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200; Zheng Y, 2011, BIOCHEMISTRY-US, V50, P4068, DOI 10.1021/bi2002955; Zimetti F, 2006, J LIPID RES, V47, P605, DOI 10.1194/jlr.M500466-JLR200	84	37	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131997	10.1371/journal.pone.0131997	http://dx.doi.org/10.1371/journal.pone.0131997			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207756	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000020
J	Kinoshita, S; Kiyama, R; Yoshimoto, Y				Kinoshita, Satomi; Kiyama, Ryoji; Yoshimoto, Yoichi			Effect of Handrail Height on Sit-To-Stand Movement	PLOS ONE			English	Article							LOWER-LIMB MOVEMENT; BIOMECHANICAL ANALYSIS; SAGITTAL SPINE; HEALTHY; SUPPORT; WALKING; YOUNG; DETERMINANTS; POSITION; RISK	Background Care-needing older adults and disabled individuals often require handrails for assistance of movements, such as sit-to-stand movements. Handrails must be set at the appropriate position; however, the effects of handrail height on joint movement and center-of-gravity movements during sit-to-stand movement remain unclear. In the present study, we sought to clarify the effects of handrail height on joint movement, center-of-gravity, and floor reaction force during sit-to-stand movement. Methods Subjects included 16 healthy young adults and 25 older adults who require long-term care. Kinetic and kinematic measurements during sit-to-stand movement of young adults were conducted using a 3-D motion analyzer and a force plate. Trunk forward tilt angle during sit-to- stand movement of older adults was measured using a still image from a video recording. Results Using low handrails, sit-to-stand movement resulted in an increased hip flexion angle, ankle dorsiflexion angle, and trunk forward tilt angle and a greater forward center-of-gravity shift than when not using handrails in young adults during seat-off. In contrast, using high handrails resulted in a smaller hip flexion angle and trunk forward tilt angle in young adults. The backward force on the floor was decreased in the low handrail condition, and was increased in the high handrail condition rather than that of sit-to-stand movement without handrails in young adults. The effect of handrail height on trunk forward tilt angle was the same in both healthy young adults and care-needing older adults during seat-off. Conclusion Because handrail height affects joint movement and shift in the center-of-gravity during sitto- stand movement, handrail position should be selected to match the status of older adults with functional impairment.	[Kinoshita, Satomi] Kagoshima Univ, Grad Sch Hlth Sci, Doctor Course, Kagoshima 890, Japan; [Kiyama, Ryoji; Yoshimoto, Yoichi] Kagoshima Univ, Sch Hlth Sci, Course Phys Therapy, Fac Med, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Kinoshita, S (corresponding author), Kagoshima Univ, Grad Sch Hlth Sci, Doctor Course, Kagoshima 890, Japan.	monko@giga.ocn.ne.jp						ALEXANDER NB, 1991, J GERONTOL, V46, pM91, DOI 10.1093/geronj/46.3.M91; BAER GD, 1995, ARCH PHYS MED REHAB, V76, P844, DOI 10.1016/S0003-9993(95)80550-8; Bahrami F, 2000, CLIN BIOMECH, V15, P123, DOI 10.1016/S0268-0033(99)00044-3; Bernardi M, 2004, J ELECTROMYOGR KINES, V14, P401, DOI 10.1016/j.jelekin.2003.09.001; Chen G, 2005, GAIT POSTURE, V22, P57, DOI 10.1016/j.gaitpost.2004.06.008; Cheng PT, 2004, AM J PHYS MED REHAB, V83, P10, DOI 10.1097/01.PHM.0000104665.34557.56; Chihara T, 2014, APPL ERGON, V45, P261, DOI 10.1016/j.apergo.2013.04.006; Chou SW, 2003, AM J PHYS MED REHAB, V82, P42, DOI 10.1097/01.PHM.0000043769.93584.4D; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; DeVincenzo DK, 2012, REHABIL NURS, V12, P248; Edlich Richard F, 2003, J Long Term Eff Med Implants, V13, P31, DOI 10.1615/JLongTermEffMedImplants.v13.i1.40; GARDNER AW, 1991, AM J CARDIOL, V68, P99, DOI 10.1016/0002-9149(91)90719-2; IJmker T, 2013, ARCH PHYS MED REHAB, V94, P2255, DOI 10.1016/j.apmr.2013.04.022; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Kinoshita S, 2012, J BACK MUSCULOSKELET, V25, P33, DOI 10.3233/BMR-2012-0308; Kuo YL, 2010, SPINE, V35, pE1, DOI 10.1097/BRS.0b013e3181c47a0e; Mak MKY, 2003, CLIN BIOMECH, V18, P197, DOI 10.1016/S0268-0033(02)00191-2; Maki BE, 2011, J SAFETY RES, V42, P473, DOI 10.1016/j.jsr.2011.02.002; MANFRE MJ, 1994, CLIN CARDIOL, V17, P445, DOI 10.1002/clc.4960170808; Mazza C, 2004, J AM GERIATR SOC, V52, P1750, DOI 10.1111/j.1532-5415.2004.52472.x; MILLINGTON PJ, 1992, ARCH PHYS MED REHAB, V73, P609; Mion LC, 2013, REHABIL NURS, V14, P17; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; O'Connor SE, 2000, REHABILITATION NURSI, V25, P224; O'Meara DM, 2006, HUM MOVEMENT SCI, V25, P257, DOI 10.1016/j.humov.2005.11.003; O'Meara DM, 2005, J APPL BIOMECH, V21, P57, DOI 10.1123/jab.21.1.57; Papa E, 2000, J BIOMECH, V33, P1113, DOI 10.1016/S0021-9290(00)00046-4; Ploutz-Snyder LL, 2002, J GERONTOL A-BIOL, V57, pB144, DOI 10.1093/gerona/57.4.B144; RODOSKY MW, 1989, J ORTHOPAED RES, V7, P266, DOI 10.1002/jor.1100070215; ROEBROECK ME, 1994, CLIN BIOMECH, V9, P235, DOI 10.1016/0268-0033(94)90004-3; Sato S, 2012, JPN J COMPR REHABIL, V3, P6; Scarborough DM, 2007, J REHABIL RES DEV, V44, P33, DOI 10.1682/JRRD.2005.08.0134; Schenkman M, 1996, CLIN BIOMECH, V11, P153, DOI 10.1016/0268-0033(95)00060-7; Talis VL, 2008, CLIN BIOMECH, V23, P424, DOI 10.1016/j.clinbiomech.2007.11.010; Tully EA, 2005, GAIT POSTURE, V22, P338, DOI 10.1016/j.gaitpost.2004.11.007; VANDERLINDEN DW, 1994, ARCH PHYS MED REHAB, V75, P653, DOI 10.1016/0003-9993(94)90188-0; Yamada T, 2009, ARCH GERONTOL GERIAT, V48, P73, DOI 10.1016/j.archger.2007.10.006	37	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133747	10.1371/journal.pone.0133747	http://dx.doi.org/10.1371/journal.pone.0133747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207755	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000130
J	Gao, B; Wang, YQ; Liu, WB; Chen, ZY; Zhou, H; Yang, JY; Cohen, Z; Zhu, YH; Zang, YF				Gao, Bin; Wang, Yiquan; Liu, Weibo; Chen, Zhiyu; Zhou, Heshan; Yang, Jinyu; Cohen, Zachary; Zhu, Yihong; Zang, Yufeng			Spontaneous Activity Associated with Delusions of Schizophrenia in the Left Medial Superior Frontal Gyrus: A Resting-State fMRI Study	PLOS ONE			English	Article							1ST-EPISODE PSYCHOTIC DISORDERS; TEMPORAL-LOBE EPILEPSY; REGIONAL HOMOGENEITY; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; ALZHEIMERS-DISEASE; POSITIVE SYMPTOMS; DEFAULT MODE; CORTEX; MRI	Delusions of schizophrenia have been found to be associated with alterations of some brain regions in structure and task-induced activation. However, the relationship between spontaneously occurring symptoms and spontaneous brain activity remains unclear. In the current study, 14 schizophrenic patients with delusions and 14 healthy controls underwent a resting-state functional magnetic resonance imaging (RS-fMRI) scan. Patients with delusions of schizophrenia patients were rated with Positive and Negative Syndrome Scale (PANSS) and Characteristics of Delusional Rating Scale (CDRS). Regional homogeneity (ReHo) was calculated to measure the local synchronization of the spontaneous activity in a voxel-wise way. A two-sample t-test showed that ReHo of the right anterior cingulate gyrus and left medial superior frontal gyrus were higher in patients, and ReHo of the left superior occipital gyrus was lower, compared to healthy controls. Further, among patients, correlation analysis showed a significant difference between delusion scores of CRDS and ReHo of brain regions. ReHo of the left medial superior frontal gyrus was negatively correlated with patients' CDRS scores but not with delusional PANSS scores. These results suggested that altered local synchronization of spontaneous brain activity may be related to the pathophysiology of delusion in schizophrenia.	[Gao, Bin; Liu, Weibo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Psychiat, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yiquan; Chen, Zhiyu] Hangzhou Seventh Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhou, Heshan] Hangzhou First Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Yang, Jinyu; Zhu, Yihong] Zhejiang Univ, Sch Med, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Cohen, Zachary] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Zhu, Yihong] Zhejiang Univ, Mental Hlth Educ & Counseling Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zang, Yufeng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zang, Yufeng] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Wang, Yiquan] Zhejiang Univ, Sch Med, Mental Hlth Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Brown University; Zhejiang University; Hangzhou Normal University; Zhejiang University	Zhu, YH (corresponding author), Zhejiang Univ, Sch Med, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	zhyh@zju.edu.cn			Key Specialty Project of Hangzhou Science and Technology Bureau [20100733Q19]; Type A Project of Hangzhou Health Bureau [2010A019]	Key Specialty Project of Hangzhou Science and Technology Bureau; Type A Project of Hangzhou Health Bureau	This work was supported by the Key Specialty Project of Hangzhou Science and Technology Bureau (No. 20100733Q19, http://www.hzst.gov.cn/), and the Type A Project of Hangzhou Health Bureau (No. 2010A019, http://www.hzwsjsw.gov.cn/index/index.jhtml).	Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Barch DM, 2014, SCHIZOPHRENIA BULL, V40, P1200, DOI 10.1093/schbul/sbu076; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; GARETY PA, 1987, EUR ARCH PSY CLIN N, V236, P294, DOI 10.1007/BF00380955; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hashimoto R, 2010, CEREB CORTEX, V20, P46, DOI 10.1093/cercor/bhp079; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Holzel BK, 2007, NEUROSCI LETT, V421, P16, DOI 10.1016/j.neulet.2007.04.074; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Kronmuller KT, 2011, COMPR PSYCHIAT, V52, P102, DOI 10.1016/j.comppsych.2010.04.014; Lahti AC, 2006, NEUROPSYCHOPHARMACOL, V31, P221, DOI 10.1038/sj.npp.1300837; Liu HH, 2012, SCHIZOPHRENIA BULL, V38, P285, DOI 10.1093/schbul/sbq074; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Menon M, 2011, BIOL PSYCHIAT, V70, P1127, DOI 10.1016/j.biopsych.2011.05.037; Nagahama Y, 2010, BRAIN, V133, P557, DOI 10.1093/brain/awp295; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Palaniyappan L, 2011, PSYCHOL MED, V41, P1701, DOI 10.1017/S0033291710002205; Park IH, 2011, ACTA PSYCHIAT SCAND, V123, P43, DOI 10.1111/j.1600-0447.2010.01597.x; Prasad KMR, 2004, AM J PSYCHIAT, V161, P1612, DOI 10.1176/appi.ajp.161.9.1612; Prasad KMR, 2004, PROG NEURO-PSYCHOPH, V28, P651, DOI 10.1016/j.pnpbp.2004.01.017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sabri O, 1997, LANCET, V349, P1735, DOI 10.1016/S0140-6736(96)08380-8; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spencer MD, 2007, NEUROIMAGE, V35, P1181, DOI 10.1016/j.neuroimage.2007.01.008; Steel C, 2007, INT J METH PSYCH RES, V16, P88, DOI 10.1002/mpr.203; Suga M, 2010, EUR ARCH PSY CLIN N, V260, P465, DOI 10.1007/s00406-009-0094-1; Sumich A, 2005, BIOL PSYCHIAT, V57, P947, DOI 10.1016/j.biopsych.2004.12.041; Sun YY, 2014, CHINESE MENTAL HEALT; Szeszko PR, 1999, PSYCHIAT RES-NEUROIM, V90, P1, DOI 10.1016/S0925-4927(99)00002-5; Takahashi T, 2011, PROG NEURO-PSYCHOPH, V35, P177, DOI 10.1016/j.pnpbp.2010.10.023; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Turner JA, 2012, TWIN RES HUM GENET, V15, P324, DOI 10.1017/thg.2012.1; Weaver KE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00043; Whitford TJ, 2009, PSYCHIAT RES-NEUROIM, V172, P175, DOI 10.1016/j.pscychresns.2008.07.011; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xi Q, 2012, CHINESE MED J-PEKING, V125, P858, DOI 10.3760/cma.j.issn.0366-6999.2012.05.023; Yamasaki S, 2007, EUR ARCH PSY CLIN N, V257, P318, DOI 10.1007/s00406-007-0723-5; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng HW, 2013, EPILEPSIA, V54, P658, DOI 10.1111/epi.12066; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063477	55	27	30	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133766	10.1371/journal.pone.0133766	http://dx.doi.org/10.1371/journal.pone.0133766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204264	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000038
J	Li, J; Zhao, LN; You, Y; Lu, TL; Jia, MX; Yu, H; Ruan, YY; Yue, WH; Liu, J; Lu, L; Zhang, D; Wang, LF				Li, Jun; Zhao, Linnan; You, Yang; Lu, Tianlan; Jia, Meixiang; Yu, Hao; Ruan, Yanyan; Yue, Weihua; Liu, Jing; Lu, Lin; Zhang, Dai; Wang, Lifang			Schizophrenia Related Variants in CACNA1C also Confer Risk of Autism	PLOS ONE			English	Article							SCAFFOLDING PROTEIN SHANK3; GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; SUBUNIT GENE; COPY NUMBER; SPECTRUM; CONNECTIVITY; MUTATIONS; DISORDER; CA(V)1.2	Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders with a strong genetic component. Many lines of evidence indicated that ASD shares common genetic variants with other psychiatric disorders (for example, schizophrenia). Previous studies detected that calcium channels are involved in the etiology of many psychiatric disorders including schizophrenia and autism. Significant association between CACNA1C (calcium channel, voltage-dependent, L type, alpha 1C subunit) and schizophrenia was detected. Furthermore, rare mutation in CACNA1C is suggested to cause Timothy syndrome, a multisystem disorder including autism-associated phenotype. However, there is no evidence for association between CACNA1C and autism in Chinese Han population. To investigate the association between single nucleotide polymorphisms (SNP) in CACNA1C and autism, we first performed a family-based association study between eighteen SNPs in CACNA1C and autism in 239 trios. All SNPs were genotyped by using Sequenom genotyping platform. Two SNPs (rs1006737 and rs4765905) have a trend of association with autism. To further confirm the association between these two SNPs with autism, we expanded the sample size to 553 trios by adding 314 trios. Association analyses for SNPs and haplotype were performed by using family-based association test (FBAT) and Haploview software. Permutation tests were used for multiple testing corrections of the haplotype analyses (n=10,000). The significance level for all statistical tests was two-tailed (p<0.05). The results demonstrated that G allele of rs1006737 and G allele of rs4765905 showed a preferential transmission to affected offspring in 553 trios (p=0.035). Haplotype analyses showed that two haplotypes constructed from rs1006737 and rs4765905 were significantly associated with autism (p=0.030, 0.023, respectively; Global p=0.046). These results were still significant after permutation correction (n=10,000, p=0.027). Our research suggests that CACNA1C might play a role in the genetic etiology of autism in Chinese Han population.	[Li, Jun; Zhao, Linnan; You, Yang; Lu, Tianlan; Jia, Meixiang; Yu, Hao; Ruan, Yanyan; Yue, Weihua; Liu, Jing; Lu, Lin; Zhang, Dai; Wang, Lifang] Peking Univ, Inst Mental Hlth, Hosp 6, Beijing 100871, Peoples R China; [Li, Jun; Zhao, Linnan; You, Yang; Lu, Tianlan; Jia, Meixiang; Yu, Hao; Ruan, Yanyan; Yue, Weihua; Liu, Jing; Lu, Lin; Zhang, Dai; Wang, Lifang] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Li, Jun; Zhao, Linnan; You, Yang; Lu, Tianlan; Jia, Meixiang; Yu, Hao; Ruan, Yanyan; Yue, Weihua; Liu, Jing; Lu, Lin; Zhang, Dai; Wang, Lifang] Peking Univ, Natl Clin Res Ctr Mental Disorders, Beijing 100871, Peoples R China; [Yu, Hao; Zhang, Dai] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Lu, Lin; Zhang, Dai] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Zhang, D (corresponding author), Peking Univ, Inst Mental Hlth, Hosp 6, Beijing 100871, Peoples R China.	daizhang@bjmu.edu.cn; lifangwang@bjmu.edu.cn	Jia, Mei/GXZ-9967-2022; You, Yang/AEF-1080-2022; Yu, Hao/GYD-8698-2022	You, Yang/0000-0003-0574-7827; Yu, Hao/0000-0002-9785-8489	National Natural Science Foundation [81471383, 81471360]; Beijing Municipal Science & Technology Commission [Z131107002213100]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This research was supported by research grants from the National Natural Science Foundation (grant numbers 81471383 and 81471360) (http://www.nsfc.gov.cn/), and Beijing Municipal Science & Technology Commission (No. Z131107002213100) (http://mis.bjkw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Suzuki M, 2005, BIOL PSYCHIAT, V57, P382, DOI 10.1016/j.biopsych.2004.11.022; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhat S, 2012, PROG NEUROBIOL, V99, P1, DOI 10.1016/j.pneurobio.2012.06.001; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Breitenkamp AFS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095579; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; COON H, 1994, AM J MED GENET, V54, P12, DOI 10.1002/ajmg.1320540105; Craddock N, 2010, BRIT J PSYCHIAT, V197, P158, DOI 10.1192/bjp.197.2.158; Dima D, 2013, JAMA PSYCHIAT, V70, P1303, DOI 10.1001/jamapsychiatry.2013.2099; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Gauderman WJ, 2006, QUANTO 1 1 A COMPUTE; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Jurinke C, 2001, Methods Mol Biol, V170, P103; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Kakinuma H, 2008, AM J MED GENET B, V147B, P973, DOI 10.1002/ajmg.b.30663; Kenny EM, 2014, MOL PSYCHIATR, V19, P872, DOI 10.1038/mp.2013.127; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Krug A, 2010, NEUROIMAGE, V49, P1831, DOI 10.1016/j.neuroimage.2009.09.028; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Leung RC, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-51; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lu ATH, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-18; Ivorra JL, 2014, SCHIZOPHR RES, V159, P107, DOI 10.1016/j.schres.2014.07.004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Radulescu E, 2013, NEUROIMAGE-CLIN, V2, P716, DOI 10.1016/j.nicl.2013.05.010; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saus E, 2010, J PSYCHIATR RES, V44, P971, DOI 10.1016/j.jpsychires.2010.03.007; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Shukla DK, 2010, J AM ACAD CHILD PSY, V49, P1269, DOI 10.1016/j.jaac.2010.08.018; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Storm N, 2003, METHOD MOL BIOL, V212, P241; Strom SP, 2010, MOL PSYCHIATR, V15, P996, DOI 10.1038/mp.2009.41; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Verly M, 2014, NEUROIMAGE-CLIN, V4, P374, DOI 10.1016/j.nicl.2014.01.008; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	65	25	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133247	10.1371/journal.pone.0133247	http://dx.doi.org/10.1371/journal.pone.0133247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204268	gold, Green Published, Green Submitted			2022-12-27	WOS:000358621000024
J	Rojas, F; Hernandez, ME; Silva, M; Li, LH; Subramanian, S; Wilson, MJ; Liu, P				Rojas, Fausto; Hernandez, Maria E.; Silva, Milagros; Li, Lihua; Subramanian, Subbaya; Wilson, Michael J.; Liu, Ping			The Oncogenic Response to MiR-335 Is Associated with Cell Surface Expression of Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP) Activity	PLOS ONE			English	Article							UP-REGULATION; LUNG-CANCER; TUMOR-CELLS; INVASION; METASTASIS; MIGRATION; GROWTH; PROLIFERATION; ACTIVATION; MICRORNAS	MicroRNA miR-335 has been reported to have both tumor suppressor and oncogenic activities. In order to determine possible tissue and cell type differences in response to miR-335, we examined the effect of miR-335 on cell expression of MT1-MMP, a proteinase commonly expressed in tumors and associated with cell proliferation and migration. miR-335 increased cell surface expression of MT1-MMP in fibrosarcoma HT-1080 and benign prostate BPH-1 cells, but not in prostate LNCaP or breast MCF-7 tumor cells. miR-335 stimulated proliferation and cell migration in a wound healing in vitro assay in HT-1080, BPH-1, and U87 glioblastoma cells, cells which demonstrated significant cell surface expression of MT1-MMP. In contrast, miR-335 did not affect proliferation or migration in cells without a prominent plasma membrane associated MT1-MMP activity. Our data suggest that differences in response to miR-335 by tumor cells may lie in part in the mechanism of regulation of MT1-MMP production.	[Rojas, Fausto; Hernandez, Maria E.; Silva, Milagros] Univ Veracruzana, Ctr Invest Cerebrales, Xalapa 91000, Veracruz, Mexico; [Rojas, Fausto; Hernandez, Maria E.; Silva, Milagros; Wilson, Michael J.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Li, Lihua; Subramanian, Subbaya] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Subramanian, Subbaya; Wilson, Michael J.; Liu, Ping] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Wilson, Michael J.; Liu, Ping] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Wilson, Michael J.] Minneapolis VA Med Ctr, Minneapolis, MN USA	Universidad Veracruzana; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Wilson, MJ (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	Wilso042@umn.edu		Hernandez, Maria Elena/0000-0002-1617-5636; Rojas-Duran, Fausto/0000-0003-4497-0909; Subramanian, Subbaya/0000-0002-2544-480X; Silva Morales, Milagros/0000-0002-0794-2362	National Institutes Health [CA114418-01A2]; Karen Wyckoff Sarcoma Foundation; CONACyT [106531, 35159, 165708]; Sabbatical Support [159818]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NATIONAL CANCER INSTITUTE [R01CA114418] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karen Wyckoff Sarcoma Foundation; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Sabbatical Support; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for these studies was provided through National Institutes Health grant number: CA114418-01A2 (MJW), the Karen Wyckoff Sarcoma Foundation (SS), Sabbatical Support: 159818 (MEH), CONACyT grant 106531 (MEH), CONACyT Predoctoral Fellowship 35159 (MS), CONCyT Postdoctoral Fellowship 165708 (FR), and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (MJW). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Cheng Q, 2014, MOL MED REP, V10, P399, DOI 10.3892/mmr.2014.2150; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Di Gregoli K, 2014, ARTERIOSCL THROM VAS, V34, P1990, DOI 10.1161/ATVBAHA.114.304088; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; Jiang J, 2012, MED ONCOL, V29, P3472, DOI 10.1007/s12032-012-0259-z; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Ma J, 2014, J BIOL CHEM, V289, P8442, DOI 10.1074/jbc.M113.516039; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; Nakayama I, 2013, INT J ONCOL, V43, P63, DOI 10.3892/ijo.2013.1935; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Ronchetti D, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-37; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Shi L, 2012, J NEURO-ONCOL, V110, P155, DOI 10.1007/s11060-012-0951-z; Shu MF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-59; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Takino T, 2013, BIOCHEM BIOPH RES CO, V436, P503, DOI 10.1016/j.bbrc.2013.05.134; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; Vickers MM, 2012, CLIN EXP METASTAS, V29, P123, DOI 10.1007/s10585-011-9435-3; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang HQ, 2013, TUMOR BIOL, V34, P3101, DOI 10.1007/s13277-013-0878-9; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Wang X, 2009, J ANDROL, V30, P259, DOI 10.2164/jandrol.108.006494; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Willis AL, 2013, J MICROSC-OXFORD, V251, P250, DOI 10.1111/jmi.12064; Xiao HB, 2014, ONCOL REP, V31, P1832, DOI 10.3892/or.2014.3048; Xu M, 2013, ONCOL REP, V30, P1398, DOI 10.3892/or.2013.2548; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yan JL, 2013, BRIT J HAEMATOL, V163, P93, DOI 10.1111/bjh.12489; Yan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040037; Zhang H, 2014, ONCOGENE, V33, P387, DOI 10.1038/onc.2012.574; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	51	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132026	10.1371/journal.pone.0132026	http://dx.doi.org/10.1371/journal.pone.0132026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204513	Green Published, Green Submitted, gold			2022-12-27	WOS:000358621000005
J	Kurogochi, M; Mori, M; Osumi, K; Tojino, M; Sugawara, S; Takashima, S; Hirose, Y; Tsukimura, W; Mizuno, M; Amano, J; Matsuda, A; Tomita, M; Takayanagi, A; Shoda, SI; Shirai, T				Kurogochi, Masaki; Mori, Masako; Osumi, Kenji; Tojino, Mami; Sugawara, Shu-ichi; Takashima, Shou; Hirose, Yuriko; Tsukimura, Wataru; Mizuno, Mamoru; Amano, Junko; Matsuda, Akio; Tomita, Masahiro; Takayanagi, Atsushi; Shoda, Shin-Ichiro; Shirai, Takashi			Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for Fc gamma RIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; HUMAN IGG1; TRANSGENIC SILKWORMS; TRANSGLYCOSYLATION ACTIVITY; MEDIATED CYTOTOXICITY; RECOMBINANT ANTIBODY; EFFECTOR FUNCTIONS; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; IN-VITRO	Many therapeutic antibodies have been developed, and IgG antibodies have been extensively generated in various cell expression systems. IgG antibodies contain N-glycans at the constant region of the heavy chain (Fc domain), and their N-glycosylation patterns differ during various processes or among cell expression systems. The Fc N-glycan can modulate the effector functions of IgG antibodies, such as antibody-dependent cellular cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC). To control Fc N-glycans, we performed a rearrangement of Fc N-glycans from a heterogeneous N-glycosylation pattern to homogeneous N-glycans using chemoenzymatic approaches with two types of endo-beta-N-acetyl glucosaminidases (ENG'ases), one that works as a hydrolase to cleave all heterogeneous N-glycans, another that is used as a glycosynthase to generate homogeneous N-glycans. As starting materials, we used an anti-Her2 antibody produced in transgenic silkworm cocoon, which consists of non-fucosylated pauci-mannose type (Man(2-3)GlcNAc(2)), high-mannose type (Man(4-9)GlcNAc(2)), and complex type (Man(3)GlcNAc(3-4)) N-glycans. As a result of the cleavage of several ENG'ases (endoS, endoM, endoD, endoH, and endoLL), the heterogeneous glycans on antibodies were fully transformed into homogeneous-GlcNAc by a combination of endoS, endoD, and endoLL. Next, the desired N-glycans (M-3; Man(3)-GlcNAc(1), G0; GlcNAc(2)Man(3)GlcNAc(1), G2; Gal(2)GlcNAc(2)Man(3)GlcNAc(1), A2; NeuAc(2)Gal(2)Glc-NAc(2)Man(3)GlcNAc(1)) were transferred from the corresponding oxazolines to the GlcNAcresidue on the intact anti-Her2 antibody with an ENG'ase mutant (endoS-D233Q), and the glycoengineered anti-Her2 antibody was obtained. The binding assay of anti-Her2 antibody with homogenous N-glycans with Fc gamma RIIIa-V158 showed that the glycoform influenced the affinity for Fc gamma RIIIa-V158. In addition, the ADCC assay for the glycoengineered anti-Her2 antibody (mAb-M3, mAb-G0, mAb-G2, and mAb-A2) was performed using SKBR-3 and BT-474 as target cells, and revealed that the glycoform influenced ADCC activity.	[Kurogochi, Masaki; Takashima, Shou; Amano, Junko; Shirai, Takashi] Noguchi Inst, Lab Glycobiol, Itabashi Ku, Tokyo, Japan; [Mori, Masako; Tsukimura, Wataru; Matsuda, Akio; Shirai, Takashi] Noguchi Inst, Lab Glycobioengn, Itabashi Ku, Tokyo, Japan; [Osumi, Kenji; Tojino, Mami; Sugawara, Shu-ichi; Hirose, Yuriko; Mizuno, Mamoru; Shirai, Takashi] Noguchi Inst, Lab Glycoorgan Chem, Itabashi Ku, Tokyo, Japan; [Tomita, Masahiro] Immunobiol Labs Co Ltd, Fujioka, Gunma, Japan; [Takayanagi, Atsushi] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo, Japan; [Shoda, Shin-Ichiro] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 980, Japan	Immuno-Biological Laboratories Co. Ltd.; Keio University; Tohoku University	Shirai, T (corresponding author), Noguchi Inst, Lab Glycobiol, Itabashi Ku, 1-8-1 Kaga, Tokyo, Japan.	shirai.tb@noguchi.or.jp	Amano, Junko/ABA-6890-2020; Amano, Junko/ABA-6882-2020	Amano, Junko/0000-0001-7602-0794; 	Immuno-Biological Laboratories Co. Ltd.	Immuno-Biological Laboratories Co. Ltd.	The authors received no specific funding for this work. Co-author Masahiro Tomita is employed by Immuno-Biological Laboratories Co. Ltd. Immuno-Biological Laboratories Co. Ltd. provided support in the form of salary for author MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adachi T, 2010, BIOTECHNOL BIOENG, V106, P860, DOI 10.1002/bit.22752; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Ahmed AA, 2014, J MOL BIOL, V426, P3166, DOI 10.1016/j.jmb.2014.07.006; Barb AW, 2011, NAT CHEM BIOL, V7, P147, DOI 10.1038/NCHEMBIO.511; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Crispin M, 2009, J MOL BIOL, V387, P1061, DOI 10.1016/j.jmb.2009.02.033; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; Green MC, 2000, CANCER TREAT REV, V26, P269, DOI 10.1053/ctrv.2000.0176; Ha S, 2011, GLYCOBIOLOGY, V21, P1087, DOI 10.1093/glycob/cwr047; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Hodoniczky J, 2005, BIOTECHNOL PROGR, V21, P1644, DOI 10.1021/bp050228w; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Iizuka M, 2008, J BIOSCI BIOENG, V105, P595, DOI 10.1263/jbb.105.595; Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kurogochi M, 2014, MOLECULES, V19, P9944, DOI 10.3390/molecules19079944; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Loos A, 2012, ARCH BIOCHEM BIOPHYS, V526, P167, DOI 10.1016/j.abb.2012.05.011; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Parekh BS, 2012, MABS-AUSTIN, V4, P310, DOI 10.4161/mabs.19873; PAULSEN H, 1984, LIEBIGS ANN CHEM, P951; Prang N, 2005, BRIT J CANCER, V92, P342, DOI 10.1038/sj.bjc.6602310; Ricart AD, 2007, NAT CLIN PRACT ONCOL, V4, P245, DOI 10.1038/ncponc0774; SARMA VR, 1971, J BIOL CHEM, V246, P3753; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Smith EL, 2014, BIOCONJUGATE CHEM, V25, P788, DOI 10.1021/bc500061s; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; STRECKER G, 1977, EUR J BIOCHEM, V81, P165, DOI 10.1111/j.1432-1033.1977.tb11937.x; Sun BY, 2014, CARBOHYD RES, V396, P62, DOI 10.1016/j.carres.2014.07.013; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Tada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095787; TAI T, 1975, J BIOL CHEM, V250, P8569; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Wang SY, 2010, J CHROMATOGR A, V1217, P6496, DOI 10.1016/j.chroma.2010.08.044; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; Wright A, 2000, GLYCOBIOLOGY, V10, P1347, DOI 10.1093/glycob/10.12.1347; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yoshikawa M, 2013, BLOOD, V121, P2804, DOI 10.1182/blood-2012-12-468363; Zhang NY, 2011, MABS-AUSTIN, V3, P289, DOI 10.4161/mabs.3.3.15532; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	72	77	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132848	10.1371/journal.pone.0132848	http://dx.doi.org/10.1371/journal.pone.0132848			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200113	gold, Green Submitted, Green Published			2022-12-27	WOS:000358597100049
J	Schauerte, B; Stiefelhagen, R				Schauerte, Boris; Stiefelhagen, Rainer			On the Distribution of Salient Objects in Web Images and Its Influence on Salient Object Detection	PLOS ONE			English	Article								In recent years it has become apparent that a Gaussian center bias can serve as an important prior for visual saliency detection, which has been demonstrated for predicting human eye fixations and salient object detection. Tseng et al. have shown that the photographer's tendency to place interesting objects in the center is a likely cause for the center bias of eye fixations. We investigate the influence of the photographer's center bias on salient object detection, extending our previous work. We show that the centroid locations of salient objects in photographs of Achanta and Liu's data set in fact correlate strongly with a Gaussian model. This is an important insight, because it provides an empirical motivation and justification for the integration of such a center bias in salient object detection algorithms and helps to understand why Gaussian models are so effective. To assess the influence of the center bias on salient object detection, we integrate an explicit Gaussian center bias model into two state-of-the-art salient object detection algorithms. This way, first, we quantify the influence of the Gaussian center bias on pixel- and segment-based salient object detection. Second, we improve the performance in terms of F-1 score, F-beta score, area under the recall-precision curve, area under the receiver operating characteristic curve, and hit-rate on the well-known data set by Achanta and Liu. Third, by debiasing Cheng et al.'s region contrast model, we exemplarily demonstrate that implicit center biases are partially responsible for the outstanding performance of state-of-the-art algorithms. Last but not least, we introduce a non-biased salient object detection method, which is of interest for applications in which the image data is not likely to have a photographer's center bias (e.g., image data of surveillance cameras or autonomous robots).	[Schauerte, Boris; Stiefelhagen, Rainer] Karlsruhe Inst Technol, Inst Anthropomat & Robot, Baden, Switzerland		Schauerte, B (corresponding author), Karlsruhe Inst Technol, Inst Anthropomat & Robot, Baden, Switzerland.	boris.schauerte@kit.edu			Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology.	Achanta R, 2010, P INT C IM PROC; Achanta R, 2009, P INT C COMP VIS PAT; Alexe B, 2010, P INT C COMP VIS PAT; Borji A, 2012, P INT C COMP VIS PAT; Borji A., 2012, P EUR C COMP VIS; Busswell G., 1935, PEOPLE LOOK PICTURES; Cheng MM, 2011, PROC CVPR IEEE, P409, DOI 10.1109/CVPR.2011.5995344; Davis J, 2006, PROC INT CONF MACHIN; Einhauser W, 2008, J VISION, V8; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Goferman S., 2012, IEEE T PATTERN ANAL; Goferman S, 2010, P INT C COMP VIS PAT; Guthrie W. F, 2020, NISTSEMATECH E HDB S, V151, DOI DOI 10.18434/M32189; Harel Jonathan, 2007, GRAPH BASED VISUAL S, V1, P4; Hou X, 2007, P INT C COMP VIS PAT; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L., 2006, ADV NEURAL INFORM PR; Jiang HZ, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.110; Judd T., 2009, P INT C COMP VIS; Klein D., 2011, P INT C COMP VIS; Liu T, 2007, P INT C COMP VIS PAT; Luo Y., 2008, P EUR C COMP VIS; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Scharfenberger C, 2013, P INT C COMP VIS PAT; Schauerte B, 2014, P INT C INT ROB SYST; Schauerte B, 2012, P WORKSH APPL COMP V; Schauerte B, 2009, P INT C MULT INT; Schauerte B, 2011, SPECTRAL VISUAL SALI; Schauerte B, 2013, P INT C IM PROC; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Tseng PH, 2009, J VISION, V9, DOI 10.1167/9.7.4; Tsotsos JK, 2011, COMPUTATIONAL PERSPECTIVE ON VISUAL ATTENTION, P1; VOGEL RM, 1989, J WATER RES PL-ASCE, V115, P338, DOI 10.1061/(ASCE)0733-9496(1989)115:3(338); Yang Y, 2010, P EUR C COMP VIS	38	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0130316	10.1371/journal.pone.0130316	http://dx.doi.org/10.1371/journal.pone.0130316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201078	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100008
J	Wagner, F; Wimmer, W; Leidolt, L; Vischer, M; Weder, S; Wiest, R; Mantokoudis, G; Caversaccio, MD				Wagner, Franca; Wimmer, Wilhelm; Leidolt, Lars; Vischer, Mattheus; Weder, Stefan; Wiest, Roland; Mantokoudis, Georgios; Caversaccio, Marco D.			Significant Artifact Reduction at 1.5T and 3T MRI by the Use of a Cochlear Implant with Removable Magnet: An Experimental Human Cadaver Study	PLOS ONE			English	Article							CLINICAL-APPLICATION; INTERNAL MAGNET; SAFETY ASPECTS; COMPATIBILITY; CONTRAINDICATION; DISPLACEMENT; SCHWANNOMAS; EAR	Objective Cochlear implants (CIs) are standard treatment for postlingually deafened individuals and prelingually deafened children. This human cadaver study evaluated diagnostic usefulness, image quality and artifacts in 1.5T and 3T magnetic resonance (MR) brain scans after CI with a removable magnet. Methods Three criteria (diagnostic usefulness, image quality, artifacts) were assessed at 1.5T and 3T in five cadaver heads with CI. The brain magnetic resonance scans were performed with and without the magnet in situ. The criteria were analyzed by two blinded neuroradiologists, with focus on image distortion and limitation of the diagnostic value of the acquired MR images. Results MR images with the magnet in situ were all compromised by artifacts caused by the CI. After removal of the magnet, MR scans showed an unequivocal artifact reduction with significant improvement of the image quality and diagnostic usefulness, both at 1.5T and 3T. Visibility of the brain stem, cerebellopontine angle, and parieto-occipital lobe ipsilateral to the CI increased significantly after magnet removal. Conclusions The results indicate the possible advantages for 1.5T and 3T MR scanning of the brain in CI carriers with removable magnets. Our findings support use of CIs with removable magnets, especially in patients with chronic intracranial pathologies.	[Wagner, Franca; Leidolt, Lars; Wiest, Roland] Inselspital Bern, Univ Dept Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Wimmer, Wilhelm; Vischer, Mattheus; Weder, Stefan; Mantokoudis, Georgios; Caversaccio, Marco D.] Inselspital Bern, Univ Dept Otorhinolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland; [Wimmer, Wilhelm; Caversaccio, Marco D.] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Wagner, F (corresponding author), Inselspital Bern, Univ Dept Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland.	franca.wagner@insel.ch	Mantokoudis, Georgios/J-6318-2013	Mantokoudis, Georgios/0000-0003-2268-7811; Wimmer, Wilhelm/0000-0001-5392-2074	MEDEL Corporation [MED-EL Corporation, Innsbruck, Austria]; MED-EL Corporation [MED-EL Corporation, Innsbruck, Austria]	MEDEL Corporation [MED-EL Corporation, Innsbruck, Austria]; MED-EL Corporation [MED-EL Corporation, Innsbruck, Austria]	The authors of this manuscript declare that they thank the MEDEL Corporation [MED-EL Corporation, Innsbruck, Austria] for loan of the cochlear implants and funding that study [total amount 15 000(sic)]. The authors state that this work has received funding from MED-EL Corporation [MED-EL Corporation, Innsbruck, Austria] in the amount of 15 000(sic). Additionally, the authors confirm that the funders had no role in our study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS HL, 1989, JAMA-J AM MED ASSOC, V261, P46, DOI 10.1001/jama.1989.03420010056027; Alberty J, 2002, HNO, V50, P739, DOI 10.1007/s00106-001-0601-9; Baumgartner WD, 2000, WIEN KLIN WOCHENSCHR, V112, P512; Baumgartner WD, 2000, ADV OTO-RHINO-LARYNG, V57, P28; Baumgartner WD, 2001, OTOL NEUROTOL, V22, P818, DOI 10.1097/00129492-200111000-00018; Bittencourt AG, 2014, INT ARCH OTORHINOLAR, V18, P322, DOI 10.1055/s-0033-1364170; CHOU CK, 1995, BIOELECTROMAGNETICS, V16, P307, DOI 10.1002/bem.2250160507; Crane BT, 2010, OTOL NEUROTOL, V31, P1215, DOI 10.1097/MAO.0b013e3181ec1d61; Czerny C, 2001, EUR J RADIOL, V40, P105, DOI 10.1016/S0720-048X(01)00378-3; Deneuve S, 2008, OTOL NEUROTOL, V29, P789, DOI 10.1097/MAO.0b013e3181825695; Dubrulle F, 2013, EUR RADIOL, V23, P1510, DOI 10.1007/s00330-012-2760-3; Fritsch Michael H, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P335, DOI 10.1097/MOO.0b013e328270b8b4; Fruauff K, 2015, TOP MAGN RESON IMAG, V24, P55; Graham J, 1999, J LARYNGOL OTOL, V113, P458, DOI 10.1017/S0022215100144214; Gubbels SP, 2006, LARYNGOSCOPE, V116, P865, DOI 10.1097/01.MLG.0000216807.03225.CE; Heller JW, 1996, AM J OTOL, V17, P724; Hochmair E S, 2001, Cochlear Implants Int, V2, P98, DOI 10.1179/cim.2001.2.2.98; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; Majdani O, 2008, OTOLARYNG HEAD NECK, V139, P833, DOI 10.1016/j.otohns.2008.07.026; Migirov L, 2013, ORL J OTO-RHINO-LARY, V75, P1, DOI 10.1159/000346239; Schmerber S, 2003, EUR ARCH OTO-RHINO-L, V260, P293, DOI 10.1007/s00405-002-0568-5; Teissl C, 1998, RADIOLOGY, V208, P700, DOI 10.1148/radiology.208.3.9722849; Teissl C, 1999, J MAGN RESON IMAGING, V9, P26, DOI 10.1002/(SICI)1522-2586(199901)9:1<26::AID-JMRI4>3.0.CO;2-H; Tieleman A, 2008, AM J NEURORADIOL, V29, P898, DOI 10.3174/ajnr.A1026; Todt I, 2015, OTOL NEUROTOL, DOI [10.1097/MAO.0000000000000720, DOI 10.1097/MA0.0000000000000720]; Tysome JR, 2012, OTOL NEUROTOL, V33, P466, DOI 10.1097/MAO.0b013e318248eaaa; Wackym PA, 2004, LARYNGOSCOPE, V114, P1355, DOI 10.1097/00005537-200408000-00007; Wagner J, 2014, 13 INT C COCHL IMPL; Weber BP, 1999, ANN OTO RHINOL LARYN, V108, P22; Youssefzadeh S, 1998, J COMPUT ASSIST TOMO, V22, P346, DOI 10.1097/00004728-199805000-00002; Yun JM, 2005, OTOLARYNG HEAD NECK, V133, P275, DOI 10.1016/j.otohns.2005.02.018	31	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132483	10.1371/journal.pone.0132483	http://dx.doi.org/10.1371/journal.pone.0132483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200775	gold, Green Published			2022-12-27	WOS:000358597100037
J	Galka, MM; Rajagopalan, N; Buhrow, LM; Nelson, KM; Switala, J; Cutler, AJ; Palmer, DRJ; Loewen, PC; Abrams, SR; Loewen, MC				Galka, Marek M.; Rajagopalan, Nandhakishore; Buhrow, Leann M.; Nelson, Ken M.; Switala, Jacek; Cutler, Adrian J.; Palmer, David R. J.; Loewen, Peter C.; Abrams, Suzanne R.; Loewen, Michele C.			Identification of Interactions between Abscisic Acid and Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase	PLOS ONE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; COMPARTMENTAL DISTRIBUTION; MOLECULAR-STRUCTURE; PHOSPHATE-BINDING; CRYSTAL-STRUCTURE; RUBISCO ACTIVITY; INTACT LEAVES; LARGE SUBUNIT; ACTIVATION; SPINACH	Abscisic acid ((+)-ABA) is a phytohormone involved in the modulation of developmental processes and stress responses in plants. A chemical proteomics approach using an ABA mimetic probe was combined with in vitro assays, isothermal titration calorimetry (ITC), x-ray crystallography and in silico modelling to identify putative (+)-ABA binding-proteins in crude extracts of Arabidopsis thaliana. Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) was identified as a putative ABA-binding protein. Radiolabelled-binding assays yielded a K-d of 47 nM for (+)-ABA binding to spinach Rubisco, which was validated by ITC, and found to be similar to reported and experimentally derived values for the native ribulose-1,5-bisphosphate (RuBP) substrate. Functionally, (+)-ABA caused only weak inhibition of Rubisco catalytic activity (K-i of 2.1 mM), but more potent inhibition of Rubisco activation (K-i of similar to 130 mu M). Comparative structural analysis of Rubisco in the presence of (+)-ABA with RuBP in the active site revealed only a putative low occupancy (+)-ABA binding site on the surface of the large subunit at a location distal from the active site. However, subtle distortions in electron density in the binding pocket and in silico docking support the possibility of a higher affinity (+)-ABA binding site in the RuBP binding pocket. Overall we conclude that (+)-ABA interacts with Rubisco. While the low occupancy (+)-ABA binding site and weak non-competitive inhibition of catalysis may not be relevant, the high affinity site may allow ABA to act as a negative effector of Rubisco activation.	[Galka, Marek M.; Rajagopalan, Nandhakishore; Buhrow, Leann M.; Nelson, Ken M.; Cutler, Adrian J.; Abrams, Suzanne R.; Loewen, Michele C.] Natl Res Council Canada, Saskatoon, SK, Canada; [Galka, Marek M.; Palmer, David R. J.; Abrams, Suzanne R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 0W0, Canada; [Switala, Jacek; Loewen, Peter C.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Loewen, Michele C.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	National Research Council Canada; University of Saskatchewan; University of Manitoba; University of Saskatchewan	Loewen, MC (corresponding author), Natl Res Council Canada, Saskatoon, SK, Canada.	michele.loewen@nrc.ca	Palmer, David R J/F-1934-2010	Palmer, David R J/0000-0001-9300-7460	Genome and Health Initiative, National Research Council of Canada [64-GH4P14]; Natural Sciences and Engineering Research Council of Canada [261683-2012, 9600-2012]; Canada Research Chair Program [950-214844]	Genome and Health Initiative, National Research Council of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs)	This work was funded by the Genome and Health Initiative, National Research Council of Canada #64-GH4P14 (http://www.nrc-cnrc.gc.ca/eng/index.html) to M.C.L and S.R.A., and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to M.C.L (261683-2012) and P.C.L. (9600-2012), and by the Canada Research Chair Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) to P.C.L (950-214844).	ABRAMS SR, 1989, PHYTOCHEMISTRY, V28, P2885, DOI 10.1016/0031-9422(89)80246-8; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; BADGER MR, 1981, BIOCHEMISTRY-US, V20, P2219, DOI 10.1021/bi00511a023; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Benson CL, 2015, PHYTOCHEMISTRY, V113, P96, DOI 10.1016/j.phytochem.2014.03.017; BRADFORD KJ, 1983, PLANT PHYSIOL, V72, P245, DOI 10.1104/pp.72.1.245; Bricogne G, 2009, BUSTER VERSION 2 8 0; Chattopadhyay A, 2011, PHYTOCHEMISTRY, V72, P1293, DOI 10.1016/j.phytochem.2011.01.024; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Desimone M, 1996, PLANT PHYSIOL, V111, P789, DOI 10.1104/pp.111.3.789; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Dupeux F, 2011, EMBO J, V30, P4171, DOI 10.1038/emboj.2011.294; Eichelmann H, 2009, J EXP BOT, V60, P4077, DOI 10.1093/jxb/erp242; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Frank J, 1998, J CHEM SOC FARADAY T, V94, P2127, DOI 10.1039/a802124d; Fukayama H, 2010, PLANT PHYSIOL BIOCH, V48, P808, DOI 10.1016/j.plaphy.2010.08.002; Greene DN, 2007, BIOCHEM J, V404, P517, DOI 10.1042/BJ20070071; Ishida H, 1997, PLANT CELL PHYSIOL, V38, P471, DOI 10.1093/oxfordjournals.pcp.a029191; Jensen RG, 2000, P NATL ACAD SCI USA, V97, P12937, DOI 10.1073/pnas.97.24.12937; JORDAN DB, 1983, J BIOL CHEM, V258, P3752; Kharenko OA, 2013, J BIOCHEM, V154, P383, DOI 10.1093/jb/mvt067; Kharenko OA, 2011, BIOCHEM J, V437, P117, DOI 10.1042/BJ20101898; LAING WA, 1976, BIOCHEM J, V159, P563, DOI 10.1042/bj1590563; LAN Y, 1991, PLANT PHYSIOL, V95, P604, DOI 10.1104/pp.95.2.604; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Loewen PC, 2013, ACTA CRYSTALLOGR F, V69, P10, DOI 10.1107/S1744309112047549; LORIMER GH, 1980, BIOCHEMISTRY-US, V19, P5321, DOI 10.1021/bi00564a027; Marcus Y, 2005, J BACTERIOL, V187, P4222, DOI 10.1128/JB.187.12.4222-4228.2005; Matsumura H, 2012, J MOL BIOL, V422, P75, DOI 10.1016/j.jmb.2012.05.014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer S, 1999, PLANTA, V210, P126, DOI 10.1007/s004250050661; Miyakawa T, 2013, TRENDS PLANT SCI, V18, P259, DOI 10.1016/j.tplants.2012.11.002; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nyangulu JM, 2006, ORG BIOMOL CHEM, V4, P1400, DOI 10.1039/b509193d; Nyangulu JM, 2005, J AM CHEM SOC, V127, P1662, DOI 10.1021/ja0429059; OHKUMA K, 1965, TETRAHEDRON LETT, P2529; Parry MAJ, 2002, ANN BOT-LONDON, V89, P833, DOI 10.1093/aob/mcf103; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Portis AR, 2007, PHOTOSYNTH RES, V94, P121, DOI 10.1007/s11120-007-9225-6; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rakwal R, 2004, MOL BIOL REP, V31, P217, DOI 10.1007/s11033-005-2710-0; SCHMALLE HW, 1977, ACTA CRYSTALLOGR B, V33, P2218, DOI 10.1107/S0567740877008036; Schrodinger L., 2020, PYMOL; SLOVIK S, 1992, PLANTA, V187, P37, DOI [10.1007/BF00201619, 10.1007/BF00201621]; SLOVIK S, 1992, PLANTA, V187, P26, DOI 10.1007/BF00201620; SWAMINATHAN P, 1976, ACTA CRYSTALLOGR B, V32, P2351, DOI 10.1107/S0567740876007747; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Taylor TC, 1997, BIOCHEMISTRY-US, V36, P4041, DOI 10.1021/bi962818w; Taylor TC, 1997, J MOL BIOL, V265, P432, DOI 10.1006/jmbi.1996.0738; VATER J, 1979, ARCH BIOCHEM BIOPHYS, V194, P190, DOI 10.1016/0003-9861(79)90609-X; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	60	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133033	10.1371/journal.pone.0133033	http://dx.doi.org/10.1371/journal.pone.0133033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197050	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600061
J	Janicki, AF; Frick, WF; Kilpatrick, AM; Parise, KL; Foster, JT; McCracken, GF				Janicki, Amanda F.; Frick, Winifred F.; Kilpatrick, A. Marm; Parise, Katy L.; Foster, Jeffrey T.; McCracken, Gary F.			Efficacy of Visual Surveys for White-Nose Syndrome at Bat Hibernacula	PLOS ONE			English	Article							PSEUDOGYMNOASCUS-DESTRUCTANS; GEOMYCES-DESTRUCTANS; SYNDROME FUNGUS; INFECTIOUS-DISEASE; EMERGING DISEASE; HIBERNATING BATS; NORTH-AMERICA; UNITED-STATES; PERSISTENCE; PHENOLOGY	White-Nose Syndrome (WNS) is an epizootic disease in hibernating bats caused by the fungus Pseudogymnoascus destructans. Surveillance for P. destructans at bat hibernacula consists primarily of visual surveys of bats, collection of potentially infected bats, and submission of these bats for laboratory testing. Cryptic infections (bats that are infected but display no visual signs of fungus) could lead to the mischaracterization of the infection status of a site and the inadvertent spread of P. destructans. We determined the efficacy of visual detection of P. destructans by examining visual signs and molecular detection of P. destructans on 928 bats of six species at 27 sites during surveys conducted from January through March in 2012-2014 in the southeastern USA on the leading edge of the disease invasion. Cryptic infections were widespread with 77% of bats that tested positive by qPCR showing no visible signs of infection. The probability of exhibiting visual signs of infection increased with sampling date and pathogen load, the latter of which was substantially higher in three species (Myotis lucifugus, M. septentrionalis, and Perimyotis subflavus). In addition, M. lucifugus was more likely to show visual signs of infection than other species given the same pathogen load. Nearly all infections were cryptic in three species (Eptesicus fuscus, M. grisescens, and M. sodalis), which had much lower fungal loads. The presence of M. lucifugus or M. septentrionalis at a site increased the probability that P. destructans was visually detected on bats. Our results suggest that cryptic infections of P. destructans are common in all bat species, and visible infections rarely occur in some species. However, due to very high infection prevalence and loads in some species, we estimate that visual surveys examining at least 17 individuals of M. lucifugus and M. septentrionalis, or 29 individuals of P. subflavus are still effective to determine whether a site has bats infected with P. destructans. In addition, because the probability of visually detecting the fungus was higher later in winter, surveys should be done as close to the end of the hibernation period as possible.	[Janicki, Amanda F.; McCracken, Gary F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Frick, Winifred F.; Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Parise, Katy L.; Foster, Jeffrey T.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA	University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Santa Cruz; Northern Arizona University	Janicki, AF (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	ajanicki@vols.utk.edu	Frick, Winifred/ABA-3519-2020	Frick, Winifred/0000-0002-9469-1839; McCracken, Gary/0000-0002-2493-8103; Foster, Jeffrey/0000-0001-8235-8564	National Science Foundation Ecology of Infectious Diseases [DEB-1115895, DEB-1336290]; University of Tennessee Department of Ecology and Evolutionary Biology	National Science Foundation Ecology of Infectious Diseases(National Science Foundation (NSF)); University of Tennessee Department of Ecology and Evolutionary Biology	Funding was provided by the National Science Foundation Ecology of Infectious Diseases (DEB-1115895 and DEB-1336290) to WFF, AMK, JTF, and GFM; and the University of Tennessee Department of Ecology and Evolutionary Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchong JA, 2006, J WILDLIFE DIS, V42, P33, DOI 10.7589/0090-3558-42.1.33; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Canadian Wildlife Health Cooperative, 2015, NAT PLAN MAN WHIT NO; Coleman J, 2011, NATL PLAN ASSISTING; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frank CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113958; Frick WF, 2015, GLOBAL ECOL BIOGEOGR, V24, P741, DOI 10.1111/geb.12290; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Hallam TG, 2011, CONSERV BIOL, V25, P189, DOI 10.1111/j.1523-1739.2010.01603.x; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hoyt JR, 2015, ECOHEALTH, V12, P330, DOI 10.1007/s10393-014-0981-4; Johnson JS, 2015, ECOL EVOL, V5, P2203, DOI 10.1002/ece3.1502; Langwig KE, 2015, EMERG INFECT DIS, V21, P1023, DOI 10.3201/eid2106.150123; Langwig KE, 2015, FRONT ECOL ENVIRON, V13, P195, DOI 10.1890/140241; Langwig KE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2335; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Leopardi S, 2015, CURR BIOL, V25, pR217, DOI 10.1016/j.cub.2015.01.047; Loeb S.C., 2015, SRS208; Lorch JM, 2015, J WILDLIFE DIS, V51, P36, DOI 10.7589/2014-05-134; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Maher SP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2301; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Muller LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242; Norquay KJO, 2014, J ZOOL, V294, P85, DOI 10.1111/jzo.12155; O'Regan SM, 2015, ECOL APPL, V25, P621, DOI 10.1890/14-0417.1; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reynolds HT, 2015, J WILDLIFE DIS, V51, P318, DOI 10.7589/2014-06-157; Sachanowicz K, 2014, CENT EUR J BIOL, V9, P437, DOI 10.2478/s11535-013-0280-z; Shelley V, 2013, J CAVE KARST STUD, V75, P1, DOI 10.4311/2011LSC0249; Shuey MM, 2014, APPL ENVIRON MICROB, V80, P1726, DOI 10.1128/AEM.02897-13; Sleeman JM, 2013, ECOHEALTH, V10, P335, DOI 10.1007/s10393-013-0880-0; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Thogmartin WE, 2013, BIOL CONSERV, V160, P162, DOI 10.1016/j.biocon.2013.01.010; Turner GG, 2014, J WILDLIFE DIS, V50, P566, DOI 10.7589/2014-03-058; U.S. Fish and Wildlife Service, 2015, WHIT NOS SYNDR MAP; Verant Michelle L., 2014, BMC Physiology, V14, P10, DOI 10.1186/s12899-014-0010-4; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wilder AP, 2011, BIOL LETTERS, V7, P950, DOI 10.1098/rsbl.2011.0355	44	28	28	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133390	10.1371/journal.pone.0133390	http://dx.doi.org/10.1371/journal.pone.0133390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197236	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600092
J	Lai, YH; Tsao, Y; Chen, F				Lai, Ying-Hui; Tsao, Yu; Chen, Fei			Effects of Adaptation Rate and Noise Suppression on the Intelligibility of Compressed-Envelope Based Speech	PLOS ONE			English	Article							DYNAMIC-RANGE; SPECTRAL CHANNELS; BACKGROUND-NOISE; RELEASE TIME; COCHLEAR; RECOGNITION; REDUCTION; HEARING; NUMBER; ALGORITHMS	Temporal envelope is the primary acoustic cue used in most cochlear implant (CI) speech processors to elicit speech perception for patients fitted with CI devices. Envelope compression narrows down envelope dynamic range and accordingly degrades speech understanding abilities of CI users, especially under challenging listening conditions (e.g., in noise). A new adaptive envelope compression (AEC) strategy was proposed recently, which in contrast to the traditional static envelope compression, is effective at enhancing the modulation depth of envelope waveform by making best use of its dynamic range and thus improving the intelligibility of envelope-based speech. The present study further explored the effect of adaptation rate in envelope compression on the intelligibility of compressed-envelope based speech. Moreover, since noise reduction is another essential unit in modern CI systems, the compatibility of AEC and noise reduction was also investigated. In this study, listening experiments were carried out by presenting vocoded sentences to normal hearing listeners for recognition. Experimental results demonstrated that the adaptation rate in envelope compression had a notable effect on the speech intelligibility performance of the AEC strategy. By specifying a suitable adaptation rate, speech intelligibility could be enhanced significantly in noise compared to when using static envelope compression. Moreover, results confirmed that the AEC strategy was suitable for combining with noise reduction to improve the intelligibility of envelope-based speech in noise.	[Lai, Ying-Hui; Tsao, Yu] Acad Sinica, Res Ctr Informat Technol Innovat, Taipei 115, Taiwan; [Chen, Fei] South Univ Sci & Technol China, Dept Elect & Elect Engn, Shenzhen, Peoples R China	Academia Sinica - Taiwan; Southern University of Science & Technology	Tsao, Y (corresponding author), Acad Sinica, Res Ctr Informat Technol Innovat, Taipei 115, Taiwan.	yu.tsao@citi.sinica.edu.tw; fchen@sustc.edu.cn	Tsao, Yu/AAP-4779-2020; Chen, Fei/AAK-6755-2020; Chen, Fei/G-4674-2018	Tsao, Yu/0000-0001-6956-0418; Chen, Fei/0000-0002-6988-492X; Chen, Fei/0000-0002-6988-492X	Ministry of Science and Technology of Taiwan [MOST103-2221-E-001-003]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan under Project MOST103-2221-E-001-003.	Blamey Peter J, 2005, Trends Amplif, V9, P77, DOI 10.1177/108471380500900203; Buechner A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095542; Buechner A, 2010, OTOL NEUROTOL, V31, P1386, DOI 10.1097/MAO.0b013e3181f1cdc6; Chen F, 2014, EAR HEARING; Chen F, 2013, J SPEECH LANG HEAR R, V56, P1166, DOI 10.1044/1092-4388(2012/12-0255); Chung King, 2004, Trends Amplif, V8, P83, DOI 10.1177/108471380400800302; Dawson PW, 2011, EAR HEARING, V32, P382, DOI 10.1097/AUD.0b013e318201c200; Dawson PW, 2004, EAR HEARING, V25, P230, DOI 10.1097/01.AUD.0000130795.66185.28; Dorman MF, 1997, J ACOUST SOC AM, V102, P2993, DOI 10.1121/1.420354; Dorman MF, 1997, J ACOUST SOC AM, V102, P2403, DOI 10.1121/1.419603; Eddington DK, 1977, ANN OTOLOGY RHINOL 2, V87, P1; Fetterman BL, 2002, OTOLARYNG HEAD NECK, V126, P257, DOI 10.1067/mhn.2002.123044; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 1998, J ACOUST SOC AM, V104, P3586, DOI 10.1121/1.423941; Gatehouse S, 2006, INT J AUDIOL, V45, P130, DOI 10.1080/14992020500429518; Goupell MJ, 2010, J ACOUST SOC AM, V127, P990, DOI 10.1121/1.3283014; Hamacher V, 1997, AM J OTOL, V18, pS46; Hansen M, 2002, EAR HEARING, V23, P369, DOI 10.1097/00003446-200208000-00012; Hersbach AA, 2013, J ACOUST SOC AM, V133, P2412, DOI 10.1121/1.4794391; Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21; HOCHBERG I, 1992, EAR HEARING, V13, P263, DOI 10.1097/00003446-199208000-00008; Hu Y, 2003, IEEE T SPEECH AUDI P, V11, P334, DOI 10.1109/TSA.2003.814458; Hu Y, 2007, J ACOUST SOC AM, V122, P1777, DOI 10.1121/1.2766778; James CJ, 2002, EAR HEARING, V23, p49S, DOI 10.1097/00003446-200202001-00006; Jerlvall L, 1977, SCANDINAVIAN AUDIO S, P341; Kasturi K, 2007, EAR HEARING, V28, P402, DOI 10.1097/AUD.0b013e31804793c4; Khing PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082263; Lai Y- H, 2014, 2014 INT S IN PRESS; Lai Y-H, 2013, INT J SPEECH LANGUAG, V1, P43; Lai YH, 2014, INTERSPEECH, P481; Lai YH, 2013, J AM ACAD AUDIOL, V24, P671, DOI 10.3766/jaaa.24.8.4; Loizou PC, 2005, J ACOUST SOC AM, V118, P2791, DOI 10.1121/1.2065847; Loizou PC, 2000, EAR HEARING, V21, P25, DOI 10.1097/00003446-200002000-00006; Muller-Deile J, 2008, Cochlear Implants Int, V9, P8, DOI 10.1179/cim.2008.9.1.8; NABELEK IV, 1977, AUDIOLOGY, V16, P73; National Institute on Deafness and other communication disorders N, 2013, NIH PUBL, V11-4798; Naylor G, 2009, J AM ACAD AUDIOL, V20, P161, DOI 10.3766/jaaa.20.3.2; Neuman AC, 1995, J ACOUST SOC AM, V98, P3182, DOI 10.1121/1.413807; Neuman AC, 1998, J ACOUST SOC AM, V103, P2273, DOI 10.1121/1.422745; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Noel-Petroff N, 2013, AUDIOLOGY RES, V3, P9; Patrick James F, 2006, Trends Amplif, V10, P175, DOI 10.1177/1084713806296386; Scalart P, 1996, AC SPEECH SIGN PROC; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Souza Pamela E, 2002, Trends Amplif, V6, P131, DOI 10.1177/108471380200600402; Souza PE, 2006, J SPEECH LANG HEAR R, V49, P138, DOI 10.1044/1092-4388(2006/011); Spriet A, 2007, EAR HEARING, V28, P62, DOI 10.1097/01.aud.0000252470.54246.54; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; van Hoesel R, 2005, EAR HEARING, V26, P381, DOI 10.1097/00003446-200508000-00002; VANHOESEL RJM, 1995, J ACOUST SOC AM, V97, P2498, DOI 10.1121/1.411970; Venema T, 2006, COMPRESSION CLIN; Wong LLN, 2007, EAR HEARING, V28, p70S, DOI 10.1097/AUD.0b013e31803154d0; Wouters J, 2001, EAR HEARING, V22, P420, DOI 10.1097/00003446-200110000-00006; Yang LP, 2005, J ACOUST SOC AM, V117, P1001, DOI 10.1121/1.1852873; Zeng Fan-Gang, 2004, Trends Amplif, V8, P1, DOI 10.1177/108471380400800102; ZENG FG, 1992, HEARING RES, V60, P231, DOI 10.1016/0378-5955(92)90024-H; Zeng FG, 2002, J ACOUST SOC AM, V111, P377, DOI 10.1121/1.1423926	57	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133519	10.1371/journal.pone.0133519	http://dx.doi.org/10.1371/journal.pone.0133519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196508	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600108
J	Pica, A; Graziano, G				Pica, Andrea; Graziano, Giuseppe			On the Effect of Sodium Chloride and Sodium Sulfate on Cold Denaturation	PLOS ONE			English	Article							SCALED-PARTICLE THEORY; CONFORMATIONAL ENTROPY CHANGE; AQUEOUS-SOLUTIONS; HYDROPHOBIC HYDRATION; PROTEIN STABILITY; CRYSTAL-STRUCTURE; WATER-STRUCTURE; YEAST FRATAXIN; TEMPERATURE; DENSITY	Both sodium chloride and sodium sulfate are able to stabilize yeast frataxin, causing an overall increase of its thermodynamic stability curve, with a decrease in the cold denaturation temperature and an increase in the hot denaturation one. The influence of low concentrations of these two salts on yeast frataxin stability can be assessed by the application of a theoretical model based on scaled particle theory. First developed to figure out the mechanism underlying cold denaturation in water, this model is able to predict the stabilization of globular proteins provided by these two salts. The densities of the salt solutions and their temperature dependence play a fundamental role.	[Pica, Andrea] Univ Naples Federico II, Dipartimento Sci Chim, I-80126 Naples, Italy; [Pica, Andrea] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy; [Graziano, Giuseppe] Univ Sannio, Dipartimento Sci & Tecnol, I-82100 Benevento, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Sannio	Graziano, G (corresponding author), Univ Sannio, Dipartimento Sci & Tecnol, Via Port Arsa 11, I-82100 Benevento, Italy.	graziano@unisannio.it		Graziano, Giuseppe/0000-0001-6935-8172; PICA, Andrea/0000-0002-8736-8742				Adrover M, 2010, J AM CHEM SOC, V132, P16240, DOI 10.1021/ja1070174; Ashbaugh HS, 2007, J PHYS CHEM B, V111, P9330, DOI 10.1021/jp071969d; Ashbaugh HS, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3366718; Ashbaugh HS, 2006, REV MOD PHYS, V78, P159, DOI 10.1103/RevModPhys.78.159; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Ball P, 2015, PHYS CHEM CHEM PHYS, V17, P8297, DOI 10.1039/c4cp04564e; Baxa MC, 2014, P NATL ACAD SCI USA, V111, P15396, DOI 10.1073/pnas.1407768111; Buchner GS, 2012, BIOCHEMISTRY-US, V51, P6496, DOI 10.1021/bi300916v; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; CONNAUGHTON LM, 1986, J SOLUTION CHEM, V15, P989, DOI 10.1007/BF00645194; DAquino JA, 1996, PROTEINS, V25, P143, DOI 10.1002/prot.1; Despretz M., 1840, ANN CHIM PHYS, V73, P296; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; Fitter J, 2003, BIOPHYS J, V84, P3924, DOI 10.1016/S0006-3495(03)75120-0; Garde S, 1996, PHYS REV LETT, V77, P4966, DOI 10.1103/PhysRevLett.77.4966; Graziano G, 2004, CHEM PHYS LETT, V396, P226, DOI 10.1016/j.cplett.2004.07.126; Graziano G, 2002, J PHYS CHEM B, V106, P7713, DOI 10.1021/jp014558k; Graziano G, 2001, J PHYS CHEM B, V105, P10367, DOI 10.1021/jp011382d; Graziano G, 2006, J PHYS CHEM B, V110, P11421, DOI 10.1021/jp0571269; Graziano G, 2014, PHYS CHEM CHEM PHYS, V16, P21755, DOI 10.1039/c4cp02729a; Graziano G, 2012, PHYS CHEM CHEM PHYS, V14, P2769, DOI 10.1039/c2cp23463g; Graziano G, 2011, PHYS CHEM CHEM PHYS, V13, P17689, DOI 10.1039/c1cp22176k; Graziano G, 2011, PHYS CHEM CHEM PHYS, V13, P12008, DOI 10.1039/c1cp20843h; Graziano G, 2010, PHYS CHEM CHEM PHYS, V12, P14245, DOI 10.1039/c0cp00945h; Graziano G, 2009, J PHYS CHEM B, V113, P11232, DOI 10.1021/jp9025738; Graziano G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2972979; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Hruby J, 2014, J PHYS CHEM LETT, V5, P425, DOI 10.1021/jz402571a; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; KAULGUD MV, 1995, J CHEM SOC FARADAY T, V91, P999, DOI 10.1039/ft9959100999; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KELL GS, 1975, J CHEM ENG DATA, V20, P97, DOI 10.1021/je60064a005; LEBERMAN R, 1995, NATURE, V378, P364, DOI 10.1038/378364a0; LEE B, 1994, BIOPHYS CHEM, V51, P271, DOI 10.1016/0301-4622(94)00048-4; LEE B, 1985, BIOPOLYMERS, V24, P813, DOI 10.1002/bip.360240507; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Luan BW, 2013, BIOCHEMISTRY-US, V52, P2402, DOI 10.1021/bi3016789; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; Martin SR, 2008, J AM CHEM SOC, V130, P9963, DOI 10.1021/ja803280e; Paschek D, 2004, J CHEM PHYS, V120, P6674, DOI 10.1063/1.1652015; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Pauling L, 1960, NATURE CHEM BOND, VThird, P644; PIEROTTI RA, 1976, CHEM REV, V76, P717, DOI 10.1021/cr60304a002; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Rees DC, 2001, PROTEIN SCI, V10, P1187, DOI 10.1110/ps.180101; Riess H., 1965, ADV CHEM PHYS, V9, P1, DOI DOI 10.1002/9780470143551.CHL; Sanfelice D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095801; Shah PP, 2008, J PHYS CHEM B, V112, P1049, DOI 10.1021/jp075783q; Sorenson JM, 2000, J CHEM PHYS, V113, P9149, DOI 10.1063/1.1319615; Tang KES, 2000, BIOPHYS J, V79, P2222, DOI 10.1016/S0006-3495(00)76470-8; Tran HT, 2006, BIOPHYS J, V91, P1868, DOI 10.1529/biophysj.106.086264; Waldron TT, 2005, J MOL BIOL, V346, P895, DOI 10.1016/j.jmb.2004.12.018; Yang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6773; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhang YJ, 2010, ANNU REV PHYS CHEM, V61, P63, DOI 10.1146/annurev.physchem.59.032607.093635	59	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133550	10.1371/journal.pone.0133550	http://dx.doi.org/10.1371/journal.pone.0133550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197394	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600113
J	Takami, H; Arai, W; Takemoto, K; Uchiyama, I; Taniguchi, T				Takami, Hideto; Arai, Wataru; Takemoto, Kazuhiro; Uchiyama, Ikuo; Taniguchi, Takeaki			Functional Classification of Uncultured "Candidatus Caldiarchaeum subterraneum" Using the Maple System	PLOS ONE			English	Article							ATP-DEPENDENT 6-PHOSPHOFRUCTOKINASE; CITRATE CLEAVAGE REACTION; NON-ALLOSTERIC ENZYME; SINGLE-CELL GENOMICS; SP. NOV.; NITROSOPUMILUS-MARITIMUS; GEN. NOV.; ARCHAEA; SEQUENCE; INSIGHTS	In this study, the metabolic and physiological potential evaluator system based on Kyoto Encyclopedia of Genes and Genomes (KEGG) functional modules was employed to establish a functional classification of archaeal species and to determine the comprehensive functions (functionome) of the previously uncultivated thermophile "Candidatus Caldiarchaeum subterraneum" (Ca. C. subterraneum). A phylogenetic analysis based on the concatenated sequences of proteins common among 142 archaea and 2 bacteria, and among 137 archaea and 13 unicellular eukaryotes suggested that Ca. C. subterraneum is closely related to thaumarchaeotic species. Consistent with the results of the phylogenetic analysis, clustering and principal component analyses based on the completion ratio patterns for all KEGG modules in 79 archaeal species suggested that the overall metabolic and physiological potential of Ca. C. subterraneum is similar to that of thaumarchaeotic species. However, Ca. C. subterraneum possessed almost no genes in the modules required for nitrification and the hydroxypropionate-hydroxybutyrate cycle for carbon fixation, unlike thaumarchaeotic species. However, it possessed all genes in the modules required for central carbohydrate metabolism, such as glycolysis, pyruvate oxidation, the tricarboxylic acid (TCA) cycle, and the glyoxylate cycle, as well as multiple sets of sugar and branched chain amino acid ABC transporters. These metabolic and physiological features appear to support the predominantly aerobic character of Ca. C. subterraneum, which lives in a subsurface thermophilic microbial mat community with a heterotrophic lifestyle.	[Takami, Hideto; Arai, Wataru] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokohama Inst, Microbial Genome Res Grp, Yokohama, Kanagawa, Japan; [Takemoto, Kazuhiro] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, Okazaki, Aichi, Japan; [Taniguchi, Takeaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Taniguchi, Takeaki] Mitsubishi Res Inst Inc MRI, Adv Sci & Innovat Grp, Tokyo, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyushu Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Institute of Technology	Takami, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokohama Inst, Microbial Genome Res Grp, Yokohama, Kanagawa, Japan.	takamih@jamstec.go.jp	Takami, Hideto/D-4200-2012; Takemoto, Kazuhiro/H-2915-2019	Takami, Hideto/0000-0003-3433-7018; Takemoto, Kazuhiro/0000-0002-6355-1366; Uchiyama, Ikuo/0000-0002-9197-5000	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26550053, 20310124]; National Institute for Basic Biology (NIBB); Mitsubishi Research Institute Inc.	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Basic Biology (NIBB)(National Institutes of Natural Sciences (NINS) - Japan); Mitsubishi Research Institute Inc.	This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to H.T. (Nos. 26550053 and 20310124). This research was also supported in part by the collaborative research programs of the National Institute for Basic Biology (NIBB). Computational resources were provided partly by the Data Integration and Analysis Facility of NIBB. Mitsubishi Research Institute Inc. provided support in the form of salaries for T.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author (T.T.) is articulated in the 'author contributions' section.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aoshima M, 2004, MOL MICROBIOL, V52, P763, DOI 10.1111/j.1365-2958.2004.04010.x; Aoshima M, 2004, MOL MICROBIOL, V52, P751, DOI 10.1111/j.1365-2958.2004.04009.x; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; BARTOLUCCI S, 1987, J BIOL CHEM, V262, P7725; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Blochl E, 1997, EXTREMOPHILES, V1, P14; Borrel G, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00453-13; Borrel G, 2012, J BACTERIOL, V194, P6944, DOI 10.1128/JB.01867-12; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Futterer O, 2004, P NATL ACAD SCI USA, V101, P9091, DOI 10.1073/pnas.0401356101; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hansen T, 2001, ARCH MICROBIOL, V177, P62, DOI 10.1007/s00203-001-0359-1; Hansen T, 2000, ARCH MICROBIOL, V173, P103, DOI 10.1007/s002039900114; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; Huber R, 1998, INT J SYST BACTERIOL, V48, P31, DOI 10.1099/00207713-48-1-31; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Kanao T, 2001, EUR J BIOCHEM, V268, P1670, DOI 10.1046/j.1432-1033.2001.02034.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KERSCHER L, 1981, EUR J BIOCHEM, V116, P587, DOI 10.1111/j.1432-1033.1981.tb05376.x; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Lindblad A, 1996, MOL MICROBIOL, V20, P559, DOI 10.1046/j.1365-2958.1996.5311054.x; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Nikitin Frederic, 2004, Genome Inform, V15, P266; Nishizawa M, 2013, GEOCHIM COSMOCHIM AC, V113, P152, DOI 10.1016/j.gca.2013.03.027; Nunoura T, 2005, ENVIRON MICROBIOL, V7, P1967, DOI 10.1111/j.1462-2920.2005.00881.x; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Otte J, 2015, APPL ENVIRON MICROB, V81, P1700, DOI 10.1128/AEM.03390-14; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perevalova AA, 2010, INT J SYST EVOL MICR, V60, P2082, DOI 10.1099/ijs.0.019042-0; Qin W, 2014, P NATL ACAD SCI USA, V111, P12504, DOI 10.1073/pnas.1324115111; R Core Team, 2021, R LANGUAGE ENV STAT; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Ronimus RS, 2001, EXTREMOPHILES, V5, P357, DOI 10.1007/s007920100215; Sako Y, 1996, INT J SYST BACTERIOL, V46, P1070, DOI 10.1099/00207713-46-4-1070; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Takai K, 2002, APPL ENVIRON MICROB, V68, P3046, DOI 10.1128/AEM.68.6.3046-3054.2002; Takami H, 2014, ENCY METAGENOMICS, P525, DOI DOI 10.1007/978-1-4899-7478-5; Takami H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-699; Takami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030559; Takemoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025874; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Xhang Q, 1996, J BIOCH, V120, P587; Xhen Yan, 2014, BIOCHIM BIOPHYS ACTA, V1844, P736, DOI [10.1016/j.bbapap.2014.01.015, DOI 10.1016/J.BBAPAP.2014.01.015]; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	65	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132994	10.1371/journal.pone.0132994	http://dx.doi.org/10.1371/journal.pone.0132994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196861	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600060
J	Therit, B; Cheung, JK; Rood, JI; Melville, SB				Therit, Blair; Cheung, Jackie K.; Rood, Julian I.; Melville, Stephen B.			NanR, a Transcriptional Regulator That Binds to the Promoters of Genes Involved in Sialic Acid Metabolism in the Anaerobic Pathogen Clostridium perfringens	PLOS ONE			English	Article							ALPHA-TOXIN; EXPRESSION; PROTEIN; VIRULENCE; CLONING; CPE; SPORULATION; CATABOLISM; SIALIDASES; SEQUENCE	Among many other virulence factors, Clostridium perfringens produces three sialidases NanH, NanI and NanJ. NanH lacks a secretion signal peptide and is predicted to be an intracellular enzyme, while NanI and NanJ are secreted. Previously, we had identified part of an operon encoding NanE (epimerase) and NanA (sialic acid lyase) enzymes. Further analysis of the entire operon suggests that it encodes a complete pathway for the transport and metabolism of sialic acid along with a putative transcriptional regulator, NanR. The addition of 30 mM N-acetyl neuraminic acid (Neu5Ac) to a semi-defined medium significantly enhanced the growth yield of strain 13, suggesting that Neu5Ac can be used as a nutrient. C. perfringens strain 13 lacks a nanH gene, but has NanI- and NanJ-encoding genes. Analysis of nanI, nanJ, and nanInanJ mutants constructed by homologous recombination revealed that the expression of the major sialidase, NanI, was induced by the addition of Neu5Ac to the medium, and that in separate experiments, the same was true of a nanI-gusA transcriptional fusion. For the nanI and nanJ genes, primer extension identified three and two putative transcription start sites, respectively. Gel mobility shift assays using purified NanR and DNA from the promoter regions of the nanI and nanE genes showed high affinity, specific binding by NanR. We propose that NanR is a global regulator of sialic acid-associated genes and that it responds, in a positive feedback loop, to the concentration of sialic acid in the cell.	[Therit, Blair; Melville, Stephen B.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Cheung, Jackie K.; Rood, Julian I.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Virginia Polytechnic Institute & State University; Monash University	Melville, SB (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	melville@vt.edu	Rood, Julian I/A-4858-2008; Melville, Steve/D-4763-2016	Rood, Julian I/0000-0003-2126-7209; Melville, Steve/0000-0002-0116-4280	NRICGP/NIFA/USDA [200002621, 2003-35201-13580, 2004-04069]; Australian National Health and Medical Research Council [GNT1065985]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109391] Funding Source: NIH RePORTER	NRICGP/NIFA/USDA; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants 200002621, 2003-35201-13580 and 2004-04069 from NRICGP/NIFA/USDA (http://www.csrees.usda.gov/index.html) awarded to SBM and Project Grant GNT1065985 from the Australian National Health and Medical Research Council (http://www.nhmrc.gov.au/) awarded to JIR.	Abe K, 2010, BIOSCI BIOTECH BIOCH, V74, P1564, DOI 10.1271/bbb.100135; Afzal M, 2015, APPL ENVIRON MICROB, V81, P3121, DOI 10.1128/AEM.00499-15; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Chiarezza M, 2009, INFECT IMMUN, V77, P4421, DOI 10.1128/IAI.00548-09; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; Fekete RA, 2003, BIOTECHNIQUES, V35, P90, DOI 10.2144/03351rr01; FRASER AG, 1978, J MED MICROBIOL, V11, P269, DOI 10.1099/00222615-11-3-269; GOLDNER SB, 1985, APPL ENVIRON MICROB, V50, P202, DOI 10.1128/AEM.50.2.202-206.1985; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Hartman AH, 2011, APPL ENVIRON MICROB, V77, P471, DOI 10.1128/AEM.01536-10; Hassan KA, 2015, RES MICROBIOL, V166, P255, DOI 10.1016/j.resmic.2014.10.003; Hiscox TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073525; Hiscox TJ, 2011, INFECT IMMUN, V79, P2145, DOI 10.1128/IAI.00060-11; Hwang J, 2013, P NATL ACAD SCI USA, V110, pE2829, DOI 10.1073/pnas.1302859110; Kalivoda KA, 2013, J BACTERIOL, V195, P4689, DOI 10.1128/JB.00692-13; Kim BS, 2011, J BIOL CHEM, V286, P40889, DOI 10.1074/jbc.M111.300988; Li JH, 2014, APPL ENVIRON MICROB, V80, P1701, DOI 10.1128/AEM.03440-13; MAHONY DE, 1977, INFECT IMMUN, V15, P19, DOI 10.1128/IAI.15.1.19-25.1977; MELVILLE SB, 1994, INFECT IMMUN, V62, P5550, DOI 10.1128/IAI.62.12.5550-5558.1994; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nees S, 1974, BEHRING I MITT, V55, P68; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Obana N, 2011, J BACTERIOL, V193, P4417, DOI 10.1128/JB.00262-11; Ohtani K, 2010, ANAEROBE, V16, P258, DOI 10.1016/j.anaerobe.2009.10.003; Ohtani K, 2009, J BACTERIOL, V191, P3919, DOI 10.1128/JB.01455-08; Olson ME, 2013, J BACTERIOL, V195, P1779, DOI 10.1128/JB.02294-12; ROGGENTIN P, 1995, BIOL CHEM H-S, V376, P569; Roggentin P, 1997, CLOSTRIDIA MOL BIOL, P423; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SEBALD M, 1975, APPL MICROBIOL, V29, P1; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Traving C, 1997, GLYCOCONJUGATE J, V14, P821, DOI 10.1023/A:1018585920853; TRAVING C, 1994, GLYCOCONJUGATE J, V11, P141, DOI 10.1007/BF00731154; Varga J, 2004, J BACTERIOL, V186, P5221, DOI 10.1128/JB.186.16.5221-5229.2004; Vimr Eric R, 2013, ISRN Microbiol, V2013, P816713, DOI 10.1155/2013/816713; Walters DM, 1999, J BACTERIOL, V181, P4526, DOI 10.1128/JB.181.15.4526-4532.1999; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	43	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133217	10.1371/journal.pone.0133217	http://dx.doi.org/10.1371/journal.pone.0133217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197388	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600073
J	Yamazoe, K; Yoshida, S; Yasuda, M; Hatou, S; Inagaki, E; Ogawa, Y; Tsubota, K; Shimmura, S				Yamazoe, Katsuya; Yoshida, Satoru; Yasuda, Miyuki; Hatou, Shin; Inagaki, Emi; Ogawa, Yoko; Tsubota, Kazuo; Shimmura, Shigeto			Development of a Transgenic Mouse with R124H Human TGFBI Mutation Associated with Granular Corneal Dystrophy Type 2	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; JAPANESE PATIENTS; OXIDATIVE STRESS; GENE-MUTATIONS; BIGH3 GENE; PROTEIN; FIBROBLASTS; DEPOSITS	Purpose To investigate the phenotype and predisposing factors of a granular corneal dystrophy type 2 transgenic mouse model. Methods Human TGFBI cDNA with R124H mutation was used to make a transgenic mouse expressing human protein (TGFBI(R124H) mouse). Reverse transcription PCR (RT-PCR) was performed to analyze TGFBI(R124H) expression. A total of 226 mice including 23 homozygotes, 106 heterozygotes and 97 wild-type mice were examined for phenotype. Affected mice were also examined by histology, immunohistochemistry and electron microcopy. Results RT-PCR confirmed the expression of TGFBI(R124H) in transgenic mice. Corneal opacity defined as granular and lattice deposits was observed in 45.0% of homozygotes, 19.4% of heterozygotes. The incidence of corneal opacity was significantly higher in homozygotes than in heterozygotes (p = 0.02). Histology of affected mice was similar to histology of human disease. Lesions were Congo red and Masson Trichrome positive, and were observed as a deposit of amorphous material by electron microscopy. Subepithelial stroma was also stained with thioflavin T and LC3, a marker of autophagy activation. The incidence of corneal opacity was higher in aged mice in each group. Homozygotes were not necessarily more severe than heterozygotes, which deffers from human cases. Conclusions We established a granular corneal dystrophy type 2 mouse model caused by R124H mutation of human TGFBI. Although the phenotype of this mouse model is not equivalent to that in humans, further studies using this model may help elucidate the pathophysiology of this disease.	[Yamazoe, Katsuya; Yoshida, Satoru; Yasuda, Miyuki; Hatou, Shin; Inagaki, Emi; Ogawa, Yoko; Tsubota, Kazuo; Shimmura, Shigeto] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Keio University	Shimmura, S (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	shige@z8.keio.jp	Inagaki, Emi/GXG-8422-2022	Hatou, Shin/0000-0001-9273-5909	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the project for realization of regenerative medicine and support for the core institutes for iPS cell research from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Abazi Z, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-30; Awwad ST, 2008, AM J OPHTHALMOL, V145, P656, DOI 10.1016/j.ajo.2007.12.008; Basaiawmoit RV, 2011, J MOL BIOL, V408, P503, DOI 10.1016/j.jmb.2011.02.052; Cao WP, 2009, MOL VIS, V15, P70; Choi SI, 2012, AUTOPHAGY, V8, P1782, DOI 10.4161/auto.22067; Choi SI, 2011, J PINEAL RES, V51, P94, DOI 10.1111/j.1600-079X.2011.00866.x; Choi SI, 2011, INVEST OPHTH VIS SCI, V52, P3293, DOI 10.1167/iovs.10-6405; Choi SI, 2009, AM J PATHOL, V175, P248, DOI 10.2353/ajpath.2009.081001; de Sousa L, 2011, CORNEA, V3rd, P826; FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; Fujiki K, 2001, J HUM GENET, V46, P431, DOI 10.1007/s100380170041; Grothe HL, 2013, MOL VIS, V19, P593; Han KE, 2012, MOL VIS, V18, P1755; HOLLAND EJ, 1992, OPHTHALMOLOGY, V99, P1564; Jun RM, 2004, OPHTHALMOLOGY, V111, P463, DOI 10.1016/j.ophtha.2003.06.026; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Kato Y, 2013, J BIOL CHEM, V288, P25109, DOI 10.1074/jbc.M113.477695; Kim TI, 2011, AM J PATHOL, V179, P684, DOI 10.1016/j.ajpath.2011.04.005; Konishi M, 1999, CORNEA, V18, P424, DOI 10.1097/00003226-199907000-00006; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Mashima Y, 1998, BRIT J OPHTHALMOL, V82, P1280, DOI 10.1136/bjo.82.11.1280; Mashima Y, 2000, AM J OPHTHALMOL, V130, P516, DOI 10.1016/S0002-9394(00)00571-7; Okada M, 1998, INVEST OPHTH VIS SCI, V39, P1947; Wan XH, 2002, CORNEA, V21, P223, DOI 10.1097/00003226-200203000-00021; Yamamoto S, 2000, CORNEA, V19, pS21, DOI 10.1097/00003226-200005001-00005; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648	26	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133397	10.1371/journal.pone.0133397	http://dx.doi.org/10.1371/journal.pone.0133397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197481	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600094
J	Zhang, F; Kwan, A; Xu, A; Suel, GM				Zhang, Fang; Kwan, Anna; Xu, Amy; Sueel, Guerol M.			A Synthetic Quorum Sensing System Reveals a Potential Private Benefit for Public Good Production in a Biofilm	PLOS ONE			English	Article							BACILLUS-SUBTILIS BIOFILMS; VIBRIO-CHOLERAE; PSEUDOMONAS-AERUGINOSA; TRANSCRIPTOME ANALYSIS; STAPHYLOCOCCUS-AUREUS; MATRIX; COOPERATION; GENES; PEPTIDE; MULTICELLULARITY	Bacteria predominantly reside in microbial communities known as biofilms, where cells are encapsulated and protected by the extracellular matrix (ECM). While all biofilm cells benefit from the ECM, only a subgroup of cells carries the burden of producing this public good. This dilemma provokes the question of how these cells balance the cost of ECM production. Here we show that ECM producing cells have a higher gene expression response to quorum sensing (QS) signals, which can lead to a private benefit. Specifically, we constructed a synthetic quorum-sensing system with designated "Sender" and "Receiver" cells in Bacillus subtilis. This synthetic QS system allowed us to uncouple and independently investigate ECM production and QS in both biofilms and single cells. Results revealed that ECM production directly enhances the response to QS signals, which may offset the cost of ECM production.	[Zhang, Fang; Kwan, Anna; Xu, Amy; Sueel, Guerol M.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, San Diego, CA 92103 USA; [Zhang, Fang] Univ Texas Dallas, SW Med Ctr, Dallas, TX 75230 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Suel, GM (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, San Diego, CA 92103 USA.	gsuel@ucsd.edu			National Institutes of Health, National Institute of General Medical Sciences Grant [R01 GM088428]; National Science Foundation Grant [MCB-1450867]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088428] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health, National Institute of General Medical Sciences Grant R01 GM088428 (http://www.nigms.nih.gov) and the National Science Foundation Grant MCB-1450867 (http://www.nsf.gov), both to GMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borenstein DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063304; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brockhurst MA, 2007, CURR BIOL, V17, P761, DOI 10.1016/j.cub.2007.02.057; Comella N, 2005, MOL MICROBIOL, V57, P1159, DOI 10.1111/j.1365-2958.2005.04749.x; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Drescher K, 2014, CURR BIOL, V24, P50, DOI 10.1016/j.cub.2013.10.030; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hammer BK, 2009, J BACTERIOL, V191, P169, DOI 10.1128/JB.01307-08; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Irnov I, 2010, MOL MICROBIOL, V76, P559, DOI 10.1111/j.1365-2958.2010.07131.x; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Lopez D, 2009, GENE DEV, V23, P1631, DOI 10.1101/gad.1813709; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; Middleton R, 2004, PLASMID, V51, P238, DOI 10.1016/j.plasmid.2004.01.006; Nadell CD, 2011, P NATL ACAD SCI USA, V108, P14181, DOI 10.1073/pnas.1111147108; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Otto M, 1998, FEBS LETT, V424, P89, DOI 10.1016/S0014-5793(98)00145-8; Pottathil M, 2003, FRONT BIOSCI-LANDMRK, V8, pD32, DOI 10.2741/913; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Romero D, 2014, J BACTERIOL, V196, P1505, DOI 10.1128/JB.01363-13; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Schluter J, 2015, ISME J, V9, P139, DOI 10.1038/ismej.2014.174; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108; Seviour T, 2015, J BIOL CHEM, V290, P6457, DOI 10.1074/jbc.M114.613810; Shank EA, 2011, CURR OPIN MICROBIOL, V14, P741, DOI 10.1016/j.mib.2011.09.016; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; van Gestel J, 2014, ISME J, V8, P2069, DOI 10.1038/ismej.2014.52; Vivant AL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00160; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Zhang LS, 2002, J BIOL CHEM, V277, P34736, DOI 10.1074/jbc.M205367200; Zhao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101887	45	17	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132948	10.1371/journal.pone.0132948	http://dx.doi.org/10.1371/journal.pone.0132948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196509	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600058
J	Zhang, Y; Li, JY; Wang, CS; Zhang, L				Zhang, Yuan; Li, Jingyun; Wang, Chengshuo; Zhang, Luo			Association between the Interaction of Key Genes Involved in Effector T-Cell Pathways and Susceptibility to Developallergic Rhinitis: A Population-Based Case-Control Association Study	PLOS ONE			English	Article							ALLERGIC RHINITIS; ARIA 2008; ASTHMA; POLYMORPHISMS; PREVALENCE; MECHANISMS; CYTOKINES; GENETICS; CHILDREN; DISEASES	Background Evidence suggests that interaction between key genes mediating signaling and transcriptional networks involving effector T-cell responses may influence an individual's susceptibility to develop allergic rhinitis(AR). Objective The aim of this study was to determine whether specific interactions between key genes involved in effector T-cell pathways are associated with an individual's susceptibility to develop AR in Han Chinese subjects. Method A cohort of 489 patients with AR and 421 healthy controls was enrolled from the Han Chinese population in Beijing, China. AR was established by questionnaire and clinical examination, and peripheral blood was drawn from all subjects for DNA extraction. A total of 96 single nucleotide polymorphisms (SNPs) in 26 reprehensive candidate genes involved in T helper 1 (Th1), Th2, Th17, Th9 and T regulatory cell pathways were selected from the International Haplotype Mappingdatabase for Han Chinese in Beijing (CHB) population, and Illumina Golden Gate assay was conducted for SNP genotyping. The PLINK software package was used to perform statistical analyses. Results Simple SNP-phenotype association analysis using logistic regression showed SNP rs8193036 in IL17A gene, rs2569254 in IL-12 and rs1898413 in ROR alpha were significantly associated with AR. Simple SNP-phenotype association analysis with genetic models demonstrated thatrs2569254 in IL-12, rs1031508 in STAT4, and rs3741809 in IL-26 were likely to be recessive, rs8193036 in IL17A allelic, rs897200 in STAT4 genotypic, and rs1898413 in ROR alpha dominant. Epistasis analyses exhibited that 83 SNPs in 23 genes were significantly interactive; of which 59 interactions/SNP pairs demonstrated OR values higher than 2 or lower than 0.5, and 12 interactions/SNP pairs OR values higher than 4 or lower than 0.25. STAT3, ROR alpha and IL-26, involved in Th17 pathway, were the most frequently interactive genes. Conclusion This study suggests that interactions between several SNPs in key genes involved in effector T-cell pathways are likely to influence an individual's susceptibility to develop AR.	[Zhang, Yuan; Wang, Chengshuo; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Zhang, Yuan; Li, Jingyun; Wang, Chengshuo; Zhang, Luo] Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing 100005, Peoples R China; [Zhang, Yuan; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Allergy, Beijing 100730, Peoples R China	Capital Medical University; Capital Medical University	Wang, CS (corresponding author), Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China.	wangcs830@126.com; dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	Program for Changjiang Scholars and Innovative Research Team [IRT13082]; National Science Fund for the Major International Joint Research Program [81420108009]; National Natural Science Foundation of China [30973282, 81100706, 81441031, 81400447]; Beijing Natural Science Foundation [7131006]; 12th five year science and technology support program [2014BAI07B04]; Ministry of Health Foundation [201202005]; Capital Health Research and Development of Special [2011-1017-06]; Special Fund of Sanitation Elite Reconstruction of Beijing [2009-2-007]; Beijing Health Bureau Program for high level talents [2011-3-043]	Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science Fund for the Major International Joint Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); 12th five year science and technology support program; Ministry of Health Foundation; Capital Health Research and Development of Special; Special Fund of Sanitation Elite Reconstruction of Beijing; Beijing Health Bureau Program for high level talents	This work was supported by the grants from the Program for Changjiang Scholars and Innovative Research Team (IRT13082), the National Science Fund for the Major International Joint Research Program (81420108009), National Natural Science Foundation of China (30973282, 81100706, 81441031 and 81400447), Beijing Natural Science Foundation (7131006), The 12th five year science and technology support program (2014BAI07B04), Ministry of Health Foundation (201202005), the Capital Health Research and Development of Special (2011-1017-06), the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007) and Beijing Health Bureau Program for high level talents (2011-3-043) to LZ, YZ and JYL.	Afzali B, 2010, CLIN EXP IMMUNOL, V159, P120, DOI 10.1111/j.1365-2249.2009.04038.x; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barnes KC, 2000, J ALLERGY CLIN IMMUN, V106, pS192; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chan IHS, 2006, J ALLERGY CLIN IMMUN, V117, P127, DOI 10.1016/j.jaci.2005.09.031; Chatila TA, 2008, J ALLERGY CLIN IMMUN, V121, P812, DOI 10.1016/j.jaci.2008.02.025; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kim SH, 2009, ALLERGY, V64, P1221, DOI 10.1111/j.1398-9995.2009.01989.x; Liu X, 2004, J ALLERGY CLIN IMMUN, V113, P489, DOI 10.1016/j.jaci.2003.12.037; Liu Y, 2014, CLIN EXP ALLERGY; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Melchiotti R, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-73; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullol J, 2008, J INVEST ALLERG CLIN, V18, P327; Orsmark-Pietras C, 2008, HUM MOL GENET, V17, P1673, DOI 10.1093/hmg/ddn058; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stelmaszczyk-Emmel A, 2013, ADV EXP MED BIOL, V788, P321, DOI 10.1007/978-94-007-6627-3_43; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wang JY, 2009, ALLERGY, V64, P1056, DOI 10.1111/j.1398-9995.2009.01950.x; Wang M, 2012, HUM IMMUNOL, V73, P647, DOI 10.1016/j.humimm.2012.03.010; Wisniewski JA, 2011, ALLERGY ASTHMA PROC, V32, P83, DOI 10.2500/aap.2011.32.3428; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306; Zhang Y, 2014, ALLERGY ASTHMA IMMUN, V6, P105, DOI 10.4168/aair.2014.6.2.105; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	35	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131248	10.1371/journal.pone.0131248	http://dx.doi.org/10.1371/journal.pone.0131248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196693	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600009
J	Alonso-Sardon, M; Chamorro, AJ; Hernandez-Garcia, I; Iglesias-de-Sena, H; Martin-Rodero, H; Herrera, C; Marcos, M; Miron-Canelo, JA				Alonso-Sardon, Montserrat; Chamorro, Antonio-J.; Hernandez-Garcia, Ignacio; Iglesias-de-Sena, Helena; Martin-Rodero, Helena; Herrera, Cristian; Marcos, Miguel; Antonio Miron-Canelo, Jose			Association between Occupational Exposure to Wood Dust and Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SINONASAL CANCER; LUNG-CANCER; NASAL CANCER; POOLED REANALYSIS; PARANASAL SINUSES; ORGANIC DUSTS; RISK-FACTORS; WOODWORKERS; ADENOCARCINOMA; WORKERS	Objective To perform a systematic review to analyze the association between occupational exposure to wood dust and cancer. Methods A systematic literature search of entries made in the MEDLINE-PubMed database between 1957 and 2013 was conducted to identify studies that had assessed the relationship between occupational exposure to wood dust and different types of cancer. A meta-analysis of selected case-control and cohort studies was subsequently performed. Results A total of 114 studies were identified and 70 were selected for review. Of these, 42 studies focused on the relationship between wood dust and nasal cancer (n = 22), lung cancer (n = 11), and other types of cancer (n = 9). Low-to-moderate quality evidence that wood dust acts as a carcinogen was obtained, and a stronger association between wood dust and nasal adenocarcinoma was observed. A lesser association between wood dust exposure and lung cancer was also observed. Several studies suggested that there is a relationship between wood dust and the onset of other cancers, although there was no evidence to establish an association. A meta-analysis that included four case-controls studies showed that workers exposed to wood dust exhibited higher rates of nasal adenocarcinoma than other workers (odds ratio = 10.28; 95% confidence interval: 5.92 and 17.85; P<0,0001), although a large degree of heterogeneity was found. Conclusions Low-to-moderate quality evidence supports a causal association between cancer and occupational exposure to wood dust, and this association was stronger for nasal adenocarcinoma than for lung cancer. There was no evidence of an association between wood dust exposure and the other cancers examined.	[Alonso-Sardon, Montserrat; Antonio Miron-Canelo, Jose] Univ Salamanca, Inst Biomed Res Salamanca, Dept Prevent Med & Publ Hlth, E-37008 Salamanca, Spain; [Chamorro, Antonio-J.; Marcos, Miguel] Univ Salamanca, Inst Biomed Res Salamanca, Dept Med, E-37008 Salamanca, Spain; [Hernandez-Garcia, Ignacio] Univ Hosp Infanta Leonor Virgen Torre, Dept Prevent Med, Madrid, Spain; [Iglesias-de-Sena, Helena] Univ Salamanca, Dept Prevent Med & Publ Hlth, E-37008 Salamanca, Spain; [Martin-Rodero, Helena] Univ Salamanca, Sch Med, Biomed Branch Lib, E-37008 Salamanca, Spain; [Herrera, Cristian] Univ Salamanca, Sch Med, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca; Hospital Universitario Infanta Leonor; University of Salamanca; University of Salamanca; University of Salamanca	Miron-Canelo, JA (corresponding author), Univ Salamanca, Inst Biomed Res Salamanca, Dept Prevent Med & Publ Hlth, E-37008 Salamanca, Spain.	miroxx@usal.es	Martín-Rodero, Helena/E-3365-2013; CANELO, JOSE-A. MIRON/AAC-8001-2020; Alonso-Sardon, Montserrat/E-2185-2018; Chamorro, Antonio-J/A-6257-2013; Marcos, Miguel/B-3550-2008	Martín-Rodero, Helena/0000-0002-6698-9240; Chamorro, Antonio-J/0000-0002-2345-2873; Marcos, Miguel/0000-0003-1269-4487; Herrera Flores, Cristian/0000-0002-9048-9609; Hernandez-Garcia, Ignacio/0000-0003-1334-6783; Alonso-Sardon, Montserrat/0000-0003-1829-5858	National School of Occupational Medicine, Institute of Health Carlos III, Ministry of Health, Social Services and Equality (Spain)	National School of Occupational Medicine, Institute of Health Carlos III, Ministry of Health, Social Services and Equality (Spain)	The National School of Occupational Medicine, Institute of Health Carlos III, Ministry of Health, Social Services and Equality (Spain) funded this review.	ACHESON ED, 1968, BRIT MED J, V2, P587, DOI 10.1136/bmj.2.5605.587; ANDERSEN HC, 1977, BRIT J IND MED, V34, P201; [Anonymous], 2008, REV MAN REVMAN COMP; Bahia SHA, 2005, ENVIRON RES, V99, P132, DOI 10.1016/j.envres.2004.12.005; Barcenas CH, 2005, AM J IND MED, V47, P349, DOI 10.1002/ajim.20137; BATTISTA G, 1983, SCAND J WORK ENV HEA, V9, P25, DOI 10.5271/sjweh.2446; Bhatti P, 2011, OCCUP ENVIRON MED, V68, P599, DOI 10.1136/oem.2010.060004; Blot WJ, 1997, J OCCUP ENVIRON MED, V39, P148, DOI 10.1097/00043764-199702000-00012; Bonzini M, 2013, RHINOLOGY, V51, P31, DOI [10.4193/Rhin11.228, 10.4193/Rhino11.228]; Briggs NC, 2003, AM J PUBLIC HEALTH, V93, P1748, DOI 10.2105/AJPH.93.10.1748; BRINTON LA, 1984, AM J EPIDEMIOL, V119, P896, DOI 10.1093/oxfordjournals.aje.a113812; Bussi M, 2002, ACTA OTO-LARYNGOL, V122, P197, DOI 10.1080/00016480252814225; CAROSSO A, 1987, BRIT J IND MED, V44, P53; CECCHI F, 1980, BRIT J IND MED, V37, P222; Celik A, 2006, ENVIRON MOL MUTAGEN, V47, P693, DOI 10.1002/em.20257; Centre for Evidence-based Medicine (CEBM), 2009, LEV EV MARCH 2009; Chamorro AJ, 2012, AUTOIMMUN REV, V11, P705, DOI 10.1016/j.autrev.2011.12.006; Chamorro AJ, 2012, ADDICT BIOL, V17, P505, DOI 10.1111/j.1369-1600.2012.00442.x; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Corbin M, 2011, AM J IND MED, V54, P89, DOI 10.1002/ajim.20906; d'Errico A, 2009, OCCUP ENVIRON MED, V66, P448, DOI 10.1136/oem.2008.041277; De Gabory L, 2009, Rev Laryngol Otol Rhinol (Bord), V130, P93; Dement J, 2003, J OCCUP ENVIRON MED, V45, P1059, DOI 10.1097/01.jom.0000085892.01486.6a; DEMERS PA, 1995, SCAND J WORK ENV HEA, V21, P179, DOI 10.5271/sjweh.26; DEMERS PA, 1995, AM J IND MED, V28, P151, DOI 10.1002/ajim.4700280202; Fincham SM, 2000, J OCCUP ENVIRON MED, V42, P318, DOI 10.1097/00043764-200003000-00013; Fontana L, 2008, Ann Otolaryngol Chir Cervicofac, V125, P65, DOI 10.1016/j.aorl.2007.10.003; Fritschi L, 2005, CANCER CAUSE CONTROL, V16, P599, DOI 10.1007/s10552-004-7845-0; Gomez ME, 2010, IND HEALTH, V48, P222, DOI 10.2486/indhealth.48.222; HAYES RB, 1986, AM J EPIDEMIOL, V124, P569, DOI 10.1093/oxfordjournals.aje.a114429; Hemelt M, 2004, J OCCUP ENVIRON MED, V46, P1033, DOI 10.1097/01.jom.0000141653.30337.82; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hildesheim A, 2001, CANCER EPIDEM BIOMAR, V10, P1145; Hinds W.C., 1988, APPL IND HYG, V3, P67, DOI [10.1080/08828032.1988.10389273, DOI 10.1080/08828032.1988.10389273]; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1995, WOOD DUST FORM; Innos K, 2000, AM J IND MED, V37, P501, DOI 10.1002/(SICI)1097-0274(200005)37:5&lt;501::AID-AJIM6&gt;3.0.CO;2-T; IRONSIDE P, 1975, CANCER, V36, P1115, DOI 10.1002/1097-0142(197509)36:3<1115::AID-CNCR2820360342>3.0.CO;2-V; Jansing Paul J, 2003, Int J Occup Med Environ Health, V16, P329; Jansson C, 2005, CANCER CAUSE CONTROL, V16, P755, DOI 10.1007/s10552-005-1723-2; Jayaprakash V, 2008, OCCUP ENVIRON MED, V65, P647, DOI 10.1136/oem.2007.036210; KAWACHI I, 1989, CANCER, V64, P2609, DOI 10.1002/1097-0142(19891215)64:12&lt;2609::AID-CNCR2820641234&gt;3.0.CO;2-E; Laakkonen A, 2006, OCCUP ENVIRON MED, V63, P726, DOI 10.1136/oem.2005.025825; Labreche F, 2013, AM J IND MED, V56, P1040, DOI 10.1002/ajim.22200; LECLERC A, 1994, AM J EPIDEMIOL, V140, P340, DOI 10.1093/oxfordjournals.aje.a117256; Lee WJ, 2003, INT J CANCER, V107, P134, DOI 10.1002/ijc.11351; Luce D, 2002, CANCER CAUSE CONTROL, V13, P147, DOI 10.1023/A:1014350004255; MACBETH R, 1965, J Laryngol Otol, V79, P592, DOI 10.1017/S0022215100064112; MAIER H, 1992, HNO, V40, P44; Matos EL, 2000, J OCCUP ENVIRON MED, V42, P653, DOI 10.1097/00043764-200006000-00017; Merletti F, 2006, INT J CANCER, V118, P721, DOI 10.1002/ijc.21388; NYLANDER LA, 1993, AM J IND MED, V24, P619, DOI 10.1002/ajim.4700240511; Paget-Bailly S, 2012, J OCCUP ENVIRON MED, V54, P71, DOI 10.1097/JOM.0b013e31823c1343; Pesch B, 2008, OCCUP ENVIRON MED, V65, P191, DOI 10.1136/oem.2007.033886; Pronk A, 2009, OCCUP ENVIRON MED, V66, P672, DOI 10.1136/oem.2008.043695; Pukkala E, 2009, ACTA ONCOL, V48, P646, DOI 10.1080/02841860902913546; Punal-Rioboo J, 2010, ACTA OTORRINOLAR ESP, V61, P375, DOI 10.1016/j.otorri.2009.03.009; Rake C, 2009, BRIT J CANCER, V100, P1175, DOI 10.1038/sj.bjc.6604879; ROUSH GC, 1980, AM J EPIDEMIOL, V111, P183, DOI 10.1093/oxfordjournals.aje.a112886; SCHEEPER B, 1995, ANN OCCUP HYG, V39, P141, DOI 10.1016/0003-4878(94)00105-A; Schunemann H, 2011, J EPIDEMIOL COMMUN H, V65, P392, DOI 10.1136/jech.2010.119933; Stellman SD, 1998, AM J IND MED, V34, P229, DOI 10.1002/(SICI)1097-0274(199809)34:3&lt;229::AID-AJIM4&gt;3.0.CO;2-Q; Szadkowska-Stanczyk I, 2001, AM J IND MED, V39, P547, DOI 10.1002/ajim.1053; t'Mannetje A, 1999, AM J IND MED, V36, P101; Teschke K, 1999, ANN OCCUP HYG, V43, P247, DOI 10.1016/S0003-4878(99)00028-9; Urrutia G, 2010, MED CLIN-BARCELONA, V135, P507, DOI 10.1016/j.medcli.2010.01.015; US Preventive Task Force, 1989, GUID CLIN PREV SERV; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; VAUGHAN TL, 1991, AM J EPIDEMIOL, V133, P560, DOI 10.1093/oxfordjournals.aje.a115927; WILLS JH, 1982, J OCCUP ENVIRON MED, V24, P526; WU XF, 1995, CANCER EPIDEM BIOMAR, V4, P583	70	21	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133024	10.1371/journal.pone.0133024	http://dx.doi.org/10.1371/journal.pone.0133024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191795	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400046
J	Van Den Berge, N; Vanhove, C; Descamps, B; Dauwe, I; van Mierlo, P; Vonck, K; Keereman, V; Raedt, R; Boon, P; Van Holen, R				Van Den Berge, Nathalie; Vanhove, Christian; Descamps, Benedicte; Dauwe, Ine; van Mierlo, Pieter; Vonck, Kristl; Keereman, Vincent; Raedt, Robrecht; Boon, Paul; Van Holen, Roel			Functional MRI during Hippocampal Deep Brain Stimulation in the Healthy Rat Brain	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; ELECTRICAL-STIMULATION; PERFORANT PATHWAY; PARKINSON-DISEASE; BOLD RESPONSE; FMRI; EPILEPSY; CORTEX; SAFETY; SEIZURES	Deep Brain Stimulation (DBS) is a promising treatment for neurological and psychiatric disorders. The mechanism of action and the effects of electrical fields administered to the brain by means of an electrode remain to be elucidated. The effects of DBS have been investigated primarily by electrophysiological and neurochemical studies, which lack the ability to investigate DBS-related responses on a whole-brain scale. Visualization of whole-brain effects of DBS requires functional imaging techniques such as functional Magnetic Resonance Imaging (fMRI), which reflects changes in blood oxygen level dependent (BOLD) responses throughout the entire brain volume. In order to visualize BOLD responses induced by DBS, we have developed an MRI-compatible electrode and an acquisition protocol to perform DBS during BOLD fMRI. In this study, we investigate whether DBS during fMRI is valuable to study local and whole-brain effects of hippocampal DBS and to investigate the changes induced by different stimulation intensities. Seven rats were stereotactically implanted with a custom-made MRI-compatible DBS-electrode in the right hippocampus. High frequency Poisson distributed stimulation was applied using a block-design paradigm. Data were processed by means of Independent Component Analysis. Clusters were considered significant when p-values were <0.05 after correction for multiple comparisons. Our data indicate that real-time hippocampal DBS evokes a bilateral BOLD response in hippocampal and other mesolimbic structures, depending on the applied stimulation intensity. We conclude that simultaneous DBS and fMRI can be used to detect local and whole-brain responses to circuit activation with different stimulation intensities, making this technique potentially powerful for exploration of cerebral changes in response to DBS for both preclinical and clinical DBS.	[Van Den Berge, Nathalie; Vanhove, Christian; Descamps, Benedicte; van Mierlo, Pieter; Keereman, Vincent; Van Holen, Roel] Univ Ghent, iMinds Med IT Dept, Med Image & Signal Proc Grp, B-9000 Ghent, Belgium; [Dauwe, Ine; Vonck, Kristl; Raedt, Robrecht; Boon, Paul] Ghent Univ Hosp, Lab Clin & Expt Neurophysiol Neurobiol & Neuropsy, Ghent, Belgium	Ghent University; IMEC; Ghent University; Ghent University Hospital	Van Den Berge, N (corresponding author), Univ Ghent, iMinds Med IT Dept, Med Image & Signal Proc Grp, B-9000 Ghent, Belgium.	Nathalie.VanDenBerge@UGent.be	Vanhove, Christian/I-2095-2019	Vanhove, Christian/0000-0002-3988-5980; Boon, Paul/0000-0002-4180-8896; Van Den Berge, Nathalie/0000-0001-9384-1279; vonck, kristl/0000-0002-2671-2650; van Mierlo, Pieter/0000-0003-1650-5401; Keereman, Vincent/0000-0001-5833-5960; Raedt, Robrecht/0000-0002-8939-0169	iMinds; Research Foundation - Flanders, Belgium (FWO); GROUP-ID consortium of Ghent University; FWO; Special Research Fund from Ghent University; Ghent University Hospital; Ghent University	iMinds; Research Foundation - Flanders, Belgium (FWO)(FWO); GROUP-ID consortium of Ghent University; FWO(FWO); Special Research Fund from Ghent University; Ghent University Hospital(Ghent University); Ghent University(Ghent University)	This work is funded by iMinds and Ghent University. RVH is supported by the Research Foundation - Flanders, Belgium (FWO). CV is supported by the GROUP-ID consortium of Ghent University. PB is supported by grants from FWO, grants from the Special Research Fund from Ghent University, and by the Clinical Epilepsy Grant from Ghent University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FWO: http://www.fwo.be/en/, Special Research Fund: https://www.ugent.be/nl/onderzoek/financiering/bof	Akman T, 2011, TURK NEUROSURG, V21, P1; Alvarez-Salvado E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0152; Angenstein F, 2013, NEUROIMAGE, V75, P213, DOI 10.1016/j.neuroimage.2013.03.007; Baker KB, 2005, J MAGN RESON IMAGING, V21, P72, DOI 10.1002/jmri.20224; Becerra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025701; Boon P, 2007, EPILEPSIA, V48, P1551, DOI 10.1111/j.1528-1167.2007.01005.x; Boon P, 2009, NEUROTHERAPEUTICS, V6, P218, DOI 10.1016/j.nurt.2008.12.003; Bozzi Y, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00045; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; BUCHHALTER JR, 1990, DEV BRAIN RES, V56, P211, DOI 10.1016/0165-3806(90)90084-C; Bunzeck N, 2012, HUM BRAIN MAPP, V33, P1309, DOI 10.1002/hbm.21288; Canals S, 2008, MAGN RESON IMAGING, V26, P978, DOI 10.1016/j.mri.2008.02.018; Canals S, 2009, CURR BIOL, V19, P398, DOI 10.1016/j.cub.2009.01.037; Carmichael DW, 2007, NEUROIMAGE, V37, P508, DOI 10.1016/j.neuroimage.2007.04.058; Ceballos-Baumann AO, 1999, ARCH NEUROL-CHICAGO, V56, P997, DOI 10.1001/archneur.56.8.997; Chao THH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097305; Cuellar-Herrera M, 2006, EPILEPSY RES, V72, P10, DOI 10.1016/j.eplepsyres.2006.07.002; Cukiert A, 2014, SEIZURE-EUR J EPILEP, V23, P6, DOI 10.1016/j.seizure.2013.08.005; Finelli DA, 2002, AM J NEURORADIOL, V23, P1795; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2014, NAT REV NEUROL, V10, P261, DOI 10.1038/nrneurol.2014.59; Georgi JC, 2004, MAGNET RESON MED, V51, P380, DOI 10.1002/mrm.10699; Goodman JH, 2005, EPILEPSIA, V46, P1, DOI 10.1111/j.0013-9580.2005.03804.x; Haslinger B, 2003, NEUROIMAGE, V18, P517, DOI 10.1016/S1053-8119(02)00043-5; Helbing C, 2013, NEUROIMAGE, V64, P43, DOI 10.1016/j.neuroimage.2012.09.001; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jech R, 2003, MOVEMENT DISORD, V18, P461, DOI 10.1002/mds.10366; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Klein J, 2011, J PSYCHIATR RES, V45, P927, DOI 10.1016/j.jpsychires.2010.12.008; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krautwald K, 2013, NEUROIMAGE, V77, P14, DOI 10.1016/j.neuroimage.2013.03.046; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lai HY, 2014, NEUROIMAGE, V84, P11, DOI 10.1016/j.neuroimage.2013.08.026; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; LIEB JP, 1991, EPILEPSIA, V32, P822, DOI 10.1111/j.1528-1157.1991.tb05539.x; Liu H, P SPIE, V4319; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Velasco AL, 2007, EPILEPSIA, V48, P1895, DOI 10.1111/j.1528-1167.2007.01181.x; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; McKeown MJ, 2003, CURR OPIN NEUROBIOL, V13, P620, DOI 10.1016/j.conb.2003.09.012; Min HK, 2012, NEUROIMAGE, V63, P1408, DOI 10.1016/j.neuroimage.2012.08.006; Morrell M, 2006, CURR OPIN NEUROL, V19, P164, DOI 10.1097/01.wco.0000218233.60217.84; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078; Osorio I, 2005, ANN NEUROL, V57, P258, DOI 10.1002/ana.20377; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Paxinos G., 2007, RAT BRAIN STEREOTACT; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Quigley MA, 2002, AM J NEURORADIOL, V23, P49; Rezai AR, 2004, INVEST RADIOL, V39, P300, DOI 10.1097/01.rli.0000124940.02340.ab; Shyu BC, 2004, MAGN RESON MED, V52, P47, DOI 10.1002/mrm.20111; Simeral JD, 1999, C P ISMRM, P1716; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Starr M.S., 1993, D1 D2 DOPAMINE RECEP, P235; Starr MS, 1996, SYNAPSE, V22, P159, DOI 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C; Stefurak T, 2003, MOVEMENT DISORD, V18, P1508, DOI 10.1002/mds.10593; Tagliati M, 2009, NEUROIMAGE, V47, pT53, DOI 10.1016/j.neuroimage.2009.04.044; Tanabe J, 2002, NEUROIMAGE, V15, P902, DOI 10.1006/nimg.2002.1053; Theodore WH, 2007, ACTA NEUROCHIR SUPPL, V97, P261; Van Den Berge N, 2015, MOL IMAGING BIOL, V17, P373, DOI 10.1007/s11307-014-0801-9; Van Nieuwenhuyse B, 2015, BRAIN STIMUL, V8, P192, DOI 10.1016/j.brs.2014.11.016; Velasco F, 2001, STEREOT FUNCT NEUROS, V77, P223, DOI 10.1159/000064610; Vonck K, 2002, ANN NEUROL, V52, P556, DOI 10.1002/ana.10323; Vonck K, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065712500347; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; White AM, 2006, J NEUROSCI METH, V152, P255, DOI 10.1016/j.jneumeth.2005.09.014; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Wyckhuys T, 2007, EPILEPSIA, V48, P1543, DOI 10.1111/j.1528-1167.2007.01038.x; Wyckhuys T, 2010, EPILEPSIA, V51, P2297, DOI 10.1111/j.1528-1167.2010.02750.x; Wyckhuys T, 2010, NEUROIMAGE, V52, P55, DOI 10.1016/j.neuroimage.2010.04.017; Yang PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066821; Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089; Younce JR, 2014, JOVE-J VIS EXP, DOI 10.3791/51271; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zrinzo L, 2011, WORLD NEUROSURG, V76, P164, DOI 10.1016/j.wneu.2011.02.029	75	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133245	10.1371/journal.pone.0133245	http://dx.doi.org/10.1371/journal.pone.0133245			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193653	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400068
J	Doria, MS; de Sousa, AO; Barbosa, CD; Costa, MGC; Gesteira, AD; Souza, RM; Freitas, ACO; Pirovani, CP				Doria, Milena Santos; de Sousa, Aurizangela Oliveira; Barbosa, Cristiane de Jesus; Cardoso Costa, Marcio Gilberto; Gesteira, Abelmon da Silva; Souza, Regina Martins; Oliveira Freitas, Ana Camila; Pirovani, Carlos Priminho			Citrus tristeza virus (CTV) Causing Proteomic and Enzymatic Changes in Sweet Orange Variety "Westin"	PLOS ONE			English	Article							SUPEROXIDE DISMUTASES; PLANT CHITINASES; OXIDATIVE STRESS; MOSAIC-VIRUS; INFECTION; PROTEINS; WATER; SUPPRESSION; METABOLISM; EXPRESSION	Citrus Tristeza disease, caused by CTV (Citrus tristeza virus), committs citrus plantations around the world and specifically attacks phloem tissues of the plant. The virus exists as a mixture of more or less severe variants, which may or may not cause symptoms of Tristeza. The objective of this study was to analyze the changes caused by CTV in the proteome of stems of sweet orange, as well as in the activity and gene expression of antioxidant enzymes. The CTV-infected sweet orange displayed mild symptoms, which were characterized by the presence of sparse stem pitting throughout their stems. The presence of virus was confirmed by RT-PCR. Proteomic analysis by 2DE-PAGE-MS / MS revealed the identity of 40 proteins differentially expressed between CTV-infected and -non-infected samples. Of these, 33 were up-regulated and 7 were down-regulated in CTV-infected samples. Among the proteins identified stands out a specific from the virus, the coat protein. Other proteins identified are involved with oxidative stress and for this their enzymatic activity was measured. The activity of superoxide dismutase (SOD) was higher in CTV-infected samples, as catalase (CAT) showed higher activity in uninfected samples. The activity of guaiacol peroxidase (GPX) did not vary significantly between samples. However, ascorbate peroxidase (APX) was more active in the infected samples. The relative expression of the genes encoding CAT, SOD, APX and GPX was analyzed by quantitative real time PCR (RT-qPCR). The CTV-infected samples showed greater accumulation of transcripts, except for the CAT gene. This gene showed higher expression in the uninfected samples. Taken together, it can be concluded that the CTV affects the protein profile and activity and gene expression of antioxidant enzymes in plants infected by this virus.	[Doria, Milena Santos; de Sousa, Aurizangela Oliveira; Cardoso Costa, Marcio Gilberto; Souza, Regina Martins; Oliveira Freitas, Ana Camila; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Ctr Biotechnol & Genet, BR-45662000 Ilheus, BA, Brazil; [Barbosa, Cristiane de Jesus; Gesteira, Abelmon da Silva] Embrapa Mandioca & Fruticultura, BR-44380000 Cruz Das Almas, BA, Brazil	Universidade Estadual de Santa Cruz; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Pirovani, CP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotechnol & Genet, Rodovia Ilheus Itabuna,Km 16, BR-45662000 Ilheus, BA, Brazil.	pirovani@uesc.br	Costa, Marcio/AAG-3285-2020; Pirovani, Carlos P/J-3426-2017; Pirovani, Carlos Priminho/N-1153-2019; da Silva Gesteira, Abelmon/I-2136-2013	Costa, Marcio/0000-0002-4358-5489; Pirovani, Carlos P/0000-0002-6176-4069; Pirovani, Carlos Priminho/0000-0002-6176-4069; da Silva Gesteira, Abelmon/0000-0002-7590-0455	Coordenacao de perfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305309/2012-9]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); Programa de Pos-graduacao em Biologia e Biotecnologia de Micro-organismos; CNPq (PRONEM) [PNE0005/2011]	Coordenacao de perfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Programa de Pos-graduacao em Biologia e Biotecnologia de Micro-organismos; CNPq (PRONEM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	MSD was supported by the Coordenacao de perfeicoamento de Pessoal de Nivel Superior (CAPES). CPP was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(http://www.cnpq.br, Process number 305309/2012-9). The authors thank Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) and Programa de Pos-graduacao em Biologia e Biotecnologia de Micro-organismos (http;//http://www.fapesb.ba.gov.br/) and the and CNPq (PRONEM, Process number PNE0005/2011) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiach-Marti MR, 2000, J VIROL, V74, P6856, DOI 10.1128/JVI.74.15.6856-6865.2000; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177; BARJOSEPH M, 1989, ANNU REV PHYTOPATHOL, V27, P291, DOI 10.1146/annurev.py.27.090189.001451; Bordignon Rita, 2003, Bragantia, V62, P345, DOI 10.1590/S0006-87052003000300002; Bulbovas Patricia, 2005, Braz. J. Bot., V28, P687, DOI 10.1590/S0100-84042005000400004; BUTTNER M, 1992, P NATL ACAD SCI USA, V89, P8135, DOI 10.1073/pnas.89.17.8135; Cantu MD, 2008, PHYTOPATHOLOGY, V98, P1084, DOI 10.1094/PHYTO-98-10-1084; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; CordobaPedregosa MD, 1996, PLANT PHYSIOL, V112, P1119, DOI 10.1104/pp.112.3.1119; de Oliveira GAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045620; Di Carli M, 2010, J PROTEOME RES, V9, P5684, DOI 10.1021/pr100487x; Feichtenberger E, 1997, MANUAL FITOPATOLOGIA, V2, P706; Garavaglia Betiana S, 2010, Commun Integr Biol, V3, P382; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Giribaldi M, 2011, J PROTEOMICS, V75, P306, DOI 10.1016/j.jprot.2011.08.006; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Elvira MI, 2008, J EXP BOT, V59, P1253, DOI 10.1093/jxb/ern032; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kerbauy GB., 2004, FISIOLOGIA VEGETAL; KHAN AA, 1994, FOOD CHEM, V49, P407, DOI 10.1016/0308-8146(94)90013-2; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Liu XY, 2014, BIOTECHNOL BIOTEC EQ, V28, P408, DOI 10.1080/13102818.2014.925317; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meissner Filho Paulo E., 2002, Fitopatologia Brasileira, V27, P312, DOI 10.1590/S0100-41582002000300014; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI 10.1111/J.1364-3703.2007.00455.X; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NWUGO CC, 2013, PLANT BIOLOGY, V13, P1; Nwugo CC, 2011, J PROTEOME RES, V10, P518, DOI 10.1021/pr100716h; Tanaka Francisco André Ossamu, 2009, Summa phytopathol., V35, P316, DOI 10.1590/S0100-54052009000400010; Owens RA, 2001, MOL PLANT MICROBE IN, V14, P905, DOI 10.1094/MPMI.2001.14.7.905; Pineda M, 2010, PHOTOSYNTH RES, V103, P31, DOI 10.1007/s11120-009-9499-y; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; READ SM, 1983, EUR J BIOCHEM, V134, P561, DOI 10.1111/j.1432-1033.1983.tb07603.x; Rehem BC., 2011, ENVIRON EXP BOT, V56, P158, DOI DOI 10.1016/J.ENVEXPB0T.2005.01.012; Roy A, 2005, VIRUS RES, V113, P132, DOI 10.1016/j.virusres.2005.04.023; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh BK, 2010, SCI HORTIC-AMSTERDAM, V124, P9, DOI 10.1016/j.scienta.2009.12.011; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Wu LJ, 2013, J PROTEOMICS, V89, P124, DOI 10.1016/j.jprot.2013.06.005; Zhang Z, 2004, MOL PLANT PATHOL, V5, P537, DOI [10.1111/j.1364-3703.2004.00251.x, 10.1111/J.1364-3703.2004.00251.X]	50	17	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130950	10.1371/journal.pone.0130950	http://dx.doi.org/10.1371/journal.pone.0130950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207751	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000010
J	Murcio, R; Morphet, R; Gershenson, C; Batty, M				Murcio, Roberto; Morphet, Robin; Gershenson, Carlos; Batty, Michael			Urban Transfer Entropy across Scales	PLOS ONE			English	Article							LAND-USE	The morphology of urban agglomeration is studied here in the context of information exchange between different spatio-temporal scales. Urban migration to and from cities is characterised as non-random and following non-random pathways. Cities are multidimensional non-linear phenomena, so understanding the relationships and connectivity between scales is important in determining how the interplay of local/regional urban policies may affect the distribution of urban settlements. In order to quantify these relationships, we follow an information theoretic approach using the concept of Transfer Entropy. Our analysis is based on a stochastic urban fractal model, which mimics urban growing settlements and migration waves. The results indicate how different policies could affect urban morphology in terms of the information generated across geographical scales.	[Murcio, Roberto; Morphet, Robin; Batty, Michael] UCL, Ctr Adv Spatial Anal, London, England; [Gershenson, Carlos] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Mexico City 04510, DF, Mexico	University of London; University College London; Universidad Nacional Autonoma de Mexico	Murcio, R (corresponding author), UCL, Ctr Adv Spatial Anal, London, England.	r.murcio@ucl.ac.uk	Gershenson, Carlos/F-2241-2010; Batty, Michael/D-4422-2011	Gershenson, Carlos/0000-0003-0193-3067; Batty, Michael/0000-0002-9931-1305	European Research Council (ERC) MECHANICITY Project [249393 ERC-2009-AdG]; Consejo Nacional de Ciencia y Tecnologia, Mexico [56935, 47907]; Engineering and Physical Sciences Research Council [EP/G060983/1] Funding Source: researchfish; EPSRC [EP/G060983/1] Funding Source: UKRI	European Research Council (ERC) MECHANICITY Project(European Research Council (ERC)); Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	RM, MB and RMo were partially funded by the European Research Council (ERC) MECHANICITY Project (249393 ERC-2009-AdG); RM by the Sistema Nacional de Investigadores membership 56935 of the Consejo Nacional de Ciencia y Tecnologia, Mexico and CG by the Sistema Nacional de Investigadores membership 47907 of the Consejo Nacional de Ciencia y Tecnologia, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson C, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026204; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bak P., 1996, NATURE WORKS; Batty M, 2007, CITIES COMPLEXITY; Batty M, 2012, AGENT BASED MODELS G; Batty M., 2008, DYNAMICS COMPLEX URB, P1, DOI https://doi.org/10.1007/978-3-7908-1937-3_1; CHIU S, 1994, J INTELL FUZZY SYST, V2, P3; Evans A., 2012, AGENT BASED MODELS G; Fujita M, 2004, PAP REG SCI, V83, P139, DOI 10.1007/s10110-003-0180-0; Fujita M., 2002, EC AGGLOMERATION CIT; Hu JH, 2003, IEEE COMPUT GRAPH, V23, P62, DOI 10.1109/MCG.2003.1242383; Jin Y, 2013, ENVIRON PLANN B, V40, P1027, DOI 10.1068/b39134; Lee J, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-19; Makse HA, 1998, PHYS REV E, V58, P7054, DOI 10.1103/PhysRevE.58.7054; Masucci AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069469; Murcio R, 2011, UNIFYING THEMES COMP, VVIII, P630; Murcio R, 2013, CHAOS SOLITON FRACT, V48, P22, DOI 10.1016/j.chaos.2013.01.001; Schopf JW, 1991, MAJOR EVENTS HIST LI; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; VICSEK T, 1987, PHYS REV LETT, V58, P2818, DOI 10.1103/PhysRevLett.58.2818; Waddell P, 2011, TRANSPORT REV, V31, P209, DOI 10.1080/01441647.2010.525671; Wegener M., 2014, HDB REGIONAL SCI, P741, DOI DOI 10.1007/978-3-642-23430-9_41; WHITE R, 1993, ENVIRON PLANN A, V25, P1175, DOI 10.1068/a251175; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400	26	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133780	10.1371/journal.pone.0133780	http://dx.doi.org/10.1371/journal.pone.0133780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207628	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000139
J	Piersanti, S; Burla, R; Licursi, V; Brito, C; La Torre, M; Alves, PM; Simao, D; Mottini, C; Salinas, S; Negri, R; Tagliafico, E; Kremer, EJ; Saggio, I				Piersanti, Stefania; Burla, Romina; Licursi, Valerio; Brito, Catarina; La Torre, Mattia; Alves, Paula M.; Simao, Daniel; Mottini, Carla; Salinas, Sara; Negri, Rodolfo; Tagliafico, Enrico; Kremer, Eric J.; Saggio, Isabella			Transcriptional Response of Human Neurospheres to Helper-Dependent CAV-2 Vectors Involves the Modulation of DNA Damage Response, Microtubule and Centromere Gene Groups	PLOS ONE			English	Article							CANINE ADENOVIRUS TYPE-2; CELLULAR TRANSCRIPTION; RECEPTOR; COMPLEX; COXSACKIEVIRUS; INFECTION; THERAPY; NEURONS	Brain gene transfer using viral vectors will likely become a therapeutic option for several disorders. Helper-dependent (HD) canine adenovirus type 2 vectors (CAV-2) are well suited for this goal. These vectors are poorly immunogenic, efficiently transduce neurons, are retrogradely transported to afferent structures in the brain and lead to long-term transgene expression. CAV-2 vectors are being exploited to unravel behavior, cognition, neural networks, axonal transport and therapy for orphan diseases. With the goal of better understanding and characterizing HD-CAV-2 for brain therapy, we analyzed the transcriptomic modulation induced by HD-CAV-2 in human differentiated neurospheres derived from mid-brain progenitors. This 3D model system mimics several aspects of the dynamic nature of human brain. We found that differentiated neurospheres are readily transduced by HD-CAV- 2 and that transduction generates two main transcriptional responses: a DNA damage response and alteration of centromeric and microtubule probes. Future investigations on the biochemistry of processes highlighted by probe modulations will help defining the implication of HD-CAV-2 and CAR receptor binding in enchaining these functional pathways. We suggest here that the modulation of DNA damage genes is related to viral DNA, while the alteration of centromeric and microtubule probes is possibly enchained by the interaction of the HD-CAV-2 fibre with CAR.	[Piersanti, Stefania; Burla, Romina; Licursi, Valerio; La Torre, Mattia; Mottini, Carla; Negri, Rodolfo; Saggio, Isabella] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, I-00185 Rome, Italy; [Licursi, Valerio; Negri, Rodolfo; Saggio, Isabella] Cenci Bolognetti Fdn, Inst Pasteur, Rome, Italy; [Brito, Catarina; Alves, Paula M.; Simao, Daniel] Inst Biol Expt & Tecnol, P-2780901 Oeiras, Portugal; [Brito, Catarina; Alves, Paula M.; Simao, Daniel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Tagliafico, Enrico] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Salinas, Sara; Kremer, Eric J.] CNRS, Inst Genet Mol Montpellier, UMR 5535, Montpellier, France; [Salinas, Sara; Kremer, Eric J.] Univ Montpellier, F-34059 Montpellier, France; [Saggio, Isabella] CNR, Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Universidade Nova de Lisboa; Universita di Modena e Reggio Emilia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Saggio, I (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	isabella.saggio@uniroma1.it	Saggio, Isabella/H-2417-2015; Simão, Daniel/AAF-2747-2021; Tagliafico, Enrico/C-9079-2009; Salinas, Sara/O-1856-2013; Kremer, EJ/P-9838-2019; Alves, Paula M/C-1070-2008; La Torre, Mattia/AAR-2612-2021; Brito, Catarina/A-2389-2009; La Torre, Mattia/AHD-9999-2022; Salinas, Sara/O-1150-2019; Kremer, Eric J/D-3734-2013	Simão, Daniel/0000-0002-7532-8081; Tagliafico, Enrico/0000-0003-0981-2542; Salinas, Sara/0000-0003-4492-2093; Kremer, EJ/0000-0001-6114-7530; Alves, Paula M/0000-0003-1445-3556; Brito, Catarina/0000-0002-8926-279X; La Torre, Mattia/0000-0002-1178-6948; Salinas, Sara/0000-0003-4492-2093; Licursi, Valerio/0000-0002-8172-1437; saggio, isabella/0000-0002-9497-7415; Burla, Romina/0000-0002-5640-4464	EU [222992, 286071]; Fundacao para a Ciencia eTecnologia (FCT), Portugal [PTD/EBBBIO/119243/2010]; FCT, Portugal [SFRH/BD/78308/2011]	EU(European Commission); Fundacao para a Ciencia eTecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by EU FP7 grants BrainCAV (n. 222992) and BrainVectors (n. 286071) and by PTD/EBBBIO/119243/2010, funded by Fundacao para a Ciencia eTecnologia (FCT), Portugal. DS was the recipient of a PhD fellowship from FCT, Portugal (SFRH/BD/78308/2011).	Brito C, 2012, METHODS, V56, P452, DOI 10.1016/j.ymeth.2012.03.005; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Carson CT, 2009, EMBO J, V28, P652, DOI 10.1038/emboj.2009.15; Coelho PA, 2013, DEV CELL, V27, P586, DOI 10.1016/j.devcel.2013.09.029; Costantini LC, 2000, GENE THER, V7, P93, DOI 10.1038/sj.gt.3301119; Dermody TS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000481; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Fernandes P, 2013, GENE THER, V20, P353, DOI 10.1038/gt.2012.52; Fernandes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060342; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Fok PT, 2007, J BIOL CHEM, V282, P7512, DOI 10.1074/jbc.M607230200; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gudimchuk N, 2013, NAT CELL BIOL, V15, P1079, DOI 10.1038/ncb2831; Haberberger TC, 2000, GENE THER, V7, P903, DOI 10.1038/sj.gt.3301181; Ibanes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071032; Junyent F, 2015, CURRENT OPI IN PRESS; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Lowenstein PR, 2003, GENE THER, V10, P946, DOI 10.1038/sj.gt.3302048; Martina Y, 2007, VIRUS RES, V130, P71, DOI 10.1016/j.virusres.2007.05.019; McMenamin MM, 2010, GENE THER, V17, P448, DOI 10.1038/gt.2010.2; Milosevic J, 2007, STEM CELLS DEV, V16, P625, DOI 10.1089/scd.2006.0113; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; Mitchell R, 2003, MOL THER, V8, P674, DOI 10.1016/S1525-0016(03)00215-6; Patzke C, 2010, J NEUROSCI, V30, P2897, DOI 10.1523/JNEUROSCI.5725-09.2010; Piersanti Stefania, 2004, Am J Pharmacogenomics, V4, P345, DOI 10.2165/00129785-200404060-00002; Piersanti S, 2014, METHODS MOL BIOL, V1089, P89, DOI 10.1007/978-1-62703-679-5_7; Piersanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069808; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Salinas S, 2014, J BIOL CHEM, V289, P680, DOI 10.1074/jbc.M113.518365; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Simao D, 2014, TISSUE ENG A; Simao Daniel, 2011, BMC Proc, V5 Suppl 8, pP53, DOI 10.1186/1753-6561-5-S8-P53; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soudais C, 2003, FASEB J, V17, P391, DOI 10.1096/fj.03-0438fje; Stilwell JL, 2003, J VIROL, V77, P12881, DOI 10.1128/JVI.77.23.12881-12885.2003; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Warren JC, 2006, MOL BIOL CELL, V17, P3557, DOI 10.1091/mbc.E05-09-0850; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zhao HX, 2003, J VIROL, V77, P11006, DOI 10.1128/JVI.77.20.11006-11015.2003	46	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133607	10.1371/journal.pone.0133607	http://dx.doi.org/10.1371/journal.pone.0133607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207738	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000110
J	Sadot, E; Simpson, AL; Do, RKG; Gonen, M; Shia, J; Allen, PJ; D'Angelica, MI; DeMatteo, RP; Kingham, TP; Jarnagin, WR				Sadot, Eran; Simpson, Amber L.; Do, Richard K. G.; Gonen, Mithat; Shia, Jinru; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Kingham, T. Peter; Jarnagin, William R.			Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PRIMARY LIVER-CANCER; INTRAHEPATIC CHOLANGIOCARCINOMA; REGIONAL CHEMOTHERAPY; PROGNOSTIC-FACTOR; CD24 EXPRESSION; BREAST-CANCER; CARCINOMA; GENE; SURVIVAL	Purpose To investigate associations between imaging features of cholangiocarcinoma by visual assessment and texture analysis, which quantifies heterogeneity in tumor enhancement patterns, with molecular profiles based on hypoxia markers. Methods The institutional review board approved this HIPAA-compliant retrospective study of CT images of intrahepatic cholangiocarcinoma, obtained before surgery. Immunostaining for hypoxia markers (EGFR, VEGF, CD24, P53, MDM2, MRP-1, HIF-1 alpha, CA-IX, and GLUT1) was performed on pre-treatment liver biopsies. Quantitative imaging phenotypes were determined by texture analysis with gray level co-occurrence matrixes. The correlations between quantitative imaging phenotypes, qualitative imaging features (measured by radiographic inspection alone), and expression levels of the hypoxia markers from the 25 tumors were assessed. Results Twenty-five patients were included with a median age of 62 years (range: 54-84). The median tumor size was 10.2 cm (range: 4-14), 10 (40%) were single tumors, and 90% were moderately differentiated. Positive immunostaining was recorded for VEGF in 67% of the cases, EGFR in 75%, and CD24 in 55%. On multiple linear regression analysis, quantitative imaging phenotypes correlated significantly with EGFR and VEGF expression levels (R-2 = 0.4, p<0.05 and R-2 = 0.2, p<0.05, respectively), while a trend was demonstrated with CD24 expression (R-2 = 0.33, p = 0.1). Three qualitative imaging features correlated with VEGF and CD24 expression (P<0.05), however, none of the qualitative features correlated with the quantitative imaging phenotypes. Conclusion Quantitative imaging phenotypes, as defined by texture analysis, correlated with expression of specific markers of hypoxia, regardless of conventional imaging features.	[Sadot, Eran; Simpson, Amber L.; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Kingham, T. Peter; Jarnagin, William R.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Simpson, Amber L.; Do, Richard K. G.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Shia, Jinru] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jarnagin, WR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	jarnagiw@mskcc.org	Gonen, Mithat/E-4826-2012	Gonen, Mithat/0000-0001-8683-8477; Kingham, T Peter/0000-0002-3359-3186; Do, Richard/0000-0002-6554-0310; Shia, Jinru/0000-0002-4351-2511; Simpson, Amber/0000-0002-4387-8417	National Institutes of Health Cancer Center Support Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health Cancer Center Support Grant P30 CA008748 (MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, J GASTROINTEST SURG, V11, P445, DOI 10.1007/s11605-007-0091-5; Cleven AHG, 2007, CELL ONCOL, V29, P229; Cui CY, 2011, EUR RADIOL, V21, P2318, DOI 10.1007/s00330-011-2182-7; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Davenport MS, 2014, RADIOLOGY, V272, P132, DOI 10.1148/radiol.14131963; Di T, 2006, ONCOL REP, V15, P525; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Ding ZY, 2010, J CANCER RES CLIN, V136, P1697, DOI 10.1007/s00432-010-0828-5; Ganeshan B, 2013, CANCER IMAGING, V13, P140, DOI 10.1102/1470-7330.2013.0015; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gwak GY, 2005, J CANCER RES CLIN, V131, P649, DOI 10.1007/s00432-005-0016-1; Haralick, 1973, IEEE T SYST MAN CYB, V3, P610; Huang YL, 2006, ACAD RADIOL, V13, P713, DOI 10.1016/j.acra.2005.07.014; Ito Y, 2001, PATHOL RES PRACT, V197, P95, DOI 10.1078/0344-0338-00016; Jarnagin WR, 2009, ANN ONCOL, V20, P1589, DOI 10.1093/annonc/mdp029; Keeratichamroen S, 2011, INT J ONCOL, V39, P873, DOI 10.3892/ijo.2011.1088; Kemeny NE, 2011, ONCOLOGY-BASEL, V80, P153, DOI 10.1159/000324704; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Konstantinidis IT, 2014, ANN SURG ONCOL, V21, P2675, DOI 10.1245/s10434-014-3649-y; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Lee JH, 2012, J BIOL CHEM, V287, P20898, DOI 10.1074/jbc.M111.336875; Leone F, 2006, CLIN CANCER RES, V12, P1680, DOI 10.1158/1078-0432.CCR-05-1692; Marme D., 2008, TUMOR ANGIOGENESIS B; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mascaux C, 2011, CLIN CANCER RES, V17, P7796, DOI 10.1158/1078-0432.CCR-11-0209; National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines&REG;), 2014, NCCN CLIN PRACT GUID; Perez-Sayans M, 2013, J ORAL PATHOL MED, V42, P1, DOI 10.1111/j.1600-0714.2012.01144.x; Russ JC, 2011, IMAGE PROCESSING HDB, Vxviii; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Shia J, 2005, MODERN PATHOL, V18, P1350, DOI 10.1038/modpathol.3800417; Simpson AL, 2014, J AM COLL SURG; Simpson AL, 2014, J AM COLL SURGEONS, V219, P199, DOI 10.1016/j.jamcollsurg.2014.02.027; Skogen K, 2013, J NEURO-ONCOL, V111, P213, DOI 10.1007/s11060-012-1010-5; Su MC, 2006, CANCER LETT, V235, P34, DOI 10.1016/j.canlet.2005.03.059; Thelen A, 2010, AM J GASTROENTEROL, V105, P1123, DOI 10.1038/ajg.2009.674; Thomas S, 2012, CANCER RES, V72, P5600, DOI 10.1158/0008-5472.CAN-11-3666; Tortora G, 2008, NAT CLIN PRACT ONCOL, V5, P521, DOI 10.1038/ncponc1161; Yopp AC, 2011, ANN SURG ONCOL, V18, P2192, DOI 10.1245/s10434-011-1570-1; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Yousef GM., 2014, MOL TESTING CANC; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	41	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132953	10.1371/journal.pone.0132953	http://dx.doi.org/10.1371/journal.pone.0132953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207380	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000048
J	Assante, R; Zampella, E; Acampa, W; Nappi, C; Gaudieri, V; Frega, N; D'Arienzo, D; Tuccillo, M; Di Lorenzo, P; Buccelli, C; Petretta, M; Cuocolo, A				Assante, Roberta; Zampella, Emilia; Acampa, Wanda; Nappi, Carmela; Gaudieri, Valeria; Frega, Nicola; D'Arienzo, Davide; Tuccillo, Marianna; Di Lorenzo, Pierpaolo; Buccelli, Claudio; Petretta, Mario; Cuocolo, Alberto			Prevalence and Severity of Myocardial Perfusion Imaging Abnormalities in Inmate Subjects	PLOS ONE			English	Article							HEALTH-CARE; CARDIOVASCULAR RISK; HEART-DISEASE; PRISON; INCARCERATION; COMMUNITY; DIAGNOSIS; RELEASE	Aim We evaluated the prevalence and severity of myocardial perfusion abnormalities among inmates undergoing cardiac single-photon emission computed tomography. We also compared the results with those obtained in a cohort of non-inmates. Methods Between January 2009 and December 2013, 2420 consecutive subjects (258 inmates and 2162 non-inmates) with suspected or known coronary artery disease underwent stress myocardial perfusion single-photon emission computed tomography (MPS) to our institution. The decision to submit inmates to MPS was taken by the physicians of the penal institutions or ordered by the court based on the survey of part. To account for differences in clinical characteristics between inmates and non-inmates, we created a propensity score-matched cohort considering clinical variables and stress type. Results Before matching, inmates were younger and had higher prevalence of male gender, smoking, chest pain, and previous myocardial infarction or revascularization (all p < 0.001). After matching, all characteristics were comparable in 258 inmates and 258 non-inmates. The total amount of abnormal myocardium was similar in inmates and non-inmates before and after matching. Infarct size and severity were larger in inmates before (p < 0.001) and after (p < 0.01) matching and left ventricular ejection fraction was lower in inmates compared to non-inmates (p < 0.01). Conclusions Detention is associated with larger infarct size compared to a general population of subjects referred to stress MPS also after matching for clinical variables and stress type. The similar prevalence of normal MPS in the matched cohort suggests that this imaging technique might be appropriate in inmates.	[Assante, Roberta; Zampella, Emilia; Nappi, Carmela; Gaudieri, Valeria; Frega, Nicola; D'Arienzo, Davide; Tuccillo, Marianna; Di Lorenzo, Pierpaolo; Buccelli, Claudio; Cuocolo, Alberto] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Acampa, Wanda] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Petretta, Mario] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II	Cuocolo, A (corresponding author), Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy.	cuocolo@unina.it	Petretta, Mario/K-9892-2015; nappi, carmela/G-1620-2018; Cuocolo, Alberto/AAI-7148-2020	Petretta, Mario/0000-0002-8001-4298; Cuocolo, Alberto/0000-0003-3431-7658; DI LORENZO, Pierpaolo/0000-0002-8688-6257; Gaudieri, Valeria/0000-0002-0560-2997; NAPPI, CARMELA/0000-0001-9404-4677; BUCCELLI, Claudio/0000-0002-1070-7048; ACAMPA, Wanda/0000-0003-2187-4076				Acampa W, 2012, EUR J NUCL MED MOL I, V39, P387, DOI 10.1007/s00259-011-1983-x; Arries EJ, 2013, J FORENSIC NURS, V9, P52, DOI 10.1097/JFN.0b013e31827a59ef; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Ceelen M, 2012, J FORENSIC LEG MED, V19, P324, DOI 10.1016/j.jflm.2012.02.012; DIAMOND GA, 1983, J AM COLL CARDIOL, V1, P444, DOI 10.1016/S0735-1097(83)80072-2; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Germano G, 2000, J NUCL MED, V41, P712; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Hesse B, 2005, EUR J NUCL MED MOL I, V32, P855, DOI 10.1007/s00259-005-1779-y; Lee H, 2014, AM J PUBLIC HEALTH, V104, P421, DOI 10.2105/AJPH.2013.301504; Massoglia M, 2008, J HEALTH SOC BEHAV, V49, P56, DOI 10.1177/002214650804900105; Olubodun JOB, 1996, J HUM HYPERTENS, V10, P235; Patel K, 2014, HEALTH AFFAIR, V33, P468, DOI 10.1377/hlthaff.2013.1164; Rich JD, 2011, NEW ENGL J MED, V364, P2081, DOI 10.1056/NEJMp1102385; Richmond RL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-783; Ritter C, 2011, J PUBLIC HEALTH POL, V32, P32, DOI 10.1057/jphp.2010.47; Wang EA, 2013, JAMA INTERN MED, V173, P1621, DOI 10.1001/jamainternmed.2013.9008; Wang EA, 2009, ARCH INTERN MED, V169, P687, DOI 10.1001/archinternmed.2009.26; Wilper AP, 2011, AM J PUBLIC HEALTH, V99, P666; Winter SJ, 2011, J NATL MED ASSOC, V103, P109, DOI 10.1016/S0027-9684(15)30259-5	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133360	10.1371/journal.pone.0133360	http://dx.doi.org/10.1371/journal.pone.0133360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200782	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100061
J	Gan, JY; Sonntag, HJ; Tang, MK; Cai, DQ; Lee, KKH				Gan, Jingyi; Sonntag, Hans-Joachim; Tang, Mei Kuen; Cai, Dongqing; Lee, Kenneth Ka Ho			Integrative Analysis of the Developing Postnatal Mouse Heart Transcriptome	PLOS ONE			English	Article							CARDIAC STEM-CELLS; TERMINAL DIFFERENTIATION; CYCLE EXIT; CARDIOMYOCYTES; EXPRESSION; GATA4; FIBROBLASTS; WITHDRAWAL; MYOCYTES; MEF2C	In mammals, cardiomyocytes rapidly proliferate in the fetus and continue to do so for a few more days after birth. These cardiomyocytes then enter into growth arrest but the detailed molecular mechanisms involved have not been fully elucidated. We have addressed this issue by comparing the transcriptomes of 2-day-old (containing dividing cardiomyocytes) with 13-day-old (containing growth arrested cardiomyocytes) postnatal mouse hearts. We performed comparative microarray analysis on the heart tissues and then conducted Functional annotation, Gene ontology, KEGG pathway and Gene Set enrichment analyses on the differentially expressed genes. The bioinformatics analysis revealed that gene ontology categories associated with the "cell cycle", "DNA replication", "chromosome segregation" and "microtubule cytoskeleton" were down-regulated. Inversely, "immune response", "extracellular matrix", "cell differentiation" and "cell membrane" were up-regulated. Ingenuity Pathways Analysis (IPA) has revealed that GATA4, MYH7 and IGF1R were the key drivers of the gene interaction networks. In addition, Regulator Effects network analysis suggested that TASP1, TOB1, C1orf61, AIF1, ROCK1, TFF2 and miR503-5p may be acting on the cardiomyocytes in 13-day-old mouse hearts to inhibit cardiomyocyte proliferation and G1/S phase transition. RT-qPCR was used to validate genes which were differentially expressed and genes that play a prominent role in the pathways and interaction networks that we identified. In sum, our integrative analysis has provided more insights into the transcriptional regulation of cardiomyocyte exit from the cell cycle during postnatal heart development. The results also pinpoint potential regulators that could be used to induce growth arrested cardiomyocytes to proliferate in the infarcted heart.	[Gan, Jingyi; Tang, Mei Kuen; Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China; [Sonntag, Hans-Joachim] Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cai, Dongqing; Lee, Kenneth Ka Ho] Ji Nan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou 510632, Guangdong, Peoples R China	Chinese University of Hong Kong; University of Edinburgh; Jinan University	Lee, KKH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China.	kaholee@cuhk.edu.hk	Tang, Florence/AAW-4103-2021; Lee, Kenneth Ka Ho/H-6698-2013	Lee, Kenneth Ka Ho/0000-0002-6520-304X	 [CUHK469313]		This study was supported by General Research Fund (CUHK469313). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Burton PBJ, 1999, DEV BIOL, V216, P659, DOI 10.1006/dbio.1999.9524; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067896; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; D'Amario D, 2011, CIRC RES, V108, P1467, DOI 10.1161/CIRCRESAHA.111.240648; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Giudice J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4603; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gupta V, 2013, CURR BIOL, V23, P1221, DOI 10.1016/j.cub.2013.05.028; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067266; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kawaguchi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014297; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liu Y, 2007, PROTEOMICS, V7, P23, DOI 10.1002/pmic.200600456; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Marshall-Clarke S, 2000, IMMUNOL TODAY, V21, P35, DOI 10.1016/S0167-5699(99)01548-0; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; O'Meara CC, 2015, CIRC RES, V116, P804, DOI 10.1161/CIRCRESAHA.116.304269; Paradis AN, 2014, DRUG DISCOV TODAY, V19, P602, DOI 10.1016/j.drudis.2013.10.019; Parmacek MS, 2009, NEW ENGL J MED, V361, P86, DOI 10.1056/NEJMcibr0903347; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tane S, 2014, J BIOL CHEM, V289, P18033, DOI 10.1074/jbc.M113.541953; Tane S, 2014, BIOCHEM BIOPH RES CO, V443, P1105, DOI 10.1016/j.bbrc.2013.12.109; Tang MK, 2004, CELL TISSUE RES, V316, P339, DOI 10.1007/s00441-004-0881-y; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; Wang F, 2013, J MOL CELL CARDIOL, V62, P122, DOI 10.1016/j.yjmcc.2013.05.016; YOSHIZUMI M, 1995, J CLIN INVEST, V95, P2275, DOI 10.1172/JCI117918; Yu XY, 2009, MOL CELL BIOCHEM, V332, P25, DOI 10.1007/s11010-009-0170-x; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048028	40	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133288	10.1371/journal.pone.0133288	http://dx.doi.org/10.1371/journal.pone.0133288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200114	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100057
J	Potter, AW; Gonzalez, JA; Karis, AJ; Xu, XJ				Potter, Adam W.; Gonzalez, Julio A.; Karis, Anthony J.; Xu, Xiaojiang			Biophysical Assessment and Predicted Thermophysiologic Effects of Body Armor	PLOS ONE			English	Article							HEAT STRAIN; EXERCISE; PERFORMANCE; RESISTANCES; MECHANISMS; STRESS; HOT	Introduction Military personnel are often required to wear ballistic protection in order to defend against enemies. However, this added protection increases mass carried and imposes additional thermal burden on the individual. Body armor (BA) is known to reduce combat casualties, but the effects of BA mass and insulation on the physical performance of soldiers are less well documented. Until recently, the emphasis has been increasing personal protection, with little consideration of the adverse impacts on human performance. Objective The purpose of this work was to use sweating thermal manikin and mathematical modeling techniques to quantify the tradeoff between increased BA protection, the accompanying mass, and thermal effects on human performance. Methods Using a sweating thermal manikin, total insulation (I-T, clo) and vapor permeability indexes (i(m)) were measured for a baseline clothing ensemble with and without one of seven increasingly protective U.S. Army BA configurations. Using mathematical modeling, predictions were made of thermal impact on humans wearing each configuration while working in hot/dry (desert), hot/humid (jungle), and temperate environmental conditions. Results In nearly still air (0.4 m/s), IT ranged from 1.57 to 1.63 clo and i(m) from 0.35 to 0.42 for the seven BA conditions, compared to IT and i(m) values of 1.37 clo and 0.45 respectively, for the baseline condition (no BA). Conclusion Biophysical assessments and predictive modeling show a quantifiable relationship exists among increased protection and increased thermal burden and decreased work capacity. This approach enables quantitative analysis of the tradeoffs between ballistic protection, thermal-work strain, and physical work performance.	[Potter, Adam W.; Gonzalez, Julio A.; Karis, Anthony J.; Xu, Xiaojiang] US Army, Environm Med Res Inst, Biophys & Biomed Modeling Div, Natick, MA 01760 USA		Potter, AW (corresponding author), US Army, Environm Med Res Inst, Biophys & Biomed Modeling Div, Natick, MA 01760 USA.	adam.w.potter.civ@mail.mil	Potter, Adam/D-9893-2014	Potter, Adam/0000-0003-4980-8353				American Society of Testing and Materials International (ASTM), 2010, F237010 ASTM; American Society of Testing and Materials International (ASTM), 2010, F129110 ASTM; Buller MJ, 2008, T0901 US ARM NAT SOL; Cadarette BS, 2001, T019 US ARM NAT SOLD; Caldwell JN, 2011, MIL MED, V176, P488, DOI 10.7205/MILMED-D-10-00010; Cheuvront SN, 2010, J APPL PHYSIOL, V109, P1989, DOI 10.1152/japplphysiol.00367.2010; Dorman LE, 2009, EUR J APPL PHYSIOL, V105, P463, DOI 10.1007/s00421-008-0924-2; EPSTEIN Y, 1988, EUR J APPL PHYSIOL O, V57, P243, DOI 10.1007/BF00640670; Gagge AP, 1941, SCIENCE, V94, P428, DOI 10.1126/science.94.2445.428; GIVONI B, 1972, J APPL PHYSIOL, V32, P812, DOI 10.1152/jappl.1972.32.6.812; Goldman R. F., 2001, MED ASPECTS HARSH EN, V1, P3; Gonzalez RR, 1997, J APPL PHYSIOL, V83, P1017, DOI 10.1152/jappl.1997.83.3.1017; Loverro KL, 2015, APPL ERGON, V46, P168, DOI 10.1016/j.apergo.2014.07.015; Maciejczyk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095797; Matthew WT, 2001, T0113 US ARM RES I E; Mazurek Michael T, 2006, J Am Acad Orthop Surg, V14, pS18; Mitchell KB, 2013, T13033 US ARM NAT SO; O'Brien C, 2011, J OCCUP ENVIRON HYG, V8, P588, DOI 10.1080/15459624.2011.613291; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Pang TY, 2014, APPL ERGON, V45, P300, DOI 10.1016/j.apergo.2013.04.011; Parsons Ken., 2002, HUMAN THERMAL ENV EF, V3rd; Potter A., 2013, J SPORT HUMAN PERFOR, V1, P34, DOI [10.12922/9, DOI 10.12922/9, DOI 10.12922/JSHP.0009.2013]; Potter AW, 2014, T147 US ARM RES I EN; Pyke AJ, 2015, APPL ERGON, V47, P11, DOI 10.1016/j.apergo.2014.08.016; Sawka MN, 2011, COMPR PHYSIOL, V1, P1883, DOI 10.1002/cphy.c100082; Sawka MN, 2001, MED SCI SPORT EXER, V33, P422, DOI 10.1097/00005768-200103000-00014; Smith CJ, 2011, EUR J APPL PHYSIOL, V111, P1391, DOI 10.1007/s00421-010-1744-8; Stewart IB, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-22; Tharion WJ, 2005, APPETITE, V44, P47, DOI 10.1016/j.appet.2003.11.010; Welles AP, 2013, MIL MED, V178, P1141, DOI 10.7205/MILMED-D-12-00538; Woodcock A.H., 1962, TEXT RES J, V32, P628, DOI DOI 10.1177/004051756203200802; Woodcock AH, 1961, TREP149; Xu XJ, 2014, J OCCUP ENVIRON HYG, V11, pD187, DOI 10.1080/15459624.2014.946517	33	18	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132698	10.1371/journal.pone.0132698	http://dx.doi.org/10.1371/journal.pone.0132698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200906	gold, Green Published, Green Submitted			2022-12-27	WOS:000358597100046
J	Zhou, JJ; Yu, XL; Deng, YF; Yan, HF; Lin, ZL				Zhou, Jian-Jun; Yu, Xun-Lin; Deng, Yun-Fei; Yan, Hai-Fei; Lin, Zhe-Li			Lysimachia huangsangensis (Primulaceae), a New Species from Hunan, China	PLOS ONE			English	Article							SP-NOV PRIMULACEAE; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; DABIESHAN MOUNTAIN; TRNL-F; MYRSINACEAE; ERICALES; L.; EVOLUTION; ANAGALLIS	A new species, Lysimachia huangsangensis (Primulaceae), from Hunan, China is described and illustrated. The new species is closely related to L. carinata because of the crested calyx, but differs in the leaf blades that are ovate to elliptic and (3-)4.5-9 x 2-3.4 cm, 2-5-flowered racemes, and the calyx lobes that are ovate-lanceolate and 5-6 x 3-4 mm. The systematic placement and conservation status are also discussed.	[Zhou, Jian-Jun; Yu, Xun-Lin] Cent South Univ Forestry & Technol, Sch Forestry, Changsha 410004, Hunan, Peoples R China; [Deng, Yun-Fei; Yan, Hai-Fei; Lin, Zhe-Li] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Lin, Zhe-Li] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Central South University of Forestry & Technology; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, XL (corresponding author), Cent South Univ Forestry & Technol, Sch Forestry, Changsha 410004, Hunan, Peoples R China.	csfuyuxl@163.com; yfdeng@scbg.ac.cn			major special foundation of Science and Technology Department of Hunan Province [2012FJ1005]; special program of scientific investigation from the Huangsang National Natural Reserve; National Natural Science Foundation of China [30900160, 31270247, 31470302]	major special foundation of Science and Technology Department of Hunan Province; special program of scientific investigation from the Huangsang National Natural Reserve; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the major special foundation of Science and Technology Department of Hunan Province (Gran no. 2012FJ1005, www.hnst.gov.cn) and special program of scientific investigation from the Huangsang National Natural Reserve (grant no. N/A) to Xun-Lin Yu, and the National Natural Science Foundation of China (grant no. 30900160, 31270247, 31470302, www.nsfc.gov.cn) to Hai-Fei Yan and Yun-Fei Deng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderberg AA, 2002, AM J BOT, V89, P677, DOI 10.3732/ajb.89.4.677; Anderberg AA, 1998, PLANT SYST EVOL, V211, P93, DOI 10.1007/BF00984914; ANDERBERG AA, 1995, CAN J BOT, V73, P1699, DOI 10.1139/b95-184; Anderberg Arne A., 2007, Willdenowia, V37, P407, DOI 10.3372/wi.37.37202; Banfi E., 2005, ATTI SOC ITALIANA SC, V146, P219; Barthlott W., 1984, CURRENT CONCEPTPLA, P95; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; BENNELL A P, 1983, Notes from the Royal Botanic Garden Edinburgh, V40, P425; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen F.H., 1979, ACTA PHYTOTAXON SIN, V17, P21; Chen FH, 1989, FLORA REIPUBLICAE PO; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cronquist A, 1981, INTEGRATED SYSTEM CL; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; DONOGHUE MJ, 1985, BRYOLOGIST, V88, P172, DOI 10.2307/3243026; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Erdtman G, 1972, PLANT MORPHOLOGY PLA; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; HANDEL-MAZZETTI H., 1928, NOTES ROY BOT GARD EDINBURGH, V16, P51; Hao G, 2004, MOL PHYLOGENET EVOL, V31, P323, DOI 10.1016/S1055-7903(03)00286-0; Hao Gang, 2001, Journal of Tropical and Subtropical Botany, V9, P93; Heywood V. H., 2007, FLOWERING PLANT FAMI; Hu C.M., 1996, FLORA CHINA, V15, P39, DOI DOI 10.2307/2656725; Huang T.-C, 1972, POLLEN FLORA TAIWAN; HUYNH K-L, 1971, Candollea, V26, P279; HUYNH K-L, 1970, Candollea, V25, P267; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN Standards and Pertition Subcommittee, 2014, GUID US IUCN RED LIS; Juan R, 2000, ANN BOT-LONDON, V86, P323, DOI 10.1006/anbo.2000.1188; Judd WS, 1994, HARVARD PAPERS BOTAN, V5, P1; Judd WS, 2008, PLANT SYSTEMATIC PHY; Kallersjo M, 2000, AM J BOT, V87, P1325, DOI 10.2307/2656725; Kao MT, 1998, FLORA OF TAIWAN, P59; Klatt F.W., 1866, ABHANDLUNGEN GEBIETE, V4, P1; Liu K, 2014, PLANT SYST EVOL, V300, P1615, DOI 10.1007/s00606-014-0986-z; Liu K, 2014, PHYTOTAXA, V174, P119, DOI 10.11646/phytotaxa.174.2.8; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; Manns U, 2005, INT J PLANT SCI, V166, P1019, DOI 10.1086/449318; Manns Ulrika, 2009, Willdenowia, V39, P49, DOI 10.3372/wi.39.39103; Martins L, 2003, PLANT SYST EVOL, V237, P75, DOI 10.1007/s00606-002-0258-1; Mast AR, 2001, INT J PLANT SCI, V162, P1381, DOI 10.1086/323444; Nowicke J.W., 1977, SMITHSON CONTRIB BOT, V37, P1; Oh IC, 2008, PLANT SYST EVOL, V271, P177, DOI 10.1007/s00606-007-0625-z; Pax F, 1905, PFLANZENREICH, V22; Peng CI, 1999, BOT BULL ACAD SINICA, V40, P49; Loc PK, 2011, NORD J BOT, V29, P601, DOI 10.1111/j.1756-1051.2011.01174.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PUNT W, 1974, REV PALAEOBOT PALYNO, V17, P31, DOI 10.1016/0034-6667(74)90037-2; Qian YY, 1998, GUIHAIA, V18, P354; RAY JAMES DAVE, 1956, ILLINOIS BIOL MONOGR, V24, P1; Ren XF, 1994, J ANHUI NORM U NAT S, V17, P61; Reveal JL, 2011, PHYTOTAXA, V19, P71, DOI 10.11646/phytotaxa.19.1.4; Reveal JL., 2012, PHYTONEURON, V37, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouhan G, 2014, METHODS MOL BIOL, V1115, P1, DOI 10.1007/978-1-62703-767-9_1; Shao JW, 2006, ACTA PHYTOTAXON SIN, V44, P589, DOI 10.1360/aps050135; Shao Jian-Wen, 2006, Acta Botanica Yunnanica, V28, P378; [邵剑文 Shao Jianwen], 2005, [微体古生物学报, Acta Micropalaeontologica Sinica], V22, P78; [邵剑文 Shao Jianwen], 2004, [植物研究, Bulletin of Botanical Research], V24, P389; Stahl B, 2004, FA GE VAS P, V6, P266; Stevens P.F., 2012, ANGIOSPERM PHYLOGENY; Stuessy TF, 2014, PLANT SYSTEMATIC ORI; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Takhtajan A, 1997, DIVERSITY CLASSIFICA; Thiers B., 2015, INDEX HERBARIORUM GL; Wettstein R, 1935, HDB SYSTEMATISCHEN B; Willis J. C., 1973, DICT FLOWERING PLANT; Yan HF, 2012, NORD J BOT, V30, P443, DOI 10.1111/j.1756-1051.2012.01401.x; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhang MD, 2006, ANN BOT FENN, V43, P317; Zhao ZE, 2000, J WUHAN BOT RES, V18, P283; [赵子恩 Zhao Zien], 2002, [武汉植物学研究, Journal of Wuhan Botanical Research], V20, P263; Zwickl D. J, 2006, GENETIC ALGORITHM AP	76	7	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132713	10.1371/journal.pone.0132713	http://dx.doi.org/10.1371/journal.pone.0132713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201028	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100047
J	Fan, HY; Zhang, YL; Sun, HW; Liu, JY; Wang, Y; Wang, XB; Li, DW; Yu, JL; Han, CG				Fan, Huiyan; Zhang, Yongliang; Sun, Haiwen; Liu, Junying; Wang, Ying; Wang, Xianbing; Li, Dawei; Yu, Jialin; Han, Chenggui			Transcriptome Analysis of Beta macrocarpa and Identification of Differentially Expressed Transcripts in Response to Beet Necrotic Yellow Vein Virus Infection	PLOS ONE			English	Article							SUGAR-BEET; SSR-MARKERS; SILENCING-SUPPRESSION; GENE-EXPRESSION; RESISTANCE; RHIZOMANIA; DISEASE; PLANT; PATHOGENICITY; BREAKING	Background Rhizomania is one of the most devastating diseases of sugar beet. It is caused by Beet necrotic yellow vein virus (BNYVV) transmitted by the obligate root-infecting parasite Polymyxa betae. Beta macrocarpa, a wild beet species widely used as a systemic host in the laboratory, can be rub-inoculated with BNYVV to avoid variation associated with the presence of the vector P. betae. To better understand disease and resistance between beets and BNYVV, we characterized the transcriptome of B. macrocarpa and analyzed global gene expression of B. macrocarpa in response to BNYVV infection using the Illumina sequencing platform. Results The overall de novo assembly of cDNA sequence data generated 75,917 unigenes, with an average length of 1054 bp. Based on a BLASTX search (E-value <= 10(-5)) against the non-redundant (NR, NCBI) protein, Swiss-Prot, the Gene Ontology (GO), Clusters of Orthologous Groups of proteins (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, there were 39,372 unigenes annotated. In addition, 4,834 simple sequence repeats (SSRs) were also predicted, which could serve as a foundation for various applications in beet breeding. Furthermore, comparative analysis of the two transcriptomes revealed that 261 genes were differentially expressed in infected compared to control plants, including 128 up-and 133 down-regulated genes. GO analysis showed that the changes in the differently expressed genes were mainly enrichment in response to biotic stimulus and primary metabolic process. Conclusion Our results not only provide a rich genomic resource for beets, but also benefit research into the molecular mechanisms of beet-BNYVV interaction.	[Fan, Huiyan; Zhang, Yongliang; Sun, Haiwen; Liu, Junying; Wang, Ying; Wang, Xianbing; Li, Dawei; Yu, Jialin; Han, Chenggui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Fan, Huiyan; Zhang, Yongliang; Sun, Haiwen; Liu, Junying; Wang, Ying; Wang, Xianbing; Li, Dawei; Yu, Jialin; Han, Chenggui] China Agr Univ, Dept Plant Pathol, Beijing 100193, Peoples R China; [Fan, Huiyan] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou 310053, Zhejiang, Peoples R China	China Agricultural University; China Agricultural University; Zhejiang Chinese Medical University	Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	hanchenggui@cau.edu.cn	Zhang, Yongliang/AAE-7639-2021; Wang, Xianbing/E-4831-2013; Li, Dawei/CAJ-5076-2022; Li, Dawei/I-8751-2016	Zhang, Yongliang/0000-0002-6790-1044; Li, Dawei/0000-0003-4133-1263; Liu, Jun-Ying/0000-0002-8388-1557; Wang, Xian-Bing/0000-0003-3082-2462	earmarked fund for China Agriculture Research System [CARS-210202]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]	earmarked fund for China Agriculture Research System; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported in part by the earmarked fund for China Agriculture Research System (CARS-210202) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1042).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Biancardi E, 2002, EUPHYTICA, V127, P383, DOI 10.1023/A:1020310718166; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Chiba S, 2013, MOL PLANT MICROBE IN, V26, P168, DOI 10.1094/MPMI-06-12-0142-R; Chiba S, 2011, MOL PLANT MICROBE IN, V24, P207, DOI 10.1094/MPMI-10-10-0241; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Cureton AN, 2002, MOL ECOL NOTES, V2, P402, DOI 10.1046/j.1471-8286.2002.00253.x; Dai SH, 2008, P NATL ACAD SCI USA, V105, P21012, DOI 10.1073/pnas.0810303105; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Dohm JC, 2012, PLANT J, V70, P528, DOI 10.1111/j.1365-313X.2011.04898.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085284; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Geyl L, 1995, PLANT PATHOL, V44, P819, DOI 10.1111/j.1365-3059.1995.tb02741.x; Gidner S, 2005, GENOME, V48, P279, DOI [10.1139/G04-108, 10.1139/g04-108]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Heijbroek W, 1999, EUR J PLANT PATHOL, V105, P397, DOI 10.1023/A:1008705111232; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Itaya A, 2002, MOL PLANT MICROBE IN, V15, P990, DOI 10.1094/MPMI.2002.15.10.990; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Larson RL, 2008, PHYSIOL MOL PLANT P, V72, P62, DOI 10.1016/j.pmpp.2008.04.003; Laurent V, 2007, THEOR APPL GENET, V115, P793, DOI 10.1007/s00122-007-0609-y; Li JQ, 2010, EUPHYTICA, V175, P35, DOI 10.1007/s10681-010-0161-8; Liu HY, 2005, PLANT DIS, V89, P464, DOI 10.1094/PD-89-0464; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; McGrann GRD, 2009, MOL PLANT PATHOL, V10, P129, DOI 10.1111/j.1364-3703.2008.00514.x; Monteiro F., 2013, American Journal of Plant Sciences, V4, P21; Peltier C, 2011, TRANSGENIC RES, V20, P443, DOI 10.1007/s11248-010-9424-3; Rahim MD, 2007, J GEN VIROL, V88, P1611, DOI 10.1099/vir.0.82720-0; RICHARDS KE, 1992, ANNU REV PHYTOPATHOL, V30, P291, DOI 10.1146/annurev.py.30.090192.001451; Rush CM, 2003, ANNU REV PHYTOPATHOL, V41, P567, DOI 10.1146/annurev.phyto.41.052002.095705; Schmidlin L, 2008, MOL PLANT PATHOL, V9, P741, DOI 10.1111/J.1364-3703.2008.00498.X; Scholten OE, 2000, EUPHYTICA, V112, P219, DOI 10.1023/A:1003988003165; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tamada T, 1999, PHYTOPATHOLOGY, V89, P1000, DOI 10.1094/PHYTO.1999.89.11.1000; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Verma P, 2013, PLANT BIOTECHNOL J, V11, P894, DOI 10.1111/pbi.12082; Viard F, 2004, MOL ECOL, V13, P1357, DOI 10.1111/j.1365-294X.2004.02150.x; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang YN, 2011, STAT BIOPHARM RES, V3, P1, DOI 10.1198/sbr.2011.09051; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang LD, 2005, CHINESE SCI BULL, V50, P305, DOI 10.1360/982004-731; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045953	53	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132277	10.1371/journal.pone.0132277	http://dx.doi.org/10.1371/journal.pone.0132277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196682	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600029
J	Ferreira, S; Karali, B				Ferreira, Susana; Karali, Berna			Do Earthquakes Shake Stock Markets?	PLOS ONE			English	Article							NATURAL DISASTERS; HETEROSCEDASTICITY; AFTERMATH; CONTAGION; VARIANCE; RETURNS; PRICES; IMPACT; INCOME; EVENT	This paper examines how major earthquakes affected the returns and volatility of aggregate stock market indices in thirty-five financial markets over the last twenty years. Results show that global financial markets are resilient to shocks caused by earthquakes even if these are domestic. Our analysis reveals that, in a few instances, some macroeconomic variables and earthquake characteristics (gross domestic product per capita, trade openness, bilateral trade flows, earthquake magnitude, a tsunami indicator, distance to the epicenter, and number of fatalities) mediate the impact of earthquakes on stock market returns, resulting in a zero net effect. However, the influence of these variables is market-specific, indicating no systematic pattern across global capital markets. Results also demonstrate that stock market volatility is unaffected by earthquakes, except for Japan.	[Ferreira, Susana; Karali, Berna] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Karali, B (corresponding author), Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA.	bkarali@uga.edu		Karali, Berna/0000-0001-7969-7506; Ferreira, Susana/0000-0002-9049-4408				Anbarci N, 2005, J PUBLIC ECON, V89, P1907, DOI 10.1016/j.jpubeco.2004.08.002; [Anonymous], 2013, AFR DEV IND 2012 201; [Anonymous], 1985, THEORY PRACTICE ECON; BAILLIE RT, 1989, J BUS ECON STAT, V7, P297, DOI 10.2307/1391527; BAILLIE RT, 1990, J FINANC QUANT ANAL, V25, P203, DOI 10.2307/2330824; Beyer H. L, 2012, GEOSPATIAL MODELLING; Binder, 1998, REV QUANT FINAN ACC, V11, P111, DOI [10.1023/A:1008295500105, DOI 10.1023/A:1008295500105]; BOLLERSLEV T, 1988, J POLIT ECON, V96, P116, DOI 10.1086/261527; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; BOLLERSLEV T, 1987, REV ECON STAT, V69, P542, DOI 10.2307/1925546; Brenner RJ, 1996, J FINANC QUANT ANAL, V31, P85, DOI 10.2307/2331388; Cavallo E, 2011, INT REV ENVIRON RESO, V5, P63, DOI 10.1561/101.00000039; Cavallo E, 2010, ECON J, V120, pF298, DOI 10.1111/j.1468-0297.2010.02378.x; CIESIN/SEDAC/CIAT. Center for International Earth Science Information Network NASA Socioeconomic Data and Applications Center (SEDAC) Inter-American Development Bank International Food Policy Research Institute to the Centro Internacional de Agricultura Tropical (CIAT), 2013, GRIDD POP WORLD GPW; CRED/OFDA, 2011, INT DIS DAT; CUTLER DM, 1989, J PORTFOLIO MANAGE, V15, P4, DOI 10.3905/jpm.1989.409212; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Fama E.F., 1969, INT ECON REV, V10, P1, DOI [10.2307/2525569, DOI 10.2307/2525569]; Ferreira S, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011701; Field CB, 2012, SPECIAL REPORT WORKI; Fomby T, 2013, J APPL ECONOMET, V28, P412, DOI 10.1002/jae.1273; Forbes KJ, 2002, J FINANC, V57, P2223, DOI 10.1111/0022-1082.00494; Forbes KJ, 2004, J INT ECON, V63, P59, DOI 10.1016/S0022-1996(03)00044-8; Forbes KJ, 2002, NBER CONF R, P77; FRENCH KR, 1987, J FINANC ECON, V19, P3, DOI 10.1016/0304-405X(87)90026-2; GIACCOTTO C, 1982, J FINANC, V37, P1247, DOI 10.2307/2327848; Hatase M, 2013, VANDERBIT U DEP EC W, V13-00007; HSIEH DA, 1989, J BUS ECON STAT, V7, P307, DOI 10.2307/1391528; IPCC, 2007, INT PAN CLIM CHANG I; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Kajitani Y, 2013, EARTHQ SPECTRA, V29, pS457, DOI 10.1193/1.4000108; Keefer P, 2011, WORLD DEV, V39, P1530, DOI 10.1016/j.worlddev.2011.02.010; Kousky C, 2014, ENERG ECON, V46, P576, DOI 10.1016/j.eneco.2013.09.029; Lee HY, 2007, RES INT BUS FINANC, V21, P281, DOI 10.1016/j.ribaf.2006.05.001; LEE TH, 1994, J INT MONEY FINANC, V13, P375, DOI 10.1016/0261-5606(94)90034-5; Lo AW, 1988, REV FINANC STUD, V1, P41, DOI 10.1093/rfs/1.1.41; MacKinlay AC, 1997, J ECON LIT, V35, P13; NOAA, 2013, NAT GEOPH DAT CTR WO; Noy I, 2009, J DEV ECON, V88, P221, DOI 10.1016/j.jdeveco.2008.02.005; Odell KA, 2004, J ECON HIST, V64, P1002, DOI 10.1017/S0022050704043062; Raddatz C, 2009, POLICY RES WORKING P; Raddatz C, 2007, J DEV ECON, V84, P155, DOI 10.1016/j.jdeveco.2006.11.001; Scholtens B, 2013, EARTHQ SPECTRA, V29, P325, DOI 10.1193/1.4000103; SHELOR RM, 1992, J RISK INSUR, V59, P476, DOI 10.2307/253059; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Tao ZR, 2014, NAT HAZARDS, V70, P1247, DOI 10.1007/s11069-013-0871-z; Worthington A, 2004, APPL ECON, V36, P2177, DOI 10.1080/0003684042000282489; Yamori N, 2002, J JPN INT ECON, V16, P92, DOI 10.1006/jjie.2001.0477; Yang CC, 2008, J RISK FINANC, V9, P232, DOI 10.1108/15265940810875568	49	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133319	10.1371/journal.pone.0133319	http://dx.doi.org/10.1371/journal.pone.0133319			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197482	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600084
J	Nutsua, ME; Fischer, A; Nebel, A; Hofmann, S; Schreiber, S; Krawczak, M; Nothnagel, M				Nutsua, Marcel Elie; Fischer, Annegret; Nebel, Almut; Hofmann, Sylvia; Schreiber, Stefan; Krawczak, Michael; Nothnagel, Michael			Family-Based Benchmarking of Copy Number Variation Detection Software	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM ARRAYS; INTERNATIONAL HAPMAP PROJECT; GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; STRUCTURAL VARIATION; MISSING HERITABILITY; GENETIC-VARIATION; HAPLOTYPE MAP; SEQUENCE	The analysis of structural variants, in particular of copy-number variations (CNVs), has proven valuable in unraveling the genetic basis of human diseases. Hence, a large number of algorithms have been developed for the detection of CNVs in SNP array signal intensity data. Using the European and African HapMap trio data, we undertook a comparative evaluation of six commonly used CNV detection software tools, namely Affymetrix Power Tools (APT), QuantiSNP, PennCNV, GLAD, R-gada and VEGA, and assessed their level of pair-wise prediction concordance. The tool-specific CNV prediction accuracy was assessed in silico by way of intra-familial validation. Software tools differed greatly in terms of the number and length of the CNVs predicted as well as the number of markers included in a CNV. All software tools predicted substantially more deletions than duplications. Intra-familial validation revealed consistently low levels of prediction accuracy as measured by the proportion of validated CNVs (34-60%). Moreover, up to 20% of apparent family-based validations were found to be due to chance alone. Software using Hidden Markov models (HMM) showed a trend to predict fewer CNVs than segmentation-based algorithms albeit with greater validity. PennCNV yielded the highest prediction accuracy (60.9%). Finally, the pair-wise concordance of CNV prediction was found to vary widely with the software tools involved. We recommend HMM-based software, in particular PennCNV, rather than segmentation-based algorithms when validity is the primary concern of CNV detection. QuantiSNP may be used as an additional tool to detect sets of CNVs not detectable by the other tools. Our study also reemphasizes the need for laboratory-based validation, such as qPCR, of CNVs predicted in silico.	[Nutsua, Marcel Elie; Fischer, Annegret; Nebel, Almut; Hofmann, Sylvia; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Krawczak, Michael; Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	University of Kiel; University of Kiel; University of Cologne	Nothnagel, M (corresponding author), Univ Kiel, Inst Med Informat & Stat, Kiel, Germany.	michael.nothnagel@uni-koeln.de	Nothnagel, Michael/L-7187-2019; Nothnagel, Michael/G-6545-2014; Krawczak, Michael/A-8964-2010; Hofmann, Sylvia/AAO-4802-2021; Nebel, Almut/E-4196-2010	Nothnagel, Michael/0000-0001-8305-7114; Krawczak, Michael/0000-0003-2603-1502; Hofmann, Dr. S./0000-0003-0621-9049	German Ministry of Education and Research (BMBF) through DFG Cluster of Excellence "Inflammation at Interfaces" [EXC 306]	German Ministry of Education and Research (BMBF) through DFG Cluster of Excellence "Inflammation at Interfaces"	This study was supported by the German Ministry of Education and Research (BMBF) through the DFG Cluster of Excellence EXC 306 "Inflammation at Interfaces". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc, 2012, AFFYMETRIX POWER TOO; Affymetrix Inc, 2011, AFF GEN WID HUM SNP; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chen WT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023087; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; Coin LJM, 2012, BIOINFORMATICS, V28, pI370, DOI 10.1093/bioinformatics/bts379; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Eckel-Passow JE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-220; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Ju YS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq730; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007958; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Morganella S, 2010, BIOINFORMATICS, V26, P3020, DOI 10.1093/bioinformatics/btq586; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pique-Regi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-380; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scharpf RB, 2011, BIOSTATISTICS, V12, P33, DOI 10.1093/biostatistics/kxq043; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133465	10.1371/journal.pone.0133465	http://dx.doi.org/10.1371/journal.pone.0133465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197066	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600101
J	Wiangkham, T; Duda, J; Haque, S; Madi, M; Rushton, A				Wiangkham, Taweewat; Duda, Joan; Haque, Sayeed; Madi, Mohammad; Rushton, Alison			The Effectiveness of Conservative Management for Acute Whiplash Associated Disorder (WAD) II: A Systematic Review and Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Review							2000-2010 TASK-FORCE; NECK PAIN; PROGNOSTIC-FACTORS; PHYSICAL-THERAPY; CLINICAL-TRIAL; INJURIES; QUALITY; INTERVENTION; RECOVERY; HEALTH	Objective To evaluate the effectiveness of conservative management (except drug therapy) for acute Whiplash Associated Disorder (WAD) II. Design Systematic review and meta-analysis of Randomised Controlled Trials (RCTs) using a predefined protocol. Two independent reviewers searched information sources, decided eligibility of studies, and assessed risk of bias (RoB) of included trials. Data were extracted by one reviewer and checked by the other. A third reviewer mediated any disagreements throughout. Qualitative trial and RoB data were summarised descriptively. Quantitative syntheses were conducted across trials for comparable interventions, outcome measures and assessment points. Meta-analyses compared effect sizes with random effects, using STATA version 12. Data Sources PEDro, Medline, Embase, AMED, CINAHL, PsycINFO, and Cochrane Library with manual searching in key journals, reference lists, British National Bibliography for Report Literature, Center for International Rehabilitation Research Information & Exchange, and National Technical Information Service were searched from inception to 15th April 2015. Active researchers in the field were contacted to determine relevant studies. Eligibility Criteria for Selecting Studies RCTs evaluating acute (<4 weeks) WADII, any conservative intervention, with outcome measures important to the International Classification of Function, Disability and Health. Results Fifteen RCTs all assessed as high RoB (n= 1676 participants) across 9 countries were included. Meta-analyses enabled 4 intervention comparisons: conservative versus standard/ control, active versus passive, behavioural versus standard/control, and early versus late. Conservative intervention was more effective for pain reduction at 6 months (95% CI: -20.14 to -3.38) and 1-3 years (-25.44 to -3.19), and improvement in cervical mobility in the horizontal plane at <3 months (0.43 to 5.60) compared with standard/control intervention. Active intervention was effective for pain alleviation at 6 months (-17.19 to -3.23) and 1-3 years (-26.39 to -10.08) compared with passive intervention. Behavioural intervention was more effective than standard/control intervention for pain reduction at 6 months (-15.37 to -1.55), and improvement in cervical movement in the coronal (0.93 to 4.38) and horizontal planes at 3-6 months (0.43 to 5.46). For early (< 4 days) versus late (>10 days) interventions, there were no statistically significant differences in all outcome measures between interventions at any time. Conclusions Conservative and active interventions may be useful for pain reduction in patients with acute WADII. Additionally, cervical horizontal mobility could be improved by conservative intervention. The employment of a behavioural intervention (e.g. act-as-usual, education and self-care including regularly exercise) could have benefits for pain reduction and improvement in cervical movement in the coronal and horizontal planes. The evidence was evaluated as low/very low level according to the Grading of Recommendations Assessment, Development and Evaluation system.	[Wiangkham, Taweewat; Duda, Joan; Madi, Mohammad; Rushton, Alison] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England; [Haque, Sayeed] Univ Birmingham, Sch Hlth & Populat Sci, Primary Care Clin Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Wiangkham, T (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England.	txw214@bham.ac.uk	Wiangkham, Taweewat/I-9818-2019; Duda, Joan/ABA-5207-2020; Madi, Mohammad/AAE-6422-2021; Rushton, Alison/V-1260-2017; Haque, Mohammad S/B-9160-2018	Wiangkham, Taweewat/0000-0003-4115-704X; Madi, Mohammad/0000-0001-8521-286X; Rushton, Alison/0000-0001-8114-7669; Haque, (Mohammad) Sayeed/0000-0002-2467-8575				Abraha I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2697; Aigner N, 2006, WIEN KLIN WOCHENSCHR, V118, P95, DOI 10.1007/s00508-006-0530-4; [Anonymous], 2001, HLTH SCI RES HDB QUA; BARNSLEY L, 1994, PAIN, V58, P283, DOI 10.1016/0304-3959(94)90123-6; Barnsley L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5966; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bonk AD, 2000, J MUSCULOSKELET PAIN, V8, P123, DOI 10.1300/J094v08n01_10; Borchgrevink GE, 1998, SPINE, V23, P25, DOI 10.1097/00007632-199801010-00006; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Buitenhuis J, 2009, SPINE, V34, P262, DOI 10.1097/BRS.0b013e3181913d07; Buitenhuis J, 2011, SPINE, V36, pS238, DOI 10.1097/BRS.0b013e3182388400; Burton K, 2003, WHIPL C 2003 6 8 MAY; Carroll LJ, 2008, SPINE, V33, pS214, DOI 10.1097/BRS.0b013e318164462c; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Chappuis G, 2008, EUR SPINE J, V17, P1350, DOI 10.1007/s00586-008-0732-8; Conforti Maria, 2013, Muscles Ligaments Tendons J, V3, P106, DOI 10.11138/mltj/2013.3.2.106; Cote P, 2007, ARTHRIT RHEUM-ARTHR, V57, P861, DOI 10.1002/art.22775; de Koning CHP, 2008, EUR SPINE J, V17, P905, DOI 10.1007/s00586-008-0656-3; Dehner C, 2006, ARCH PHYS MED REHAB, V87, P1423, DOI 10.1016/j.apmr.2006.07.268; Dehner C, 2009, PATIENT SAF SURG, V3, DOI 10.1186/1754-9493-3-2; Eck JC, 2001, AM J MED, V110, P651, DOI 10.1016/S0002-9343(01)00680-5; Ferrari R, 2005, ACAD EMERG MED, V12, P699, DOI 10.1197/j.aem.2005.03.531; FOLEYNOLAN D, 1992, SCAND J REHABIL MED, V24, P51; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Galasko CSB, 2002, BRIT COLUMBIA MED J, V44; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holm LW, 2008, SPINE, V33, pS52, DOI 10.1097/BRS.0b013e3181643ece; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Jennum P, 2013, SPINE, V38, P449, DOI 10.1097/BRS.0b013e3182819203; Jull G, 2007, PAIN, V129, P28, DOI 10.1016/j.pain.2006.09.030; Jull G, 2013, PAIN, V154, P1798, DOI 10.1016/j.pain.2013.05.041; Jull GA, 2011, SPINE, V36, pS173, DOI 10.1097/BRS.0b013e31823883e6; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Leth-Petersen S, 2009, J HEALTH ECON, V28, P996, DOI 10.1016/j.jhealeco.2009.06.013; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Merrick Daniel, 2010, BMC Res Notes, V3, P190, DOI 10.1186/1756-0500-3-190; Michaleff ZA, 2014, LANCET, V384, P133, DOI 10.1016/S0140-6736(14)60457-8; Miettinen T, 2004, SPINE, V29, pE47, DOI 10.1097/01.BRS.0000106496.23202.60; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097e1000097, DOI 10.1371/JOURNAL.PMED.1000097]; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Mooney H, 2012, INSURANCE COMPANIES; Moore A, 2005, CLIN GUIDELINES PHYS; Myran R, 2011, SPINE, V36, pE862, DOI 10.1097/BRS.0b013e3181ff1dde; Nijs J, 2011, CLIN RHEUMATOL, V30, P927, DOI 10.1007/s10067-011-1712-7; Oostendorp RAB, 2013, J EVAL CLIN PRACT, V19, P1044, DOI 10.1111/jep.12025; Ottosson Carin, 2007, PLoS Clin Trials, V2, pe14, DOI 10.1371/journal.pctr.0020014; Picelli A, 2011, EUR J PHYS REHAB MED, V47, P561; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; Rosenfeld M, 2003, SPINE, V28, P2491, DOI 10.1097/01.BRS.0000090822.96814.13; Rosenfeld M, 2006, SPINE, V31, P1799, DOI 10.1097/01.brs.0000225975.12978.6c; Rushton A, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000265; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; Schnabel M, 2004, EMERG MED J, V21, P306, DOI 10.1136/emj.2003.010165; Scholten-Peeters GGM, 2006, SPINE, V31, P723, DOI 10.1097/01.brs.0000206381.15224.0f; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Scholten-Peeters GGM, 2003, J MANIP PHYSIOL THER, V26, P412, DOI 10.1016/S0161-4754(03)00092-7; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SPITZER WO, 1995, SPINE, V20, pS1; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Sterling M, 2004, MANUAL THER, V9, P60, DOI 10.1016/j.math.2004.01.006; Sterling M, 2014, J PHYSIOTHER, V60, P5, DOI 10.1016/j.jphys.2013.12.004; Sterling M, 2011, SPINE, V36, pS322, DOI 10.1097/BRS.0b013e318238853f; Sterling M, 2010, CLIN J PAIN, V26, P573, DOI 10.1097/AJP.0b013e3181e5c25e; Stewart MJ, 2007, PAIN, V128, P59, DOI 10.1016/j.pain.2006.08.030; TRACsa, 2008, CLIN GUID BEST PRACT; Vassiliou T, 2006, PAIN, V124, P69, DOI 10.1016/j.pain.2006.03.017; Verhagen AP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003338.pub3; Walker E, 2008, CLEV CLIN J MED, V75, P431, DOI 10.3949/ccjm.75.6.431; World Health Organization, 2001, ICF INT CLASFUNCT	75	33	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133415	10.1371/journal.pone.0133415	http://dx.doi.org/10.1371/journal.pone.0133415			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196127	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600095
J	Barbet-Massin, C; Giuliano, S; Alletto, L; Dayde, J; Berger, M				Barbet-Massin, Claire; Giuliano, Simon; Alletto, Lionel; Dayde, Jean; Berger, Monique			Nitrogen Limitation Alters Biomass Production but Enhances Steviol Glycoside Concentration in Stevia rebaudiana Bertoni	PLOS ONE			English	Article							RESOURCE AVAILABILITY; SECONDARY METABOLITES; NUTRIENT AVAILABILITY; ACCUMULATION; BIOSYNTHESIS; LEAVES; PLANTS; LIGHT; GLYCOSYLTRANSFERASES; ALLOCATION	The need for medicinal and aromatic plants for industrial uses creates an opportunity for farmers to produce alternative crops. Stevia rebaudiana Bertoni, a perennial shrub originating from Paraguay, is of increasing interest as a source of zero-calorie natural sweeteners: the steviol glycosides (SVglys). The aim of this study was to investigate the relevance of nitrogen (N) supply for leaf yield and for SVgly concentrations in leaves, which are the two major components of S. rebaudiana productivity. In this regard, the relationship between leaf N concentration, CO2 assimilation, leaf production and SVgly accumulation was investigated. The experiments were conducted consecutively in growth-chamber (CC: controlled conditions), in greenhouse (SCC: semi-controlled conditions) and in field conditions (FC) on two genotypes. In CC and SCC, three levels of N fertilization were applied. Plants were grown on four locations in the FC experiment. Both N supply (CC and SCC) and location (FC) had a significant effect on N content in leaves. When light was not limiting (SCC and FC) N content in leaves was positively correlated with CO2 assimilation rate and biomass accumulation. Irrespective of the growth conditions, N content in leaves was negatively correlated with SVgly content. However, increased SVgly content was correlated with a decreased ratio of rebaudioside A over stevioside. The evidence that the increased SVgly accumulation compensates for the negative effect on biomass production suggests that adequate SVgly productivity per plant may be achieved with relatively low fertilization.	[Barbet-Massin, Claire; Dayde, Jean; Berger, Monique] Univ Toulouse, EI Purpan, INP, Dept Sci Agron & Agroalimentaires, F-31076 Toulouse, France; [Giuliano, Simon; Alletto, Lionel] Univ Toulouse, EI Purpan, INP, Dept Sci Agron & Agroalimentaires,AGIR UMR1248, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Berger, M (corresponding author), Univ Toulouse, EI Purpan, INP, Dept Sci Agron & Agroalimentaires, 75 Voie TOEC,BP 57611, F-31076 Toulouse, France.	monique.berger@purpan.fr	Giuliano, Simon/B-4206-2015	Alletto, Lionel/0000-0003-0933-9476	Fonds Unique Interministeriel (STEVIANOV) [F11 07 018M]	Fonds Unique Interministeriel (STEVIANOV)	This work was supported by the Fonds Unique Interministeriel (STEVIANOV - F11 07 018M) (http://competitivite.gouv.fr/le-11e-appel-a-projets/lesresultats-du-11e-appel-a-projets-r-d-fui-784.html). Authors MB and SG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES LM, 1979, PLANT CELL PHYSIOL, V20, P123; Andolfi L., 2006, Italian Journal of Agronomy, V1, P257; Baly ECC, 1935, PROC R SOC SER B-BIO, V117, P218, DOI 10.1098/rspb.1935.0026; Bondarev NI, 2003, BIOL PLANTARUM, V47, P261, DOI 10.1023/B:BIOP.0000022261.35259.4f; Brandle J, 1999, CAN J PLANT SCI, V79, P85, DOI 10.4141/P98-048; Brandle JE, 2007, PHYTOCHEMISTRY, V68, P1855, DOI 10.1016/j.phytochem.2007.02.010; Brandle JE, 1998, CAN J PLANT SCI, V78, P527, DOI 10.4141/P97-114; BRANDLE JE, 1992, CAN J PLANT SCI, V72, P1263, DOI 10.4141/cjps92-159; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Ceunen S, 2013, PLANT SCI, V198, P72, DOI 10.1016/j.plantsci.2012.10.003; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cordoba E, 2011, J EXP BOT, V62, P2023, DOI 10.1093/jxb/erq393; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Cronin G, 1996, OIKOS, V77, P93, DOI 10.2307/3545589; Hale BK, 2005, J CHEM ECOL, V31, P2601, DOI 10.1007/s10886-005-7616-8; Haukioja E, 1998, CHEMOECOLOGY, V8, P133, DOI 10.1007/s000490050018; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Humphrey TV, 2006, PLANT MOL BIOL, V61, P47, DOI 10.1007/s11103-005-5966-9; Ibrahim MH, 2011, INT J MOL SCI, V12, P5238, DOI 10.3390/ijms12085238; Janawade A.D., 2012, KARNATAKA J AGR SCI, V25, P25, DOI DOI 10.2307/2399915; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kienle U, 2010, J VERBRAUCH LEBENSM, V5, P241, DOI 10.1007/s00003-010-0558-2; Kim KK, 1996, ARCH BIOCHEM BIOPHYS, V332, P223, DOI 10.1006/abbi.1996.0336; Koricheva J, 1998, OIKOS, V83, P212, DOI 10.2307/3546833; Kumar H, 2012, GENE, V492, P276, DOI 10.1016/j.gene.2011.10.015; Kumar R, 2013, ARCH AGRON SOIL SCI, V59, P963, DOI 10.1080/03650340.2012.699676; Lambers H., 2008, PLANT PHYSL ECOLOGY, p11Routl, DOI [DOI 10.1007/978-0-387-78341-3_2, 10.1007/978-0-387-78341-3_2]; Lobo FD, 2013, PHOTOSYNTHETICA, V51, P445, DOI 10.1007/s11099-013-0045-y; Massad TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047554; Mohamed AAA, 2011, J PLANT PHYSIOL, V168, P1136, DOI 10.1016/j.jplph.2011.01.030; Izquierdo AM, 2011, ACTA PHYSIOL PLANT, V33, P2135, DOI 10.1007/s11738-011-0753-5; Muller V, 2013, J PLANT PHYSIOL, V170, P1165, DOI 10.1016/j.jplph.2013.03.010; Pal PK, 2013, J PLANT PHYSIOL, V170, P1526, DOI 10.1016/j.jplph.2013.06.017; Patil N. M., 2010, Recent Research in Science and Technology, V2, P42; R Core Team, 2021, R LANGUAGE ENV STAT; Rajasekaran T, 2007, J SCI FOOD AGR, V87, P420, DOI 10.1002/jsfa.2713; Richman A, 2005, PLANT J, V41, P56, DOI 10.1111/j.1365-313X.2004.02275.x; Richman AS, 1999, PLANT J, V19, P411, DOI 10.1046/j.1365-313X.1999.00531.x; Tavarini S, 2013, J SCI FOOD AGR, V93, P2121, DOI 10.1002/jsfa.6016; Totte N, 2000, TETRAHEDRON LETT, V41, P6407, DOI 10.1016/S0040-4039(00)01094-7; Tschoep H, 2009, PLANT CELL ENVIRON, V32, P300, DOI 10.1111/j.1365-3040.2008.01921.x; TUOMI J, 1984, OECOLOGIA, V61, P208, DOI 10.1007/BF00396762; Ward JL, 2011, P NATL ACAD SCI USA, V108, P10762, DOI 10.1073/pnas.1018875108; Yadav AK, 2011, CAN J PLANT SCI, V91, P1, DOI 10.4141/CJPS10086	44	34	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133067	10.1371/journal.pone.0133067	http://dx.doi.org/10.1371/journal.pone.0133067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192921	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400052
J	Bautista-Arredondo, S; Gonzalez, A; Servan-Mori, E; Beynon, F; Juarez-Figueroa, L; Conde-Glez, CJ; Gras, N; Sierra-Madero, J; Lopez-Ridaura, R; Volkow, P; Bertozzi, SM				Bautista-Arredondo, Sergio; Gonzalez, Andrea; Servan-Mori, Edson; Beynon, Fenella; Juarez-Figueroa, Luis; Conde-Glez, Carlos J.; Gras, Nathalie; Sierra-Madero, Juan; Lopez-Ridaura, Ruy; Volkow, Patricia; Bertozzi, Stefano M.			A Cross-Sectional Study of Prisoners in Mexico City Comparing Prevalence of Transmissible Infections and Chronic Diseases with That in the General Population	PLOS ONE			English	Article							RISK; HIV; INCARCERATION; INMATES; VIRUS	Objectives To describe patterns of transmissible infections, chronic illnesses, socio-demographic characteristics and risk behaviors in Mexico City prisons, including in comparison to the general population, to identify those currently needing healthcare and inform policy. Materials and Methods A cross-sectional study among 17,000 prisoners at 4 Mexico City prisons (June to December 2010). Participation was voluntary, confidential and based on informed consent. Participants were tested for HIV, Hepatitis B & C, syphilis, hypertension, obesity, and, if at risk, glucose and cholesterol. A subset completed a questionnaire on socio-demographic characteristics and risk behaviors. Positive results were delivered with counseling and treatment or referral. Results 76.8% (15,517/20,196) of men and 92.9% (1,779/1,914) of women participated. Complete data sets were available for 98.8%. The following prevalence data were established for transmissible infections: HIV 0.7%; syphilis: Anti-TP+/VDRL+2.0%; Hepatitis B: HBcAb 2.8%, HBsAg 0.15%; Anti-HCV 3.2%. Obesity: 9.5% men, 33.8% women. Compared with national age-and sex-matched data, the relative prevalence was greater for HIV and syphilis among women, HIV and Hepatitis C in men, and all infections in younger participants. Obesity prevalence was similar for women and lower among male participants. The prevalence of previously diagnosed diabetes and hypertension was lower. Questionnaire data (1,934 men, 520 women) demonstrated lower educational levels, increased smoking and substance use compared to national data. High levels of non-sterile tattooing, physical abuse and histories of sexual violence were found. Conclusion The study identified that health screening is acceptable to Mexico City prisoners and feasible on a large-scale. It demonstrated higher prevalence of HIV and other infections compared to national data, though low rates compared to international data. Individual participants benefited from earlier diagnosis, treatment and support. The data collected will also enable the formulation of improved policy for this vulnerable group.	[Bautista-Arredondo, Sergio; Servan-Mori, Edson; Beynon, Fenella; Juarez-Figueroa, Luis; Conde-Glez, Carlos J.; Lopez-Ridaura, Ruy] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Gonzalez, Andrea; Gras, Nathalie] Mexico Citys AIDS Program, Mexico City, DF, Mexico; [Sierra-Madero, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Volkow, Patricia] Natl Inst Oncol, Mexico City, DF, Mexico; [Bertozzi, Stefano M.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Instituto Nacional de Salud Publica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of California System; University of California Berkeley	Servan-Mori, E (corresponding author), Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.	eservan@insp.mx	Sierra Madero, Juan/AAW-8825-2021; Bautista-Arredondo, Sergio/N-7305-2016; González Ríos, Andrea/HGU-7618-2022	Bautista-Arredondo, Sergio/0000-0001-8910-3011; Beynon, Fenella/0000-0002-4758-8847; Servan-Mori, Edson/0000-0001-9820-8325; Bertozzi, Stefano M/0000-0002-1723-7085	Ministry of Health of Mexico City [INSP-2010-340]	Ministry of Health of Mexico City	This work was supported by the Ministry of Health of Mexico City under contract INSP-2010-340.	Alvarado-Esquivel C, 2005, EPIDEMIOL INFECT, V133, P679, DOI 10.1017/S0950268805003961; American Diabetes Association, 2008, Diabetes Care, V31 Suppl 1, pS87, DOI 10.2337/dc08-S087; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Brown JL, 2013, CARIES RES, V47, P40, DOI 10.1159/000351827; Butler T, 2004, AUST NZ J PUBL HEAL, V28, P344, DOI 10.1111/j.1467-842X.2004.tb00442.x; Comision de Derechos Humanos del Distrito Federal, 2011, INF QUE PRES COM DER; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Dolan K, 2010, EUR J EPIDEMIOL, V25, P143, DOI 10.1007/s10654-009-9421-0; HERMAN WH, 1995, DIABETES CARE, V18, P382, DOI 10.2337/diacare.18.3.382; ICPS, 2004, PRIS HLTH PUBL HLTH; INEGI, 2010, MORT DAT 2010; Izazola Licea JA, 1998, ESTUDIOS CASO PRACTI; Johnson RC, 2009, J LAW ECON, V52, P251, DOI 10.1086/597102; Juarez-Figueroa L, 18 INT AIDS C JUL 18; Juarez-Figueroa L, 2011, 19 BIENN C INT SOC S; Jurado S, 1998, SALUD MENTAL, V21; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; Leddy Meaghan A, 2009, J Correct Health Care, V15, P318, DOI 10.1177/1078345809340426; Miranda AE, 2000, SEX TRANSM DIS, V27, P491, DOI 10.1097/00007435-200010000-00001; Nara K, 1998, IND HLTH, P1; Olaiz-Fernandez G, 2006, ENCUESTA NACL SALUD; Organizacion Panamericana de la Salud; Instituto Nacional de Salud Publica (MX), 2009, ENC GLOB TAB AD; Rojas R, 2010, SALUD PUBLICA MEXICO, V52, pS11, DOI 10.1590/s0036-36342010000700004; Salla F, 2009, HUMAN RIGHTS PRISON; Stata Corp. LP, 2011, STAT SE 12 1 WIND XP; Subsecretaria de Sistema Penitenciario G de DF2010, 2010, MOV DIAR POBL PEN; Thomas JC, 2008, J URBAN HEALTH, V85, P90, DOI 10.1007/s11524-007-9231-1; Vescio MF, 2008, J EPIDEMIOL COMMUN H, V62, P305, DOI 10.1136/jech.2006.051599; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS72; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; World Health Organization (WHO), 2007, HLTH PRIS WHO GUID E	33	35	35	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131718	10.1371/journal.pone.0131718	http://dx.doi.org/10.1371/journal.pone.0131718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192811	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400015
J	Kohyama-Koganeya, A; Kurosawa, M; Hirabayashi, Y				Kohyama-Koganeya, Ayako; Kurosawa, Mizuki; Hirabayashi, Yoshio			Differential Effects of Tissue-Specific Deletion of BOSS on Feeding Behaviors and Energy Metabolism	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DROSOPHILA; INSULIN; GPRC5B; BRIDE; HOMEOSTASIS; SECRETION; OBESITY; CELLS; CREB	Food intake and energy metabolism are tightly controlled to maintain stable energy homeostasis and healthy states. Thus, animals detect their stored energy levels, and based on this, they determine appropriate food intake and meal size. Drosophila melanogaster putative G protein-coupled receptor, Bride of sevenless (BOSS) is a highly evolutionarily conserved protein that responds to extracellular glucose levels in order to regulate energy homeostasis. To address how BOSS regulates energy homeostasis, we characterized a boss mutant by assessing its food intake and stored energy levels. Boss mutants exhibited increased food intake but decreased stored triacylglyceride levels. Using boss-GAL4 drivers, we found that boss is expressed in select tissues that are involved in nutrient sensing and food intake, in a subset of neurons in brain and chemosensory organs, in fat body, and in endocrine cells in gut (enteroendocrine cells). Flies with tissue-specific boss knockdowns in these tissues had abnormal stored energy levels and abnormal food intake. These results suggest that BOSS in either neurons or peripheral nutrient-sensing tissues affects energy homeostasis in ways that relate to the sensing of nutrients and regulation of food intake.	[Kohyama-Koganeya, Ayako; Kurosawa, Mizuki; Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Mol Membrane Neurosci, Wako, Saitama, Japan	RIKEN	Hirabayashi, Y (corresponding author), RIKEN, Brain Sci Inst, Mol Membrane Neurosci, Wako, Saitama, Japan.	hirabaya@riken.jp	香山, 綾子/ABF-4396-2021	香山, 綾子/0000-0002-7632-7953; Hirabayashi, Yoshio/0000-0002-5774-7354	RIKEN Brain Science Institute; General Research Grant from Nestle Nutrition Council, Japan	RIKEN Brain Science Institute; General Research Grant from Nestle Nutrition Council, Japan	This work was supported in part by grants from the RIKEN Brain Science Institute (to YH) and by 2010 General Research Grant from Nestle Nutrition Council, Japan (to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; Badisco L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00202; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; Kannan K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00288; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Kohyama-Koganeya A, 2008, P NATL ACAD SCI USA, V105, P15328, DOI 10.1073/pnas.0807833105; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; Li SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076131; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Nassel DR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00252; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Padmanabha D, 2014, TRENDS ENDOCRIN MET, V25, P518, DOI 10.1016/j.tem.2014.03.011; Park JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029022; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Rajan A, 2011, DEV CELL, V21, P29, DOI 10.1016/j.devcel.2011.06.034; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Sano T, 2011, BIOCHEM BIOPH RES CO, V412, P460, DOI 10.1016/j.bbrc.2011.07.118; Shiraiwa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002191; Smith WW, 2014, PHYSIOL BEHAV, V136, P15, DOI 10.1016/j.physbeh.2014.01.017; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sunio A, 1999, MOL BIOL CELL, V10, P847, DOI 10.1091/mbc.10.4.847; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006	35	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133083	10.1371/journal.pone.0133083	http://dx.doi.org/10.1371/journal.pone.0133083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193363	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400054
J	Guardia, GDA; Pires, LF; Vencio, RZN; Malmegrim, KCR; de Farias, CRG				Guardia, Gabriela D. A.; Pires, Luis Ferreira; Vencio, Ricardo Z. N.; Malmegrim, Kelen C. R.; de Farias, Clever R. G.			A Methodology for the Development of RESTful Semantic Web Services for Gene Expression Analysis	PLOS ONE			English	Article							BIOINFORMATICS SOFTWARE; RNA-SEQ; TOOL; ONTOLOGY; UNIFICATION; INTEGRATION; PROFILE; SYSTEM	Gene expression studies are generally performed through multi-step analysis processes, which require the integrated use of a number of analysis tools. In order to facilitate tool/data integration, an increasing number of analysis tools have been developed as or adapted to semantic web services. In recent years, some approaches have been defined for the development and semantic annotation of web services created from legacy software tools, but these approaches still present many limitations. In addition, to the best of our knowledge, no suitable approach has been defined for the functional genomics domain. Therefore, this paper aims at defining an integrated methodology for the implementation of RESTful semantic web services created from gene expression analysis tools and the semantic annotation of such services. We have applied our methodology to the development of a number of services to support the analysis of different types of gene expression data, including microarray and RNASeq. All developed services are publicly available in the Gene Expression Analysis Services (GEAS) Repository at http://dcm.ffclrp.usp.br/lssb/geas. Additionally, we have used a number of the developed services to create different integrated analysis scenarios to reproduce parts of two gene expression studies documented in the literature. The first study involves the analysis of one-color microarray data obtained from multiple sclerosis patients and healthy donors. The second study comprises the analysis of RNA-Seq data obtained from melanoma cells to investigate the role of the remodeller BRG1 in the proliferation and morphology of these cells. Our methodology provides concrete guidelines and technical details in order to facilitate the systematic development of semantic web services. Moreover, it encourages the development and reuse of these services for the creation of semantically integrated solutions for gene expression analysis.	[Guardia, Gabriela D. A.; Vencio, Ricardo Z. N.; de Farias, Clever R. G.] Univ Sao Paulo, Fac Philosophy Sci & Letters Ribeirao Preto FFCLR, Dept Comp Sci & Math, BR-14049 Ribeirao Preto, Brazil; [Pires, Luis Ferreira] Univ Twente, Fac Elect Engn Math & Comp Sci, NL-7500 AE Enschede, Netherlands; [Malmegrim, Kelen C. R.] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Clin Toxicol & Bromatol Anal, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo; University of Twente; Universidade de Sao Paulo	de Farias, CRG (corresponding author), Univ Sao Paulo, Fac Philosophy Sci & Letters Ribeirao Preto FFCLR, Dept Comp Sci & Math, BR-14049 Ribeirao Preto, Brazil.	farias@ffclrp.usp.br	de Farias, Clever R. G./M-3639-2016; Malmegrim, Kelen/H-1016-2015	de Farias, Clever R. G./0000-0002-8105-2923; Malmegrim, Kelen/0000-0002-9303-0086; Ferreira Pires, Luis/0000-0001-7432-7653	Brazilian Ministry of Education (CAPES)	Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Publication for this article has been funded by the Brazilian Ministry of Education (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartocci E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S2; Belouadha F, 2010, INT J COMPUTER SCI I, V7, P7; Benslimane D, 2008, IEEE INTERNET COMPUT, V12, P13, DOI 10.1109/MIC.2008.110; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; Cardoso J, 2005, LECT NOTES COMPUT SC, V3387, P1; Corcho O, 2003, DATA KNOWL ENG, V46, P41, DOI 10.1016/S0169-023X(02)00195-7; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Oliveira GLV, 2015, CELL TRANSPLANT, V24, P151, DOI 10.3727/096368913X675142; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Fernandez-Lopez M, 2002, KNOWL ENG REV, V17, P129, DOI 10.1017/S0269888902000462; Fielding Roy Thomas, 2000, THESIS U CALIFORNIA; Flanagan D, 2006, JAVASCRIPT DEFINITIV, V5th; Gamma E., 1994, DESIGN PATTERNS ELEM; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gomadam K, 2005, 4 INT SEM WEB C ISWC; Gordon Paul M. K., 2008, 2008 IEEE International Conference on Web Services (ICWS), P608, DOI 10.1109/ICWS.2008.112; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guardia GDA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S5-S3; Hunter J., 2001, JAVA SERVLET PROGRAM; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Knublauch H, 2004, LECT NOTES COMPUT SC, V3298, P229; Kumar S, 2007, BIOINFORMATICS, V23, P1713, DOI 10.1093/bioinformatics/btm239; Laitkorpi M, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON WEB SERVICES, VOLS 1 AND 2, P173, DOI 10.1109/ICWS.2009.63; Laurette P, 2015, ELIFE, V4, DOI 10.7554/eLife.06857; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; McIlraith SA, 2001, IEEE INTELL SYST APP, V16, P46, DOI 10.1109/5254.920599; Miyazaki FA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S6-S2; Neerincx PBT, 2005, BRIEF BIOINFORM, V6, P178, DOI 10.1093/bib/6.2.178; Object Management Group, 2011, OMG UN MOD LANG INFR; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; Oldevik J, 2011, P 1 INT WORKSH MOD D, P4; Pautasso C., 2008, P 17 INT C WORLD WID, P805, DOI DOI 10.1145/1367497.1367606; Pettifer S, 2010, NUCLEIC ACIDS RES, V38, pW683, DOI 10.1093/nar/gkq297; Pettifer S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S19; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rserve Urbanek S., 2003, P 3 INT WORKSH DISTR; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shannon PT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-176; Sheth A, 2006, COMMUN ACM, V49, P55, DOI 10.1145/1139922.1139949; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun Microsystems, 2008, JAX RS JAV API RESTF; Sun Microsystems, 2006, JAV ARCH XML BIND JA; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkinson MD, 2011, J BIOMED SEMANT, V2, DOI 10.1186/2041-1480-2-8; World Wide Web Consortium, 2012, OWL 2 WEB ONT LANG S; World Wide Web Consortium, 2010, SA REST SEM ANN WEB; World Wide Web Consortium, 2007, SOAP VERS 1 2 1; World Wide Web Consortium, 2004, OWL S SEM MARK WEB S; World Wide Web Consortium, 2008, SPARQL QUERY LANGUAG; World Wide Web Consortium, 2007, XSL TRANSF XSLT VERS; World Wide Web Consortium, 2007, SEM ANN WSDL XML SCH; World Wide Web Consortium, 2007, WEB SERV DESCR LANG; Yan Liu, 2008, 2008 IEEE 32nd International Computer Software and Applications Conference (COMPSAC), P785, DOI 10.1109/COMPSAC.2008.89; Zhang M, 2008, INT C COMP SUPP COOP, P470; Zhang Z, 2009, BRIEF BIOINFORM, V10, P1, DOI 10.1093/bib/bbn041	65	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134011	10.1371/journal.pone.0134011	http://dx.doi.org/10.1371/journal.pone.0134011			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207740	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000190
J	Schyth, BD; Bela-ong, DB; Jalali, SAH; Kristensen, LBJ; Einer-Jensen, K; Pedersen, FS; Lorenzen, N				Schyth, Brian Dall; Bela-ong, Dennis Berbulla; Jalali, Seyed Amir Hossein; Kristensen, Lasse Bogelund Juel; Einer-Jensen, Katja; Pedersen, Finn Skou; Lorenzen, Niels			Two Virus-Induced MicroRNAs Known Only from Teleost Fishes Are Orthologues of MicroRNAs Involved in Cell Cycle Control in Humans	PLOS ONE			English	Article							HEMORRHAGIC SEPTICEMIA VIRUS; IMMUNE-RESPONSE; EMERGING PLAYER; MIRNA GENES; EXPRESSION; RNA; TRANSCRIPTION; PROTEIN; GAMMA; INFECTION	MicroRNAs (miRNAs) are similar to 22 base pair-long non-coding RNAs which regulate gene expression in the cytoplasm of eukaryotic cells by binding to specific target regions in mRNAs to mediate transcriptional blocking or mRNA cleavage. Through their fundamental roles in cellular pathways, gene regulation mediated by miRNAs has been shown to be involved in almost all biological phenomena, including development, metabolism, cell cycle, tumor formation, and host-pathogen interactions. To address the latter in a primitive vertebrate host, we here used an array platform to analyze the miRNA response in rainbow trout (Oncorhynchus mykiss) following inoculation with the virulent fish rhabdovirus Viral hemorrhagic septicaemia virus. Two clustered miRNAs, miR-462 and miR-731 (herein referred to as miR-462 cluster), described only in teleost fishes, were found to be strongly upregulated, indicating their involvement in fish-virus interactions. We searched for homologues of the two teleost miRNAs in other vertebrate species and investigated whether findings related to ours have been reported for these homologues. Gene synteny analysis along with gene sequence conservation suggested that the teleost fish miR-462 and miR-731 had evolved from the ancestral miR-191 and miR-425 (herein called miR-191 cluster), respectively. Whereas the miR-462 cluster locus is found between two protein-coding genes (intergenic) in teleost fish genomes, the miR-191 cluster locus is found within an intron of a protein-coding gene (intragenic) in the human genome. Interferon (IFN)-inducible and immune-related promoter elements found upstream of the teleost miR-462 cluster locus suggested roles in immune responses to viral pathogens in fish, while in humans, the miR-191 cluster functionally associated with cell cycle regulation. Stimulation of fish cell cultures with the IFN inducer poly I:C accordingly upregulated the expression of miR-462 and miR-731, while no stimulatory effect on miR-191 and miR-425 expression was observed in human cell lines. Despite high sequence conservation, evolution has thus resulted in different regulation and presumably also different functional roles of these orthologous miRNA clusters in different vertebrate lineages.	[Schyth, Brian Dall; Bela-ong, Dennis Berbulla; Kristensen, Lasse Bogelund Juel] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Bela-ong, Dennis Berbulla; Lorenzen, Niels] Aarhus Univ, Dept Anim Sci, Fish Hlth Sect, Aarhus N, Denmark; [Jalali, Seyed Amir Hossein] Isfahan Univ Technol, Inst Biotechnol & Bioengn, Esfahan, Iran; [Kristensen, Lasse Bogelund Juel; Pedersen, Finn Skou] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Einer-Jensen, Katja] QIAGEN AAR, Aarhus C, Denmark	Technical University of Denmark; Aarhus University; Isfahan University of Technology; Aarhus University	Bela-ong, DB (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	dbelaong@alumni.nus.edu.sg; niels.lorenzen@anis.au.dk	Bela-ong, Dennis/H-6782-2019; Lorenzen, Niels/L-3967-2017	Bela-ong, Dennis/0000-0002-9483-3542; Lorenzen, Niels/0000-0002-6946-3252; Jalali, Seyed Amir Hossein/0000-0003-1381-0865	Danish Research Council for Technology and Production Sciences [26-03-0059, 274-05-0585]; Lundbeck Foundation [52/03]; European Commission [FP6007103 IMAQUANIM]; John Birthe Meyer Foundation	Danish Research Council for Technology and Production Sciences; Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); John Birthe Meyer Foundation	This work was supported through grants to NL: Grant nos. 26-03-0059 and 274-05-0585 from the Danish Research Council for Technology and Production Sciences (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council-1/the-danish-council-for-independent-research-technology-and-production-sciences); grant no. 52/03 from the Lundbeck Foundation (http://www.lundbeckfoundation.com/Frontpage.327.aspx); the European Commission (http://ec.europa.eu/index_en.htm) through contract FP6007103 IMAQUANIM; and the John Birthe Meyer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson MK, 2001, P NATL ACAD SCI USA, V98, P553, DOI 10.1073/pnas.021478998; Andreassen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-482; Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bela-ong DB, 2015, VACCINE, V33, P3215, DOI 10.1016/j.vaccine.2015.04.092; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Castro R, 2008, MOL IMMUNOL, V45, P3454, DOI 10.1016/j.molimm.2008.03.015; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cheng JC, 2012, CELL MOL LIFE SCI, V69, P2621, DOI 10.1007/s00018-012-0940-6; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; DALY C, 1993, MOL CELL BIOL, V13, P3756, DOI 10.1128/MCB.13.6.3756; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Einer-Jensen K, 2014, J GEN VIROL, V95, P307, DOI 10.1099/vir.0.057448-0; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Fender A., 2013, MICRORNAS MED; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Gao L, 2013, J VIROL, V87, P8808, DOI 10.1128/JVI.00718-13; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gong BD, 2010, INT J MOL MED, V25, P853, DOI 10.3892/ijmm_00000414; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Grinchuk OV, 2010, NUCLEIC ACIDS RES, V38, P534, DOI 10.1093/nar/gkp954; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He YH, 2011, NEOPLASIA, V13, P841, DOI 10.1593/neo.11698; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hu ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4263; ICTV, 2012, VIR TAX 2011 REL; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Isshiki T, 2001, DIS AQUAT ORGAN, V47, P87, DOI 10.3354/dao047087; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lena AM, 2012, BIOCHEM BIOPH RES CO, V423, P509, DOI 10.1016/j.bbrc.2012.05.153; Li SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S8; Lin JM, 2013, MODERN PATHOL, V26, P148, DOI 10.1038/modpathol.2012.131; Liu X, 2012, IMMUNOL LETT, V143, P208, DOI 10.1016/j.imlet.2012.02.014; Lorenzen N, 2002, FISH SHELLFISH IMMUN, V12, P439, DOI 10.1006/fsim.2002.0422; Ma J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-40; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Nagpal N, 2013, CARCINOGENESIS, V34, P1889, DOI 10.1093/carcin/bgt107; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Netterwald J, 2005, J VIROL, V79, P5035, DOI 10.1128/JVI.79.8.5035-5046.2005; Olesen NJ, 1998, J APPL ICHTHYOL, V14, P173, DOI 10.1111/j.1439-0426.1998.tb00638.x; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng WZ, 2014, INT J MOL SCI, V15, P4031, DOI 10.3390/ijms15034031; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Ribas L, 2008, FISH SHELLFISH IMMUN, V24, P35, DOI 10.1016/j.fsi.2007.07.009; RIO DC, 1985, SCIENCE, V227, P23, DOI 10.1126/science.2981116; Ross K., 1995, Bulletin of the European Association of Fish Pathologists, V14, P213; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Rust K, 1996, AM J RESP CELL MOL, V14, P121, DOI 10.1165/ajrcmb.14.2.8630261; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schyth BD, 2007, MOL THER, V15, P1366, DOI 10.1038/sj.mt.6300150; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shen J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-47; Shintani S, 2000, P NATL ACAD SCI USA, V97, P7417, DOI 10.1073/pnas.110505597; Sisk JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-95; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Smail DA, 1999, FISH DISEASES AND DISORDERS, VOL 3, P123; Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11; Sperling EA, 2008, ANIMAL EVOLUTION: GENOMES, FOSSILS, AND TREES, P157; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Swaminathan G, 2013, PHYSIOL GENOMICS, V45, P1035, DOI 10.1152/physiolgenomics.00112.2013; Tarver JE, 2013, MOL BIOL EVOL, V30, P2369, DOI 10.1093/molbev/mst133; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Thoulouze MI, 2004, J VIROL, V78, P4098, DOI 10.1128/JVI.78.8.4098-4107.2004; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; USDA-APHIS, 2008, FED ORD PREV SPREAD; USDA-APHIS (US Department of Agriculture-Animal and Plant Health Inspection Service), 2008, REG SPEC SUSC VHSV U; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vestergard JOrgensen P. E., 1974, THESIS COPENHAGEN, P1; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu SS, 2015, DEV COMP IMMUNOL, V48, P124, DOI 10.1016/j.dci.2014.09.012; Xu J, 2013, GENOME RES, V23, P1810, DOI 10.1101/gr.148916.112; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Zhang JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081366; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhang Y, 2013, J ZHEJIANG UNIV-SC B, V14, P1, DOI 10.1631/jzus.B1200292; Zhuo Y, 2013, CELL PHYSIOL BIOCHEM, V32, P499, DOI 10.1159/000354455; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484	103	34	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132434	10.1371/journal.pone.0132434	http://dx.doi.org/10.1371/journal.pone.0132434			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207374	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000028
J	Gilca, R; Skowronski, DM; Douville-Fradet, M; Amini, R; Boulianne, N; Rouleau, I; Martineau, C; Charest, H; De Serres, G				Gilca, Rodica; Skowronski, Danuta M.; Douville-Fradet, Monique; Amini, Rachid; Boulianne, Nicole; Rouleau, Isabelle; Martineau, Christine; Charest, Hugues; De Serres, Gaston			Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015	PLOS ONE			English	Article							VIRUS; ASSOCIATION; INFECTION; EFFICACY	Background The 2014/15 influenza season in Canada was characterized by an early epidemic due to vaccine-mismatched influenza A(H3N2) viruses, disproportionately affecting elderly individuals >= 65-years-old. We assessed vaccine effectiveness (VE) against A(H3N2) hospitalization among elderly individuals during the peak weeks of the 2014/15 epidemic in Quebec, Canada. Methods Nasal specimens and clinical/epidemiological data were collected within 7 days of illness onset from elderly patients admitted with respiratory symptoms to one of four participating hospitals between November 30, 2014 and January 13, 2015. Cases tested RT-PCR positive for influenza A(H3N2) and controls tested negative for any influenza. VE was assessed by test-negative case-control design. Results There were 314 participants including 186 cases (62% vaccinated) and 128 controls (59% vaccinated) included in primary VE analysis. Median age was 81.5 years, two-thirds were admitted from the community and 91% had underlying comorbidity. Crude VE against A (H3N2) hospitalization was -17% (95% CI: -86% to 26%), decreasing to -23% (95% CI: -99 to 23%) with adjustment for age and comorbidity, and to -39% (95% CI: -142 to 20%) with additional adjustment for specimen collection interval, calendar time, type of residence and hospital. In sensitivity analyses, VE estimates were improved toward the null with restriction to participants admitted from the community (-2%; 95% CI: -105 to 49%) or with specimen collection <= 4 days since illness onset (-8%; 95% CI: -104 to 43%) but further from the null with restriction to participants with comorbidity (-51%; 95% CI: -169 to 15%). Conclusion The 2014/15 mismatched influenza vaccine provided elderly patients with no cross-protection against hospitalization with the A(H3N2) epidemic strain, reinforcing the need for adjunct protective measures among high-risk individuals and improved vaccine options.	[Gilca, Rodica; Douville-Fradet, Monique; Amini, Rachid; Boulianne, Nicole; De Serres, Gaston] Inst Natl Sante Publ Quebec, Biol Environm & Occupat Risks, Quebec City, PQ, Canada; [Gilca, Rodica; Boulianne, Nicole; De Serres, Gaston] CHU Quebec, Quebec City, PQ, Canada; [Gilca, Rodica; De Serres, Gaston] Univ Laval, Quebec City, PQ, Canada; [Skowronski, Danuta M.] British Columbia Ctr Dis Control, Influenza & Emerging Resp Pathogens, Vancouver, BC, Canada; [Rouleau, Isabelle] Minist Sante & Serv Sociaux Quebec, Bur Surveillance & Vigie, Quebec City, PQ, Canada; [Martineau, Christine; Charest, Hugues] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Montreal, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Laval University; Laval University; Institut national de sante publique du Quebec (INSPQ)	Gilca, R (corresponding author), Inst Natl Sante Publ Quebec, Biol Environm & Occupat Risks, Quebec City, PQ, Canada.	rodica.gilca@inspq.qc.ca		Martineau, Christine/0000-0003-2020-2657	Minsitry of Health of Quebec	Minsitry of Health of Quebec	The Minsitry of Health of Quebec provided financial support for this project. IR from the funding source contributed to the analysis and preparation of the manuscript.	BC Centre for Disease Control, INFL SURV REP BC INF; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Centers for Disease Control and Prevention, 2005, REAL TIM RT PCR RRT; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; De Serres G, 2013, EURO SURVEILL, V18, P37; Dube E, 2015, ENQUETE QUEBECOISE V; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; Gilca R, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu086; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; McNeil S, 2013, EFFECTIVENESS 2012 1; McNeil SA, 2015, EURO SURVEILL, V20, P21024; McNeil SA, 2014, EURO SURVEILL, V19; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Oughton M, 2011, DIAGN MICR INFEC DIS, V70, P213, DOI 10.1016/j.diagmicrobio.2010.12.013; Pabbaraju K, 2008, J CLIN MICROBIOL, V46, P3056, DOI 10.1128/JCM.00878-08; Pebody RG, 2015, EUROSURVEILLANCE, V20, P6, DOI [10.2807/1560-7917.ES2015.20.5.21025, 10.2807/1560-7917.ES.2015.20.36.30013]; Rondy M, 2015, EURO SURVEILL, V20; SKOWRONSKI D, 2015, EUROSURVEILLANCE, V20, P1, DOI DOI 10.2807/1560-7917.ES.2015.20.43.30047; Skowronski DM, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.5.20690; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086555; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skull SA, 2007, VACCINE, V25, P4775, DOI 10.1016/j.vaccine.2007.04.015; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tsuchihashi Y, 2012, CLIN INFECT DIS, V54, P381, DOI 10.1093/cid/cir787; van der Werf S, 2015, Euro Surveill, V20, P21030; World Health Organization (WHO), 2014, REC COMP INFL VIR VA	34	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132195	10.1371/journal.pone.0132195	http://dx.doi.org/10.1371/journal.pone.0132195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200655	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100028
J	Venn-Watson, SK; Parry, C; Baird, M; Stevenson, S; Carlin, K; Daniels, R; Smith, CR; Jones, R; Wells, RS; Ridgway, S; Jensen, ED				Venn-Watson, Stephanie K.; Parry, Celeste; Baird, Mark; Stevenson, Sacha; Carlin, Kevin; Daniels, Risa; Smith, Cynthia R.; Jones, Richard; Wells, Randall S.; Ridgway, Sam; Jensen, Eric D.			Increased Dietary Intake of Saturated Fatty Acid Heptadecanoic Acid (C17:0) Associated with Decreasing Ferritin and Alleviated Metabolic Syndrome in Dolphins	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; INSULIN-RESISTANCE; DIABETES-MELLITUS; DAIRY CONSUMPTION; FISH CONSUMPTION; ARACHIDONIC-ACID; SERUM FERRITIN; LIVER-DISEASE; JAPANESE MEN	Similar to humans, bottlenose dolphins (Tursiops truncatus) can develop metabolic syndrome and associated high ferritin. While fish and fish-based fatty acids may protect against metabolic syndrome in humans, findings have been inconsistent. To assess potential protective factors against metabolic syndrome related to fish diets, fatty acids were compared between two dolphin populations with higher (n = 30, Group A) and lower (n = 19, Group B) mean insulin (11 +/- 12 and 2 +/- 5 mu IU/ml, respectively; P < 0.0001) and their dietary fish. In addition to higher insulin, triglycerides, and ferritin, Group A had lower percent serum heptadecanoic acid (C17:0) compared to Group B (0.3 +/- 0.1 and 1.3 +/- 0.4%, respectively; P < 0.0001). Using multivariate stepwise regression, higher percent serum C17:0, a saturated fat found in dairy fat, rye, and some fish, was an independent predictor of lower insulin in dolphins. Capelin, a common dietary fish for Group A, had no detectable C17:0, while pin-fish and mullet, common in Group B's diet, had C17:0 (41 and 67 mg/100g, respectively). When a modified diet adding 25% pinfish and/or mullet was fed to six Group A dolphins over 24 weeks (increasing the average daily dietary C17:0 intake from 400 to 1700 mg), C17:0 serum levels increased, high ferritin decreased, and blood-based metabolic syndrome indices normalized toward reference levels. These effects were not found in four reference dolphins. Further, higher total serum C17:0 was an independent and linear predictor of lower ferritin in dolphins in Group B dolphins. Among off the shelf dairy products tested, butter had the highest C17:0 (423mg/100g); nonfat dairy products had no detectable C17:0. We hypothesize that humans' movement away from diets with potentially beneficial saturated fatty acid C17:0, including whole fat dairy products, could be a contributor to widespread low C17:0 levels, higher ferritin, and metabolic syndrome.	[Venn-Watson, Stephanie K.; Parry, Celeste; Baird, Mark; Stevenson, Sacha; Carlin, Kevin; Daniels, Risa; Smith, Cynthia R.; Ridgway, Sam] Natl Marine Mammal Fdn, Translat Med & Res Program, San Diego, CA 92106 USA; [Jones, Richard] Kennedy Krieger Inst, Baltimore, MD USA; [Wells, Randall S.] Chicago Zool Soc Mote Marine Lab, Sarasota, FL USA; [Jensen, Eric D.] US Navy Marine Mammal Program, San Diego, CA USA	Kennedy Krieger Institute; Mote Marine Laboratory & Aquarium; United States Department of Defense; United States Navy	Venn-Watson, SK (corresponding author), Natl Marine Mammal Fdn, Translat Med & Res Program, San Diego, CA 92106 USA.	stephanie.venn-watson@nmmf.org		Ridgway, Sam/0000-0001-7474-9880	Office of Naval Research Grant [N000141210294]	Office of Naval Research Grant(Office of Naval Research)	This study was funded by the Office of Naval Research Grant Number N000141210294. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MMH, 2015, BRIT J NUTR, V113, P435, DOI 10.1017/S0007114514003894; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Anderson AJC, 1954, MARGARINE; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Benatar JR, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-32; Berens McCabe Elizabeth J., 2010, Marine Biology (Berlin), V157, P931; Centers for Disease Control, 2020, NATL DIABETES STAT R; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Choi KM, 2005, METABOLISM, V54, P1510, DOI 10.1016/j.metabol.2005.05.018; Ellervik C, 2001, LANCET, V358, P1405, DOI 10.1016/S0140-6736(01)06526-6; Fernandes R, 2013, DIS MARKERS, V2013, P105, DOI 10.1155/2013/913715; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; GIBSON RA, 1983, LIPIDS, V18, P743, DOI 10.1007/BF02534631; GLAUBER H, 1988, ANN INTERN MED, V108, P663, DOI 10.7326/0003-4819-108-5-663; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Johnson SP, 2009, JAVMA-J AM VET MED A, V235, P194, DOI 10.2460/javma.235.2.194; Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005; Lagerstedt SA, 2001, MOL GENET METAB, V73, P38, DOI 10.1006/mgme.2001.3170; Luzia LA, 2003, FOOD CHEM, V83, P93, DOI 10.1016/S0308-8146(03)00054-2; Magnusdottir OK, 2014, EUR J CLIN NUTR, V68, P453, DOI 10.1038/ejcn.2014.12; Mansson HL, 2008, FOOD NUTR RES, V52, P4; Maruyama C, 2008, J ATHEROSCLER THROMB, V15, P306, DOI 10.5551/jat.E564; Mazzaro LM, 2012, COMPARATIVE MED, V62, P508; Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5; Nanri A, 2011, AM J CLIN NUTR, V94, P884, DOI 10.3945/ajcn.111.012252; Ozogul Y, 2007, FOOD CHEM, V103, P217, DOI 10.1016/j.foodchem.2006.08.009; Patel PS, 2009, DIABETES CARE, V32, P1857, DOI 10.2337/dc09-0116; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Pfeuffer M, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2006.00265.x; Phillips BE, 2014, J WILDLIFE DIS, V50, P891, DOI 10.7589/2013-08-212; POPPSNIJDERS C, 1987, DIABETES RES CLIN EX, V4, P141; Ruidavets JB, 2007, J EPIDEMIOL COMMUN H, V61, P810, DOI 10.1136/jech.2006.052126; Sandrou DK, 2000, CRIT REV FOOD SCI, V40, P427, DOI 10.1080/10408690091189211; Slifka KA, 2013, INTERNET J VET MED, V10, P1, DOI DOI 10.1638/2014-0064R1.1; Suresh Y, 2001, PROSTAG LEUKOTR ESS, V64, P37, DOI 10.1054/plef.2000.0236; Swaminathan S, 2007, DIABETES CARE, V30, P1926, DOI 10.2337/dc06-2625; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Venn-Watson S, 2008, J WILDLIFE DIS, V44, P318, DOI 10.7589/0090-3558-44.2.318; Venn-Watson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126538; Venn-Watson Stephanie, 2013, Front Endocrinol (Lausanne), V4, P136, DOI 10.3389/fendo.2013.00136; Venn-Watson S, 2012, J ZOO WILDLIFE MED, V43, pS35, DOI 10.1638/2011-0146.1; Venn-Watson S, 2011, GEN COMP ENDOCR, V170, P193, DOI 10.1016/j.ygcen.2010.10.005; Venn-Watson SK, 2015, JAVMA-J AM VET MED A, V246, P893, DOI 10.2460/javma.246.8.893; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wells R.S., 2014, PRIMATES CETACEANS F, P149, DOI DOI 10.1007/978-4-431-54523-1_8; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells Randall S, 2013, Front Endocrinol (Lausanne), V4, P139, DOI 10.3389/fendo.2013.00139; Xun PC, 2012, DIABETES CARE, V35, P930, DOI 10.2337/dc11-1869	50	48	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132117	10.1371/journal.pone.0132117	http://dx.doi.org/10.1371/journal.pone.0132117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200116	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100025
J	D'Anna, C; Schmid, M; Bibbo, D; Bertollo, M; Comani, S; Conforto, S				D'Anna, Carmen; Schmid, Maurizio; Bibbo, Daniele; Bertollo, Maurizio; Comani, Silvia; Conforto, Silvia			The Effect of Continuous and Discretized Presentations of Concurrent Augmented Visual Biofeedback on Postural Control in Quiet Stance	PLOS ONE			English	Article							STANDING BALANCE; STROKE PATIENTS; HEALTHY-ADULTS; UPRIGHT STANCE; EXTERNAL-FOCUS; OLDER-ADULTS; FEEDBACK; SWAY; PRESSURE; YOUNG	The purpose of this study was to evaluate the effect of a continuous and a discretized Visual Biofeedback (VBF) on balance performance in upright stance. The coordinates of the Centre of Pressure (CoP), extracted from a force plate, were processed in real-time to implement the two VBFs, administered to two groups of 12 healthy participants. In the first group, a representation of the CoP was continuously shown, while in the second group, the discretized VBF was provided at an irregular frequency (that depended on the subject's performance) by displaying one out of a set of five different emoticons, each corresponding to a specific area covered by the current position of the CoP. In the first case, participants were asked to maintain a white spot within a given square area, whereas in the second case they were asked to keep the smiling emoticon on. Trials with no VBF were administered as control. The effect of the two VBFs on balance was studied through classical postural parameters and a subset of stabilogram diffusion coefficients. To quantify the amount of time spent in stable conditions, the percentage of time during which the CoP was inside the stability area was calculated. Both VBFs improved balance maintainance as compared to the absence of any VBF. As compared to the continuous VBF, in the discretized VBF a significant decrease of sway path, diffusion and Hurst coefficients was found. These results seem to indicate that a discretized VBF favours a more natural postural behaviour by promoting a natural intermittent postural control strategy.	[D'Anna, Carmen; Schmid, Maurizio; Bibbo, Daniele; Conforto, Silvia] Roma Tre Univ, Dept Engn, Rome, Italy; [Bertollo, Maurizio] Univ G DAnnunzio, Dept Basic & Appl Med Sci, Chieti, Italy; [Comani, Silvia] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [D'Anna, Carmen; Schmid, Maurizio; Bibbo, Daniele; Bertollo, Maurizio; Comani, Silvia; Conforto, Silvia] Univ G DAnnunzio, Behav Imaging & Neural Dynam Ctr BIND, Chieti, Italy	Roma Tre University; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	D'Anna, C (corresponding author), Roma Tre Univ, Dept Engn, Rome, Italy.	carmen.danna@uniroma3.it	D'Anna, Carmen/AAE-1667-2019; Schmid, Maurizio/E-5140-2010; D'Anna, Carolina/P-3831-2019; Bertollo, Maurizio/K-5469-2013	D'Anna, Carmen/0000-0003-3271-3075; Schmid, Maurizio/0000-0003-3380-6994; Bertollo, Maurizio/0000-0002-0972-9178; COMANI, Silvia/0000-0001-8100-457X; Bibbo, Daniele/0000-0003-1341-5427				Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Balasubramaniam R, 2002, TRENDS COGN SCI, V6, P531, DOI 10.1016/S1364-6613(02)02021-1; Bechly KE, 2013, GAIT POSTURE, V37, P391, DOI 10.1016/j.gaitpost.2012.08.007; Bibbo D, 2012, PROC SPIE, V8295, DOI 10.1117/12.910605; Borg G, 2001, INT J SPORT PSYCHOL, V32, P110; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Caudron S, 2014, NEUROPHYSIOL CLIN, V44, P77, DOI 10.1016/j.neucli.2013.10.134; Cawsey RP, 2009, GAIT POSTURE, V29, P280, DOI 10.1016/j.gaitpost.2008.09.007; Chiari L, 2000, GAIT POSTURE, V12, P225, DOI 10.1016/S0966-6362(00)00086-2; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; Conforto S, 2001, GAIT POSTURE, V14, P28, DOI 10.1016/S0966-6362(01)00112-6; D'Anna C, 2014, 13 MED C MED BIOL EN, P1755; Dault MC, 2003, HUM MOVEMENT SCI, V22, P221, DOI 10.1016/S0167-9457(03)00034-4; Davis JR, 2010, GAIT POSTURE, V31, P465, DOI 10.1016/j.gaitpost.2010.02.002; DIENER HC, 1988, PROG BRAIN RES, V76, P253; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Goffredo M, 2006, MED ENG PHYS, V28, P719, DOI 10.1016/j.medengphy.2005.10.007; Goldie PA, 1996, CLIN BIOMECH, V11, P333, DOI 10.1016/0268-0033(96)00014-9; Hagger MS, 2001, J SPORT SCI, V19, P711, DOI 10.1080/02640410152475847; Halicka Z, 2014, GAIT POSTURE, V39, P410, DOI 10.1016/j.gaitpost.2013.08.005; Ikegami T, 2012, J NEUROSCI, V32, P653, DOI 10.1523/JNEUROSCI.4230-11.2012; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Kamen G, 1998, GERONTOLOGY, V44, P40, DOI 10.1159/000021981; Kapteyn T S, 1983, Agressologie, V24, P321; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Kiemel T, 2008, J NEUROPHYSIOL, V100, P3394, DOI 10.1152/jn.01272.2007; Laurens J, 2010, GAIT POSTURE, V31, P37, DOI 10.1016/j.gaitpost.2009.08.241; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Murnaghan CD, 2014, J NEUROPHYSIOL, V111, P1920, DOI 10.1152/jn.00853.2012; Nichols DS, 1997, PHYS THER, V77, P553, DOI 10.1093/ptj/77.5.553; Paillex R, 2005, GAIT POSTURE, V21, P403, DOI 10.1016/j.gaitpost.2004.04.011; Peterka RJ, 1998, IDENTIFYING CONTROL, P73; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; POULTON EC, 1966, PSYCHOL BULL, V66, P1, DOI 10.1037/h0023427; Rougier P, 2004, GAIT POSTURE, V19, P154, DOI 10.1016/S0966-6362(03)00056-0; Sackley C M, 1991, Int Disabil Stud, V13, P1; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Sayenko DG, 2012, GAIT POSTURE, V35, P339, DOI 10.1016/j.gaitpost.2011.10.005; Freitas SMSF, 2012, GAIT POSTURE, V35, P83, DOI 10.1016/j.gaitpost.2011.08.011; Schmid M, 2004, HUM MOVEMENT SCI, V23, P105, DOI 10.1016/j.humov.2004.06.001; Schmid M, 2002, MED ENG PHYS, V24, P623, DOI 10.1016/S1350-4533(02)00046-2; Schmid Maurizio, 2005, J Neuroeng Rehabil, V2, P29, DOI 10.1186/1743-0003-2-29; Schmidt R. A., 1991, TUTORIALS MOTOR NEUR; Severini G, 2012, J ELECTROMYOGR KINES, V22, P878, DOI 10.1016/j.jelekin.2012.04.010; Shea CH, 1999, HUM MOVEMENT SCI, V18, P553, DOI 10.1016/S0167-9457(99)00031-7; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Sullivan EV, 2009, NEUROBIOL AGING, V30, P793, DOI 10.1016/j.neurobiolaging.2007.08.021; Tanaka Hideyuki, 2002, J Hum Ergol (Tokyo), V31, P1; Torricelli D, 2008, COMPUT METH PROG BIO, V92, P66, DOI 10.1016/j.cmpb.2008.06.008; van der Kooij H, 2007, J NEUROPHYSIOL, V98, P730, DOI 10.1152/jn.00457.2006; Vannozzi G, 2010, J ELECTROMYOGR KINES, V20, P767, DOI 10.1016/j.jelekin.2010.02.007; Vuillerme N, 2007, EXP BRAIN RES, V179, P409, DOI 10.1007/s00221-006-0800-4; Wade MG, 1997, PHYS THER, V77, P619, DOI 10.1093/ptj/77.6.619; Walker C, 2000, PHYS THER, V80, P886, DOI 10.1093/ptj/80.9.886; Walther JB, 2001, SOC SCI COMPUT REV, V19, P324, DOI 10.1177/089443930101900307; Wulf G, 2001, PSYCHON B REV, V8, P648, DOI 10.3758/BF03196201; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G., 2013, INT REV SPORT EXERCI, V6, P77; Wulf G., 2010, EFFORTLESS ATTENTION, P75, DOI [10.7551/MITPRESS/9780262013840.003.0004, DOI 10.7551/MITPRESS/9780262013840.003.0004]	62	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132711	10.1371/journal.pone.0132711	http://dx.doi.org/10.1371/journal.pone.0132711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196518	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600048
J	Gao, YH; Zhao, HS; Zhang, FR; Gao, Y; Shen, P; Chen, RC; Zhang, GJ				Gao, Yong-hua; Zhao, Hua-si; Zhang, Fu-rui; Gao, Yang; Shen, Pamela; Chen, Rong-chang; Zhang, Guo-jun			The Relationship between Depression and Asthma: A Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							INCIDENT ASTHMA; MAJOR DEPRESSION; HIGHER RISK; COMORBIDITY; ASSOCIATION; DISORDERS; SYMPTOMS; ADULTS; EPIDEMIOLOGY; ADOLESCENTS	Background Previous studies have suggested that asthmatic patients often have comorbid depression; however, temporal associations remain unclear. Objectives To determine whether depression predicts asthma and, conversely, whether asthma predicts depression. Methods A literature search was conducted without language restrictions using Pubmed, Embase, Cochrane and PsycINFO for studies published before January, 2015. Papers referenced by the obtained articles were also reviewed. Only comparative prospective studies with reported risk estimates of the association between depression and asthma were included. In order to investigate whether one of these conditions was predictive of the other, studies were excluded if enrolled participants had pre-existing depression or asthma. A randomeffects model was used to calculate the pooled risk estimates for two outcomes: depression predicting asthma and asthma predicting depression. Results Seven citations, derived from 8 cohort studies, met our inclusion criteria. Of these, six studies reported that depression predicted incident adult-onset asthma, including 83684 participants and 2334 incident cases followed for 8 to 20 years. Conversely, two studies reported that asthma predicted incident depression. These studies involved 25566 participants and 2655 incident cases followed for 10 and 20 years, respectively. The pooled adjusted relative risks (RRs) of acquiring asthma associated with baseline depression was 1.43 (95% CI, 1.28-1.61) (P<0.001). The adjusted RRs for acquiring depression associated with baseline asthma was 1.23 (95% CI, 0.72-2.10) (P = 0.45). Conclusions Depression was associated with a 43% increased risk of developing adult-onset asthma. However, asthma did not increase the risk of depression based on limited studies. Further prospective studies ascertaining the true association between asthma and subsequent risk of depression are warranted.	[Gao, Yong-hua; Zhao, Hua-si; Zhang, Fu-rui; Zhang, Guo-jun] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou 450052, Henan, Peoples R China; [Gao, Yang; Chen, Rong-chang] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Shen, Pamela] McMaster Univ, Med Sci Grad Program, Hamilton, ON, Canada	Zhengzhou University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; McMaster University	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chenrc@vip.163.com; zhanggj1966@sina.com		Shen, Pamela/0000-0002-3187-8567	Ministry of Major Science and Technology of Henan [201302005]	Ministry of Major Science and Technology of Henan	This study was supported by the Ministry of Major Science and Technology of Henan (201302005).	Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Brumpton B, 2013, INT J EPIDEMIOL, V42, P1455, DOI 10.1093/ije/dyt151; Brunner WM, 2014, AM J RESP CRIT CARE, V189, P1044, DOI 10.1164/rccm.201307-1349OC; Chen MH, 2014, J AFFECT DISORDERS, V156, P232, DOI 10.1016/j.jad.2013.10.053; Chen MH, 2014, J PSYCHIATR RES, V49, P25, DOI 10.1016/j.jpsychires.2013.10.015; Chen YC, 2013, OBES REV, V14, P222, DOI 10.1111/j.1467-789X.2012.01055.x; Chida Y, 2008, PSYCHOSOM MED, V70, P102, DOI 10.1097/PSY.0b013e31815c1b71; Coogan PF, 2014, ANN ALLERG ASTHMA IM, V112, P333, DOI 10.1016/j.anai.2013.12.025; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jiang MD, 2014, J AFFECT DISORDERS, V166, P22, DOI 10.1016/j.jad.2014.04.027; JONAS BS, 1999, J APPL BIOBEHAVIORAL, V4, P91; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P381, DOI 10.1001/archgenpsychiatry.2011.1603; Loerbroks A, 2010, PSYCHOSOM MED, V72, P309, DOI 10.1097/PSY.0b013e3181d2f0f1; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Thomson NC, 2004, EUR RESPIR J, V24, P822, DOI 10.1183/09031936.04.00039004; Tinuoye O, 2013, NICOTINE TOB RES, V15, P1475, DOI 10.1093/ntr/ntt033; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Van Lieshout RJ, 2009, PSYCHOSOM MED, V71, P187, DOI 10.1097/PSY.0b013e3181907012; Voynow JA, 2011, BBA-GEN SUBJECTS, V1810, P1091, DOI 10.1016/j.bbagen.2011.04.016; Walters P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020750	24	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132424	10.1371/journal.pone.0132424	http://dx.doi.org/10.1371/journal.pone.0132424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197472	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600034
J	Seo, Y; Park, J; Kim, M; Lee, HK; Kim, JH; Jeong, JH; Namkung, W				Seo, Yohan; Park, Jinhong; Kim, Minseo; Lee, Ho K.; Kim, Jin-Hee; Jeong, Jin-Hyun; Namkung, Wan			Inhibition of ANO1/TMEM16A Chloride Channel by Idebenone and Its Cytotoxicity to Cancer Cell Lines	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNEL; CARCINOMA; TMEM16A; ANO1; MICONAZOLE; EXPRESSION; MIGRATION; PLUMBAGIN; PROGRESSION; METABOLISM	The expression levels of anoctamin 1 (ANO1, TMEM16A), a calcium-activated chloride channel (CaCC), are significantly increased in several tumors, and inhibition of ANO1 is known to reduce cell proliferation and migration. Here, we performed cell-based screening of a collection of natural products and drug-like compounds to identify inhibitors of ANO1. As a result of the screening, idebenone, miconazole and plumbagin were identified as novel ANO1 inhibitors. Electrophysiological studies showed that idebenone, a synthetic analog of coenzyme Q10, completely blocked ANO1 activity in FRT cells expressing ANO1 without any effect on intracellular calcium signaling and CFTR, a cAMP-regulated chloride channel. The CaCC activities in PC-3 and CFPAC-1 cells expressing abundant endogenous ANO1 were strongly blocked by idebenone. Idebenone inhibited cell proliferation and induced apoptosis in PC-3 and CFPAC-1 cells, but not in A549 cells, which do not express ANO1. These data suggest that idebenone, a novel ANO1 inhibitor, has potential for use in cancer therapy.	[Seo, Yohan; Park, Jinhong; Lee, Ho K.; Namkung, Wan] Yonsei Univ, Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea; [Kim, Minseo; Kim, Jin-Hee; Jeong, Jin-Hyun; Namkung, Wan] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon 406840, South Korea	Yonsei University; Yonsei University	Namkung, W (corresponding author), Yonsei Univ, Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea.	wnamkung@yonsei.ac.kr	서, 요한/AAZ-6433-2020; Kim, minseo/HHS-8532-2022	Seo, Yohan/0000-0002-9335-8604; Lee, Ho Kyun/0000-0003-1707-3217	Yonsei University Global Specialization Project; Grant of the Korea Healthcare technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea [HI08C2149]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1040142]	Yonsei University Global Specialization Project; Grant of the Korea Healthcare technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea)	This work was funded by Yonsei University Global Specialization Project of 2014, a Grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (HI08C2149) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology [NRF-2012R1A1A1040142].	Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; Berglund E, 2014, EXP CELL RES, V326, P315, DOI 10.1016/j.yexcr.2014.05.003; Bodmer M, 2009, EUR J CLIN PHARMACOL, V65, P493, DOI 10.1007/s00228-008-0596-1; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Buyse GM, 2011, NEUROMUSCULAR DISORD, V21, P396, DOI 10.1016/j.nmd.2011.02.016; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen CA, 2009, PANCREATOLOGY, V9, P797, DOI 10.1159/000210028; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Gutzmann H, 1998, J NEURAL TRANSM-SUPP, P301; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583; Jacobsen KS, 2013, PFLUG ARCH EUR J PHY, V465, P1753, DOI 10.1007/s00424-013-1315-z; Jamal MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087309; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Li YD, 2014, MED ORAL PATOL ORAL, V19, pE313, DOI 10.4317/medoral.19076; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Oh SJ, 2013, MOL PHARMACOL, V84, P726, DOI 10.1124/mol.113.087502; Park JY, 2014, CELL ONCOL, V37, P269, DOI 10.1007/s13402-014-0182-8; Parkinson MH, 2013, J NEUROCHEM, V126, P125, DOI 10.1111/jnc.12322; Pierard GE, 2012, EXPERT OPIN PHARMACO, V13, P1187, DOI 10.1517/14656566.2012.687047; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Shih YW, 2009, HEPATOL RES, V39, P998, DOI 10.1111/j.1872-034X.2009.00540.x; Thal LJ, 2003, NEUROLOGY, V61, P1498, DOI 10.1212/01.WNL.0000096376.03678.C1; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Wu CH, 2002, TOXICOL APPL PHARM, V180, P22, DOI 10.1006/taap.2002.9352; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	40	48	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133656	10.1371/journal.pone.0133656	http://dx.doi.org/10.1371/journal.pone.0133656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196390	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600127
J	Chang, HY; Sung, YH; Wang, SM; Lung, HL; Chang, JH; Hsu, CH; Jim, WT; Lee, CH; Hung, HF				Chang, Hung-Yang; Sung, Yi-Hsiang; Wang, Shwu-Meei; Lung, Hou-Ling; Chang, Jui-Hsing; Hsu, Chyong-Hsin; Jim, Wai-Tim; Lee, Ching-Hsiao; Hung, Hsiao-Fang			Short- and Long-Term Outcomes in Very Low Birth Weight Infants with Admission Hypothermia	PLOS ONE			English	Article							BODY-TEMPERATURE; VLBW INFANTS; BORN; ENVIRONMENT; MORTALITY; DELIVERY; WRAP	Background Neonatal hypothermia remains a common problem and is related to elevated morbidities and mortality. However, the long-term neurodevelopmental effects of admission hypothermia are still unknown. This study attempted to determine the short-term and long-term consequences of admission hypothermia in VLBW preterm infants. Study Design This retrospective study measured the incidence and compared the outcomes of admission hypothermia in very low birth weight (VLBW) preterm infants in a tertiary-level neonatal intensive care unit. Infants were divided into the following groups: normothermia (36.5-37.5 degrees C), mild hypothermia (36.0-36.4 degrees C), moderate hypothermia (32.0-35.9 degrees C), and severe hypothermia (< 32 degrees C). We compared the distribution, demographic variables, short-term outcomes, and neurodevelopmental outcomes at 24 months of corrected age among groups. Results We studied 341 infants: 79 with normothermia, 100 with mild hypothermia, 162 with moderate hypothermia, and 0 with severe hypothermia. Patients in the moderate hypothermia group had significantly lower gestational ages (28.1 wk vs. 29.7 wk, P < .02) and smaller birth weight (1004 g vs. 1187 g, P < .001) compared to patients in the normothermia group. Compared to normothermic infants, moderately hypothermic infants had significantly higher incidences of 1-min Apgar score < 7 (63.6% vs. 31.6%, P < .001), respiratory distress syndrome (RDS) (58.0% vs. 39.2%, P = .006), and mortality (18.5% vs. 5.1%, P = .005). Moderate hypothermia did not affect neurodevelopmental outcomes at 2 years' corrected age. Mild hypothermia had no effect on short-term or long-term outcomes. Conclusions Admission hypothermia was common in VLBW infants and correlated inversely with birth weight and gestational age. Although moderate hypothermia was associated with higher RDS and mortality rates, it may play a limited role among multifactorial causes of neurodevelopmental impairment.	[Chang, Hung-Yang; Sung, Yi-Hsiang; Lung, Hou-Ling] MacKay Mem Hosp, Dept Pediat, Hsinchu Branch, Hsinchu, Taiwan; [Chang, Hung-Yang; Lee, Ching-Hsiao; Hung, Hsiao-Fang] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Wang, Shwu-Meei; Chang, Jui-Hsing; Hsu, Chyong-Hsin; Jim, Wai-Tim] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan	Mackay Memorial Hospital	Wang, SM (corresponding author), MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan.	smwang65@gmail.com						Aylott Marion, 2006, Paediatr Nurs, V18, P38; Bartels DB, 2005, ARCH DIS CHILD-FETAL, V90, pF53, DOI 10.1136/adc.2004.053892; BERTEROTTIERE D, 1990, J DEV PHYSIOL, V13, P303; Bhatt DR, 2007, J PERINATOL, V27, pS45, DOI 10.1038/sj.jp.7211842; Billimoria Z, 2013, J PERINAT MED, V41, P455, DOI 10.1515/jpm-2012-0259; Bissinger Robin L, 2010, Adv Neonatal Care, V10, P230, DOI 10.1097/ANC.0b013e3181f0ae63; Boo NY, 2013, J TROP PEDIATRICS, V59, P447, DOI 10.1093/tropej/fmt051; de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Bredemeyer S, 2005, J ADV NURS, V52, P482, DOI 10.1111/j.1365-2648.2005.03616.x; Chitty H, 2013, SEMIN FETAL NEONAT M, V18, P362, DOI 10.1016/j.siny.2013.08.002; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; DAGA AS, 1991, J TROP PEDIATRICS, V37, P53, DOI 10.1093/tropej/37.2.53; Fransson AL, 2005, ARCH DIS CHILD-FETAL, V90, pF500, DOI 10.1136/adc.2004.066589; GANDY GM, 1964, J CLIN INVEST, V43, P751, DOI 10.1172/JCI104959; HAMMARLUND K, 1982, ACTA PAEDIATR SCAND, V71, P191, DOI 10.1111/j.1651-2227.1982.tb09398.x; HERTING E, 1992, BIOL NEONATE, V61, P26; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; MANN TP, 1957, LANCET, V1, P229; Mathur NB, 2005, J TROP PEDIATRICS, V51, P341, DOI 10.1093/tropej/fmi049; McCall EM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004210.pub4; Miller SS, 2011, J PERINATOL, V31, pS49, DOI 10.1038/jp.2010.177; Mitchell Ann, 2002, Adv Neonatal Care, V2, P316, DOI 10.1053/adnc.2002.36831; Pinheiro JMB, 2014, PEDIATRICS, V133, pE218, DOI 10.1542/peds.2013-1293; POMERANC.JJ, 1974, PEDIATR RES, V8, P449; Reilly MC, 2015, J PEDIATR-US, V166, P262, DOI 10.1016/j.jpeds.2014.09.068; Russo A, 2014, PEDIATRICS, V133, pE1055, DOI 10.1542/peds.2013-2544; Smith J, 2013, NEONATAL NETW, V32, P235, DOI [10.1891/0730-0832.32.4.235, 10.1891/0730-0832.32.1.16]; Takayama JI, 2000, CLIN PEDIATR, V39, P503, DOI 10.1177/000992280003900901; van der Spek RDG, 2009, ACTA PAEDIATR, V98, P282, DOI 10.1111/j.1651-2227.2008.01063.x; World Health Organization, 1997, THERM PROT NEWB PRAC	31	49	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131976	10.1371/journal.pone.0131976	http://dx.doi.org/10.1371/journal.pone.0131976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193370	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400018
J	Eisenstein, SA; Gredysa, DM; Antenor-Dorsey, JA; Green, L; Arbelaez, AM; Koller, JM; Black, KJ; Perlmutter, JS; Moerlein, SM; Hershey, T				Eisenstein, Sarah A.; Gredysa, Danuta M.; Antenor-Dorsey, Jo Ann; Green, Leonard; Arbelaez, Ana Maria; Koller, Jonathan M.; Black, Kevin J.; Perlmutter, Joel S.; Moerlein, Stephen M.; Hershey, Tamara			Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity	PLOS ONE			English	Article							HUMAN BRAIN; FOOD-INTAKE; INTRAVENTRICULAR INSULIN; SUBJECTIVE VALUE; BINDING; FUTURE; AVAILABILITY; IMPULSIVITY; DELAY; SENSITIVITY	Animal research finds that insulin regulates dopamine signaling and reward behavior, but similar research in humans is lacking. We investigated whether individual differences in body mass index, percent body fat, pancreatic beta-cell function, and dopamine D2 receptor binding were related to reward discounting in obese and non-obese adult men and women. Obese (n = 27; body mass index>30) and non-obese (n = 20; body mass index<30) adults were assessed for percent body fat with dual-energy X-ray absorptiometry and for beta-cell function using disposition index. Choice of larger, but delayed or less certain, monetary rewards relative to immediate, certain smaller monetary rewards was measured using delayed and probabilistic reward discounting tasks. Positron emission tomography using a non-displaceable D2-specific radioligand, [C-11](N-methyl) benperidol quantified striatal D2 receptor binding. Groups differed in body mass index, percent body fat, and disposition index, but not in striatal D2 receptor specific binding or reward discounting. Higher percent body fat in non-obese women related to preference for a smaller, certain reward over a larger, less likely one (greater probabilistic discounting). Lower beta-cell function in the total sample and lower insulin sensitivity in obese related to stronger preference for an immediate and smaller monetary reward over delayed receipt of a larger one (greater delay discounting). In obese adults, higher striatal D2 receptor binding related to greater delay discounting. Interestingly, striatal D2 receptor binding was not significantly related to body mass index, percent body fat, or beta-cell function in either group. Our findings indicate that individual differences in percent body fat, beta-cell function, and striatal D2 receptor binding may each contribute to altered reward discounting behavior in non-obese and obese individuals. These results raise interesting questions about whether and how striatal D2 receptor binding and metabolic factors, including beta-cell function, interact to affect reward discounting in humans.	[Eisenstein, Sarah A.; Antenor-Dorsey, Jo Ann; Koller, Jonathan M.; Black, Kevin J.; Hershey, Tamara] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Eisenstein, Sarah A.; Black, Kevin J.; Perlmutter, Joel S.; Moerlein, Stephen M.; Hershey, Tamara] Washington Univ, Dept Radiol, St Louis, MO USA; [Gredysa, Danuta M.; Green, Leonard] Washington Univ, Dept Psychol, St Louis, MO USA; [Arbelaez, Ana Maria] Washington Univ, Dept Pediat, St Louis, MO USA; [Black, Kevin J.] Washington Univ, Dept Neurol, St Louis, MO USA; [Black, Kevin J.; Perlmutter, Joel S.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Programs Phys Therapy & Occupat Therapy, St Louis, MO USA; [Moerlein, Stephen M.] Washington Univ, Biochem & Mol Biophys Dept, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hershey, T (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63130 USA.	tammy@npg.wustl.edu	Black, Kevin John/B-8272-2008	Black, Kevin John/0000-0002-6921-9567; Hershey, Tamara/0000-0001-7549-0698	National Institutes of Health [R01 DK085575, T32DA007261, T32DA007313, K24 MH087913, R21 MH098670, P60 DK20579]; Clinical and Translational Science Award [UL1 TR000448]; Barnes Jewish Hospital Foundation (Elliot Stein Family Fund); McDonnell Center for Higher Brain Function; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK056341, P60DK020579, R01DK085575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH098670, K24MH087913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261, T32DA007313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award; Barnes Jewish Hospital Foundation (Elliot Stein Family Fund); McDonnell Center for Higher Brain Function; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (R01 DK085575 (TH), T32DA007261 (SAE), T32DA007313 (DMG, JAD); K24 MH087913 (KJB), R21 MH098670 (KJB), P60 DK20579), Clinical and Translational Science Award (UL1 TR000448), Barnes Jewish Hospital Foundation (Elliot Stein Family Fund, JSP), and the McDonnell Center for Higher Brain Function (JSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2015, PEDIATR OBES, V10, P30, DOI 10.1111/j.2047-6310.2013.00210.x; Air EL, 2002, PHARMACOL BIOCHEM BE, V72, P423, DOI 10.1016/S0091-3057(01)00780-8; Antenor-Dorsey JAV, 2008, NUCL MED BIOL, V35, P335, DOI 10.1016/j.nucmedbio.2007.12.004; Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Antonelli F, 2014, HUM BRAIN MAPP, V35, P2499, DOI 10.1002/hbm.22344; Arrondo G, 2015, EUR NEUROPSYCHOPHARM, V25, P817, DOI 10.1016/j.euroneuro.2015.02.011; Babbs RK, 2013, PHYSIOL BEHAV, V121, P103, DOI 10.1016/j.physbeh.2013.03.025; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Ballard ME, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu119; Bechara A, 1999, J NEUROSCI, V19, P5473; Breda E, 2001, DIABETES, V50, P150, DOI 10.2337/diabetes.50.1.150; Brogan A, 2011, J PSYCHOSOM RES, V70, P189, DOI 10.1016/j.jpsychores.2010.07.012; Burger Kyle S, 2011, Curr Drug Abuse Rev, V4, P182; Cardinal RN, 2006, NEURAL NETWORKS, V19, P1277, DOI 10.1016/j.neunet.2006.03.004; Carr KD, 2000, BRAIN RES, V863, P160, DOI 10.1016/S0006-8993(00)02143-0; Christensen J, 1998, J EXP ANAL BEHAV, V69, P123, DOI 10.1901/jeab.1998.69-123; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cropley VL, 2008, SYNAPSE, V62, P399, DOI 10.1002/syn.20506; Dalla Man C, 2002, IEEE T BIO-MED ENG, V49, P419, DOI 10.1109/10.995680; Davis C, 2004, OBES RES, V12, P929, DOI 10.1038/oby.2004.113; Davis C, 2013, PHYSIOL BEHAV, V118, P63, DOI 10.1016/j.physbeh.2013.05.014; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; de Weijer BA, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-37; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DEWEY SL, 1993, SYNAPSE, V13, P350, DOI 10.1002/syn.890130407; Dunn JP, 2012, DIABETES CARE, V35, P1105, DOI 10.2337/dc11-2250; Eisenstein SA, 2015, SCI REP IN PRESS; Eisenstein SA, 2013, SYNAPSE, V67, P748, DOI 10.1002/syn.21680; Eisenstein SA, 2012, SYNAPSE, V66, P770, DOI 10.1002/syn.21566; Elias Merrill F, 2005, Neurobiol Aging, V26 Suppl 1, P11, DOI 10.1016/j.neurobiolaging.2005.08.019; Elsinga PH, 2006, CURR MED CHEM, V13, P2139, DOI 10.2174/092986706777935258; Epstein LH, 2014, OBESITY, V22, P1394, DOI 10.1002/oby.20661; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; First M.B., 2016, STRUCTURED CLIN INTE; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Freeman TP, 2013, DRUG ALCOHOL DEPEN, V130, P109, DOI 10.1016/j.drugalcdep.2012.10.016; Green L, 1999, J EXP PSYCHOL LEARN, V25, P418, DOI 10.1037/0278-7393.25.2.418; Green L, 1999, BEHAV PROCESS, V46, P89, DOI 10.1016/S0376-6357(99)00021-2; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Green L, 2013, J EXP ANAL BEHAV, V99, P3, DOI 10.1002/jeab.1; Guo J, 2014, MOL PSYCHIATR, V19, P1078, DOI 10.1038/mp.2014.102; Guo JF, 2006, PSYCHOL MED, V36, P547, DOI 10.1017/S0033291705006732; Hallschmid M, 2012, DIABETES, V61, P782, DOI 10.2337/db11-1390; Haltia LT, 2007, SYNAPSE, V61, P748, DOI 10.1002/syn.20418; Hamidovic A, 2008, J CLIN PSYCHOPHARM, V28, P45, DOI 10.1097/jcp.0b013e3181602fab; Heni M, 2012, DIABETOLOGIA, V55, P1773, DOI 10.1007/s00125-012-2528-y; Hershey T, 2003, J NEUROL NEUROSUR PS, V74, P844, DOI 10.1136/jnnp.74.7.844; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Jastreboff AM, 2013, DIABETES CARE, V36, P394, DOI 10.2337/dc12-1112; Jauch-Chara K, 2012, DIABETES, V61, P2261, DOI 10.2337/db12-0025; Joutsa J, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.133; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Karimi M, 2011, MOVEMENT DISORD, V26, P100, DOI 10.1002/mds.23401; Karlsson HK, 2015, J NEUROSCI, V35, P3959, DOI 10.1523/JNEUROSCI.4744-14.2015; Kessler RM, 2014, SYNAPSE, V68, P317, DOI 10.1002/syn.21738; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Kroemer NB, 2013, HUM BRAIN MAPP, V34, P2367, DOI 10.1002/hbm.22071; Kullmann S, 2013, NEUROENDOCRINOLOGY, V97, P176, DOI 10.1159/000341406; Leroi I, 2013, J NEUROPSYCHOL, V7, P306, DOI 10.1111/jnp.12026; MacKillop J, 2013, J EXP ANAL BEHAV, V99, P14, DOI 10.1002/jeab.4; Manwaring JL, 2011, PSYCHOL REC, V61, P561, DOI 10.1007/BF03395777; Marco-Pallares J, 2010, BRAIN RES, V1320, P123, DOI 10.1016/j.brainres.2010.01.025; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Michaelides M, 2012, NEUROIMAGE, V59, P1508, DOI 10.1016/j.neuroimage.2011.08.028; Moerlein SM, 2010, EUR J NUCL MED MOL I, V37, pS366; Moerlein SM, 2004, RADIOCHIM ACTA, V92, P333, DOI 10.1524/ract.92.4.333.35584; Moerlein SM, 1997, J CEREBR BLOOD F MET, V17, P833, DOI 10.1097/00004647-199708000-00002; Myerson J, 2003, J ECON PSYCHOL, V24, P619, DOI 10.1016/S0167-4870(03)00005-9; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Onoda K, 2011, EXP BRAIN RES, V212, P593, DOI 10.1007/s00221-011-2771-3; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Pietras CJ, 2003, PSYCHOPHARMACOLOGY, V170, P390, DOI 10.1007/s00213-003-1547-2; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Sipols AJ, 2000, PEPTIDES, V21, P1361, DOI 10.1016/S0196-9781(00)00279-5; Smith CT, 2014, J NEUROSCI, V34, P5468, DOI 10.1523/JNEUROSCI.0014-14.2014; Soper DS, 2015, EFFECT SIZE CALCULAT; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang GJ, 2012, MOL PSYCHIATR, V17, P918, DOI 10.1038/mp.2011.86; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y	93	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133621	10.1371/journal.pone.0133621	http://dx.doi.org/10.1371/journal.pone.0133621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192187	gold, Green Published			2022-12-27	WOS:000358546400107
J	Kupers, LK; L'Abee, C; Bocca, G; Stolk, RP; Sauer, PJJ; Corpeleijn, E				Kupers, Leanne K.; L'Abee, Carianne; Bocca, Gianni; Stolk, Ronald P.; Sauer, Pieter J. J.; Corpeleijn, Eva			Determinants of Weight Gain during the First Two Years of Life-The GECKO Drenthe Birth Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; EARLY-CHILDHOOD; INFANT GROWTH; POSTNATAL-GROWTH; MATERNAL SMOKING; ADULT DISEASE; RISK-FACTORS; FOLLOW-UP; OBESITY; CHILDREN	Objectives To explain weight gain patterns in the first two years of life, we compared the predictive values of potential risk factors individually and within four different domains: prenatal, nutrition, lifestyle and socioeconomic factors. Methods In a Dutch population-based birth cohort, length and weight were measured in 2475 infants at 1, 6, 12 and 24 months. Factors that might influence weight gain (e.g. birth weight, parental BMI, breastfeeding, hours of sleep and maternal education) were retrieved from health care files and parental questionnaires. Factors were compared with linear regression to best explain differences in weight gain, defined as changes in Z-score of weight-for-age and weight-for-length over 1- 6, 6-12 and 12-24 months. In a two-step approach, factors were first studied individually for their association with growth velocity, followed by a comparison of the explained variance of the four domains. Results Birth weight and type of feeding were most importantly related to weight gain in the first six months. Breastfeeding versus formula feeding showed distinct growth patterns in the first six months, but not thereafter. From six months onwards, the ability to explain differences in weight gain decreased substantially (from R-total(2) = 38.7% to R-total(2)<7%). Conclusion Birth weight and breast feeding were most important to explain early weight gain, especially in the first six months of life. After the first six months of life other yet undetermined factors start to play a role.	[Kupers, Leanne K.; L'Abee, Carianne; Stolk, Ronald P.; Corpeleijn, Eva] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [L'Abee, Carianne; Bocca, Gianni; Sauer, Pieter J. J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, Groningen, Netherlands	University of Groningen; University of Groningen	Kupers, LK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	l.k.kupers@umcg.nl		Kupers, Leanne/0000-0001-9850-5215; Corpeleijn, Eva/0000-0002-2974-3305; Stolk, Ronald/0000-0002-0518-1205	Hutchison Whampoa Ltd.; University Medical Center Groningen	Hutchison Whampoa Ltd.; University Medical Center Groningen	The GECKO Drenthe is supported by an unlimited grant from Hutchison Whampoa Ltd. and by the University Medical Center Groningen. The study sponsors had no involvement in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baker JL, 2004, AM J CLIN NUTR, V80, P1579, DOI 10.1093/ajcn/80.6.1579; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bocca G, 2014, CLIN NUTR, V33, P1095, DOI 10.1016/j.clnu.2013.12.002; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; Claris O, 2010, SEMIN PERINATOL, V34, P207, DOI 10.1053/j.semperi.2010.02.005; Danielsson P, 2012, ARCH PEDIAT ADOL MED, V166, P1103, DOI 10.1001/2013.jamapediatrics.319; de Hoog MLA, 2011, BRIT J NUTR, V106, P1592, DOI 10.1017/S0007114511002327; Dietz WH, 1998, PEDIATRICS, V101, P518; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; DutchGrowthFoundation, 2001, GROWTH ANAL, V3.5; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gaillard R, 2014, MATERNAL PARITY FETA; Griffiths LJ, 2009, ARCH DIS CHILD, V94, P577, DOI 10.1136/adc.2008.137554; Gunnarsdottir I, 2010, PUBLIC HEALTH NUTR, V13, P201, DOI 10.1017/S1368980009005874; Heerman WJ, 2014, ACAD PEDIATR, V14, P463, DOI 10.1016/j.acap.2014.05.005; Heude B, 2005, INT J OBESITY, V29, P1222, DOI 10.1038/sj.ijo.0802920; Hindmarsh PC, 2008, PEDIATR RES, V63, P99, DOI 10.1203/PDR.0b013e31815b8e8f; Horta BL, 2007, EVIDENCE LONG TERM E; Karaolis-Danckert N, 2008, AM J CLIN NUTR, V87, P1356, DOI 10.1093/ajcn/87.5.1356; Knight B, 2007, DIABETES CARE, V30, P777, DOI 10.2337/dc06-1849; L'Abee C, 2008, INT J EPIDEMIOL, V37, P486, DOI 10.1093/ije/dym218; Lalonde M, 1974, NEW PERSPECTIVE HLTH; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Regnault N, 2010, AM J CLIN NUTR, V92, P594, DOI 10.3945/ajcn.2010.29292; Robinson S, 2012, NARRATIVE LIT REV DE; Sijtsma A, 2014, EUR J PEDIAT; StatisticsNetherlands S, 2014, GEB NAAR DIV KENM; StatisticsNetherlands S, 2015, BEV GEB 1989 2013; StatisticsNetherlands S, 2014, PER ZUIG ZWANG EEN E; Touwslager RNH, 2011, J PEDIATR-US, V158, P566, DOI 10.1016/j.jpeds.2010.10.005; Vielwerth SE, 2007, EARLY HUM DEV, V83, P491, DOI 10.1016/j.earlhumdev.2006.09.010; Wabitsch M, 2000, EUR J PEDIATR, V159, pS8, DOI 10.1007/PL00014368; WHITEHEAD RG, 1995, PEDIATR RES, V37, P239, DOI 10.1203/00006450-199502000-00019; Willers SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039517	38	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133326	10.1371/journal.pone.0133326	http://dx.doi.org/10.1371/journal.pone.0133326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192417	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400073
J	Tarhini, AA; Lin, Y; Zahoor, H; Shuai, YL; Butterfield, LH; Ringquist, S; Gogas, H; Sander, C; Lee, S; Agarwala, SS; Kirwood, JM				Tarhini, Ahmad A.; Lin, Yan; Zahoor, Haris; Shuai, Yongli; Butterfield, Lisa H.; Ringquist, Steven; Gogas, Helen; Sander, Cindy; Lee, Sandra; Agarwala, Sanjiv S.; Kirwood, John M.			Pro-Inflammatory Cytokines Predict RelapseFree Survival after One Month of Interferon-a but Not Observation in Intermediate Risk Melanoma Patients	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MALIGNANT-MELANOMA; INTERLEUKIN-2 RECEPTORS; SERUM INTERLEUKIN-6; IL-2 RECEPTORS; III MELANOMA; IFN-ALPHA; EXPRESSION; GENE; ANGIOGENESIS	Background E1697 was a phase III trial of adjuvant interferon (IFN)-alpha 2b for one month (Arm B) versus observation (Arm A) in patients with resected melanoma at intermediate risk. We evaluated the levels of candidate serum cytokines, the HLA genotype, polymorphisms of CTLA4 and FOXP3 genes and the development of autoantibodies for their association with relapse free survival (RFS) in Arm A and Arm B among 268 patients with banked biospecimens. Methods ELISA was used to test 5 autoantibodies. Luminex/One Lambda LABTypeRSSO was used for HLA Genotyping. Selected CTLA4 and FOXP3 Single nucleotide polymorphisms (SNPs) and microsatellites were tested for by polymerase chain reaction (PCR). Sixteen serum cytokines were tested at baseline and one month by Luminex xMAP multiplex technology. Cox Proportional Hazards model was applied and the Wald test was used to test the marginal association of each individual marker and RFS. We used the Lasso approach to select the markers to be included in a multi-marker Cox Proportional Hazards model. The ability of the resulting models to predict one year RFS was evaluated by the time-dependent ROC curve. The leave-one-out method of cross validation (LOOCV) was used to avoid over-fitting of the data. Results In the multi-marker modeling analysis conducted in Arm B, one month serum IL2R alpha, IL-12p40 and IFNa levels predicted one year RFS with LOOCV AUC = 82%. Among the three markers selected, IL2R alpha and IFN alpha were the most stable (selected in all the cross validation cycles). The risk score (linear combination of the 3 markers) separated the RFS curves of low and high risk groups well (p = 0.05). This model did not hold for Arm A, indicating a differential marker profile in Arm B linked to the intervention (adjuvant therapy). Conclusions Early on-treatment proinflammatory serum markers (IL2R alpha, IL-12p40, IFN alpha) significantly predict RFS in our cohort of patients treated with adjuvant IFN-alpha 2b and warrant further study.	[Tarhini, Ahmad A.; Zahoor, Haris; Butterfield, Lisa H.; Ringquist, Steven; Sander, Cindy; Kirwood, John M.] Univ Pittsburgh, Pittsburgh, PA 15261 USA; [Lin, Yan; Shuai, Yongli] Univ Pittsburgh, Canc Inst Biostat Facil, Pittsburgh, PA USA; [Gogas, Helen] Hellen Cooperat Oncol Grp, Athens, Greece; [Lee, Sandra] Dana Farber Canc Inst, Boston, MA 02115 USA; [Agarwala, Sanjiv S.] St Lukes Canc Ctr, Bethlehem, PA USA; [Agarwala, Sanjiv S.] Temple Univ, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hellenic Cooperative Oncology Group; Harvard University; Dana-Farber Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Tarhini, AA (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15261 USA.	tarhiniaa@upmc.edu	Butterfield, Lisa H./W-1564-2019	Butterfield, Lisa H./0000-0002-3439-9844	DiaSorin Inc; Merck; Public Health Service Grants [CA180820, CA180794, CA180844]; National Cancer Institute; National Institutes of Health; Department of Health and Human Services; National Institutes of Health [P50CA121973]; National Institutes of Health/National Cancer Institute [P30CA047904]; NATIONAL CANCER INSTITUTE [U10CA021115, U10CA180820, U10CA066636, U10CA180844, U24CA196172, P30CA047904, U10CA180794, P50CA121973, U10CA023318] Funding Source: NIH RePORTER	DiaSorin Inc; Merck(Merck & Company); Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by DiaSorin Inc and Merck. This study was coordinated by the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN) Cancer Research Group (Robert L. Comis, MD and Mitchell D. Schnall, MD, PhD, Group Co-Chairs) and supported in part by Public Health Service Grants CA180820, CA180794, CA180844, and from the National Cancer Institute, National Institutes of Health and the Department of Health and Human Services. This study was supported by National Institutes of Health award P50CA121973 and in part by DiaSorin Inc. University of Pittsburgh Cancer Institute shared resources that are supported in part by National Institutes of Health/National Cancer Institute award P30CA047904 were used for this project. HLA Genotyping and PCR studies of CTLA4 and FOXP3 polymorphisms were conducted in the laboratory of Dr. Massimo Trucco at the Children's Hospital of Pittsburgh. Its content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. DiaSorin Inc. and Merck had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. On the other hand, the study design, conduct and analysis plan were approved by ECOG-ACRIN Cancer Research Group and the National Cancer Institute and the National Institutes of Health. The final submitted manuscript was reviewed and approved for submission by ECOG-ACRIN.	Agarwala SS, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8505; Agarwala SS, 1998, HEMATOL ONCOL CLIN N, V12, P823, DOI 10.1016/S0889-8588(05)70025-3; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Boyano MD, 2000, BRIT J CANCER, V83, P847, DOI 10.1054/bjoc.2000.1402; Butterfield LH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-173; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Dias S, 1998, INT J CANCER, V78, P361, DOI 10.1002/(SICI)1097-0215(19981029)78:3<361::AID-IJC17>3.0.CO;2-9; DUMMER W, 1995, MELANOMA RES, V5, P67, DOI 10.1097/00008390-199502000-00008; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Gogas H, 2010, CANCER-AM CANCER SOC, V116, P4326, DOI 10.1002/cncr.25211; Hakansson A, 1996, BRIT J CANCER, V74, P670, DOI 10.1038/bjc.1996.420; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOLTER W, 1987, J IMMUNOL, V138, P2917; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Ji RR, 2011, CANC IMMUNOL IMMUNOT; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; LISSONI P, 1990, EUR J CANCER, V26, P33, DOI 10.1016/0277-5379(90)90253-P; Louahed J, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9045; Martin-Henao CA, 2000, HAEMATOLOGICA, V85, P139; Mihm MC, 1996, LAB INVEST, V74, P43; Moschos SJ, 2006, J CLIN ONCOL, V24, P3164, DOI 10.1200/JCO.2005.05.2498; Mouawad R, 2002, CYTOKINES CELL MOL T, V7, P151, DOI 10.1080/13684730210002328; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; RAND TH, 1991, J CLIN INVEST, V88, P825, DOI 10.1172/JCI115383; RIMOLDI D, 1993, ANTICANCER RES, V13, P555; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tarhini AA, 2014, IMMUNE RELATED PATHW; Tarhini AA, 2014, HEMATOL ONCOL CLIN N, V28, P471, DOI 10.1016/j.hoc.2014.02.004; Tarhini AA, 2014, MELANOMA RES, V24, P150, DOI 10.1097/CMR.0000000000000050; Tarhini AA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-19; Tarhini AA, 2012, J IMMUNOL, V189, P3789, DOI 10.4049/jimmunol.1290060; TARTOUR E, 1994, BRIT J CANCER, V69, P911, DOI 10.1038/bjc.1994.175; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; VONSTAMM U, 1993, MELANOMA RES, V3, P173, DOI 10.1097/00008390-199306000-00005; Vuoristo MS, 2001, EUR J CANCER, V37, P1629, DOI 10.1016/S0959-8049(01)00192-7; WALDMANN TA, 1984, J EXP MED, V160, P1450, DOI 10.1084/jem.160.5.1450; WEIDMANN E, 1992, CANCER RES, V52, P5963; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Wittke F, 1999, BRIT J CANCER, V79, P1182, DOI 10.1038/sj.bjc.6690189; Yano T, 1996, LUNG CANCER-J IASLC, V16, P13, DOI 10.1016/S0169-5002(96)00608-3; Yao L, 1999, BLOOD, V93, P1612, DOI 10.1182/blood.V93.5.1612.405a13_1612_1621; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805	57	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132745	10.1371/journal.pone.0132745	http://dx.doi.org/10.1371/journal.pone.0132745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192408	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000358546400037
J	Tsakraklides, V; Brevnova, E; Stephanopoulos, G; Shaw, AJ				Tsakraklides, Vasiliki; Brevnova, Elena; Stephanopoulos, Gregory; Shaw, A. Joe			Improved Gene Targeting through Cell Cycle Synchronization	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID SYNTHESIS; YARROWIA-LIPOLYTICA STRAINS; STRAND BREAK REPAIR; AGROBACTERIUM T-DNA; HUMAN SOMATIC-CELLS; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; KLUYVEROMYCES-LACTIS; YEAST; INTEGRATION	Gene targeting is a challenge in organisms where non-homologous end-joining is the predominant form of recombination. We show that cell division cycle synchronization can be applied to significantly increase the rate of homologous recombination during transformation. Using hydroxyurea-mediated cell cycle arrest, we obtained improved gene targeting rates in Yarrowia lipolytica, Arxula adeninivorans, Saccharomyces cerevisiae, Kluyveromyces lactis and Pichia pastoris demonstrating the broad applicability of the method. Hydroxyurea treatment enriches for S-phase cells that are active in homologous recombination and enables previously unattainable genomic modifications.	[Tsakraklides, Vasiliki; Brevnova, Elena] Total New Energies, Emeryville, CA 94608 USA; [Stephanopoulos, Gregory; Shaw, A. Joe] Novogy Inc, Cambridge, MA USA; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Total SA; Massachusetts Institute of Technology (MIT)	Tsakraklides, V (corresponding author), Total New Energies, Emeryville, CA 94608 USA.	vtsakraklides@novogyinc.com		Tsakraklides, Vasiliki/0000-0003-1998-1075	Total New Energies; Novogy Inc.	Total New Energies(Total SA); Novogy Inc.	The author(s) received no specific funding for this work. VT and EB are employed by Total New Energies. JS is employed by Novogy Inc. A patent application relating to the method described in the submitted manuscript was filed with the USPTO (PCT/US14/036905) on 5/6/2014. Total New Energies and Novogy Inc. provided support in the form of salaries for authors (VT, EB, JS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Amberg DC, 2006, COLD SPRING HARBOR P, V2006, DOI [10.1101/pdb.prot4174, DOI 10.1101/PDB.PR0T4174]; Amon A, 2002, METHOD ENZYMOL, V351, P457; Aylon Y, 2005, CELL CYCLE, V4, P259; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Beckerich J M, 1998, Int Microbiol, V1, P123; Bertolini LR, 2009, MOL BIOTECHNOL, V41, P106, DOI 10.1007/s12033-008-9098-8; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; de Boer P, 2010, FUNGAL GENET BIOL, V47, P839, DOI 10.1016/j.fgb.2010.07.008; DORFMAN BZ, 1969, GENETICS, V61, P377; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fattah FJ, 2008, P NATL ACAD SCI USA, V105, P8703, DOI 10.1073/pnas.0712060105; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Galli A, 1996, MUTAT RES-FUND MOL M, V354, P69, DOI 10.1016/0027-5107(96)00037-1; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Goswami RS, 2012, METHODS MOL BIOL, V835, P255, DOI 10.1007/978-1-61779-501-5_16; Herrero AB, 1999, MICROBIOL-SGM, V145, P2727, DOI 10.1099/00221287-145-10-2727; Iiizumi S, 2008, NUCLEIC ACIDS RES, V36, P6333, DOI 10.1093/nar/gkn649; Jia Q., 2012, J BOT, V2012, P1, DOI [10.1155/2012/989272, DOI 10.1155/2012/989272]; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Klinner U, 2004, FEMS MICROBIOL REV, V28, P201, DOI 10.1016/j.femsre.2003.10.002; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Kretzschmar A, 2013, CURR GENET, V59, P63, DOI 10.1007/s00294-013-0389-7; Kuijpers NGA, 2013, FEMS YEAST RES, V13, P769, DOI 10.1111/1567-1364.12087; Kunze G, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-66; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maassen N, 2008, FEMS YEAST RES, V8, P735, DOI 10.1111/j.1567-1364.2008.00383.x; Manthey Glenn M, 2004, Methods Mol Biol, V262, P157; Manukyan A, 2011, METHODS MOL BIOL, V761, P173, DOI 10.1007/978-1-61779-182-6_12; Mathiasen DP, 2014, FEMS MICROBIOL REV, V38, P172, DOI 10.1111/1574-6976.12066; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Nakazawa T, 2011, FUNGAL GENET BIOL, V48, P939, DOI 10.1016/j.fgb.2011.06.003; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nishizawa-Yokoi A, 2012, NEW PHYTOL, V196, P1048, DOI 10.1111/j.1469-8137.2012.04350.x; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; RODRIGUEZ C, 1990, EXP MYCOL, V14, P310, DOI 10.1016/0147-5975(90)90054-W; ROSENKRANZ HS, 1965, BIOCHIM BIOPHYS ACTA, V95, P181, DOI 10.1016/0005-2787(65)90225-X; Sabirova JS, 2011, MICROB BIOTECHNOL, V4, P47, DOI 10.1111/j.1751-7915.2010.00187.x; SINCLAIR WK, 1965, SCIENCE, V150, P1729, DOI 10.1126/science.150.3704.1729; SLATER ML, 1973, J BACTERIOL, V113, P263, DOI 10.1128/JB.113.1.263-270.1973; Tanaka S, 2010, BIOCHEM BIOPH RES CO, V396, P289, DOI 10.1016/j.bbrc.2010.04.082; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Ushimaru T, 2010, MOL GENET GENOMICS, V284, P357, DOI 10.1007/s00438-010-0572-1; van Attikum H, 2001, EMBO J, V20, P6550, DOI 10.1093/emboj/20.22.6550; van Attikum H, 2003, NUCLEIC ACIDS RES, V31, P826, DOI 10.1093/nar/gkg183; Verbeke J, 2013, BIOTECHNOL LETT, V35, P571, DOI 10.1007/s10529-012-1107-0; Zhang XJ, 2012, J IND MICROBIOL BIOT, V39, P917, DOI 10.1007/s10295-012-1097-x; ZONNEVELD BJM, 1995, YEAST, V11, P823, DOI 10.1002/yea.320110904	53	41	43	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133434	10.1371/journal.pone.0133434	http://dx.doi.org/10.1371/journal.pone.0133434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192309	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400084
J	Chang, CY; Lin, CY; Chen, LC; Sun, CH; Li, TY; Tsai, TH; Chang, ST; Wu, YT				Chang, Chih-Ya; Lin, Ching-Yueh; Chen, Liang-Cheng; Sun, Chia-Hung; Li, Tsung-Ying; Tsai, Tung-Han; Chang, Shin-Tsu; Wu, Yung-Tsan			The Predictor of Mortality within Six-Months in Patients with Spontaneous Cerebellar Hemorrhage: A Retrospective Study	PLOS ONE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; PROGNOSTIC-FACTORS; MANAGEMENT; DEATH	Background and Purpose The mortality rate of cerebellar hemorrhage (CH) is generally higher than other types of intracranial hemorrhage. Recently, the increased survey rate of CH has come from improved clinical imaging and earlier surgical intervention. Hence, the predictors of intermittent-(1 to 6 months) and long-term (>6months) mortality are clinically practical use for educational and therapeutic decisions. Unfortunately, the factors predictive mortality within six-month had not yet been systematically investigated. Methods Seventy-two patients with acute spontaneous CH were retrospectively analyzed. The patients were divided into the six-month mortality group (n = 21, died within 6 months after CH onset) and survival group (n = 51, survived beyond 6 months). The independent predictors of six-month mortality were investigated by multivariate Cox proportional hazards regression. Results The radiological brainstem compression (hazard ratios = 23.5; p < 0.001) was independent predictor of mortality within six-month after CH onset. The median onset time of six-month mortality was 5 days in patients with brainstem compression (p < 0.001) and the hazard ratios for the onset time was 13.1 compared with those without brainstem compression (95% CI, 4.7 to 36.3, p < 0.001). Conclusions We report the first study that radiological brainstem compression predicted the mortality within six-month after onset of CH. Patients with radiological brainstem compression were about 23 times more likely to die within 6 months after CH than those without radiological brainstem compression.	[Chang, Chih-Ya; Lin, Ching-Yueh; Chen, Liang-Cheng; Sun, Chia-Hung; Li, Tsung-Ying; Wu, Yung-Tsan] Triserv Gen Hosp, Dept Phys Med & Rehabil, 325,Sec 2, Taipei, Taiwan; [Chang, Chih-Ya; Lin, Ching-Yueh; Chen, Liang-Cheng; Sun, Chia-Hung; Li, Tsung-Ying; Chang, Shin-Tsu; Wu, Yung-Tsan] Natl Def Med Ctr, Dept Phys Med & Rehabil, Sch Med, Taipei, Taiwan; [Tsai, Tung-Han] Natl Def Med Ctr, Triserv Gen Hosp, Dept Neurosurg, Taipei, Taiwan; [Chang, Shin-Tsu] Taichung Vet Gen Hosp, Dept Rehabil, Taichung, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taichung Veterans General Hospital	Wu, YT (corresponding author), Triserv Gen Hosp, Dept Phys Med & Rehabil, 325,Sec 2, Taipei, Taiwan.	crwu98@gmail.com	Li, Tsung-Ying/AAJ-2359-2020; Chang, Shin-Tsu/AAF-8506-2020; chihya, Chang/AAI-6537-2021	Chang, Shin-Tsu/0000-0003-4005-2094				Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Da Pian R, 1984, Neurol Res, V6, P145; Dammann P, 2011, NEUROSURG REV, V34, P77, DOI 10.1007/s10143-010-0279-0; DAVERAT P, 1991, STROKE, V22, P1, DOI 10.1161/01.STR.22.1.1; Dolderer S, 2004, EUR NEUROL, V52, P112, DOI 10.1159/000080268; Garibi J, 2002, BRIT J NEUROSURG, V16, P355, DOI 10.1080/0268869021000007579; Hardemark HG, 1999, CEREBROVASC DIS, V9, P10, DOI 10.1159/000015890; Hemphill JC, 2009, NEUROLOGY, V73, P1088, DOI 10.1212/WNL.0b013e3181b8b332; Inagawa T, 2000, J NEUROSURG, V93, P967, DOI 10.3171/jns.2000.93.6.0967; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nilsson OG, 2002, J NEUROSURG, V97, P531, DOI 10.3171/jns.2002.97.3.0531; Pong V, 2012, CEREBELLUM, V11, P939, DOI 10.1007/s12311-012-0371-9; Rajajee Venkatakrishna, 2004, J Stroke Cerebrovasc Dis, V13, P47, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.002; Saloheimo P, 2006, STROKE, V37, P487, DOI 10.1161/01.STR.0000198868.78546.fc; Salvati M, 2001, SURG NEUROL, V55, P156, DOI 10.1016/S0090-3019(01)00347-0; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; St Louis EK, 1998, NEUROLOGY, V51, P1364, DOI 10.1212/WNL.51.5.1364; St Louis EK, 2000, CAN J NEUROL SCI, V27, P32; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; Wu YT, 2013, CEREBELLUM, V12, P165, DOI 10.1007/s12311-012-0410-6; Wu YT, 2012, CEREBELLUM, V11, P543, DOI 10.1007/s12311-011-0317-7; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132975	10.1371/journal.pone.0132975	http://dx.doi.org/10.1371/journal.pone.0132975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186721	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700080
J	Andoh, M; Sakata, A; Takano, A; Kawabata, H; Fujita, H; Une, Y; Goka, K; Kishimoto, T; Ando, S				Andoh, Masako; Sakata, Akiko; Takano, Ai; Kawabata, Hiroki; Fujita, Hiromi; Une, Yumi; Goka, Koichi; Kishimoto, Toshio; Ando, Shuji			Detection of Rickettsia and Ehrlichia spp. in Ticks Associated with Exotic Reptiles and Amphibians Imported into Japan	PLOS ONE			English	Article							CANDIDATUS NEOEHRLICHIA-MIKURENSIS; IXODES-OVATUS TICKS; COWDRIA-RUMINANTIUM; WILD RODENTS; INFECTION; ANAPLASMATACEAE; IDENTIFICATION; IXODIDAE; ISLAND; ACARI	One of the major routes of transmission of rickettsial and ehrlichial diseases is via ticks that infest numerous host species, including humans. Besides mammals, reptiles and amphibians also carry ticks that may harbor Rickettsia and Ehrlichia strains that are pathogenic to humans. Furthermore, reptiles and amphibians are exempt from quarantine in Japan, thus facilitating the entry of parasites and pathogens to the country through import. Accordingly, in the current study, we examined the presence of Rickettsia and Ehrlichia spp. genes in ticks associated with reptiles and amphibians originating from outside Japan. Ninety-three ticks representing nine tick species (genera Amblyomma and Hyalomma) were isolated from at least 28 animals spanning 10 species and originating from 12 countries (Ghana, Jordan, Madagascar, Panama, Russia, Sri Lanka, Sudan, Suriname, Tanzania, Togo, Uzbekistan, and Zambia). None of the nine tick species are indigenous in Japan. The genes encoding the common rickettsial 17-kDa antigen, citrate synthase (gltA), and outer membrane protein A (ompA) were positively detected in 45.2% (42/93), 40.9% (38/93), and 23.7% (22/93) of the ticks, respectively, by polymerase chain reaction (PCR). The genes encoding ehrlichial heat shock protein (groEL) and major outer membrane protein (omp-1) were PCR-positive in 7.5% (7/93) and 2.2% (2/93) of the ticks, respectively. The p44 gene, which encodes the Anaplasma outer membrane protein, was not detected. Phylogenetic analysis showed that several of the rickettsial and ehrlichial sequences isolated in this study were highly similar to human pathogen genes, including agents not previously detected in Japan. These data demonstrate the global transportation of pathogenic Rickettsia and Ehrlichia through reptile-and amphibian-associated ticks. These imported animals have potential to transfer pathogens into human life. These results highlight the need to control the international transportation of known and potential pathogens carried by ticks in reptiles, amphibians, and other animals, in order to improve national and international public health.	[Andoh, Masako; Sakata, Akiko; Kishimoto, Toshio; Ando, Shuji] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Andoh, Masako] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Publ Hlth, Kagoshima 890, Japan; [Takano, Ai; Kawabata, Hiroki] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Takano, Ai] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Yamaguchi, Japan; [Fujita, Hiromi] Mahara Inst Med Acarol, Tokushima, Japan; [Une, Yumi] Azabu Univ, Sch Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa, Japan; [Goka, Koichi] Natl Inst Environm Studies, Ibaraki, Japan; [Kishimoto, Toshio] Okayama Prefectural Inst Environm Sci & Publ Hlth, Okayama, Japan	National Institute of Infectious Diseases (NIID); Kagoshima University; National Institute of Infectious Diseases (NIID); Yamaguchi University; Azabu University; National Institute for Environmental Studies - Japan	Ando, S (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.	shuando@nih.go.jp		TAKANO, Ai/0000-0002-5919-3738	Japanese Ministry of Health, Labor and Welfare [H21-Shinkou-Ippan-006, H24-Shinkou-Ippan-008]; Global Environment Research Fund of the Ministry of the Environment and Japan [F-3, F-081]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Global Environment Research Fund of the Ministry of the Environment and Japan; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by a grant of the Japanese Ministry of Health, Labor and Welfare (H21-Shinkou-Ippan-006 and H24-Shinkou-Ippan-008) (http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h25/gaiyo/19.html) and the Global Environment Research Fund (F-3 and F-081) of the Ministry of the Environment and Japan 2008 (http://www.env.go.jp/policy/kenkyu/suishin/english/index.html)(http://www.env.go.jp/policy/kenkyu/suishin/kadai_hyouka/h23/detail.html#D-0801). This research was partially supported by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp BA, 2010, VET PARASITOL, V167, P123, DOI 10.1016/j.vetpar.2009.09.014; ANDERSON BE, 1989, J BACTERIOL, V171, P5199, DOI 10.1128/jb.171.9.5199-5201.1989; Bermudez SE, 2012, EXP APPL ACAROL, V58, P81, DOI 10.1007/s10493-012-9564-7; Burridge MJ, 2000, J PARASITOL, V86, P1135, DOI 10.1645/0022-3395(2000)086[1135:EOCRIH]2.0.CO;2; Dantas-Torres F, 2008, REV BRAS PARASITOL V, V17, P218, DOI 10.1590/S1984-29612008000400009; De Sousa R, 2012, APPL ENVIRON MICROB, V78, P3767, DOI 10.1128/AEM.07945-11; Duh D, 2010, INT J SYST EVOL MICR, V60, P977, DOI 10.1099/ijs.0.011049-0; Ekner A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-182; Imaoka K, 2011, CASE REP DERMATOL, V3, P68, DOI 10.1159/000326941; Inayoshi M, 2004, MICROBIOL IMMUNOL, V48, P737, DOI 10.1111/j.1348-0421.2004.tb03599.x; Jensenius M, 2003, LANCET INFECT DIS, V3, P557, DOI 10.1016/S1473-3099(03)00739-4; Kar S, 2013, EXP APPL ACAROL, V61, P349, DOI 10.1007/s10493-013-9698-2; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Kawahara M, 2009, EMERG INFECT DIS, V15, P1991, DOI 10.3201/eid1512.081667; Kim HY, 2002, CLIN DIAGN LAB IMMUN, V9, P1079, DOI 10.1128/CDLI.9.5.1079-1084.2002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Li H, 2012, EMERG INFECT DIS, V18, P1636, DOI 10.3201/eid1810.120594; Naitou H, 2006, MICROBIOL IMMUNOL, V50, P45, DOI 10.1111/j.1348-0421.2006.tb03769.x; Nieto NC, 2009, J PARASITOL, V95, P1165, DOI 10.1645/GE-1983.1; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; NORVAL RAI, 1981, VET PARASITOL, V8, P189, DOI 10.1016/0304-4017(81)90047-9; OLIVER JH, 1993, J PARASITOL, V79, P786, DOI 10.2307/3283624; Pacheco RC, 2007, BIOMEDICA, V27, P364, DOI 10.7705/biomedica.v27i3.199; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Parola P, 2009, EMERG INFECT DIS, V15, P1105, DOI 10.3201/eid1507.081449; Randolph SE, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P40, DOI 10.1017/CBO9780511551802.003; Reeves WK, 2006, J MED ENTOMOL, V43, P1099, DOI 10.1603/0022-2585(2006)43[1099:ASFGRF]2.0.CO;2; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Rikihisa Y, 1999, MICROBES INFECT, V1, P367, DOI 10.1016/S1286-4579(99)80053-7; Shibata S, 2000, J CLIN MICROBIOL, V38, P1331, DOI 10.1128/JCM.38.4.1331-1338.2000; Stenos J, 2003, AM J TROP MED HYG, V69, P314, DOI 10.4269/ajtmh.2003.69.314; Switaj Karolina, 2012, Przegl Epidemiol, V66, P347; Tabara K, 2007, MICROBIOL IMMUNOL, V51, P359, DOI 10.1111/j.1348-0421.2007.tb03923.x; Takano A, 2010, ENVIRON MICROBIOL, V12, P134, DOI 10.1111/j.1462-2920.2009.02054.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ushijima Y, 2003, J PARASITOL, V89, P196, DOI 10.1645/0022-3395(2003)089[0196:MSVICC]2.0.CO;2; Vaclav R, 2011, MICROB ECOL, V61, P245, DOI 10.1007/s00248-010-9736-0	37	41	41	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133700	10.1371/journal.pone.0133700	http://dx.doi.org/10.1371/journal.pone.0133700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207382	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000118
J	Callol, A; Reyes-Lopez, FE; Roig, FJ; Goetz, G; Goetz, FW; Amaro, C; MacKenzie, SA				Callol, Agnes; Reyes-Lopez, Felipe E.; Roig, Francisco J.; Goetz, Giles; Goetz, Frederick W.; Amaro, Carmen; MacKenzie, Simon A.			An Enriched European Eel Transcriptome Sheds Light upon Host-Pathogen Interactions with Vibrio vulnificus	PLOS ONE			English	Article							DUPLEX-SPECIFIC NUCLEASE; IMMUNE-RELATED GENES; EXPRESSION PROFILE; VIRULENCE PLASMID; CELL-DEATH; SEROVAR-E; RESPONSES; GILLS; IMMUNOGENOMICS; IDENTIFICATION	Infectious diseases are one of the principal bottlenecks for the European eel recovery. The aim of this study was to develop a new molecular tool to be used in host-pathogen interaction experiments in the eel. To this end, we first stimulated adult eels with different pathogen-associated molecular patterns (PAMPs), extracted RNA from the immune-related tissues and sequenced the transcriptome. We obtained more than 2x10(6) reads that were assembled and annotated into 45,067 new descriptions with a notable representation of novel transcripts related with pathogen recognition, signal transduction and the immune response. Then, we designed a DNA-microarray that was used to analyze the early immune response against Vibrio vulnificus, a septicemic pathogen that uses the gills as the portal of entry into the blood, as well as the role of the main toxin of this species (RtxA1(3)) on this early interaction. The gill transcriptomic profiles obtained after bath infecting eels with the wild type strain or with a mutant deficient in rtxA1(3) were analyzed and compared. Results demonstrate that eels react rapidly and locally against the pathogen and that this immuneresponse is rtxA1(3)-dependent as transcripts related with cell destruction were highly up-regulated only in the gills from eels infected with the wild-type strain. Furthermore, significant differences in the immune response against the wild type and the mutant strain also suggest that host survival after V. vulnificus infection could depend on an efficient local phagocytic activity. Finally, we also found evidence of the presence of an interbranchial lymphoid tissue in European eel gills although further experiments will be necessary to identify such tissue.	[Callol, Agnes; Roig, Francisco J.; Amaro, Carmen] Univ Valencia, Dept Microbiol & Ecol, E-46100 Burjassot, Spain; [Callol, Agnes; Reyes-Lopez, Felipe E.; MacKenzie, Simon A.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Reyes-Lopez, Felipe E.] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol Anim & Immunol, Bellaterra, Spain; [Goetz, Giles; Goetz, Frederick W.] NW Fisheries Sci Ctr, Seattle, WA USA; [MacKenzie, Simon A.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	University of Valencia; Autonomous University of Barcelona; Autonomous University of Barcelona; National Oceanic Atmospheric Admin (NOAA) - USA; University of Stirling	MacKenzie, SA (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain.	simon.mackenzie@stir.ac.uk	Amaro, Carmen/K-7873-2014; Reyes-López, Felipe E./S-1760-2018; MacKenzie, Simon/Q-2362-2019	Amaro, Carmen/0000-0003-1323-6330; Reyes-López, Felipe E./0000-0002-5001-457X; MacKenzie, Simon/0000-0003-1845-6826; Roig Molina, Francisco Jose/0000-0002-8853-2428	FEDER funds [AGL2011-29639]; MICINN of Spanish Government [CSD2009-00006, CSD2007-00002]; MICINN [BES-2009-024776]; CONICYT [BCH 4311/2013]	FEDER funds(European Commission); MICINN of Spanish Government(Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by AGL2011-29639 (co-funded with FEDER funds), and Consolider-Ingenio Programs CSD2009-00006 and CSD2007-00002 from MICINN of Spanish Government. Grant support to Agnes Callol (BES-2009-024776, MICINN) and Felipe E. Reyes-Lopez (BCH 4311/2013, CONICYT) are thankfully acknowledged.	Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Adams A, 2006, TRENDS BIOTECHNOL, V24, P201, DOI 10.1016/j.tibtech.2006.03.004; Amaro C, 1996, APPL ENVIRON MICROB, V62, P1454, DOI 10.1128/AEM.62.4.1454-1457.1996; Aoyama J, 2001, MOL PHYLOGENET EVOL, V20, P450, DOI 10.1006/mpev.2001.0959; Austin B., 2012, BACTERIAL FISH PATHO; Baillon L, 2015, ECOTOXICOLOGY, V24, P71, DOI 10.1007/s10646-014-1356-x; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bright MD, 2011, INT J BIOCHEM CELL B, V43, P1776, DOI 10.1016/j.biocel.2011.08.015; Buonaguro L, 2011, IMMUNOL REV, V239, P197, DOI 10.1111/j.1600-065X.2010.00971.x; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Callol A, 2015, FISH SHELLFISH IMMUN, V43, P502, DOI 10.1016/j.fsi.2015.01.009; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Cummings RD, 2009, ESSENTIALS GLYCOBIOL; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Douglas SE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-144; Douglas SE, 2006, OMICS, V10, P474, DOI 10.1089/omi.2006.10.474; Esteve-Gassent MD, 2003, FISH SHELLFISH IMMUN, V15, P51, DOI 10.1016/S1050-4648(02)00138-9; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Garlanda C, 2013, SEMIN IMMUNOL, V25, P408, DOI 10.1016/j.smim.2013.10.019; Gerdol M, 2015, MAR GENOM, V20, P13, DOI 10.1016/j.margen.2014.12.005; Gu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09836; Haugarvoll E, 2008, J ANAT, V213, P202, DOI 10.1111/j.1469-7580.2008.00943.x; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kalujnaia S, 2007, PHYSIOL GENOMICS, V31, P385, DOI 10.1152/physiolgenomics.00059.2007; Kim YR, 2013, J INFECT DIS, V207, P1406, DOI 10.1093/infdis/jis746; Kirkegaard E, 2010, DTU AQUA REPORT NO 2; Koppang EO, 2010, J ANAT, V217, P728, DOI 10.1111/j.1469-7580.2010.01305.x; Lee CT, 2008, J BACTERIOL, V190, P1638, DOI 10.1128/JB.01484-07; Lee CT, 2013, ENVIRON MICROBIOL, V15, P419, DOI 10.1111/j.1462-2920.2012.02854.x; Lee JH, 2007, J MICROBIOL, V45, P146; Li YW, 2011, PARASITE IMMUNOL, V33, P679, DOI 10.1111/j.1365-3024.2011.01337.x; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Marco-Noales E, 2001, APPL ENVIRON MICROB, V67, P4717, DOI 10.1128/AEM.67.10.4717-4725.2001; Mayank G, 2009, INT J PHARM RES DEV, V1, P1; Minegishi Y, 2012, MAR BIOTECHNOL, V14, P583, DOI 10.1007/s10126-012-9444-5; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Mohd-Shaharuddin N, 2013, FISH SHELLFISH IMMUN, V34, P762, DOI 10.1016/j.fsi.2012.11.052; Nielsen T., 2008, FAO Fisheries Technical Paper, P141; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ohara O, 2009, FEBS LETT, V583, P1662, DOI 10.1016/j.febslet.2009.04.021; Ortiz NN, 2014, DEV COMP IMMUNOL, V47, P309, DOI 10.1016/j.dci.2014.07.015; Pajuelo D, 2015, ENVIRON MICROBIOL, DOI [10.1111/1462-2920.1278, DOI 10.1111/1462-2920.1278]; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Press C, 1999, FISH SHELLFISH IMMUN; Rebl A, 2014, MAR BIOTECHNOL, V16, P333, DOI 10.1007/s10126-013-9552-x; Ribas L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-180; Ricciardi-Castagnoli P, 2002, NAT REV IMMUNOL, V2, P881, DOI 10.1038/nri936; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sainz J, 2007, ARTERIOSCL THROM VAS, V27, P263, DOI 10.1161/01.ATV.0000256727.34148.e2; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Thebault P, 2009, J IMMUNOL, V183, P3099, DOI 10.4049/jimmunol.0803767; Valiente E, 2008, FISH SHELLFISH IMMUN, V24, P134, DOI 10.1016/j.fsi.2007.10.007; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-356; Yufera M, 2012, MAR BIOTECHNOL, V14, P423, DOI 10.1007/s10126-011-9422-3; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	61	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133328	10.1371/journal.pone.0133328	http://dx.doi.org/10.1371/journal.pone.0133328			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207370	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000078
J	Fu, L; Chen, C; Wang, B; Zhou, XS; Li, SH; Guo, P; Shen, ZG; Wang, GP; Chen, YH				Fu, Lei; Chen, Chen; Wang, Bin; Zhou, Xishi; Li, Shuhuan; Guo, Pan; Shen, Zhenguo; Wang, Guiping; Chen, Yahua			Differences in Copper Absorption and Accumulation between Copper-Exclusion and Copper-Enrichment Plants: A Comparison of Structure and Physiological Responses	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ABSCISIC-ACID INCREASES; OENOTHERA-PICENSIS; ELSHOLTZIA-HAICHOWENSIS; DURUM-WHEAT; CADMIUM; TRANSPIRATION; TOLERANCE; CU; PHYTOREMEDIATION	Differences in copper (Cu) absorption and transport, physiological responses and structural characteristics between two types of Cu-resistant plants, Oenothera glazioviana (Cu-exclusion type) and Elsholtzia haichowensis (Cu-enrichment type), were investigated in the present study. The results indicated the following: (1) After 50 mu M Cu treatment, the Cu ratio in the xylem vessels of E. haichowensis increased by 60%. A Cu adsorption experiment indicated that O. glazioviana exhibited greater resistance to Cu, and Cu absorption and the shoot/root ratio of Cu were significantly lower in O. glazioviana than in E. haichowensis. (2) An analysis of the endogenous abscisic acid (ABA) variance and exogenous ABA treatment demonstrated that the ABA levels of both plants did not differ; exogenous ABA treatment clearly reduced Cu accumulation in both plants. (3) The leaf stomatal density of O. glazioviana was significantly less than that of E. haichowensis. Guard cells in E. haichowensis plants were covered with a thick cuticle layer, the epidermal hair was more numerous and longer, and the number of xylem conduits in the root was small. (4) The transpiration rate and the stomatal conductance of O. glazioviana were both significantly lower than those of E. haichowensis, regardless of whether the plants were treated with Cu. Taken together, these results indicate that the differences in the structural characteristics between these two plant species, particularly in the characteristics related to plant transpiration, are important factors that govern whether plants acquire or exclude Cu.	[Fu, Lei; Chen, Chen; Wang, Bin; Zhou, Xishi; Li, Shuhuan; Guo, Pan; Shen, Zhenguo; Wang, Guiping; Chen, Yahua] Nanjing Agr Univ, Coll Life Sci, Natl Joint Local Engn Res Ctr Rural Land Resource, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, YH (corresponding author), Nanjing Agr Univ, Coll Life Sci, Natl Joint Local Engn Res Ctr Rural Land Resource, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing, Jiangsu, Peoples R China.	yahuachen@njau.edu.cn			National Natural Science Foundation of China [31371545]; Science Foundation of Jiangsu Province, China [BE2014742]; Agricultural Science and Technology Innovation Foundation of Jiangsu Province, China [CX(14)2095]; Three Innovations of Agriculture Engineering of Jiangsu Province, China [SXGC[2015]320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province, China; Agricultural Science and Technology Innovation Foundation of Jiangsu Province, China; Three Innovations of Agriculture Engineering of Jiangsu Province, China	This work was funded by the National Natural Science Foundation of China (31371545), http://www.nsfc.gov.cn/(YHC); the Science Foundation of Jiangsu Province, China (BE2014742), http://www.jstd.gov.cn/(YHC); the Agricultural Science and Technology Innovation Foundation of Jiangsu Province, China (CX(14)2095), http://www.jsnyzzcx.cn/(YHC); and the Three Innovations of Agriculture Engineering of Jiangsu Province, China (SXGC[2015]320), http://keyan.jaas.ac.cn/(YHC). The funders provided great help in study design and data collection and analysis.	BAKER AJM, 1981, J PLANT NUTR, V3, P643, DOI 10.1080/01904168109362867; Ben-Yehoshua S., 2002, POSTHARVEST PHYSL PA, P111, DOI DOI 10.1016/J.P0STHARVBI0.2004.09.004; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; Dixit P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016360; Gonzalez I, 2011, CHEMOSPHERE, V84, P490, DOI 10.1016/j.chemosphere.2011.03.015; GREGER M, 1992, PHYSIOL PLANTARUM, V86, P465, DOI 10.1111/j.1399-3054.1992.tb01345.x; Guo P, 2014, ENVIRON SCI POLLUT R, V21, P631, DOI 10.1007/s11356-013-1899-z; Hart JJ, 1998, PLANT PHYSIOL, V116, P1413, DOI 10.1104/pp.116.4.1413; He JP, 2011, J PLANT PHYSIOL, V168, P687, DOI 10.1016/j.jplph.2010.10.009; Isaure MP, 2006, SPECTROCHIM ACTA B, V61, P1242, DOI 10.1016/j.sab.2006.10.009; Konno H, 2010, J PLANT PHYSIOL, V167, P358, DOI 10.1016/j.jplph.2009.09.011; Kovacik J, 2011, WATER AIR SOIL POLL, V218, P681, DOI 10.1007/s11270-010-0677-5; Kovacik J, 2010, ENVIRON TOXICOL, V25, P581, DOI 10.1002/tox.20519; Krober W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035742; Krzeslowska M, 2011, ACTA PHYSIOL PLANT, V33, P35, DOI 10.1007/s11738-010-0581-z; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; Li F, 2009, PLANT MOL BIOL, V71, P251, DOI 10.1007/s11103-009-9521-y; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039690; Liu TY, 2009, CURR OPIN PLANT BIOL, V12, P312, DOI 10.1016/j.pbi.2009.04.004; Liu XQ, 2010, CHEMOSPHERE, V78, P1136, DOI 10.1016/j.chemosphere.2009.12.030; Lochlainn SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017814; Lou LQ, 2004, ENVIRON EXP BOT, V51, P111, DOI 10.1016/j.envexpbot.2003.08.002; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Meier S, 2015, J PLANT NUTR SOIL SC, V178, P126, DOI 10.1002/jpln.201400092; Meier S, 2011, APPL SOIL ECOL, V48, P117, DOI 10.1016/j.apsoil.2011.04.005; Naidoo Y, 2012, PLANTA, V236, P1215, DOI 10.1007/s00425-012-1671-5; Nardini A, 2011, J EXP BOT, V62, P4701, DOI 10.1093/jxb/err208; Peng HY, 2013, ENVIRON SCI TECHNOL, V47, P6120, DOI 10.1021/es3050746; Pineda-Garcia F, 2011, PLANT CELL ENVIRON, V34, P1536, DOI 10.1111/j.1365-3040.2011.02351.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Renkema H, 2012, PLANT SOIL, V354, P239, DOI 10.1007/s11104-011-1069-3; Salah SA, 2006, AGR WATER MANAGE, V82, P177, DOI 10.1016/j.agwat.2005.06.002; SALT DE, 1995, PLANT PHYSIOL, V107, P1293, DOI 10.1104/pp.107.4.1293; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Tani FH, 2005, ENVIRON POLLUT, V138, P548, DOI 10.1016/j.envpol.2004.06.004; Thompson SW, 2012, J ENVIRON RADIOACTIV, V112, P133, DOI 10.1016/j.jenvrad.2012.05.017; Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014; Wei SH, 2005, ENVIRON INT, V31, P829, DOI 10.1016/j.envint.2005.05.045; Wenzel WW, 2003, ENVIRON POLLUT, V123, P131, DOI 10.1016/S0269-7491(02)00341-X; Wu B, 2011, INT J MASS SPECTROM, V307, P85, DOI 10.1016/j.ijms.2011.01.018; Wu LH, 2012, INT J PHYTOREMEDIAT, V14, P570, DOI 10.1080/15226514.2011.619227; Xing Y, 2012, J ZHEJIANG UNIV-SC B, V13, P487, DOI 10.1631/jzus.B1100298; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Yoon J, 2006, SCI TOTAL ENVIRON, V368, P456, DOI 10.1016/j.scitotenv.2006.01.016; Zhang HX, 2010, J HAZARD MATER, V178, P834, DOI 10.1016/j.jhazmat.2010.02.014; ZHAO F, 1994, COMMUN SOIL SCI PLAN, V25, P407, DOI 10.1080/00103629409369047; Zhao L, 2009, BIOL PLANTARUM, V53, P728, DOI 10.1007/s10535-009-0132-x; Zheng SJ, 2004, PLANT SOIL, V261, P85, DOI 10.1023/B:PLSO.0000035576.71760.2b; ZHONG HL, 1993, J EXP BOT, V44, P773, DOI 10.1093/jxb/44.4.773; Zhu XF, 2012, PLANTA, V236, P989, DOI 10.1007/s00425-012-1652-8	52	17	17	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133424	10.1371/journal.pone.0133424	http://dx.doi.org/10.1371/journal.pone.0133424			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207743	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000090
J	Smerlak, M; Stoll, B; Gupta, A; Magdanz, JS				Smerlak, Matteo; Stoll, Brady; Gupta, Agam; Magdanz, James S.			Mapping Systemic Risk: Critical Degree and Failures Distribution in Financial Networks	PLOS ONE			English	Article							DEFAULT CASCADES; TOPOLOGY; MODEL; INSURANCE; EVOLUTION; MARKET	The financial crisis illustrated the need for a functional understanding of systemic risk in strongly interconnected financial structures. Dynamic processes on complex networks being intrinsically difficult to model analytically, most recent studies of this problem have relied on numerical simulations. Here we report analytical results in a network model of interbank lending based on directly relevant financial parameters, such as interest rates and leverage ratios. We obtain a closed-form formula for the "critical degree" (the number of creditors per bank below which an individual shock can propagate throughout the network), and relate failures distributions to network topologies, in particular scalefree ones. Our criterion for the onset of contagion turns out to be isomorphic to the condition for cooperation to evolve on graphs and social networks, as recently formulated in evolutionary game theory. This remarkable connection supports recent calls for a methodological rapprochement between finance and ecology.	[Smerlak, Matteo] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Stoll, Brady] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA; [Gupta, Agam] Indian Inst Management Calcutta, Kolkata 700104, W Bengal, India; [Magdanz, James S.] Univ Alaska Fairbanks, Resilience & Adaptat Program, Fairbanks, AK 99775 USA	Perimeter Institute for Theoretical Physics; University of Texas System; University of Texas Austin; Indian Institute of Management (IIM System); Indian Institute of Management Calcutta; University of Alaska System; University of Alaska Fairbanks	Smerlak, M (corresponding author), Perimeter Inst Theoret Phys, 31 Caroline St North, Waterloo, ON N2L 2Y5, Canada.	msmerlak@perimeterinstitute.ca	Magdanz, James S/C-9348-2011; Smerlak, Matteo/AAA-5639-2022	Magdanz, James S/0000-0002-2412-2788; Smerlak, Matteo/0000-0002-0844-8868	Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation	Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	Research at the Perimeter Institute is supported in part by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D., 2013, 134 COL BUS SCH; Aghion P, 2000, EUR ECON REV, V44, P713, DOI 10.1016/S0014-2921(00)00058-1; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Allen F, 2009, ANNU REV FINANC ECON, V1, P97, DOI 10.1146/annurev.financial.050808.114321; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P18338, DOI 10.1073/pnas.1213767109; Ashcraft AB, 2007, AM ECON REV, V97, P221, DOI 10.1257/aer.97.2.221; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Basel III Basel C., 2010, BASEL; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Battiston S, 2012, J FINANC STABIL, V8, P138, DOI 10.1016/j.jfs.2012.01.002; Bech ML, 2010, PHYSICA A, V389, P5223, DOI 10.1016/j.physa.2010.05.058; Billio M, 2012, J FINANC ECON, V104, P535, DOI 10.1016/j.jfineco.2011.12.010; Bisias D, 2012, ANNU REV FINANC ECON, V4, P255, DOI 10.1146/annurev-financial-110311-101754; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Caccioli F., 2012, 201210018 SFI; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; de Bandt, 2000, EUROPEAN CENTRAL BAN; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Eisenberg L, 2001, MANAGE SCI, V47, P236, DOI 10.1287/mnsc.47.2.236.9835; Fotouhi B, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40920-6; Freixas X., 2010, 371 FRB NEW YORK STA, V371; Furfine C., 1999, FINANCIAL MARKETS IN, V8, P24, DOI DOI 10.1111/1468-0416.00031; Furfine CH, 2003, J MONEY CREDIT BANK, V35, P111, DOI 10.1353/mcb.2003.0004; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Garlaschelli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268701; Haldane A., 2009, BIS REV, V18; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Inoguchi M, 2013, PAC-BASIN FINANC J, V25, P136, DOI 10.1016/j.pacfin.2013.08.006; Kambhu J., 2007, NEW DIRECTIONS UNDER; Markose S, 2012, J ECON BEHAV ORGAN, V83, P627, DOI 10.1016/j.jebo.2012.05.016; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Minoiu C, 2013, J FINANC STABIL, V9, DOI 10.1016/j.jfs.2013.03.001; Mistrulli PE, 2011, J BANK FINANC, V35, P1114, DOI 10.1016/j.jbankfin.2010.09.018; Musmeci N, 2013, J STAT PHYS, V151, P720, DOI 10.1007/s10955-013-0720-1; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016132, 10.1103/PhysRevE.64.026118]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nguyen G., 2007, INT J CENTRAL BANKIN, V3, P123, DOI DOI 10.2139/ssrn.1691645; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; POSTLEWAITE A, 1987, J POLIT ECON, V95, P485, DOI 10.1086/261468; Propper M., 2008, NETWORK DESCRIPTION, V177, P1; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roukny T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02759; Soramaki K, 2007, PHYSICA A, V379, P317, DOI 10.1016/j.physa.2006.11.093; Stiglitz JE, 2010, AM ECON REV, V100, P388, DOI 10.1257/aer.100.2.388; Taylor J. B., 2008, 13943 NBER, P36; Temme NM, 2003, J COMPUT APPL MATH, V153, P441, DOI 10.1016/S0377-0427(02)00627-1; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	54	10	11	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130948	10.1371/journal.pone.0130948	http://dx.doi.org/10.1371/journal.pone.0130948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26207631	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000009
J	Branchini, S; Meschini, M; Covi, C; Piccinetti, C; Zaccanti, F; Goffredo, S				Branchini, Simone; Meschini, Marta; Covi, Claudia; Piccinetti, Corrado; Zaccanti, Francesco; Goffredo, Stefano			Participating in a Citizen Science Monitoring Program: Implications for Environmental Education	PLOS ONE			English	Article							EGYPTIAN RED-SEA; CORAL-REEFS; COASTAL TOURISM; DIVING IMPACTS; SCUBA-DIVERS; MANAGEMENT; BRIEFINGS; DAMAGE; FORCE; AREAS	Tourism is of growing economical importance to many nations, in particular for developing countries. Although tourism is an important economic vehicle for the host country, its continued growth has led to on-going concerns about its environmental sustainability. Coastal and marine tourism can directly affect the environment through direct and indirect tourist activities. For these reasons tourism sector needs practical actions of sustainability. Several studies have shown how education minimizes the impact on and is proactive for, preserving the natural resources. This paper evaluates the effectiveness of a citizen science program to improve the environmental education of the volunteers, by means of questionnaires provided to participants to a volunteer-based Red Sea coral reef monitoring program (STEproject). Fifteen multiple-choice questions evaluated the level of knowledge on the basic coral reef biology and ecology and the awareness on the impact of human behaviour on the environment. Volunteers filled in questionnaires twice, once at the beginning, before being involved in the project and again at the end of their stay, after several days participation in the program. We found that the participation in STEproject significantly increased both the knowledge of coral reef biology and ecology and the awareness of human behavioural impacts on the environment, but was more effective on the former. We also detected that tourists with a higher education level have a higher initial level of environmental education than less educated people and that the project was more effective on divers than snorkelers. This study has emphasized that citizen science projects have an important and effective educational value and has suggested that tourism and diving stakeholders should increase their commitment and efforts to these programs	[Branchini, Simone; Meschini, Marta; Covi, Claudia; Zaccanti, Francesco; Goffredo, Stefano] Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, Marine Sci Grp,Citizen Sci Lab, I-40126 Bologna, Italy; [Piccinetti, Corrado] Univ Bologna, Lab Fisheries & Marine Biol Fano, I-61032 Fano, PU, Italy	University of Bologna; University of Bologna	Goffredo, S (corresponding author), Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, Marine Sci Grp,Citizen Sci Lab, Via F Selmi 3, I-40126 Bologna, Italy.	s.goffredo@unibo.it	Meschini, Marta/AAM-3264-2020	goffredo, stefano/0000-0002-5022-9503; MESCHINI, MARTA/0000-0001-6575-6384; BRANCHINI, SIMONE/0000-0001-6374-8161	Italian Government (Ministry of the Education, University and Research); Egyptian Government (Ministry of Tourism of the Arab Republic of Egypt, Egyptian Tourist Authority); tour operator Settemari; diving agency SNSI, Scuba Nitrox Safety International; diving centers Viaggio nel Blu; Project Aware Foundation	Italian Government (Ministry of the Education, University and Research); Egyptian Government (Ministry of Tourism of the Arab Republic of Egypt, Egyptian Tourist Authority); tour operator Settemari; diving agency SNSI, Scuba Nitrox Safety International; diving centers Viaggio nel Blu; Project Aware Foundation	"STE: Scuba Tourism for the Environment" was funded by the Italian Government (Ministry of the Education, University and Research; www.istruzione.it), the Egyptian Government (Ministry of Tourism of the Arab Republic of Egypt, Egyptian Tourist Authority; www.egypt.travel), the tour operator Settemari (www.settemari.it), the diving agency SNSI, Scuba Nitrox Safety International (www.scubasnsi.com), the diving centers Viaggio nel Blu (www.viaggionelblu.org) and the Project Aware Foundation (www.projectaware.org). In-kind support was provided by the airline Neos (www.neosair.it), the diving center Holiday Service (www.holidaydiving.org), the diving agency SSI, Scuba School International (www.divessi.com) and the association Underwater Life Project (www.underwaterlifeproject.it). The project has also had the patronage of the Ministry of the Environment and Land and Sea Protection (www.minambiente.it) and of the ASTOI (Association of Italian Tour Operators; www.astoi.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WR, 1996, CORAL REEFS, V15, P215, DOI 10.1007/s003380050045; Ammar Mohammed S.A., 2006, Egyptian Journal of Aquatic Research, V32, P184; Barker N, 2003, THESIS U YORK W INDI; Barker NHL, 2004, BIOL CONSERV, V120, P481, DOI 10.1016/j.biocon.2004.03.021; Barradas JI, 2012, ARQUIVOS CIENCIAS MA; BEEKHUIS JV, 1981, AMBIO, V10, P325; Bellan GL, 2001, AQUAT CONSERV, V11, P325, DOI 10.1002/aqc.461; Branchini S, 2014, BIODIVERS C IN PRESS; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Camp E, 2012, OCEAN COAST MANAGE, V61, P30, DOI 10.1016/j.ocecoaman.2012.02.002; Cohen R., 2000, GLOBAL SOCIOLOGY; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fulton D.C., 1996, HUMAN DIMENSIONS WIL, V1, P24, DOI DOI 10.1080/10871209609359060; Goffredo S, 2004, CONSERV BIOL, V18, P1492, DOI 10.1111/j.1523-1739.2004.00015.x; Goffredo S, 2010, ECOL APPL, V20, P2170, DOI 10.1890/09-1546.1; Hall CM, 2001, OCEAN COAST MANAGE, V44, P601, DOI 10.1016/S0964-5691(01)00071-0; Hasler H, 2008, MAR POLLUT BULL, V56, P1788, DOI 10.1016/j.marpolbul.2008.06.002; Hawkins JP, 1999, CONSERV BIOL, V13, P888, DOI 10.1046/j.1523-1739.1999.97447.x; Higgins-Desbiolles F, 2006, TOURISM MANAGE, V27, P1192, DOI 10.1016/j.tourman.2005.05.020; Jameson S. C., 2007, Journal of Sustainable Tourism, V15, P309, DOI 10.2167/jost719.0; Jennings S, 2004, ANN TOURISM RES, V31, P899, DOI 10.1016/j.annals.2004.02.005; Lansing P, 2007, J BUS ETHICS, V72, P77, DOI 10.1007/s10551-006-9157-7; Lynn NA, 2003, LANDSCAPE URBAN PLAN, V64, P77, DOI 10.1016/S0169-2046(02)00202-5; Marshall NA, 2011, CURR ISSUES TOUR, V14, P507, DOI 10.1080/13683500.2010.512075; Mathieson A., 1982, TOURISM EC PHYS SOCI; Medio D, 1997, BIOL CONSERV, V79, P91, DOI 10.1016/S0006-3207(96)00074-2; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; MILLER ML, 1991, MAR POLICY, V15, P75, DOI 10.1016/0308-597X(91)90008-Y; Moufaddal WM, 2005, ENVIRON MONIT ASSESS, V107, P427, DOI 10.1007/s10661-005-3576-2; Needham MD, 2010, J SUSTAIN TOUR, V18, P757, DOI 10.1080/09669581003690486; Orams Mark, 1999, MARINE TOURISM DEV I; ORAMS MB, 1998, J ENVIRON EDUC, V29, P33, DOI DOI 10.1080/00958969809599116; Plathong S, 2000, CONSERV BIOL, V14, P1821, DOI [10.1046/j.1523-1739.2000.99301.x, 10.1111/j.1523-1739.2000.99301.x]; Rouphael AB, 1997, BIOL CONSERV, V82, P329, DOI 10.1016/S0006-3207(97)00047-5; Russell D., 2003, Pacific island tourism, P38; Smith Kirby, 2009, Journal and Proceedings of the Royal Society of New South Wales, V142, P31; UNEP, 2009, SUST COAST TOUR INT; UNWTO, 2018, UNWTO TOUR HIGHL 201, Vxxx; UNWTO, 2011, UNWTO TOUR 2030 GLOB; Zakai D, 2002, BIOL CONSERV, V105, P179, DOI 10.1016/S0006-3207(01)00181-1	41	35	36	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131812	10.1371/journal.pone.0131812	http://dx.doi.org/10.1371/journal.pone.0131812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200660	gold, Green Submitted, Green Published			2022-12-27	WOS:000358597100020
J	Gormley-Gallagher, AM; Douglas, RW; Rippey, B				Gormley-Gallagher, Aine Marie; Douglas, Richard William; Rippey, Brian			The Applicability of the Distribution Coefficient, K-D, Based on Non-Aggregated Particulate Samples from Lakes with Low Suspended Solids Concentrations	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; TRACE-ELEMENTS; FRESH-WATER; SEDIMENT; METALS; CU; PH; ZN; REDISTRIBUTION; VARIABILITY	Separate phases of metal partitioning behaviour in freshwater lakes that receive varying degrees of atmospheric contamination and have low concentrations of suspended solids were investigated to determine the applicability of the distribution coefficient, K-D. Concentrations of Pb, Ni, Co, Cu, Cd, Cr, Hg and Mn were determined using a combination of filtration methods, bulk sample collection and digestion and Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). Phytoplankton biomass, suspended solids concentrations and the organic content of the sediment were also analysed. By distinguishing between the phyto-plankton and (inorganic) lake sediment, transient variations in K-D were observed. Suspended solids concentrations over the 6-month sampling campaign showed no correlation with the K-D (n = 15 for each metal, p > 0.05) for Mn (r(2) = 0.0063), Cu (r(2) = 0.0002, Cr (r(2) = 0.021), Ni (r(2) = 0.0023), Cd (r(2) = 0.00001), Co (r(2) = 0.096), Hg (r(2) = 0.116) or Pb (r(2) = 0.164). The results implied that colloidal matter had less opportunity to increase the dissolved (filter passing) fraction, which inhibited the spurious lowering of K-D. The findings conform to the increasingly documented theory that the use of K-D in modelling may mask true information on metal partitioning behaviour. The root mean square error of prediction between the directly measured total metal concentrations and those modelled based on the separate phase fractions were +/- 3.40, 0.06, 0.02, 0.03, 0.44, 484.31, 80.97 and 0.1 mu g/L for Pb, Cd, Mn, Cu, Hg, Ni, Cr and Co respectively. The magnitude of error suggests that the separate phase models for Mn and Cu can be used in distribution or partitioning models for these metals in lake water.	[Gormley-Gallagher, Aine Marie; Douglas, Richard William; Rippey, Brian] Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Gormley-Gallagher, Aine Marie] Cranfield Univ, Sch Appl Sci, Cranfield MK43 0AL, Beds, England	Ulster University; Cranfield University	Gormley-Gallagher, AM (corresponding author), Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	aine.gormley@cranfield.ac.uk	Gormley-Gallagher, Aine/M-2855-2016	Gormley-Gallagher, Aine/0000-0003-2080-2134; douglas, richard/0000-0001-8156-0920	Department for Employment and Learning (DEL) Northern Ireland	Department for Employment and Learning (DEL) Northern Ireland	This work was funded by the Department for Employment and Learning (DEL) Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, GEOCHEM T, DOI [DOI 10.1039/B104809K, DOI 10.1186/1467-4866-2-57]; APHA, 1995, STANDARD METHODS EXA; Arain MB, 2008, CHEMOSPHERE, V70, P1845, DOI 10.1016/j.chemosphere.2007.08.005; Atkinson CA, 2007, CHEMOSPHERE, V69, P1428, DOI 10.1016/j.chemosphere.2007.04.068; Baldwin DS, 2008, WATER RES, V42, P4711, DOI 10.1016/j.watres.2008.08.020; BALISTRIERI LS, 1994, GEOCHIM COSMOCHIM AC, V58, P3993, DOI 10.1016/0016-7037(94)90262-3; BALLS PW, 1989, NETH J SEA RES, V23, P7, DOI 10.1016/0077-7579(89)90037-9; Bennion H, 1996, ENVIRON SCI TECHNOL, V30, P2004, DOI 10.1021/es9508030; BENOIT G, 1994, MAR CHEM, V45, P307, DOI 10.1016/0304-4203(94)90076-0; BIRKS HJB, 1990, PHILOS T R SOC B, V327, P263, DOI 10.1098/rstb.1990.0062; Bock R, 1979, HDB DECOMPOSITION ME; Boyer JN, 2009, ECOL INDIC, V9, pS56, DOI 10.1016/j.ecolind.2008.11.013; Caddick MX, 1998, SOC GEN MICROBIOLOGY, P56; Chen CY, 2005, ENVIRON SCI TECHNOL, V39, P115, DOI 10.1021/es0403007; Croteau MN, 2007, AQUAT TOXICOL, V83, P116, DOI 10.1016/j.aquatox.2007.03.016; DANIELSSON LG, 1983, ESTUAR COAST SHELF S, V17, P73, DOI 10.1016/0272-7714(83)90046-X; Douglas RW, 2000, LIMNOL OCEANOGR, V45, P686, DOI 10.4319/lo.2000.45.3.0686; Douglas RW, 2003, FRESHWATER BIOL, V48, P512, DOI 10.1046/j.1365-2427.2003.01027.x; Gagnon C, 2003, ENVIRON POLLUT, V124, P47, DOI 10.1016/S0269-7491(02)00433-5; Gaiero DM, 2003, GEOCHIM COSMOCHIM AC, V67, P3603, DOI 10.1016/S0016-7037(03)00211-4; Hart GL, 1997, SOIL SCI SOC AM J, V61, P1765, DOI 10.2136/sssaj1997.03615995006100060031x; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Henderson GM, 1999, DEEP-SEA RES PT I, V46, P1861, DOI 10.1016/S0967-0637(99)00030-8; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; HILTON J, 1985, LIMNOL OCEANOGR, V30, P1131, DOI 10.4319/lo.1985.30.6.1131; Ho TY, 2007, LIMNOL OCEANOGR, V52, P1776, DOI 10.4319/lo.2007.52.5.1776; Hurley JP, 1996, ENVIRON SCI TECHNOL, V30, P2093, DOI 10.1021/es9509543; Jiang L, 2005, AM NAT, V166, P496, DOI 10.1086/444442; Juggins S, 1996, FRESHWATER BIOL, V36, P203, DOI 10.1046/j.1365-2427.1996.00079.x; Kogut MB, 2003, ENVIRON SCI TECHNOL, V37, P509, DOI 10.1021/es020723d; Kozelka PB, 1998, MAR CHEM, V60, P267, DOI 10.1016/S0304-4203(97)00107-2; Last W. M., 2001, TRACKING ENV CHANGE, V1; Lepparanta M., 2015, FREEZING LAKES EVOLU; Lindsay W.L., 1979, CHEM EQUILIBRIA SOIL; Lindstrom M., 2000, THESIS ACTA U UPSALI; Long SE, 1990, 2008 US ENV PROT AG; MacIntyre S, 2009, LIMNOL OCEANOGR, V54, P2255, DOI 10.4319/lo.2009.54.6.2255; McKergow LA, 2010, NEW ZEAL J MAR FRESH, V44, P53, DOI 10.1080/00288331003721471; Meylan S, 2004, ANAL CHIM ACTA, V510, P91, DOI 10.1016/j.aca.2003.12.052; MONISMITH SG, 2009, ENCY INLAND WATERS, V1, P636, DOI DOI 10.1016/B978-012370626-3.00078-8; MURRAY JW, 1987, ADV CHEM SER, P153; Nguyen TH, 2005, ENVIRON SCI TECHNOL, V39, P913, DOI 10.1021/es048839s; Olrik K, 1998, 4860 SWED ENV PROT A; Opuene K, 2008, INT J ENVIRON RES, V2, P343; Palleiro L, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1651-9; PATRICK S, 1995, UK ACID WATERS MONIT; Pham MK, 1998, ENVIRON SCI TECHNOL, V32, P440, DOI 10.1021/es970183y; REYNOLDS GL, 1992, LIMNOL OCEANOGR, V37, P1759, DOI 10.4319/lo.1992.37.8.1759; Rippey B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002305; Rippey B, 2004, LIMNOL OCEANOGR, V49, P2256, DOI 10.4319/lo.2004.49.6.2256; Shafer MM, 1997, CHEM GEOL, V136, P71, DOI 10.1016/S0009-2541(96)00139-8; SMITH VH, 1985, WATER RESOUR BULL, V21, P433; Sykes JM, 1999, UK ENV CHANGE NETWOR; Tack FM, 1996, ENVIRON POLLUT, V91, P199, DOI 10.1016/0269-7491(95)00049-6; Turner A, 2007, ENVIRON SCI TECHNOL, V41, P3977, DOI 10.1021/es0620336; Tyler G., 2001, WATER AIR SOIL POLL, V3, P279, DOI DOI 10.1023/A:1017528826641; US. EPA, 2012, UND VAR PART COEFF K; Vesely J, 2001, APPL GEOCHEM, V16, P437, DOI 10.1016/S0883-2927(00)00041-X; Vignati DAL, 2005, ENVIRON SCI TECHNOL, V39, P489, DOI 10.1021/es049322j; Wang WX, 2006, ENVIRON POLLUT, V142, P303, DOI 10.1016/j.envpol.2005.10.005; Yu MQ, 2003, ANAL CHIM ACTA, V479, P225, DOI 10.1016/S0003-2670(02)01528-3; Zhang XB, 2004, GLOBAL PLANET CHANGE, V41, P221, DOI 10.1016/j.gloplacha.2004.01.008	62	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133069	10.1371/journal.pone.0133069	http://dx.doi.org/10.1371/journal.pone.0133069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200885	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100054
J	Tian, R; Yang, G; Tang, Y; Liu, XM; Li, R; Zhu, HL; Li, H				Tian, Rui; Yang, Gang; Tang, Ying; Liu, Xinmin; Li, Rui; Zhu, Hualing; Li, Hang			Origin of Hofmeister Effects for Complex Systems	PLOS ONE			English	Article							DENSITY DISTRIBUTION ANALYSIS; ELECTRON-DENSITY; COLLOIDAL PARTICLES; ION ADSORPTION; DOUBLE-LAYERS; CO-ION; SURFACE; ENERGY; AGGREGATION; KAOLINITE	Hofmeister effects have been recognized as important as Mendel's work was to genetics while remain largely controversial, especially for the mechanistic aspects. Here we demonstrated that complex colloids in electrolyte solutions show resembling aggregation kinetics as model colloid, and then quantitatively evaluated the resulting Hofmeister effects. Mechanism for the aggregation of complex colloids has been proposed that is closely associated with the charges of their constituents; despite that, electrostatic interactions play a minor role while polarization effect is evidenced to be the driving force for the aggregation processes. Polarization effect is further ascribed to arouse the resulting Hofmeister effects, which is supported by the fine correlation of activation energies vs. polarizability data of different alkali ions and the calculations of dipole moments for minerals with different charges and adsorbed alkali ions. Because of neglecting polarization effect, the prevailing DLVO theory is not sufficient to describe Hofmeister effects that are ubiquitous in nature. We speculate that polarization effect should also be responsible for Hofmeister effects of other charged systems such as proteins and membranes.	[Tian, Rui; Yang, Gang; Tang, Ying; Liu, Xinmin; Li, Rui; Zhu, Hualing; Li, Hang] Southwest Univ, Chongqing Key Lab Soil Multi Scale Interfacial Pr, Coll Resources & Environm, Chongqing, Peoples R China	Southwest University - China	Yang, G (corresponding author), Southwest Univ, Chongqing Key Lab Soil Multi Scale Interfacial Pr, Coll Resources & Environm, Chongqing, Peoples R China.	theobiochem@gmail.com; lihangswu@163.com	Yang, Gang/B-2616-2008; Yang, Gang/AAG-9666-2021	Yang, Gang/0000-0003-1032-6840; Yang, Gang/0000-0003-1032-6840; , Rui/0000-0002-8849-7706	National Natural Science Foundation of China [21473137]; Fourth Excellent Talents Program of Higher Education in Chongqing [2014-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fourth Excellent Talents Program of Higher Education in Chongqing	National Natural Science Foundation of China (21473137) and the Fourth Excellent Talents Program of Higher Education in Chongqing (2014-03) support this research.	BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Boncina M, 2008, BIOPHYS J, V95, P1285, DOI 10.1529/biophysj.108.128694; Bostrom M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168103; Bostrom M, 2003, EUROPHYS LETT, V63, P610, DOI 10.1209/epl/i2003-00559-8; Bradl HB, 2004, J COLLOID INTERF SCI, V277, P1, DOI 10.1016/j.jcis.2004.04.005; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; Dahirel V, 2010, CURR OPIN COLLOID IN, V15, P2, DOI 10.1016/j.cocis.2009.05.006; dos Santos AP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.167801; Dubois M, 1998, J CHEM PHYS, V108, P7855, DOI 10.1063/1.476505; Duignan TT, 2013, J PHYS CHEM B, V117, P9412, DOI 10.1021/jp403595x; Elouear Z, 2014, SOIL SEDIMENT CONTAM, V23, P628, DOI 10.1080/15320383.2014.857640; Flegmann AW, 1969, P BR CERAM SOC, V13, P31; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; Frisch M.J., 2016, GAUSSIAN 16 REV C 01; Garcia-Garcia S, 2007, J COLLOID INTERF SCI, V315, P512, DOI 10.1016/j.jcis.2007.07.002; Gupta V, 2011, J COLLOID INTERF SCI, V359, P95, DOI 10.1016/j.jcis.2011.03.043; He YT, 2008, J NANOPART RES, V10, P321, DOI 10.1007/s11051-007-9255-1; HIRSHFELD FL, 1977, THEOR CHIM ACTA, V44, P129, DOI 10.1007/BF00549096; Hofmeister F., 1888, ARCH EXP PATHOL PHAR, V25, P1, DOI DOI 10.1007/BF01838161; Holthoff H, 1996, LANGMUIR, V12, P5541, DOI 10.1021/la960326e; Jungsuttiwong S, 2011, INT J QUANTUM CHEM, V111, P2275, DOI 10.1002/qua.22531; Jungwirth P, 2006, CHEM REV, V106, P1259, DOI 10.1021/cr0403741; Kim HK, 2001, EUR PHYS J E, V4, P411, DOI 10.1007/s101890170096; Kjellander R, 2001, J CHEM PHYS, V114, P9565, DOI 10.1063/1.1366639; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P19, DOI 10.1016/j.cocis.2004.05.005; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P1, DOI 10.1016/j.cocis.2004.05.004; Kunz W, 2010, CURR OPIN COLLOID IN, V15, P34, DOI 10.1016/j.cocis.2009.11.008; Laidler K. J., 1987, CHEM KINETICS; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Levin Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257802; Lima ERA, 2008, LANGMUIR, V24, P3944, DOI 10.1021/la7037069; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Liu XM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05047; Liu XM, 2014, RSC ADV, V4, P1189, DOI 10.1039/c3ra44984j; Liu XM, 2013, J PHYS CHEM C, V117, P6245, DOI 10.1021/jp312682u; Peula-Garcia JM, 2010, J PHYS CHEM C, V114, P11133, DOI 10.1021/jp912035v; Marcus Y., 1997, ION PROPERTIES; Moller J, 2014, PHYS CHEM CHEM PHYS, V16, P7423, DOI 10.1039/c3cp55278k; Nihonyanagi S, 2014, J AM CHEM SOC, V136, P6155, DOI 10.1021/ja412952y; Ninham BW, 1997, LANGMUIR, V13, P2097, DOI 10.1021/la960974y; Parsons DF, 2011, PHYS CHEM CHEM PHYS, V13, P12352, DOI 10.1039/c1cp20538b; Parsons DF, 2009, COLLOID SURFACE A, V343, P57, DOI 10.1016/j.colsurfa.2009.01.029; PASHLEY RM, 1986, J PHYS CHEM-US, V90, P1637, DOI 10.1021/j100399a037; Petrache HI, 2006, P NATL ACAD SCI USA, V103, P7982, DOI 10.1073/pnas.0509967103; RITCHIE JP, 1987, J COMPUT CHEM, V8, P499, DOI 10.1002/jcc.540080430; RITCHIE JP, 1985, J AM CHEM SOC, V107, P1829, DOI 10.1021/ja00293a005; Salis A, 2014, CHEM SOC REV, V43, P7358, DOI 10.1039/c4cs00144c; Scheu R, 2014, J AM CHEM SOC, V136, P2040, DOI 10.1021/ja4120117; Solans-Monfort X, 2002, J PHYS CHEM B, V106, P10220, DOI 10.1021/jp026303s; Stumm W., 1996, AQUATIC CHEMISTRY CH; Sumner ME, 2000, HANDBOOK OF SOIL SCI; Tian R, 2015, J PHYS CHEM C, V119, P4856, DOI 10.1021/jp512078v; Tian R, 2014, PHYS CHEM CHEM PHYS, V16, P8828, DOI 10.1039/c3cp54813a; Tobias DJ, 2008, SCIENCE, V319, P1197, DOI 10.1126/science.1152799; Van Olphen H, 1951, DISCUSS FARADAY SOC, V11, P82; Vasconcelos IF, 2007, J PHYS CHEM C, V111, P6753, DOI 10.1021/jp065687+; Whittinghill KA, 2012, BIOGEOCHEMISTRY, V111, P569, DOI 10.1007/s10533-011-9688-6; WILLIAMS DJA, 1978, J COLLOID INTERF SCI, V65, P79, DOI 10.1016/0021-9797(78)90260-6; Yang G, 2014, SCI REP-UK, V4, DOI 10.1038/srep06594; Yang G, 2011, CHEM-EUR J, V17, P1614, DOI 10.1002/chem.201002241	60	13	13	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0128602	10.1371/journal.pone.0128602	http://dx.doi.org/10.1371/journal.pone.0128602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200350	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100002
J	Trieu, K; Neal, B; Hawkes, C; Dunford, E; Campbell, N; Rodriguez-Fernandez, R; Legetic, B; McLaren, L; Barberio, A; Webster, J				Trieu, Kathy; Neal, Bruce; Hawkes, Corinna; Dunford, Elizabeth; Campbell, Norm; Rodriguez-Fernandez, Rodrigo; Legetic, Branka; McLaren, Lindsay; Barberio, Amanda; Webster, Jacqui			Salt Reduction Initiatives around the World - A Systematic Review of Progress towards the Global Target	PLOS ONE			English	Review							SODIUM-INTAKE; PREVENT HYPERTENSION; URINARY SODIUM; BLOOD-PRESSURE; REDUCING SALT; NUTRITION; POLICY; EXCRETION; HEALTH; DIETS	Objective To quantify progress with the initiation of salt reduction strategies around the world in the context of the global target to reduce population salt intake by 30% by 2025. Methods A systematic review of the published and grey literature was supplemented by questionnaires sent to country program leaders. Core characteristics of strategies were extracted and categorised according to a pre-defined framework. Results A total of 75 countries now have a national salt reduction strategy, more than double the number reported in a similar review done in 2010. The majority of programs are multifaceted and include industry engagement to reformulate products (n = 61), establishment of sodium content targets for foods (39), consumer education (71), front-of-pack labelling schemes (31), taxation on high-salt foods (3) and interventions in public institutions (54). Legislative action related to salt reduction such as mandatory targets, front of pack labelling, food procurement policies and taxation have been implemented in 33 countries. 12 countries have reported reductions in population salt intake, 19 reduced salt content in foods and 6 improvements in consumer knowledge, attitudes or behaviours relating to salt. Conclusion The large and increasing number of countries with salt reduction strategies in place is encouraging although activity remains limited in low- and middle-income regions. The absence of a consistent approach to implementation highlights uncertainty about the elements most important to success. Rigorous evaluation of ongoing programs and initiation of salt reduction programs, particularly in low- and middle-income countries, will be vital to achieving the targeted 30% reduction in salt intake.	[Trieu, Kathy; Neal, Bruce; Dunford, Elizabeth; Webster, Jacqui] Univ Sydney, George Inst Global Hlth, Food Policy Div, Sydney, NSW 2006, Australia; [Hawkes, Corinna] World Canc Res Fund, Policy & Publ Affairs, London, England; [Campbell, Norm] Univ Calgary, Dept Med, Libin Cardiovasc Inst, Calgary, AB, Canada; [Rodriguez-Fernandez, Rodrigo] Int SOS Freeport Ind Publ Hlth & Malaria Control, Kuala Kencana, Papua, Indonesia; [Legetic, Branka] WHO, Pan Amer Hlth Org, Unit Noncommunicable Dis & Disabil, Dept Noncommunicable Dis & Mental Hlth, Washington, DC USA; [McLaren, Lindsay; Barberio, Amanda] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada	George Institute for Global Health; University of Sydney; Libin Cardiovascular Institute Of Alberta; University of Calgary; Pan American Health Organization; World Health Organization; University of Calgary	Webster, J (corresponding author), Univ Sydney, George Inst Global Hlth, Food Policy Div, Sydney, NSW 2006, Australia.	jwebster@georgeinstitute.org.au		Neal, Bruce/0000-0002-0490-7465; Trieu, Kathy/0000-0003-1848-2741; Webster, Jacqui/0000-0003-3513-3340	Australian Research Council [DP100100295]; National Health and Medical Research Council of Australia [APP100311]; NHMRC Centre for Research Excellence [APP1052555]; NHMRC Sidney-Sax Overseas Fellowship; Heart and Stroke Foundation of Canada, Canadian Institute for Health Research Chair in Hypertension Prevention and Control; Population Health Investigator Award from Alberta Innovates-Health Solutions; Applied Public Health Chair from the Canadian Institutes of Health Research; Public Health Agency of Canada; Alberta Innovates-Health Solutions; Canadian Institutes of Health Research [SOK-116970]; National Health and Medical Research Council (NHMRC); National Heart Foundation Career Development Fellowship; World Health Organization; Victorian Health Promotion Foundation; NHMRC Program Grant [APP1052555]; Alberta Innovates [201400593] Funding Source: researchfish	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Centre for Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Sidney-Sax Overseas Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Heart and Stroke Foundation of Canada, Canadian Institute for Health Research Chair in Hypertension Prevention and Control(Canadian Institutes of Health Research (CIHR)); Population Health Investigator Award from Alberta Innovates-Health Solutions; Applied Public Health Chair from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Alberta Innovates-Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Career Development Fellowship(National Heart Foundation of Australia); World Health Organization(World Health Organization); Victorian Health Promotion Foundation; NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Alberta Innovates	BN is supported by an Australian Research Council Future Fellowship (DP100100295) and a National Health and Medical Research Council of Australia Senior Research Fellowship (APP100311). BN works within a NHMRC Centre for Research Excellence (APP1041020) and holds an NHMRC Program Grant (APP1052555). ED is supported by a NHMRC Sidney-Sax Overseas Fellowship. NC is supported by the Heart and Stroke Foundation of Canada, Canadian Institute for Health Research Chair in Hypertension Prevention and Control. LM is supported by a Population Health Investigator Award from Alberta Innovates-Health Solutions (until June 2014) and an Applied Public Health Chair from the Canadian Institutes of Health Research, the Public Health Agency of Canada, and Alberta Innovates-Health Solutions (starting October 2014). LM's work on this project was supported in part by an operating grant from the Canadian Institutes of Health Research, Ref # SOK-116970. JW is supported in her work on salt reduction through a National Health and Medical Research Council (NHMRC) and National Heart Foundation Career Development Fellowship. JW also gratefully acknowledges additional funding for work on salt reduction from the World Health Organization, the NHMRC and the Victorian Health Promotion Foundation throughout the period of this study.	Allemandi L, 2013, MAPPING CIVIL SOC OR; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 1988, BMJ, V297, P319; Ballesteros J, 2009, WORKSH SALT RED BREA; Blanco-Metzler A, 2012, REV PANAM SALUD PUBL, V32, P316, DOI 10.1590/S1020-49892012001000011; Bundesamt fur Gesundheit, 2013, SALT STRAT 2013 16 P; Bundesministerium Fur Gesundheit, 2013, AUSTR NAT SALT RED I; Campbell NRC, 2011, NUTRIENTS, V3, P756, DOI 10.3390/nu3080756; Campbell NRC, 2014, J CLIN HYPERTENSION; Charlton K, 2007, DIETARY INTERVENTION; Charlton K, 2014, NUTRIENTS, V6, P3672, DOI 10.3390/nu6093672; Charry D, 2011, STRATEGY REDUCE SODI; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Department of Environment Food and Rural Affairs, 2014, GOV BUYING STAND FOO; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; European Commission, 2009, NAT SALT IN IMPL EU; European Commission, 2013, SURV MEMB STAT IMPL; European Commission, 2008, COLL INF SALT RED EU; European Food Information Council, 2014, GLOB UPD NUTR LAB; Federal Public Service Health. Food Chain Safety and Environment, 2009, FOOD CHAIN SAF ENV S; Nilson EAF, 2012, REV PANAM SALUD PUBL, V32, P287, DOI 10.1590/S1020-49892012001000007; Food Safety Authority of Ireland. Salt and Health, 2014, SALT AND HLTH; Food Standards Agency, 2009, UK SALT RED IN; Global Agricultural Information Network, 2013, IND FOOD AGR IMP REG; Gorton D, 2010, NEW ZEAL MED J, V123, P102; Hawkes C, 2013, OBES REV, V14, P159, DOI 10.1111/obr.12098; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; He F.J., 2014, BMJ OPEN, V4, P1; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; He FJ, 2012, REV PANAM SALUD PUBL, V32, P293, DOI 10.1590/S1020-49892012001000008; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; Health Promotion Board, 2011, HBP DECL WAR SALT SI; Health Promotion Board, 2010, REP NAT NUTR SURV 20; Henney JE, 2010, STRATEGIES TO REDUCE SODIUM INTAKE IN THE UNITED STATES, P1; Hofman K, 2013, LANCET GLOB HLTH, V1; Jelakovic Bojan, 2009, Lijec Vjesn, V131, P87; Land MA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003720; Levings J, 2012, REV PANAM SALUD PUBL, V32, P301, DOI 10.1590/S1020-49892012001000009; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mclaren L, 2012, COCHRANE DATABASE SY; McLean RM, 2014, NUTRIENTS, V6, P4651, DOI 10.3390/nu6114651; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Ministry of Health NCD health promotion and control department, 2011, MEN SAL MAS VIDA IN; Ministry of Health Paraguay, 2011, ADV CHALL PAR; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Nainggolan L, 2009, PORTUGESE SUCCESS ST; National Food and Veterinary Risk Assessment Institute, 2013, PROM RED SALT CONS L; National Institute for Food and Nutrition Science, 2011, IMPL SPOT SALT HUNG; New York City Department of Health and Mental Hygiene, 2008, NAT SALT RED IN; Niebylski ML, 2014, INT J ENV RES PUB HE, V11, P2608, DOI 10.3390/ijerph110302608; Pan American Health Organization, 2013, TECHN M SETT TARG TI; Pan American Health Organization, 2013, SALT SMART AM GUID C; Penney S., 2009, DROPPING SALT PRACTI; Pietinen P, 2009, FINLANDS EXPERIENCES; Pietinen P, 2008, PUBLIC HEALTH NUTR, V11, P335, DOI 10.1017/S1368980007000249; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P920, DOI 10.1017/S1368980010001102; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P901, DOI 10.1017/S1368980010001072; Polonia J, 2009, J HUM HYPERTENS, V23, P771, DOI 10.1038/jhh.2009.64; Republic of Mauritius Ministry of Health and Quality of Life, 2009, NAT PLAN ACT NUTR 20; Ribic CH, 2010, PUBLIC HEALTH NUTR, V13, P1803, DOI 10.1017/S136898001000025X; Safefood, 2006, AM SAF WAV; Sixty-sixth World Health Assembly, 2013, FOLL UP POL DECL HIG; SMATE I, 2012, P LATV ACAD SCI B NA, V66, P128, DOI DOI 10.2478/v10046-012-0008-x; Sodium, 2014, NEW ENGL J MED, V371, P2134; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P161, DOI 10.1016/j.numecd.2011.10.004; Suckling R, 2010, J HYPERTENS, V28, pE219, DOI 10.1097/01.hjh.0000378867.74072.1c; Tipping S., 2011, NATL DIET NUTR SURVE; Udagawa K, 2008, ASIA PAC J CLIN NUTR, V17, P445; United Nations, 2011, REPORT SPECIAL RAPPO; United States Department of Agriculture, 2014, NUTR STAND SCH MEALS; Walton J, 2013, SALT INTAKES IRISH P; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; Webster J, 2014, NUTRIENTS, V6, P3274, DOI 10.3390/nu6083274; Weir MR, 2010, J CARDIOVASC PHARM T, V15, P356, DOI 10.1177/1074248410377173; WHO, 2010, GLOB STAT REP NONC D; WHO, 2011, UN HIGH LEV M NONC D; World Cancer Research Fund International, 2014, WCRF NOUR FRAM OFF H; World Cancer Research Fund International, 2014, WCRF INT FOOD POL FR; World Health Organization, 2013, JOINT TECHN M CONV W; World Health Organization, 2013, REG HLTH FOR WHO S E; World Health Organization, 2010, CREAT EN ENV POP BAS; World Health Organization, 2013, EXP M POP SOD RED ST; World Health Organization, 2014, STEPWISE APPR SURV S; World Health Organization, 2013, PROGR RED SALT CONS; World Health Organization, 2013, SALT RED MONG; World Health Organization, SALT MATT PAC ISL CO; World Health Organization, 2013, MAPP DIET SALT SOD R; World Health Organization, 2013, CONS DEV STRAT DIR S; World Health Organization, 2011, JOINT TECHN M CONV W; World Health Organization, 2014, POP SOD RED STRAT; World Health Orginization, 2010, REG CONS STRAT RED S; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966; Xi B, 2014, LANCET, V383, P1128, DOI 10.1016/S0140-6736(14)60567-5	93	270	279	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0130247	10.1371/journal.pone.0130247	http://dx.doi.org/10.1371/journal.pone.0130247			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201031	Green Accepted, Green Published, gold			2022-12-27	WOS:000358597100007
J	Wang, L; Wang, QM				Wang, Long; Wang, Qi-Ming			Molecular Phylogenetic Analysis of Ballistoconidium-Forming Yeasts in Trichosporonales (Tremellomycetes): A Proposal for Takashimella gen. nov and Cryptotrichosporon tibetense sp nov.	PLOS ONE			English	Article							BASIDIOMYCETOUS YEASTS; PLANT-LEAVES; BALLISTOSPOROUS YEASTS; CRYPTOCOCCUS; SYSTEMATICS; SPOROBOLOMYCES; PERFORMANCE; SEQUENCES; SOFTWARE; D1/D2	Bullera species in the Trichosporonales (Tremellomycetes, Agaricomycotina) are phylogenetically distinct from Bullera alba (teleomorph: Bulleromyces albus), the type species of Bullera that belongs to Tremellales. In the present study, the three Bullera species, namely Bullera formosensis, Bullera koratensis and Bullera lagerstroemiae, and Cryptococcus tepidarius belonging to the Trichosporonales are transferred into a new genus Takashimella gen. nov. (MycoBank No. MB 810672) based on sequence analysis of the small subunit (SSU) rRNA gene, the D1/D2 domains of large subunit (LSU) rRNA gene and the ITS+5.8S rRNA gene sequences. In addition, the genus Cryptotrichosporon is emended to accommodate a novel ballistoconidium-forming species of the Trichosporonales, which is named as Cryptotrichosporon tibetense (type strain CGMCC 2.02614(T) = CBS 10455(T)). The MycoBank number of this new species is MB 810688.	[Wang, Long; Wang, Qi-Ming] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, QM (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	wangqm@im.ac.cn			National Natural Science Foundation of China (NSFC) [30700001, 30970013]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants No. 30700001 and No. 30970013 from the National Natural Science Foundation of China (NSFC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai FY, 2002, INT J SYST EVOL MICR, V52, P2309, DOI [10.1099/ijs.0.02297-0, 10.1099/00207713-52-6-2309]; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1623, DOI 10.1016/B978-0-444-52149-1.00137-3; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1339, DOI 10.1016/B978-0-444-52149-1.00100-2; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Derx HG, 1930, ANN MYCOL, V28, P1; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Fungsin B, 2006, J GEN APPL MICROBIOL, V52, P73, DOI 10.2323/jgam.52.73; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; NAKASE T, 1987, STUD MYCOL, P375; NAKASE T, 1993, J GEN APPL MICROBIOL, V39, P107, DOI 10.2323/jgam.39.107; Nakase T, 2002, J GEN APPL MICROBIOL, V48, P345, DOI 10.2323/jgam.48.345; NAKASE T, 1991, J GEN APPL MICROBIOL, V37, P175, DOI 10.2323/jgam.37.175; NAKASE T, 1992, FEMS MICROBIOL LETT, V100, P497, DOI 10.1111/j.1574-6968.1992.tb05746.x; Nakase T, 2000, J GEN APPL MICROBIOL, V46, P189, DOI 10.2323/jgam.46.189; NAKASE T, 1989, YEAST, V5, P511; Nakase T, 1993, RIKEN REV, V3, P33; Okoli I, 2007, FEMS YEAST RES, V7, P339, DOI 10.1111/j.1567-1364.2006.00164.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rodrigues de Miranda L., 1984, YEASTS TAXONOMIC STU, P577; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; STADELMANN F, 1975, A VAN LEEUW J MICROB, V41, P575, DOI 10.1007/BF02565099; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoll M, 2005, MYCOL RES, V109, P342, DOI 10.1017/S0953756204002229; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Takashima M, 2001, J GEN APPL MICROBIOL, V47, P75, DOI 10.2323/jgam.47.75; Takashima M, 2009, INT J SYST EVOL MICR, V59, P181, DOI 10.1099/ijs.0.004515-0; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Vogelmann SA, 2012, INT J SYST EVOL MICR, V62, P1715, DOI 10.1099/ijs.0.032748-0; Wang QM, 2008, FEMS YEAST RES, V8, P799, DOI 10.1111/j.1567-1364.2008.00403.x; Wang QM, 2011, INT J SYST EVOL MICR, V61, P210, DOI 10.1099/ijs.0.019299-0; Wang QM, 2003, INT J SYST EVOL MICR, V53, P2085, DOI 10.1099/ijs.0.02736-0; WEISS M, 2014, MYCOTA SYSTEMATICS A, V7, P331; YAMADA Y, 1973, J GEN APPL MICROBIOL, V19, P59, DOI 10.2323/jgam.19.59	36	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132653	10.1371/journal.pone.0132653	http://dx.doi.org/10.1371/journal.pone.0132653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200459	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100043
J	Liu, J; Kim, KH; Morales, MJ; Heximer, SP; Hui, CC; Backx, PH				Liu, Jie; Kim, Kyoung-Han; Morales, Michael J.; Heximer, Scott P.; Hui, Chi-chung; Backx, Peter H.			Kv4.3-Encoded Fast Transient Outward Current Is Presented in Kv4.2 Knockout Mouse Cardiomyocytes	PLOS ONE			English	Article							K+ CURRENTS; POTASSIUM CHANNEL; MESSENGER-RNA; GENE-EXPRESSION; DOWN-REGULATION; BETA-SUBUNIT; CANINE; HEART; REPOLARIZATION; HETEROGENEITY	Gradients of the fast transient outward K+ current (I-to,I- f) contribute to heterogeneity of ventricular repolarization in a number of species. Cardiac I-to,I- f levels and gradients change notably with heart disease. Human cardiac I-to,I- f appears to be encoded by the Kv4.3 pore-forming alpha-subunit plus the auxiliary KChIP2 beta-subunit while mouse cardiac I-to,I- f requires Kv4.2 and Kv4.3 alpha-subunits plus KChIP2. Regional differences in cardiac I-to,I- f are associated with expression differences in Kv4.2 and KChIP2. Although I-to,I- f was reported to be absent in mouse ventricular cardiomyocytes lacking the Kv4.2 gene (Kv4.2-/-) when short depolarizing voltage pulses were used to activate voltage-gated K+ currents, in the present study, we showed that the use of long depolarization steps revealed a heteropodatoxin-sensitive I-to,I- f (at similar to 40% of the wild-type levels). Immunohistological studies further demonstrated membrane expression of Kv4.3 in Kv4.2-/- cardiomyocytes. Transmural I-to,I- f gradients across the left ventricular wall were reduced by similar to 3.5-fold in Kv4.2-/- heart, compared to wild-type. The I-to,I- f gradient in Kv4.2-/- hearts was associated with gradients in KChIP2 mRNA expression while in wild-type there was also a gradient in Kv4.2 expression. In conclusion, we found that Kv4.3-based I-to,I- f exists in the absence of Kv4.2, although with a reduced transmural gradient. Kv4.2-/- mice may be a useful animal model for studying Kv4.3-based I-to,I- f as observed in humans.	[Liu, Jie; Kim, Kyoung-Han; Heximer, Scott P.; Backx, Peter H.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Liu, Jie; Kim, Kyoung-Han; Heximer, Scott P.; Backx, Peter H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Liu, Jie; Kim, Kyoung-Han; Backx, Peter H.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Kim, Kyoung-Han; Hui, Chi-chung] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Morales, Michael J.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Hui, Chi-chung] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto	Hui, CC (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cchui@sickkids.ca; p.backx@utoronto.ca	Kim, Kyoung-Han/AAZ-4908-2021	Kim, Kyoung-Han/0000-0002-0433-656X	Canadian Institutes for Health Research [MOP 119339]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	PHB received a grant (MOP 119339) from the Canadian Institutes for Health Research.	Bertaso F, 2002, BASIC RES CARDIOL, V97, P424, DOI 10.1007/s00395-002-0377-4; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Cordeiro JM, 2004, AM J PHYSIOL-HEART C, V286, pH1471, DOI 10.1152/ajpheart.00748.2003; Crank J, 1975, MATH DIFFUSION, V2nd; DELBALZO U, 1992, CIRCULATION, V85, P1464, DOI 10.1161/01.CIR.85.4.1464; Deschenes I, 2002, CIRCULATION, V106, P423, DOI 10.1161/01.CIR.0000025417.65658.B6; Dilks D, 1999, J NEUROPHYSIOL, V81, P1974, DOI 10.1152/jn.1999.81.4.1974; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; Faivre JF, 1999, CARDIOVASC RES, V41, P188, DOI 10.1016/S0008-6363(98)00215-6; Fedida D, 1996, J PHYSIOL-LONDON, V494, P377, DOI 10.1113/jphysiol.1996.sp021499; Fick A, 1855, PHILOS MAG, P10; Fiset C'L, 2006, CIRC RES, V98, P1237, DOI 10.1161/01.RES.0000225859.82676.ba; Glover DM JW, 2005, MODELING METHODS FOR; Grubb S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00118; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Holzem KM, 2012, EUROPACE, V14, pV50, DOI 10.1093/europace/eus275; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Kaprielian R, 2002, AM J PHYSIOL-HEART C, V283, pH1157, DOI 10.1152/ajpheart.00518.2001; Kassiri Z, 2002, CIRC RES, V90, P578, DOI 10.1161/01.RES.0000012223.86441.A1; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; Liu J, 2011, BASIC RES CARDIOL, V106, P189, DOI 10.1007/s00395-010-0134-z; MATSUBARA H, 1993, J CLIN INVEST, V92, P1659, DOI 10.1172/JCI116751; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; NABAUER M, 1993, CIRC RES, V73, P386, DOI 10.1161/01.RES.73.2.386; Niwa N, 2008, J MOL CELL CARDIOL, V44, P95, DOI 10.1016/j.yjmcc.2007.10.007; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Patberg KW, 2003, CIRC RES, V93, P472, DOI 10.1161/01.RES.0000088785.24381.2F; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Perrin MJ, 2014, CIRC-CARDIOVASC GENE, V7, P782, DOI 10.1161/CIRCGENETICS.114.000623; Petersen KR, 1999, PFLUG ARCH EUR J PHY, V437, P381, DOI 10.1007/s004240050792; Rosati B, 2003, J PHYSIOL-LONDON, V548, P815, DOI 10.1113/jphysiol.2002.033704; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Sah R, 2001, J PHYSIOL-LONDON, V533, P201, DOI 10.1111/j.1469-7793.2001.0201b.x; Teutsch C, 2007, CARDIOVASC RES, V73, P739, DOI 10.1016/j.cardiores.2006.11.034; Wickenden AD, 1997, J PHYSIOL-LONDON, V504, P271, DOI 10.1111/j.1469-7793.1997.271be.x; Yan GX, 1996, CIRCULATION, V93, P372, DOI 10.1161/01.CIR.93.2.372; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; Zhou J, 2003, AM J PHYSIOL-HEART C, V284, pH491, DOI 10.1152/ajpheart.00576.2002; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387; Zicha S, 2004, J PHYSIOL-LONDON, V561, P735, DOI 10.1113/jphysiol.2004.075861	46	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133274	10.1371/journal.pone.0133274	http://dx.doi.org/10.1371/journal.pone.0133274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196737	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600079
J	Qi, WH; Jiang, XM; Du, LM; Xiao, GS; Hu, TZ; Yue, BS; Quan, QM				Qi, Wen-Hua; Jiang, Xue-Mei; Du, Lian-Ming; Xiao, Guo-Sheng; Hu, Ting-Zhang; Yue, Bi-Song; Quan, Qiu-Mei			Genome-Wide Survey and Analysis of Microsatellite Sequences in Bovid Species	PLOS ONE			English	Article							GC CONTENT; SECONDARY STRUCTURES; REPEATS; DNA; IDENTIFICATION; CONSERVATION; EXPRESSION; MUTATIONS; DIVERSITY; PATTERNS	Microsatellites or simple sequence repeats (SSRs) have become the most popular source of genetic markers, which are ubiquitously distributed in many eukaryotic and prokaryotic genomes. This is the first study examining and comparing SSRs in completely sequenced genomes of the Bovidae. We analyzed and compared the number of SSRs, relative abundance, relative density, guanine-cytosine (GC) content and proportion of SSRs in six taxonomically different bovid species: Bos taurus, Bubalus bubalis, Bos mutus, Ovis aries, Capra hircus, and Pantholops hodgsonii. Our analysis revealed that, based on our search criteria, the total number of perfect SSRs found ranged from 663,079 to 806,907 and covered from 0.44% to 0.48% of the bovid genomes. Relative abundance and density of SSRs in these Bovinae genomes were non-significantly correlated with genome size (Pearson, r < 0.420, p > 0.05). Perfect mononucleotide SSRs were the most abundant, followed by the pattern: perfect di- > tri- > penta- > tetra- > hexanucleotide SSRs. Generally, the number of SSRs, relative abundance, and relative density of SSRs decreased as the motif repeat length increased in each species of Bovidae. The most GC-content was in trinucleotide SSRs and the least was in the mononucleotide SSRs in the six bovid genomes. The GC-contents of tri- and pentanucleotide SSRs showed a great deal of similarity among different chromosomes of B. taurus, O. aries, and C. hircus. SSR number of all chromosomes in the B. taurus, O. aries, and C. hircus is closely positively correlated with chromosome sequence size (Pearson, r > 0.980, p < 0.01) and significantly negatively correlated with GC-content (Pearson, r < -0.638, p < 0.01). Relative abundance and density of SSRs in all chromosomes of the three species were significantly negatively correlated with GC-content (Pearson, r <-0.333, P< 0.05) but not significantly correlated with chromosome sequence size (Pearson, r< -0.185, P > 0.05). Relative abundances of the same nucleotide SSR type showed great similarity among different chromosomes of B. taurus, O. aries, and C. hircus.	[Qi, Wen-Hua; Xiao, Guo-Sheng; Hu, Ting-Zhang] Chongqing Three Gorges Univ, Coll Life Sci & Engn, Chongqing, Peoples R China; [Jiang, Xue-Mei] Chongqing Three Gorges Univ, Coll Environm & Chem Engn, Chongqing 404100, Peoples R China; [Du, Lian-Ming; Yue, Bi-Song] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China; [Quan, Qiu-Mei] China West Normal Univ, Sch Life Sci, Nanchong 637009, Peoples R China	Chongqing Three Gorges University; Chongqing Three Gorges University; Sichuan University; China West Normal University	Qi, WH (corresponding author), Chongqing Three Gorges Univ, Coll Life Sci & Engn, Chongqing, Peoples R China.	wenhuaqi357@163.com			Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1401004]; Chongqing Three Gorges University [13QN12, 201403068, 12RC03]	Scientific and Technological Research Program of Chongqing Municipal Education Commission; Chongqing Three Gorges University	This work was supported by the Scientific and Technological Research Program of Chongqing Municipal Education Commission (No. KJ1401004) and Wanzhou District (No. 201403068), Talent Introduction Project (No. 12RC03) and Youth Project (No. 13QN12) of Chongqing Three Gorges University.	Alam CM, 2014, INFECT GENET EVOL, V21, P287, DOI 10.1016/j.meegid.2013.11.018; Bachmann L, 2004, J ZOOL SYST EVOL RES, V42, P215, DOI 10.1111/j.1439-0469.2004.00275.x; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; Castagnone-Sereno P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-598; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; Coenye T, 2005, DNA RES, V12, P221, DOI 10.1093/dnares/dsi009; Dieringer D, 2003, GENOME RES, V13, P2242, DOI 10.1101/gr.1416703; Du LM, 2013, J HERED, V104, P154, DOI 10.1093/jhered/ess082; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ESTOUP A, 1993, NUCLEIC ACIDS RES, V21, P1427, DOI 10.1093/nar/21.6.1427; Glenn TC, 1996, MOL BIOL EVOL, V13, P1151, DOI 10.1093/oxfordjournals.molbev.a025678; Griffiths A, 2006, J VIROL, V80, P6568, DOI 10.1128/JVI.00155-06; Grimwood J, 2001, INFECT IMMUN, V69, P2383, DOI 10.1128/IAI.69.4.2383-2389.2001; Hagerman PJ, 2004, MENT RETARD DEV D R, V10, P25, DOI 10.1002/mrdd.20005; Hefferon TW, 2004, P NATL ACAD SCI USA, V101, P3504, DOI 10.1073/pnas.0400182101; Hiratani I, 2004, P NATL ACAD SCI USA, V101, P16861, DOI 10.1073/pnas.0406687101; Hong CP, 2007, MOL CELLS, V23, P349; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jarne P, 1998, MOL BIOL EVOL, V15, P28, DOI 10.1093/oxfordjournals.molbev.a025844; Jayashree B., 2006, In Silico Biology, V6, P607; JURKA J, 1995, J MOL EVOL, V40, P120, DOI 10.1007/BF00167107; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Khrustalev VV, 2009, COMPUT BIOL CHEM, V33, P295, DOI 10.1016/j.compbiolchem.2009.06.005; Kim TS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-31; Korpelainen H, 2007, BIOTECHNIQUES, V42, P479, DOI 10.2144/000112415; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li CY, 2009, INTERDISCIP SCI, V1, P141, DOI 10.1007/s12539-009-0014-5; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Ouyang QJ, 2012, GENE, V499, P37, DOI 10.1016/j.gene.2012.02.049; Prasad MD, 2005, GENETICS, V169, P197, DOI 10.1534/genetics.104.031005; Qian J, 2013, GENE, V512, P331, DOI 10.1016/j.gene.2012.09.127; Ren LC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r35; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P2031, DOI 10.1093/nar/30.9.2031; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sharma PC, 2007, TRENDS BIOTECHNOL; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Vinogradov AE, 2001, MOL BIOL EVOL, V18, P2195, DOI 10.1093/oxfordjournals.molbev.a003766; Wang Y, 2014, BIOMED RES INT; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Zhao XY, 2011, GENE, V488, P52, DOI 10.1016/j.gene.2011.08.016	53	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133667	10.1371/journal.pone.0133667	http://dx.doi.org/10.1371/journal.pone.0133667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196922	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600130
J	Wang, X; Zhang, B; Zhang, KB; Zhou, JX; Ahmad, B				Wang, Xiao; Zhang, Bo; Zhang, Kebin; Zhou, Jinxing; Ahmad, Bilal			The Spatial Pattern and Interactions of Woody Plants on the Temperate Savanna of Inner Mongolia, China: The Effects of Alternating Seasonal Grazing-Mowing Regimes	PLOS ONE			English	Article							HORQIN SANDY LAND; SHRUB ENCROACHMENT; ULMUS-PUMILA; CARAGANA-MICROPHYLLA; GRASSLAND DEGRADATION; PROPERTY-RIGHTS; ECOSYSTEM; CLIMATE; FACILITATION; RESTORATION	Ulmus pumila tree-dominated temperate savanna, which is distributed widely throughout the forest-steppe ecotone on the Mongolian Plateau, is a relatively stable woody-herbaceous complex ecosystem in northern China. Relatively more attention has been paid to the degradation of typical steppe areas, whereas less focus has been placed on the succession of this typical temperate savanna under the present management regime. In this study, we established 3 sample plots 100 mx100m in size along a gradient of fixed distances from one herder's stationary site and then surveyed all the woody plants in these plots. A spatial point pattern analysis was employed to clarify the spatial distribution and interaction of these woody plants. The results indicated that old U. pumila trees (DBH >= 20 cm) showed a random distribution and that medium U. pumila trees (5 cm <= DBH < 20 cm) showed an aggregated distribution at a smaller scale and a random distribution at a larger scale; few or no juvenile trees (DBH < 5 cm) were present, and seedlings (without DBH) formed aggregations in all 3 plots. These findings can be explained by an alternate seasonal grazing-mowing regime (exclosure in summer, mowing in autumn and grazing in winter and spring); the shrubs in all 3 plots exist along a grazing gradient that harbors xerophytic and mesophytic shrubs. Of these shrubs, xerophytic shrubs show significant aggregation at a smaller scale (0-5.5 m), whereas mesophytic shrubs show significant aggregation at a larger scale (0-25 m), which may be the result of the dual effects of grazing pressure and climate change. Medium trees and seedlings significantly facilitate the distributions of xerophytic shrubs and compete significantly with mesophytic shrubs due to differences in water use strategies. We conclude that the implementation of an alternative grazing-mowing regime results in xerophytic shrub encroachment or existence, breaking the chain of normal succession in a U. pumila tree community in this typical temperate savanna ecosystem. This might eventually result in the degradation of the original tree-dominated savanna to a xerophytic shrub-dominated savanna.	[Wang, Xiao; Zhang, Bo; Zhang, Kebin; Zhou, Jinxing; Ahmad, Bilal] Beijing Forestry Univ, Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University	Zhang, KB (corresponding author), Beijing Forestry Univ, Soil & Water Conservat, Beijing, Peoples R China.	ctccd@126.com; zjx9277@126.com	Jinxing, Zhou/I-6015-2017	Jinxing, Zhou/0000-0003-2182-9849	"948" Project of State Forestry Administration P.R. China [2015-4-27]; International S&T Cooperation Program of China [2015DFR31130]; National Natural Science Foundation of China [41271033, 41471029, 41371500]	"948" Project of State Forestry Administration P.R. China; International S&T Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from "948" Project of State Forestry Administration P.R. China (2015-4-27), International S&T Cooperation Program of China (2015DFR31130), and the National Natural Science Foundation of China (41271033; 41471029; 41371500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, TEMPERATE DESERTS SE; [Anonymous], WOODY PLANTS AGROECO; Barnes PW, 1999, J VEG SCI, V10, P525, DOI 10.2307/3237187; Bossdorf O, 2000, J VEG SCI, V11, P253, DOI 10.2307/3236804; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Cabral AC, 2003, J VEG SCI, V14, P145, DOI 10.1111/j.1654-1103.2003.tb02139.x; Callaway R. M., 2007, POSITIVE INTERACTION; Calvo L, 2005, PLANT ECOL, V180, P175, DOI 10.1007/s11258-005-0200-z; Ci Longjun YX, 2010, DESERTIFICATION ITS; Cipriotti PA, 2012, APPL VEG SCI, V15, P35, DOI 10.1111/j.1654-109X.2011.01138.x; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; D'Odorico P, 2012, ECOHYDROLOGY, V5, P520, DOI 10.1002/eco.259; D'Odorico P, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00073.1; DALE MRT, 1999, ECOLOGY, V0088, P00366; Davies KW, 2012, RANGELAND ECOL MANAG, V65, P268, DOI 10.2111/REM-D-11-00146.1; Dormann CF, 2002, PLANT BIOLOGY, V4, P647, DOI 10.1055/s-2002-35437; Druckenbrod DL, 2005, J VEG SCI, V16, P37, DOI 10.1111/j.1654-1103.2005.tb02336.x; Dunn C. P., 2000, ELMS BREEDING CONSER; Fang J., 2011, ATLAS WOODY PLANTS C, V1; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; GARNER W, 1989, J ARID ENVIRON, V16, P257, DOI 10.1016/S0140-1963(18)30941-8; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gordon I.J., 2008, ECOLOGY BROWSING GRA; Grace J., 2012, PERSPECTIVES PLANT C; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Guo K, 2003, ACTA ECOLOGICA SINIC, V24, P2024; Gutterman Y, 2001, REGENERATION PLANTS; HALL LM, 1992, J RANGE MANAGE, V45, P503, DOI 10.2307/4002912; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; Hilbig W., 1995, VEGETATION MONGOLIA; Ho P, 2001, J DEV STUD, V37, P99, DOI 10.1080/00220380412331321991; Illian J, 2008, STAT ANAL MODELLING; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jiang DM, 2014, J ARID LAND, V6, P343, DOI 10.1007/s40333-013-0204-9; Jiuru X, 2001, J BEIJING FORESTRY U, V23, P75; Kirilyuk V.E., 2012, EURASIAN STEPPES ECO; Li A, 2012, LANDSCAPE ECOL, V27, P969, DOI 10.1007/s10980-012-9751-2; Li WJ, 2007, J ENVIRON MANAGE, V85, P461, DOI 10.1016/j.jenvman.2006.10.010; Li XY, 2013, AGR FOREST METEOROL, V171, P20, DOI 10.1016/j.agrformet.2012.11.001; Li XR, 2001, J ARID ENVIRON, V47, P271, DOI 10.1006/jare.2000.0707; Li YL, 2013, ECOL ENG, V53, P299, DOI 10.1016/j.ecoleng.2012.12.061; Liu Gui-feng, 2011, Yingyong Shengtai Xuebao, V22, P9; Liu L, 2013, CHINESE GEOGR SCI, V23, P321, DOI 10.1007/s11769-013-0607-8; Maestre FT, 2011, SOIL BIOL BIOCHEM, V43, P1746, DOI 10.1016/j.soilbio.2011.04.023; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Manly BFL., 2007, RESOURCE SELECTION A; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Peng HY, 2013, CATENA, V109, P39, DOI 10.1016/j.catena.2013.05.008; Pontes LD, 2012, ACTA OECOL, V45, P25, DOI 10.1016/j.actao.2012.08.006; Quero JL, 2013, ECOSYSTEMS, V16, P1248, DOI 10.1007/s10021-013-9683-y; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Roy J, 2012, EXPLOITATION ENV HET; Schurr FM, 2004, PLANT ECOL, V173, P271, DOI 10.1023/B:VEGE.0000029335.13948.87; Schwinning S, 2013, FUNCT ECOL, V27, P886, DOI 10.1111/1365-2435.12115; Shao C, 2012, J ARID ENVIRON, V82, P1, DOI 10.1016/j.jaridenv.2012.02.019; Shi L, 2004, ANN BOT-LONDON, V94, P553, DOI 10.1093/aob/mch174; Smit C, 2011, J VEG SCI, V22, P377, DOI 10.1111/j.1654-1103.2011.01264.x; Spencer DF, 2014, WEED RES, V54, P140, DOI 10.1111/wre.12058; Squires VR, 2009, RANGELAND DEGRATION; Stoyan D, 2000, SCAND J STAT, V27, P641, DOI 10.1111/1467-9469.00213; Stoyan D., 1994, FRACTALS RANDOM SHAP; Su H, 2014, TREES-STRUCT FUNCT, V28, P41, DOI 10.1007/s00468-013-0928-3; Su YZ, 2003, ECOL ENG, V20, P223, DOI 10.1016/S0925-8574(03)00042-9; Thwaites R, 1998, SOC NATUR RESOUR, V11, P319, DOI 10.1080/08941929809381085; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Vallentine, 2000, GRAZING MANAGEMENT; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; [王雪 WANG Xue], 2011, [干旱区研究, Arid Zone Research], V28, P542; WANG Y, 2013, PLOS ONE, V2013; WATT TA, 1988, VEGETATIO, V78, P91, DOI 10.1007/BF00045643; Wesche K, 2011, FLORA, V206, P91, DOI 10.1016/j.flora.2010.01.012; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T., 2013, HDB SPATIAL POINT PA; Williams DM, 2002, GREAT WALLS ENV IDEN; WU B, 2013, PLOS ONE, V8; Wu Z.Y., 2013, FLORA CHINA; Xie YN, 2008, NOMAD PEOPLES, V12, P35, DOI 10.3167/np.2008.120203; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Yang HX, 2014, APPL VEG SCI, V17, P338, DOI 10.1111/avsc.12062; Yu P, 2005, RESTORING DEGRADED E; Zhang Jian, 2007, Yingyong Shengtai Xuebao, V18, P1681; Zhang MA, 2007, ECOL ECON, V62, P19, DOI 10.1016/j.ecolecon.2006.11.005; Zhang TH, 2006, PEDOSPHERE, V16, P319, DOI 10.1016/S1002-0160(06)60058-1; Zhang X.S, 2007, VEGETATION MAP CHINA, P296; Zheng YR, 2006, J ARID ENVIRON, V64, P523, DOI 10.1016/j.jaridenv.2005.06.007; Zida D, 2009, AFR J ECOL, V47, P97, DOI 10.1111/j.1365-2028.2008.01011.x; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	89	8	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133277	10.1371/journal.pone.0133277	http://dx.doi.org/10.1371/journal.pone.0133277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196956	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600080
J	di Giuseppe, R; Kuhn, T; Hirche, F; Buijsse, B; Dierkes, J; Fritsche, A; Kaaks, R; Boeing, H; Stangl, GI; Weikert, C				di Giuseppe, Romina; Kuehn, Tilman; Hirche, Frank; Buijsse, Brian; Dierkes, Jutta; Fritsche, Andreas; Kaaks, Rudolf; Boeing, Heiner; Stangl, Gabriele I.; Weikert, Cornelia			Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR-DISEASE; PARATHYROID-HORMONE; DIETARY PHOSPHORUS; RENAL-FUNCTION; FGF23; RISK; HEART; POPULATION	Background Increased fibroblast growth factor 23 (FGF23), a bone-derived hormone involved in the regulation of phosphate and vitamin D metabolism, has been related to the development of cardiovascular disease (CVD) in chronic kidney disease patients and in the general population. However, what determines higher FGF23 levels is still unclear. Also, little is known about the influence of diet on FGF23. The aim of this study was therefore to identify demographic, clinical and dietary correlates of high FGF23 concentrations in the general population. Methods We performed a cross-sectional analysis within a randomly selected subcohort of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany comprising 2134 middle-aged men and women. The Human FGF23 (C-Terminal) ELISA kit was used to measure FGF23 in citrate plasma. Dietary data were obtained at baseline via validated food frequency questionnaires including up to 148 food items. Results Multivariable adjusted logistic regression showed that men had a 66% lower and smokers a 64% higher probability of having higher FGF23 (>= 90 RU/mL) levels compared, respectively, with women and nonsmokers. Each doubling in parathyroid hormone, creatinine, and C-reactive protein was related to higher FGF23. Among the dietary factors, each doubling in calcium and total energy intake was related, respectively, to a 1.75 and to a 4.41 fold increased probability of having higher FGF23. Finally, each doubling in the intake of iron was related to an 82% lower probability of having higher FGF23 levels. Results did not substantially change after exclusion of participants with lower kidney function. Conclusions In middle-aged men and women traditional and non-traditional CVD risk factors were related to higher FGF23 concentrations. These findings may contribute to the understanding of the potential mechanisms linking increased FGF23 to increased CVD risk.	[di Giuseppe, Romina; Weikert, Cornelia] German Inst Human Nutr Potsdam Rehbrucke, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany; [Kuehn, Tilman; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Hirche, Frank; Stangl, Gabriele I.] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Human Nutr Grp, D-06108 Halle, Germany; [Buijsse, Brian; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Dierkes, Jutta] Univ Bergen, Dept Clin Med, Bergen, Norway; [Fritsche, Andreas] Univ Tubingen, Dept Internal Med 4, Tubingen, Germany; [Fritsche, Andreas] German Ctr Diabet Res DZD eV, Neuherberg, Germany; [Weikert, Cornelia] Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [di Giuseppe, Romina; Weikert, Cornelia] Partner Site Berlin, German Ctr Cardiovasc Res DZHK, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ); Martin Luther University Halle Wittenberg; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Bergen; Eberhard Karls University of Tubingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	di Giuseppe, R (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany.	romina.digiuseppe@dife.de		di Giuseppe, Romina/0000-0002-5214-8897	German Heart Research Foundation; Federal Ministry of Education and Research (BMBF) [FZK0315668]	German Heart Research Foundation; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Heart Research Foundation (http://www.dshf.de/forschung_en.php). Measurements of PTH and 25(OH)D3 in the subcohort were paid for by a grant from the Federal Ministry of Education and Research (BMBF FZK0315668) (http://www.bmbf.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barril-Cuadrado G, 2013, NEFROLOGIA, V33, P362, DOI 10.3265/Nefrologia.pre2013.Feb.11918; Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Bots ML, 2002, J EPIDEMIOL COMMUN H, V56, pI8, DOI 10.1136/jech.56.suppl_1.i8; Bozentowicz-Wikarek M, 2015, CLIN BIOCHEM, V48, P431, DOI 10.1016/j.clinbiochem.2014.12.027; Braithwaite V, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-27; Buijsse B, 2013, EUR J EPIDEMIOL, V28, P743, DOI 10.1007/s10654-013-9844-5; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; di Giuseppe R, 2015, EUR J EPIDEMIOL, V30, P131, DOI 10.1007/s10654-014-9982-4; di Giuseppe R, 2014, J CLIN ENDOCR METAB, V99, P947, DOI 10.1210/jc.2013-2963; di Giuseppe R, 2012, ANN CLIN BIOCHEM, V49, P542, DOI 10.1258/acb.2012.011273; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fukumoto Seiji, 2007, Nihon Naika Gakkai Zasshi, V96, P719; Gutierrez OM, CLIN J AM SOC NEPHRO; Gutierrez OM, 2013, ADV NUTR, V4, P723, DOI 10.3945/an.113.004812; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO, V6, P2871, DOI 10.2215/CJN.02740311; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Ix JH, 2011, AM J KIDNEY DIS, V58, P737, DOI 10.1053/j.ajkd.2011.06.011; Jimbo R, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/381082; Juppner H, 2012, J CLIN INVEST, V122, P4336, DOI 10.1172/JCI67055; Kestenbaum B, 2014, CIRC-HEART FAIL, V7, P409, DOI 10.1161/CIRCHEARTFAILURE.113.000952; Kido S, 2014, TOXICOL SCI, V139, P301, DOI 10.1093/toxsci/kfu043; Krupp K, 2014, INT J CARDIOL, V176, P1341, DOI 10.1016/j.ijcard.2014.07.142; Kuhn T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069080; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Larsson TE, 2011, CLIN J AM SOC NEPHRO, V6, P2735, DOI 10.2215/CJN.10711011; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lutsey PL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000936; Lutsey PL, 2014, CIRCULATION S1, V129; Fernandez-Real JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058961; Marsell R, 2009, OSTEOPOROSIS INT, V20, P1167, DOI 10.1007/s00198-008-0780-2; Marsell R, 2008, EUR J ENDOCRINOL, V158, P125, DOI 10.1530/EJE-07-0534; Mirza MAI, 2011, ARTERIOSCL THROM VAS, V31, P219, DOI 10.1161/ATVBAHA.110.214619; Miyazaki TTT, 2010, TRACE NUTR RES, V27, P92; Moe SM, 2011, CLIN J AM SOC NEPHRO, V6, P257, DOI 10.2215/CJN.05040610; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P683, DOI 10.2215/CJN.08601209; Ortiz A, 2012, NAT REV NEPHROL, V8, P141, DOI 10.1038/nrneph.2011.170; Panwar B, 2014, STROKE S1, V45; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Sachez-Rodriuez JE, 2015, ENVIRON RES, V136, P227, DOI 10.1016/j.envres.2014.09.033; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Takeda E, 2014, ADV NUTR, V5, P92, DOI 10.3945/an.113.004002; Udell JA, 2014, J AM COLL CARDIOL, V63, P2421, DOI 10.1016/j.jacc.2014.03.026; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wright CB, 2014, NEUROLOGY, V82, P1700, DOI 10.1212/WNL.0000000000000410; Xiao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072545	55	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133580	10.1371/journal.pone.0133580	http://dx.doi.org/10.1371/journal.pone.0133580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193703	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400105
J	Furmston, T; Morton, AJ; Hailes, S				Furmston, Thomas; Morton, A. Jennifer; Hailes, Stephen			A Significance Test for Inferring Affiliation Networks from Spatio-Temporal Data	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; BEHAVIOR; COHESION	Scientists have long been interested in studying social structures within groups of gregarious animals. However, obtaining evidence about interactions between members of a group is difficult. Recent technologies, such as Global Positioning System technology, have made it possible to obtain a vast wealth of animal movement data, but inferring the underlying ( latent) social structure of the group from such data remains an important open problem. While intuitively appealing measures of social interaction exist in the literature, they typically lack formal statistical grounding. In this article, we provide a statistical approach to the problem of inferring the social structure of a group from the movement patterns of its members. By constructing an appropriate null model, we are able to construct a significance test to detect meaningful affiliations between members of the group. We demonstrate our method on large-scale real-world data sets of positional data of flocks of Merino sheep, Ovis aries.	[Furmston, Thomas; Hailes, Stephen] UCL, Dept Comp Sci, London, England; [Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of London; University College London; University of Cambridge	Furmston, T (corresponding author), UCL, Dept Comp Sci, London, England.	T.Furmston@cs.ucl.ac.uk	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346	CHDI Foundation, Inc.	CHDI Foundation, Inc.	This work was supported by a grant to AJM from CHDI Foundation, Inc. (http://www.highqfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAYESIAN REASONING M; [Anonymous], 2010, MATLAB VERS 7 10 0 R; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Croft DP, 2004, P ROY SOC B-BIOL SCI, V271, pS516, DOI 10.1098/rsbl.2004.0206; Delcourt J, 2009, BEHAV RES METHODS, V41, P228, DOI 10.3758/BRM.41.1.228; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Farine DR, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0578; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Frugier T, 2008, NEUROBIOL DIS, V29, P306, DOI 10.1016/j.nbd.2007.09.006; Haddadi H, 2011, BEHAV ECOL SOCIOBIOL, V65, P1659, DOI 10.1007/s00265-011-1193-3; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Jolly RD, 2002, NEW ZEAL VET J, V50, P199, DOI 10.1080/00480169.2002.36311; Krause J, 2009, BEHAV ECOLOGY SOCIOB; Miller NY, 2008, BEHAV BRAIN RES, V193, P148, DOI 10.1016/j.bbr.2008.05.004; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Psorakis I, 2012, J R SOC INTERFACE, V9, P3055, DOI 10.1098/rsif.2012.0223; Read T., 1988, GOODNESS OF FIT STAT; Sriperumbudur BK, 2010, J MACH LEARN RES, V11, P1517; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Willis CKR, 2004, ANIM BEHAV, V68, P495, DOI 10.1016/j.anbehav.2003.08.028; Yasuda T, 2005, ZOOL SCI, V22, P547, DOI 10.2108/zsj.22.547	25	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132417	10.1371/journal.pone.0132417	http://dx.doi.org/10.1371/journal.pone.0132417			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192280	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400024
J	Guan, HJ; Chow, KM; Song, E; Verma, N; Despa, F; Hersh, LB				Guan, Hanjun; Chow, K. Martin; Song, Eunsuk; Verma, Nirmal; Despa, Florin; Hersh, Louis B.			The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells	PLOS ONE			English	Article							A-BETA; DIABETES-MELLITUS; TYPE-2; DEGRADATION; DYSFUNCTION; APOPTOSIS; OLIGOMERS; HUMANS; AMYLIN; ACCUMULATION	Amyloid formation and mitochondrial dysfunction are characteristics of type 2 diabetes. The major peptide constituent of the amyloid deposits in type 2 diabetes is islet amyloid polypeptide (IAPP). In this study, we found that pitrilysin, a zinc metallopeptidase of the inverzincin family, degrades monomeric, but not oligomeric, islet amyloid polypeptide in vitro. In insulinoma cells when pitrilysin expression was decreased to 5% of normal levels, there was a 60% increase in islet amyloid polypeptide-induced apoptosis. In contrast, overexpression of pitrilysin protects insulinoma cells from human islet amyloid polypeptide-induced apoptosis. Since pitrilysin is a mitochondrial protein, we used immunofluorescence staining of pancreases from human IAPP transgenic mice and Western blot analysis of IAPP in isolated mitochondria from insulinoma cells to provide evidence for a putative intramitochondrial pool of IAPP. These results suggest that pitrilysin regulates islet amyloid polypeptide in beta cells and suggest the presence of an intramitochondrial pool of islet amyloid polypeptide involved in beta-cell apoptosis.	[Guan, Hanjun; Chow, K. Martin; Song, Eunsuk; Hersh, Louis B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Verma, Nirmal; Despa, Florin] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Guan, HJ (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Biomed Biol Sci Res Bldg, Lexington, KY 40536 USA.	hguan2@uky.edu	Verma, Nirmal/O-4255-2019	verma, nirmal/0000-0002-9218-2475	National Institutes on Drug Abuse [RO1DA02243]; National Institutes of General Medical Sciences [P2ORR020171]; National Institutes Heart Lung and Blood [R01-HL118474]; National Science Foundation [CBET 1133339]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes Heart Lung and Blood; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes on Drug Abuse (http://www.drugabuse.gov/; grant RO1DA02243; LBH), National Institutes of General Medical Sciences (http://www.nigms.nih.gov; grant P2ORR020171; LBH), National Institutes Heart Lung and Blood (http://www.nhlbi.nih.gov; grant R01-HL118474; FD), and National Science Foundation (http://www.nsf.gov; grant CBET 1133339; FD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Bhushan S, 2006, BIOL CHEM, V387, P1087, DOI 10.1515/BC.2006.134; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chow KM, 2009, BIOCHEMISTRY-US, V48, P2868, DOI 10.1021/bi8016125; Despa S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001015; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; FOLK JE, 1963, J BIOL CHEM, V238, P3884; Glaser E, 2010, BBA-BIOENERGETICS, V1797, P1076, DOI 10.1016/j.bbabio.2009.12.016; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Guan H, 2012, DIABETOLOGIA, V55, P2989, DOI 10.1007/s00125-012-2678-y; Guan HJ, 2010, CEREB CORTEX, V20, P2684, DOI 10.1093/cercor/bhq016; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; JOHNSON KH, 1992, LAB INVEST, V66, P522; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Khemtemourian L, 2008, EXP DIABETES RES, DOI 10.1155/2008/421287; Law E, 2010, DIABETOLOGIA, V53, P1415, DOI 10.1007/s00125-010-1717-9; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Li XL, 2011, INT J BIOCHEM CELL B, V43, P525, DOI 10.1016/j.biocel.2010.12.008; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mzhavia N, 1999, DNA CELL BIOL, V18, P369, DOI 10.1089/104454999315268; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; SANKE T, 1988, J BIOL CHEM, V263, P17243; Szabadkai G, 2009, APOPTOSIS, V14, P1405, DOI 10.1007/s10495-009-0363-5; Trikha S, 2011, J BIOL CHEM, V286, P36086, DOI 10.1074/jbc.M111.240762; Wang CH, 2010, ANN NY ACAD SCI, V1201, P157, DOI 10.1111/j.1749-6632.2010.05625.x; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	43	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133263	10.1371/journal.pone.0133263	http://dx.doi.org/10.1371/journal.pone.0133263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191799	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400070
J	Kuijsters, A; Redi, J; de Ruyter, B; Heynderickx, I				Kuijsters, Andre; Redi, Judith; de Ruyter, Boris; Heynderickx, Ingrid			Lighting to Make You Feel Better: Improving the Mood of Elderly People with Affective Ambiences	PLOS ONE			English	Article							INDUCTION PROCEDURES; CIRCADIAN-RHYTHMS; OLDER-ADULTS; COLOR; PERFORMANCE; AROUSAL; AGE; ENVIRONMENTS; PERCEPTION; THERAPY	Current lighting technologies extend the options for changing the appearance of rooms and closed spaces, as such creating ambiences with an affective meaning. Using intelligence, these ambiences may instantly be adapted to the needs of the room's occupant(s), possibly improving their well-being. We hypothesized that ambiences with a clearly recognizable, positive affective meaning could be used to effectively mitigate negative mood in elderly. After inducing a sad mood with a short movie one group of elderly was immersed in a positive high arousing (i.e., activating) ambience, and another group in a neutral ambience. Similarly, after inducing anxiety with a short movie one group of elderly was immersed in a pleasant low arousing (i.e., cozy) ambience, and another group in a neutral ambience. We monitored the evolution of the mood of the four groups of elderly over a period of ten minutes after the mood induction, with both self-reported mood measurements (every 2 minutes) and constant measurements of the skin conductance response (SCR) and electrocardiography (ECG). In line with our hypothesis we found that the activating ambience was physiologically more arousing than the neutral ambience. The cozy ambience was more effective in calming anxious elderly than the neutral ambience, as reflected by both the self-reported and physiological measurements.	[Kuijsters, Andre; Heynderickx, Ingrid] Eindhoven Univ Technol, Ind Engn & Innovat Sci, Human Technol Interact Grp, NL-5600 MB Eindhoven, Netherlands; [Redi, Judith] Delft Univ Technol, Intelligent Syst, Multimedia Comp Grp, Delft, Netherlands; [de Ruyter, Boris] Philips Res, Eindhoven, Netherlands; [de Ruyter, Boris] Radboud Univ Nijmegen, Social Sci, Human Interact Intelligent Syst, NL-6525 ED Nijmegen, Netherlands	Eindhoven University of Technology; Delft University of Technology; Philips; Philips Research; Radboud University Nijmegen	Kuijsters, A (corresponding author), Eindhoven Univ Technol, Ind Engn & Innovat Sci, Human Technol Interact Grp, POB 513, NL-5600 MB Eindhoven, Netherlands.	andrekuijsters@gmail.com			PointOne of Agentschap NL [PNU 10C11]; Philips Research	PointOne of Agentschap NL; Philips Research	This research is part of the ACE project, which is a collaboration between Philips Research, Eindhoven University of Technology, and Delft University of Technology, funded by PointOne of Agentschap NL [PNU 10C11]. Website: http://www.rvo.nl/. Co-author BdR is employed by Philips Research. Philips Research provided support in the form of salary for author BdR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the	Aarts E, 2009, J AMB INTEL SMART EN, V1, P5, DOI 10.3233/AIS-2009-0001; ALBERSNAGEL FA, 1988, BEHAV RES THER, V26, P79, DOI 10.1016/0005-7967(88)90035-6; ALI MR, 1972, ELECTROEN CLIN NEURO, V33, P332, DOI 10.1016/0013-4694(72)90162-9; BARON RA, 1992, MOTIV EMOTION, V16, P1, DOI 10.1007/BF00996485; Bedrosian TA, 2013, MOL PSYCHIATR, V18, P751, DOI 10.1038/mp.2013.70; Bellizzi J.A., 1992, PSYCHOL MARK, V9, P347, DOI [10.1002/mar.4220090502, DOI 10.1002/MAR.4220090502]; Boyce P, 2010, AUST FAM PHYSICIAN, V39, P307; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Camm AJ, 1996, CIRCULATION, V93, P1043; Chou KL, 2007, PSYCHOL AGING, V22, P310, DOI 10.1037/0882-7974.22.2.310; Custers PJM, 2010, LIGHTING RES TECHNOL, V42, P331, DOI 10.1177/1477153510377836; Demme Jonathan, 1991, SILENCE LAMBS; Dewsbury G, DEPENDABILITY HEALTH; Feng MC, 2011, PSYCHOL AGING, V26, P752, DOI 10.1037/a0023110; Fox LS, 1998, PSYCHOL AGING, V13, P519, DOI 10.1037/0882-7974.13.3.519; Fredrickson B. L., 2000, PREVENTION TREATMENT, DOI [10.1037/1522-3736.3.1.31a, DOI 10.1037/1522-3736.3.1.31A]; Gerard R. M., 1958, THESIS; GERRARDSHESSE A, 1994, BRIT J PSYCHOL, V85, P55, DOI 10.1111/j.2044-8295.1994.tb02508.x; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Gomez P, 2004, BIOL PSYCHOL, V67, P359, DOI 10.1016/j.biopsycho.2004.03.013; Gomez P, 2009, J PSYCHOPHYSIOL, V23, P7, DOI 10.1027/0269-8803.23.1.7; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Huldtgren A, 2015, INT C SMART HOM HLTH; JACOBS KW, 1974, PERCEPT MOTOR SKILL, V38, P763, DOI 10.2466/pms.1974.38.3.763; Johnson ML, 2005, CAMBRIDGE HDB PSYCHO; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; KAISER PK, 1984, COLOR RES APPL, V9, P29, DOI 10.1002/col.5080090106; Knez I, 1998, ENVIRON BEHAV, V30, P553, DOI 10.1177/001391659803000408; Knez I, 2000, ENVIRON BEHAV, V32, P817, DOI 10.1177/00139160021972810; KNEZ I, 1995, J ENVIRON PSYCHOL, V15, P39, DOI 10.1016/0272-4944(95)90013-6; Knez I, 2001, J ENVIRON PSYCHOL, V21, P201, DOI 10.1006/jevp.2000.0198; Kuijsters A, 2015, LIGHTING RES TECHNOL, V47, P859, DOI 10.1177/1477153514560423; Kuller R, 2006, ERGONOMICS, V49, P1496, DOI 10.1080/00140130600858142; Kuller R, 2009, COLOR RES APPL, V34, P141, DOI 10.1002/col.20476; Kunzmann U, 2005, PSYCHOL AGING, V20, P47, DOI 10.1037/0882-7974.20.1.47; Kwallek N, 1996, COLOR RES APPL, V21, P448, DOI 10.1002/(SICI)1520-6378(199612)21:6<448::AID-COL7>3.0.CO;2-W; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lee DTF, 2002, J ADV NURS, V37, P19, DOI 10.1046/j.1365-2648.2002.02060.x; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; LEWY AJ, 1989, CHRONOBIOL INT, V6, P93, DOI 10.3109/07420528909059144; Liu XY, 2015, LIGHTING RES TECHNOL, V47, P581, DOI 10.1177/1477153514528934; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MARTIN M, 1990, CLIN PSYCHOL REV, V10, P669, DOI 10.1016/0272-7358(90)90075-L; MCINTYRE IM, 1989, J PINEAL RES, V6, P149; MIKELLIDES B, 1990, J ARCHIT PLAN RES, V7, P13; NAY R, 1995, J CLIN NURS, V4, P319, DOI 10.1111/j.1365-2702.1995.tb00030.x; NOURSE JC, 1971, PERCEPT MOTOR SKILL, V32, P403, DOI 10.2466/pms.1971.32.2.403; Perakakis P, 2010, COMPUT METH PROG BIO, V98, P83, DOI 10.1016/j.cmpb.2009.10.002; ROBINS CJ, 1988, J CLIN PSYCHOL, V44, P958, DOI 10.1002/1097-4679(198811)44:6<958::AID-JCLP2270440618>3.0.CO;2-D; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; RUSSELL JA, 1981, ENVIRON BEHAV, V13, P259, DOI 10.1177/0013916581133001; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V38, P311; Seider BH, 2011, SOC COGN AFFECT NEUR, V6, P186, DOI 10.1093/scan/nsq069; Seuntiens PJH, 2008, 6 INT C DES EM; Shikder S, 2012, PERSPECT PUBLIC HEAL, V132, P282, DOI 10.1177/1757913911422288; Stone NJ, 2001, J ENVIRON PSYCHOL, V21, P179, DOI 10.1006/jevp.2000.0193; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; Veitch JA, 2008, LIGHTING RES TECHNOL, V40, P133, DOI 10.1177/1477153507086279; Vogels IMLC, 2008, PROBING EXPERIECE AS, P25; Wang HH, 2014, LIGHTING RES TECHNOL, V46, P661, DOI 10.1177/1477153513506591; Warman VL, 2003, NEUROSCI LETT, V342, P37, DOI 10.1016/S0304-3940(03)00223-4; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; WILSON GD, 1966, PERCEPT MOTOR SKILL, V23, P947, DOI 10.2466/pms.1966.23.3.947; Wirz-Justice A, 2005, PSYCHOL MED, V35, P939, DOI 10.1017/S003329170500437X; Yoto Ai, 2007, Journal of Physiological Anthropology, V26, P373, DOI 10.2114/jpa2.26.373; Zeffirelli Franco, 1979, THE CHAMP	69	30	30	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132732	10.1371/journal.pone.0132732	http://dx.doi.org/10.1371/journal.pone.0132732			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192281	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400036
J	Takano, Y; Kasai, K; Takagishi, Y; Kikumori, T; Imai, T; Murata, Y; Hayashi, Y				Takano, Yuko; Kasai, Kenji; Takagishi, Yoshiko; Kikumori, Toyone; Imai, Tsuneo; Murata, Yoshiharu; Hayashi, Yoshitaka			Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides	PLOS ONE			English	Article							ALPHA-CELL HYPERPLASIA; ANGIOPOIETIN-LIKE PROTEIN; GLUCAGON RECEPTOR; TRANSCRIPTIONAL REGULATION; G(S)ALPHA DEFICIENCY; BETA-CELLS; LIVER; ABSENCE; HYPERGLUCAGONEMIA; PROLIFERATION	Animal models with defective glucagon action show hyperplasia of islet alpha-cells, however, the regulatory mechanisms underlying the proliferation of islet endocrine cells remain largely to be elucidated. The Gcg(gfp/gfp) mice, which are homozygous for glucagon/green fluorescent protein knock-in allele (GCGKO), lack all proglucagon-derived peptides including glucagon and GLP-1. The present study was aimed to characterize pancreatic neuroendocrine tumors (panNETs), which develop in the GCGKO mice. At 15 months of age, macroscopic GFP-positive tumors were identified in the pancreas of all the GCGKO mice, but not in that of the control heterozygous mice. The tumor manifested several features that were consistent with pancreatic neuroendocrine tumors (panNETs), such as organoid structures with trabecular and cribriform patterns, and the expression of chromogranin A and synaptophysin. Dissemination of GFP-positive cells was observed in the liver and lungs in 100% and 95%, respectively, of 15-month-old GCGKO mice. To elucidate the regulatory mechanism for tumor growth, PanNET grafts were transplanted into subrenal capsules in GCGKO and control mice. Ki-67 positive cells were identified in panNET grafts transplanted to GCGKO mice 1 month after transplantation, but not in those to control mice. These results suggest that humoral factors or conditions specific to GCGKO mice, are involved in the proliferation of panNETs. Taken together, GCGKO mice are novel animal model for studying the development, pathogenesis, and metastasis panNETs.	[Takano, Yuko; Takagishi, Yoshiko; Murata, Yoshiharu; Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 4648601, Japan; [Takano, Yuko; Kikumori, Toyone; Imai, Tsuneo] Nagoya Univ, Grad Sch Med, Dept Transplantat & Endocrine Surg, Nagoya, Aichi 4668550, Japan; [Kasai, Kenji] Aichi Med Univ, Dept Pathol, Nagakute, Aichi 4801195, Japan; [Imai, Tsuneo] Aichi Med Univ, Dept Breast & Endocrine Surg, Nagakute, Aichi 4801195, Japan	Nagoya University; Nagoya University; Aichi Medical University; Aichi Medical University	Hayashi, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 4648601, Japan.	hayashiy@riem.nagoya-u.ac.jp	Kikumori, Toyone/M-4905-2014; Kasai, Kenji/K-6382-2019; Hayashi, Yoshitaka/I-6168-2014	Kikumori, Toyone/0000-0003-3203-3766; Hayashi, Yoshitaka/0000-0002-7557-4303	Japan Society for the Promotion of Science [24659451, 15K15356]; Ministry of Education, Culture, Sports, Science and Technology [25122708, 15H04681]; SOYU medical foundation; Grants-in-Aid for Scientific Research [15K15356] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SOYU medical foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html, Grant #24659451 and #15K15356), Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/, Grant #25122708 and #15H04681), and SOYU medical foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J CLIN INVEST, V121, P1917, DOI 10.1172/JCI43615; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bramswig NC, 2011, DIABETES OBES METAB, V13, P13, DOI 10.1111/j.1463-1326.2011.01440.x; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chen M, 2011, ENDOCRINOLOGY, V152, P3343, DOI 10.1210/en.2011-0012; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Fukami A, 2013, DIABETES, V62, P510, DOI 10.2337/db12-0294; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Futaki S, 2003, J BIOL CHEM, V278, P50691, DOI 10.1074/jbc.M304985200; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Habener JF, 2013, TRENDS ENDOCRIN MET, V24, P153, DOI 10.1016/j.tem.2012.10.009; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hayashi Y, 2011, DIABETES OBES METAB, V13, P151, DOI 10.1111/j.1463-1326.2011.01456.x; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Henopp T, 2009, J CLIN ENDOCR METAB, V94, P213, DOI 10.1210/jc.2008-1300; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Klimstra DS., 2010, WHO CLASSIFICATION T, P322; Kloppel G, 2011, ENDOCR-RELAT CANCER, V18, pS1, DOI 10.1530/ERC-11-0013; Longuet C, 2013, DIABETES, V62, P1196, DOI 10.2337/db11-1605; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Xie T, 2010, J ENDOCRINOL, V206, P261, DOI 10.1677/JOE-10-0030; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255; Yu R, 2008, PANCREAS, V36, P428, DOI 10.1097/MPA.0b013e31815ceb23; Yu R, 2014, J CLIN ENDOCR METAB, V99, P748, DOI 10.1210/jc.2013-2952; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133812	10.1371/journal.pone.0133812	http://dx.doi.org/10.1371/journal.pone.0133812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192435	Green Submitted, gold, Green Published			2022-12-27	WOS:000358546400121
J	Barbosa, TM; Morais, JE; Forte, P; Neiva, H; Garrido, ND; Marinho, DA				Barbosa, Tiago M.; Morais, Jorge E.; Forte, Pedro; Neiva, Henrique; Garrido, Nuno D.; Marinho, Daniel A.			A Comparison of Experimental and Analytical Procedures to Measure Passive Drag in Human Swimming	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; SWIMMERS; FORCES; DESIGN	The aim of this study was to compare the swimming hydrodynamics assessed with experimental and analytical procedures, as well as, to learn about the relative contributions of the friction drag and pressure drag to total passive drag. Sixty young talented swimmers (30 boys and 30 girls with 13.59 +/- 0.77 and 12.61 +/- 0.07 years-old, respectively) were assessed. Passive drag was assessed with inverse dynamics of the gliding decay speed. The theoretical modeling included a set of analytical procedures based on naval architecture adapted to human swimming. Linear regression models between experimental and analytical procedures showed a high correlation for both passive drag (D-p = 0.777*Df+pr; R-2 = 0.90; R-a(2) = 0.90; SEE = 8.528; P<0.001) and passive drag coefficient (C-Dp = 1.918*CDf+pr; R-2 = 0.96; R-a(2) = 0.96; SEE = 0.029; P<0.001). On average the difference between methods was -7.002N (95%CI: -40.480; 26.475) for the passive drag and 0.127 (95%CI: 0.007; 0.247) for the passive drag coefficient. The partial contribution of friction drag and pressure drag to total passive drag was 14.12 +/- 9.33% and 85.88 +/- 9.33%, respectively. As a conclusion, there is a strong relationship between the passive drag and passive drag coefficient assessed with experimental and analytical procedures. The analytical method is a novel, feasible and valid way to gather insight about one's passive drag during training and competition. Analytical methods can be selected not only to perform race analysis during official competitions but also to monitor the swimmer's status on regular basis during training sessions without disrupting or time-consuming procedures.	[Barbosa, Tiago M.] Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore; [Morais, Jorge E.] Polytech Inst Braganca, Dept Sport Sci, Braganca, Portugal; [Forte, Pedro; Neiva, Henrique; Marinho, Daniel A.] Univ Beira Interior, Dept Sport Sci, Covilha, Portugal; [Garrido, Nuno D.] Univ Tras Os Montes & Alto Douro, Dept Sport Sci, Vila Real, Portugal; [Barbosa, Tiago M.; Morais, Jorge E.; Forte, Pedro; Neiva, Henrique; Garrido, Nuno D.; Marinho, Daniel A.] Res Ctr Sports Hlth & Human Dev, Vila Real, Portugal	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; Instituto Politecnico de Braganca; Universidade da Beira Interior; University of Tras-os-Montes & Alto Douro	Barbosa, TM (corresponding author), Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore.	tiago.barbosa@nie.edu.sg	Morais, Jorge E./AAX-9541-2020; Barbosa, Tiago M./ABE-6789-2020; Garrido, Nuno Domingos/K-6842-2014; Neiva, Henrique Pereira/M-5893-2013; Forte, Pedro/L-2858-2014; Barbosa, Tiago M./U-5335-2017	Morais, Jorge E./0000-0002-6885-0648; Barbosa, Tiago M./0000-0001-7071-2116; Garrido, Nuno Domingos/0000-0002-8105-7580; Neiva, Henrique Pereira/0000-0001-9283-312X; Forte, Pedro/0000-0003-0184-6780; Barbosa, Tiago M./0000-0001-7071-2116; Marinho, Daniel/0000-0003-2351-3047	Portuguese Science and Technology Foundation (FCT) [SFRH/BD/76287/2011, SFRH/BD/74950/2010]	Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology)	Jorge E. Morais (SFRH/BD/76287/2011) and Henrique Neiva (SFRH/BD/74950/2010) gratefully acknowledge the scholarships granted by the Portuguese Science and Technology Foundation (FCT).	Barbosa TM, 2015, SCAND J MED SCI SPOR, V25, pe184, DOI 10.1111/sms.12281; Barbosa TM, 2013, HUM MOVEMENT SCI, V32, P1214, DOI 10.1016/j.humov.2012.07.009; Barbosa TM, 2010, J SCI MED SPORT, V13, P262, DOI 10.1016/j.jsams.2009.01.003; Bixler B, 2007, SPORT BIOMECH, V6, P81, DOI 10.1080/14763140601058581; Caspersen C, 2010, J BIOMECH, V43, P2369, DOI 10.1016/j.jbiomech.2010.04.022; COUTTS KD, 1991, J REHABIL RES DEV, V28, P45, DOI 10.1682/JRRD.1991.07.0045; KENNEDY P, 1990, INT J SPORT BIOMECH, V6, P187, DOI 10.1123/ijsb.6.2.187; Kjendile PL, 2008, J APPL BIOMECH, V24, P35, DOI 10.1123/jab.24.1.35; Marinho D. A., 2009, LECT NOTES COMPUTATI, V72, P33, DOI DOI 10.1007/978-3-642-04466-3_; Marinho DA, 2013, BRIT J SPORT MED, V47, pe3; Marinho DA, 2011, J HUM KINET, V29, P49, DOI 10.2478/v10078-011-0039-4; Milgram JH, 1998, ANNU REV FLUID MECH, V30, P613, DOI 10.1146/annurev.fluid.30.1.613; Molland AF, 2011, SHIP RESISTANCE PROP; Mollendorf JC, 2004, MED SCI SPORT EXER, V36, P1029, DOI 10.1249/01.MSS.0000128179.02306.57; Morais JE, 2011, J HUM KINET, V28, P5, DOI 10.2478/v10078-011-0017-x; Naemi R, 2010, J SCI MED SPORT, V13, P444, DOI 10.1016/j.jsams.2009.04.009; Pendergast DR, 2011, PORTUGUESE J SPOR S3, V11, P51; Rouboa A, 2006, J BIOMECH, V39, P1239, DOI 10.1016/j.jbiomech.2005.03.012; Sacilotto GBD, 2014, J APPL BIOMECH, V30, P119, DOI 10.1123/jab.2013-0046; Schlichting H., 2017, BOUNDARY LAYER THEOR; Toussaint HM, 2004, J BIOMECH, V37, P1655, DOI 10.1016/j.jbiomech.2004.02.020; Veiga S, 2013, J SPORT SCI, V31, P159, DOI 10.1080/02640414.2012.723130; Vennell R, 2006, J BIOMECH, V39, P664, DOI 10.1016/j.jbiomech.2005.01.023; Vilas-Boas JP, 2010, J APPL BIOMECH, V26, P324, DOI 10.1123/jab.26.3.324; Vorontsov AR., 2000, BIOMECHANICS SPORT P, P184; Webb A, 2011, PROCEDIA ENGINEER, V13, P133, DOI 10.1016/j.proeng.2011.05.063; Zamparo P, 2011, EUR J APPL PHYSIOL, V111, P367, DOI [10.1007/s00421-010-1433-7, 10.1007/s00421-010-1396-8]	27	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130868	10.1371/journal.pone.0130868	http://dx.doi.org/10.1371/journal.pone.0130868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207364	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000008
J	Cho, KI; Ann, SH; Singh, GB; Her, AY; Shin, ES				Cho, Kyoung Im; Ann, Soe Hee; Singh, Gillian Balbir; Her, Ae-Young; Shin, Eun-Seok			Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ALL-CAUSE MORTALITY; NEUTROPHIL/LYMPHOCYTE RATIO; CLINICAL-OUTCOMES; ARTERY-DISEASE; ATHEROSCLEROSIS; COUNT; INFLAMMATION; ANGIOGRAPHY; SEVERITY	Objectives The aim of this study was to investigate the combined usefulness of platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention (PCI) with a drug-eluting stent (DES). Methods 798 patients with stable angina, unstable angina and non-ST elevated myocardial infarction (NSTEMI) who underwent elective successful PCI with DES were consecutively enrolled. The value of PLR and NLR in predicting adverse coronary artery disease (CAD) events and the correlations between these markers and adverse events (all-cause mortality, cardiac death, and nonfatal myocardial infarction) were analyzed. Results The follow-up period was 62.8 +/- 28.8 months. When patients were classified into four groups according to the optimal cut-off values for the PLR and NLR on receiver operating characteristic analysis, patients with a high PLR (>128) and high NLR (>2.6) had the highest occurrence of adverse events among the groups. On Cox multivariate analysis, the NLR >2.6 [hazard ratio (HR) 2.352, 95% confidence interval (CI) 1.286 to 4.339, p = 0.006] and the PLR >128 (HR 2.372, 95% CI 1.305 to 3.191, p = 0.005) were independent predictors of long-term adverse events after adjusting for cardiovascular risk factors. Moreover, both a PLR >128 and a NLR >2.6 were the strongest predictors of adverse events (HR 2.686, 95% CI 1.452 to 4.970, p = 0.002). Conclusion High pre-intervention PLR and NLR, especially when combined, are independent predictors of long-term adverse clinical outcomes such as all-cause mortality, cardiac death, and myocardial infarction in patients with unstable angina and NSTEMI who have undergone successful PCI with DES.	[Cho, Kyoung Im] Kosin Univ, Sch Med, Dept Cardiol, Busan, South Korea; [Ann, Soe Hee; Singh, Gillian Balbir; Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan 680749, South Korea; [Her, Ae-Young] Kangwon Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Chunchon, South Korea	University of Ulsan; Ulsan University Hospital; Kangwon National University	Shin, ES (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan 680749, South Korea.	sesim1989@gmail.com						Acar G, 2015, CLIN APPL THROMB-HEM, V21, P462, DOI 10.1177/1076029613508599; Al Suwaidi J, 2002, CIRCULATION, V106, P974, DOI 10.1161/01.CIR.0000027560.41358.B3; Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009; Azab B, 2012, J THROMB THROMBOLYS, V34, P326, DOI 10.1007/s11239-012-0718-6; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Balta S, 2013, HEMODIAL INT, V17, P668, DOI 10.1111/hdi.12058; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; D'Ascenzo F, 2014, THROMB RES, V134, P558, DOI 10.1016/j.thromres.2014.05.037; Damas JK, 2003, CIRCULATION, V107, P2670, DOI 10.1161/01.CIR.0000070542.18001.87; Fowler AJ, 2013, ATHEROSCLEROSIS, V228, P44, DOI 10.1016/j.atherosclerosis.2013.02.008; Gary T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067688; Gurm HS, 2003, AM HEART J, V146, P692, DOI 10.1016/S0002-8703(03)00230-8; Han YC, 2013, KOREAN CIRC J, V43, P93, DOI 10.4070/kcj.2013.43.2.93; Iijima R, 2007, THROMB HAEMOSTASIS, V98, P852, DOI 10.1160/TH07-04-0285; Kurtul A, 2014, AM J CARDIOL, V114, P342, DOI 10.1016/j.amjcard.2014.04.045; Lee JM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-65; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Luft FC, 2000, BASIC RES CARDIOL, V95, P72; Nikolsky E, 2007, AM J CARDIOL, V99, P1055, DOI 10.1016/j.amjcard.2006.11.066; Ommen SR, 1997, AM J CARDIOL, V79, P812, DOI 10.1016/S0002-9149(96)00878-8; Park JJ, 2013, AM J CARDIOL, V111, P636, DOI 10.1016/j.amjcard.2012.11.012; Poludasu Shyam, 2009, Clin Cardiol, V32, pE6, DOI 10.1002/clc.20503; Prasad A, 2007, AM J CARDIOL, V99, P1067, DOI 10.1016/j.amjcard.2006.11.063; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smith C, 2006, J AM COLL CARDIOL, V48, P1591, DOI 10.1016/j.jacc.2006.06.060; Sunbul M, 2014, CLIN EXP HYPERTENS, V36, P217, DOI 10.3109/10641963.2013.804547; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Thygesen K, 2007, EUR HEART J, V28, P2525; Tsiara S, 2003, CLIN APPL THROMB-HEM, V9, P177, DOI 10.1177/107602960300900301; Waehre T, 2004, THROMB HAEMOSTASIS, V92, P1358, DOI 10.1160/TH04-03-0146; Wang XD, 2014, ATHEROSCLEROSIS, V234, P206, DOI 10.1016/j.atherosclerosis.2014.03.003; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	33	53	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133934	10.1371/journal.pone.0133934	http://dx.doi.org/10.1371/journal.pone.0133934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207383	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000178
J	Yokomichi, H; Tanaka, T; Suzuki, K; Akiyama, T; Yamagata, Z				Yokomichi, Hiroshi; Tanaka, Taichiro; Suzuki, Kohta; Akiyama, Tomoki; Yamagata, Zentaro		Okinawa Child Hlth Study Grp	Macrosomic Neonates Carry Increased Risk of Dental Caries in Early Childhood: Findings from a Cohort Study, the Okinawa Child Health Study, Japan	PLOS ONE			English	Article							MATERNAL WEIGHT-GAIN; LOW-BIRTH-WEIGHT; OFFSPRING ADIPOSITY; FETAL MACROSOMIA; UNITED-STATES; BORN SMALL; FOLLOW-UP; OBESITY; ASSOCIATION; GROWTH	Background Although many studies have discussed health risks in neonates with a low birth weight, few studies have focused on the risks in neonates with a high birth weight. The objective of this study was to determine whether differences in the incidence of dental caries in early childhood are associated with birth weight status. Methods A total of 117,175 children born in Okinawa Prefecture, Japan from 1997 to 2007 were included in this study. Medical professionals collected information about birth records, growth and development, parental child-rearing practices and dental health at 3 months, 18 months and 3 years of age. The risk of dental caries among neonates with macrosomia (birth weight >= 4000 g) was compared with that among neonates with normal weight (2500-3999 g). Sensitivity analyses included 'large for gestational age' (LGA, birth weight above the 90th percentile for gestational age), which was relative to 'appropriate for gestational age' (birth weight between 10th and 90th percentiles). Relative risks and relative risk increases were estimated by multivariate Poisson regression. Results At 3 years of age, the relative risk increases for dental caries after adjusting for confounding factors were 19% [95% confidence interval (CI), 11%-28%, P < 0.001] for macrosomic neonates and 12% (95% CI, 9%-16%, P < 0.001) for LGA neonates. Conclusion Macrosomia and LGA were associated with an increased risk of dental caries in early childhood. Particular attention should be paid to abnormally large neonates.	[Yokomichi, Hiroshi; Suzuki, Kohta; Akiyama, Tomoki; Yamagata, Zentaro] Univ Yamanashi, Dept Hlth Sci, Div Med, Grad Sch,Dept Interdisciplinary Res, Chuo City, Yamanashi, Japan; [Tanaka, Taichiro] Toho Univ, Fac Med, Dept Social Med, Tokyo, Japan	University of Yamanashi; Toho University	Yokomichi, H (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, New Radcliffe House,Woodstock Rd, Oxford, Oxon, England.	hyokomichi@yamanashi.ac.jp; zenymgt@yamanashi.ac.jp	Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	Ministry of Health, Labour and Welfare of Japan [Jisedai-Ippan] [H25-002]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24790614, 15K08730]	Ministry of Health, Labour and Welfare of Japan [Jisedai-Ippan]; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Health, Labour and Welfare of Japan [Jisedai-Ippan (H25-002, http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h25/gaiyo/08.html) to ZY] and by the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Young Scientists (B) 24790614, https://kaken.nii.ac.jp/d/p/24790614.en.html) and Grant-in-Aid for Scientific Research (C) (15K08730, https://kaken.nii.ac.jp/d/p/15K08730.en.html) to HY]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS L, 1977, J ENDOCRINOL, V73, P339, DOI 10.1677/joe.0.0730339; Aligne CA, 2003, JAMA-J AM MED ASSOC, V289, P1258, DOI 10.1001/jama.289.10.1258; ANDERSON TD, 2004, PEDIATRICS, V113, P152; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; BOYD ME, 1983, OBSTET GYNECOL, V61, P715; Burt B A, 2001, J Dent Educ, V65, P1024; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; ERIKSSON U, 1982, BIOL NEONATE, V42, P239; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Gibson S, 1999, CARIES RES, V33, P101, DOI 10.1159/000016503; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Harris Rebecca, 2004, Community Dent Health, V21, P71; Hediger ML, 1998, ARCH PEDIAT ADOL MED, V152, P1225; Hediger ML, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e33; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; HOEGSBERG B, 1993, DIABETES CARE, V16, P32, DOI 10.2337/diacare.16.1.32; Hong L, 2008, J PUBLIC HEALTH DENT, V68, P227, DOI 10.1111/j.1752-7325.2008.00083.x; Iida H, 2007, PEDIATRICS, V120, pE944, DOI 10.1542/peds.2006-0124; Japanese Society of Pediatric Dentistry, WAY THINK US PAC 200; Ji Y, 2006, PEDIATR DENT J, V16, P91, DOI 10.1016/S0917-2394(06)70070-2; Kantovitz Kamila Rosamilia, 2006, Oral Health Prev Dent, V4, P137; Kay EJ, 2010, COMMUNITY DENT ORAL, V38, P408, DOI 10.1111/j.1600-0528.2010.00548.x; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Lai P. Y., 1997, Pediatric Dentistry, V19, P42; Lawlor DA, 2011, AM J CLIN NUTR, V94, P142, DOI 10.3945/ajcn.110.009324; McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855; Ministry of Health Labour and Welfare of Japan, 2007, SUPP GUID BREASTF AB; Ministry of Health Labour and Welfare of Japan, CHILDR CHILDR 2014; Morikawa M, 2013, J OBSTET GYNAECOL RE, V39, P960, DOI 10.1111/j.1447-0756.2012.02059.x; Moyer VA, 2014, PEDIATRICS, V133, P1102, DOI 10.1542/peds.2014-0483; Ogawa Y, 1998, ACTA NEONATOLOGICA J, V34, P624; Ohsuka Keiko, 2009, Environmental Health and Preventive Medicine, V14, P103, DOI 10.1007/s12199-008-0065-6; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Saraiva MCD, 2007, COMMUNITY DENT ORAL, V35, P364, DOI 10.1111/j.1600-0528.2006.00345.x; Shulman JD, 2005, CARIES RES, V39, P161, DOI 10.1159/000084792; Strauss RS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e85; SUSA JB, 1979, DIABETES, V28, P1058, DOI 10.2337/diab.28.12.1058; Tanaka K, 2009, J PEDIATR-US, V155, P410, DOI 10.1016/j.jpeds.2009.03.032; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; The Okinawa Society of Child Health, SEC REP HLTH EX INF; Warren JJ, 2009, COMMUNITY DENT ORAL, V37, P116, DOI 10.1111/j.1600-0528.2008.00447.x; World Health Organization, 1987, CONS DEF STAND REL M; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	51	12	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133872	10.1371/journal.pone.0133872	http://dx.doi.org/10.1371/journal.pone.0133872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207737	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000160
J	Shao, ZR; Bao, Q; Jiang, FZ; Qian, H; Fang, Q; Hu, XQ				Shao, Zheren; Bao, Qi; Jiang, Fangzhen; Qian, Huan; Fang, Quan; Hu, Xueqing			VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo	PLOS ONE			English	Article							EFFICIENTLY INDUCES APOPTOSIS; PROSTATE-CANCER; BCL-XL; PATHWAY; MTOR; TARGETS; ABT-737; PI3K	Melanomas cause over 76% of skin cancer deaths annually. Phosphatidylinositol 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) signaling pathway is important for melanoma initiation and progression. In the current study, we evaluated the potential anti-melanoma effect of VS-5584, a novel and highly potent PI3K-mTOR dual inhibitor. We demonstrated that VS-5584 potently inhibited survival and proliferation of established (A375, A-2058 and SK-MEL-3 lines) and primary human melanoma cells, but was non-cytotoxic to non-cancerous human skin keratinocytes and B10BR murine melanocytes. At the meantime, VS-5584 induced caspase-dependent apoptotic death in melanoma cells, and its cytotoxicity was alleviated by the caspase inhibitors. At the molecular level, VS-5584 blocked AKT-mTOR activation and downregulated cyclin D1 expression in melanoma cells, while the expressions of Bcl-xL and Bcl-2 were not affected by VS-5584 treatment. On the other hand, a BH-3 mimetic Bcl-xL/Bcl-2 inhibitor ABT-737, as well as siRNA-mediated knockdown of Bcl-xL or Bcl-2, enhanced the activity of VS-5584 in melanoma cells. In vivo, oral administration of VS-5584 suppressed A375 melanoma xenograft growth in nude mice, and its activity was further enhanced by co-administration of ABT-737. These results provide the rationale for the clinical assessment of VS-5584 in melanoma patients and development of ABT-737 and other Bcl-xL/Bcl-2 inhibitors as the possible adjuvants.	[Shao, Zheren; Bao, Qi; Jiang, Fangzhen; Qian, Huan; Fang, Quan; Hu, Xueqing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Plast Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, XQ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Plast Surg, Hangzhou 310003, Zhejiang, Peoples R China.	huxueqing163@126.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Davies MA, 2012, CANCER J, V18, P142, DOI 10.1097/PPO.0b013e31824d448c; Dienstmann R, 2014, MOL CANCER THER, V13, P1021, DOI 10.1158/1535-7163.MCT-13-0639; Edlind MP, 2014, ASIAN J ANDROL, V16, P378, DOI 10.4103/1008-682X.122876; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hart S, 2013, MOL CANCER THER, V12, P151, DOI 10.1158/1535-7163.MCT-12-0466; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hutchinson Lisa, 2015, Nat Rev Clin Oncol, V12, P1, DOI 10.1038/nrclinonc.2014.219; Hutchinson L, 2014, NAT REV CLIN ONCOL, V11, P299, DOI [10.1038/nrclinonc.2014.87, 10.1038/nrclinonc.2014.132]; Kolev VN, 2015, CANCER RES, V75, P446, DOI 10.1158/0008-5472.CAN-14-1223; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Populo H, 2012, EXPERT OPIN THER TAR, V16, P689, DOI 10.1517/14728222.2012.691472; Risberg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024012; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Schadendorf D, 2014, NAT REV CLIN ONCOL, V11, P75, DOI 10.1038/nrclinonc.2013.246; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Tang KD, 2014, CURR MED CHEM, V21, P3048, DOI 10.2174/0929867321666140414100127; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Webster RM, 2014, NAT REV DRUG DISCOV, V13, P491, DOI 10.1038/nrd4326	26	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132655	10.1371/journal.pone.0132655	http://dx.doi.org/10.1371/journal.pone.0132655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204252	gold, Green Submitted, Green Published			2022-12-27	WOS:000358621000010
J	Takao, Y; Tomaru, Y; Nagasaki, K; Honda, D				Takao, Yoshitake; Tomaru, Yuji; Nagasaki, Keizo; Honda, Daiske			Ecological Dynamics of Two Distinct Viruses Infecting Marine Eukaryotic Decomposer Thraustochytrids (Labyrinthulomycetes, Stramenopiles)	PLOS ONE			English	Article							HETEROSIGMA-AKASHIWO RAPHIDOPHYCEAE; SCHIZOCHYTRIUM SP; FUNGOID PROTIST; HETEROCAPSA-CIRCULARISQUAMA; PHYTOPLANKTON; BLOOM; SEA; ABUNDANCE; BACTERIA; IMPACTS	Thraustochytrids are cosmopolitan osmotrophic or heterotrophic microorganisms that are considered as important decomposers in coastal ecosystems. However, because of a lack of estimation method for each genus or systematic group of them, relatively little is known about their ecology in situ. Previously, we reported two distinct types of virus infecting thraustochytrids (AuRNAV: reported as SssRNAV, and SmDNAV) suggesting they have wide distributions in the host-virus systems of coastal environments. Here we conducted a field survey from 2004 through 2005 to show the fluctuation pattern of thraustochytrids and their viruses in Hiroshima Bay, Japan. During the field survey, we monitored the dynamics of the two types of thraustochytrid-infecting virus: small viruses causing lysis of Aurantiochytrium sp. NIBH N1-27 (identified as AuRNAV) and the large viruses of Sicyoidochytrium minutum NBRC 102975 (similar to SmDNAV in physiology and morphology). Fluctuation patterns of the two distinct types of virus were different from each other. This may reflect the difference in the preference of organic substrates; i.e., it may be likely the host of AuRNAV (Aurantiochytrium sp.) increases utilizing algal dead bodies or feeble cells as the virus shows a large increase in abundance following raphidophyte blooms; whereas, the trophic nutrient supply for S. minutum may primarily depend on other constantly-supplied organic compounds because it did not show any significant change in abundance throughout the survey. Further study concerning the population composition of thraustochytrids and their viruses may demonstrate the microbial ecology (especially concerning the detrital food web) of marine environments.	[Takao, Yoshitake] Fukui Prefectural Univ, Dept Marine Biosci, Obama, Fukui 9170003, Japan; [Tomaru, Yuji; Nagasaki, Keizo] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hatsukaichi, Hiroshima 7390452, Japan; [Honda, Daiske] Konan Univ, Dept Biol, Fac Sci & Engn, Higashinada Ku, Kobe, Hyogo 6588501, Japan	Fukui Prefectural University; Japan Fisheries Research & Education Agency (FRA); Konan University	Takao, Y (corresponding author), Fukui Prefectural Univ, Dept Marine Biosci, 1-1 Gakuencho, Obama, Fukui 9170003, Japan.	takyoshi@fpu.ac.jp		Honda, Daiske/0000-0002-3436-4561; Takao, Yoshitake/0000-0002-0741-7445	Asahi Glass Foundation; Kato Memorial Bioscience Foundation	Asahi Glass Foundation; Kato Memorial Bioscience Foundation	This work was partially supported by the Asahi Glass Foundation and Kato Memorial Bioscience Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bongiorni L, 2002, AQUAT MICROB ECOL, V25, P355; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; GAERTNER A, 1979, Veroeffentlichungen des Instituts fuer Meeresforschung in Bremerhaven, V18, P29; GAERTNER A, 1968, VEROFF I MEERESFORSC, V3, P75; Honda D, 1998, MYCOL RES, V102, P439, DOI 10.1017/S0953756297005170; Kimura H, 2001, AQUAT MICROB ECOL, V25, P293, DOI 10.3354/ame025293; Kimura H, 1999, MAR ECOL PROG SER, V189, P27, DOI 10.3354/meps189027; Lewis TE, 1999, MAR BIOTECHNOL, V1, P580, DOI 10.1007/PL00011813; Naganuma T, 1998, MAR ECOL PROG SER, V162, P105, DOI 10.3354/meps162105; Nagasaki K, 1997, AQUAT MICROB ECOL, V13, P135, DOI 10.3354/ame013135; Nagasaki K, 2008, J MICROBIOL, V46, P235, DOI 10.1007/s12275-008-0098-y; Nakahara T, 1996, J AM OIL CHEM SOC, V73, P1421, DOI 10.1007/BF02523506; NISHIHARA T, 1986, EISEI KAGAKU, V32, P226, DOI 10.1248/jhs1956.32.226; PORTER D, 1989, HDB PROTOCTISTA, P388; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Raghukumar S, 2002, EUR J PROTISTOL, V38, P127, DOI 10.1078/0932-4739-00832; RAGHUKUMAR S, 1992, MAR BIOL, V113, P165, DOI 10.1007/BF00367650; Raghukumar S, 2001, AQUAT MICROB ECOL, V24, P175, DOI 10.3354/ame024175; Raghukumar S, 1996, ADV ZOOSPORIC FUNGI, P35; Suttle C. A., 1993, HDB METHODS AQUATIC, P121; Takao Y, 2006, J GEN VIROL, V87, P723, DOI 10.1099/vir.0.81204-0; Takao Y, 2005, APPL ENVIRON MICROB, V71, P4516, DOI 10.1128/AEM.71.8.4516-4522.2005; Takao Y, 2007, AQUAT MICROB ECOL, V49, P101, DOI 10.3354/ame01141; Tarutani K, 2000, APPL ENVIRON MICROB, V66, P4916, DOI 10.1128/AEM.66.11.4916-4920.2000; Tomaru Y, 2004, AQUAT MICROB ECOL, V34, P227, DOI 10.3354/ame034227; Tomaru Y, 2004, AQUAT MICROB ECOL, V34, P207, DOI 10.3354/ame034207; Tomaru Y, 2007, ENVIRON MICROBIOL, V9, P1376, DOI 10.1111/j.1462-2920.2007.01252.x; Ueda M, 2015, AQUAT MICROB ECOL, V74, P187, DOI 10.3354/ame01736; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Yokoyama Rinka, 2007, Mycoscience, V48, P199, DOI 10.1007/s10267-006-0362-0	31	2	2	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133395	10.1371/journal.pone.0133395	http://dx.doi.org/10.1371/journal.pone.0133395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203654	Green Published, Green Submitted, gold			2022-12-27	WOS:000358621000028
J	Bao, KS; Shen, J; Wang, GP; Gao, CY				Bao, Kunshan; Shen, Ji; Wang, Guoping; Gao, Chuanyu			Anthropogenic Black Carbon Emission Increase during the Last 150 Years at Coastal Jiangsu, China	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SURFACE SEDIMENTS; HISTORICAL TRENDS; PYROGENIC CARBON; ELEMENTAL CARBON; LAKE-SEDIMENTS; SOILS; LAND; SEA; QUANTIFICATION	Black carbon (BC) is one of the major drivers of climate change and a useful indicator of environmental pollution from industrialization, and thus it is essential to reconstruct the historical trend in BC flux to better understand its impact. The Yancheng coastal wetland reserve in Jiangsu province is an area sensitive to global sea level change and is also located in the most developed as well as most polluted region of China. We investigated the concentration and historical flux of BC over the past 150 years through geochemical analysis of two Pb-210-dated sediment cores from Yancheng coastal wetland. Measured BC contents ranged from 0.24 mg g(-1) to 1.41 mg g(-1) with average values of 0.51mg g(-1)-0.69 mg g(-1), and BC fluxes ranged from 0.69 g m(-2) yr(-1) to 11.80 g m(-2) yr(-1) with averages of 2.94g m(-2) yr-1-3.79 g m(-2) yr(-1). These values are consistent with other records worldwide. Both BC content and flux show a gradual and continuous increase over time and clearly reflect increased emissions from anthropogenic activities. The BC records have a significant peak in recent years (from 2000 to 2007), which is accompanied by the sharp increase of energy consumption and total carbon emission in the region. It is reasonable to conclude that changes in BC from increasing human activities have controlled BC fluxes during the last 150 years. Industrial contamination, especially BC emission, in the coastal region of eastern China should be taken into account when developing management strategies for protecting the natural environment.	[Bao, Kunshan; Shen, Ji] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Wang, Guoping; Gao, Chuanyu] Chinese Acad Sci, Key Lab Wetland Ecol & Environm, Northeast Inst Geog & Agroecol, Changchun, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Bao, KS (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	ksbao@niglas.ac.cn	Gao, Chuanyu/O-3946-2019; Bao, Kunshan/HGC-3930-2022; Bao, Kunshan/AFP-8998-2022; Wang, Guoping/A-8140-2008	Bao, Kunshan/0000-0002-7668-1522; Gao, Chuanyu/0000-0003-2792-5022; Wang, Guoping/0000-0002-8350-812X	Natural Science Foundation of Jiangsu Province, China [BK20131058]; National Natural Science Foundation of China [41301215]; National Basic Research Program of China [2012CB956100]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research was supported by the Natural Science Foundation of Jiangsu Province, China (no. BK20131058), the National Natural Science Foundation of China (no. 41301215), and the National Basic Research Program of China (no. 2012CB956100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby PG, 2008, HOLOCENE, V18, P83, DOI 10.1177/0959683607085598; BALDWIN B, 1985, AAPG BULL, V69, P622; Bao K, 2010, J ENVIRON RADIOACTIV, V101, P773, DOI 10.1016/j.jenvrad.2010.05.004; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Bogdal C, 2011, J ENVIRON MONITOR, V13, P1316, DOI 10.1039/c0em00655f; Bond TC, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002840; Cao GL, 2006, ATMOS ENVIRON, V40, P6516, DOI 10.1016/j.atmosenv.2006.05.070; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Choi YH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002261; Chuai XW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05667; Cong ZY, 2013, ENVIRON SCI TECHNOL, V47, P2579, DOI 10.1021/es3048202; Cordeiro RC, 2002, SCI TOTAL ENVIRON, V293, P247, DOI 10.1016/S0048-9697(02)00045-1; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; DeLaune RD, 2012, CLIMATIC CHANGE, V110, P297, DOI 10.1007/s10584-011-0089-6; Elmquist M, 2007, ENVIRON SCI TECHNOL, V41, P6926, DOI 10.1021/es070546m; Fang SB, 2010, J HAZARD MATER, V184, P375, DOI 10.1016/j.jhazmat.2010.08.046; [方引 Fang Yin], 2014, [海洋学报, Acta Oceanologica Sinica], V36, P98; Gao CA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05723; Gao JH, 2012, J COASTAL RES, V28, P486, DOI 10.2112/JCOASTRES-D-11-00062.1; Gustafsson O, 2001, GLOBAL BIOGEOCHEM CY, V15, P881, DOI 10.1029/2000GB001380; Gustafsson O, 1998, GEOCHIM COSMOCHIM AC, V62, P465, DOI 10.1016/S0016-7037(97)00370-0; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Hammes K, 2006, ORG GEOCHEM, V37, P1629, DOI 10.1016/j.orggeochem.2006.07.003; Han YM, 2011, ENVIRON SCI TECHNOL, V45, P5287, DOI 10.1021/es103518c; [韩永明 Han Yongming], 2010, [第四纪研究, Quaternary Sciences], V30, P550; Husain L, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009398; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Jiang X, 2009, ECO ENV SCI, V19, P1617; Jiangsu Provincial Bureau of Statistics, 2013, JIANGS STAT YB; Kang YJ, 2009, CHIN J OCEANOL LIMN, V27, P297, DOI 10.1007/s00343-009-9151-x; Kapicka A, 1999, J GEOCHEM EXPLOR, V66, P291, DOI 10.1016/S0375-6742(99)00008-4; Ke CQ, 2011, REG ENVIRON CHANGE, V11, P161, DOI 10.1007/s10113-010-0130-8; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; KUHLBUSCH TAJ, 1995, GLOBAL BIOGEOCHEM CY, V9, P491, DOI 10.1029/95GB02742; Lal R, 2003, CRIT REV PLANT SCI, V22, P151, DOI 10.1080/713610854; Lim B, 1996, CHEM GEOL, V131, P143, DOI 10.1016/0009-2541(96)00031-9; Lin Tian, 2012, Huanjing Kexue, V33, P2335; Liu ZY, 2010, J GEOGR SCI, V20, P91, DOI 10.1007/s11442-010-0091-3; Lohmann R, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003253; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Muri G, 2002, CHEMOSPHERE, V46, P1225, DOI 10.1016/S0045-6535(01)00295-8; Pennings SC, 2012, NATURE, V490, P352, DOI 10.1038/490352a; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Qin Y, 2012, ATMOS CHEM PHYS, V12, P4825, DOI 10.5194/acp-12-4825-2012; Qiu JN, 2011, NATURE, V471, P19, DOI 10.1038/471019a; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; Sanchez-Garcia L, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003956; Schwarz JP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01356; Singh BP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03687; SMITH DM, 1973, NATURE, V241, P268, DOI 10.1038/241268a0; Song JZ, 2002, ENVIRON SCI TECHNOL, V36, P3960, DOI 10.1021/es025502m; Song ML, 2015, J CLEAN PROD, V103, P620, DOI 10.1016/j.jclepro.2014.05.095; SPSS, 2002, STAT PROD SERV SOL V; Streets DG, 2001, ATMOS ENVIRON, V35, P4281, DOI 10.1016/S1352-2310(01)00179-0; Sun XS, 2008, APPL GEOCHEM, V23, P3464, DOI 10.1016/j.apgeochem.2008.08.006; Thevenon F, 2010, GLOBAL PLANET CHANGE, V72, P381, DOI 10.1016/j.gloplacha.2010.01.014; [王爱军 Wang Aijun], 2005, [地理学报, Acta Geographica Sinica], V60, P61; Wang R, 2012, ENVIRON SCI TECHNOL, V46, P7595, DOI 10.1021/es3003684; Wang X, 2013, QUATERNARY SCI REV, V59, P18, DOI 10.1016/j.quascirev.2012.10.033; Wang XC, 2007, CHINESE SCI BULL, V52, P3155, DOI 10.1007/s11434-007-0452-1	61	9	11	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0129680	10.1371/journal.pone.0129680	http://dx.doi.org/10.1371/journal.pone.0129680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200665	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100004
J	Chen, ZJ; Han, HQ; Ren, W; Huang, GJ				Chen, Zejun; Han, Huiquan; Ren, Wei; Huang, Guangjie			Heat Transfer Modeling of an Annular On-Line Spray Water Cooling Process for Electric-Resistance-Welded Steel Pipe	PLOS ONE			English	Article							AIR-ATOMIZED SPRAY	On-line spray water cooling (OSWC) of electric-resistance-welded (ERW) steel pipes can replace the conventional off-line heat treatment process and become an important and critical procedure. The OSWC process improves production efficiency, decreases costs, and enhances the mechanical properties of ERW steel pipe, especially the impact properties of the weld joint. In this paper, an annular OSWC process is investigated based on an experimental simulation platform that can obtain precise real-time measurements of the temperature of the pipe, the water pressure and flux, etc. The effects of the modes of annular spray water cooling and related cooling parameters on the mechanical properties of the pipe are investigated. The temperature evolutions of the inner and outer walls of the pipe are measured during the spray water cooling process, and the uniformity of mechanical properties along the circumferential and longitudinal directions is investigated. A heat transfer coefficient model of spray water cooling is developed based on measured temperature data in conjunction with simulation using the finite element method. Industrial tests prove the validity of the heat transfer model of a steel pipe undergoing spray water cooling. The research results can provide a basis for the industrial application of the OSWC process in the production of ERW steel pipes.	[Chen, Zejun; Ren, Wei; Huang, Guangjie] Chongqing Univ, Coll Mat Sci & Engn, State Key Lab Mech Transmiss, Chongqing 400044, Peoples R China; [Han, Huiquan] CISDI Engn Co Ltd, Chongqing 400013, Peoples R China	Chongqing University	Chen, ZJ (corresponding author), Chongqing Univ, Coll Mat Sci & Engn, State Key Lab Mech Transmiss, Chongqing 400044, Peoples R China.	zjchen@cqu.edu.cn	chen, zejun/AAC-7734-2021	chen, zejun/0000-0002-8633-5842	Fundamental Research Funds for the Central Universities [CDJZR14135504]; National Natural Science Foundation of China [51421001]; CISDI Engineering Co., Ltd.	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CISDI Engineering Co., Ltd.	The authors would like to acknowledge the project is supported by the Fundamental Research Funds for the Central Universities (No. CDJZR14135504), and supported by National Natural Science Foundation of China (No. 51421001). Coauthor Huiquan Han is employed by CISDI Engineering Co., Ltd. CISDI Engineering Co., Ltd. provided support in the form of salary for author HH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abdalrahman KHM, 2014, INT J HEAT MASS TRAN, V78, P76, DOI 10.1016/j.ijheatmasstransfer.2014.06.070; Al-Ahmadi HM, 2008, EXP HEAT TRANSFER, V21, P38, DOI 10.1080/08916150701647827; [Anonymous], 2004, 11960 ISO; Buckland B, 2005, KAWASAKI STEEL TECHN, V1, P26; Buckland B, 2005, KAWASAKI STEEL TECHN, V1, P20; Dou RF, 2014, APPL THERM ENG, V62, P738, DOI 10.1016/j.applthermaleng.2013.10.037; [韩会全 Han Huiquan], 2014, [钢铁, Iron and Steel], V49, P55; Kim JH, 2007, INT J HEAT FLUID FL, V28, P753, DOI 10.1016/j.ijheatfluidflow.2006.09.003; Liu SC, 2011, THESIS YANSHAN U; Liu ZH, 2001, INT J HEAT MASS TRAN, V44, P2475, DOI 10.1016/S0017-9310(00)00281-7; Masamura K., 2006, JFE TECH REP, V7, P1; Mohapatra SS, 2012, EXP HEAT TRANSFER, V25, P111, DOI 10.1080/08916152.2011.582567; Mohapatra SS, 2012, J ENHANC HEAT TRANSF, V19, P397, DOI 10.1615/JEnhHeatTransf.2012004285; Rosado DB, 2013, SUSTAINABLE CONSTRUC, V4, DOI 10.13140/2.1.4498.5287; Sarkocevic Z., 2010, ZAVARIVANHE ZAVARENE, V55, P137; Toyooka T, 2002, KAWASAKI STEEL TECHN, V47, P1; Pedrosa IRV, 2013, MATER RES-IBERO-AM J, V16, P489, DOI [10.1590/S1516-14392013005000024, 10.1590/S1516-14392013000200026]; Wang F, 2008, INT J ADV MANUF TECH, V38, P38, DOI 10.1007/s00170-007-1085-x; Wang HM, 2012, J MATER PROCESS TECH, V212, P1825, DOI 10.1016/j.jmatprotec.2012.04.008; Wendelstorf J, 2008, INT J HEAT MASS TRAN, V51, P4902, DOI 10.1016/j.ijheatmasstransfer.2008.01.032; Wendelstorf R, 2008, INT J HEAT MASS TRAN, V51, P4892, DOI 10.1016/j.ijheatmasstransfer.2008.01.033; Zhang X, 2014, APPL THERM ENG, V71, P43, DOI 10.1016/j.applthermaleng.2014.06.026	22	2	2	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131574	10.1371/journal.pone.0131574	http://dx.doi.org/10.1371/journal.pone.0131574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201073	Green Submitted, gold, Green Published			2022-12-27	WOS:000358597100016
J	Mbonye, AK; Magnussen, P; Lal, S; Hansen, KS; Cundill, B; Chandler, C; Clarke, SE				Mbonye, Anthony K.; Magnussen, Pascal; Lal, Sham; Hansen, Kristian S.; Cundill, Bonnie; Chandler, Clare; Clarke, Sian E.			A Cluster Randomised Trial Introducing Rapid Diagnostic Tests into Registered Drug Shops in Uganda: Impact on Appropriate Treatment of Malaria	PLOS ONE			English	Article							CASE-MANAGEMENT; COMBINATION THERAPY; MARKET SHARE; CARE; MEDICINES; ACCURACY; CHILDREN; IMPLEMENTATION; AVAILABILITY; FACILITIES	Background Inappropriate treatment of malaria is widely reported particularly in areas where there is poor access to health facilities and self-treatment of fevers with anti-malarial drugs bought in shops is the most common form of care-seeking. The main objective of the study was to examine the impact of introducing rapid diagnostic tests for malaria (mRDTs) in registered drug shops in Uganda, with the aim to increase appropriate treatment of malaria with artemisinin-based combination therapy (ACT) in patients seeking treatment for fever in drug shops. Methods A cluster-randomized trial of introducing mRDTs in registered drug shops was implemented in 20 geographical clusters of drug shops in Mukono district, central Uganda. Ten clusters were randomly allocated to the intervention (diagnostic confirmation of malaria by mRDT followed by ACT) and ten clusters to the control arm (presumptive treatment of fevers with ACT). Treatment decisions by providers were validated by microscopy on a reference blood slide collected at the time of consultation. The primary outcome was the proportion of febrile patients receiving appropriate treatment with ACT defined as: malaria patients with microscopically-confirmed presence of parasites in a peripheral blood smear receiving ACT or rectal artesunate, and patients with no malaria parasites not given ACT. Findings A total of 15,517 eligible patients (8672 intervention and 6845 control) received treatment for fever between January-December 2011. The proportion of febrile patients who received appropriate ACT treatment was 72.9% versus 33.7% in the control arm; a difference of 36.1% (95% CI: 21.3 - 50.9), p < 0.001. The majority of patients with fever in the intervention arm accepted to purchase an mRDT (97.8%), of whom 58.5% tested mRDT-positive. Drug shop vendors adhered to the mRDT results, reducing over-treatment of malaria by 72.6% (95% CI: 46.7-98.4), p < 0.001) compared to drug shop vendors using presumptive diagnosis (control arm). Conclusion Diagnostic testing with mRDTs compared to presumptive treatment of fevers implemented in registered drug shops substantially improved appropriate treatment of malaria with ACT.	[Mbonye, Anthony K.] Minist Hlth, Kampala, Uganda; [Mbonye, Anthony K.] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Magnussen, Pascal] Univ Copenhagen, Ctr Med Parasitol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Lal, Sham; Clarke, Sian E.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Hansen, Kristian S.; Chandler, Clare] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Cundill, Bonnie] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Makerere University; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Mbonye, AK (corresponding author), Minist Hlth, Box 7272, Kampala, Uganda.	akmbonye@yahoo.com	Clarke, Sian/AAF-5805-2019	Chandler, Clare/0000-0001-6499-7522; Lal, Sham/0000-0002-3650-1398; Magnussen, Pascal/0000-0001-7372-0250; Cundill, Bonnie/0000-0002-3648-820X	ACT Consortium through Bill & Melinda Gates Foundation [39640]; Wellcome Trust through a Research Career Development Fellowship [084933]; MRC [MR/N003810/1] Funding Source: UKRI; Medical Research Council [MR/N003810/1] Funding Source: researchfish	ACT Consortium through Bill & Melinda Gates Foundation; Wellcome Trust through a Research Career Development Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the ACT Consortium, funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine [grant number 39640]. Sian Clarke is supported by the Wellcome Trust through a Research Career Development Fellowship (084933). The funding source had no role in the design, data collection, analysis, interpretation of data, writing and decision to submit the manuscript. The corresponding author had access to the data and the final responsibility to submit the manuscript.	Abraha I, 2010, BMJ, V340; Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; [Anonymous], 2011, DEMOGRAPHIC HLTH SUR; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Barnish G, 2004, BMJ-BRIT MED J, V328, P1511, DOI 10.1136/bmj.328.7455.1511; Bastiaens GJH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001590; Chandler CIR, 2011, SOC SCI MED, V72, P937, DOI 10.1016/j.socscimed.2011.01.009; Chong CK, 2014, KOREAN J PARASITOL, V52, P501, DOI 10.3347/kjp.2014.52.5.501; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Danish Health Authority, 2019, KRAEFTPL 3; Davies EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032704; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Hansen KS, 2013, HEALTH POLICY PLANN, V28, P185, DOI 10.1093/heapol/czs048; Hayes RJ, 2009, INTERD STAT, P3; Hopkins H., 2008, AM SOC TROP MED HYG; Hutchinson E, HLTH POLICY PL UNPUB; Hutchinson E, 2015, CRIT PUBLIC HEALTH, V25, P48, DOI 10.1080/09581596.2014.886762; Ivers NM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-120; Kindermans JM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-91; Kyabayinze DJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-306; Kyabayinze DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-200; Mbonye AK, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-303; Mbonye AK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-237; Mbonye AK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-131; Mbonye AK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-367; Millar KR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-447; Ministry of Health, 2010, UG CLIN GUID; Ministry of Health, 2011, UG NAT MAL CONTR POL; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Reyburn H, 2004, BMJ-BRIT MED J, V329, P121; RUEBUSH TK, 1995, B WORLD HEALTH ORGAN, V73, P229; SNOW RW, 1992, T ROY SOC TROP MED H, V86, P237, DOI 10.1016/0035-9203(92)90290-S; Steinhardt LC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-64; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; USAID Quality Assurance Project and World Health Organization, 2008, US RAP DIAGN TEST RD; VANDERGEEST S, 1987, SOC SCI MED, V25, P293, DOI 10.1016/0277-9536(87)90232-2; Visser T, B WHO UNPUB; WHO, 2010, GUID TREATM MAL, V2nd	41	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0129545	10.1371/journal.pone.0129545	http://dx.doi.org/10.1371/journal.pone.0129545			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200467	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358597100003
J	Abdalla, FC; Domingues, CED				Abdalla, Fabio Camargo; da Costa Domingues, Caio Eduardo			Hepato-Nephrocitic System: A Novel Model of Biomarkers for Analysis of the Ecology of Stress in Environmental Biomonitoring	PLOS ONE			English	Article							FAT-BODY; PERICARDIAL CELLS; PROTEIN; BOMBUS; HYMENOPTERA; DROSOPHILA; DECLINE	Bombus presents a serious global decline of populations and even loss of species. This phenomenon is complex and multifactorial: environmental degradation due to increasing cultivation and grazing areas, indiscriminate use of agrochemicals, and a plethora of xeno-biotics daily discharged in the environment. We proposed that bees have an integrated cell system, which ensures protection against chemical stressors up to a certain limit. Therefore, this hypothesis was tested, exposing workers of Bombus morio to cadmium, a harmful trace metal nowadays widespread in our society. The workers were kept in BOD (26 degrees C, RH 70%, in the dark), fed ad libitum, and divided into a control group (n = 20) and an experimental group (n = 20). For the first group, we offered 2 mL of distilled water; for the experimental groups, 2mL of cadmium at 1 ppb. In relation to the control group, exposed bees showed that their fat body and hemocytes responded in synchronization with pericardial cells in a topographical and temporal cascade of events, where the fat body is the first barrier against xenobiotics, followed by pericardial cells. The immune cells participate throughout the process. To this system, we proposed the name of hepato-nephrocitic system (HNS), which may explain many phenomena that remain unclear in similar research with Apis mellifera and other species of bees, as shown in this paper. The bee's HNS is a system of highly responsive cells to toxicants, considered a novel parameter for the study of the ecology of stress applied in environmental management.	[Abdalla, Fabio Camargo; da Costa Domingues, Caio Eduardo] Univ Fed Sao Carlos, Dept Biol, Lab Struct & Funct Biol, Sorocaba, SP, Brazil	Universidade Federal de Sao Carlos	Abdalla, FC (corresponding author), Univ Fed Sao Carlos, Dept Biol, Lab Struct & Funct Biol, Sorocaba, SP, Brazil.	fabdalla@ufscar.br	Abdalla, Fabio Camargo/W-4022-2019; Domingues, Caio Eduardo C/V-4142-2017; Abdalla, Fábio C/F-2390-2012	Abdalla, Fabio Camargo/0000-0002-1180-8211; Domingues, Caio Eduardo C/0000-0001-8575-2735; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/17840-6, 14/04697-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: 11/17840-6, 14/04697-9), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Abdalla FC, 2014, REV BRAS ENTOMOL, V58, P343, DOI 10.1590/S0085-56262014000400003; Abdalla FC, 2014, ECOTOX 2014, V8, P44; Babthan NMG, 1972, Z ZELLFORSCH MIKR AN, V124, P433; Baranski M, 2014, BRIT J NUTR, V112, P794, DOI 10.1017/S0007114514001366; BEHAN M, 1978, CELL TISSUE RES, V186, P499, DOI 10.1007/BF00224938; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chapman RF, 2012, INSECT STRUCTURE FUN; Cruz-Landim C, 2009, ABELHAS MORTOLOGIA F; Cruz-Landim C, 2000, MORTE CELULAR PROGRA; da Cruz Landin C., 1985, Revista Brasileira de Biologia, V45, P221; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; de Olliveira Vagner Tadeu Paes, 2003, Biociencias (Porto Alegre), V11, P195; Dean R.L., 1985, P155; ENGELMANN F, 1971, ARCH BIOCHEM BIOPHYS, V145, P439, DOI 10.1016/S0003-9861(71)80003-6; FIFE HG, 1987, INSECT BIOCHEM, V17, P829, DOI 10.1016/0020-1790(87)90017-5; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Keeley L.L., 1985, P211; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; LOCKE M, 1969, Tissue and Cell, V1, P103, DOI 10.1016/S0040-8166(69)80009-1; LOCKE M, 1966, NATURE, V210, P552, DOI 10.1038/210552a0; Locke M., 1984, P151; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Martins AC, 2010, J INSECT CONSERV, V14, P207, DOI 10.1007/s10841-009-9237-y; MILLS RP, 1965, Q J MICROSC SCI, V106, P261; MUNN EA, 1969, J INSECT PHYSIOL, V15, P1601, DOI 10.1016/0022-1910(69)90180-2; MUNN EA, 1967, BIOCHEM J, V102, pP5; Poiani SB, 2007, MICRON, V38, P766, DOI 10.1016/j.micron.2006.11.008; Pywell RF, 2006, BIOL CONSERV, V129, P192, DOI 10.1016/j.biocon.2005.10.034; Roma GC, 2010, MICRON, V41, P395, DOI 10.1016/j.micron.2009.12.007; ROSELL RC, 1995, INT J INSECT MORPHOL, V24, P413, DOI 10.1016/0020-7322(95)00008-R; SHIGEMATSU H, 1958, NATURE, V182, P880, DOI 10.1038/182880b0; Silva-Zacarin E.C.M., 2012, CURRENT MICROSCOPY C, P696; Snodgrass R.E., 1956, ANATOMY HONEY BEE; TADKOWSKI TM, 1979, J MORPHOL, V159, P185, DOI 10.1002/jmor.1051590203; Tonolli PN, 2011, ANN ENTOMOL SOC AM, V104, P761, DOI 10.1603/AN10143; Viviani VR, 2008, PHOTOCH PHOTOBIO SCI, V7, P448, DOI 10.1039/b718016k; Wigglesworth VB, 1942, J EXP BIOL, V19, P56; Wyatt G.R., 1980, P201	39	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132349	10.1371/journal.pone.0132349	http://dx.doi.org/10.1371/journal.pone.0132349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197058	Green Published, gold			2022-12-27	WOS:000358547600031
J	Conover, MM; Funk, MJ; Kinlaw, AC; Borawski, KM; Wu, JM				Conover, Mitchell M.; Funk, Michele Jonsson; Kinlaw, Alan C.; Borawski, Kristy M.; Wu, Jennifer M.			Trends and Patterns of Urodynamic Studies in US Males, 2000-2012	PLOS ONE			English	Article								Objective To evaluate trends in urodynamic procedures in the U.S. males from 2000-2012 and determine if a 2010 decline in reimbursement was associated with decreased utilization. Subjects and methods We analyzed 2000-2012 administrative healthcare claims from Truven Health's Marketscan Database and evaluated males >= 18 years of age. We identified cystometrograms and any concurrent procedures using procedure billing codes. Covariates included age, year of cystometrogram, region and associated diagnosis codes. We estimated standardized cystometrogram utilization rates per 10,000 person-years (PY). We used age, region, and calendar year adjusted Poisson regression models to estimate the independent effect of calendar year and region. Results During 127,558,186 PY of observation, we identified 153,168 cystometrograms for an overall utilization rate of 12.0 per 10,000 PY (95% CI 11.9-12.1). Cystometrogram utilization increased with age, peaking at age 85 with a rate of 77.7 per 10,000 PY (95% CI 74.7-80.7). Adjusted cystometrogram utilization rate ratios show that compared to a referent of 2000-2004, utilization was significantly higher in each year 2005 to 2011 among all patients and in 2012 among patients >= 65. Standardized utilization rates peaked in 2008 at 12.4 per 10,000 PY (95% CI 12.2-12.6), remained elevated until 2010, then decreased slightly in 2011 and substantially in 2012 to 8.5 per 10,000 PY (95% CI 8.4-8.7). Conclusions Utilization of urodynamic procedures increased until 2010 and decreased thereafter. Utilization was greatest among men older than 65.	[Conover, Mitchell M.; Funk, Michele Jonsson; Kinlaw, Alan C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Borawski, Kristy M.] Univ N Carolina, Dept Urol, Chapel Hill, NC USA; [Wu, Jennifer M.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Conover, MM (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.	mconover@email.unc.edu	Funk, Michele Jonsson/F-6885-2011; Wu, Jennifer/GRX-1831-2022	Funk, Michele Jonsson/0000-0002-3756-7540; Conover, Mitchell/0000-0001-5682-3688; Wu, Jennifer/0000-0002-4477-3932; Wu, Jennifer/0000-0002-3171-1054; Kinlaw, Alan/0000-0002-4279-8685	Amgen; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K23HD068404]; Agency for Healthcare Research and Quality [K02HS017950]; Department of Epidemiology; UNC Gillings School of Global Public Health; Cecil G. Sheps Center for Health Services Research; CER Strategic Initiative of UNC's Clinical Translational Science Award [UL1TR001111]; UNC School of Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017950] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD068404] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER	Amgen(Amgen); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Department of Epidemiology; UNC Gillings School of Global Public Health; Cecil G. Sheps Center for Health Services Research; CER Strategic Initiative of UNC's Clinical Translational Science Award; UNC School of Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by Amgen (MC, pharmacoepidemiology fellowship recipient; www.amgen.com); the Eunice Kennedy Shriver National Institute of Child Health & Human Development (JMW salary paid by K23HD068404; http://www.nichd.nih.gov/); Agency for Healthcare Research and Quality (MJF salary paid by K02HS017950; http://www.ahrq.gov/); The Department of Epidemiology, UNC Gillings School of Global Public Health (http://sph.unc.edu/epid); the Cecil G. Sheps Center for Health Services Research http://www.shepscenter.unc.edu/); the CER Strategic Initiative of UNC's Clinical Translational Science Award (MJF salary paid by UL1TR001111, http://tracs.unc.edu/), and the UNC School of Medicine (https://www.med.unc.edu/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Agency for Healthcare Research and Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Urological Association Education and Research, 2010, GUID MAN BEN PROST H; [Anonymous], 2003, GUID MAN BEN PROST H; [Anonymous], 2015, MARKETSCAN COMM CLAI; [Anonymous], 2012, MARKETSCAN CCAE MDCR, V2011; Clement Keiran D, 2014, COCHRANE COLLABORATI, P1; Danielson E, WHITE PAPER HLTH RES; DeNavas-Walt C, 2013, US CENSUS BUREAU CUR; Medicare Program, 2009, FED REGISTER, V74, P62017; Medicare Program, 2010, FED REGISTER, V75, P26360; Medicare Program, 2008, FED REGISTER, V73, P69944; Painter R, 2009, UROL TIMES       DEC, P30; Reynolds WS, 2013, J UROLOGY, V189, P1791, DOI 10.1016/j.juro.2012.11.066; Rosier PFWM, 2010, NEUROUROL URODYNAM, V29, P146, DOI 10.1002/nau.20763; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P121; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; U.S. Census Bureau, 2011, CURR POP SURV ANN SO; Winters JC, 2012, J UROLOGY, V188, P2464, DOI 10.1016/j.juro.2012.09.081	17	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133657	10.1371/journal.pone.0133657	http://dx.doi.org/10.1371/journal.pone.0133657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196514	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600128
J	Danoff, EJ; Fleming, KG				Danoff, Emily J.; Fleming, Karen G.			Aqueous, Unfolded OmpA Forms Amyloid-Like Fibrils upon Self-Association	PLOS ONE			English	Article							BARREL MEMBRANE-PROTEIN; IN-VITRO; BETA-BARREL; ALPHA-SYNUCLEIN; THIOFLAVINE-T; DISEASE; AGGREGATION; DOMAIN	Unfolded outer membrane beta-barrel proteins have been shown to self-associate in the absence of lipid bilayers. We previously investigated the formation of high molecular weight species by OmpA, with both the transmembrane domain alone and the full-length protein, and discovered that the oligomeric form contains non-native beta-sheet structure. We have further probed the conformation of self-associated OmpA by monitoring binding to Thioflavin T, a dye that is known to bind the cross-beta a structure inherent in amyloid fibrils, and by observing the species by electron microscopy. The significant increase in fluorescence indicative of Thioflavin T binding and the appearance of fibrillar species by electron microscopy verify that the protein forms amyloid-like fibril structures upon oligomerization. These results are also consistent with our previous kinetic analysis of OmpA self-association that revealed a nucleated growth polymerization mechanism, which is frequently observed in amyloid formation. The discovery of OmpA's ability to form amyloid-like fibrils provides a new model protein with which to study fibrillization, and implicates periplasmic chaperone proteins as capable of inhibiting fibril formation.	[Danoff, Emily J.; Fleming, Karen G.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Fleming, KG (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA.	karen.fleming@jhu.edu			National Science Foundation (NSF) [MCB 0919868, MCB 1412108]; National Institutes of Health (NIH) [R01 GM079440, T32 GM008403]; NSF graduate research fellowship [DGE-0707427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079440, T32GM008403] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1412108] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF graduate research fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (NSF) (MCB 0919868 and MCB 1412108) and the National Institutes of Health (NIH) (R01 GM079440 and T32 GM008403). EJD is a recipient of an NSF graduate research fellowship (DGE-0707427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Danoff EJ, 2011, BIOPHYS CHEM, V159, P194, DOI 10.1016/j.bpc.2011.06.013; Denoncin K, 2012, PROTEOMICS, V12, P1391, DOI 10.1002/pmic.201100633; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Khan MA, 2007, BIOCHEMISTRY-US, V46, P4565, DOI 10.1021/bi602526k; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; McMorran LM, 2014, ARCH BIOCHEM BIOPHYS, V564, P265, DOI 10.1016/j.abb.2014.02.011; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; SURREY T, 1995, J BIOL CHEM, V270, P28199; Tan AE, 2010, MACROMOL BIOSCI, V10, P763, DOI 10.1002/mabi.200900479; Ulmschneider MB, 2005, PROTEINS, V59, P252, DOI 10.1002/prot.20334; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; WOODY RW, 1995, METHOD ENZYMOL, V246, P34	26	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132301	10.1371/journal.pone.0132301	http://dx.doi.org/10.1371/journal.pone.0132301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196893	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600030
J	Shahbazi, M; Zahedifard, F; Taheri, T; Taslimi, Y; Jamshidi, S; Shirian, S; Mahdavi, N; Hassankhani, M; Daneshbod, Y; Zarkesh-Esfahani, SH; Papadopoulou, B; Rafati, S				Shahbazi, Mehdi; Zahedifard, Farnaz; Taheri, Tahereh; Taslimi, Yasaman; Jamshidi, Shahram; Shirian, Sadegh; Mahdavi, Niousha; Hassankhani, Mehdi; Daneshbod, Yahya; Zarkesh-Esfahani, Sayyed Hamid; Papadopoulou, Barbara; Rafati, Sima			Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis	PLOS ONE			English	Article							CENTRIN DELETED PARASITES; POLYMERASE-CHAIN-REACTION; MEDIATED IMMUNE-RESPONSE; IGG2 ANTIBODY-RESPONSES; LONG-LASTING PROTECTION; PRIME-BOOST VACCINATION; NATURALLY INFECTED-DOGS; NITRIC-OXIDE PRODUCTION; CUTANEOUS LEISHMANIASIS; KALA-AZAR	Canine Visceral Leishmaniasis (CVL) is a major veterinary and public health problem caused by Leishmania infantum (L. infantum) in many endemic countries. It is a severe chronic disease with generalized parasite spread to the reticuloendothelial system, such as spleen, liver and bone marrow and is often fatal when left untreated. Control of VL in dogs would dramatically decrease infection pressure of L. infantum for humans, since dogs are the main domestic reservoir. In the past decade, various subunits and DNA antigens have been identified as potential vaccine candidates in experimental animal models, but none has been approved for human use so far. In this study, we vaccinated outbreed dogs with a prime-boost regimen based on recombinant L. tarentolae expressing the L. donovani A2 antigen along with cysteine proteinase genes (CPA and CPB without its unusual C-terminal extension (CPB-CTE) and evaluated its immunogenicity and protective immunity against L. infantum infectious challenge. We showed that vaccinated animals produced significantly higher levels of IgG2, but not IgG1, and also IFN-gamma and TNF-alpha, but low IL-10 levels, before and after challenge as compared to control animals. Protection in dogs was also correlated with a strong DTH response and low parasite burden in the vaccinated group. Altogether, immunization with recombinant L. tarentolae A2-CPA-CPB-CTE was proven to be immunogenic and induced partial protection in dogs, hence representing a promising live vaccine candidate against CVL.	[Shahbazi, Mehdi; Zahedifard, Farnaz; Taheri, Tahereh; Taslimi, Yasaman; Rafati, Sima] Pasteur Inst Iran, Dept Immunotherapy & Leishmania Vaccine Res, Tehran 13164, Iran; [Shahbazi, Mehdi; Zarkesh-Esfahani, Sayyed Hamid] Isfahan Univ Med Sci, Sch Med, Dept Immunol, Esfahan, Iran; [Jamshidi, Shahram; Mahdavi, Niousha; Hassankhani, Mehdi] Univ Tehran, Fac Vet Med, Dept Internal Med, Tehran, Iran; [Shirian, Sadegh; Daneshbod, Yahya] Dept Mol & Cytopathol, Daneshbod Pathol Lab, Shiraz, Iran; [Papadopoulou, Barbara] Univ Laval, Res Ctr Infect Dis, CHU Quebec Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Papadopoulou, Barbara] Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ G1K 7P4, Canada	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Isfahan University Medical Science; University of Tehran; Laval University; Laval University	Rafati, S (corresponding author), Pasteur Inst Iran, Dept Immunotherapy & Leishmania Vaccine Res, 69 Pasteur Ave, Tehran 13164, Iran.	s_rafati@yahoo.com	Rafati, Sima/L-2202-2017; Shirian, Sadegh/ABA-6006-2021	Rafati, Sima/0000-0002-7221-1320; hassankhani, mehdi/0000-0002-3915-1514; Taheri, Tahereh/0000-0002-2619-6879; Zarkesh Esfahani, Sayyed Hamid/0000-0002-7720-4859	Pasteur Institute of Iran [564]; Iran Ministry of Health [700/4038]; Isfahan University Medical Sciences [391434]	Pasteur Institute of Iran; Iran Ministry of Health; Isfahan University Medical Sciences	The study is funded by Pasteur Institute of Iran (grant number 564) and Iran Ministry of Health (Grant 700/4038) and Isfahan University Medical Sciences (391434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Baneth G, 2002, VET PARASITOL, V106, P315, DOI 10.1016/S0304-4017(02)00115-2; Barbieri CL, 2006, PARASITE IMMUNOL, V28, P329, DOI 10.1111/j.1365-3024.2006.00840.x; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Borj-Cabrera GP, 2002, VACCINE, V20, P3277, DOI 10.1016/S0264-410X(02)00294-3; Borja-Cabrera GP, 2004, VACCINE, V22, P2234, DOI 10.1016/j.vaccine.2003.11.039; Bourdoiseau G, 2009, VET IMMUNOL IMMUNOP, V128, P71, DOI 10.1016/j.vetimm.2008.10.309; Bourdoiseau G, 1997, VET IMMUNOL IMMUNOP, V59, P21, DOI 10.1016/S0165-2427(97)00072-X; Breton M, 2005, INFECT IMMUN, V73, P6372, DOI 10.1128/IAI.73.10.6372-6382.2005; Carrillo E, 2007, VACCINE, V25, P1534, DOI 10.1016/j.vaccine.2006.10.036; Chhajer R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00213; Daneshvar H, 2010, PARASITE IMMUNOL, V32, P722, DOI 10.1111/j.1365-3024.2010.01237.x; Day MJ, 2007, VET PARASITOL, V147, P2, DOI 10.1016/j.vetpar.2007.03.037; DEPLAZES P, 1995, PARASITE IMMUNOL, V17, P451, DOI 10.1111/j.1365-3024.1995.tb00914.x; Dunning N., 2009, BIOSCI HORIZONS, V2, P73, DOI [10.1093/biohorizons/hzp004, DOI 10.1093/BIOHORIZONS/HZP004]; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Ferreira JFL, 2008, VACCINE, V26, P677, DOI 10.1016/j.vaccine.2007.11.044; Fiuza JA, 2015, VACCINE, V33, P280, DOI 10.1016/j.vaccine.2014.11.039; Fiuza JA, 2013, VACCINE, V31, P1785, DOI 10.1016/j.vaccine.2013.01.048; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Fujiwara RT, 2005, VET RES, V36, P827, DOI 10.1051/vetres:2005033; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; Gicheru MM, 2001, INFECT IMMUN, V69, P245, DOI 10.1128/IAI.69.1.245-251.2001; Ginel PJ, 1998, J SMALL ANIM PRACT, V39, P271, DOI 10.1111/j.1748-5827.1998.tb03649.x; Gradoni L, 2005, VACCINE, V23, P5245, DOI 10.1016/j.vaccine.2005.07.001; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Kenney RT, 1998, J INFECT DIS, V177, P815, DOI 10.1086/517817; Lachaud L, 2002, PARASITOLOGY, V125, P197, DOI 10.1017/S0031182002002081; Lachaud L, 2002, J CLIN MICROBIOL, V40, P210, DOI 10.1128/JCM.40.1.210-215.2002; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061; Leontides LS, 2002, VET PARASITOL, V109, P19, DOI 10.1016/S0304-4017(02)00201-7; LIEW FY, 1990, J IMMUNOL, V145, P4306; Manna L, 2006, VET PARASITOL, V142, P271, DOI 10.1016/j.vetpar.2006.06.028; MARTINEZMORENO A, 1995, VET IMMUNOL IMMUNOP, V48, P209, DOI 10.1016/0165-2427(95)05434-8; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Masina S, 2003, J INFECT DIS, V188, P1250, DOI 10.1086/378677; McCall LI, 2013, VACCINE, V31, P1420, DOI 10.1016/j.vaccine.2012.11.065; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Mendes CD, 2003, VACCINE, V21, P2589, DOI 10.1016/S0264-410X(03)00046-X; Misra A, 2001, VACCINE, V19, P3485, DOI 10.1016/S0264-410X(01)00058-5; Molano I, 2003, VET IMMUNOL IMMUNOP, V92, P1, DOI 10.1016/S0165-2427(02)00315-X; Moreno J, 2014, VET IMMUNOL IMMUNOP, V158, P199, DOI 10.1016/j.vetimm.2014.01.011; Moreno J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001683; Okwor I, 2009, HUM VACCINES, V5, P291, DOI 10.4161/hv.5.5.7607; Oryan A, 2013, INFECT GENET EVOL, V19, P226, DOI 10.1016/j.meegid.2013.07.021; Panaro MA, 2001, COMP IMMUNOL MICROB, V24, P187, DOI 10.1016/S0147-9571(00)00026-6; PINELLI E, 1995, EUR J IMMUNOL, V25, P1594, DOI 10.1002/eji.1830250619; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; Pinelli E, 2000, VET PARASITOL, V92, P181, DOI 10.1016/S0304-4017(00)00312-5; Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; Rafati S, 2005, VACCINE, V23, P3716, DOI 10.1016/j.vaccine.2005.02.009; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Reis AB, 2006, CLIN EXP IMMUNOL, V146, P303, DOI 10.1111/j.1365-2249.2006.03206.x; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Rhalem A, 1999, VET PARASITOL, V81, P173, DOI 10.1016/S0304-4017(98)00240-4; Ritter U, 2002, PARASITE IMMUNOL, V24, P295, DOI 10.1046/j.1365-3024.2002.00467.x; Roberts MTM, 2005, BRIT MED BULL, V75-76, P115, DOI 10.1093/bmb/ldl003; Rolao N, 2004, J PARASITOL, V90, P1150, DOI 10.1645/GE-264R1; Saljoughian N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002174; Santos FN, 2007, VACCINE, V25, P6176, DOI 10.1016/j.vaccine.2007.06.005; Shirian S, 2014, ARCH PATHOL LAB MED, V138, P235, DOI 10.5858/arpa.2013-0098-OA; Silvestre R, 2007, J IMMUNOL, V179, P3161, DOI 10.4049/jimmunol.179.5.3161; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Solano-Gallego L, 2001, VET PARASITOL, V96, P265, DOI 10.1016/S0304-4017(00)00446-5; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Tewary P, 2006, VACCINE, V24, P2409, DOI 10.1016/j.vaccine.2005.11.058; Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; Vouldoukis I, 1996, ANTIMICROB AGENTS CH, V40, P253, DOI 10.1128/AAC.40.1.253; World Health Organization, 1996, MAN VISC LEISHM CONT; Zahedifard F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002751; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108	77	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132794	10.1371/journal.pone.0132794	http://dx.doi.org/10.1371/journal.pone.0132794			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197085	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600051
J	Sheahan, TD; Copits, BA; Golden, JP; Gereau, RW				Sheahan, Tayler D.; Copits, Bryan A.; Golden, Judith P.; Gereau, Robert W.			Voluntary Exercise Training: Analysis of Mice in Uninjured, Inflammatory, and Nerve-Injured Pain States	PLOS ONE			English	Article							PERIPHERAL NEUROPATHIC PAIN; STRESS-INDUCED ANALGESIA; QUALITY-OF-LIFE; PHYSICAL-EXERCISE; HSP72 EXPRESSION; BETA-ENDORPHIN; MUSCLE ATROPHY; RATS; INTENSITY; SKIN	Both clinical and animal studies suggest that exercise may be an effective way to manage inflammatory and neuropathic pain conditions. However, existing animal studies commonly use forced exercise paradigms that incorporate varying degrees of stress, which itself can elicit analgesia, and thus may complicate the interpretation of the effects of exercise on pain. We investigated the analgesic potential of voluntary wheel running in the formalin model of acute inflammatory pain and the spared nerve injury model of neuropathic pain in mice. In uninjured, adult C57BL/6J mice, 1 to 4 weeks of exercise training did not alter nociceptive thresholds, lumbar dorsal root ganglia neuronal excitability, or hindpaw intraepidermal innervation. Further, exercise training failed to attenuate formalin-induced spontaneous pain. Lastly, 2 weeks of exercise training was ineffective in reversing spared nerve injury-induced mechanical hypersensitivity or in improving muscle wasting or hindpaw denervation. These findings indicate that in contrast to rodent forced exercise paradigms, short durations of voluntary wheel running do not improve pain-like symptoms in mouse models of acute inflammation and peripheral nerve injury.	[Sheahan, Tayler D.; Copits, Bryan A.; Golden, Judith P.; Gereau, Robert W.] Washington Univ, Pain Ctr, St Louis, MO 63130 USA; [Sheahan, Tayler D.; Copits, Bryan A.; Golden, Judith P.; Gereau, Robert W.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Sheahan, Tayler D.; Gereau, Robert W.] Washington Univ, Sch Med, Washington Univ Program Neurosci, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gereau, RW (corresponding author), Washington Univ, Pain Ctr, St Louis, MO 63130 USA.	gereaur@wustl.edu		Sheahan, Tayler/0000-0002-5015-0600; Golden, Judith/0000-0002-5168-8525	National Institutes of Neurological Disorders and Stroke [R01 NS48602]; Washington University in St. Louis W.M. Keck Fellowship in Molecular Medicine; National Institutes of General Medical Sciences [TR32 GM108539]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM108539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048602] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Washington University in St. Louis W.M. Keck Fellowship in Molecular Medicine; National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	RWG was supported by National Institutes of Neurological Disorders and Stroke R01 NS48602 (nih.gov). BAC was supported by Washington University in St. Louis W.M. Keck Fellowship in Molecular Medicine (http://www.wmkeck.org) and National Institutes of General Medical Sciences TR32 GM108539 (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Almeida C, 2015, PAIN, V156, P504, DOI 10.1097/01.j.pain.0000460339.23976.12; Armada-da-Silva PAS, 2013, INT REV NEUROBIOL, V109, P125, DOI 10.1016/B978-0-12-420045-6.00006-7; Baldo G, 2013, J INHERIT METAB DIS, V36, P499, DOI 10.1007/s10545-012-9530-x; Belter JG, 2004, J APPL PHYSIOL, V96, P1270, DOI 10.1152/japplphysiol.00838.2003; Bement MKH, 2005, ARCH PHYS MED REHAB, V86, P1736, DOI 10.1016/j.apmr.2005.03.029; BENRATH J, 1995, NEUROSCI LETT, V200, P17, DOI 10.1016/0304-3940(95)12062-9; Binder E, 2004, BEHAV BRAIN RES, V155, P197, DOI 10.1016/j.bbr.2004.04.017; Bobinski F, 2011, NEUROSCIENCE, V194, P337, DOI 10.1016/j.neuroscience.2011.07.075; Boeltz T, 2013, J NEUROPHYSIOL, V109, P2645, DOI 10.1152/jn.00946.2012; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Brenner DS, 2015, JOVE-J VIS EXP, DOI 10.3791/52640; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; CAGGIULA AR, 1995, PSYCHOPHARMACOLOGY, V122, P301, DOI 10.1007/BF02246552; CARMODY J, 1987, NEUROSCI LETT, V74, P358, DOI 10.1016/0304-3940(87)90324-7; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen YW, 2013, ANESTH ANALG, V116, P482, DOI 10.1213/ANE.0b013e318274e4a0; Chiang HY, 1998, EXP NEUROL, V154, P137, DOI 10.1006/exnr.1998.6896; Cobianchi S, 2010, NEUROSCIENCE, V168, P273, DOI 10.1016/j.neuroscience.2010.03.035; Cobianchi S, 2013, EXP NEUROL, V240, P157, DOI 10.1016/j.expneurol.2012.11.023; Courneya KS, 2013, JNCI-J NATL CANCER I, V105, P1821, DOI 10.1093/jnci/djt297; Daenen L, 2015, CLIN J PAIN, V31, P108, DOI 10.1097/AJP.0000000000000099; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Detloff MR, 2014, EXP NEUROL, V255, P38, DOI 10.1016/j.expneurol.2014.02.013; Dixit S, 2014, QUAL LIFE RES, V23, P1629, DOI 10.1007/s11136-013-0602-7; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Dobson JL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00102; Draxler P, 2014, J NEUROSCI, V34, P12015, DOI 10.1523/JNEUROSCI.2157-14.2014; Dubreucq S, 2011, HIPPOCAMPUS, V21, P239, DOI 10.1002/hipo.20778; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Duraku LS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-61; Gereau RW, 2014, J PAIN, V15, P1203, DOI 10.1016/j.jpain.2014.09.004; Geva N, 2013, PAIN, V154, P2317, DOI 10.1016/j.pain.2013.06.031; Grace PM, 2014, J PAIN, V15, P121, DOI 10.1016/j.jpain.2013.10.001; Groover AL, 2013, PAIN, V154, P2658, DOI 10.1016/j.pain.2013.07.052; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; HOFFMANN P, 1990, REGUL PEPTIDES, V28, P233, DOI 10.1016/0167-0115(90)90021-N; Hurkmans E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006853.pub2; Ilha J, 2008, NEUROREHAB NEURAL RE, V22, P355, DOI 10.1177/1545968307313502; Inst Med, 2011, RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH, P1; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Klusakova I, 2009, ANN ANAT, V191, P248, DOI 10.1016/j.aanat.2009.02.007; Koltyn KF, 2000, SPORTS MED, V29, P85, DOI 10.2165/00007256-200029020-00002; Korb A, 2010, NEUROCHEM RES, V35, P380, DOI 10.1007/s11064-009-0066-x; Kuphal KE, 2007, J PAIN, V8, P989, DOI 10.1016/j.jpain.2007.08.001; Lame IE, 2005, EUR J PAIN, V9, P15, DOI 10.1016/j.ejpain.2004.02.006; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Li YB, 1997, EXP NEUROL, V147, P452, DOI 10.1006/exnr.1997.6624; Mathes WF, 2006, PHARMACOL BIOCHEM BE, V83, P578, DOI 10.1016/j.pbb.2006.03.020; Michaelis M, 2000, J NEUROSCI, V20, P2742; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Noble EG, 1999, J APPL PHYSIOL, V86, P1696, DOI 10.1152/jappl.1999.86.5.1696; Ploughman M, 2007, BRAIN RES, V1150, P207, DOI 10.1016/j.brainres.2007.02.065; Ren Ke, 1999, ILAR J, V40, P111; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; Salam JN, 2009, BEHAV BRAIN RES, V197, P31, DOI 10.1016/j.bbr.2008.07.036; Sciolino NR, 2012, NEUROSCI BIOBEHAV R, V36, P1965, DOI 10.1016/j.neubiorev.2012.06.005; Sharma NK, 2010, PHYS THER, V90, P714, DOI 10.2522/ptj.20090168; Shen J, 2013, PAIN MED, V14, P516, DOI 10.1111/pme.12057; SHYU BC, 1982, LIFE SCI, V30, P833; Sluka KA, 2013, J APPL PHYSIOL, V114, P725, DOI 10.1152/japplphysiol.01317.2012; Stagg NJ, 2011, ANESTHESIOLOGY, V114, P940, DOI 10.1097/ALN.0b013e318210f880; TAKAHASHI K, 1993, J INVEST DERMATOL, V101, P646, DOI 10.1111/1523-1747.ep12371670; Tesarz J, 2012, PAIN, V153, P1253, DOI 10.1016/j.pain.2012.03.005; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; van der Heijden MMP, 2013, DIABETOLOGIA, V56, P1210, DOI 10.1007/s00125-013-2871-7; Wright A, 2001, CLIN J PAIN, V17, P33, DOI 10.1097/00002508-200103000-00006; Xu QH, 2011, CURR OPIN ANESTHESIO, V24, P400, DOI 10.1097/ACO.0b013e32834871df; Zhao L, 2012, NEURAL REGEN RES, V7, P2507, DOI 10.3969/j.issn.1673-5374.2012.32.004	72	26	28	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133191	10.1371/journal.pone.0133191	http://dx.doi.org/10.1371/journal.pone.0133191			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196858	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600070
J	Ball, RL; Knapp, CM; Whitehead, KA				Ball, Rebecca L.; Knapp, Christopher M.; Whitehead, Kathryn A.			Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model	PLOS ONE			English	Article							TNF-ALPHA-SIRNA; FUNCTIONAL DIVERSITY; CELL-LINE; DRUG; MECHANISMS; PERMEABILITY; INFLAMMATION; ABSORPTION; EXPRESSION; GENETICS	Short interfering ribonucleic acid (siRNA) therapeutics show promise for the treatment of intestinal diseases by specifically suppressing the expression of disease relevant proteins. Recently, a class of lipid-like materials termed "lipidoids" have been shown to potently deliver siRNA to the liver and immune cells. Here, we seek to establish the utility of lipidoid nanoparticles (LNPs) in the context of siRNA delivery to the intestinal epithelium. Initial studies demonstrated that the siRNA-loaded LNPs mediated potent, dose dependent, and durable gene silencing in Caco-2 intestinal epithelial cells, with a single 10 nM dose depressing GAPDH mRNA expression for one week. Transfection with siRNA-loaded LNPs did not induce significant cytotoxicity in Caco-2 cells or alter intestinal barrier function. Protein silencing was confirmed by Western blotting, with the lowest levels of GAPDH protein expression observed five days post-transfection. Together, these data underscore the potential of LNPs for the treatment of intestinal disorders.	[Ball, Rebecca L.; Knapp, Christopher M.; Whitehead, Kathryn A.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Whitehead, Kathryn A.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Whitehead, KA (corresponding author), Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.	kawhite@cmu.edu	Whitehead, Kathryn/ABF-3857-2020	Whitehead, Kathryn/0000-0002-0100-7824	Center for Nucleic Acids Science and Technology	Center for Nucleic Acids Science and Technology	This work was funded by the Center for Nucleic Acids Science and Technology (http://www.cmu.edu/cnast/). This is an internal grant and no grant # was provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collnot EM, 2012, J CONTROL RELEASE, V161, P235, DOI 10.1016/j.jconrel.2012.01.028; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Franch HA, 2001, J BIOL CHEM, V276, P19126, DOI 10.1074/jbc.M101777200; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; Guo JF, 2013, INT J PHARMACEUT, V447, P150, DOI 10.1016/j.ijpharm.2013.02.050; He CL, 2012, ADV HEALTHC MATER, V1, P48, DOI 10.1002/adhm.201100008; He CB, 2013, BIOMATERIALS, V34, P2843, DOI 10.1016/j.biomaterials.2013.01.033; He F, 2012, CYTOKINE, V59, P264, DOI 10.1016/j.cyto.2012.04.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kriegel C, 2011, J CONTROL RELEASE, V150, P77, DOI 10.1016/j.jconrel.2010.10.002; Lautenschlager C, 2014, ADV DRUG DELIVER REV, V71, P58, DOI 10.1016/j.addr.2013.10.001; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Mahon KP, 2010, BIOCONJUGATE CHEM, V21, P1448, DOI 10.1021/bc100041r; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mladenovska K, 2007, INT J PHARMACEUT, V342, P124, DOI 10.1016/j.ijpharm.2007.05.028; Nielsen OH, 2011, J INTERN MED, V270, P15, DOI 10.1111/j.1365-2796.2011.02344.x; Nielsen OH, 2013, NEW ENGL J MED, V369, P754, DOI 10.1056/NEJMct1209614; PINTO M, 1983, BIOL CELL, V47, P323; Ponder Alexis, 2013, Clin Epidemiol, V5, P237, DOI 10.2147/CLEP.S33961; Press B, 2008, CURR DRUG METAB, V9, P893, DOI 10.2174/138920008786485119; Reineke JJ, 2013, P NATL ACAD SCI USA, V110, P13803, DOI 10.1073/pnas.1305882110; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SERAFINI EP, 1981, GUT, V22, P648, DOI 10.1136/gut.22.8.648; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Siegwart DJ, 2011, P NATL ACAD SCI USA, V108, P12996, DOI 10.1073/pnas.1106379108; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Suzuki M., 2014, PLOS ONE, V9; Tahara K, 2011, BIOMATERIALS, V32, P870, DOI 10.1016/j.biomaterials.2010.09.034; Talaei F, 2013, EUR J PHARM SCI, V49, P712, DOI 10.1016/j.ejps.2013.04.031; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Walsh CL, 2013, BIOCONJUGATE CHEM, V24, P36, DOI 10.1021/bc300346h; Whitehead K, 2008, PHARM RES-DORDR, V25, P1782, DOI 10.1007/s11095-007-9488-9; Whitehead KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5277; Whitehead KA, 2012, ACS NANO, V6, P6922, DOI 10.1021/nn301922x; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]; Yonchevai K, 2008, J MICROENCAPSUL, V25, P82, DOI [10.1080/02652040701776083, 10.1080/02652040701776083 ]; Zhang YD, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/705238	48	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133154	10.1371/journal.pone.0133154	http://dx.doi.org/10.1371/journal.pone.0133154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192592	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400062
J	Chang, SH; Fang, KC; Zhang, KL; Wang, J				Chang, Suhua; Fang, Kechi; Zhang, Kunlin; Wang, Jing			Network-Based Analysis of Schizophrenia Genome-Wide Association Data to Detect the Joint Functional Association Signals	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; VARIANTS CONFERRING RISK; COMMON VARIANTS; BIPOLAR DISORDER; PATHWAY ANALYSIS; HAN CHINESE; GENETIC ASSOCIATION; SUSCEPTIBILITY; METAANALYSIS; PROVIDE	Schizophrenia is a common psychiatric disorder with high heritability and complex genetic architecture. Genome-wide association studies (GWAS) have identified several significant loci associated with schizophrenia. However, the explained heritability is still low. Growing evidence has shown schizophrenia is attributable to multiple genes with moderate effects. In-depth mining and integration of GWAS data is urgently expected to uncover disease-related gene combination patterns. Network-based analysis is a promising strategy to better interpret GWAS to identify disease-related network modules. We performed a network-based analysis on three independent schizophrenia GWASs by using a refined analysis framework, which included a more accurate gene P-value calculation, dynamic network module searching algorithm and detailed functional analysis for the obtained modules genes. The result generated 79 modules including 238 genes, which form a highly connected subnetwork with more statistical significance than expected by chance. The result validated several reported disease genes, such as MAD1L1, MCC, SDCCAG8, VAT1L, MAPK14, MYH9 and FXYD6, and also obtained several novel candidate genes and gene-gene interactions. Pathway enrichment analysis of the module genes suggested they were enriched in several neural and immune system related pathways/GO terms, such as neurotrophin signaling pathway, synaptosome, regulation of protein ubiquitination, and antigen processing and presentation. Further crosstalk analysis revealed these pathways/GO terms were cooperated with each other, and identified several important genes, which might play vital roles to connect these functions. Our network-based analysis of schizophrenia GWASs will facilitate the understanding of genetic mechanisms of schizophrenia.	[Chang, Suhua; Fang, Kechi; Zhang, Kunlin; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Wang, J (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangjing@psych.ac.cn	Chang, Suhua/AGZ-1921-2022		National Natural Science Foundation of China [NSFC] [31401139]; Strategic Priority Research Program (B) of Chinese Academy of Sciences [XDB02030002]; State Administration of Foreign Experts Affairs of Chinese Academy of Sciences (CAS/SAFEA) International Partnership Program for Creative Research Teams [Y2CX131003]	National Natural Science Foundation of China [NSFC](National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program (B) of Chinese Academy of Sciences; State Administration of Foreign Experts Affairs of Chinese Academy of Sciences (CAS/SAFEA) International Partnership Program for Creative Research Teams	This work was supported by the National Natural Science Foundation of China [NSFC, Grant No. 31401139], Strategic Priority Research Program (B) of the Chinese Academy of Sciences (Grant No. XDB02030002) and State Administration of Foreign Experts Affairs of Chinese Academy of Sciences (CAS/SAFEA) International Partnership Program for Creative Research Teams (Grant No. Y2CX131003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amagane H, 2010, SCHIZOPHR RES, V118, P106, DOI 10.1016/j.schres.2010.01.023; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bousman CA, 2010, AM J MED GENET B, V153B, P494, DOI 10.1002/ajmg.b.31006; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang SH, 2013, BIOL PSYCHIAT, V74, P727, DOI 10.1016/j.biopsych.2013.04.016; Choudhury K, 2007, AM J HUM GENET, V80, P664, DOI 10.1086/513475; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; DELAROSA EJ, 1994, NEUROSCIENCE, V58, P347, DOI 10.1016/0306-4522(94)90041-8; Efron B, 2010, J AM STAT ASSOC, V105, P1042, DOI 10.1198/jasa.2010.tm09129; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; He KJ, 2014, PROG NEURO-PSYCHOPH, V51, P34, DOI 10.1016/j.pnpbp.2013.12.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; INTERNATIONAL S, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; Jia PL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S15; Jia PL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002587; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khvotchev M, 2010, BIOL PSYCHIAT, V67, P197, DOI 10.1016/j.biopsych.2009.12.007; Kondo K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070964; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Luo X, 2013, SCHIZOPHRENIA BULLET, DOI [10.1093/schbultsbt066, DOI 10.1093/SCHBULTSBT066]; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Olsen L, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-39; Opal SM, 2005, INFECT IMMUN, V73, P5101, DOI 10.1128/IAI.73.8.5101-5105.2005; Pedroso I, 2012, BIOL PSYCHIAT, V72, P311, DOI 10.1016/j.biopsych.2011.12.031; Prabhu S, 2012, GENOME RES, V22, P2230, DOI 10.1101/gr.137885.112; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Rubio MD, 2013, NEUROPSYCHOPHARMACOL, V38, P1910, DOI 10.1038/npp.2013.84; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Yu H, 2014, J PSYCHIATR RES, V50, P73, DOI 10.1016/j.jpsychires.2013.11.014; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhang KL, 2011, CHINESE SCI BULL, V56, P3398, DOI 10.1007/s11434-011-4742-2	68	27	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133404	10.1371/journal.pone.0133404	http://dx.doi.org/10.1371/journal.pone.0133404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193471	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400079
J	Kerstjens, JM; Nijhuis, A; Hulzebos, CV; van Imhoff, DE; van Wassenaer-Leemhuis, AG; van Haastert, IC; Lopriore, E; Katgert, T; Swarte, RM; van Lingen, RA; Mulder, TL; Laarman, CR; Steiner, K; Dijk, PH				Kerstjens, Jorien M.; Nijhuis, Ard; Hulzebos, Christian V.; van Imhoff, Deirdre E.; van Wassenaer-Leemhuis, Aleid G.; van Haastert, Ingrid C.; Lopriore, Enrico; Katgert, Titia; Swarte, Renate M.; van Lingen, Richard A.; Mulder, Twan L.; Laarman, Celeste R.; Steiner, Katerina; Dijk, Peter H.			The Ages and Stages Questionnaire and Neurodevelopmental Impairment in Two-Year-Old Preterm-Born Children	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; RANDOMIZED CONTROLLED-TRIAL; BAYLEY-III SCALE; DEVELOPMENTAL DELAY; FOLLOW-UP; SURVEILLANCE; PREMATURE; VALIDITY; OUTCOMES; 2ND	Objective To test the ability of the Ages and Stages Questionnaire, Third Edition (ASQ3) to help identify or exclude neurodevelopmental impairment (NDI) in very preterm-born children at the corrected age of two. Methods We studied the test results of 224 children, born at <32 postmenstrual weeks, who had scores on ASQ3 and Bayley Scales of Infant and Toddler Development, Third Edition (BSIDIII) and neurological examination at 22-26 months' corrected age. We defined NDI as a score of <70 on the cognitive-or motor composite scale of BSIDIII, or impairment on neurological examination or audiovisual screening. We compared NDI with abnormal ASQ3 scores, i.e., < -2SDs on any domain, and with ASQ3 total scores. To correct for possible overestimation of BSIDIII, we also analyzed the adjusted BSIDIII thresholds for NDI, i.e., scores < 80 and <85. Results We found 61 (27%) children with abnormal ASQ3 scores, and 10 (4.5%) children who had NDI with original BSIDIII thresholds (<70). Twelve children had NDI at BSIDIII thresholds at <80, and 15 had <85. None of the 163 (73%) children who passed ASQ3 had NDI. The sensitivity of ASQ3 to detect NDI was excellent (100%), its specificity was acceptable (76%), and its negative predictive value (NPV) was 100%. Sensitivity and NPV remained high with the adjusted BSIDIII thresholds. Conclusion The Ages and Stages Questionnaire is a simple, valid and cost-effective screening tool to help identify and exclude NDI in very preterm-born children at the corrected age of two years.	[Kerstjens, Jorien M.; Nijhuis, Ard; Hulzebos, Christian V.; van Imhoff, Deirdre E.; Dijk, Peter H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat,Div Neonatol, Groningen, Netherlands; [van Wassenaer-Leemhuis, Aleid G.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Neonatol, NL-1105 AZ Amsterdam, Netherlands; [van Haastert, Ingrid C.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Lopriore, Enrico] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands; [Katgert, Titia] Maxima Med Ctr, Dept Med Psychol, Veldhoven, Netherlands; [Swarte, Renate M.] Erasmus MC Sophia, Dept Neonatol, Rotterdam, Netherlands; [van Lingen, Richard A.] Isala, Princess Amalia Dept Pediat, Dept Neonatol, Zwolle, Netherlands; [Mulder, Twan L.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pediat, Maastricht, Netherlands; [Laarman, Celeste R.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Div Neonatol, Amsterdam, Netherlands; [Steiner, Katerina] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Pediat, Div Neonatol, NL-6525 ED Nijmegen, Netherlands	University of Groningen; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maxima Medical Center; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Vrije Universiteit Amsterdam; Radboud University Nijmegen	Dijk, PH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat,Div Neonatol, Groningen, Netherlands.	p.h.dijk@umcg.nl	Lopriore, Enrico/ABE-3576-2021; Mulder, Antonius/AAJ-5935-2021; Hulzebos, Christian Victor/AAY-6803-2021; Steiner, K./L-4672-2015	Lopriore, Enrico/0000-0002-3513-5066; Mulder, Antonius/0000-0001-8625-4359; Hulzebos, Christian Victor/0000-0002-8159-7501; 	Netherlands Organization for Health Research and Development (ZonMw) Cost-Effectiveness Program [94507407]	Netherlands Organization for Health Research and Development (ZonMw) Cost-Effectiveness Program	This work was funded by The Netherlands Organization for Health Research and Development (ZonMw) Cost-Effectiveness Program: 94507407. The authors received no other specific funding for this work.	Acton BV, 2011, PEDIATRICS, V128, pE794, DOI 10.1542/peds.2011-0331; Adams-Chapman I, 2013, J PEDIATR-US, V163, P961, DOI 10.1016/j.jpeds.2013.04.034; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; [Anonymous], 2006, BAYLEY SCALES INFANT; [Anonymous], BAYLEY SCALES INFANT; Bayley N, 1993, BAYLEY SCALES INFANT; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; Gollenberg AL, 2010, CHILD CARE HLTH DEV, V36, P485, DOI 10.1111/j.1365-2214.2009.01041.x; Harcourt Assessment Inc, 2007, 2 HARC ASS INC; Hulzebos CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099466; Jary S, 2011, J PEDIATR-US, V159, P211, DOI 10.1016/j.jpeds.2011.01.037; Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10; KLOOSTERMAN GJ, 1970, INT J GYNECOL OBSTET, V8, P895, DOI DOI 10.1002/J.1879-3479.1970.TB00313.X; Limbos MM, 2011, J DEV BEHAV PEDIATR, V32, P499, DOI 10.1097/DBP.0b013e31822552e9; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Morris C, 2004, DEV MED CHILD NEUROL, V46, P60, DOI 10.1017/S0012162204000118; Msall ME, 2010, J PEDIATR-US, V157, P863, DOI 10.1016/j.jpeds.2010.09.022; Nordhov SM, 2012, PEDIATRICS, V129, pE9, DOI 10.1542/peds.2011-0248; Nordhov SM, 2010, PEDIATRICS, V126, pE1088, DOI 10.1542/peds.2010-0778; Schonhaut L, 2013, PEDIATRICS, V131, pE1468, DOI 10.1542/peds.2012-3313; Silveira RC, 2012, ARCH PEDIAT ADOLESC, V24, P1; Skellern CY, 2001, J PAEDIATR CHILD H, V37, P125, DOI 10.1046/j.1440-1754.2001.00604.x; Squire J, 2009, ASQ 3 USER S GUIDE; Stark AR, 2013, J PEDIAT; Touwen BCL, 1984, NEUROLOGISCHE ONTWIK; van Imhoff DE, 2011, EARLY HUM DEV, V87, P521, DOI 10.1016/j.earlhumdev.2011.04.004; van Wyk L, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2012.02.003, DOI 10.1016/J.AJOG.2012.02.003]; Vandborg PK, 2012, PEDIATRICS, V130, P61, DOI 10.1542/peds.2011-2760; Woodward BJ, 2011, J PERINATOL, V31, P641, DOI 10.1038/jp.2011.1	32	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133087	10.1371/journal.pone.0133087	http://dx.doi.org/10.1371/journal.pone.0133087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193474	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400055
J	Liu, X; Ma, XR; Lei, ZG; Feng, H; Wang, SSS; Cen, X; Gao, SY; Jiang, YP; Jiang, J; Chen, QM; Tang, YJ; Tang, YL; Liang, XH				Liu, Xin; Ma, Xiangrui; Lei, Zhengge; Feng, Hao; Wang, Shasha; Cen, Xiao; Gao, Shiyu; Jiang, Yaping; Jiang, Jian; Chen, Qianming; Tang, Yajie; Tang, Yaling; Liang, Xinhua			Chronic Inflammation-Related HPV: A Driving Force Speeds Oropharyngeal Carcinogenesis	PLOS ONE			English	Article							IMMATURE MYELOID CELLS; HUMAN-PAPILLOMAVIRUS INFECTION; COLONY-STIMULATING FACTOR; NF-KAPPA-B; TNF-ALPHA; TGF-BETA; CANCER; ASSOCIATION; CARCINOMA; SURVIVAL	Oropharyngeal squamous cell carcinoma (OPSCC) has been known to be a highly aggressive disease associated with human papilloma virus (HPV) infection. To investigate the relationship between HPV and chronic inflammation in oropharyngeal carcinogenesis, we collected 140 oral mucous fresh specimens including 50 OPSCC patients, 50 cancer in situ, 30 precancerous lesions, and 10 normal oral mucous. Our data demonstrated that there was a significantly higher proportion of severe chronic inflammation in dysplastic epithelia in comparison with that in normal tissues (P<0.001). The positive rate of HPV 16 was parallel with the chronic inflammation degrees from mild to severe inflammation (P<0.05). The positive rate of HPV 16 was progressively improved with the malignant progression of oral mucous (P<0.05). In addition, CD11b+ LIN-HLA-DR-CD33+ MDSCs were a critical cell population that mediates inflammation response and immune suppression in HPV-positive OPSCC. These indicated that persistent chronic inflammation-related HPV infection might drive oropharyngeal carcinogenesis and MDSCs might pay an important role during this process. Thus, a combination of HPV infection and inflammation expression might become a helpful biomedical marker to predict oropharyngeal carcinogenesis.	[Liu, Xin; Ma, Xiangrui; Lei, Zhengge; Feng, Hao; Wang, Shasha; Cen, Xiao; Gao, Shiyu; Jiang, Yaping; Jiang, Jian; Chen, Qianming; Tang, Yaling; Liang, Xinhua] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Tang, Yajie] Hubei Univ Technol, Key Lab Fermentat Engn, Minist Educ, Wuhan, Peoples R China; [Tang, Yaling] Sichuan Univ, West China Hosp Stomatol, Dept Oral Pathol, Chengdu 610064, Peoples R China; [Liang, Xinhua] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu 610064, Peoples R China	Sichuan University; Hubei University of Technology; Sichuan University; Sichuan University	Tang, YL (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	tangyaling@scu.edu.cn; lxh88866@scu.edu.cn	Tang, Ya-Jie/M-2538-2016; ma, xiangrui xiangrui/GSN-6533-2022	ma, xiangrui xiangrui/0000-0003-2756-8774; Cen, Xiao/0000-0002-3959-1608	National Natural Science Foundation of China [81361120399, 81321002, 81272961, 81372891]; State Key Laboratory of Oral Diseases Special Funded Projects [SKLOD201512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oral Diseases Special Funded Projects	This work was supported by National Natural Science Foundation of China grants (Nos. 81361120399, 81321002, 81272961, and 81372891) and by State Key Laboratory of Oral Diseases Special Funded Projects (SKLOD201512).	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bronte V, 1999, J IMMUNOL, V162, P5728; Bronte V, 2001, J IMMUNOTHER, V24, P431, DOI 10.1097/00002371-200111000-00001; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Cecco L, 2015, ONCOTARGET; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Farhan-Alanie OM, 2015, BRIT J ORAL MAX SURG, V53, P126, DOI 10.1016/j.bjoms.2014.10.007; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Han Y W, 2014, Adv Dent Res, V26, P47, DOI 10.1177/0022034514528334; Hawes SE, 2002, J NATL CANCER I, V94, P1592; Hormia M, 2005, J PERIODONTOL, V76, P358, DOI 10.1902/jop.2005.76.3.358; Huh WK, 2009, OBSTET GYNECOL, V114, P139, DOI 10.1097/AOG.0b013e3181ab6878; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Jin L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-80; Jones KB, 2013, INT J ORAL SCI, V5, P121, DOI 10.1038/ijos.2013.46; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Li W, 2003, INT J CANCER, V106, P553, DOI 10.1002/ijc.11261; Li Y, 2015, INT J ORAL SCI, V7, P161, DOI 10.1038/ijos.2015.5; Li YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118391; Liang XH, 2011, ORAL ONCOL, V47, P92, DOI 10.1016/j.oraloncology.2010.11.014; Lin RH, 2015, ONCOTARGET, V6, P2856, DOI 10.18632/oncotarget.3091; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mellin H, 2002, INT J CANCER, V102, P152, DOI 10.1002/ijc.10669; Mroz EA, 2011, J CLIN ONCOL, V29, P4222, DOI 10.1200/JCO.2011.37.8893; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Rubin DT, 2013, CLIN GASTROENTEROL H, V11, P1601, DOI 10.1016/j.cgh.2013.06.023; Samoff E, 2005, AM J EPIDEMIOL, V162, P668, DOI 10.1093/aje/kwi262; Schafer G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-185; Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979; Schwebke JR, 1997, GENITOURIN MED, V73, P383; Scott ME, 2009, INT J CANCER, V124, P1379, DOI 10.1002/ijc.24117; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Singh PK, 2015, CANCER BIOMARK, V15, P125, DOI 10.3233/CBM-140444; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Tezal M, 2012, ARCH OTOLARYNGOL, V138, P669, DOI 10.1001/archoto.2012.873; Thamphiwatana S, 2014, P NATL ACAD SCI USA, V111, P17600, DOI 10.1073/pnas.1418230111; Warif NMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127155; Williams D A, 2001, J Natl Cancer Inst Monogr, P26; Woodford D, 2014, J CLIN CELL IMMUNOL, V5; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Young MRI, 1997, INT J CANCER, V74, P69, DOI 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D	55	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133681	10.1371/journal.pone.0133681	http://dx.doi.org/10.1371/journal.pone.0133681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193368	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400114
J	Sankar, S; Upadhyay, M; Ramamurthy, M; Vadivel, K; Sagadevan, K; Nandagopal, B; Vivekanandan, P; Sridharan, G				Sankar, Sathish; Upadhyay, Mohita; Ramamurthy, Mageshbabu; Vadivel, Kumaran; Sagadevan, Kalaiselvan; Nandagopal, Balaji; Vivekanandan, Perumal; Sridharan, Gopalan			Novel Insights on Hantavirus Evolution: The Dichotomy in Evolutionary Pressures Acting on Different Hantavirus Segments	PLOS ONE			English	Article							DINUCLEOTIDE FREQUENCIES; NUCLEOCAPSID PROTEIN; MOLECULAR EVOLUTION; PUUMALA HANTAVIRUS; EFFECTIVE NUMBER; VIRUS EVOLUTION; DNA METHYLATION; RNA VIRUSES; CODON USAGE; CPG	Background Hantaviruses are important emerging zoonotic pathogens. The current understanding of hantavirus evolution is complicated by the lack of consensus on co-divergence of hantaviruses with their animal hosts. In addition, hantaviruses have long-term associations with their reservoir hosts. Analyzing the relative abundance of dinucleotides may shed new light on hantavirus evolution. We studied the relative abundance of dinucleotides and the evolutionary pressures shaping different hantavirus segments. Methods A total of 118 sequences were analyzed; this includes 51 sequences of the S segment, 43 sequences of the M segment and 23 sequences of the L segment. The relative abundance of dinucleotides, effective codon number (ENC), codon usage biases were analyzed. Standard methods were used to investigate the relative roles of mutational pressure and translational selection on the three hantavirus segments. Results All three segments of hantaviruses are CpG depleted. Mutational pressure is the predominant evolutionary force leading to CpG depletion among hantaviruses. Interestingly, the S segment of hantaviruses is GpU depleted and in contrast to CpG depletion, the depletion of GpU dinucleotides from the S segment is driven by translational selection. Our findings also suggest that mutational pressure is the primary evolutionary pressure acting on the S and the M segments of hantaviruses. While translational selection plays a key role in shaping the evolution of the L segment. Our findings highlight how different evolutionary pressures may contribute disproportionally to the evolution of the three hantavirus segments. These findings provide new insights on the current understanding of hantavirus evolution. Conclusions There is a dichotomy among evolutionary pressures shaping a) the relative abundance of different dinucleotides in hantavirus genomes b) the evolution of the three hantavirus segments.	[Sankar, Sathish; Ramamurthy, Mageshbabu; Vadivel, Kumaran; Sagadevan, Kalaiselvan; Nandagopal, Balaji; Sridharan, Gopalan] Sri Narayani Hosp & Res Ctr, Sri Sakthi Amma Inst Biomed Res, Vellore 632055, Tamil Nadu, India; [Upadhyay, Mohita; Vivekanandan, Perumal] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Vivekanandan, P (corresponding author), Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi 110016, India.	vperumal@bioschool.iitd.ac.in	Sankar, Sathish/E-8348-2011	Sankar, Sathish/0000-0002-9389-5231	Division of Biomedical Research of Sri Narayani Hospital and Research Center	Division of Biomedical Research of Sri Narayani Hospital and Research Center	This work was supported by the Division of Biomedical Research of Sri Narayani Hospital and Research Center.	Arai S, 2012, VIROLOGY, V424, P99, DOI 10.1016/j.virol.2011.11.013; Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Bennett SN, 2014, TRENDS MICROBIOL, V22, P473, DOI 10.1016/j.tim.2014.04.008; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Chinnery HR, 2012, AM J PATHOL, V180, P209, DOI 10.1016/j.ajpath.2011.09.041; Duret L, 2000, MOL BIOL EVOL, V17, P1620, DOI 10.1093/oxfordjournals.molbev.a026261; Escutenaire S, 2001, VIRUS RES, V74, P1, DOI 10.1016/S0168-1702(00)00224-0; Fuglsang A, 2004, BIOCHEM BIOPH RES CO, V317, P957, DOI 10.1016/j.bbrc.2004.03.138; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; GRIOT C, 1993, ANNU REV MICROBIOL, V47, P117, DOI 10.1146/annurev.mi.47.100193.001001; Gu SH, 2013, INFECT GENET EVOL, V20, P118, DOI 10.1016/j.meegid.2013.08.016; Guo WP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003159; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hughes AL, 2000, MOL BIOL EVOL, V17, P1558, DOI 10.1093/oxfordjournals.molbev.a026254; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; JONAS E, 1985, P NATL ACAD SCI USA, V82, P5413, DOI 10.1073/pnas.82.16.5413; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kang HJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-373; Kang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006149; Kaukinen P, 2005, ARCH VIROL, V150, P1693, DOI 10.1007/s00705-005-0555-4; Lednicky JA, 2003, ARCH PATHOL LAB MED, V127, P30; Lee BH, 2003, VIRUS RES, V98, P83, DOI 10.1016/j.virusres.2003.09.001; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Nemirov K, 2003, J VIROL, V77, P8793, DOI 10.1128/JVI.77.16.8793-8800.2003; Nikaido M, 2001, J MOL EVOL, V53, P508, DOI 10.1007/s002390010241; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Plyusnin A, 1996, J GEN VIROL, V77, P2677, DOI 10.1099/0022-1317-77-11-2677; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Ramsden C, 2008, MOL BIOL EVOL, V25, P1488, DOI 10.1093/molbev/msn093; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; Simmonds P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-610; Souza WM, 2014, INFECT GENET EVOL, V21, P198, DOI 10.1016/j.meegid.2013.11.015; Upadhyay M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111793; Upadhyay M, 2013, J VIROL, V87, P13816, DOI 10.1128/JVI.02515-13; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470	45	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133407	10.1371/journal.pone.0133407	http://dx.doi.org/10.1371/journal.pone.0133407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193652	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400080
J	Awad, AS; You, HN; Gao, T; Gvritishvili, A; Cooper, TK; Tombran-Tink, J				Awad, Alaa S.; You, Hanning; Gao, Ting; Gvritishvili, Anzor; Cooper, Timothy K.; Tombran-Tink, Joyce			Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EXPRESSION; RECEPTOR; NEPHROPATHY; IDENTIFICATION; INFLAMMATION; MACROPHAGES; ACTIVATION; PODOCYTES; INCREASE	Our recent publication showed that a small bioactive pigment epithelium derived factor (PEDF) peptide (P78-PEDF) prevents the development of diabetic nephropathy (DN). However, its effects on the progression of established DN were not clear. Therefore, the purpose of this study was to determine the effect of P78-PEDF in the progression of DN and to compare the effects of P78-PEDF and an ACE inhibitor (ACEi), a standard of care in DN. Experiments were conducted in Ins2(Akita) mice treated with P78-PEDF or captopril starting at 6 wks of age for 12 wks (early treatment) or starting at 12 wks of age for 6 wks (late treatment). We first established the optimal dose of the P78-PEDF peptide to ameliorate DN in Ins2(Akita) mouse for a 6 wk study period and found that the peptide was effective at 0.1-0.5 mu g/g/day. We next showed that early or late treatment with P78-PEDF resulted in protection from DN as indicated by reduced albuminuria, kidney macrophage recruitment, histological changes, inflammatory cytokines and fibrotic markers (kidney TNF-alpha, fibronectin, VEGFA and EGFR), and restored nephrin expression compared with vehicle-treated Ins2(Akita) mice. Interestingly, only early but not late treatment with captopril was as effective as P78-PEDF in reducing most DN complications, despite its lack of effect on nephrin, VEGFA and EGFR expression. These findings highlight the importance of P78-PEDF peptide as a potential therapeutic modality in both the development and progression of diabetic renal injury.	[Awad, Alaa S.; You, Hanning; Gao, Ting] Penn State Univ, Coll Med, Dept Med, Div Nephrol, Hershey, PA 17033 USA; [Gvritishvili, Anzor; Tombran-Tink, Joyce] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Cooper, Timothy K.] Penn State Univ, Coll Med, Dept Comparat Med, Hershey, PA USA; [Tombran-Tink, Joyce] Penn State Univ, Coll Med, Dept Ophthalmol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Awad, AS (corresponding author), Penn State Univ, Coll Med, Dept Med, Div Nephrol, Hershey, PA 17033 USA.	asa17@psu.edu			NIH [DK094930, DK094930S1]; Novo Nordisk; JDRF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009493, R01DK094930] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk(Novo Nordisk); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH Grants DK094930 and DK094930S1, and grants from Novo Nordisk and JDRF. The PI only received grant money from Novo Nordisk to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman EM, 2012, J GEN INTERN MED, V27, P458, DOI 10.1007/s11606-011-1912-5; Awad AS, 2013, AM J PHYSIOL-RENAL, V305, pF891, DOI 10.1152/ajprenal.00149.2013; Awad AS, 2011, AM J PHYSIOL-RENAL, V301, pF1358, DOI 10.1152/ajprenal.00332.2011; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; BREYER MD, 1990, AM J PHYSIOL, V259, pF553, DOI 10.1152/ajprenal.1990.259.4.F553; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chen HB, 2010, AM J NEPHROL, V32, P47, DOI 10.1159/000314326; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Gattu AK, 2014, ENDOCRINOLOGY, V155, P1373, DOI 10.1210/en.2013-1785; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; HARRIS RC, 1988, J CLIN INVEST, V82, P1028, DOI 10.1172/JCI113659; Kalantarinia K, 2003, KIDNEY INT, V64, P1208, DOI 10.1046/j.1523-1755.2003.00237.x; Li H, 2006, EXP EYE RES, V83, P824, DOI 10.1016/j.exer.2006.04.014; Liu E, 2007, J AM SOC NEPHROL, V18, P2094, DOI 10.1681/ASN.2006010075; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; Liu YL, 2012, MOL MED, V18, P1387, DOI 10.2119/molmed.2012.00008; Morris SM, 2011, DIABETES, V60, P3015, DOI 10.2337/db11-0901; Motomiya Y, 2006, CLIN CHEM, V52, P1970, DOI 10.1373/clinchem.2006.073171; Nakamura K, 2010, INT J CARDIOL, V143, P96, DOI 10.1016/j.ijcard.2008.11.169; NAKAMURA T, 1993, CLIN IMMUNOL IMMUNOP, V66, P33, DOI 10.1006/clin.1993.1005; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Pina AL, 2007, CELL TISSUE RES, V329, P329, DOI 10.1007/s00441-007-0420-8; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; Tombran-Tink J, 2003, TRENDS MOL MED, V9, P244, DOI 10.1016/S1471-4914(03)00074-1; Tombran-Tink J, 2010, CURR MOL MED, V10, P267, DOI 10.2174/156652410791065336; Veron D, 2011, DIABETOLOGIA, V54, P1227, DOI 10.1007/s00125-010-2034-z; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wang JJ, 2005, DIABETES, V54, P243, DOI 10.2337/diabetes.54.1.243; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; You H, 2013, KIDNEY INT, DOI [10.1038/ki2013.215, DOI 10.1038/KI2013.215]; You HN, 2013, AM J PHYSIOL-RENAL, V305, pF1719, DOI 10.1152/ajprenal.00141.2013; You HN, 2013, KIDNEY INT, V84, P1189, DOI 10.1038/ki.2013.215; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279	37	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133777	10.1371/journal.pone.0133777	http://dx.doi.org/10.1371/journal.pone.0133777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207369	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000138
J	Huang, PC; Tsai, CH; Liang, WY; Li, SS; Pan, WH; Chiang, HC				Huang, Po-Chin; Tsai, Chih-Hsin; Liang, Wei-Yen; Li, Sih-Syuan; Pan, Wen-Harn; Chiang, Hung-Che			Age and Gender Differences in Urinary Levels of Eleven Phthalate Metabolites in General Taiwanese Population after a DEHP Episode	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; EXPOSURE; CHILDREN; ASSOCIATION; ADOLESCENTS; HORMONES; SAMPLES; ADULTS; RISK	Introduction In 2011, the Taiwan FDA disclosed illegal di(2-ethylhexyl phthalate) (DEHP) and dibutyl phthalate (DBP) use in beverage and nutrition supplements. We aim to determine phthalate exposure and other relevant factors in a sample of the general Taiwanese population in order to evaluate actual phthalate exposure levels after this disclosure of DEHP use. Method We selected subjects aged 7 years old and older in 2013 from the general Taiwanese population. First morning urine samples from each participant were collected to analyze 11 phthalate metabolites representing 7 parent phthalates using on-line liquid chromatography/tandem mass spectrometry. An interview questionnaire was applied to obtain participant demographic characteristics, lifestyle, and other relevant factors. Results The median levels of metabolites of DEHP, including mono-ethylhexyl phthalate (MEHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP), DBP (DnBP and DiBP), including mono-n-butyl phthalate (MnBP) and mono-iso-butyl phthalate (MiBP), and monoethyl phthalate (MEP) in urine samples of 290 adults/97 minors (<18 years) were 7.9/6.1, 12.6/17.8, 22.0/25.8, 25.4/30.8, 18.1/23.6, 9.4/13.6 and 14.5/12.4 mu g/g creatinine, respectively. Women (. 18 years) were exposed to significantly higher levels of MEHHP (P=0.011), MECPP (P=0.01), MnBP (P=0.001) and MEP (P<0.001) than men (>= 18 years), whereas no gender difference was observed in minors. We found significant higher level of MEP (creatinine-unadjusted) in subject aged between 18 to 40 years old (P<0.001), especially for women. Exposure levels of MEOHP (P<0.001), MECPP (P=0.002) and MnBP (P=0.044) in minors were significantly higher than those of adults. High frequency usage of food preservation film and bags, and personal care products are potential sources of phthalates exposure in general Taiwanese. Conclusion Our findings indicated that DEHP and DBP exposure in a sample of the general Taiwanese population varied by age and gender, possibly affected by different lifestyles, and continuing bio-monitoring surveillance is warranted.	[Huang, Po-Chin; Tsai, Chih-Hsin; Liang, Wei-Yen; Li, Sih-Syuan; Chiang, Hung-Che] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Natl Environm Hlth Res Ctr, Miaoli, Taiwan; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan; [Chiang, Hung-Che] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Div Environm Hlth & Occupat Med, Miaoli, Taiwan	National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	pan@ibms.sinica.edu.tw; hcchiang@nhri.org.tw	Pan, Wen-Harn/F-9972-2010	Pan, Wen-Harn/0000-0001-9136-0658; Huang, Po-Chin/0000-0002-9243-0838	National Health Research Institutes [102-EH-PP05, 103-EH-PP05, 104-EH-PP05]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	Support was provided by National Health Research Institutes grant, 102-EH-PP05, 103-EH-PP05, 104-EH-PP05 [http://nehrc.nhri.org.tw/toxic/project_research_en.php]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122140; Bao J, 2015, ARCH ENVIRON CON TOX, V69, P202, DOI 10.1007/s00244-015-0146-7; Becker K, 2014, INT J HYG ENVIR HEAL, V217, P312, DOI 10.1016/j.ijheh.2013.07.004; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316; CDC, 2012, 4 CDC; Chen CY, 2015, SCI TOTAL ENVIRON, V517, P125, DOI 10.1016/j.scitotenv.2015.02.021; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Dewalque L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/649314; Frederiksen H, 2014, REPRODUCTION, V147, P555, DOI 10.1530/REP-13-0522; Ha M, 2014, INT J HYG ENVIR HEAL, V217, P260, DOI 10.1016/j.ijheh.2013.06.001; Huang PC, 2012, INT SOC EXP SCI C P; Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205; Huang PC, 2014, ENVIRON SCI POLLUT R, V21, P13964, DOI 10.1007/s11356-014-3260-6; Huang PC, 2012, J FOOD DRUG ANAL, V20, P719, DOI 10.6227/jfda.2012200401; Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Kobrosly RW, 2014, ENVIRON HEALTH PERSP, V122, P521, DOI 10.1289/ehp.1307063; Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7; Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009; Ku HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123309; Li JH, 2012, KAOHSIUNG J MED SCI, V28, pS17, DOI 10.1016/j.kjms.2012.05.005; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Mendiola J, 2012, J ANDROL, V33, P488, DOI 10.2164/jandrol.111.013557; Pan WH, 2011, ASIA PAC J CLIN NUTR, V20, P238; Parlett LE, 2013, J EXPO SCI ENV EPID, V23, P197, DOI 10.1038/jes.2012.105; Philippat C, 2015, ENVIRON RES, V140, P369, DOI 10.1016/j.envres.2015.04.009; Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x; Saravanabhavan G, 2013, INT J HYG ENVIR HEAL, V216, P652, DOI 10.1016/j.ijheh.2012.12.009; Sathyanarayana S, 2014, REPRODUCTION, V147, P401, DOI 10.1530/REP-13-0415; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Schindler BK, 2014, INT J HYG ENVIR HEAL, V217, P653, DOI 10.1016/j.ijheh.2013.12.002; Schutze A, 2014, INT J HYG ENVIR HEAL, V217, P421, DOI 10.1016/j.ijheh.2013.08.004; Schulz C, 2011, INT J HYG ENVIR HEAL, V215, P26, DOI 10.1016/j.ijheh.2011.06.007; Smerieri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117831; Swan SH, 2015, HUM REPROD, V30, P963, DOI 10.1093/humrep/deu363; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; Toft G, 2012, ENVIRON HEALTH PERSP, V120, P458, DOI 10.1289/ehp.1103552; Wang IJ, 2014, ENVIRON INT, V62, P48, DOI 10.1016/j.envint.2013.09.002; Wu MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055005, 10.1371/journal.pone.0055044]; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104852; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	46	58	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133782	10.1371/journal.pone.0133782	http://dx.doi.org/10.1371/journal.pone.0133782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207744	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000140
J	Hurren, B; Collins, JJP; Duxson, MJ; Deries, M				Hurren, Bradley; Collins, Jennifer J. P.; Duxson, Marilyn J.; Deries, Marianne			First Neuromuscular Contact Correlates with Onset of Primary Myogenesis in Rat and Mouse Limb Muscles	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; SKELETAL-MUSCLE; CHICK HINDLIMB; PROJECTION PATTERNS; PATHWAY SELECTION; VERTEBRATE LIMB; SOLEUS MUSCLE; SPINAL-CORD; INNERVATION; DIFFERENTIATION	Skeletal muscle development has been the focus of intensive study for many decades. Recent advances in genetic manipulation of the mouse have increased our understanding of the cell signalling involved in the development of muscle progenitors which give rise to adult skeletal muscles and their stem cell populations. However, the influence of a vital tissue type - the peripheral nerve-has largely been ignored since its earliest descriptions. Here we carefully describe the timing in which myogenic progenitors expressing Pax3 and Pax7 (the earliest markers of myogenic cells) enter the limb buds of rat and mouse embryos, as well as the spatiotemporal relationship between these progenitors and the ingrowing peripheral nerve. We show that progenitors expressing Pax3 enter the limb bud one full day ahead of the first neurites and that Pax7-expressing progenitors (associated with secondary myogenesis in the limb) are first seen in the limb bud at the time of nerve entry and in close proximity to the nerve. The initial entry of the nerve also coincides with the first expression of myosin heavy chain showing that the first contact between nerves and myogenic cells correlates with the onset of myogenic differentiation. Furthermore, as the nerve grows into the limb, Pax3 expression is progressively replaced by Pax7 expression in myogenic progenitors. These findings indicate that the ingrowing nerve enters the limb presumptive muscle masses earlier than what was generally described and raises the possibility that nerve may influence the differentiation of muscle progenitors in rodent limbs.	[Hurren, Bradley; Duxson, Marilyn J.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Collins, Jennifer J. P.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Deries, Marianne] Univ Lisbon, Fac Ciencias, Ctr Evol Ecol & Alteracoes Ambientais, Lisbon, Portugal	University of Otago; University of Ottawa; Ottawa Hospital Research Institute; Universidade de Lisboa	Deries, M (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Evol Ecol & Alteracoes Ambientais, Lisbon, Portugal.	mederies@fc.ul.pt		Collins, Jennifer/0000-0002-7556-0526	Department of Anatomy, University of Otago; Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH / BPD / 65370 / 2009]	Department of Anatomy, University of Otago; Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	This work was funded by the postgraduate student funding from the Department of Anatomy, University of Otago. MD holds a post doc grant SFRH / BPD / 65370 / 2009 from Fundacao para a Ciencia e a Tecnologia (Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; ASHBY PR, 1993, DEV BIOL, V156, P519, DOI 10.1006/dbio.1993.1098; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Bardeen Charles R., 1900, JOHNS HOPKINS HOSP R, V9, P367; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; BRAITHWAITE AW, 1979, NATURE, V279, P549, DOI 10.1038/279549a0; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Burden SJ, 2002, J NEUROBIOL, V53, P501, DOI 10.1002/neu.10137; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; CAMERON J, 1982, J ANAT, V134, P795; COHEN SA, 1980, P NATL ACAD SCI-BIOL, V77, P644, DOI 10.1073/pnas.77.1.644; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6; Deries M, 2008, EVOL DEV, V10, P746, DOI 10.1111/j.1525-142X.2008.00289.x; ENTWISTLE A, 1988, J CELL BIOL, V106, P1703, DOI 10.1083/jcb.106.5.1703; Florini JR, 1996, J BIOL CHEM, V271, P12699, DOI 10.1074/jbc.271.22.12699; FREDETTE BJ, 1991, DEV BIOL, V143, P19, DOI 10.1016/0012-1606(91)90051-4; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HARRIS AJ, 1981, PHILOS T ROY SOC B, V293, P257, DOI 10.1098/rstb.1981.0076; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; HOLLYDAY M, 1995, J COMP NEUROL, V357, P242, DOI 10.1002/cne.903570205; Hollyday M, 1983, DEV REGENERATION A, P183; HUGHES DS, 1992, DEV DYNAM, V193, P164, DOI 10.1002/aja.1001930208; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Kardon G, 2002, DEV CELL, V3, P533, DOI 10.1016/S1534-5807(02)00291-5; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kardon G, 2011, DEVELOPMENT, V138, P2855, DOI 10.1242/dev.067181; Kim DG, 1999, J BIOL CHEM, V274, P15395, DOI 10.1074/jbc.274.22.15395; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P559; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LANDMESSER L, 1986, DEV BIOL, V118, P511, DOI 10.1016/0012-1606(86)90023-0; LANDMESSER L, 1975, J PHYSIOL-LONDON, V249, P301, DOI 10.1113/jphysiol.1975.sp011017; Lee ASJ, 2013, DEV DYNAM, V242, P1043, DOI 10.1002/dvdy.23998; Lewis WH, 1902, AM J ANAT, V1, P145, DOI 10.1002/aja.1000010204; Luria V, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-13; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; MCLENNAN IS, 1983, DEV BIOL, V98, P287, DOI 10.1016/0012-1606(83)90359-7; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; ONTELL M, 1988, AM J ANAT, V181, P267, DOI 10.1002/aja.1001810305; ONTELL M, 1984, AM J ANAT, V171, P149, DOI 10.1002/aja.1001710203; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; POURQUIE O, 1993, P NATL ACAD SCI USA, V90, P5242, DOI 10.1073/pnas.90.11.5242; Pownall ME, 1996, DEVELOPMENT, V122, P1475; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; REYNOLDS ML, 1991, NEUROSCIENCE, V41, P201, DOI 10.1016/0306-4522(91)90210-F; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; VALLETTE FM, 1987, DEV BIOL, V120, P77, DOI 10.1016/0012-1606(87)90105-9; Van Ho AT, 2011, DEV CELL, V21, P273, DOI 10.1016/j.devcel.2011.06.019; VRBOVA G, 1963, J PHYSIOL-LONDON, V169, P513, DOI 10.1113/jphysiol.1963.sp007276; Wang GY, 2000, J NEUROSCI, V20, P5358, DOI 10.1523/JNEUROSCI.20-14-05358.2000; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	60	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133811	10.1371/journal.pone.0133811	http://dx.doi.org/10.1371/journal.pone.0133811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207754	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000150
J	Ma, YY; Liu, Y; Song, HM; Sun, JY; Lei, Y; Wang, YC				Ma, Yongyong; Liu, Yu; Song, Huiming; Sun, Junyan; Lei, Ying; Wang, Yanchao			A Standardized Precipitation Evapotranspiration Index Reconstruction in the Taihe Mountains Using Tree-Ring Widths for the Last 283 Years	PLOS ONE			English	Article							DROUGHT RECONSTRUCTION; INNER-MONGOLIA; CHINA; VARIABILITY; PACIFIC; DATASET; RECORDS; GROWTH; 1920S	Tree-ring samples from Chinese Pine (Pinus tabulaeformis Carr.) that were collected in the Taihe Mountains on the western Loess Plateau, China, were used to analyze the effects of climate and drought on radial growth and to reconstruct the mean April-June Standardized Precipitation Evapotranspiration Index (SPEI) during the period 1730-2012 AD. Precipitation positively affected tree growth primarily during wet seasons, while temperature negatively affected tree growth during dry seasons. Tree growth responded positively to SPEI at long time scales most likely because the trees were able to withstand water deficits but lacked a rapid response to drought. The 10-month scale SPEI was chosen for further drought reconstruction. A calibration model for the period 1951-2011 explained 51% of the variance in the modeled SPEI data. Our SPEI reconstruction revealed long-term patterns of drought variability and captured some significant drought events, including the severe drought of 1928-1930 and the clear drying trend since the 1950s which were widespread across northern China. The reconstruction was also consistent with two other reconstructions on the western Loess Plateau at both interannual and decadal scales. The reconstructed SPEI series showed synchronous variations with the drought/wetness indices and spatial correlation analyses indicated that this reconstruction could be representative of large-scale SPEI variability in northern China. Period analysis discovered 128-year, 25-year, 2.62-year, 2.36-year, and 2.04-year cycles in this reconstruction. The time-dependency of the growth response to drought should be considered in further studies of the community dynamics. The SPEI reconstruction improves the sparse network of long-term climate records for an enhanced understanding of climatic variability on the western Loess Plateau, China.	[Ma, Yongyong; Liu, Yu; Song, Huiming; Sun, Junyan; Lei, Ying] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710061, Peoples R China; [Ma, Yongyong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Liu, Yu; Song, Huiming] Beijing Normal Univ, Joint Ctr Global Change Studies, Beijing 100875, Peoples R China; [Wang, Yanchao] Xingtai Univ, Dept Geog, Xingtai 054001, Peoples R China	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Normal University; Xingtai University	Liu, Y (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710061, Peoples R China.	liuyu@loess.llqg.ac.cn	Wang, Yanchao/GZH-3084-2022; Wang, Yanchao/V-9700-2019; Liu, Yu/AAA-6165-2019	Wang, Yanchao/0000-0003-3316-0177; liu, yu/0000-0002-1402-0737	National Basic Research Program of China [2013CB955900]; Chinese Academy of Sciences [KZZD-EW-04-01]; Project of State Key Laboratory of Loess and Quaternary Geology Institute of Earth Environment, CAS [SKLLQG1314]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Project of State Key Laboratory of Loess and Quaternary Geology Institute of Earth Environment, CAS	This study was supported by grants from the National Basic Research Program of China (no. 2013CB955900), the Chinese Academy of Sciences (KZZD-EW-04-01) and the Project of State Key Laboratory of Loess and Quaternary Geology Institute of Earth Environment, CAS (SKLLQG1314). This research is an initiative of the Sino-Swedish Tree-Ring Research Center (SISTRR): Contribution (No. 024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun BJ, 2013, CLIM DYNAM, V41, P277, DOI 10.1007/s00382-012-1523-9; Allan R., 1997, OCEANOGR LIT REV, V6, P555; Allen KJ, 2011, CLIM DYNAM, V37, P1799, DOI 10.1007/s00382-011-1011-7; Cai Q, 2014, CLIM PAST, V10, P509, DOI 10.5194/cp-10-509-2014; Central Meteorological Bureau of China, 1981, YEARL CHARTS DRYN WE; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107501; Cook E.R., 2013, METHODS DENDROCHRONO; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Fang KY, 2010, INT J CLIMATOL, V30, P1137, DOI 10.1002/joc.1974; Feng S, 2004, J CLIMATE, V17, P4871, DOI 10.1175/JCLI-3245.1; FRITTS H C, 1986, Tree-Ring Bulletin, V46, P31; Fritts H. C., 1976, TREE RINGS CLIMATE; Gou XH, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005705; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li JB, 2007, INT J CLIMATOL, V27, P903, DOI 10.1002/joc.1450; Li WeiGuang, 2012, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V20, P643, DOI 10.3724/SP.J.1011.2012.00643; Liang EY, 2006, CLIMATIC CHANGE, V79, P403, DOI 10.1007/s10584-006-9082-x; Liang EY, 2003, ANN FOREST SCI, V60, P145, DOI 10.1051/forest:2003007; Libiseller C, 2002, ENVIRONMETRICS, V13, P71, DOI 10.1002/env.507; Liu Y, 2003, CHINESE SCI BULL, V48, P1140, DOI 10.1360/02wd0455; Liu Y, 1996, SCI CHINA SER D, V39, P152; Liu Y, 2001, EARTH SCI FRONT, V8, P91; Liu Y, 2007, TREE-RING RES, V63, P3, DOI 10.3959/1536-1098-63.1.3; Liu Y, 2013, DENDROCHRONOLOGIA, V31, P290, DOI 10.1016/j.dendro.2013.02.001; Liu Y, 2013, INT J BIOMETEOROL, V57, P927, DOI 10.1007/s00484-012-0618-7; Liu Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012330; Liu Y, 2009, PALAEOGEOGR PALAEOCL, V282, P81, DOI 10.1016/j.palaeo.2009.08.012; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Martin-Benito D, 2013, EUR J FOREST RES, V132, P33, DOI 10.1007/s10342-012-0652-3; MEEHL GA, 1987, MON WEATHER REV, V115, P27, DOI 10.1175/1520-0493(1987)115<0027:TACAIV>2.0.CO;2; MEKO D, 1995, WATER RESOUR BULL, V31, P605; Mendivelso HA, 2014, AGR FOREST METEOROL, V188, P13, DOI 10.1016/j.agrformet.2013.12.010; Searcy J.K., 1960, CYCL DATA, DOI [10.3133/wsp1541B, DOI 10.3133/WSP1541B]; Song HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093504; Song HM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016220; Stokes M.A., 1996, INTRO TREE RING DATI; Vicente-Serrano SM, 2010, J HYDROMETEOROL, V11, P1033, DOI 10.1175/2010JHM1224.1; Vicente-Serrano SM, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000434.1; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Vicente-Serrano SM, 2011, ADV GLOB CHANGE RES, V46, P23, DOI 10.1007/978-94-007-1372-7_3; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Wang Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023344; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Xu GC., 1997, CLIMATE CHANGE ARID; Xu GB, 2014, THEOR APPL CLIMATOL, V116, P385, DOI 10.1007/s00704-013-0958-1; YANG WJ, 2003, SOIL WATER CONSERVAT, V12, P24; Zhang Q, 2004, SCI TECHNOLOGY REV, V7, P21; Zou XK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021853	53	17	19	7	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133605	10.1371/journal.pone.0133605	http://dx.doi.org/10.1371/journal.pone.0133605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207621	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000109
J	Rosani, U; Tarricone, E; Venier, P; Brun, P; Deligianni, V; Zuin, M; Martines, E; Leonardi, A; Brun, P				Rosani, Umberto; Tarricone, Elena; Venier, Paola; Brun, Paola; Deligianni, Velika; Zuin, Matteo; Martines, Emilio; Leonardi, Andrea; Brun, Paola			Atmospheric-Pressure Cold Plasma Induces Transcriptional Changes in Ex Vivo Human Corneas	PLOS ONE			English	Article							ARGON PLASMA; MEDICINE; EXPRESSION; KERATITIS; PROTEINS; WOUNDS; CELLS; DNA	Background Atmospheric pressure cold plasma (APCP) might be considered a novel tool for tissue disinfection in medicine since the active chemical species produced by low plasma doses, generated by ionizing helium gas in air, induces reactive oxygen species (ROS) that kill microorganisms without substantially affecting human cells. Objectives In this study, we evaluated morphological and functional changes in human corneas exposed for 2 minutes (min) to APCP and tested if the antioxidant n-acetyl l-cysteine (NAC) was able to inhibit or prevent damage and cell death. Results Immunohistochemistry and western blotting analyses of corneal tissues collected at 6 hours (h) post-APCP treatment demonstrated no morphological tissue changes, but a transient increased expression of OGG1 glycosylase that returned to control levels in 24 h. Transcriptome sequencing and quantitative real time PCR performed on different corneas revealed in the treated corneas many differentially expressed genes: namely, 256 and 304 genes showing expression changes greater than +/- 2 folds in the absence and presence of NAC, respectively. At 6 h post-treatment, the most over-expressed gene categories suggested an active or enhanced cell functioning, with only a minority of genes specifically concerning oxidative DNA damage and repair showing slight over-expression values (<2 folds). Moreover, time-related expression analysis of eight genes up-regulated in the APCP-treated corneas overall demonstrated the return to control expression levels after 24 h. Conclusions These findings of transient oxidative stress accompanied by wide-range transcriptome adjustments support the further development of APCP as an ocular disinfectant.	[Rosani, Umberto; Venier, Paola] Univ Padua, Dept Biol, Padua, Italy; [Tarricone, Elena; Brun, Paola] Univ Padua, Dept Mol Med, Histol Unit, Padua, Italy; [Brun, Paola] Univ Padua, Microbiol Unit, Dept Mol Med, Padua, Italy; [Deligianni, Velika] S Antonio Hosp, Dept Ophthalmol, Padua, Italy; [Zuin, Matteo; Martines, Emilio] Consorzio RFX, Padua, Italy; [Leonardi, Andrea] Univ Padua, Dept Neurosci, Ophthalmol Unit, Padua, Italy	University of Padua; University of Padua; University of Padua; ULSS 6 Euganea; Ospedale Sant'antonio Padova; University of Padua	Venier, P (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	paola.venier@unipd.it; paola.brun@unipd.it	zuin, matteo/AAX-8015-2020; rosani, umbero/I-6007-2019; ZUIN, Matteo/G-5540-2018; Brun, Paola/K-5729-2016; Martines, Emilio/B-1418-2009; Venier, Paola/J-6302-2019	rosani, umbero/0000-0003-0685-1618; ZUIN, Matteo/0000-0002-0282-2978; Martines, Emilio/0000-0002-4181-2959; Venier, Paola/0000-0001-9634-3662; Brun, Paola/0000-0002-4204-3549	Italian Research; University Ministry (MIUR); University of Padova, Italy	Italian Research; University Ministry (MIUR); University of Padova, Italy	This study was supported by the Italian Research and University Ministry (MIUR) and by the University of Padova, Italy.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Alekseev O, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.2.2; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Brehmer F, 2015, J EUR ACAD DERMATOL, V29, P148, DOI 10.1111/jdv.12490; Brun P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104397; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Calabrese EJ, 2013, ENVIRON POLLUT, V182, P452, DOI 10.1016/j.envpol.2013.07.046; Calabrese EJ, 2011, J CELL COMMUN SIGNAL, V5, P25, DOI 10.1007/s12079-011-0119-1; Carregaro F, 2013, ARCH DERMATOL RES, V305, P857, DOI 10.1007/s00403-013-1415-9; Delaney S, 2012, FREE RADICAL RES, V46, P420, DOI 10.3109/10715762.2011.653968; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Dobrynin D, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103033; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Garreis F, 2010, DEV OPHTHALMOL, V45, P16, DOI 10.1159/000315016; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x; Isbary G, 2013, EXPERT REV MED DEVIC, V10, P367, DOI [10.1586/erd.13.4, 10.1586/ERD.13.4]; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Knickelbein JE, 2014, INVEST OPHTH VIS SCI, V55, P1118, DOI 10.1167/iovs.13-13523; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Kulkarni B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022301; Lackmann JW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0591; Madureira PA, 2013, INT J MOL SCI, V14, P3568, DOI 10.3390/ijms14023568; Martines E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115014; McDonald EM, 2014, BRIT J OPHTHALMOL, V98, P1470, DOI 10.1136/bjophthalmol-2013-304660; Rozen S, 2000, Methods Mol Biol, V132, P365; Runkel F, 2006, J MOL HISTOL, V37, P353, DOI 10.1007/s10735-006-9063-4; Takai E, 2012, PLASMA PROCESS POLYM, V9, P77, DOI 10.1002/ppap.201100063; Thomas PA, 2007, CURR OPIN INFECT DIS, V20, P129, DOI 10.1097/QCO.0b013e328017f878; Tian X, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S107; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; von Woedtke T, 2014, CONTRIB PLASM PHYS, V54, P104, DOI 10.1002/ctpp.201310068; Winczura A, 2012, FREE RADICAL RES, V46, P442, DOI 10.3109/10715762.2012.658516	38	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133173	10.1371/journal.pone.0133173	http://dx.doi.org/10.1371/journal.pone.0133173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203910	Green Submitted, Green Published, gold			2022-12-27	WOS:000358621000022
J	Suita, K; Fujita, T; Hasegawa, N; Cai, WQ; Jin, HL; Hidaka, Y; Prajapati, R; Umemura, M; Yokoyama, U; Sato, M; Okumura, S; Ishikawa, Y				Suita, Kenji; Fujita, Takayuki; Hasegawa, Nozomi; Cai, Wenqian; Jin, Huiling; Hidaka, Yuko; Prajapati, Rajesh; Umemura, Masanari; Yokoyama, Utako; Sato, Motohiko; Okumura, Satoshi; Ishikawa, Yoshihiro			Norepinephrine-Induced Adrenergic Activation Strikingly Increased the Atrial Fibrillation Duration through beta 1-and alpha 1-Adrenergic Receptor-Mediated Signaling in Mice	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; HEART-FAILURE; LIFETIME RISK; PATHOPHYSIOLOGY; TACHYCARDIA; PREVALENCE; OVEREXPRESSION; MECHANISMS; INDUCTION; PROTEINS	Background Atrial fibrillation (AF) is the most common arrhythmias among old people. It causes serious long-term health problems affecting the quality of life. It has been suggested that the autonomic nervous system is involved in the onset and maintenance of AF in human. However, investigation of its pathogenesis and potential treatment has been hampered by the lack of suitable AF models in experimental animals. Objectives Our aim was to establish a long-lasting AF model in mice. We also investigated the role of adrenergic receptor (AR) subtypes, which may be involved in the onset and duration of AF. Methods and Results Trans-esophageal atrial burst pacing in mice could induce AF, as previously shown, but with only a short duration (29.0 +/- 8.1 sec). We found that adrenergic activation by intraperitoneal norepinephrine (NE) injection strikingly increased the AF duration. It increased the duration to more than 10 minutes, i.e., by more than 20-fold (656.2 +/- 104.8 sec; P<0.001). In this model, a prior injection of a specific beta 1-AR blocker metoprolol and an alpha 1-AR blocker prazosin both significantly attenuated NE-induced elongation of AF. To further explore the mechanisms underlying these receptors' effects on AF, we assessed the SR Ca2+ leak, a major trigger of AF, and consequent spontaneous SR Ca2+ release (SCR) in atrial myocytes. Consistent with the results of our in-vivo experiments, both metoprolol and prazosin significantly inhibited the NE-induced SR Ca2+ leak and SCR. These findings suggest that both beta 1-AR and alpha 1-AR may play important roles in the development of AF. Conclusions We have established a long-lasting AF model in mice induced by adrenergic activation, which will be valuable in future AF study using experimental animals, such as transgenic mice. We also revealed the important role of beta 1- and alpha 1-AR-mediated signaling in the development of AF through in-vivo and in-vitro experiments.	[Suita, Kenji; Fujita, Takayuki; Hasegawa, Nozomi; Cai, Wenqian; Jin, Huiling; Hidaka, Yuko; Prajapati, Rajesh; Umemura, Masanari; Yokoyama, Utako; Sato, Motohiko; Okumura, Satoshi; Ishikawa, Yoshihiro] Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan; [Sato, Motohiko] Aichi Med Univ, Sch Med, Dept Physiol, Nagakute, Aichi, Japan; [Okumura, Satoshi] Tsurumi Univ, Sch Dent Med, Dept Physiol, Yokohama, Kanagawa, Japan	Yokohama City University; Aichi Medical University; Tsurumi University	Fujita, T (corresponding author), Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan.	fujitaka@yokohama-cu.ac.jp; yishikaw@med.yokohama-cu.ac.jp	Cai, Wenqian/GXV-1498-2022; Yokoyama, Utako/AAD-1404-2022; Umemura, Masanari/D-3607-2018	Cai, Wenqian/0000-0002-3876-1185; Yokoyama, Utako/0000-0003-1803-0155; Umemura, Masanari/0000-0002-1812-5720; Prajapati, Rajesh/0000-0002-3252-0073	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grant for Strategic Research Promotion of Yokohama City University; Ministry of Health, Labor and Welfare; Kitsuen Kagaku Research Foundation; Japan Space Forum; Takeda Science Foundation; Yokohama Foundation for Advancement of Medical Science; Mitsubishi Pharma Research Foundation; Suzuken Memorial Foundation; Yokohama Academic Foundation; Commercialization Promotion Program for Biotechnology-related Studies; Grants for Research and Development Project II from Yokohama City University; Research Foundation for Community Medicine	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant for Strategic Research Promotion of Yokohama City University; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Kitsuen Kagaku Research Foundation; Japan Space Forum; Takeda Science Foundation(Takeda Science Foundation (TSF)); Yokohama Foundation for Advancement of Medical Science; Mitsubishi Pharma Research Foundation; Suzuken Memorial Foundation; Yokohama Academic Foundation; Commercialization Promotion Program for Biotechnology-related Studies; Grants for Research and Development Project II from Yokohama City University; Research Foundation for Community Medicine	This study was supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KS, TF, SO, YI), a Grant for Strategic Research Promotion of Yokohama City University (TF, SO), the Ministry of Health, Labor and Welfare (YI), a Grant-in-Aid for Scientific Research on Innovative Areas (YI), the Kitsuen Kagaku Research Foundation (YI), the Japan Space Forum (YI), Takeda Science Foundation (YI), Yokohama Foundation for Advancement of Medical Science (SO), Mitsubishi Pharma Research Foundation (SO), Suzuken Memorial Foundation (SO), Yokohama Academic Foundation (SO), 2010 Commercialization Promotion Program for Biotechnology-related Studies (SO), Grants for Research and Development Project II from Yokohama City University (SO, YI), and Research Foundation for Community Medicine (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Armour JA, 1997, CAN J CARDIOL, V13, P277; Armour JA, 2005, AUTON NEUROSCI-BASIC, V118, P68, DOI 10.1016/j.autneu.2005.01.006; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772; Fukui A, 2013, CIRC-ARRHYTHMIA ELEC, V6, P402, DOI 10.1161/CIRCEP.111.000104; Grimm M, 2007, J MOL CELL CARDIOL, V42, P643, DOI 10.1016/j.yjmcc.2006.12.010; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; Haugan K, 2004, J CARDIOVASC PHARM, V44, P125, DOI 10.1097/00005344-200407000-00017; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Hirose M, 2009, HEART RHYTHM, V6, P78, DOI 10.1016/j.hrthm.2008.10.018; Ishibashi H, 2003, J PHYSIOL-LONDON, V548, P111, DOI 10.1113/jphysiol.2002.033100; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Katritsis DG, 2013, J AM COLL CARDIOL, V62, P2318, DOI 10.1016/j.jacc.2013.06.053; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Muller FU, 2005, J BIOL CHEM, V280, P6906, DOI 10.1074/jbc.M407864200; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; Ogrodnik J, 2010, J PHYSIOL-LONDON, V588, P225, DOI 10.1113/jphysiol.2009.181800; ORTIZ J, 1994, CIRC RES, V74, P882, DOI 10.1161/01.RES.74.5.882; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Pretorius L, 2009, AM J PATHOL, V175, P998, DOI 10.2353/ajpath.2009.090126; Rathore SS, 2000, CIRCULATION, V101, P969, DOI 10.1161/01.CIR.101.9.969; Riley G, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00296; Rose RA, 2007, CIRC RES, V101, P1274, DOI 10.1161/CIRCRESAHA.107.158428; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Sapra G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6705; SATO R, 1995, J MEMBRANE BIOL, V148, P185; Sato S, 2008, AM J PHYSIOL-HEART C, V294, pH1708, DOI 10.1152/ajpheart.01122.2007; Schrickel JW, 2002, BASIC RES CARDIOL, V97, P452, DOI 10.1007/s003950200052; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Stavrakis S, 2009, J AM COLL CARDIOL, V54, P1309, DOI 10.1016/j.jacc.2009.07.015; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Van Noord T, 2004, EUROPACE, V6, P343, DOI 10.1016/j.eupc.2004.04.001; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wakimoto H, 2001, CARDIOVASC RES, V50, P463, DOI 10.1016/S0008-6363(01)00264-4; Wang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094005; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Yoshioka I, 2009, THORAC CARDIOV SURG, V57, P464, DOI 10.1055/s-0029-1186069; Zeng Z, 2014, J PHARMACOL SCI, V126, P37, DOI 10.1254/jphs.14029FP; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	45	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133664	10.1371/journal.pone.0133664	http://dx.doi.org/10.1371/journal.pone.0133664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203906	Green Published, Green Submitted, gold			2022-12-27	WOS:000358621000036
J	Chen, WN; Han, C; Zhang, JQ; Song, K; Wang, Y; Wu, T				Chen, Weina; Han, Chang; Zhang, Jinqiang; Song, Kyoungsub; Wang, Ying; Wu, Tong			miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; FACTOR C-MYB; HEPATOCYTE APOPTOSIS; MEDIATED APOPTOSIS; SIGNALING PATHWAY; DOWN-REGULATION; IMMUNE-SYSTEM; MICRORNA; RECEPTOR; ACTIVATION	Although miR-150 is implicated in the regulation of immune cell differentiation and activation, it remains unknown whether miR-150 is involved in liver biology and disease. This study was performed to explore the potential role of miR-150 in LPS/D-GalN and Fas-induced liver injuries by using wild type and miR-150 knockout (KO) mice. Whereas knockout of miR-150 did not significantly alter LPS/D-GalN-induced animal death and liver injury, it protected against Fas-induced liver injury and mortality. The Jo2-induced increase in serum transaminases, apoptotic hepatocytes, PARP cleavage, as well as caspase-3/7, caspase-8, and caspase-9 activities were significantly attenuated in miR-150 KO mice. The liver tissues from Jo2-treated miR-150 KO mice expressed higher levels of Akt1, Akt2, total Akt, as well as p-Akt (Ser473) compared to the wild type livers. Pretreatment with the Akt inhibitor V reversed Jo2-induced liver injury in miR-150 KO mice. The primary hepatocytes isolated from miR-150 KO mice also showed protection against Fas-induced apoptosis in vitro (characterized by less prominent PARP cleavage, less nuclear fragmentation and less caspase activation) in comparison to hepatocytes from wild type mice. Luciferase reporter assays in hepatocytes transfected with the Akt1 or Akt2 3'-UTR reporter constructs (with or without mutation of miR-150 binding site) established Akt1 and Akt2 as direct targets of miR-150. Tail vein injection of lentiviral particles containing pre-miR-150 enhanced Jo2-induced liver injury in miR-150 KO mice. These findings demonstrate that miR-150 deficiency prevents Fas-induced hepatocyte apoptosis and liver injury through regulation of the Akt pathway.	[Chen, Weina; Han, Chang; Zhang, Jinqiang; Song, Kyoungsub; Wang, Ying; Wu, Tong] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70118 USA; [Wang, Ying] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastroenterol & Internal Med, Wuhan 430074, Peoples R China	Tulane University; Huazhong University of Science & Technology	Wu, T (corresponding author), Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave SL-79, New Orleans, LA 70118 USA.	twu@tulane.edu			National Institutes of Health [CA106280, CA102325, CA134568, DK077776]; NATIONAL CANCER INSTITUTE [R01CA106280, R01CA102325, R01CA134568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK077776, R01DK077776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants CA106280, CA102325, CA134568, and DK077776 (to T.W.).	Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Farhana L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061015; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Han C, 2010, HEPATOLOGY, V52, P644, DOI 10.1002/hep.23703; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hatano E, 2001, AM J PHYSIOL-GASTR L, V281, pG1357, DOI 10.1152/ajpgi.2001.281.6.G1357; Honda N, 2013, AM J PATHOL, V182, P206, DOI 10.1016/j.ajpath.2012.09.023; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Li GY, 2009, HEPATOLOGY, V50, P834, DOI 10.1002/hep.23052; Li PF, 2010, J BIOL CHEM, V285, P22713, DOI 10.1074/jbc.M110.105692; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; LUSTER MI, 1994, HEPATOLOGY, V19, P480; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Minana JB, 2002, HEPATOLOGY, V35, P1205, DOI 10.1053/jhep.2002.32969; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Morris VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075815; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Mraz M, 2014, BLOOD, V124, P84, DOI 10.1182/blood-2013-09-527234; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Pianko S, 2001, J VIRAL HEPATITIS, V8, P406, DOI 10.1046/j.1365-2893.2001.00316.x; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Rolland-Turner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054135; Salehi S, 2013, AM J TRANSPLANT, V13, P1282, DOI 10.1111/ajt.12183; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Schultze Simon M., 2011, Archives of Physiology and Biochemistry, V117, P70, DOI 10.3109/13813455.2010.539236; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Sharma AD, 2011, HEPATOLOGY, V53, P1651, DOI 10.1002/hep.24243; Shen J, 2013, CANCER EPIDEM BIOMAR, V22, P2364, DOI 10.1158/1055-9965.EPI-13-0237; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Valva P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053519; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wang CM, 2015, HEPATOLOGY, V61, P200, DOI 10.1002/hep.27396; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036818; Wang SL, 2015, ONCOL REP, V33, P819, DOI 10.3892/or.2014.3641; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yeh YY, 2015, BLOOD, V125, P3297, DOI 10.1182/blood-2014-12-618470; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zheng JJ, 2013, INT J MOL MED, V32, P17, DOI 10.3892/ijmm.2013.1356; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	58	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132734	10.1371/journal.pone.0132734	http://dx.doi.org/10.1371/journal.pone.0132734			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196694	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600049
J	Kapadia, MZ; Park, CK; Beyene, J; Giglia, L; Maxwell, C; McDonald, SD				Kapadia, Mufiza Zia; Park, Christina K.; Beyene, Joseph; Giglia, Lucy; Maxwell, Cindy; McDonald, Sarah D.			Weight Loss Instead of Weight Gain within the Guidelines in Obese Women during Pregnancy: A Systematic Review and Meta-Analyses of Maternal and Infant Outcomes	PLOS ONE			English	Article							PREPREGNANCY OVERWEIGHT; BIRTH-WEIGHT; RISK; ASSOCIATIONS; MOTHERS; 2ND-TRIMESTER; GROWTH	Background Controversy exists about how much, if any, weight obese pregnant women should gain. While the revised Institute of Medicine guidelines on gestational weight gain (GWG) in 2009 recommended a weight gain of 5-9 kg for obese pregnant women, many studies suggested even gestational weight loss (GWL) for obese women. Objectives A systematic review was conducted to summarize pregnancy outcomes in obese women with GWL compared to GWG within the 2009 Institute of Medicine guidelines (5-9 kg). Design Five databases were searched from 1 January 2009 to 31 July 2014. The Cochrane Handbook for Systematic Reviews of Interventions and the PRISMA Statement were followed. A modified version of the Newcastle-Ottawa scale was used to assess individual study quality. Small for gestational age (SGA), large for gestational age (LGA) and preterm birth were our primary outcomes. Results Six cohort studies were included, none of which assessed preterm birth. Compared to GWG within the guidelines, women with GWL had higher odds of SGA <10th percentile (adjusted odds ratio [AOR] 1.76; 95% confidence interval [CI] 1.45-2.14) and SGA <3rd percentile (AOR 1.62; 95% CI 1.19-2.20) but lower odds of LGA >90th percentile (AOR 0.57; 95% CI 0.52-0.62). There was a trend towards a graded relationship between SGA <10th percentile and each of three obesity classes (I: AOR 1.73; 95% CI 1.53-1.97; II: AOR 1.63; 95% CI 1.44-1.85 and III: AOR 1.39; 95% CI 1.17-1.66, respectively). Conclusion Despite decreased odds of LGA, increased odds of SGA and a lack of information on preterm birth indicate that GWL should not be advocated in general for obese women.	[Kapadia, Mufiza Zia] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Park, Christina K.; Beyene, Joseph; McDonald, Sarah D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Giglia, Lucy] McMaster Univ, Dept Pediat, Div Gen Pediat, Hamilton, ON, Canada; [Maxwell, Cindy] Mt Sinai Hosp, Div Maternal Fetal Med, Dept Obstet & Gynaecol, Toronto, ON M5G 1X5, Canada; [Maxwell, Cindy] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Radiol, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; McMaster University	McDonald, SD (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	mcdonals@mcmaster.ca	Maxwell, Cindy/T-8663-2019	Maxwell, Cindy/0000-0003-4734-1251	Canadian Institutes of Health Research grant [KRS-134301]; Canadian Institutes of Health Research Investigator Salary Award [CNI95357]; Canadian Institutes of Health Research Canada Research Chairs Award [950-229920]; John D. Cameron Chair in Genetic Determinants of Chronic Disease at McMaster University; Canadian Institutes of Health Research Training Program in Reproduction, Early Development and the Impact on Health [TGF-96122]	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Canada Research Chairs Award(Canadian Institutes of Health Research (CIHR)); John D. Cameron Chair in Genetic Determinants of Chronic Disease at McMaster University; Canadian Institutes of Health Research Training Program in Reproduction, Early Development and the Impact on Health(Canadian Institutes of Health Research (CIHR))	This research is funded by a Canadian Institutes of Health Research grant (KRS-134301). SDM was supported by a Canadian Institutes of Health Research Investigator Salary Award (CNI95357) and is now supported by a Canadian Institutes of Health Research Canada Research Chairs Award (950-229920). JB is supported by John D. Cameron Chair in the Genetic Determinants of Chronic Disease at McMaster University. CKP is supported by a Canadian Institutes of Health Research Training Program in Reproduction, Early Development and the Impact on Health (TGF-96122). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2013, OBSTET GYNECOL, V121, P210, DOI 10.1097/01.aog.0000425668.87506.4c; Beyerlein A, 2011, BJOG-INT J OBSTET GY, V118, P55, DOI 10.1111/j.1471-0528.2010.02761.x; Beyerlein A, 2009, AM J CLIN NUTR, V90, P1552, DOI 10.3945/ajcn.2009.28026; Bish CL, 2009, MATERN CHILD HLTH J, V13, P286, DOI 10.1007/s10995-008-0349-x; Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; Bodnar LM, 2010, AM J CLIN NUTR, V91, P1642, DOI 10.3945/ajcn.2009.29008; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Durie DE, 2011, OBSTET GYNECOL, V118, P569, DOI 10.1097/AOG.0b013e3182289f42; Escobar GJ, 2006, SEMIN PERINATOL, V30, P28, DOI 10.1053/j.semperi.2006.01.005; Furber CM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009334.pub2; Gore SA, 2003, ANN BEHAV MED, V26, P149, DOI 10.1207/S15324796ABM2602_07; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinkle SN, 2010, AM J CLIN NUTR, V92, P644, DOI 10.3945/ajcn.2010.29726; Institute of Medicine, 2009, WEIGHT GAIN DURING P; Kapadia MZ, 2015, OBES REV, V16, P189, DOI 10.1111/obr.12238; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Kominiarek MA, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.035; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McDonald Sarah D, 2010, BMJ, V341, pc3428, DOI 10.1136/bmj.c3428; McIntyre HD, 2012, MED J AUSTRALIA, V196, P184, DOI 10.5694/mja11.11120; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Neufeld LM, 2004, AM J CLIN NUTR, V79, P646; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Oken E, 2009, AM J EPIDEMIOL, V170, P173, DOI 10.1093/aje/kwp101; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Park S, 2011, MATERN CHILD HLTH J, V15, P289, DOI 10.1007/s10995-010-0596-5; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Poobalan AS, 2009, OBES REV, V10, P28, DOI 10.1111/j.1467-789X.2008.00537.x; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Roos N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6460; Schaefer-Graf UM, 2002, AM J OBSTET GYNECOL, V187, P913, DOI 10.1067/mob.2002.126962; Sharma Puneet, 2004, BMC Pediatr, V4, P9, DOI 10.1186/1471-2431-4-9; SPELLACY WN, 1985, OBSTET GYNECOL, V66, P158; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Vahratian A, 2004, OBSTET GYNECOL, V104, P943, DOI 10.1097/01.AOG.0000142713.53197.91; Vahratian A, 2009, MATERN CHILD HLTH J, V13, P268, DOI 10.1007/s10995-008-0340-6; Vesco KK, 2011, OBSTET GYNECOL, V117, P812, DOI 10.1097/AOG.0b013e3182113ae4; Vrebosch L, 2012, OBES SURG, V22, P1568, DOI 10.1007/s11695-012-0740-y; Wells GA., 2015, NEWCASTLE OTTAWA SCA; World Health Organization, OB OV; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007	49	74	75	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132650	10.1371/journal.pone.0132650	http://dx.doi.org/10.1371/journal.pone.0132650			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196130	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600045
J	Liu, MF; Miao, NF; Chen, IH; Lin, YK; Ho, MH; Roberts, BL; Chang, CC				Liu, Megan F.; Miao, Nae-Fang; Chen, I-Hui; Lin, Yen-Kuang; Ho, Mu-Hsing; Roberts, Beverly L.; Chang, Chia-Chi			Development and Psychometric Evaluation of the Chinese Feeding Difficulty Index (Ch-FDI) for People with Dementia	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; OLDER-ADULTS; MEALTIME DIFFICULTIES; DISABILITY	Aims To develop and evaluate the psychometric properties of a Chinese Feeding Difficulty Index (Ch-FDI) which assesses feeding difficulties in people with dementia (PwD). Research Design and Method Scale items were developed using literature review based on Model of Feeding Difficulty. Content validity was evaluated and items were modified by expert panel. Following translation and back-translation, the Ch-FDI was piloted on residents with dementia. The reliability was tested by inter-rater reliability and test-retest reliability. Internal reliability was established by calculating Cronbach's a coefficient. The concurrent validity was evaluated by correlating with similar scale, the Edinburgh Feeding Evaluation in Dementia (EdFED). The exploratory factor analysis (EFA) with varimax rotation and parallel analysis (PA) was performed to test construct validity. Method Participants were recruited from long-term care facilities in Taiwan. A total of 213 residents with dementia participated in this study during May, 2010 to February, 2011. Results Content validation, translation and psychometric testing were completed on the 19 items of the Ch-FDI. The translated scale was piloted on 213 residents with dementia of feeding difficulty who were recruited from eight long-term care facilities in Taiwan. The reliability was supported by the internal consistency of Cronbach's a of 0.68 and a test-retest coefficient of 0.85. The content validity, face validity, concurrent validity, and construct validity were used. Conclusions The Ch-FDI is a newly developed scale with fair psychometric properties aimed to measure feeding difficulties among residents with dementia in long-term care facilities in Taiwan. Using this reliable and valid tool can help healthcare providers to assess feeding problems of PwD and provide feeding assistance in order to promote quality of care during mealtime in long-term care facilities.	[Liu, Megan F.; Chang, Chia-Chi] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan; [Miao, Nae-Fang] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Chen, I-Hui] Asia Univ, Coll Med & Hlth Sci, Dept Nursing, Taichung, Taiwan; [Lin, Yen-Kuang] Taipei Med Univ, Biostat Res Ctr, Taipei, Taiwan; [Lin, Yen-Kuang; Ho, Mu-Hsing] Taipei Med Univ, Coll Nursing, Grad Inst Nursing, Taipei, Taiwan; [Roberts, Beverly L.] Univ Florida, Sch Nursing, Gainesville, FL USA	Taipei Medical University; Taipei Medical University; Asia University Taiwan; Taipei Medical University; Taipei Medical University; State University System of Florida; University of Florida	Chang, CC (corresponding author), Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan.	cchang@tmu.edu.tw	Ho, Mu Hsing/Y-9105-2019	Ho, Mu-Hsing/0000-0002-9443-4082; Chang, Chia-Chi/0000-0002-5257-0238; YIHUA, TANG/0000-0001-7156-141X	National Health Research Institutes [NHRI-EX99-9921PC, NHRI-EX100-9921PC]	National Health Research Institutes(National Health Research Institutes, Japan)	Grants (NHRI-EX99-9921PC and NHRI-EX100-9921PC) from the National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amella EJ, 2004, NURS CLIN N AM, V39, P607, DOI 10.1016/j.cnur.2004.02.014; Amella EJ, 1998, GERIATR NURS, V19, P269, DOI 10.1016/S0197-4572(98)90100-8; Aselage MB, 2011, NURS OUTLOOK, V59, P210, DOI 10.1016/j.outlook.2011.05.009; Chang CC, 2012, J NUTR HEALTH AGING, V16, P258, DOI 10.1007/s12603-011-0158-6; Chang CC, 2008, J NURS SCHOLARSHIP, V40, P235, DOI 10.1111/j.1547-5069.2008.00231.x; Chang CC, 2008, J CLIN NURS, V17, P2266, DOI 10.1111/j.1365-2702.2007.02275.x; Chang CC, 2011, AM J NURS, V111, P36, DOI 10.1097/01.NAJ.0000396553.01996.5e; Dunlop DD, 1997, AM J PUBLIC HEALTH, V87, P378, DOI 10.2105/AJPH.87.3.378; Durnbaugh T, 1996, GERIATR NURS, V17, P63, DOI 10.1016/S0197-4572(96)80170-4; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Huang HC, 2009, J LONG TERM CARE, V13, P121; Li L, 2009, J LONG TERM CARE, V13, P157; Lin LC, 2010, J CLIN NURS, V19, P53, DOI 10.1111/j.1365-2702.2009.02962.x; Liu W, 2014, INT J NURS STUD, V51, P14, DOI 10.1016/j.ijnurstu.2012.12.021; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Slaughter SE, 2011, CLIN NUTR, V30, P172, DOI 10.1016/j.clnu.2010.09.001; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Stockdell R, 2008, AM J NURS, V108, P46, DOI 10.1097/01.NAJ.0000327831.51782.8e; Touhy TA, 2010, EBERSOLE HESS GERONT; Volicer L, 1989, J Geriatr Psychiatry Neurol, V2, P188, DOI 10.1177/089198878900200404; Watson R, 1994, J Psychiatr Ment Health Nurs, V1, P45, DOI 10.1111/j.1365-2850.1994.tb00009.x; WATSON R, 1994, J ADV NURS, V19, P257, DOI 10.1111/j.1365-2648.1994.tb01079.x; WATSON R, 1994, J ADV NURS, V19, P850, DOI 10.1111/j.1365-2648.1994.tb01160.x; WATSON R, 1994, J ADV NURS, V20, P283, DOI 10.1046/j.1365-2648.1994.20020283.x	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133716	10.1371/journal.pone.0133716	http://dx.doi.org/10.1371/journal.pone.0133716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196126	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600135
J	Maluck, J; Donner, RV				Maluck, Julian; Donner, Reik V.			A Network of Networks Perspective on Global Trade	PLOS ONE			English	Article								Mutually intertwined supply chains in contemporary economy result in a complex network of trade relationships with a highly non-trivial topology that varies with time. In order to understand the complex interrelationships among different countries and economic sectors, as well as their dynamics, a holistic view on the underlying structural properties of this network is necessary. This study employs multi-regional input-output data to decompose 186 national economies into 26 industry sectors and utilizes the approach of interdependent networks to analyze the substructure of the resulting international trade network for the years 1990-2011. The partition of the network into national economies is observed to be compatible with the notion of communities in the sense of complex network theory. By studying internal versus cross-subgraph contributions to established complex network metrics, new insights into the architecture of global trade are obtained, which allow to identify key elements of global economy. Specifically, financial services and business activities dominate domestic trade whereas electrical and machinery industries dominate foreign trade. In order to further specify each national sector's role individually, (cross-) clustering coefficients and cross-betweenness are obtained for different pairs of subgraphs. The corresponding analysis reveals that specific industrial sectors tend to favor distinct directionality patterns and that the cross-clustering coefficient for geographically close country pairs is remarkably high, indicating that spatial factors are still of paramount importance for the organization of trade patterns in modern economy. Regarding the evolution of the trade network's substructure, globalization is well-expressed by trends of several structural characteristics (e.g., link density and node strength) in the interacting network framework. Extreme events, such as the financial crisis 2008/2009, are manifested as anomalies superimposed to these trends. The marked reorganization of trade patterns, associated with this economic crisis in comparison to "normal" annual fluctuations in the network structure is traced and quantified by a new widely applicable generalization of the Hamming distance to weighted networks.	[Maluck, Julian; Donner, Reik V.] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Maluck, Julian] Humboldt Univ, Dept Phys, D-10099 Berlin, Germany	Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin	Maluck, J (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	Julian.Maluck@pik-potsdam.de	Donner, Reik/F-4400-2017	Donner, Reik/0000-0001-7023-6375	German Federal Ministry of Education and Research via Young Investigators Group CoSy-CC2 [01LN1306A]	German Federal Ministry of Education and Research via Young Investigators Group CoSy-CC2	This work has been financially supported by the German Federal Ministry of Education and Research (www.bmbf.de) via the Young Investigators Group CoSy-CC2 (grant no. 01LN1306A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/176; Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004; Barigozzi M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046104; Baxter GJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248701; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Bhattacharya K, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02002; Bierkandt Robert, 2014, Environment Systems & Decisions, V34, P507, DOI 10.1007/s10669-014-9523-4; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bureau of Labor Statistics, 2014, CONSUMER PRICE INDEX; Contreras MGA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062812; D'Agostino G, 2014, UNDERST COMPLEX SYST, pVII; Deguchi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100338; Donges JF, 2011, EUR PHYS J B, V84, P635, DOI 10.1140/epjb/e2011-10795-8; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fagiolo G, 2008, PHYSICA A, V387, P3868, DOI 10.1016/j.physa.2008.01.050; Fagiolo G, 2010, J EVOL ECON, V20, P479, DOI 10.1007/s00191-009-0160-x; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Fan Y, 2014, ECON MODEL, V39, P71, DOI 10.1016/j.econmod.2014.02.027; Feldhoff JH, 2012, PHYS LETT A, V376, P3504, DOI 10.1016/j.physleta.2012.10.008; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; Garlaschelli D, 2007, EUR PHYS J B, V57, P159, DOI 10.1140/epjb/e2007-00131-6; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Gozolchiani A, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/28005; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.198701; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; International Monetary Fund, 2009, WORLD EC OUTL APR 20; Kali R, 2007, J INT BUS STUD, V38, P595, DOI 10.1057/palgrave.jibs.8400286; Karpiarz M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.248701; Kim Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016103; Kravis IB, 1971, PRICE COMPETITIVENES; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Li X, 2003, PHYSICA A, V328, P287, DOI 10.1016/S0378-4371(03)00567-3; Malliaros FD, 2013, PHYS REP, V533, P95, DOI 10.1016/j.physrep.2013.08.002; McNerney J, 2013, PHYSICA A, V392, P6427, DOI 10.1016/j.physa.2013.07.063; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Murray J., 2010, SUSTAINABILITY PRACT; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016132, 10.1103/PhysRevE.64.026118]; Radebach A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052807; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Timmer, 2012, 10 WIOD; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; WTO Secretariat, 2014, WORLD TRAD REP 2014; Yamasaki K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228501	50	37	37	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133310	10.1371/journal.pone.0133310	http://dx.doi.org/10.1371/journal.pone.0133310			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197439	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600083
J	Matteau, D; Baby, V; Pelletier, S; Rodrigue, S				Matteau, Dominick; Baby, Vincent; Pelletier, Stephane; Rodrigue, Sebastien			A Small-Volume, Low-Cost, and Versatile Continuous Culture Device	PLOS ONE			English	Article							SYSTEMS BIOLOGY; EVOLUTION; SURFACES; GROWTH; CHEMOSTAT; BACTERIA	Background Continuous culture devices can be used for various purposes such as establishing reproducible growth conditions or maintaining cell populations under a constant environment for long periods. However, commercially available instruments are expensive, were not designed to handle small volumes in the milliliter range, and can lack the flexibility required for the diverse experimental needs found in several laboratories. Methodology/Principal Findings We developed a versatile continuous culture system and provide detailed instructions as well as a graphical user interface software for potential users to assemble and operate their own instrument. Three culture chambers can be controlled simultaneously with the proposed configuration, and all components are readily available from various sources. We demonstrate that our continuous culture device can be used under different modes, and can easily be programmed to behave either as a turbidostat or chemostat. Addition of fresh medium to the culture vessel can be controlled by a real-time feedback loop or simply calibrated to deliver a defined volume. Furthermore, the selected light-emitting diode and photodetector enable the use of phenol red as a pH indicator, which can be used to indirectly monitor the bulk metabolic activity of a cell population rather than the turbidity. Conclusions/Significance This affordable and customizable system will constitute a useful tool in many areas of biology such as microbial ecology as well as systems and synthetic biology.	[Matteau, Dominick; Baby, Vincent; Rodrigue, Sebastien] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Pelletier, Stephane] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Rodrigue, S (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	sebastien.rodrigue@usherbrooke.ca			Fonds de recherche du Quebec - Nature et technologies (FRQNT) [144858]; Natural Sciences and Engineering Research Council of Canada (NSERC) [386393]	Fonds de recherche du Quebec - Nature et technologies (FRQNT); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grant 144858 from the Fonds de recherche du Quebec - Nature et technologies (FRQNT; www.frqnt.gouv.qc.ca) and grant 386393 from the Natural Sciences and Engineering Research Council of Canada (NSERC; www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baby V, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00879-13; Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Bijmans MFM, 2010, BIOTECHNOL PROGR, V26, P1029, DOI 10.1002/btpr.400; Bull AT, 2010, J IND MICROBIOL BIOT, V37, P993, DOI 10.1007/s10295-010-0816-4; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Clyde WA, 1985, MYCOPLASMA PATHOGENI, V6, P391; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Gilbert A, 2009, BIOTECHNOL BIOENG, V103, P500, DOI 10.1002/bit.22272; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Lee KS, 2011, LAB CHIP, V11, P1730, DOI 10.1039/c1lc20019d; MARKX GH, 1991, J GEN MICROBIOL, V137, P735, DOI 10.1099/00221287-137-4-735; MARTIN GA, 1976, ARCH MICROBIOL, V107, P41, DOI 10.1007/BF00427865; MCCOY RE, 1984, INT J SYST BACTERIOL, V34, P11, DOI 10.1099/00207713-34-1-11; Miller AW, 2013, JOVE-J VIS EXP, DOI 10.3791/50262; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; STEMKE GW, 1982, J CLIN MICROBIOL, V16, P959, DOI 10.1128/JCM.16.5.959-961.1982; Takahashi CN, 2015, ACS SYNTH BIOL, V4, P32, DOI 10.1021/sb500165g; Toda K, 2003, J GEN APPL MICROBIOL, V49, P219, DOI 10.2323/jgam.49.219; Tomson K, 2006, J MICROBIOL METH, V64, P380, DOI 10.1016/j.mimet.2005.05.014; Toprak E, 2013, NAT PROTOC, V8, P555, DOI [10.1038/nprot.2013.021, 10.1038/nprot.nprot.2013.021]; Winder CL, 2011, METHOD ENZYMOL, V500, P261, DOI 10.1016/B978-0-12-385118-5.00014-1; Zhang ZY, 2006, LAB CHIP, V6, P906, DOI 10.1039/b518396k	30	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133384	10.1371/journal.pone.0133384	http://dx.doi.org/10.1371/journal.pone.0133384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197065	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600091
J	Matuszek, MA; Anton, A; Thillainathan, S; Armstrong, NJ				Matuszek, Maria A.; Anton, Angelyn; Thillainathan, Sobana; Armstrong, Nicola J.			Increased Insulin following an Oral Glucose Load, Genetic Variation near the Melatonin Receptor MTNR1B, but No Biochemical Evidence of Endothelial Dysfunction in Young Asian Men and Women	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; TYPE-2 DIABETES RISK; METABOLIC SYNDROME; MENSTRUAL-CYCLE; SEX-DIFFERENCES; ADIPOSE-TISSUE; VARIANTS; RESISTANCE; ASSOCIATION; SENSITIVITY	Aim To identify biochemical and genetic variation relating to increased risk of developing type 2 diabetes mellitus and cardiovascular disease in young, lean male and female adults of different ethnicities. Method Fasting blood and urine and non-fasting blood following oral glucose intake were analysed in 90 Caucasians, South Asians and South East/East Asians. Results There were no differences in age, birthweight, blood pressure, body mass index, percent body fat, total energy, percentage of macronutrient intake, microalbumin, leptin, cortisol, adrenocorticotropic hormone, nitric oxide metabolites, C-reactive protein, homocysteine, tumor necrosis factor-alpha, interleukin-6, von Willebrand factor, vascular cell adhesion molecule-1, plasminogen activator inhibitor-1, and tissue plasminogen activator. Fasting total cholesterol (P =.000), triglycerides (P = .050), low density lipoprotein (P = .009) and non-fasting blood glucose (15 min) (P = .024) were elevated in South Asians compared with Caucasians, but there was no significant difference in glucose area under curve (AUC). Non-fasting insulin in South Asians (15-120 min), in South East/East Asians (60-120 min), and insulin AUC in South Asians and South East/East Asians, were elevated compared with Caucasians (P <= 0.006). The molar ratio of C-peptide AUC/Insulin AUC (P = .045) and adiponectin (P = .037) were lower in South Asians compared with Caucasians. A significant difference in allele frequency distributions in Caucasians and South Asians was found for rs2166706 (P = 0.022) and rs10830963 (P = 0.009), which are both near the melatonin receptor MTNR1B. Conclusions Elevated non-fasting insulin exists in young South Asians of normal fasting glucose and insulin. Hepatic clearance of insulin may be reduced in South Asians. No current biochemical evidence exists of endothelial dysfunction at this stage of development. MTNR1B signalling may be a useful therapeutic target in Asian populations in the prevention of type 2 diabetes mellitus.	[Matuszek, Maria A.; Anton, Angelyn; Thillainathan, Sobana] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Armstrong, Nicola J.] Murdoch Univ, Math & Stat, Perth, WA, Australia	University of New South Wales Sydney; Murdoch University	Matuszek, MA (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia.	m.matuszek@unsw.edu.au	Armstrong, Nicola J./AAF-3045-2021	Armstrong, Nicola J./0000-0002-4477-293X	University of New South Wales Faculty Grant Project [PS12293]	University of New South Wales Faculty Grant Project	The author MAM received a University of New South Wales Faculty Grant Project PS12293. The funding committee had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; Abate N, 2001, J DIABETES COMPLICAT, V15, P320, DOI 10.1016/S1056-8727(01)00161-1; Avogaro A, 2005, CLIN CHIM ACTA, V360, P9, DOI 10.1016/j.cccn.2005.04.020; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575; Bingley CA, 2008, HORM METAB RES, V40, P901, DOI 10.1055/s-0028-1082081; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; Carulli L, 2005, ALIMENT PHARM THERAP, V22, P16, DOI 10.1111/j.1365-2036.2005.02588.x; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Chew GT, 2006, MED J AUSTRALIA, V185, P445, DOI 10.5694/j.1326-5377.2006.tb00644.x; Chowdhury TA, 2003, BRIT MED J, V327, P1059, DOI 10.1136/bmj.327.7423.1059; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dickinson S, 2002, J NUTR, V132, P2574, DOI 10.1093/jn/132.9.2574; DIMSDALE JE, 1991, CIRCULATION, V83, P36; Donahue RP, 2007, DIABETES CARE, V30, P354, DOI 10.2337/dc06-1772; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Elbein Steven C, 2009, J Diabetes Sci Technol, V3, P685; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Faerch K, 2010, DIABETOLOGIA, V53, P858, DOI 10.1007/s00125-010-1673-4; Faerch K, 2013, DIABETES CARE, V36, P3691, DOI 10.2337/dc13-0592; Feldstein CA, 2002, J HUM HYPERTENS, V16, pS48, DOI 10.1038/sj.jhh.1001342; Frayling TM, 2007, DIABETIC MED, V24, P696, DOI 10.1111/j.1464-5491.2007.02172.x; Gordon BA, 2009, DIABETES RES CLIN PR, V83, P157, DOI 10.1016/j.diabres.2008.11.024; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hong KW, 2009, DIABETES RES CLIN PR, V84, P117, DOI 10.1016/j.diabres.2009.02.019; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Kalsbeek A, 2014, MOL METAB, V3, P372, DOI 10.1016/j.molmet.2014.03.002; Karamitri A, 2013, MOL ENDOCRINOL, V27, P1217, DOI 10.1210/me.2013-1101; Ko GTC, 2001, BRIT J NUTR, V85, P239, DOI 10.1079/BJN2000251; Kuriyan R, 1998, INDIAN J MED RES, V107, P37; Kurose T, 2011, J DIABETES INVEST, V2, P176, DOI 10.1111/j.2040-1124.2011.00105.x; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f; Lardone PJ, 2014, CURR PHARM DESIGN, V20, P4841; Liao SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040113; Liew CF, 2003, INT J OBESITY, V27, P784, DOI 10.1038/sj.ijo.0802307; Liu C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-59; Liu PH, 2009, J CLIN ENDOCR METAB, V94, P3575, DOI 10.1210/jc.2009-0609; Lopez LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006133.pub2; Luo YY, 2009, DIABETES RES CLIN PR, V85, P139, DOI 10.1016/j.diabres.2009.04.024; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Marchetti P, 2012, ISLETS, V4, P323, DOI 10.4161/isl.22282; Marques RG, 2004, PANCREAS, V29, P231, DOI 10.1097/00006676-200410000-00009; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Meier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE849, DOI 10.1152/ajpendo.00289.2007; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Mohan V, 2007, INDIAN J MED RES, V125, P217; Mora MEV, 2003, J AM COLL NUTR, V22, P487, DOI 10.1080/07315724.2003.10719326; Mussig K, 2010, ANN MED, V42, P387, DOI 10.3109/07853890.2010.502125; Nagorny C, 2012, CURR DIABETES REP, V12, P667, DOI 10.1007/s11892-012-0327-y; Okamoto K, 2010, AM J HUM GENET, V86, P54, DOI 10.1016/j.ajhg.2009.12.009; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Peschke E, 2012, J PINEAL RES, V52, P389, DOI 10.1111/j.1600-079X.2011.00951.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Pulido JME, 1999, ARCH MED RES, V30, P19, DOI 10.1016/S0188-0128(98)00008-6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2008, CURR MOL MED, V8, P519, DOI 10.2174/156652408785747915; Radha V, 2007, INDIAN J MED RES, V125, P259; Rattarasarn C, 2006, ACTA PHYSIOL, V186, P87, DOI 10.1111/j.1748-1716.2005.01521.x; Rees SD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-83; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sanghera DK, 2010, METABOLISM, V59, P492, DOI 10.1016/j.metabol.2009.07.043; She MH, 2014, EUR J PHARMACOL, V744, P220, DOI 10.1016/j.ejphar.2014.08.012; SHUSTER LT, 1988, DIABETES, V37, P200, DOI 10.2337/diabetes.37.2.200; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Sluijs I, 2010, DIABETES CARE, V33, P43, DOI 10.2337/dc09-1321; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Srinivasan V, 2013, RECENT PATENTS ENDOC, V7, P11, DOI 10.2174/187221413804660953; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003962; Taddei S, 1996, CIRCULATION, V94, P1298, DOI 10.1161/01.CIR.94.6.1298; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Tosini G, 2014, BIOESSAYS, V36, P778, DOI 10.1002/bies.201400017; TOTH EL, 1987, J CLIN ENDOCR METAB, V64, P74, DOI 10.1210/jcem-64-1-74; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; Twigg SM, 2007, MED J AUSTRALIA, V186, P461, DOI 10.5694/j.1326-5377.2007.tb00998.x; VALDES CT, 1991, J CLIN ENDOCR METAB, V72, P642, DOI 10.1210/jcem-72-3-642; Wahlqvist ML, 2001, ASIA PAC J CLIN NUTR, V10, P90, DOI 10.1111/j.1440-6047.2001.00228.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zhou DZ, 2009, J HUM GENET, V54, P433, DOI 10.1038/jhg.2009.54; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295; Zizek B, 2001, J INTERN MED, V249, P189, DOI 10.1046/j.1365-2796.2001.00794.x	91	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133611	10.1371/journal.pone.0133611	http://dx.doi.org/10.1371/journal.pone.0133611			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196519	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600118
J	Romer, JD; Gitelman, AI; Clements, S; Schreck, CB				Romer, Jeremy D.; Gitelman, Alix I.; Clements, Shaun; Schreck, Carl B.			Designing a Monitoring Program to Estimate Estuarine Survival of Anadromous Salmon Smolts: Simulating the Effect of Sample Design on Inference	PLOS ONE			English	Article							PACIFIC SALMON; COLUMBIA RIVER; JUVENILE SALMONIDS; BRITISH-COLUMBIA; STEELHEAD SMOLTS; CHINOOK SALMON; CONSERVATION; MIGRATION; BEHAVIOR; OREGON	A number of researchers have attempted to estimate salmonid smolt survival during outmigration through an estuary. However, it is currently unclear how the design of such studies influences the accuracy and precision of survival estimates. In this simulation study we consider four patterns of smolt survival probability in the estuary, and test the performance of several different sampling strategies for estimating estuarine survival assuming perfect detection. The four survival probability patterns each incorporate a systematic component (constant, linearly increasing, increasing and then decreasing, and two pulses) and a random component to reflect daily fluctuations in survival probability. Generally, spreading sampling effort (tagging) across the season resulted in more accurate estimates of survival. All sampling designs in this simulation tended to under-estimate the variation in the survival estimates because seasonal and daily variation in survival probability are not incorporated in the estimation procedure. This under-estimation results in poorer performance of estimates from larger samples. Thus, tagging more fish may not result in better estimates of survival if important components of variation are not accounted for. The results of our simulation incorporate survival probabilities and run distribution data from previous studies to help illustrate the tradeoffs among sampling strategies in terms of the number of tags needed and distribution of tagging effort. This information will assist researchers in developing improved monitoring programs and encourage discussion regarding issues that should be addressed prior to implementation of any telemetry-based monitoring plan. We believe implementation of an effective estuary survival monitoring program will strengthen the robustness of life cycle models used in recovery plans by providing missing data on where and how much mortality occurs in the riverine and estuarine portions of smolt migration. These data could result in better informed management decisions and assist in guidance for more effective estuarine restoration projects.	[Romer, Jeremy D.; Clements, Shaun] Oregon Dept Fish & Wildlife Fish Res, Corvallis, OR USA; [Gitelman, Alix I.] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA; [Schreck, Carl B.] Oregon State Univ, United States Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey	Romer, JD (corresponding author), Oregon Dept Fish & Wildlife Fish Res, Corvallis, OR USA.	Jeremy.Romer2@oregonstate.edu		Romer, Jeremy/0000-0001-8107-2134				Adrean L, 2013, AVIAN PREDATION PROG; Allendorf FW, 1997, CONSERV BIOL, V11, P140, DOI 10.1046/j.1523-1739.1997.95248.x; American Banker, 2002, WASHINGTON COMPREHEN, V5, P1; [Anonymous], 1998, OREGON PLAN SALMON W; Brosnan IG, 2014, MAR ECOL PROG SER, V496, P181, DOI 10.3354/meps10550; Brown E, 2011, OPSWODFW201109; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Buchanan RA, 2013, N AM J FISH MANAGE, V33, P216, DOI 10.1080/02755947.2012.728178; Clemens BJ, 2009, T AM FISH SOC, V138, P169, DOI 10.1577/T07-090.1; Clements S, 2012, AQUACULTURE, V362, P148, DOI 10.1016/j.aquaculture.2011.11.029; Drenner SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031311; Harnish RA, 2012, T AM FISH SOC, V141, P507, DOI 10.1080/00028487.2012.670576; JACOBS S, 2000, OPSWODFW20003; Johnson SL, 2010, N AM J FISH MANAGE, V30, P55, DOI 10.1577/M08-224.1; Lichatowich J.A., 1999, SALMON RIVERS HIST P; MEFFE GK, 1992, CONSERV BIOL, V6, P350, DOI 10.1046/j.1523-1739.1992.06030350.x; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Romer JD, 2013, ENVIRON BIOL FISH, V96, P849, DOI 10.1007/s10641-012-0080-8; Slaney TL, 1996, FISHERIES, V21, P20, DOI 10.1577/1548-8446(1996)021<0020:SOASAT>2.0.CO;2; Suring E., 2012, OPSWODFW20122; Suring E, 2009, OPSWODFW20091; United States Fish and Wildlife Service (USFWS) and National Marine Fisheries Service (NMFS), 1976, LOW SNAK RIV COMP PL; Waples RS, 2008, EVOL APPL, V1, P183, DOI 10.1111/j.1752-4571.2008.00035.x; Washington Department of Fish and Wildlife, 2008, 21 CENT SALM STEELH; Welch DW, 2011, P NATL ACAD SCI USA, V108, P8708, DOI 10.1073/pnas.1014044108; Williams JG, 2005, EFFECTS FEDERAL COLU, P63; [No title captured]	29	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132912	10.1371/journal.pone.0132912	http://dx.doi.org/10.1371/journal.pone.0132912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196283	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600056
J	Raman, K; Wang, HQ; Troncone, MJ; Khan, WI; Pare, G; Terry, J				Raman, Kripa; Wang, Huaqing; Troncone, Michael J.; Khan, Waliul I.; Pare, Guillaume; Terry, Jefferson			Overlap Chronic Placental Inflammation Is Associated with a Unique Gene Expression Pattern	PLOS ONE			English	Article							B-CELL DEVELOPMENT; UNKNOWN ETIOLOGY; FETOMATERNAL INTERFACE; IMMUNE-SYSTEM; VILLITIS; CHORIOAMNIONITIS; MICROARRAY; TOLERANCE; PREGNANCY; REJECTION	Breakdown of the balance between maternal pro- and anti-inflammatory pathways is thought to allow an anti-fetal maternal immune response that underlies development of chronic placental inflammation. Chronic placental inflammation is manifested by the influx of maternal inflammatory cells, including lymphocytes, histiocytes, and plasma cells, into the placental membranes, villi, and decidua. These infiltrates are recognized pathologically as chronic chorioamnionitis, chronic villitis of unknown etiology, and chronic deciduitis. Each of these histological entities is associated with adverse fetal outcomes including intrauterine growth restriction and preterm birth. Studying the gene expression patterns in chronically inflamed placenta, particularly when overlapping histologies are present, may lead to a better understanding of the underlying mechanism(s). Therefore, this study compared tissue with and without chronic placental inflammation, manifested as overlapping chronic chorioamnionitis, chronic villitis of unknown etiology, and chronic deciduitis. RNA expression profiling was conducted on formalin fixed, paraffin embedded placental tissue using Illumina microarrays. IGJ was the most significant differentially expressed gene identified and had increased expression in the inflamed tissue. In addition, IGLL1, CXCL13, CD27, CXCL9, ICOS, and KLRC1 had increased expression in the inflamed placental samples. These differentially expressed genes are associated with T follicular helper cells, natural killer cells, and B cells. Furthermore, these genes differ from those typically associated with the individual components of chronic placental inflammation, such as chronic villitis, suggesting that the inflammatory infiltrate associated with overlapping chronic chorioamnionitis, chronic villitis of unknown etiology, and chronic deciduitis differs is unique. To further explore and validate gene expression findings, we conducted immunohistochemical assessment of protein level expression and demonstrate that IgJ expression was largely attributable to the presence of plasma cells as part of chronic deciduitis and that IgA positive plasma cells are associated with chronic deciduitis occurring in combination with chronic chorioamnionitis and chronic villitis of unknown etiology but not with isolated chronic deciduitis.	[Raman, Kripa; Pare, Guillaume] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Raman, Kripa; Wang, Huaqing; Troncone, Michael J.; Khan, Waliul I.; Pare, Guillaume; Terry, Jefferson] McMaster Univ, Hamilton, ON, Canada; [Raman, Kripa; Pare, Guillaume] Hamilton Hlth Sci, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Wang, Huaqing; Khan, Waliul I.; Pare, Guillaume] Hamilton Hlth Sci, Famcombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Wang, Huaqing; Troncone, Michael J.; Khan, Waliul I.; Terry, Jefferson] Hamilton Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University	Terry, J (corresponding author), Hamilton Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada.	terryj@hhsc.ca	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760; Terry, Jefferson/0000-0001-5464-8679	Hamilton Health Sciences New Investigator Fund	Hamilton Health Sciences New Investigator Fund	Funding for this work is provided by the Hamilton Health Sciences New Investigator Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Ben-Hur H, 2001, IN VIVO, V15, P429; Billingham RE, 2010, J IMMUNOL, V184, P5, DOI 10.4049/jimmunol.0990109; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; Edmondson N, 2009, PEDIATR DEVEL PATHOL, V12, P16, DOI 10.2350/07-04-0270.1; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Munoz-Fernandez R, 2012, HUM REPROD, V27, P2775, DOI 10.1093/humrep/des198; Nagamatsu T, 2011, IMMUNOL CELL BIOL, V89, P417, DOI 10.1038/icb.2010.101; Nutku E, 2003, BLOOD, V101, P5014, DOI 10.1182/blood-2002-10-3058; Ohnishi K, 2000, J BIOL CHEM, V275, P31134, DOI 10.1074/jbc.M005901200; Pinar H, 1996, PEDIATR PATHOL LAB M, V16, P901, DOI 10.1080/15513819609168713; Plancade S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-329; Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; REDLINE RW, 1993, AM J PATHOL, V143, P473; Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P443, DOI 10.1007/s10024-004-2020-x; Riella LV, 2013, AM J PATHOL, V182, P2204, DOI 10.1016/j.ajpath.2013.02.014; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tamblyn JA, 2013, PLACENTA, V34, P846, DOI 10.1016/j.placenta.2013.07.002; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Waddell N, 2010, J PATHOL, V221, P452, DOI 10.1002/path.2728; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360	33	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133738	10.1371/journal.pone.0133738	http://dx.doi.org/10.1371/journal.pone.0133738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207633	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000129
J	Arif, M; Kattan, A				Arif, Muhammad; Kattan, Ahmed			Physical Activities Monitoring Using Wearable Acceleration Sensors Attached to the Body	PLOS ONE			English	Article							ACTIVITY RECOGNITION; ROTATION FOREST; CLASSIFICATION; ACCELEROMETRY; EXERCISE; OVERWEIGHT; WEIGHT; DIET	Monitoring physical activities by using wireless sensors is helpful for identifying postural orientation and movements in the real-life environment. A simple and robust method based on time domain features to identify the physical activities is proposed in this paper; it uses sensors placed on the subjects' wrist, chest and ankle. A feature set based on time domain characteristics of the acceleration signal recorded by acceleration sensors is proposed for the classification of twelve physical activities. Nine subjects performed twelve different types of physical activities, including sitting, standing, walking, running, cycling, Nordic walking, ascending stairs, descending stairs, vacuum cleaning, ironing clothes and jumping rope, and lying down (resting state). Their ages were 27.2 +/- 3.3 years and their body mass index (BMI) is 25.11 +/- 2.6 Kg/m(2). Classification results demonstrated a high validity showing precision (a positive predictive value) and recall (sensitivity) of more than 95% for all physical activities. The overall classification accuracy for a combined feature set of three sensors is 98%. The proposed framework can be used to monitor the physical activities of a subject that can be very useful for the health professional to assess the physical activity of healthy individuals as well as patients.	[Arif, Muhammad; Kattan, Ahmed] Umm Alqura Univ, Dept Comp Sci, Coll Comp & Informat Syst, Mecca, Saudi Arabia	Umm Al Qura University	Arif, M (corresponding author), Umm Alqura Univ, Dept Comp Sci, Coll Comp & Informat Syst, Mecca, Saudi Arabia.	syedmarif2003@yahoo.com	Kattan, Ahmed/AAN-8954-2020	Arif, Muhammad/0000-0003-0513-9872	National Plan for Science, Technology and Innovation (MAARIFAH) King Abdul Aziz city for science and Technology, Kingdom of Saudi Arabia [12-INF2290-10]	National Plan for Science, Technology and Innovation (MAARIFAH) King Abdul Aziz city for science and Technology, Kingdom of Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH) King Abdul Aziz city for science and Technology, the Kingdom of Saudi Arabia, award number (12-INF2290-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Alves N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-23; Atallah L, 2011, IEEE T BIOMED CIRC S, V5, P320, DOI 10.1109/TBCAS.2011.2160540; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Chuy OY, 2007, IEEE T ROBOT, V23, P899, DOI 10.1109/TRO.2007.907920; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Ermes M, 2008, IEEE T INF TECHNOL B, V12, P20, DOI 10.1109/TITB.2007.899496; Fausett LV, 2006, FUNDAMENTALS NEURAL; Forster M, 2011, INT J OBESITY, V35, P1071, DOI 10.1038/ijo.2010.246; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Glover J, 2004, IEEE INT CONF ROBOT, P3306, DOI 10.1109/ROBOT.2004.1308764; Gubbi J, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-33; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Hall M.A, 1999, CORRELATION BASED FE; Hanai Y, 2009, 2009 IEEE 13TH DIGITAL SIGNAL PROCESSING WORKSHOP & 5TH IEEE PROCESSING EDUCATION WORKSHOP, VOLS 1 AND 2, PROCEEDINGS, P675, DOI 10.1109/DSP.2009.4786008; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; Ibata Y, 2013, IEEE ENG MED BIO, P4891, DOI 10.1109/EMBC.2013.6610644; Khan M, 2011, FEATURE EXTRACTION M; Kuncheva LI, 2007, LECT NOTES COMPUT SC, V4472, P459; Kwapisz JR., 2011, ACM SIGKDD EXPLORATI, V12, P74, DOI [10.1145/1964897.1964918, DOI 10.1145/1964897.1964918]; Vinh LT, 2011, APPL INTELL, V35, P226, DOI 10.1007/s10489-010-0216-5; Lara OD, 2013, IEEE COMMUN SURV TUT, V15, P1192, DOI 10.1109/SURV.2012.110112.00192; Lester J, 2006, LECT NOTES COMPUT SC, V3968, P1; Lopez FG, 2006, EUR J OPER RES, V169, P477, DOI 10.1016/j.ejor.2004.08.010; Lyons GM, 2005, MED ENG PHYS, V27, P497, DOI 10.1016/j.medengphy.2004.11.006; Mannini A, 2010, SENSORS-BASEL, V10, P1154, DOI 10.3390/s100201154; Mantyla T.J., 2001, P IEEE INT C SYST MA, V3494, P747, DOI DOI 10.1109/ICSMC.2001.973004; Marti R, 2006, EUR J OPER RES, V169, P359, DOI 10.1016/j.ejor.2004.08.004; Mathie MJ, 2004, MED BIOL ENG COMPUT, V42, P679, DOI 10.1007/BF02347551; Mathie MJ, 2004, PHYSIOL MEAS, V25, pR1, DOI 10.1088/0967-3334/25/2/R01; Maurer U, 2006, BSN 2006: INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P113; McGlynn D, 2011, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXVII: INCORPORATING APPLICATIONS AND INNOVATIONS IN INTELLIGENT SYSTEMS XVIII, P339, DOI 10.1007/978-0-85729-130-1_26; Minnen D, 2007, IFMBE PROC, V13, P236; Ohtaki Y., 2004, POWER, V100, P102; Parkka J, 2006, IEEE T INF TECHNOL B, V10, P119, DOI 10.1109/TITB.2005.856863; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Phinyomark A., 2009, ARXIV09123973; Preece SJ, 2009, IEEE T BIO-MED ENG, V56, P871, DOI 10.1109/TBME.2008.2006190; Reiss A, 2012, CREATING BENCHMARKIN, P40; Reiss A, 2012, IEEE INT SYM WRBL CO, P108, DOI 10.1109/ISWC.2012.13; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Sekine M, 2000, MED ENG PHYS, V22, P285, DOI 10.1016/S1350-4533(00)00041-2; Seon-Woo Lee, 2002, IEEE Pervasive Computing, V1, P24, DOI 10.1109/MPRV.2002.1037719; Shammas L, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-10; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; W.H.O, 2013, OB OV FACT SHEETS WH; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Zhu C, 2009, HUMAN DAILY ACTIVITY, P2154	50	64	64	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0130851	10.1371/journal.pone.0130851	http://dx.doi.org/10.1371/journal.pone.0130851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203909	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000001
J	Bailleul, F; Vacquie-Garcia, J; Guinet, C				Bailleul, Frederic; Vacquie-Garcia, Jade; Guinet, Christophe			Dissolved Oxygen Sensor in Animal-Borne Instruments: An Innovation for Monitoring the Health of Oceans and Investigating the Functioning of Marine Ecosystems	PLOS ONE			English	Article							ELEPHANT SEALS; SOUTHERN-OCEAN; INDIAN-OCEAN; WATER; CIRCULATION; TILETAMINE; SWORDFISH; ZOLAZEPAM; WHALES	The current decline in dissolved oxygen concentration within the oceans is a sensitive indicator of the effect of climate change on marine environment. However the impact of its declining on marine life and ecosystems' health is still quite unclear because of the difficulty in obtaining in situ data, especially in remote areas, like the Southern Ocean (SO). Southern elephant seals (Mirounga leonina) proved to be a relevant alternative to the traditional oceanographic platforms to measure physical and biogeochemical structure of oceanic regions rarely observed. In this study, we use a new stage of development in biologging technology to draw a picture of dissolved oxygen concentration in the SO. We present the first results obtained from a dissolved oxygen sensor added to Argos CTD-SRDL tags and deployed on 5 female elephant seals at Kerguelen. From October 2010 and October 2011, 742 oxygen profiles associated with temperature and salinity measurements were recorded. Whether a part of the data must be considered cautiously, especially because of offsets and temporal drifts of the sensors, the range of values recorded was consistent with a concomitant survey conducted from a research vessel (Keops-2 project). Once again, elephant seals reinforced the relationship between marine ecology and oceanography, delivering essential information about the water masses properties and the biological status of the Southern Ocean. But more than the presentation of a new stage of development in animal-borne instrumentation, this pilot study opens a new field of investigation in marine ecology and could be enlarged in a near future to other key marine predators, especially large fish species like swordfish, tuna or sharks, for which dissolved oxygen is expected to play a crucial role in distribution and behaviour.	[Bailleul, Frederic] South Australian Res & Dev Inst Aquat Sci, Adelaide, SA 5024, Australia; [Bailleul, Frederic; Vacquie-Garcia, Jade; Guinet, Christophe] Univ La Rochelle, CNRS, Ctr Etudes Biol Chize, UMR 7372, F-79360 Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Bailleul, F (corresponding author), South Australian Res & Dev Inst Aquat Sci, 2 Hamra Ave,West Beach, Adelaide, SA 5024, Australia.	fred.bailleul@sa.gov.au	Guinet, Christophe/AAR-8457-2020	VACQUIE GARCIA, Jade/0000-0002-3126-3423	French Polar Institute (Institut Paul Emile Victor, IPEV); Territoire des Terres Australes et Antarctiques Francaises (TAAF); Total Foundation	French Polar Institute (Institut Paul Emile Victor, IPEV); Territoire des Terres Australes et Antarctiques Francaises (TAAF); Total Foundation(Total SA)	This study is part of the National Research Program (no. 109, H. Weimerskirch and the observatory Mammiferes Explorateurs du Milieu Oceanique, MEMO SOERE CTD 02) supported by the French Polar Institute (Institut Paul Emile Victor, IPEV) and the Territoire des Terres Australes et Antarctiques Francaises (TAAF). This work was carried out in the framework of ANR TOPP-PATCHES and CNES-TOSCA programs and was supported by the Total Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2010, ICES J MAR SCI, V67, P466, DOI 10.1093/icesjms/fsp252; Bailleul Frederic, 2012, Endangered Species Research, V17, P27, DOI 10.3354/esr00420; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bindoff NL, 2000, J PHYS OCEANOGR, V30, P1207, DOI 10.1175/1520-0485(2000)030<1207:DCAAIO>2.0.CO;2; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Coppola L, 2012, WHITE PAPER DISSOLVE; Costa DP, 2008, DEEP-SEA RES PT II, V55, P323, DOI 10.1016/j.dsr2.2007.11.003; Dehairs F, 1990, GLOBAL BIOGEOCHEM CY, V4, P85, DOI 10.1029/GB004i001p00085; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Guinet C, 2013, EARTH SYST SCI DATA, V5, P15, DOI 10.5194/essd-5-15-2013; Joos F., 2003, EOS T AM GEOPHYS UN, V84, P197, DOI [10.1029/2003EO210001, DOI 10.1029/2003EO210001, DOI 10.1029/2003E0210001]; Jorgensen SJ, 2009, J FISH BIOL, V74, P1682, DOI 10.1111/j.1095-8649.2009.02230.x; Kortzinger A, 2005, J ATMOS OCEAN TECH, V22, P302, DOI 10.1175/JTECH1701.1; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; Matear RJ, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000086; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; McGillicuddy DJ, 1999, J GEOPHYS RES, V104, P13; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; PAPASTAVROU V, 1989, CAN J ZOOL, V67, P839, DOI 10.1139/z89-124; PARK YH, 1993, J GEOPHYS RES-OCEANS, V98, P12361, DOI 10.1029/93JC00938; Potier M, 2007, FISH RES, V83, P60, DOI 10.1016/j.fishres.2006.08.020; Riser SC, 2008, NATURE, V451, P323, DOI 10.1038/nature06441; Roquet F, 2013, GEOPHYS RES LETT, V40, P6176, DOI 10.1002/2013GL058304; Roquet F, 2011, J ATMOS OCEAN TECH, V28, P787, DOI 10.1175/2010JTECHO801.1; Roquet F, 2009, J MARINE SYST, V78, P377, DOI 10.1016/j.jmarsys.2008.11.017; Schmittner A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002953; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Sparrow MD, 1996, J GEOPHYS RES-OCEANS, V101, P6377, DOI 10.1029/95JC03750; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Vacquie-Garcia J, 2015, DEEP-SEA RES PT II, V113, P145, DOI 10.1016/j.dsr2.2014.10.029	39	11	11	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132681	10.1371/journal.pone.0132681	http://dx.doi.org/10.1371/journal.pone.0132681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200780	Green Published, gold			2022-12-27	WOS:000358597100045
J	Suzuki-Hashido, N; Hayakawa, T; Matsui, A; Go, Y; Ishimaru, Y; Misaka, T; Abe, K; Hirai, H; Satta, Y; Imai, H				Suzuki-Hashido, Nami; Hayakawa, Takashi; Matsui, Atsushi; Go, Yasuhiro; Ishimaru, Yoshiro; Misaka, Takumi; Abe, Keiko; Hirai, Hirohisa; Satta, Yoko; Imai, Hiroo			Rapid Expansion of Phenylthiocarbamide Non-Tasters among Japanese Macaques	PLOS ONE			English	Article							RECEPTOR GENE REPERTOIRE; HAPLOTYPE RECONSTRUCTION; POSITIVE SELECTION; STATISTICAL-METHOD; EVOLUTION; SENSITIVITY; POLYMORPHISM; HUMANS; ALLELE; MODEL	Bitter taste receptors (TAS2R proteins) allow mammals to detect and avoid ingestion of toxins in food. Thus, TAS2Rs play an important role in food choice and are subject to complex natural selection pressures. In our previous study, we examined nucleotide variation in TAS2R38, a gene expressing bitter taste receptor for phenylthiocarbamide (PTC), in 333 Japanese macaques (Macaca fuscata) from 9 local populations in Japan. We identified a PTC "non-taster" TAS2R38 allele in Japanese macaques that was caused by a loss of the start codon. This PTC non-taster allele was only found in a limited local population (the Kii area), at a frequency of 29%. In this study, we confirmed that this allele was present in only the Kii population by analyzing an additional 264 individuals from eight new populations. Using cellular and behavioral experiments, we found that this allele lost its receptor function for perceiving PTC. The nucleotide sequences of the allele including flanking regions (of about 10 kb) from 23 chromosomes were identical, suggesting that a non-taster allele arose and expanded in the Kii population during the last 13,000 years. Genetic analyses of non-coding regions in Kii individuals and neighboring populations indicated that the high allele frequency in the Kii population could not be explained by demographic history, suggesting that positive selection resulted in a rapid increase in PTC non-tasters in the Kii population. The loss-of-function that occurred at the TAS2R38 locus presumably provided a fitness advantage to Japanese macaques in the Kii population. Because TAS2R38 ligands are often found in plants, this functional change in fitness is perhaps related to feeding habit specificity. These findings should provide valuable insights for elucidating adaptive evolutionary changes with respect to various environments in wild mammals.	[Suzuki-Hashido, Nami; Hayakawa, Takashi; Matsui, Atsushi; Go, Yasuhiro; Hirai, Hirohisa; Imai, Hiroo] Kyoto Univ, Primate Res Inst, Mol Biol Sect, Dept Cellular & Mol Biol, Inuyama, Aichi 484, Japan; [Suzuki-Hashido, Nami; Hayakawa, Takashi] Japan Soc Promot Sci, Tokyo, Japan; [Ishimaru, Yoshiro; Misaka, Takumi; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Satta, Yoko] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan	Kyoto University; Japan Society for the Promotion of Science; University of Tokyo; Graduate University for Advanced Studies - Japan	Satta, Y (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.	satta@soken.ac.jp; imai.hiroo.5m@kyoto-u.ac.jp	Hayakawa, Takashi/U-9518-2018; Ishimaru, Yoshiro/AAI-3049-2020; Imai, Hiroo/AAP-2393-2020; Go, Yasuhiro/AAD-3313-2020	Hayakawa, Takashi/0000-0002-1037-0350; Imai, Hiroo/0000-0003-0729-0322; Go, Yasuhiro/0000-0003-4581-0325; Satta, Yoko/0000-0002-5305-493X; Misaka, Takumi/0000-0002-9547-5767; Suzuki-Hashido, Nami/0000-0002-9934-7324	MEXT; JSPS KAKENHI [12J04300, 21370109, 24370096, 26117512]; Grants-in-Aid for Scientific Research [26304008, 26242007] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from MEXT and JSPS KAKENHI to NS (12J04300) and to HI (21370109, 24370096, and 26117512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; CHIARELLI B., 1963, FOLIA PRIMATOLOGICA [BASEL], V1, P88, DOI 10.1159/000165784; Conte C, 2003, PHYSIOL GENOMICS, V14, P73, DOI 10.1152/physiolgenomics.00060.2003; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Fisher RA, 1939, NATURE, V144, P750, DOI 10.1038/144750a0; Go Y, 2006, MOL BIOL EVOL, V23, P964, DOI 10.1093/molbev/msj106; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; Hayakawa T, 2014, MOL BIOL EVOL, V31, P2018, DOI 10.1093/molbev/msu144; Hayakawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043277; HIRAI M, 1990, J JPN SOC HORTIC SCI, V59, P1, DOI 10.2503/jjshs.59.1; Iwahori S, 1990, GENERAL REMARKS OF C; Kawamoto Y, 2007, PRIMATES, V48, P27, DOI 10.1007/s10329-006-0013-2; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KIMURA M, 1971, GENET RES, V18, P125, DOI 10.1017/S0016672300012520; KIMURA M, 1964, GENETICS, V49, P561; KIMURA M, 1973, GENETICS, V75, P199; Li DY, 2014, MOL BIOL EVOL, V31, P303, DOI 10.1093/molbev/mst219; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marmi J, 2004, MOL PHYLOGENET EVOL, V30, P676, DOI 10.1016/S1055-7903(03)00247-1; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; NEI M, 1977, AM J HUM GENET, V29, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NOZAWA K, 1982, Primates, V23, P252, DOI 10.1007/BF02381165; NOZAWA K, 1991, PRIMATES, V32, P411, DOI 10.1007/BF02381934; NOZAWA K, 1972, Primates, V13, P381, DOI 10.1007/BF01793658; Osada N, 2010, MOL ECOL, V19, P2884, DOI 10.1111/j.1365-294X.2010.04687.x; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Sandell MA, 2006, CURR BIOL, V16, pR792, DOI 10.1016/j.cub.2006.08.049; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shishikura M, 2013, GSJ CHISHITSU NEWS, V2, P201; Sivakumar K, 2010, HYSTRIX, V21, P35; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suzuki N, 2010, PRIMATES, V51, P285, DOI 10.1007/s10329-010-0209-3; TAJIMA F, 1989, GENETICS, V123, P585; Takaki A, 2012, IMMUNOGENETICS, V64, P15, DOI 10.1007/s00251-011-0556-2; Tsuji Yamato, 2012, Primate Research, V28, P109; Ueda T, 2003, J NEUROSCI, V23, P7376; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Wooding S, 2011, J MOL EVOL, V73, P257, DOI 10.1007/s00239-011-9481-0; Wooding S, 2010, CHEM SENSES, V35, P685, DOI 10.1093/chemse/bjq061; Wright S, 1931, GENETICS, V16, P0097	53	8	9	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132016	10.1371/journal.pone.0132016	http://dx.doi.org/10.1371/journal.pone.0132016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201026	Green Submitted, gold, Green Published			2022-12-27	WOS:000358597100023
J	Zhang, G; Li, Q; Zhang, RR; Wei, X; Wang, JY; Qin, XY				Zhang, Gang; Li, Qi; Zhang, Rongrong; Wei, Xiao; Wang, Junyi; Qin, Xinyue			Subtypes and Prognosis of Guillain-Barre Syndrome in Southwest China	PLOS ONE			English	Article							BRAIN-STEM ENCEPHALITIS; RETROSPECTIVE ANALYSIS; CLINICAL-FEATURES; FISHER SYNDROME; MORTALITY	The proportion of different subtypes of Guillain-Barre syndrome (GBS) and their prognosis varied significantly among different regions. This study attempts to investigate the clinical subtypes and outcome of GBS in southwest China. Patients with GBS admitted to The First Affiliated Hospital of Chongqing Medical University from January 2006 to March 2013 were included in our study. Patients were classified into acute inflammatory demyelinating polyneuropathy (AIDP) group, acute motor axonal neuropathy (AMAN) group, Miller-Fisher syndrome (MFS) group, cranial nerve variants(CNV), Bickerstaff's brainstem encephalitis overlaps with GBS (BBE-GBS) group and unclassifiable group based on clinical features and electrophysiological findings. Hughes function grade score (HFGS) was used to assess the prognosis at 3 and 6 months. The prognosis of different subtypes and outcome predictors were analyzed. The most common subtype of GBS was AIDP (57%), followed by AMAN (22%) and MFS (7%). The prognosis of AMAN and BBE-GBS is similar at 3 month (P = 0.0704) and 6 month (P = 0.1614) follow-up. The prognosis of AMAN group was poorer than that of AIDP group at 3 month and 6 month follow-up (P<0.001). Outcome of MFS group and that of CNV group at 6 months were both good(Hughes <= 1). Hughes >= 3 (P<0.0001, OR = 6.650,95% CI = 2.865 to 15.023)) and dysautonomia (P = 0.043, OR = 2.820,95% CI = 1.031 to 7.715)) were associated with poor outcome at 6 month follow-up. AIDP is the most common subtype of GBS. Prognosis of AMAN group and BBE-GBS group is poorer than that of AIDP group at 3 month and 6 month follow-up. Hughes >= 3 at nadir and dysautonomia are predictors of poor prognosis at 6 month follow-up.	[Zhang, Gang; Li, Qi; Zhang, Rongrong; Wang, Junyi; Qin, Xinyue] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Wei, Xiao] Chongqing Med & Pharmaceut Coll, Dept Med Technol, Chongqing, Peoples R China	Chongqing Medical University	Qin, XY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	Qinxinyue@yahoo.com	wang, junyi/GYA-3213-2022; Li, Qi/ABE-4182-2021	Li, Qi/0000-0002-9144-148X	National Key Clinical Specialties Construction Program of China	National Key Clinical Specialties Construction Program of China	This study is supported by National Key Clinical Specialties Construction Program of China.	Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4; [Anonymous], 1978, Ann Neurol, V3, P565; [Anonymous], 1996, Brain, V119 ( Pt 6), P2053; Bai HX, 2013, J PERIPHER NERV SYST, V18, P195, DOI 10.1111/jns5.12030; Bhargava A, 2014, J NEUROSCI RURAL PRA, V5, pS43, DOI 10.4103/0976-3147.145200; Dhar R, 2008, J NEUROL SCI, V264, P121, DOI 10.1016/j.jns.2007.08.005; Drenthen J, 2011, J NEUROL NEUROSUR PS, V82, P300, DOI 10.1136/jnnp.2010.226639; Gonzalez-Suarez I, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-95; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Hughes RAC, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008630.pub3, DOI 10.1002/14651858.CD008630, 10.1002/14651858.CD008630]; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub5; Kalita J, 2014, J PERIPHER NERV SYST, V19, P36, DOI 10.1111/jns5.12050; Kokubun N, 2013, CLIN NEUROPHYSIOL, V124, P1671, DOI 10.1016/j.clinph.2013.02.010; Kuwabara S, 2002, J NEUROL SCI, V199, P89, DOI 10.1016/S0022-510X(02)00088-6; Lin JJ, 2012, PEDIATR NEUROL, V47, P91, DOI 10.1016/j.pediatrneurol.2012.05.011; Ma YM, 2010, PEDIATR INT, V52, P13, DOI 10.1111/j.1442-200X.2009.02951.x; Mitsui Y, 2015, J NEUROL NEUROSUR PS, V86, P110, DOI 10.1136/jnnp-2013-306509; Mori M, 2001, NEUROLOGY, V56, P1104, DOI 10.1212/WNL.56.8.1104; Ng YS, 2004, ANN ACAD MED SINGAP, V33, P314; Odaka M, 2003, BRAIN, V126, P2279, DOI 10.1093/brain/awg233; Omejec G, 2012, J PERIPHER NERV SYST, V17, P217, DOI 10.1111/j.1529-8027.2012.00397.x; Shahrizaila N, 2013, J NEUROL NEUROSUR PS, V84, P576, DOI 10.1136/jnnp-2012-302824; van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc; van Doorn PA, 2010, J CLIN IMMUNOL, V30, pS74, DOI 10.1007/s10875-010-9407-4; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; Visser LH, 1999, NEUROLOGY, V53, P598, DOI 10.1212/WNL.53.3.598; Vucic S, 2004, CLIN NEUROPHYSIOL, V115, P2329, DOI 10.1016/j.clinph.2004.05.009; Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138; Witsch J, 2013, J NEUROL, V260, P1367, DOI 10.1007/s00415-012-6806-x; Ye YQ, 2013, MUSCLE NERVE, V47, P68, DOI 10.1002/mus.23477; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; Yuki N, 1998, ANN NEUROL, V43, P546, DOI 10.1002/ana.410430424; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	38	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133520	10.1371/journal.pone.0133520	http://dx.doi.org/10.1371/journal.pone.0133520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200903	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100070
J	Cai, XB; Hu, X; Tan, XJ; Cheng, WJ; Wang, QJ; Chen, XF; Guan, YH; Chen, C; Jing, XB				Cai, Xianbin; Hu, Xi; Tan, Xiaojun; Cheng, Weijie; Wang, Qinjia; Chen, Xiaofeng; Guan, Yinghong; Chen, Chong; Jing, Xubin			Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo	PLOS ONE			English	Article							PROTEIN-KINASE; CANCER-CELLS; PROLIFERATION; CISPLATIN; ANGIOGENESIS; INDUCTION; APOPTOSIS; PROSTATE; LIVER	Esophageal squamous cell carcinomas (ESCC) have become a severe threat to health and the current treatments for ESCC are frequently not effective. Recent epidemiological studies suggest that the anti-hyperglycemic agent metformin may reduce the risk of developing cancer, including ESCC, among diabetic patients. However, the antitumor effects of metformin on ESCC and the mechanisms underlying its cell cycle regulation remain elusive. The findings reported herein show that the anti-proliferative action of metformin on ESCC cell lines is partially mediated by AMPK. Moreover, we observed that metformin induced G0/G1 phase arrest accompanied by the up-regulation of p21(CIP1) and p27(KIP1). In vivo experiments further showed that metformin inhibited tumor growth in a ESCC xenograft model. Most importantly, the up-regulation of AMPK, p53, p21(CIP1), p27(KIP1) and the down-regulation of cyclinD1 are involved in the anti-tumor action of metformin in vivo. In conclusion, metformin inhibits the growth of ESCC cells both in cell cultures and in an animal model. AMPK, p53, p21(CIP1), p27(KIP1) and cyclinD1 are involved in the inhibition of tumor growth that is induced by metformin and cell cycle arrest in ESCC. These findings indicate that metformin has the potential for use in the treatment of ESCC.	[Cai, Xianbin; Hu, Xi; Cheng, Weijie; Wang, Qinjia; Chen, Xiaofeng; Guan, Yinghong; Chen, Chong; Jing, Xubin] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Shantou 515031, Guangdong, Peoples R China; [Tan, Xiaojun] Chancheng Dist Cent Hosp, Dept Internal Med, Foshan 528031, Guangdong, Peoples R China	Shantou University	Jing, XB (corresponding author), Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Shantou 515031, Guangdong, Peoples R China.	xbjing@stu.edu.cn	tan, xiao/GZL-0264-2022		National Natural Science Foundation of China [81172263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81172263).	BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Baron JA, 2011, CANCER CAUSE CONTROL, V12, P875; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Deng XK, 2014, J MED FOOD, V17, P787, DOI 10.1089/jmf.2013.2886; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gartel AL, 2002, MOL CANCER THER, V1, P639; Hirst J, 2011, ANN SURG ONCOL, V18, P1766, DOI 10.1245/s10434-010-1508-z; Hung CM, 2012, J AGR FOOD CHEM, V60, P8427, DOI 10.1021/jf302754w; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Kim HJ, 2010, J AGR FOOD CHEM, V58, P8643, DOI 10.1021/jf101510z; Kobayashi M, 2013, INT J ONCOL, V42, P517, DOI 10.3892/ijo.2012.1722; Komninou D, 2003, EXP BIOL MED, V228, P396, DOI 10.1177/153537020322800410; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Luo H, 2012, FOOD CHEM, V130, P321, DOI 10.1016/j.foodchem.2011.07.045; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Memmott RM, 2011, CANCER PREV RES, V3, P1066; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qu Z, 2012, HEPATOL RES, V42, P922, DOI 10.1111/j.1872-034X.2012.01007.x; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Ravi R, 2000, GENE DEV, V14, P34; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Shi P, 2010, J CELL MOL MED, V14, P1777, DOI 10.1111/j.1582-4934.2009.00795.x; Song HY, 2014, EXP THER MED, V8, P1484, DOI 10.3892/etm.2014.1972; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Wu H, 2014, PAK J PHARM SCI, V27, P1661; Xavier DO, 2010, BIOMED PHARMACOTHER, V64, P220, DOI 10.1016/j.biopha.2009.08.004; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Yu L, 2014, CANCER LETT, V355, P34, DOI 10.1016/j.canlet.2014.09.020; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zu XY, 2013, MOLECULES, V18, P1704, DOI 10.3390/molecules18021704	36	64	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133349	10.1371/journal.pone.0133349	http://dx.doi.org/10.1371/journal.pone.0133349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196392	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600087
J	Cheong, HT; Chow, WZ; Takebe, Y; Chook, JB; Chan, KG; Al-Darraji, HAA; Koh, C; Kamarulzaman, A; Tee, KK				Cheong, Hui Ting; Chow, Wei Zhen; Takebe, Yutaka; Chook, Jack Bee; Chan, Kok Gan; Al-Darraji, Haider Abdulrazzaq Abed; Koh, Clayton; Kamarulzaman, Adeeba; Tee, Kok Keng			Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1	In many parts of Southeast Asia, the HIV-1 epidemic has been driven by the sharing of needles and equipment among intravenous drug users (IDUs). Over the last few decades, many studies have proven time and again that the diversity of HIV-1 epidemics can often be linked to the route of infection transmission. That said, the diversity and complexity of HIV-1 molecular epidemics in the region have been increasing at an alarming rate, due in part to the high tendency of the viral RNA to recombine. This scenario was exemplified by the discovery of numerous circulating recombinant forms (CRFs), especially in Thailand and Malaysia. In this study, we characterized a novel CRF designated CRF74_01B, which was identified in six epidemiologically unlinked IDUs in Kuala Lumpur, Malaysia. The near-full length genomes were composed of CRF01_AE and subtype B', with eight breakpoints dispersed in the gag-pol and nef regions. Remarkably, this CRF shared four and two recombination hotspots with the previously described CRF33_01B and the less prevalent CRF53_01B, respectively. Genealogy-based Bayesian phylogenetic analysis of CRF74_01B genomic regions showed that it is closely related to both CRF33_01B and CRF53_01B. This observation suggests that CRF74_01B was probably a direct descendent from specific lineages of CRF33_01B, CRF53_01B and subtype B' that could have emerged in the mid-1990s. Additionally, it illustrated the active recombination processes between prevalent HIV-1 subtypes and recombinants in Malaysia. In summary, we report a novel HIV-1 genotype designated CRF74_01B among IDUs in Kuala Lumpur, Malaysia. The characterization of the novel CRF74_01B is of considerable significance towards the understanding of the genetic diversity and population dynamics of HIV-1 circulating in the region.	[Cheong, Hui Ting; Chow, Wei Zhen; Takebe, Yutaka; Chook, Jack Bee; Al-Darraji, Haider Abdulrazzaq Abed; Koh, Clayton; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Ctr Excellence Res AIDS CERiA, Dept Med, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Takebe, Yutaka] Yokohama City Univ, Sch Med, Yokohama, Kanagawa 232, Japan; [Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia	Universiti Malaya; National Institute of Infectious Diseases (NIID); Yokohama City University; Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Fac Med, Ctr Excellence Res AIDS CERiA, Dept Med, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Chan, Kok Gan/B-8347-2010; Al-Darraji, Haider Abdulrazzaq Abed/B-7978-2012; KAMARULZAMAN, ADEEBA/B-5216-2010; Tee, Kok Keng/A-8148-2008	Chan, Kok Gan/0000-0002-1883-1115; Al-Darraji, Haider Abdulrazzaq Abed/0000-0003-2576-3218; Tee, Kok Keng/0000-0002-7923-5448	Ministry of Education, Malaysia: High Impact Research [H-500001-00-A000012-000001]	Ministry of Education, Malaysia: High Impact Research	The work was supported by grants from the Ministry of Education, Malaysia: High Impact Research H-500001-00-A000012-000001 to KKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; Chen JHK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012198; Cheong HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111236; Chow WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085250; Chow WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062560; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Frost SDW, 2015, EPIDEMICS-NETH, V10, P88, DOI 10.1016/j.epidem.2014.09.001; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kijak GH, 2013, J VIROL, V87, P7265, DOI 10.1128/JVI.03070-12; Lemey P, 2006, AIDS REV, V8, P125; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020	22	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133883	10.1371/journal.pone.0133883	http://dx.doi.org/10.1371/journal.pone.0133883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196131	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600145
J	Ehler, M; Dobrosotskaya, J; Cunningham, D; Wong, WT; Chew, EY; Czaja, W; Bonner, RF				Ehler, Martin; Dobrosotskaya, Julia; Cunningham, Denise; Wong, Wai T.; Chew, Emily Y.; Czaja, Wojtek; Bonner, Robert F.			Modeling Photo-Bleaching Kinetics to Create High Resolution Maps of Rod Rhodopsin in the Human Retina	PLOS ONE			English	Article							FUNDUS AUTOFLUORESCENCE; DARK-ADAPTATION; MACULAR PIGMENT; GEOGRAPHIC ATROPHY; BLOOD-VESSELS; IMAGES; SEGMENTATION; RECOVERY; DENSITY; LIGHT	We introduce and describe a novel non-invasive in-vivo method for mapping local rod rhodopsin distribution in the human retina over a 30-degree field. Our approach is based on analyzing the brightening of detected lipofuscin autofluorescence within small pixel clusters in registered imaging sequences taken with a commercial 488nm confocal scanning laser ophthalmoscope (cSLO) over a 1 minute period. We modeled the kinetics of rhodopsin bleaching by applying variational optimization techniques from applied mathematics. The physical model and the numerical analysis with its implementation are outlined in detail. This new technique enables the creation of spatial maps of the retinal rhodopsin and retinal pigment epithelium (RPE) bisretinoid distribution with an approximate to 50 mu m resolution.	[Ehler, Martin] Univ Vienna, Fac Math, Vienna, Austria; [Dobrosotskaya, Julia] Case Western Reserve Univ, Dept Math Appl Math & Stat, Cleveland, OH 44106 USA; [Cunningham, Denise] NEI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Wong, Wai T.] NEI, Unit Neuron Glia Interact, NIH, Bethesda, MD 20892 USA; [Chew, Emily Y.] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Czaja, Wojtek] Univ Maryland, Dept Math, College Pk, MD 20742 USA; [Bonner, Robert F.] NICHHD, Sect Med Biophys, NIH, Bethesda, MD 20892 USA	University of Vienna; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ehler, M (corresponding author), Univ Vienna, Fac Math, Vienna, Austria.	martin.ehler@univie.ac.at	Wong, Wai/B-6118-2017; Bonner, Robert/GQO-9087-2022	Wong, Wai/0000-0003-0681-4016; 	National Institute of Child Health and Human Development/National Institutes of Health; Research Career Transition Awards Program of National Institutes of Health; German Science Foundation [EH 405/1-1/575910]; National Science Foundation [CBET 0854233]; Defense Threat Reduction Agency [HDTRA 1-13-1-0015]; Vienna Science and Technology Fund [VRG12-009]; NATIONAL EYE INSTITUTE [ZIAEY000489, ZIAEY000485] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Research Career Transition Awards Program of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Vienna Science and Technology Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This material is based upon work supported in part by intramural research funds from the National Institute of Child Health and Human Development/National Institutes of Health, the Research Career Transition Awards Program of the National Institutes of Health and the German Science Foundation under Grant EH 405/1-1/575910, the National Science Foundation under Grant CBET 0854233, the Defense Threat Reduction Agency under Grant HDTRA 1-13-1-0015, and the Vienna Science and Technology Fund under Grant VRG12-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERN M, 1974, J PHYSIOL-LONDON, V237, P341, DOI 10.1113/jphysiol.1974.sp010485; ALPERN M, 1971, J PHYSIOL-LONDON, V217, P447, DOI 10.1113/jphysiol.1971.sp009580; Bedggood P, 2012, INVEST OPHTH VIS SCI, V53, P3673, DOI 10.1167/iovs.11-8796; Benedetto J. J., 2013, INT J GEOMATHEMATICS, V4, P137, DOI DOI 10.1007/S13137-013-0052-Y; Bernstein PS, 2010, VISION RES, V50, P716, DOI 10.1016/j.visres.2009.10.014; Bertalmio M, 2003, IEEE T IMAGE PROCESS, V12, P882, DOI 10.1109/TIP.2003.815261; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bone RA, 2007, VISION RES, V47, P3259, DOI 10.1016/j.visres.2007.09.002; Burns ME, 2009, BIOPHYS J, V97, P1538, DOI 10.1016/j.bpj.2009.06.037; Cai JF, 2008, APPL COMPUT HARMON A, V24, P131, DOI 10.1016/j.acha.2007.10.002; Cameron AM, 2008, J PHYSIOL-LONDON, V586, P5419, DOI 10.1113/jphysiol.2008.160028; Chan TF, 2002, SIAM J APPL MATH, V62, P1019, DOI 10.1137/S0036139900368844; Chan TF, 2006, J MATH IMAGING VIS, V25, P107, DOI 10.1007/s10851-006-5257-3; Cunningham D, 2007, J OPHTHALMIC PHOTO S, V29, P93; Curcio CA, 2001, EYE, V15, P376, DOI 10.1038/eye.2001.140; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Czaja W, 2013, IEEE T PATTERN ANAL, V35, P1274, DOI 10.1109/TPAMI.2012.270; Delori FC, 2006, J OPT SOC AM A, V23, P521, DOI 10.1364/JOSAA.23.000521; Delori FC, 2001, J OPT SOC AM A, V18, P1212, DOI 10.1364/JOSAA.18.001212; Dobrosotskaya J, 2010, IFMBE PROC, V32, P361, DOI 10.1007/978-3-642-14998-6_92; Dobrosotskaya J, 2011, SPIE MED IMAGING, V7962; Dobrosotskaya JA, 2008, IEEE T IMAGE PROCESS, V17, P657, DOI 10.1109/TIP.2008.919367; Ehler M., 2011, IEEE INT C COMP ADV, P93; Ehler M, 2011, SPIE MED IMAGING, V7963; Ehler M, 2010, IFMBE PROC, V32, P344, DOI 10.1007/978-3-642-14998-6_88; Elad M, 2005, APPL COMPUT HARMON A, V19, P340, DOI 10.1016/j.acha.2005.03.005; Fawzi AA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3640813; FEENEYBURNS L, 1987, INVEST OPHTH VIS SCI, V28, P1138; Fornasier M, 2006, J MATH IMAGING VIS, V24, P359, DOI 10.1007/s10851-006-4242-1; Fornasier M, 2009, ADV COMPUT MATH, V31, P157, DOI 10.1007/s10444-008-9103-6; Galic I, 2008, J MATH IMAGING VIS, V31, P255, DOI 10.1007/s10851-008-0087-0; Gang L, 2002, IEEE T BIO-MED ENG, V49, P168, DOI 10.1109/10.979356; GLOSTER J, 1964, Br J Ophthalmol, V48, P260, DOI 10.1136/bjo.48.5.260; Gross OG, 2012, IN PRESS BIOPHYSICAL; Grossauer H, 2003, LECT NOTES COMPUT SC, V2695, P225; Holz FG, 1999, GRAEF ARCH CLIN EXP, V237, P145, DOI 10.1007/s004170050209; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Kainerstorfer JM, 2011, BIOMED OPT EXPRESS, V2, P1040, DOI 10.1364/BOE.2.001040; Kainerstorfer JM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470094; Kainerstorfer JM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463010; Krause M, 2012, TECHNICAL REPORT, P320; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839; Lowell J, 2004, IEEE T MED IMAGING, V23, P1196, DOI 10.1109/TMI.2004.830524; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Mahroo OAR, 2004, J PHYSIOL-LONDON, V554, P417, DOI 10.1113/jphysiol.2003.051250; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Meyers Sanford M, 2004, Trans Am Ophthalmol Soc, V102, P83; Morgan JIW, 2013, INVEST OPHTH VIS SCI, V54, P2048, DOI 10.1167/iovs.12-11089; Morgan JW, 2009, INVEST OPHTHALMOL VI, V50; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; RIPPS H, 1969, J PHYSIOL-LONDON, V200, P151, DOI 10.1113/jphysiol.1969.sp008686; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; RUSHTON WAH, 1972, VISION RES, V12, P1073, DOI 10.1016/0042-6989(72)90098-3; Sandberg MA, 1996, INVEST OPHTH VIS SCI, V37, P1693; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Sparrow JR, 2010, INVEST OPHTH VIS SCI, V51, P4351, DOI 10.1167/iovs.10-5852; Teschke G, 2007, INVERSE PROBL, V23, P1851, DOI 10.1088/0266-5611/23/5/005; Theelen T, 2008, EXP EYE RES, V86, P296, DOI 10.1016/j.exer.2007.10.022; Thomas MM, 1999, J PHYSIOL-LONDON, V518, P479, DOI 10.1111/j.1469-7793.1999.0479p.x; Tornow RP, 1998, ACTA ANAT, V162, P163; Vermeer KA, 2004, COMPUT BIOL MED, V34, P209, DOI 10.1016/S0010-4825(03)00055-6; Wang L, 2007, IEEE T MED IMAGING, V26, P137, DOI 10.1109/TMI.2006.889732; Weickert J, 2006, VISUALIZATION AND PROCESSING OF TENSOR FIELDS, P315, DOI 10.1007/3-540-31272-2_19	69	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131881	10.1371/journal.pone.0131881	http://dx.doi.org/10.1371/journal.pone.0131881			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196397	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600017
J	Eshima, Y; Higuchi, Y; Kinoshita, T; Nakakita, SI; Takegawa, K				Eshima, Yasunari; Higuchi, Yujiro; Kinoshita, Takashi; Nakakita, Shin-Ichi; Takegawa, Kaoru			Transglycosylation Activity of Glycosynthase Mutants of Endo-beta-N-Acetylglucosaminidase from Coprinopsis cinerea	PLOS ONE			English	Article							CHEMOENZYMATIC SYNTHESIS; GLYCOPROTEINS; PURIFICATION; CLONING	Endo-beta-N-acetylglucosaminidase (ENGase), which catalyzes hydrolysis of N-linked oligosaccharides, is a useful tool for analyzing oligosaccharide contents of glycoproteins. However, there are only a few known ENGases that can catalyze the hydrolysis of human complex type oligosaccharides, and although commercially available, they are expensive. Here, we report the cloning of two ENGase encoding cDNAs from the basidiomycete fungus Coprinopsis cinerea, Endo-CC1 and Endo-CC2. We successfully expressed recombinant His(6)-tagged Endo-CC1 and Endo-CC2 in Escherichia coli and purified them for enzymatic characterization. Both Endo-CC1 and Endo-CC2 showed hydrolytic activity on high-mannose and complex type oligosaccharides. Since Endo-CC1 could be prepared more easily than Endo-CC2 from E. coli cultures, we examined the enzymatic properties of Endo-CC1 in detail. Our results showed that Endo-CC1 acted on both N-linked high-mannose type and sialobiantennary type complex oligosaccharides of glycoproteins RNase B and human transferrin, respectively, but not on the sialotriantennary type complex oligosaccharide of glycoprotein fetuin. Examination of the transglycosylation activity of Endo-CC1 revealed that the wild-type Endo-CC1 could not transfer the sialobiantennary type complex oligosaccharide onto the deglycosylated RNase B. To obtain an Endo-CC1 mutant with desired transglycosylation activity, we performed mutation analysis of the active site residue Asn 180 (N180), known to be important for catalysis, by individually replacing it with the remaining 19 amino acid residues. Transglycosylation analyses of these mutants led us to identify one mutant, namely Endo-CC1(N180H), which exhibited the desired transglycosylation activity. Taken together, we suggest that Endo-CC1 would potentially be a valuable tool for analyzing oligosaccharides on glycoproteins, as large quantities of it could be made available more easily and less expensively than the currently used enzyme, Endo-M.	[Eshima, Yasunari; Higuchi, Yujiro; Takegawa, Kaoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Kinoshita, Takashi] Fushimi Pharmaceut Co Ltd, Marugame, Kagawa, Japan; [Nakakita, Shin-Ichi] Kagawa Univ, Life Sci Res Ctr, Dept Funct Glyc, Kagawa, Japan	Kyushu University; Kagawa University	Takegawa, K (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, 6-10-1 Hakozaki, Fukuoka 812, Japan.	takegawa@agr.kyushu-u.ac.jp		Higuchi, Yujiro/0000-0001-7309-291X; Kinoshita, Takashi/0000-0002-3468-002X	JSPS KAKENHI [26292054]; Fushimi Pharmaceutical Co. Ltd.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fushimi Pharmaceutical Co. Ltd.	This study was supported in part by JSPS KAKENHI Grant Number 26292054 (KT). Fushimi Pharmaceutical Co. Ltd. provided support in the form of the salary for the author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Fujita K, 2001, BIOCHEM BIOPH RES CO, V282, P678, DOI 10.1006/bbrc.2001.4631; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; IWASE H, 1981, ANAL BIOCHEM, V113, P93, DOI 10.1016/0003-2697(81)90048-8; KADOWAKI S, 1991, J BIOCHEM-TOKYO, V110, P17, DOI 10.1093/oxfordjournals.jbchem.a123536; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; TAKEGAWA K, 1995, J BIOL CHEM, V270, P3094, DOI 10.1074/jbc.270.7.3094; Takegawa K, 1997, ARCH BIOCHEM BIOPHYS, V338, P22, DOI 10.1006/abbi.1996.9803; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tharmalingam T, 2013, GLYCOCONJUGATE J, V30, P137, DOI 10.1007/s10719-012-9443-9; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wang LX, 2011, TRENDS GLYCOSCI GLYC, V23, P33, DOI 10.4052/tigg.23.33; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72	23	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132859	10.1371/journal.pone.0132859	http://dx.doi.org/10.1371/journal.pone.0132859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197478	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600054
J	Gasier, HG; Hughes, LM; Young, CR; Richardson, AM				Gasier, Heath G.; Hughes, Linda M.; Young, Colin R.; Richardson, Annely M.			Comparison of Body Composition Assessed by Dual-Energy X-Ray Absorptiometry and BMI in Current and Former US Navy Service Members	PLOS ONE			English	Article							MASS INDEX; OBESITY; FAT; PREVALENCE; OVERWEIGHT; PERSONNEL	Background Little is known of the diagnostic accuracy of BMI in classifying obesity in active duty military personnel and those that previously served. Thus, the primary objectives were to determine the relationship between lean and fat mass, and body fat percentage (BF%) with BMI, and assess the agreement between BMI and BF% in defining obesity. Methods Body composition was measured by dual-energy X-ray absorptiometry in 462 males (20-91 years old) who currently or previously served in the U.S. Navy. A BMI of >= 30 kg/m(2) and a BF% >= 25% were used for obesity classification. Results The mean BMI (+/- SD) and BF% were 28.8 +/- 4.1 and 28.9 +/- 6.6%, respectively, with BF% increasing with age. Lean mass, fat mass, and BF% were significantly correlated with BMI for all age groups. The exact agreement of obesity defined by BMI and BF% was fair (61%), however, 38% were misclassified by a BMI cut-off of 30 when obesity was defined by BF%. Conclusions From this data we determined that there is a good correlation between body composition and BMI, and fair agreement between BMI and BF% in classifying obesity in a group of current and former U.S. Navy service members. However, as observed in the general population, a significant proportion of individuals with excess fat are misclassified by BMI cutoffs.	[Gasier, Heath G.] Duke Univ, Med Ctr, Ctr Hyperbar Med & Environm Physiol, Durham, NC 27708 USA; [Hughes, Linda M.; Young, Colin R.] Naval Submarine Med Res Lab, Groton, CT USA; [Richardson, Annely M.] Baystate Childrens Hosp, Dept Pediat, Springfield, MA USA	Duke University	Gasier, HG (corresponding author), Duke Univ, Med Ctr, Ctr Hyperbar Med & Environm Physiol, Durham, NC 27708 USA.	heath.gasier@dm.duke.edu		Young, Colin/0000-0002-4786-5840	Office of Naval Research, Warfighter Performance Department (Code 34) [N0001411WX20143]	Office of Naval Research, Warfighter Performance Department (Code 34)(Office of Naval Research)	We would like to extend our gratitude to our subjects for their participation in this study, and Commander, Submarine Force and the Submarine Force Atlantic Medical Officer (Captain Jeffery McClellen) for their permission to conduct this research. In addition, we are grateful for the technical expertise provided by Mr. Darrin Way, Ms. Abaigeal Caras, Mr. Andrew Way and Mr. David Kerr (NSMRL), and the Radiology Department (Naval Branch Health Clinic, Groton, CT). This work was supported by the Office of Naval Research, Warfighter Performance Department (Code 34), work unit number N0001411WX20143.	Almond N, 2008, MIL MED, V173, P544, DOI 10.7205/MILMED.173.6.544; An R., 2014, ISRN OBES, V2014, P1, DOI [10.1155/2014/185132, DOI 10.1155/2014/185132]; Borrud Lori G, 2010, Vital Health Stat 11, P1; Bray G A, 1993, Obes Res, V1, P203; Bray RM, 2009, DEP DEFENSE SURVEY H; Crawford AG, 2010, POPUL HEALTH MANAG, V13, P151, DOI 10.1089/pop.2009.0039; De Lorenzo A, 2003, ACTA DIABETOL, V40, pS254, DOI 10.1007/s00592-003-0079-x; De Lorenzo A, 2013, INT J CARDIOL, V166, P111, DOI 10.1016/j.ijcard.2011.10.006; Department of Defense, 2020, 2020 DEM REP PROF MI; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 2001, BRIT J NUTR, V85, P135, DOI 10.1079/BJN2000273; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gasier HG, 2014, OSTEOPOROSIS INT, V25, P2225, DOI 10.1007/s00198-014-2753-y; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Gregg MA, 2012, MIL MED, V177, P1302, DOI 10.7205/MILMED-D-12-00016; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Koepsell TD, 2012, OBESITY, V20, P434, DOI 10.1038/oby.2011.2; Kolar AS, 2005, EPIDEMIOLOGY, V16, P579, DOI 10.1097/01.ede.0000165363.27323.ac; Peltz G, 2010, AM J HUM BIOL, V22, P639, DOI 10.1002/ajhb.21056; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Reyes-Guzman CM, 2015, AM J PREV MED, V48, P145, DOI 10.1016/j.amepre.2014.08.033; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Smith TJ, 2012, OBESITY, V20, P1534, DOI 10.1038/oby.2012.25; Staten LK, 2001, MED SCI SPORT EXER, V33, P1959, DOI 10.1097/00005768-200111000-00024; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; US Department of Agriculture & US Departmentr of Health and Human Services, 2010, DIET GUID AM; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; WANG ZM, 1992, AM J CLIN NUTR, V56, P19, DOI 10.1093/ajcn/56.1.19; Weaver B, 2013, BEHAV RES METHODS, V45, P880, DOI 10.3758/s13428-012-0289-7; WHO, 2000, OB PREV MAN GLOB EP	34	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132157	10.1371/journal.pone.0132157	http://dx.doi.org/10.1371/journal.pone.0132157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197480	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600024
J	Kita, Y; Yoshida, K; Tokuoka, SM; Hamano, F; Yamazaki, M; Sakimura, K; Kano, M; Shimizu, T				Kita, Yoshihiro; Yoshida, Kenij; Tokuoka, Suzumi M.; Hamano, Fumie; Yamazaki, Maya; Sakimura, Kenji; Kano, Masanobu; Shimizu, Takao			Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E-2	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); BRAIN ENDOTHELIAL-CELLS; FEBRILE RESPONSE; HUMAN-PLATELETS; RECEPTORS; LIPASE; LIPOPOLYSACCHARIDE; SUPPRESSION; HYDROLYSIS; MICE	Fever is a common response to inflammation and infection. The mechanism involves prostaglandin E-2 (PGE(2))-EP3 receptor signaling in the hypothalamus, which raises the set point of hypothalamic thermostat for body temperature, but the lipid metabolic pathway for pyretic PGE(2) production remains unknown. To reveal the molecular basis of fever initiation, we examined lipopolysaccharides (LPS)-induced fever model in monoacylglycerol lipase (MGL)-deficient (Mgll(-/-)) mice, CB1 receptor-MGL compound-deficient (Cnr1(-/-)Mgll(-/-)) mice, cytosolic phospholipase A(2)alpha (cPLA(2)alpha)-deficient (Pla2g4a(-/-)) mice, and diacylglycerol lipase alpha (DGL alpha)-deficient (Dagla(-/-)) mice. Febrile reactions were abolished in Mgll(-/-) and Cnr1(-/-)Mgll(-/-) mice, whereas Cnr1(-/-)Mgll(+/+), Pla2g4a(-/-) and Dagla(-/-) mice responded normally, demonstrating that MGL is a critical enzyme for fever, which functions independently of endocannabinoid signals. Intracerebroventricular administration of PGE(2) caused fever similarly in Mgll(-/-) and wild-type control mice, suggesting a lack of pyretic PGE(2) production in Mgll(-/-) hypothalamus, which was confirmed by lipidomics analysis. Normal blood cytokine responses after LPS administration suggested that MGL-deficiency does not affect pyretic cytokine productions. Diurnal body temperature profiles were normal in Mgll(-/-) mice, demonstrating that MGL is unrelated to physiological thermoregulation. In conclusion, MGL-dependent hydrolysis of endocannabinoid 2-arachidonoylglycerol is necessary for pyretic PGE(2) production in the hypothalamus.	[Kita, Yoshihiro; Yoshida, Kenij; Tokuoka, Suzumi M.; Hamano, Fumie; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo, Japan; [Kita, Yoshihiro; Hamano, Fumie] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Bunkyo Ku, Tokyo, Japan; [Yamazaki, Maya; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Niigata, Japan; [Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo, Japan; [Shimizu, Takao] Natl Ctr Global Hlth & Med, Res Inst, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Niigata University; University of Tokyo; National Center for Global Health & Medicine - Japan	Kita, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo, Japan.	kita@m.u-tokyo.ac.jp	Shimizu, Takao/AAV-7052-2021; Yamazaki, Maya/C-6952-2012	Kano, Masanobu/0000-0002-0725-3292	MEXT KAKENHI [23790356, 25116707, 21220006, 25000015, 24229003]; Tokyo Society of Medical Sciences, Japan; Takeda Science Foundation; Ono Pharmaceutical Co., LTD. (Osaka, Japan); Shimadzu Corp. (Kyoto, Japan)	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Society of Medical Sciences, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Pharmaceutical Co., LTD. (Osaka, Japan); Shimadzu Corp. (Kyoto, Japan)	This work was supported by MEXT KAKENHI Grant Numbers 23790356, 25116707 (to Y.K.), 21220006, 25000015 (to M.K.), and 24229003 (to T.S.), a grant from the Tokyo Society of Medical Sciences, Japan (to Y.K.), and Takeda Science Foundation (to T.S.). Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, is funded in part by Ono Pharmaceutical Co., LTD. (Osaka, Japan) and Shimadzu Corp. (Kyoto, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL RL, 1979, P NATL ACAD SCI USA, V76, P3238, DOI 10.1073/pnas.76.7.3238; Cabanac M, 2006, J APPL PHYSIOL, V100, P1338, DOI 10.1152/japplphysiol.01021.2005; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Engstrom L, 2012, ENDOCRINOLOGY, V153, P4849, DOI 10.1210/en.2012-1375; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Li ZH, 2006, AM J PHYSIOL-REG I, V290, pR1262, DOI 10.1152/ajpregu.00724.2005; Lovegrove BG, 2009, J COMP PHYSIOL B, V179, P451, DOI 10.1007/s00360-008-0329-x; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Plaisance KI, 2000, CLIN INFECT DIS, V31, pS219, DOI 10.1086/317518; PRESCOTT SM, 1983, J BIOL CHEM, V258, P764; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanimura A, 2012, P NATL ACAD SCI USA, V109, P12195, DOI 10.1073/pnas.1204404109; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233	27	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133663	10.1371/journal.pone.0133663	http://dx.doi.org/10.1371/journal.pone.0133663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196692	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600129
J	Shemesh, N; Alvarez, GA; Frydman, L				Shemesh, Noam; Alvarez, Gonzalo A.; Frydman, Lucio			Size Distribution Imaging by Non-Uniform Oscillating-Gradient Spin Echo (NOGSE) MRI	PLOS ONE			English	Article							AXON DIAMETER DISTRIBUTION; DIFFUSION; NMR; MATTER; LENGTH; BRAIN; ARCHITECTURE; ANISOTROPY; SYSTEMS; DENSITY	Objects making up complex porous systems in Nature usually span a range of sizes. These size distributions play fundamental roles in defining the physicochemical, biophysical and physiological properties of a wide variety of systems - ranging from advanced catalytic materials to Central Nervous System diseases. Accurate and noninvasive measurements of size distributions in opaque, three-dimensional objects, have thus remained long-standing and important challenges. Herein we describe how a recently introduced diffusion-based magnetic resonance methodology, Non-Uniform-Oscillating-Gradient-Spin-Echo (NOGSE), can determine such distributions noninvasively. The method relies on its ability to probe confining lengths with a (length) 6 parametric sensitivity, in a constant-time, constant-number-of-gradients fashion; combined, these attributes provide sufficient sensitivity for characterizing the underlying distributions in mu m-scaled cellular systems. Theoretical derivations and simulations are presented to verify NOGSE's ability to faithfully reconstruct size distributions through suitable modeling of their distribution parameters. Experiments in yeast cell suspensions - where the ground truth can be determined from ancillary microscopy - corroborate these trends experimentally. Finally, by appending to the NOGSE protocol an imaging acquisition, novel MRI maps of cellular size distributions were collected from a mouse brain. The ensuing micro-architectural contrasts successfully delineated distinctive hallmark anatomical sub-structures, in both white matter and gray matter tissues, in a non-invasive manner. Such findings highlight NOGSE's potential for characterizing aberrations in cellular size distributions upon disease, or during normal processes such as development.	[Shemesh, Noam; Alvarez, Gonzalo A.; Frydman, Lucio] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Frydman, L (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	lucio.frydman@weizmann.ac.il	Shemesh, Noam/GPK-7972-2022; Alvarez, Gonzalo A/B-2329-2010	Alvarez, Gonzalo A/0000-0002-7328-357X; Shemesh, Noam/0000-0001-6681-5876	Israel Science Foundation [ISF 1142/13]; Helen and Martin Kimmel Award for Innovative Investigation; Perlman Family Foundation; Weizmann Institute; European Commission under the Marie Curie Intra-European Fellowship for Career Development [PIEF-GA-2012-328605]	Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel Award for Innovative Investigation; Perlman Family Foundation; Weizmann Institute; European Commission under the Marie Curie Intra-European Fellowship for Career Development	This work was supported by the Israel Science Foundation grant ISF 1142/13, Helen and Martin Kimmel Award for Innovative Investigation, and Perlman Family Foundation. NS acknowledges a Dean's Fellowship of the Weizmann Institute; GAA acknowledges the support of the European Commission under the Marie Curie Intra-European Fellowship for Career Development Grant No. PIEF-GA-2012-328605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Aggarwal M, 2012, MAGN RESON MED, V67, P98, DOI 10.1002/mrm.22981; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Altamura C, 2007, CEREB CORTEX, V17, P1394, DOI 10.1093/cercor/bhl051; Alvarez GA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.080404; Ambrosone L, 2004, J PHYS CHEM B, V108, P18472, DOI 10.1021/jp046480o; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; CALLAGHAN PT, 1995, J MAGN RESON SER A, V117, P118, DOI 10.1006/jmra.1995.9959; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; Cruz L, 2004, P NATL ACAD SCI USA, V101, P15846, DOI 10.1073/pnas.0407002101; CULLHEIM S, 1978, NEUROSCI LETT, V8, P17, DOI 10.1016/0304-3940(78)90090-3; DeLuca GC, 2004, BRAIN, V127, P1009, DOI 10.1093/brain/awh118; Drobnjak I, 2010, J MAGN RESON, V206, P41, DOI 10.1016/j.jmr.2010.05.017; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Gore JC, 2010, NMR BIOMED, V23, P745, DOI 10.1002/nbm.1531; Hagemann G, 2003, NEUROSCIENCE, V117, P991, DOI 10.1016/S0306-4522(02)00959-4; Innocenti GM, 2011, PROG BRAIN RES, V189, P65, DOI 10.1016/B978-0-444-53884-0.00018-X; Innocenti GM, 2013, CORTEX IN PRESS; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; KLAUDER JR, 1962, PHYS REV, V125, P912, DOI 10.1103/PhysRev.125.912; Latt J, 2007, IEEE T MED IMAGING, V26, P1437, DOI 10.1109/TMI.2007.907278; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lasic S, 2006, J MAGN RESON, V182, P208, DOI 10.1016/j.jmr.2006.06.030; LAWSON SN, 1979, J NEUROCYTOL, V8, P275, DOI 10.1007/BF01236123; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Mitchell S, 2012, NAT CHEM, V4, P825, DOI [10.1038/NCHEM.1403, 10.1038/nchem.1403]; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Ozarslan E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/015010; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Pajevic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054095; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Shemesh N, 2013, J MAGN RESON, V237, P49, DOI 10.1016/j.jmr.2013.09.009; Shemesh N, 2012, MAGN RESON MED, V68, P794, DOI 10.1002/mrm.23300; Shemesh N, 2012, NMR BIOMED, V25, P236, DOI 10.1002/nbm.1737; Shemesh N, 2011, J AM CHEM SOC, V133, P6028, DOI 10.1021/ja200303h; Shemesh N, 2011, MAGN RESON MED, V65, P1216, DOI 10.1002/mrm.22738; Shemesh N, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3285299; Siow B, 2012, J MAGN RESON, V214, P51, DOI 10.1016/j.jmr.2011.10.004; Smith PES, 2012, P NATL ACAD SCI USA, V109, P5958, DOI 10.1073/pnas.1120704109; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepisnik J, 1999, PHYSICA B, V270, P110, DOI 10.1016/S0921-4526(99)00160-X; STEPISNIK J, 1993, PHYSICA B, V183, P343, DOI 10.1016/0921-4526(93)90124-O; Stepisnik J, 2006, J MAGN RESON, V182, P195, DOI 10.1016/j.jmr.2006.06.023; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Uhrig GS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.100504	56	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133201	10.1371/journal.pone.0133201	http://dx.doi.org/10.1371/journal.pone.0133201			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197220	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600072
J	Spampinato, SF; Obermeier, B; Cotleur, A; Love, A; Takeshita, Y; Sano, Y; Kanda, T; Ransohoff, RM				Spampinato, Simona F.; Obermeier, Birgit; Cotleur, Anne; Love, Anna; Takeshita, Yukio; Sano, Yasuteru; Kanda, Takashi; Ransohoff, Richard M.			Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS PATHOGENESIS; GM-CSF; SPHINGOSINE-1-PHOSPHATE RECEPTOR-2; 1-PHOSPHATE RECEPTOR-1; REACTIVE ASTROCYTES; LYMPHOCYTE EGRESS; GROWTH-FACTOR; IN-VIVO	The ability of the Blood Brain Barrier (BBB) to maintain proper barrier functions, keeping an optimal environment for central nervous system (CNS) activity and regulating leukocytes' access, can be affected in CNS diseases. Endothelial cells and astrocytes are the principal BBB cellular constituents and their interaction is essential to maintain its function. Both endothelial cells and astrocytes express the receptors for the bioactive sphingolipid S1P. Fingolimod, an immune modulatory drug whose structure is similar to S1P, has been approved for treatment in multiple sclerosis (MS): fingolimod reduces the rate of MS relapses by preventing leukocyte egress from the lymph nodes. Here, we examined the ability of S1P and fingolimod to act on the BBB, using an in vitro co-culture model that allowed us to investigate the effects of S1P on endothelial cells, astrocytes, and interactions between the two. Acting selectively on endothelial cells, S1P receptor signaling reduced cell death induced by inflammatory cytokines. When acting on astrocytes, fingolimod treatment induced the release of a factor, granulocyte macrophage colony-stimulating factor (GM-CSF) that reduced the effects of cytokines on endothelium. In an in vitro BBB model incorporating shear stress, S1P receptor modulation reduced leukocyte migration across the endothelial barrier, indicating a novel mechanism that might contribute to fingolimod efficacy in MS treatment.	[Spampinato, Simona F.; Obermeier, Birgit; Cotleur, Anne; Love, Anna; Takeshita, Yukio; Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Sano, Yasuteru; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan	Cleveland Clinic Foundation; Yamaguchi University	Ransohoff, RM (corresponding author), Biogen, Neuroimmunol Res, Cambridge, MA 02142 USA.	richard.ransohoff@biogen.com	Spampinato, Simona Federica/AAJ-8087-2020; Love, Anna/GWN-0733-2022	Spampinato, Simona Federica/0000-0001-7564-1986; Love, Anna/0000-0001-5657-2858	Novartis funding [CFTY7220DUSNC10T]	Novartis funding	The study was supported by Novartis funding #CFTY7220DUSNC10T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASI T, 2013, HDB EXP PHARM, V216, P201, DOI DOI 10.1007/978-3-7091-1511-4_; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Brana C, 2014, NEUROPATH APPL NEURO, V40, P564, DOI 10.1111/nan.12048; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; COOMBER BL, 1986, ANAT REC, V215, P256, DOI 10.1002/ar.1092150308; Cruz-Orengo L, 2014, J CLIN INVEST, V124, P2571, DOI 10.1172/JCI73408; Du J, 2012, PATHOL RES PRACT, V208, P82, DOI 10.1016/j.prp.2011.11.008; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Fischer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023905; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Furukawa A, 2007, MOL CELL BIOCHEM, V305, P27, DOI 10.1007/s11010-007-9524-4; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Galicia-Rosas G, 2012, J IMMUNOL, V189, P3700, DOI 10.4049/jimmunol.1102261; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Haruki H, 2013, J NEUROL SCI, V331, P136, DOI 10.1016/j.jns.2013.05.035; HLA T, 1990, J BIOL CHEM, V265, P9308; Kimura A, 2007, STEM CELLS, V25, P115, DOI 10.1634/stemcells.2006-0223; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kooij G, 2011, BRAIN, V134, P555, DOI 10.1093/brain/awq330; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; McGeachy MJ, 2011, NAT IMMUNOL, V12, P521, DOI 10.1038/ni.2044; McVerry BJ, 2004, J CELL BIOCHEM, V92, P1075, DOI 10.1002/jcb.20088; Mizee MR, 2014, ACTA NEUROPATHOL, V128, P691, DOI 10.1007/s00401-014-1335-6; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Nishihara H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121488; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pebay A, 2001, EUR J NEUROSCI, V13, P2067, DOI 10.1046/j.0953-816x.2001.01585.x; Prager B, 2015, TRENDS MOL MED, V21, P354, DOI 10.1016/j.molmed.2015.03.006; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rosen H, 2014, CURR TOP MICROBIOL, V378, P1, DOI 10.1007/978-3-319-05879-5_1; Rutherford C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.455; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Sato K, 1999, MOL BRAIN RES, V74, P182, DOI 10.1016/S0169-328X(99)00279-X; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Takeshita Y, 2014, J NEUROSCI METH, V232, P165, DOI 10.1016/j.jneumeth.2014.05.013; Teitelbaum D, 1996, J NEUROIMMUNOL, V64, P209, DOI 10.1016/0165-5728(95)00180-8; Tisato V., 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/561689; van Doorn R, 2012, ACTA NEUROPATHOL, V124, P397, DOI 10.1007/s00401-012-1014-4; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	64	52	53	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133392	10.1371/journal.pone.0133392	http://dx.doi.org/10.1371/journal.pone.0133392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197437	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600093
J	Sun, PF; Sun, CK; Li, WQ; Wang, P				Sun, Pengfei; Sun, Changku; Li, Wenqiang; Wang, Peng			A New Pose Estimation Algorithm Using a Perspective-Ray-Based Scaled Orthographic Projection with Iteration	PLOS ONE			English	Article							ACCURATE; OBJECT; MODEL	Pose estimation aims at measuring the position and orientation of a calibrated camera using known image features. The pinhole model is the dominant camera model in this field. However, the imaging precision of this model is not accurate enough for an advanced pose estimation algorithm. In this paper, a new camera model, called incident ray tracking model, is introduced. More importantly, an advanced pose estimation algorithm based on the perspective ray in the new camera model, is proposed. The perspective ray, determined by two positioning points, is an abstract mathematical equivalent of the incident ray. In the proposed pose estimation algorithm, called perspective-ray-based scaled orthographic projection with iteration (PRSOI), an approximate ray-based projection is calculated by a linear system and refined by iteration. Experiments on the PRSOI have been conducted, and the results demonstrate that it is of high accuracy in the six degrees of freedom (DOF) motion. And it outperforms three other state-of-the-art algorithms in terms of accuracy during the contrast experiment.	[Sun, Pengfei; Sun, Changku; Li, Wenqiang; Wang, Peng] Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin 300072, Peoples R China; [Li, Wenqiang; Wang, Peng] Luoyang Inst Electroopt Equipment, Sci & Technol Electroopt Control Lab, Luoyang, Peoples R China	Tianjin University	Wang, P (corresponding author), Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin 300072, Peoples R China.	wang_peng@tju.edu.cn	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [51375339]; Aviation Science Foundation of China [20135148004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aviation Science Foundation of China	This work is supported by the National Natural Science Foundation of China (No. 51375339), http://www.nsfc.gov.cn/. This work is also supported by the Aviation Science Foundation of China (No. 20135148004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertok K, 2011, ROBUST HEAD POSE ESI; Borui Li, 2012, 2012 Third International Conference on Intelligent Control and Information Processing (ICICIP 2012), P1, DOI 10.1109/ICICIP.2012.6391480; Bujnak M., 2008, 2008 IEEE C COMPUTER, P1; David P, 2004, INT J COMPUT VISION, V59, P259, DOI 10.1023/B:VISI.0000025800.10423.1f; DEMENTHON DF, 1992, LECT NOTES COMPUT SC, V588, P335, DOI 10.1007/BF01450852; Gramegna T, 2004, ROBOT AUTON SYST, V48, P145, DOI 10.1016/j.robot.2004.05.001; Grossberg MD, 2005, INT J COMPUT VISION, V61, P119, DOI 10.1023/B:VISI.0000043754.56350.10; Grossberg MD, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P108, DOI 10.1109/ICCV.2001.937611; Guo Y, 2012, I C CONT AUTOMAT ROB, P1413, DOI 10.1109/ICARCV.2012.6485396; He M., 2011, INT J DIGIT CONTENT, V5, P153; Hesch JA, 2011, IEEE I CONF COMP VIS, P383, DOI 10.1109/ICCV.2011.6126266; Hu ZY, 2002, IEEE T PATTERN ANAL, V24, P550, DOI 10.1109/34.993561; Kim W.W., 2011, 2011 8 INT C INF COM, P1; Klein George, 2007, P1; Kuang Y, 2013, POSE ESTIMATION UNKN, P529; Lepetit Vincent, 2005, Foundations and Trends in Computer Graphics and Vision, V1, P1, DOI 10.1561/0600000001; Lepetit V, 2009, INT J COMPUT VISION, V81, P155, DOI 10.1007/s11263-008-0152-6; Li L, 2013, OPTIK, V124, P1116, DOI 10.1016/j.ijleo.2012.03.018; Li SQ, 2012, IEEE T PATTERN ANAL, V34, P1444, DOI 10.1109/TPAMI.2012.41; Lin PD, 2006, J DYN SYST-T ASME, V128, P548, DOI 10.1115/1.2192824; Lin PD, 2006, OPTIK, V117, P329, DOI 10.1016/j.ijleo.2005.10.004; Liu ML, 1999, PATTERN RECOGN LETT, V20, P69, DOI 10.1016/S0167-8655(98)00128-7; Lu CP, 2000, IEEE T PATTERN ANAL, V22, P610, DOI 10.1109/34.862199; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Martinez C, 2013, ROBOT AUTON SYST, V61, P876, DOI 10.1016/j.robot.2013.02.006; Martins P, 2008, IMAGE ANAL RECOGNITI; Park JS, 2013, 2013 13TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS 2013), P386, DOI 10.1109/ICCAS.2013.6703930; Sturm P, 2010, FOUND TRENDS COMPUT, V6, P1, DOI 10.1561/0600000023; Taketomi T, 2014, COMPUT GRAPH-UK, V44, P11, DOI 10.1016/j.cag.2014.07.003; Wu Ping, 2014, MMSP 2014 IEEE 16 IN, P1; Xu GL, 2013, CHINESE J AERONAUT, V26, P1498, DOI 10.1016/j.cja.2013.07.049; Zheng YQ, 2013, IEICE T INF SYST, VE96D, P1525, DOI 10.1587/transinf.E96.D.1525	32	7	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0134029	10.1371/journal.pone.0134029	http://dx.doi.org/10.1371/journal.pone.0134029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197272	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600152
J	Roskam, I; Galdiolo, S; Hansenne, M; Massoudi, K; Rossier, J; Gicquel, L; Rolland, JP				Roskam, Isabelle; Galdiolo, Sarah; Hansenne, Michel; Massoudi, Koorosh; Rossier, Jerome; Gicquel, Ludovic; Rolland, Jean-Pierre			The Psychometric Properties of the French Version of the Personality Inventory for DSM-5	PLOS ONE			English	Article							HIERARCHICAL STRUCTURE; PATHOLOGICAL PERSONALITY; TRAITS; DISORDERS; PID-5; MODEL; VALIDITY; SAMPLE	In the context of the publication of DSM-5, the Personality Inventory for DSM-5 (PID-5) has been proposed as a new dimensional assessment tool for personality disorders. This instrument includes a pool of 220 items organized around 25 facets included in a five-factor second-order domain structure. The examination of the replicability of the trait structure across methods and populations is of primary importance. In view of this need, the main objective of the current study was to validate the French version of the PID-5 among French-speaking adults from a European community sample (N=2,532). In particular, the assumption of unidimensionality of the 25 facet and the five domain scales was tested, as well as the extent to which the five-factor structure of the PID-5 and the DSM-5 personality trait hierarchical structure are replicated in the current sample. The results support the assumption of unidimensionality of both the facets and the domains. Exploratory factor and hierarchical analyses replicated the five-factor structure as initially proposed in the PID-5.	[Roskam, Isabelle; Galdiolo, Sarah] Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Hansenne, Michel] Univ Liege, Dept Psychol, Liege, Belgium; [Massoudi, Koorosh; Rossier, Jerome] Univ Lausanne, Inst Psychol, Lausanne, Switzerland; [Gicquel, Ludovic] Ctr Hosp Specialise Henri Laborit, Unite Rech Clin, St Benoit, France; [Rolland, Jean-Pierre] Univ Paris Ouest La Def, Nanterre, France	Universite Catholique Louvain; University of Liege; University of Lausanne	Roskam, I (corresponding author), Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.	isabelle.roskam@uclouvain.be	Galdiolo, Sarah/AAD-2595-2021; Hansenne, Michel/D-2138-2015; roskam, isabelle/ABH-5227-2020; Rossier, Jerome/A-3494-2009	Galdiolo, Sarah/0000-0002-8912-3116; Hansenne, Michel/0000-0002-3478-4953; roskam, isabelle/0000-0002-1449-1133; Rossier, Jerome/0000-0002-9924-3672				ACHENBAC.TM, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0093906; Bastiaens T, 2015, THE VALIDATION OF TH; Bo S, 2016, J PERS DISORD, V30, P112, DOI 10.1521/pedi_2015_29_187; Byrne B.M., 2013, STRUCTURAL EQUATION, DOI 10.4324/9781410600219; De Clercq B, 2006, J ABNORM PSYCHOL, V115, P639, DOI 10.1037/0021-843X.115.4.639; De Clercq B, 2014, J PERS, V82, P158, DOI 10.1111/jopy.12042; De Fruyt F, 2013, ASSESSMENT, V20, P295, DOI 10.1177/1073191113475808; Eysenck H. J., 1994, DEV STRUCTURE TEMPER, P37; Fossati A, 2013, ASSESSMENT, V20, P689, DOI 10.1177/1073191113504984; Goldberg LR, 2006, J RES PERS, V40, P347, DOI 10.1016/j.jrp.2006.01.001; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Griffin SA, 2014, PERSONALITY DISORDER; Harkness A.R., 1992, PSYCHOL, V4, P251, DOI [10.1037/1040-3590.4.2.251, DOI 10.1037/1040-3590.4.2.251, 10.1037/1040-3590.4.2.251.]; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Krueger RF, 2012, PSYCHOL MED, V42, P1879, DOI 10.1017/S0033291711002674; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Krueger RF, 2013, ANNUAL REVIEW OF CLI, V10, P1; Krueger RF, 2011, J PERS ASSESS, V93, P325, DOI 10.1080/00223891.2011.577478; Krueger RF, 2011, J PERS DISORD, V25, P170, DOI 10.1521/pedi.2011.25.2.170; Kushner SC, 2011, J PERS DISORD, V25, P504, DOI 10.1521/pedi.2011.25.4.504; Livesley W.J., 2009, DIMENSIONAL ASSESSME; Livesley WJ, 2001, HANDBOOK OF PERSONALITY DISORDERS: THEORY, RESEARCH, AND TREATMENT, P3; Lorenzo-Seva U, 2013, FACTOR; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; Markon KE, 2013, ASSESSMENT, V20, P370, DOI 10.1177/1073191113486513; Morey LC, 2013, J ABNORM PSYCHOL, V122, P836, DOI 10.1037/a0034003; Quilty LC, 2013, ASSESSMENT, V20, P362, DOI 10.1177/1073191113486183; Rossi G, 2012, QUESTIONNAIRE DE PER; Rossier J, 2008, CAN J PSYCHIAT, V53, P534, DOI 10.1177/070674370805300808; Rothbart MK, 2007, CURR DIR PSYCHOL SCI, V16, P207, DOI 10.1111/j.1467-8721.2007.00505.x; Watson D, 2013, ASSESSMENT, V20, P312, DOI 10.1177/1073191113485810; Widiger TA, 2005, J PERS DISORD, V19, P110, DOI 10.1521/pedi.19.2.110.62628; Wright AGC, 2012, J ABNORM PSYCHOL, V121, P951, DOI 10.1037/a0027669; Zimmermann J, 2014, JOURNAL OF PERSONALI, V28, P130	35	48	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133413	10.1371/journal.pone.0133413	http://dx.doi.org/10.1371/journal.pone.0133413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26193699	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400081
J	Skinner, C; Patfield, S; Hernlem, BJ; He, XH				Skinner, Craig; Patfield, Stephanie; Hernlem, Bradley J.; He, Xiaohua			New Stx2e Monoclonal Antibodies for Immunological Detection and Distinction of Stx2 Subtypes	PLOS ONE			English	Article							SHIGA TOXIN 2; NEUTRALIZATION; PURIFICATION; VARIANTS; SUBUNIT; PIGS	Background Stx2e is a primary virulence factor in STEC strains that cause edema disease in neonatal piglets. Though Stx2a and Stx2e are similar, many antibody-based Stx detection kits are designed to detect Stx2a and do not recognize the Stx2e subtype. Methods and Findings Four monoclonal antibodies against Stx2e were developed and characterized. Two of these mAbs recognize the B subunit of Stx2e, Stx2f, and to a lesser extent, Stx2b, Stx2c, and Stx2d. The other two mAbs recognize the A subunit of Stx2e, and cross-react with all Stx2 subtypes except Stx2f. The most sensitive sandwich ELISA using these mAbs has a limit of detection for Stx2e of 11.8 pg/mL. The ability of the neutralizing antibody Stx2e-2 to block Stx2e-receptor binding in Vero cells was visualized using immunofluorescence. Combinations of these and previously developed mAbs permit ELISA-based differentiation between closely related Stx2a, Stx2c, and Stx2d (using mAbs Stx2-5/2-1, Stx2-5/2e-2, and Stx2e-3/2e-2, respectively). Conclusions The sensitive immunoassays developed in this study should augment our capacity to detect Stx2e in porcine environments and biological samples. Moreover, immunoassays that can distinguish between the closely related Stx2a, Stx2c, and Stx2d subtypes can be useful in quickly analyzing Stx subtypes in samples containing more than one strain of STEC.	[Skinner, Craig; Patfield, Stephanie; Hernlem, Bradley J.; He, Xiaohua] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA	United States Department of Agriculture (USDA)	He, XH (corresponding author), USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.	xiaohua.he@ars.usda.gov			United States Department of Agriculture-Agricultural Research Service (USDA-ARS) National Program Current Research Information System (CRIS) [5325-42000-048-00D, NP108]	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) National Program Current Research Information System (CRIS)	This study was funded by the United States Department of Agriculture-Agricultural Research Service (USDA-ARS) National Program NP108 Current Research Information System (CRIS) project 5325-42000-048-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Beutin L, 2008, APPL ENVIRON MICROB, V74, P4806, DOI 10.1128/AEM.00623-08; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fagerquist CK, 2015, J AM SOC MASS SPECTR, V26, P788, DOI 10.1007/s13361-015-1076-3; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Gupta P, 2010, PROTEIN PEPTIDE LETT, V17, P774, DOI 10.2174/092986610791190291; He X, 2012, J IMMUNOLOGICAL METH; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076368; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; He XH, 2011, APPL ENVIRON MICROB, V77, P3558, DOI 10.1128/AEM.02205-10; Lienemann T, 2011, CURR MICROBIOL, V62, P1239, DOI 10.1007/s00284-010-9832-x; Lo AWH, 2014, J BIOL CHEM, V289, P25374, DOI 10.1074/jbc.M114.566257; Moxley RA, 2000, VET CLIN N AM-FOOD A, V16, P175, DOI 10.1016/S0749-0720(15)30142-0; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Muthing J, 2009, THROMB HAEMOSTASIS, V101, P252, DOI 10.1160/TH08-05-0317; Parma YR, 2011, TOXICON, V58, P380, DOI 10.1016/j.toxicon.2011.07.009; Paton AW, 2000, NAT MED, V6, P265, DOI 10.1038/73111; Paton AW, 2001, INFECT IMMUN, V69, P1967, DOI 10.1128/IAI.69.3.1967-1970.2001; Rasooly R, 2012, FEMS IMMUNOL MED MIC, V64, P169, DOI 10.1111/j.1574-695X.2011.00874.x; Rocha LB, 2012, TOXINS, V4, P729, DOI 10.3390/toxins4090729; SAMUEL JE, 1990, INFECT IMMUN, V58, P611, DOI 10.1128/IAI.58.3.611-618.1990; SCHMITT CK, 1991, INFECT IMMUN, V59, P1065, DOI 10.1128/IAI.59.3.1065-1073.1991; Silva CJ, 2014, ANAL CHEM, V86, P4698, DOI 10.1021/ac402930r; Skinner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099854; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076563; Sonntag AK, 2005, APPL ENVIRON MICROB, V71, P8855, DOI 10.1128/AEM.71.12.8855-8863.2005; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132419	10.1371/journal.pone.0132419	http://dx.doi.org/10.1371/journal.pone.0132419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192407	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400025
J	Budge, GE; Pietravalle, S; Brown, M; Laurenson, L; Jones, B; Tomkies, V; Delaplane, KS				Budge, Giles E.; Pietravalle, Stephane; Brown, Mike; Laurenson, Lynn; Jones, Ben; Tomkies, Victoria; Delaplane, Keith S.			Pathogens as Predictors of Honey Bee Colony Strength in England and Wales	PLOS ONE			English	Article							NATIONAL-SURVEY; VARROA MITES; VIRUS; LOSSES	Inspectors with the UK National Bee Unit were asked for 2007-2008 to target problem apiaries in England and Wales for pathogen screening and colony strength measures. Healthy colonies were included in the sampling to provide a continuum of health conditions. A total of 406 adult bee samples was screened and yielded 7 viral, 1 bacterial, and 2 micro-sporidial pathogens and 1 ectoparasite (Acarapis woodi). In addition, 108 samples of brood were screened and yielded 4 honey bee viruses. Virus prevalence varied from common (deformed wing virus, black queen cell virus) to complete absence (Israeli acute paralysis virus). When colonies were forced into one of two classes, strong or weak, the weak colonies contained more pathogens in adult bees. Among observed pathogens, only deformed wing virus was able to predict colony strength. The effect was negative such that colonies testing positive for deformed wing virus were likely to have fewer combs of bees or brood. This study constitutes the first record for Nosema ceranae in Great Britain. These results contribute to the growing body of evidence linking pathogens to poor honey bee health.	[Budge, Giles E.; Pietravalle, Stephane; Brown, Mike; Laurenson, Lynn; Jones, Ben; Tomkies, Victoria] Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England; [Delaplane, Keith S.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	Food & Environment Research Agency; University System of Georgia; University of Georgia	Delaplane, KS (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	ksd@uga.edu	Delaplane, Keith/AAN-5197-2021	Delaplane, Keith/0000-0001-9323-441X	DEFRA; BBSRC; US [BB/I025220/1]; BBSRC [BB/I025220/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025220/1] Funding Source: researchfish	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded jointly between a grant from DEFRA and a BBSRC Partnering award with the US between GEB and KSD (BB/I025220/1).	Bacandritsos N, 2010, J INVERTEBR PATHOL, V105, P335, DOI 10.1016/j.jip.2010.08.004; Budge GE, 2010, J INVERTEBR PATHOL, V105, P164, DOI 10.1016/j.jip.2010.06.004; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Delaplane KS, 2012, J APIC RES, V51; Dietemann V, 2012, J APICULT RES, V51, P125, DOI 10.3896/IBRA.1.51.1.15; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Dussaubat C, 2013, VET MICROBIOL, V162, P670, DOI 10.1016/j.vetmic.2012.09.012; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; GOODMAN RA, 2002, FIELD EPIDEMIOLOGY, P3; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Hooper T, 1997, GUIDE BEES HONEY; Kajobe R, 2010, J INVERTEBR PATHOL, V104, P153, DOI 10.1016/j.jip.2010.02.007; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Ward L, 2007, APIDOLOGIE, V38, P181, DOI 10.1051/apido:2006072; Wilkins S, 2007, PEST MANAG SCI, V63, P1062, DOI 10.1002/ps.1461	32	34	35	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133228	10.1371/journal.pone.0133228	http://dx.doi.org/10.1371/journal.pone.0133228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186735	gold, Green Published			2022-12-27	WOS:000358198700112
J	Janssen, PA; Mitton, C; Aghajanian, J				Janssen, Patricia A.; Mitton, Craig; Aghajanian, Jaafar			Costs of Planned Home vs. Hospital Birth in British Columbia Attended by Registered Midwives and Physicians	PLOS ONE			English	Article							LOW-RISK; MIDWIFERY; EXPERIENCES	Background Home birth is available to women in Canada who meet eligibility requirements for low risk status after assessment by regulated midwives. While UK researchers have reported lower costs associated with planned home birth, there have been no published studies of the costs of home versus hospital birth in Canada. Methods Costs for all women planning home birth with a regulated midwife in British Columbia, Canada were compared with those of all women who met eligibility requirements for home birth and were planning to deliver in hospital with a registered midwife, and with a sample of women of similar low risk status planning birth in the hospital with a physician. We calculated costs of physician service billings, midwifery fees, hospital in-patient costs, pharmaceuticals, home birth supplies, and transport. We compared costs among study groups using the Kruskall Wallis test for independent groups. Results In the first 28 days postpartum, we report a $2,338 average savings per birth among women planning home birth compared to hospital birth with a midwife and $2,541 compared to hospital birth planned with a physician. In longer term outcomes, similar reductions were observed, with cost savings per birth at $1,683 compared to the planned hospital birth with a midwife, and $1,100 compared to the physician group during the first eight weeks postpartum. During the first year of life, costs for infants of mothers planning home birth were reduced overall. Cost savings compared to planned hospital births with a midwife were $810 and with a physician $1,146. Costs were similarly reduced when findings were stratified by parity. Conclusions Planned home birth in British Columbia with a registered midwife compared to planned hospital birth is less expensive for our health care system up to 8 weeks postpartum and to one year of age for the infant.	[Janssen, Patricia A.; Mitton, Craig] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Janssen, Patricia A.] Child & Family Res Inst, Vancouver, BC, Canada; [Mitton, Craig] Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Aghajanian, Jaafar] BC Ctr Epidemiol & Int Ophthalmol, Vancouver, BC, Canada	University of British Columbia; Child & Family Research Institute	Janssen, PA (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	patti.janssen@ubc.ca	Janssen, Patricia/B-1036-2018	Janssen, Patricia/0000-0002-4178-1195	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research. The agency does not issue grant numbers. The URL is http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RE, 1999, J NURSE-MIDWIFERY, V44, P30, DOI 10.1016/S0091-2182(98)00072-X; [Anonymous], 2009, BC AMB SERV DAT EXTR; [Anonymous], 2009, PHARMANET; [Anonymous], 2008, DISCH ABSTRACT DAT H; [Anonymous], 2008, CONS FIL MSP REG PRE; BC Go, 2012, PAYM SCH MIDW SERV 2; British Columbia Perinatal Health Program, 2008, MIDW BRIT COL; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Canadian Institutes of Health Research, 2006, GIV BRITH CAN COSTS; College of Midwives in Ontario, 2011, FACTS HOM BIRTH ONT; CUNNINGHAM JD, 1993, SOC SCI MED, V36, P475, DOI 10.1016/0277-9536(93)90409-W; de Jonge A, 2009, BJOG-INT J OBSTET GY, V116, P1177, DOI 10.1111/j.1471-0528.2009.02175.x; Health Management Associates, 2007, MIDW LIC DISC PROGR; Henderson J, 2008, BIRTH-ISS PERINAT C, V35, P136, DOI 10.1111/j.1523-536X.2008.00227.x; Hendrix MJC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-211; Hutton EK, 2009, BIRTH-ISS PERINAT C, V36, P180, DOI 10.1111/j.1523-536X.2009.00322.x; Janssen PA, 2006, J MIDWIFERY WOM HEAL, V51, P91, DOI 10.1016/j.jmwh.2005.10.012; Janssen PA, 2002, CAN MED ASSOC J, V166, P315; Janssen PA, 2009, BIRTH-ISS PERINAT C, V36, P297, DOI 10.1111/j.1523-536X.2009.00357.x; Janssen PA, 2009, CAN MED ASSOC J, V181, P377, DOI 10.1503/cmaj.081869; Lindgren H, 2006, MIDWIFERY, V22, P15, DOI 10.1016/j.midw.2005.04.002; Longworth L, 2001, HEALTH SOC CARE COMM, V9, P404, DOI 10.1046/j.1365-2524.2001.00319.x; Medical Services Plan (MSP), 2008, MED SERVICES PLAN MS; Neuhaus W, 2002, J Obstet Gynaecol, V22, P143; Ogden J., 1997, BRIT J MIDWIFERY, V5, P208, DOI [https://doi.org/10.12968/bjom.1997.5.4.208, DOI 10.12968/BJOM.1997.5.4.208]; Reinharz D, 2000, CAN J PUBLIC HEALTH, V91, pI12, DOI 10.1007/BF03404261; Schroeder E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2292; Sjoblom I, 2006, MIDWIFERY, V22, P348, DOI 10.1016/j.midw.2005.11.004; University of Manitoba-Manitoba Centre for Health Policy, 2012, CONC CALC HOSP COSTS	29	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133524	10.1371/journal.pone.0133524	http://dx.doi.org/10.1371/journal.pone.0133524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186720	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700152
J	Lee, U; Skinner, JJ; Reinitz, J; Rosner, MR; Kim, EJ				Lee, Unjin; Skinner, John J.; Reinitz, John; Rosner, Marsha Rich; Kim, Eun-Jin			Noise-Driven Phenotypic Heterogeneity with Finite Correlation Time in Clonal Populations	PLOS ONE			English	Article							BREAST-CANCER; TUMOR; MODEL; CANALIZATION; VARIABILITY; EMERGENCE; EVOLUTION; DYNAMICS	There has been increasing awareness in the wider biological community of the role of clonal phenotypic heterogeneity in playing key roles in phenomena such as cellular bet-hedging and decision making, as in the case of the phage-lambda lysis/lysogeny and B. Subtilis competence/vegetative pathways. Here, we report on the effect of stochasticity in growth rate, cellular memory/intermittency, and its relation to phenotypic heterogeneity. We first present a linear stochastic differential model with finite auto-correlation time, where a randomly fluctuating growth rate with a negative average is shown to result in exponential growth for sufficiently large fluctuations in growth rate. We then present a non-linear stochastic selfregulation model where the loss of coherent self-regulation and an increase in noise can induce a shift from bounded to unbounded growth. An important consequence of these models is that while the average change in phenotype may not differ for various parameter sets, the variance of the resulting distributions may considerably change. This demonstrates the necessity of understanding the influence of variance and heterogeneity within seemingly identical clonal populations, while providing a mechanism for varying functional consequences of such heterogeneity. Our results highlight the importance of a paradigm shift from a deterministic to a probabilistic view of clonality in understanding selection as an optimization problem on noise-driven processes, resulting in a wide range of biological implications, from robustness to environmental stress to the development of drug resistance.	[Lee, Unjin] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Skinner, John J.; Rosner, Marsha Rich] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Skinner, John J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Kim, Eun-Jin] Univ Sheffield, Sch Math & Stat, Sheffield, S Yorkshire, England	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Sheffield	Lee, U (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.	unjin@uchicago.edu	Kim, Eun-Jin/I-1261-2019	Kim, Eun-Jin/0000-0001-5607-6635; Lee, UnJin/0000-0003-2424-650X	National Institute of Health [GM 87630, RO1CA-184494]; NATIONAL CANCER INSTITUTE [R01CA184494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197, R01GM087630] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institute of Health grants GM 87630 and RO1CA-184494 to MRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Arkin A, 1998, GENETICS, V149, P1633; Bose T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051903; BUEHRING GC, 1976, CANCER RES, V36, P3742; CALDERON CP, 1991, MATH BIOSCI, V103, P97, DOI 10.1016/0025-5564(91)90093-X; d'Onofrio A, 2009, CHAOS SOLITON FRACT, V41, P875, DOI 10.1016/j.chaos.2008.04.014; Diego D, 2013, J MATH BIOL, V67, P657, DOI 10.1007/s00285-012-0565-2; Dingli D, 2007, CANCER BIOL THER, V6, P383, DOI 10.4161/cbt.6.3.3720; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Frank SA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001296; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Hart D, 1998, BRIT J CANCER, V78, P382, DOI 10.1038/bjc.1998.503; Hasegawa H, 2008, PHYSICA A, V387, P2697, DOI [10.1016/j.physa-2008.01.072, 10.1016/j.physa.2008.01.072]; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; HERNANDEZMACHADO A, 1984, PHYS REV A, V29, P3388, DOI 10.1103/PhysRevA.29.3388; HONEYCUTT RL, 1992, PHYS REV A, V45, P604, DOI 10.1103/PhysRevA.45.604; Kim E, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3033751; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Li DX, 2012, PHYS LETT A, V376, P1771, DOI 10.1016/j.physleta.2012.04.006; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mombach JCM, 2002, EUROPHYS LETT, V59, P923, DOI 10.1209/epl/i2002-00244-6; Nevozhay D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002480; Newton APL, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4817955; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Royston P, 2001, STAT NEERL, V55, P89, DOI 10.1111/1467-9574.00158; Sahoo S, 2010, PHYSICA A, V389, P1197, DOI 10.1016/j.physa.2009.11.015; Schultz D, 2007, P NATL ACAD SCI USA, V104, P17582, DOI 10.1073/pnas.0707965104; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang NX, 2012, BRAZ J PHYS, V42, P253, DOI 10.1007/s13538-012-0082-1; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092; Whitesell L, 2014, P NATL ACAD SCI USA, V111, P18297, DOI 10.1073/pnas.1421323111; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	37	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132397	10.1371/journal.pone.0132397	http://dx.doi.org/10.1371/journal.pone.0132397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203903	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358621000008
J	van Hoeven, L; Vergouwe, Y; de Buck, PDM; Luime, JJ; Hazes, JMW; Weel, AEAM				van Hoeven, Lonneke; Vergouwe, Yvonne; de Buck, P. D. M.; Luime, Jolanda J.; Hazes, Johanna M. W.; Weel, Angelique E. A. M.			External Validation of a Referral Rule for Axial Spondyloarthritis in Primary Care Patients with Chronic Low Back Pain	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; GLOBAL BURDEN; DISEASE; PREDICTION; IDENTIFICATION; PERFORMANCE; DISABILITY; DIAGNOSIS	Objectives To validate and optimize a referral rule to identify primary care patients with chronic low back pain (CLBP) suspected for axial spondyloarthritis (axSpA). Design Cross-sectional study with data from 19 Dutch primary care practices for development and 38 for validation. Participants Primary care patients aged 18-45 years with CLBP existing more than three months and onset of back pain started before the age of 45 years. Main Outcome The number of axSpA patients according to the ASAS criteria. Methods The referral rule (CaFaSpA referral rule) was developed using 364 CLBP patients from 19 primary care practices and contains four easy to use variables; inflammatory back pain, good response to nonsteriodal anti-inflammatory drugs, family history of spondyloarthritis and a back pain duration longer than five years. This referral rule is positive when at least two variables are present. Validation of the CaFaSpA rule was accomplished in 579 primary care CLBP patients from 38 practices from other areas. Performance of the referral rule was assessed by c-statistic and calibration plot. To fit the final referral rule the development and validation datasets were pooled leading to a total study population of 943 primary care participants. Results The referral rule was validated in 579 patients (41% male, mean age 36 (sd7.0). The percentage of identified axSpA patients was 16% (n=95). External validation resulted in satisfactory calibration and reasonable discriminative ability (c-statistics 0.70 [95% CI, 0.64-0.75]). In the pooled dataset sensitivity and specificity of the referral rule were 75% and 58%. Conclusions The CaFaSpA referral rule for axSpA consists of four easy to use predictors for primary care physicians and has a good predictive value in this validation study. The referral rule has the potential to be a screening tool for primary care by identifying CLBP patients suspected for axSpA.	[van Hoeven, Lonneke; Luime, Jolanda J.; Hazes, Johanna M. W.; Weel, Angelique E. A. M.] Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands; [van Hoeven, Lonneke; Weel, Angelique E. A. M.] Maasstad Hosp, Dept Rheumatol, Rotterdam, Netherlands; [Vergouwe, Yvonne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [de Buck, P. D. M.] MC Haaglanden, Dept Rheumatol, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Maasstad Hospital; Erasmus University Rotterdam; Erasmus MC	van Hoeven, L (corresponding author), Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands.	l.vanhoeven@erasmusmc.nl	, Angelique/O-1699-2016		AbbVie Netherlands [IMM-10-0147]	AbbVie Netherlands(AbbVie)	An unrestricted research grant was provided by AbbVie Netherlands, grantnumber IMM-10-0147 (www.abbvie.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Boonen A, 2006, J RHEUMATOL, V33, P4; Brandt HC, 2007, ANN RHEUM DIS, V66, P1479, DOI 10.1136/ard.2006.068734; Braun A, 2013, RHEUMATOLOGY, V52, P1418, DOI 10.1093/rheumatology/ket115; Braun J, 2010, ANN RHEUM DIS, V69, P1264, DOI 10.1136/ard.2010.130559; Callhoff J, 2014, ANN RHEUM DIS; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gebel RS, 1997, ST HEAL T, V43, P421; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hermann J, 2009, RHEUMATOLOGY, V48, P812, DOI 10.1093/rheumatology/kep119; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; Molto A, 2014, ANN RHEUM DIS; Poddubnyy D, 2011, J RHEUMATOL, V38, P2452, DOI 10.3899/jrheum.110070; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sieper J, 2013, ANN RHEUM DIS, V72, P1621, DOI 10.1136/annrheumdis-2012-201777; Sieper J, 2013, ANN RHEUM DIS, V72, P815, DOI 10.1136/annrheumdis-2012-201766; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; THE H S G, 1985, British Journal of Rheumatology, V24, P242; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Underwood MR, 1995, BRIT J RHEUMATOL, V34, P1074; van den Berg R, 2013, RHEUMATOLOGY, V52, P1492, DOI 10.1093/rheumatology/ket164; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van der Horst-Bruinsma IE, 2012, RHEUM DIS CLIN N AM, V38, P523, DOI 10.1016/j.rdc.2012.08.010; van Hoeven L, 2014, ARTHRIT CARE RES, V66, P446, DOI 10.1002/acr.22180; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Yazici H, 2009, BULL HOSP JT DIS, V67, P206	35	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131963	10.1371/journal.pone.0131963	http://dx.doi.org/10.1371/journal.pone.0131963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200904	Green Published, Green Submitted, gold			2022-12-27	WOS:000358597100022
J	Neupane, B; Beyene, J				Neupane, Binod; Beyene, Joseph			Multivariate Meta-Analysis of Genetic Association Studies: A Simulation Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HDL CHOLESTEROL; TRAITS; SIZE	In a meta-analysis with multiple end points of interests that are correlated between or within studies, multivariate approach to meta-analysis has a potential to produce more precise estimates of effects by exploiting the correlation structure between end points. However, under random-effects assumption the multivariate estimation is more complex (as it involves estimation of more parameters simultaneously) than univariate estimation, and sometimes can produce unrealistic parameter estimates. Usefulness of multivariate approach to meta-analysis of the effects of a genetic variant on two or more correlated traits is not well understood in the area of genetic association studies. In such studies, genetic variants are expected to roughly maintain Hardy-Weinberg equilibrium within studies, and also their effects on complex traits are generally very small to modest and could be heterogeneous across studies for genuine reasons. We carried out extensive simulation to explore the comparative performance of multivariate approach with most commonly used univariate inverse-variance weighted approach under random-effects assumption in various realistic meta-analytic scenarios of genetic association studies of correlated end points. We evaluated the performance with respect to relative mean bias percentage, and root mean square error (RMSE) of the estimate and coverage probability of corresponding 95% confidence interval of the effect for each end point. Our simulation results suggest that multivariate approach performs similarly or better than univariate method when correlations between end points within or between studies are at least moderate and between-study variation is similar or larger than average within-study variation for meta-analyses of 10 or more genetic studies. Multivariate approach produces estimates with smaller bias and RMSE especially for the end point that has randomly or informatively missing summary data in some individual studies, when the missing data in the endpoint are imputed with null effects and quite large variance.	[Neupane, Binod; Beyene, Joseph] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Beyene, Joseph] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada	McMaster University; McMaster University	Beyene, J (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	beyene@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR) [84392]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	JB acknowledges grant funding from the Natural Sciences and Engineering Research Council of Canada (NSERC), and The Canadian Institutes of Health Research (CIHR, grant 84392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dahabreh I.J., 2012, EMPIRICAL ASSESSMENT; Edwards KL, 1999, ARTERIOSCL THROM VAS, V19, P2456, DOI 10.1161/01.ATV.19.10.2456; Falconer DS, 1996, INTRODUCTION TO QUAN; Follmann DA, 1999, BIOMETRICS, V55, P732, DOI 10.1111/j.0006-341X.1999.00732.x; Higgins JP, 2002, STAT MED; Hindorff LA, CATALOG PUBLISHED GE; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Kirkham JJ, 2012, STAT MED, V31, P2179, DOI 10.1002/sim.5356; Kullo IJ, 2005, AM J HYPERTENS, V18, P99, DOI 10.1016/j.amjhyper.2004.09.002; Lebrec JJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1503; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Ma Y, 2011, STAT MED, V30, P2911, DOI 10.1002/sim.4327; Neupane B, 2012, EUR J HUM GENET, V20, P1174, DOI 10.1038/ejhg.2012.75; Pfeiffer RM, 2009, STAT SCI, V24, P547, DOI 10.1214/09-STS286; Riley RD, 2007, STAT MED, V26, P78, DOI 10.1002/sim.2524; Riley RD, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-3; Riley RD, 2008, BIOSTATISTICS, V9, P172, DOI 10.1093/biostatistics/kxm023; Riley RD, 2009, J R STAT SOC A STAT, V172, P789, DOI 10.1111/j.1467-985X.2008.00593.x; Ritz J, 2008, J STAT PLAN INFER, V138, P1919, DOI 10.1016/j.jspi.2007.07.004; Trikalinos TA, 2013, AGENCY HEALTHCARE RE; Trikalinos TA, 2014, STAT MED, V33, P1441, DOI 10.1002/sim.6044; Yang F, 2009, J GENET GENOMICS, V36, P733, DOI 10.1016/S1673-8527(08)60166-6; Yuan Mengdie, 2011, BMC Proc, V5 Suppl 9, pS74, DOI 10.1186/1753-6561-5-S9-S74	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133243	10.1371/journal.pone.0133243	http://dx.doi.org/10.1371/journal.pone.0133243			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196398	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600077
J	Orsenigo, S; Abeli, T; Rossi, G; Bonasoni, P; Pasquaretta, C; Gandini, M; Mondoni, A				Orsenigo, Simone; Abeli, Thomas; Rossi, Graziano; Bonasoni, Paolo; Pasquaretta, Cristian; Gandini, Maurizia; Mondoni, Andrea			Effects of Autumn and Spring Heat Waves on Seed Germination of High Mountain Plants	PLOS ONE			English	Article							CLIMATE EXTREMES; ELEVATED CO2; GROWTH; TOLERANCE; RESPONSES; TEMPERATURE; VEGETATION; EUROPE; ESTABLISHMENT; REPRODUCTION	Alpine plants are considered to be particularly vulnerable to climate change and related extreme episodes, such as heat waves. Despite growing interest in the impact of heat waves on alpine plants, knowledge about their effects on regeneration is still fragmentary. Recruitment from seeds will be crucial for the successful migration and survival of these species and will play a key role in their future adaptation to climate change. In this study, we assessed the impacts of heat waves on the seed germination of 53 high mountain plants from the Northern Apennines ( Italy). The seeds were exposed to laboratory simulations of three seasonal temperature treatments, derived from real data recorded at a meteorological station near the species growing site, which included two heat wave episodes that occurred both in spring 2003 and in autumn 2011. Moreover, to consider the effect of increasing drought conditions related to heat waves, seed germination was also investigated under four different water potentials. In the absence of heat waves, seed germination mainly occurred in spring, after seeds had experienced autumn and winter seasons. However, heat waves resulted in a significant increase of spring germination in c. 30% of the species and elicited autumn germination in 50%. When heat waves were coupled with drought, seed germination decreased in all species, but did not stop completely. Our results suggest that in the future, heat waves will affect the germination phenology of alpine plants, especially conditionally dormant and strictly cold-adapted chorotypes, by shifting the emergence time from spring to autumn and by increasing the proportion of emerged seedlings. The detrimental effects of heat waves on recruitment success is less likely to be due to the inhibition of seed germination per se, but rather due to seedling survival in seasons, and temperature and water conditions that they are not used to experiencing. Changes in the proportion and timing of emergence suggest that there may be major implications for future plant population size and structure.	[Orsenigo, Simone; Abeli, Thomas; Rossi, Graziano; Mondoni, Andrea] Univ Pavia, Dept Earth & Environm Sci, I-27100 Pavia, Italy; [Bonasoni, Paolo] Inst Atmospher Sci & Climate, Bologna, Italy; [Pasquaretta, Cristian] CNRS, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Gandini, Maurizia] MUSE Sci Museum, Trento, Italy	University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Orsenigo, S (corresponding author), Univ Milan, Dept Agr & Environm Sci Prod Landscape Agroenergy, Milan, Italy.	simone.orsenigo@unipv.it	Pasquaretta, Cristian/AAA-3364-2021; Rossi, Graziano/P-3353-2015; Orsenigo, Simone/E-5961-2017; Bonasoni, Paolo/C-6338-2015	Pasquaretta, Cristian/0000-0001-8308-9968; Rossi, Graziano/0000-0002-5102-5019; Orsenigo, Simone/0000-0003-0348-9115; Bonasoni, Paolo/0000-0002-8812-5291; MONDONI, ANDREA/0000-0002-4605-6304; Abeli, Thomas/0000-0003-3096-2035	Ministry of Education, University and Research (MIUR); Provincia Autonoma di Trento, through the program "People" (Marie Curie Action - COFUND) within European Union's Seventh Framework Programme (FP7)	Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Provincia Autonoma di Trento, through the program "People" (Marie Curie Action - COFUND) within European Union's Seventh Framework Programme (FP7)	This work was carried out in the framework of SHARE project (Ev-K2-CNR, Bergamo), of the Italian Project of National Interest NextData, supported by the Ministry of Education, University and Research (MIUR), and of the project CLIMBIVEG, funded by the Provincia Autonoma di Trento, through the program "People" (Marie Curie Action - COFUND) within European Union's Seventh Framework Programme (FP7).	Abeli T, 2014, AGROCHIMICA, V58, P128; Abeli T, 2012, NORD J BOT, V30, P109, DOI 10.1111/j.1756-1051.2011.01303.x; ALESSANDRINI A., 2003, FLORA ALTITUDINE APP; Andrello M, 2012, BIOL CONSERV, V147, P99, DOI 10.1016/j.biocon.2011.12.012; [Anonymous], 2014, R LANG ENV STAT COMP; ARPA, 2010, ATL IDR EM ROM 1961; Ballester J, 2010, CLIM DYNAM, V35, P1191, DOI 10.1007/s00382-009-0641-5; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Bauweraerts I, 2014, PLANT ECOL, V215, P733, DOI 10.1007/s11258-014-0352-9; Bokhorst S, 2011, GLOBAL CHANGE BIOL, V17, P2817, DOI 10.1111/j.1365-2486.2011.02424.x; Buchner O, 2003, ARCT ANTARCT ALP RES, V35, P411, DOI 10.1657/1523-0430(2003)035[0411:VOHTIA]2.0.CO;2; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; De Boeck HJ, 2011, NEW PHYTOL, V189, P806, DOI 10.1111/j.1469-8137.2010.03515.x; De Boeck HJ, 2010, GLOBAL CHANGE BIOL, V16, P1992, DOI 10.1111/j.1365-2486.2009.02049.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elguindi N, 2013, CLIMATIC CHANGE, V117, P415, DOI 10.1007/s10584-012-0528-z; Erlat E, 2013, INT J CLIMATOL, V33, P1898, DOI 10.1002/joc.3556; EVANS CE, 1990, NEW PHYTOL, V115, P539, DOI 10.1111/j.1469-8137.1990.tb00482.x; Gerdol R, 2008, NEW PHYTOL, V179, P142, DOI 10.1111/j.1469-8137.2008.02429.x; Gerdol R, 2013, J VEG SCI, V24, P569, DOI 10.1111/j.1654-1103.2012.01472.x; Gill EC, 2013, J GEOPHYS RES-ATMOS, V118, P8297, DOI 10.1002/jgrd.50635; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Graae BJ, 2009, POLAR BIOL, V32, P1117, DOI 10.1007/s00300-009-0608-3; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Hay F.R., 2003, SEED CONSERVATION TU, P97; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoyle GL, 2013, GLOBAL CHANGE BIOL, V19, P1549, DOI 10.1111/gcb.12135; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Larcher W, 2010, FLORA, V205, P3, DOI 10.1016/j.flora.2008.12.005; Marcante S, 2014, PLANT ECOL, V215, P747, DOI 10.1007/s11258-014-0361-8; Marcante S, 2012, J VEG SCI, V23, P858, DOI 10.1111/j.1654-1103.2012.01411.x; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Milbau A, 2009, ANN BOT-LONDON, V104, P287, DOI 10.1093/aob/mcp117; Mondoni A, 2015, ANN BOT LON IN PRESS; Mondoni A, 2012, ANN BOT-LONDON, V110, P155, DOI 10.1093/aob/mcs097; Niu SL, 2014, ENVIRON EXP BOT, V98, P13, DOI 10.1016/j.envexpbot.2013.10.004; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Ooi MKJ, 2012, PLANT SOIL, V353, P289, DOI 10.1007/s11104-011-1032-3; Orlowsky B, 2012, CLIMATIC CHANGE, V110, P669, DOI 10.1007/s10584-011-0122-9; Orsenigo S, 2014, PLANT ECOL, V215, P677, DOI 10.1007/s11258-014-0363-6; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Passalacqua NG, 2015, J BIOGEOGR, V42, P611, DOI 10.1111/jbi.12473; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Penuelas J, 2007, GLOBAL CHANGE BIOL, V13, P2563, DOI 10.1111/j.1365-2486.2007.01464.x; Peruzzi L., 2010, INFORM BOT ITALIANO, V42, P151; Probert R. J., 2000, Seeds: the ecology of regeneration in plant communities, P261, DOI 10.1079/9780851994321.0261; Schaberg PG, 2008, GLOBAL CHANGE BIOL, V14, P1282, DOI 10.1111/j.1365-2486.2008.01577.x; Schwienbacher E, 2011, FLORA, V206, P845, DOI 10.1016/j.flora.2011.05.001; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Shaver GR, 1997, PLANT FUNCTIONAL TYP, P153; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Shevtsova A, 2009, GLOBAL CHANGE BIOL, V15, P2662, DOI 10.1111/j.1365-2486.2009.01947.x; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Stanisci A, 2016, PLANT BIOSYST, V150, P227, DOI 10.1080/11263504.2014.968232; Tank AMGK, 2003, J CLIMATE, V16, P3665, DOI [10.1175/1520-0442(2003)016<3665:TIIODT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3665:TIIODT&gt;2.0.CO;2]; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Tomaselli M., 1994, FITOSOCIOLOGIA, V26, P35; Trenberth KE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022760; Valt M, 2010, COLD REG SCI TECHNOL, V64, P146, DOI 10.1016/j.coldregions.2010.08.008; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	65	28	32	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133626	10.1371/journal.pone.0133626	http://dx.doi.org/10.1371/journal.pone.0133626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197387	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600122
J	Roman, E; Alonso-Monge, R; Miranda, A; Pla, J				Roman, Elvira; Alonso-Monge, Rebeca; Miranda, Alberto; Pla, Jesus			The Mkk2 MAPKK Regulates Cell Wall Biogenesis in Cooperation with the Cek1-Pathway in Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLOBAL TRANSCRIPTIONAL RESPONSE; OXIDATIVE-STRESS-RESPONSE; SACCHAROMYCES-CEREVISIAE; CHLAMYDOSPORE FORMATION; HYPHAL FORMATION; GENE-EXPRESSION; YEAST; PATHWAY; VIRULENCE	The cell wall integrity pathway (CWI) plays an important role in the biogenesis of the cell wall in Candida albicans and other fungi. In the present work, the C. albicans MKK2 gene that encodes the putative MAPKK of this pathway was deleted in different backgrounds and the phenotypes of the resultant mutants were characterised. We show here that Mkk2 mediates the phosphorylation of the Mkc1 MAPK in response to cell wall assembly interfering agents such as zymolyase or tunicamycin and also to oxidative stress. Remarkably, mkk2 and mkc1 mutants display related but distinguishable-cell wall associated phenotypes and differ in the pattern of MAPK phosphorylation under different stress conditions. mkk2 and mkc1 mutants display an altered expression of GSC1, CEK1 and CRH11 genes at different temperatures. Combined deletion of MKK2 with HST7 supports a cooperative role for the Cek1-mediated and CWI pathways in regulating cell wall architecture under vegetative growth. However, and in contrast to Mkc1, Mkk2 does not seem to play a role in the virulence of C. albicans in the mouse systemic model or the Galleria mellonella model of infection.	[Roman, Elvira; Alonso-Monge, Rebeca; Miranda, Alberto; Pla, Jesus] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain	Complutense University of Madrid	Pla, J (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon y Cajal S-N, E-28040 Madrid, Spain.	jpla@ucm.es	Alonso, Rebeca/H-8841-2015; Román, Elvira/H-8894-2015; Pla, Jesús/ABG-9609-2020; Pla, Jesús/G-8238-2015; GONZALEZ, ELVIRA ROMAN/U-3576-2019	Román, Elvira/0000-0002-7335-7292; Pla, Jesús/0000-0003-0897-1963; GONZALEZ, ELVIRA ROMAN/0000-0002-7335-7292; Alonso Monge, Rebeca/0000-0001-8390-917X; Miranda-Bedate, Alberto/0000-0003-2623-2857	 [BIO2012-31839];  [PIM2010EPA-00658];  [S2010-BMD2414]	; ; 	Work in the authors' laboratory is supported by Grants BIO2012-31839, PIM2010EPA-00658 and S2010-BMD2414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Alonso-Monge R, 2009, EVOLUTIONARY BIOL BA, P105; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Arana DM, 2005, MICROBIOL-SGM, V151, P1033, DOI 10.1099/mic.0.27723-0; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Cheetham J, 2007, MOL BIOL CELL, V18, P4603, DOI 10.1091/mbc.E07-06-0581; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Diez-Orejas R, 1997, INFECT IMMUN, V65, P833; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; FONZI WA, 1993, GENETICS, V134, P717; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Heilmann CJ, 2013, EUKARYOT CELL, V12, P254, DOI 10.1128/EC.00278-12; de Dios CH, 2013, FUNGAL GENET BIOL, V50, P21, DOI 10.1016/j.fgb.2012.11.001; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jendretzki A, 2011, EUR J CELL BIOL, V90, P740, DOI 10.1016/j.ejcb.2011.04.006; Jimenez-Sanchez M, 2007, J BIOL CHEM, V282, P31174, DOI 10.1074/jbc.M706270200; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Lee BN, 1999, P NATL ACAD SCI USA, V96, P12679, DOI 10.1073/pnas.96.22.12679; Li DM, 2009, FUNGAL GENET BIOL, V46, P731, DOI 10.1016/j.fgb.2009.06.008; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MAZUR P, 1995, MOL CELL BIOL, V15, P5671; Mio T, 1997, J BACTERIOL, V179, P4096, DOI 10.1128/jb.179.13.4096-4105.1997; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Naglik JR, 2011, MICROBES INFECT, V13, P963, DOI 10.1016/j.micinf.2011.06.009; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Navarro-Garcia F, 1998, MICROBIOL-UK, V144, P411, DOI 10.1099/00221287-144-2-411; NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197; Ohkuni K, 2003, GENETICS, V165, P517; Pardini G, 2006, J BIOL CHEM, V281, P40399, DOI 10.1074/jbc.M606361200; Park YN, 2013, EUKARYOT CELL, V12, P1120, DOI 10.1128/EC.00112-13; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Popolo L, 2001, MED MYCOL, V39, P111, DOI 10.1080/744118881; Ramirez-Zavala B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003696; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Roman E, 2009, EUKARYOT CELL, V8, P1235, DOI 10.1128/EC.00081-09; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Sahni N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000363; Saito H, 2013, MICROB PATHOGENESIS, V56, P16, DOI 10.1016/j.micpath.2013.01.002; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; SOLER M, 1995, MOL MICROBIOL, V17, P833, DOI 10.1111/j.1365-2958.1995.mmi_17050833.x; Urrialde V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00118; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; WHITEWAY M, 1992, P NATL ACAD SCI USA, V89, P9410, DOI 10.1073/pnas.89.20.9410; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x	66	23	23	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133476	10.1371/journal.pone.0133476	http://dx.doi.org/10.1371/journal.pone.0133476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197240	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358547600102
J	Sousa, L; Garcia, IJP; Costa, TGF; Silva, LND; Reno, CO; Oliveira, ES; Tilelli, CQ; Santos, LL; Cortes, VF; Santos, HL; Barbosa, LA				Sousa, Leilismara; Garcia, Israel J. P.; Costa, Tamara G. F.; Silva, Lilian N. D.; Reno, Cristiane O.; Oliveira, Eneida S.; Tilelli, Cristiane Q.; Santos, Luciana L.; Cortes, Vanessa F.; Santos, Herica L.; Barbosa, Leandro A.			Effects of Iron Overload on the Activity of Na, K-ATPase and Lipid Profile of the Human Erythrocyte Membrane	PLOS ONE			English	Article							HFE GENE-MUTATIONS; RED-BLOOD-CELLS; P-TYPE ATPASES; SODIUM-POTASSIUM PUMP; HEREDITARY HEMOCHROMATOSIS; ION-TRANSPORT; MOLECULAR ACTIVITY; BRAZILIAN PATIENTS; CRYSTAL-STRUCTURE; NA,K-ATPASE	Iron is an essential chemical element for human life. However, in some pathological conditions, such as hereditary hemochromatosis type 1 (HH1), iron overload induces the production of reactive oxygen species that may lead to lipid peroxidation and a change in the plasma-membrane lipid profile. In this study, we investigated whether iron overload interferes with the Na, K-ATPase activity of the plasma membrane by studying erythrocytes that were obtained from the whole blood of patients suffering from iron overload. Additionally, we treated erythrocytes of normal subjects with 0.8 mM H2O2 and 1 mu M FeCl3 for 24 h. We then analyzed the lipid profile, lipid peroxidation and Na, K-ATPase activity of plasma membranes derived from these cells. Iron overload was more frequent in men (87.5%) than in women and was associated with an increase (446%) in lipid peroxidation, as indicated by the amount of the thiobarbituric acid reactive substances (TBARS) and an increase (327%) in the Na, K-ATPase activity in the plasma membrane of erythrocytes. Erythrocytes treated with 1 mu M FeCl3 for 24 h showed an increase (132%) in the Na, K-ATPase activity but no change in the TBARS levels. Iron treatment also decreased the cholesterol and phospholipid content of the erythrocyte membranes and similar decreases were observed in iron overload patients. In contrast, erythrocytes treated with 0.8 mM H2O2 for 24 h showed no change in the measured parameters. These results indicate that erythrocytes from patients with iron overload exhibit higher Na, K-ATPase activity compared with normal subjects and that this effect is specifically associated with altered iron levels.	[Sousa, Leilismara; Garcia, Israel J. P.; Costa, Tamara G. F.; Silva, Lilian N. D.; Reno, Cristiane O.; Cortes, Vanessa F.; Santos, Herica L.; Barbosa, Leandro A.] Univ Fed Sao Joao Rei, Lab Bioquim Celular, BR-35501296 Divinopolis, Brazil; [Tilelli, Cristiane Q.] Univ Fed Sao Joao Rei, Lab Estudos Neurociencias Epilepsias & Comorbidad, BR-35501296 Divinopolis, Brazil; [Oliveira, Eneida S.; Santos, Luciana L.] Univ Fed Sao Joao Rei, Lab Biol Mol, BR-35501296 Divinopolis, Brazil		Barbosa, LA (corresponding author), Univ Fed Sao Joao Rei, Lab Bioquim Celular, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, Brazil.	leaugust@yahoo.com.br	Sousa, Leilismara/AAS-3853-2021; Cortes, Vanessa Faria/GWC-0392-2022; Garcia, Israel J. P./M-9539-2015; Barbosa, Leandro/K-1008-2013; Santos, Luciana L/C-9688-2013	Sousa, Leilismara/0000-0002-8598-973X; Garcia, Israel J. P./0000-0002-4972-6561; Barbosa, Leandro/0000-0002-4631-0130; Santos, Luciana L/0000-0001-6186-4062; Fernandes Costa, Tamara Gabriela/0000-0003-0806-540X; Cortes, Vanessa Faria/0000-0002-6464-7634; Tilelli, Cristiane/0000-0002-9489-7933	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico).	Adams PC, 2015, INT J LAB HEMATOL, V37, P25, DOI 10.1111/ijlh.12347; Adams PC, 1997, HEPATOLOGY, V25, P162, DOI 10.1002/hep.510250130; ADAMS PE, 1995, J CHEM EDUC, V72, P649, DOI 10.1021/ed072p649; Almeida AM, 2006, AN ACAD BRAS CIENC, V78, P505, DOI 10.1590/S0001-37652006000300010; Apell HJ, 2004, BIOELECTROCHEMISTRY, V63, P149, DOI 10.1016/j.bioelechem.2003.09.021; Beutler E., 2006, WILLIAMS HEMATOLOGY; Bittencourt PL, 2009, CLINICS, V64, P837, DOI 10.1590/S1807-59322009000900003; Bogdanova A, 2009, ACTA PHYSIOL, V195, P305, DOI 10.1111/j.1748-1716.2008.01934.x; Brissot Pierre, 2006, Hematology Am Soc Hematol Educ Program, P36; BRITTON RS, 1990, HEPATOLOGY, V11, P93, DOI 10.1002/hep.1840110116; BRUGNARA C, 1989, ANN NY ACAD SCI, V565, P96; Buege J A, 1978, Methods Enzymol, V52, P302; Bueno Simone, 2006, Rev. Bras. Hematol. Hemoter., V28, P293, DOI 10.1590/S1516-84842006000400015; Calado RT, 2000, BRAZ J MED BIOL RES, V33, P301, DOI 10.1590/S0100-879X2000000300007; Cançado Rodolfo D., 2007, Rev. Bras. Hematol. Hemoter., V29, P351, DOI 10.1590/S1516-84842007000400007; Cançado Rodolfo Delfini, 2006, Sao Paulo Med. J., V124, P55; Cançado Rodolfo Delfini, 2010, Rev. Bras. Hematol. Hemoter., V32, P469, DOI 10.1590/S1516-84842010000600011; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CLARET M, 1978, J PHYSIOL-LONDON, V274, P247, DOI 10.1113/jphysiol.1978.sp012145; Cluitmans JCA, 2012, BLOOD TRANSFUS-ITALY, V10, pS12, DOI 10.2450/2012.004S; Cornelius F, 2015, BBA-BIOMEMBRANES, V1848, P1729, DOI 10.1016/j.bbamem.2015.03.012; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Dhar-Chowdhury P, 2007, CELL MOL LIFE SCI, V64, P3069, DOI 10.1007/s00018-007-7332-3; Else PL, 1999, J COMP PHYSIOL B, V169, P296, DOI 10.1007/s003600050224; Esmann M, 2006, CHEM PHYS LIPIDS, V141, P94, DOI 10.1016/j.chemphyslip.2006.02.018; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; Gallagher PG, 2013, CURR OPIN HEMATOL, V20, P201, DOI 10.1097/MOH.0b013e32835f6870; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Goldshleger R, 1997, P NATL ACAD SCI USA, V94, P9596, DOI 10.1073/pnas.94.18.9596; Goldshleger R, 1999, J BIOL CHEM, V274, P16213, DOI 10.1074/jbc.274.23.16213; Haro KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048841; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Hoffman JF, 2002, P NATL ACAD SCI USA, V99, P14572, DOI 10.1073/pnas.222539999; Hollan S, 1996, HAEMATOLOGIA, V27, P109; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kelley M, 2014, CAN J GASTROENTEROL, V28, P198, DOI 10.1155/2014/468521; KUMAR V., 2005, PATOLOGIA BASES PATO; Leao GDR, 2010, JOURNAL OF MEDICINE, V1, P453; Md AWY, 2006, AM J MED, V119, P391, DOI 10.1016/j.amjmed.2005.10.041; Mendanha SA, 2012, BRAZ J MED BIOL RES, V45, P473, DOI 10.1590/S0100-879X2012007500050; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Motta VT, 2009, BIOQUIMICA CLINICA P; Moura E, 1998, BLOOD, V92, P2511, DOI 10.1182/blood.V92.7.2511.2511_2511_2519; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Oliveira TM, 2006, BRAZ J MED BIOL RES, V39, P1575, DOI 10.1590/S0100-879X2006005000041; Oliveira VC, 2009, GENET MOL RES, V8, P794, DOI 10.4238/vol8-3gmr562; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pretorius E, 2014, INTEGR BIOL-UK, V6, P486, DOI 10.1039/c4ib00025k; Pretorius E, 2014, LANCET, V383, P722, DOI 10.1016/S0140-6736(13)61208-8; Pretorius E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085271; Pretorius E, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-63; Rega A., 1979, CATION FLUX BIOMEMBR, P67; Rodrigo R, 2007, MOL CELL BIOCHEM, V303, P73, DOI 10.1007/s11010-007-9457-y; ROSE HG, 1965, J LIPID RES, V6, P428; Santos HD, 2005, COLLOID SURFACE B, V41, P239, DOI 10.1016/j.colsurfb.2004.12.013; Santos PCJL, 2011, BLOOD CELL MOL DIS, V46, P302, DOI 10.1016/j.bcmd.2011.02.008; Santos Paulo C. J. L., 2009, Rev. Bras. Hematol. Hemoter., V31, P192; Santos RD, 2006, COMP BIOCHEM PHYS C, V142, P309, DOI 10.1016/j.cbpc.2005.11.003; SARKADI B, 1991, BIOCHIM BIOPHYS ACTA, V1071, P407, DOI 10.1016/0304-4157(91)90005-H; Suhail Mohd, 2010, J Clin Med Res, V2, P1, DOI 10.4021/jocmr2010.02.263w; Turi JL, 2008, BIOMETALS, V21, P571, DOI 10.1007/s10534-008-9143-x; Vokurkova M, 2005, LIFE SCI, V77, P1452, DOI 10.1016/j.lfs.2005.03.014; WHITTAM R, 1965, BIOCHEM J, V97, P214, DOI 10.1042/bj0970214; Yin W, 2003, J MEMBRANE BIOL, V193, P177, DOI 10.1007/s00232-003-2016-x; YOUNG IS, 1994, FREE RADICAL BIO MED, V16, P393, DOI 10.1016/0891-5849(94)90041-8; Zhou XM, 2003, AM J PHYSIOL-CELL PH, V285, pC319, DOI 10.1152/ajpcell.00536.2002	74	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132852	10.1371/journal.pone.0132852	http://dx.doi.org/10.1371/journal.pone.0132852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197432	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600053
J	Wang, RR; Ding, YY; Bai, HL; Duan, S; Ye, RH; Yang, YC; Wang, JB; Tang, RH; Gao, MY; Ha, N				Wang, Rongrong; Ding, Yingying; Bai, Hongling; Duan, Song; Ye, Runhua; Yang, Yuecheng; Wang, Jibao; Tang, Renhai; Gao, Meiyang; Ha, Na			Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China	PLOS ONE			English	Article							DRUG-USE; TREATMENT PROGRAM; HIV EPIDEMIC; REDUCTION	Objective Methadone maintenance treatment (MMT) was introduced to China in 2004 to reduce the harm of injecting drug users (IDUs). However, little is known about continued drug use, especially methamphetamine (MAMP), among MMT patients. Methods A survey was conducted among patients attending five major MMT clinics in Dehong Prefecture in 2014 to investigate the heroin and MAMP use and their associated risk factors. Participants were administered with face-to-face interviews, and urine tests for morphine and MAMP. Results A total of 2,121 were eligible and participated in the study. Among them, 220 (10.4%) were only positive for morphine, 12.9% were only positive for MAMP, and 196 (9.2%) were positive for both morphine and MAMP. Compared with neither use of heroin nor MAMP during MMT, heroin use (not using MAMP) was associated with ethnicity, shorter duration of MMT, lower dose of methadone, and having had no more than two sex partners in the past year; MAMP use (not using heroin) was associated with ethnicity, longer duration of MMT, higher dose of methadone and being aged <30 years (vs. >= 50 years); use of both heroin and MAMP was associated with being Dai minority (vs. Han), a marital status of divorced or widowed, having used drugs for >= 10 years and shorter duration of MMT. Conclusion These findings indicate the complexity in the treatment of heroin users and underscore the importance in prescribing appropriate methadone dosages in order to reduce both heroin and MAMP use.	[Wang, Rongrong; Ding, Yingying; Bai, Hongling; Gao, Meiyang; Ha, Na] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Wang, Rongrong; Ding, Yingying; Bai, Hongling; Gao, Meiyang; Ha, Na] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Wang, Rongrong; Ding, Yingying; Bai, Hongling; Gao, Meiyang; Ha, Na] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai 200433, Peoples R China; [Wang, Rongrong] Natl Hlth & Family Planning Commiss, Dept Dis Control & Prevent, Beijing, Peoples R China; [Duan, Song; Ye, Runhua; Yang, Yuecheng; Wang, Jibao; Tang, Renhai] Dehong Prefecture Ctr Dis Control & Prevent, Mangshi, Yunnan, Peoples R China	Fudan University; Fudan University; Fudan University	Ha, N (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	nhe@shmu.edu.cn	ding, yy/HHS-9589-2022		China National Major AIDS Research Project [2012ZX10001001-004]; Shanghai Municipal Health Bureau [XBR2011043, KBF201232]; Junior Faculty Award of Fudan University [JJF201016]	China National Major AIDS Research Project; Shanghai Municipal Health Bureau; Junior Faculty Award of Fudan University	This study was supported by China National Major AIDS Research Project (grant no. 2012ZX10001001-004 to Na He) and Shanghai Municipal Health Bureau (grant no. XBR2011043 to Na He; KBF201232 to Yingying Ding) and the Junior Faculty Award of Fudan University (grant no. JJF201016 to Yingying Ding).	Bao YP, 2015, ADDICTION, V110, P11, DOI 10.1111/add.12770; Baumeister M, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-46; Cao XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082476; [常亚萍 Chang Yaping], 2011, [中国药物依赖性杂志, Chinese Journal of Drug Dependence], V20, P37; Chen W, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-23; China Ministry of Health World Health Organization (WHO), 2012, 2011 EST HIV AIDS EP; China National Narcotics Control Commission (CNNCC), 2012, 2012 ANN REP DRUG CO; China National Narcotics Control Commission (CNNCC), 2013, 2013 ANN REP DRUG CO; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; Ding Ying-ying, 2012, Fudan Xuebao (Yixueban), V39, P551, DOI 10.3969/j.issn.1672-8467.2012.06.001; Ding YY, 2013, AIDS BEHAV, V17, P2439, DOI 10.1007/s10461-012-0380-1; Faggiano F., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002208; Fareed A, 2009, J ADDICT DIS, V28, P399, DOI 10.1080/10550880903183042; Gossop M, 2001, DRUG ALCOHOL DEPEN, V62, P255, DOI 10.1016/S0376-8716(00)00211-8; Hittner JB, 2012, ADDICT BEHAV, V37, P790, DOI 10.1016/j.addbeh.2012.02.018; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Kamal F, 2007, Ir Med J, V100, P393; Ko NY, 2012, J STUD ALCOHOL DRUGS, V73, P469, DOI 10.15288/jsad.2012.73.469; Li L, 2011, DRUG ALCOHOL DEPEN, V116, P246, DOI 10.1016/j.drugalcdep.2010.12.007; Li L, 2012, ADDICT BEHAV, V37, P264, DOI 10.1016/j.addbeh.2011.11.004; Liu En-wu, 2008, Zhonghua Yufang Yixue Zazhi, V42, P875; Palha AP, 2002, J SEX MARITAL THER, V28, P427, DOI 10.1080/00926230290001547; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Shariatirad S, 2013, INT J DRUG POLICY, V24, P636, DOI [10.1016/j.drugpo.2013.04.003, 10.1016/j.drugpo.2013.05.003]; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Sullivan SG, 2014, J SUBST ABUSE TREAT, V47, P86, DOI 10.1016/j.jsat.2013.12.004; Sun HM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005997; Trujillo KA, 2011, PHARMACOL BIOCHEM BE, V99, P451, DOI 10.1016/j.pbb.2011.04.014; Wang L, 2015, ADDICTION, V110, P20, DOI 10.1111/add.12779; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210	30	22	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133431	10.1371/journal.pone.0133431	http://dx.doi.org/10.1371/journal.pone.0133431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196394	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600097
J	Zhang, MJ; Gilbert, M; Yuki, N; Cao, FF; Li, JJ; Liu, HY; Li, Q; Meng, FL; Zhang, JZ				Zhang, Maojun; Gilbert, Michel; Yuki, Nobuhiro; Cao, Fangfang; Li, Jianjun; Liu, Hongying; Li, Qun; Meng, Fanliang; Zhang, Jianzhong			Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barre Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain	PLOS ONE			English	Article							STRUCTURAL-CHARACTERIZATION; FOODBORNE BOTULISM; MASS-SPECTROMETRY; BIOSYNTHESIS; EPIDEMIOLOGY; PATHOGEN; CLUSTERS; FEATURES; GENES	An outbreak of Guillain-Barre syndrome (GBS), subsequent to Campylobacter jejuni enteritis, occurred in China in 2007. Serum anti-ganglioside antibodies were measured in GBS patients and controls. Genome sequencing was used to determine the phylogenetic relationship among three C. jejuni strains from a patient with GBS (ICDCCJ07001), a patient with gastroenteritis (ICDCCJ07002) and a healthy carrier (ICDCCJ07004), which were all associated with the outbreak. The ganglioside-like structures of the lipo-oligosaccharides of these strains were determined by mass spectrometry. Seventeen (53%) of the GBS patients had anti-GT1a IgG antibodies. GT1a mimicry was found in the lipo-oligosaccharides of strain ICDCCJ07002 and ICDCCJ07004; but a combination of GM3/GD3 mimics was observed in ICDCCJ07001, although this patient had anti-GT1a IgG antibodies. A single-base deletion in a glycosyltransferase gene caused the absence of GT1a mimicry in ICDCCJ07001. The phylogenetic tree showed that ICDCCJ07002 and ICDCCJ07004 were genetically closer to each other than to ICDCCJ07001. C. jejuni, bearing a GT1a-like lipooligosaccharide, might have caused the GBS outbreak and the loss of GT1a mimicry may have helped ICDCCJ07001 to survive in the host.	Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Zhang, Maojun; Zhang, Jianzhong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Gilbert, Michel; Li, Jianjun] Natl Res Council Canada, Human Hlth Therapeut, Ottawa, ON K1A 0R6, Canada; [Yuki, Nobuhiro] Natl Neurosci Inst, Singapore 308433, Singapore; [Li, Qun] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; National Research Council Canada; National Neuroscience Institute (NNI); Chinese Center for Disease Control & Prevention	Zhang, JZ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.	zhangjianzhong@icdc.cn	Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206; Gilbert, Michel/0000-0002-0204-4408; Li, Jianjun/0000-0002-6531-3687	General Program of National Natural Science Foundation of China [81071314, 81271789]; National Basic Research Program of China [2013CB127204]; Singapore National Medical Research Council [IRG 10nov086, CSA/047/2012]; Yong Loo Lin School of Medicine [R-172-000-264-733]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Singapore National Medical Research Council(National Medical Research Council, Singapore); Yong Loo Lin School of Medicine(National University of Singapore)	This work was supported by The General Program of National Natural Science Foundation of China (81071314 and 81271789), the National Basic Research Program of China (2013CB127204), Singapore National Medical Research Council (IRG 10nov086 and CSA/047/2012 to N.Y.) and Yong Loo Lin School of Medicine (R-172-000-264-733 to N.Y.).	Ang CW, 2000, J NEUROIMMUNOL, V111, P229, DOI 10.1016/S0165-5728(00)00369-6; Chen JH, 2003, FEMS MICROBIOL LETT, V224, P277, DOI 10.1016/S0378-1097(03)00470-1; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Jackson BR, 2011, EPIDEMIOL INFECT, V7, P1; KAPLAN JE, 1983, JAMA-J AM MED ASSOC, V250, P2635; Kimoto K, 2006, NEUROLOGY, V67, P1837, DOI 10.1212/01.wnl.0000244468.22377.6b; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; Leclair D, 2013, EMERG INFECT DIS, V19, P961, DOI 10.3201/eid1906.120873; Li JJ, 2007, RAPID COMMUN MASS SP, V21, P952, DOI 10.1002/rcm.2916; Li JJ, 2007, MASS SPECTROM REV, V26, P35, DOI 10.1002/mas.20105; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; Nagashima T, 2007, ARCH NEUROL-CHICAGO, V64, P1519, DOI 10.1001/archneur.64.10.1519; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602; Prendergast MM, 1998, INFECT IMMUN, V66, P3649, DOI 10.1128/IAI.66.8.3649-3655.1998; Richards VP, 2013, INFECT GENET EVOL, V14, P200, DOI 10.1016/j.meegid.2012.12.010; SLIMAN NA, 1978, BMJ-BRIT MED J, V1, P751, DOI 10.1136/bmj.1.6115.751; Sun ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117912; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Susuki K, 2012, EXP NEUROL, V233, P534, DOI 10.1016/j.expneurol.2011.11.039; Takahashi M, 2005, J CLIN MICROBIOL, V43, P335, DOI 10.1128/JCM.43.1.335-339.2005; Wakerley BR, 2013, J NEUROL NEUROSUR PS, P1; Wangroongsarb P, 2013, JPN J INFECT DIS, V66, P353, DOI 10.7883/yoken.66.353; Ye YQ, 2010, MUSCLE NERVE, V42, P311, DOI 10.1002/mus.21701; YUKI N, 1995, J PEDIATR-US, V126, P162, DOI 10.1016/S0022-3476(95)70539-2; Yuki N, 1997, J NEUROIMMUNOL, V74, P30, DOI 10.1016/S0165-5728(96)00201-9; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Zhang MJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00256-13; Zhang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015060; Zhang MJ, 2010, FOODBORNE PATHOG DIS, V7, P913, DOI 10.1089/fpd.2009.0493	41	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131730	10.1371/journal.pone.0131730	http://dx.doi.org/10.1371/journal.pone.0131730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197476	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600014
J	Castillo, A; Rodriguez-Suarez, C; Martin, AC; Piston, F				Castillo, Almudena; Rodriguez-Suarez, Cristina; Martin, Azahara C.; Piston, Fernando			Contribution of Chromosomes 1H(ch)S and 6H(ch)S to Fertility Restoration in the Wheat msH1 CMS System under Different Environmental Conditions	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY	Exploiting hybrid wheat heterosis has been long pursued to increase crop yield, stability and uniformity. Cytoplasmic male sterility (CMS) systems based in the nuclear-cytoplasmic incompatible interactions are a classic way for hybrid seed production, but to date, no definitive system is available in wheat. The msH1 CMS system results from the incompatibility between the nuclear genome of wheat and the cytoplasmic genome of the wild barley Hordeum chilense. Fertility restoration of the CMS phenotype was first associated with the disomic addition of the short arm of chromosome 6H from H. chilense. In further studies it was observed that chromosome arm 1H(ch)S was also implicated, and the combination of genes in both chromosome arms restored fertility more efficiently. In this work we aim to dissect the effect of each chromosome in fertility restoration when combined in different genomic backgrounds and under different environmental conditions. We propose a model to explain how restoration behaves in the msH1 system and generate valuable information necessary to develop an efficient system for hybrid wheat production.	[Castillo, Almudena; Rodriguez-Suarez, Cristina; Piston, Fernando] CSIC, Inst Agricultura Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain; [Martin, Azahara C.] John Innes Ctr, Crop Genet, Norwich, Norfolk, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Piston, F (corresponding author), CSIC, Inst Agricultura Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain.	fpiston@ias.csic.es	Piston, Fernando/AAD-6975-2020; Martin, Azahara C./AAH-8797-2019; Rodríguez-Suárez, Cristina/M-2304-2014	Martin, Azahara C./0000-0002-6087-7491; Rodríguez-Suárez, Cristina/0000-0002-5409-1839	Spanish Ministerio de Economia y Competitividad (MINECO) [AGL2013-43329-R, AGL2011-22596]; Ramon y Cajal research contract from MINECO [RYC-2010-07345]	Spanish Ministerio de Economia y Competitividad (MINECO); Ramon y Cajal research contract from MINECO	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO, AGL2013-43329-R, and AGL2011-22596). FP is supported by a Ramon y Cajal research contract from the MINECO (RYC-2010-07345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza SG, 2007, J AGR FOOD CHEM, V55, P4244, DOI 10.1021/jf070342p; Atienza SG, 2004, PLANT BREEDING, V123, P303, DOI 10.1111/j.1439-0523.2004.00918.x; Castillo A, 2014, J EXP BOT, V65, P6667, DOI 10.1093/jxb/eru388; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Coors JG, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P225; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kaul M. L. H., 1988, MALE STERILITY HIGHE, P97, DOI [10.1007/978-3-642-83139-3, DOI 10.1007/978-3-642-83139-3]; Lenth RV, 2014, LSMEANS LEAST SQUARE; Martin A, 1996, DEV PLANT BREED, V5, P57; Martin A, 1998, TRITICEAE III, P377; Martin AC, 2008, AUST J AGR RES, V59, P206, DOI 10.1071/AR07239; Martin AC, 2010, THEOR APPL GENET, V121, P1093, DOI 10.1007/s00122-010-1374-x; Martin AC, 2009, MOL BREEDING, V24, P397, DOI 10.1007/s11032-009-9301-z; R Core Team, 2012, R LANG ENV STAT COMP; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Song XY, 2014, EUPHYTICA, V196, P129, DOI 10.1007/s10681-013-1020-1; Song XY, 2013, EUPHYTICA, V192, P393, DOI 10.1007/s10681-013-0871-9; TRACY WF, 1991, J HERED, V82, P343, DOI 10.1093/oxfordjournals.jhered.a111096; VONBOTHMER R, 1986, PLANT SYST EVOL, V153, P49, DOI 10.1007/BF00989417; WELSH JR, 1971, CROP SCI, V11, P864, DOI 10.2135/cropsci1971.0011183X001100060029x; Whitford R, 2013, J EXP BOT, V64, P5411, DOI 10.1093/jxb/ert333	22	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0121479	10.1371/journal.pone.0121479	http://dx.doi.org/10.1371/journal.pone.0121479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192191	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400001
J	Klemm, M; Schweitzer, D; Peters, S; Sauer, L; Hammer, M; Haueisen, J				Klemm, Matthias; Schweitzer, Dietrich; Peters, Sven; Sauer, Lydia; Hammer, Martin; Haueisen, Jens			FLIMX: A Software Package to Determine and Analyze the Fluorescence Lifetime in Time-Resolved Fluorescence Data from the Human Eye	PLOS ONE			English	Article							IMAGING OPHTHALMOSCOPY; DECAY CURVES; AUTOFLUORESCENCE; FUNDUS; DECONVOLUTION	Fluorescence lifetime imaging ophthalmoscopy (FLIO) is a new technique for measuring the in vivo autofluorescence intensity decays generated by endogenous fluorophores in the ocular fundus. Here, we present a software package called FLIM eXplorer (FLIMX) for analyzing FLIO data. Specifically, we introduce a new adaptive binning approach as an optimal tradeoff between the spatial resolution and the number of photons required per pixel. We also expand existing decay models (multi-exponential, stretched exponential, spectral global analysis, incomplete decay) to account for the layered structure of the eye and present a method to correct for the influence of the crystalline lens fluorescence on the retina fluorescence. Subsequently, the Holm-Bonferroni method is applied to FLIO measurements to allow for group comparisons between patients and controls on the basis of fluorescence lifetime parameters. The performance of the new approaches was evaluated in five experiments. Specifically, we evaluated static and adaptive binning in a diabetes mellitus patient, we compared the different decay models in a healthy volunteer and performed a group comparison between diabetes patients and controls. An overview of the visualization capabilities and a comparison of static and adaptive binning is shown for a patient with macular hole. FLIMX's applicability to fluorescence lifetime imaging microscopy is shown in the ganglion cell layer of a porcine retina sample, obtained by a laser scanning microscope using two-photon excitation.	[Klemm, Matthias; Haueisen, Jens] Tech Univ Ilmenau, Inst Biomed Engn & Informat, D-98694 Ilmenau, Germany; [Schweitzer, Dietrich; Peters, Sven; Sauer, Lydia; Hammer, Martin] Univ Hosp Jena, Expt Ophthalmol, D-07740 Jena, Germany	Technische Universitat Ilmenau; Friedrich Schiller University of Jena	Klemm, M (corresponding author), Tech Univ Ilmenau, Inst Biomed Engn & Informat, POB 100565, D-98694 Ilmenau, Germany.	matthias.klemm@tu-ilmenau.de	; Haueisen, Jens/B-7183-2011	Klemm, Matthias/0000-0002-2418-0259; Haueisen, Jens/0000-0003-3871-2890	German Federal Ministry of Education and Research [03IPT605A]; German Research Council [DFG HA 2899/19-1]; German Research Foundation; Open Access Publication Fund of the Technische Universitat Ilmenau	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Council(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Fund of the Technische Universitat Ilmenau	The authors gratefully acknowledge funding from the German Federal Ministry of Education and Research (Grant No. 03IPT605A; http://www.unternehmen-region.de) and the German Research Council (DFG HA 2899/19-1; www.dfg.de). We acknowledge support for the Article Processing Charge by the German Research Foundation and the Open Access Publication Fund of the Technische Universitat Ilmenau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ophthalmology, V98, P786; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Becker W, 2005, ADV TIME CORRELATED; Becker W., 2012, BH TCPSC HDB; Berendschot TTJM, 2003, PROG RETIN EYE RES, V22, P171, DOI 10.1016/S1350-9462(02)00060-5; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; DILLON J, 1990, PHOTOCHEM PHOTOBIOL, V51, P465, DOI 10.1111/j.1751-1097.1990.tb01738.x; Dysli C, 2014, INVEST OPHTH VIS SCI, V55, P2106, DOI 10.1167/iovs.13-13627; Enderlein J, 1997, OPT COMMUN, V134, P371, DOI 10.1016/S0030-4018(96)00384-7; Goss DA, 2001, INTRO OPTICS EYE; Hammer M, 2008, GRAEF ARCH CLIN EXP, V246, P105, DOI 10.1007/s00417-007-0639-9; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; HOLM S, 1979, SCAND J STAT, V6, P65; Institute ANS, 2007, Z1361 ANSI; Jentsch S, 2015, ACTA OPHTHALMOL, V93, pE241, DOI 10.1111/aos.12609; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Klemm M, 2013, CURR EYE RES, V38, P793, DOI 10.3109/02713683.2013.779723; KOLLNER M, 1992, CHEM PHYS LETT, V200, P199, DOI 10.1016/0009-2614(92)87068-Z; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laptenok S, 2007, J STAT SOFTW, V18; Lee KCB, 2001, BIOPHYS J, V81, P1265, DOI 10.1016/S0006-3495(01)75784-0; Leung RWK, 2011, BIOMED OPT EXPRESS, V2, P2517, DOI 10.1364/BOE.2.002517; Luchowski R, 2010, APPL SPECTROSC, V64, P918, DOI 10.1366/000370210792081000; Marcu L, 2012, ANN BIOMED ENG, V40, P304, DOI 10.1007/s10439-011-0495-y; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Neyman J, 1928, BIOMETRIKA, V20A, P263, DOI 10.2307/2332112; OCONNOR DV, 1979, J PHYS CHEM-US, V83, P1333, DOI 10.1021/j100473a019; PAU H, 1993, GRAEF ARCH CLIN EXP, V231, P656, DOI 10.1007/BF00921961; Peters S, 2011, PROC SPIE, V8086, DOI 10.1117/12.889807; Ramm L, 2014, GRAEF ARCH CLIN EXP, V252, P2025, DOI 10.1007/s00417-014-2813-1; Rechenberg I., 1973, EVOLUTIONSSTRATEGIE; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; Schweitzer D, 2007, MICROSC RES TECHNIQ, V70, P410, DOI 10.1002/jemt.20427; Schweitzer D, 2004, J BIOMED OPT, V9, P1214, DOI 10.1117/1.1806833; Schweitzer D, 2009, OPHTHALMOLOGE, V106, P714, DOI 10.1007/s00347-009-1975-4; Schweitzer D, 2009, CLIN BIOMEDICAL SPEC, V7368, DOI [10.1364/ECS0.200977368_04, DOI 10.1364/ECSO.200977368_04]; Schweitzer D, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.6.061106; Schweitzer D, 2012, INVEST OPHTH VIS SCI, V53, P3376, DOI 10.1167/iovs.11-8970; Schweitzer D, 2010, ESSENT OPHTHALMOL, P107, DOI 10.1007/978-3-540-85540-8_10; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Turton DA, 2003, ANAL CHEM, V75, P4182, DOI 10.1021/ac034325k; WARE WR, 1973, J PHYS CHEM-US, V77, P2038, DOI 10.1021/j100636a003; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687	44	33	34	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131640	10.1371/journal.pone.0131640	http://dx.doi.org/10.1371/journal.pone.0131640			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192624	Green Submitted, gold, Green Published			2022-12-27	WOS:000358546400014
J	Lu, WW; Ding, WX; Zhang, JH; Zhang, HJ; Luo, JF; Bolan, N				Lu, Weiwei; Ding, Weixin; Zhang, Junhua; Zhang, Huanjun; Luo, Jiafa; Bolan, Nanthi			Nitrogen Amendment Stimulated Decomposition of Maize Straw-Derived Biochar in a Sandy Loam Soil: A Short-Term Study	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ORGANIC-MATTER; LITTER DECOMPOSITION; ENZYME-ACTIVITY; BLACK CARBON; PINE FOREST; BIOMASS; MINERALIZATION; GRASSLAND; RESPONSES	This study examined the effect of nitrogen (N) on biochar stability in relation to soil microbial community as well as biochar labile components using delta C-13 stable isotope technology. A sandy loam soil under a long-term rotation of C-3 crops was amended with biochar produced from maize (a C(4)plant) straw in absence (BC0) and presence (BCN) of N and monitored for dynamics of carbon dioxide (CO2) flux, phospholipid fatty acids (PLFAs) profile and dissolved organic carbon (DOC) content. N amendment significantly increased the decomposition of biochar during the first 5 days of incubation (P < 0.05), and the proportions of decomposed biochar carbon (C) were 2.30% and 3.28% in BC0 and BCN treatments, respectively, during 30 days of incubation. The magnitude of decomposed biochar C was significantly (P < 0.05) higher than DOC in biochar (1.75%) and part of relatively recalcitrant biochar C was mineralized in both treatments. N amendment increased soil PLFAs concentration at the beginning of incubation, indicating that microorganisms were N-limited in test soil. Furthermore, N amendment significantly (P < 0.05) increased the proportion of grampositive (G(+)) bacteria and decreased that of fungi, while no noticeable changes were observed for gram-negative (G(-)) bacteria and actinobacteria at the early stage of incubation. Our results indicated that N amendment promoted more efficiently the proliferation of G(+) bacteria and accelerated the decomposition of relatively recalcitrant biochar C, which in turn reduced the stability of maize straw-derived biochar in test soil.	[Lu, Weiwei; Ding, Weixin; Zhang, Junhua; Zhang, Huanjun] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Luo, Jiafa] AgResearch, Land & Environm, Hamilton, New Zealand; [Bolan, Nanthi] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Adelaide, SA 5001, Australia	Chinese Academy of Sciences; Institute of Soil Science, CAS; AgResearch - New Zealand; University of South Australia	Ding, WX (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	wxding@issas.ac.cn	SPRP, XDB150200/N-7373-2016; Bolan, Nanthi Sirangie/E-8535-2011	Bolan, Nanthi Sirangie/0000-0003-2056-1692; lu, weiwei/0000-0003-1361-686X; Luo, Jiafa/0000-0001-6198-6887	Chinese Academy of Sciences [XDB15020101]; Postdoctoral Science Foundation of China [2013M531411]; Postdoctoral Scientific Funding of Jiangsu province [1301060C]; AgResearch	Chinese Academy of Sciences(Chinese Academy of Sciences); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Scientific Funding of Jiangsu province; AgResearch	This study was funded by the Chinese Academy of Sciences (http://www.cas.cn/), the Postdoctoral Science Foundation of China (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml) and the Postdoctoral Scientific Funding of Jiangsu province (http://bsh.jshrss.gov.cn/), under the contract numbers of XDB15020101, 2013M531411 and 1301060C, respectively. The first supported author WXD, the two postdoctoral fundings supported author WWL. AgResearch (http://www.agresearch.co.nz/) provided support in the form of a salary for JFL. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Ameloot N, 2013, EUR J SOIL SCI, V64, P379, DOI 10.1111/ejss.12064; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; Ascough PL, 2010, ISOT ENVIRON HEALT S, V46, P64, DOI 10.1080/10256010903388436; BALDOCK JA, 1992, BIOGEOCHEMISTRY, V16, P1, DOI 10.1007/BF02402261; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Balesdent J., 1996, Mass spectrometry of soils., P83; Biasi C, 2005, RAPID COMMUN MASS SP, V19, P1401, DOI 10.1002/rcm.1911; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1025, DOI 10.1111/j.1365-2486.2008.01562.x; Bird JA, 2011, SOIL BIOL BIOCHEM, V43, P718, DOI 10.1016/j.soilbio.2010.08.010; Blagodatskaya EV, 2009, EUR J SOIL SCI, V60, P186, DOI 10.1111/j.1365-2389.2008.01103.x; Brant JB, 2006, SOIL BIOL BIOCHEM, V38, P2219, DOI 10.1016/j.soilbio.2006.01.022; Bruun S, 2008, ORG GEOCHEM, V39, P839, DOI 10.1016/j.orggeochem.2008.04.020; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; Cai YJ, 2013, ATMOS ENVIRON, V65, P112, DOI 10.1016/j.atmosenv.2012.10.038; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chapman SK, 2007, PLANT SOIL, V299, P153, DOI 10.1007/s11104-007-9372-8; Cheng W. X., 2005, Roots and soil management: interactions between roots and the soil, P119; Chenu C, 2006, EUR J SOIL SCI, V57, P596, DOI 10.1111/j.1365-2389.2006.00834.x; Chodak M, 2003, BIOL FERT SOILS, V39, P123, DOI 10.1007/s00374-003-0688-0; Compton JE, 2004, FOREST ECOL MANAG, V196, P143, DOI 10.1016/j.foreco.2004.03.017; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; de Vries FT, 2007, SOIL BIOL BIOCHEM, V39, P1620, DOI 10.1016/j.soilbio.2007.01.013; Demoling F, 2008, SOIL BIOL BIOCHEM, V40, P370, DOI 10.1016/j.soilbio.2007.08.019; Denef K, 2009, SOIL BIOL BIOCHEM, V41, P144, DOI 10.1016/j.soilbio.2008.10.008; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Farrell M, 2013, SCI TOTAL ENVIRON, V465, P288, DOI 10.1016/j.scitotenv.2013.03.090; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Gul S, 2015, AGR ECOSYST ENVIRON, V206, P46, DOI 10.1016/j.agee.2015.03.015; HACKETT WF, 1977, APPL ENVIRON MICROB, V33, P43, DOI 10.1128/AEM.33.1.43-51.1977; Hilscher A, 2011, SOIL BIOL BIOCHEM, V43, P261, DOI 10.1016/j.soilbio.2010.10.007; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Kramer MG, 2012, GLOBAL CHANGE BIOL, V18, P2594, DOI 10.1111/j.1365-2486.2012.02681.x; Kuehn KA, 2000, LIMNOL OCEANOGR, V45, P862, DOI 10.4319/lo.2000.45.4.0862; Kuzyakov Y, 2004, PLANT SOIL, V263, P85, DOI 10.1023/B:PLSO.0000047728.61591.fd; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Li LJ, 2010, BIOL FERT SOILS, V46, P653, DOI 10.1007/s00374-010-0463-y; Lu R, 2000, METHODS SOIL AGROCHE; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; McMahon SK, 2005, SOIL SCI SOC AM J, V69, P1238, DOI 10.2136/sssaj2004.0289; Michelsen A, 2004, SOIL BIOL BIOCHEM, V36, P1707, DOI 10.1016/j.soilbio.2004.04.028; Midwood AJ, 1998, SOIL BIOL BIOCHEM, V30, P1301, DOI 10.1016/S0038-0717(98)00030-3; Min K, 2011, SOIL BIOL BIOCHEM, V43, P2461, DOI 10.1016/j.soilbio.2011.08.019; Nguyen BT, 2009, ORG GEOCHEM, V40, P846, DOI 10.1016/j.orggeochem.2009.05.004; Novak JM, 2009, SOIL SCI, V174, P105, DOI 10.1097/SS.0b013e3181981d9a; Potthoff M, 2005, SOIL BIOL BIOCHEM, V37, P1259, DOI 10.1016/j.soilbio.2004.11.022; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Santos F, 2012, SOIL BIOL BIOCHEM, V51, P115, DOI 10.1016/j.soilbio.2012.04.005; Schulz H, 2012, J PLANT NUTR SOIL SC, V175, P410, DOI 10.1002/jpln.201100143; Smith JL, 2010, SOIL BIOL BIOCHEM, V42, P2345, DOI 10.1016/j.soilbio.2010.09.013; SOLUM MS, 1989, ENERG FUEL, V3, P187, DOI 10.1021/ef00014a012; Spokas KA, 2010, CARBON MANAG, V1, P289, DOI 10.4155/CMT.10.32; Spring S, 2000, FEMS MICROBIOL REV, V24, P573, DOI 10.1016/S0168-6445(00)00046-2; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Thirukkumaran CM, 2000, SOIL BIOL BIOCHEM, V32, P59, DOI 10.1016/S0038-0717(99)00129-7; Treseder KK, 2011, ECOL LETT, V14, P933, DOI 10.1111/j.1461-0248.2011.01650.x; Tscherko D, 2004, SOIL BIOL BIOCHEM, V36, P1685, DOI 10.1016/j.soilbio.2004.07.004; Uchimiya M, 2013, J ANAL APPL PYROL, V104, P84, DOI 10.1016/j.jaap.2013.09.003; USDA (United States Department of Agriculture), 1994, KEYS SOIL TAX; Vanotti MB, 1996, SOIL ORGANIC MATTER, P105; Watzinger A, 2014, EUR J SOIL SCI, V65, P40, DOI 10.1111/ejss.12100; Xie ZB, 2013, PLANT SOIL, V370, P527, DOI 10.1007/s11104-013-1636-x; Zhang HJ, 2013, SOIL BIOL BIOCHEM, V57, P228, DOI 10.1016/j.soilbio.2012.08.024; Zimmerman AR, 2013, BIOCHAR AND SOIL BIOTA, P1; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	68	11	12	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133131	10.1371/journal.pone.0133131	http://dx.doi.org/10.1371/journal.pone.0133131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192282	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000358546400060
J	Tan, WK; Lim, TK; Loh, CS; Kumar, P; Lin, QS				Tan, Wee-Kee; Lim, Teck-Kwang; Loh, Chiang-Shiong; Kumar, Prakash; Lin, Qingsong			Proteomic Characterisation of the Salt Gland-Enriched Tissues of the Mangrove Tree Species Avicennia officinalis	PLOS ONE			English	Article							CHLORIS-GAYANA KUNTH; HEAT-SHOCK PROTEINS; SECRETE NA+; PLANT; LOCALIZATION; TOLERANCE; MEMBRANE; ABILITY; ATPASE; LEAVES	Plant salt glands are nature's desalination devices that harbour potentially useful information pertaining to salt and water transport during secretion. As part of the program toward deciphering secretion mechanisms in salt glands, we used shotgun proteomics to compare the protein profiles of salt gland-enriched (isolated epidermal peels) and salt gland-deprived (mesophyll) tissues of the mangrove species Avicennia officinalis. The purpose of the work is to identify proteins that are present in the salt gland-enriched tissues. An average of 2189 and 977 proteins were identified from the epidermal peel and mesophyll tissues, respectively. Among these, 2188 proteins were identified in salt gland-enriched tissues and a total of 1032 selected proteins were categorized by Gene Ontology (GO) analysis. This paper reports for the first time the proteomic analysis of salt gland-enriched tissues of a mangrove tree species. Candidate proteins that may play a role in the desalination process of the mangrove salt glands and their potential localization were identified. Information obtained from this study paves the way for future proteomic research aiming at elucidating the molecular mechanism underlying secretion in plant salt glands. The data have been deposited to the ProteomeXchange with identifier PXD000771.	[Tan, Wee-Kee; Lim, Teck-Kwang; Loh, Chiang-Shiong; Kumar, Prakash; Lin, Qingsong] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Tan, Wee-Kee; Loh, Chiang-Shiong; Lin, Qingsong] Natl Univ Singapore, NUS Environm Res Inst, Singapore 117411, Singapore	National University of Singapore; National University of Singapore	Lin, QS (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslinqs@nus.edu.sg	Kumar, Prakash P/A-6236-2009	Kumar, Prakash P/0000-0002-0963-1664; TAN, WEE KEE/0000-0001-5770-068X	Singapore National Research Foundation; NRF-EWI-IRIS [2P 10004/81, R-706-000010-272, R-706-000-040-279]; National University of Singapore [R-154-000-505-651]; Water Industry Programme Office of the PUB	Singapore National Research Foundation(National Research Foundation, Singapore); NRF-EWI-IRIS; National University of Singapore(National University of Singapore); Water Industry Programme Office of the PUB	This work was supported by research grants from Singapore National Research Foundation [under its Environmental & Water Technologies Strategic Research Programme administered by the Environment] & Water Industry Programme Office of the PUB, NRF-EWI-IRIS (2P 10004/81) (R-706-000010-272) and (R-706-000-040-279) and the National University of Singapore (R-154-000-505-651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Cosette, 2012, Int J Plant Genomics, V2012, P494572, DOI 10.1155/2012/494572; [Anonymous], 2009, CHECKLIST TOTAL VASC; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balsamo RA, 1996, PLANT CELL REP, V15, P418, DOI 10.1007/BF00232067; BALSAMO RA, 1995, INT J PLANT SCI, V156, P658, DOI 10.1086/297288; Ben Hassine A, 2009, ANN BOT-LONDON, V104, P925, DOI 10.1093/aob/mcp174; BHATTI AS, 1993, ENVIRON EXP BOT, V33, P259, DOI 10.1016/0098-8472(93)90071-M; Chen JA, 2010, TREE PHYSIOL, V30, P1570, DOI 10.1093/treephys/tpq086; Delahunty C, 2001, PROTEOMICS SHOTGUN A; DSCHIDA WJ, 1992, ANN BOT-LONDON, V70, P501, DOI 10.1093/oxfordjournals.aob.a088510; FARADAY CD, 1986, J EXP BOT, V37, P482, DOI 10.1093/jxb/37.4.482; Flowers TJ, 2010, FUNCT PLANT BIOL, V37, P604, DOI 10.1071/FP09269; Geiser L, 2011, METHODS MOL BIOL, V681, P459, DOI 10.1007/978-1-60761-913-0_27; HILL AE, 1973, J MEMBRANE BIOL, V12, P129, DOI 10.1007/BF01869995; HILL AE, 1973, INT REV CYTOL, V35, P299, DOI 10.1016/S0074-7696(08)60357-5; Jyothi-Prakash PA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0291-6; Kobayashi H, 2008, SOIL SCI PLANT NUTR, V54, P393, DOI 10.1111/j.1747-0765.2008.00246.x; Kobayashi H, 2007, SOIL SCI PLANT NUTR, V53, P764, DOI 10.1111/j.1747-0765.2007.00192.x; Krishnamurthy P, 2014, PROTEOMICS, V14, P2545, DOI 10.1002/pmic.201300527; Krishnamurthy P, 2014, PLANT CELL ENVIRON, V37, P1656, DOI 10.1111/pce.12272; KYLIN A, 1970, PLANT PHYSIOL, V45, P169, DOI 10.1104/pp.45.2.169; Labidi N, 2010, ACTA BIOL HUNG, V61, P299, DOI 10.1556/ABiol.61.2010.3.6; Ma HY, 2011, SCI CHINA LIFE SCI, V54, P282, DOI 10.1007/s11427-011-4145-2; Morgany, 1999, GUIDE MANGROVES SING; Naidoo Y, 1999, S AFR J BOT, V65, P370, DOI 10.1016/S0254-6299(15)31024-3; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Pont F, 2010, PROTEOMICS, V10, P1091, DOI 10.1002/pmic.200900667; Sadowski PG, 2006, NAT PROTOC, V1, P1778, DOI 10.1038/nprot.2006.254; Tada Y, 2009, PLANT CELL PHYSIOL, V50, P439, DOI 10.1093/pcp/pcp002; Tan WK, 2013, PLANT CELL ENVIRON, V36, P1410, DOI 10.1111/pce.12068; Tan WK, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-24; Thomson W. W., 1988, Solute transport in plant cells and tissues., P498; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tyerman SD, 2013, PLANT CELL ENVIRON, V36, P1407, DOI 10.1111/pce.12110; VASSILYEV AE, 1990, J EXP BOT, V41, P41, DOI 10.1093/jxb/41.1.41; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang LX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083141; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhu Z, 2012, TREE PHYSIOL, V32, P1378, DOI 10.1093/treephys/tps097	41	7	8	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133386	10.1371/journal.pone.0133386	http://dx.doi.org/10.1371/journal.pone.0133386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193361	Green Submitted, gold, Green Published			2022-12-27	WOS:000358546400078
J	Kiware, SS; Corliss, G; Merrill, S; Lwetoijera, DW; Devine, G; Majambere, S; Killeen, GF				Kiware, Samson S.; Corliss, George; Merrill, Stephen; Lwetoijera, Dickson W.; Devine, Gregor; Majambere, Silas; Killeen, Gerry F.			Predicting Scenarios for Successful Autodissemination of Pyriproxyfen by Malaria Vectors from Their Resting Sites to Aquatic Habitats; Description and Simulation Analysis of a Field-Parameterizable Model	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE; BED NETS; OVIPOSITION BEHAVIOR; TRANSMISSION; MOSQUITOS; IMPACT; INDOOR; PREVENTION; ARABIENSIS	Background Large-cage experiments indicate pyriproxifen (PPF) can be transferred from resting sites to aquatic habitats by Anopheles arabiensis - malaria vector mosquitoes to inhibit emergence of their own offspring. PPF coverage is amplified twice: (1) partial coverage of resting sites with PPF contamination results in far higher contamination coverage of adult mosquitoes because they are mobile and use numerous resting sites per gonotrophic cycle, and (2) even greater contamination coverage of aquatic habitats results from accumulation of PPF from multiple oviposition events. Methods and Findings Deterministic mathematical models are described that use only field-measurable input parameters and capture the biological processes that mediate PPF autodissemination. Recent successes in large cages can be rationalized, and the plausibility of success under full field conditions can be evaluated a priori. The model also defines measurable properties of PPF delivery prototypes that may be optimized under controlled experimental conditions to maximize chances of success in full field trials. The most obvious flaw in this model is the endogenous relationship that inevitably occurs between the larval habitat coverage and the measured rate of oviposition into those habitats if the target mosquito species is used to mediate PPF transfer. However, this inconsistency also illustrates the potential advantages of using a different, non-target mosquito species for contamination at selected resting sites that shares the same aquatic habitats as the primary target. For autodissemination interventions to eliminate malaria transmission or vector populations during the dry season window of opportunity will require comprehensive contamination of the most challenging subset of aquatic habitats (C-lx) that persist or retain PPF activity (U-x) for only one week (C-lx -> 1, where U-x = 7 days). To achieve >99% contamination coverage of these habitats will necessitate values for the product of the proportional coverage of the ovipositing mosquito population with PPF contamination (C-M) by the ovitrap-detectable rates of oviposition by wild mosquitoes into this subset of habitats (m(lx,z,d)), divided by the titre of contaminated mosquitoes required to render them unproductive (T-lx,T-z,T-d), that approximately approach unity (C(M)m(lx,z,d)/T-lx,T-z,T-d -> 1). Conclusions The simple multiplicative relationship between C-M and m(lx,z,d)/T-lx,T-z,T-d, and the simple exponential decay effect they have upon uncontaminated aquatic habitats, allows application of this model by theoreticians and field biologists alike.	[Kiware, Samson S.; Lwetoijera, Dickson W.; Majambere, Silas; Killeen, Gerry F.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Kiware, Samson S.; Corliss, George; Merrill, Stephen] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53201 USA; [Devine, Gregor] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Lwetoijera, Dickson W.; Majambere, Silas; Killeen, Gerry F.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England	Ifakara Health Institute; Marquette University; QIMR Berghofer Medical Research Institute; Liverpool School of Tropical Medicine	Kiware, SS (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, POB 53, Ifakara, Tanzania.	skiware@ihi.or.tz	Devine, Gregor J/H-1141-2014	Devine, Gregor J/0000-0001-6312-0390; Kiware, Samson/0000-0001-7252-520X	Bill & Melinda Gates Foundation [OPP52644]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The funds for this study was received from the Bill & Melinda Gates Foundation, http://www.gatesfoundation.org/, award number OPP52644 awarded to GD and SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702; Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], 1998, COCHRANE DB SYST REV; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Brady OJ, 2015, INT HEALTH, V7, P121, DOI 10.1093/inthealth/ihv010; Briet OJT, 2002, MED VET ENTOMOL, V16, P22, DOI 10.1046/j.0269-283x.2002.00335.x; Butail S, 2012, J R SOC INTERFACE, V9, P2624, DOI 10.1098/rsif.2012.0150; Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793; Chen H, 2006, AM J TROP MED HYG, V75, P246, DOI 10.4269/ajtmh.2006.75.246; Clements A, 1995, AM J TROP MED HYG, V52, P579; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188; Devine GJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-142; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Dugassa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068948; Dugassa S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-374; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger Ulrike, 2011, Malar J, V10, P353, DOI 10.1186/1475-2875-10-353; Gillies M, 1968, THE ANOPHELINAE OF A, P54; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hardy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081931; Harris C., 2011, Parasites and Vectors, V4; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Holstein M., 1954, BIOLOGY OF ANOPHELES; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-338; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-146; Killeen GF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-172; Killeen GF, 2013, AM J TROP MED HYG, V88, P809, DOI 10.4269/ajtmh.13-0065; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Kimani EW, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-63; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kiware SS, 2012, BIOL LETTERS, V8, P874, DOI 10.1098/rsbl.2012.0352; Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Macintyre K, 2003, INT J EPIDEMIOL, V32, P157, DOI 10.1093/ije/dyg019; Mbare O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-94; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210; MULLA MS, 1989, J AM MOSQUITO CONTR, V5, P15; Mutuku FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-356; Mwangangi JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-114; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Russell TL, 2011, P ROY SOC B-BIOL SCI, V278, P3142, DOI 10.1098/rspb.2011.0153; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Smith DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071247; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; WHO, 2013, LARVAL SOURCE MANAGE	71	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131835	10.1371/journal.pone.0131835	http://dx.doi.org/10.1371/journal.pone.0131835			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186730	Green Published, gold, Green Accepted			2022-12-27	WOS:000358198700024
J	Hov, JR; Zhong, HZ; Qin, BC; Anmarkrud, JA; Holm, K; Franke, A; Lie, BA; Karlsen, TH				Hov, Johannes R.; Zhong, Huanzi; Qin, Bingcai; Anmarkrud, Jarl Andreas; Holm, Kristian; Franke, Andre; Lie, Benedicte A.; Karlsen, Tom H.			The Influence of the Autoimmunity-Associated Ancestral HLA Haplotype AH8.1 on the Human Gut Microbiota: A Cross-Sectional Study	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; INTESTINAL MICROBIOTA; DISEASE; GENES; SENSITIVITY; INDUCTION	Multiple immune-related genes are encoded in the HLA complex on chromosome 6p21. The 8.1 ancestral haplotype (AH8.1) include the classical HLA alleles HLA-B*08:01 and HLA-DRB1*03: 01, and has been associated with a large number of autoimmune diseases, but the underlying mechanisms for this association are largely unknown. Given the recently established links between the gut microbiota and inflammatory diseases, we hypothesized that the AH8.1 influences the host gut microbial community composition. To study this further, healthy individuals were selected from the Norwegian Bone Marrow Donor Registry and categorized as either I. AH8.1 homozygote (n=34), II. AH8.1 heterozygote (n=38), III. Non AH8.1 heterozygote or IV. HLA-DRB1 homozygote but non AH8.1 (n=15). Bacterial DNA from stool samples were subjected to sequencing of the V3-V5 region of the 16S rRNA gene on the 454 Life Sciences platform and data analyzed using Mothur and QIIME. The results showed that the abundances of different taxa were highly variable within all pre-defined AH8.1 genotype groups. Using univariate non-parametric statistics, there were no differences regarding alpha or beta diversity between AH8.1 carriers (categories I and II) and non-carriers (categories III and IV), however four different taxa (Prevotellaceae, Clostridium XVIII, Coprococcus, Enterorhabdus) had nominally significant lower abundances in AH8.1 carriers than non-carriers. After including possible confounders in a multivariate linear regression, only the two latter genera remained significantly associated. In conclusion, the overall contribution of the AH8.1 haplotype to the variation in gut microbiota profile of stool in the present study was small.	[Hov, Johannes R.; Anmarkrud, Jarl Andreas; Holm, Kristian; Karlsen, Tom H.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Hov, Johannes R.; Lie, Benedicte A.; Karlsen, Tom H.] Univ Oslo, Fac Med, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Hov, Johannes R.; Karlsen, Tom H.] Oslo Univ Hosp, Internal Med Res Inst, Rikshosp, Oslo, Norway; [Hov, Johannes R.; Karlsen, Tom H.] Oslo Univ Hosp, Gastroenterol Sect, Div Canc Med Surg & Transplantat, Dept Transplantat Med,Rikshosp, Oslo, Norway; [Zhong, Huanzi; Qin, Bingcai] BGI Shenzhen, Shenzhen, Peoples R China; [Qin, Bingcai] Shanghai Majorbio Biopharm Technol Co Ltd, Shanghai, Peoples R China; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Dept Immunol, Rikshosp, Oslo, Norway; [Karlsen, Tom H.] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Beijing Genomics Institute (BGI); University of Kiel; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Bergen	Hov, JR (corresponding author), Oslo Univ Hosp, Div Canc Med, Dept Transplantat Med, Norwegian PSC Res Ctr,Rikshosp, Oslo, Norway.	j.e.r.hov@medisin.uio.no	Anmarkrud, Jarl Andreas/R-1822-2019; Franke, Andre/B-2151-2010; Hov, Johannes R/J-1480-2019	Anmarkrud, Jarl Andreas/0000-0002-7496-4430; Franke, Andre/0000-0003-1530-5811; Hov, Johannes R/0000-0002-5900-8096	Norwegian PSC Research Center; Shanghai Majorbio Bio-pharm Technology Co. Ltd	Norwegian PSC Research Center; Shanghai Majorbio Bio-pharm Technology Co. Ltd	The study was funded by the Norwegian PSC Research Center. The funding sources of Norwegian PSC Research Center had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shanghai Majorbio Bio-pharm Technology Co. Ltd provided support in the form of salaries for authors BQ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHLQUIST DA, 1988, ANN INTERN MED, V108, P609, DOI 10.7326/0003-4819-108-4-609; Arumugam M, 2014, NATURE, V506, DOI 10.1038/nature13075; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Candore Giuseppina, 2002, Autoimmunity Reviews, V1, P29, DOI 10.1016/S1568-9972(01)00004-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Couturier-Maillard A, 2013, J CLIN INVEST; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Palma G, 2010, CURR ISSUES MOL BIOL, V12, P1; De Palma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030791; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Goyette P, 2015, NAT GENET; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Marild K, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-109; Morris DL, 2012, AM J HUM GENET, V91, P778, DOI 10.1016/j.ajhg.2012.08.026; Naess S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114486; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Olivares M., 2014, GUT; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Thorsby E, 2005, TRANSPL IMMUNOL, V14, P175, DOI 10.1016/j.trim.2005.03.021; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	50	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133804	10.1371/journal.pone.0133804	http://dx.doi.org/10.1371/journal.pone.0133804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207384	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000148
J	Huh, JH; Choi, SI; Lim, JS; Chung, CH; Shin, JY; Lee, MY				Huh, Ji Hye; Choi, Soo In; Lim, Jung Soo; Chung, Choon Hee; Shin, Jang Yel; Lee, Mi Young			Lower Serum Creatinine Is Associated with Low Bone Mineral Density in Subjects without Overt Nephropathy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SURVEY KNHANES IV; MUSCLE MASS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; NATIONWIDE SURVEY; SARCOPENIA; WOMEN; MEN; OSTEOPOROSIS	Background Low skeletal muscle mass is associated with deterioration of bone mineral density. Because serum creatinine can serve as a marker of muscle mass, we evaluated the relationship between serum creatinine and bone mineral density in an older population with normal renal function. Methods Data from a total of 8,648 participants (4,573 men and 4,075 postmenopausal women) aged 45-95 years with an estimated glomerular filtration rate >60 ml/min/1.73 m2 were analyzed from the Fourth Korea National Health and Nutrition Examination Survey (2008-2010). Bone mineral density (BMD) and appendicular muscle mass (ASM) were measured using dual-energy X-ray absorptiometry. Receiver operating characteristic curve analysis revealed that the cut points of serum creatinine for sarcopenia were below 0.88 mg/dl in men and 0.75 mg/dl in women. Subjects were divided into two groups: low creatinine and upper normal creatinine according to the cut point value of serum creatinine for sarcopenia. Results In partial correlation analysis adjusted for age, serum creatinine was positively associated with both BMD and ASM. Subjects with low serum creatinine were at a higher risk for low BMD (T-score <= -1.0) at the femur neck, total hip and lumbar spine in men, and at the total hip and lumbar spine in women after adjustment for confounding factors. Each standard deviation increase in serum creatinine was significantly associated with reduction in the likelihood of low BMD at the total hip and lumbar spine in both sexes (men: odds ratio (OR) = 0.84 [95% CI = 0.74-0.96] at the total hip, OR = 0.8 [95% CI = 0.68-0.96] at the lumbar spine; women: OR = 0.83 [95% CI = 0.73-0.95] at the total hip, OR = 0.81 [95% CI = 0.67-0.99] at the lumbar spine). Conclusions Serum creatinine reflected muscle mass, and low serum creatinine was independently associated with low bone mineral density in subjects with normal kidney function.	[Huh, Ji Hye; Choi, Soo In; Lim, Jung Soo; Chung, Choon Hee; Shin, Jang Yel; Lee, Mi Young] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, Gangwon Do, South Korea	Yonsei University	Lee, MY (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, Gangwon Do, South Korea.	domoe46@yonsei.ac.kr		Chung, Choon/0000-0003-1144-7206	National Research Foundation (NRF) of Korea grant - Korean government (MEST) [20110001024]	National Research Foundation (NRF) of Korea grant - Korean government (MEST)	This work was supported by a National Research Foundation (NRF) of Korea grant funded by the Korean government (MEST) (No. 20110001024).	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Binkley N, 2013, OSTEOPOROSIS INT, V24, P2955, DOI 10.1007/s00198-013-2427-1; Bonewald LF, 2013, J BONE MINER RES, V28, P1857, DOI 10.1002/jbmr.1980; Cooper C, 2012, OSTEOPOROSIS INT, V23, P1839, DOI 10.1007/s00198-012-1913-1; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Di Monaco M, 2012, ARCH GERONTOL GERIAT, V55, pE48, DOI 10.1016/j.archger.2012.05.002; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Haderslev Kent Valentin, 2005, Dyn Med, V4, P1, DOI 10.1186/1476-5918-4-1; Harita N, 2009, DIABETES CARE, V32, P424, DOI 10.2337/dc08-1265; Hjelmesaeth J, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-6; Huh JH, 2014, OSTEOPOROSIS INT, V25, P1053, DOI 10.1007/s00198-013-2531-2; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Kim JE, 2014, OSTEOPOROSIS INT, V25, P2189, DOI 10.1007/s00198-014-2745-y; Kim KM, 2013, J BONE MINER METAB, V31, P144, DOI 10.1007/s00774-012-0386-9; Klein GL, 2014, WORLD J DIABETES, V5, P14, DOI 10.4239/wjd.v5.i1.14; Lee YH, 2014, J CLIN ENDOCR METAB, V99, P3879, DOI 10.1210/jc.2013-3764; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu-Ambrose T, 2003, J GERONTOL A-BIOL, V58, P862; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mo Chenglin, 2012, Recent Pat Biotechnol, V6, P223; Mudali S, 2004, MECH AGEING DEV, V125, P297, DOI 10.1016/j.mad.2004.01.004; Patel SS, 2013, J CACHEXIA SARCOPENI, V4, P19, DOI 10.1007/s13539-012-0079-1; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; Schoenau E, 2002, CALCIFIED TISSUE INT, V70, P405, DOI 10.1007/s00223-001-0048-8; SCHUTTE JE, 1981, J APPL PHYSIOL, V51, P762, DOI 10.1152/jappl.1981.51.3.762; Thomas T, 2002, J BONE MINER RES, V17, P1563, DOI 10.1359/jbmr.2002.17.9.1563; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yonemura K, 2004, KIDNEY INT, V65, P1395, DOI 10.1111/j.1523-1755.2004.00521.x; Yu R, 2014, J AM MED DIR ASSOC, V15, P551, DOI 10.1016/j.jamda.2014.02.005; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	31	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133062	10.1371/journal.pone.0133062	http://dx.doi.org/10.1371/journal.pone.0133062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207750	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000060
J	Kremsky, I; Bellora, N; Eyras, E				Kremsky, Isaac; Bellora, Nicolas; Eyras, Eduardo			A Quantitative Profiling Tool for Diverse Genomic Data Types Reveals Potential Associations between Chromatin and Pre-mRNA Processing	PLOS ONE			English	Article							SPLICING ENHANCER MOTIFS; NASCENT RNA; IDENTIFICATION; SPECIFICITIES; TRANSCRIPTION; TRANSLATION; METHYLATION; INCLUSION; PROTEIN	High-throughput sequencing, and genome-based datasets in general, are often represented as profiles centered at reference points to study the association of protein binding and other signals to particular regulatory mechanisms. Although these profiles often provide compelling evidence of these associations, they do not provide a quantitative assessment of the enrichment, which makes the comparison between signals and conditions difficult. In addition, a number of biases can confound profiles, but are rarely accounted for in the tools currently available. We present a novel computational method, ProfileSeq, for the quantitative assessment of biological profiles to provide an exact, nonparametric test that specific regions of the test profile have higher or lower signal densities than a control set. The method is applicable to high-throughput sequencing data (ChIP-Seq, GRO-Seq, CLIP-Seq, etc.) and to genome-based datasets (motifs, etc.). We validate ProfileSeq by recovering and providing a quantitative assessment of several results reported before in the literature using independent datasets. We show that input signal and mappability have confounding effects on the profile results, but that normalizing the signal by input reads can eliminate these biases while preserving the biological signal. Moreover, we apply ProfileSeq to ChIP-Seq data for transcription factors, as well as for motif and CLIP-Seq data for splicing factors. In all examples considered, the profiles were robust to biases in mappability of sequencing reads. Furthermore, analyses performed with ProfileSeq reveal a number of putative relationships between transcription factor binding to DNA and splicing factor binding to pre-mRNA, adding to the growing body of evidence relating chromatin and pre-mRNA processing. ProfileSeq provides a robust way to quantify genome-wide coordinate-based signal. Software and documentation are freely available for academic use at https://bitbucket.org/regulatorygenomicsupf/profileseq/.	[Kremsky, Isaac; Eyras, Eduardo] Univ Pompeu Fabra, Computat Genom Grp, E-08003 Barcelona, Spain; [Bellora, Nicolas] Univ Nacl Comahue, INIBIOMA CONICET UNComa, Ctr Reg Univ Bariloche, Lab Microbiol Aplicada & Biotecnol, San Carlos De Bariloche, Rio Negro, Argentina; [Eyras, Eduardo] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Pompeu Fabra University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; ICREA	Eyras, E (corresponding author), Univ Pompeu Fabra, Computat Genom Grp, E-08003 Barcelona, Spain.	eduardo.eyras@upf.edu	Eduardo, Eyras/L-1053-2014; Gasull, Martina/J-4076-2019; Eyras, Eduardo/ABG-7144-2020; Bellora, Nicolas/E-6356-2014	Eduardo, Eyras/0000-0003-0793-6218; Eyras, Eduardo/0000-0003-0793-6218; Bellora, Nicolas/0000-0001-6637-3465	Initial Training Network grant RNPNet from the European Commission [289007]; Ministerio de Economia y Competitividad (MINECO) from the Spanish Government [BIO2011-23920, CSD2009-00080]; Fundacion Sandra Ibarra de Solidaridad Frente al Cancer; ICREA Funding Source: Custom	Initial Training Network grant RNPNet from the European Commission; Ministerio de Economia y Competitividad (MINECO) from the Spanish Government; Fundacion Sandra Ibarra de Solidaridad Frente al Cancer; ICREA(ICREA)	Support was provided by an Initial Training Network grant RNPNet (289007) from the European Commission [http://ec.europa.eu/research/mariecurieactions/]; grants BIO2011-23920 and CSD2009-00080 from Ministerio de Economia y Competitividad (MINECO) from the Spanish Government [http://www.mineco.gob.es/portal/site/mineco/]; and Fundacion Sandra Ibarra de Solidaridad Frente al Cancer [http://www.fundacionsandraibarra.org/].	Allo M, 2014, P NATL ACAD SCI USA, V111, P15622, DOI 10.1073/pnas.1416858111; Althammer S, 2011, BIOINFORMATICS, V27, P3333, DOI 10.1093/bioinformatics/btr570; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blin K, 2015, NUCLEIC ACIDS RES, V43, pD160, DOI 10.1093/nar/gku1180; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Fu X, 2014, NATURE REV GENETICS, P1; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Acuna LIG, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.28726; Guillouf C, 2006, J BIOL CHEM, V281, P19145, DOI 10.1074/jbc.M512049200; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kakaradov B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S11; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khan DH, 2014, NUCLEIC ACIDS RES, V42, P1656, DOI 10.1093/nar/gkt1134; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pervouchine DD, 2013, BIOINFORMATICS, V29, P273, DOI 10.1093/bioinformatics/bts678; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Richardson JE, 2006, J COMPUT BIOL, V13, P1457, DOI 10.1089/cmb.2006.13.1457; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Sharma S, 2011, MOL CELL, V41, P579, DOI 10.1016/j.molcel.2011.02.012; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Ye Z, 2013, NUCL ACIDS RES, P1; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132448	10.1371/journal.pone.0132448	http://dx.doi.org/10.1371/journal.pone.0132448			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207626	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000029
J	Zhang, C; Sanders, JPM; Xiao, TT; Bruins, ME				Zhang, Chen; Sanders, Johan P. M.; Xiao, Ting T.; Bruins, Marieke E.			How Does Alkali Aid Protein Extraction in Green Tea Leaf Residue: A Basis for Integrated Biorefinery of Leaves	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; ANTIOXIDANT ACTIVITY; SUGAR-BEET; PECTINS; CELL; CELLULOSE; BIOMASS; ACID; POLYSACCHARIDES; DEGRADATION	Leaf protein can be obtained cost-efficiently by alkaline extraction, but overuse of chemicals and low quality of (denatured) protein limits its application. The research objective was to investigate how alkali aids protein extraction of green tea leaf residue, and use these results for further improvements in alkaline protein biorefinery. Protein extraction yield was studied for correlation to morphology of leaf tissue structure, protein solubility and hydrolysis degree, and yields of non-protein components obtained at various conditions. Alkaline protein extraction was not facilitated by increased solubility or hydrolysis of protein, but positively correlated to leaf tissue disruption. HG pectin, RGII pectin, and organic acids were extracted before protein extraction, which was followed by the extraction of cellulose and hemi-cellulose. RGI pectin and lignin were both linear to protein yield. The yields of these two components were 80% and 25% respectively when 95% protein was extracted, which indicated that RGI pectin is more likely to be the key limitation to leaf protein extraction. An integrated biorefinery was designed based on these results.	[Zhang, Chen; Sanders, Johan P. M.; Bruins, Marieke E.] AFSG, Biobased Chem & Technol Grp, NL-6708 WG Wageningen, Wageningen Ur, Netherlands; [Sanders, Johan P. M.; Bruins, Marieke E.] Food & Biobased Res Inst, NL-6708 WG Wageningen, Wageningen Ur, Netherlands; [Xiao, Ting T.] Mol Biol Lab, Dept Plant Sci, NL-6708 PB Wageningen, Wageningen Ur, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Zhang, C (corresponding author), AFSG, Biobased Chem & Technol Grp, Bornse Weilanden 9, NL-6708 WG Wageningen, Wageningen Ur, Netherlands.	chen.zhang@wur.nl	Zhang, Chen/AAB-1292-2021; Bruins, Marieke E/G-3226-2014; Zhang, Chen/ABG-7131-2020	Zhang, Chen/0000-0002-9461-1755	STW project (Netherlands); DSM; Mali Biocarburant; Agrifirm	STW project (Netherlands); DSM; Mali Biocarburant; Agrifirm	This research is funded by STW project (Netherlands), and it is co-funded by DSM (http://www.dsm.com/countrysites/dsmnl/nl_NL/home.html), Agrifirm (http://www.agrifirm.com/) and Mali Biocarburant (http://www.malibiocarburant.com/malibio/). CZ, JS, and MB have received this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESON WR, 1965, J AGR FOOD CHEM, V13, P145, DOI 10.1021/jf60138a014; Badar K. V., 2011, Current Botany, V2, P5; Bals B, 2011, BIOTECHNOL BIOENG, V108, P530, DOI 10.1002/bit.22973; Brovko FA, 1998, PLANT PHYSIOL BIOCH, V36, P773, DOI 10.1016/S0981-9428(98)80029-6; Carvalheiro F, 2008, J SCI IND RES INDIA, V67, P849; Chen X, 2012, APPL MECH MATER, V138-139, P933, DOI 10.4028/www.scientific.net/AMM.138-139.933; Chiesa S, 2011, BIORESOURCE TECHNOL, V102, P427, DOI 10.1016/j.biortech.2010.07.125; Dashek W. V., 2006, PLANT CELL BIOL, P33; Dashek WV, 2006, PLANT CELL BIOL, P107; Durling NE, 2007, FOOD CHEM, V101, P1417, DOI 10.1016/j.foodchem.2006.03.050; Ele-Ekouna JP, 2011, CARBOHYD POLYM, V83, P1232, DOI 10.1016/j.carbpol.2010.09.028; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; GERLOFF ED, 1965, J AGR FOOD CHEM, V13, P139, DOI 10.1021/jf60138a012; Ghaly A. E., 2010, American Journal of Applied Sciences, V7, P331, DOI 10.3844/ajassp.2010.331.342; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; HENRIQUES F, 1976, BIOCHIM BIOPHYS ACTA, V430, P312, DOI 10.1016/0005-2728(76)90087-6; Jamdar SN, 2010, FOOD CHEM, V121, P178, DOI 10.1016/j.foodchem.2009.12.027; JAYASURIYA MCN, 1978, ANIM FEED SCI TECH, V3, P219, DOI 10.1016/0377-8401(78)90029-9; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Knill CJ, 2003, CARBOHYD POLYM, V51, P281, DOI 10.1016/S0144-8617(02)00183-2; Kondo M, 2004, ANIM FEED SCI TECH, V113, P71, DOI 10.1016/j.anifeedsci.2003.10.018; Lamsal BP, 2007, LWT-FOOD SCI TECHNOL, V40, P1520, DOI 10.1016/j.lwt.2006.11.010; Li P, 2005, J FOOD ENG, V67, P253, DOI 10.1016/j.jfoodeng.2004.04.009; Maas RHW, 2008, APPL MICROBIOL BIOT, V78, P751, DOI 10.1007/s00253-008-1361-1; Mauseth JD, 2009, BOT INTRO PLANT BIOL, P120; Nielsen PM, 2001, J FOOD SCI, V66, P642, DOI 10.1111/j.1365-2621.2001.tb04614.x; Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009; Parajo JC, 1996, FOOD CHEM, V57, P531, DOI 10.1016/S0308-8146(96)00012-X; Renard CMGC, 1996, PROGR BIOTECHNOL, V14, P603, DOI 10.1016/S0921-0423(96)80292-9; RENARD CMGC, 1990, CARBOHYD POLYM, V12, P9, DOI 10.1016/0144-8617(90)90101-W; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sanders J, 2007, MACROMOL BIOSCI, V7, P105, DOI 10.1002/mabi.200600223; Saulnier L, 1999, J SCI FOOD AGR, V79, P396, DOI [10.1002/(SICI)1097-0010(19990301)79:3<396::AID-JSFA262>3.0.CO;2-B, 10.1002/(SICI)1097-0010(19990301)79:3&lt;396::AID-JSFA262&gt;3.0.CO;2-B]; Shen L, 2008, FOOD CHEM, V107, P929, DOI 10.1016/j.foodchem.2007.08.047; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Testova L, 2014, CARBOHYD POLYM, V100, P185, DOI 10.1016/j.carbpol.2013.01.093; Thompson JE, 2000, PLANTA, V211, P275, DOI 10.1007/s004250000287; Turkmen N, 2006, FOOD CHEM, V99, P835, DOI 10.1016/j.foodchem.2005.08.034; Van Dongen FEM, 2011, CARBOHYD POLYM, V86, P722, DOI 10.1016/j.carbpol.2011.05.007; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; de Toledo NMV, 2013, FOOD CHEM, V138, P776, DOI 10.1016/j.foodchem.2012.11.079; Willats WGT, 2006, TRENDS FOOD SCI TECH, V17, P97, DOI 10.1016/j.tifs.2005.10.008; Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X; Yalcin E, 2007, FOOD CHEM, V104, P1641, DOI 10.1016/j.foodchem.2007.03.029; Zaidel DNA, 2012, BIOCATAL AGRIC BIOTE, V1, P207, DOI 10.1016/j.bcab.2012.03.007; Zhang C, 2014, BIOMASS BIOENERG, V67, P466, DOI 10.1016/j.biombioe.2014.05.020; Zykwinska A, 2006, CARBOHYD POLYM, V65, P510, DOI 10.1016/j.carbpol.2006.02.012; Zykwinska AW, 2005, PLANT PHYSIOL, V139, P397, DOI 10.1104/pp.105.065912	50	23	25	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133046	10.1371/journal.pone.0133046	http://dx.doi.org/10.1371/journal.pone.0133046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200774	gold, Green Published, Green Submitted			2022-12-27	WOS:000358597100053
J	Bonvini, JM; Beck-Schimmer, B; Kuhn, SJ; Graber, SM; Neff, TA; Schlapfer, M				Bonvini, John M.; Beck-Schimmer, Beatrice; Kuhn, Sonja J.; Graber, Sereina M.; Neff, Thomas A.; Schlaepfer, Martin			Late Post-Conditioning with Sevoflurane after Cardiac Surgery - Are Surrogate Markers Associated with Clinical Outcome?	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; BYPASS GRAFT-SURGERY; TROPONIN-T ELEVATION; LONG-TERM SURVIVAL; VOLATILE ANESTHETICS; CARDIOPULMONARY BYPASS; MYOCARDIAL-INFARCTION; CORONARY SURGERY; CARDIOPROTECTIVE PROPERTIES; REPERFUSION INJURY	Introduction In a recent randomized controlled trial our group has demonstrated in 102 patients that late post-conditioning with sevoflurane performed in the intensive care unit after surgery involving extracorporeal circulation reduced damage to cardiomyocytes exposed to ischemia reperfusion injury. On the first post-operative day the sevoflurane patients presented with lower troponin T values when compared with those undergoing propofol sedation. In order to assess possible clinical relevant long-term implications in patients enrolled in this study, we performed the current retrospective analysis focusing on cardiac and non-cardiac events during the first 6 months after surgery. Methods All patients who had successfully completed the late post-conditioning trial were included into this follow-up. Our primary and secondary endpoints were the proportion of patients experiencing cardiac and non-cardiac events, respectively. Additionally, we were interested in assessing therapeutic interventions such as initiation or change of drug therapy, interventional treatment or surgery. Results Of 102 patients analyzed in the primary study 94 could be included in this follow-up. In the sevoflurane group (with 41 patients) 16 (39%) experienced one or several cardiac events within 6 months after cardiac surgery, in the propofol group (with 53 patients) 19 (36%, p=0.75). Four patients (9%) with sevoflurane vs. 7 (13%) with propofol sedation had non-cardiac events (p=0.61). While a similar percentage of patients suffered from cardiac and/or non-cardiac events, only 12 patients in the sevoflurane group compared to 20 propofol patients needed a therapeutic intervention (OR: 0.24, 95% CI: 0.04-1.43, p=0.12). A similar result was found for hospital admissions: 2 patients in the sevoflurane group had to be re-admitted to the hospital compared to 8 in the propofol group (OR 0.23, 95% CI: 0.041.29, p=0.10). Conclusions Sevoflurane does not seem to provide protection with regard to the occurrence of cardiac and non-cardiac events in the 6-month period following cardiac surgery with the use of extracorporeal circulation. However, there was a clear trend towards fewer interventions (less need for treatment, fewer hospital admissions) associated with sevoflurane post-conditioning in patients experiencing any event. Such results might encourage launching large multicenter post-conditioning trials with clinical outcome defined as primary endpoint.	[Bonvini, John M.; Beck-Schimmer, Beatrice; Kuhn, Sonja J.; Schlaepfer, Martin] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Beck-Schimmer, Beatrice; Schlaepfer, Martin] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Beck-Schimmer, Beatrice] Univ Illinois, Coll Med Chicago, Dept Anesthesiol, Chicago, IL 60612 USA; [Graber, Sereina M.] Univ Zurich, Antropol Inst & Museum, CH-8057 Zurich, Switzerland; [Neff, Thomas A.] Cantonal Hosp Muensterlingen, Dept Anesthesia & Intens Care Med, CH-8596 Muensterlingen, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Zurich	Beck-Schimmer, B (corresponding author), Univ Zurich Hosp, Inst Anesthesiol, Raemistr 100, CH-8091 Zurich, Switzerland.	beatrice.beckschimmer@uzh.ch	Schlaepfer, Martin/B-9243-2017; Schlaepfer, Martin/AAA-3587-2021	Schlaepfer, Martin/0000-0003-4288-7124; Schlaepfer, Martin/0000-0003-4288-7124				Beck-Schimmer B, 2012, ANN SURG, V256, P837, DOI 10.1097/SLA.0b013e318272df7c; Beck-Schimmer B, 2008, ANN SURG, V248, P909, DOI 10.1097/SLA.0b013e31818f3dda; Belhomme D, 1999, CIRCULATION, V100, P340; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Brown JR, 2008, HEART SURG FORUM, V11, pE163, DOI 10.1532/HSF98.20081017; Cromheecke S, 2006, ANESTH ANALG, V103, P289, DOI 10.1213/01.ane.0000226097.22384.f4; Dai AL, 2010, J ZHEJIANG UNIV-SC B, V11, P267, DOI 10.1631/jzus.B0900390; De Hert S, 2009, ANAESTHESIA, V64, P953, DOI 10.1111/j.1365-2044.2009.06008.x; De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009; De Hert SG, 2002, ANESTHESIOLOGY, V97, P42, DOI 10.1097/00000542-200207000-00007; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Erbel C, 2013, TRANSPL INT, V26, P267, DOI 10.1111/tri.12024; Fang NX, 2010, MOL BIOL REP, V37, P3763, DOI 10.1007/s11033-010-0030-5; Feldman DN, 2011, CATHETER CARDIO INTE, V77, P1020, DOI 10.1002/ccd.22962; Garcia C, 2005, BRIT J ANAESTH, V94, P159, DOI 10.1093/bja/aei026; Guarracino F, 2006, J CARDIOTHOR VASC AN, V20, P477, DOI 10.1053/j.jvca.2006.05.012; Haitsma JJ, 2009, ACTA ANAESTH SCAND, V53, P176, DOI 10.1111/j.1399-6576.2008.01844.x; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; Hellstrom J, 2011, ACTA ANAESTH SCAND, V55, P460, DOI 10.1111/j.1399-6576.2011.02405.x; Huang ZY, 2011, CLIN SCI, V121, P57, DOI 10.1042/CS20100435; Knapp J, 2013, RESUSCITATION, V84, P1450, DOI 10.1016/j.resuscitation.2013.04.012; Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013; Liu Q, 2012, ACTA PHARMACOL SIN, V33, P1495, DOI 10.1038/aps.2012.86; Lou PH, 2013, CARDIOVASC RES, V97, P251, DOI 10.1093/cvr/cvs323; MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67; Meiser A, 2003, BRIT J ANAESTH, V90, P273, DOI 10.1093/bja/aeg059; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; MURRY CE, 1990, CIRC RES, V66, P913, DOI 10.1161/01.RES.66.4.913; Pravdic D, 2010, BRIT J PHARMACOL, V160, P220, DOI 10.1111/j.1476-5381.2010.00698.x; Riedel BJ, 2006, J CARDIOTHOR VASC AN, V20, P781, DOI 10.1053/j.jvca.2006.01.015; Rohm KD, 2008, INTENS CARE MED, V34, P1683, DOI 10.1007/s00134-008-1157-x; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Steurer MP, 2012, CRIT CARE, V16, DOI 10.1186/cc11676; Tritapepe L, 2007, EUR J ANAESTH, V24, P323, DOI 10.1017/S0265021506001931; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Winkel TA, 2010, EUR J VASC ENDOVASC, V40, P739, DOI 10.1016/j.ejvs.2010.08.012; Xiao YY, 2011, ANESTH ANALG, V113, P224, DOI 10.1213/ANE.0b013e3182239b71; Zaugg M, 2003, BRIT J ANAESTH, V91, P551, DOI 10.1093/bja/aeg205; Zaugg M, 2002, ANESTHESIOLOGY, V97, P4, DOI 10.1097/00000542-200207000-00003; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132165	10.1371/journal.pone.0132165	http://dx.doi.org/10.1371/journal.pone.0132165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196133	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000358547600025
J	Emerenini, BO; Hense, BA; Kuttler, C; Eberl, HJ				Emerenini, Blessing O.; Hense, Burkhard A.; Kuttler, Christina; Eberl, Hermann J.			A Mathematical Model of Quorum Sensing Induced Biofilm Detachment	PLOS ONE			English	Article							PLANKTONIC-CELL YIELD; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; DIFFUSION; AUTOINDUCER; MECHANISMS; DISPERSAL; COMMUNICATION; BIOSYNTHESIS; ANTIBIOTICS	Background Cell dispersal (or detachment) is part of the developmental cycle of microbial biofilms. It can be externally or internally induced, and manifests itself in discrete sloughing events, whereby many cells disperse in an instance, or in continuous slower dispersal of single cells. One suggested trigger of cell dispersal is quorum sensing, a cell-cell communication mechanism used to coordinate gene expression and behavior in groups based on population densities. Method To better understand the interplay of colony growth and cell dispersal, we develop a dynamic, spatially extended mathematical model that includes biofilm growth, production of quorum sensing molecules, cell dispersal triggered by quorum sensing molecules, and reattachment of cells. This is a highly nonlinear system of diffusion-reaction equations that we study in computer simulations. Results Our results show that quorum sensing induced cell dispersal can be an efficient mechanism for bacteria to control the size of a biofilm colony, and at the same time enhance its downstream colonization potential. In fact we find that over the lifetime of a biofilm colony the majority of cells produced are lost into the aqueous phase, supporting the notion of biofilms as cell nurseries. We find that a single quorum sensing based mechanism can explain both, discrete dispersal events and continuous shedding of cells from a colony. Moreover, quorum sensing induced cell dispersal affects the structure and architecture of the biofilm, for example it might lead to the formation of hollow inner regions in a biofilm colony.	[Emerenini, Blessing O.; Eberl, Hermann J.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Hense, Burkhard A.] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Kuttler, Christina] Tech Univ Munich, Zentrum Math, Neuherberg, Germany	University of Guelph; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Emerenini, BO (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	buzor@uoguelph.ca		Eberl, Hermann/0000-0001-5558-0872; Emerenini, Blessing/0000-0001-9178-2738	Natural Sciences and Engineering Research Council, Discovery Grants; OMAFRA - UofG Partnership	Natural Sciences and Engineering Research Council, Discovery Grants; OMAFRA - UofG Partnership	This work was supported by Natural Sciences and Engineering Research Council, Discovery Grants (http:///www.nserc.ca) and OMAFRA - UofG Partnership (http://www.uoguelph.ca/omafra_partnership/hqp/en/index.asp).	Abbas F, 2012, MATH BIOSC ENG, V9; ADAR YY, 1992, J BACTERIOL, V174, P7138, DOI 10.1128/jb.174.22.7138-7143.1992; ADAR YY, 1993, J BIOLUM CHEMILUM, V8, P261, DOI 10.1002/bio.1170080506; Anguige K, 2005, J MATH BIOL, V51, P557, DOI 10.1007/s00285-005-0316-8; Annous Bassam A, 2009, J Food Sci, V74, pR24, DOI 10.1111/j.1750-3841.2008.01022.x; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Baty AM, 2000, APPL ENVIRON MICROB, V66, P3574, DOI 10.1128/AEM.66.8.3574-3585.2000; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Bester E, 2005, APPL ENVIRON MICROB, V71, P7792, DOI 10.1128/AEM.71.12.7792-7798.2005; Bester E, 2009, CAN J MICROBIOL, V55, P1195, DOI 10.1139/W09-075; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x; Bollinger N, 2001, J BACTERIOL, V183, P1990, DOI 10.1128/JB.183.6.1990-1996.2001; BOYD A, 1994, APPL ENVIRON MICROB, V60, P2355, DOI 10.1128/AEM.60.7.2355-2359.1994; Bruchmann J, 2013, ENVIRON SCI POLLUT R, V20, P3539, DOI 10.1007/s11356-013-1521-4; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Chopp DL, 2007, TOP BIOMED ENG, P1, DOI 10.1007/978-0-387-68413-0_1; D'Acunto B, J MATH BIOSCIENCE, V259, P20; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; Dockery J, 2002, SIAM J APPL MATH, V62, P853, DOI 10.1137/S0036139900371709; Dockery JD, 2001, B MATH BIOL, V63, P95, DOI 10.1006/bulm.2000.0205; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Duddu R, 2009, BIOTECHNOL BIOENG, V103, P92, DOI 10.1002/bit.22233; Eberl H.J., 2002, RIMS KOKYUROKO, V1258, P49; Eberl H. J., 2007, ELECTRON J DIFFER EQ, V15, P77; Eberl HJ, 2008, J THEOR BIOL, V253, P788, DOI 10.1016/j.jtbi.2008.04.013; Eberl HJ., 2001, J THEORETICAL MED, V3, P161, DOI [10.1080/10273660108833072, DOI 10.1080/10273660108833072]; Efendiev MA, 2009, COMMUN PUR APPL ANAL, V8, P509, DOI 10.3934/cpaa.2009.8.509; Fekete A, 2010, FEMS MICROBIOL ECOL, V72, P22, DOI 10.1111/j.1574-6941.2009.00828.x; Fratamico PM, 2009, WOODHEAD PUBL FOOD S, P1; Frederick M.R., 2010, CAN APPL MATH Q, V18, P267; Frederick MR, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-8; Gilbert KB, 2009, MOL MICROBIOL, V73, P1072, DOI 10.1111/j.1365-2958.2009.06832.x; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hense BA, 2012, SENSORS-BASEL, V12, P4156, DOI 10.3390/s120404156; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Hunt SM, 2003, MICROBIOL-SGM, V149, P1155, DOI 10.1099/mic.0.26134-0; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Khassehkhan H, 2009, LECT NOTES COMPUT SC, V5544, P735, DOI 10.1007/978-3-642-01970-8_73; Kirov SM, 2005, MICROBIOL-SGM, V151, P3452, DOI 10.1099/mic.0.28295-0; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Kuttler C, 2008, J THEOR BIOL, V251, P167, DOI 10.1016/j.jtbi.2007.11.015; Langebrake JB, 2014, J THEOR BIOL, V363, P53, DOI 10.1016/j.jtbi.2014.07.033; Liang W, 2008, FEBS LETT, V582, P3744, DOI 10.1016/j.febslet.2008.10.008; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Mellbye B, 2014, J BACTERIOL, V196, P1155, DOI 10.1128/JB.01223-13; Morgenroth E, 2000, WATER RES, V34, P417, DOI 10.1016/S0043-1354(99)00157-8; Muller J, 2006, J MATH BIOL, V53, P672, DOI 10.1007/s00285-006-0024-z; Muhammad N, 2011, MATH BIOSCI, V233, P1, DOI 10.1016/j.mbs.2011.05.006; Muhammad N, 2010, LECT NOTES COMPUT SC, V5976, P180, DOI 10.1007/978-3-642-12659-8_14; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205; PICIOREANU C, 2001, J BIOTECHNOLOGY BIOE, V58, P101; Pizarro GE, 2005, J COMPUT CIVIL ENG, V19, P258, DOI 10.1061/(ASCE)0887-3801(2005)19:3(258); Rice SA, 2005, J BACTERIOL, V187, P3477, DOI 10.1128/JB.187.10.3477-3485.2005; SAAD Y, 2003, ITERATIVE METHODS SP, V2nd; Sawyer LK, 1998, WATER SCI TECHNOL, V37, P211, DOI 10.1016/S0273-1223(98)00108-5; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Scutera S, 2014, EXPERT OPIN DRUG DIS, V9, P353, DOI 10.1517/17460441.2014.894974; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Smoller J., 2012, SHOCK WAVES REACTION, V258; Solano C, 2014, CURR OPIN MICROBIOL, V18, P96, DOI 10.1016/j.mib.2014.02.008; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Sudarsan R, 2015, ARXIV150107221V1PHYS; Suppiger A, 2013, VIRULENCE, V4, P400, DOI 10.4161/viru.25338; Tatek YB, 2006, PHYSICA A, V362, P382, DOI 10.1016/j.physa.2005.08.011; Thomas MS, 2012, TOPICS ECOLOGICAL EN, P265; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Vaughan BL, 2010, B MATH BIOL, V72, P1143, DOI 10.1007/s11538-009-9485-8; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wanner O, 1996, BIOTECHNOL BIOENG, V49, P172; WANNER O, 1986, BIOTECHNOL BIOENG, V28, P314, DOI 10.1002/bit.260280304; Wanner O, 2006, 18 IWA; Ward J., 2008, CONTROL BIOFILM INFE, P79; Ward JP, 2001, IMA J MATH APPL MED, V18, P263; Webb J. S., 2007, BOOK CHAPTER BIOFILM; Willcox MDP, 2008, MICROBIOL-SGM, V154, P2184, DOI 10.1099/mic.0.2008/019281-0; Wilson S, 2004, APPL ENVIRON MICROB, V70, P5847, DOI 10.1128/AEM.70.10.5847-5852.2004; Xavier JB, 2005, MICROBIOL-SGM, V151, P3817, DOI 10.1099/mic.0.28165-0; Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Zhang W., 2011, CHARACTERIZATION PAS	94	50	51	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132385	10.1371/journal.pone.0132385	http://dx.doi.org/10.1371/journal.pone.0132385			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197231	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600032
J	Lella, LK; Sales, VL; Goldsmith, Y; Chan, J; Iskandir, M; Gulkarov, I; Tortolani, A; Brener, SJ; Sacchi, TJ; Heitner, JF				Lella, Leela K.; Sales, Virna L.; Goldsmith, Yulia; Chan, Jacqueline; Iskandir, Marina; Gulkarov, Iosif; Tortolani, Anthony; Brener, Sorin J.; Sacchi, Terrence J.; Heitner, John F.			Reduced Right Ventricular Function Predicts Long-Term Cardiac Re-Hospitalization after Cardiac Surgery	PLOS ONE			English	Article							ARTERY-BYPASS-SURGERY; LOW EJECTION FRACTION; CARDIOPULMONARY BYPASS; NONCARDIAC SURGERY; OFF-PUMP; DYSFUNCTION; SURVIVAL; GUIDELINES; MORTALITY; FAILURE	Background The significance of right ventricular ejection fraction (RVEF), independent of left ventricular ejection fraction (LVEF), following isolated coronary artery bypass grafting (CABG) and valve procedures remains unknown. The aim of this study is to examine the significance of abnormal RVEF by cardiac magnetic resonance (CMR), independent of LVEF in predicting outcomes of patients undergoing isolated CABG and valve surgery. Methods From 2007 to 2009, 109 consecutive patients (mean age, 66 years; 38% female) were referred for pre-operative CMR. Abnormal RVEF and LVEF were considered <35% and <45%, respectively. Elective primary procedures include CABG (56%) and valve (44%). Thirty-day outcomes were perioperative complications, length of stay, cardiac re-hospitalizations and early mortaility; long-term (> 30 days) outcomes included, cardiac re-hospitalization, worsening congestive heart failure and mortality. Mean clinical follow up was 14 months. Findings Forty-eight patients had reduced RVEF (mean 25%) and 61 patients had normal RVEF (mean 50%) (p<0.001). Fifty-four patients had reduced LVEF (mean 30%) and 55 patients had normal LVEF (mean 59%) (p<0.001). Patients with reduced RVEF had a higher incidence of long-term cardiac re-hospitalization vs. patients with normal RVEF (31% vs. 13%, p<0.05). Abnormal RVEF was a predictor for long-term cardiac re-hospitalization (HR 3.01 [CI 1.5-7.9], p<0.03). Reduced LVEF did not influence long-term cardiac re-hospitalization. Conclusion Abnormal RVEF is a stronger predictor for long-term cardiac re-hospitalization than abnormal LVEF in patients undergoing isolated CABG and valve procedures.	[Lella, Leela K.; Sales, Virna L.; Goldsmith, Yulia; Chan, Jacqueline; Iskandir, Marina; Brener, Sorin J.; Sacchi, Terrence J.; Heitner, John F.] New York Methodist Hosp, Div Cardiol, Brooklyn, NY 11215 USA; [Gulkarov, Iosif; Tortolani, Anthony] New York Methodist Hosp, Dept Cardiothorac Surg, Brooklyn, NY 11215 USA	NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital	Heitner, JF (corresponding author), New York Methodist Hosp, Div Cardiol, Brooklyn, NY 11215 USA.	jfh9003@nyp.org						Adhyapak Srilakshmi M, 2010, Prev Cardiol, V13, P72, DOI 10.1111/j.1751-7141.2009.00053.x; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Bove T, 2014, EUR J CARDIO-THORAC, V45, pE6, DOI 10.1093/ejcts/ezt505; Cuspidi C, 2014, J CARDIOVASC MED HAG; Davidson MJ, 2008, CIRCULATION, V117, P2181, DOI 10.1161/CIRCULATIONAHA.108.767723; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Denault AY, 2010, SEMIN CARDIOTHORAC V, V14, P165, DOI 10.1177/1089253210376673; Dupuis JY, 2001, ANESTHESIOLOGY, V94, P194, DOI 10.1097/00000542-200102000-00006; Filsoufi F, 2007, ANN THORAC SURG, V84, P808, DOI 10.1016/j.athoracsur.2007.04.117; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Greil GF, 2008, HEART, V94, P803, DOI 10.1136/hrt.2005.079111; Hillis GS, 2006, CIRCULATION, V114, pI414, DOI 10.1161/CIRCULATIONAHA.105.000661; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Joshi SB, 2010, CARDIOVASC REVASCULA, V11, P98, DOI 10.1016/j.carrev.2009.04.002; Kjaergaard J, 2006, EUR J ECHOCARDIOGR, V7, P430, DOI 10.1016/j.euje.2005.10.009; Maslow AD, 2002, ANESTH ANALG, V95, P1507, DOI 10.1097/00000539-200212000-00009; McCarthy Patrick M, 2010, Curr Treat Options Cardiovasc Med, V12, P587, DOI 10.1007/s11936-010-0098-1; McCarthy PM, 2004, J THORAC CARDIOV SUR, V127, P674, DOI 10.1016/j.jtcvs.2003.11.019; Messika-Zeitoun D, 2004, J THORAC CARDIOV SUR, V128, P296, DOI 10.1016/j.jtcvs.2004.01.035; Nardi P, 2009, ANN THORAC SURG, V87, P1401, DOI 10.1016/j.athoracsur.2009.02.062; PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603; Pegg TJ, 2008, CIRCULATION, V117, P2202, DOI 10.1161/CIRCULATIONAHA.107.735621; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; RAPER R, 1987, WORLD J SURG, V11, P154, DOI 10.1007/BF01656397; Reichert C L, 1992, J Cardiothorac Vasc Anesth, V6, P429, DOI 10.1016/1053-0770(92)90008-U; SIBBALD WJ, 1983, CRIT CARE MED, V11, P339, DOI 10.1097/00003246-198305000-00004; Siddiqui MMA, 2012, HEART SURG FORUM, V15, pE185, DOI 10.1532/HSF98.20111142; STEIN KL, 1990, CRIT CARE MED, V18, P1197, DOI 10.1097/00003246-199011000-00001; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Yoo JS, 2013, INT J CARDIOL, V168, P5316, DOI 10.1016/j.ijcard.2013.08.009; Zhao XQ, 2003, J CARDIOTHOR VASC AN, V17, P193, DOI 10.1053/jcan.2003.46	32	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132808	10.1371/journal.pone.0132808	http://dx.doi.org/10.1371/journal.pone.0132808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197273	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600052
J	Mahmoud-Awny, M; Attia, AS; Abd-Ellah, MF; El-Abhar, HS				Mahmoud-Awny, Magdy; Attia, Ahmed S.; Abd-Ellah, Mohamed F.; El-Abhar, Hanan Salah			Mangiferin Mitigates Gastric Ulcer in Ischemia/Reperfused Rats: Involvement of PPAR-gamma, NF-kappa B and Nrf2/HO-1 Signaling Pathways	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ISCHEMIA-REPERFUSION INJURY; INDICA L. EXTRACT; HEME OXYGENASE-1; CARBON-MONOXIDE; NITRIC-OXIDE; ANTIOXIDANT RESPONSE; EXPRESSION; DAMAGE; STRESS	Mangiferin (MF), a xanthonoid from Mangifera indica, has been proved to have antisecretory and antioxidant gastroprotective effects against different gastric ulcer models; however, its molecular mechanism has not been previously elucidated. Therefore, the aim of this study was to test its modulatory effect on several signaling pathways using the ischemia/ reperfusion model for the first time. Animals were treated with MF, omeprazole (OMP), and the vehicle. The mechanistic studies revealed that MF mediated its gastroprotective effect partly via inducing the expression of Nrf2, HO-1 and PPAR-gamma along with downregulating that of NF-kappa B. Surprisingly, the effect of MF, especially the high dose, exceeded that mediated by OMP except for Nrf2. The molecular results were reflected on the biomarkers measured, where the antioxidant effect of MF was manifested by increasing total antioxidant capacity and glutathione, besides normalizing malondialdehyde level. Additionally, MF decreased the I/R-induced nitric oxide elevation, an effect that was better than that of OMP. In the serum, MF, dose dependently, enhanced endothelial nitric oxide synthase, while reduced the inducible isoform. Regarding the anti-inflammatory effect of MF, it reduced serum level of IL-1 beta and sE-selectin, effects that were mirrored on the tissue level of myeloperoxidase, the neutrophil infiltration marker. In addition, MF possessed an antiapoptotic character evidenced by elevating Bcl-2 level and reducing that of caspase-3 in a dose related order. As a conclusion, the intimated gastroprotective mechanisms of MF are mediated, partially, by modulation of oxidative stress, inflammation and apoptosis possibly via the Nrf2/HO-1, PPAR-gamma/NF-kappa B signaling pathways.	[Mahmoud-Awny, Magdy] October Univ, Dept Pharmacol & Toxicol, Cairo, Egypt; [Attia, Ahmed S.] Cairo Univ, Dept Microbiol & Immunologyol, Cairo, Egypt; [Abd-Ellah, Mohamed F.] El Azhar Univ, Dept Pharmacol & Toxicol, Cairo, Egypt; [El-Abhar, Hanan Salah] Cairo Univ, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); October 6 University (O6U); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Cairo University	El-Abhar, HS (corresponding author), Cairo Univ, Dept Pharmacol & Toxicol, Cairo, Egypt.	Hanabhar@yahoo.com	El-Abhar, Hanan/L-2289-2019; Attia, Ahmed S./F-6875-2011	El-Abhar, Hanan/0000-0001-8819-9891; Attia, Ahmed S./0000-0003-0491-1007				Abdallah DM, 2009, EUR J PHARMACOL, V603, P93, DOI 10.1016/j.ejphar.2008.11.057; AHMED AE, 1991, J BIOCHEM TOXICOL, V6, P115, DOI 10.1002/jbt.2570060205; ANDERSON ME, 1983, P NATL ACAD SCI-BIOL, V80, P707, DOI 10.1073/pnas.80.3.707; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Carvalho ACS, 2007, PLANTA MED, V73, P1372, DOI 10.1055/s-2007-990231; Chamoun F, 2000, FRONT BIOSCI, V5, pE103, DOI 10.2741/chamoun; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; Dou W, 2014, INT IMMUNOPHARMACOL, V23, P170, DOI 10.1016/j.intimp.2014.08.025; El-Abhar HS, 2003, J ETHNOPHARMACOL, V84, P251, DOI 10.1016/S0378-8741(02)00324-0; Flogel U, 1999, J MOL CELL CARDIOL, V31, P827, DOI 10.1006/jmcc.1998.0921; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Ghosal S, 1996, INDIAN J CHEM B, V35, P561; Ghosh M, 2012, FREE RADICAL RES, V46, P116, DOI 10.3109/10715762.2011.644240; Giakoustidis AE, 2008, FREE RADICAL RES, V42, P180, DOI 10.1080/10715760701840039; Gilberto L, 2006, PHARMACOLOGY, V3, P712; Glantzounis GK, 2005, LIVER TRANSPLANT, V11, P1031, DOI 10.1002/lt.20504; Gong X, 2013, J NUTR BIOCHEM, V24, P1173, DOI 10.1016/j.jnutbio.2012.09.003; Handa O, 2006, INFLAMM RES, V55, P476, DOI 10.1007/s00011-006-6056-4; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Idriss NK, 2008, J AM COLL CARDIOL, V52, P971, DOI 10.1016/j.jacc.2008.06.019; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jangra A, 2014, EUR J PHARMACOL, V740, P337, DOI 10.1016/j.ejphar.2014.07.031; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Konturek PC, 2003, EUR J PHARMACOL, V472, P213, DOI 10.1016/S0014-2999(03)01932-0; Kotani T, 2007, LIFE SCI, V80, P1984, DOI 10.1016/j.lfs.2007.02.041; Leiro J, 2004, INT IMMUNOPHARMACOL, V4, P763, DOI 10.1016/j.intimp.2004.03.002; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marquez L, 2010, WORLD J GASTROENTERO, V16, P4922, DOI 10.3748/wjg.v16.i39.4922; Matsuyama M, 2005, TRANSPL P, V37, P1684, DOI 10.1016/j.transproceed.2005.02.068; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nakajima A, 2001, GASTROENTEROLOGY, V120, P460, DOI 10.1053/gast.2001.21191; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nishida K, 1998, NITRIC OXIDE-BIOL CH, V2, P215, DOI 10.1006/niox.1998.0178; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pae HO, 2008, RECENT PATENTS INFLA, V2, P159, DOI 10.2174/187221308786241929; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114186; Qiao WL, 2011, WORLD J GASTROENTERO, V17, P1718, DOI 10.3748/wjg.v17.i13.1718; Rajendran P, 2008, NAT PROD RES, V22, P672, DOI 10.1080/14786410701824973; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80; Sanchez GM, 2003, PHYTOTHER RES, V17, P197, DOI 10.1002/ptr.921; Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200; SATO N, 1995, SCAND J GASTROENTERO, V30, P14, DOI 10.3109/00365529509107756; Sener-Muratoglu G, 2001, DIGEST DIS SCI, V46, P318, DOI 10.1023/A:1005652815921; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Takahashi T, 2009, J CLIN BIOCHEM NUTR, V44, P28, DOI 10.3164/jcbn.08-210-HO; Tanaka J, 2001, EUR J PHARMACOL, V424, P69, DOI 10.1016/S0014-2999(01)01119-0; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vieira AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071759; Villegas I, 2004, EUR J PHARMACOL, V505, P195, DOI 10.1016/j.ejphar.2004.10.020; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wada K, 2004, AM J PHYSIOL-GASTR L, V287, pG452, DOI 10.1152/ajpgi.00523.2003; Wang B, 2014, INT IMMUNOPHARMACOL, V23, P170; Wood JG, 1996, AM J PHYSIOL, V271, P27; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Zhao XR, 2015, CNS NEUROSCI THER, V21, P357, DOI 10.1111/cns.12350	62	52	53	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132497	10.1371/journal.pone.0132497	http://dx.doi.org/10.1371/journal.pone.0132497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196679	Green Published, Green Submitted, gold			2022-12-27	WOS:000358547600039
J	Martinez, E; Ros, M; Bonilla, MA; Dirzo, R				Martinez, Eliana; Roes, Matthias; Argenis Bonilla, Maria; Dirzo, Rodolfo			Habitat Heterogeneity Affects Plant and Arthropod Species Diversity and Turnover in Traditional Cornfields	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; BETA-DIVERSITY; LANDSCAPE COMPLEXITY; WEED COMMUNITIES; NATURAL ENEMIES; CEREAL FIELDS; AFFECTS ALPHA; CROP PEST; CONSERVATION; BIODIVERSITY	The expansion of the agricultural frontier by the clearing of remnant forests has led to human-dominated landscape mosaics. Previous studies have evaluated the effect of these landscape mosaics on arthropod diversity at local spatial scales in temperate and tropical regions, but little is known about fragmentation effects in crop systems, such as the complex tropical traditional crop systems that maintain a high diversity of weeds and arthropods in low-Andean regions. To understand the factors that influence patterns of diversity in human-dominated landscapes, we investigate the effect of land use types on plant and arthropod diversity in traditionally managed cornfields, via surveys of plants and arthropods in twelve traditional cornfields in the Colombian Andes. We estimated alpha and beta diversity to analyze changes in diversity related to land uses within a radius of 100 m to 1 km around each cornfield. We observed that forests influenced alpha diversity of plants, but not of arthropods. Agricultural lands had a positive relationship with plants and herbivores, but a negative relationship with predators. Pastures positively influenced the diversity of plants and arthropods. In addition, forest cover seemed to influence changes in plant species composition and species turnover of herbivore communities among cornfields. The dominant plant species varied among fields, resulting in high differentiation of plant communities. Predator communities also exhibited high turnover among cornfields, but differences in composition arose mainly among rare species. The crop system evaluated in this study represents a widespread situation in the tropics, therefore, our results can be of broad significance. Our findings suggest that traditional agriculture may not homogenize biological communities, but instead could maintain the regional pool of species through high beta diversity.	[Martinez, Eliana] Univ Nacl Colombia, Fac Ciencias Agr, Escuela Posgrad, Bogota, Colombia; [Roes, Matthias] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico; [Roes, Matthias] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Oaxaca, Mexico; [Argenis Bonilla, Maria] Univ Nacl Colombia, Fac Ciencias, Dept Biol, Bogota, Colombia; [Dirzo, Rodolfo] Stanford Univ, Dept Biol, Palo Alto, CA 94304 USA	Universidad Nacional de Colombia; Instituto de Ecologia - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional de Colombia; Stanford University	Martinez, E (corresponding author), Univ Nacl Colombia, Fac Ciencias Agr, Escuela Posgrad, Bogota, Colombia.	emartinezpa@unal.edu.co	Rös, Matthias/AAS-5755-2021	Rös, Matthias/0000-0002-5722-6321; Martinez Pachon, Eliana/0000-0002-5144-132X	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS); Stanford University via Dirzo Lab operational budget; Research Group Biologia de Organismos Tropicales, Universidad Nacional de Colombia	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Stanford University via Dirzo Lab operational budget; Research Group Biologia de Organismos Tropicales, Universidad Nacional de Colombia	Funding for this research was provided by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) through its Creditos Condonables para estudios de Doctorado Nacionales program - 2010 (granted to EM). Additional funding for field work was obtained from Stanford University via Dirzo Lab operational budget, and the Research Group Biologia de Organismos Tropicales, Universidad Nacional de Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri MA, 1991, REV CLADES, P1; Armengot L, 2012, APPL VEG SCI, V15, P571, DOI 10.1111/j.1654-109X.2012.01190.x; Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Chen Xiao, 2003, REGRESSION STATA; Clough Y, 2005, J BIOGEOGR, V32, P2007, DOI 10.1111/j.1365-2699.2005.01367.x; Clough Y, 2007, J APPL ECOL, V44, P22, DOI 10.1111/j.1365-2664.2006.01239.x; Clough Y, 2007, J APPL ECOL, V44, P804, DOI 10.1111/j.1365-2664.2007.01294.x; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Colwell R, 2009, STAT ESTIMATION SPEC; Crawley M. J, 2002, STAT COMPUTING INTRO; de Souza Mendonça Jr. Milton, 2007, Bol. Soc. Argent. Bot., V42, P347; Drapela T, 2008, ECOGRAPHY, V31, P254, DOI 10.1111/j.0906-7590.2008.5250.x; ESRI, 1999, ARC VIEW 3 2 GIS; Fahrig L, 2015, AGR ECOSYST ENVIRON, V200, P219, DOI 10.1016/j.agee.2014.11.018; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fereres A, 2000, VIRUS RES, V71, P221, DOI 10.1016/S0168-1702(00)00200-8; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; Fernandez M., 2006, U NACL COLOMBIA, V1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Fiedler AK, 2008, BIOL CONTROL, V45, P254, DOI 10.1016/j.biocontrol.2007.12.009; Franke AC, 2009, WEED RES, V49, P131, DOI 10.1111/j.1365-3180.2009.00692.x; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; GRAU HR, 2008, ECOL SOC, V0013; Gurr GM, 2003, BASIC APPL ECOL, V4, P107, DOI 10.1078/1439-1791-00122; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2008, OIKOS, V117, P354, DOI 10.1111/j.2007.0030-1299.16303.x; Isaacs R, 2009, FRONT ECOL ENVIRON, V7, P196, DOI 10.1890/080035; Jimenez-Valverde A, 2010, INSECT CONSERV DIVER, V3, P51, DOI 10.1111/j.1752-4598.2009.00067.x; Jocque R, 2007, SPIDER FAMILIES WORL; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kahane R, 2013, AGRON SUSTAIN DEV, V33, P671, DOI 10.1007/s13593-013-0147-8; Kaston BJ, 1978, PICTURED KEY NATURE; Klein AM, 2006, J ANIM ECOL, V75, P315, DOI 10.1111/j.1365-2656.2006.01042.x; Langebank C, 1996, HIST COLOMBIA ESTABL; Lavandero B, 2006, BASIC APPL ECOL, V7, P236, DOI 10.1016/j.baae.2005.09.004; Lee JC, 2008, J ANIM ECOL, V77, P565, DOI 10.1111/j.1365-2656.2008.01355.x; Letourneau DK, 2012, J APPL ECOL, V49, P1405, DOI 10.1111/1365-2664.12001; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Limberger R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044555; Limberger R, 2012, OECOLOGIA, V168, P785, DOI 10.1007/s00442-011-2140-8; Navas ML, 2012, WEED RES, V52, P479, DOI 10.1111/j.1365-3180.2012.00941.x; Oyarzun PJ, 2013, ECOL FOOD NUTR, V52, P515, DOI 10.1080/03670244.2013.769099; PAOLETTI MG, 1992, AGR ECOSYST ENVIRON, V40, P3, DOI 10.1016/0167-8809(92)90080-U; PIMENTEL D, 1987, BIOMASS, V14, P15, DOI 10.1016/0144-4565(87)90020-5; Pluess T, 2010, AGR ECOSYST ENVIRON, V137, P68, DOI 10.1016/j.agee.2009.12.020; Poggio SL, 2010, BIOL CONSERV, V143, P2477, DOI 10.1016/j.biocon.2010.06.014; Price P.W., 2011, INSECT ECOLOGY BEHAV; R Core Team, 2018, R LANG ENV STAT COMP; Risch S.J., 1987, P217; Riveros P, 2013, THESIS PONTIFICIA U; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Rusch A, 2013, J APPL ECOL, V50, P345, DOI 10.1111/1365-2664.12055; Samu F, 2002, J ARACHNOL, V30, P389, DOI 10.1636/0161-8202(2002)030[0389:OTNOAS]2.0.CO;2; Schmidt MH, 2008, J BIOGEOGR, V35, P157, DOI 10.1111/j.1365-2699.2007.01774.x; Schmidt MH, 2005, J APPL ECOL, V42, P281, DOI 10.1111/j.1365-2664.2005.01014.x; Schmidt MH, 2005, J BIOGEOGR, V32, P467, DOI 10.1111/j.1365-2699.2004.01244.x; Settle WH, 1996, ECOLOGY, V77, P1975, DOI 10.2307/2265694; Sieving KE, 1996, AUK, V113, P944, DOI 10.2307/4088877; Sobek S, 2009, ECOL ENTOMOL, V34, P772, DOI 10.1111/j.1365-2311.2009.01132.x; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Tylianakis JM, 2004, ECOLOGY, V85, P658, DOI 10.1890/03-0222; Western AW, 2002, ANNU REV EARTH PL SC, V30, P149, DOI 10.1146/annurev.earth.30.091201.140434; Wharton R. A., 1997, MANUAL NEW WORLD GEN; Wyckhuys KAG, 2007, INT J PEST MANAGE, V53, P89, DOI 10.1080/09670870701245207; Zuckerberg B, 2012, J WILDLIFE MANAGE, V76, P1072, DOI 10.1002/jwmg.326	71	8	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0128950	10.1371/journal.pone.0128950	http://dx.doi.org/10.1371/journal.pone.0128950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197473	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600004
J	Wirshing, HH; Baker, AC				Wirshing, Herman H.; Baker, Andrew C.			Molecular and Morphological Species Boundaries in the Gorgonian Octocoral Genus Pterogorgia (Octocorallia: Gorgoniidae)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SECONDARY STRUCTURES; DNA-SEQUENCES; CNIDARIA; CORAL; MITOCHONDRIAL; ANTHOZOA; FAMILY; ALCYONACEA; EVOLUTION	Most gorgonian octocoral species are described using diagnostic characteristics of their sclerites (microscopic skeletal components). Species in the genus Pterogorgia, however, are separated primarily by differences in their calyx and branch morphology. Specimens of a morphologically unusual Pterogorgia collected from Saba Bank in the NE Caribbean Sea were found with calyx morphology similar to P. citrina and branch morphology similar to P. guadalupensis. In order to test morphological species boundaries, and the validity of calyx and branch morphology as systematic characters, a phylogenetic analysis was undertaken utilizing partial gene fragments of three mitochondrial (mtMutS, cytochrome b, and igr4; 726bp total) and two nuclear (ITS2, 166bp; and SRP54 intron, 143bp) loci. The datasets for nuclear and mitochondrial loci contained few phylogenetically informative sites, and tree topologies did not resolve any of the morphological species as monophyletic groups. Instead, the mitochondrial loci and SRP54 each recovered two clades but were slightly incongruent, with a few individuals of P. guadalupensis represented in both clades with SRP54. A concatenated dataset of these loci grouped all P. anceps and P. guadalupensis in a clade, and P. citrina and the Pterogorgia sp. from Saba Bank in a sister clade, but with minimal variation/resolution within each clade. However, in common with other octocoral taxa, the limited genetic variation may not have been able to resolve whether branch variation represents intraspecific variation or separate species. Therefore, these results suggest that there are at least two phylogenetic lineages of Pterogorgia at the species level, and the atypical Pterogorgia sp. may represent an unusual morphotype of P. citrina, possibly endemic to Saba Bank. Branch morphology does not appear to be a reliable morphological character to differentiate Pterogorgia species (e.g., branches "flat" or "3-4 edges" in P. guadalupensis and P. anceps, respectively), and a re-evaluation of species-level characters (e.g., sclerites) is needed.	[Wirshing, Herman H.; Baker, Andrew C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, Miami, FL 33149 USA	University of Miami	Wirshing, HH (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	wirshingh@si.edu		Baker, Andrew/0000-0002-7866-2587; Wirshing, Herman H./0000-0003-4926-4237	U.S. National Science Foundation [OCE-0527184]; Rowlands Graduate Fellowship, University of Miami; Knight Graduate Fellowship, University of Miami	U.S. National Science Foundation(National Science Foundation (NSF)); Rowlands Graduate Fellowship, University of Miami; Knight Graduate Fellowship, University of Miami	This work was supported by the U.S. National Science Foundation OCE-0527184 to ACB and Rowlands and Knight Graduate Fellowships, University of Miami to HHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, MOL PHYLOGENET EVOL, V43, P774, DOI 10.1016/j.ympev.2006.11.005; [Anonymous], 1961, SHALLOW WATER OCTOCO; BAYER F M, 1981, Proceedings of the Biological Society of Washington, V94, P902; Bayer F.M., 1956, TREATISE INVERTEBR F, P167; BAYER FREDERICK M., 1951, JOUR WASHINGTON ACAD SCI, V41, P91; Bilewitch JP, 2014, MOL PHYLOGENET EVOL, V73, P106, DOI 10.1016/j.ympev.2014.01.023; Bilewitch JP, 2010, P BIOL SOC WASH, V123, P93, DOI 10.2988/09-22.1; Cairns S., 1977, GUIDE COMMONER SHALL; Concepcion GT, 2008, CORAL REEFS, V27, P323, DOI 10.1007/s00338-007-0323-x; Concepcion GT, 2010, MAR ECOL PROG SER, V401, P113, DOI 10.3354/meps08364; Drummond AJ, 2008, GENEIOUS V4 8 5; Duenas LF, 2014, MOL PHYLOGENET EVOL, V74, P15, DOI 10.1016/j.ympev.2014.01.031; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etnoyer PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010668; Frade PR, 2010, MOL PHYLOGENET EVOL, V57, P1072, DOI 10.1016/j.ympev.2010.09.010; France SC, 2002, HYDROBIOLOGIA, V471, P149, DOI 10.1023/A:1016517724749; France SC, 2007, B MAR SCI, V81, P323; France Scott C., 2001, Bulletin of the Biological Society of Washington, P110; Franzosa EA, 2007, TREEROT VERSION 3; GOLDBERG WM, 1973, B MAR SCI, V23, P465; Grajales A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-90; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez-Rodriguez C, 2009, MOL PHYLOGENET EVOL, V50, P1, DOI 10.1016/j.ympev.2008.09.019; Hoeksema BW, 2011, MAR ECOL-EVOL PERSP, V32, P135, DOI 10.1111/j.1439-0485.2011.00434.x; Hoetjes PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010769; Jaap WC, 1984, US FISH WILDL SER, VFWS/OBS-82/08; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Kim E, 2004, HYDROBIOLOGIA, V530, P423, DOI 10.1007/s10750-004-2646-8; LASKER HR, 1983, MAR ECOL PROG SER, V13, P21, DOI 10.3354/meps013021; LEWIS JC, 1991, BIOL BULL, V181, P275, DOI 10.2307/1542099; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; McFadden CS, 2013, ZOOKEYS, P59, DOI 10.3897/zookeys.346.6270; McFadden CS, 2012, INVERTEBR SYST, V26, P331, DOI 10.1071/IS12035; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; McFadden CS, 2010, INTEGR COMP BIOL, V50, P389, DOI 10.1093/icb/icq056; McFadden CS, 2004, MOL ECOL, V13, P1495, DOI 10.1111/j.1365-294X.2004.02167.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; Quattrini AM, 2014, DEEP-SEA RES PT II, V99, P92, DOI 10.1016/j.dsr2.2013.05.027; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez JA, 2003, MOL PHYLOGENET EVOL, V29, P31, DOI 10.1016/S1055-7903(03)00090-3; Sanchez JA, 2003, MAR BIOL, V142, P975, DOI 10.1007/s00227-003-1018-7; Sanchez JA, 1997, B MAR SCI, V61, P453; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; van der Ham JL, 2009, MAR GENOM, V2, P183, DOI 10.1016/j.margen.2009.10.002; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2004, MOL ECOL, V13, P2763, DOI 10.1111/j.1365-294X.2004.02265.x; Wareham VE, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P289; Wirshing HH, 2005, MAR BIOL, V147, P497, DOI 10.1007/s00227-005-1592-y; [No title captured]	57	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133517	10.1371/journal.pone.0133517	http://dx.doi.org/10.1371/journal.pone.0133517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196389	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600107
J	Hung, GY; Horng, JL; Yen, HJ; Lee, CY; Lee, YS				Hung, Giun-Yi; Horng, Jiun-Lin; Yen, Hsiu-Ju; Lee, Chih-Ying; Lee, Yu-Sheng			Geographic Variation in Cancer Incidence among Children and Adolescents in Taiwan (1995-2009)	PLOS ONE			English	Article							TRAFFIC AIR-POLLUTION; CHILDHOOD LEUKEMIA; EXPOSURE; ASSOCIATION; TRENDS; RISK	Background Evidence from our recent study suggested that the overall trend for cancer incidence in children and adolescents has been increasing in Taiwan. Methods To analyze geographic variations in this trend, cancer frequencies and incidence rates of disease groups were quantified according to geographic areas among 12,633 patients aged <20 years during 1995-2009 by using the population-based Taiwan Cancer Registry. Three geographic levels were defined, namely county or city, region (Northern, Central, Southern, and Eastern Taiwan), and local administrative area (special municipality, provincial city, county-administered city, township, and aboriginal area). Results Of the regions, Northern Taiwan had the highest incidence rate at 139.6 per million person-years, followed by Central (132.8), Southern (131.8), and Eastern (128.4) Taiwan. Significantly higher standardized rate ratios (SRRs) were observed in Northern Taiwan (SRR = 1.06, 95% confidence interval [CI] = 1.02-1.10) and at the township level (SRR = 1.07, 95% CI = 1.03-1.11). Of the cities or counties, New Taipei City yielded the highest SRR (1.08), followed by Taipei City (SRR = 1.07). A comparison of the rates in the four regions and the remainder of Taiwan according to cancer type revealed that only the rate of neuroblastomas in Eastern Taiwan was significantly low. Trend analysis showed that the most significant increase in incidence rate was observed at the township level, with an annual percent change of 1.8% during the 15-year study period. Conclusions The high rate of childhood cancer in Northern Taiwan and at the township level deserves further attention. The potential impacts of environmental factors on the upward trend of childhood cancer incidence rate in townships warrant further investigation.	[Hung, Giun-Yi; Yen, Hsiu-Ju; Lee, Chih-Ying] Taipei Vet Gen Hosp, Div Pediat Hematol & Oncol, Taipei, Taiwan; [Hung, Giun-Yi; Yen, Hsiu-Ju; Lee, Chih-Ying; Lee, Yu-Sheng] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Hung, Giun-Yi; Yen, Hsiu-Ju; Lee, Chih-Ying; Lee, Yu-Sheng] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Hung, Giun-Yi] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Horng, Jiun-Lin] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Lee, Yu-Sheng] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan Normal University; Taipei Medical University; National Yang Ming Chiao Tung University	Hung, GY (corresponding author), Taipei Vet Gen Hosp, Div Pediat Hematol & Oncol, Taipei, Taiwan.	gyhung@vghtpe.gov.tw			Ministry of Science and Technology, Taiwan (MOST) [103-2311-B-038-002]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	This study was supported by the grants designated to Jiun-Lin Horng, PhD from the Ministry of Science and Technology, Taiwan (MOST 103-2311-B-038-002, http://www.most.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander FE, 1997, BRIT J CANCER, V75, P457, DOI 10.1038/bjc.1997.77; [Anonymous], 1995, TAIW CANC REG ANN RE; [Anonymous], TAIW GEOGR NAM INF S; [Anonymous], 1999, CANC INCIDENCE SURVI; [Anonymous], NUMB FOR SPOUS COUNT; [Anonymous], POP DENS TOT AR COUN; Boyle P, 1991, CANC REGISTRATION PR, V95; Buka I, 2007, PEDIATR CLIN N AM, V54, P177, DOI 10.1016/j.pcl.2006.11.010; Chen CL, 2010, ENVIRON RES, V110, P455, DOI 10.1016/j.envres.2009.08.010; Chen CL, 2010, CANCER EPIDEM BIOMAR, V19, P101, DOI 10.1158/1055-9965.EPI-09-0333; Chen CL, 2004, JAMA-J AM MED ASSOC, V292, P2984, DOI 10.1001/jama.292.24.2984; Chen YM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-247; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiang CJ, 2015, JPN J CLIN ONCOL, V45, P291, DOI 10.1093/jjco/hyu211; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Curado MP, 2007, CANC INCIDENCE 5 CON, VIx, p[160, 961]; Engel A, 2008, J ENVIRON HEALTH, V71, P12; Francis SS, 2012, CHEM-BIOL INTERACT, V196, P102, DOI 10.1016/j.cbi.2011.02.019; Hung GY, 2014, CANCER-AM CANCER SOC, V120, P3545, DOI 10.1002/cncr.28903; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KINLEN LJ, 1990, LANCET, V336, P577, DOI 10.1016/0140-6736(90)93389-7; Li CY, 2012, SCI TOTAL ENVIRON, V435, P472, DOI 10.1016/j.scitotenv.2012.06.078; Li CY, 1998, INT J EPIDEMIOL, V27, P587, DOI 10.1093/ije/27.4.587; Linet MS, 2003, PEDIATRICS, V112, P218; Monthly Bulletin of Interior Statistics, MONTHL B INT STAT; National Cancer Institute, 2013, JOINP REGR PROGR VER; Steinmaus C, 2004, ENVIRON HEALTH PERSP, V112, P766, DOI 10.1289/ehp.6592; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stiller CA, 2004, ONCOGENE, V23, P6429, DOI 10.1038/sj.onc.1207717; Tseng CH, 2005, J ENVIRON SCI HEAL C, V23, P55, DOI 10.1081/GNC-200051860; Wang HK, 2010, J HAZARD MATER, V179, P1115, DOI 10.1016/j.jhazmat.2010.03.122; Weng HH, 2008, INHAL TOXICOL, V20, P31, DOI [10.1080/08958370701758734, 10.1080/08958370701758734 ]; Weng HH, 2008, J TOXICOL ENV HEAL A, V71, P434, DOI 10.1080/15287390701839042; Weng HH, 2009, J TOXICOL ENV HEAL A, V72, P83, DOI 10.1080/15287390802477338	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133051	10.1371/journal.pone.0133051	http://dx.doi.org/10.1371/journal.pone.0133051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192415	gold, Green Submitted, Green Published			2022-12-27	WOS:000358546400049
J	Komic, D; Marusic, SL; Marusic, A				Komic, Dubravka; Marusic, Stjepan Ljudevit; Marusic, Ana			Research Integrity and Research Ethics in Professional Codes of Ethics: Survey of Terminology Used by Professional Organizations across Research Disciplines	PLOS ONE			English	Article							CORPORATE CODES; BUSINESS CODES; KNOWLEDGE	Professional codes of ethics are social contracts among members of a professional group, which aim to instigate, encourage and nurture ethical behaviour and prevent professional misconduct, including research and publication. Despite the existence of codes of ethics, research misconduct remains a serious problem. A survey of codes of ethics from 795 professional organizations from the Illinois Institute of Technology's Codes of Ethics Collection showed that 182 of them (23%) used research integrity and research ethics terminology in their codes, with differences across disciplines: while the terminology was common in professional organizations in social sciences (82%), mental health (71%), sciences (61%), other organizations had no statements (construction trades, fraternal social organizations, real estate) or a few of them (management, media, engineering). A subsample of 158 professional organizations we judged to be directly involved in research significantly more often had statements on research integrity/ethics terminology than the whole sample: an average of 10.4% of organizations with a statement (95% CI = 10.4-23-5%) on any of the 27 research integrity/ethics terms compared to 3.3% (95% CI = 2.1-4.6%), respectively (P<0.001). Overall, 62% of all statements addressing research integrity/ethics concepts used prescriptive language in describing the standard of practice. Professional organizations should define research integrity and research ethics issues in their ethics codes and collaborate within and across disciplines to adequately address responsible conduct of research and meet contemporary needs of their communities.	[Komic, Dubravka] Univ Split, Sch Med, Split, Croatia; [Marusic, Stjepan Ljudevit] Rogor, Zagreb, Croatia; [Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia	University of Split; University of Split	Marusic, A (corresponding author), Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia.	ana.marusic@mefst.hr	Marusic, Ana/E-7683-2013	Marusic, Ana/0000-0001-6272-0917				Antiel RM, 2011, ARCH INTERN MED, V171, P469, DOI 10.1001/archinternmed.2011.47; Bateman Connie R, 2012, WORK QUALITY LIFE ET, P21; Bazdaric K, 2012, SCI ENG ETHICS, V18, P223, DOI 10.1007/s11948-011-9347-2; Bosnjak L, 2012, SCIENTOMETRICS, V93, P751, DOI 10.1007/s11192-012-0773-y; Bullock M, 2003, SCI ENG ETHICS, V9, P159, DOI 10.1007/s11948-003-0003-3; Center for the Study of Ethics in the Professions, 2014, COD ETH COLL; Cogan ML, 1953, HARVARD EDUC REV, V23, P33; Erwin PM, 2011, J BUS ETHICS, V99, P535, DOI 10.1007/s10551-010-0667-y; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Farrell H, 1998, J BUS ETHICS, V17, P587; Joseph A, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001315, DOI 10.1371/JOURNAL.PMED.1001315]; Kaptein M, 2008, J BUS ETHICS, V77, P111, DOI 10.1007/s10551-006-9305-0; Komic D, 2013, 3 WORLD C RES INT MO; Marusic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023477; Olson A., 1998, AUTHORING CODE ETHIC; Rose M., 1998, SCI EDITING INFORM M, P15; Sama LM, 2008, J BUS ETHICS, V78, P39, DOI 10.1007/s10551-006-9309-9; Schwartz MS, 2004, J BUS ETHICS, V55, P323; Steneck NH, 2006, SCI ENG ETHICS, V12, P53, DOI 10.1007/PL00022268; Wynia MK, 2014, JAMA-J AM MED ASSOC, V311, P799, DOI 10.1001/jama.2014.504	20	19	20	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133662	10.1371/journal.pone.0133662	http://dx.doi.org/10.1371/journal.pone.0133662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192805	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400111
J	Liu, Y; Hui, M; Cui, ZX; Luo, DL; Song, CW; Li, YD; Liu, L				Liu, Yuan; Hui, Min; Cui, Zhaoxia; Luo, Danli; Song, Chengwen; Li, Yingdong; Liu, Lei			Comparative Transcriptome Analysis Reveals Sex-Biased Gene Expression in Juvenile Chinese Mitten Crab Eriocheir sinensis	PLOS ONE			English	Article							ANALYSIS PROVIDES INSIGHTS; GLAND HORMONE GENE; CALLINECTES-SAPIDUS; GENDER-DIFFERENCES; VITELLOGENIN GENE; MOLECULAR-BASIS; BLUE-CRAB; FOX GENES; MUD CRAB; RNA	Sex-biased genes are considered to account for most of phenotypic differences between males and females. In order to explore the sex-biased gene expression in crab, we performed the whole-body transcriptome analysis in male and female juveniles of the Chinese mitten crab Eriocheir sinensis using next-generation sequencing technology. Of the 23,349 annotated unigenes, 148 were identified as sex-related genes. A total of 29 candidate genes involved in primary sex determination pathways were detected, indicating the sex determination cascade of the mitten crab might be more complex than previously supposed. Differential expression analysis showed 448 differentially expressed genes (DEGs) between the two transcriptomes. Most of DEGs were involved in processes such as metabolism and immunity, and not associated with obvious sexual function. The pathway predominantly enriched for DEGs were related to lysosome, which might reflect the differences in metabolism between males and females. Of the immune DGEs, 18 up-regulated genes in females were humoral immune factors, and eight up-regulated genes in males were pattern recognition receptors, suggesting sex differences of immune defense might exist in the mitten crab. In addition, two reproduction-related genes, vitellogenin and insulin-like androgenic gland factor, were identified to express in both sexes but with significantly higher level in males. Our research provides the first whole-body RNA sequencing of sex-specific transcriptomes for juvenile E. sinensis and will facilitate further studies on molecular mechanisms of crab sexual dimorphism.	[Liu, Yuan; Hui, Min; Cui, Zhaoxia; Luo, Danli; Song, Chengwen; Li, Yingdong; Liu, Lei] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Cui, Zhaoxia] Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China; [Luo, Danli; Song, Chengwen] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, ZX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	zhxcui@qdio.ac.cn		Li, Yingdong/0000-0002-9570-3715	Chinese National "863" Project [2012AA10A409]; National Natural Science Foundation of China [41276165, 41206147]	Chinese National "863" Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese National "863" Project (No. 2012AA10A409, http://www.most.gov.cn/eng/) and National Natural Science Foundation of China (41276165 and 41206147, http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2004, GENE, V334, P35, DOI 10.1016/j.gene.2004.02.036; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Chen DW, 2007, FOOD CHEM, V103, P1343, DOI 10.1016/j.foodchem.2006.10.047; Chung JS, 2011, GEN COMP ENDOCR, V173, P4, DOI 10.1016/j.ygcen.2011.04.017; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connallon T, 2005, TRENDS GENET, V21, P495, DOI 10.1016/j.tig.2005.07.006; Cooper G. M., 2000, CELL MOL APPROACH, DOI DOI 10.1007/978-1-4615-6484-3_4; Cui Z, 2015, HEREDITY, V115, P206, DOI 10.1038/hdy.2015.26; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; El-Sankary W, 2002, DRUG METAB DISPOS, V30, P1029, DOI 10.1124/dmd.30.9.1029; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Farlora R, 2014, MAR GENOM, V15, P85, DOI 10.1016/j.margen.2014.02.005; FLOURIOT G, 1995, J MOL ENDOCRINOL, V15, P143, DOI 10.1677/jme.0.0150143; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guidugli KR, 2005, ARCH INSECT BIOCHEM, V59, P211, DOI 10.1002/arch.20061; Hale MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-404; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hartnoll R.G., 1982, P111; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Huang XS, 2014, GEN COMP ENDOCR, V204, P229, DOI 10.1016/j.ygcen.2014.06.002; Hui M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114187; INOUE K, 1992, P NATL ACAD SCI USA, V89, P8092, DOI 10.1073/pnas.89.17.8092; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kocer A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-36; Kurtz J, 2001, J INVERTEBR PATHOL, V78, P53, DOI 10.1006/jipa.2001.5040; Kurtz J, 2000, DEV COMP IMMUNOL, V24, P1, DOI 10.1016/S0145-305X(99)00057-9; Lee HH, 2003, J CRUSTACEAN BIOL, V23, P691, DOI 10.1651/C-2358; LEE TH, 1994, INVERTEBR REPROD DEV, V25, P123, DOI 10.1080/07924259.1994.9672377; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li S, 2012, SEX DEV, V6, P267, DOI 10.1159/000341377; Li SH, 2012, GEN COMP ENDOCR, V177, P246, DOI 10.1016/j.ygcen.2012.04.010; Li YD, 2015, COMP BIOCHEM PHYS D, V13, P1, DOI 10.1016/j.cbd.2014.10.002; Lindsey E, 2009, EVOL ECOL, V23, P607, DOI 10.1007/s10682-008-9258-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Mank JE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-148; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mokhtari M, 2008, ESTUAR COAST SHELF S, V76, P273, DOI 10.1016/j.ecss.2007.07.010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niimi T, 2006, GENOME, V49, P263, DOI 10.1139/G05-108; PALMER BD, 1995, ENVIRON HEALTH PERSP, V103, P19, DOI 10.2307/3432407; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Perry JC, 2014, MOL BIOL EVOL, V31, P1206, DOI 10.1093/molbev/msu072; Piulachs MD, 2003, INSECT BIOCHEM MOLEC, V33, P459, DOI 10.1016/S0965-1748(03)00021-3; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Radhika M, 1998, HYDROBIOLOGIA, V377, P161, DOI 10.1023/A:1003244318887; Raikhel A.S., 2005, P433; Rolff J, 2001, CAN J ZOOL, V79, P2176, DOI 10.1139/cjz-79-12-2176; Rudnick DA, 2003, BASIC APPL ECOL, V4, P249, DOI 10.1078/1439-1791-00152; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; Shen HS, 2014, DEV GENES EVOL, V224, P97, DOI 10.1007/s00427-014-0467-y; Shimeld SM, 2010, DEV BIOL, V340, P234, DOI 10.1016/j.ydbio.2010.01.015; Small CM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-579; Song CW, 2015, GENE, V558, P88, DOI 10.1016/j.gene.2014.12.048; Suzuki MG, 2010, J GENET, V89, P357, DOI 10.1007/s12041-010-0047-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsutsui N, 2000, ZOOL SCI, V17, P651, DOI 10.2108/zsj.15.651; Valenzuela-Munoz V, 2014, AQUAC RES, V45, P1026, DOI 10.1111/are.12044; Veilleux E, 2007, CANADIAN MANUSCRIPT, V2812; Wang Q, 2012, J INSECT PHYSIOL, V58, P960, DOI 10.1016/j.jinsphys.2012.04.012; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhao M, 2011, INSECT SCI, V18, P607, DOI 10.1111/j.1744-7917.2010.01392.x; Zhou LY, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-36; Zmora N, 2007, BIOL REPROD, V77, P138, DOI 10.1095/biolreprod.106.055483	81	40	40	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133068	10.1371/journal.pone.0133068	http://dx.doi.org/10.1371/journal.pone.0133068			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193085	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400053
J	Gariepy, G; Thombs, BD; Kestens, Y; Kaufman, JS; Blair, A; Schmitz, N				Gariepy, Genevieve; Thombs, Brett D.; Kestens, Yan; Kaufman, Jay S.; Blair, Alexandra; Schmitz, Norbert			The Neighbourhood Built Environment and Trajectories of Depression Symptom Episodes in Adults: A Latent Class Growth Analysis	PLOS ONE			English	Article							MENTAL-HEALTH; DISORDERS; DURATION; BENEFITS; RISK	Aim To investigate the effect of the neighbourhood built environment on trajectories of depression symptom episodes in adults from the general Canadian population. Research Design and Methods We used 10 years of data collection (2000/01-2010/11) from the Canadian National Population Health Study (n = 7114). Episodes of depression symptoms were identified using the Composite International Diagnostic Interview Short-Form. We assessed the presence of local parks, healthy food stores, fast food restaurants, health services and cultural services using geospatial data. We used latent class growth modelling to identify different trajectories of depression symptom episodes in the sample and tested for the effect of neighbourhood variables on the trajectories over time. Results We uncovered three distinct trajectories of depression symptom episodes: low prevalence (76.2% of the sample), moderate prevalence (19.2%) and high prevalence of depression symptom episodes (2.8%). The presence of any neighbourhood service (healthy food store, fast-food restaurant, health service, except for cultural service) was significantly associated with a lower probability of a depression symptom episode for those following a trajectory of low prevalence of depression symptom episodes. The presence of a local park was also a significant protective factor in trajectory groups with both low and moderate prevalence of depression symptom episodes. Neighbourhood characteristics did not significantly affect the trajectory of high prevalence of depression symptom episodes. Conclusions For individuals following a trajectory of low and moderate prevalence of depression symptom episodes, the neighbourhood built environment was associated with a shift in the trajectory of depression symptom episodes. Future intervention studies are recommended to make policy recommendations.	[Gariepy, Genevieve] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Thombs, Brett D.; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Kestens, Yan; Blair, Alexandra] Univ Montreal, Dept Social & Preventat Med, Montreal, PQ, Canada; [Kaufman, Jay S.; Schmitz, Norbert] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal; McGill University	Gariepy, G (corresponding author), McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada.	genevieve.gariepy@mail.mcgill.ca	Schmitz, Norbert/A-5177-2010; Kestens, Yan/D-1631-2012; Schmitz, Norbert/AAH-3624-2020	Schmitz, Norbert/0000-0001-7777-6323; Kestens, Yan/0000-0003-2619-5750; Kaufman, Jay/0000-0003-1606-401X	Canadian Institutes of Health Research [SEC-117118]; Canadian Institutes of Health; Fonds de Recherche en Sante du Quebec; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canada Research Chairs program(Canada Research Chairs)	This work was supported by Operating Grant SEC-117118 from the Canadian Institutes of Health Research. GG was supported by funding from the Canadian Institutes of Health. YK and AB were supported by the Fonds de Recherche en Sante du Quebec. JSK was funded by the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN 4; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; [Anonymous], DEPR; [Anonymous], 2014, CANADA POST; Berndt ER, 2000, AM J PSYCHIAT, V157, P940, DOI 10.1176/appi.ajp.157.6.940; Bow C Jennifer D, 2004, Int J Health Geogr, V3, P5, DOI 10.1186/1476-072X-3-5; Colman I, 2010, CAN J PSYCHIAT, V55, P622, DOI 10.1177/070674371005501002; DMTI Spatial Inc, 2010, DESKT MAPP TECHN INC; Evans GW, 2003, J URBAN HEALTH, V80, P536, DOI 10.1093/jurban/jtg063; Gariepy G, 2014, HEALTH PLACE, V30, P279, DOI 10.1016/j.healthplace.2014.10.009; Glymour MM, 2010, ANN EPIDEMIOL, V20, P856, DOI 10.1016/j.annepidem.2010.08.003; Holzel L, 2011, J AFFECT DISORDERS, V129, P1, DOI 10.1016/j.jad.2010.03.025; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kim J, 2009, J COMMUNITY PSYCHOL, V37, P725, DOI 10.1002/jcop.20327; Kubzansky LD, 2005, AM J EPIDEMIOL, V162, P253, DOI 10.1093/aje/kwi185; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Melchior M, 2013, MOL PSYCHIATR, V18, P112, DOI 10.1038/mp.2011.116; Nabi H, 2011, HYPERTENSION, V57, P710, DOI 10.1161/HYPERTENSIONAHA.110.164061; Paczkowski MM, 2010, CURR OPIN PSYCHIATR, V23, P337, DOI 10.1097/YCO.0b013e32833ad70b; Patten S B, 2000, Chronic Dis Can, V21, P68; Paykel ES, 2005, EUR NEUROPSYCHOPHARM, V15, P411, DOI 10.1016/j.euroneuro.2005.04.008; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Public Health Agency of Canada, 2013, WHAT IS DEPR; Renalds A, 2010, FAM COMMUNITY HEALTH, V33, P68, DOI 10.1097/FCH.0b013e3181c4e2e5; Sarkar C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-695; Sheline YI, 1999, J NEUROSCI, V19, P5034; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Statistics Canada, 2011, NAT POP HLTH SURV HO; Statistics Canada, LOW INC MEAS 2009; Stockdale SE, 2007, SOC SCI MED, V65, P1867, DOI 10.1016/j.socscimed.2007.05.045; van Ham M, 2012, ENVIRON PLANN A, V44, P2787, DOI 10.1068/a45439	33	17	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133603	10.1371/journal.pone.0133603	http://dx.doi.org/10.1371/journal.pone.0133603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207368	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000108
J	Tan, CH; Cai, SH; Huang, YQ				Tan, Chunhua; Cai, Shuhui; Huang, Yuqing			Spatially Localized Two-Dimensional J-Resolved NMR Spectroscopy via Intermolecular Double-Quantum Coherences for Biological Samples at 7 T	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; IN-VIVO; HIGH-RESOLUTION; INHOMOGENEOUS FIELDS; BRAIN-TUMORS; MRS; SPECTRA; METABOLITES; GRADIENT; HEALTHY	Background and Purpose Magnetic resonance spectroscopy (MRS) constitutes a mainstream technique for characterizing biological samples. Benefiting from the separation of chemical shifts and J couplings, spatially localized two-dimensional (2D) J-resolved spectroscopy (JPRESS) shows better identification of complex metabolite resonances than one-dimensional MRS does and facilitates the extraction of J coupling information. However, due to variations of macroscopic magnetic susceptibility in biological samples, conventional JPRESS spectra generally suffer from the influence of field inhomogeneity. In this paper, we investigated the implementation of the localized 2D J-resolved spectroscopy based on intermolecular double-quantum coherences (iDQCs) on a 7 T MRI scanner. Materials and Methods A gamma-aminobutyric acid (GABA) aqueous solution, an intact pig brain tissue, and a whole fish (Harpadon nehereus) were explored by using the localized iDQC J-resolved spectroscopy (iDQCJRES) method, and the results were compared to those obtained by using the conventional 2D JPRESS method. Results Inhomogeneous line broadening, caused by the variations of macroscopic magnetic susceptibility in the detected biological samples (the intact pig brain tissue and the whole fish), degrades the quality of 2D JPRESS spectra, particularly when a large voxel is selected and some strongly structured components are included (such as the fish spinal cord). By contrast, high-resolution 2D J-resolved information satisfactory for metabolite analyses can be obtained from localized 2D iDQCJRES spectra without voxel size limitation and field shimming. From the contrastive experiments, it is obvious that the spectral information observed in the localized iDQCJRES spectra acquired from large voxels without field shimming procedure (i.e. in inhomogeneous fields) is similar to that provided by the JPRESS spectra acquired from small voxels after field shimming procedure (i.e. in relatively homogeneous fields). Conclusion The localized iDQCJRES method holds advantage for recovering high-resolution 2D J-resolved information from inhomogeneous fields caused by external non-ideal field condition or internal macroscopic magnetic susceptibility variations in biological samples, and it is free of voxel size limitation and time-consuming field shimming procedure. This method presents a complementary way to the conventional JPRESS method for MRS measurements on MRI systems equipped with broad inner bores, and may provide a promising tool for in vivo MRS applications.	[Tan, Chunhua; Cai, Shuhui; Huang, Yuqing] Xiamen Univ, Dept Elect Sci, Fujian Prov Key Lab Plasma & Magnet Resonance, Xiamen, Peoples R China	Xiamen University	Huang, YQ (corresponding author), Xiamen Univ, Dept Elect Sci, Fujian Prov Key Lab Plasma & Magnet Resonance, Xiamen, Peoples R China.	yqhuangw@xmu.edu.cn	Cai, SH/G-3334-2010	Cai, SH/0000-0003-2767-9490	National Natural Science Foundation of China [11205129, 11275161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grants 11205129 (YH) and 11275161 (SC). The URL for the grants is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1997, J MAGN RESON, V128, P114, DOI 10.1006/jmre.1997.1226; Balla DZ, 2008, CONCEPT MAGN RESON A, V32A, P117, DOI 10.1002/cmr.a.20104; Balla DZ, 2006, MAGN RESON MED, V56, P745, DOI 10.1002/mrm.21007; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; BRUCH RC, 1982, J BIOL CHEM, V257, P3409; Cai HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086422; Chen Z, 2004, J AM CHEM SOC, V126, P446, DOI 10.1021/ja036491f; Cui XH, 2013, J MAGN RESON IMAGING, V37, P359, DOI 10.1002/jmri.23839; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Faber C, 2005, J MAGN RESON, V176, P120, DOI 10.1016/j.jmr.2005.05.014; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Gribbestad IS, 2005, AQUACULTURE, V250, P445, DOI 10.1016/j.aquaculture.2005.02.031; Hall EL, 2014, NEUROIMAGE, V86, P35, DOI 10.1016/j.neuroimage.2013.04.077; Hamaed H, 2008, J AM CHEM SOC, V130, P11056, DOI 10.1021/ja802486q; Herminghaus S, 2002, NMR BIOMED, V15, P385, DOI 10.1002/nbm.793; Huang RZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044665; Huang YQ, 2014, BIOPHYS J, V106, P2061, DOI 10.1016/j.bpj.2014.03.022; Kim DH, 2002, MAGNET RESON MED, V48, P715, DOI 10.1002/mrm.10267; Kurhanewicz J, 2002, J MAGN RESON IMAGING, V16, P451, DOI 10.1002/jmri.10172; Lee S, 1996, J CHEM PHYS, V105, P874, DOI 10.1063/1.471968; Lin YY, 2000, PHYS REV LETT, V85, P3732, DOI 10.1103/PhysRevLett.85.3732; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Ludwig C, 2010, PHYTOCHEM ANALYSIS, V21, P22, DOI 10.1002/pca.1186; Nath N, 2012, CHEMPHYSCHEM, V13, P645, DOI 10.1002/cphc.201100748; Nestor G, 2010, J AGR FOOD CHEM, V58, P10799, DOI 10.1021/jf103338j; Pola A, 2012, PROG NUCL MAG RES SP, V65, P66, DOI 10.1016/j.pnmrs.2012.02.002; Righi V, 2009, J PROTEOME RES, V8, P1859, DOI 10.1021/pr801094b; Sack M, 2014, NMR BIOMED, V27, P709, DOI 10.1002/nbm.3110; Shah T, 2011, J MAGN RESON IMAGING, V34, P1053, DOI 10.1002/jmri.22711; Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775; Solanky BS, 2013, NMR BIOMED, V26, P357, DOI 10.1002/nbm.2867; Springer F, 2010, INVEST RADIOL, V45, P484, DOI 10.1097/RLI.0b013e3181df2afb; Tal A, 2010, PROG NUCL MAG RES SP, V57, P241, DOI 10.1016/j.pnmrs.2010.04.001; Terpstra M, 1998, J MAGN RESON, V131, P139, DOI 10.1006/jmre.1997.1353; Thomas MA, 1996, JMRI-J MAGN RESON IM, V6, P453, DOI 10.1002/jmri.1880060307; Traber F, 2006, EUR RADIOL, V16, P1096, DOI 10.1007/s00330-005-0108-y; Tugnoli V, 2005, INT J MOL MED, V16, P301; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Vathyam S, 1996, SCIENCE, V272, P92, DOI 10.1126/science.272.5258.92; Wu EL, 2013, BIOPHYS J, V105, P1444, DOI 10.1016/j.bpj.2013.08.002; Zheng G, 2010, PROG NUCL MAG RES SP, V56, P267, DOI 10.1016/j.pnmrs.2010.01.001	41	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134109	10.1371/journal.pone.0134109	http://dx.doi.org/10.1371/journal.pone.0134109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207739	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000210
J	Chung, YE; You, JS; Lee, HJ; Lim, JS; Lee, HS; Baek, SE; Kim, MJ				Chung, Yong Eun; You, Je Sung; Lee, Hye-Jeong; Lim, Joon Seok; Lee, Hye Sun; Baek, Song-Ee; Kim, Myeong-Jin			Possible Contrast Media Reduction with Low keV Monoenergetic Images in the Detection of Focal Liver Lesions: A Dual-Energy CT Animal Study	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; INDUCED NEPHROPATHY; DYNAMIC CT; KVP CT; ROW CT; AGENT; ENHANCEMENT; ANGIOGRAPHY; PROTOCOL; QUALITY	Objective To investigate the feasibility of dual-energy CT for contrast media (CM) reduction in the diagnosis of hypervascular and hypovascular focal liver lesions (FLL). Subjects and Methods The Institutional Animal Care and Use Committee approved this study. VX2 tumors were implanted in two different segments of the liver in 13 rabbits. After 2 weeks, two phase contrast enhanced CT scans including the arterial phase (AP) and portal-venous phase (PVP) were performed three times with 24-hour intervals with three different concentrations of iodine, 300 (I-300), 150 (I-150) and 75 mg I/mL (I-75). The mean HU and standard deviation (SD) were measured in the liver, the hypervascular portion of the VX2 tumor which represented hypervascular tumors, and the central necrotic area of the VX2 tumor which represented hypovascular tumors in 140kVp images with I-300 as a reference standard and in monoenergetic images (between 40keV and 140keV) with I-150 and I-75. The contrast-to-noise ratio (CNR) for FLLs and the ratio of the CNRs (CNRratio) between monoenergetic image sets with I-150 and I-75, and the reference standard were calculated. Results For hypervascular lesions, the CNRratio was not statistically different from 1.0 between 40keV and 70keV images with I-150, whereas the CNRratio was significantly lower than 1.0 in all keV images with I-75. For hypovascular lesions, the CNRratio was similar to or higher than 1.0 between 40keV and 80keV with I-150 and between 40keV and 70keV with I-75. Conclusions With dual-energy CT, the total amount of CM might be halved in the diagnosis of hypervascular FLLs and reduced to one-fourth in the diagnosis of hypovascular FLLs, while still preserving CNRs.	[Chung, Yong Eun; Lee, Hye-Jeong; Lim, Joon Seok; Baek, Song-Ee; Kim, Myeong-Jin] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea; [You, Je Sung] Yonsei Univ, Coll Med, Dept Emergency Med, Severance Hosp, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Dept Res Affairs, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea.	yelv@yuhs.ac	Lim, Joon Seok/R-7753-2019; Lee, Hye Sun/J-2154-2015; Kim, Myeong-Jin/E-1623-2011	You, Je Sung/0000-0002-2074-6745; Chung, Yong Eun/0000-0003-0811-9578; Lee, Hye Sun/0000-0001-6328-6948; Lim, Joon seok/0000-0002-0334-5042; Lee, Hye-Jeong/0000-0003-4349-9174; Kim, Myeong-Jin/0000-0001-7949-5402	Yonsei University College of Medicine [6-2012-0039]; national research foundation of Korea - Ministry of Education [NRF-2014R1A1A2057091]	Yonsei University College of Medicine(General Electric); national research foundation of Korea - Ministry of Education	This work was supported by the faculty research grant of Yonsei University College of Medicine (6-2012-0039) and the national research foundation of Korea funded by the Ministry of Education (NRF-2014R1A1A2057091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACR Committee on Drugs, 2013, MAN CONTR MED VERS 9; Altenbernd J, 2011, EUR RADIOL, V21, P738, DOI 10.1007/s00330-010-1964-7; [Anonymous], 2009, CONTRAST MEDIA SAFET; Blake MA, 2011, RADIOGRAPHICS, V31, P1047, DOI 10.1148/rg.314105159; Chen CM, 2014, EUR RADIOL, V24, P460, DOI 10.1007/s00330-013-3027-3; Cho ES, 2015, EUR RADIOL, V25, P1421, DOI 10.1007/s00330-014-3540-z; Choi SH, 2010, INVEST RADIOL, V45, P427, DOI 10.1097/RLI.0b013e3181e07516; Dong J, 2013, J COMPUT ASSIST TOMO, V37, P618, DOI 10.1097/RCT.0b013e31828f5020; Dubourg B, 2014, EUR RADIOL, V24, P2659, DOI 10.1007/s00330-014-3263-1; European Society of Urogenital Radiology, 2012, ESUR GUID CONTR MED; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Kane GC, 2008, J AM COLL CARDIOL, V51, P89, DOI 10.1016/j.jacc.2007.09.019; Kim KW, 2011, AM J ROENTGENOL, V196, P102, DOI 10.2214/AJR.09.3971; Kim MJ, 2010, J COMPUT ASSIST TOMO, V34, P496, DOI 10.1097/RCT.0b013e3181d34532; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Machida H, 2014, JPN J RADIOL, V32, P217, DOI 10.1007/s11604-014-0288-y; Marenzi G, 2009, ANN INTERN MED, V150, P170, DOI 10.7326/0003-4819-150-3-200902030-00006; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; Nakaura T, 2011, RADIOLOGY, V261, P467, DOI 10.1148/radiol.11110021; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Robinson E, 2010, INVEST RADIOL, V45, P413, DOI 10.1097/RLI.0b013e3181dfda78; Schindera ST, 2008, RADIOLOGY, V246, P125, DOI 10.1148/radiol.2461070307; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Solomon RJ, 2009, CLIN J AM SOC NEPHRO, V4, P1162, DOI 10.2215/CJN.00550109; Takahashi H, 2014, EUR J RADIOL, V83, P684, DOI 10.1016/j.ejrad.2013.12.014; Wu HP, 2009, ACAD RADIOL, V16, P1483, DOI 10.1016/j.acra.2009.09.009; Yamada Y, 2012, INVEST RADIOL, V47, P292, DOI 10.1097/RLI.0b013e318240a874; Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592; Zhang D, 2011, MED PHYS, V38, P1178, DOI 10.1118/1.3551999	31	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133170	10.1371/journal.pone.0133170	http://dx.doi.org/10.1371/journal.pone.0133170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203652	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000021
J	Senolt, L; Sumova, B; Jandova, R; Hulejova, H; Mann, H; Pavelka, K; Vencovsky, J; Filkova, M				Senolt, Ladislav; Sumova, Barbora; Jandova, Romana; Hulejova, Hana; Mann, Herman; Pavelka, Karel; Vencovsky, Jiri; Filkova, Maria			Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis	PLOS ONE			English	Article							IL-35; CELLS	Objectives To study the association of systemic and local interleukin-35 (IL-35) levels in rheumatoid arthritis. Methods 37 patients with treatment naive early RA, 49 with established RA and 29 control patients with osteoarthritis (OA) were studied. Serum and paired synovial fluid samples were analysed for IL-35. Disease activity of RA patients was assessed according to the 28-Joint Count Disease Activity Score (DAS28). Results The levels of serum IL-35 were significantly higher in patients with treatment naive early RA compared to those with established disease and control OA subjects. In addition, serum levels of IL-35 significantly decreased 12 weeks after initiation of glucocorticoids and conventional synthetic disease modifying antirheumatic drugs in patients with treatment naive early RA. Synovial fluid IL-35 levels were significantly higher in RA compared to OA patients, were significantly elevated compared to serum counterparts and correlated with synovial fluid leukocyte count (r=0.412; p<0.01), serum CRP levels (r=0.362; p<0.05) and DAS28 (r=0.430, p<0.01). Conclusion This is the first study showing elevated circulating levels of IL-35 in treatment naive early RA, its significant decrease after treatment initiation and positive association between increased synovial fluid IL-35 and disease activity in patients with long-lasting RA.	[Senolt, Ladislav; Sumova, Barbora; Jandova, Romana; Hulejova, Hana; Mann, Herman; Pavelka, Karel; Vencovsky, Jiri; Filkova, Maria] Inst Rheumatol, Prague, Czech Republic; [Senolt, Ladislav; Sumova, Barbora; Mann, Herman; Pavelka, Karel; Vencovsky, Jiri] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic	Institute of Rheumatology; Charles University Prague	Senolt, L (corresponding author), Inst Rheumatol, Prague, Czech Republic.	senolt@revma.cz	Hulejová, Hana/H-1909-2019; Vencovsky, Jiri/G-6094-2017; Šenolt, Ladislav/O-6097-2017; Šumová, Barbora/E-8628-2017; Pavelka, Karel/E-6578-2017; Mann, Herman Felix/G-5871-2014; Filkova, Maria/M-9307-2017	Hulejová, Hana/0000-0002-2335-6996; Vencovsky, Jiri/0000-0002-0851-0713; Šenolt, Ladislav/0000-0001-5500-7312; Šumová, Barbora/0000-0003-1864-2629; Pavelka, Karel/0000-0003-1952-8422; Mann, Herman Felix/0000-0002-4243-235X; Filkova, Maria/0000-0002-8488-9227	Ministry of Health of the Czech Republic (MHCR) [IGA 12440-4]; Project of MHCR for conceptual development of a research organization [00023728, SVV 260 031]	Ministry of Health of the Czech Republic (MHCR); Project of MHCR for conceptual development of a research organization	Funded by Ministry of Health of the Czech Republic (MHCR) grant project IGA 12440-4, Project of MHCR for conceptual development of a research organization 00023728, Research Project SVV 260 031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Filkova M, 2015, CYTOKINE, V73, P36, DOI 10.1016/j.cyto.2015.01.019; Gu XB, 2015, TUMOR BIOL, V36, P2651, DOI 10.1007/s13277-014-2887-8; Jafarzadeh A, 2015, J MOL NEUROSCI, V55, P891, DOI 10.1007/s12031-014-0443-z; Jin P, 2014, HUM IMMUNOL, V75, P29, DOI 10.1016/j.humimm.2013.09.018; Kim WU, 2000, CLIN EXP IMMUNOL, V119, P175, DOI 10.1046/j.1365-2249.2000.01095.x; Kuo J, 2011, CLIN VACCINE IMMUNOL, V18, P1125, DOI 10.1128/CVI.00052-11; Li YM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/136329; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; Melis L, 2010, ANN RHEUM DIS, V69, P618, DOI 10.1136/ard.2009.107649; Ospelt C, 2008, BEST PRACT RES CL RH, V22, P239, DOI 10.1016/j.berh.2008.01.004; Ouyang H, 2014, AM J MED SCI, V348, P156, DOI 10.1097/MAJ.0000000000000215; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Senolt L, 2009, AUTOIMMUN REV, V9, P102, DOI 10.1016/j.autrev.2009.03.010; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Thiolat A, 2014, CYTOKINE, V69, P87, DOI 10.1016/j.cyto.2014.05.015; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wong CK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3067; Zeng JC, 2013, INT J CLIN EXP PATHO, V6, P1806	23	26	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132674	10.1371/journal.pone.0132674	http://dx.doi.org/10.1371/journal.pone.0132674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204444	Green Published, Green Submitted, gold			2022-12-27	WOS:000358621000011
J	Koo, KC; Hong, JH; Lee, HS; Jeh, SU; Choi, YD; Rha, KH; Ham, WS				Koo, Kyo Chul; Hong, Jung Hwa; Lee, Hye Sun; Jeh, Seong Uk; Choi, Young Deuk; Rha, Koon Ho; Ham, Won Sik			Accuracy of Urinary Neutrophil Gelatinase-Associated Lipocalin in Quantifying Acute Kidney Injury after Partial Nephrectomy in Patients with Normal Contralateral Kidney	PLOS ONE			English	Article							LAPAROSCOPIC PARTIAL NEPHRECTOMY; BIOMARKERS; ISCHEMIA; NGAL; CREATININE; SURGERY; MARKERS	Background To evaluate the efficacy of urinary neutrophil gelatinase-associated lipocalin (uNGAL) for predicting the degree of acute kidney injury (AKI) in patients following partial nephrectomy (PN). Methods This prospective study included 176 patients who underwent open or laparoscopic PN for solid renal tumors between June 2013 and May 2014. Urine samples were collected preoperatively and at 3, 24, and 48 h after renal pedicle clamp removal. Changes in uNGAL levels were analyzed for all patients and between subgroups that were dichotomized based on preoperative eGFR values of <60 and >= 60 mL/min/1.73m(2), open and laparoscopic surgery, and according to the onset of AKI. Linear mixed models were used to investigate preoperative and perioperative features associated with postoperative uNGAL and eGFR changes at 6 months postoperatively. Results Among 146 patients included in the final analysis, 10 (6.8%) patients had preoperative eGFR <60 mL/min/1.73m(2). In the overall group, uNGAL levels increased following PN. However, all subgroups demonstrated comparable changes in uNGAL levels over time. Multivariate analyses failed to reveal any correctable clinical features associated with postoperative uNGAL changes, whereas preoperative serum creatinine levels and the onset of AKI correlated with eGFR at 6 months postoperatively. Conclusions uNGAL levels may increase following PN. However, it does not appear to be a useful marker for quantifying the degree of AKI or predicting postoperative renal function in patients with normal contralateral kidney and relatively good preoperative renal function. Further analysis is necessary to assess the usefulness of uNGAL in patients with poor preoperative renal function.	[Koo, Kyo Chul; Jeh, Seong Uk; Choi, Young Deuk; Rha, Koon Ho; Ham, Won Sik] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul 120749, South Korea; [Hong, Jung Hwa; Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ham, WS (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul 120749, South Korea.	uroham@yuhs.ac	Lee, Hye Sun/J-2154-2015	Lee, Hye Sun/0000-0001-6328-6948; Ham, Won Sik/0000-0003-2246-8838; Koo, Kyo Chul/0000-0001-7303-6256; Rha, Koon Ho/0000-0001-8588-7584; Choi, Young Deuk/0000-0002-8545-5797	Yonsei University College of Medicine [6-2013-0029]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine for 6-2013-0029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi Z, 2013, J UROLOGY, V189, P1559, DOI 10.1016/j.juro.2012.10.029; Clerico A, 2012, CLIN CHEM LAB MED, V50, P1505, DOI 10.1515/cclm-2011-0814; Cruz DN, 2010, INTENS CARE MED, V36, P444, DOI 10.1007/s00134-009-1711-1; de Geus HRH, 2011, AM J RESP CRIT CARE, V183, P907, DOI 10.1164/rccm.200908-1214OC; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Fahmy N, 2013, J ENDOUROL, V27, P1455, DOI 10.1089/end.2013.0188; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Jeon HG, 2012, YONSEI MED J, V53, P151, DOI 10.3349/ymj.2012.53.1.151; Jeong W, 2009, J ENDOUROL, V23, P1457, DOI 10.1089/end.2009.0302; Lane BR, 2013, UROL ONCOL-SEMIN ORI, V31, P682, DOI 10.1016/j.urolonc.2011.05.007; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mir MC, 2014, J UROLOGY, V192, P665, DOI 10.1016/j.juro.2014.03.036; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; Parekh DJ, 2013, J AM SOC NEPHROL, V24, P506, DOI 10.1681/ASN.2012080786; Shikanov S, 2010, J UROLOGY, V183, P1714, DOI 10.1016/j.juro.2010.01.007; Simmons MN, 2012, J UROLOGY, V187, P1667, DOI 10.1016/j.juro.2011.12.068; Sprenkle PC, 2013, J UROLOGY, V190, P159, DOI 10.1016/j.juro.2013.01.101; Thomas AA, 2011, UROLOGY, V77, P5, DOI 10.1016/j.urology.2010.05.004; Tuladhar SM, 2009, J CARDIOVASC PHARM, V53, P261, DOI 10.1097/FJC.0b013e31819d6139; Volpe A, 2015, EUR UROL, DOI [10.1016/j.eururo.2015.01.025, DOI 10.1016/J.EURUR0.2015.01.025]; Weight CJ, 2011, UROLOGY, V77, P1142, DOI 10.1016/j.urology.2010.11.058; Weight CJ, 2010, J UROLOGY, V183, P1317, DOI 10.1016/j.juro.2009.12.030; Woodson BW, 2013, J ENDOUROL, V27, P1510, DOI 10.1089/end.2013.0198	24	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133675	10.1371/journal.pone.0133675	http://dx.doi.org/10.1371/journal.pone.0133675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200468	Green Submitted, Green Published, gold			2022-12-27	WOS:000358597100075
J	Denicol, AC; Leao, BCS; Dobbs, KB; Mingoti, GZ; Hansen, PJ				Denicol, Anna C.; Leao, Beatriz C. S.; Dobbs, Kyle B.; Mingoti, Gisele Z.; Hansen, Peter J.			Influence of Sex on Basal and Dickkopf-1 Regulated Gene Expression in the Bovine Morula	PLOS ONE			English	Article							MOUSE PREIMPLANTATION DEVELOPMENT; COLONY-STIMULATING FACTOR-2; EMBRYONIC GENOME ACTIVATION; MESSENGER-RNA EXPRESSION; INNER CELL-MASS; IN-VITRO; STEM-CELLS; HEAT-SHOCK; MOLECULAR-MECHANISMS; CULTURE-CONDITIONS	Sex affects function of the developing mammalian embryo as early as the preimplantation period. There were two goals of the current objective. The first was to determine the degree and nature of differences in gene expression between female and male embryos in the cow at the morula stage of development. The second objective was to determine whether DKK1, a molecule known to alter differentiation of the blastocyst, would affect gene expression differently for female and male morulae. In Experiment 1, female and male embryos were treated with DKK1 at Day 5 after insemination. Morulae were harvested 24 h after treatment, pooled in groups of 20 for microarray analysis and RNA subjected to analysis of gene expression by microarray hybridization. There were 662 differentially expressed genes between females and males and 128 of these genes had a fold change >= 1.5 between the two sexes. Of the genes upregulated in females, 49.5% were located in the X chromosome. Functional analysis predicted that cell survival was greater in female embryos. Experiment 2 involved a similar design except that transcripts for 12 genes previously reported to be affected by sex, DKK1 or the interaction were quantified by quantitative polymerase chain reaction. Expression of all genes tested that were affected by sex in experiment 1 was affected in a similar manner in Experiment 2. In contrast, effects of DKK1 on gene expression were largely not repeatable in Experiment 2. The exception was for the Hippo signaling gene AMOT, which was inhibited by DKK1. In Experiment 3, embryos produced by fertilization with unsorted sperm were treated with DKK1 at Day 5 and abundance of transcripts for CDX2, GATA6, and NANOG determined at Days 5, 6 and 7 after insemination. There was no effect of DKK1 on expression of any of the three genes. In conclusion, female and male bovine embryos have a different pattern of gene expression as early as the morula stage, and this is due to a large extent to expression of genes in the X chromosomes in females. Differential gene expression between female and male embryos is likely the basis for increased resistance to cell death signals in female embryos and disparity in responses of female and male embryos to changes in the maternal environment.	[Denicol, Anna C.; Dobbs, Kyle B.; Hansen, Peter J.] Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA; [Denicol, Anna C.; Dobbs, Kyle B.; Hansen, Peter J.] Univ Florida, Genet Inst, Gainesville, FL USA; [Leao, Beatriz C. S.; Mingoti, Gisele Z.] UNESP, Sch Vet Med, Reprod Physiol Lab, Aracatuba, SP, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade Estadual Paulista	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA.	pjhansen@ufl.edu	Hansen, Peter/AAI-4693-2021; Leao, Beatriz/GRJ-5642-2022; Mingoti, Gisele Zoccal/D-6902-2012; Caetano da Silva Leao, Beatriz/N-9242-2016	Hansen, Peter/0000-0003-3061-9333; Mingoti, Gisele Zoccal/0000-0002-3059-4458; Caetano da Silva Leao, Beatriz/0000-0003-2737-5614	National Institutes of Health and Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [R03 HD080855, 2011-67015-30688]; CAPES/PDSE (Coordination for the Improvement of Higher Level Personnel, Brazil) scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD080855] Funding Source: NIH RePORTER	National Institutes of Health and Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; CAPES/PDSE (Coordination for the Improvement of Higher Level Personnel, Brazil) scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research was supported by Grant R03 HD080855 from the National Institutes of Health and Agriculture and Food Research Initiative Competitive Grant no. 2011-67015-30688 from the USDA National Institute of Food and Agriculture. BCSL was supported by a CAPES/PDSE (Coordination for the Improvement of Higher Level Personnel, Brazil) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Naib A, 2011, J REPROD IMMUNOL, V91, P31, DOI 10.1016/j.jri.2011.05.005; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2011, REPRODUCTION, V141, P801, DOI 10.1530/REP-11-0006; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bermejo-Alvarez P, 2012, STEM CELLS DEV, V21, P1215, DOI 10.1089/scd.2011.0685; Block J, 2003, J ANIM SCI, V81, P1590; Bonilla AQS, 2011, GROWTH HORM IGF RES, V21, P107, DOI 10.1016/j.ghir.2011.03.003; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Carvajal-Rodriguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024700; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; De La Fuente R, 1999, BIOL REPROD, V60, P769, DOI 10.1095/biolreprod60.3.769; Denicol AC, 2014, FASEB J, V28, P3975, DOI 10.1096/fj.14-253112; Dobbs KB, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121087; Dobbs KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066230; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Galve-Roperh I, 2013, PROG LIPID RES, V52, P633, DOI 10.1016/j.plipres.2013.05.004; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Gebert C, 2009, GENOMICS, V94, P63, DOI 10.1016/j.ygeno.2009.03.004; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Guo WJ, 2013, EXP CELL RES, V319, P2801, DOI 10.1016/j.yexcr.2013.09.006; Gutierrez-Adan A, 2000, MOL REPROD DEV, V55, P146, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;146::AID-MRD3&gt;3.0.CO;2-F; GutierrezAdan A, 1996, THERIOGENOLOGY, V46, P515, DOI 10.1016/0093-691X(96)00173-2; Hendricks KEM, 2009, J REPROD DEVELOP, V55, P69, DOI 10.1262/jrd.20097; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Ideta A, 2010, ANIM REPROD SCI, V117, P18, DOI 10.1016/j.anireprosci.2009.04.004; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; Kimura K, 2005, MOL REPROD DEV, V72, P201, DOI 10.1002/mrd.20342; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Laguna-Barraza R, 2013, REPROD FERT DEVELOP, V25, P38, DOI 10.1071/RD12262; Larson MA, 2001, P NATL ACAD SCI USA, V98, P9677, DOI 10.1073/pnas.171305398; LARSON RC, 1992, MOL REPROD DEV, V33, P432, DOI 10.1002/mrd.1080330409; Lim KT, 2013, THERIOGENOLOGY, V79, P284, DOI 10.1016/j.theriogenology.2012.08.018; Liu WS, 2009, CYTOGENET GENOME RES, V126, P318, DOI 10.1159/000266168; Loureiro B, 2007, REPRODUCTION, V133, P1129, DOI 10.1530/REP-06-0307; Loureiro B, 2011, REPRODUCTION, V141, P617, DOI 10.1530/REP-10-0511; Loureiro B, 2009, ENDOCRINOLOGY, V150, P5046, DOI 10.1210/en.2009-0481; Lowe R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1506-4; Maekawa M, 2007, DEVELOPMENT, V134, P2751, DOI 10.1242/dev.003756; Meazza R, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/861920; Morris Samantha A, 2012, Results Probl Cell Differ, V55, P203, DOI 10.1007/978-3-642-30406-4_11; Morton KM, 2007, MOL REPROD DEV, V74, P931, DOI 10.1002/mrd.20573; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Nones J, 2010, CELL BIOL INT, V34, P399, DOI 10.1042/CBI20090036; Oh HA, 2013, MOL HUM REPROD, V19, P93, DOI 10.1093/molehr/gas049; Oliveira CS, 2013, REPRODUCTION, V145, P9, DOI 10.1530/REP-11-0343; Ozawa M, 2012, THERIOGENOLOGY, V78, P1243, DOI 10.1016/j.theriogenology.2012.05.020; Ozawa M, 2011, FERTIL STERIL, V95, P799, DOI 10.1016/j.fertnstert.2010.10.006; Peippo JP, 2002, MOL HUM REPROD, V8, P923, DOI 10.1093/molehr/8.10.923; Perez-Crespo M, 2005, MOL REPROD DEV, V72, P502, DOI 10.1002/mrd.20366; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosner A, 2007, CURR MED CHEM, V14, P2517, DOI 10.2174/092986707782023677; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sturmey RG, 2010, MOL REPROD DEV, V77, P285, DOI 10.1002/mrd.21145; TIFFIN GJ, 1991, J REPROD FERTIL, V93, P125; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Watkins AJ, 2010, BRIT J NUTR, V103, P1762, DOI 10.1017/S0007114509993783; YANG BK, 1993, THERIOGENOLOGY, V40, P521, DOI 10.1016/0093-691X(93)90405-T	68	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133587	10.1371/journal.pone.0133587	http://dx.doi.org/10.1371/journal.pone.0133587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196299	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600116
J	Motsa, SS; Makukula, ZG; Shateyi, S				Motsa, S. S.; Makukula, Z. G.; Shateyi, S.			Numerical Investigation of the Effect of Unsteadiness on Three-Dimensional Flow of an Oldroyb-B Fluid	PLOS ONE			English	Article							HELICAL FLOWS	A spectral relaxation method used with bivariate Lagrange interpolation is used to find numerical solutions for the unsteady three-dimensional flow problem of an Oldroyd-B fluid with variable thermal conductivity and heat generation. The problem is governed by a set of three highly coupled nonlinear partial differential equations. The method, originally used for solutions of systems of ordinary differential equations is extended to solutions of systems of nonlinear partial differential equations. The modified approach involves seeking solutions that are expressed as bivariate Lagrange interpolating polynomials and applying pseudospectral collocation in both independent variables of the governing PDEs. Numerical simulations were carried out to generate results for some of the important flow properties such as the local skin friction and the heat transfer rate. Numerical analysis of the error and convergence properties of the method are also discussed. One of the benefits of the proposed method is that it is computationally fast and gives very accurate results after only a few iterations using very few grid points in the numerical discretization process.	[Motsa, S. S.; Makukula, Z. G.] Univ KwaZulu Natal, ZA-3209 Pietermaritzburg, South Africa; [Shateyi, S.] Univ Venda, Dept Math & Appl Math, ZA-0950 Thohoyandou, South Africa	University of Kwazulu Natal; University of Venda	Motsa, SS (corresponding author), Univ KwaZulu Natal, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.	sandilemotsa@gmail.com	Shateyi, Stanford/G-3172-2016					Ariel PD, 2003, Z ANGEW MATH MECH, V83, P844, DOI 10.1002/zamm.200310052; CANUTO C, 1988, SPECTRAL METHODS IN; Fetecau C, 2008, APPL MATH COMPUT, V205, P497, DOI 10.1016/j.amc.2008.08.017; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P489, DOI 10.1007/s10483-013-1685-9; Hayat T, 2011, ARAB J SCI ENG, V36, P1113, DOI 10.1007/s13369-011-0066-4; Hayat T, 2004, INT J ENG SCI, V42, P65, DOI 10.1016/S0020-7225(03)00277-5; Hayat T, 2014, J HYDROL HYDROMECH, V62, P117, DOI 10.2478/johh-2014-0016; Khan WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105107; Liu YQ, 2011, COMPUT MATH APPL, V61, P443, DOI 10.1016/j.camwa.2010.11.021; Motsa SS, 2014, SCI WORLD J; Nadeem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069811; Pires M., 2011, PARABOLIC PROBLEMS P, V80, P21; Qi HT, 2009, NONLINEAR ANAL-REAL, V10, P2700, DOI 10.1016/j.nonrwa.2008.07.008; Rubbab Q, 2009, J PRIME RES MATH, V5, P139; Sajid M, 2014, J EGYPTIAN IN PRESS; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078240; Takhar HS, 2001, ACTA MECH, V146, P59, DOI 10.1007/BF01178795; Tong DK, 2009, J NON-NEWTON FLUID, V156, P75, DOI 10.1016/j.jnnfm.2008.07.004; Trefethen L. N., 2000, NUMERICAL LINEAR ALG	19	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133507	10.1371/journal.pone.0133507	http://dx.doi.org/10.1371/journal.pone.0133507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196291	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600106
J	Zhang, F; Liu, M; Huang, H				Zhang, Fan; Liu, Ming; Huang, He			Investigation of Timing to Switch Control Mode in Powered Knee Prostheses during Task Transitions	PLOS ONE			English	Article							MECHANICAL WORK; VOLITIONAL CONTROL; RECOGNITION; MOMENTUM; AMPUTEE; DESIGN; FALLS; COST	Current powered prosthetic legs require switching control modes according to the task the user is performing (e.g. level-ground walking, stair climbing, walking on slopes, etc.). To allow prosthesis users safely and seamlessly transition between tasks, it is critical to determine when to switch the prosthesis control mode during task transitions. Our previous study defined critical timings for different types of task transitions in ambulation; however, it is unknown whether it is the unique timing that allows safe and seamless transitions. The goals of this study were to (1) systematically investigate the effects of mode switch timing on the prosthesis user's performance in task transitions, and (2) identify appropriate timing to switch the prosthesis control mode so that the users can seamlessly transition between different locomotion tasks. Five able-bodied (AB) and two transfemoral (TF) amputee subjects were tested as they wore a powered knee prosthesis. The prosthesis control mode was switched manually at various times while the subjects performed different types of task transitions. The subjects' task transition performances were evaluated by their walking balance and success in performing seamless task transitions. The results demonstrated that there existed a time window within which switching the prosthesis control mode neither interrupted the subjects' task transitions nor disturbed their walking balance. Therefore, the results suggested the control mode switching of a lower limb prosthesis can be triggered within an appropriate time window instead of a specific timing or an individual phase. In addition, a generalized criterion to determine the appropriate mode switch timing was proposed. The outcomes of this study could provide important guidance for future designs of neurally controlled powered knee prostheses that are safe and reliable to use.	[Zhang, Fan] N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; Univ N Carolina, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina	Zhang, F (corresponding author), N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.	fzhang9@ncsu.edu		Huang, He/0000-0001-5581-1423	National Science Foundation (NSF) [1406750, 1361549]; National Institute on Disability and Rehabilitation Research (NIDRR) [H133G130308]; Direct For Computer & Info Scie & Enginr [1406750] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute on Disability and Rehabilitation Research (NIDRR); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by National Science Foundation (NSF) #1406750, to HH; National Science Foundation (NSF) #1361549, to HH; National Institute on Disability and Rehabilitation Research (NIDRR) # H133G130308, to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Detrembleur C, 2003, GAIT POSTURE, V18, P47, DOI 10.1016/S0966-6362(02)00193-5; Donelan JM, 2002, J EXP BIOL, V205, P3717; Du L, 2012, IEEE T BIO-MED ENG, V59, P2716, DOI 10.1109/TBME.2012.2208641; Ha KH, 2011, IEEE T BIO-MED ENG, V58, P144, DOI 10.1109/TBME.2010.2070840; HANAVAN E P Jr, 1964, AMRL TR, P1; Hargrove LJ, 2013, NEW ENGL J MED, V369, P1237, DOI 10.1056/NEJMoa1300126; Hargrove LJ, 2011, JAMA-J AM MED ASSOC, V305, P1542, DOI 10.1001/jama.2011.465; Herr H, 2008, J EXP BIOL, V211, P467, DOI 10.1242/jeb.008573; Huang H, 2011, IEEE T BIO-MED ENG, V58, P2867, DOI 10.1109/TBME.2011.2161671; Huang H, 2009, IEEE T BIO-MED ENG, V56, P65, DOI 10.1109/TBME.2008.2003293; Industry IOBO, 1998, MAN 3C 100 OTT BOCK; iWalk, BIOM ANKL SYST; Kaya BK, 1998, J GERONTOL A-BIOL, V53, pM126, DOI 10.1093/gerona/53A.2.M126; Liu M, 2016, IEEE T NEUR SYS REH, V24, P434, DOI 10.1109/TNSRE.2015.2420539; Liu M, 2014, J INTELL ROBOT SYST, V76, P461, DOI 10.1007/s10846-013-9979-3; Seroussi RE, 1996, ARCH PHYS MED REHAB, V77, P1209, DOI 10.1016/S0003-9993(96)90151-3; SHELDON JH, 1960, BRIT MED J, V2, P1685, DOI 10.1136/bmj.2.5214.1685; Sup F., 2009, THESIS VANDERBILT U; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Varol HA, 2010, IEEE T BIO-MED ENG, V57, P542, DOI 10.1109/TBME.2009.2034734; WILD D, 1981, RHEUMATOL REHABIL, V20, P153, DOI 10.1093/rheumatology/20.3.153; Zhang F, 2014, JOVE-J VIS EXP, DOI 10.3791/51059; Zhang F, 2015, IEEE T NEUR SYS REH, V23, P64, DOI 10.1109/TNSRE.2014.2327230; Zhang F, 2013, IEEE J BIOMED HEALTH, V17, P907, DOI 10.1109/JBHI.2012.2236563	25	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133965	10.1371/journal.pone.0133965	http://dx.doi.org/10.1371/journal.pone.0133965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197084	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600151
J	Wang, JL; Wang, GD; Khan, MF				Wang, Jianling; Wang, Gangduo; Khan, M. Firoze			Disorder of G2-M Checkpoint Control in Aniline-Induced Cell Proliferation in Rat Spleen	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; CANCER; ACTIVATION; SPLENOTOXICITY; HYDROCHLORIDE; INDUCTION; MICRORNAS; TOXICITY; SARCOMAS	Aniline, a toxic aromatic amine, is known to cause hemopoietic toxicity both in humans and animals. Aniline exposure also leads to toxic response in spleen which is characterized by splenomegaly, hyperplasia, fibrosis and the eventual formation of tumors on chronic in vivo exposure. Previously, we have shown that aniline exposure leads to iron overload, oxidative DNA damage, and increased cell proliferation, which could eventually contribute to a tumorigenic response in the spleen. Despite our demonstration that cell proliferation was associated with deregulation of G1 phase cyclins and increased expression of G1 phase cyclin-dependent kinases (CDKs), molecular mechanisms, especially the regulation of G2 phase and contribution of epigenetic mechanisms in aniline-induced splenic cellular proliferation remain largely unclear. This study therefore, mainly focused on the regulation of G2 phase in an animal model preceding a tumorigenic response. Male Sprague-Dawley rats were given aniline ( 0.5 mmol/kg/day) in drinking water or drinking water only ( controls) for 30 days, and expression of G2 phase cyclins, CDK1, CDK inhibitors and miRNAs were measured in the spleen. Aniline treatment resulted in significant increases in cell cycle regulatory proteins, including cyclins A, B and CDK1, particularly phosphor-CDK1, and decreases in CDK inhibitors p21 and p27, which could promote the splenocytes to go through G2/M transition. Our data also showed upregulation of tumor markers Trx-1 and Ref-1 in rats treated with aniline. More importantly, we observed lower expression of miRNAs including Let-7a, miR-15b, miR24, miR-100 and miR-125, and greater expression of CDK inhibitor regulatory miRNAs such as miR-181a, miR-221 and miR-222 in the spleens of aniline-treated animals. Our findings suggest that significant increases in the expression of cyclins, CDK1 and aberrant regulation of miRNAs could lead to an accelerated G2/M transition of the splenocytes, and potentially to a tumorigenic response on chronic aniline exposure.	[Wang, Jianling; Wang, Gangduo; Khan, M. Firoze] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Khan, MF (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	mfkhan@utmb.edu			National Institute of Environmental Health Sciences (NIEHS), NIH [ES06476]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES006476, R01ES006476] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant ES06476 from the National Institute of Environmental Health Sciences (NIEHS), NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]; BUS JS, 1987, FOOD CHEM TOXICOL, V25, P619, DOI 10.1016/0278-6915(87)90024-X; Chiu J, 2012, TRENDS CELL BIOL, V22, P592, DOI 10.1016/j.tcb.2012.08.002; Chulu Julius L C, 2009, Recent Pat Biotechnol, V3, P1; Di Girolamo F, 2009, ECOTOX ENVIRON SAFE, V72, P1601, DOI 10.1016/j.ecoenv.2008.09.006; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Emmendoerffer A, 2000, TOXICOL LETT, V112, P185, DOI 10.1016/S0378-4274(99)00285-4; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GOODMAN DG, 1984, JNCI-J NATL CANCER I, V73, P265; Henkler Frank, 2010, Cancers (Basel), V2, P376, DOI 10.3390/cancers2020376; Hillman GG, 2011, FREE RADICAL BIO MED, V51, P289, DOI 10.1016/j.freeradbiomed.2011.04.039; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kakehashi Anna, 2013, Cancers (Basel), V5, P1332, DOI 10.3390/cancers5041332; Khan MF, 2006, TOXICOL APPL PHARM, V210, P86, DOI 10.1016/j.taap.2005.08.006; Khan MF, 1999, TOXICOL SCI, V48, P134, DOI 10.1093/toxsci/48.1.134; Khan MF, 2003, J TOXICOL ENV HEAL A, V66, P93, DOI 10.1080/15287390390155778; Khan MF, 1999, J TOXICOL ENV HEAL A, V57, P173, DOI 10.1080/009841099157746; KHAN MF, 1993, ARCH ENVIRON CON TOX, V24, P368, DOI 10.1007/BF01128736; Khan MF, 1997, FUND APPL TOXICOL, V35, P22, DOI 10.1006/faat.1996.2259; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Ma HX, 2013, TOXICOL APPL PHARM, V267, P276, DOI 10.1016/j.taap.2013.01.005; Ma HX, 2011, TOXICOL APPL PHARM, V251, P1, DOI 10.1016/j.taap.2010.12.001; Ma HX, 2008, TOXICOL APPL PHARM, V233, P247, DOI 10.1016/j.taap.2008.08.010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Poirier MC, 2012, DISCOV MED, V14, P283; Powis G, 2007, CURR OPIN PHARMACOL, V7, P392, DOI 10.1016/j.coph.2007.04.003; Saeidnia S, 2013, TOXICOL APPL PHARM, V273, P442, DOI 10.1016/j.taap.2013.09.031; Sankpal UT, 2012, TUMOR BIOL, V33, P1265, DOI 10.1007/s13277-012-0413-4; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Wang JL, 2008, TOXICOL APPL PHARM, V230, P227, DOI 10.1016/j.taap.2008.02.022; Wang JL, 2011, TOXICOL APPL PHARM, V250, P213, DOI 10.1016/j.taap.2010.10.026; Wang JL, 2010, FREE RADICAL BIO MED, V48, P513, DOI 10.1016/j.freeradbiomed.2009.11.027; Wang JL, 2005, TOXICOL APPL PHARM, V203, P36, DOI 10.1016/j.taap.2004.07.012; WEINBERGER MA, 1985, JNCI-J NATL CANCER I, V75, P681; Williams GM, 2002, TOXICOL PATHOL, V30, P41, DOI 10.1080/01926230252824699; Wolgemuth DJ, 2013, INT J DEV BIOL, V57, P159, DOI 10.1387/ijdb.130047av	41	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131457	10.1371/journal.pone.0131457	http://dx.doi.org/10.1371/journal.pone.0131457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192324	Green Submitted, gold, Green Published			2022-12-27	WOS:000358546400012
J	Bizzarro, T; Martini, M; Marrocco, C; D'Amato, D; Traini, E; Lombardi, CP; Pontecorvi, A; Fadda, G; Larocca, LM; Rossi, ED				Bizzarro, Tommaso; Martini, Maurizio; Marrocco, Carla; D'Amato, Donato; Traini, Emanuela; Lombardi, Celestino Pio; Pontecorvi, Alfredo; Fadda, Guido; Larocca, Luigi Maria; Rossi, Esther Diana			The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology	PLOS ONE			English	Article							FOLLICULAR-PATTERNED LESIONS; UNDETERMINED SIGNIFICANCE; HISTOLOGICAL CONTROL; DOWN-REGULATION; CYTOKERATIN 19; CARCINOMA; EXPRESSION; DIAGNOSIS; NODULES; BIOPSIES	Background Fine needle aspiration Cytology (FNAC) fulfills a reliable role in the evaluation of thyroid lesions. Although the majority of nodules are quite easily diagnosed as benign or malignant, 30% of them represent an indeterminate category whereby the application of ancillary techniques (i.e. immunocytochemistry-ICC and molecular testing) has been encouraged. The search for a specific immunomarker of malignancy sheds light on a huge number of ICC stains although none of them attempt to yield 100% conclusive results. Our aim was to define in a pilot study on thyroid FNAC whether CD56 might be a valid marker also in comparison with HBME-1 and Galectin-3. Materials and Methods Inasmuch as this is the largest pilot study using only liquid based cytology (LBC), we selected all the cases only in the categories of benign nodules (BN) and positive for malignancy (PM) for validation purposes. Eighty-five consecutive (including 50 PM and 35 BN) out of 950 thyroid FNACs had surgical follow-up. The ICC panel (HBME-1, Galectin-3 and CD56) was carried out on LBC and histology. Results All BNs and PMs were histological confirmed. CD56 was negative in 96% of the PM while 68.5% of the BNs showed cytoplasmic positivity for this marker, with an overall high sensitivity (96%) but lower specificity (69%). In specific, our 96% of the PMs did not show any follicular cell with CD56 expression. Different ICC combinations were evaluated showing that the panel made up of CD56 plus HBME-1 and Galectin-3 had the highest sensitivity (98%) and specificity (86%). Conclusions Our pilot study suggests that CD56 may be a good marker for ruling out PTC and its variants. The low specificity suggests that an immunopanel including also HBME-1 and Galectin- 3 could obtain the highest diagnostic accuracy in thyroid lesions. Our results suggest that CD56 may be a feasible additional marker for identifying malignancies also in the FNs and SMs.	[Bizzarro, Tommaso; Martini, Maurizio; Marrocco, Carla; D'Amato, Donato; Fadda, Guido; Larocca, Luigi Maria; Rossi, Esther Diana] Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Div Anat Pathol & Histol, Rome, Italy; [Traini, Emanuela; Lombardi, Celestino Pio] Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Div Endocrine Surg, Rome, Italy; [Pontecorvi, Alfredo] Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Div Endocrinol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Rossi, ED (corresponding author), Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Div Anat Pathol & Histol, Rome, Italy.	esther.rossi@rm.unicatt.it	FADDA, Guido/AAR-3196-2021; Larocca, Luigi Maria/M-9590-2019; Martini, Maurizio/AAB-1564-2019; Rossi, esther/R-8601-2017; Fadda, Guido/AAY-5511-2020; Larocca, Luigi M/A-1577-2008; fadda, guido/AAQ-5754-2021	Larocca, Luigi Maria/0000-0003-1739-4758; Martini, Maurizio/0000-0002-6260-6310; Larocca, Luigi M/0000-0003-1739-4758; fadda, guido/0000-0001-9736-0544; Traini, Emanuela/0000-0002-6387-6558; Rossi, Esther/0000-0003-3819-4229				Abd El Atti RM, 2012, J EGYPT NATL CANCER, V24, P175, DOI 10.1016/j.jnci.2012.10.002; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; American Joint Commission on Cancer (AJCC), 2013, AM JOINT COMM CANC A; Baloch ZW, 2002, AM J CLIN PATHOL, V117, P143; Baloch ZW, 2002, DIAGN CYTOPATHOL, V26, P41, DOI 10.1002/dc.10043; Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; British Thyroid Association Guidelines for the Management of Thyroid Cancer, 2007, FIN NEEDL ASP, P10; Cibas ES, 2001, AM J CLIN PATHOL, V32, P658; Cochand-Priollet B, 2003, CYTOPATHOLOGY, V14, P343, DOI 10.1046/j.0956-5507.2003.00098.x; Cochand-Priollet B, 2011, THYROID, V21, P1067, DOI 10.1089/thy.2011.0014; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Rodrigues HGC, 2012, ENDOCR J, V59, P417; D Rossi E, 2006, HISTOPATHOLOGY, V48, P795, DOI 10.1111/j.1365-2559.2006.02428.x; Dabbs DJ, 1997, DIAGN CYTOPATHOL, V17, P388, DOI 10.1002/(SICI)1097-0339(199711)17:5<388::AID-DC14>3.0.CO;2-J; El Demellawy D, 2009, PATHOL RES PRACT, V205, P303, DOI 10.1016/j.prp.2008.11.011; Fada G, 2010, PATHOLOGICA, V102, P405; Fadda G, 2011, ACTA CYTOL, V55, P389, DOI 10.1159/000329029; Fadda G, 2011, EUR J ENDOCRINOL, V165, P447, DOI 10.1530/EJE-11-0181; Faquin WC, 2010, DIAGN CYTOPATHOL, V38, P731, DOI 10.1002/dc.21292; Herrmann ME, 2002, ARCH PATHOL LAB MED, V126, P710; Kim JH, 2012, HUM PATHOL, V43, P1221, DOI 10.1016/j.humpath.2011.09.008; Lobo C, 2011, ACTA CYTOL, V55, P499, DOI 10.1159/000333234; Mokhtari M, 2013, J RES MED SCI, V18, P1046; Nardi F, 2014, J ENDOCRINOL INVEST, V37, DOI 10.1007/s40618-014-0062-0; Nasr MR, 2006, MODERN PATHOL, V19, P1631, DOI 10.1038/modpathol.3800705; Nechifor-Boila A, 2013, PATHOL RES PRACT, V209, P585, DOI 10.1016/j.prp.2013.06.012; Nikiforov YE, 2009, J CLIN ENDOCR METAB, V94, P2092, DOI 10.1210/jc.2009-0247; Ohori NP, 2010, CANCER CYTOPATHOL, V118, P17, DOI 10.1002/cncy.20063; Ozolins A, 2012, MEDICINA-LITHUANIA, V48, P507; Park WY, 2009, BASIC APPL PATHOLOGY, V2, P63; Pazaitou-Panayiotou K, 2010, J ONCOL, V2010, DOI 10.1155/2010/963926; Poller DN, 2000, CANCER CYTOPATHOL, V90, P239, DOI 10.1002/1097-0142(20000825)90:4<239::AID-CNCR7>3.0.CO;2-S; Pusztaszeri MP, 2014, CANCER CYTOPATHOL, V122, P666, DOI 10.1002/cncy.21441; Pusztaszeri MP, 2014, CANCER CYTOPATHOL, V122, P596, DOI 10.1002/cncy.21437; Ravetto C, 2000, CANCER CYTOPATHOL, V90, P357, DOI 10.1002/1097-0142(20001225)90:6<357::AID-CNCR6>3.0.CO;2-4; Rossi ED, 2005, CANCER CYTOPATHOL, V105, P87, DOI 10.1002/cncr.21026; Rossi ED, 2013, EUR J ENDOCRINOL, V168, P853, DOI 10.1530/EJE-13-0023; Scarpino S, 2007, J PATHOL, V212, P411, DOI 10.1002/path.2183; Schmitt AC, 2010, CANCER CYTOPATHOL, V118, P196, DOI 10.1002/cncy.20082; Walts AE, 2014, DIAGN CYTOPATHOL, V42, P18, DOI 10.1002/dc.23019; ZEROMSKI J, 1992, CLIN EXP IMMUNOL, V89, P474	41	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132939	10.1371/journal.pone.0132939	http://dx.doi.org/10.1371/journal.pone.0132939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186733	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700072
J	Castelli, A; Daidone, S; Jacobs, R; Kasteridis, P; Street, AD				Castelli, Adriana; Daidone, Silvio; Jacobs, Rowena; Kasteridis, Panagiotis; Street, Andrew David			The Determinants of Costs and Length of Stay for Hip Fracture Patients	PLOS ONE			English	Article							MORTALITY; RISK; OUTCOMES; MODELS; TRENDS; CARE	Background and Purpose An ageing population at greater risk of proximal femoral fracture places an additional clinical and financial burden on hospital and community medical services. We analyse the variation in i) length of stay (LoS) in hospital and ii) costs across the acute care pathway for hip fracture from emergency admission, to hospital stay and follow-up outpatient appointments. Patients and Methods We analyse patient-level data from England for 2009/10 for around 60,000 hip fracture cases in 152 hospitals using a random effects generalized linear multi-level model where the dependent variable is given by the patient's cost or length of stay (LoS). We control for socio-economic characteristics, type of fracture and intervention, co-morbidities, discharge destination of patients, and quality indicators. We also control for provider and social care characteristics. Results Older patients and those from more deprived areas have higher costs and LoS, as do those with specific co-morbidities or that develop pressure ulcers, and those transferred between hospitals or readmitted within 28 days. Costs are also higher for those having a computed tomography (CT) scan or cemented arthroscopy. Costs and LoS are lower for those admitted via a 24h emergency department, receiving surgery on the same day of admission, and discharged to their own homes. Interpretation Patient and treatment characteristics are more important as determinants of cost and LoS than provider or social care factors. A better understanding of the impact of these characteristics can support providers to develop treatment strategies and pathways to better manage this patient population.	[Castelli, Adriana; Jacobs, Rowena; Kasteridis, Panagiotis; Street, Andrew David] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Daidone, Silvio] UN, FAO, I-00153 Rome, Italy	University of York - UK; Food & Agriculture Organization of the United Nations (FAO)	Castelli, A (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	adriana.castelli@york.ac.uk	Daidone, Silvio/ABC-5526-2021; Daidone, Silvio/AAJ-4490-2021	Daidone, Silvio/0000-0002-1789-5635; 	Policy Research Programme in the English Department of Health from the Economics of Social and Health Care Research Unit (ESHCRU) [103/0001]	Policy Research Programme in the English Department of Health from the Economics of Social and Health Care Research Unit (ESHCRU)	The work was funded by the Policy Research Programme in the English Department of Health from the Economics of Social and Health Care Research Unit (ESHCRU) (Ref 103/0001). The funders have approved the manuscript for submission but had no role in the design or conduct of the study. The views expressed are those of the authors and not necessarily those of the funders.	Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Austin PC, 2002, HLTH SERV OUTCOME RE, V3, P107, DOI DOI 10.1023/A:1024260023851; Blough DK, 1999, J HEALTH ECON, V18, P153, DOI 10.1016/S0167-6296(98)00032-0; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Department of Health, 2008, NHS COST MAN 2009 10; Department of Health, 2009 10 2010 11 PCT; Draper B, 1998, INT J GERIATR PSYCH, V13, P1, DOI 10.1002/(SICI)1099-1166(199801)13:1<1::AID-GPS716>3.0.CO;2-V; Duan N, 1983, J BUS ECON STAT, V1, P115, DOI DOI 10.2307/1391852; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Frakt AB, 2011, MILBANK Q, V89, P90, DOI 10.1111/j.1468-0009.2011.00621.x; Garcia AE, 2012, J ORTHOP TRAUMA, V26, P620, DOI 10.1097/BOT.0b013e3182695416; Gehlbach SH, 2007, OSTEOPOROSIS INT, V18, P585, DOI 10.1007/s00198-006-0281-0; Holt G, 2009, INJURY, V40, P722, DOI 10.1016/j.injury.2008.11.004; Laudicella M, 2010, SOC SCI MED, V71, P1872, DOI 10.1016/j.socscimed.2010.06.049; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Marsh D, 2007, CARE PATIENTS FRAGIL; Moran JL, 2012, BMC MED RES METHODOL, V12, P1; National Clinical Guideline Centre, 2011, MAN HIP FRACT AD, P664; Nikkel LE, 2012, J BONE JOINT SURG AM, V94A, P9, DOI [10.2106/JBJS.J.01077, 10.2106/JBJS.K.01214]; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Richmond J, 2003, J ORTHOP TRAUMA, V17, P53, DOI 10.1097/00005131-200301000-00008; Rosen AB, 1999, AM HEART J, V138, P69, DOI 10.1016/S0002-8703(99)70249-8; Titler M, 2007, NURS OUTLOOK, V55, P5, DOI 10.1016/j.outlook.2006.06.006; White SM, 2011, INJURY, V42, P1230, DOI 10.1016/j.injury.2010.11.010	27	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133545	10.1371/journal.pone.0133545	http://dx.doi.org/10.1371/journal.pone.0133545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NJ	26204450	Green Submitted, Green Published, gold			2022-12-27	WOS:000358621000032
J	Kim, J; Chung, M; Kim, S; Jo, DH; Kim, JH; Jeon, NL				Kim, Jaerim; Chung, Minhwan; Kim, Sudong; Jo, Dong Hyun; Kim, Jeong Hun; Jeon, Noo Li			Engineering of a Biomimetic Pericyte-Covered 3D Microvascular Network	PLOS ONE			English	Article							IN-VITRO; TUMOR VASCULATURE; VESSEL MATURATION; ENDOTHELIAL-CELLS; ANGIOGENESIS; MICROVESSELS; IL-1	Pericytes enveloping the endothelium play an important role in the physiology and pathology of microvessels, especially in vessel maturation and stabilization. However, our understanding of fundamental pericyte biology is limited by the lack of a robust in vitro model system that allows researchers to evaluate the interactions among multiple cell types in perfusable blood vessels. The present work describes a microfluidic platform that can be used to investigate interactions between pericytes and endothelial cells (ECs) during the sprouting, growth, and maturation steps of neovessel formation. A mixture of ECs and pericytes was attached to the side of a pre-patterned three dimensional fibrin matrix and allowed to sprout across the matrix. The effects of intact coverage and EC maturation by the pericytes on the perfused EC network were confirmed using a confocal microscope. Compared with EC monoculture conditions, EC-pericyte co-cultured vessels showed a significant reduction in diameter, increased numbers of junctions and branches and decreased permeability. In response to biochemical factors, ECs and pericytes in the platform showed the similar features with previous reports from in vivo experiments, thus reflect various pathophysiological conditions of in vivo microvessels. Taken together, these results support the physiological relevancy of our three-dimensional microfluidic culture system but also that the system can be used to screen drug effect on EC-pericyte biology.	[Kim, Jaerim; Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Div WCU Multiscale Mech Design, Seoul, South Korea; [Chung, Minhwan; Kim, Sudong; Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul, South Korea; [Jo, Dong Hyun; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 110744, South Korea; [Jo, Dong Hyun; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Jo, Dong Hyun; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Jeon, Noo Li] Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jeon, NL (corresponding author), Seoul Natl Univ, Sch Mech & Aerosp Engn, Div WCU Multiscale Mech Design, Seoul, South Korea.	steph25@snu.ac.kr; njeon@snu.ac.kr	chung, minhwan/AAH-5541-2019; Jo, Dong Hyun/D-5962-2012	chung, minhwan/0000-0001-6720-7514; Jo, Dong Hyun/0000-0002-6320-6829; Kim, Jeong Hun/0000-0003-2957-1766	National Research Foundation - Ministry of Education [NRF-2015R1A2A1A09005662]; Seoul National University Hospital Research Fund [03-2014-0260]; Seoul National University Research Grant [800-20140542]; Seoul National University (SNU)	National Research Foundation - Ministry of Education; Seoul National University Hospital Research Fund; Seoul National University Research Grant; Seoul National University (SNU)	This work was supported by the National Research Foundation funded by the Ministry of Education (NRF-2015R1A2A1A09005662), Seoul National University Hospital Research Fund (03-2014-0260), Seoul National University Research Grant (800-20140542) and Research Grant for Foreign Professors through Seoul National University (SNU) in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005; Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007; Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891; Chang WG, 2013, CARDIOVASC RES, V100, P492, DOI 10.1093/cvr/cvt215; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jeon JS, 2014, INTEGR BIOL-UK, V6, P555, DOI 10.1039/c3ib40267c; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Lee H, 2014, MRS BULL, V39, P51, DOI 10.1557/mrs.2013.286; Lee H, 2014, MICROVASC RES, V91, P90, DOI 10.1016/j.mvr.2013.12.001; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Tarallo S, 2012, ACTA DIABETOL, V49, pS141, DOI 10.1007/s00592-012-0390-5; Tigges U, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-33; van der Meer AD, 2013, LAB CHIP, V13, P3562, DOI 10.1039/c3lc50435b; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Wang SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045499; Waters JP, 2013, J VASC RES, V50, P324, DOI 10.1159/000353303; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	40	73	76	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133880	10.1371/journal.pone.0133880	http://dx.doi.org/10.1371/journal.pone.0133880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204526	Green Published, gold, Green Submitted			2022-12-27	WOS:000358621000041
J	Xing, MY; Yan, FF; Yu, SF; Shen, P				Xing, Meiyuan; Yan, Feifei; Yu, Sufen; Shen, Peng			Efficacy and Cardiotoxicity of Liposomal Doxorubicin-Based Chemotherapy in Advanced Breast Cancer: A Meta-Analysis of Ten Randomized Controlled Trials	PLOS ONE			English	Article							PHASE-III TRIAL; 1ST-LINE TREATMENT; CONVENTIONAL DOXORUBICIN; THERAPY; MULTICENTER; COMBINATION; WOMEN; DOCETAXEL; TAXANE; OMEGA	Background Various trials have compared the efficacy and toxicity of liposomal doxorubicin-based chemotherapy with the conventional formulation of doxorubicin although arriving at inconsistent conclusions. To derive a conclusive assessment of the efficacy and cardiotoxicity associated with chemotherapy, we performed a meta-analysis by combining data from all eligible randomized controlled trials. Methods We used the PubMed database to identify relevant studies published through December 28, 2014. Eligible studies included randomized controlled trials directly comparing the efficacy and cardiotoxicity of liposomal doxorubicin-based chemotherapy with conventional doxorubicin in advanced breast cancer with adequate data. Odds ratios (ORs) or hazard ratios (HRs) with 95% confidence intervals (CIs) were used to assess the efficacy and cardiotoxicity in a fixed-effects or random-effects model. Results Ten randomized controlled trials containing efficacy and data from a total of 2,889 advanced breast cancer patients were included in this report. Liposomal doxorubicin-based chemotherapy was associated with a significant reduction in the risk of cardiotoxicity (OR = 0.46, 95% CI 0.23 to 0.92, p = 0.03) and a significant improvement in the overall response rate (ORR) (OR = 1.25, 95% CI 1.02 to 1.52, p=0.03) compared with conventional doxorubicin. An apparent improvement in progression-free survival (PFS) for patients treated with liposomal doxorubicin-based chemotherapy was noted; however, this difference was not significant (HR = 1.14, 95% CI 0.96 to 1.34, p = 0.12). In terms of overall survival (OS), no significant difference between the two chemotherapy regimens was noted (HR = 1.00, 95% CI 0.91 to 1.10, p = 0.93). Conclusion The results of this meta-analysis suggest that liposomal doxorubicin-based chemotherapy is associated with a significant improvement in the ORR and a significant reduction in the risk of cardiotoxicity.	[Xing, Meiyuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Lib, Hangzhou, Zhejiang, Peoples R China; [Yan, Feifei; Yu, Sufen; Shen, Peng] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Shen, P (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China.	lance_ru@hotmail.com						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Alba E, 2010, BREAST CANCER RES TR, V122, P169, DOI 10.1007/s10549-010-0860-9; Ban KA, 2014, SURG ONCOL CLIN N AM, V23, P409, DOI 10.1016/j.soc.2014.03.011; Baselga J, 2014, ANN ONCOL, V25, P592, DOI 10.1093/annonc/mdt543; Batist G, 2001, J CLIN ONCOL, V19, P1444, DOI 10.1200/JCO.2001.19.5.1444; Bria E, 2008, BREAST CANCER RES TR, V109, P231, DOI 10.1007/s10549-007-9663-z; Chan S, 2004, ANN ONCOL, V15, P1527, DOI 10.1093/annonc/mdh393; Crivellari D, 2013, BREAST, V22, P130, DOI 10.1016/j.breast.2013.01.015; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Hamaker ME, 2014, BREAST, V23, P81, DOI 10.1016/j.breast.2013.11.004; Harris L, 2002, CANCER, V94, P25, DOI 10.1002/cncr.10201; Kanter P M, 1993, In Vivo, V7, P85; Keller AM, 2004, J CLIN ONCOL, V22, P3893, DOI 10.1200/JCO.2004.08.157; Lao J, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/456409; Levine MN, 2006, NEW ENGL J MED, V355, P1920, DOI 10.1056/NEJMe068204; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Parmar MK, 2004, STAT MED, V23, DOI DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.C0;2-8; Rochlitz C, 2011, ANN ONCOL, V22, P80, DOI 10.1093/annonc/mdq319; Rosati MS, 2011, ANN ONCOL, V22, P315, DOI 10.1093/annonc/mdq392; Schmid P, 2009, CANCER CHEMOTH PHARM, V64, P401, DOI 10.1007/s00280-008-0887-3; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Smorenburg CH, 2014, ANN ONCOL, V25, P599, DOI 10.1093/annonc/mdt588; Sparano JA, 2009, J CLIN ONCOL, V27, P4522, DOI 10.1200/JCO.2008.20.5013; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Verma S, 2008, CANCER TREAT REV, V34, P391, DOI 10.1016/j.ctrv.2008.01.008; Vici P, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-39; Yardley DA, 2009, CLIN BREAST CANCER, V9, P247, DOI 10.3816/CBC.2009.n.042	28	74	87	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133569	10.1371/journal.pone.0133569	http://dx.doi.org/10.1371/journal.pone.0133569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204517	Green Published, Green Submitted, gold			2022-12-27	WOS:000358621000033
J	Jalbrzikowski, M; Lazaro, MT; Gao, FY; Huang, A; Chow, C; Geschwind, DH; Coppola, G; Bearden, CE				Jalbrzikowski, Maria; Lazaro, Maria T.; Gao, Fuying; Huang, Alden; Chow, Carolyn; Geschwind, Daniel H.; Coppola, Giovanni; Bearden, Carrie E.			Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; LOW-COPY REPEATS; PREFRONTAL CORTEX; GENE-EXPRESSION; MITOCHONDRIAL DYSFUNCTION; DIAGNOSTIC INTERVIEW; MICRORNA EXPRESSION; MENTAL-RETARDATION; WHITE-MATTER; SCHIZOPHRENIA	Background 22q11.2 Deletion Syndrome (22q11DS) represents one of the greatest known genetic risk factors for the development of psychotic illness, and is also associated with high rates of autistic spectrum disorders (ASD) in childhood. We performed integrated genomic analyses of 22q11DS to identify genes and pathways related to specific phenotypes. Methods We used a high-resolution aCGH array to precisely characterize deletion breakpoints. Using peripheral blood, we examined differential expression (DE) and networks of co-expressed genes related to phenotypic variation within 22q11DS patients. Whole-genome transcriptional profiling was performed using Illumina Human HT-12 microarrays. Data mining techniques were used to validate our results against independent samples of both peripheral blood and brain tissue from idiopathic psychosis and ASD cases. Results Eighty-five percent of 22q11DS individuals (N = 39) carried the typical 3 Mb deletion, with significant variability in deletion characteristics in the remainder of the sample (N = 7). DE analysis and weighted gene co-expression network analysis (WGCNA) identified expression changes related to psychotic symptoms in patients, including a module of co-expressed genes which was associated with psychosis in 22q11DS and involved in pathways associated with transcriptional regulation. This module was enriched for brain-expressed genes, was not related to antipsychotic medication use, and significantly overlapped with transcriptional changes in idiopathic schizophrenia. In 22q11DS-ASD, both DE and WGCNA analyses implicated dysregulation of immune response pathways. The ASD-associated module showed significant overlap with genes previously associated with idiopathic ASD. Conclusion These findings further support the use of peripheral tissue in the study of major mutational models of diseases affecting the brain, and point towards specific pathways dysregulated in 22q11DS carriers with psychosis and ASD.	[Jalbrzikowski, Maria; Gao, Fuying; Chow, Carolyn; Geschwind, Daniel H.; Coppola, Giovanni; Bearden, Carrie E.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Lazaro, Maria T.; Huang, Alden] Univ Calif Los Angeles, Interdept Neurosci Program, Los Angeles, CA USA; [Geschwind, Daniel H.; Coppola, Giovanni] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bearden, CE (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	cbearden@mednet.ucla.edu		Bearden, Carrie/0000-0002-8516-923X	ACE Center [5P50 HD055784]; National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics [P30 NS06269]; Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome [R01MH085953]; NINDS Training Grant [T32NS048004]; Heyler Research Award; National Science Foundation (NSF) Graduate Research Fellowship Program [NSF-GRFP DGE-0707424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048004, P30NS062691] Funding Source: NIH RePORTER	ACE Center; National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics; Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome; NINDS Training Grant; Heyler Research Award; National Science Foundation (NSF) Graduate Research Fellowship Program(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to acknowledge the following funding sources: 5P50 HD055784 ACE Center (Daniel H. Geschwind), P30 NS06269 National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics (Giovanni Coppola), R01MH085953 Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome (Carrie E. Bearden), T32NS048004 NINDS Training Grant (Maria Jalbrzikowski), Heyler Research Award (Maria Jalbrzikowski), and NSF-GRFP DGE-0707424 National Science Foundation (NSF) Graduate Research Fellowship Program (Maria T. Lazaro). Dr. Bearden had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to and have approved the final manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkustsiri K, 2014, J AUTISM DEV DISORD, V44, P739, DOI 10.1007/s10803-013-1920-x; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Baker K, 2012, CURR OPIN NEUROL, V25, P131, DOI 10.1097/WCO.0b013e328352dd58; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Bertolino A, 2006, PSYCHIAT RES-NEUROIM, V147, P221, DOI 10.1016/j.pscychresns.2006.04.001; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Bittel DC, 2009, CYTOGENET GENOME RES, V124, P113, DOI 10.1159/000207515; Cai CC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-589; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Coppola G, 2011, ANN NEUROL, V70, P790, DOI 10.1002/ana.22526; Coppola G, 2011, METHODS MOL BIOL, V793, P417, DOI 10.1007/978-1-61779-328-8_28; Couture SM, 2010, PSYCHOL MED, V40, P569, DOI 10.1017/S003329170999078X; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eliez S, 2007, J AM ACAD CHILD PSY, V46, P433, DOI 10.1097/CHI.0b013e31802f5490; First MB, 2002, BIOMETRICS RESEARCH; Fung WLA, 2010, AM J PSYCHIAT, V167, P998, DOI 10.1176/appi.ajp.2010.09101463; Gadow KD, 2009, J AUTISM DEV DISORD, V39, P1542, DOI 10.1007/s10803-009-0794-4; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Goncalves VF, 2015, HUM GENET, V134, P13, DOI 10.1007/s00439-014-1491-8; Gothelf D, 2004, AM J MED GENET B, V126B, P99, DOI 10.1002/ajmg.b.20124; Gothelf D, 2007, AM J PSYCHIAT, V164, P663, DOI 10.1176/appi.ajp.164.4.663; Gothelf D, 2014, BIOL PSYCHIAT, V75, P406, DOI 10.1016/j.biopsych.2013.07.021; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Hiramoto T, 2011, HUM MOL GENET, V20, P4775, DOI 10.1093/hmg/ddr404; Ho JS, 2012, AUTISM RES, V5, P407, DOI 10.1002/aur.1252; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jolin EM, 2009, J AFFECT DISORDERS, V119, P177, DOI 10.1016/j.jad.2009.02.016; Jonas RK, 2013, BIOLOGICAL PSYCHIATR, P1; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kates WR, 2007, AM J MED GENET A, V143A, P2642, DOI 10.1002/ajmg.a.32012; Kikinis Z, 2012, SCHIZOPHR RES, V141, P35, DOI 10.1016/j.schres.2012.06.032; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Li Y, 2011, PSYCHIAT RES, V187, P457, DOI 10.1016/j.psychres.2010.04.019; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; McGlashan TH, 2001, EARLY INTERVENTION P, P135, DOI DOI 10.1007/978-94-010-0892-1_7; McKernan DP, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.37; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; Morgan JT, 2012, BRAIN RES, V1456, P72, DOI 10.1016/j.brainres.2012.03.036; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Niklasson L, 2001, GENET MED, V3, P79, DOI 10.1097/00125817-200101000-00017; Niklasson L, 2009, RES DEV DISABIL, V30, P763, DOI 10.1016/j.ridd.2008.10.007; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Nott A, 2013, NAT NEUROSCI, V16, P1163, DOI 10.1038/nn.3506; Paemka L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080737; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Pasternak O, 2012, J NEUROSCI, V32, P17365, DOI 10.1523/JNEUROSCI.2904-12.2012; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prata DP, 2009, BIOL PSYCHIAT, V65, P473, DOI 10.1016/j.biopsych.2008.09.027; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Radoeva PD, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-38; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Schneider M, 2014, AM J PSYCHIAT; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shaikh TH, 2007, GENOME RES, V17, P482, DOI 10.1101/gr.5986507; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Toritsuka M, 2013, P NATL ACAD SCI USA, V110, P17552, DOI 10.1073/pnas.1312661110; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; van Beveren NJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033473; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Vorstman JAS, 2013, SCHIZOPHR RES, V143, P55, DOI 10.1016/j.schres.2012.10.010; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yoo HJ, 2013, J KOREAN MED SCI, V28, P1403, DOI 10.3346/jkms.2013.28.9.1403; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	99	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132542	10.1371/journal.pone.0132542	http://dx.doi.org/10.1371/journal.pone.0132542			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201030	gold, Green Published, Green Submitted			2022-12-27	WOS:000358597100039
J	Annandale, E; Hammarstrom, A				Annandale, Ellen; Hammarstrom, Anne			Gender Inequality in the Couple Relationship and Leisure-Based Physical Exercise	PLOS ONE			English	Article							HEALTH; TIME; WOMEN; MEN; HOUSEWORK; EQUALITY; WORK; CONVERGENCE; DIVISION; QUALITY	Aims To analyse whether gender inequality in the couple relationship was related to leisure-based physical activity, after controlling for earlier physical activity and confounders. Methods Data drawn from the Northern Swedish Cohort of all pupils in their final year of compulsory schooling in a town in the North of Sweden. The sample consisted of 772 respondents (n = 381 men, n = 391 women) in the 26-year follow-up (in 2007, aged 42) who were either married or cohabiting. Ordinal regression, for men and women separately, was used to assess the association between gender inequality (measured as self-perceived equality in the couple relationship using dummy variables) and a measure of exercise frequency, controlling for prior exercise frequency, socioeconomic status, the presence of children in the home, and longer than usual hours in paid work. Results The perception of greater gender equality in the couple relationship was associated with higher levels of physical activity for both men and women. This remained significant when the other variables were controlled for. Amongst men the confidence intervals were high. Conclusions The results point to the potential of perceived gender equality in the couple relationship to counteract the general time poverty and household burden that often arises from the combination of paid work and responsibility for children and the home, especially for women. The high confidence intervals among men indicate the need for more research within the field with larger samples.	[Annandale, Ellen] Univ York, Dept Sociol, York YO10 5DD, N Yorkshire, England; [Hammarstrom, Anne] Umea Univ, Unit Social Med, Dept Publ Hlth & Clin Med, Umea, Sweden	University of York - UK; Umea University	Annandale, E (corresponding author), Univ York, Dept Sociol, York YO10 5DD, N Yorkshire, England.	ellen.annandale@york.ac.uk		Hammarstrom, Anne/0000-0002-4095-7961	Swedish Council for Working Life and Social Research [Dnr 2007-2073]; Swedish Research Council Formas [Dnr 259-2012-37]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Financial support was provided by the Swedish Council for Working Life and Social Research, grant number: Dnr 2007-2073 and by the Swedish Research Council Formas: Dnr 259-2012-37. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, FOLKHALSORAPPORT2014; Backhans MC, 2007, SOC SCI MED, V64, P1892, DOI 10.1016/j.socscimed.2007.01.016; Bellows-Riecken KH, 2008, PREV MED, V46, P99, DOI 10.1016/j.ypmed.2007.08.003; Bianchi SM, 2010, J MARRIAGE FAM, V72, P705, DOI 10.1111/j.1741-3737.2010.00726.x; Biblarz TJ, 2010, J MARRIAGE FAM, V72, P480, DOI 10.1111/j.1741-3737.2010.00714.x; Bird C, 2008, GENDER AND HLTH, P256; Bittman M, 2000, SOC FORCES, V79, P165, DOI 10.2307/2675568; Bittman M, 2003, AM J SOCIOL, V109, P186, DOI 10.1086/378341; Brown H, 2011, SOC SCI MED, V73, P383, DOI 10.1016/j.socscimed.2011.06.001; Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x; Cockerham WC, 2005, J HEALTH SOC BEHAV, V46, P51, DOI 10.1177/002214650504600105; Connell R, 2012, SOC SCI MED, V74, P1675, DOI 10.1016/j.socscimed.2011.06.006; Davis SN, 2013, J FAM THEOR REV, V5, P63, DOI 10.1111/jftr.12004; European Commission, 2014, SPEC EUR 414 SPORT P, P135; Evertsson M, 2007, EUR SOCIOL REV, V23, P455, DOI 10.1093/esr/jcm018; Ferree MM, 2010, J MARRIAGE FAM, V72, P420, DOI 10.1111/j.1741-3737.2010.00711.x; Grzywacz JG, 2000, J MARRIAGE FAM, V62, P336, DOI 10.1111/j.1741-3737.2000.00336.x; Hallerod B, 2007, MODERN COUPLES SHARING MONEY, SHARING LIFE, P143; Harryson L, 2013, EQUAL SHARE THATS MY; Harryson L, 2012, J EPIDEMIOL COMMUN H, V66, P271, DOI 10.1136/jech.2010.109231; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; Markula P, 2011, WOMEN EXERCISE BODY, P320; Mattingly MJ, 2003, SOC FORCES, V81, P999, DOI 10.1353/sof.2003.0036; Moss N, 2009, SOC SCI MED, V54, P649; National Centre for Health Research, 2009, HLTH SURV ENGL, V1; Nomaguchi KM, 2004, J MARRIAGE FAM, V66, P413, DOI 10.1111/j.1741-3737.2004.00029.x; Nordenmark M, 2003, EUR J WOMENS STUD, V10, P181, DOI 10.1177/1350506803010002004; Payne S, 2006, HLTH MEN WOMEN, P229; Ridgeway CL, 2004, GENDER SOC, V18, P510, DOI 10.1177/0891243204265269; Roos E, 2007, PUBLIC HEALTH NUTR, V10, P222, DOI 10.1017/S1368980007248487; Sayer LC, 2005, SOC FORCES, V84, P285, DOI 10.1353/sof.2005.0126; Solomon SE, 2005, SEX ROLES, V52, P561, DOI 10.1007/s11199-005-3725-7; Statistics Sweden, 2014, MEN WOM SWED 2014; Such E, 2008, LEISURE STUD, V25, P185; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Van de Velde S, 2013, SOCIOL HEALTH ILL, V35, P682, DOI 10.1111/j.1467-9566.2012.01521.x; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002	37	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133348	10.1371/journal.pone.0133348	http://dx.doi.org/10.1371/journal.pone.0133348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196280	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600086
J	Deguen, S; Petit, C; Delbarre, A; Kihal, W; Padilla, C; Benmarhnia, T; Lapostolle, A; Chauvin, P; Zmirou-Navier, D				Deguen, Severine; Petit, Claire; Delbarre, Angelique; Kihal, Wahida; Padilla, Cindy; Benmarhnia, Tarik; Lapostolle, Annabelle; Chauvin, Pierre; Zmirou-Navier, Denis			Neighbourhood Characteristics and Long-Term Air Pollution Levels Modify the Association between the Short-Term Nitrogen Dioxide Concentrations and All-Cause Mortality in Paris	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSES; SOCIAL INEQUALITIES; PARTICULATE MATTER; TIME-SERIES; SOCIOECONOMIC-STATUS; HEALTH; EXPOSURE; DESIGN; SUSCEPTIBILITY; TEMPERATURE	Background While a great number of papers have been published on the short-term effects of air pollution on mortality, few have tried to assess whether this association varies according to the neighbourhood socioeconomic level and long-term ambient air concentrations measured at the place of residence. We explored the effect modification of 1) socioeconomic status, 2) long-term NO2 ambient air concentrations, and 3) both combined, on the association between short-term exposure to NO2 and all-cause mortality in Paris (France). Methods A time-stratified case-crossover analysis was performed to evaluate the effect of short-term NO2 variations on mortality, based on 79,107 deaths having occurred among subjects aged over 35 years, from 2004 to 2009, in the city of Paris. Simple and double interactions were statistically tested in order to analyse effect modification by neighbourhood characteristics on the association between mortality and short-term NO2 exposure. The data was estimated at the census block scale (n=866). Results The mean of the NO2 concentrations during the five days prior to deaths were associated with an increased risk of all-cause mortality: overall Excess Risk (ER) was 0.94% (95% CI=[0.08;1.80]. A higher risk was revealed for subjects living in the most deprived census blocks in comparison with higher socioeconomic level areas (ER=3.14% (95% CI=[1.4-14.90], p<0.001). Among these deprived census blocks, excess risk was even higher where long-term average NO2 concentrations were above 55.8 mu g/m(3) (the top tercile of distribution): ER=4.84%(95% CI=[1.56;8.24], p for interaction= 0.02). Conclusion Our results show that people living in census blocks characterized by low socioeconomic status are more vulnerable to air pollution episodes. There is also an indication that people living in these disadvantaged census blocks might experience even higher risk following short-term air pollution episodes, when they are also chronically exposed to higher NO2 levels.	[Deguen, Severine; Petit, Claire; Delbarre, Angelique; Kihal, Wahida; Padilla, Cindy; Benmarhnia, Tarik; Zmirou-Navier, Denis] EHESP Sch Publ Hlth, Rennes, France; [Deguen, Severine; Petit, Claire; Kihal, Wahida; Padilla, Cindy; Benmarhnia, Tarik; Zmirou-Navier, Denis] INSERM U1085 IRSET, Rennes, France; [Lapostolle, Annabelle; Chauvin, Pierre] INSERM U707, Res Grp Social Determinants Hlth & Healthcare, Paris, France; [Zmirou-Navier, Denis] Lorraine Univ, Sch Med, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Lorraine	Deguen, S (corresponding author), EHESP Sch Publ Hlth, Rennes, France.	severine.deguen@ehesp.fr	Chauvin, Pierre/S-2981-2019; deguen, Severine/K-4958-2015; Chauvin, Pierre/G-1095-2015; Zmirou, Denis/J-9433-2015	Chauvin, Pierre/0000-0002-9183-6406; Chauvin, Pierre/0000-0002-9183-6406; PADILLA, Cindy.M/0000-0001-6673-7847	ANR [2010-PRSP-002-01]	ANR(French National Research Agency (ANR))	Support for this study was provided by the LERES laboratory at EHESP, which provided the weather variables. Nitrogen concentrations were modelled at census block level by the Paris region air surveillance network AirParif, as part of a research project on environment and social health disparities (ANR grant 2010-PRSP-002-01).	Adamkiewicz G, 2011, AM J PUBLIC HEALTH, V101, pS238, DOI 10.2105/AJPH.2011.300119; Anderson H R, 2003, Eur Respir J Suppl, V40, p39s; Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa; Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013; Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090; Breitner S, 2014, SCI TOTAL ENVIRON, V485, P49, DOI 10.1016/j.scitotenv.2014.03.048; Brochu PJ, 2011, AM J PUBLIC HEALTH, V101, pS224, DOI 10.2105/AJPH.2011.300232; Chardon B, 2008, REV EPIDEMIOL SANTE, V56, P31, DOI 10.1016/j.respe.2007.11.002; Chen Bingheng, 2008, Environmental Health and Preventive Medicine, V13, P94, DOI 10.1007/s12199-007-0018-5; Chiusolo M, 2011, ENVIRON HEALTH PERSP, V119, P1233, DOI 10.1289/ehp.1002904; Clarisse B, 2007, EUR J EPIDEMIOL, V22, P203, DOI 10.1007/s10654-007-9109-2; Danet S, 1999, Circulation, V100, pE1; Deguen S, 2010, EUR J PUBLIC HEALTH, V20, P27, DOI 10.1093/eurpub/ckp220; Deschenes O., 18345 NBER; ERS (European Respiratory Society), AIR QUAL HLTH; Filleul L, 2004, J OCCUP ENVIRON MED, V46, P1115, DOI 10.1097/01.jom.0000144998.82543.9d; Forastiere F, 2007, AM J IND MED, V50, P208, DOI 10.1002/ajim.20368; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hoibian S, 2012, S3916 CRED, pS3916; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Jerrett M, 2004, J EPIDEMIOL COMMUN H, V58, P31, DOI 10.1136/jech.58.1.31; Kloog I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034664; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Kruize H, 2007, ENVIRON MANAGE, V40, P578, DOI 10.1007/s00267-005-0378-9; Lalloue B, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-21; Lepeule J, 2006, ENVIRON HEALTH PERSP, V114, P242, DOI 10.1289/ehp.8311; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; McLeod H., 2000, REG ENV CHANG, V1, P18; Mesle F, 1996, HIST METHOD, V29, P72, DOI 10.1080/01615440.1996.10112731; Montero JC, 2012, SCI TOTAL ENVIRON, V414, P73, DOI 10.1016/j.scitotenv.2011.10.009; Niedhammer I, 2008, SOC SCI MED, V67, P1870, DOI 10.1016/j.socscimed.2008.09.007; Ou CQ, 2008, ENVIRON RES, V107, P237, DOI 10.1016/j.envres.2008.02.002; Padilla CM, 2014, ENVIRON RES, V34, P315; Ren C, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-56; Samoli E, 2006, EUR RESPIR J, V27, P1129, DOI 10.1183/09031936.06.00143905; Samoli E, 2008, ENVIRON HEALTH PERSP, V116, P1480, DOI 10.1289/ehp.11345; Schwartz J, 2001, EPIDEMIOLOGY, V12, P55, DOI 10.1097/00001648-200101000-00010; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Vardoulakis S, 2003, ATMOS ENVIRON, V37, P155, DOI 10.1016/S1352-2310(02)00857-9; Wojtyniak B, 2001, EPIDEMIOLOGY, V12, pS64; Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1189, DOI 10.1289/ehp.10850; Zanobetti A, 2004, CIRCULATION, V110, P2184, DOI 10.1161/01.CIR.0000143831.33243.D8; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; Zanobetti A, 2000, J OCCUP ENVIRON MED, V42, P469, DOI 10.1097/00043764-200005000-00002; Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116	47	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131463	10.1371/journal.pone.0131463	http://dx.doi.org/10.1371/journal.pone.0131463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197409	Green Published, gold			2022-12-27	WOS:000358547600013
J	Gesualdo, F; Stilo, G; D'Ambrosio, A; Carloni, E; Pandolfi, E; Velardi, P; Fiocchi, A; Tozzi, AE				Gesualdo, Francesco; Stilo, Giovanni; D'Ambrosio, Angelo; Carloni, Emanuela; Pandolfi, Elisabetta; Velardi, Paola; Fiocchi, Alessandro; Tozzi, Alberto E.			Can Twitter Be a Source of Information on Allergy? Correlation of Pollen Counts with Tweets Reporting Symptoms of Allergic Rhinoconjunctivitis and Names of Antihistamine Drugs	PLOS ONE			English	Article							INTERNET; MEDIA	Pollen forecasts are in use everywhere to inform therapeutic decisions for patients with allergic rhinoconjunctivitis (ARC). We exploited data derived from Twitter in order to identify tweets reporting a combination of symptoms consistent with a case definition of ARC and those reporting the name of an antihistamine drug. In order to increase the sensitivity of the system, we applied an algorithm aimed at automatically identifying jargon expressions related to medical terms. We compared weekly Twitter trends with National Allergy Bureau weekly pollen counts derived from US stations, and found a high correlation of the sum of the total pollen counts from each stations with tweets reporting ARC symptoms (Pearson's correlation coefficient: 0.95) and with tweets reporting antihistamine drug names (Pearson's correlation coefficient: 0.93). Longitude and latitude of the pollen stations affected the strength of the correlation. Twitter and other social networks may play a role in allergic disease surveillance and in signaling drug consumptions trends.	[Gesualdo, Francesco; D'Ambrosio, Angelo; Carloni, Emanuela; Pandolfi, Elisabetta; Fiocchi, Alessandro; Tozzi, Alberto E.] Bambino Gesu Childrens Hosp IRCCS, Multifactorial Dis & Complex Phenotype Res Area, Rome, Italy; [Stilo, Giovanni; Velardi, Paola] Univ Roma La Sapienza, Dept Informat, I-00185 Rome, Italy	IRCCS Bambino Gesu; Sapienza University Rome	Gesualdo, F (corresponding author), Bambino Gesu Childrens Hosp IRCCS, Multifactorial Dis & Complex Phenotype Res Area, Rome, Italy.	f.gesualdo@gmail.com	Fiocchi, Alessandro/K-9235-2016; Gesualdo, Francesco/H-9221-2012; D'Ambrosio, Angelo/Y-1798-2018; Carloni, Emanuela/AAB-5959-2020; Tozzi, Alberto Eugenio/F-9494-2012; Stilo, Giovanni/AAE-5484-2020; Pandolfi, Elisabetta/K-5173-2016	Fiocchi, Alessandro/0000-0002-2549-0523; Gesualdo, Francesco/0000-0002-9087-4398; D'Ambrosio, Angelo/0000-0002-2045-5155; Tozzi, Alberto Eugenio/0000-0002-6884-984X; Velardi, Paola/0000-0003-0884-1499; Pandolfi, Elisabetta/0000-0003-2424-2736; Carloni, Emanuela/0000-0002-3486-4507				Baptist AP, 2011, J ASTHMA, V48, P824, DOI 10.3109/02770903.2011.608460; Bauchau V, 2005, ALLERGY, V60, P350, DOI 10.1111/j.1398-9995.2005.00751.x; Bousquet J, 2014, EUR RESPIR J, V44, P304, DOI 10.1183/09031936.00014614; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Eberth JM, 2014, J ADOLESCENT HEALTH, V54, P289, DOI 10.1016/j.jadohealth.2013.09.005; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Freifeld CC, 2014, DRUG SAFETY, V37, P343, DOI 10.1007/s40264-014-0155-x; Gesualdo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082489; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Imonikhe R, 2011, EYE, V25, P1663, DOI 10.1038/eye.2011.249; Keith PK, 2012, ALLERGY ASTHMA CL IM, V8, DOI 10.1186/1710-1492-8-7; Maurer M, 2007, ALLERGY, V62, P1057, DOI 10.1111/j.1398-9995.2007.01367.x; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Simmering JE, 2014, RES SOCIAL ADM PHARM; Velardi P, 2014, ARTIF INTELL MED, V61, P153, DOI 10.1016/j.artmed.2014.01.002; Zuckerman O, 2014, ANN ALLERGY ASTHMA I	18	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133706	10.1371/journal.pone.0133706	http://dx.doi.org/10.1371/journal.pone.0133706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197474	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600134
J	Horowitz-Kraus, T; Toro-Serey, C; DiFrancesco, M				Horowitz-Kraus, Tzipi; Toro-Serey, Claudio; DiFrancesco, Mark			Increased Resting-State Functional Connectivity in the Cingulo-Opercular Cognitive-Control Network after Intervention in Children with Reading Difficulties	PLOS ONE			English	Article							ERROR-DETECTION MECHANISM; VISUAL-SPATIAL ATTENTION; SMALL-WORLD NETWORKS; EXECUTIVE FUNCTIONS; DEVELOPMENTAL DYSLEXIA; WORKING-MEMORY; TERM-MEMORY; BRAIN; FMRI; DEFICITS	Dyslexia, or reading difficulty, is characterized by slow, inaccurate reading accompanied by executive dysfunction. Reading training using the Reading Acceleration Program improves reading and executive functions in both children with dyslexia and typical readers. This improvement is associated with increased activation in and functional connectivity between the anterior cingulate cortex, part of the cingulo-opercular cognitive-control network, and the fusiform gyrus during a reading task after training. The objective of the current study was to determine whether the training also has an effect on functional connectivity of the cingulo-opercular and fronto-parietal cognitive-control networks during rest in children with dyslexia and typical readers. Fifteen children with reading difficulty and 17 typical readers (8-12 years old) were included in the study. Reading and executive functions behavioral measures and resting-state functional magnetic resonance imaging data were collected before and after reading training. Imaging data were analyzed using a graphical network-modeling tool. Both reading groups had increased reading and executive-functions scores after training, with greater gains among the dyslexia group. Training may have less effect on cognitive control in typical readers and a more direct effect on the visual area, as previously reported. Statistical analysis revealed that compared to typical readers, children with reading difficulty had significantly greater functional connectivity in the cingulo-opercular network after training, which may demonstrate the importance of cognitive control during reading in this population. These results support previous findings of increased error-monitoring activation after reading training in children with dyslexia and confirm greater gains with training in this group.	[Horowitz-Kraus, Tzipi; DiFrancesco, Mark] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi; Toro-Serey, Claudio] Cincinnati Childrens Hosp Med Ctr, Reading & Literacy Discovery Ctr, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Horowitz-Kraus, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA.	Tzipi.Horowitz-Kraus@cchmc.org	DiFrancesco, Mark William/AAE-6138-2020	DiFrancesco, Mark William/0000-0001-8002-0332; Toro-Serey, Claudio/0000-0002-5273-2276	Fulbright Foundation; US-Israel Binational Science Foundation [2009053]	Fulbright Foundation; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	The study was supported by the Fulbright Foundation and the US-Israel Binational Science Foundation number 2009053.	Altemeier LE, 2008, J CLIN EXP NEUROPSYC, V30, P588, DOI 10.1080/13803390701562818; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; BREZNITZ Z, 1992, J EDUC PSYCHOL, V84, P193, DOI 10.1037/0022-0663.84.2.193; Breznitz Z, 1997, J EDUC PSYCHOL, V89, P103, DOI 10.1037/0022-0663.89.1.103; Breznitz Z, 1997, J EDUC PSYCHOL, V89, P289, DOI 10.1037/0022-0663.89.2.289; Breznitz Z., 2006, FLUENCY READING SYNC; Breznitz Z., 2010, READING ACCELERATION; Breznitz Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2488; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Brown L., 1997, TEST NONVERBAL INTEL; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; Conners C.K., 1989, CONNERS RATING SCALE; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Dellis D. C., 2001, DELIS KAPLAN EXECUTI; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Fair D. A., 2012, COGNITIVE NEUROSCIEN, P291; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gabrieli JDE, 2012, CURR BIOL, V22, pR298, DOI 10.1016/j.cub.2012.03.041; Gooch D, 2011, J CHILD PSYCHOL PSYC, V52, P195, DOI 10.1111/j.1469-7610.2010.02312.x; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Gratton C, 2015, NETWORK PROPERTIES A; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Hoeft F, 2007, BEHAV NEUROSCI, V121, P602, DOI 10.1037/0735-7044.121.3.602; Horowitz-Kraus T, 2015, INCREASED FUNCTIONAL; Horowitz-Kraus T, 2014, INCREASED FUNCTIONAL; Horowitz-Kraus T., 2010, LESS IS MORE ABILITY; Horowitz-Kraus T, 2008, CLIN NEUROPHYSIOL, V119, P2238, DOI 10.1016/j.clinph.2008.06.009; Horowitz-Kraus T, 2015, ANN DYSLEXIA, V65, P1, DOI 10.1007/s11881-015-0096-9; Horowitz-Kraus T, 2014, BRAIN BEHAV, V4, P886, DOI 10.1002/brb3.281; Horowitz-Kraus T, 2014, ANN DYSLEXIA, V64, P183, DOI 10.1007/s11881-014-0093-4; Horowitz-Kraus T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00447; Horowitz-Kraus T, 2014, J LEARN DISABIL-US, V47, P208, DOI 10.1177/0022219412453084; Horowitz-Kraus T, 2014, BRAIN RES, V1544, P1, DOI 10.1016/j.brainres.2013.11.027; Horowitz-Kraus T, 2011, INT J DISABIL DEV ED, V58, P33, DOI 10.1080/1034912X.2011.548466; Horowitz-Kraus T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007141; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Ihnen SKZ, 2015, CEREB CORTEX, V25, P1198, DOI 10.1093/cercor/bht313; Korinth S. P., 2009, EJ SAFR IN C HAIF IS; Koyama MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055454; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leikin M, 2001, GENET SOC GEN PSYCH, V127, P193; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Manly T, 1999, TEST EVERYDAY ATTENT; Masur D, 2013, NEUROLOGY, V81, P1572, DOI 10.1212/WNL.0b013e3182a9f3ca; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; Menghini D, 2010, DYSLEXIA, V16, P213, DOI 10.1002/dys.410; Neta M, 2014, NEUROIMAGE, V99, P59, DOI 10.1016/j.neuroimage.2014.05.053; Niedo J, 2014, LEARN DISABILITY Q, V37, P100, DOI 10.1177/0731948713507263; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Snellings P, 2009, J LEARN DISABIL-US, V42, P291, DOI 10.1177/0022219408331038; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Swanson E, 2011, J LEARN DISABIL-US, V44, P258, DOI 10.1177/0022219410378444; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Szaflarski JP, 2006, ANN NEUROL, V59, P796, DOI 10.1002/ana.20817; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tiffin-Richards MC, 2008, J NEURAL TRANSM, V115, P227, DOI 10.1007/s00702-007-0816-3; Torgesen J.K., 1999, TOWRE TEST WORD READ; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Vogel AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00088; Vogel AC, 2012, CEREB CORTEX, V22, P537, DOI 10.1093/cercor/bhr100; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wechsler D., 1999, WECHSLER INTELLIGENC, V1; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073	73	46	46	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133762	10.1371/journal.pone.0133762	http://dx.doi.org/10.1371/journal.pone.0133762			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197049	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600141
J	Huber, S; Huettner, JP; Hacker, K; Bernhardt, G; Konig, J; Buschauer, A				Huber, Stefan; Huettner, Johannes Philip; Hacker, Kristina; Bernhardt, Guenther; Koenig, Joerg; Buschauer, Armin			Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ORGANIC CATION TRANSPORTERS; RANDOMIZED PHASE-III; MYELOMA CELLS; IN-VITRO; MELPHALAN; RITUXIMAB; PROFILE; ANIONS; DETERMINANTS	The alkylating agent bendamustine is approved for the treatment of hematopoietic malignancies such as non-Hodgkin lymphoma, chronic lymphocytic leukemia and multiple myeloma. As preliminary data on recently disclosed bendamustine esters suggested increased cytotoxicity, we investigated representative derivatives in more detail. Especially basic esters, which are positively charged under physiological conditions, were in the crystal violet and the MTT assay up to approximately 100 times more effective than bendamustine, paralleled by a higher fraction of early apoptotic cancer cells and increased expression of p53. Analytical studies performed with bendamustine and representative esters revealed pronounced cellular accumulation of the derivatives compared to the parent compound. In particular, the pyrrolidinoethyl ester showed a high enrichment in tumor cells and inhibition of OCT1-and OCT3-mediated transport processes, suggesting organic cation transporters to be involved. However, this hypothesis was not supported by the differential expression of OCT1 (SLC22A1) and OCT3 (SLC22A3), comparing a panel of human cancer cells. Bendamustine esters proved to be considerably more potent cytotoxic agents than the parent compound against a broad panel of human cancer cell types, including hematologic and solid malignancies (e.g. malignant melanoma, colorectal carcinoma and lung cancer), which are resistant to bendamustine. Interestingly, spontaneously immortalized human keratinocytes, as a model of "normal" cells, were by far less sensitive than tumor cells against the most potent bendamustine esters.	[Huber, Stefan; Bernhardt, Guenther; Buschauer, Armin] Univ Regensburg, Inst Pharm, Pharmaceut & Med Chem 2, D-93053 Regensburg, Germany; [Huettner, Johannes Philip] Univ Regensburg, Inst Pharm, Pharmacol & Toxicol, D-93053 Regensburg, Germany; [Hacker, Kristina; Koenig, Joerg] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany	University of Regensburg; University of Regensburg; University of Erlangen Nuremberg	Buschauer, A (corresponding author), Univ Regensburg, Inst Pharm, Pharmaceut & Med Chem 2, D-93053 Regensburg, Germany.	armin.buschauer@chemie.uni-regensburg.de		Koenig, Joerg/0000-0001-7016-5482	Arevipharma (Radebeul, Germany); DFG	Arevipharma (Radebeul, Germany); DFG(German Research Foundation (DFG))	This study was sponsored in part by Arevipharma (Radebeul, Germany), and supported within the DFG funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmakov L, 2008, DIABETES, V57, P1463, DOI 10.2337/db07-1515; Bakale RP, 2014, Patent, Patent No. [WO2014075035A1, 2014075035]; BERNHARDT G, 1992, J CANCER RES CLIN, V118, P35, DOI 10.1007/BF01192309; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cheson BD, 2010, CL LYMPH MYELOM LEUK, V10, P452, DOI 10.3816/CLML.2010.n.079; Cheson BD, 2009, J CLIN ONCOL, V27, P1492, DOI 10.1200/JCO.2008.18.7252; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2004, J CELL PHYSIOL, V201, P420, DOI 10.1002/jcp.20081; Cives M, 2013, CELL SIGNAL, V25, P1108, DOI 10.1016/j.cellsig.2013.01.020; Colledge J, 2010, Patent, Patent No. [WO2010063476, 2010063476]; Colledge J, 2010, Patent, Patent No. [WO2010063493, 2010063493, WO2010063493A1]; DOBRETSOV GE, 1985, BIOFIZIKA+, V30, P833; Eichbaum MHR, 2007, ANTI-CANCER DRUG, V18, P963; Friedberg JW, 2011, BLOOD, V117, P2807, DOI 10.1182/blood-2010-11-314708; Gaul L, 2008, J CANCER RES CLIN, V134, P245, DOI 10.1007/s00432-007-0278-x; Gil L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0944-1; Gupta S, 2012, J PHARMACOL EXP THER, V341, P16, DOI 10.1124/jpet.111.190561; Gust R, 1997, MONATSH CHEM, V128, P291, DOI 10.1007/BF00807895; Hallek M, 2013, HEMATOL-AM SOC HEMAT, P138, DOI 10.1182/asheducation-2013.1.138; Hiraoka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090675; Huber S, 2015, J PHARMACEUT BIOMED, V104, P137, DOI 10.1016/j.jpba.2014.11.038; Kahl BS, 2010, CANCER-AM CANCER SOC, V116, P106, DOI 10.1002/cncr.24714; Kalaycio M, 2009, CANCER-AM CANCER SOC, V115, P473, DOI 10.1002/cncr.24057; Knauf WU, 2012, BRIT J HAEMATOL, V159, P67, DOI 10.1111/bjh.12000; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Labell RY, 2010, Patent, Patent No. [WO2010126676, 2010126676]; Lammers PE, 2014, J THORAC ONCOL, V9, P559, DOI 10.1097/JTO.0000000000000079; Lentzsch S, 2014, BLOOD, V123, P948, DOI 10.1182/blood-2013-12-539817; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; Leoni LM, 2011, SEMIN HEMATOL, V48, pS4, DOI 10.1053/j.seminhematol.2011.03.002; Ludwig H, 2014, BLOOD, V123, P985, DOI 10.1182/blood-2013-08-521468; Massmann V, 2014, PFLUG ARCH EUR J PHY, V466, P517, DOI 10.1007/s00424-013-1335-8; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; More SS, 2010, MOL CANCER THER, V9, P1058, DOI 10.1158/1535-7163.MCT-09-1084; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Owen JS, 2010, CANCER CHEMOTH PHARM, V66, P1039, DOI 10.1007/s00280-010-1254-8; OZEGOWSKI W, 1963, J PRAKT CHEM, V20, P178, DOI 10.1002/prac.19630200310; Ozegowski W., 1971, ZBL PHARM, V110, P1013; Pencheva I, 2008, J PHARMACEUT BIOMED, V48, P1143, DOI 10.1016/j.jpba.2008.09.001; PIETRUCK F, 1995, KIDNEY INT, V47, P1647, DOI 10.1038/ki.1995.229; Ponisch W, 2014, J CANCER RES CLIN, V140, P1947, DOI 10.1007/s00432-014-1737-9; Ponisch W, 2006, J CANCER RES CLIN, V132, P205, DOI 10.1007/s00432-005-0074-4; Preiss S, 2011, THESIS CHARITE UNIVE; REILE H, 1990, ANAL BIOCHEM, V187, P262, DOI 10.1016/0003-2697(90)90454-H; ROHLICEK V, 1994, RENAL PHYSIOL BIOCH, V17, P57; Rummel MJ, 2005, J CLIN ONCOL, V23, P3383, DOI 10.1200/JCO.2005.08.100; Rummel MJ, 2002, SEMIN ONCOL, V29, P12, DOI 10.1053/sonc.2002.34873; Schickaneder H, 2013, Patent, Patent No. [EP2656843, 2656843]; Scutaru AM, 2010, BIOCONJUGATE CHEM, V21, P1728, DOI 10.1021/bc900453f; Seithel A, 2007, DRUG METAB DISPOS, V35, P779, DOI 10.1124/dmd.106.014407; Shnitsar V, 2009, CANCER RES, V69, P1494, DOI 10.1158/0008-5472.CAN-08-2483; Solbach TF, 2011, J CARDIOVASC PHARM, V58, P409, DOI 10.1097/FJC.0b013e3182270783; Surget S, 2014, LEUKEMIA LYMPHOMA, V55, P2165, DOI 10.3109/10428194.2013.871277; Tageja N, 2010, CANCER CHEMOTH PHARM, V66, P413, DOI 10.1007/s00280-010-1317-x; Ullrich KJ, 1996, PFLUG ARCH EUR J PHY, V432, P471, DOI 10.1007/s004240050159; WERNER W, 1991, PHARMAZIE, V46, P113; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687; Yokoo S, 2008, DRUG METAB DISPOS, V36, P2299, DOI 10.1124/dmd.108.023168; Zhang L, 1998, J PHARMACOL EXP THER, V286, P354; Zhang SZ, 2006, CANCER RES, V66, P8847, DOI 10.1158/0008-5472.CAN-06-0769	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133743	10.1371/journal.pone.0133743	http://dx.doi.org/10.1371/journal.pone.0133743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196503	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600138
J	Li, DD; Wang, L; Zhu, HH; Dou, LP; Liu, DH; Fu, L; Ma, C; Ma, XB; Yao, YS; Zhou, L; Wang, Q; Wang, LJ; Zhao, Y; Jing, Y; Wang, LL; Li, YH; Yu, L				Li, Dandan; Wang, Li; Zhu, Honghu; Dou, Liping; Liu, Daihong; Fu, Lin; Ma, Cong; Ma, Xuebin; Yao, Yushi; Zhou, Lei; Wang, Qian; Wang, Lijun; Zhao, Yu; Jing, Yu; Wang, Lili; Li, Yonghui; Yu, Li			Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; HIGH-DOSE CYTARABINE; VERSUS-HOST-DISEASE; POSTREMISSION THERAPY; INTENSIFICATION CHEMOTHERAPY; INTENSIVE CHEMOTHERAPY; REDUCED-INTENSITY; YOUNGER ADULTS; DONOR-PROGRAM	Hematopoietic stem cell transplantation (HSCT) and consolidation chemotherapy have been used to treat intermediate-risk acute myeloid leukemia (AML) patients in first complete remission (CR1). However, it is still unclear which treatments are most effective for these patients. The aim of our study was to analyze the relapse-free survival (RFS) and overall survival (OS) benefit of allogeneic HSCT (alloHSCT) for intermediate-risk AML patients in CR1. A meta-analysis of prospective trials comparing alloHSCT to non-alloHSCT (autologous HSCT [autoHSCT] and/or chemotherapy) was undertaken. We systematically searched PubMed, Embase, and the Cochrane Library though October 2014, using keywords and relative MeSH or Emtree terms, 'allogeneic'; 'acut*' and 'leukem*/aml/leukaem*/ leucem*/leucaem*'; and 'nonlympho*' or 'myelo*'. A total of 7053 articles were accessed. The primary outcomes were RFS and OS, while the secondary outcomes were treatment-related mortality (TRM) and relapse rate (RR). Hazard ratios (HR) and 95% confidence intervals (CI) were calculated for each outcome. The primary outcomes were RFS and OS, while the secondary outcomes were TRM and RR. We included 9 prospective controlled studies including 1950 adult patients. Patients with intermediate-risk AML in CR1 who received either alloHSCT or non-alloHSCT were considered eligible. AlloHSCT was found to be associated with significantly better RFS, OS, and RR than non-alloHSCT (HR, 0.684 [95% CI: 0.48, 0.95]; HR, 0.76 [95% CI: 0.61, 0.95]; and HR, 0.58 [95% CI: 0.45, 0.75], respectively). TRM was significantly higher following alloHSCT than non-alloHSCT (HR, 3.09 [95% CI: 1.38, 6.92]). However, subgroup analysis showed no OS benefit for alloHSCT over autoHSCT (HR, 0.99 [95% CI: 0.70, 1.39]). In conclusion, alloHSCT is associated with more favorable RFS, OS, and RR benefits (but not TRM outcomes) than non-alloHSCT generally, but does not have an OS advantage over autoHSCT specifically, in patients with intermediate-risk AML in CR1.	[Li, Dandan; Wang, Li; Dou, Liping; Liu, Daihong; Yao, Yushi; Zhou, Lei; Wang, Qian; Wang, Lijun; Zhao, Yu; Jing, Yu; Wang, Lili; Li, Yonghui; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Li, Dandan; Wang, Li] Med Coll Chinese PLA, Beijing, Peoples R China; [Zhu, Honghu] Peking Univ, Inst Hematol, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China; [Fu, Lin] Peking Univ, Hosp 3, Dept Hematol, Beijing 100871, Peoples R China; [Ma, Cong] PLA Navy Gen Hosp, Dept Clin Lab, Beijing, Peoples R China; [Ma, Xuebin] PLA Navy Gen Hosp, Tumor Diag & Treatment Ctr, Beijing, Peoples R China; [Zhou, Lei] 202 Hosp PLA, Dept Hematol, Shenyang, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University; Peking University; Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital	Li, YH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China.	yonghuililab@163.com; chunhuiliyu@yahoo.com	wang, lili/HDL-7210-2022	Wang, Li/0000-0002-4706-2482; Yu, Li/0000-0001-6872-2665	Doctor Scientific research innovation projects; National Natural Science Foundation of China [81370635, 81170518, 81270611, 81470010]; Capital Medical Development Scientific Research Fund [SF2001-5001-07]; Beijing Natural Science Foundation [7151009]; National Public Health Grant Research Foundation [201202017]; capital of the public health project [Z111107067311070]	Doctor Scientific research innovation projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical Development Scientific Research Fund; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Public Health Grant Research Foundation; capital of the public health project	This work was supported by grants from the Doctor Scientific research innovation projects, National Natural Science Foundation of China (81370635, 81170518, 81270611, and 81470010), Capital Medical Development Scientific Research Fund (SF2001-5001-07), Beijing Natural Science Foundation (7151009), National Public Health Grant Research Foundation (No. 201202017), and the capital of the public health project (Z111107067311070).	ARCHIMBAUD E, 1994, J CLIN ONCOL, V12, P262, DOI 10.1200/JCO.1994.12.2.262; Barker JN, 2010, BIOL BLOOD MARROW TR, V16, P1541, DOI 10.1016/j.bbmt.2010.08.011; Basara N, 2009, LEUKEMIA, V23, P635, DOI 10.1038/leu.2008.352; Bloomfield C. D., 2004, Annals of Hematology, V83, pS84; Brunet S, 2004, HAEMATOLOGICA, V89, P940; Burnett AK, 2002, BRIT J HAEMATOL, V118, P385, DOI 10.1046/j.1365-2141.2002.03724.x; Burnett Alan K, 2006, Clin Adv Hematol Oncol, V4, P445; Byrd JC, 2004, J CLIN ONCOL, V22, P1087, DOI 10.1200/JCO.2004.07.012; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cai XJ, 2015, INT J CLIN PHARM-NET, V37, P44, DOI 10.1007/s11096-014-0036-5; Cassileth PA, 1998, NEW ENGL J MED, V339, P1649, DOI 10.1056/NEJM199812033392301; CASSILETH PA, 1992, LEUKEMIA, V6, P116; CHAMPLIN RE, 1985, ANN INTERN MED, V102, P285, DOI 10.7326/0003-4819-102-3-285; CONDE E, 1988, BRIT J HAEMATOL, V68, P219, DOI 10.1111/j.1365-2141.1988.tb06193.x; Cornelissen JJ, 2007, BLOOD, V109, P3658, DOI 10.1182/blood-2006-06-025627; Cornelissen JJ, 2011, BLOOD, V118; FERRANT A, 1991, BONE MARROW TRANSPL, V7, P303; GHIELMINI M, 1995, ANN ONCOL, V6, P533, DOI 10.1093/oxfordjournals.annonc.a059240; Gorin NC, 2013, BLOOD, V122; Grimwade D., 2007, ACUTEMYELOGENOUS LEU, P177; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hamadani M, 2008, BIOL BLOOD MARROW TR, V14, P556, DOI 10.1016/j.bbmt.2008.02.019; Harousseau JL, 1997, BLOOD, V90, P2978; HEWLETT J, 1995, LEUKEMIA, V9, P562; Hospital MA, 2012, BONE MARROW TRANSPL, V47, P1436, DOI 10.1038/bmt.2012.49; Hospital MA, 2010, BLOOD, V116; Huang XJ, 2012, BLOOD, V119, P5584, DOI 10.1182/blood-2011-11-389809; Hubel K, 2011, LEUKEMIA LYMPHOMA, V52, P444, DOI 10.3109/10428194.2010.546918; Johansen KA, 2008, TRANSFUSION MED, V18, P250, DOI 10.1111/j.1365-3148.2008.00865.x; Jourdan E, 2005, J CLIN ONCOL, V23, P7676, DOI 10.1200/JCO.2005.02.5940; Juliusson G, 2011, CANCER-AM CANCER SOC, V117, P4238, DOI 10.1002/cncr.26033; Kasper C, 2004, BONE MARROW TRANSPL, V33, P65, DOI 10.1038/sj.bmt.1704299; Kayser S, 2012, BLOOD, V119, P551, DOI 10.1182/blood-2011-07-367508; Keating S, 1998, BRIT J HAEMATOL, V102, P1344, DOI 10.1111/j.1365-2141.1998.896hm3674.x; Koreth J, 2009, JAMA-J AM MED ASSOC, V301, P2349, DOI 10.1001/jama.2009.813; Labar B, 1994, TRANSPLANTATION MED, V6, P235; Levi I, 2004, LEUKEMIA RES, V28, P605, DOI 10.1016/j.leukres.2003.10.029; LOWENBERG B, 1990, J CLIN ONCOL, V8, P287; Mohr B, 2013, BRIT J HAEMATOL, V161, P237, DOI 10.1111/bjh.12253; Mohty M, 2009, LEUKEMIA, V23, P194, DOI 10.1038/leu.2008.164; National Comprehensive Cancer Network, 2014, AC MYEL LEUK VERS 1; Oliansky DM, 2008, BIOL BLOOD MARROW TR, V14, P137, DOI 10.1016/j.bbmt.2007.11.002; Pfirrmann M, 2012, LANCET ONCOL, V13, P207, DOI 10.1016/S1470-2045(11)70326-6; REIFFERS J, 1989, BRIT J HAEMATOL, V72, P57, DOI 10.1111/j.1365-2141.1989.tb07652.x; Sakamaki H, 2010, INT J HEMATOL, V91, P284, DOI 10.1007/s12185-009-0483-2; SCHILLER GJ, 1992, J CLIN ONCOL, V10, P41, DOI 10.1200/JCO.1992.10.1.41; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schlenk RF, 2013, BLOOD, V122, P1576, DOI 10.1182/blood-2013-05-503847; Schlenk RF, 2010, J CLIN ONCOL, V28, P4642, DOI 10.1200/JCO.2010.28.6856; Sierra J, 1996, J CLIN ONCOL, V14, P1353, DOI 10.1200/JCO.1996.14.4.1353; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Spellman S, 2008, BIOL BLOOD MARROW TR, V14, P37, DOI 10.1016/j.bbmt.2008.05.001; Stelljes M, 2014, J CLIN ONCOL, V32, P288, DOI 10.1200/JCO.2013.50.5768; Stelljes M, 2011, HAEMATOL-HEMATOL J, V96, P972, DOI 10.3324/haematol.2011.041004; Suciu S, 2003, BLOOD, V102, P1232, DOI 10.1182/blood-2002-12-3714; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tsimberidou AM, 2003, CANCER-AM CANCER SOC, V97, P1721, DOI 10.1002/cncr.11240; Wahid SFA, 2014, STEM CELLS DEV, V23, P2535, DOI 10.1089/scd.2014.0123; Wells GA, 2012, NEWCASTLE OTTAWA QUA; Yanada M, 2014, INT J HEMATOL; Yanik G, 2000, BONE MARROW TRANSPL, V26, P161, DOI 10.1038/sj.bmt.1702472; Yoon JH, 2013, BLOOD, V122; Zhu HH, 2013, BLOOD, V121, P4056, DOI 10.1182/blood-2012-11-468348; ZITTOUN RA, 1995, NEW ENGL J MED, V332, P217, DOI 10.1056/NEJM199501263320403	64	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132620	10.1371/journal.pone.0132620	http://dx.doi.org/10.1371/journal.pone.0132620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197471	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600044
J	Tafreshi, M; Zwickel, N; Gorrell, RJ; Kwok, T				Tafreshi, Mona; Zwickel, Nicolas; Gorrell, Rebecca Jane; Kwok, Terry			Preservation of Helicobacter pylori CagA Translocation and Host Cell Proinflammatory Responses in the Face of CagL Hypervariability at Amino Acid Residues 58/59	PLOS ONE			English	Article							IV SECRETION; PROTEIN; SYSTEM; TRANSFORMATION; EXPRESSION	Carriage of the CagA oncoprotein by the human gastric cancer-associated pathogen Helicobacter pylori is significantly associated with this typically benign chronic infection advancing to a potentially fatal outcome. However it remains to be elucidated why only a small subset of individuals infected with H. pylori CagA-positive strains develops gastric cancer. H. pylori translocates CagA into host cells using a type IV secretion apparatus that interacts with host integrin receptors via a three-amino-acid-residue RGD motif on the H. pylori protein CagL. The RGD motif of CagL also plays a major role in the induction of proinflammatory responses. Upstream of this motif is a conserved glycine flanked by four hypervariable amino acid residues (residues 58, 59, 61 and 62). Certain amino acid polymorphisms at 58 and 59 are significantly prevalent in strains from gastric cancer patients in particular geographic regions; Y58E59 is seen in Taiwan and D58K59 in India. In light of the seemingly contradictory findings of recent CagL mutagenesis studies, we have examined the contribution of sequence promiscuity specifically at CagL residues 58 and 59 to CagA translocation and H. pylori-mediated proinflammatory responses of gastric epithelial cells. Using isogenic mutants of H. pylori strains P12 and 26695 with amino acid substitutions at CagL residues 58 and 59, we determined that carriage of the polymorphisms Y58E59, D58K59, D58E59, N58E59 or N58K59 did not significantly alter the capacity of H. pylori to translocate CagA into, or induce IL-8 secretion in, host cells. Our findings, together with other recently published data, suggest that the variation at CagL residues 58 and 59 does not influence type IV secretion system function in isolation, but rather may work in concert with particular polymorphisms elsewhere in CagL to modulate disease progression.	[Tafreshi, Mona; Zwickel, Nicolas; Gorrell, Rebecca Jane; Kwok, Terry] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Gorrell, Rebecca Jane; Kwok, Terry] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Monash University; Monash University	Kwok, T (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	terry.kwok@monash.edu	Gorrell, Rebecca/H-5259-2019	Gorrell, Rebecca/0000-0003-0728-3325; Kwok, Terry/0000-0002-5905-3233	National Health and Medical Research Council Australia project grant [545983]; Monash University Research Accelerator Program Award	National Health and Medical Research Council Australia project grant(National Health and Medical Research Council (NHMRC) of Australia); Monash University Research Accelerator Program Award	TK was supported by National Health and Medical Research Council Australia project grant 545983, and the Monash University Research Accelerator Program Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barden S, 2014, ACTA CRYSTALLOGR D, V70, P1391, DOI 10.1107/S1399004714003150; Barden S, 2013, STRUCTURE, V21, P1931, DOI 10.1016/j.str.2013.08.018; BARRANCO SC, 1983, CANCER RES, V43, P1703; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; Gorrell RJ, 2005, FEMS IMMUNOL MED MIC, V44, P213, DOI 10.1016/j.femsim.2004.10.019; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Rizzato C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029605; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Saha A, 2010, GUT, V59, P874, DOI 10.1136/gut.2009.194795; Tegtmeyer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097782; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Yeh YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101912, DOI 10.1371/JOURNAL.PONE.0101912]; Yeh YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072735; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753	20	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133531	10.1371/journal.pone.0133531	http://dx.doi.org/10.1371/journal.pone.0133531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196862	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600110
J	Thomsen, SB; Gjesing, AP; Rathcke, CN; Ekstrom, CT; Eiberg, H; Hansen, T; Pedersen, O; Vestergaard, H				Thomsen, Stine B.; Gjesing, Anette P.; Rathcke, Camilla N.; Ekstrom, Claus T.; Eiberg, Hans; Hansen, Torben; Pedersen, Oluf; Vestergaard, Henrik			Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; CHITINASE 3-LIKE 1; SERUM YKL-40; ENDOTHELIAL DYSFUNCTION; INSULIN SENSITIVITY; PROMOTER REGION; PLASMA YKL-40; CHI3L1; BIOMARKER; DISEASE	Introduction Circulating levels of the inflammatory marker YKL-40 are elevated in cardiovascular disease and obesity-related type 2 diabetes (T2D), and serum YKL-40 levels are related to elements of dyslipidaemia. Objective We aimed to investigate the associations between serum YKL-40 and obesity-related traits in a Danish sample of non-diabetic relatives to T2D patients and, furthermore, to estimate the heritability of YKL-40. Research Design and Methods 324 non-diabetic individuals with family relation to a T2D patient were included in the study. The participants underwent oral-and intravenous glucose tolerance tests for estimation of glucose tolerance and surrogate measures of insulin sensitivity. Anthropometric measures were retrieved and biochemical measures of the plasma lipid profile and serum YKL-40 levels were obtained. Association-analyses between serum YKL-40 and obesity-related traits and estimates of the narrow sense heritability of YKL-40 were based on a polygenic variance component model. Results Fasting serum levels of YKL-40 were positively associated with waist-hip-ratio (p<0.001) and fasting plasma triglyceride levels (p<0.001). None of the insulin sensitivity indexes were significantly associated with YKL-40. According to the AE model, the familiality-estimate h(2) of YKL-40 was 0.45 (SE 0.13). When the ACE-model was applied, the heritability-estimate h(2) of YKL-40 did not reach statistical significance. Conclusions Our results suggest a role of serum YKL-40 in obesity-related low grade inflammation, but do not indicate that YKL-40 is directly involved in the development of T2D.	[Thomsen, Stine B.; Gjesing, Anette P.; Hansen, Torben; Pedersen, Oluf; Vestergaard, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Rathcke, Camilla N.] Copenhagen Univ Hosp, Dept Med, Ctr Endocrinol & Metab, Herlev, Denmark; [Ekstrom, Claus T.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Biostat, Copenhagen, Denmark; [Eiberg, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Hansen, Torben] Univ Southern Denmark, Sect Mol Diabet & Metab, Inst Clin Res, Odense, Denmark; [Hansen, Torben] Univ Southern Denmark, Inst Mol Med, Fac Hlth Sci, Odense, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of Southern Denmark; University of Copenhagen; Aarhus University	Thomsen, SB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark.	sbt@dadlnet.dk	Gjesing, Anette/ACC-7521-2022; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019	Gjesing, Anette/0000-0003-4580-1576; Pedersen, Oluf/0000-0002-3321-3972; Ekstrom, Claus Thorn/0000-0003-1191-373X; Vestergaard, Henrik/0000-0003-3090-269X	Novo Nordisk Foundation; Research Foundation of Copenhagen University Hospital Herlev; Jacobsen Foundation; A.P. Moeller and wife Chastine McKinney Moeller Foundation; Novo Nordisk Fonden [NNF11OC1014593] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Foundation of Copenhagen University Hospital Herlev; Jacobsen Foundation; A.P. Moeller and wife Chastine McKinney Moeller Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by grants from The Novo Nordisk Foundation, The Research Foundation of Copenhagen University Hospital Herlev, The Jacobsen Foundation and The A.P. Moeller and wife Chastine McKinney Moeller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE401, DOI 10.1152/ajpendo.00674.2007; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ANDERSEN L, 1993, CLIN CHEM, V39, P578; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Brix JM, 2011, EUR J CLIN INVEST, V41, P589, DOI 10.1111/j.1365-2362.2010.02446.x; Catalan V, 2011, J CLIN ENDOCR METAB, V96, P200, DOI 10.1210/jc.2010-0994; Gjesing AP, 2012, DIABETOLOGIA, V55, P1338, DOI 10.1007/s00125-012-2484-6; Gjesing AP, 2014, DIABETOLOGIA, V57, P1173, DOI 10.1007/s00125-014-3207-y; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hansen T, 2001, DIABETOLOGIA, V44, P1330, DOI 10.1007/s001250100651; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Hempen M, 2009, OBES SURG, V19, P1557, DOI 10.1007/s11695-009-9917-4; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Kjaergaard AD, 2013, J MED GENET, V50, P831, DOI 10.1136/jmedgenet-2013-101908; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Michelsen AE, 2010, ATHEROSCLEROSIS, V211, P589, DOI 10.1016/j.atherosclerosis.2010.02.035; Mygind ND, 2011, INFLAMM RES, V60, P281, DOI 10.1007/s00011-010-0266-5; Nielsen AR, 2008, DIABETES, V57, P3078, DOI 10.2337/db08-0182; Nielsen KR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3391; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2009, DIABETES CARE, V32, P323, DOI 10.2337/dc08-1144; Rathcke CN, 2006, INFLAMM RES, V55, P53, DOI 10.1007/s00011-005-0010-8; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Rondbjerg AK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-54; Shao R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00122; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Thomsen SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047094; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; World Health Organization, 1999, WHO DIAGN CLASS DI 1; Zhao XZ, 2007, AM J HUM GENET, V80, P12, DOI 10.1086/510438; Zhao YF, 2006, INT J BIOCHEM CELL B, V38, P804, DOI 10.1016/j.biocel.2005.11.008; Zheng JL, 2011, CYTOKINE, V54, P51, DOI 10.1016/j.cyto.2010.12.018	44	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133672	10.1371/journal.pone.0133672	http://dx.doi.org/10.1371/journal.pone.0133672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197239	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600132
J	Wang, R; Ma, JQ; Niu, G; Zheng, J; Liu, Z; Du, YH; Yu, BL; Yang, J				Wang, Rong; Ma, Jiaqi; Niu, Gang; Zheng, Jie; Liu, Zhe; Du, Yonghao; Yu, Bolang; Yang, Jian			Differentiation between Solitary Cerebral Metastasis and Astrocytoma on the Basis of Subventricular Zone Involvement on Magnetic Resonance Imaging	PLOS ONE			English	Article							NERVOUS-SYSTEM TUMORS; HIGH-GRADE GLIOMA; GLIOBLASTOMA-MULTIFORME; BRAIN-TUMORS; STEM-CELLS; VOLUMETRIC ASSESSMENT; SUBEPENDYMAL PLATE; ANGIOGENESIS; SURVIVAL; MRI	Purpose To determine the relationship between the subventricular zone (SVZ) and astrocytoma based on magnetic resonance imaging (MRI) and whether SVZ involvement can be used to distinguish solitary cerebral metastases (SCMs) from astrocytomas. Methods This retrospective study involved 154 patients with solitary low-grade astrocytoma (LGA), high-grade astrocytoma (HGA), and SCM, who underwent T1-weighted imaging (T1WI), Gd-DTPA-enhanced T1WI, and T2-weighted imaging (T2WI) or fluid-attenuated inversion recovery (FLAIR) T2WI. The spatial relationship between the tumor and SVZ was classified as "involvement" or "segregation" on contrast-enhanced T1WI for enhanced tumors and T2WI/FLAIR T2WI for non-enhanced tumors. Patient-based SVZ-contact rates were compared between the LGA, HGA, and SCM groups. The frequencies of involvement of various lateral ventricle regions by astrocytoma were compared. The correlation between SVZ involvement and tumor necrosis was analyzed. Results Patient-based SVZ-contact rates in SCM, LGA, and HGA were 24.1%, 68.8%, and 85.4%, respectively. Univariate analysis showed that the SVZ-contact rate was significantly different between SCM and astrocytoma (24.1% vs. 75.2% P < 0.001), also between LGA and HGA (68.1% vs. 85.4% P=0.037). After the tumor volume was adjusted as a covariate, SVZ-contact rates still differed between SCMs and astrocytomas (Odds ratio [OR]: 4.58, 95% Confidence interval [CI]: 1.65 to 12.8, P=0.004). Tumor volume differed between LGA and HGA (P < 0.001), and influenced the association between SVZ involvement and astrocytoma grade (P = 0.05). Among the lateral ventricle regions, the frontal horn was the most frequently involved by astrocytomas. SVZ-contact rates were higher in necrosis group compared with non-necrosis groups (83.9% vs. 50.0%, P < 0.001) among astrocytoma patients. Necrosis positively correlated with SVZ involvement in astrocytomas (r(s) = 0.342, P < 0.001), but did not correlate with SVZ involvement in SCMs (P = 0.193). Conclusions Compared to SCMs, solitary cerebral astrocytomas exhibited spatial proximity to the SVZ, which might distinguish the supratentorial astrocytomas from SCMs.	[Wang, Rong; Ma, Jiaqi; Niu, Gang; Liu, Zhe; Du, Yonghao; Yu, Bolang; Yang, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian 710049, Shaanxi, Peoples R China; [Zheng, Jie] Xi An Jiao Tong Univ, Affiliated Hosp 1, Clin Res Ctr, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian 710049, Shaanxi, Peoples R China.	cjr.yangjian@vip.163.com		ZHENG, JIE/0000-0003-4958-2091	National Natural Science Foundation of China [30970797, 81201134]; New Century Excellent Talent Support Plan from Ministry of Education of China [NCET-11-0438]; Fund for National Clinical Key Specialty from Ministry of Health of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talent Support Plan from Ministry of Education of China; Fund for National Clinical Key Specialty from Ministry of Health of China	This work was supported by the grant from National Natural Science Foundation of China (No. 30970797 to JY, 81201134 to RW), the 2011 New Century Excellent Talent Support Plan from Ministry of Education of China (NCET-11-0438) and the Fund for the National Clinical Key Specialty from the Ministry of Health of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Barami K, 2009, J CLIN NEUROSCI, V16, P195, DOI 10.1016/j.jocn.2008.03.006; Blanchet L, 2011, AM J NEURORADIOL, V32, P67, DOI 10.3174/ajnr.A2269; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Chen LD, 2013, INT J RADIAT ONCOL, V86, P616, DOI 10.1016/j.ijrobp.2013.02.014; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Goebell E, 2006, RADIOLOGY, V239, P217, DOI 10.1148/radiol.2383050059; Hakyemez B, 2010, CLIN RADIOL, V65, P15, DOI 10.1016/j.crad.2009.09.005; HOPEWELL JW, 1975, J PATHOL, V117, P101, DOI 10.1002/path.1711170208; Hwang TL, 1996, CANCER, V77, P1551; Jafri NF, 2013, NEURO-ONCOLOGY, V15, P91, DOI 10.1093/neuonc/nos268; Jamshidi N, 2014, RADIOLOGY, V270, P212, DOI 10.1148/radiol.13130078; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANTOS PL, 1976, EXPERIENTIA, V32, P1467, DOI 10.1007/BF01937439; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lee EJ, 2013, CLIN RADIOL, V68, pE689, DOI 10.1016/j.crad.2013.06.021; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Marsh JC, 2011, INT J RAD ONCOL BIOL; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Nimsky C, 2004, NEUROSURGERY, V55, P358, DOI 10.1227/01.NEU.0000129694.64671.91; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Quinones-Hinojosa A, 2007, EXP NEUROL, V205, P313, DOI 10.1016/j.expneurol.2007.03.016; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Rhoton AL, 2002, NEUROSURGERY, V51, pS207, DOI 10.1227/01.NEU.0000028161.91504.4F; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Schellinger PD, 1999, J NEURO-ONCOL, V44, P275, DOI 10.1023/A:1006308808769; SIMPSON JR, 1993, INT J RADIAT ONCOL, V26, P239, DOI 10.1016/0360-3016(93)90203-8; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Talos IF, 2007, ACAD RADIOL, V14, P431, DOI 10.1016/j.acra.2007.01.033; Tsuchiya K, 2005, BRIT J RADIOL, V78, P533, DOI 10.1259/bjr/68749637; Vergani F, 2011, NEUROSURGERY, V68, P1293, DOI 10.1227/NEU.0b013e31820b522a; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; VICK NA, 1977, ACTA NEUROPATHOL, V40, P63, DOI 10.1007/BF00688574; Zhong H, 1999, CANCER RES, V59, P5830; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	39	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133480	10.1371/journal.pone.0133480	http://dx.doi.org/10.1371/journal.pone.0133480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197398	gold, Green Submitted, Green Published			2022-12-27	WOS:000358547600103
J	Chong, YH; Pankhurst, MW; McLennan, IS				Chong, Yih Harng; Pankhurst, Michael W.; McLennan, Ian S.			The Daily Profiles of Circulating AMH and INSL3 in Men are Distinct from the Other Testicular Hormones, Inhibin B and Testosterone	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; INSULIN-LIKE FACTOR-3; ANTIMULLERIAN HORMONE; IMMUNOREACTIVE INHIBIN; LUTEINIZING-HORMONE; CIRCADIAN-RHYTHM; SERUM-LEVELS; HUMAN BLOOD; YOUNG MEN; GONADOTROPINS	The testes secrete four hormones (anti-Mullerian hormone, insulin-like peptide 3, Inhibin B and testosterone) from two endocrine cell types. It is unknown whether anti-Mullerian hormone and insulin-like peptide 3 levels have a diurnal variation, and if so, whether they covary during the day with testosterone and InhB. Sera were obtained from 13 men at 00:00, 06:00, 09:00, 12:00, 14:00, 17:00 and 19:00 hours and the levels of their testicular hormones measured by ELISA. A second cohort of 20 men was similarly examined with blood drawn at 19:00 and the following 06:00. Anti-Mullerian hormone levels exhibited a subtle diurnal pattern with a 19:00 peak that was 4.9% higher on average than the 06:00 nadir (p = 0.004). The decrease in anti-Mullerian hormone coincided with a rise in testosterone and InhB, but there was no association between the person-to-person variation in the diurnal patterns of anti-Mullerian hormone and testosterone or Inhibin B. Insulin-like peptide 3 had no diurnal pattern, with only minor sporadic variation between time points being observed in some men. In conclusion, the diurnal and sporadic variation of each testicular hormone is distinct, indicating that the major regulation is at the level of the hormone rather than at the endocrine cell type. Consequently, the balance of the hormones being released by the testes has complex variation during the day. The physiological significance of this will vary depending on which combinations of testicular hormones that the target cells respond to.	[Chong, Yih Harng; Pankhurst, Michael W.; McLennan, Ian S.] Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Chong, Yih Harng] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; [McLennan, Ian S.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	McLennan, IS (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand.	ian.mclennan@otago.ac.nz	Pankhurst, Michael/F-2585-2017	Pankhurst, Michael/0000-0002-0976-5742	Ministry of Business, Innovation and Employment, New Zealand; Frances Cotter PhD Scholarship (Dunedin School of Medicine, University of Otago)	Ministry of Business, Innovation and Employment, New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Frances Cotter PhD Scholarship (Dunedin School of Medicine, University of Otago)	This study was funded by the Ministry of Business, Innovation and Employment, New Zealand. YHC was a recipient of the Frances Cotter PhD Scholarship (Dunedin School of Medicine, University of Otago). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand-Ivell R, 2006, INT J ANDROL, V29, P618, DOI 10.1111/j.1365-2605.2006.00714.x; Appt SE, 2012, MENOPAUSE, V19, P1353, DOI 10.1097/gme.0b013e31825b4fe2; Axelsson J, 2005, J CLIN ENDOCR METAB, V90, P4530, DOI 10.1210/jc.2005-0520; Bay K, 2005, J CLIN ENDOCR METAB, V90, P3410, DOI 10.1210/jc.2004-2257; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Bungum L, 2011, HUM REPROD, V26, P678, DOI 10.1093/humrep/deq380; Carlsen E, 1999, J CLIN ENDOCR METAB, V84, P1664, DOI 10.1210/jc.84.5.1664; Chong YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070967; CHRISTENSEN RB, 1994, J ANDROL, V15, P125; de Kretser DM, 2000, MOL CELL ENDOCRINOL, V161, P43, DOI 10.1016/S0303-7207(99)00222-1; Dennis NA, 2013, J ENDOCRINOL, V219, P13, DOI 10.1530/JOE-13-0125; Diver MJ, 2003, CLIN ENDOCRINOL, V58, P710, DOI 10.1046/j.1365-2265.2003.01772.x; Eldar-Geva T, 2010, EUR J ENDOCRINOL, V162, P177, DOI 10.1530/EJE-09-0366; ELDER PA, 1985, J STEROID BIOCHEM, V22, P635, DOI 10.1016/0022-4731(85)90217-1; Ferlin A, 2013, NAT REV ENDOCRINOL, V9, P548, DOI 10.1038/nrendo.2013.135; Griesinger G, 2012, J CLIN ENDOCR METAB, V97, P2160, DOI 10.1210/jc.2012-1070; Ivell R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108969; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Lehtihet M, 2012, ANDROLOGIA, V44, P405, DOI 10.1111/j.1439-0272.2012.01296.x; Luboshitzky R, 1999, J ANDROL, V20, P731; Nicks Kristy M, 2010, Curr Osteoporos Rep, V8, P60, DOI 10.1007/s11914-010-0014-3; Pankhurst MW, 2014, FERTIL STERIL, V101, P846, DOI 10.1016/j.fertnstert.2013.12.009; Pankhurst MW, 2013, AM J PHYSIOL-ENDOC M, V305, pE1241, DOI 10.1152/ajpendo.00395.2013; Roney JR, 2007, HORM BEHAV, V52, P326, DOI 10.1016/j.yhbeh.2007.05.008; Stewart J, 2013, BIRTH DEFECTS RES B, V98, P104, DOI 10.1002/bdrb.21049; TENOVER JS, 1991, J GERONTOL, V46, pM181, DOI 10.1093/geronj/46.5.M181; Trumble BC, 2013, EVOL HUM BEHAV, V34, P350, DOI 10.1016/j.evolhumbehav.2013.06.002; VELDHUIS JD, 1987, J CLIN ENDOCR METAB, V65, P929, DOI 10.1210/jcem-65-5-929; Veldhuis JD, 2010, EUR J ENDOCRINOL, V162, P787, DOI 10.1530/EJE-09-1085; VIGIER B, 1983, J REPROD FERTIL, V69, P207; WINTERS SJ, 1990, J CLIN ENDOCR METAB, V70, P548, DOI 10.1210/jcem-70-2-548; YAMAGUCHI M, 1991, J CLIN ENDOCR METAB, V72, P554, DOI 10.1210/jcem-72-3-554; Young J, 1999, J CLIN ENDOCR METAB, V84, P2696, DOI 10.1210/jc.84.8.2696	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133637	10.1371/journal.pone.0133637	http://dx.doi.org/10.1371/journal.pone.0133637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192622	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400110
J	Gonzalez-Morales, N; Mendoza-Ortiz, MA; Blowes, LM; Missirlis, F; Riesgo-Escovar, JR				Gonzalez-Morales, Nicanor; Angel Mendoza-Ortiz, Miguel; Blowes, Liisa M.; Missirlis, Fanis; Riesgo-Escovar, Juan R.			Ferritin Is Required in Multiple Tissues during Drosophila melanogaster Development	PLOS ONE			English	Article							IRON-METABOLISM; MULTICOPPER OXIDASE-1; H-FERRITIN; MALVOLIO; HOMOLOG; OVEREXPRESSION; PROTEINS; STORAGE; CHAIN; ACCUMULATION	In Drosophila melanogaster, iron is stored in the cellular endomembrane system inside a protein cage formed by 24 ferritin subunits of two types (Fer1HCH and Fer2LCH) in a 1: 1 stoichiometry. In larvae, ferritin accumulates in the midgut, hemolymph, garland, pericardial cells and in the nervous system. Here we present analyses of embryonic phenotypes for mutations in Fer1HCH, Fer2LCH and in both genes simultaneously. Mutations in either gene or deletion of both genes results in a similar set of cuticular embryonic phenotypes, ranging from non-deposition of cuticle to defects associated with germ band retraction, dorsal closure and head involution. A fraction of ferritin mutants have embryonic nervous systems with ventral nerve cord disruptions, misguided axonal projections and brain malformations. Ferritin mutants die with ectopic apoptotic events. Furthermore, we show that ferritin maternal contribution, which varies reflecting the mother's iron stores, is used in early development. We also evaluated phenotypes arising from the blockage of COPII transport from the endoplasmic reticulum to the Golgi apparatus, feeding the secretory pathway, plus analysis of ectopically expressed and fluorescently marked Fer1HCH and Fer2LCH. Overall, our results are consistent with insect ferritin combining three functions: iron storage, intercellular iron transport, and protection from iron-induced oxidative stress. These functions are required in multiple tissues during Drosophila embryonic development.	[Gonzalez-Morales, Nicanor; Angel Mendoza-Ortiz, Miguel; Blowes, Liisa M.; Missirlis, Fanis; Riesgo-Escovar, Juan R.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro 76230, Mexico	Universidad Nacional Autonoma de Mexico	Riesgo-Escovar, JR (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Campus UNAM Juriquilla, Queretaro 76230, Mexico.	juanriesgo@prodigy.net.mx	Missirlis, Fanis/C-1137-2011	Missirlis, Fanis/0000-0003-0467-8444; Gonzalez-Morales, Nicanor/0000-0003-1305-8992; Blowes, Liisa/0000-0002-9614-9074	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [164428, 177962]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN203110]; Universidad Nacional Autonoma de Mexico laboratory	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico laboratory	Miguel Angel Mendoza-Ortiz is a PhD student in the Programa de Doctorado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico (UNAM), and received a PhD fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACYT) [164428]. This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT) [177962 to J.R.R.E.], Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN203110 to J.R.R.E], and Universidad Nacional Autonoma de Mexico laboratory budget to J.R.R.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Bettedi L, 2011, J EXP BIOL, V214, P971, DOI 10.1242/jeb.051664; Biffar L, 2014, DEV BIOL, V388, P103, DOI 10.1016/j.ydbio.2014.01.028; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; D'Souza J, 1999, J EXP BIOL, V202, P1909; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Denton D, 2008, METHOD ENZYMOL, V446, P17, DOI 10.1016/S0076-6879(08)01602-9; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Evans IR, 2011, CURR BIOL, V21, pR173, DOI 10.1016/j.cub.2011.01.061; Fisher J, 2007, AM J PHYSIOL-CELL PH, V293, pC641, DOI 10.1152/ajpcell.00599.2006; Folwell JL, 2006, J EXP BIOL, V209, P1988, DOI 10.1242/jeb.02193; Galay RL, 2013, J EXP BIOL, V216, P1905, DOI 10.1242/jeb.081240; Gambis A, 2011, DEV BIOL, V351, P128, DOI 10.1016/j.ydbio.2010.12.040; Georgieva T, 2002, INSECT BIOCHEM MOLEC, V32, P295, DOI 10.1016/S0965-1748(01)00090-X; Georgieva T, 1999, P NATL ACAD SCI USA, V96, P2716, DOI 10.1073/pnas.96.6.2716; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Gutierrez L, 2013, METALLOMICS, V5, P997, DOI 10.1039/c3mt00118k; Gutierrez L, 2010, FEBS LETT, V584, P2942, DOI 10.1016/j.febslet.2010.05.029; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; Hamburger AE, 2005, J MOL BIOL, V349, P558, DOI 10.1016/j.jmb.2005.03.074; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Kosmidis S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00066; Kosmidis S, 2011, NEUROBIOL DIS, V43, P213, DOI 10.1016/j.nbd.2011.03.013; Kumar S, 2011, BIOINFORMATICS, V27, P3319, DOI 10.1093/bioinformatics/btr567; Lang ML, 2012, P NATL ACAD SCI USA, V109, P13337, DOI 10.1073/pnas.1208703109; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Lind MI, 2006, J BIOL CHEM, V281, P18707, DOI 10.1074/jbc.M603354200; Mandilaras K, 2013, NUTRIENTS, V5, P1622, DOI 10.3390/nu5051622; Mandilaras K, 2012, METALLOMICS, V4, P928, DOI 10.1039/c2mt20065a; Mehta A, 2009, BIOCHIMIE, V91, P1331, DOI 10.1016/j.biochi.2009.05.003; Metzendorf C, 2009, BIOCHEM J, V421, P463, DOI 10.1042/BJ20082231; Meyron-Holtz EG, 2011, J NEURAL TRANSM, V118, P337, DOI 10.1007/s00702-011-0582-0; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150; Na JB, 2013, J AM SOC NEPHROL, V24, P161, DOI 10.1681/ASN.2012121227; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Peng ZY, 2015, INSECT BIOCHEM MOLEC, V59, P58, DOI 10.1016/j.ibmb.2015.02.005; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; RODRIGUES V, 1995, EMBO J, V14, P3007, DOI 10.1002/j.1460-2075.1995.tb07303.x; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Sheftel AD, 2012, BBA-GEN SUBJECTS, V1820, P161, DOI 10.1016/j.bbagen.2011.08.002; Spradling AC, 1999, GENETICS, V153, P135; Tang XN, 2013, FASEB J, V27, P288, DOI 10.1096/fj.12-213595; Tennessen JM, 2014, G3-GENES GENOM GENET, V4, P839, DOI 10.1534/g3.114.010652; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Todorich B, 2008, J NEUROCHEM, V107, P1495, DOI 10.1111/j.1471-4159.2008.05678.x; Uhrigshardt H, 2013, J BIOL INORG CHEM, V18, P441, DOI 10.1007/s00775-013-0988-2; Wu ZH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.018; XU T, 1993, DEVELOPMENT, V117, P1223; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	62	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133499	10.1371/journal.pone.0133499	http://dx.doi.org/10.1371/journal.pone.0133499			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192321	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400096
J	Khan, AU; Mikut, R; Reischl, M				Khan, Arif ul Maula; Mikut, Ralf; Reischl, Markus			A Benchmark Data Set to Evaluate the Illumination Robustness of Image Processing Algorithms for Object Segmentation and Classification	PLOS ONE			English	Article							VISION	Developers of image processing routines rely on benchmark data sets to give qualitative comparisons of new image analysis algorithms and pipelines. Such data sets need to include artifacts in order to occlude and distort the required information to be extracted from an image. Robustness, the quality of an algorithm related to the amount of distortion is often important. However, using available benchmark data sets an evaluation of illumination robustness is difficult or even not possible due to missing ground truth data about object margins and classes and missing information about the distortion. We present a new framework for robustness evaluation. The key aspect is an image benchmark containing 9 object classes and the required ground truth for segmentation and classification. Varying levels of shading and background noise are integrated to distort the data set. To quantify the illumination robustness, we provide measures for image quality, segmentation and classification success and robustness. We set a high value on giving users easy access to the new benchmark, therefore, all routines are provided within a software package, but can as well easily be replaced to emphasize other aspects.	[Khan, Arif ul Maula; Mikut, Ralf; Reischl, Markus] Karlsruhe Inst Technol, Inst Appl Comp Sci, Image & Data Anal Grp, D-76021 Karlsruhe, Baden Wuerttemb, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Reischl, M (corresponding author), Karlsruhe Inst Technol, Inst Appl Comp Sci, Image & Data Anal Grp, D-76021 Karlsruhe, Baden Wuerttemb, Germany.	markus.reischl@kit.edu	Reischl, Markus/H-6970-2013; Mikut, Ralf/A-5949-2013	Reischl, Markus/0000-0002-7780-6374; Mikut, Ralf/0000-0001-9100-5496	German Academic Exchange Service (DAAD); BioInterfaces International Graduate School (BIF-IGS) in KIT; Helmholtz Association	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); BioInterfaces International Graduate School (BIF-IGS) in KIT; Helmholtz Association(Helmholtz Association)	The first author has received funding from German Academic Exchange Service (DAAD: https://www.daad.de/de/). The role of DAAD is to provide research opportunities for international students in Germany. The authors also acknowledge BioInterfaces International Graduate School (BIF-IGS) in KIT and Helmholtz Association for supporting this research work.	Anderson E., 1935, B AM IRIS SOC, V59, P2; Bock R, 2009, DATA ANAL TECHNIQUES; Boehme HJ, 1999, GESTURE BASED COMMUN; Brosnan T, 2004, J FOOD ENG, V61, P3, DOI 10.1016/S0260-8774(03)00183-3; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Du CJ, 2004, TRENDS FOOD SCI TECH, V15, P230, DOI 10.1016/j.tifs.2003.10.006; Forina M., 1991, PARVUS EXTENDIBLE PA; Ge F, 2007, J ELECTRON IMAGING, V16, DOI 10.1117/1.2762250; Gelasca ED, 2008, IEEE IMAGE PROC, P1816, DOI 10.1109/ICIP.2008.4712130; Guthaus MR, 2001, WWC-4: IEEE INTERNATIONAL WORKSHOP ON WORKLOAD CHARACTERIZATION, P3, DOI 10.1109/WWC.2001.990739; Escalante HJ, 2010, COMPUT VIS IMAGE UND, V114, P419, DOI 10.1016/j.cviu.2009.03.008; Kavoussanos M, 1998, INT J ADV MANUF TECH, V14, P358, DOI 10.1007/BF01178915; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Malamas EN, 2003, IMAGE VISION COMPUT, V21, P171, DOI 10.1016/S0262-8856(02)00152-X; Nickel K, 2007, IMAGE VISION COMPUT, V25, P1875, DOI 10.1016/j.imavis.2005.12.020; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Patil G, 2013, INT J ADV RES COMPUT, V3, P196; Ruusuvuori P., 2008, P 16 EUR SIGN PROC C; Sobel I, 1968, A3 3 ISOTORPIC GRADI; Stallkamp J, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1453, DOI 10.1109/IJCNN.2011.6033395; Stegmaier J., 2012, BIOMED TECH, V57, P458; Stegmaier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090036; Wang W H, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2219; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131098	10.1371/journal.pone.0131098	http://dx.doi.org/10.1371/journal.pone.0131098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191792	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400010
J	Rhee, J; Kim, R; Kim, Y; Tam, M; Lai, YZ; Keum, N; Oldenburg, CE				Rhee, Jongeun; Kim, Rockli; Kim, Yongjoo; Tam, Melanie; Lai, Yizhen; Keum, NaNa; Oldenburg, Catherine Elizabeth			Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; ENVIRONMENTAL TOBACCO-SMOKE; COFFEE CONSUMPTION; FETAL-GROWTH; PRETERM BIRTH; SPONTANEOUS-ABORTION; EXPOSURE; ASSOCIATION; OUTCOMES; METABOLISM	Epidemiologic studies have shown inconsistent conclusions about the effect of caffeine intake during pregnancy on the risk of low birth weight (LBW). We performed a meta-analysis and linear-dose response analysis examining the association between caffeine consumption during pregnancy and risk of LBW. PubMed and EMBASE were searched for relevant articles published up to March 2014. Eight cohort and four case-control studies met all inclusion criteria. Using a random-effects model of the twelve studies, the pooled odds ratio (OR) for the risk of LBW comparing the highest versus lowest level of caffeine intake during pregnancy was 1.38 (95% CI: 1.10, 1.73). Linear dose-response analysis showed that every additional 100 mg of caffeine intake (1 cup of coffee or 2 cups of tea) per day during pregnancy was associated with a 3.0% increase in OR for LBW. There was a moderate level of overall heterogeneity with an I-squared value of 55% (95% CI: 13, 76%), and no evidence of publication bias based on Egger's test (P = 0.20) and the funnel plot. Thus, high caffeine intake during pregnancy is associated with a significant increase in the risk of LBW, and this risk appears to increase linearly as caffeine intake increases.	[Rhee, Jongeun] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Kim, Rockli; Kim, Yongjoo] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Tam, Melanie] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Lai, Yizhen] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Keum, NaNa] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Keum, NaNa; Oldenburg, Catherine Elizabeth] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Rhee, J (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	jerhee@mail.harvard.edu	Kim, Rockli/W-3512-2019; Lai, Yizhen/AAF-8378-2021; Lai, Yizhen/M-7187-2015; Kim, Yongjoo/N-9751-2019	Kim, Yongjoo/0000-0002-0768-9256	NIAID NIH HHS [T32 AI007535] Funding Source: Medline; NIDA NIH HHS [T32 DA013911] Funding Source: Medline; NIMH NIH HHS [R25 MH083620] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447; ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310; Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; Azzeh F. S., 2013, Journal of Biological Sciences, V13, P417; Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792; Balat O, 2003, Clin Exp Obstet Gynecol, V30, P57; BISTOLETTI P, 1981, BIOL NEONATE, V40, P145; Bracken MB, 2003, AM J EPIDEMIOL, V157, P456, DOI 10.1093/aje/kwf220; Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288; CAAN BJ, 1989, AM J PUBLIC HEALTH, V79, P1299, DOI 10.2105/AJPH.79.9.1299; Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6; Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Daly JW, 2000, J AUTONOM NERV SYST, V81, P44, DOI 10.1016/S0165-1838(00)00110-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eskenazi B, 1999, EPIDEMIOLOGY, V10, P242, DOI 10.1097/00001648-199905000-00009; FENSTER L, 1991, AM J PUBLIC HEALTH, V81, P458, DOI 10.2105/AJPH.81.4.458; Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; GOLDING J, 1995, EARLY HUM DEV, V43, P1, DOI 10.1016/0378-3782(95)01660-U; GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x; Gynecologists ACoOa, 2010, MOD CAFF CONS PREGN; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horta BL, 1997, PAEDIATR PERINAT EP, V11, P140, DOI 10.1046/j.1365-3016.1997.d01-17.x; Infante-Rivard C, 2007, PAEDIATR PERINAT EP, V21, P300, DOI 10.1111/j.1365-3016.2007.00825.x; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Jarosz M, 2012, EUR J OBSTET GYN R B, V160, P156, DOI 10.1016/j.ejogrb.2011.11.021; KNUTTI R, 1981, EUR J CLIN PHARMACOL, V21, P121, DOI 10.1007/BF00637512; LARROQUE B, 1993, AM J EPIDEMIOL, V137, P941, DOI 10.1093/oxfordjournals.aje.a116764; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; LINN S, 1982, NEW ENGL J MED, V306, P141, DOI 10.1056/NEJM198201213060304; MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718; Maslova E, 2010, AM J CLIN NUTR, V92, P1120, DOI 10.3945/ajcn.2010.29789; MCDONALD AD, 1992, AM J PUBLIC HEALTH, V82, P87, DOI 10.2105/AJPH.82.1.87; MILLS JL, 1993, JAMA-J AM MED ASSOC, V269, P593, DOI 10.1001/jama.269.5.593; Momoi N, 2012, J OBSTET GYNAECOL RE, V38, P1343, DOI 10.1111/j.1447-0756.2012.01880.x; OLSEN J, 1991, EPIDEMIOLOGY, V2, P370, DOI 10.1097/00001648-199109000-00011; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Santos IS, 1998, AM J EPIDEMIOL, V147, P620, DOI 10.1093/oxfordjournals.aje.a009502; Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42; SOYKA LF, 1981, SEMIN PERINATOL, V5, P305; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TASSANEEYAKUL W, 1994, BIOCHEM PHARMACOL, V47, P1767, DOI 10.1016/0006-2952(94)90304-2; Tsutsumi K, 2001, CLIN PHARMACOL THER, V70, P121, DOI 10.1067/mcp.2001.116495; Windham GC, 2000, EPIDEMIOLOGY, V11, P427, DOI 10.1097/00001648-200007000-00011; Xue F, 2008, HUM REPROD, V23, P168, DOI 10.1093/humrep/dem316	48	55	56	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132334	10.1371/journal.pone.0132334	http://dx.doi.org/10.1371/journal.pone.0132334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193706	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400021
J	van Bakelen, NB; Vermeulen, KM; Buijs, GJ; Jansma, J; de Visscher, JGAM; Hoppenreijs, TJM; Bergsma, JE; Stegenga, B; Bos, RRM				van Bakelen, N. B.; Vermeulen, K. M.; Buijs, G. J.; Jansma, J.; de Visscher, J. G. A. M.; Hoppenreijs, Th. J. M.; Bergsma, J. E.; Stegenga, B.; Bos, R. R. M.			Cost-Effectiveness of a Biodegradable Compared to a Titanium Fixation System in Maxillofacial Surgery: A Multicenter Randomized Controlled Trial	PLOS ONE			English	Article							ORTHOGNATHIC SURGERY; MANDIBULAR FRACTURES; REMOVAL; OSTEOSYNTHESIS; STRENGTH; SCREWS; PLATES	Background Biodegradable fixation systems could reduce/delete the problems associated with titanium plate removal. This means less surgical discomfort, and a reduction in costs. Aim The aim of the present study was to compare the cost-effectiveness between a biodegradable and a titanium system in Maxillofacial surgery. Materials and Methods This multicenter RCT was performed in the Netherlands from December 2006 to July 2009. Included were 230 patients who underwent a bilateral sagittal split osteotomy (BSSO), a Le Fort-I osteotomy, or a bi-maxillary osteotomy and those treated for fractures of the mandible, maxilla, or zygoma. The patients were randomly assigned to a titanium group (KLS Martin) or to a biodegradable group (Inion CPS). Costs were assessed from a societal perspective. Health outcomes in the incremental cost-effectiveness ratio (ICER) were bone healing (8 weeks) and plate removal (2 years). Results In 25 out of the 117 patients who were randomized to the biodegradable group, the maxillofacial surgeon made the decision to switch to the titanium system intra-operatively. This resulted in an Intention-To-Treat (ITT-) analysis and a Treatment-Received (TR-) analysis. Both analyses indicated that operations performed with titanium plates and screws had better health outcomes. In the TR-analysis the costs were lower in the biodegradable group, in the ITT-analysis costs were lower in the titanium group. Conclusion and Discussion The difference in costs between the ITT and the TR analyses can be explained by the intra-operative switches: In the TR-analysis the switches were analysed in the titanium group. In the ITT-analysis they were analysed in the biodegradable group. Considering the cost-effectiveness the titanium system is preferable to the biodegradable system in the regular treatment spectrum of mandibular, Le Fort-I, and zygomatic fractures, and BSSO's, Le Fort-I osteotomies and bimaxillary osteotomies.	[van Bakelen, N. B.; Buijs, G. J.; Jansma, J.; Stegenga, B.; Bos, R. R. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [Vermeulen, K. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [de Visscher, J. G. A. M.] Med Ctr Leeuwarden, Dept Oral & Maxillofacial Surg, Leeuwarden, Netherlands; [Hoppenreijs, Th. J. M.] Rijnstate Hosp Arnhem, Dept Oral & Maxillofacial Surg, Arnhem, Netherlands; [Bergsma, J. E.] Amphia Hosp Breda, Dept Oral & Maxillofacial Surg, Breda, Netherlands; [Stegenga, B.] Univ Groningen, Univ Med Ctr Groningen, Ctr Dent & Oral Hyg, Dept Oral Hlth Care & Clin Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; Medical Center Leeuwarden; Rijnstate Hospital; Amphia Hospital; University of Groningen	van Bakelen, NB (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands.	n.b.van.bakelen@umcg.nl	Bergsma, je/AAE-9107-2021					Bakathir AA, 2008, ORAL SURG ORAL MED O, V105, pE32, DOI 10.1016/j.tripleo.2008.01.006; Bhatt K, 2010, J ORAL MAXIL SURG, V68, P1842, DOI 10.1016/j.joms.2009.09.005; BLACK WC, 1990, MED DECIS MAKING, V10, P212, DOI 10.1177/0272989X9001000308; BOSTMAN O, 1991, J TRAUMA, V31, P1400; Buijs GJ, 2012, J DENT RES, V91, P299, DOI 10.1177/0022034511434353; Buijs G, 2007, J ORAL MAXIL SURG, V65, P2148, DOI 10.1016/j.joms.2007.04.010; Buijs G, 2007, J ORAL MAXIL SURG, V65, P2142, DOI 10.1016/j.joms.2007.08.002; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ferretti C, 2008, INT J ORAL MAX SURG, V37, P242, DOI 10.1016/j.ijom.2007.11.015; Hakkaart-van Roijen L, 2010, GEACTUALISEERDE VERS, V2010; Kuhlefelt M, 2010, INT J ORAL MAX SURG, V39, P430, DOI 10.1016/j.ijom.2010.01.016; Laine P, 2004, INT J ORAL MAX SURG, V33, P240, DOI 10.1006/ijom.2003.0510; Landes CA, 2006, CLEFT PALATE-CRAN J, V43, P67, DOI 10.1597/04-167R1.1; Lee HB, 2010, J ORAL MAXIL SURG, V68, P2065, DOI 10.1016/j.joms.2009.08.004; Leonhardt H, 2008, BRIT J ORAL MAX SURG, V46, P631, DOI 10.1016/j.bjoms.2008.04.021; Manor Y, 1999, J ORAL MAXIL SURG, V57, P679, DOI 10.1016/S0278-2391(99)90430-5; Matthew IR, 1999, BRIT J ORAL MAX SURG, V37, P110, DOI 10.1054/bjom.1997.0084; Mazzonetto R, 2004, INT J ORAL MAX SURG, V33, P664, DOI 10.1016/j.ijom.2004.02.001; Nasser M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006087.pub3; Oomens MA, 2013, BR J ORAL MAXILLOFAC; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Stegenga Boudewijn, 1993, Journal of Orofacial Pain, V7, P183; van Bakelen NB, 2014, J CRANIO MAXILL SURG, V42, P417, DOI 10.1016/j.jcms.2013.05.032	23	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0130330	10.1371/journal.pone.0130330	http://dx.doi.org/10.1371/journal.pone.0130330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192813	gold, Green Published, Green Submitted			2022-12-27	WOS:000358546400005
J	van Poppel, PCM; Breedveld, P; Abbink, EJ; Roelofs, H; van Heerde, W; Smits, P; Lin, WZ; Tan, AH; Russel, FG; Donders, R; Tack, CJ; Rongen, GA				van Poppel, Pleun C. M.; Breedveld, Pauline; Abbink, Evertine J.; Roelofs, Hennie; van Heerde, Waander; Smits, Paul; Lin, Wenzhi; Tan, Aaitje H.; Russel, Frans G.; Donders, Rogier; Tack, Cees J.; Rongen, Gerard A.			Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ESSENTIAL-HYPERTENSION; BOILED COFFEE; NITRIC-OXIDE; DISEASE; CHOLESTEROL; PLASMA; THERAPY; PRODUCTS; QUALITY	Purpose Danshen is the dried root extract of the plant Salvia Miltiorrhiza and it is used as traditional Chinese medicinal herbal product to prevent and treat atherosclerosis. However, its efficacy has not been thoroughly investigated. This study evaluates the effect of Danshen on hyperlipidemia and hypertension, two well known risk factors for the development of atherosclerosis. Methods This was a randomized, placebo-controlled, double-blind crossover study performed at a tertiary referral center. Participants were recruited by newspaper advertisement and randomized to treatment with Danshen (water-extract of the Salvia Miltiorrhiza root) or placebo for 4 consecutive weeks. There was a wash out period of 4 weeks. Of the 20 analysed participants, 11 received placebo first. Inclusion criteria were: age 40-70 years, hyperlipidemia and hypertension. At the end of each treatment period, plasma lipids were determined (primary outcome), 24 hours ambulant blood pressure measurement (ABPM) was performed, and vasodilator endothelial function was assessed in the forearm. Results LDL cholesterol levels were 3.82 +/- 0.14 mmol/l after Danshen and 3.52 +/- 0.16 mmol/l after placebo treatment (mean +/- SE; p<0.05 for treatment effect corrected for baseline). Danshen treatment had no effect on blood pressure (ABPM 138/84 after Danshen and 136/87 after placebo treatment). These results were further substantiated by the observation that Danshen had neither an effect on endothelial function nor on markers of inflammation, oxidative stress, glucose metabolism, hemostasis and blood viscosity. Conclusion Four weeks of treatment with Danshen (water-extract) slightly increased LDL-cholesterol without affecting a wide variety of other risk markers. These observations do not support the use of Danshen to prevent or treat atherosclerosis.	[van Poppel, Pleun C. M.; Tack, Cees J.; Rongen, Gerard A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Abbink, Evertine J.] Radboud Univ Nijmegen, Med Ctr, Clin Res Ctr Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Roelofs, Hennie] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, NL-6525 ED Nijmegen, Netherlands; [van Heerde, Waander] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6525 ED Nijmegen, Netherlands; [Breedveld, Pauline; Smits, Paul; Russel, Frans G.; Rongen, Gerard A.] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands; [Donders, Rogier] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Lin, Wenzhi] Med Ctr Balans, The Hague, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Rongen, GA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	gerard.rongen@radboudumc.nl	Rongen, Gerard A/C-1578-2018; van Heerde, Waander/L-4357-2015; Smits, P.A.B.M./E-2889-2015; Russel, Frans G.M./B-3184-2014; Rongen, Gerard/AAJ-9694-2021; Donders, A.R.T./L-4277-2015; Tack, Cees J/A-2368-2014	van Heerde, Waander/0000-0001-7101-8775; Russel, Frans G.M./0000-0002-7959-2314; Donders, A.R.T./0000-0002-0484-1419; 	Cinmar Pharma BV, 's Hertogenbosch, the Netherlands; Department of Pharmacology-Toxicology, Radboud university medical centre, Nijmegen, the Netherlands; Dutch Association of Acupuncture Medicine (NAAV, Amsterdam, the Netherlands)	Cinmar Pharma BV, 's Hertogenbosch, the Netherlands; Department of Pharmacology-Toxicology, Radboud university medical centre, Nijmegen, the Netherlands; Dutch Association of Acupuncture Medicine (NAAV, Amsterdam, the Netherlands)	This study was financed by Cinmar Pharma BV, 's Hertogenbosch, the Netherlands, Department of Pharmacology-Toxicology, Radboud university medical centre, Nijmegen, the Netherlands, and the Dutch Association of Acupuncture Medicine (NAAV, Amsterdam, the Netherlands). Cinmar Pharma had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AHT is a representative of NAAV and was involved in preparation of the manuscript. He nor NAAV have any financial interest in Danshen.	AHOLA I, 1991, J INTERN MED, V230, P293, DOI 10.1111/j.1365-2796.1991.tb00447.x; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; BAK AAA, 1989, NEW ENGL J MED, V321, P1432, DOI 10.1056/NEJM198911233212103; BENJAMIN N, 1995, HYPERTENSION, V25, P918, DOI 10.1161/01.HYP.25.5.918; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gluckman TJ, 2004, ARCH INTERN MED, V164, P1490, DOI 10.1001/archinte.164.14.1490; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Joyner MJ, 1985, J APPL PHYSIOL, V83, P1785; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; Klingbeil AU, 2003, AM J HYPERTENS, V16, P123, DOI 10.1016/S0895-7061(02)03154-0; LENDERS J, 1991, CLIN SCI, V80, P413, DOI 10.1042/cs0800413; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; On YK, 2002, HYPERTENS RES, V25, P365, DOI 10.1291/hypres.25.365; Pitt B, 1996, CARDIOVASC DRUG THER, V10, P469, DOI 10.1007/BF00051113; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Senn S., 2002, CROSS OVER TRIALS CL, V5; Sieveking DP, 2005, INT J CARDIOL, V105, P40, DOI 10.1016/j.ijcard.2004.10.052; Tachjian A, 2010, J AM COLL CARDIOL, V55, P515, DOI 10.1016/j.jacc.2009.07.074; Tan Y, 2011, CLIN SCI, V120, P297, DOI 10.1042/CS20100441; TREASURE CB, 1995, NEW ENGL J MED, V332, P481, DOI 10.1056/NEJM199502233320801; van Geffen M, 2011, HEMATOLOGY, V16, P327, DOI 10.1179/102453311X13085644680348; van Tits LJH, 2001, FREE RADICAL BIO MED, V30, P1122, DOI 10.1016/S0891-5849(01)00519-6; WEUSTENVANDERWOUW MPME, 1994, J LIPID RES, V35, P721; WHO, 2014, TOP 10 CAUS DEATH WO; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Williamson EM, 2013, J ETHNOPHARMACOL, V149, P453, DOI 10.1016/j.jep.2013.06.050; Wu B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004295.pub3; Wu TX, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004465.pub2; Yu SC, 2009, J ALTERN COMPLEM MED, V15, P557, DOI 10.1089/acm.2008.0436; Yu XY, 2007, XENOBIOTICA, V37, P375, DOI 10.1080/00498250701230559; Zanchetti A, 2004, BLOOD PRESSURE, V13, P17, DOI 10.1080/08038020410016548; Zhou LM, 2006, J PHARMACEUT BIOMED, V41, P744, DOI 10.1016/j.jpba.2005.12.032; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	39	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0128695	10.1371/journal.pone.0128695	http://dx.doi.org/10.1371/journal.pone.0128695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192328	Green Submitted, Green Published, gold			2022-12-27	WOS:000358546400002
J	Miao, W; Man, FY; Wu, SQ; Lv, B; Wang, ZC; Xian, JF; Sabel, BA; He, HG; Jiao, YH				Miao, Wen; Man, Fengyuan; Wu, Shaoqin; Lv, Bin; Wang, Zhenchang; Xian, Junfang; Sabel, Bernhard A.; He, Huiguang; Jiao, Yonghong			Brain Abnormalities in Congenital Fibrosis of the Extraocular Muscles Type 1: A Multimodal MRI Imaging Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; EXTERNAL OPHTHALMOPLEGIA; ORBITOFRONTAL CORTEX; DYSINNERVATION; INNERVATION; HOMOGENEITY; MUTATIONS; KIF21A	Purpose To explore the possible brain structural and functional alterations in congenital fibrosis of extraocular muscles type 1 (CFEOM1) patients using multimodal MRI imaging. Methods T1-weighted, diffusion tensor images and functional MRI data were obtained from 9 KIF21A positive patients and 19 age-and gender-matched healthy controls. Voxel based morphometry and tract based spatial statistics were applied to the T1-weighted and diffusion tensor images, respectively. Amplitude of low frequency fluctuations and regional homogeneity were used to process the functional MRI data. We then compared these multimodal characteristics between CFEOM1 patients and healthy controls. Results Compared with healthy controls, CFEOM1 patients demonstrated increased grey matter volume in bilateral frontal orbital cortex and in the right temporal pole. No diffusion indices changes were detected, indicating unaffected white matter microstructure. In addition, from resting state functional MRI data, trend of amplitude of low-frequency fluctuations increases were noted in the right inferior parietal lobe and in the right frontal cortex, and a trend of ReHo increase (p<0.001 uncorrected) in the left precentral gyrus, left orbital frontal cortex, temporal pole and cingulate gyrus. Conclusions CFEOM1 patients had structural and functional changes in grey matter, but the white matter was unaffected. These alterations in the brain may be due to the abnormality of extraocular muscles and their innervating nerves. Future studies should consider the possible correlations between brain morphological/functional findings and clinical data, especially pertaining to eye movements, to obtain more precise answers about the role of brain area changes and their functional consequence in CFEOM1.	[Miao, Wen; Sabel, Bernhard A.; He, Huiguang] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Man, Fengyuan; Xian, Junfang] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China; [Sabel, Bernhard A.; Jiao, Yonghong] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Wu, Shaoqin] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Lv, Bin] China Acad Telecommun Res, Minist Ind & Informat Technol, Beijing, Peoples R China; [Wang, Zhenchang] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China; [Sabel, Bernhard A.] Univ Magdeburg, Fac Med, Inst Med Psychol, Magdeburg, Germany	Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Otto von Guericke University	He, HG (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China.	huiguang.he@ia.ac.cn; yhjiao2001@aliyun.com	He, Huiguang/AAD-7643-2020; yongbei, Zhu/L-7015-2016	He, Huiguang/0000-0002-0684-1711; 	National Natural Science Foundation of China [81070762, 61271151, 81401397, 61201066]; 863 Project [2013AA013803]; Beijing Natural Science Foundation [7152039]; Chinese Academy of Sciences; Beijing Tongren Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Beijing Tongren Hospital	This work was partly supported by the National Natural Science Foundation of China (81070762, 61271151, 81401397 and 61201066), 863 Project (2013AA013803) and Beijing Natural Science Foundation (7152039). Prof. Sabel was partly supported by Chinese Academy of Sciences Senior Visiting Professorships Programs and by the "Hai-ju" by Beijing Overseas Talents Program at Beijing Tongren Hospital. The funding organizations had no role in design or conduct of this research.	Andersson J. L., 2007, TR07JA2 FMRIB AN GRO; Andrews CV, 1993, GENEREVIEWS; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Assaf AA, 2011, EYE, V25, P1251, DOI 10.1038/eye.2011.38; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Brodsky MC, 1998, OPHTHALMOLOGY, V105, P717, DOI 10.1016/S0161-6420(98)94029-5; Cavada C, 2000, CEREB CORTEX, V10, P205, DOI 10.1093/cercor/10.3.205; Cheng L, 2014, NEURON, V82, P334, DOI 10.1016/j.neuron.2014.02.038; Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125; Desai J, 2012, GENE EXPR PATTERNS, V12, P180, DOI 10.1016/j.gep.2012.03.003; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Engle EC, 2006, PEDIATR RES, V59, P343, DOI 10.1203/01.pdr.0000200797.91630.08; ENGLE EC, 1995, AM J HUM GENET, V57, P1086; Engle EC, 1997, ANN NEUROL, V41, P314, DOI 10.1002/ana.410410306; Engle EC, 2002, ANN NY ACAD SCI, V956, P55, DOI 10.1111/j.1749-6632.2002.tb02808.x; Flaherty MP, 2001, OPHTHALMOLOGY, V108, P1313, DOI 10.1016/S0161-6420(01)00582-6; Haier Richard J, 2009, BMC Res Notes, V2, P174, DOI 10.1186/1756-0500-2-174; Heidary Gena, 2008, Semin Ophthalmol, V23, P3, DOI 10.1080/08820530701745181; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Li W, 2015, RESTOR NEUROL NEUROS; Lin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043373; Liu YO, 2011, J NEUROL SCI, V304, P127, DOI 10.1016/j.jns.2011.01.023; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063447, 10.1371/journal.pone.0076105]; Miao W, 2013, AM J NEURORADIOL, V34, P1264, DOI 10.3174/ajnr.A3370; Muller-Vahl KR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-47; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; NAKAMURA K, 1994, J NEUROPHYSIOL, V71, P1206, DOI 10.1152/jn.1994.71.3.1206; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual B, 2015, CEREB CORTEX, V25, P680, DOI 10.1093/cercor/bht260; Reck AC, 1998, BRIT J OPHTHALMOL, V82, P676, DOI 10.1136/bjo.82.6.676; Scheuerecker J, 2010, J PSYCHIATR NEUROSCI, V35, P311, DOI 10.1503/jpn.090076; Shi XFF, 2012, RESTOR NEUROL NEUROS, V30, P445, DOI 10.3233/RNN-2012-129000; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tiab Leila, 2004, Ophthalmic Genet, V25, P241, DOI 10.1080/13816810490902828; Traboulsi EI, 2007, J AAPOS, V11, P215, DOI 10.1016/j.jaapos.2007.04.007; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	46	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133473	10.1371/journal.pone.0133473	http://dx.doi.org/10.1371/journal.pone.0133473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186732	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700144
J	Franchini, AG; Ihssen, J; Egli, T				Franchini, Alessandro G.; Ihssen, Julian; Egli, Thomas			Effect of Global Regulators RpoS and Cyclic-AMP/CRP on the Catabolome and Transcriptome of Escherichia coli K12 during Carbon- and Energy-Limited Growth	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; STATIONARY-PHASE; GENE-EXPRESSION; RNA-POLYMERASE; SALMONELLA-ENTERICA; CONTINUOUS-CULTURE; SIGMA(S)-DEPENDENT GENES; PROTEIN TRANSLOCATION; SIGMA(S) ACTIVITY; MICROBIAL-GROWTH	For heterotrophic microbes, limited availability of carbon and energy sources is one of the major nutritional factors restricting the rate of growth in most ecosystems. Physiological adaptation to this hunger state requires metabolic versatility which usually involves expression of a wide range of different catabolic pathways and of high-affinity carbon transporters; together, this allows for simultaneous utilization of mixtures of carbonaceous compounds at low concentrations. In Escherichia coli the stationary phase sigma factor RpoS and the signal molecule cAMP are the major players in the regulation of transcription under such conditions; however, their interaction is still not fully understood. Therefore, during growth of E. coli in carbon-limited chemostat culture at different dilution rates, the transcriptomes, expression of periplasmic proteins and catabolomes of strains lacking one of these global regulators, either rpoS or adenylate cyclase (cya), were compared to those of the wild-type strain. The inability to synthesize cAMP exerted a strong negative influence on the expression of alternative carbon source uptake and degradation systems. In contrast, absence of RpoS increased the transcription of genes belonging to high-affinity uptake systems and central metabolism, presumably due to reduced competition of sigma(D) with sigma(S). Phenotypical analysis confirmed this observation: The ability to respire alternative carbon substrates and to express periplasmic high-affinity binding proteins was eliminated in cya and crp mutants, while these properties were not affected in the rpoS mutant. As expected, transcription of numerous stress defence genes was negatively affected by the rpoS knock-out mutation. Interestingly, several genes of the RpoS stress response regulon were also down-regulated in the cAMP-negative strain indicating a coordinated global regulation. The results demonstrate that cAMP is crucial for catabolic flexibility during slow, carbon-limited growth, whereas RpoS is primarily involved in the regulation of stress response systems necessary for the survival of this bacterium under hunger conditions.	[Franchini, Alessandro G.; Ihssen, Julian; Egli, Thomas] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Franchini, Alessandro G.; Ihssen, Julian; Egli, Thomas] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Franchini, AG (corresponding author), Univ Zurich, Univ Zurich Hosp, Surg Intens Care Med, Zurich, Switzerland.	alessandro.franchini@usz.ch			Swiss National Science Foundation (SNF) [31-63466.00]; Eawag, Swiss Federal Institute of Aquatic Science and Technology	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Eawag, Swiss Federal Institute of Aquatic Science and Technology	The authors gratefully acknowledge the financial support for this research, which was provided for AGF by the Swiss National Science Foundation (SNF grant 31-63466.00) and for JI by Eawag, Swiss Federal Institute of Aquatic Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; [Anonymous], 1975, PRINCIPLES MICROBIAL; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Berney M, 2006, APPL ENVIRON MICROB, V72, P2586, DOI 10.1128/AEM.72.4.2586-2593.2006; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; BISHOP RE, 1995, J BIOL CHEM, V270, P23097, DOI 10.1074/jbc.270.39.23097; Bougdour A, 2007, P NATL ACAD SCI USA, V104, P12896, DOI 10.1073/pnas.0705561104; Campanacci V, 2004, FEBS LETT, V562, P183, DOI 10.1016/S0014-5793(04)00199-1; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Chubukov V, 2014, APPL ENVIRON MICROB, V80, P2901, DOI 10.1128/AEM.00061-14; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Egli T, 1995, ADV MICROB ECOL, V14, P305; Egli T, 2009, DESK ENCY MICROBIOLO, P788; Egli T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00287; Egli T, 2010, WATER RES, V44, P4826, DOI 10.1016/j.watres.2010.07.023; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; Ferenci T, 1996, FEMS MICROBIOL REV, V18, P301, DOI 10.1016/0168-6445(96)00019-8; Ferenci T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-62; Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08; Franchini AG, 2006, MICROBIOL-SGM, V152, P2111, DOI 10.1099/mic.0.28939-0; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Gross CA, 1996, ESCHERICHIA COLI SAL, P1382; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; HARDER W, 1977, J APPL BACTERIOL, V43, P1, DOI 10.1111/j.1365-2672.1977.tb00717.x; HARDER W, 1982, PHILOS T ROY SOC B, V297, P459, DOI 10.1098/rstb.1982.0055; Hengge-Aronis R, 2002, CURR OPIN MICROBIOL, V5, P591, DOI 10.1016/S1369-5274(02)00372-7; Hengge-Aronis R., 1996, ESCHERICHIA COLI SAL, P1497; Herbert D., 1961, S SOC GEN MICROBIOL, V11, P391; Hung SP, 2002, J BIOL CHEM, V277, P40309, DOI 10.1074/jbc.M204044200; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; Ihssen J, 2005, ENVIRON MICROBIOL, V7, P1568, DOI 10.1111/j.1462-2920.2005.00846.x; Ihssen J, 2004, MICROBIOL-SGM, V150, P1637, DOI 10.1099/mic.0.26849-0; Ikegami A, 2005, BIOSCI BIOTECH BIOCH, V69, P1595, DOI 10.1271/bbb.69.1595; Ingraham JL, 2009, GROWTH BACTERIAL CEL; Izutsu K, 2001, J BACTERIOL, V183, P2765, DOI 10.1128/JB.183.9.2765-2773.2001; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jeong KC, 2006, BBA-GENE STRUCT EXPR, V1759, P51, DOI 10.1016/j.bbaexp.2006.02.001; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Khankal Reza, 2009, J Biol Eng, V3, P13, DOI 10.1186/1754-1611-3-13; Klumpp S, 2014, CURR OPIN BIOTECH, V28, P96, DOI 10.1016/j.copbio.2014.01.001; Koch A L, 1971, Adv Microb Physiol, V6, P147, DOI 10.1016/S0065-2911(08)60069-7; KOMINE Y, 1990, J MOL BIOL, V212, P579, DOI 10.1016/0022-2836(90)90224-A; Kovarova K, 1996, J BACTERIOL, V178, P4530, DOI 10.1128/jb.178.15.4530-4539.1996; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; Lee SK, 2005, J BACTERIOL, V187, P2793, DOI 10.1128/JB.187.8.2793-2800.2005; Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Martinez-Antonio A, 2008, J MOL BIOL, V381, P238, DOI 10.1016/j.jmb.2008.05.054; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; MATIN A, 1982, J BACTERIOL, V149, P801, DOI 10.1128/JB.149.3.801-807.1982; Matin A., 1979, STRATEGIES MICROBIAL; MORITA RY, 1988, CAN J MICROBIOL, V34, P436, DOI 10.1139/m88-076; Morita RY, 1993, STARVATION BACTERIA, P1, DOI [10.1007/978-1-4899-2439-1_1, DOI 10.1007/978-1-4899-2439-1_1]; MUNSTER U, 1993, ANTON LEEUW INT J G, V63, P243, DOI 10.1007/BF00871222; Nahku R, 2010, J BIOTECHNOL, V145, P60, DOI 10.1016/j.jbiotec.2009.10.007; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, V1, P1310; NISHIYAMA K, 1993, EMBO J, V12, P3409, DOI 10.1002/j.1460-2075.1993.tb06015.x; Notley L, 1996, J BACTERIOL, V178, P1465, DOI 10.1128/jb.178.5.1465-1468.1996; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P33, DOI 10.1046/j.1462-2920.1999.00002.x; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; NotleyMcRobb L, 1997, MICROBIOL-SGM, V143, P1909, DOI 10.1099/00221287-143-6-1909; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Nystrom T, 1998, FEMS MICROBIOL REV, V21, P283, DOI 10.1111/j.1574-6976.1998.tb00354.x; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Phan K, 2013, ISME J, V7, P2034, DOI 10.1038/ismej.2013.82; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; SCHULTZ JE, 1988, J BACTERIOL, V170, P3903, DOI 10.1128/jb.170.9.3903-3909.1988; Tan K, 2001, GENOME RES, V11, P566, DOI 10.1101/gr.149301; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Teich A, 1999, BIOTECHNOL PROGR, V15, P123, DOI 10.1021/bp980102h; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Vieira HLA, 2004, APPL ENVIRON MICROB, V70, P5682, DOI 10.1128/AEM.70.9.5682-5684.2004; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Vital M, 2012, WATER RES, V46, P6279, DOI 10.1016/j.watres.2012.08.043; Wang L, 2005, J BACTERIOL, V187, P2066, DOI 10.1128/JB.187.6.2066-2076.2005; WANNER U, 1990, FEMS MICROBIOL LETT, V75, P19, DOI 10.1111/j.1574-6968.1990.tb04084.x; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wei BD, 2000, J BACTERIOL, V182, P1632, DOI 10.1128/JB.182.6.1632-1640.2000; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Wick LM, 2002, MICROBIOL-SGM, V148, P2889, DOI 10.1099/00221287-148-9-2889; Wick LM, 2001, ENVIRON MICROBIOL, V3, P588, DOI 10.1046/j.1462-2920.2001.00231.x; Yang HH, 1996, J BACTERIOL, V178, P1012, DOI 10.1128/jb.178.4.1012-1017.1996	103	45	46	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133793	10.1371/journal.pone.0133793	http://dx.doi.org/10.1371/journal.pone.0133793			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204448	Green Published, gold			2022-12-27	WOS:000358621000039
J	Han, L; Xue, S; Zhao, SC; Yan, JC; Qian, LB; Chen, MF				Han, Lu; Xue, Song; Zhao, Shichen; Yan, Jingchun; Qian, Linbo; Chen, Mengfang			Biochar Supported Nanoscale Iron Particles for the Efficient Removal of Methyl Orange Dye in Aqueous Solutions	PLOS ONE			English	Article							ZERO-VALENT IRON; ZEROVALENT IRON; AZO-DYE; ACTIVATED CARBON; NANOPARTICLES; DEGRADATION; ADSORPTION; PHOSPHATE; ADSORBENTS; REDUCTION	The presence of organic contaminants in industrial effluents is an environmental concern of increasing global importance. One innovative technology for treating contaminated industrial effluents is nanoscale zero-valent iron supported on biochar (nZVI/BC). Based on Transmission Electron Microscopy, X-Ray Diffraction, and Brunauer-Emmett-Teller characterizations, the nZVI was well dispersed on the biochar and aggregation was dramatically reduced. Methyl orange (MO) served as the representative organic contaminant for verifying the effectiveness of the composite. Using decolorization efficiency as an indicator of treatment effectiveness, increasing doses of nZVI/BC yielded progressively better results with 98.51% of MO decolorized by 0.6 g/L of composite at an nZVI/BC mass ratio of 1: 5. The superior decolorization efficiency of the nZVI/BC was attributed to the increase in the dispersion and reactivity of nZVI while biochar increasing the contact area with contaminant and the adsorption of composites. Additionally, the buffering function of acid-washed biochar could be in favor of maintaining the reactivity of nZVI. Furthermore, the aging nZVI/BC for 30 day was able to maintain the removal efficiency indicating that the oxidation of nZVI may be delayed in the presence of biochar. Therefore, the composite of nZVI/BC could represent an effective functional material for treating wastewater containing organic dyes in the future.	[Han, Lu; Xue, Song; Yan, Jingchun; Qian, Linbo; Chen, Mengfang] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Peoples R China; [Xue, Song] Suzhou Univ Sci & Technol, Coll Environm Sci & Engn, Suzhou 215011, Peoples R China; [Zhao, Shichen] Nanjing Agr Univ, Coll Resource & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Suzhou University of Science & Technology; Nanjing Agricultural University	Chen, MF (corresponding author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Peoples R China.	mfchen@issas.ac.cn	Qian, Linbo/H-3736-2019		National High Technology Research and Development Program (863 Program) [2013AA06A208]; National Science Foundation of China [41471404, 51309214]; Ministry of Environmental Protection of the People's Republic of China [201309005]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Environmental Protection of the People's Republic of China	The National High Technology Research and Development Program (863 Program) (2013AA06A208), the National Science Foundation of China (Grants Nos. 41471404 and 51309214), and the Public Wealth Research Funding from the Ministry of Environmental Protection of the People's Republic of China (201309005) supported the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; Almeelbi T, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0900-y; Bhowmick S, 2014, CHEM ENG J, V243, P14, DOI 10.1016/j.cej.2013.12.049; Bleyl S, 2012, CHEM ENG J, V191, P588, DOI 10.1016/j.cej.2012.03.021; Cao JS, 1999, CHEMOSPHERE, V38, P565, DOI 10.1016/S0045-6535(98)00201-X; Chang C, 2011, ENVIRON POLLUT, V159, P2507, DOI 10.1016/j.envpol.2011.06.021; Chatterjee S, 2010, CHEM ENG J, V160, P27, DOI 10.1016/j.cej.2010.02.045; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Chen ZX, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0899-0; Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001; Deng B., 2002, INNOVATIVE STRATEGIE, P181, DOI DOI 10.1021/BK-2002-0837.CH013; Dries J, 2005, ENVIRON SCI TECHNOL, V39, P8460, DOI 10.1021/es050251d; Fan J, 2009, J HAZARD MATER, V166, P904, DOI 10.1016/j.jhazmat.2008.11.091; Fukuchi S, 2014, APPL CATAL B-ENVIRON, V147, P411, DOI 10.1016/j.apcatb.2013.09.032; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Gu ZM, 2005, ENVIRON SCI TECHNOL, V39, P3833, DOI 10.1021/es048179r; He Y, 2012, CHEM ENG J, V179, P8, DOI 10.1016/j.cej.2011.05.107; Hou MF, 2007, J HAZARD MATER, V145, P305, DOI 10.1016/j.jhazmat.2006.11.019; Kanel SR, 2006, ENVIRON SCI TECHNOL, V40, P2045, DOI 10.1021/es0520924; Kim HS, 2010, ENVIRON SCI TECHNOL, V44, P1760, DOI 10.1021/es902772r; Kumar S, 2015, CARBON, V89, P31, DOI 10.1016/j.carbon.2015.03.012; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085686; Liu HN, 2007, J HAZARD MATER, V144, P180, DOI 10.1016/j.jhazmat.2006.10.009; Liu TY, 2014, CHEM ENG J, V245, P34, DOI 10.1016/j.cej.2014.02.011; Luo S, 2013, CHEM ENG J, V223, P1, DOI 10.1016/j.cej.2012.10.088; Mackenzie K, 2012, WATER RES, V46, P3817, DOI 10.1016/j.watres.2012.04.013; Nurmi JT, 2005, ENVIRON SCI TECHNOL, V39, P1221, DOI 10.1021/es049190u; Ponder SM, 2000, ENVIRON SCI TECHNOL, V34, P2564, DOI 10.1021/es9911420; Qian LB, 2013, ENVIRON SCI TECHNOL, V47, P8759, DOI 10.1021/es401756h; Qiu YP, 2009, BIORESOURCE TECHNOL, V100, P5348, DOI 10.1016/j.biortech.2009.05.054; Shih YH, 2010, CHEMOSPHERE, V78, P1200, DOI 10.1016/j.chemosphere.2009.12.061; Shu HY, 2007, J COLLOID INTERF SCI, V314, P89, DOI 10.1016/j.jcis.2007.04.071; Sohn K, 2006, ENVIRON SCI TECHNOL, V40, P5514, DOI 10.1021/es0525758; Su CM, 2001, ENVIRON SCI TECHNOL, V35, P4562, DOI 10.1021/es010768z; Uzum C, 2009, APPL CLAY SCI, V43, P172, DOI 10.1016/j.clay.2008.07.030; Wang Q, 2009, ENVIRON SCI TECHNOL, V43, P3292, DOI 10.1021/es803540b; Wang T, 2013, J HAZARD MATER, V262, P819, DOI 10.1016/j.jhazmat.2013.09.028; Xie Y, 2012, ENVIRON SCI TECHNOL, V46, P8365, DOI 10.1021/es301753u; Yan JC, 2015, BIORESOURCE TECHNOL, V175, P269, DOI 10.1016/j.biortech.2014.10.103; Yan WL, 2010, J CONTAM HYDROL, V118, P96, DOI 10.1016/j.jconhyd.2010.09.003; Yao Y, 2013, BIORESOURCE TECHNOL, V138, P8, DOI 10.1016/j.biortech.2013.03.057; Yao YJ, 2011, CHEM ENG J, V170, P82, DOI 10.1016/j.cej.2011.03.031; Zhan JJ, 2011, ENVIRON SCI TECHNOL, V45, P1949, DOI 10.1021/es103493e; Zhan JJ, 2009, ENVIRON SCI TECHNOL, V43, P8616, DOI 10.1021/es901968g; Zhang M, 2013, CHEM ENG J, V226, P286, DOI 10.1016/j.cej.2013.04.077; Zhang WX, 2012, BIORESOURCE TECHNOL, V117, P40, DOI 10.1016/j.biortech.2012.04.064; Zhang WX, 2003, J NANOPART RES, V5, P323, DOI 10.1023/A:1025520116015; Zhu HJ, 2009, J HAZARD MATER, V172, P1591, DOI 10.1016/j.jhazmat.2009.08.031	49	117	118	19	246	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132067	10.1371/journal.pone.0132067	http://dx.doi.org/10.1371/journal.pone.0132067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204523	gold, Green Submitted, Green Published			2022-12-27	WOS:000358621000006
J	Felipe-Lucia, MR; Martin-Lopez, B; Lavorel, S; Berraquero-Diaz, L; Escalera-Reyes, J; Comin, FA				Felipe-Lucia, Maria R.; Martin-Lopez, Berta; Lavorel, Sandra; Berraquero-Diaz, Luis; Escalera-Reyes, Javier; Comin, Francisco A.			Ecosystem Services Flows: Why Stakeholders' Power Relationships Matter	PLOS ONE			English	Article							POVERTY ALLEVIATION; TRADE-OFFS; MANAGEMENT; GOVERNANCE; VALUATION; SYNERGIES; FRAMEWORK; CAPACITY; SCALES; FUTURE	The ecosystem services framework has enabled the broader public to acknowledge the benefits nature provides to different stakeholders. However, not all stakeholders benefit equally from these services. Rather, power relationships are a key factor influencing the access of individuals or groups to ecosystem services. In this paper, we propose an adaptation of the "cascade" framework for ecosystem services to integrate the analysis of ecological interactions among ecosystem services and stakeholders' interactions, reflecting power relationships that mediate ecosystem services flows. We illustrate its application using the floodplain of the River Piedra (Spain) as a case study. First, we used structural equation modelling (SEM) to model the dependence relationships among ecosystem services. Second, we performed semi-structured interviews to identify formal power relationships among stakeholders. Third, we depicted ecosystem services according to stakeholders' ability to use, manage or impair ecosystem services in order to expose how power relationships mediate access to ecosystem services. Our results revealed that the strongest power was held by those stakeholders who managed (although did not use) those keystone ecosystem properties and services that determine the provision of other services (i.e., intermediate regulating and final services). In contrast, non-empowered stakeholders were only able to access the remaining non-excludable and non-rival ecosystem services (i.e., some of the cultural services, freshwater supply, water quality, and biological control). In addition, land stewardship, access rights, and governance appeared as critical factors determining the status of ecosystem services. Finally, we stress the need to analyse the role of stakeholders and their relationships to foster equal access to ecosystem services.	[Felipe-Lucia, Maria R.] CSIC, Inst Pirena Ecol, Jaca 22700, Huesca, Spain; [Martin-Lopez, Berta] Univ Autonoma Madrid, Dept Ecol, Social Ecol Syst Lab, E-28049 Madrid, Spain; [Martin-Lopez, Berta] Univ Oxford, Ctr Environm, Environm Change Inst, Oxford OX1 3QY, England; [Lavorel, Sandra] Univ Grenoble Alpes, CNRS, Lab Ecol Alpine, F-38041 Grenoble 9, France; [Berraquero-Diaz, Luis; Escalera-Reyes, Javier] Univ Pablo de Olavide, Dept Social Anthropol Basic Psychol & Publ Hlth, Social & Participatory Act Res Grp GISAP, Seville 41013, Spain; [Comin, Francisco A.] CSIC, Inst Pirenaico Ecol, Zaragoza 50192, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Autonomous University of Madrid; University of Oxford; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Felipe-Lucia, MR (corresponding author), CSIC, Inst Pirena Ecol, Av Nuestra Senora de la Victoria S-N, Jaca 22700, Huesca, Spain.	maria.felipe.lucia@gmail.com	Felipe-Lucia, Maria/ABC-5216-2020; Berraquero-Díaz, Luis/GZG-5258-2022; Martin-Lopez, Berta/R-9397-2017	Berraquero-Díaz, Luis/0000-0001-9902-5141; Martin-Lopez, Berta/0000-0003-2622-0135; Felipe-Lucia, Maria/0000-0003-1915-8169	CSIC (Spanish National Research Council) under the JAE-predoc program [JAE-Pre-2010-044]; European Social Fund; European Union [308393, 308428]	CSIC (Spanish National Research Council) under the JAE-predoc program; European Social Fund(European Social Fund (ESF)); European Union(European Commission)	MFL was awarded a grant by the CSIC (Spanish National Research Council, www.csic.es) under the JAE-predoc program (JAE-Pre-2010-044), co-financed by the European Social Fund (http://ec.europa.eu/esf/home.jsp). This work contributes to the OPERAs FP7-ENV-2012-two-stage-308393 and OpenNESS FP7-EC-308428 European Union's Seventh Program projects. The authors declare that no competing interests exist and that the funding sources had any involvement in study design, in data collection, analyses, and interpretation, and in the decision to submit the article.	Akbulut B, 2012, CAMB J ECON, V36, P1143, DOI 10.1093/cje/bes034; Amato S, 2005, TECHNICAL REPORT HEC; American Public Health Association (APHA) American Water Works Association (AWWA) Water Environment Federation (WEF), 1998, STANDARD METHODS FOR; Bagstad KJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06523-190264; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Balzano S, 2011, CONTRIB STAT, P55, DOI 10.1007/978-3-7908-2375-2_4; Barnaud C, 2014, GEOFORUM, V56, P113, DOI 10.1016/j.geoforum.2014.07.003; Barnaud C, 2013, ECOL SOC, V18, DOI 10.5751/ES-05459-180221; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Berbes-Blazquez M, 2012, ENVIRON MANAGE, V49, P862, DOI 10.1007/s00267-012-9822-9; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Boletin Oficial de Aragon (BOA), 2012, BOE; Bowd R, 2012, ECOL SOC, V17, DOI 10.5751/ES-04840-170315; Bryan BA, 2010, LANDSCAPE URBAN PLAN, V97, P111, DOI 10.1016/j.landurbplan.2010.05.002; Bryan BA, 2010, ECOSYSTEMS, V13, P539, DOI 10.1007/s10021-010-9339-0; Casalegno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068437; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chin WW., MODERN METHODS FOR B, P295; Confederacion Hidrografica del Ebro, CONCESIONES DEL RIO; Corbera E, 2007, DEV CHANGE, V38, P587, DOI 10.1111/j.1467-7660.2007.00425.x; Costanza R, 2008, BIOL CONSERV, V141, P350, DOI 10.1016/j.biocon.2007.12.020; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Crona B, 2010, ECOL SOC, V15; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Daw T, 2011, ENVIRON CONSERV, V38, P370, DOI 10.1017/S0376892911000506; De Groot R.S., 2010, ECOL COMPLEX, V7, P260, DOI DOI 10.1016/J.EC0C0M.2009.10.006; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; EMERSON RM, 1962, AM SOCIOL REV, V27, P31, DOI 10.2307/2089716; Escalera-Reyes J, 2011, REV ANTROPOL SOC, V20, P109, DOI DOI 10.5209/REV_RASO.2011.V20.36264; Esposito Vinzi V., 2010, HANDBOOK OF PARTIAL; Fabinyi M, 2014, ECOL SOC, V19, DOI 10.5751/ES-07029-190428; Felipe-Lucia MR, 2014, ECOL SOC, V19, DOI 10.5751/ES-06249-190120; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fisher JA, 2014, ECOSYST SERV, V7, P34, DOI 10.1016/j.ecoser.2013.08.002; Fisher JA, 2013, GLOBAL ENVIRON CHANG, V23, P1098, DOI 10.1016/j.gloenvcha.2013.04.002; Forouzangohar M, 2014, SCI WORLD J, DOI 10.1155/2014/483298; Forrester J, 2014, COMPLEXITY, V19, P73, DOI 10.1002/cplx.21524; Foucault M., 1988, REV MEX SOCIOL, V50, P3, DOI DOI 10.2307/3540551; Geijzendorffer IR, 2015, ECOL INDIC, V52, P320, DOI 10.1016/j.ecolind.2014.12.016; Gliscynski P., 1989, LA AGROCIUDAD MEDITE; Gobierno de Aragon, INDICE DE PRECIOS AG; Gomez-Baggethun E, 2013, SOC NATUR RESOUR, V26, P1202, DOI 10.1080/08941920.2013.820817; del Tanago MG, 2011, LIMNETICA, V30, P235; GOODALL DW, 1952, BIOL REV, V27, P194, DOI 10.1111/j.1469-185X.1952.tb01393.x; Grace J.B., 2006, STRUCT EQ MOD NAT; Haase D, 2012, ECOL SOC, V17, DOI 10.5751/ES-04853-170322; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Harrington R, 2010, BIODIVERS CONSERV, V19, P2773, DOI 10.1007/s10531-010-9834-9; Harrison PA, 2010, BIODIVERS CONSERV, V19, P2791, DOI 10.1007/s10531-010-9789-x; Hauck J, 2014, BRUSS OPENNESS; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Hicks CC, 2013, GLOBAL ENVIRON CHANG, V23, P1444, DOI 10.1016/j.gloenvcha.2013.07.028; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Iniesta-Arandia I, 2014, ECOL ECON, V108, P36, DOI 10.1016/j.ecolecon.2014.09.028; Instituto Aragones de Estadistica. Gobierno de Aragon Zaragoza Spain. Padron Municipal of Inhabitants, 2011, GOBIERNO DE ARAGON Z; Instituto Nacional de Estadistica, ANUARIO ESTADISTICO; Kandziora M, 2013, ECOL INDIC, V28, P54, DOI 10.1016/j.ecolind.2012.09.006; Kenward RE, 2011, P NATL ACAD SCI USA, V108, P5308, DOI 10.1073/pnas.1007933108; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; Lavorel S, 2012, J ECOL, V100, P128, DOI 10.1111/j.1365-2745.2011.01914.x; Lund JF, 2008, WORLD DEV, V36, P2780, DOI 10.1016/j.worlddev.2008.01.014; Martin-Lopez B, 2015, SUSTAIN SCI, V10, P699, DOI 10.1007/s11625-014-0283-3; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; Martin-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038970; Martin-Lopez B, 2009, J ENVIRON MANAGE, V90, P1050, DOI 10.1016/j.jenvman.2008.03.013; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS AND HUMAN; Montero G, 2005, PRODUCCION DE BIOMAS; Nagendra H, 2013, CURR OPIN ENV SUST, V5, P503, DOI 10.1016/j.cosust.2013.05.010; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Palm C, 2014, AGR ECOSYST ENVIRON, V187, P87, DOI 10.1016/j.agee.2013.10.010; Raik DB, 2008, SOC NATUR RESOUR, V21, P729, DOI 10.1080/08941920801905195; Reed MS, 2009, LAND USE POLICY, V26, pS204, DOI 10.1016/j.landusepol.2009.09.013; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Ribot JC, 2003, RURAL SOCIOL, V68, P153, DOI 10.1111/j.1549-0831.2003.tb00133.x; Rodriguez JP, 2006, ECOL SOC, V11; Santos-Martin F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073249; Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018; Spangenberg JH, 2014, ECOL ECON, V104, P22, DOI 10.1016/j.ecolecon.2014.04.025; STONE CN, 1988, AM J POLIT SCI, V32, P82, DOI 10.2307/2111311; Trabucchi M, 2014, ENVIRON MANAGE, V53, P1132, DOI 10.1007/s00267-014-0264-4; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7; Valles M. S., 1999, TECNICAS CUALITATIVA; van Oudenhoven APE, 2012, ECOL INDIC, V21, P110, DOI 10.1016/j.ecolind.2012.01.012; Vatn A, 2010, ECOL ECON, V69, P1245, DOI 10.1016/j.ecolecon.2009.11.018; Gutierrez MRVA, 2013, BIODIVERS CONSERV, V22, P2469, DOI 10.1007/s10531-013-0532-2; Villa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091001; Villa F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0286; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004	91	106	109	15	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132232	10.1371/journal.pone.0132232	http://dx.doi.org/10.1371/journal.pone.0132232			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26201000	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100031
J	Gullon, S; Marin, S; Mellado, RP				Gullon, Sonia; Marin, Silvia; Mellado, Rafael P.			Overproduction of a Model Sec- and Tat-Dependent Secretory Protein Elicits Different Cellular Responses in Streptomyces lividans	PLOS ONE			English	Article							SIGNAL PEPTIDASE; BACILLUS-SUBTILIS; COELICOLOR A3(2); GENE; OVEREXPRESSION; CONSTRUCTION; SPORULATION; DEFICIENCY; ALPHA; SIPY	Streptomyces lividans is considered an efficient host for the secretory production of homologous and heterologous proteins. To identify possible bottlenecks in the protein production process, a comparative transcriptomic approach was adopted to study cellular responses during the overproduction of a Sec-dependent model protein (alpha-amylase) and a Tat-dependent model protein (agarase) in Streptomyces lividans. The overproduction of the model secretory proteins via the Sec or the Tat route in S. lividans does elicit a different major cell response in the bacterium. The stringent response is a bacterial response to nutrients' depletion, which naturally occurs at late times of the bacterial cell growth. While the induction of the stringent response at the exponential phase of growth may limit overall productivity in the case of the Tat route, the induction of that response does not take place in the case of the Sec route, which comparatively is an advantage in secretory protein production processes. Hence, this study identifies a potential major drawback in the secretory protein production process depending on the secretory route, and provides clues to improving S. lividans as a protein production host.	[Gullon, Sonia; Marin, Silvia; Mellado, Rafael P.] Ctr Nacl Biotecnol CNB CSIC, Dept Biotecnol Microbiana, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Mellado, RP (corresponding author), Ctr Nacl Biotecnol CNB CSIC, Dept Biotecnol Microbiana, C Darwin 3, Madrid 28049, Spain.	rpmellado@cnb.csic.es	Gullón, Sonia/P-7460-2018; Mellado, Rafael P/D-2680-2009		Spanish Ministry of the Environment and Rural and Marine Affairs [EGO22008]	Spanish Ministry of the Environment and Rural and Marine Affairs(Spanish Government)	This work was funded by Spanish Ministry of the Environment and Rural and Marine Affairs grant no. EGO22008 to RPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne J, 2014, BBA-MOL CELL RES, V1843, P1750, DOI 10.1016/j.bbamcr.2013.12.023; Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; D'Huys PJ, 2011, J BIOTECHNOL, V152, P132, DOI 10.1016/j.jbiotec.2010.08.011; Diaz M, 2008, APPL MICROBIOL BIOT, V79, P1001, DOI 10.1007/s00253-008-1495-1; Escutia MR, 2006, PROTEOMICS, V6, P4137, DOI 10.1002/pmic.200500927; GIBERT M, 1995, CRIT REV BIOTECHNOL, V15, P13, DOI 10.3109/07388559509150530; Gullon S, 2013, APPL MICROBIOL BIOT, V97, P10069, DOI 10.1007/s00253-013-5219-9; Gullon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048987; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hyyrylainen HL, 2005, APPL MICROBIOL BIOT, V67, P389, DOI 10.1007/s00253-005-1898-1; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lule I, 2012, APPL MICROBIOL BIOT, V96, P367, DOI 10.1007/s00253-012-4182-1; Lulko AT, 2007, APPL ENVIRON MICROB, V73, P5354, DOI 10.1128/AEM.00472-07; MartinezCosta OH, 1996, J BIOL CHEM, V271, P10627, DOI 10.1074/jbc.271.18.10627; Mellado RP, 2011, WORLD J MICROB BIOT, V27, P2231, DOI 10.1007/s11274-011-0709-3; Palacin A, 2002, J BACTERIOL, V184, P4875, DOI 10.1128/JB.184.17.4875-4880.2002; Palomino C, 2008, INT MICROBIOL, V11, P25, DOI 10.2436/20.1501.01.41; PARRO V, 1994, GENE, V145, P49, DOI 10.1016/0378-1119(94)90321-2; PARRO V, 1993, FEMS MICROBIOL LETT, V106, P347; Posta K, 2004, J BASIC MICROB, V44, P383, DOI 10.1002/jobm.200410422; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Rozas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031760; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sianidis G, 2006, J BIOTECHNOL, V121, P498, DOI 10.1016/j.jbiotec.2005.08.002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; THOMPSON CJ, 1982, GENE, V20, P51, DOI 10.1016/0378-1119(82)90086-5; TIMMONS TM, 1990, METHOD ENZYMOL, V182, P679; Vrancken K, 2007, APPL MICROBIOL BIOT, V73, P1150, DOI 10.1007/s00253-006-0571-7; Vrancken K, 2009, FUTURE MICROBIOL, V4, P181, DOI 10.2217/17460913.4.2.181; WARD JM, 1986, MOL GEN GENET, V203, P468, DOI 10.1007/BF00422072; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103	36	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133645	10.1371/journal.pone.0133645	http://dx.doi.org/10.1371/journal.pone.0133645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200356	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100074
J	Penzo-Mendez, AI; Chen, YJ; Li, JY; Witze, ES; Stanger, BZ				Penzo-Mendez, Alfredo I.; Chen, Yi-Ju; Li, Jinyang; Witze, Eric S.; Stanger, Ben Z.			Spontaneous Cell Competition in Immortalized Mammalian Cell Lines	PLOS ONE			English	Article							DROSOPHILA MYC; FETAL LIVER; GROWTH; DIFFERENTIATION; NEIGHBORS; ELIMINATE; WINGLESS; MUTANTS; FITNESS; YORKIE	Cell competition is a form of cell-cell interaction by which cells compare relative levels of fitness, resulting in the active elimination of less-fit cells, "losers," by more-fit cells, "winners." Here, we show that in three routinely-used mammalian cell lines - U2OS, 3T3, and MDCK cells - sub-clones arise stochastically that exhibit context-dependent competitive behavior. Specifically, cell death is elicited when winner and loser sub-clones are cultured together but not alone. Cell competition and elimination in these cell lines is caspase-dependent and requires cell-cell contact but does not require de novo RNA synthesis. Moreover, we show that the phenomenon involves differences in cellular metabolism. Hence, our study demonstrates that cell competition is a common feature of immortalized mammalian cells in vitro and implicates cellular metabolism as a mechanism by which cells sense relative levels of "fitness."	[Penzo-Mendez, Alfredo I.; Chen, Yi-Ju; Li, Jinyang; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Penzo-Mendez, Alfredo I.; Chen, Yi-Ju; Li, Jinyang; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Witze, Eric S.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Penzo-Mendez, Alfredo I.; Chen, Yi-Ju; Li, Jinyang; Witze, Eric S.; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Stanger, BZ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.	bstanger@exchange.upenn.edu		Li, Jinyang/0000-0001-8125-6603	Pew Charitable Trusts; Abramson Family Cancer Research Institute	Pew Charitable Trusts; Abramson Family Cancer Research Institute	This work was supported by the Pew Charitable Trusts and the Abramson Family Cancer Research Institute.	Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Dabeva MD, 2000, AM J PATHOL, V156, P2017, DOI 10.1016/S0002-9440(10)65074-2; de Beco S, 2012, DEV DYNAM, V241, P831, DOI 10.1002/dvdy.23783; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; de la Cova C, 2014, CELL METAB, V19, P470, DOI 10.1016/j.cmet.2014.01.012; Diaz B, 2005, EXP CELL RES, V306, P317, DOI 10.1016/j.yexcr.2005.03.017; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Johnston LA, 2014, COLD SPRING HARBOR P, V4; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Lolo FN, 2012, CELL REP, V2, P526, DOI 10.1016/j.celrep.2012.08.012; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Petrova E, 2012, DIS MODEL MECH, V5, P553, DOI 10.1242/dmm.008623; Rhiner C, 2010, DEV CELL, V18, P985, DOI 10.1016/j.devcel.2010.05.010; Rodrigues AB, 2012, DEVELOPMENT, V139, P4051, DOI 10.1242/dev.076760; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Senoo-Matsuda N, 2007, P NATL ACAD SCI USA, V104, P18543, DOI 10.1073/pnas.0709021104; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Vincent JP, 2011, DEV CELL, V21, P366, DOI 10.1016/j.devcel.2011.06.021; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	34	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132437	10.1371/journal.pone.0132437	http://dx.doi.org/10.1371/journal.pone.0132437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200654	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100036
J	Snir, A; Nadel, D; Groman-Yaroslavski, I; Melamed, Y; Sternberg, M; Bar-Yosef, O; Weiss, E				Snir, Ainit; Nadel, Dani; Groman-Yaroslavski, Iris; Melamed, Yoel; Sternberg, Marcelo; Bar-Yosef, Ofer; Weiss, Ehud			The Origin of Cultivation and Proto-Weeds, Long Before Neolithic Farming	PLOS ONE			English	Article							PLANT-FOOD PREPARATION; WILD CEREAL-GRAINS; OHALO-II; NICHE CONSTRUCTION; AGRICULTURE; GALILEE; ISRAEL; SEA; DOMESTICATION; RESOURCES	Weeds are currently present in a wide range of ecosystems worldwide. Although the beginning of their evolution is largely unknown, researchers assumed that they developed in tandem with cultivation since the appearance of agricultural habitats some 12,000 years ago. These rapidly-evolving plants invaded the human disturbed areas and thrived in the new habitat. Here we present unprecedented new findings of the presence of "proto-weeds" and small-scale trial cultivation in Ohalo II, a 23,000-year-old hunter-gatherers' sedentary camp on the shore of the Sea of Galilee, Israel. We examined the plant remains retrieved from the site (ca. 150,000 specimens), placing particular emphasis on the search for evidence of plant cultivation by Ohalo II people and the presence of weed species. The archaeobotanically- rich plant assemblage demonstrates extensive human gathering of over 140 plant species and food preparation by grinding wild wheat and barley. Among these, we identified 13 well-known current weeds mixed with numerous seeds of wild emmer, barley, and oat. This collection provides the earliest evidence of a human-disturbed environment-at least 11 millennia before the onset of agriculture-that provided the conditions for the development of "proto-weeds", a prerequisite for weed evolution. Finally, we suggest that their presence indicates the earliest, small-scale attempt to cultivate wild cereals seen in the archaeological record.	[Snir, Ainit; Weiss, Ehud] Bar Ilan Univ, Inst Archaeol, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel; [Nadel, Dani; Groman-Yaroslavski, Iris] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel; [Melamed, Yoel] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Sternberg, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel; [Bar-Yosef, Ofer] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA	Bar Ilan University; University of Haifa; Bar Ilan University; Tel Aviv University; Harvard University	Weiss, E (corresponding author), Bar Ilan Univ, Inst Archaeol, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel.	ehud.weiss@biu.ac.il	Weiss, Ehud/F-2588-2016; Weiss, Ehud/AAJ-3619-2020; Sternberg, Marcelo/AFQ-1615-2022	Weiss, Ehud/0000-0002-9730-4726; Weiss, Ehud/0000-0002-9730-4726; Sternberg, Marcelo/0000-0001-8710-4141; Nadel, Dani/0000-0001-7736-1830	Individual Research Grant, Israel Science Foundation [711/08]	Individual Research Grant, Israel Science Foundation	This work was supported by an Individual Research Grant, Israel Science Foundation (http:// www.isf.org.il/), grant No. 711/08 for EW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2012, CRIT REV PLANT SCI, V31, P241, DOI 10.1080/07352689.2011.645428; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Anderson PC, 1999, PREHISTORY AGR NEW E, P118; [Anonymous], 1991, ANALYTICAL FLORA ERE; Bocquet-Appel JP, 2011, CURR ANTHROPOL, V52, pS497, DOI 10.1086/659243; Chernoff M.C., 1988, ARCHAEOBOTANICAL MAT; Chernoff MC, 1998, J FIELD ARCHAEOL, V25, P397, DOI 10.1179/009346998792005289; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dafni A, 1984, EDIBLE WILD PLANTS I; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DELCOURT HR, 1987, TRENDS ECOL EVOL, V2, P39, DOI 10.1016/0169-5347(87)90097-8; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Feinbrun-Dothan N., 1978, FLORA PALAESTINA; Feinbrun-Dothan N., 1986, FLORA PALAESTINA; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Groman-Yaroslavski I, 2014, TRANSITION EARLY NEO; HARLAN J. R., 1965, Economic Botany, V19, P16, DOI 10.1007/BF02971181; HARLAN JR, 1967, ARCHAEOLOGY, V20, P197; Hartmann-Shenkman A, 2015, VEG HIST ARCHAEOBOT, V24, P9, DOI 10.1007/s00334-014-0498-3; HERSHKOVITZ I, 1995, AM J PHYS ANTHROPOL, V96, P215, DOI 10.1002/ajpa.1330960302; Hershkovitz L, 1993, INT J OSTEOARCHAEOL, V3, P177; Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones Glynis, 2002, Acta Palaeobotanica, V42, P185; Kislev M.E., 2006, TIMNAH TEL BATASH 3, P295; Kislev M.E., 1989, PEOPLE CULTURE CHANG, P147; Kislev ME, 2004, P NATL ACAD SCI USA, V101, P2692, DOI 10.1073/pnas.0308739101; Kislev ME, 2002, ISRAEL J PLANT SCI, V50, pS85, DOI 10.1560/QV07-WYET-WPQ5-QRDC; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; Nadel D, 2004, P NATL ACAD SCI USA, V101, P6821, DOI 10.1073/pnas.0308557101; NADEL D, 1991, CURR ANTHROPOL, V32, P631, DOI 10.1086/204012; NADEL D, 1994, CURR ANTHROPOL, V35, P451, DOI 10.1086/204303; NADEL D, 1995, J ARCHAEOL SCI, V22, P811, DOI 10.1016/0305-4403(95)90010-1; Nadel D, 2002, LITHIC TECHNOLOGY, V26, P118; Nadel D, 2012, ANTIQUITY, V86, P990, DOI 10.1017/S0003598X00048201; Nadel Dani, 2004, Israel Journal of Earth Sciences, V53, P207, DOI 10.1560/V3CU-EBR7-UKAT-UCA6; Piperno DR, 2004, NATURE, V430, P670, DOI 10.1038/nature02734; Rabinovich R, 1995, J ISRAEL PREHISTORIC, V26, P32; Simmons T, 1998, INT J OSTEOARCHAEOL, V8, P79, DOI 10.1002/(SICI)1099-1212(199803/04)8:2<79::AID-OA386>3.0.CO;2-I; Smith BD, 2007, EVOL ANTHROPOL, V16, P188, DOI 10.1002/evan.20135; Smith BD, 2007, SCIENCE, V315, P1797, DOI 10.1126/science.1137740; Smith BD, 2013, ANTHROPOCENE, V4, P8, DOI 10.1016/j.ancene.2013.05.001; Smith BD, 2011, PHILOS T R SOC B, V366, P836, DOI 10.1098/rstb.2010.0253; Snir A, 2015, J ARCHAEOL SCI, V53, P61, DOI 10.1016/j.jas.2014.09.023; Snir A, 2014, J ARCHAEOL SCI, V44, P69, DOI 10.1016/j.jas.2014.01.014; Stuart Davies M., 1999, PREHISTORY AGR NEW E, P70, DOI DOI 10.2307/J.CTVHHHG2J.14; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Tanno K, 2012, VEG HIST ARCHAEOBOT, V21, P107, DOI 10.1007/s00334-011-0316-0; Unger-Hamilton R, 1999, PREHISTORY AGR NEW E, P145, DOI 10.2307/j.ctvhhhg2j.17; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; Weiss E., 2002, ISSUES RECONSTRUCTIO; Weiss E, 2008, J ARCHAEOL SCI, V35, P2400, DOI 10.1016/j.jas.2008.03.012; Willcox G, 2012, VEG HIST ARCHAEOBOT, V21, P163, DOI 10.1007/s00334-011-0307-1; Wittfogel K., 1956, MANS ROLE CHANGING F; Yamada S., 2000, DEV NEOLITHIC LITHIC; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307; Zohar I, 2008, PALAEOGEOGR PALAEOCL, V258, P292, DOI 10.1016/j.palaeo.2007.11.004; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary D., 1969, The domestication and exploitation of plants and animals., P47; Zohary M., 1950, PLANT ECOL, V2, P387, DOI DOI 10.1007/BF00179724; Zohary M., 1972, FLORA PALAESTINA; Zohary M, 1966, FLORA PALAESTINA	62	106	107	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131422	10.1371/journal.pone.0131422	http://dx.doi.org/10.1371/journal.pone.0131422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200895	Green Published, gold, Green Submitted			2022-12-27	WOS:000358597100014
J	Gao, JJ; Wang, Q; Dong, C; Chen, SQ; Qi, Y; Liu, YH				Gao, Juanjuan; Wang, Qi; Dong, Cheng; Chen, Siqi; Qi, Yu; Liu, Yuhe			Whole Exome Sequencing Identified MCM2 as a Novel Causative Gene for Autosomal Dominant Nonsyndromic Deafness in a Chinese Family	PLOS ONE			English	Article							HEARING-LOSS; INDUCED APOPTOSIS; DNA-REPLICATION; HAIR-CELLS; MUTATION; LOCALIZATION; EXPRESSION; COMPLEX; INNER; OVEREXPRESSION	We report the genetic analysis of autosomal dominant, nonsyndromic, progressive sensorineural hearing loss in a Chinese family. Using whole exome sequencing, we identified a missense variant (c.130C>T, p.R44C) in the MCM2 gene, which has a pro-apoptosis effect and is involved in the initiation of eukaryotic genome replication. This missense variant is very likely to be the disease causing variant. It segregated with hearing loss in this pedigree, and was not found in the dbSNP database or databases of genomes and SNP in the Chinese population, in 76 patients with sporadic hearing loss, or in 145 normal individuals. We performed western blot and immunofluorescence to test the MCM2 protein expression in the cochlea of rats and guinea pigs, demonstrating that MCM2 was widely expressed in the cochlea and was also surprisingly expressed in the cytoplasm of terminally differentiated hair cells. We then transiently expressed the variant MCM2 cDNA in HEK293 cells, and found that these cells displayed a slight increase in apoptosis without any changes in proliferation or cell cycle, supporting the view that this variant is pathogenic. In summary, we have identified MCM2 as a novel gene responsible for nonsyndromic hearing loss of autosomal dominant inheritance in a Chinese family.	[Gao, Juanjuan; Wang, Qi; Dong, Cheng; Chen, Siqi; Liu, Yuhe] Peking Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Beijing 100871, Peoples R China; [Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, YH (corresponding author), Peking Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Beijing 100871, Peoples R China.	liuyuhefeng@163.com	gao, juan/GXV-1381-2022		National Natural Science Foundation of China [81271083, 81470691]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by National Natural Science Foundation of China under the grant 81271083 and 81470691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040129; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Bayazit YA, 2006, ORL-J OTO-RHIN-LARYN, V68, P57, DOI 10.1159/000091090; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; de Beeck KO, 2011, HEARING RES, V281, P18, DOI 10.1016/j.heares.2011.07.002; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Gao J, 2013, CLIN GENET, V83, P477, DOI 10.1111/cge.12006; Hasegawa M, 2009, LEUKEMIA RES, V33, P1100, DOI 10.1016/j.leukres.2008.10.025; Hildebrand MS, 2007, AM J MED GENET A, V143A, P1599, DOI 10.1002/ajmg.a.31860; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Holland L, 2002, EUR J BIOCHEM, V269, P5192, DOI 10.1046/j.1432-1033.2002.03224.x; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Kuhlenbaumer G, 2011, HUM MUTAT, V32, P144, DOI 10.1002/humu.21400; Lallemend F, 2005, CURR PHARM DESIGN, V11, P2257, DOI 10.2174/1381612054367346; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Ramnath N, 2001, J CLIN ONCOL, V19, P4259, DOI 10.1200/JCO.2001.19.22.4259; Riera A, 2013, CELL CYCLE, V12, P2155, DOI 10.4161/cc.25336; Robertson NG, 2003, J MED GENET, V40, P479, DOI 10.1136/jmg.40.7.479; Sanders SS, 2011, CLIN GENET, V79, P132, DOI 10.1111/j.1399-0004.2010.01585.x; Smith RJ., 1993, GENEREVIEWS; Stelma F, 2014, J LARYNGOL OTOL, V128, P13, DOI 10.1017/S0022215113003265; Suzuki S, 2012, EXP MOL PATHOL, V92, P160, DOI 10.1016/j.yexmp.2011.11.003; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tsuruga H, 1997, BIOCHEM BIOPH RES CO, V236, P118, DOI 10.1006/bbrc.1997.6865; Van De Water TR, 2004, OTOL NEUROTOL, V25, P627, DOI 10.1097/00129492-200407000-00035; Walsh T, 2010, AM J HUM GENET, V87, P101, DOI 10.1016/j.ajhg.2010.05.011; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069549	35	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133522	10.1371/journal.pone.0133522	http://dx.doi.org/10.1371/journal.pone.0133522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196677	Green Published, gold, Green Submitted			2022-12-27	WOS:000358547600109
J	Huang, YJ; Wu, JY; Wang, P; Lin, YQ; Fu, C; Deng, ZH; Wang, QN; Li, QW; Chen, RK; Zhang, MQ				Huang, Yongji; Wu, Jiayun; Wang, Ping; Lin, Yanquan; Fu, Cheng; Deng, Zuhu; Wang, Qinnan; Li, Qiwei; Chen, Rukai; Zhang, Muqing			Characterization of Chromosome Inheritance of the Intergeneric BC2 and BC3 Progeny between Saccharum spp. and Erianthus arundinaceus	PLOS ONE			English	Article							HALF-TETRAD ANALYSIS; SEXUAL POLYPLOIDIZATION; MEIOTIC STABILITY; SUGARCANE; RELATIVES; HYBRIDS; ANDROPOGONEAE; INTROGRESSION; TRANSMISSION; RESISTANCE	Erianthus arundinaceus (E. arundinaceus) has many desirable agronomic traits for sugarcane improvement, such as high biomass, vigor, rationing ability, tolerance to drought, and water logging, as well as resistance to pests and disease. To investigate the introgression of the E. arundinaceus genome into sugarcane in the higher generations, intergeneric BC2 and BC3 progeny generated between Saccharum spp. and E. arundinaceus were studied using the genomic in situ hybridization (GISH) technique. The results showed that the BC2 and BC3 generations resulted from n + n chromosome transmission. Furthermore, chromosome translocation occurred at terminal fragments from the E. arundinaceus chromosome in some progeny of Saccharum spp. and E. arundinaceus. Notably, the translocated chromosomes could be stably transmitted to their progeny. This study illustrates the characterization of chromosome inheritance of the intergeneric BC2 and BC3 progeny between Saccharum spp. and E. arundinaceus. This work could provide more useful molecular cytogenetic information for the germplasm resources of E. arundinaceus, and may promote further understanding of the germplasm resources of E. arundinaceus for sugarcane breeders to accelerate its progress in sugarcane commercial breeding.	[Huang, Yongji; Wang, Ping; Lin, Yanquan; Deng, Zuhu; Chen, Rukai] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Peoples R China; [Wu, Jiayun; Fu, Cheng; Wang, Qinnan; Li, Qiwei] Guangzhou Sugarcane Ind Res Inst, Guangdong Key Lab Sugarcane Improvement & Biorefi, Guangzhou, Guangdong, Peoples R China; [Deng, Zuhu; Zhang, Muqing] Guangxi Collaborat Ctr Sugarcane & Cane Sugar Ind, Guangxi, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Guangdong Academy of Sciences; Institute of Nanfan & Seed Industry, Guangdong Academy of Sciences	Deng, ZH (corresponding author), Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Peoples R China.	dengzuhu@163.com		zhang, muqing/0000-0003-3138-3422	National Natural Science Foundation of China [31401440]; earmarked fund for the Modern Agriculture Technology of China [CARS-20-1-5]; Guangxi Natural Science Foundation [2014GXNSFFA118002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agriculture Technology of China; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was funded by National Natural Science Foundation of China (31401440, http://www.nsfc.gov.cn/), the earmarked fund for the Modern Agriculture Technology of China (CARS-20-1-5). This project is also supported by Guangxi Natural Science Foundation (2014GXNSFFA118002, http://gxnsf.gxsti.net/stms/login.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleza P, 2010, PLANT CELL REP, V29, P1023, DOI 10.1007/s00299-010-0888-7; Alix K, 1999, THEOR APPL GENET, V99, P962, DOI 10.1007/s001220051403; Alix K, 1998, GENOME, V41, P854, DOI 10.1139/gen-41-6-854; Amalraj VA, 2006, GENET RESOUR CROP EV, V53, P35, DOI 10.1007/s10722-004-0581-1; An DG, 2013, CHROMOSOME RES, V21, P419, DOI 10.1007/s10577-013-9366-8; Barba-Gonzalez R, 2004, THEOR APPL GENET, V109, P1125, DOI 10.1007/s00122-004-1739-0; BREMER G, 1961, EUPHYTICA, V10, P121, DOI 10.1007/BF00037206; BURNER DM, 1991, EUPHYTICA, V54, P125, DOI 10.1007/BF00145639; BURNER DM, 1993, CROP SCI, V33, P600, DOI 10.2135/cropsci1993.0011183X003300030036x; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Cuenca J, 2011, HEREDITY, V107, P462, DOI 10.1038/hdy.2011.33; Cuenca J, 2013, ANN BOT-LONDON, V111, P731, DOI 10.1093/aob/mct032; De Storme N, 2013, NEW PHYTOL, V198, P670, DOI 10.1111/nph.12184; Deng ZH, 2010, AGR SCI CHINA, V9, P1271, DOI 10.1016/S1671-2927(09)60216-9; DHONT A, 1995, THEOR APPL GENET, V91, P320, DOI 10.1007/BF00220894; DHONT A, 1996, MOL GEN GENET, V250, P405, DOI DOI 10.1007/BF02174028; Harper J, 2011, ANN BOT-LONDON, V107, P1313, DOI 10.1093/aob/mcr083; Hermann SR, 2012, EUPHYTICA, V187, P359, DOI 10.1007/s10681-012-0698-9; Lavia GI, 2011, ANN BOT-LONDON, V108, P103, DOI 10.1093/aob/mcr108; Irvine JE, 1999, THEOR APPL GENET, V98, P186, DOI 10.1007/s001220051057; JACKSON P, 2011, WILD CROP RELATIVES, P97, DOI DOI 10.1007/978-3-642-21102-7_5; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jansky SH, 2006, GENET RESOUR CROP EV, V53, P669, DOI 10.1007/s10722-004-2949-7; Kynast RG, 2001, PLANT PHYSIOL, V125, P1216, DOI 10.1104/pp.125.3.1216; Lam E, 2009, GCB BIOENERGY, V1, P251, DOI 10.1111/j.1757-1707.2009.01016.x; Lim KB, 2004, BREEDING SCI, V54, P13, DOI 10.1270/jsbbs.54.13; LU YH, 1994, EUPHYTICA, V78, P7; Manzanero S, 2002, CHROMOSOMA, V111, P228, DOI 10.1007/s00412-002-0211-7; Markova M, 2007, CHROMOSOME RES, V15, P1051, DOI 10.1007/s10577-007-1180-8; Mason AS, 2015, TRENDS GENET, V31, P5, DOI 10.1016/j.tig.2014.09.011; Mestiri I, 2010, NEW PHYTOL, V186, P86, DOI 10.1111/j.1469-8137.2010.03186.x; Nair NV, 1999, GENET RESOUR CROP EV, V46, P73, DOI 10.1023/A:1008696808645; Park TH, 2007, GENETICS, V176, P85, DOI 10.1534/genetics.107.070870; Piperidis G, 2000, GENOME, V43, P1033, DOI 10.1139/gen-43-6-1033; Piperidis G, 2010, MOL GENET GENOMICS, V284, P65, DOI 10.1007/s00438-010-0546-3; Piperidis N, 2013, INT SUGAR J, P1; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; Ram B, 2001, EUPHYTICA, V122, P145, DOI 10.1023/A:1012626805467; Ramanna MS, 2003, EUPHYTICA, V133, P3, DOI 10.1023/A:1025600824483; Roach BT, 1972, P INT SOC SUGAR CANE, V14, P206; Rott P, 1997, PHYTOPATHOLOGY, V87, P1202, DOI 10.1094/PHYTO.1997.87.12.1202; SOBRAL BWS, 1994, THEOR APPL GENET, V87, P843, DOI 10.1007/BF00221137; Ssebuliba RN, 2008, EUPHYTICA, V164, P53, DOI 10.1007/s10681-007-9637-6; Su YC, 2013, PLANT CELL REP, V32, P1503, DOI 10.1007/s00299-013-1463-9; Su YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084426; Wu JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110390; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P19466, DOI 10.1073/pnas.1319598110; Zhang P, 2008, GENETICS, V179, P1169, DOI 10.1534/genetics.108.089599	48	18	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133722	10.1371/journal.pone.0133722	http://dx.doi.org/10.1371/journal.pone.0133722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196281	Green Submitted, Green Published, gold			2022-12-27	WOS:000358547600136
J	Mayaka, TB; Kamla, AT; Self-Sullivan, C				Mayaka, Theodore B.; Kamla, Aristide Takoukam; Self-Sullivan, Caryn			Using Pooled Local Expert Opinions (PLEO) to Discern Patterns in Sightings of Live and Dead Manatees (Trichechus senegalensis, Link 1785) in Lower Sanaga Basin, Cameroon	PLOS ONE			English	Article							TRADITIONAL ECOLOGICAL KNOWLEDGE; WEST-INDIAN MANATEE; BIODIVERSITY CONSERVATION; INDIGENOUS KNOWLEDGE; FLORIDA MANATEE; AFRICAN MANATEE; BIAS REDUCTION; DROWNED CAYES; HABITAT USE; MARINE	We aimed at unveiling patterns in live and dead manatee sightings in the Lower Sanaga Basin, Cameroon. For this purpose, the expert opinions of 133 local fishers were collected during in-person interviews, distilled using categorical data analysis, and checked against scientific literature. The five main results are as follows: manatees were sighted averagely once a week in lakes, rivers, and the coast & estuaries, mostly in group sizes of 2-3; the odds of sighting live manatees (respectively dead manatees) decreased (respectively increased) from inland lakes to estuaries and the coast, via rivers; manatee carcasses were reported in all habitats, albeit more frequently in rivers; a distribution map based on fishers' reports show two manatee concentration areas: Lake Ossa and the Malimba-Mbiako section of River Sanaga; the number of manatees was perceived as increasing despite incidental and directed catches. Thus, our findings corroborate earlier assessments of the Lower Sanaga Basin as being a major manatee conservation area. Additionally, from these results and the literature, we identified three hypotheses about local manatee persistence: deep pools such as lakes offer year round sanctuaries, not just dry-season refugia; seasonality of specific habitat variables determine manatee occurrence patterns; and local variability in habitat encroachment mediate the meta-population dynamics of manatee in the Lower Sanaga Basin. Finally, we examine the implications for data requirements in light of the small ecological scale at which the surveyed fishers ply their trade. Thus, consonant with the Malawi principles for the ecosystem approach to management (www.cbd.int/ecosystem), we recommend collecting data preferably at landscape scale, through a participatory monitoring program that fully integrates scientific and traditional knowledge systems. This program should include, amongst others, a standardised necropsy protocol for collecting mortality and biological data together with sonar and radio-telemetry technology to discern manatee use and movements between critical habitat components.	[Mayaka, Theodore B.; Kamla, Aristide Takoukam] Univ Dschang, Dept Anim Biol, Dschang, West Region, Cameroon; [Self-Sullivan, Caryn] Nova SE Univ, Oceanog Ctr, Dania, FL 33004 USA	Nova Southeastern University	Mayaka, TB (corresponding author), Univ Dschang, Dept Anim Biol, Dschang, West Region, Cameroon.	theodoremayaka@yahoo.com						Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; [Anonymous], 2008, DRAFT ACTION PLAN CO; Aswani S, 2004, ENVIRON CONSERV, V31, P69, DOI 10.1017/S037689290400116X; Auil NE, 1998, BZE92G31 UNDP GEF CO; Auil NE, 2004, THESIS TEXAM A M U; Bacchus Marie-Lys C., 2009, Aquatic Mammals, V35, P62, DOI 10.1578/AM.35.1.2009.62; Barlas ME, 2011, 40181AG037 USFWS; BECK CA, 1991, MAR POLLUT BULL, V22, P508, DOI 10.1016/0025-326X(91)90406-I; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; BIRD A., 1998, PHILOS SCI; Bonde R.K., 1983, MANUAL PROCEDURES SA; Bonde R.K., 2004, ECOHEALTH, V1, P255, DOI [10.1007/s10393-004-0095-5.2, DOI 10.1007/S10393-004-0095-5.2]; Carney J, 2014, GEOFORUM, V53, P126, DOI 10.1016/j.geoforum.2014.02.013; Christensen R, 1990, LOG LINEAR MODELS LO, V2nd; Cochran W.G, 1971, SAMPLING TECHNIQUES; Courbis Sarah S., 2003, Aquatic Mammals, V29, P104, DOI 10.1578/016754203101023942; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Deutsch CJ, 2010, 2010 IUCN RED LIST T; DEWALT BR, 1994, HUM ORGAN, V53, P123, DOI 10.17730/humo.53.2.ku60563817m03n73; Dodman T., 2008, CONSERVATION STRATEG; Drew JA, 2005, CONSERV BIOL, V19, P1286, DOI 10.1111/j.1523-1739.2005.00158.x; Drew JA, 2006, ECOL SOC, V11; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Fazey I, 2006, ENVIRON CONSERV, V33, P1, DOI 10.1017/S037689290600275X; Feka Njisuh Z., 2011, International Journal of Biodiversity Science Ecosystem Services & Management, V7, P217, DOI 10.1080/21513732.2011.634436; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Fraser DJ, 2006, ECOL SOC, V11; GADGIL M, 1993, AMBIO, V22, P151; Gagnon CA, 2009, ECOL SOC, V14; Gannon JG, 2007, MAR MAMMAL SCI, V23, P133, DOI 10.1111/j.1748-7692.2006.00096.x; Gonzalez-Socoloske Daniel, 2009, Endangered Species Research, V8, P249, DOI 10.3354/esr00232; Gorzelany J, 2003, 874 MOT MAR LAB; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Grigione MM, 1996, AFR J ECOL, V34, P189; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; IRVINE AB, 1983, BIOL CONSERV, V25, P315; Jimenez I, 2002, ORYX, V36, P272, DOI 10.1017/S0030605302000492; Kosmidis I, 2011, BIOMETRIKA, V98, P755, DOI 10.1093/biomet/asr026; Kouadio A., 2004, THESIS U KENT; LaCommare KS, 2012, BIOL CONSERV, V152, P169, DOI 10.1016/j.biocon.2012.02.021; LaCommare Katherine S., 2008, Aquatic Mammals, V34, P35, DOI 10.1578/AM.34.1.2008.35; Lefebvre Lynn W., 2001, P425; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lightsey JD, 2006, J ZOO WILDLIFE MED, V37, P262, DOI 10.1638/04-095.1; Marsh H., 1994, Aquatic Mammals, V20, P155; Marsh H., 2012, ECOLOGY CONSERVATION, DOI [10.1017/CBO9781139013277, DOI 10.1017/CBO9781139013277]; Mayaka TB, 2012, TROPICAL CONSERVATIO, V6, P521; Miksis-Olds JL, 2011, MAR MAMMAL SCI, V27, P130, DOI 10.1111/j.1748-7692.2010.00381.x; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Nataly Castelblanco-Martinez Delma, 2012, Endangered Species Research, V18, P129, DOI 10.3354/esr00439; Castelblanco-Martinez DN, 2012, ESTUAR COAST, V35, P60, DOI 10.1007/s12237-011-9420-8; Castelblanco-Martinez DN, 2009, ORYX, V43, P235, DOI 10.1017/S0030605307000944; NISHIWAKI M, 1982, RECENT SURVEY DISTRI, V34, P137; Nishiwaki M, 1984, ACTA ZOOL FENN, V20, P155; Ortiz RM, 1998, PHYSIOL ZOOL, V71, P449, DOI 10.1086/515427; Osterblom H, 2010, MAR POLICY, V34, P1290, DOI 10.1016/j.marpol.2010.05.007; PACKARD JM, 1986, COAST MANAGE, V14, P279, DOI 10.1080/08920758609362007; Powell J, 2010, IUCN 2010 IUCN RED L; Powell J, 1985, MANATEES GAMBIA RIVE; POWELL JA, 1978, J MAMMAL, V59, P442, DOI 10.2307/1379938; Powell JA, 1996, DISTRIBUTION BIOL W; Quintana-Rizzo E, 2008, REGIONAL MANATEE PLA; *R DEV COR TEAM, 2007, LANG ENV STAT COMP; RATHBUN GB, 1983, BIOL CONSERV, V26, P301, DOI 10.1016/0006-3207(83)90094-0; Raymond CM, 2010, J ENVIRON MANAGE, V91, P1766, DOI 10.1016/j.jenvman.2010.03.023; Reynolds J. E., 1991, MANATEES AND DUGONGS; REYNOLDS JE, 1995, BIOL CONSERV, V71, P193, DOI 10.1016/0006-3207(94)00046-S; Rist L, 2010, ECOL SOC, V15; Rodas-Trejo J, 2008, TROP CONSERV SCI, V1, P321, DOI 10.1177/194008290800100403; Self-Sullivan C, 2008, THESIS TEXAS A M U; Self-Sullivan Caryn, 2003, Aquatic Mammals, V29, P342, DOI 10.1578/01675420360736514; Semeyn DJ, 2011, J COAST CONSERV, V15, P573, DOI 10.1007/s11852-011-0146-3; Shackeroff J.M., 2007, CONSERV SOC, V5, P343; Silva MA, 2001, MAR MAMMAL SCI, V17, P418, DOI 10.1111/j.1748-7692.2001.tb01285.x; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Snedecor GW, 1980, STAT METHODS, V7th; Stith BM, 2006, REV SYNTHESIS MANATE; van der Hoeven Christiaan A., 2004, Journal for Nature Conservation (Jena), V12, P193, DOI 10.1016/j.jnc.2004.06.003; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	83	4	4	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0128579	10.1371/journal.pone.0128579	http://dx.doi.org/10.1371/journal.pone.0128579			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197396	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600003
J	Tasca, F; Farias, D; Castro, C; Acuna-Rougier, C; Antiochia, R				Tasca, Federico; Farias, Diego; Castro, Carmen; Acuna-Rougier, Cristina; Antiochia, Riccarda			Bilirubin Oxidase from Myrothecium verrucaria Physically Absorbed on Graphite Electrodes. Insights into the Alternative Resting Form and the Sources of Activity Loss	PLOS ONE			English	Article							ELECTROCATALYTIC REDUCTION; MULTICOPPER OXIDASES; HYDROGEN-PEROXIDE; COPPER CENTERS; O-2; LACCASE; OXYGEN; H2O; CHALLENGES; KINETICS	The oxygen reduction reaction is one of the most important chemical processes in energy converting systems and living organisms. Mediator-less, direct electro-catalytic reduction of oxygen to water was achieved on spectrographite electrodes modified by physical adsorption of bilirubin oxidases from Myrothecium verrucaria. The existence of an alternative resting form of the enzyme is validated. The effect on the catalytic cycle of temperature, pH and the presence of halogens in the buffer was investigated. Previous results on the electrochemistry of bilirubin oxidase and on the impact of the presence of halogens are reviewed and reinterpreted.	[Tasca, Federico; Castro, Carmen; Acuna-Rougier, Cristina] Univ Santiago Chile, Fac Quim & Biol, Dept Quim Mat, Santiago, RM, Chile; [Farias, Diego] Univ Tecnol Metropolitana, Fac Ciencias Nat Matemat & Medioambiente, Santiago, RM, Chile; [Antiochia, Riccarda] Univ Roma La Sapienza, Dept Chem & Drug Technol, I-00185 Rome, Italy	Universidad de Santiago de Chile; Universidad Tecnologica Metropolitana; Sapienza University Rome	Tasca, F (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Quim Mat, Santiago, RM, Chile.	federico.tasca@usach.cl	Tasca, Federico/J-4134-2015	Tasca, Federico/0000-0002-4111-4624; ANTIOCHIA, RICCARDA/0000-0001-8990-8506	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [1130167]; Direccion de Investigacion Cientifica y Tecnologica (Dicyt) [021342TG_DAS]; Center for the Development of Nanoscience and Nanotechnology (CEDENNA); MECESUP project [USA1298]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion Cientifica y Tecnologica (Dicyt); Center for the Development of Nanoscience and Nanotechnology (CEDENNA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); MECESUP project	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) Project No 1130167 (http://www.conicyt.cl/fondecyt/) and Direccion de Investigacion Cientifica y Tecnologica (Dicyt) Project No 021342TG_DAS (http://dicyt.usach.cl/). The Center for the Development of Nanoscience and Nanotechnology (CEDENNA) is also acknowledged for financial support. C. A. thanks MECESUP project USA1298 (http://www.mecesup.cl/) for financing her post-doc.	Armaroli N, 2007, ANGEW CHEM INT EDIT, V46, P52, DOI 10.1002/anie.200602373; Balzani V., 2001, ELECT TRANSFER CHEM; Bard A. J., 2007, ENCY ELECTROCHEMISTR; Blanford CF, 2008, FARADAY DISCUSS, V140, P319, DOI 10.1039/b808939f; Cadet M, 2013, CHEMPHYSCHEM, V14, P2097, DOI 10.1002/cphc.201300027; Christenson A, 2006, BBA-BIOENERGETICS, V1757, P1634, DOI 10.1016/j.bbabio.2006.08.008; DOUMAS BT, 1987, CLIN CHEM, V33, P1349; Frasconi M, 2010, ELECTROCHIM ACTA, V56, P817, DOI 10.1016/j.electacta.2010.09.056; Gewirth AA, 2010, INORG CHEM, V49, P3557, DOI 10.1021/ic9022486; GRAY HB, 2001, ELECT TRANSFER CHEM; Kjaergaard CH, 2012, J AM CHEM SOC, V134, P5548, DOI 10.1021/ja211872j; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; Mano N, 2003, J AM CHEM SOC, V125, P15290, DOI 10.1021/ja038285d; Mano N, 2003, J ELECTROCHEM SOC, V150, pA1136, DOI 10.1149/1.1592519; Mano N, 2002, J AM CHEM SOC, V124, P6480, DOI 10.1021/ja025874v; Mano N, 2002, J PHYS CHEM B, V106, P8842, DOI 10.1021/jp025955d; Mano N, 2013, BIOSENS BIOELECTRON, V50, P478, DOI 10.1016/j.bios.2013.07.014; McCrory CCL, 2007, J PHYS CHEM A, V111, P12641, DOI 10.1021/jp076106z; MESSERSCHMIDT A, 1992, J MOL BIOL, V224, P179, DOI 10.1016/0022-2836(92)90583-6; Milton RD, 2014, CHEM COMMUN, V50, P94, DOI 10.1039/c3cc47689h; MURAO S, 1981, AGR BIOL CHEM TOKYO, V45, P2383, DOI 10.1080/00021369.1981.10864896; PETERSEN LC, 1978, BIOCHIM BIOPHYS ACTA, V526, P85, DOI 10.1016/0005-2744(78)90292-9; Ramirez P, 2008, BBA-BIOENERGETICS, V1777, P1364, DOI 10.1016/j.bbabio.2008.06.010; Shleev S, 2004, ELECTROCHEM COMMUN, V6, P934, DOI 10.1016/j.elecom.2004.07.008; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 2011, FARADAY DISCUSS, V148, P11, DOI 10.1039/c005500j; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Vaz-Dominguez C, 2008, BIOSENS BIOELECTRON, V24, P531, DOI 10.1016/j.bios.2008.05.002; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018	29	24	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132181	10.1371/journal.pone.0132181	http://dx.doi.org/10.1371/journal.pone.0132181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196288	gold, Green Published, Green Submitted			2022-12-27	WOS:000358547600026
J	Wagner, CS; Park, HW; Leydesdorff, L				Wagner, Caroline S.; Park, Han Woo; Leydesdorff, Loet			The Continuing Growth of Global Cooperation Networks in Research: A Conundrum for National Governments	PLOS ONE			English	Article							INTERNATIONAL SCIENTIFIC COOPERATION; RESEARCH COLLABORATION; EUROPEAN-UNION; CO-AUTHORSHIP; TEAM SCIENCE; IMPACT; INFORMATION; PATTERNS	Global collaboration continues to grow as a share of all scientific cooperation, measured as coauthorships of peer-reviewed, published papers. The percent of all scientific papers that are internationally coauthored has more than doubled in 20 years, and they account for all the growth in output among the scientifically advanced countries. Emerging countries, particularly China, have increased their participation in global science, in part by doubling their spending on R & D; they are increasingly likely to appear as partners on internationally coauthored scientific papers. Given the growth of connections at the international level, it is helpful to examine the phenomenon as a communications network and to consider the network as a new organization on the world stage that adds to and complements national systems. When examined as interconnections across the globe over two decades, a global network has grown denser but not more clustered, meaning there are many more connections but they are not grouping into exclusive 'cliques'. This suggests that power relationships are not reproducing those of the political system. The network has features an open system, attracting productive scientists to participate in international projects. National governments could gain efficiencies and influence by developing policies and strategies designed to maximize network benefits-a model different from those designed for national systems.	[Wagner, Caroline S.] Ohio State Univ, Milton & Roslyn Wolf Chair Int Affairs, John Glenn Sch Publ Affairs, Columbus, OH 43210 USA; [Wagner, Caroline S.] Ohio State Univ, Battelle Ctr Sci & Technol Policy, Columbus, OH 43210 USA; [Park, Han Woo] Yeungnam Univ, Dept Media & Commun, Gyongsan, Gyeongsangbuk D, South Korea; [Leydesdorff, Loet] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Yeungnam University; University of Amsterdam	Wagner, CS (corresponding author), Ohio State Univ, Milton & Roslyn Wolf Chair Int Affairs, John Glenn Sch Publ Affairs, Columbus, OH 43210 USA.	wagner.911@osu.edu	Leydesdorff, Loet/E-2903-2010; Park, Han Woo/F-4051-2011; Wagner, Caroline S/A-7170-2012	Leydesdorff, Loet/0000-0002-7835-3098; Park, Han Woo/0000-0002-1378-2473; Wagner, Caroline S/0000-0002-1724-8489				Adams J, 2014, SCIENTOMETRICS, V98, P547, DOI 10.1007/s11192-013-1060-2; Adams J, 2013, NATURE, V497, P557, DOI 10.1038/497557a; Aghion P, 2009, RES POLICY, V38, P681, DOI 10.1016/j.respol.2009.01.016; Ahlgren P, 2003, J AM SOC INF SCI TEC, V54, P550, DOI 10.1002/asi.10242; Allen T, 1971, TECHNOLOGY TRANSFER; ALLEN TJ, 1969, ADMIN SCI QUART, V14, P12, DOI 10.2307/2391357; Barnett GA, 2016, COMPARE, V46, P533, DOI 10.1080/03057925.2015.1015965; Bechtel W., 2010, DISCOVERING COMPLEXI, DOI DOI 10.7551/MITPRESS/8328.001.0001; Behrendt J, 2014, ARCT ANTARCT ALP RES, V46, P287; Ben-David J, 1971, SCI ROLE SOC; Benaim M, 2014, 201413 UDS BUR EC; Bernal J. D., 1939, SOCIAL FUNCTION SCI; Bowcutt K, 2008, 15 AIAA INT SPAC PLA; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Bozeman B, 2004, RES POLICY, V33, P599, DOI 10.1016/j.respol.2004.01.008; Bozeman B, 2014, RES COLLABORATION TE, P33; Choi S, 2015, QUAL QUANT, V49, P1381, DOI 10.1007/s11135-014-0052-5; Choi S, 2015, J ASSOC INF SCI TECH, V66, P201, DOI 10.1002/asi.23165; Crane D., 1972, INVISIBLE COLL; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Frenken K, 2004, INNOVATION, ENTREPRENEURSHIP AND CULTURE: THE INTERACTION BETWEEN TECHNOLOGY, PROGRESS AND ECONOMIC GROWTH, P87; Gazni A, 2012, J AM SOC INF SCI TEC, V63, P323, DOI 10.1002/asi.21688; Georghiou L, 1998, RES POLICY, V27, P611, DOI 10.1016/S0048-7333(98)00054-7; Glanzel W, 1999, SCIENTOMETRICS, V45, P185, DOI 10.1007/BF02458432; Glanzel W, 2001, SCIENTOMETRICS, V50, P199, DOI 10.1023/A:1010561321723; Gostin LO, 2014, LANCET, V384, P1323, DOI 10.1016/S0140-6736(14)61791-8; Griliches Z, 1998, R D PRODUCTIVITY ECO, P347; Hall KL, 2008, AM J PREV MED, V35, pS243, DOI 10.1016/j.amepre.2008.05.007; HAMERS L, 1989, INFORM PROCESS MANAG, V25, P315, DOI 10.1016/0306-4573(89)90048-4; Hoekman J., 2013, GEOGRAPHY NETWORKS R, P263; Hoekman J, 2010, RES POLICY, V39, P662, DOI 10.1016/j.respol.2010.01.012; Hollingsworth J. R., 2013, EXCEPTIONAL CREATIVI, P25; Horlings E, 2013, CONVERGENCE SCI GROW; Jiang Ke, 2014, J CONT E ASIA, V13, P83; Jones C, 1997, ACAD MANAGE REV, V22, P911, DOI 10.5465/AMR.1997.9711022109; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Kinne BJ, 2013, AM POLIT SCI REV, V107, P766, DOI 10.1017/S0003055413000440; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Laudel G, 2002, RES EVALUAT, V11, P3, DOI 10.3152/147154402781776961; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Leigh N.G., 2013, PLANNING LOCAL EC DE; Lemarchand GA, 2012, RES POLICY, V41, P291, DOI 10.1016/j.respol.2011.10.009; Leydesdorff L, 2000, SCIENTOMETRICS, V47, P265, DOI 10.1023/A:1005639026643; Leydesdorff L, 2008, J INFORMETR, V2, P317, DOI 10.1016/j.joi.2008.07.003; Leydesdorff L, 2014, J INFORMETR, V8, P606, DOI 10.1016/j.joi.2014.05.002; Liu HI, 2012, SCIENTOMETRICS, V92, P145, DOI 10.1007/s11192-012-0719-4; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; LUUKKONEN T, 1992, SCI TECHNOL HUM VAL, V17, P101, DOI 10.1177/016224399201700106; Megnigbeto E, 2013, SCIENTOMETRICS, V96, P761, DOI 10.1007/s11192-013-0963-2; Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600; Monge P, 2001, NEW HDB ORG COMMUNIC; Narin F., 1976, EVALUATIVE BIBLIOMET; National Research Council, 2015, ENH EFF TEAM SCI; National Research Council, 2011, US INT PERSP GLOB SC; National Science Board, 2014, SCI ENG IND; Organisation for Economic Co Operation and Development, 2013, OECD SCI TECHN IND S, DOI [10.1787/sti_scoreboard-2013-en, DOI 10.1787/STI_SCOREBOARD-2013-EN]; Organization for Economic Cooperation and Development (OECD), 2013, SCI TECHNOLOGY IND; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; Persson O, 2004, SCIENTOMETRICS, V60, P421, DOI 10.1023/B:SCIE.0000034384.35498.7d; Strasser BJ, 2009, OSIRIS, V24, P165, DOI 10.1086/605974; Suttmeier R, 2014, SCI TECHNOLOGY EMPIR, V2, P143; Theil H., 1972, STAT DECOMPOSITION A; United Nations Educational Scientific and Cultural Organization, 2010, UNESCO SCI REP 2010; Van Raan AFJ, 1998, SCIENTOMETRICS, V42, P423, DOI 10.1007/BF02458380; Wagner C. S., 2005, INT J TECHNOLOGY GLO, V1, P185, DOI [DOI 10.1504/IJTG.2005.007050, 10/c4jn8k]; Wagner CS, 2005, RES POLICY, V34, P1608, DOI 10.1016/j.respol.2005.08.002; Wagner CS, 2008, NEW INVISIBLE COLLEGE: SCIENCE FOR DEVELOPMENT, P1; Woolgar S, 1976, PERSPECTIVES EMERGEN; Ynalvez MA, 2011, RES POLICY, V40, P204, DOI 10.1016/j.respol.2010.10.004; Young OR, 2005, GLOB GOV, V11, P9, DOI 10.1163/19426720-01101002	71	125	129	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131816	10.1371/journal.pone.0131816	http://dx.doi.org/10.1371/journal.pone.0131816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196296	Green Submitted, gold, Green Published			2022-12-27	WOS:000358547600016
J	Dang, MT; Wehrli, S; Dang, CV; Curran, T				Dang, Mai T.; Wehrli, Suzanne; Dang, Chi V.; Curran, Tom			The Ketogenic Diet Does Not Affect Growth of Hedgehog Pathway Medulloblastoma in Mice	PLOS ONE			English	Article							GLUTAMINE-METABOLISM; XENOGRAFT MODEL; CACHEXIA MODEL; CANCER CELLS; TUMOR-GROWTH; WEIGHT-LOSS; CARBOHYDRATE; CHILDREN; BRAIN; INHIBITOR	The altered metabolism of cancer cells has long been viewed as a potential target for therapeutic intervention. In particular, brain tumors often display heightened glycolysis, even in the presence of oxygen. A subset of medulloblastoma, the most prevalent malignant brain tumor in children, arises as a consequence of activating mutations in the Hedgehog (HH) pathway, which has been shown to promote aerobic glycolysis. Therefore, we hypothesized that a low carbohydrate, high fat ketogenic diet would suppress tumor growth in a genetically engineered mouse model of medulloblastoma. However, we found that the ketogenic diet did not slow the growth of spontaneous tumors or allograft flank tumors, and it did not exhibit synergy with a small molecule inhibitor of Smoothened. Serum insulin was significantly reduced in mice fed the ketogenic diet, but no alteration in PI3 kinase activity was observed. These findings indicate that while the ketogenic diet may be effective in inhibiting growth of other tumor types, it does not slow the growth of HH-medulloblastoma in mice.	[Dang, Mai T.; Wehrli, Suzanne; Curran, Tom] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Dang, Chi V.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Curran, T (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	currant@email.chop.edu	Curran, Tom/F-5234-2018; Dang, Chi/Y-3375-2019; Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019	Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Dang, Chi/0000-0002-4031-2522	National Institutes of Health [T32NS007413, R25NS065745]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007413, R25NS065745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institutes of Health T32NS007413 and R25NS065745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Akyuz C, 2008, J NEURO-ONCOL, V90, P99, DOI 10.1007/s11060-008-9638-x; Allen BG, 2013, CLIN CANCER RES, V19, P3905, DOI 10.1158/1078-0432.CCR-12-0287; Ashley DM, 2012, J CLIN ONCOL, V30, P3181, DOI 10.1200/JCO.2010.34.4341; BECK SA, 1989, BRIT J CANCER, V59, P677, DOI 10.1038/bjc.1989.140; Bhatia B, 2012, ACTA NEUROPATHOL, V123, P587, DOI 10.1007/s00401-012-0968-6; Borghjid S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-69; Caso J, 2013, PROSTATE, V73, P449, DOI 10.1002/pros.22586; Champ CE, 2014, J NEURO-ONCOL, V117, P125, DOI 10.1007/s11060-014-1362-0; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Dutton SBB, 2011, EPILEPSIA, V52, P2050, DOI 10.1111/j.1528-1167.2011.03211.x; Gajjar A, 2013, CLIN CANCER RES, V19, P6305, DOI 10.1158/1078-0432.CCR-13-1425; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gershon TR, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-2; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Manninen AH, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mavropoulos JC, 2009, CANCER PREV RES, V2, P557, DOI 10.1158/1940-6207.CAPR-08-0188; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramanan M, 2012, J CLIN NEUROSCI, V19, P1387, DOI 10.1016/j.jocn.2012.01.028; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; SOKOLOFF L, 1973, ANNU REV MED, V24, P271, DOI 10.1146/annurev.me.24.020173.001415; Taylor RE, 2005, EUR J CANCER, V41, P727, DOI 10.1016/j.ejca.2004.12.017; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; TISDALE MJ, 1987, BRIT J CANCER, V56, P39, DOI 10.1038/bjc.1987.149; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wetmore C, 2001, CANCER RES, V61, P513; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5	42	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133633	10.1371/journal.pone.0133633	http://dx.doi.org/10.1371/journal.pone.0133633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192445	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400109
J	Fochi, MML; Baring, S; Spegiorin, LCJF; Vaz-Oliani, DCM; Galao, EA; Oliani, AH; de Mattos, LC; de Mattos, CCB				Lemos Fochi, Mariana Machado; Baring, Sabrina; Junqueira Franco Spegiorin, Ligia Cosentino; Mos Vaz-Oliani, Denise Cristina; Galao, Eloisa Aparecida; Oliani, Antonio Helio; de Mattos, Luiz Carlos; Brandao de Mattos, Cinara Cassia			Prematurity and Low Birth Weight did not Correlate with Anti-Toxoplasma gondii Maternal Serum Profiles - a Brazilian Report	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; PREGNANT-WOMEN; SAO-PAULO; RISK-FACTORS; OCULAR TOXOPLASMOSIS; INFECTION; STATE; HIV; ASSOCIATION; ANTIBODIES	Gestational Toxoplasma gondii infection is considered a major risk factor for miscarriage, prematurity and low birth weight in animals. However, studies focusing on this topic in humans are scarce. The objective of this study is to determine whether anti-Toxoplasma gondii maternal serum profiles correlate prematurity and low birth weight in humans. The study examined 213 pregnant women seen at the High-Risk Pregnancy Hospital de Base, Sao Jose do Rio Preto, Sao Paulo, Brazil. All serological profiles (IgM-/IgG+; IgM-/IgG-; IgM +/IgG+) were determined by ELISA commercial kits. Maternal age, gestational age and weight of the newborn at birth were collected and recorded in the Statement of Live Birth. Prematurity was defined as gestational age <37 weeks and low birth weight <= 2499 grams. The t-test was used to compare values (p < 0.05). The mean maternal age was 27.6 +/- 6.6 years. Overall, 56.3% (120/213) of the women studied were IgM-/IgG+, 36.2% (77/213) were IgM-/IgG-and 7.5% (16/213) were IgM+/IgG+. The average age of the women with serological profile IgM+/IgG+ (22.3 +/- 3.9 years) was different from women with the profile IgM-/IgG+ (27.9 +/- 6.7 years, p = 0.0011) and IgM-/IgG-(27.9 +/- 6.4 years, p = 0.0012). There was no statistically significant difference between the different serological profiles in relation to prematurity (p = 0.6742) and low birth weight (p = 0.7186). The results showed that prematurity and low birth weight did not correlate with anti-Toxoplasma gondii maternal serum profiles.	[Lemos Fochi, Mariana Machado; de Mattos, Luiz Carlos; Brandao de Mattos, Cinara Cassia] Fac Med Sao Jose do Rio Preto FAMERP, Dept Mol Biol, Immunogenet Lab, Sao Jose Do Rio Preto, SP, Brazil; [Baring, Sabrina; Junqueira Franco Spegiorin, Ligia Cosentino; Mos Vaz-Oliani, Denise Cristina; Galao, Eloisa Aparecida] Fundacao Fac Reg Med Sao Jose do Rio Preto HB FUN, Hosp Base, Obstet & Gynecol Serv, Sao Jose Do Rio Preto, SP, Brazil; [Junqueira Franco Spegiorin, Ligia Cosentino; Mos Vaz-Oliani, Denise Cristina; Galao, Eloisa Aparecida; Oliani, Antonio Helio] Fac Med Sao Jose do Rio Preto FAMERP, Dept Gynecol & Obstet, Sao Jose Do Rio Preto, SP, Brazil; [Junqueira Franco Spegiorin, Ligia Cosentino; Mos Vaz-Oliani, Denise Cristina; Galao, Eloisa Aparecida; Oliani, Antonio Helio] Hosp Crianca & Maternidade Sao Jose do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil; [Lemos Fochi, Mariana Machado; Junqueira Franco Spegiorin, Ligia Cosentino; de Mattos, Luiz Carlos; Brandao de Mattos, Cinara Cassia] Fac Med Sao Jose do Rio Preto FAMERP, FAMERP Toxoplasma Res Grp, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	de Mattos, CCB (corresponding author), Fac Med Sao Jose do Rio Preto FAMERP, Dept Mol Biol, Immunogenet Lab, Sao Jose Do Rio Preto, SP, Brazil.	cinara.brandao@famerp.br	DE MATTOS, LUIZ CARLOS/F-6739-2010; de Mattos, Luiz Carlos/P-4005-2019; OLIANI, ANTONIO/O-1673-2019; de Mattos, Luiz Carlos/P-3574-2019; BRANDÃO, CINARA/B-3650-2008	DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; de Mattos, Luiz Carlos/0000-0002-8572-8177; BRANDÃO, CINARA/0000-0002-4836-3113; Spegiorin, Ligia Cosentino Junqueira Franco/0000-0003-4405-8098; Oliani, Antonio Helio/0000-0003-1242-4364	Scientific Initiation Scholarship from the Brazilian Ministry of Science Technology and Inovation - PIBIC - CNPq (The National Council for Scientific and Technological Development); Brazilian Ministry of Education CAPES PhD Scholarship; Institutional Scientific Initiation Scholarship BIC FAMERP; Institutional Research Grant BAP-FAMERP; Sao Paulo Research Foundation FAPESP [2013/03269-0]; FAPESP [2009/17540-2]	Scientific Initiation Scholarship from the Brazilian Ministry of Science Technology and Inovation - PIBIC - CNPq (The National Council for Scientific and Technological Development); Brazilian Ministry of Education CAPES PhD Scholarship; Institutional Scientific Initiation Scholarship BIC FAMERP; Institutional Research Grant BAP-FAMERP; Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a Scientific Initiation Scholarship from the Brazilian Ministry of Science Technology and Inovation - PIBIC - CNPq (The National Council for Scientific and Technological Development) to MMLF; a Brazilian Ministry of Education CAPES PhD Scholarship to CCBM; an Institutional Scientific Initiation Scholarship BIC FAMERP to MMLF; an Institutional Research Grant BAP-FAMERP to LCM, DCMVO, and LCJFS; and Sao Paulo Research Foundation FAPESP #2013/03269-0 to CCBM and FAPESP #2009/17540-2 to LCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; [Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; Asilsoy S, 2008, J TROP PEDIATRICS, V54, P129, DOI 10.1093/tropej/fmm069; Avelino MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-33; Bortoletti Filho Joao, 2013, Interdiscip Perspect Infect Dis, V2013, P370769, DOI 10.1155/2013/370769; da Fonseca CRB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-255; de Mattos CDB, 2011, SAO PAULO MED J, V129, P261; Bichara CNC, 2012, REV SOC BRAS MED TRO, V45, P122, DOI 10.1590/S0037-86822012000100024; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Collantes-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032123; Nascimento LFC, 2014, REV BRAS GINECOL OBS, V36, P303, DOI 10.1590/SO100-720320140005012; De Carolis S, 2012, LUPUS, V21, P773, DOI 10.1177/0961203312447866; de Inagaki AD M, REV SOC BRAS MED TRO, V42, P532; de Jong EP, 2013, ARCH DIS CHILDHOOD-E, V98, P93, DOI 10.1136/archdischild-2012-303327; de Romanelli RM C, 2014, REV MED MINAS GERIAS, V24, P202; de Souza-e-Silva CH, 2013, PEDIATR INFECT DIS J, V32, P13, DOI 10.1097/INF.0b013e3182703460; de Toxoplasmose RB, 2010, SCI MED, P5; Deorari AK, 2000, J TROP PEDIATRICS, V46, P155, DOI 10.1093/tropej/46.3.155; Di Mario S, 2009, DATABASE SYST REV; Dias RCF, REV I MED TROPICAL S, V53, P185; Goncalves MAD, 2010, BRAZ J INFECT DIS, V14, P601, DOI 10.1590/S1413-86702010000600009; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Porto AMF, 2008, REV ASSOC MED BRAS, V54, P242, DOI 10.1590/S0104-42302008000300018; Ferezin RI, 2013, REV BRAS GINECOL OBS, V35, P66, DOI 10.1590/S0100-72032013000200005; Fernandez-Sabe N, 2012, CLIN INFECT DIS, V54, P355, DOI 10.1093/cid/cir806; Ferreira AIC, 2014, EPIDEMIOL INFECT, V142, P142, DOI 10.1017/S0950268813000526; Filisetti Denis, 2004, Ann Ist Super Sanita, V40, P71; Fricker-Hidalgo H, 2013, J CLIN MICROBIOL, V51, P2103, DOI 10.1128/JCM.00169-13; Furtado JM, 2012, REV OCULAR TOXOPLASM; Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002; GARCIA AGP, 1983, J TROP PEDIATRICS, V29, P95, DOI 10.1093/tropej/29.2.95; Gonzalez-Padilla M, 2013, INT J INFECT DIS, V17, pE681, DOI 10.1016/j.ijid.2013.01.021; Herrmann DC, 2014, INT J MED MICROBIOL, V304, P911, DOI 10.1016/j.ijmm.2014.06.008; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003012; House PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023277; Inacio P, 2007, TOXOPLASMOSE GESTANT, P57; Kiatchoosakun Pakaphan, 2012, Journal of the Medical Association of Thailand, V95, P52; Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15; Lima RRCM, 2011, ENS CIENC, V15, P53; Lopes AP, 2014, PARASITOLOGY, V141, P1699, DOI 10.1017/S0031182014001413; Machala L, 2013, INT J INFECT DIS, V17, pE892, DOI 10.1016/j.ijid.2013.03.017; Mandelbrot L., 2014, EMC GINECOLOGIA OBST, V50, P1; Martins LM, 2015, J IMMUNOL METHODS, V417, P97, DOI 10.1016/j.jim.2014.12.012; McLeod R., 2014, CURR PEDIAT REP, V2, P166; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; Moraes Maria Sílvia de, 2004, Rev. Bras. Saude Mater. Infant., V4, P375, DOI 10.1590/S1519-38292004000400006; Munoz-Zanzi CA, 2010, EMERG INFECT DIS, V16, P1591, DOI 10.3201/eid1610.091674; Mussi-Pinhata MM, 2012, CURR WOMENS HEALTH R, V8, P158, DOI 10.2174/157340412800194902; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Pardini L, 2014, PARASITOL INT, V63, P470, DOI 10.1016/j.parint.2013.10.011; Pessanha Tatiana Melino, 2011, Rev. paul. pediatr., V29, P341; Pinto FS, REV SOC BRASILEIRA M, V46, P196; Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141; Porto LC, 2012, INT J INFECT DIS, V16, pE480, DOI 10.1016/j.ijid.2012.01.016; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rodrigues ACF, 2011, J VENOM ANIM TOXINS, V17, P184, DOI 10.1590/S1678-91992011000200009; Rodrigues IMX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-349; Sagel U, 2013, J BACTERIOLOGY PARAS, V01; Said RN, 2011, J TROP PEDIATRICS, V57, P333, DOI 10.1093/tropej/fmq097; Segundo GRS, 2004, J TROP PEDIATRICS, V50, P50, DOI 10.1093/tropej/50.1.50; Silva LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090237; Stillwaggon E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001333; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Ursini T, 2013, INT J INFECT DIS, V17, pE280, DOI 10.1016/j.ijid.2012.11.031; Vaz S., 2011, FIELD ACTIONS SCI RE; Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032; Wallon M, 2014, PEDIATRICS, V133, pE601, DOI 10.1542/peds.2013-2153; Watts P, 2013, J AAPOS, V17, P70, DOI 10.1016/j.jaapos.2012.07.012	68	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132719	10.1371/journal.pone.0132719	http://dx.doi.org/10.1371/journal.pone.0132719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192182	Green Published, gold, Green Submitted			2022-12-27	WOS:000358546400035
J	Lench, AM; Robson, E; Jones, RSG				Lench, Alex M.; Robson, Emma; Jones, Roland S. G.			Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site	PLOS ONE			English	Article							PRESYNAPTIC NMDA; COGNITIVE IMPAIRMENT; GLUTAMATE RELEASE; ANTICONVULSANT ACTIVITY; SOMATOSENSORY CORTEX; ANTIEPILEPTIC DRUGS; SYNAPTIC INHIBITION; ALZHEIMERS-DISEASE; DECLARATIVE MEMORY; TONIC FACILITATION	Partial agonists at the NMDA receptor co-agonist binding site may have potential therapeutic efficacy in a number of cognitive and neurological conditions. The entorhinal cortex is a key brain area in spatial memory and cognitive processing. At synapses in the entorhinal cortex, NMDA receptors not only mediate postsynaptic excitation but are expressed in presynaptic terminals where they tonically facilitate glutamate release. In a previous study we showed that the co-agonist binding site of the presynaptic NMDA receptor is endogenously and tonically activated by D-serine released from astrocytes. In this study we determined the effects of two co-agonist site partial agonists on both presynaptic and postsynaptic NMDA receptors in layer II of the entorhinal cortex. The high efficacy partial agonist, D-cycloserine, decreased the decay time of postsynaptic NMDA receptor mediated currents evoked by electrical stimulation, but had no effect on amplitude or other kinetic parameters. In contrast, a lower efficacy partial agonist, 1-aminocyclobutane-1-carboxylic acid, decreased decay time to a greater extent than D-cycloserine, and also reduced the peak amplitude of the evoked NMDA receptor mediated postsynaptic responses. Presynaptic NMDA receptors, (monitored indirectly by effects on the frequency of AMPA receptor mediated spontaneous excitatory currents) were unaffected by D-cycloserine, but were reduced in effectiveness by 1-aminocyclobutane-1-carboxylic acid. We discuss these results in the context of the effect of endogenous regulation of the NMDA receptor co-agonist site on receptor gating and the potential therapeutic implications for cognitive disorders.	[Lench, Alex M.; Robson, Emma; Jones, Roland S. G.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Bath	Jones, RSG (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	r.s.g.jones@bath.ac.uk	Jones, Roland/K-1539-2016	Jones, Roland/0000-0002-3072-7505; Robson, Emma/0000-0001-5136-6158	Medical Research Council; Biological Sciences Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Medical Research Council provided a studentship and materials for Alex Lench. The Biotechnology and Biological Sciences Research Council Provided a studentship for Emma Robson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnaou A, 2014, NEUROPHARMACOLOGY, V86, P362, DOI 10.1016/j.neuropharm.2014.08.015; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bora E, 2015, PSYCHOL MED, V45, P1, DOI 10.1017/S0033291714001263; Bortolato B, 2014, CNS NEUROL DISORD-DR, V13, P1804; Brainin M, 2015, EUR J NEUROL, V22, P229, DOI 10.1111/ene.12626; Brasier DJ, 2008, J NEUROSCI, V28, P2199, DOI 10.1523/JNEUROSCI.3915-07.2008; Chamberlain SEL, 2008, NEURAL PLASTICITY; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Coutureau E, 2009, PROG NEURO-PSYCHOPH, V33, P753, DOI 10.1016/j.pnpbp.2009.03.038; Cunningham MO, 2006, J NEUROSCI, V26, P2767, DOI 10.1523/JNEUROSCI.5054-05.2006; De Sarro G, 2000, EPILEPSY RES, V40, P109, DOI 10.1016/S0920-1211(00)00113-3; Dravid SM, 2010, J NEUROSCI, V30, P2741, DOI 10.1523/JNEUROSCI.5390-09.2010; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Feld GB, 2013, NEUROPSYCHOPHARMACOL, V38, P2688, DOI 10.1038/npp.2013.179; FLOOD JF, 1992, EUR J PHARMACOL, V221, P249, DOI 10.1016/0014-2999(92)90709-D; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; GOFF DC, 1995, AM J PSYCHIAT, V152, P1213; Greenhill SD, 2010, NEUROSCIENCE, V167, P456, DOI 10.1016/j.neuroscience.2010.02.021; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hashimoto K, 2014, EXPERT OPIN THER TAR, V18, P1049, DOI 10.1517/14728222.2014.934225; Hashimoto K, 2013, EUR ARCH PSY CLIN N, V263, P367, DOI 10.1007/s00406-013-0399-y; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; JONES RSG, 1988, J NEUROPHYSIOL, V59, P1476, DOI 10.1152/jn.1988.59.5.1476; Jones RSG, 2005, J PHYSIOL-LONDON, V562, P107, DOI 10.1113/jphysiol.2004.076133; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Klatte K, 2013, J NEUROSCI, V33, P13066, DOI 10.1523/JNEUROSCI.5423-12.2013; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Le Bail M, 2015, P NATL ACAD SCI USA, V112, pE204, DOI 10.1073/pnas.1416668112; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; Lehrner J, 2015, INT PSYCHOGERIATR, V27, P357, DOI 10.1017/S1041610214002245; Lench AM, 2014, NEUROPHARMACOLOGY, V83, P118, DOI 10.1016/j.neuropharm.2014.04.004; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Li YH, 2007, J NEUROPHYSIOL, V97, P817, DOI 10.1152/jn.00980.2006; Menlove L, 2015, SEIZURE-EUR J EPILEP, V25, P126, DOI 10.1016/j.seizure.2014.10.002; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Moskal JR, 2014, EXPERT OPIN INV DRUG, V23, P243, DOI 10.1517/13543784.2014.852536; Myers KM, 2012, BIOL PSYCHIAT, V71, P947, DOI 10.1016/j.biopsych.2012.02.030; Nave AM, 2012, J CLIN PSYCHIAT, V73, P1179, DOI 10.4088/JCP.11m07564; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; Paganelli MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080953; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Parsons CG, 2013, NEUROTOX RES, V24, P358, DOI 10.1007/s12640-013-9398-z; Popescu GK, 2012, J PHYSIOL-LONDON, V590, P73, DOI 10.1113/jphysiol.2011.223750; PRIESTLEY T, 1994, MOL PHARMACOL, V46, P1191; QUARTERMAIN D, 1994, EUR J PHARMACOL, V257, P7, DOI 10.1016/0014-2999(94)90687-4; Rodrigues H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093519; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Schwartz TL, 2012, CURR PHARM DESIGN, V18, P1580, DOI 10.2174/138161212799958594; Sheinin A, 2001, NEUROPHARMACOLOGY, V41, P151, DOI 10.1016/S0028-3908(01)00073-9; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; vanBerckel BNM, 1996, BIOL PSYCHIAT, V40, P1298, DOI 10.1016/S0006-3223(96)00311-3; Vinther-Jensen T, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0114-8; Weickert CS, 2013, MOL PSYCHIATR, V18, P1185, DOI 10.1038/mp.2012.137; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Wlaz P, 2011, PHARMACOL REP, V63, P1231; Woodhall G, 2001, J NEUROPHYSIOL, V86, P1644, DOI 10.1152/jn.2001.86.4.1644; Woodhall GL, 2005, HIPPOCAMPUS, V15, P232, DOI 10.1002/hipo.20047; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006; Yang J, 2008, J PHYSIOL-LONDON, V586, P4905, DOI 10.1113/jphysiol.2008.157974	71	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133548	10.1371/journal.pone.0133548	http://dx.doi.org/10.1371/journal.pone.0133548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193112	Green Published, Green Submitted, gold			2022-12-27	WOS:000358546400101
